PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sahin, M; Sur, M				Sahin, Mustafa; Sur, Mriganka			Genes, circuits, and precision therapies for autism and related neurodevelopmental disorders	SCIENCE			English	Review							DOMAIN CRITERIA RDOC; WILD-TYPE MICROGLIA; FRAGILE-X-SYNDROME; MOUSE MODEL; RETT-SYNDROME; SPECTRUM DISORDERS; PROTEIN-SYNTHESIS; MUTANT MICE; SYNAPTIC PLASTICITY; CEREBELLAR INJURY	Research in the genetics of neurodevelopmental disorders such as autism suggests that several hundred genes are likely risk factors for these disorders. This heterogeneity presents a challenge and an opportunity at the same time. Although the exact identity of many of the genes remains to be discovered, genes identified to date encode proteins that play roles in certain conserved pathways: protein synthesis, transcriptional and epigenetic regulation, and synaptic signaling. The next generation of research in neurodevelopmental disorders must address the neural circuitry underlying the behavioral symptoms and comorbidities, the cell types playing critical roles in these circuits, and common intercellular signaling pathways that link diverse genes. Results from clinical trials have been mixed so far. Only when we can leverage the heterogeneity of neurodevelopmental disorders into precision medicine will the mechanism-based therapeutics for these disorders start to unlock success.	[Sahin, Mustafa] Boston Childrens Hosp, Dept Neurol, Translat Neurosci Ctr, FM Kirby Ctr Neurobiol, Boston, MA 02115 USA; [Sur, Mriganka] MIT, Dept Brain & Cognit Sci, Simons Ctr Social Brain, Picower Inst Learning & Memory, Cambridge, MA 02139 USA	Harvard University; Boston Children's Hospital; Massachusetts Institute of Technology (MIT); Northwell Health	Sahin, M (corresponding author), Boston Childrens Hosp, Dept Neurol, Translat Neurosci Ctr, FM Kirby Ctr Neurobiol, Boston, MA 02115 USA.	mustafa.sahin@childrens.harvard.edu; msur@mit.edu	SAHIN, MUSTAFA/I-8653-2019; Sala, Carlo/A-2493-2009	SAHIN, MUSTAFA/0000-0001-7044-2953; Sala, Carlo/0000-0003-0662-9523	NIH [MH085802, NS090473, EY007023, U01 NS082320, P20 NS080199, P30 HD018655]; NSF [EF1451125]; Simons Foundation Autism Research Initiative; Department of Defense [W81XWH-13-1-0040]; Tuberous Sclerosis Alliance; Autism Speaks; Nancy Lurie Marks Family Foundation; Simons Foundation; Boston Children's Hospital Translational Research Program; Novartis; Shire; NCATS; NIMH; National Institute of Neurological Disorders and Stroke; Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY007023, F32EY007023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P20NS080199, U54NS092090, U01NS082320, U01NS090473] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Simons Foundation Autism Research Initiative; Department of Defense(United States Department of Defense); Tuberous Sclerosis Alliance; Autism Speaks; Nancy Lurie Marks Family Foundation; Simons Foundation; Boston Children's Hospital Translational Research Program; Novartis(Novartis); Shire; NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Kleiman, A. Poduri, and K. Dies for critically reviewing the manuscript. Due to limited space, we have not quoted all literature in the field, and we apologize to those whose articles are not referenced. Research in M. Sur's laboratory is supported by NIH grants MH085802, NS090473, and EY007023; NSF grant EF1451125; and the Simons Foundation Autism Research Initiative. Research in M. Sahin's laboratory is supported by the NIH (U01 NS082320, P20 NS080199, and P30 HD018655), Department of Defense (W81XWH-13-1-0040), Tuberous Sclerosis Alliance, Autism Speaks, Nancy Lurie Marks Family Foundation, Simons Foundation, Boston Children's Hospital Translational Research Program, and Novartis and Shire. The Developmental Synaptopathies Consortium (U54NS092090) is a part of the National Center for Advancing Translational Sciences (NCATS) Rare Diseases Clinical Research Network (RDCRN). RDCRN is an initiative of the Office of Rare Diseases Research (ORDR), NCATS, funded through collaboration between NCATS, NIMH, the National Institute of Neurological Disorders and Stroke, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Akshoomoff N, 2004, J AM ACAD CHILD PSY, V43, P349, DOI 10.1097/00004583-200403000-00018; Allen G, 2003, AM J PSYCHIAT, V160, P262, DOI 10.1176/appi.ajp.160.2.262; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Asano E, 2001, NEUROLOGY, V57, P1269, DOI 10.1212/WNL.57.7.1269; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Bhattacharya A, 2012, NEURON, V76, P325, DOI 10.1016/j.neuron.2012.07.022; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Bozdagi O, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-9; Calfa G, 2015, HIPPOCAMPUS, V25, P159, DOI 10.1002/hipo.22360; Casanova MF, 2007, BRAIN PATHOL, V17, P422, DOI 10.1111/j.1750-3639.2007.00100.x; Casey BJ, 2014, BIOL PSYCHIAT, V76, P350, DOI 10.1016/j.biopsych.2014.01.006; Castro J, 2014, P NATL ACAD SCI USA, V111, P9941, DOI 10.1073/pnas.1311685111; Castro J, 2013, CURR OPIN NEUROL, V26, P154, DOI 10.1097/WCO.0b013e32835f19a7; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chen NY, 2012, P NATL ACAD SCI USA, V109, pE2832, DOI 10.1073/pnas.1206557109; COURCHESNE E, 1988, NEW ENGL J MED, V318, P1349, DOI 10.1056/NEJM198805263182102; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Durand S, 2012, NEURON, V76, P1078, DOI 10.1016/j.neuron.2012.12.004; Ebrahimi-Fakhari D, 2015, CURR OPIN NEUROL, V28, P91, DOI 10.1097/WCO.0000000000000186; Ehninger D, 2012, MOL PSYCHIATR, V17, P469, DOI 10.1038/mp.2011.39; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Fatemi SH, 2012, CEREBELLUM, V11, P777, DOI 10.1007/s12311-012-0355-9; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Gandal MJ, 2010, BIOL PSYCHIAT, V68, P1100, DOI 10.1016/j.biopsych.2010.09.031; Ganz M., 2006, UNDERSTANDING AUTISM, P475, DOI [10.1201/9781420004205.ch20, DOI 10.1201/1745691610383516]; Garay PA, 2013, BRAIN BEHAV IMMUN, V31, P54, DOI 10.1016/j.bbi.2012.07.008; Garay Paula A, 2010, Front Synaptic Neurosci, V2, P136, DOI 10.3389/fnsyn.2010.00136; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Geschwind DH, 2015, LANCET NEUROL, V14, P1109, DOI 10.1016/S1474-4422(15)00044-7; Gillberg C, 2014, J AUTISM DEV DISORD, V44, P3274, DOI 10.1007/s10803-014-2163-1; Goffin D, 2014, NAT NEUROSCI, V17, P804, DOI 10.1038/nn.3710; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Gross C, 2015, CELL REP, V11, P727, DOI 10.1016/j.celrep.2015.03.060; Gross C, 2015, CELL REP, V11, P681, DOI 10.1016/j.celrep.2015.03.065; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Haydon PG, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020438; Higashimori H, 2013, HUM MOL GENET, V22, P2041, DOI 10.1093/hmg/ddt055; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322; Kanner L, 1943, NERV CHILD, V2, P217; Kates WR, 2004, AM J PSYCHIAT, V161, P539, DOI 10.1176/appi.ajp.161.3.539; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Khwaja OS, 2014, P NATL ACAD SCI USA, V111, P4596, DOI 10.1073/pnas.1311141111; Kondo M, 2008, EUR J NEUROSCI, V27, P3342, DOI 10.1111/j.1460-9568.2008.06305.x; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Lawrence YA, 2010, ACTA NEUROL SCAND, V121, P99, DOI 10.1111/j.1600-0404.2009.01234.x; Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001; Limperopoulos C, 2007, PEDIATRICS, V120, P584, DOI 10.1542/peds.2007-1041; Limperopoulos C, 2010, PEDIATR RES, V68, P145, DOI 10.1203/00006450-201011001-00282; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Lipton JO, 2014, NEURON, V84, P275, DOI 10.1016/j.neuron.2014.09.034; Lord C., 2006, UNDERSTANDING AUTISM, P1, DOI DOI 10.1201/9781420004205.CH1; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; MEEHAN RR, 1992, NUCLEIC ACIDS RES, V20, P5085, DOI 10.1093/nar/20.19.5085; Mellios N, 2014, P NATL ACAD SCI USA, V111, P9947, DOI 10.1073/pnas.1309426111; Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Mulle JG, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-012-0337-0; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Peters JM, 2012, ACAD RADIOL, V19, P17, DOI 10.1016/j.acra.2011.08.016; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Qin M, 2013, J CEREBR BLOOD F MET, V33, P499, DOI 10.1038/jcbfm.2012.205; Reeb-Sutherland BC, 2015, J AUTISM DEV DISORD, V45, P376, DOI 10.1007/s10803-013-1905-9; Reith RM, 2013, NEUROBIOL DIS, V51, P93, DOI 10.1016/j.nbd.2012.10.014; Restivo L, 2005, P NATL ACAD SCI USA, V102, P11557, DOI 10.1073/pnas.0504984102; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rothwell PE, 2014, CELL, V158, P198, DOI 10.1016/j.cell.2014.04.045; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Schafer DP, 2013, GLIA, V61, P24, DOI 10.1002/glia.22389; Scharf SH, 2015, CURR OPIN PHARMACOL, V20, P124, DOI 10.1016/j.coph.2014.11.004; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Scott-Van Zeeland AA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001344; Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tian D, 2015, NAT NEUROSCI, V18, P182, DOI 10.1038/nn.3911; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Turner TN, 2015, NATURE, V520, P51, DOI 10.1038/nature14186; Udagawa T, 2013, NAT MED, V19, P1473, DOI 10.1038/nm.3353; Urdinguio RG, 2010, EPIGENETICS-US, V5, P656, DOI 10.4161/epi.5.7.13055; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Vivanti G, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00354; Vogt D, 2015, CELL REP, V11, P944, DOI 10.1016/j.celrep.2015.04.019; Wang JQ, 2015, NATURE, V521, pE1, DOI 10.1038/nature14444; Weir RK, 2015, BRAIN BEHAV IMMUN, V48, P139, DOI 10.1016/j.bbi.2015.03.009; Whitney ER, 2008, CEREBELLUM, V7, P406, DOI 10.1007/s12311-008-0043-y; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Wohr M, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.19; Wood L, 2009, J NEUROSCI, V29, P12440, DOI 10.1523/JNEUROSCI.3321-09.2009; Wu H, 2010, P NATL ACAD SCI USA, V107, P18161, DOI 10.1073/pnas.1005595107; Xavier AL, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0593; Yasui DH, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-3; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	118	162	164	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					890	+	aab3897	10.1126/science.aab3897	http://dx.doi.org/10.1126/science.aab3897			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW4IP	26472761	Green Accepted, Green Submitted			2022-12-28	WOS:000364955200035
J	Makkar, RR; Fontana, G; Jilaihawi, H; Chakravarty, T; Kofoed, KF; de Backer, O; Asch, FM; Ruiz, CE; Olsen, NT; Trento, A; Friedman, J; Berman, D; Cheng, W; Kashif, M; Jelnin, V; Kliger, CA; Guo, H; Pichard, AD; Weissman, NJ; Kapadia, S; Manasse, E; Bhatt, DL; Leon, MB; Sondergaard, L				Makkar, R. R.; Fontana, G.; Jilaihawi, H.; Chakravarty, T.; Kofoed, K. F.; de Backer, O.; Asch, F. M.; Ruiz, C. E.; Olsen, N. T.; Trento, A.; Friedman, J.; Berman, D.; Cheng, W.; Kashif, M.; Jelnin, V.; Kliger, C. A.; Guo, H.; Pichard, A. D.; Weissman, N. J.; Kapadia, S.; Manasse, E.; Bhatt, D. L.; Leon, M. B.; Sondergaard, L.			Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EUROPEAN ASSOCIATION; TRANSCATHETER; REPLACEMENT; RECOMMENDATIONS; STENOSIS; ECHOCARDIOGRAPHY; IMPLANTATION; RISK	BACKGROUND A finding of reduced aortic-valve leaflet motion was noted on computed tomography (CT) in a patient who had a stroke after transcatheter aortic-valve replacement (TAVR) during an ongoing clinical trial. This finding raised a concern about possible subclinical leaflet thrombosis and prompted further investigation. METHODS We analyzed data obtained from 55 patients in a clinical trial of TAVR and from two single-center registries that included 132 patients who were undergoing either TAVR or surgical aortic-valve bioprosthesis implantation. We obtained four-dimensional, volume-rendered CT scans along with data on anticoagulation and clinical outcomes (including strokes and transient ischemic attacks [TIAs]). RESULTS Reduced leaflet motion was noted on CT in 22 of 55 patients (40%) in the clinical trial and in 17 of 132 patients (13%) in the two registries. Reduced leaflet motion was detected among patients with multiple bioprosthesis types, including transcatheter and surgical bioprostheses. Therapeutic anticoagulation with warfarin, as compared with dual antiplatelet therapy, was associated with a decreased incidence of reduced leaflet motion (0% and 55%, respectively, P = 0.01 in the clinical trial; and 0% and 29%, respectively, P = 0.04 in the pooled registries). In patients who were reevaluated with follow-up CT, restoration of leaflet motion was noted in all 11 patients who were receiving anticoagulation and in 1 of 10 patients who were not receiving anticoagulation (P<0.001). There was no significant difference in the incidence of stroke or TIA between patients with reduced leaflet motion and those with normal leaflet motion in the clinical trial (2 of 22 patients and 0 of 33 patients, respectively; P = 0.16), although in the pooled registries, a significant difference was detected (3 of 17 patients and 1 of 115 patients, respectively; P = 0.007). CONCLUSIONS Reduced aortic-valve leaflet motion was shown in patients with bioprosthetic aortic valves. The condition resolved with therapeutic anticoagulation. The effect of this finding on clinical outcomes including stroke needs further investigation. (Funded by St. Jude Medical and Cedars-Sinai Heart Institute; Portico-IDE ClinicalTrials.gov number, NCT02000115; SAVORY registry, NCT02426307; and RESOLVE registry, NCT02318342.)	[Makkar, R. R.; Jilaihawi, H.; Chakravarty, T.; Trento, A.; Friedman, J.; Berman, D.; Cheng, W.; Kashif, M.] Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA; [Fontana, G.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Kofoed, K. F.; de Backer, O.; Olsen, N. T.; Sondergaard, L.] Univ Copenhagen, Rigshosp, DK-2100 Copenhagen, Denmark; [Asch, F. M.; Pichard, A. D.; Weissman, N. J.] MedStar Hlth Res Inst, Washington, DC USA; [Ruiz, C. E.; Jelnin, V.] Hackensack Univ, Med Ctr, Hackensack, NJ USA; [Ruiz, C. E.; Jelnin, V.] Joseph M Sanzari Childrens Hosp, Hackensack, NJ USA; [Kliger, C. A.] Lenox Hill Heart & Vasc Inst New York, New York, NY USA; [Leon, M. B.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA; [Guo, H.; Manasse, E.] St Jude Med, Plymouth, MN USA; [Kapadia, S.] Cleveland Clin, Cleveland, OH 44106 USA; [Bhatt, D. L.] Brigham & Womens Hosp, Heart & Vasc Ctr, Boston, MA 02115 USA; [Bhatt, D. L.] Harvard Univ, Sch Med, Boston, MA USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Rigshospitalet; University of Copenhagen; MedStar Health Research Institute; Hackensack University Medical Center; Lenox Hill Heart & Vascular Institute of New York; Columbia University; NewYork-Presbyterian Hospital; St. Jude Medical; Cleveland Clinic Foundation; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Makkar, RR (corresponding author), Cedars Sinai Heart Inst, Dept Intervent Cardiol, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	makkarr@cshs.org	Doğan, Ali/AAN-5331-2020; Asch, Federico/AAS-7653-2021; De Backer, Ole/AAQ-2369-2020	Asch, Federico/0000-0002-1744-5271; De Backer, Ole/0000-0002-9674-0278; Olsen, Niels Thue/0000-0003-1466-5225; Kofoed, Klaus Fuglsang/0000-0001-9742-1554	St. Jude Medical; Cedars-Sinai Heart Institute	St. Jude Medical(St. Jude Medical); Cedars-Sinai Heart Institute	Funded by St. Jude Medical and Cedars-Sinai Heart Institute; Portico-IDE Clinical-Trials.gov number, NCT02000115; SAVORY registry, NCT02426307; and RESOLVE registry, NCT02318342.	Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; Baumgartner H, 2009, J AM SOC ECHOCARDIOG, V22, P1, DOI 10.1016/j.echo.2008.11.029; De Backer O, 2015, EUR HEART J; De Marchena E, 2015, JACC-CARDIOVASC INTE, V8, P728, DOI 10.1016/j.jcin.2015.03.005; Kapadia SR, 2015, LANCET, V385, P2485, DOI 10.1016/S0140-6736(15)60290-2; Lancellotti P, 2010, EUR J ECHOCARDIOGR, V11, P307, DOI 10.1093/ejechocard/jeq031; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Latib A, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.001779; Leetmaa T, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.001596; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Mack MJ, 2015, LANCET, V385, P2477, DOI 10.1016/S0140-6736(15)60308-7; Pache G, 2013, EUR HEART J, V34, DOI 10.1093/eurheartj/eht316; Popma JJ, 2014, J AM COLL CARDIOL, V63, P1972, DOI 10.1016/j.jacc.2014.02.556; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Trepels T, 2009, CIRCULATION, V120, pE23, DOI 10.1161/CIRCULATIONAHA.109.864892; Zoghbi WA, 2009, J AM SOC ECHOCARDIOG, V22, P975, DOI 10.1016/j.echo.2009.07.013	16	682	695	1	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2015	373	21					2015	2024		10.1056/NEJMoa1509233	http://dx.doi.org/10.1056/NEJMoa1509233			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW4JN	26436963	Bronze			2022-12-28	WOS:000364957700007
J	Bassler, D; Plavka, R; Shinwell, ES; Hallman, M; Jarreau, PH; Carnielli, V; Van den Anker, JN; Meisner, C; Engel, C; Schwab, M; Halliday, HL; Poets, CF				Bassler, Dirk; Plavka, Richard; Shinwell, Eric S.; Hallman, Mikko; Jarreau, Pierre-Henri; Carnielli, Virgilio; Van den Anker, Johannes N.; Meisner, Christoph; Engel, Corinna; Schwab, Matthias; Halliday, Henry L.; Poets, Christian F.		NEUROSIS Trial Grp	Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BIRTH-WEIGHT INFANTS; PRETERM INFANTS; OXYGEN-SATURATION; INFLAMMATION; INSIGHTS; OUTCOMES; INJURY; TRIAL	BACKGROUND Systemic glucocorticoids reduce the incidence of bronchopulmonary dysplasia among extremely preterm infants, but they may compromise brain development. The effects of inhaled glucocorticoids on outcomes in these infants are unclear. METHODS We randomly assigned 863 infants (gestational age, 23 weeks 0 days to 27 weeks 6 days) to early (within 24 hours after birth) inhaled budesonide or placebo until they no longer required oxygen and positive-pressure support or until they reached a postmenstrual age of 32 weeks 0 days. The primary outcome was death or bronchopulmonary dysplasia, confirmed by means of standardized oxygen-saturation monitoring, at a postmenstrual age of 36 weeks. RESULTS A total of 175 of 437 infants assigned to budesonide for whom adequate data were available (40.0%), as compared with 194 of 419 infants assigned to placebo for whom adequate data were available (46.3%), died or had bronchopulmonary dysplasia (relative risk, stratified according to gestational age, 0.86; 95% confidence interval [CI], 0.75 to 1.00; P = 0.05). The incidence of bronchopulmonary dysplasia was 27.8% in the budesonide group versus 38.0% in the placebo group (relative risk, stratified according to gestational age, 0.74; 95% CI, 0.60 to 0.91; P = 0.004); death occurred in 16.9% and 13.6% of the patients, respectively (relative risk, stratified according to gestational age, 1.24; 95% CI, 0.91 to 1.69; P = 0.17). The proportion of infants who required surgical closure of a patent ductus arteriosus was lower in the budesonide group than in the placebo group (relative risk, stratified according to gestational age, 0.55; 95% CI, 0.36 to 0.83; P = 0.004), as was the proportion of infants who required reintubation (relative risk, stratified according to gestational age, 0.58; 95% CI, 0.35 to 0.96; P = 0.03). Rates of other neonatal illnesses and adverse events were similar in the two groups. CONCLUSIONS Among extremely preterm infants, the incidence of bronchopulmonary dysplasia was lower among those who received early inhaled budesonide than among those who received placebo, but the advantage may have been gained at the expense of increased mortality.	[Bassler, Dirk] Univ Zurich, Univ Zurich Hosp, Dept Neonatol, CH-8091 Zurich, Switzerland; [Van den Anker, Johannes N.] Univ Childrens Hosp, Dept Pediat Pharmacol, Basel, Switzerland; [Bassler, Dirk; Poets, Christian F.] Univ Childrens Hosp Tubingen, Dept Neonatol, Tubingen, Germany; [Engel, Corinna] Univ Childrens Hosp Tubingen, Ctr Pediat Clin Studies, Tubingen, Germany; [Meisner, Christoph] Univ Tubingen Hosp, Inst Clin Epidemiol & Appl Biometry, Tubingen, Germany; [Meisner, Christoph] Univ Tubingen Hosp, Inst Clin Epidemiol & Appl Biometry, Tubingen, Germany; [Schwab, Matthias] Univ Tubingen Hosp, Dept Clin Pharmacol, Tubingen, Germany; [Schwab, Matthias] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Plavka, Richard] Charles Univ Prague, Gen Univ Hosp, Prague, Czech Republic; [Plavka, Richard] Fac Med 1, Prague, Czech Republic; [Shinwell, Eric S.] Bar Ilan Univ, Ziv Med Ctr, Ramat Gan, Israel; [Hallman, Mikko] Oulu Univ Hosp, Dept Pediat, Oulu, Finland; [Hallman, Mikko] Univ Oulu, Oulu, Finland; [Jarreau, Pierre-Henri] Univ Paris 05, Hop Cochin, AP HP, Dept Hosp Univ,Serv Med & Reanim Neonatales Port, Paris, France; [Carnielli, Virgilio] Polytech Univ Marche, Salesi Childrens Hosp, Ancona, Italy; [Van den Anker, Johannes N.] Childrens Natl Med Ctr, Div Pediat Clin Pharmacol, Washington, DC 20010 USA; [Van den Anker, Johannes N.] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Intens Care, Rotterdam, Netherlands; [Van den Anker, Johannes N.] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Pediat Surg, Rotterdam, Netherlands; [Halliday, Henry L.] Queens Univ Belfast, Dept Child Hlth, Inst Clin Sci, Belfast BT7 1NN, Antrim, North Ireland	University of Zurich; University Zurich Hospital; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Charles University Prague; General University Hospital Prague; Charles University Prague; Bar Ilan University; Ziv Medical Center; University of Oulu; University of Oulu; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Marche Polytechnic University; Children's National Health System; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Queens University Belfast	Bassler, D (corresponding author), Univ Zurich, Univ Zurich Hosp, Dept Neonatol, Frauenklinikstr 10, CH-8091 Zurich, Switzerland.	dirk.bassler@usz.ch	Hallman, Niilo/AHD-9810-2022; Schwab, Matthias/ABH-7449-2020; nobile, stefano/G-9775-2017; Metsvaht, Tuuli/H-6897-2015; Plavka, Richard/K-2222-2017	nobile, stefano/0000-0002-5304-1485; Metsvaht, Tuuli/0000-0003-3206-3092; Hallman, Mikko/0000-0002-8172-729X; Yaari, Maya/0000-0002-0052-7094; Plavka, Richard/0000-0003-2579-2393; Bassler, Dirk/0000-0003-2358-4419; Halliday, Henry/0000-0001-7978-4992	European Union; Chiesi Farmaceutici; ClinicalTrials.gov [NCT01035190]	European Union(European Commission); Chiesi Farmaceutici(Chiesi Pharmaceuticals Inc); ClinicalTrials.gov	Funded by the European Union and Chiesi Farmaceutici; ClinicalTrials.gov number, NCT01035190.	Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Bassler D, 2010, NEONATOLOGY, V97, P52, DOI 10.1159/000227294; Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; Cole C H, 2001, Semin Neonatol, V6, P343, DOI 10.1053/siny.2001.0069; Contreras M, 1996, CRIT CARE MED, V24, P29, DOI 10.1097/00003246-199601000-00008; Doyle LW, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001146.pub4; Doyle LW, 2006, PEDIATR PULM, V41, P570, DOI 10.1002/ppul.20412; Elliott AC, 2011, COMPUT METH PROG BIO, V102, P75, DOI 10.1016/j.cmpb.2010.11.002; Fok TF, 1999, ARCH DIS CHILD-FETAL, V80, pF203, DOI 10.1136/fn.80.3.F203; Fok TF, 1996, PEDIATR PULM, V21, P301, DOI 10.1002/(SICI)1099-0496(199605)21:5<301::AID-PPUL5>3.0.CO;2-P; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Gortner L, 2011, NEONATOLOGY, V99, P112, DOI 10.1159/000313024; Halliday HL, 2001, PEDIATRICS, V107, P232, DOI 10.1542/peds.107.2.232; Jobe AH, 2012, EARLY HUM DEV, V88, pS27, DOI 10.1016/S0378-3782(12)70009-9; Kallopur SG, 2006, ARCH DIS CHILD-FETAL, V91, pF132, DOI 10.1136/adc.2004.068544; Kugelman A, 2007, PEDIATRICS, V120, pE788, DOI 10.1542/peds.2006-3765; Mazela J, 2011, EUR J PEDIATR, V170, P433, DOI 10.1007/s00431-010-1292-6; PINTOMARTIN JA, 1995, PEDIATRICS, V95, P249; Schmidt B, 2006, NEW ENGL J MED, V354, P2112, DOI 10.1056/NEJMoa054065; Schmidt B, 2003, JAMA-J AM MED ASSOC, V289, P1124, DOI 10.1001/jama.289.9.1124; Shah VS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001969.pub3; Speer CP, 2001, BIOL NEONATE, V79, P205; Stenson BJ, 2013, NEW ENGL J MED, V368, P2094, DOI 10.1056/NEJMoa1302298; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Vom Hove M, 2014, J PEDIAT, V164; Walsh Michele C, 2003, J Perinatol, V23, P451, DOI 10.1038/sj.jp.7210963; Wright CJ, 2011, PEDIATRICS, V128, P111, DOI 10.1542/peds.2010-3875; Yong WSC, 1999, ARCH DIS CHILD, V80, pG64	28	147	167	1	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2015	373	16					1497	1506		10.1056/NEJMoa1501917	http://dx.doi.org/10.1056/NEJMoa1501917			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5VX	26465983	Green Accepted, Green Published			2022-12-28	WOS:000362880300006
J	Mandelli, D; Tosatti, E				Mandelli, Davide; Tosatti, Erio			NANOPHYSICS Microscopic friction emulators	NATURE			English	Editorial Material							FRENKEL-KONTOROVA MODEL		[Mandelli, Davide; Tosatti, Erio] Int Sch Adv Studies SISSA, I-34136 Trieste, Italy; [Tosatti, Erio] Abdus Salam Int Ctr Theoret Phys, Trieste, Italy; [Tosatti, Erio] CNR, Democritos Natl Lab, Ist Officina Mat, Trieste, Italy	International School for Advanced Studies (SISSA); Abdus Salam International Centre for Theoretical Physics (ICTP); Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR)	Mandelli, D (corresponding author), Int Sch Adv Studies SISSA, I-34136 Trieste, Italy.	davide.mandelli@sissa.it; tosatti@sissa.it	Mandelli, Davide/M-8923-2019	Mandelli, Davide/0000-0002-6869-9511				ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; AUBRY S, 1983, PHYSICA D, V8, P381, DOI 10.1016/0167-2789(83)90233-6; Benassi A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1230; Braun O. M., 1998, FRENKEL KONTOROVA MO; Bylinskii A, 2015, SCIENCE, V348, P1115, DOI 10.1126/science.1261422; Gangloff D., 2015, NATURE PHYS; Garcia-Mata I, 2007, EUR PHYS J D, V41, P325, DOI 10.1140/epjd/e2006-00220-2; Krylov SY, 2014, PHYS STATUS SOLIDI B, V251, P711, DOI 10.1002/pssb.201350154; Muser MH, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.125419; Pruttivarasin T, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/7/075012; Sang Y, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.174301; SHARMA SR, 1984, PHYS REV B, V29, P6335, DOI 10.1103/PhysRevB.29.6335; Vanossi A, 2013, REV MOD PHYS, V85, P529, DOI 10.1103/RevModPhys.85.529	13	6	6	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					332	333		10.1038/526332a	http://dx.doi.org/10.1038/526332a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT3TQ	26469041	Green Submitted			2022-12-28	WOS:000362730200033
J	Imazio, M; Gaita, F; LeWinter, M				Imazio, Massimo; Gaita, Fiorenzo; LeWinter, Martin			Evaluation and Treatment of Pericarditis A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							POSTOPERATIVE ATRIAL-FIBRILLATION; RECURRENT PERICARDITIS; POSTPERICARDIOTOMY-SYNDROME; TUBERCULOUS PERICARDITIS; ADENOSINE-DEAMINASE; ETIOLOGIC DIAGNOSIS; MAGNETIC-RESONANCE; RANDOMIZED-TRIAL; SYNDROME COPPS; DOUBLE-BLIND	IMPORTANCE Pericarditis is the most common form of pericardial disease and a relatively common cause of chest pain. OBJECTIVE To summarize published evidence on the causes, diagnosis, therapy, prevention, and prognosis of pericarditis. EVIDENCE REVIEW A literature search of BioMedCentral, Google Scholar, MEDLINE, Scopus, and the Cochrane Database of Systematic Reviews was performed for human studies without language restriction from January 1, 1990, to August 31, 2015. After literature review and selection of meta-analyses, randomized clinical trials, and large observational studies, 30 studies (5 meta-analyses, 10 randomized clinical trials, and 16 cohort studies) with 7569 adult patients were selected for inclusion. FINDINGS The etiology of pericarditis may be infectious (eg, viral and bacterial) or noninfectious (eg, systemic inflammatory diseases, cancer, and post-cardiac injury syndromes). Tuberculosis is a major cause of pericarditis in developing countries but accounts for less than 5% of cases in developed countries, where idiopathic, presumed viral causes are responsible for 80% to 90% of cases. The diagnosis is based on clinical criteria including chest pain, a pericardial rub, electrocardiographic changes, and pericardial effusion. Certain features at presentation (temperature >38 degrees C [>100.4 degrees F], subacute course, large effusion or tamponade, and failure of nonsteroidal anti-inflammatory drug [NSAID] treatment) indicate a poorer prognosis and identify patients requiring hospital admission. The most common treatment for idiopathic and viral pericarditis in North America and Europe is NSAID therapy. Adjunctive colchicine can ameliorate the initial episode and is associated with approximately 50% lower recurrence rates. Corticosteroids are a second-line therapy for those who do not respond, are intolerant, or have contraindications to NSAIDs and colchicine. Recurrences may occur in 30% of patients without preventive therapy. CONCLUSIONS AND RELEVANCE Pericarditis is the most common form of pericardial disease worldwide and may recur in as many as one-third of patients who present with idiopathic or viral pericarditis. Appropriate triage and treatment with NSAIDs may reduce readmission rates for pericarditis. Treatment with colchicine can reduce recurrence rates.	[Imazio, Massimo] Univ Turin, Maria Vittoria Hosp, Dept Cardiol, I-10141 Turin, Italy; [Imazio, Massimo] Univ Turin, Dept Publ Hlth & Pediat, I-10141 Turin, Italy; [Gaita, Fiorenzo] Univ Turin, Univ Div Cardiol, Dept Med Sci Citta Salute & Sci, I-10141 Turin, Italy; [LeWinter, Martin] Univ Vermont, Cardiol Unit, Coll Med, Burlington, VT 05405 USA; [LeWinter, Martin] Univ Vermont, Med Ctr, Burlington, VT 05405 USA	Maria Vittoria Hospital; University of Turin; University of Turin; University of Turin; University of Vermont; University of Vermont; University of Vermont Medical Center	Imazio, M (corresponding author), Univ Turin, Maria Vittoria Hosp, Dept Cardiol, Via Luigi Cibrario 72, I-10141 Turin, Italy.	massimo_imazio@yahoo.it		Gaita, Fiorenzo/0000-0003-3178-6205; Imazio, Massimo/0000-0002-5722-0245				Adler Y, 2015, EUR HEART J, V36, P2921, DOI 10.1093/eurheartj/ehv318; Alabed S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010652.pub2; Alraies MC, 2015, AM J CARDIOL, V115, P542, DOI 10.1016/j.amjcard.2014.11.041; Ben-Horin S, 2007, AM J CARDIOL, V99, P1294, DOI 10.1016/j.amjcard.2006.12.048; Briasoulis A, 2015, J CARDIOVASC MED, V16, P144, DOI 10.2459/JCM.0000000000000237; Buiatti A, 2013, J CARDIOVASC MED, V14, P235, DOI 10.2459/JCM.0b013e328351da6e; Cosyns B, 2015, EUR HEART J-CARD IMG, V16, P12, DOI 10.1093/ehjci/jeu128; FOWLER NO, 1986, J AM COLL CARDIOL, V7, P300, DOI 10.1016/S0735-1097(86)80495-8; Gouriet F, 2015, AM J MED, V128, DOI 10.1016/j.amjmed.2015.01.040; HORNEFFER PJ, 1990, J THORAC CARDIOV SUR, V100, P292; Imazio M, 2008, HEART, V94, P498, DOI 10.1136/hrt.2006.104067; Imazio M, 2005, CIRCULATION, V112, P2012, DOI 10.1161/CIRCULATIONAHA.105.542738; Imazio M, 2005, ARCH INTERN MED, V165, P1987, DOI 10.1001/archinte.165.17.1987; Imazio M, 2004, AM J CARDIOL, V94, P973, DOI 10.1016/j.amjcard.2004.06.046; Imazio M, 2008, CIRCULATION, V118, P667, DOI 10.1161/CIRCULATIONAHA.107.761064; Imazio M, 2007, AM J CARDIOL, V100, P1026, DOI 10.1016/j.amjcard.2007.04.047; Imazio M, 2007, CIRCULATION, V115, P2739, DOI 10.1161/CIRCULATIONAHA.106.662114; Imazio M, 2016, J CARDIOVASC MED, V17, P263, DOI 10.2459/JCM.0000000000000260; Imazio M, 2014, J CARDIOVASC MED, V15, P840, DOI 10.2459/JCM.0000000000000103; Imazio M, 2014, J CARDIOVASC MED, V15, P835, DOI 10.2459/JCM.0000000000000082; Imazio M, 2014, JAMA-J AM MED ASSOC, V312, P1016, DOI 10.1001/jama.2014.11026; Imazio M, 2014, LANCET, V383, P2232, DOI 10.1016/S0140-6736(13)62709-9; Imazio M, 2013, NEW ENGL J MED, V369, P1522, DOI 10.1056/NEJMoa1208536; Imazio M, 2013, INT J CARDIOL, V168, P648, DOI 10.1016/j.ijcard.2012.09.052; Imazio M, 2013, CIRCULATION, V128, P42, DOI 10.1161/CIRCULATIONAHA.113.001531; Imazio M, 2013, EXPERT REV CARDIOVAS, V11, P193, DOI [10.1586/erc.12.184, 10.1586/ERC.12.184]; Imazio M, 2012, WOMENS HEALTH, V8, P341, DOI [10.2217/whe.12.9, 10.2217/WHE.12.9]; Imazio M, 2011, CIRCULATION, V124, P2290, DOI 10.1161/CIRCULATIONAHA.111.026153; Imazio M, 2011, ANN INTERN MED, V155, P409, DOI 10.7326/0003-4819-155-7-201110040-00359; Imazio M, 2011, CIRCULATION, V124, P1270, DOI 10.1161/CIRCULATIONAHA.111.018580; Imazio M, 2010, EUR HEART J, V31, P2749, DOI 10.1093/eurheartj/ehq319; Imazio M, 2010, J CARDIOVASC MED, V11, P557, DOI 10.2459/JCM.0b013e3283352356; Imazio M, 2010, CIRCULATION, V121, P916, DOI 10.1161/CIRCULATIONAHA.108.844753; Imazio M, 2009, J CARDIOVASC MED, V10, P217, DOI 10.2459/JCM.0b013e328322f9b1; Karatolios K, 2013, HEART FAIL REV, V18, P337, DOI 10.1007/s10741-012-9327-x; Khandaker MH, 2012, MAYO CLIN PROC, V87, P1062, DOI 10.1016/j.mayocp.2012.05.024; Klein AL, 2013, J AM SOC ECHOCARDIOG, V26, P965, DOI 10.1016/j.echo.2013.06.023; Kyto V, 2014, CIRCULATION, V130, P1601, DOI 10.1161/CIRCULATIONAHA.114.010376; Lazaros G, J CARDIOVASC MED, DOI 10.2459/JCM.0000000000000266; Lazaros G, 2014, ANN RHEUM DIS, V73, P2215, DOI 10.1136/annrheumdis-2014-205990; LeWinter MM, 2014, NEW ENGL J MED, V371, P2410, DOI 10.1056/NEJMcp1404070; Lotrionte M, 2010, AM HEART J, V160, P662, DOI 10.1016/j.ahj.2010.06.015; Maisch B, 2004, EUR HEART J, V25, P587, DOI 10.1016/j.ehj.2004.02.002; Mayosi BM, 2014, NEW ENGL J MED, V371, P1121, DOI 10.1056/NEJMoa1407380; Mayosi BM, 2007, HEART, V93, P1176, DOI 10.1136/hrt.2007.127746; Moretti M, 2013, AM J CARDIOL, V112, P1493, DOI 10.1016/j.amjcard.2013.06.036; Pandie S, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-101; Pawlak Cieslik A, 2012, KARDIOL POL, V70, P1147; PERMANYERMIRALDA G, 1985, AM J CARDIOL, V56, P623, DOI 10.1016/0002-9149(85)91023-9; Raatikka M, 2003, J AM COLL CARDIOL, V42, P759, DOI 10.1016/S0735-1097(03)00778-2; Reuter H, 2006, QJM-INT J MED, V99, P827, DOI 10.1093/qjmed/hcl123; Reuter Helmuth, 2005, Cardiovasc J S Afr, V16, P143; Shakti D, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001483; Tuon FF, 2006, ACTA TROP, V99, P67, DOI 10.1016/j.actatropica.2006.07.004; Vianello F, 2011, INT J CARDIOL, V147, P477, DOI 10.1016/j.ijcard.2011.01.027; ZAYAS R, 1995, AM J CARDIOL, V75, P378, DOI 10.1016/S0002-9149(99)80558-X	56	199	202	1	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2015	314	14					1498	1506		10.1001/jama.2015.12763	http://dx.doi.org/10.1001/jama.2015.12763			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2QI	26461998	Green Published			2022-12-28	WOS:000362647800017
J	Carter, M				Carter, Meg			COMMERCIALISING PUBLIC HEALTH Backlash against "pinkwashing" of breast cancer awareness campaigns	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												meg@megcarter.com						Briggs B., 2014, NBC NEWS; Potts J., 2015, TELEGRAPH; Rothberg P., 2012, NATION; Smith SE, 2012, GUARDIAN	4	5	5	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 12	2015	351								h5399	10.1136/bmj.h5399	http://dx.doi.org/10.1136/bmj.h5399			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT8XR	26459305				2022-12-28	WOS:000363100700003
J	Paddison, JAM; Jacobsen, H; Petrenko, OA; Fernandez-Diaz, MT; Deen, PP; Goodwin, AL				Paddison, Joseph A. M.; Jacobsen, Henrik; Petrenko, Oleg A.; Fernandez-Diaz, Maria Teresa; Deen, Pascale P.; Goodwin, Andrew L.			Hidden order in spin-liquid Gd3Ga5O12	SCIENCE			English	Article							MONTE-CARLO-SIMULATION; RANGE ORDER; MAGNET	Frustrated magnetic materials are promising candidates for new states of matter because lattice geometry suppresses conventional magnetic dipole order, potentially allowing "hidden" order to emerge in its place. Amodel of a hidden-order state at the atomic scale is difficult to deduce because microscopic probes are not directly sensitive to hidden order. Here, we develop such a model of the spin-liquid state in the canonical frustrated magnet gadolinium gallium garnet (Gd3Ga5O12). We show that this state exhibits a long-range hidden order in which multipoles are formed from 10-spin loops. The order is a consequence of the interplay between antiferromagnetic spin correlations and local magnetic anisotropy, which allows it to be indirectly observed in neutron-scattering experiments.	[Paddison, Joseph A. M.; Goodwin, Andrew L.] Univ Oxford, Dept Chem, Inorgan Chem Lab, Oxford OX1 3QR, England; [Paddison, Joseph A. M.] Rutherford Appleton Lab, ISIS Facil, Didcot OX11 0QX, Oxon, England; [Paddison, Joseph A. M.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Jacobsen, Henrik; Deen, Pascale P.] Univ Copenhagen, Niels Bohr Inst, Nanosci Ctr, DK-2100 Copenhagen O, Denmark; [Jacobsen, Henrik; Deen, Pascale P.] European Spallat Source, Lund, Sweden; [Petrenko, Oleg A.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Fernandez-Diaz, Maria Teresa] Inst Max von Laue Paul Langevin, F-38042 Grenoble 9, France	University of Oxford; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University System of Georgia; Georgia Institute of Technology; University of Copenhagen; Niels Bohr Institute; European Spallation Source (ESS); University of Warwick; Institut Laue-Langevin (ILL)	Deen, PP (corresponding author), Univ Copenhagen, Niels Bohr Inst, Nanosci Ctr, DK-2100 Copenhagen O, Denmark.	pascale.deen@esss.se; andrew.goodwin@chem.ox.ac.uk	Petrenko, Oleg/AAN-5286-2021; Petrenko, Oleg/E-2717-2013; Goodwin, Andrew/A-5256-2016; Jacobsen, Henrik/B-6500-2015; Deen, Pascale/C-6557-2015	Petrenko, Oleg/0000-0003-1529-303X; Petrenko, Oleg/0000-0003-1529-303X; Goodwin, Andrew/0000-0001-9231-3749; Jacobsen, Henrik/0000-0001-6950-3990; Paddison, Joseph/0000-0002-2274-0988; Deen, Pascale/0000-0002-0204-0802	Danish Research Council for Nature and Universe through DANSCATT; STFC; EPSRC [EP/G004528/2]; ERC [279705]; Engineering and Physical Sciences Research Council [1112242, EP/G004528/2] Funding Source: researchfish	Danish Research Council for Nature and Universe through DANSCATT; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ERC(European Research Council (ERC)European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank S. A. Hall, M. E. Zhitomirsky, N. d'Ambrumenil, J. R. Stewart, M. J. P. Gingras, T. Yavors'kii, S. E. Dutton, M. Mourigal, M. Evans, W. J. K. Fletcher, and M. J. Cliffe for useful discussions; O. Young and S. Holm for assistance with the early experimental work; and the staff at the Institut Max von Laue-Paul Langevin for experimental support. P.P.D. and H.J. gratefully acknowledge financial support from the Danish Research Council for Nature and Universe through DANSCATT. J. A. M. P. and A.L.G. gratefully acknowledge financial support from the STFC, EPSRC (EP/G004528/2), and ERC (279705). The experimental data collected in this study are available as supplementary materials.	Bonville P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.167202; Chakravarty S, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.094503; CHALKER JT, 1992, PHYS REV LETT, V68, P855, DOI 10.1103/PhysRevLett.68.855; CHANDRA P, 1991, PHYS REV LETT, V66, P100, DOI 10.1103/PhysRevLett.66.100; d'Ambrumenil N, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.227203; Deen PP, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.174408; Dunsiger SR, 2000, PHYS REV LETT, V85, P3504, DOI 10.1103/PhysRevLett.85.3504; Ghosh S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.157205; Ikeda H, 2012, NAT PHYS, V8, P528, DOI [10.1038/NPHYS2330, 10.1038/nphys2330]; KINNEY WI, 1979, J APPL PHYS, V50, P2115, DOI 10.1063/1.326954; Lee SH, 2002, NATURE, V418, P856, DOI 10.1038/nature00964; Machida Y, 2010, NATURE, V463, P210, DOI 10.1038/nature08680; Marshall IM, 2002, J PHYS-CONDENS MAT, V14, pL157, DOI 10.1088/0953-8984/14/6/104; McGreevy RL, 1988, MOL SIMULAT, V1, P359, DOI 10.1080/08927028808080958; Melko RG, 2004, J PHYS-CONDENS MAT, V16, pR1277, DOI 10.1088/0953-8984/16/43/R02; Moessner R, 2006, PHYS TODAY, V59, P24, DOI 10.1063/1.2186278; Mydosh JA, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1301; Onoda S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.047201; Paddison JAM, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/45/454220; Paddison JAM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.017204; Parker CV, 2010, NATURE, V468, P677, DOI 10.1038/nature09597; Petrenko OA, 1998, PHYS REV LETT, V80, P4570, DOI 10.1103/PhysRevLett.80.4570; Petrenko OA, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.024409; Quilliam JA, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.174421; Ressouche E, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.067202; Ruhwandl RW, 1997, PHYS REV E, V56, P5561, DOI 10.1103/PhysRevE.56.5561; Santini P, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.207203; SCHIFFER P, 1995, PHYS REV LETT, V74, P2379, DOI 10.1103/PhysRevLett.74.2379; SHULL CG, 1949, PHYS REV, V76, P1256, DOI 10.1103/PhysRev.76.1256.2; Tomiyasu K, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.077205; Yavors'kii T, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.267203	32	68	68	5	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257					179	181		10.1126/science.aaa5326	http://dx.doi.org/10.1126/science.aaa5326			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9JB	26450205	Green Submitted			2022-12-28	WOS:000362405600031
J	Aiken, C				Aiken, Christopher			HIV Antiviral action countered by Nef	NATURE			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-1; INFECTIVITY; SENSITIVITY; ENVELOPE		Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University	Aiken, C (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.	chris.aiken@vanderbilt.edu	Aiken, Christopher/Y-9252-2019					Aiken C, 1997, J VIROL, V71, P5871, DOI 10.1128/JVI.71.8.5871-5877.1997; Chazal N, 2001, J VIROL, V75, P4014, DOI 10.1128/JVI.75.8.4014-4018.2001; Day JR, 2004, J VIROL, V78, P1069, DOI 10.1128/JVI.78.3.1069-1079.2004; Inuzuka M, 2005, J BIOL CHEM, V280, P35776, DOI 10.1074/jbc.M505712200; Pizzato M, 2007, P NATL ACAD SCI USA, V104, P6812, DOI 10.1073/pnas.0607622104; Pizzato M, 2010, P NATL ACAD SCI USA, V107, P9364, DOI 10.1073/pnas.1001554107; Qi ML, 2007, J VIROL, V81, P1534, DOI 10.1128/JVI.02099-06; Rosa A, 2015, NATURE, V526, P212, DOI 10.1038/nature15399; Usami Y, 2015, NATURE, V526, P218, DOI 10.1038/nature15400; Usami Y, 2013, CELL REP, V5, P802, DOI 10.1016/j.celrep.2013.09.028; Zhou J, 2001, J VIROL, V75, P5851, DOI 10.1128/JVI.75.13.5851-5859.2001	11	7	7	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					202	203		10.1038/nature15637	http://dx.doi.org/10.1038/nature15637			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26416750				2022-12-28	WOS:000362399000034
J	Chi, KR				Chi, Kelly Rae			MASCULINITY Men's makeover	NATURE			English	Editorial Material							BODY-IMAGE											Agliata D, 2004, J SOC CLIN PSYCHOL, V23, P7, DOI 10.1521/jscp.23.1.7.26988; Barlett CP, 2008, J SOC CLIN PSYCHOL, V27, P279, DOI 10.1521/jscp.2008.27.3.279; Engeln R, 2013, BODY IMAGE, V10, P300, DOI 10.1016/j.bodyim.2013.02.001; Field AE, 2014, JAMA PEDIATR, V168, P34, DOI 10.1001/jamapediatrics.2013.2915; Golan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091778; Hall M., 2012, J MENS STUDIES, V20, P209, DOI [https://doi.org/10.3149/jms.2003.209, DOI 10.3149/JMS.2003.209]	6	3	3	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					S12	S13		10.1038/526S12a	http://dx.doi.org/10.1038/526S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26444368	Bronze			2022-12-28	WOS:000362399000006
J	Le Hur, K				Le Hur, Karyn			CONDENSED-MATTER PHYSICS Quantum dots and the Kondo effect	NATURE			English	Editorial Material							METALS; FIELD		[Le Hur, Karyn] Univ Paris Saclay, Ecole Polytech, Ctr Theoret Phys CPHT, F-91128 Palaiseau, France; [Le Hur, Karyn] Univ Paris Saclay, CNRS, F-91128 Palaiseau, France	Institut Polytechnique de Paris; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Le Hur, K (corresponding author), Univ Paris Saclay, Ecole Polytech, Ctr Theoret Phys CPHT, F-91128 Palaiseau, France.	karyn.le-hur@polytechnique.edu						AFFLECK I, 1993, PHYS REV B, V48, P7297, DOI 10.1103/PhysRevB.48.7297; Cox DL, 1998, ADV PHYS, V47, P599, DOI 10.1080/000187398243500; Furusaki A, 1995, PHYS REV B, V52, P16676, DOI 10.1103/PhysRevB.52.16676; Iftikhar Z, 2015, NATURE, V526, P233, DOI 10.1038/nature15384; Keller AJ, 2015, NATURE, V526, P237, DOI 10.1038/nature15261; KONDO J, 1964, PROG THEOR PHYS, V32, P37, DOI 10.1143/PTP.32.37; Kouwenhoven L, 2001, PHYS WORLD, V14, P33; Le Hur K, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165338; Matveev K. A., 1991, Soviet Physics - JETP, V72, P892; NOZIERES P, 1980, J PHYS-PARIS, V41, P193, DOI 10.1051/jphys:01980004103019300; NOZIERES P, 1974, J LOW TEMP PHYS, V17, P31, DOI 10.1007/BF00654541; Sachdev S., 2011, QUANTUM PHASE TRANSI; Sela E, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.147202	14	4	4	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					203	204		10.1038/526203a	http://dx.doi.org/10.1038/526203a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26450053				2022-12-28	WOS:000362399000035
J	Tomko, RJ; Taylor, DW; Chen, ZA; Wang, HW; Rappsilber, J; Hochstrasser, M				Tomko, Robert J., Jr.; Taylor, David W.; Chen, Zhuo A.; Wang, Hong-Wei; Rappsilber, Juri; Hochstrasser, Mark			A Single alpha Helix Drives Extensive Remodeling of the Proteasome Lid and Completion of Regulatory Particle Assembly	CELL			English	Article							26S PROTEASOME; MASS-SPECTROMETRY; TERMINAL DOMAIN; SUBUNIT RPN11; CROSS-LINKING; DEGRADATION; SYSTEM; ARCHITECTURE; REVEALS; DEUBIQUITINATION	Most short-lived eukaryotic proteins are degraded by the proteasome. A proteolytic core particle (CP) capped by regulatory particles (RPs) constitutes the 26S proteasome complex. RP biogenesis culminates with the joining of two large subcomplexes, the lid and base. In yeast and mammals, the lid appears to assemble completely before attaching to the base, but how this hierarchical assembly is enforced has remained unclear. Using biochemical reconstitutions, quantitative cross-linking/mass spectrometry, and electron microscopy, we resolve the mechanistic basis for the linkage between lid biogenesis and lid-base joining. Assimilation of the final lid subunit, Rpn12, triggers a large-scale conformational remodeling of the nascent lid that drives RP assembly, in part by relieving steric clash with the base. Surprisingly, this remodeling is triggered by a single Rpn12 a helix. Such assembly-coupled conformational switching is reminiscent of viral particle maturation and may represent a commonly used mechanism to enforce hierarchical assembly in multisubunit complexes.	[Tomko, Robert J., Jr.; Hochstrasser, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Taylor, David W.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Chen, Zhuo A.; Rappsilber, Juri] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3BF, Midlothian, Scotland; [Wang, Hong-Wei] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Rappsilber, Juri] Tech Univ Berlin, Inst Biotechnol, Dept Bioanalyt, D-13355 Berlin, Germany	Yale University; University of California System; University of California Berkeley; University of Edinburgh; Tsinghua University; Technical University of Berlin	Tomko, RJ (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.	robert.tomko@med.fsu.edu; mark.hochstrasser@yale.edu	Rappsilber, Juri/B-7265-2015; Rappsilber, Juri/ABF-3328-2020	Rappsilber, Juri/0000-0001-5999-1310; Taylor, David/0000-0002-6198-1194; Tomko Jr., Robert/0000-0003-2515-1078; Hochstrasser, Mark/0000-0002-1131-5484; CHEN, ZHUO/0000-0003-0811-8348	NIH [GM083050]; Wellcome Trust [103139, 092076]; American Cancer Society postdoctoral fellowship; Damon Runyon Cancer Research Foundation [DRG-2218-15]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083050] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); American Cancer Society postdoctoral fellowship(American Cancer Society); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Rui Zhang for helpful comments, Eva Nogales for use of her electron microscopy resources, Andreas Martin for base expression plasmids, and Dan Finley for antibodies. This work was supported by NIH grant GM083050 to M.H and the Wellcome Trust (Senior Research Fellowship 103139 and Centre core grant 092076) to J.R. R.J.T. Jr. was supported in part by an American Cancer Society postdoctoral fellowship. D.W.T. is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRG-2218-15).	Aksyuk AA, 2011, VIRUSES-BASEL, V3, P172, DOI 10.3390/v3030172; Beckwith R, 2013, NAT STRUCT MOL BIOL, V20, P1164, DOI 10.1038/nsmb.2659; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cheriyath Venugopalan, 2007, Drugs R D, V8, P1, DOI 10.2165/00126839-200708010-00001; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crawford LJ, 2013, BLOOD REV, V27, P297, DOI 10.1016/j.blre.2013.10.002; Dou QP, 2014, CURR CANCER DRUG TAR, V14, P517, DOI 10.2174/1568009614666140804154511; Estrin E, 2013, STRUCTURE, V21, P1624, DOI 10.1016/j.str.2013.06.023; Fane BA, 2003, ADV PROTEIN CHEM, V64, P259; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fischer L, 2013, J PROTEOMICS, V88, P120, DOI 10.1016/j.jprot.2013.03.005; Fukunaga K, 2010, BIOCHEM BIOPH RES CO, V396, P1048, DOI 10.1016/j.bbrc.2010.05.061; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Hofmann L, 2009, J CELL SCI, V122, P3673, DOI 10.1242/jcs.050229; Kock M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7123; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lingaraju GM, 2014, NATURE, V512, P161, DOI 10.1038/nature13566; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Mateu MG, 2013, ARCH BIOCHEM BIOPHYS, V531, P65, DOI 10.1016/j.abb.2012.10.015; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; Nanduri P, 2015, J BIOL CHEM, V290, P9455, DOI 10.1074/jbc.M114.627950; Nyquist K, 2014, TRENDS BIOCHEM SCI, V39, P53, DOI 10.1016/j.tibs.2013.11.003; Pathare GR, 2012, P NATL ACAD SCI USA, V109, P149, DOI 10.1073/pnas.1117648108; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Rinaldi T, 2004, BIOCHEM J, V381, P275, DOI 10.1042/BJ20040008; Rinaldi T, 2008, MOL BIOL CELL, V19, P1022, DOI 10.1091/mbc.E07-07-0717; Schmidt C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2985; Sharon M, 2007, J BIOL CHEM, V282, P18448, DOI 10.1074/jbc.M701534200; Sharon M, 2006, PLOS BIOL, V4, P1314, DOI 10.1371/journal.pbio.0040267; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Tomko RJ, 2014, MOL CELL, V53, P433, DOI 10.1016/j.molcel.2013.12.009; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Tomko RJ, 2011, MOL CELL, V44, P907, DOI 10.1016/j.molcel.2011.11.020; Unverdorben P, 2014, P NATL ACAD SCI USA, V111, P5544, DOI 10.1073/pnas.1403409111; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Witt S, 2006, STRUCTURE, V14, P1179, DOI 10.1016/j.str.2006.05.019; Worden EJ, 2014, NAT STRUCT MOL BIOL, V21, P220, DOI 10.1038/nsmb.2771; Yu ZL, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140173	40	52	53	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2					432	444		10.1016/j.cell.2015.09.022	http://dx.doi.org/10.1016/j.cell.2015.09.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26451487	Green Published, hybrid			2022-12-28	WOS:000362952700019
J	Jaffe, M; Allam, S				Jaffe, Michael; Allam, Sahitya			Safer fuels by integrating polymer theory into design	SCIENCE			English	Editorial Material									[Jaffe, Michael; Allam, Sahitya] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA	New Jersey Institute of Technology	Jaffe, M (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.	michael.jaffe@njit.edu						BROSTOW W, 1983, POLYMER, V24, P631, DOI 10.1016/0032-3861(83)90119-2; CHAO KK, 1984, AICHE J, V30, P111, DOI 10.1002/aic.690300116; Eagar TW, 2001, JOM-J MIN MET MAT S, V53, P8, DOI 10.1007/s11837-001-0003-1; MALIK S, 1995, CHEM ENG SCI, V50, P105, DOI 10.1016/0009-2509(94)00125-B; Mannheimer R. J., 1985, REAL TIME QUALITY CO; MOTIER JF, 1986, Patent No. 0177649; Wei M. -H., 2010, European Patent, Patent No. [EP2419496A1, 2419496]; Wei MH, 2015, SCIENCE, V350, P72, DOI 10.1126/science.aab0642	8	5	5	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					32	32		10.1126/science.aac9827	http://dx.doi.org/10.1126/science.aac9827			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26430102				2022-12-28	WOS:000362098300028
J	Mease, PJ; McInnes, IB; Kirkham, B; Kavanaugh, A; Rahman, P; van der Heijde, D; Landewe, R; Nash, P; Pricop, L; Yuan, JC; Richards, HB; Mpofu, S				Mease, Philip J.; McInnes, Iain B.; Kirkham, Bruce; Kavanaugh, Arthur; Rahman, Proton; van der Heijde, Desiree; Landewe, Robert; Nash, Peter; Pricop, Luminita; Yuan, Jiacheng; Richards, Hanno B.; Mpofu, Shephard		FUTURE 1 Study Grp	Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTI-INTERLEUKIN-17A MONOCLONAL-ANTIBODY; RHEUMATOID-ARTHRITIS; ANKYLOSING-SPONDYLITIS; JOINT INFLAMMATION; CLINICAL-RESPONSE; DISEASE-ACTIVITY; EUROPEAN LEAGUE; BONE EROSION; DOUBLE-BLIND; MAST-CELLS	BACKGROUND In a phase 2 study, the inhibition of the interleukin-17A receptor improved signs and symptoms of psoriatic arthritis. We sought to evaluate the efficacy and safety of secukinumab, an anti-interleukin-17A monoclonal antibody, in such patients. METHODS In this double-blind, phase 3 study, 606 patients with psoriatic arthritis were randomly assigned in a 1:1:1 ratio to receive intravenous secukinumab (at a dose of 10 mg per kilogram) at weeks 0, 2, and 4, followed by subcutaneous secukinumab at a dose of either 150 mg or 75 mg every 4 weeks, or placebo. Patients in the placebo group were switched to subcutaneous secukinumab at a dose of 150 mg or 75 mg at week 16 or 24, depending on clinical response. The primary end point was the proportion of patients with an American College of Rheumatology 20 (ACR20) response at week 24, defined as a 20% improvement from baseline in the number of tender and swollen joints and at least three other important domains. RESULTS ACR20 response rates at week 24 were significantly higher in the group receiving secukinumab at doses of 150 mg (50.0%) and 75 mg (50.5%) than in those receiving placebo (17.3%) (P<0.001 for both comparisons with placebo). Secondary end points, including the ACR50 response and joint structural damage, were significantly better in the secukinumab groups than in the placebo group. Improvements were sustained through 52 weeks. Infections, including candida, were more common in the secukinumab groups. Throughout the study (mean secukinumab exposure, 438.5 days; mean placebo exposure, 128.5 days), four patients in the secukinumab groups had a stroke (0.6 per 100 patient-years; 95% confidence interval [CI], 0.2 to 1.5), and two had a myocardial infarction (0.3 per 100 patient-years; 95% CI, 0.0 to 1.0), as compared with no patients in the placebo group. CONCLUSIONS Secukinumab was more effective than placebo in patients with psoriatic arthritis, which validates interleukin-17A as a therapeutic target. Infections were more common in the secukinumab groups than in the placebo group. The study was neither large enough nor long enough to evaluate uncommon serious adverse events or the risks associated with long-term use.	[Mease, Philip J.] Univ Washington, Swedish Med Ctr, Seattle, WA 98195 USA; [McInnes, Iain B.] Univ Glasgow, Glasgow, Lanark, Scotland; [Kirkham, Bruce] Guys & St Thomas NHS Fdn Trust, London, England; [Kavanaugh, Arthur] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Rahman, Proton] Mem Univ Newfoundland, St John, NF, Canada; [van der Heijde, Desiree] Leiden Univ, Med Ctr, Leiden, Netherlands; [Landewe, Robert] Univ Amsterdam, Amsterdam, Netherlands; [Landewe, Robert] Atrium Med Ctr, Amsterdam, Netherlands; [Nash, Peter] Univ Queensland, Brisbane, Qld, Australia; [Pricop, Luminita; Yuan, Jiacheng] Nova Pharmaceut Corp, E Hanover, NJ USA; [Richards, Hanno B.; Mpofu, Shephard] Novartis Pharmaceut, Basel, Switzerland	Swedish Medical Center; University of Washington; University of Washington Seattle; University of Glasgow; Guy's & St Thomas' NHS Foundation Trust; University of California System; University of California San Diego; Memorial University Newfoundland; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Atrium Medical Center; University of Queensland; Novartis; Novartis	Mease, PJ (corresponding author), Seattle Rheumatol Associates, 601 Broadway,Suite 600, Seattle, WA 98122 USA.	pmease@philipmease.com	Nash, Peter/D-7392-2013; LANDEWE, ROBERT B.M./ABD-7388-2021; van der Heijde, Désirée/I-6774-2019; Leung, Ying Ying/J-9099-2015	Nash, Peter/0000-0002-2571-788X; LANDEWE, ROBERT B.M./0000-0002-0577-6620; van der Heijde, Désirée/0000-0002-5781-158X; Leung, Ying Ying/0000-0001-8492-6342; Reitblat, Tatiana/0000-0002-7197-641X	Novartis Pharma	Novartis Pharma	Funded by Novartis Pharma; ClinicalTrials.gov number, NCT01392326.	Baeten D, 2013, LANCET, V382, P1705, DOI 10.1016/S0140-6736(13)61134-4; Boehncke WH, 2013, AM J CLIN DERMATOL, V14, P377, DOI 10.1007/s40257-013-0032-x; Bush KA, 2002, ARTHRITIS RHEUM-US, V46, P802, DOI 10.1002/art.10173; Department of Health and Human Services National Institutes of Health National Cancer Institute, 2010, COMM TERM CRIT ADV E; Fagerli KM, 2013, ANN RHEUM DIS, V72, P1840, DOI 10.1136/annrheumdis-2012-203018; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Gladman DD, 2009, ANN RHEUM DIS, V68, P1131, DOI 10.1136/ard.2008.094839; Gladman DD, 2005, ANN RHEUM DIS, V64, P14, DOI 10.1136/ard.2004.032482; Glintborg B, 2013, ARTHRITIS RHEUM-US, V65, P1213, DOI 10.1002/art.37876; Gossec L, 2012, ANN RHEUM DIS, V71, P4, DOI 10.1136/annrheumdis-2011-200350; Han CL, 2006, J RHEUMATOL, V33, P2167; Husted JA, 2011, ARTHRIT CARE RES, V63, P1729, DOI 10.1002/acr.20627; Jandus C, 2008, ARTHRITIS RHEUM, V58, P2307, DOI 10.1002/art.23655; Kagami S, 2010, J INVEST DERMATOL, V130, P1373, DOI 10.1038/jid.2009.399; Kavanaugh A, 2007, ANN RHEUM DIS, V66, P498, DOI 10.1136/ard.2006.058339; Klein U, 2013, J INVEST DERMATOL, V133, pS172; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; McInnes IB, 2014, ANN RHEUM DIS, V73, P349, DOI 10.1136/annrheumdis-2012-202646; Mease P, 2013, CURR OPIN RHEUMATOL, V25, P287, DOI 10.1097/BOR.0b013e32835fd8d5; Mease PJ, 2014, NEW ENGL J MED, V370, P2295, DOI 10.1056/NEJMoa1315231; Mease PJ, 2014, DRUGS, V74, P423, DOI 10.1007/s40265-014-0191-y; Menon B, 2014, ARTHRITIS RHEUMATOL, V66, P1272, DOI 10.1002/art.38376; Menter A, 2011, J AM ACAD DERMATOL, V65, P137, DOI 10.1016/j.jaad.2010.11.055; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Noordenbos T, 2012, ARTHRITIS RHEUM-US, V64, P99, DOI 10.1002/art.33396; Pollinger B, 2011, J IMMUNOL, V186, P2602, DOI 10.4049/jimmunol.1003370; Saad AA, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2670; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; van der Heijde D, 2005, ARTHRITIS RHEUM-US, V52, P49, DOI 10.1002/art.20775; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weisman S, 2003, J Dermatolog Treat, V14, P158, DOI 10.1080/09546630310013360; Wells G, 2009, ANN RHEUM DIS, V68, P954, DOI 10.1136/ard.2007.084459	35	530	551	2	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2015	373	14					1329	1339		10.1056/NEJMoa1412679	http://dx.doi.org/10.1056/NEJMoa1412679			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3CI	26422723	Green Published			2022-12-28	WOS:000361948600007
J	Andrews, PJD; Sinclair, HL; Rodriguez, A; Harris, BA; Battison, CG; Rhodes, JKJ; Murray, GD				Andrews, Peter J. D.; Sinclair, H. Louise; Rodriguez, Aryelly; Harris, Bridget A.; Battison, Claire G.; Rhodes, Jonathan K. J.; Murray, Gordon D.		Eurotherm3235 Trial Collaborators	Hypothermia for Intracranial Hypertension after Traumatic Brain Injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERE HEAD-INJURY; THERAPEUTIC HYPOTHERMIA; MILD HYPOTHERMIA; PRESSURE REDUCTION; CLINICAL-TRIALS; FEVER CONTROL; MANAGEMENT; DISORDERS; DESIGN; PHASE	BACKGROUND In patients with traumatic brain injury, hypothermia can reduce intracranial hypertension. The benefit of hypothermia on functional outcome is unclear. METHODS We randomly assigned adults with an intracranial pressure of more than 20 mm Hg despite stage 1 treatments (including mechanical ventilation and sedation management) to standard care (control group) or hypothermia (32 to 35 degrees C) plus standard care. In the control group, stage 2 treatments (e.g., osmotherapy) were added as needed to control intracranial pressure. In the hypothermia group, stage 2 treatments were added only if hypothermia failed to control intracranial pressure. In both groups, stage 3 treatments (barbiturates and decompressive craniectomy) were used if all stage 2 treatments failed to control intracranial pressure. The primary outcome was the score on the Extended Glasgow Outcome Scale (GOS-E; range, 1 to 8, with lower scores indicating a worse functional outcome) at 6 months. The treatment effect was estimated with ordinal logistic regression adjusted for prespecified prognostic factors and expressed as a common odds ratio (with an odds ratio <1.0 favoring hypothermia). RESULTS We enrolled 387 patients at 47 centers in 18 countries from November 2009 through October 2014, at which time recruitment was suspended owing to safety concerns. Stage 3 treatments were required to control intracranial pressure in 54% of the patients in the control group and in 44% of the patients in the hypothermia group. The adjusted common odds ratio for the GOS-E score was 1.53 (95% confidence interval, 1.02 to 2.30; P = 0.04), indicating a worse outcome in the hypothermia group than in the control group. A favorable outcome (GOS-E score of 5 to 8, indicating moderate disability or good recovery) occurred in 26% of the patients in the hypothermia group and in 37% of the patients in the control group (P = 0.03). CONCLUSIONS In patients with an intracranial pressure of more than 20 mm Hg after traumatic brain injury, therapeutic hypothermia plus standard care to reduce intracranial pressure did not result in outcomes better than those with standard care alone.	[Andrews, Peter J. D.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Sinclair, H. Louise; Harris, Bridget A.; Battison, Claire G.; Rhodes, Jonathan K. J.] Univ Edinburgh, Dept Anaesthesia Crit Care & Pain Med, Edinburgh, Midlothian, Scotland; [Rodriguez, Aryelly; Battison, Claire G.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Harris, Bridget A.; Rhodes, Jonathan K. J.] Western Gen Hosp, Crit Care, NHS Lothian, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	Andrews, PJD (corresponding author), Western Gen Hosp, Intens Care Unit, Ward 20,Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	p.andrews@ed.ac.uk	Mellinghoff, Johannes/V-4844-2019	Mellinghoff, Johannes/0000-0002-5455-8953; Aragao, Irene/0000-0001-5750-2739; Battison, Claire/0000-0001-9549-4522; Spapen, Herbert/0000-0002-7724-886X; Deeb, Ahmad/0000-0002-3680-7338; Solodov, Aleksandr/0000-0002-8263-1433; Dimopoulos, Stavros/0000-0003-2199-3788; Vincent, Jean-Louis/0000-0001-6011-6951; Verma, Vishwajit/0000-0003-2428-2391	National Institute for Health Research Health Technology Assessment program; MRC [G0800803] Funding Source: UKRI; Medical Research Council [G0800803] Funding Source: researchfish; National Institute for Health Research [11/01/30] Funding Source: researchfish	National Institute for Health Research Health Technology Assessment program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by the National Institute for Health Research Health Technology Assessment program; Current Controlled Trials number, ISRCTN34555414.	Andrews PJD, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-277; Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; [Anonymous], 2013, LANCET NEUROL, V12, P1127, DOI 10.1016/S1474-4422(13)70266-7; BAMFORD JM, 1989, STROKE, V20, P828, DOI 10.1161/01.STR.20.6.828; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Ker K, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a865; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; NORDBY HK, 1984, ACTA NEUROCHIR, V72, P157, DOI 10.1007/BF01406868; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Sydenham E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub3; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Tokutomi T, 2009, J TRAUMA, V66, P166, DOI 10.1097/TA.0b013e318157dbec; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4	35	274	287	1	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2015	373	25					2403	2412		10.1056/NEJMoa1507581	http://dx.doi.org/10.1056/NEJMoa1507581			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5QD	26444221	Bronze, Green Published			2022-12-28	WOS:000366461400007
J	MacLaren, RE				MacLaren, Robert E.			Gene therapy for age-related macular degeneration	LANCET			English	Editorial Material							NONHUMAN-PRIMATES; DELIVERY; RETINA		[MacLaren, Robert E.] Univ Oxford, Dept Clin Neurosci, Nuffield Lab Ophthalmol, Oxford OX3 9DU, England; [MacLaren, Robert E.] Univ Oxford, Hosp Eye, Oxford OX3 9DU, England; [MacLaren, Robert E.] Moorfields Eye Hosp NHS Fdn Trust, London, England	University of Oxford; University of Oxford; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	MacLaren, RE (corresponding author), Univ Oxford, Dept Clin Neurosci, Nuffield Lab Ophthalmol, Oxford OX3 9DU, England.	enquiries@eye.ox.ac.uk		MacLaren, Robert/0000-0002-3096-4682	Wellcome Trust [091984] Funding Source: Medline	Wellcome Trust(Wellcome Trust)		Bainbridge JW, 2002, GENE THER, V9, P320; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Campochiaro PA, 2006, HUM GENE THER, V17, P167, DOI 10.1089/hum.2006.17.167; Day TP, 2014, ADV EXP MED BIOL, V801, P687, DOI 10.1007/978-1-4614-3209-8_86; Grunwald JE, 2014, OPHTHALMOLOGY, V121, P150, DOI 10.1016/j.ophtha.2013.08.015; Humayun M, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.6.5; Khandhadia S, 2012, IMMUNOBIOLOGY, V217, P127, DOI 10.1016/j.imbio.2011.07.019; Kotterman MA, 2015, GENE THER, V22, P116, DOI 10.1038/gt.2014.115; Lai CM, 2012, GENE THER, V19, P999, DOI 10.1038/gt.2011.169; Paterna JC, 2000, GENE THER, V7, P1304, DOI 10.1038/sj.gt.3301221; Rakoczy EP, 2015, LANCET, V386, P2395, DOI 10.1016/S0140-6736(15)00345-1; Schmidt-Erfurth U, 2014, BRIT J OPHTHALMOL, V98, P1144, DOI 10.1136/bjophthalmol-2014-305702; Testa F, 2013, OPHTHALMOLOGY, V120, P1283, DOI 10.1016/j.ophtha.2012.11.048	13	4	4	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2015	386	10011					2369	2370		10.1016/S0140-6736(15)00346-3	http://dx.doi.org/10.1016/S0140-6736(15)00346-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY3EE	26431822	Green Accepted, Green Submitted			2022-12-28	WOS:000366290400008
J	Yang, LH; Guell, M; Niu, D; George, H; Lesha, E; Grishin, D; Aach, J; Shrock, E; Xu, WH; Poci, J; Cortazio, R; Wilkinson, RA; Fishman, JA; Church, G				Yang, Luhan; Gueell, Marc; Niu, Dong; George, Haydy; Lesha, Emal; Grishin, Dennis; Aach, John; Shrock, Ellen; Xu, Weihong; Poci, Juergen; Cortazio, Rebeca; Wilkinson, Robert A.; Fishman, Jay A.; Church, George			Genome-wide inactivation of porcine endogenous retroviruses (PERVs)	SCIENCE			English	Article							HUMAN-CELLS; TRANSGENIC PIGS; NO EVIDENCE; XENOTRANSPLANTATION; INFECTION; DNA	The shortage of organs for transplantation is a major barrier to the treatment of organ failure. Although porcine organs are considered promising, their use has been checked by concerns about the transmission of porcine endogenous retroviruses (PERVs) to humans. Here we describe the eradication of all PERVs in a porcine kidney epithelial cell line (PK15). We first determined the PK15 PERV copy number to be 62. Using CRISPR-Cas9, we disrupted all copies of the PERV pol gene and demonstrated a >1000-fold reduction in PERV transmission to human cells, using our engineered cells. Our study shows that CRISPR-Cas9 multiplexability can be as high as 62 and demonstrates the possibility that PERVs can be inactivated for clinical application of porcine-to-human xenotransplantation.	[Yang, Luhan; Gueell, Marc; Niu, Dong; George, Haydy; Lesha, Emal; Grishin, Dennis; Aach, John; Shrock, Ellen; Poci, Juergen; Cortazio, Rebeca; Church, George] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02138 USA; [Yang, Luhan; Gueell, Marc; Church, George] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Yang, Luhan; Gueell, Marc; Church, George] eGenesis Biosci, Boston, MA 02115 USA; [Niu, Dong] Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Wilkinson, Robert A.; Fishman, Jay A.] Massachusetts Gen Hosp, Transplant Infect Dis & Compromised Host Program, Boston, MA 02115 USA; [Xu, Weihong] Harvard Univ, Sch Med, Dept Surg, Massachusetts Gen Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Zhejiang University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Yang, LH (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02138 USA.	luhan.yang@egenesisbio.com; gchurch@genetics.med.harvard.edu	Güell, Marc/AAB-3054-2021; Xu, Weihong/C-4175-2012; Lesha, Emal/GXV-3245-2022; Güell, Marc/J-2970-2017	Güell, Marc/0000-0003-4000-7912; Xu, Weihong/0000-0002-3988-3571; Güell, Marc/0000-0003-4000-7912; Shrock, Ellen/0000-0003-2484-4374; church, george/0000-0001-6232-9969; Lesha, Emal/0000-0002-8902-3537	Human Frontier Science Program Long Term fellowship; NIH [P50 HG005550]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER	Human Frontier Science Program Long Term fellowship(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Z. Herbert and M. Vangala at the Dana-Farber Genomics Core Facility for assistance with RNA analysis, Y. Shen and O. Castanon for volunteering in laboratory research, and S. Broder for scientific advice. M.G. is funded by a Human Frontier Science Program Long Term fellowship. This study was funded by NIH grant P50 HG005550. L.Y., G.C., and M.G. are inventors on a patent filed by Harvard University that covers the work in this manuscript. L.Y., G.C., and M.G. are founding members of eGenesisBio. Pig cells are available from G.C. under a materials transfer agreement with Harvard University.	[Anonymous], 1997, ILAR J, V38, P49; Butler D, 1998, NATURE, V391, P320; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dinsmore JH, 2000, TRANSPLANTATION, V70, P1382, DOI 10.1097/00007890-200011150-00020; Dunn D, 2015, FASEB J, V29; Fiebig U, 2003, VIROLOGY, V307, P406, DOI 10.1016/S0042-6822(02)00140-X; Guell M, 2014, BIOINFORMATICS, V30, P2968, DOI 10.1093/bioinformatics/btu427; Heneine W, 1998, LANCET, V352, P695, DOI 10.1016/S0140-6736(98)07145-1; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Lee D, 2011, ANIM BIOTECHNOL, V22, P175, DOI 10.1080/10495398.2011.595294; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282; Ramsoondar J, 2009, XENOTRANSPLANTATION, V16, P164, DOI 10.1111/j.1399-3089.2009.00525.x; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Schuurman HJ, 2009, XENOTRANSPLANTATION, V16, P215, DOI 10.1111/j.1399-3089.2009.00541.x; Semaan M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122059; Semaan M, 2012, XENOTRANSPLANTATION, V19, P112, DOI 10.1111/j.1399-3089.2012.00683.x; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555	20	380	428	6	279	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264					1101	1104		10.1126/science.aad1191	http://dx.doi.org/10.1126/science.aad1191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY5BJ	26456528	Green Submitted			2022-12-28	WOS:000366422600046
J	Dietl, A; Ferousi, C; Maalcke, WJ; Menzel, A; de Vries, S; Keltjens, JT; Jetten, MSM; Kartal, B; Barends, TRM				Dietl, Andreas; Ferousi, Christina; Maalcke, Wouter J.; Menzel, Andreas; de Vries, Simon; Keltjens, Jan T.; Jetten, Mike S. M.; Kartal, Boran; Barends, Thomas R. M.			The inner workings of the hydrazine synthase multiprotein complex	NATURE			English	Article							CYTOCHROME-C PEROXIDASE; ANAMMOX BACTERIUM; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SYSTEM; LIGAND	Anaerobic ammonium oxidation (anammox) has a major role in the Earth's nitrogen cycle(1,2) and is used in energy-efficient waste-water treatment(3). This bacterial process combines nitrite and ammonium to form dinitrogen (N-2) gas, and has been estimated to synthesize up to 50% of the dinitrogen gas emitted into our atmosphere from the oceans(2). Strikingly, the anammox process relies on the highly unusual, extremely reactive intermediate hydrazine(4), a compound also used as a rocket fuel because of its high reducing power. So far, the enzymatic mechanism by which hydrazine is synthesized is unknown. Here we report the 2.7 angstrom resolution crystal structure, as well as biophysical and spectroscopic studies, of a hydrazine synthase multiprotein complex isolated from the anammox organism Kuenenia stuttgartiensis. The structure shows an elongated dimer of heterotrimers, each of which has two unique c-type haem-containing active sites, as well as an interaction point for a redox partner. Furthermore, a system of tunnels connects these active sites. The crystal structure implies a two-step mechanism for hydrazine synthesis: a three-electron reduction of nitric oxide to hydroxylamine at the active site of the gamma-subunit and its subsequent condensation with ammonia, yielding hydrazine in the active centre of the alpha-subunit. Our results provide the first, to our knowledge, detailed structural insight into the mechanism of biological hydrazine synthesis, which is of major significance for our understanding of the conversion of nitrogenous compounds in nature.	[Dietl, Andreas; Barends, Thomas R. M.] Max Planck Inst Med Res, Dept Biomol Mech, Jahnstr 29, D-69120 Heidelberg, Germany; [Ferousi, Christina; Maalcke, Wouter J.; Keltjens, Jan T.; Jetten, Mike S. M.; Kartal, Boran] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Microbiol, NL-6525 AJ Nijmegen, Netherlands; [Menzel, Andreas] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [de Vries, Simon; Jetten, Mike S. M.] Delft Univ Technol, Dept Biotechnol, Delft, Netherlands; [Kartal, Boran] Univ Ghent, Microbiol Lab, Dept Biochem & Microbiol, B-9000 Ghent, Belgium	Max Planck Society; Radboud University Nijmegen; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Delft University of Technology; Ghent University	Barends, TRM (corresponding author), Max Planck Inst Med Res, Dept Biomol Mech, Jahnstr 29, D-69120 Heidelberg, Germany.	kartal@science.ru.nl; Thomas.Barends@mpimf-heidelberg.mpg.de	Menzel, Andreas/C-4388-2012; Kartal, Boran/ABD-5400-2021; Jetten, Mike/B-8834-2011; Keltjens, Jan/M-3002-2013	Menzel, Andreas/0000-0002-0489-609X; Jetten, Mike/0000-0002-4691-7039; Ferousi, Christina/0000-0001-6400-7373; Kartal, Boran/0000-0003-4199-952X	Netherlands Organization for Scientific Research [863.11.003, 142.16.1201]; European Research Council [ERC232937]; Spinoza Prize; NIGMS [P41-GM103311]; Max Planck Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); Spinoza Prize; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We dedicate this work to Simon de Vries, who passed away unexpectedly shortly before the publication of this paper. The Dortmund-Heidelberg data collection team and the staff of beamline X10SA at the Swiss Light Source of the PSI in Villigen, Switzerland are acknowledged for their help and facilities. M. Gradl and M. Muller are thanked for assistance with MALDI- and ESI-TOF mass spectrometric analyses. We thank I. Schlichting, J. Reimann, M. Cryle, J. Reinstein and R. Shoeman for suggestions and C. Kieser (electronics workshop at MPImF) for constructing the Peltier cooling controller used in post-crystallization treatment. T.R.M.B. thanks I. Schlichting for continuous support. B.K and W.J.M. were supported by the Netherlands Organization for Scientific Research (VENI grant 863.11.003 and Darwin grant 142.16.1201, respectively). C.F and M.S.M.J. are supported by the European Research Council (ERC232937) and by a Spinoza Prize awarded to M.S.M.J. Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS P41-GM103311). This work was supported by the Max Planck Society.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BLASCHKO HERMANN, 1935, BIOCHEM JOUR, V29, P2303; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Devol AH, 2015, ANNU REV MAR SCI, V7, P403, DOI 10.1146/annurev-marine-010213-135040; Echalier A, 2008, BIOCHEMISTRY-US, V47, P1947, DOI 10.1021/bi702064f; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FULOP V, 1995, STRUCTURE, V3, P1225, DOI 10.1016/S0969-2126(01)00258-1; Jensen LMR, 2010, SCIENCE, V327, P1392, DOI 10.1126/science.1182492; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kartal B, 2010, SCIENCE, V328, P702, DOI 10.1126/science.1185941; Kartal B, 2013, FEMS MICROBIOL REV, V37, P428, DOI 10.1111/1574-6976.12014; Kartal B, 2011, NATURE, V479, P127, DOI 10.1038/nature10453; Lam P, 2011, ANNU REV MAR SCI, V3, P317, DOI 10.1146/annurev-marine-120709-142814; Maalcke WJ, 2014, J BIOL CHEM, V289, P1228, DOI 10.1074/jbc.M113.525147; Moser CC, 2008, BBA-BIOENERGETICS, V1777, P1032, DOI 10.1016/j.bbabio.2008.04.021; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Petrek M, 2007, STRUCTURE, V15, P1357, DOI 10.1016/j.str.2007.10.007; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Putnam CD, 2000, J MOL BIOL, V296, P295, DOI 10.1006/jmbi.1999.3458; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shimizu H, 2001, BIOCHEMISTRY-US, V40, P13483, DOI 10.1021/bi011481h; Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; van de Vossenberg J, 2013, ENVIRON MICROBIOL, V15, P1275, DOI 10.1111/j.1462-2920.2012.02774.x; van der Star WRL, 2010, APPL MICROBIOL BIOT, V86, P311, DOI 10.1007/s00253-009-2309-9; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215	32	87	94	21	241	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					404	+		10.1038/nature15517	http://dx.doi.org/10.1038/nature15517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26479033	Green Submitted			2022-12-28	WOS:000365356800060
J	Zhang, L; Zhan, SY; Yao, J; Lowery, FJ; Zhang, QL; Huang, WC; Li, P; Li, M; Wang, X; Zhang, CY; Wang, H; Ellis, K; Cheerathodi, M; McCarty, JH; Palmieri, D; Saunus, J; Lakhani, S; Huang, SY; Sahin, AA; Aldape, KD; Steeg, PS; Yu, DH				Zhang, Lin; Zhan, Siyuan; Yao, Jun; Lowery, Frank J.; Zhang, Qingling; Huang, Wen-Chien; Li, Ping; Li, Min; Wang, Xiao; Zhang, Chenyu; Wang, Hai; Ellis, Kenneth; Cheerathodi, Mujeeburahiman; McCarty, Joseph H.; Palmieri, Diane; Saunus, Jodi; Lakhani, Sunil; Huang, Suyun; Sahin, Aysegul A.; Aldape, Kenneth D.; Steeg, Patricia S.; Yu, Dihua			Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth	NATURE			English	Article							BREAST-CANCER; CELLS; MIR-17-92; PHOSPHATASE; FAMILY	The development of life-threatening cancer metastases at distant organs requires disseminated tumour cells' adaptation to, and co-evolution with, the drastically different microenvironments of metastatic sites(1). Cancer cells of common origin manifest distinct gene expression patterns after metastasizing to different organs(2). Clearly, the dynamic interaction between metastatic tumour cells and extrinsic signals at individual metastatic organ sites critically effects the subsequent metastatic outgrowth(3,4). Yet, it is unclear when and how disseminated tumour cells acquire the essential traits from the microenvironment of metastatic organs that prime their subsequent outgrowth. Here we show that both human and mouse tumour cells with normal expression of PTEN, an important tumour suppressor, lose PTEN expression after dissemination to the brain, but not to other organs. The PTEN level in PTEN-loss brain metastatic tumour cells is restored after leaving the brain microenvironment. This brain microenvironment-dependent, reversible PTEN messenger RNA and protein downregulation is epigenetically regulated by microRNAs from brain astrocytes. Mechanistically, astrocyte-derived exosomes mediate an intercellular transfer of PTEN-targeting microRNAs to metastatic tumour cells, while astrocyte-specific depletion of PTEN-targeting microRNAs or blockade of astrocyte exosome secretion rescues the PTEN loss and suppresses brain metastasis in vivo. Furthermore, this adaptive PTEN loss in brain metastatic tumour cells leads to an increased secretion of the chemokine CCL2, which recruits IBA1-expressing myeloid cells that reciprocally enhance the outgrowth of brain metastatic tumour cells via enhanced proliferation and reduced apoptosis. Our findings demonstrate a remarkable plasticity of PTEN expression in metastatic tumour cells in response to different organ microenvironments, underpinning an essential role of co-evolution between the metastatic cells and their microenvironment during the adaptive metastatic outgrowth. Our findings signify the dynamic and reciprocal cross-talk between tumour cells and the metastatic niche; importantly, they provide new opportunities for effective anti-metastasis therapies, especially of consequence for brain metastasis patients.	[Zhang, Lin; Zhan, Siyuan; Yao, Jun; Lowery, Frank J.; Zhang, Qingling; Huang, Wen-Chien; Li, Ping; Li, Min; Wang, Xiao; Zhang, Chenyu; Wang, Hai; Ellis, Kenneth; Yu, Dihua] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Zhang, Lin; Lowery, Frank J.; Yu, Dihua] Univ Texas Houston, Hlth Sci Ctr, Grad Sch Biomed Sci, Canc Biol Program, Houston, TX 77030 USA; [Zhan, Siyuan] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Cheerathodi, Mujeeburahiman; McCarty, Joseph H.; Huang, Suyun] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Palmieri, Diane; Steeg, Patricia S.] NCI, Womans Malignancies Branch, Bethesda, MD 20892 USA; [Saunus, Jodi; Lakhani, Sunil] Univ Queensland, Clin Res Ctr, Brisbane, Qld 4029, Australia; [Lakhani, Sunil] Sch Med & Pathol Queensland, Brisbane, Qld 4029, Australia; [Lakhani, Sunil] Royal Brisbane & Womens Hosp, Brisbane, Qld 4029, Australia; [Sahin, Aysegul A.; Aldape, Kenneth D.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Yu, Dihua] China Med Univ, Ctr Mol Med, Taichung 40402, Taiwan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Notre Dame; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Queensland; Royal Brisbane & Women's Hospital; University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan	Yu, DH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	dyu@mdanderson.org	Lakhani, Sunil R/I-1970-2018; Zhang, Siyuan/A-1276-2014; Zhang, Siyuan/AAH-1157-2021; Saunus, Jodi M/C-6657-2011; Saunus, Jodi/AAE-5291-2020	Lakhani, Sunil R/0000-0003-4067-2760; Zhang, Siyuan/0000-0003-0910-3666; Zhang, Siyuan/0000-0003-0910-3666; Saunus, Jodi M/0000-0002-4604-4709; Saunus, Jodi/0000-0002-4604-4709; Yu, Dihua/0000-0001-6231-9381; Lowery, Frank/0000-0002-4620-5293	DOD Center of Excellence [W81XWH-06-2-0033]; NIH [5R00CA158066-05]; DOD [W81XWH-11-1-0003]; Isaiah Fidler Fellowship in Cancer [PO1-CA099031]; Susan G. Komen Breast Cancer Foundation [KG091020]; METAvivor Research Grant; Breast and Ovarian Cancers Moon Shot program; China Medical University Research Fund; Sowell-Huggins Pre-doctoral Fellowship and Professorship in Cancer Research;  [RO1-CA112567-06];  [R01CA184836]; NATIONAL CANCER INSTITUTE [R01CA184836, R01CA194697, R00CA158066, ZIABC010538, P01CA099031, R01CA112567, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078402, R01NS087635] Funding Source: NIH RePORTER	DOD Center of Excellence(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Isaiah Fidler Fellowship in Cancer; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); METAvivor Research Grant; Breast and Ovarian Cancers Moon Shot program; China Medical University Research Fund; Sowell-Huggins Pre-doctoral Fellowship and Professorship in Cancer Research; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M.-C. Hung, H.-K. Lin and Z. Lu for reading the manuscript, A. Yung for PTEN promoter constructs, MD Anderson Cancer Center (MDACC) shRNA and ORFome, FAGS, histology and high-resolution electron microscopy support, the animal core facilities (NIH CA16672) for technical support, and members of the Yu laboratory for helpful discussions. Thanks to A. Matsika for histological review and tissue microarray construction. This work was supported partially by DOD Center of Excellence grant (P.S.S.) subproject W81XWH-06-2-0033 (D.Y.), NIH Pathway to Independence Award 5R00CA158066-05 (S.Z.), DOD Postdoctoral Fellowship W81XWH-11-1-0003 (C.Z.), Isaiah Fidler Fellowship in Cancer Metastasis (F.J.L.), PO1-CA099031 project 4 (D.Y.), RO1-CA112567-06 (D.Y.), R01CA184836 (D.Y.), Susan G. Komen Breast Cancer Foundation Promise Grant KG091020 (D.Y), METAvivor Research Grant (D.Y.), Breast and Ovarian Cancers Moon Shot program, China Medical University Research Fund, and Sowell-Huggins Pre-doctoral Fellowship (L.Z.) and Professorship (D.Y.) in Cancer Research. D.Y. is the Hubert L. & Olive Stringer Distinguished Chair in Basic Science at the MDACC.	Bonapace L, 2014, NATURE, V515, DOI 10.1038/nature13862; Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Fruhbeis C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00119; Gonzalez-Angulo AM, 2011, MOL CANCER THER, V10, P1093, DOI 10.1158/1535-7163.MCT-10-1089; Gray J, 2010, NATURE, V464, P989, DOI 10.1038/464989a; Hopkins BD, 2013, SCIENCE, V341, P399, DOI 10.1126/science.1234907; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kesimer M, 2009, FASEB J, V23, P1858, DOI 10.1096/fj.08-119131; Liu SQ, 2014, J BIOL CHEM, V289, P12446, DOI 10.1074/jbc.M114.550723; Mecha M., 2011, PROTOCOL EXCHANGE; Miething C, 2014, NATURE, V510, P402, DOI 10.1038/nature13239; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Park ES, 2011, P NATL ACAD SCI USA, V108, P17456, DOI 10.1073/pnas.1114210108; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Suetsugu A, 2013, ADV DRUG DELIVER REV, V65, P383, DOI 10.1016/j.addr.2012.08.007; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wikman H, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3150; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zhu HQ, 2014, AM J PATHOL, V184, P2828, DOI 10.1016/j.ajpath.2014.06.024	26	761	810	15	337	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					100	104		10.1038/nature15376	http://dx.doi.org/10.1038/nature15376			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26479035	Green Accepted, Green Submitted			2022-12-28	WOS:000364270700051
J	Aakre, CD; Herrou, J; Phung, TN; Perchuk, BS; Crosson, S; Laub, MT				Aakre, Christopher D.; Herrou, Julien; Phung, Tuyen N.; Perchuk, Barrett S.; Crosson, Sean; Laub, Michael T.			Evolving New Protein-Protein Interaction Specificity through Promiscuous Intermediates	CELL			English	Article							TOXIN-ANTITOXIN SYSTEMS; SEQUENCE; EPISTASIS; BINDING; DOMAIN	Interacting proteins typically coevolve, and the identification of coevolving amino acids can pinpoint residues required for interaction specificity. This approach often assumes that an interface-disrupting mutation in one protein drives selection of a compensatory mutation in its partner during evolution. However, this model requires a non-functional intermediate state prior to the compensatory change. Alternatively, a mutation in one protein could first broaden its specificity, allowing changes in its partner, followed by a specificity-restricting mutation. Using bacterial toxin-antitoxin systems, we demonstrate the plausibility of this second, promiscuity-based model. By screening large libraries of interface mutants, we show that toxins and antitoxins with high specificity are frequently connected in sequence space to more promiscuous variants that can serve as intermediates during a reprogramming of interaction specificity. We propose that the abundance of promiscuous variants promotes the expansion and diversification of toxin-antitoxin systems and other paralogous protein families during evolution.	[Aakre, Christopher D.; Phung, Tuyen N.; Perchuk, Barrett S.; Laub, Michael T.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Laub, Michael T.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Herrou, Julien; Crosson, Sean] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Chicago	Laub, MT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	laub@mit.edu	Crosson, Sean/AAE-2453-2022	Crosson, Sean/0000-0002-1727-322X; Laub, Michael/0000-0002-8288-7607; Herrou, Julien/0000-0002-8585-8043	NIH [5R01GM082899]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082899] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Sauer, A. Murray, and the Laub laboratory for discussions and comments on the manuscript. We acknowledge S. Ovchinnikov and C. Bahl for valuable discussions on GREMLIN. This work supported by a NIH grant (5R01GM082899) to M.T.L. who is also an Investigator of the Howard Hughes Medical Institute.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Anderson DW, 2015, ELIFE, V4, DOI 10.7554/eLife.07864; Bloom JD, 2009, P NATL ACAD SCI USA, V106, P9995, DOI 10.1073/pnas.0901522106; Capra EJ, 2012, CELL, V150, P222, DOI 10.1016/j.cell.2012.05.033; Dalton KM, 2010, BIOCHEMISTRY-US, V49, P2205, DOI 10.1021/bi902133s; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Fiebig A, 2010, MOL MICROBIOL, V77, P236, DOI 10.1111/j.1365-2958.2010.07207.x; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Hallez R, 2010, MOL MICROBIOL, V76, P719, DOI 10.1111/j.1365-2958.2010.07129.x; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; Kondrashov DA, 2015, TRENDS GENET, V31, P24, DOI 10.1016/j.tig.2014.09.009; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Melamed D, 2013, RNA, V19, P1537, DOI 10.1261/rna.040709.113; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Ovchinnikov S, 2014, ELIFE, V3, DOI 10.7554/eLife.02030; Podgornaia AI, 2015, SCIENCE, V347, P673, DOI 10.1126/science.1257360; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010672; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178; Zhu L, 2010, J BIOL CHEM, V285, P39732, DOI 10.1074/jbc.M110.163105	26	100	102	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					594	606		10.1016/j.cell.2015.09.055	http://dx.doi.org/10.1016/j.cell.2015.09.055			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26478181	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000364828900014
J	Wilmot, V; Anderson, M; Bennett, A				Wilmot, Victoria; Anderson, Megan; Bennett, Alex			CASE SCENARIO A case of cement in the ear	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wilmot, Victoria; Anderson, Megan; Bennett, Alex] Ear Nose & Throat Dept, Edinburgh EH3 9HA, Midlothian, Scotland		Wilmot, V (corresponding author), Ear Nose & Throat Dept, Lauriston Bldg, Edinburgh EH3 9HA, Midlothian, Scotland.	vvwilmot@doctors.org.uk							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2015	351								h5383	10.1136/bmj.h5383	http://dx.doi.org/10.1136/bmj.h5383			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT8XS	26464341				2022-12-28	WOS:000363100800005
J	Berkowitz, T; Schaeffer, MW; Maloney, EA; Peterson, L; Gregor, C; Levine, SC; Beilock, SL				Berkowitz, Talia; Schaeffer, Marjorie W.; Maloney, Erin A.; Peterson, Lori; Gregor, Courtney; Levine, Susan C.; Beilock, Sian L.			Math at home adds up to achievement in school	SCIENCE			English	Article							MATHEMATICS; ANXIETY	With a randomized field experiment of 587 first-graders, we tested an educational intervention designed to promote interactions between children and parents relating to math. We predicted that increasing math activities at home would increase children's math achievement at school. We tested this prediction by having children engage in math story time with their parents. The intervention, short numerical story problems delivered through an iPad app, significantly increased children's math achievement across the school year compared to a reading (control) group, especially for children whose parents are habitually anxious about math. Brief, high-quality parent-child interactions about math at home help break the intergenerational cycle of low math achievement.	[Berkowitz, Talia; Schaeffer, Marjorie W.; Maloney, Erin A.; Peterson, Lori; Gregor, Courtney; Levine, Susan C.; Beilock, Sian L.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA	University of Chicago	Beilock, SL (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	s-levine@uchicago.edu; beilock@uchicago.edu		Schaeffer, Marjorie/0000-0003-1168-6741	Overdeck Family Foundation	Overdeck Family Foundation	This work was funded by an Overdeck Family Foundation grant to S.L.B. and S.C.L. The chair, Laura Overdeck, established the Bedtime Math Foundation-a nonprofit, 501(c)(3) organization that produces the Bedtime Math App. None of the authors have a financial interest in Bedtime Math. The BLT app, written for Apple iOS8, is freely available on request to S.L.B. The supplementary materials contain additional data. The BLT reading and math app can be accessed from an Apple iPad, iPod, or iPhone at URL app itms-services://?action=download-manifest& Reading code: 55dc86e7c9; Math code: 55dc8695c7. We thank S. Raudenbush for providing HLM consultation.	ALEXANDER L, 1989, MEAS EVAL COUNS DEV, V22, P143, DOI 10.1080/07481756.1989.12022923; Butterworth B, 2011, SCIENCE, V332, P1049, DOI 10.1126/science.1201536; Cannon J, 2008, EARLY EDUC DEV, V19, P238, DOI 10.1080/10409280801963913; Duursma E, 2008, ARCH DIS CHILD, V93, P554, DOI 10.1136/adc.2006.106336; Eden C, 2013, PSYCHOLOGY, V4, P27, DOI DOI 10.4236/PSYCH.2013.46A2005; Gunderson EA, 2011, DEVELOPMENTAL SCI, V14, P1021, DOI 10.1111/j.1467-7687.2011.01050.x; HEMBREE R, 1990, J RES MATH EDUC, V21, P33, DOI 10.2307/749455; Hirsh-Pasek K, 2015, PSYCHOL SCI PUBL INT, V16, P3, DOI 10.1177/1529100615569721; Levine SC, 2012, DEV PSYCHOL, V48, P530, DOI 10.1037/a0025913; Levine SC, 2010, DEV PSYCHOL, V46, P1309, DOI 10.1037/a0019671; Maloney EA, 2015, PSYCHOL SCI, V26, P1480, DOI 10.1177/0956797615592630; NRC National Research Council, 2009, MATH LEARN EARL CHIL; OECD, 2013, PISA 2012 RES READ L, V3; Parish-Morris J, 2013, MIND BRAIN EDUC, V7, P200, DOI 10.1111/mbe.12028; Pruden SM, 2011, DEVELOPMENTAL SCI, V14, P1417, DOI 10.1111/j.1467-7687.2011.01088.x; Raudenbush SW., 2020, HLM 8 1 WIND COMP SO; Tekin A.K., 2011, INT J APPL ED STUD, V11, P1; Verdine BN, 2014, J EXP CHILD PSYCHOL, V126, P37, DOI 10.1016/j.jecp.2014.02.012; Woodcock R. W., 2001, WOODCOCK JOHNSON 3 T; Zickuhr K., 2013, WHOS NOT ONLINE WHY, P19	20	160	161	7	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257					196	198		10.1126/science.aac7427	http://dx.doi.org/10.1126/science.aac7427			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS9JB	26450209				2022-12-28	WOS:000362405600036
J	Cheon, S; Kim, TH; Lee, SH; Yeom, HW				Cheon, Sangmo; Kim, Tae-Hwan; Lee, Sung-Hoon; Yeom, Han Woong			Chiral solitons in a coupled double Peierls chain	SCIENCE			English	Article							CONJUGATED DIATOMIC POLYMER; QUANTIZED HALL CONDUCTANCE; TOPOLOGICAL INSULATORS; CHARGE; INSTABILITY; TRANSPORT; SURFACE	Chiral edge states are the hallmark of two-and three-dimensional topological materials, but their one-dimensional (1D) analog has not yet been found. We report that the 1D topological edge states, solitons, of the charge density wave system of indium atomic wires self-assembled on a silicon surface have chirality. The system is described by a coupled double Peierls-dimerized atomic chain, where the interchain coupling induces dynamical sublattice symmetry breaking. This changes its topological symmetry from Z(2) x Z(2) to Z(4) and endows solitons with a chiral degree of freedom. Chiral solitons can produce quantized charge transport across the chain that is topologically protected and controllable by the soliton's chirality. Individual right-and left-chiral solitons in indium wires are directly identified by scanning tunneling microscopy.	[Cheon, Sangmo; Kim, Tae-Hwan; Lee, Sung-Hoon; Yeom, Han Woong] Inst Basic Sci IBS, Ctr Artificial Low Dimens Elect Syst, Pohang 790784, South Korea; [Kim, Tae-Hwan; Yeom, Han Woong] Pohang Univ Sci & Technol POSTECH, Dept Phys, Pohang 790784, South Korea	Institute for Basic Science - Korea (IBS); Pohang University of Science & Technology (POSTECH)	Lee, SH (corresponding author), Inst Basic Sci IBS, Ctr Artificial Low Dimens Elect Syst, Pohang 790784, South Korea.	shlee@ibs.re.kr; yeom@postech.ac.kr	Kim, Tae-Hwan/A-5636-2010; Yeom, Han Woong/AAA-7035-2021; Lee, Sung-Hoon/A-9582-2011	Kim, Tae-Hwan/0000-0001-5328-0913; Lee, Sung-Hoon/0000-0002-8553-8007; Cheon, Sangmo/0000-0002-1349-0112	Institute for Basic Science [IBS-R014-D1]	Institute for Basic Science	This work was supported by the Institute for Basic Science (IBS-R014-D1). We thank K. S. Kim and H. W. Lee for discussions. H.W.Y. appreciates the initial work of S. Takeda and D. M. Oh in shaping the soliton idea in In/Si(111).	Ahn JR, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.106401; Braun HB, 2005, NAT PHYS, V1, P159, DOI 10.1038/nphys152; Brazovskii S. A., 1980, SOV PHYS JETP, V51, P342; Bunk O, 1999, PHYS REV B, V59, P12228, DOI 10.1103/PhysRevB.59.12228; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Goldstone J., 1981, Physical Review Letters, V47, P986, DOI 10.1103/PhysRevLett.47.986; Gonzalez C, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/100; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; HALPERIN BI, 1982, PHYS REV B, V25, P2185, DOI 10.1103/PhysRevB.25.2185; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; JACKIW R, 1983, PHYS REV LETT, V50, P439, DOI 10.1103/PhysRevLett.50.439; JACKIW R, 1976, PHYS REV D, V13, P3398, DOI 10.1103/PhysRevD.13.3398; Kane C. L., 2013, TOPOLOGICAL INSULATO, P3; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Kim TH, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.246802; KIVELSON S, 1983, PHYS REV B, V28, P2653, DOI 10.1103/PhysRevB.28.2653; Marzari N, 2012, REV MOD PHYS, V84, DOI 10.1103/RevModPhys.84.1419; NIU Q, 1984, J PHYS A-MATH GEN, V17, P2453, DOI 10.1088/0305-4470/17/12/016; Peierls R.F., 1955, QUANTUM THEORY SOLID; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Qi XL, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195424; RICE MJ, 1982, PHYS REV LETT, V49, P1455, DOI 10.1103/PhysRevLett.49.1455; SU WP, 1979, PHYS REV LETT, V42, P1698, DOI 10.1103/PhysRevLett.42.1698; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; THOULESS DJ, 1983, PHYS REV B, V27, P6083, DOI 10.1103/PhysRevB.27.6083; Xiao D, 2010, REV MOD PHYS, V82, P1959, DOI 10.1103/RevModPhys.82.1959; Yeom HW, 1999, PHYS REV LETT, V82, P4898, DOI 10.1103/PhysRevLett.82.4898	27	72	72	4	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257					182	185		10.1126/science.aaa7055	http://dx.doi.org/10.1126/science.aaa7055			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9JB	26450206				2022-12-28	WOS:000362405600032
J	Gubin, MM; Schreiber, RD				Gubin, Matthew M.; Schreiber, Robert D.			The odds of immunotherapy success	SCIENCE			English	Editorial Material							CANCER-IMMUNOTHERAPY; PD-1 BLOCKADE; TUMORS		[Gubin, Matthew M.; Schreiber, Robert D.] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL)	Gubin, MM (corresponding author), Washington Univ, Dept Pathol & Immunol, St Louis, MO 63130 USA.	mgubin@path.wustl.edu	Schreiber, Robert/Q-7550-2019	Gubin, Matthew/0000-0001-7443-2752; Schreiber, Robert/0000-0003-1590-2341				Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gajewski TF, 2015, SEMIN ONCOL, V42, P663, DOI 10.1053/j.seminoncol.2015.05.011; Gubin MM, 2015, J CLIN INVEST, V125, P3413, DOI 10.1172/JCI80008; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schumacher TN, 2015, CANCER CELL, V27, P12, DOI 10.1016/j.ccell.2014.12.004; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095	15	71	73	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257					158	159		10.1126/science.aad4140	http://dx.doi.org/10.1126/science.aad4140			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9JB	26450194				2022-12-28	WOS:000362405600016
J	Rostislavleva, K; Soler, N; Ohashi, Y; Zhang, LF; Pardon, E; Burke, JE; Masson, GR; Johnson, C; Steyaert, J; Ktistakis, NT; Williams, RL				Rostislavleva, Ksenia; Soler, Nicolas; Ohashi, Yohei; Zhang, Lufei; Pardon, Els; Burke, John E.; Masson, Glenn R.; Johnson, Chris; Steyaert, Jan; Ktistakis, Nicholas T.; Williams, Roger L.			Structure and flexibility of the endosomal Vps34 complex reveals the basis of its function on membranes	SCIENCE			English	Article							PROTEIN-KINASE; PHOSPHOINOSITIDE 3-KINASE; BECLIN 1; AUTOPHAGY; ACTIVATION; INHIBITOR; DOMAIN; VPS15; BINDING	Phosphatidylinositol 3-kinase Vps34 complexes regulate intracellular membrane trafficking in endocytic sorting, cytokinesis, and autophagy. We present the 4.4 angstrom crystal structure of the 385-kilodalton endosomal complex II (PIK3C3-CII), consisting of Vps34, Vps15 (p150), Vps30/Atg6 (Beclin 1), and Vps38 (UVRAG). The subunits form a Y-shaped complex, centered on the Vps34 C2 domain. Vps34 and Vps15 intertwine in one arm, where the Vps15 kinase domain engages the Vps34 activation loop to regulate its activity. Vps30 and Vps38 form the other arm that brackets the Vps15/Vps34 heterodimer, suggesting a path for complex assembly. We used hydrogen-deuterium exchange mass spectrometry (HDX-MS) to reveal conformational changes accompanying membrane binding and identify a Vps30 loop that is critical for the ability of complex II to phosphorylate giant liposomes on which complex I is inactive.	[Rostislavleva, Ksenia; Soler, Nicolas; Ohashi, Yohei; Zhang, Lufei; Burke, John E.; Masson, Glenn R.; Johnson, Chris; Williams, Roger L.] Med Res Council MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Pardon, Els; Steyaert, Jan] Struct Biol Res Ctr, VIB, B-1050 Brussels, Belgium; [Pardon, Els; Steyaert, Jan] Vrije Univ Brussel, Struct Biol Brussels, B-1050 Brussels, Belgium; [Ktistakis, Nicholas T.] Babraham Inst, Cambridge, England	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Williams, RL (corresponding author), Med Res Council MRC Lab Mol Biol, Cambridge CB2 0QH, England.	rlw@mrc-lmb.cam.ac.uk	Masson, Glenn/AAD-6546-2022; Steyaert, Jan/H-4662-2011; Burke, John/H-3922-2019; Ohashi, Yohei/AAT-4006-2021; steyaert, jan/GQP-7811-2022	Steyaert, Jan/0000-0002-3825-874X; Burke, John/0000-0001-7904-9859; Ohashi, Yohei/0000-0002-2288-130X; Masson, Glenn/0000-0002-1386-4719; Pardon, Els/0000-0002-2466-0172; Williams, Roger/0000-0001-7754-4207; Soler, Nicolas/0000-0003-1137-1213	FWO [G0C8514N]; Cambridge Cancer Center Ph.D. fellowship; MRC; Cambridge Overseas Trust; British Heart Foundation [PG11/109/29247]; UK Biotechnology and Biological Sciences Research Council [BB/K019155/1]; MRC [U105184308]; BBSRC [BBS/E/B/0000C341, BB/K019155/1] Funding Source: UKRI; MRC [MC_U105184308] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K019155/1, BBS/E/B/00001221, BBS/E/B/0000C341] Funding Source: researchfish; British Heart Foundation [PG/11/109/29247] Funding Source: researchfish; Medical Research Council [1358691, MC_U105184308] Funding Source: researchfish	FWO(FWO); Cambridge Cancer Center Ph.D. fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge Overseas Trust; British Heart Foundation(British Heart Foundation); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank O. Perisic for help with the project and with writing the manuscript; S. Munro for helpful advice and comments on the manuscript; S. Maslen, M. Skehel, and S.-Y. Peak-Chew for help with mass spectrometry; K. Willibal for help with nanobody production; O. Kovalevskiy and G. Murshodov for advice on refinement; A. McCoy for guidance on molecular replacement; F. Rutaganira and K. Shokat (University of California, San Francisco) for Vps34 inhibitors; and K. Nagai for providing yeast strain and expression backbone plasmids. We thank the beamline scientists from European Synchrotron Radiation Facility beamlines ID29, ID23-1, and BM30A; Diamond Light Source beamlines I24, I04, and I04-1; and Swiss Light Source beamline PXIII. We also thank INSTRUCT, part of the European Strategy Forum on Research Infrastructures; the Hercules Foundation Flanders; and FWO (grant G0C8514N) for their support of nanobody discovery. The plasmid used for p40PX domain expression was a gift from M. Wilson (Babraham Institute, Cambridge, UK). K.R. was supported by a Cambridge Cancer Center Ph.D. fellowship, L.Z. by MRC and the Cambridge Overseas Trust, and J.E.B. by a grant from the British Heart Foundation (PG11/109/29247). This work was funded by the UK Biotechnology and Biological Sciences Research Council (grant BB/K019155/1) and the MRC (grant U105184308 to RLW). Coordinates and structure factors have been deposited in the Protein Data Bank with accession number 5DFZ.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Araki Y, 2013, J CELL BIOL, V203, P299, DOI 10.1083/jcb.201304123; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bago R, 2014, BIOCHEM J, V463, P413, DOI 10.1042/BJ20140889; Baskaran S, 2014, ELIFE, V3, DOI 10.7554/eLife.05115; Budovskaya YV, 2002, J BIOL CHEM, V277, P287, DOI 10.1074/jbc.M109263200; Burke JE, 2012, P NATL ACAD SCI USA, V109, P15259, DOI 10.1073/pnas.1205508109; Devereaux K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076405; Dowdle WE, 2014, NAT CELL BIOL, V16, P1069, DOI 10.1038/ncb3053; Fan W, 2011, P NATL ACAD SCI USA, V108, P7769, DOI 10.1073/pnas.1016472108; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Furuya T, 2010, MOL CELL, V38, P500, DOI 10.1016/j.molcel.2010.05.009; Heenan EJ, 2009, BIOCHEMISTRY-US, V48, P6390, DOI 10.1021/bi900621w; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; HERMAN PK, 1991, EMBO J, V10, P4049, DOI 10.1002/j.1460-2075.1991.tb04981.x; Huang WJ, 2012, CELL RES, V22, P473, DOI 10.1038/cr.2012.24; Joseph RE, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004298; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kristensen L, 2015, LEUKEMIA RES, V39, P555, DOI 10.1016/j.leukres.2015.02.008; Li XH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1648; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKnight NC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004626; McLeod IX, 2011, J IMMUNOL, V187, P5051, DOI 10.4049/jimmunol.1100710; Miller S, 2010, SCIENCE, V327, P1638, DOI 10.1126/science.1184429; Munson MJ, 2015, EMBO J, V34, P2272, DOI 10.15252/embj.201590992; Murray JT, 2002, TRAFFIC, V3, P416, DOI 10.1034/j.1600-0854.2002.30605.x; Noda NN, 2012, J BIOL CHEM, V287, P16256, DOI 10.1074/jbc.M112.348250; Paithankar KS, 2010, ACTA CRYSTALLOGR D, V66, P381, DOI 10.1107/S0907444910006724; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Reese ML, 2011, J BIOL CHEM, V286, P29366, DOI 10.1074/jbc.M111.253435; Rohatgi RA, 2015, ONCOGENE, V34, P5352, DOI 10.1038/onc.2014.454; Ronan B, 2014, NAT CHEM BIOL, V10, P1013, DOI 10.1038/nchembio.1681; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shull AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043369; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; STACK JH, 1993, EMBO J, V12, P2195, DOI 10.1002/j.1460-2075.1993.tb05867.x; Stein MP, 2003, TRAFFIC, V4, P754, DOI 10.1034/j.1600-0854.2003.00133.x; Stock D, 2005, PROG BIOPHYS MOL BIO, V88, P311, DOI 10.1016/j.pbiomolbio.2004.07.009; Taylor SS, 2012, PHILOS T R SOC B, V367, P2517, DOI 10.1098/rstb.2012.0054; Thoresen SB, 2010, EXP CELL RES, V316, P3368, DOI 10.1016/j.yexcr.2010.07.008; Uemura T, 2014, MOL CELL BIOL, V34, P1695, DOI 10.1128/MCB.01327-13; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Yang YH, 2013, P NATL ACAD SCI USA, V110, P6841, DOI 10.1073/pnas.1217692110; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	51	157	166	3	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257					140	+	aac7365	10.1126/science.aac7365	http://dx.doi.org/10.1126/science.aac7365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9JB	26450213	Green Accepted, Green Published			2022-12-28	WOS:000362405600030
J	Rubin, JD; Taatjes, DJ				Rubin, Jonathan D.; Taatjes, Dylan J.			MOLECULAR BIOLOGY Mediating transcription and RNA export	NATURE			English	Editorial Material							GENE-EXPRESSION; COMPLEX; REQUIREMENT; INTEGRATOR; MEMORY		[Rubin, Jonathan D.; Taatjes, Dylan J.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA	University of Colorado System; University of Colorado Boulder	Rubin, JD (corresponding author), Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA.	taatjes@colorado.edu		Rubin, Jonathan/0000-0003-1129-2910	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM008759, T32 GM142607] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Chen JD, 2012, RNA, V18, P2148, DOI 10.1261/rna.035725.112; D'Urso A, 2014, TRENDS GENET, V30, P230, DOI 10.1016/j.tig.2014.04.004; Green DM, 2002, J BIOL CHEM, V277, P7752, DOI 10.1074/jbc.M110053200; Huang Y, 2012, MOL CELL, V45, P459, DOI 10.1016/j.molcel.2011.12.022; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kohler A, 2008, NAT CELL BIOL, V10, P707, DOI 10.1038/ncb1733; Koschubs T, 2009, EMBO J, V28, P69, DOI 10.1038/emboj.2008.254; Mukundan B, 2013, J BIOL CHEM, V288, P11384, DOI 10.1074/jbc.M112.446773; Schneider M, 2015, CELL, V162, P1016, DOI 10.1016/j.cell.2015.07.059; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; Therizols P, 2014, SCIENCE, V346, P1238, DOI 10.1126/science.1259587; Yu MC, 2004, GENE DEV, V18, P2024, DOI 10.1101/gad.1223204	13	3	3	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					199	200		10.1038/526199a	http://dx.doi.org/10.1038/526199a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26450052	Green Accepted			2022-12-28	WOS:000362399000032
J	Schunemann, HJ; Al-Ansary, LA; Forland, F; Kersten, S; Komulainen, J; Kopp, IB; Macbeth, F; Phillips, SM; Robbins, C; Van der Wees, P; Qaseem, A				Schunemann, Holger J.; Al-Ansary, Lubna A.; Forland, Frode; Kersten, Sonja; Komulainen, Jorma; Kopp, Ina B.; Macbeth, Fergus; Phillips, Susan M.; Robbins, Craig; van der Wees, Philip; Qaseem, Amir		Board Trustees Guidelines Int	Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL-PRACTICE GUIDELINES; OF-INTEREST; AMERICAN-COLLEGE; PHYSICIANS; STATEMENT; AUTHORS; POLICY	Conflicts of interest (COIs) have been defined by the American Thoracic Society as "a divergence between an individual's private interests and his or her professional obligations such that an independent observer might reasonably question whether the individual's professional actions or decisions are motivated by personal gain, such as direct financial, academic advancement, clinical revenue streams, or community standing." In the context of guideline development, the concerns are not simply about identifying and disclosing direct financial or indirect COIs. Despite this recognition, the management of COIs in guidelines is often unsatisfactory. In response to requests from its international membership and informed by existing syntheses of the evidence and policies of international organizations, the Guidelines International Network Board of Trustees developed guidance on the disclosure of interests and management of COIs. Current approaches are relatively similar throughout the guideline development community, with an increasing recognition of the importance of disclosing and managing indirect COIs. Although there are differences in detail among the approaches, the similarities allow for the formulation of 9 core principles for managing COIs. In formulating these principles, the Guidelines International Network Board of Trustees recognizes that COIs cannot be totally avoided when panel members are being chosen for certain guidelines or in certain settings; thus, the important issue is the management of COIs in a fair, judicious, transparent manner.	[Schunemann, Holger J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4K1, Canada; [Al-Ansary, Lubna A.] King Saud Univ, Coll Med, Dept Family & Community Med, Riyadh 11461, Saudi Arabia; [Forland, Frode] Norwegian Inst Publ Hlth, Dept Int Publ Hlth, N-0473 Oslo, Norway; [Komulainen, Jorma] Finnish Med Soc Duodecim, Helsinki 00101, Finland; [Kopp, Ina B.] Univ Marburg, Assoc Sci Med Soc Germany, Inst Med Knowledge Management, D-35043 Marburg, Germany; [Kersten, Sonja] Integraal Kankercentrum Nederland, NL-3511 DT Utrecht, Netherlands; [Macbeth, Fergus] Cardiff Univ, Wales Canc Trials Unit, Cardiff CF14 4YS, Wales; [Phillips, Susan M.] Therapeut Guidelines, Melbourne, Vic 3003, Australia; [Robbins, Craig] Colorado Permanente Med Grp, Aurora, CO 80015 USA; [van der Wees, Philip] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare IQ Healthcare, Acad Sustainable Healthcare, NL-6500 HB Nijmegen, Netherlands; [Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA	McMaster University; King Saud University; Norwegian Institute of Public Health (NIPH); Philipps University Marburg; Cardiff University; Permanente Medical Groups; Radboud University Nijmegen; American College of Physicians	Schunemann, HJ (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hlth Sci Ctr Room 2C16,1280 Main St West, Hamilton, ON L8S 4K1, Canada.		van der Wees, Philip Jan/L-4748-2015	Schunemann, Holger/0000-0003-3211-8479; Al-Ansary, Lubna/0000-0001-7127-914X; Phillips, Susan/0000-0001-7336-2190				Abramson J, 2005, J AM BOARD FAM PRACT, V18, P414, DOI 10.3122/jabfm.18.5.414; Akl EA, 2014, J CLIN EPIDEMIOL, V67, P1222, DOI 10.1016/j.jclinepi.2014.05.006; Boyd Elizabeth A, 2006, Health Res Policy Syst, V4, P16, DOI 10.1186/1478-4505-4-16; Boyd Elizabeth A, 2012, Proc Am Thorac Soc, V9, P234, DOI 10.1513/pats.201208-057ST; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; Committee on Standards for Developing Trust- worthy Clinical Practice Guidelines Institute of Medi- cine (US), 2011, CLIN PRACTICE GUIDEL; Dana J, 2003, JAMA-J AM MED ASSOC, V290, P252, DOI 10.1001/jama.290.2.252; Davidoff F, 1997, ANN INTERN MED, V126, P986, DOI 10.7326/0003-4819-126-12-199706150-00011; Guyatt G, 2010, ANN INTERN MED, V152, P738, DOI 10.7326/0003-4819-152-11-201006010-00254; Jones DJ, 2012, ANN INTERN MED, V156, P809, DOI 10.7326/0003-4819-156-11-201206050-00008; Jones DJ, 2012, ANN INTERN MED, V156, pW; National Institute for Health and Care Excellence, 2015, POL CONFL INT; Neumann I, 2013, CHEST, V144, P1111, DOI 10.1378/chest.13-0169; Norris SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047343; Norris SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037413; Norris SL, 2012, J CLIN EPIDEMIOL, V65, P725, DOI 10.1016/j.jclinepi.2011.12.011; Papanikolaou G N, 2001, BMC Med Res Methodol, V1, P3, DOI 10.1186/1471-2288-1-3; Qaseem A, 2012, ANN INTERN MED, V156, P525, DOI 10.7326/0003-4819-156-7-201204030-00009; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Schunemann HJ, 2014, CAN MED ASSOC J, V186, pE123, DOI 10.1503/cmaj.131237; Schunemann HJ, 2009, AM J RESP CRIT CARE, V180, P564, DOI 10.1164/rccm.200901-0126ST; Schunemann HJ, 2009, LANCET, V373, P774, DOI 10.1016/S0140-6736(08)61347-1; Sniderman AD, 2012, J CLIN EPIDEMIOL, V65, P705, DOI 10.1016/j.jclinepi.2012.01.009; Stokes T, 2015, MANAGING CONFLICTS I; THOMPSON DF, 1993, NEW ENGL J MED, V329, P573, DOI 10.1056/NEJM199308193290812; U.S. Preventive Services Task Force, 2020, PROC MAN; World Health Organization, 2015, DECL INT WHO EXP FOR	27	156	169	1	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2015	163	7					548	+		10.7326/M14-1885	http://dx.doi.org/10.7326/M14-1885			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT0OQ	26436619				2022-12-28	WOS:000362496400008
J	Donny, EC; Denlinger, RL; Tidey, JW; Koopmeiners, JS; Benowitz, NL; Vandrey, RG; Al'Absi, M; Carmella, SG; Cinciripini, PM; Dermody, SS; Drobes, DJ; Hecht, SS; Jensen, J; Lane, T; Le, CT; McClernon, FJ; Montoya, ID; Murphy, SE; Robinson, JD; Stitzer, ML; Strasser, AA; Tindle, H; Hatsukami, DK				Donny, Eric C.; Denlinger, Rachel L.; Tidey, Jennifer W.; Koopmeiners, Joseph S.; Benowitz, Neal L.; Vandrey, Ryan G.; al'Absi, Mustafa; Carmella, Steven G.; Cinciripini, Paul M.; Dermody, Sarah S.; Drobes, David J.; Hecht, Stephen S.; Jensen, Joni; Lane, Tonya; Le, Chap T.; McClernon, F. Joseph; Montoya, Ivan D.; Murphy, Sharon E.; Robinson, Jason D.; Stitzer, Maxine L.; Strasser, Andrew A.; Tindle, Hilary; Hatsukami, Dorothy K.			Randomized Trial of Reduced-Nicotine Standards for Cigarettes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPENSATORY SMOKING; EXPOSURE; DEPENDENCE; BIOMARKERS; WITHDRAWAL; METABOLISM; REDUCTION; COTININE	BACKGROUND The Food and Drug Administration can set standards that reduce the nicotine content of cigarettes. METHODS We conducted a double-blind, parallel, randomized clinical trial between June 2013 and July 2014 at 10 sites. Eligibility criteria included an age of 18 years or older, smoking of five or more cigarettes per day, and no current interest in quitting smoking. Participants were randomly assigned to smoke for 6 weeks either their usual brand of cigarettes or one of six types of investigational cigarettes, provided free. The investigational cigarettes had nicotine content ranging from 15.8 mg per gram of tobacco (typical of commercial brands) to 0.4 mg per gram. The primary outcome was the number of cigarettes smoked per day during week 6. RESULTS A total of 840 participants underwent randomization, and 780 completed the 6-week study. During week 6, the average number of cigarettes smoked per day was lower for participants randomly assigned to cigarettes containing 2.4, 1.3, or 0.4 mg of nicotine per gram of tobacco (16.5, 16.3, and 14.9 cigarettes, respectively) than for participants randomly assigned to their usual brand or to cigarettes containing 15.8 mg per gram (22.2 and 21.3 cigarettes, respectively; P<0.001). Participants assigned to cigarettes with 5.2 mg per gram smoked an average of 20.8 cigarettes per day, which did not differ significantly from the average number among those who smoked control cigarettes. Cigarettes with lower nicotine content, as compared with control cigarettes, reduced exposure to and dependence on nicotine, as well as craving during abstinence from smoking, without significantly increasing the expired carbon monoxide level or total puff volume, suggesting minimal compensation. Adverse events were generally mild and similar among groups. CONCLUSIONS In this 6-week study, reduced-nicotine cigarettes versus standard-nicotine cigarettes reduced nicotine exposure and dependence and the number of cigarettes smoked.	[Donny, Eric C.; Denlinger, Rachel L.; Dermody, Sarah S.; Lane, Tonya] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Tindle, Hilary] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; [Tidey, Jennifer W.] Brown Univ, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA; [Koopmeiners, Joseph S.; Le, Chap T.] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Murphy, Sharon E.] Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA; [Murphy, Sharon E.] Univ Minnesota, Dept Mol Biol, Minneapolis, MN 55455 USA; [Murphy, Sharon E.] Univ Minnesota, Dept Biophys, Minneapolis, MN 55455 USA; [Hatsukami, Dorothy K.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Koopmeiners, Joseph S.; Carmella, Steven G.; Hecht, Stephen S.; Jensen, Joni; Le, Chap T.; Murphy, Sharon E.; Hatsukami, Dorothy K.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA; [al'Absi, Mustafa] Univ Minnesota, Sch Med, Duluth, MN 55812 USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA USA; [Vandrey, Ryan G.; Stitzer, Maxine L.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Montoya, Ivan D.] NIDA, Bethesda, MD 20892 USA; [Cinciripini, Paul M.; Robinson, Jason D.] Univ Texas MD Anderson Canc Ctr, Dept Behav Sci, Houston, TX 77030 USA; [Drobes, David J.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Hlth Outcomes & Behav, Tampa, FL 33682 USA; [McClernon, F. Joseph] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC USA; [Strasser, Andrew A.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Strasser, Andrew A.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Brown University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Duluth; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of Texas System; UTMD Anderson Cancer Center; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Duke University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Donny, EC (corresponding author), Univ Pittsburgh, Dept Psychol, 210 S Bouquet St, Pittsburgh, PA 15260 USA.	edonny@pitt.edu	Robinson, Jason D/C-6433-2009	Robinson, Jason D/0000-0002-1588-9637; Hecht, Stephen/0000-0001-7228-1356; Donny, Eric/0000-0003-3288-9652	National Institute on Drug Abuse; Food and Drug Administration Center for Tobacco Products; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA031659] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Food and Drug Administration Center for Tobacco Products; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funded by the National Institute on Drug Abuse and the Food and Drug Administration Center for Tobacco Products; ClinicalTrials.gov number, NCT01681875.	Benowitz NL, 2007, CANCER EPIDEM BIOMAR, V16, P2479, DOI 10.1158/1055-9965.EPI-07-0393; Benowitz NL, 2013, TOB CONTROL, V22, P14, DOI 10.1136/tobaccocontrol-2012-050860; Benowitz NL, 2012, CANCER EPIDEM BIOMAR, V21, P761, DOI 10.1158/1055-9965.EPI-11-0644; Benowitz NL, 2009, NICOTINE TOB RES, V11, P954, DOI 10.1093/ntr/ntp092; BENOWITZ NL, 1994, NEW ENGL J MED, V331, P123, DOI 10.1056/NEJM199407143310212; Camella SG, 2013, CHEM RES TOXICOL, V26, P1209, DOI 10.1021/tx400121n; Cox L S, 2001, Nicotine Tob Res, V3, P7, DOI 10.1080/14622200020032051; Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; Dermody SS, 2014, TOB CONTROL; Donny EC, 2007, ADDICTION, V102, P324, DOI 10.1111/j.1360-0443.2006.01670.x; Donny EC, 2014, PREV MED, V68, P17, DOI 10.1016/j.ypmed.2014.06.020; Hatsukami DK, 2013, BIOMARKERS PREV, V22, P1015; Hatsukami DK, 2015, CANCER EPIDEM BIOMAR, V24, P472, DOI 10.1158/1055-9965.EPI-14-0739; Hatsukami DK, 2010, ADDICTION, V105, P343, DOI 10.1111/j.1360-0443.2009.02780.x; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Henningfield JE, 1998, TOB CONTROL, V7, P281, DOI 10.1136/tc.7.3.281; HUGHES JR, 1986, ARCH GEN PSYCHIAT, V43, P289; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; Institute of Medicine, 2007, ENDING TOBACCO PROBL; Jha P., 1999, CURBING EPIDEMIC GOV; Kozlowski LT, 2002, TOB CONTROL, V11, pI40, DOI 10.1136/tc.11.suppl_1.i40; MacQueen DA, 2012, PSYCHOPHARMACOLOGY, V223, P47, DOI 10.1007/s00213-012-2685-1; Murphy SE, 2014, CARCINOGENESIS, V35, P2526, DOI 10.1093/carcin/bgu191; Murphy SE, 2013, J EXPO SCI ENV EPID, V23, P513, DOI 10.1038/jes.2013.7; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Scherer G, 2007, REGUL TOXICOL PHARM, V47, P171, DOI 10.1016/j.yrtph.2006.09.001; Smith SS, 2010, NICOTINE TOB RES, V12, P489, DOI 10.1093/ntr/ntq032; Tengs TO, 2005, PREV MED, V40, P170, DOI 10.1016/j.ypmed.2004.05.017; Thuerauf N, 1999, PSYCHOPHARMACOLOGY, V142, P236, DOI 10.1007/s002130050885; Toll BA, 2007, PSYCHOL ADDICT BEHAV, V21, P216, DOI 10.1037/0893-164X.21.2.216; WHO Study Group on Tobacco Product Regulation, 2009, REP SCI BAS TOB PROD; World Health Organization, 2003, WHO FRAM CONV TOB CO	32	271	280	1	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2015	373	14					1340	1349		10.1056/NEJMsa1502403	http://dx.doi.org/10.1056/NEJMsa1502403			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS3CI	26422724	Green Accepted, Green Submitted			2022-12-28	WOS:000361948600008
J	Wolfson, RL; Chantranupong, L; Saxton, RA; Shen, K; Scaria, SM; Cantor, JR; Sabatini, DM				Wolfson, Rachel L.; Chantranupong, Lynne; Saxton, Robert A.; Shen, Kuang; Scaria, Sonia M.; Cantor, Jason R.; Sabatini, David M.			METABOLISM Sestrin2 is a leucine sensor for the mTORC1 pathway	SCIENCE			English	Article							AMINO-ACID SUFFICIENCY; GTP-BINDING PROTEINS; P70 S6 KINASE; RAG GTPASES; DIETARY-RESTRICTION; TUMOR-SUPPRESSOR; IDENTIFICATION; ACTIVATION; INSULIN; COMPLEX	Leucine is a proteogenic amino acid that also regulatesmany aspects ofmammalian physiology, in large part by activating the mTOR complex 1 (mTORC1) protein kinase, a master growth controller. Amino acids signal to mTORC1 through the Rag guanosine triphosphatases (GTPases). Several factors regulate the Rags, including GATOR1, a GTPase-activating protein; GATOR2, a positive regulator of unknown function; and Sestrin2, a GATOR2-interacting protein that inhibits mTORC1 signaling. We find that leucine, but not arginine, disrupts the Sestrin2-GATOR2 interaction by binding to Sestrin2 with a dissociation constant of 20 micromolar, which is the leucine concentration that half-maximally activates mTORC1. The leucine-binding capacity of Sestrin2 is required for leucine to activate mTORC1 in cells. These results indicate that Sestrin2 is a leucine sensor for the mTORC1 pathway.	[Wolfson, Rachel L.; Chantranupong, Lynne; Saxton, Robert A.; Shen, Kuang; Scaria, Sonia M.; Cantor, Jason R.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Wolfson, Rachel L.; Chantranupong, Lynne; Saxton, Robert A.; Shen, Kuang; Scaria, Sonia M.; Cantor, Jason R.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Wolfson, Rachel L.; Chantranupong, Lynne; Saxton, Robert A.; Shen, Kuang; Scaria, Sonia M.; Cantor, Jason R.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Wolfson, Rachel L.; Chantranupong, Lynne; Saxton, Robert A.; Shen, Kuang; Cantor, Jason R.; Sabatini, David M.] Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Wolfson, Rachel L.; Chantranupong, Lynne; Saxton, Robert A.; Shen, Kuang; Cantor, Jason R.; Sabatini, David M.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Shen, Kuang/H-9441-2016	Saxton, Robert/0000-0001-9777-8270; /0000-0002-1446-7256	Navitor Pharmaceuticals; NIH [R01 CA103866, AI47389, T32 GM007753, F30 CA189333, F31 CA180271]; Department of Defense [W81XWH-07-0448]; Paul Gray Undergraduate Research Opportunities Program Fund [3143900]; NATIONAL CANCER INSTITUTE [F30CA189333, P30CA014051, R01CA103866, F31CA180271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389, R01AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, T32GM007287] Funding Source: NIH RePORTER	Navitor Pharmaceuticals; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Paul Gray Undergraduate Research Opportunities Program Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D.M.S. is a founder, a member of the Scientific Advisory Board, a paid consultant, and a shareholder of Navitor Pharmaceuticals, which is targeting for therapeutic benefit the amino acid sensing pathway upstream of mTORC1. The His-MBP-Sestrin2 pMAL6H-C5XT plasmid is available from Navitor Pharmaceuticals under a materials transfer agreement with Navitor Pharmaceuticals. R.L.W., L.C., R.A.S., D.M.S., and the Whitehead Institute have filed two provisional patents that relate to the Sestrin2-GATOR2 interaction. We thank all members of the Sabatini Lab for helpful insights, in particular S. Wang for experimental advice; O. Levsh, from the laboratory of J.-K. Weng, for generously providing the control proteins used in the thermal shift assays; Navitor Pharmaceuticals for providing the His-MBP-Sestrin2 pMAL6H-C5XT plasmid; and Cell Signaling Technology for providing many antibodies. This work was supported by grants from NIH (R01 CA103866 and AI47389) and the Department of Defense (W81XWH-07-0448) to D.M.S.; fellowship support from NIH to R.L.W. (T32 GM007753 and F30 CA189333) and L.C. (F31 CA180271); and a grant from the Paul Gray Undergraduate Research Opportunities Program Fund to S.M.S. (3143900). K.S. is a Pfizer Fellow of the Life Sciences Research Foundation. D.M.S. is an investigator of the Howard Hughes Medical Institute.	Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; BUCKBINDER L, 1994, P NATL ACAD SCI USA, V91, P10640, DOI 10.1073/pnas.91.22.10640; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; Chantranupong L, 2015, CELL, V161, P67, DOI 10.1016/j.cell.2015.02.041; Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014; Chen X, 2011, NUCLEIC ACIDS RES, V39, P235, DOI 10.1093/nar/gkq763; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Efeyan A, 2013, BIOCHEM SOC T, V41, P902, DOI 10.1042/BST20130063; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Fox Heather L., 1998, American Journal of Physiology, V275, pC1232; FRAME EG, 1958, J CLIN INVEST, V37, P1710, DOI 10.1172/JCI103763; Gallinetti J, 2013, BIOCHEM J, V449, P1, DOI 10.1042/BJ20121098; Greiwe JS, 2001, AM J PHYSIOL-ENDOC M, V281, pE466, DOI 10.1152/ajpendo.2001.281.3.E466; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; HARPER AE, 1984, ANNU REV NUTR, V4, P409, DOI 10.1146/annurev.nu.04.070184.002205; Hirose E, 1998, J CELL SCI, V111, P11; Katsanos CS, 2006, AM J PHYSIOL-ENDOC M, V291, pE381, DOI 10.1152/ajpendo.00488.2005; Kennedy BK, 2007, CELL MOL LIFE SCI, V64, P1323, DOI 10.1007/s00018-007-6470-y; Layman DK, 2006, J NUTR, V136, p319S, DOI 10.1093/jn/136.1.319S; Lynch CJ, 2000, J CELL BIOCHEM, V77, P234, DOI 10.1002/(SICI)1097-4644(20000501)77:2<234::AID-JCB7>3.0.CO;2-I; MCCAY CM, 1989, NUTRITION, V5, P155; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; NAIR KS, 1992, AM J PHYSIOL, V263, pE928, DOI 10.1152/ajpendo.1992.263.5.E928; PANTEN U, 1974, DIABETOLOGIA, V10, P149, DOI 10.1007/BF01219672; Parmigiani A, 2014, CELL REP, V9, P1281, DOI 10.1016/j.celrep.2014.10.019; Peeters H, 2003, HUM GENET, V112, P573, DOI 10.1007/s00439-003-0917-5; Peng M, 2014, CELL, V159, P122, DOI 10.1016/j.cell.2014.08.038; Potier M, 2009, CURR OPIN CLIN NUTR, V12, P54, DOI 10.1097/MCO.0b013e32831b9e01; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Rogez-Florent T, 2014, J MOL RECOGNIT, V27, P46, DOI 10.1002/jmr.2330; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; SCHURMANN A, 1995, J BIOL CHEM, V270, P28982, DOI 10.1074/jbc.270.48.28982; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	43	645	675	9	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268					43	48		10.1126/science.aab2674	http://dx.doi.org/10.1126/science.aab2674			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ8QM	26449471	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000367364200037
J	Peng, T; Frank, DB; Kadzik, RS; Morley, MP; Rathi, KS; Wang, T; Zhou, S; Cheng, L; Lu, MM; Morrisey, EE				Peng, Tien; Frank, David B.; Kadzik, Rachel S.; Morley, Michael P.; Rathi, Komal S.; Wang, Tao; Zhou, Su; Cheng, Lan; Lu, Min Min; Morrisey, Edward E.			Hedgehog actively maintains adult lung quiescence and regulates repair and regeneration	NATURE			English	Article							SONIC HEDGEHOG; STEM-CELLS; MOUSE; PROLIFERATION; PROGENITORS; ACTIVATION; PLASTICITY; EPITHELIUM; FIBROSIS; PATHWAY	Postnatal tissue quiescence is thought to be a default state in the absence of a proliferative stimulus such as injury. Although previous studies have demonstrated that certain embryonic developmental programs are reactivated aberrantly in adult organs to drive repair and regeneration(1-3), it is not well understood how quiescence is maintained in organs such as the lung, which displays a remarkably low level of cellular turnover(4,5). Here we demonstrate that quiescence in the adult lung is an actively maintained state and is regulated by hedgehog signalling. Epithelial-specific deletion of sonic hedgehog (Shh) during postnatal homeostasis in the murine lung results in a proliferative expansion of the adjacent lung mesenchyme. Hedgehog signalling is initially downregulated during the acute phase of epithelial injury as the mesenchyme proliferates in response, but returns to baseline during injury resolution as quiescence is restored. Activation of hedgehog during acute epithelial injury attenuates the proliferative expansion of the lung mesenchyme, whereas inactivation of hedgehog signalling prevents the restoration of quiescence during injury resolution. Finally, we show that hedgehog also regulates epithelial quiescence and regeneration in response to injury via a mesenchymal feedback mechanism. These results demonstrate that epithelial-mesenchymal interactions coordinated by hedgehog actively maintain postnatal tissue homeostasis, and deregulation of hedgehog during injury leads to aberrant repair and regeneration in the lung.	[Peng, Tien; Morley, Michael P.; Rathi, Komal S.; Morrisey, Edward E.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Frank, David B.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Kadzik, Rachel S.; Morrisey, Edward E.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Morley, Michael P.; Rathi, Komal S.; Morrisey, Edward E.] Univ Penn, Penn Ctr Pulm Biol, Philadelphia, PA 19104 USA; [Morley, Michael P.; Rathi, Komal S.; Wang, Tao; Zhou, Su; Cheng, Lan; Lu, Min Min; Morrisey, Edward E.] Univ Penn, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA; [Morrisey, Edward E.] Univ Penn, Penn Inst Regenerat Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Morrisey, EE (corresponding author), Univ Penn, Dept Med, Philadelphia, PA 19104 USA.	tien.peng@ucsf.edu; emorrise@mail.med.upenn.edu	Rathi, Komal S/ABA-1146-2021; Bertoncello, Ivan/B-9235-2008	Rathi, Komal S/0000-0001-5534-6904; Morley, Michael/0000-0002-0958-7376	National Institutes of Health [HL110942, HL100405, HL087825]; American Heart Association Fellow-to-Faculty Transition Award; Actelion ENTELLIGENCE Award;  [K08-HL121146]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL121146, U01HL100405, T32HL007915, U01HL110942, R01HL087825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Fellow-to-Faculty Transition Award(American Heart Association); Actelion ENTELLIGENCE Award; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors appreciate the input of M. Kahn, M. Beers and R. Shah in these studies. The authors are grateful to A. Stout and the Department of Cell and Developmental Biology Microscopy Core for help with imaging. These studies were supported by funds from the National Institutes of Health (HL110942, HL100405, HL087825 to E.E.M). T.P. is supported by the American Heart Association Fellow-to-Faculty Transition Award, Actelion ENTELLIGENCE Award, and K08-HL121146.	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Bai CB, 2002, DEVELOPMENT, V129, P4753; Beers MF, 2011, J CLIN INVEST, V121, P2065, DOI 10.1172/JCI45961; BLENKINSOPP WK, 1967, EXP CELL RES, V46, P144, DOI 10.1016/0014-4827(67)90416-8; BREUER R, 1990, AM J RESP CELL MOL, V2, P51, DOI 10.1165/ajrcmb/2.1.51; BUCKPITT AR, 1986, BIOCHEM PHARMACOL, V35, P645, DOI 10.1016/0006-2952(86)90361-8; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Herriges M, 2014, DEVELOPMENT, V141, P502, DOI 10.1242/dev.098186; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Li HG, 2008, GENESIS, V46, P300, DOI 10.1002/dvg.20396; Liu L, 2013, AM J RESP CELL MOL, V48, P703, DOI 10.1165/rcmb.2012-0347OC; Long FX, 2001, DEVELOPMENT, V128, P5099; Bolanos AL, 2012, AM J PHYSIOL-LUNG C, V303, pL978, DOI 10.1152/ajplung.00184.2012; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Olson LE, 2011, DEV CELL, V20, P815, DOI 10.1016/j.devcel.2011.04.019; Olson LE, 2009, DEV CELL, V16, P303, DOI 10.1016/j.devcel.2008.12.003; Peng T, 2013, NATURE, V500, P589, DOI 10.1038/nature12358; Rawlins EL, 2007, P NATL ACAD SCI USA, V104, P410, DOI 10.1073/pnas.0610770104; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Wang Y, 2013, DEV CELL, V24, P345, DOI 10.1016/j.devcel.2013.01.012; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Zemke AC, 2009, AM J RESP CELL MOL, V41, P535, DOI 10.1165/rcmb.2008-0407OC	29	130	131	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					578	U282		10.1038/nature14984	http://dx.doi.org/10.1038/nature14984			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26436454	Green Submitted, Green Accepted			2022-12-28	WOS:000364026100051
J	Cleland, AN				Cleland, Andrew N.			Pumping up the quantum	SCIENCE			English	Editorial Material									Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA	University of Chicago	Cleland, AN (corresponding author), Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA.	anc@uchicago.edu	Cleland, Andrew/AAG-7581-2019					Castellanos-Beltrana MA, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2773988; Macklin C, 2015, SCIENCE, V350, P307, DOI 10.1126/science.aaa8525; O'Brien K, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.157001; Varian RH, 1939, J APPL PHYS, V10, P321, DOI 10.1063/1.1707311	4	0	0	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2015	350	6258					280	280		10.1126/science.aad0858	http://dx.doi.org/10.1126/science.aad0858			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT5HD	26472896				2022-12-28	WOS:000362838700022
J	Clement, A; Bellomo, K; Murphy, LN; Cane, MA; Mauritsen, T; Radel, G; Stevens, B				Clement, Amy; Bellomo, Katinka; Murphy, Lisa N.; Cane, Mark A.; Mauritsen, Thorsten; Raedel, Gaby; Stevens, Bjorn			The Atlantic Multidecadal Oscillation without a role for ocean circulation	SCIENCE			English	Article							SEA-SURFACE TEMPERATURE; NORTH-ATLANTIC; THERMOHALINE CIRCULATION; CLIMATE VARIABILITY; ATMOSPHERE MODEL; IMPACT; HEMISPHERE; RAINFALL	The Atlantic Multidecadal Oscillation (AMO) is a major mode of climate variability with important societal impacts. Most previous explanations identify the driver of the AMO as the ocean circulation, specifically the Atlantic Meridional Overturning Circulation (AMOC). Here we show that the main features of the observed AMO are reproduced in models where the ocean heat transport is prescribed and thus cannot be the driver. Allowing the ocean circulation to interact with the atmosphere does not significantly alter the characteristics of the AMO in the current generation of climate models. These results suggest that the AMO is the response to stochastic forcing from the mid-latitude atmospheric circulation, with thermal coupling playing a role in the tropics. In this view, the AMOC and other ocean circulation changes would be largely a response to, not a cause of, the AMO.	[Clement, Amy; Bellomo, Katinka; Murphy, Lisa N.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Cane, Mark A.] Columbia Univ, Lamont Doherty Earth Observ, New York, NY USA; [Mauritsen, Thorsten; Raedel, Gaby; Stevens, Bjorn] Max Planck Inst Meteorol, D-20146 Hamburg, Germany	University of Miami; Columbia University; Max Planck Society	Clement, A (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	aclement@rsmas.miami.edu	Murphy, Lisa/B-8547-2013; Stevens, Bjorn/A-1757-2013; Mauritsen, Thorsten/G-5880-2013; Kushnir, Yochanan/B-4472-2013	Murphy, Lisa/0000-0003-4343-8005; Stevens, Bjorn/0000-0003-3795-0475; Mauritsen, Thorsten/0000-0003-1418-4077; Cane, Mark/0000-0001-5408-2388	U.S. Department of Energy; National Oceanographic and Atmospheric Administration; Office of Naval Research [N00014-12-1-0911]	U.S. Department of Energy(United States Department of Energy (DOE)); National Oceanographic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Office of Naval Research(Office of Naval Research)	This work was supported by grants from the U.S. Department of Energy and the National Oceanographic and Atmospheric Administration. M.A.C. was supported by Office of Naval Research grant N00014-12-1-0911. The authors are grateful to Y. Kushnir, G. Schmidt, B. Kirtman, C. Frankignoul, and C. Deser for lively discussions. All CMIP data are available at http://cmip-pcmdi.llnl.gov/. Data from simulations with the CAM4 model can be obtained by e-mailing the corresponding author.	Ba J, 2014, CLIM DYNAM, V43, P2333, DOI 10.1007/s00382-014-2056-1; Bellomo K, 2015, J CLIMATE, V28, P2725, DOI 10.1175/JCLI-D-14-00495.1; Booth BBB, 2012, NATURE, V484, P228, DOI 10.1038/nature10946; Brueck M, 2015, J ATMOS SCI, V72, P1428, DOI 10.1175/JAS-D-14-0054.1; Chiang JCH, 2004, J CLIMATE, V17, P4143, DOI 10.1175/JCLI4953.1; DELWORTH T, 1993, J CLIMATE, V6, P1993, DOI 10.1175/1520-0442(1993)006<1993:IVOTTC>2.0.CO;2; Delworth TL, 2000, CLIM DYNAM, V16, P661, DOI 10.1007/s003820000075; Delworth TL, 2000, J CLIMATE, V13, P1481, DOI 10.1175/1520-0442(2000)013<1481:MTCVDB>2.0.CO;2; Enfield DB, 1997, J GEOPHYS RES-OCEANS, V102, P929, DOI 10.1029/96JC03296; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Evan AT, 2013, J CLIMATE, V26, P3619, DOI 10.1175/JCLI-D-12-00370.1; Held I M, 1983, LARGE SCALE DYNAMICA, P127; Kerr RA, 2005, SCIENCE, V309, P41, DOI 10.1126/science.309.5731.41; Klower M, 2014, EARTH PLANET SC LETT, V406, P1, DOI 10.1016/j.epsl.2014.09.001; Knight JR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026242; Knight JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024233; Latif M, 2004, J CLIMATE, V17, P1605, DOI 10.1175/1520-0442(2004)017<1605:RMAPMC>2.0.CO;2; Mann M, 2006, EOS, V87, P238; Mann M.E., 2006, EOS, V87, P233, DOI 10.1029/2006EO240001; Marini C, 2014, CLIM DYNAM, V43, P607, DOI 10.1007/s00382-013-1852-3; McCarthy GD, 2015, NATURE, V521, P508, DOI 10.1038/nature14491; Qu X, 2014, CLIM DYNAM, V42, P2603, DOI 10.1007/s00382-013-1945-z; Saravanan R, 1998, J CLIMATE, V11, P1386, DOI 10.1175/1520-0442(1998)011<1386:ALFVAI>2.0.CO;2; Seager R, 2000, J CLIMATE, V13, P2845, DOI 10.1175/1520-0442(2000)013<2845:COAOCV>2.0.CO;2; Semenov VA, 2010, J CLIMATE, V23, P5668, DOI 10.1175/2010JCLI3347.1; Stevens B, 2015, J CLIMATE, V28, P4794, DOI 10.1175/JCLI-D-14-00656.1; Sutton RT, 2005, SCIENCE, V309, P115, DOI 10.1126/science.1109496; Tandon NF, 2015, J CLIMATE, V28, P6309, DOI 10.1175/JCLI-D-14-00664.1; Visbeck M, 1998, GEOPHYS RES LETT, V25, P4521, DOI 10.1029/1998GL900162; Wang CZ, 2013, J CLIMATE, V26, P6137, DOI 10.1175/JCLI-D-12-00721.1; Wunsch C, 1999, B AM METEOROL SOC, V80, P245, DOI 10.1175/1520-0477(1999)080<0245:TIOSCR>2.0.CO;2; Xie SP, 1999, J CLIMATE, V12, P64, DOI 10.1175/1520-0442-12.1.64; Zhang R, 2005, J CLIMATE, V18, P1853, DOI 10.1175/JCLI3460.1; Zhang R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026267; Zhang R, 2013, J ATMOS SCI, V70, P1135, DOI 10.1175/JAS-D-12-0331.1; [No title captured]	36	229	234	7	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2015	350	6258					320	+		10.1126/science.aab3980	http://dx.doi.org/10.1126/science.aab3980			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT5HD	26472908				2022-12-28	WOS:000362838700041
J	Datta, SJ; Khumnoon, C; Lee, ZH; Moon, WK; Docao, S; Nguyen, TH; Hwang, IC; Moon, D; Oleynikov, P; Terasaki, O; Yoon, KB				Datta, Shuvo Jit; Khumnoon, Chutharat; Lee, Zhen Hao; Moon, Won Kyung; Docao, Son; Nguyen, Thanh Huu; Hwang, In Chul; Moon, Dohyun; Oleynikov, Peter; Terasaki, Osamu; Yoon, Kyung Byung			CO2 capture from humid flue gases and humid atmosphere using a microporous coppersilicate	SCIENCE			English	Article							METAL-ORGANIC FRAMEWORK; CARBON-DIOXIDE CAPTURE; POROUS MATERIALS; ADSORPTION; ADSORBENTS; SEPARATION	Capturing CO2 from humid flue gases and atmosphere with porous materials remains costly because prior dehydration of the gases is required. A large number of microporous materials with physical adsorption capacity have been developed as CO2-capturing materials. However, most of them suffer from CO2 sorption capacity reduction or structure decomposition that is caused by co-adsorbed H2O when exposed to humid flue gases and atmosphere. We report a highly stable microporous coppersilicate. It has H2O-specific and CO2-specific adsorption sites but does not have H2O/CO2-sharing sites. Therefore, it readily adsorbs both H2O and CO2 from the humid flue gases and atmosphere, but the adsorbing H2O does not interfere with the adsorption of CO2. It is also highly stable after adsorption of H2O and CO2 because it was synthesized hydrothermally.	[Datta, Shuvo Jit; Khumnoon, Chutharat; Lee, Zhen Hao; Moon, Won Kyung; Docao, Son; Nguyen, Thanh Huu; Hwang, In Chul; Yoon, Kyung Byung] Sogang Univ, Dept Chem, Korea Ctr Artificial Photosynthesis, Seoul 121742, South Korea; [Moon, Dohyun] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang 790784, South Korea; [Oleynikov, Peter; Terasaki, Osamu] Stockholm Univ, Dept Mat & Environm Chem, SE-10691 Stockholm, Sweden; [Terasaki, Osamu] Korea Adv Inst Sci & Technol, Grad Sch EEWS, Taejon 305701, South Korea; [Terasaki, Osamu] ShanghaiTech Univ, Sch Phys Sci & Technol, Shanghai 201210, Peoples R China	Sogang University; Pohang University of Science & Technology (POSTECH); Stockholm University; Korea Advanced Institute of Science & Technology (KAIST); ShanghaiTech University	Yoon, KB (corresponding author), Sogang Univ, Dept Chem, Korea Ctr Artificial Photosynthesis, Seoul 121742, South Korea.	yoonkb@sogang.ac.kr	Terasaki, Osamu/Y-1137-2018; Hwang, In-Chul/ABA-7486-2020; Moon, Dohyun/AAW-9759-2021	Terasaki, Osamu/0000-0001-5803-0817; Moon, Dohyun/0000-0002-6903-0270; Datta, Shuvo/0000-0001-5156-4234	Korea Center for Artificial Photosynthesis at Sogang University; Ministry of Science, ICT and Future Planning through the National Research Foundation of Korea [2009-0093886]	Korea Center for Artificial Photosynthesis at Sogang University; Ministry of Science, ICT and Future Planning through the National Research Foundation of Korea	Supported by the Korea Center for Artificial Photosynthesis, located at Sogang University and funded by the Ministry of Science, ICT and Future Planning through the National Research Foundation of Korea, grant 2009-0093886. We thank C.-H. Shin at Chungbuk National University for helpful discussions regarding the isosteric heats of adsorption, and J.Y. Lee for help in drawing the figures.	ANDERSON MW, 1994, NATURE, V367, P347, DOI 10.1038/367347a0; Anson A, 2009, CHEM ENG SCI, V64, P3683, DOI 10.1016/j.ces.2009.05.024; Bae TH, 2013, ENERG ENVIRON SCI, V6, P128, DOI 10.1039/c2ee23337a; Bae YS, 2011, ANGEW CHEM INT EDIT, V50, P11586, DOI 10.1002/anie.201101891; Banerjee R, 2008, SCIENCE, V319, P939, DOI 10.1126/science.1152516; Britt D, 2009, P NATL ACAD SCI USA, V106, P20637, DOI 10.1073/pnas.0909718106; Caskey SR, 2008, J AM CHEM SOC, V130, P10870, DOI 10.1021/ja8036096; Datta SJ, 2010, ANGEW CHEM INT EDIT, V49, P4971, DOI 10.1002/anie.200907088; Hicks JC, 2008, J AM CHEM SOC, V130, P2902, DOI 10.1021/ja077795v; Kizzie AC, 2011, LANGMUIR, V27, P6368, DOI 10.1021/la200547k; Liu J, 2012, J PHYS CHEM C, V116, P9575, DOI 10.1021/jp300961j; Liu Z, 2012, IND ENG CHEM RES, V51, P7355, DOI 10.1021/ie3005308; Lozinska MM, 2012, J AM CHEM SOC, V134, P17628, DOI 10.1021/ja3070864; Mason JA, 2015, J AM CHEM SOC, V137, P4787, DOI 10.1021/jacs.5b00838; McDonald TM, 2015, NATURE, V519, P303, DOI 10.1038/nature14327; Nguyen NTT, 2014, ANGEW CHEM INT EDIT, V53, P10645, DOI 10.1002/anie.201403980; Nugent P, 2013, NATURE, V495, P80, DOI 10.1038/nature11893; Rocha J, 1997, ANGEW CHEM INT EDIT, V36, P100, DOI 10.1002/anie.199701001; Sculley JP, 2012, ANGEW CHEM INT EDIT, V51, P12660, DOI 10.1002/anie.201207495; Shang J, 2012, J AM CHEM SOC, V134, P19246, DOI 10.1021/ja309274y; Shekhah O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5228; Su FS, 2012, ENERG ENVIRON SCI, V5, P9021, DOI 10.1039/c2ee22647b; Sumida K, 2012, CHEM REV, V112, P724, DOI 10.1021/cr2003272; Vaidhyanathan R, 2010, SCIENCE, V330, P650, DOI 10.1126/science.1194237; Wang L, 2013, CHEM ENG SCI, V101, P615, DOI 10.1016/j.ces.2013.07.028; Wang L, 2013, IND ENG CHEM RES, V52, P7947, DOI 10.1021/ie4009716; Wang XQ, 1999, CHEM COMMUN, P973, DOI 10.1039/a901280j; Xiang SC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1956; Yang Q., 2013, ANGEW CHEM, V125, P10506, DOI DOI 10.1002/ANGE.201302682; Zhang ZJ, 2014, ENERG ENVIRON SCI, V7, P2868, DOI 10.1039/c4ee00143e	30	167	170	16	438	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2015	350	6258					302	+		10.1126/science.aab1680	http://dx.doi.org/10.1126/science.aab1680			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT5HD	26472904				2022-12-28	WOS:000362838700036
J	Mansour, MK; Ackman, JB; Branda, JA; Kradin, RL				Mansour, Michael K.; Ackman, Jeanne B.; Branda, John A.; Kradin, Richard L.			Case 32-2015: A 57-Year-Old Man with Severe Pneumonia and Hypoxemic Respiratory Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PULMONARY BLASTOMYCOSIS; GATA2 DEFICIENCY; INFECTIONS; HISTOPLASMOSIS; DIAGNOSIS; DISEASE; STATES; TESTS		[Mansour, Michael K.; Kradin, Richard L.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Ackman, Jeanne B.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Ackman, Jeanne B.; Kradin, Richard L.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Mansour, Michael K.; Kradin, Richard L.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Ackman, Jeanne B.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Ackman, Jeanne B.; Kradin, Richard L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Mansour, MK (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Branda, John/ABD-5620-2020					Aydin SE, 2015, J CLIN IMMUNOL, V35, P189, DOI 10.1007/s10875-014-0126-0; Brown GD, 2012, SCIENCE, V336, P647, DOI 10.1126/science.1222236; Chu JH, 2006, CLIN INFECT DIS, V42, P822, DOI 10.1086/500405; Falcone M, 2011, MED MYCOL, V49, P406, DOI 10.3109/13693786.2010.535030; Freeman AF, 2008, IMMUNOL ALLERGY CLIN, V28, P277, DOI 10.1016/j.iac.2008.01.005; Gathmann B, 2014, J ALLERGY CLIN IMMUN, V134, P116, DOI 10.1016/j.jaci.2013.12.1077; Gauthier GM, 2007, TRANSPL INFECT DIS, V9, P310, DOI 10.1111/j.1399-3062.2007.00227.x; Girouard G, 2007, J MED MICROBIOL, V56, P1001, DOI 10.1099/jmm.0.47162-0; Hage CA, 2011, CLIN INFECT DIS, V53, P448, DOI 10.1093/cid/cir435; Harris JR, 2013, EMERG INFECT DIS, V19, P1620, DOI 10.3201/eid1910.130441; Hsu AP, 2015, CURR OPIN ALLERGY CL, V15, P104, DOI 10.1097/ACI.0000000000000126; Khuu D, 2014, EMERG INFECT DIS, V20, P1789, DOI 10.3201/eid2011.131175; KLEIN BS, 1987, J INFECT DIS, V155, P262, DOI 10.1093/infdis/155.2.262; Lahm T, 2008, CHEST, V133, P1478, DOI 10.1378/chest.07-2778; Ledtke C, 2012, J AM GERIATR SOC, V60, P265, DOI 10.1111/j.1532-5415.2011.03825.x; Lemos L B, 2001, Ann Diagn Pathol, V5, P1, DOI 10.1053/adpa.2001.21473; Marciano BE, 2015, CLIN INFECT DIS, V60, P1176, DOI 10.1093/cid/ciu1154; McKinnell JA, 2009, CLIN CHEST MED, V30, P227, DOI 10.1016/j.ccm.2009.02.003; Meersseman W, 2007, CLIN INFECT DIS, V45, P205, DOI 10.1086/518852; MEYER KC, 1993, NEW ENGL J MED, V329, P1231, DOI 10.1056/NEJM199310213291704; Nosanchuk JD, 2006, ANTIMICROB AGENTS CH, V50, P3519, DOI 10.1128/AAC.00545-06; Plamondon M, 2010, CLIN INFECT DIS, V51, pE1, DOI 10.1086/653429; SHEFLIN JR, 1990, AM J ROENTGENOL, V154, P1177, DOI 10.2214/ajr.154.6.2110723; Spinner MA, 2014, BLOOD, V123, P809, DOI 10.1182/blood-2013-07-515528; Vinh DC, 2010, J ALLERGY CLIN IMMUN, V125, P1389, DOI 10.1016/j.jaci.2010.01.047	25	3	3	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2015	373	16					1554	1564		10.1056/NEJMcpc1503830	http://dx.doi.org/10.1056/NEJMcpc1503830			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5VX	26465989				2022-12-28	WOS:000362880300012
J	Nathan, C				Nathan, Carl			From transient infection to chronic disease	SCIENCE			English	Editorial Material							INFLAMMATION		Weill Cornell Med Coll, New York, NY 10065 USA	Cornell University	Nathan, C (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.	cnathan@med.cornell.edu						da Fonseca DM, 2015, CELL, V163, P354, DOI 10.1016/j.cell.2015.08.030; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Nathan C, 2008, MOL MED, V14, P485, DOI 10.2119/2008-00038.Nathan; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Walter MJ, 2002, J CLIN INVEST, V110, P165, DOI 10.1172/JCI200214345	5	4	4	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257					161	161		10.1126/science.aad4141	http://dx.doi.org/10.1126/science.aad4141			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9JB	26450196				2022-12-28	WOS:000362405600018
J	Kitajima, S; Yasui, A				Kitajima, Shoichiro; Yasui, Akio			Oral Maxillary Exostosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kitajima, Shoichiro; Yasui, Akio] Konan Kosei Hosp, Konan, Japan		Kitajima, S (corresponding author), Konan Kosei Hosp, Konan, Japan.	skitajima@me.com							0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2015	373	15					1457	1457		10.1056/NEJMicm1414626	http://dx.doi.org/10.1056/NEJMicm1414626			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS8XI	26444732				2022-12-28	WOS:000362372800012
J	Ridgeway-Diaz, JG; Philp, JC; North, JP				Ridgeway-Diaz, Julia G.; Philp, Julie C.; North, Jeffrey P.			Recurrent Painful Abdominal Rash	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ridgeway-Diaz, Julia G.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94115 USA; [Philp, Julie C.] Redwood Empire Dermatol, Santa Rosa, CA USA; [North, Jeffrey P.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94115 USA; [North, Jeffrey P.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	North, JP (corresponding author), Univ Calif San Francisco, UCSF Dermatol, Dept Dermatol, 1701 Divisadero St,Room 280, San Francisco, CA 94115 USA.	jeffrey.north@ucsf.edu						Aerts A, 2003, J EUR ACAD DERMATOL, V17, P340, DOI 10.1046/j.1468-3083.2003.00687.x; Balter S, 2010, RADIOLOGY, V254, P326, DOI 10.1148/radiol.2542082312; Boncher J, 2012, J CUTAN PATHOL, V39, P63, DOI 10.1111/j.1600-0560.2011.01754.x; Frazier TH, 2007, ARCH DERMATOL, V143, P637, DOI 10.1001/archderm.143.5.637; Gomez-Flores M, 2014, CASE REP DERMATOL ME, DOI [10.1155/2014/768624, DOI 10.1155/2014/768624]; Henry Michelle F, 2009, Dermatol Online J, V15, P3; Lichtenstein DA, 1996, ARCH DERMATOL, V132, P663, DOI 10.1001/archderm.132.6.663; Montesu MA, 2014, J EUR ACAD DERMATOL, DOI [10.1111/idv.12885, DOI 10.1111/JDV912885]	8	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2015	314	13					1390	1391		10.1001/jama.2015.9308	http://dx.doi.org/10.1001/jama.2015.9308			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2PH	26441185				2022-12-28	WOS:000362644700018
J	Scoma, CB; Shah, AH; Bregy, A; Komotar, RJ				Scoma, Christopher B.; Shah, Ashish H.; Bregy, Amade; Komotar, Ricardo J.			Evaluation of a ring enhancing lesion	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GLIOBLASTOMA-MULTIFORME; TEMOZOLOMIDE; RESECTION; SURVIVAL; EXTENT		[Scoma, Christopher B.; Shah, Ashish H.; Bregy, Amade; Komotar, Ricardo J.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33125 USA	University of Miami	Komotar, RJ (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33125 USA.	RKomotar@med.miami.edu		Shah, Ashish/0000-0002-0183-1274				Bregy A, 2013, EXPERT REV ANTICANC, V13, P1453, DOI 10.1586/14737140.2013.840090; Chang SC, 2002, CLIN IMAG, V26, P227, DOI 10.1016/S0899-7071(02)00436-9; Greenberg MS, 2010, HDB NEUROSURGERY, P585; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Marina O, 2011, J NEUROSURG, V115, P220, DOI 10.3171/2011.3.JNS10495; Orringer D, 2012, J NEUROSURG, V117, P851, DOI 10.3171/2012.8.JNS12234; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Stupp R, 2010, ANN ONCOL, V21, pv190, DOI 10.1093/annonc/mdq187; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Weller M, 2015, CLIN CANCER RES, V21, P2057, DOI 10.1158/1078-0432.CCR-14-2737; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	11	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 5	2015	351								h5033	10.1136/bmj.h5033	http://dx.doi.org/10.1136/bmj.h5033			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT3SC	26438566				2022-12-28	WOS:000362726200003
J	Maruthappu, M; Sood, H; Black, C				Maruthappu, Mahiben; Sood, Harpreet; Black, Carol			Prioritising prevention and the health of NHS staff	LANCET			English	Editorial Material									[Maruthappu, Mahiben; Sood, Harpreet] NHS England, Chair & Chief Execut Off, London SE1 6LH, England; [Black, Carol] Dept Hlth, London SE1 6TE, England		Maruthappu, M (corresponding author), NHS England, Chair & Chief Execut Off, London SE1 6LH, England.	mahiben.maruthappu@nhs.net						Boorman S, 2009, NHS WELL BEING FINAL; Cross Government Obesity Unit, 2009, HLTH WEIGHT HLTH LIV; Ellison J., 2015, GUARDIAN; Francis R., 2013, REPORT MID STAFFORDS; NHS England, 2013, HLTH STAFF HIGH QUAL; NHS England, 2015, S STEV ANN MAJ DRIV; NHS England, 2014, 5 YEAR FORW VIEW	7	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2015	386	10001					1322	1323		10.1016/S0140-6736(15)00383-9	http://dx.doi.org/10.1016/S0140-6736(15)00383-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS8DP	26460762				2022-12-28	WOS:000362316200011
J	Snyder, A				Snyder, Alison			Oliver Sacks Obituary	LANCET			English	Biographical-Item												amsnyder@alum.mit.edu							0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2015	386	9999					1130	1130		10.1016/S0140-6736(15)00211-1	http://dx.doi.org/10.1016/S0140-6736(15)00211-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5GE	26461894				2022-12-28	WOS:000361368000016
J	Olds, D				Olds, David			Building evidence to improve maternal and child health	LANCET			English	Editorial Material							AGE		[Olds, David] Univ Colorado Denver, Dept Pediat, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Olds, D (corresponding author), Univ Colorado Denver, Dept Pediat, Aurora, CO 80045 USA.	david.olds@ucdenver.edu						Chamberlain C., 2013, COCHRANE DB SYST REV, V10, P1; Chittleborough CR, 2011, PEDIATRICS, V127, pE1436, DOI 10.1542/peds.2010-3222; Conde-Agudelo A, 2006, JAMA-J AM MED ASSOC, V295, P1809, DOI 10.1001/jama.295.15.1809; Fair society healthy lives, 2010, MARMOT REV; Hall D, 2007, FAMILY NURSE PARTNER; Holland ML, 2014, AM J PUBLIC HEALTH, V104, pE58, DOI 10.2105/AJPH.2014.302115; Mejdoubi J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120182; Mejdoubi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078185; OLDS D, 1995, PEDIATRICS, V95, P365; Olds David L, 2002, Prev Sci, V3, P153, DOI 10.1023/A:1019990432161; Olds DL, 2004, PEDIATRICS, V114, P1550, DOI 10.1542/peds.2004-0962; Olds DL, 2002, PEDIATRICS, V110, P486, DOI 10.1542/peds.110.3.486; Robling M, 2016, LANCET, V387, P146, DOI 10.1016/S0140-6736(15)00392-X	13	19	19	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2016	387	10014					105	107		10.1016/S0140-6736(15)00476-6	http://dx.doi.org/10.1016/S0140-6736(15)00476-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA8LF	26474806	hybrid			2022-12-28	WOS:000368055500011
J	Ellis, SG; Kereiakes, DJ; Metzger, DC; Caputo, RP; Rizik, DG; Teirstein, PS; Litt, MR; Kini, A; Kabour, A; Marx, SO; Popma, JJ; McGreevy, R; Zhang, Z; Simonton, C; Stone, GW				Ellis, Stephen G.; Kereiakes, Dean J.; Metzger, D. Christopher; Caputo, Ronald P.; Rizik, David G.; Teirstein, Paul S.; Litt, Marc R.; Kini, Annapoorna; Kabour, Ameer; Marx, Steven O.; Popma, Jeffrey J.; McGreevy, Robert; Zhang, Zhen; Simonton, Charles; Stone, Gregg W.		ABSORB III Investigators	Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LONG-TERM SAFETY; STENT IMPLANTATION; VASCULAR SCAFFOLD; RANDOMIZED-TRIAL; CHEST-PAIN; FOLLOW-UP; CLINICAL-OUTCOMES; METAANALYSIS; PATHOLOGY; HUMANS	BACKGROUND In patients with coronary artery disease who receive metallic drug-eluting coronary stents, adverse events such as late target-lesion failure may be related in part to the persistent presence of the metallic stent frame in the coronary-vessel wall. Bioresorbable vascular scaffolds have been developed to attempt to improve long-term outcomes. METHODS In this large, multicenter, randomized trial, 2008 patients with stable or unstable angina were randomly assigned in a 2: 1 ratio to receive an everolimus-eluting bioresorbable vascular (Absorb) scaffold (1322 patients) or an everolimus-eluting cobalt-chromium (Xience) stent (686 patients). The primary end point, which was tested for both noninferiority (margin, 4.5 percentage points for the risk difference) and superiority, was target-lesion failure (cardiac death, target-vessel myocardial infarction, or ischemia-driven target-lesion revascularization) at 1 year. RESULTS Target-lesion failure at 1 year occurred in 7.8% of patients in the Absorb group and in 6.1% of patients in the Xience group (difference, 1.7 percentage points; 95% confidence interval, -0.5 to 3.9; P = 0.007 for noninferiority and P = 0.16 for superiority). There was no significant difference between the Absorb group and the Xience group in rates of cardiac death (0.6% and 0.1%, respectively; P = 0.29), target-vessel myocardial infarction (6.0% and 4.6%, respectively; P = 0.18), or ischemia-driven target-lesion revascularization (3.0% and 2.5%, respectively; P = 0.50). Device thrombosis within 1 year occurred in 1.5% of patients in the Absorb group and in 0.7% of patients in the Xience group (P = 0.13). CONCLUSIONS In this large-scale, randomized trial, treatment of noncomplex obstructive coronary artery disease with an everolimus-eluting bioresorbable vascular scaffold, as compared with an everolimus-eluting cobalt-chromium stent, was within the prespecified margin for noninferiority with respect to target-lesion failure at 1 year. (Funded by Abbott Vascular; ABSORB III ClinicalTrials.gov number, NCT01751906.)	[Ellis, Stephen G.] Cleveland Clin, Cleveland, OH 44106 USA; [Kereiakes, Dean J.] Christ Hosp, Heart & Vasc Ctr, Lindner Res Ctr, Cincinnati, OH 45219 USA; [Kini, Annapoorna] Mercy St Vincents Med Ctr, Toledo, OH USA; [Metzger, D. Christopher] Wellmont Holston Valley Med Ctr, Kingsport, TN USA; [Caputo, Ronald P.] St Josephs Hosp Hlth Ctr, Liverpool, NY USA; [Rizik, David G.] Scottsdale Healthcare, Scottsdale, AZ USA; [Teirstein, Paul S.] Scripps Clin, La Jolla, CA 92037 USA; [McGreevy, Robert; Zhang, Zhen; Simonton, Charles] Abbott Vasc, Santa Clara, CA USA; [Litt, Marc R.] Baptist Med Ctr, Jacksonville, FL USA; [Kabour, Ameer] Mt Sinai Med Ctr, New York, NY 10029 USA; [Marx, Steven O.; Stone, Gregg W.] Columbia Univ, Med Ctr, New York, NY 10022 USA; [Stone, Gregg W.] Cardiovasc Res Fdn, New York, NY USA; [Popma, Jeffrey J.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Cleveland Clinic Foundation; Christ Hospital - Ohio; Scottsdale Healthcare Osborn; Scripps Research Institute; Icahn School of Medicine at Mount Sinai; Columbia University; Cardiovascular Research Foundation (CRF); Harvard University; Beth Israel Deaconess Medical Center	Stone, GW (corresponding author), Columbia Univ, Med Ctr, Cardiovasc Res Fdn, 111 E 59th St,11th Fl, New York, NY 10022 USA.	gs2184@columbia.edu		Zhang, Zhen/0000-0002-0804-8741; Meelu, Omar/0000-0002-3481-2731	Abbott Vascular	Abbott Vascular(Abbott Laboratories)	Funded by Abbott Vascular; ABSORB III ClinicalTrials.gov number, NCT01751906.	Abizaid A, 2015, EUROINTERVENTION, V10, P1396, DOI 10.4244/EIJV10I12A243; Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Bosner S, 2009, EUR J GEN PRACT, V15, P141, DOI 10.3109/13814780903329528; Capodanno D, 2015, EUROINTERVENTION, V10, P1144, DOI 10.4244/EIJY14M07_11; Cohen DJ, 2011, NEW ENGL J MED, V364, P1016, DOI 10.1056/NEJMoa1001508; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; FDA, 2010, GUID IND NON CLIN TR; Gada H, 2013, JACC-CARDIOVASC INTE, V6, P1263, DOI 10.1016/j.jcin.2013.07.009; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kereiakes DJ, 2015, AM HEART J, V170, P641, DOI 10.1016/j.ahj.2015.07.013; Kimura T, 2015, EUR HEART J, V36, P3332, DOI 10.1093/eurheartj/ehv435; Kirtane AJ, 2009, CIRCULATION, V119, P3198, DOI 10.1161/CIRCULATIONAHA.108.826479; Kuramitsu S, 2012, CIRC-CARDIOVASC INTE, V5, P663, DOI 10.1161/CIRCINTERVENTIONS.112.969238; Lane JP, 2014, JACC-CARDIOVASC INTE, V7, P688, DOI 10.1016/j.jcin.2013.11.024; MANSOUR M, 1992, AM J CARDIOL, V69, P1379, DOI 10.1016/0002-9149(92)90885-3; Ong P, 2014, CLIN RES CARDIOL, V103, P11, DOI 10.1007/s00392-013-0615-9; Otsuka F, 2014, CIRC-CARDIOVASC INTE, V7, P330, DOI 10.1161/CIRCINTERVENTIONS.113.000990; Otsuka F, 2014, CIRCULATION, V129, P211, DOI 10.1161/CIRCULATIONAHA.113.001790; Palmerini T, 2015, J AM COLL CARDIOL, V65, P2496, DOI 10.1016/j.jacc.2015.04.017; Puricel S, 2015, J AM COLL CARDIOL, V65, P791, DOI 10.1016/j.jacc.2014.12.017; Sen H, 2015, JACC-CARDIOVASC INTE, V8, P889, DOI 10.1016/j.jcin.2015.01.033; Serruys PW, 2015, LANCET, V385, P43, DOI 10.1016/S0140-6736(14)61455-0; Serruys PW, 2014, EUROINTERVENTION, V9, P1271, DOI 10.4244/EIJV9I11A217; Serruys PW, 2012, EUR HEART J, V33, P16, DOI 10.1093/eurheartj/ehr384; Simsek C, 2014, EUROINTERVENTION; Stone GW, 2008, JAMA-J AM MED ASSOC, V299, P1903, DOI 10.1001/jama.299.16.1903; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Teristein PS, 2012, TXB INTERVENTIONAL C, P171; Versaci F, 2002, AM J CARDIOL, V89, P500, DOI 10.1016/S0002-9149(01)02287-1; Vlachojannis GJ, 2015, EUROINTERVENTION, V11, P272, DOI 10.4244/EIJV11I3A53; Yamaji K, 2010, CIRC-CARDIOVASC INTE, V3, P468, DOI 10.1161/CIRCINTERVENTIONS.110.958249	32	492	518	3	70	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2015	373	20					1905	1915		10.1056/NEJMoa1509038	http://dx.doi.org/10.1056/NEJMoa1509038			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV7IL	26457558				2022-12-28	WOS:000364445500005
J	Bourzac, K				Bourzac, Katherine			CELL IMAGING Beyond the limits	NATURE			English	Editorial Material							SINGLE MOLECULES; MICROSCOPY											Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; MOERNER WE, 1989, PHYS REV LETT, V62, P2535, DOI 10.1103/PhysRevLett.62.2535; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Zhong GS, 2014, ELIFE, V3, DOI 10.7554/eLife.04581	7	2	2	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					S50	S54		10.1038/526S50a	http://dx.doi.org/10.1038/526S50a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26488241	Bronze			2022-12-28	WOS:000364026100002
J	Furuta, GT; Katzka, DA				Furuta, Glenn T.; Katzka, David A.			Eosinophilic Esophagitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							6-FOOD ELIMINATION DIET; TRANSCRIPTOME ANALYSIS; ELEMENTAL DIET; FOOD IMPACTION; DISEASE; ADULTS; EXPRESSION; EOTAXIN-3; DIAGNOSIS; FEATURES		[Furuta, Glenn T.] Univ Colorado, Sch Med, Sect Gastroenterol Hepatol & Nutr, Dept Pediat, Aurora, CO USA; [Furuta, Glenn T.] Childrens Hosp Colorado, Gastrointestinal Eo sinophil Dis Program, Mucosal Inflammat Program, Digest Hlth Inst, Aurora, CO USA; [Katzka, David A.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Mayo Clinic	Katzka, DA (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, 200 First Ave SW, Rochester, MN 55905 USA.	katzka.david@mayo.edu			Genentech; Morphotek; Nutricia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI117804] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); Morphotek; Nutricia(Danone Nutricia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Furuta reports receiving consulting fees from Genentech and grant support from Morphotek and Nutricia, and is co-founder of EnteroTrack. Dr. Katzka reports that his laboratory has provided funding to Capnostics to develop an esophageal sponge. No other potential conflict of interest relevant to this article was reported.	Abonia JP, 2013, J ALLERGY CLIN IMMUN, V132, P378, DOI 10.1016/j.jaci.2013.02.030; Aceves SS, 2010, ALLERGY, V65, P109, DOI 10.1111/j.1398-9995.2009.02142.x; Aceves SS, 2014, CLIN GASTROENTEROL H, V12, P1216, DOI 10.1016/j.cgh.2013.09.007; Akei HS, 2005, GASTROENTEROLOGY, V129, P985, DOI 10.1053/j.gastro.2005.06.027; Alexander ES, 2014, J ALLERGY CLIN IMMUN, V134, P1084, DOI 10.1016/j.jaci.2014.07.021; Alexander JA, 2012, CLIN GASTROENTEROL H, V10, P742, DOI 10.1016/j.cgh.2012.03.018; Arias A, 2014, GASTROENTEROLOGY, V146, P1639, DOI 10.1053/j.gastro.2014.02.006; ATTWOOD SEA, 1993, DIGEST DIS SCI, V38, P109, DOI 10.1007/BF01296781; Beppu LY, 2014, J ALLERGY CLIN IMMUN, V134, P1100, DOI 10.1016/j.jaci.2014.04.004; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Blanchard C, 2007, J ALLERGY CLIN IMMUN, V120, P1292, DOI 10.1016/j.jaci.2007.10.024; Blanchard C, 2010, J IMMUNOL, V184, P4033, DOI 10.4049/jimmunol.0903069; Butz BK, 2014, GASTROENTEROLOGY, V147, P324, DOI 10.1053/j.gastro.2014.04.019; Cheng E, 2013, GUT, V62, P824, DOI 10.1136/gutjnl-2012-302250; Cho JY, 2014, J PEDIATR GASTR NUTR, V59, P10, DOI 10.1097/MPG.0000000000000343; Clayton F, 2014, GASTROENTEROLOGY, V147, P602, DOI 10.1053/j.gastro.2014.05.036; Collins MH, 2014, GASTROENTEROL CLIN N, V43, P257, DOI 10.1016/j.gtc.2014.02.007; Dellon ES, 2014, CLIN GASTROENTEROL H, V12; Dellon ES, 2012, GASTROENTEROLOGY, V143; Dellon ES, 2015, MODERN PATHOL, V28, P383, DOI 10.1038/modpathol.2014.110; Dellon ES, 2014, CLIN GASTROENTEROL H, V12, P2015, DOI 10.1016/j.cgh.2014.06.019; Dellon ES, 2014, GASTROENTEROL CLIN N, V43, P201, DOI 10.1016/j.gtc.2014.02.002; Dellon ES, 2013, AM J GASTROENTEROL, V108, P679, DOI 10.1038/ajg.2013.71; Dellon ES, 2009, CLIN GASTROENTEROL H, V7, P1305, DOI 10.1016/j.cgh.2009.08.030; Desai TK, 2005, GASTROINTEST ENDOSC, V61, P795, DOI 10.1016/S0016-5107(05)00313-5; Gentile N, 2014, ALIMENT PHARM THER, V40, P1333, DOI 10.1111/apt.12977; Gonsalves N, 2012, GASTROENTEROLOGY, V142; Gupta SK, 2015, CLIN GASTROENTEROL H, V13, P66, DOI 10.1016/j.cgh.2014.05.021; Hirano I, 2013, GUT, V62, P489, DOI 10.1136/gutjnl-2011-301817; Hruz P, 2011, J ALLERGY CLIN IMMUN, V128, P1349, DOI 10.1016/j.jaci.2011.09.013; Hubner M, 2005, IMMUNOL ALLERGY CLIN, V25, P469, DOI 10.1016/j.iac.2005.05.004; Ishimura N, 2015, J GASTROEN HEPATOL, V30, P71, DOI 10.1111/jgh.12746; Jensen ET, 2015, CLIN GASTROENTEROL H, V13, P1426, DOI 10.1016/j.cgh.2015.02.018; Jensen ET, 2014, AM J GASTROENTEROL, V109, P668, DOI 10.1038/ajg.2014.47; Jensen ET, 2013, J PEDIATR GASTR NUTR, V57, P67, DOI 10.1097/MPG.0b013e318290d15a; Kagalwalla AF, 2006, CLIN GASTROENTEROL H, V4, P1097, DOI 10.1016/j.cgh.2006.05.026; Kagalwalla AF, 2012, J ALLERGY CLIN IMMUN, V129, P1387, DOI 10.1016/j.jaci.2012.03.005; Kapel RC, 2008, GASTROENTEROLOGY, V134, P1316, DOI 10.1053/j.gastro.2008.02.016; Katzka DA, 2014, CLIN GASTROENTEROL H, V12; Katzka DA, 2015, CLIN GASTROENTEROL H, V13, p77e2; Katzka DA, 2015, CLIN GASTROENTEROL H, V13; KELLY KJ, 1995, GASTROENTEROLOGY, V109, P1503, DOI 10.1016/0016-5085(95)90637-1; Kottyan LC, 2014, NAT GENET, V46, P895, DOI 10.1038/ng.3033; Kuchen T, 2014, ALLERGY, V69, P1248, DOI 10.1111/all.12455; Lee J, 2012, CLIN GASTROENTEROL H, V10, P481, DOI 10.1016/j.cgh.2011.12.042; Lexmond WS, 2014, AM J GASTROENTEROL, V109, P646, DOI 10.1038/ajg.2014.12; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Lipka S, 2014, GASTROINTEST ENDOSC, V80, P592, DOI 10.1016/j.gie.2014.02.012; Lucendo AJ, 2013, J ALLERGY CLIN IMMUN, V131, P797, DOI 10.1016/j.jaci.2012.12.664; Markowitz JE, 2003, AM J GASTROENTEROL, V98, P777, DOI 10.1111/j.1572-0241.2003.07390.x; Masterson JC, 2014, GUT, V63, P43, DOI 10.1136/gutjnl-2012-303631; Menard-Katcher C, 2015, J PEDIAT GASTROENTER; Mishra A, 2007, J LEUKOCYTE BIOL, V81, P916, DOI 10.1189/jlb.1106653; Moawad FJ, 2013, ALIMENT PHARM THER, V38, P713, DOI 10.1111/apt.12438; Moawad FJ, 2013, AM J GASTROENTEROL, V108, P1938, DOI 10.1038/ajg.2013.252; Molina-Infante J, 2014, ALIMENT PHARM THER, V40, P955, DOI 10.1111/apt.12914; Molina-Infante J, 2014, J ALLERGY CLIN IMMUN, V134, P1093, DOI 10.1016/j.jaci.2014.07.023; Molina-Infante J, 2011, CLIN GASTROENTEROL H, V9, P110, DOI 10.1016/j.cgh.2010.09.019; Muir AB, 2015, EXP CELL RES, V330, P102, DOI 10.1016/j.yexcr.2014.08.026; Mulder DJ, 2012, HISTOPATHOLOGY, V61, P810, DOI 10.1111/j.1365-2559.2012.4303.x; Mulder DJ, 2011, J PEDIATR GASTR NUTR, V53, P213, DOI 10.1097/MPG.0b013e318213bf79; Nicodeme F, 2013, CLIN GASTROENTEROL H, V11; Noti M, 2013, NAT MED, V19, P1005, DOI 10.1038/nm.3281; Peterson KA, 2013, AM J GASTROENTEROL, V108, P759, DOI 10.1038/ajg.2012.468; Ravi K, 2011, DIGEST DIS SCI, V56, P1981, DOI 10.1007/s10620-011-1594-1; Rocha R, 2011, EUR J PEDIATR, V170, P1471, DOI 10.1007/s00431-011-1540-4; Ronkainen J, 2007, GUT, V56, P615, DOI 10.1136/gut.2006.107714; Rothenberg ME, 2015, J ALLERGY CLIN IMMUN, V135, P500, DOI 10.1016/j.jaci.2014.07.049; Schaefer ET, 2008, CLIN GASTROENTEROL H, V6, P165, DOI 10.1016/j.cgh.2007.11.008; Schoepfer AM, 2013, GASTROENTEROLOGY, V145, P1230, DOI 10.1053/j.gastro.2013.08.015; Sherrill JD, 2014, MUCOSAL IMMUNOL, V7, P718, DOI 10.1038/mi.2013.90; Sherrill JD, 2010, J ALLERGY CLIN IMMUN, V126, P160, DOI 10.1016/j.jaci.2010.04.037; Sleiman PMA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6593; Spergel JM, 2007, CURR OPIN ALLERGY CL, V7, P274, DOI 10.1097/ACI.0b013e32813aee4a; Spergel JM, 2012, J ALLERGY CLIN IMMUN, V129, P456, DOI 10.1016/j.jaci.2011.11.044; Sridhara S, 2012, CLIN GASTROENTEROL H, V10, P735, DOI 10.1016/j.cgh.2012.01.008; Straumann A, 2001, J ALLERGY CLIN IMMUN, V108, P954, DOI 10.1067/mai.2001.119917; STRAUMANN A, 1994, SCHWEIZ MED WSCHR, V124, P1419; Straumann A, 2012, ALLERGY, V67, P477, DOI 10.1111/j.1398-9995.2012.02787.x; Straumann A, 2008, CLIN GASTROENTEROL H, V6, P598, DOI 10.1016/j.cgh.2008.02.003; Straumann A, 2012, GASTROENTEROLOGY, V142, P1409, DOI 10.1053/j.gastro.2012.04.039; Straumann A, 2011, CLIN GASTROENTEROL H, V9, P400, DOI 10.1016/j.cgh.2011.01.017; Straumann A, 2010, GASTROENTEROLOGY, V139, P1526, DOI 10.1053/j.gastro.2010.07.048; van Nimwegen FA, 2011, J ALLERGY CLIN IMMUN, V128, P948, DOI 10.1016/j.jaci.2011.07.027; Van Rhijn BD, 2014, NEUROGASTROENT MOTIL, V26, P772, DOI 10.1111/nmo.12323; van Rhijn BD, 2013, ALLERGY, V68, P1475, DOI 10.1111/all.12257; van Rhijn BD, 2014, CLIN GASTROENTEROL H, V12, P1815, DOI 10.1016/j.cgh.2014.02.037; Wen T, 2015, J ALLERGY CLIN IMMUN, V135, P187, DOI 10.1016/j.jaci.2014.08.043; Wen T, 2013, GASTROENTEROLOGY, V145, P1289, DOI 10.1053/j.gastro.2013.08.046; Whitney-Miller CL, 2009, AM J CLIN PATHOL, V131, P788, DOI 10.1309/AJCPOMPXJFP7EB4P	90	258	267	3	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2015	373	17					1640	1648		10.1056/NEJMra1502863	http://dx.doi.org/10.1056/NEJMra1502863			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU1YH	26488694	Green Accepted			2022-12-28	WOS:000363317800009
J	Nambudiri, VE; Nambudiri, NS; Nazarian, RM; Tsao, SS				Nambudiri, Vinod E.; Nambudiri, Navya S.; Nazarian, Rosalynn M.; Tsao, Sandy S.			CASE REVIEW A rash starting on the palms and soles	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GUTTATE PSORIASIS		[Nambudiri, Vinod E.] Brigham & Womens Hosp, Dept Internal Med, Boston, MA 02115 USA; [Nambudiri, Vinod E.; Tsao, Sandy S.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Nambudiri, Navya S.] Cooperat Med Coll, Cochin, Kerala, India; [Nazarian, Rosalynn M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Nambudiri, VE (corresponding author), Brigham & Womens Hosp, Dept Internal Med, 75 Francis St, Boston, MA 02115 USA.	vinod.nambudiri@gmail.com	Nazarian, Rosalynn/AFL-3176-2022	Nazarian, Rosalynn/0000-0003-4003-7193				ALABADIE MS, 1994, BRIT J DERMATOL, V130, P199, DOI 10.1111/j.1365-2133.1994.tb02900.x; Chalmers RJG, 2001, BRIT J DERMATOL, V145, P891, DOI 10.1046/j.1365-2133.2001.04505.x; Dogan B, 2008, INT J DERMATOL, V47, P950, DOI 10.1111/j.1365-4632.2008.03663.x; Naldi L, 2001, J AM ACAD DERMATOL, V44, P433, DOI 10.1067/mjd.2001.110876	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 19	2015	351								h5452	10.1136/bmj.h5452	http://dx.doi.org/10.1136/bmj.h5452			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3FF	26481515				2022-12-28	WOS:000364143300002
J	Elshimy, N				Elshimy, Noha			SPOT DIAGNOSIS A pretty rash	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Sandwell & West Birmingham NHS Trust, Dept Med, Birmingham, W Midlands, England		Elshimy, N (corresponding author), Sandwell & West Birmingham NHS Trust, Dept Med, Birmingham, W Midlands, England.	nohaelshimy@nhs.net						Brancaccio Ronald R, 2002, Am J Contact Dermat, V13, P15, DOI 10.1053/ajcd.2002.30466; Vasilakis Vasileios, 2010, BMJ Case Rep, V2010, DOI 10.1136/bcr.09.2009.2277	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 16	2015	351								h5432	10.1136/bmj.h5432	http://dx.doi.org/10.1136/bmj.h5432			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT8YC	26475060				2022-12-28	WOS:000363101800003
J	Olive, JA; Behn, MD; Ito, G; Buck, WR; Escartin, J; Howell, S				Olive, J. -A.; Behn, M. D.; Ito, G.; Buck, W. R.; Escartin, J.; Howell, S.			Sensitivity of seafloor bathymetry to climate-driven fluctuations in mid-ocean ridge magma supply	SCIENCE			English	Article							MID-ATLANTIC RIDGE; EAST PACIFIC RISE; CRUSTAL ACCRETION; RIFT-VALLEY; MORPHOLOGY; EPISODICITY; BENEATH; FAULT	Recent studies have proposed that the bathymetric fabric of the seafloor formed at mid-ocean ridges records rapid (23,000 to 100,000 years) fluctuations in ridge magma supply caused by sealevel changes that modulate melt production in the underlying mantle. Using quantitative models of faulting and magma emplacement, we demonstrate that, in fact, seafloor-shaping processes act as a low-pass filter on variations in magma supply, strongly damping fluctuations shorter than about 100,000 years. We show that the systematic decrease in dominant seafloor wavelengths with increasing spreading rate is best explained by a model of fault growth and abandonment under a steady magma input. This provides a robust framework for deciphering the footprint of mantle melting in the fabric of abyssal hills, the most common topographic feature on Earth.	[Olive, J. -A.; Buck, W. R.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Behn, M. D.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Ito, G.; Howell, S.] Univ Hawaii, Honolulu, HI 96822 USA; [Escartin, J.] Univ Paris Diderot, Inst Phys Globe Paris, CNRS, Paris, France	Columbia University; Woods Hole Oceanographic Institution; University of Hawaii System; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Olive, JA (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	jaolive@ldeo.columbia.edu	Olive, Jean-Arthur/ABE-1290-2021; Behn, Mark D/F-5813-2012; ESCARTIN, Javier/A-1043-2010; Howell, Samuel/AAI-2549-2020; Escartin, Javier/B-3344-2008	Behn, Mark D/0000-0002-2001-1335; ESCARTIN, Javier/0000-0002-3416-6856; Howell, Samuel/0000-0002-5126-3228; 	NSF [OCE-1154238, OCE-1155098, EAR-1009839]; CNRS; Woods Hole Oceanographic Institution IRD award; Lamont-Doherty Earth Observatory Postdoctoral Fellowship; Directorate For Geosciences [1009839] Funding Source: National Science Foundation; Division Of Ocean Sciences [1155098] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Woods Hole Oceanographic Institution IRD award; Lamont-Doherty Earth Observatory Postdoctoral Fellowship; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work greatly benefited from discussions with P. Canales, A. Soule, S. Carbotte, R. Katz, P. Huybers, and B. Ryan, as well as the constructive feedback from three anonymous reviewers. Funding was provided by NSF grants OCE-1154238 (J.-A.O. and M.D.B), OCE-1155098 (G.I. and S.H.), EAR-1009839 (W.R.B), CNRS support to J.E., a Woods Hole Oceanographic Institution IR&D award to M.D.B, and a Lamont-Doherty Earth Observatory Postdoctoral Fellowship for J.-A.O. The data and model results presented here are included or fully referenced in the supplementary materials.	Behn MD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001965; Bonatti E, 2003, NATURE, V423, P499, DOI 10.1038/nature01594; Buck WR, 2005, NATURE, V434, P719, DOI 10.1038/nature03358; Buck WR, 1997, GEOLOGY, V25, P935; Canales JP, 2000, J GEOPHYS RES-SOL EA, V105, P28411, DOI 10.1029/2000JB900301; CARBOTTE SM, 1994, J GEOPHYS RES-SOL EA, V99, P13609, DOI 10.1029/93JB02971; COCHRAN JR, 1979, J GEOPHYS RES, V84, P4713, DOI 10.1029/JB084iB09p04713; COWIE PA, 1994, J GEOPHYS RES-SOL EA, V99, P15205, DOI 10.1029/94JB00041; Crowley JW, 2015, SCIENCE, V347, P1237, DOI 10.1126/science.1261508; Dunn RA, 1997, NATURE, V388, P259, DOI 10.1038/40831; Escartin J, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001399; Escartin J, 1999, J GEOPHYS RES-SOL EA, V104, P10421, DOI 10.1029/1998JB900097; GOFF JA, 1988, J GEOPHYS RES-SOLID, V93, P13589, DOI 10.1029/JB093iB11p13589; Goff JA, 1997, J GEOPHYS RES-SOL EA, V102, P15521, DOI 10.1029/97JB00781; Huybers P, 2009, EARTH PLANET SC LETT, V286, P479, DOI 10.1016/j.epsl.2009.07.014; Ito G, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001970; Jull M, 1996, J GEOPHYS RES-SOL EA, V101, P21815, DOI 10.1029/96JB01308; KAPPEL ES, 1986, J GEOPHYS RES-SOLID, V91, P13925, DOI 10.1029/JB091iB14p13925; Karsten J., 1999, INTERRIDGE NEWS, V8, P15; KUO BY, 1986, GEOPHYS RES LETT, V13, P681, DOI 10.1029/GL013i007p00681; Lund DC, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003693; MACARIO A, 1994, J GEOPHYS RES-SOL EA, V99, P17921, DOI 10.1029/94JB01409; Macdonald KC, 1996, NATURE, V380, P125, DOI 10.1038/380125a0; MALINVERNO A, 1990, EARTH PLANET SC LETT, V99, P154, DOI 10.1016/0012-821X(90)90079-D; MENARD HW, 1967, EARTH PLANET SC LETT, V2, P465, DOI 10.1016/0012-821X(67)90191-4; MORGAN JP, 1993, J GEOPHYS RES-SOL EA, V98, P6283, DOI 10.1029/92JB02650; NAKADA M, 1992, TECTONOPHYSICS, V212, P321, DOI 10.1016/0040-1951(92)90298-K; Perfit MR, 1998, GEOPH MONOG SERIES, V106, P59; REA DK, 1975, GEOLOGY, V3, P77, DOI 10.1130/0091-7613(1975)3<77:MFTFOT>2.0.CO;2; SINTON JM, 1992, J GEOPHYS RES-SOL EA, V97, P197, DOI 10.1029/91JB02508; Tolstoy M, 2015, GEOPHYS RES LETT, V42, P1346, DOI 10.1002/2014GL063015; Watts A.B., 2001, ISOSTASY FLEXURE LIT	32	51	55	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2015	350	6258					310	313		10.1126/science.aad0715	http://dx.doi.org/10.1126/science.aad0715			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT5HD	26472905	Green Submitted			2022-12-28	WOS:000362838700038
J	Cole, TB				Cole, Thomas B.			Barracks Taneyuki (Dan) Harada	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2015	314	14					1432	1433		10.1001/jama.2014.12021	http://dx.doi.org/10.1001/jama.2014.12021			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2QI	26461985				2022-12-28	WOS:000362647800030
J	Naci, H; Lehman, R; Wouters, OJ; Goldacre, B; Yudkin, JS				Naci, Huseyin; Lehman, Richard; Wouters, Olivier J.; Goldacre, Ben; Yudkin, John S.			Rethinking the appraisal and approval of drugs for type 2 diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK-SHARING ARRANGEMENTS; MYOCARDIAL-INFARCTION; COMPARATIVE EFFICACY; HEALTH; DEATH; GLUCOSE; ROSIGLITAZONE; METAANALYSIS; RECOMMENDATIONS; COMPLICATIONS		[Naci, Huseyin; Wouters, Olivier J.] Univ London London Sch Econ & Polit Sci, Dept Social Policy, LSE Hlth, London WC2A 2AE, England; [Lehman, Richard] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Goldacre, Ben] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford, England; [Yudkin, John S.] UCL, Div Med, London, England	University of London; London School Economics & Political Science; University of Oxford; University of Oxford; University of London; University College London	Naci, H (corresponding author), Univ London London Sch Econ & Polit Sci, Dept Social Policy, LSE Hlth, Houghton St, London WC2A 2AE, England.	h.naci@lse.ac.uk	Yudkin, John S/C-1988-2008; Wouters, Olivier/AAA-6345-2021	Wouters, Olivier/0000-0002-2514-476X; Goldacre, Ben/0000-0002-5127-4728				Adamski J, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-153; Alexander GC, 2011, ANN INTERN MED, V154, P833, DOI 10.7326/0003-4819-154-12-201106210-00012; [Anonymous], 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18430; Avorn J, 2008, POWERFUL MED BENEFIT; Boussageon R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001204; Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; Carpenter D, 2008, NEW ENGL J MED, V358, P1354, DOI 10.1056/NEJMsa0706341; Carpenter D, 2012, AM J POLIT SCI, V56, P98, DOI 10.1111/j.1540-5907.2011.00544.x; Chalkidou K, 2007, J ROY SOC MED, V100, P453, DOI 10.1258/jrsm.100.10.453; Chalkidou K, 2009, MILBANK Q, V87, P339, DOI 10.1111/j.1468-0009.2009.00560.x; Cohen D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4848; Cook JP, 2008, PHARMACOECONOMICS, V26, P551, DOI 10.2165/00019053-200826070-00002; Duijnhoven RG, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001407; Eichler HG, 2012, CLIN PHARMACOL THER, V91, P426, DOI 10.1038/clpt.2011.345; Ferrario A, 2015, SOC SCI MED, V124, P39, DOI 10.1016/j.socscimed.2014.11.003; Goldacre B, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4745; Graham DJ, 2010, JAMA-J AM MED ASSOC, V304, P411, DOI 10.1001/jama.2010.920; Guyatt GH, 2000, JAMA-J AM MED ASSOC, V284, P1290, DOI 10.1001/jama.284.10.1290; Hemmingsen Bianca, 2011, BMJ, V343, pd6898, DOI 10.1136/bmj.d6898; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Huang ES, 2007, DIABETES CARE, V30, P2478, DOI 10.2337/dc07-0499; International Federation of Pharmaceutical Manufacturers & Associations, 2012, PHARM IND GLOB HLTH; Jackevicius CA, 2011, JAMA-J AM MED ASSOC, V305, P1217, DOI 10.1001/jama.2011.353; Lauer MS, 2013, NEW ENGL J MED, V369, P1579, DOI 10.1056/NEJMp1310102; Lipska KJ, 2014, JAMA INTERN MED, V174, P1116, DOI 10.1001/jamainternmed.2014.1824; Menon V, 2014, CIRCULATION, V129, P2705, DOI 10.1161/CIRCULATIONAHA.113.008221; Naci H, 2015, ANNU REV PHARMACOL, V55, P169, DOI 10.1146/annurev-pharmtox-010814-124614; Naci H, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4261; Neumann PJ, 2011, HEALTH AFFAIR, V30, P2329, DOI 10.1377/hlthaff.2010.1147; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nissen SE, 2010, JAMA-J AM MED ASSOC, V303, P1194, DOI 10.1001/jama.2010.333; O'Connor AB, 2010, JAMA-J AM MED ASSOC, V303, P979, DOI 10.1001/jama.2010.257; Philipson TJ, 2005, ASSESSING SAFETY EFF; PhRMA, 2014, BIOPH RES CO AR DEV; Raftery J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1672; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Sonnad SS, 2013, CONTEMP CLIN TRIALS, V36, P356, DOI 10.1016/j.cct.2013.08.008; Sorenson C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4849; Soumerai SB, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150187; Staa Tjeerd-Pieter van, 2012, BMJ, V344, pe55, DOI 10.1136/bmj.e55; Stafford RS, 2009, NEW ENGL J MED, V361, P1230, DOI 10.1056/NEJMp0906490; Vijan S, 2014, JAMA INTERN MED, V174, P1227, DOI 10.1001/jamainternmed.2014.2894; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Yudkin JS, 2010, DIABETOLOGIA, V53, P2079, DOI 10.1007/s00125-010-1864-z	45	7	7	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2015	351								h5260	10.1136/bmj.h5260	http://dx.doi.org/10.1136/bmj.h5260			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CT3SV	26452524	Green Accepted			2022-12-28	WOS:000362728100001
J	Watanabe, S				Watanabe, Shigeki			Slow or fast? A tale of synaptic vesicle recycling	SCIENCE			English	Editorial Material							FROG NEUROMUSCULAR-JUNCTION; KISS-AND-RUN; HIPPOCAMPAL SYNAPSES; ENDOCYTOSIS; EXOCYTOSIS; MEMBRANE; RELEASE		Charite, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Watanabe, S (corresponding author), Charite, D-10117 Berlin, Germany.	shigekixx@gmail.com		Watanabe, Shigeki/0000-0001-7580-8141				Alabi AA, 2013, ANNU REV PHYSIOL, V75, P393, DOI 10.1146/annurev-physiol-020911-153305; Armbruster M, 2013, ELIFE, V2, DOI 10.7554/eLife.00845; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; CECCARELLI B, 1972, J CELL BIOL, V54, P30, DOI 10.1083/jcb.54.1.30; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Saheki Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005645; Watanabe S, 2014, NATURE, V515, P228, DOI 10.1038/nature13846; Watanabe S, 2014, NEUROMETHODS, V84, P43, DOI 10.1007/978-1-4614-9179-8_3; Watanabe S, 2013, NATURE, V504, P242, DOI 10.1038/nature12809; Watanabe S, 2013, ELIFE, V2, DOI 10.7554/eLife.00723	14	5	5	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					46	47		10.1126/science.aad2996	http://dx.doi.org/10.1126/science.aad2996			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26430111				2022-12-28	WOS:000362098300037
J	Poppy, G				Poppy, Guy			Science must prepare for impact	NATURE			English	Editorial Material									[Poppy, Guy] Univ Southampton, Ecol, Southampton SO9 5NH, Hants, England; [Poppy, Guy] Food Stand Agcy, London, England	University of Southampton	Poppy, G (corresponding author), Univ Southampton, Ecol, Southampton SO9 5NH, Hants, England.	g.m.poppy@soton.ac.uk							0	11	11	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					7	7		10.1038/526007a	http://dx.doi.org/10.1038/526007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS5CY	26432204	Bronze			2022-12-28	WOS:000362095100005
J	Bolland, MJ; Leung, W; Tai, V; Bastin, S; Gamble, GD; Grey, A; Reid, IR				Bolland, Mark J.; Leung, William; Tai, Vicky; Bastin, Sonja; Gamble, Greg D.; Grey, Andrew; Reid, Ian R.			Calcium intake and risk of fracture: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VITAMIN-D SUPPLEMENTATION; RANDOMIZED CONTROLLED-TRIAL; BONE-MINERAL DENSITY; OSTEOPOROSIS-RELATED FRACTURES; POSTMENOPAUSAL CHINESE WOMEN; HIP FRACTURE; DIETARY CALCIUM; ELDERLY-WOMEN; DOUBLE-BLIND; VERTEBRAL FRACTURES	OBJECTIVE To examine the evidence underpinning recommendations to increase calcium intake through dietary sources or calcium supplements to prevent fractures. DESIGN Systematic review of randomised controlled trials and observational studies of calcium intake with fracture as an endpoint. Results from trials were pooled with random effects meta-analyses. DATA SOURCES Ovid Medline, Embase, PubMed, and references from relevant systematic reviews. Initial searches undertaken in July 2013 and updated in September 2014. ELIGIBILITY CRITERIA FOR SELECTING STUDIES Randomised controlled trials or cohort studies of dietary calcium, milk or dairy intake, or calcium supplements (with or without vitamin D) with fracture as an outcome and participants aged >50. RESULTS There were only two eligible randomised controlled trials of dietary sources of calcium (n=262), but 50 reports from 44 cohort studies of relations between dietary calcium (n=37), milk (n=14), or dairy intake (n=8) and fracture outcomes. For dietary calcium, most studies reported no association between calcium intake and fracture (14/22 for total, 17/21 for hip, 7/8 for vertebral, and 5/7 for forearm fracture). For milk (25/28) and dairy intake (11/13), most studies also reported no associations. In 26 randomised controlled trials, calcium supplements reduced the risk of total fracture (20 studies, n=58 573; relative risk 0.89, 95% confidence interval 0.81 to 0.96) and vertebral fracture (12 studies, n=48 967. 0.86, 0.74 to 1.00) but not hip (13 studies, n=56 648; 0.95, 0.76 to 1.18) or forearm fracture (eight studies, n=51 775; 0.96, 0.85 to 1.09). Funnel plot inspection and Egger's regression suggested bias toward calcium supplements in the published data. In randomised controlled trials at lowest risk of bias (four studies, n=44 505), there was no effect on risk of fracture at any site. Results were similar for trials of calcium monotherapy and co-administered calcium and vitamin D. Only one trial in frail elderly women in residential care with low dietary calcium intake and vitamin D concentrations showed significant reductions in risk of fracture. CONCLUSIONS Dietary calcium intake is not associated with risk of fracture, and there is no clinical trial evidence that increasing calcium intake from dietary sources prevents fractures. Evidence that calcium supplements prevent fractures is weak and inconsistent.	[Bolland, Mark J.; Tai, Vicky; Gamble, Greg D.; Grey, Andrew; Reid, Ian R.] Univ Auckland, Dept Med, Auckland 1142, New Zealand; [Leung, William] Univ Otago, Dept Publ Hlth, Wellington 6242, New Zealand; [Bastin, Sonja] Starship Hosp, Dept Radiol, Auckland 1142, New Zealand	University of Auckland; University of Otago; Starship Children's Hospital	Bolland, MJ (corresponding author), Univ Auckland, Dept Med, Private Bag 92019, Auckland 1142, New Zealand.	m.bolland@auckland.ac.nz	Bolland, Mark J/A-7554-2008	Bolland, Mark J/0000-0003-0465-2674; Gamble, Greg/0000-0003-0412-3203; Reid, Ian/0000-0001-6021-5458	Health Research Council (HRC) of New Zealand; Sir Charles Hercus Health Research Fellowship	Health Research Council (HRC) of New Zealand(Health Research Council of New Zealand); Sir Charles Hercus Health Research Fellowship	The study was funded by the Health Research Council (HRC) of New Zealand. MJB is the recipient of a Sir Charles Hercus Health Research Fellowship. The authors are independent of the HRC. The HRC had no role in study design, the collection, analysis, and interpretation of data, the writing of the article, or the decision to submit it for publication.	Albrand G, 2003, BONE, V32, P78, DOI 10.1016/S8756-3282(02)00919-5; Anderson JJB, 2012, J CLIN ENDOCR METAB, V97, P4531, DOI 10.1210/jc.2012-1407; Avenell Alison, 2004, Clin Trials, V1, P490, DOI 10.1191/1740774504cn053oa; Avenell A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub3; Bailey RL, 2010, J NUTR, V140, P817, DOI 10.3945/jn.109.118539; Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; Bauer DC, 2013, NEW ENGL J MED, V369, P1537, DOI 10.1056/NEJMcp1210380; Benetou V, 2011, EUR J CLIN NUTR, V65, P132, DOI 10.1038/ejcn.2010.226; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Bischoff-Ferrari HA, 2008, AM J CLIN NUTR, V87, P1945, DOI 10.1093/ajcn/87.6.1945; Bolland MJ, 2008, BMJ-BRIT MED J, V336, P262, DOI 10.1136/bmj.39440.525752.BE; Bolland Mark J, 2011, BMJ, V342, pd2040, DOI 10.1136/bmj.d2040; Bolland MJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3691; Bolton-Smith C, 2007, J BONE MINER RES, V22, P509, DOI [10.1359/jbmr.070116, 10.1359/JBMR.070116]; Bonnick S, 2007, CURR MED RES OPIN, V23, P1341, DOI 10.1185/030079907X188035; Boonen S, 2007, J CLIN ENDOCR METAB, V92, P1415, DOI 10.1210/jc.2006-1404; Castro-Lionard K, 2013, DRUG AGING, V30, P1029, DOI 10.1007/s40266-013-0121-9; Cauley JA, 2007, J BONE MINER RES, V22, P1816, DOI 10.1359/JBMR.070713; CHAPUY MC, 1994, BRIT MED J, V308, P1081, DOI 10.1136/bmj.308.6936.1081; Chapuy MC, 2002, OSTEOPOROSIS INT, V13, P257, DOI 10.1007/s001980200023; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; CHEVALLEY T, 1994, OSTEOPOROSIS INT, V4, P245, DOI 10.1007/BF01623348; Cumming RG, 1997, AM J EPIDEMIOL, V145, P926, DOI 10.1093/oxfordjournals.aje.a009052; Dargent-Molina P, 2002, OSTEOPOROSIS INT, V13, P593, DOI 10.1007/s001980200078; Dargent-Molina P, 2008, J BONE MINER RES, V23, P1915, DOI 10.1359/JBMR.080712; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; Diez-Perez A, 2007, OSTEOPOROSIS INT, V18, P629, DOI 10.1007/s00198-006-0297-5; Domiciano DS, 2014, OSTEOPOROS INT; Feart C, 2013, OSTEOPOROSIS INT, V24, P3031, DOI 10.1007/s00198-013-2421-7; Feskanich D, 2003, AM J CLIN NUTR, V77, P504, DOI 10.1093/ajcn/77.2.504; Fujita T, 2004, J BONE MINER METAB, V22, P32, DOI 10.1007/s00774-003-0445-3; Fujiwara S, 1997, J BONE MINER RES, V12, P998, DOI 10.1359/jbmr.1997.12.7.998; Grant AM, 2005, LANCET, V365, P1621, DOI 10.1016/S0140-6736(05)63013-9; Grimes DA, 2012, OBSTET GYNECOL, V120, P920, DOI 10.1097/AOG.0b013e31826af61a; Gronskag AB, 2010, OSTEOPOROSIS INT, V21, P94; HANSSON T, 1987, CALCIFIED TISSUE INT, V40, P315, DOI 10.1007/BF02556692; Harwood RH, 2004, AGE AGEING, V33, P45, DOI 10.1093/ageing/afh002; HOLBROOK TL, 1988, LANCET, V2, P1046, DOI 10.1016/S0140-6736(88)90065-7; Honkanen RJ, 2000, OSTEOPOROSIS INT, V11, P265, DOI 10.1007/s001980050291; Huang ZP, 1996, AM J EPIDEMIOL, V144, P124, DOI 10.1093/oxfordjournals.aje.a008899; Huopio J, 2000, OSTEOPOROSIS INT, V11, P219, DOI 10.1007/s001980050284; INKOVAARA J, 1983, AGE AGEING, V12, P124, DOI 10.1093/ageing/12.2.124; IOM (Institute of Medicine), 2011, DIETARY REFERENCE IN, DOI [10.17226/13050, DOI 10.17226/13050]; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Kato I, 2000, INT J EPIDEMIOL, V29, P85, DOI 10.1093/ije/29.1.85; Key TJ, 2007, PUBLIC HEALTH NUTR, V10, P1314, DOI 10.1017/S1368980007696402; Khan B, 2012, J BONE MINER RES, V27; Koh WP, 2009, AM J EPIDEMIOL, V170, P901, DOI 10.1093/aje/kwp220; Kung AWC, 2007, J BONE MINER RES, V22, P1080, DOI [10.1359/jbmr.070320, 10.1359/JBMR.070320]; Larsen ER, 2004, J BONE MINER RES, V19, P370, DOI 10.1359/JBMR.0301240; Lau EMC, 2001, J BONE MINER RES, V16, P1704, DOI 10.1359/jbmr.2001.16.9.1704; Lewis CE, 2007, J BONE MINER RES, V22, P211, DOI 10.1359/JBMR.061017; Lewis JR, 2012, J BONE MINER RES, V27, P719, DOI 10.1002/jbmr.1484; LOOKER AC, 1993, OSTEOPOROSIS INT, V3, P177, DOI 10.1007/BF01623673; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Meier C, 2008, ARCH INTERN MED, V168, P47, DOI 10.1001/archinternmed.2007.2; Melton LJ, 2003, J BONE MINER RES, V18, P312, DOI 10.1359/jbmr.2003.18.2.312; Meyer HE, 1997, AM J EPIDEMIOL, V145, P117, DOI 10.1093/oxfordjournals.aje.a009082; Michaelsson K, 2003, BONE, V32, P694, DOI 10.1016/S8756-3282(03)00048-6; Munger RG, 1999, AM J CLIN NUTR, V69, P147; Mussolino ME, 1998, J BONE MINER RES, V13, P918, DOI 10.1359/jbmr.1998.13.6.918; Nakamura K, 2011, OSTEOPOROSIS INT, V22, P97, DOI 10.1007/s00198-010-1213-6; Nakamura K, 2009, BRIT J NUTR, V101, P285, DOI 10.1017/S0007114508993533; Nguyen ND, 2007, J CLIN ENDOCR METAB, V92, P955, DOI 10.1210/jc.2006-1476; Nguyen TV, 2001, AM J EPIDEMIOL, V153, P587, DOI 10.1093/aje/153.6.587; Nieves JW, 2008, OSTEOPOROSIS INT, V19, P673, DOI 10.1007/s00198-007-0501-2; Owusu W, 1997, J NUTR, V127, P1782, DOI 10.1093/jn/127.9.1782; Paganini-Hill A, 1991, Epidemiology, V2, P16; Papaioannou A, 2005, OSTEOPOROSIS INT, V16, P568, DOI 10.1007/s00198-004-1735-x; Peacock M, 2000, J CLIN ENDOCR METAB, V85, P3011, DOI 10.1210/jc.85.9.3011; Porthouse J, 2005, BMJ-BRIT MED J, V330, P1003, DOI 10.1136/bmj.330.7498.1003; Prentice RL, 2013, OSTEOPOROSIS INT, V24, P567, DOI 10.1007/s00198-012-2224-2; Prince RL, 2006, ARCH INTERN MED, V166, P869, DOI 10.1001/archinte.166.8.869; Recker RR, 1996, J BONE MINER RES, V11, P1961; Reid IR, 2008, ARCH INTERN MED, V168, P2276, DOI 10.1001/archinte.168.20.2276; Reid IR, 2006, AM J MED, V119, P777, DOI 10.1016/j.amjmed.2006.02.038; REID IR, 1995, AM J MED, V98, P331, DOI 10.1016/S0002-9343(99)80310-6; REID IR, 1993, NEW ENGL J MED, V328, P460, DOI 10.1056/NEJM199302183280702; RIGGS BL, 1982, NEW ENGL J MED, V306, P446, DOI 10.1056/NEJM198202253060802; Riggs BL, 1998, J BONE MINER RES, V13, P168, DOI 10.1359/jbmr.1998.13.2.168; Robbins JA, 2014, MENOPAUSE, V21, P116, DOI 10.1097/GME.0b013e3182963901; Rouzi AA, 2012, BONE, V50, P713, DOI 10.1016/j.bone.2011.11.024; Roy DK, 2003, OSTEOPOROSIS INT, V14, P19, DOI 10.1007/s00198-002-1317-8; Ruml L A, 1999, Am J Ther, V6, P303, DOI 10.1097/00045391-199911000-00004; Sahni S, 2014, J BONE MINER RES, V29, P1756, DOI 10.1002/jbmr.2219; Sahni S, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0119-2; Salovaara K, 2010, J BONE MINER RES, V25, P1487, DOI 10.1002/jbmr.48; Sambrook PN, 2012, OSTEOPOROSIS INT, V23, P615, DOI 10.1007/s00198-011-1590-5; Samieri C, 2013, OSTEOPOROSIS INT, V24, P1295, DOI 10.1007/s00198-012-2132-5; Tai V, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4183; Thomas-John M, 2009, J RHEUMATOL, V36, P1947, DOI 10.3899/jrheum.080527; van der Klift M, 2004, J BONE MINER RES, V19, P1172, DOI 10.1359/JBMR.040215; van Geel Tineke A C M, 2007, Menopause Int, V13, P110, DOI 10.1258/175404507781605668; Warensjo E, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1473; WICKHAM CAC, 1989, BMJ-BRIT MED J, V299, P889, DOI 10.1136/bmj.299.6704.889; Xiao Q, 2013, JAMA INTERN MED, V173, P639, DOI 10.1001/jamainternmed.2013.3283	97	175	182	1	50	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 29	2015	351								h4580	10.1136/bmj.h4580	http://dx.doi.org/10.1136/bmj.h4580			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS9YU	26420387	Green Published, hybrid			2022-12-28	WOS:000362450900002
J	Nichol, A; French, C; Little, L; Haddad, S; Presneill, J; Arabi, Y; Bailey, M; Cooper, DJ; Duranteau, J; Huet, O; Mak, A; McArthur, C; Pettila, V; Skrifvars, M; Vallance, S; Varma, D; Wills, J; Bellomo, R				Nichol, Alistair; French, Craig; Little, Lorraine; Haddad, Samir; Presneill, Jeffrey; Arabi, Yaseen; Bailey, Michael; Cooper, D. James; Duranteau, Jacques; Huet, Olivier; Mak, Anne; McArthur, Colin; Pettilae, Ville; Skrifvars, Markus; Vallance, Shirley; Varma, Dinesh; Wills, Judy; Bellomo, Rinaldo		EPO-TBI Investigators; ANZICS Clinical Trials Grp	Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial	LANCET			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; CRITICALLY-ILL PATIENTS; GLASGOW OUTCOME SCALE; EPOETIN-ALPHA; PROGESTERONE; RECOVERY; EFFICACY	Background Erythropoietin might have neurocytoprotective effects. In this trial, we studied its effect on neurological recovery, mortality, and venous thrombotic events in patients with traumatic brain injury. Methods Erythropoietin in Traumatic Brain Injury (IEPO-TBI) was a double-blind, placebo-controlled trial undertaken in 29 centres (all university-affiliated teaching hospitals) in seven countries (Australia, New Zealand, France, Germany, Finland, Ireland, and Saudi Arabia). Within 24 h of brain injury, 606 patients were randomly assigned by a concealed web-based computer-generated randomisation schedule to erythropoietin (40 000 units subcutaneously) or placebo (0.9% sodium chloride subcutaneously) once per week for a maximum of three doses. Randomisation was stratified by severity of traumatic brain injury (moderate vs severe) and participating site. With the exception of designated site pharmacists, the site dosing nurses at all sites, and the pharmacists at the central pharmacy in France, all study personnel, patients, and patients' relatives were masked to treatment assignment. The primary outcome, assessed at 6 months by modified intention-to-treat analysis, was improvement in the patients' neurological status, summarised as a reduction in the proportion of patients with an Extended Glasgow Outcome Scale (GOS-E) of 1-4 (death, vegetative state, and severe disability). Two equally spaced preplanned interim analyses were done (after 202 and 404 participants were enrolled). This study is registered with ClinicalTrials.gov, number NCT00987454. Findings Between May 3, 2010, and Nov 1, 2014, 606 patients were enrolled and randomly assigned to erythropoietin (n=308) or placebo (n=298). Ten of these patients (six in the erythropoietin group and four in the placebo group) were lost to follow up at 6 months; therefore, data for the primary outcome analysis was available for 596 patients (302 in the erythropoietin group and 294 in the placebo group). Compared with placebo, erythropoietin did not reduce the proportion of patients with a GOS-E level of 1-4 (134 [44%] of 302 patients in the erythropoietin group vs 132 [45%] of 294 in the placebo group; relative risk [RR] 0.99 [95% CI 0.83-1.18], p=0.90). In terms of safety, erythropoietin did not significantly affect 6-month mortality versus placebo (32 [11%] of 305 patients had died at 6 months in the erythropoietin group vs 46 [16%] of 297 [16%] in the placebo group; RR 0.68 [95% CI 0.44-1.03], p=0.07) or increase the occurrence of deep venous thrombosis of the lower limbs (48 [16%] of 305 vs 54 [18%] of 298; RR 0.87 [95% CI 0.61-1.24], p=0.44). Interpretation Following moderate or severe traumatic brain injury, erythropoietin did not reduce the number of patients with severe neurological dysfunction (IGOS-E level 1-4) or increase the incidence of deep venous thrombosis of the lower limbs. The effect of erythropoietin on mortality remains uncertain.	[Nichol, Alistair; Little, Lorraine; Presneill, Jeffrey; Arabi, Yaseen; Bailey, Michael; Cooper, D. James; Huet, Olivier; Mak, Anne; McArthur, Colin; Pettilae, Ville; Vallance, Shirley; Wills, Judy; Bellomo, Rinaldo] Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia; [French, Craig] Univ Melbourne, Melbourne, Vic, Australia; [Nichol, Alistair; Cooper, D. James; Mak, Anne; Vallance, Shirley] The Alfred, Melbourne, Vic, Australia; [Nichol, Alistair] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Nichol, Alistair] St Vincents Univ Hosp, Dublin 4, Ireland; [French, Craig] Western Hlth, Melbourne, Vic, Australia; [Haddad, Samir] King Abdul Aziz Med City, Natl Guard Hlth Aff airs, Riyadh, Saudi Arabia; [Presneill, Jeffrey] Univ Queensland, Brisbane, Qld, Australia; [Presneill, Jeffrey] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Arabi, Yaseen] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia; [Arabi, Yaseen] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Duranteau, Jacques] Univ Paris 11, Hop Bicetre, Assistance Publ Hop Paris, Dept Anesthesie Reanimat, Paris, France; [Huet, Olivier] CHU La Cavale Blanche, Dept Anaesthesiol & Intens Care Med, Brest, France; [Pettilae, Ville; Skrifvars, Markus] Univ Helsinki, Helsinki, Finland; [Pettilae, Ville; Skrifvars, Markus] Helsinki Univ Hosp, Helsinki, Finland; [McArthur, Colin] Auckland City Hosp, Auckland, New Zealand; [Bellomo, Rinaldo] Austin Hosp, Melbourne, Vic 3084, Australia	Monash University; University of Melbourne; University College Dublin; University College Dublin; Saint Vincent's University Hospital; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; University of Queensland; Royal Brisbane & Women's Hospital; King Saud Bin Abdulaziz University for Health Sciences; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; CHU Brest; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Auckland City Hospital; Austin Research Institute; Florey Institute of Neuroscience & Mental Health	French, C (corresponding author), Western Hlth, Dept Intens Care, Gordon St, Footscray, Vic 3011, Australia.	craig.french@wh.org.au	FRENCH, CRAIG/HGA-5299-2022; Presneill, Jeffrey J/B-4894-2012; Bailey, Michael J/A-4499-2012; Cooper, D. James/G-7961-2013; French, Craig/ABF-5087-2020; Arabi, Yaseen/ABF-3316-2020	Presneill, Jeffrey J/0000-0001-7177-7667; Bailey, Michael J/0000-0002-5551-1401; Cooper, D. James/0000-0002-5872-9051; French, Craig/0000-0003-1363-9711; Arabi, Yaseen/0000-0001-5735-6241; Micallef, Sharon/0000-0002-8496-2324; Huet, Olivier/0000-0001-7345-0334; Bellomo, Rinaldo/0000-0002-1650-8939; Knowles, Serena/0000-0002-5028-3825; Nichol, Alistair/0000-0002-4689-1238; Richards, Brent/0000-0003-2613-0308; Harrois, Anatole/0000-0002-5098-4656; Whitehead, Christina/0000-0003-4561-7082; Nichol, Alistair Dualta/0000-0002-4771-5615	National Health and Medical Research Council; Transport Accident Commission; National Health and Medical Research Council of Australia [545902]; Transport Accident Commission of Victoria [D162]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Transport Accident Commission; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Transport Accident Commission of Victoria	The National Health and Medical Research Council and the Transport Accident Commission.; EPO-TBI was supported by grants from the National Health and Medical Research Council of Australia (grant 545902) and the Transport Accident Commission of Victoria (grant D162). The members of the writing committee assume responsibility for the overall content and integrity of the article.	Abrishamkar S, 2012, J RES MED SCI, V17, P51; Aloizos S, 2015, TURK NEUROSURG, V25, P552, DOI 10.5137/1019-5149.JTN.9685-14.4; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Coleman T, 2004, CRIT CARE, V8, P337, DOI 10.1186/cc2897; Cook DJ, 2005, J CRIT CARE, V20, P364, DOI 10.1016/j.jcrc.2005.09.010; Corwin HL, 2002, JAMA-J AM MED ASSOC, V288, P2827, DOI 10.1001/jama.288.22.2827; Corwin HL, 2007, CAN MED ASSOC J, V177, P747, DOI 10.1503/cmaj.071150; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Corwin HL, 2014, J TRAUMA ACUTE CARE, V77, P774, DOI 10.1097/TA.0000000000000442; Hebert PC, 2007, CAN MED ASSOC J, V177, P697, DOI 10.1503/cmaj.071223; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lykissas MG, 2007, CLIN NEUROL NEUROSUR, V109, P639, DOI 10.1016/j.clineuro.2007.05.013; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nichol A, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0528-6; Nichol A, 2014, JAMA-J AM MED ASSOC, V312, P1928, DOI 10.1001/jama.2014.12738; Nirula R, 2010, CRIT CARE RES PRACT, V2010, DOI 10.1155/2010/209848; Presneill Jeffrey, 2014, Trials, V15, P501, DOI 10.1186/1745-6215-15-501; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; US Food and Drug Administration, FDA STRENGTH SAF INF; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje	30	151	157	0	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 19	2015	386	10012					2499	2506		10.1016/S0140-6736(15)00386-4	http://dx.doi.org/10.1016/S0140-6736(15)00386-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ1LD	26452709				2022-12-28	WOS:000366866400024
J	Blomen, VA; Majek, P; Jae, LT; Bigenzahn, JW; Nieuwenhuis, J; Staring, J; Sacco, R; van Diemen, FR; Olk, N; Stukalov, A; Marceau, C; Janssen, H; Carette, JE; Bennett, KL; Colinge, J; Superti-Furga, G; Brummelkamp, TR				Blomen, Vincent A.; Majek, Peter; Jae, Lucas T.; Bigenzahn, Johannes W.; Nieuwenhuis, Joppe; Staring, Jacqueline; Sacco, Roberto; van Diemen, Ferdy R.; Olk, Nadine; Stukalov, Alexey; Marceau, Caleb; Janssen, Hans; Carette, Jan E.; Bennett, Keiryn L.; Colinge, Jacques; Superti-Furga, Giulio; Brummelkamp, Thijn R.			Gene essentiality and synthetic lethality in haploid human cells	SCIENCE			English	Article							SECRETORY PATHWAY; VIRUS ENTRY; YEAST; EXPLORATION; NETWORKS; REPLICATION; MUTANTS; SCREENS; GENOME	Although the genes essential for life have been identified in less complex model organisms, their elucidation in human cells has been hindered by technical barriers. We used extensive mutagenesis in haploid human cells to identify approximately 2000 genes required for optimal fitness under culture conditions. To study the principles of genetic interactions in human cells, we created a synthetic lethality network focused on the secretory pathway based exclusively on mutations. This revealed a genetic cross-talk governing Golgi homeostasis, an additional subunit of the human oligosaccharyltransferase complex, and a phosphatidylinositol 4-kinase beta adaptor hijacked by viruses. The synthetic lethality map parallels observations made in yeast and projects a route forward to reveal genetic networks in diverse aspects of human cell biology.	[Blomen, Vincent A.; Jae, Lucas T.; Nieuwenhuis, Joppe; Staring, Jacqueline; van Diemen, Ferdy R.; Janssen, Hans; Brummelkamp, Thijn R.] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Majek, Peter; Bigenzahn, Johannes W.; Sacco, Roberto; Olk, Nadine; Stukalov, Alexey; Bennett, Keiryn L.; Colinge, Jacques; Superti-Furga, Giulio; Brummelkamp, Thijn R.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Marceau, Caleb; Carette, Jan E.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Colinge, Jacques] Univ Montpellier, Inst Rech Cancerol Montpellier, INSERM, U1194,Inst Reg Canc Montpellier, F-34000 Montpellier, France; [Superti-Furga, Giulio] Med Univ Vienna, Ctr Physiol & Pharmacol, Vienna, Austria; [Brummelkamp, Thijn R.] Canc Genom Ctr CGC Nl, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Stanford University; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Medical University of Vienna	Colinge, J (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria.	jacques.colinge@inserm.fr; gsuperti@cemm.at; t.brummelkamp@nki.nl	blomen, vincent/AAE-1477-2020; Stukalov, Alexey/AAS-3208-2021; Jae, Lucas/AAY-3438-2021; Colinge, Jacques/D-1578-2017; Jae, Lucas/AAH-5342-2020; Superti-Furga, Giulio/AAE-5681-2019; Colinge, Jacques/Z-2613-2019	Stukalov, Alexey/0000-0002-4981-8124; Colinge, Jacques/0000-0003-2466-4824; Jae, Lucas/0000-0002-3531-1760; Colinge, Jacques/0000-0003-2466-4824; Bigenzahn, Johannes/0000-0002-5214-4570; Nieuwenhuis, Joppe/0000-0003-4738-5895; Carette, Jan/0000-0002-5187-8070; Bennett, Keiryn L./0000-0001-9356-7708	Cancer Genomics Center (CGC.nl); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)-VIDI [91711316]; European Research Council (ERC) [ERC-2012-StG 309634]; Austrian Academy of Sciences; Advanced ERC grant i-FIVE; Austrian Science Fund grant [FWF SFB F4711]; ARC Foundation [PJA 20141201975]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328] Funding Source: NIH RePORTER	Cancer Genomics Center (CGC.nl); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)-VIDI(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC)(European Research Council (ERC)European Commission); Austrian Academy of Sciences; Advanced ERC grant i-FIVE; Austrian Science Fund grant; ARC Foundation(Australian Research Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Sixma, S. Nijman, J. Roix, J. Neefjes, and members of the Brummelkamp group for discussion and K. Sandhoff for antibodies directed against saposin. This work was supported by the Cancer Genomics Center (CGC.nl), Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)-VIDI grant 91711316, European Research Council (ERC) Starting Grant (ERC-2012-StG 309634) to T.R.B., the Austrian Academy of Sciences and the Advanced ERC grant i-FIVE and Austrian Science Fund grant (FWF SFB F4711) to G.S.-F, and the ARC Foundation grant PJA 20141201975 to J.C. Sequence data have been deposited at the National Center for Biotechnology Information Sequence Read Archive with accession number SRP058962.	Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Charng WL, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001777; Demaegd D, 2013, P NATL ACAD SCI USA, V110, P6859, DOI 10.1073/pnas.1219871110; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Dumax-Vorzet A, 2013, J CELL SCI, V126, P2595, DOI 10.1242/jcs.115410; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Graham TR, 2011, TRENDS CELL BIOL, V21, P113, DOI 10.1016/j.tcb.2010.10.002; Greninger AL, 2013, MBIO, V4, DOI 10.1128/mBio.00098-13; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Lipinski AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000615; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Nijman SMB, 2013, SCIENCE, V342, P809, DOI 10.1126/science.1244669; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Reiss G, 1997, EMBO J, V16, P1164, DOI 10.1093/emboj/16.6.1164; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Subramaniam VN, 1996, SCIENCE, V272, P1161, DOI 10.1126/science.272.5265.1161; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; van der Schaar HM, 2012, CELL RES, V22, P1576, DOI 10.1038/cr.2012.129; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041	28	480	490	4	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264					1092	1096		10.1126/science.aac7557	http://dx.doi.org/10.1126/science.aac7557			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY5BJ	26472760				2022-12-28	WOS:000366422600044
J	Neafsey, DE; Juraska, M; Bedford, T; Benkeser, D; Valim, C; Griggs, A; Lievens, M; Abdulla, S; Adjei, S; Agbenyega, T; Agnandji, ST; Aide, P; Anderson, S; Ansong, D; Aponte, JJ; Asante, KP; Bejon, P; Birkett, AJ; Bruls, M; Connolly, KM; D'Alessandro, U; Dobano, C; Gesase, S; Greenwood, B; Grimsby, J; Tinto, H; Hamel, MJ; Hoffman, I; Kamthunzi, P; Kariuki, S; Kremsner, PG; Leach, A; Lell, B; Lennon, NJ; Lusingu, J; Marsh, K; Martinson, F; Molel, JT; Moss, EL; Njuguna, P; Ockenhouse, CF; Ogutu, BR; Otieno, W; Otieno, L; Otieno, K; Owusu-Agyei, S; Park, DJ; Pelle, K; Robbins, D; Russ, C; Ryan, EM; Sacarlal, J; Sogoloff, B; Sorgho, H; Tanner, M; Theander, T; Valea, I; Volkman, SK; Yu, Q; Lapierre, D; Birren, BW; Gilbert, PB; Wirth, DF				Neafsey, D. E.; Juraska, M.; Bedford, T.; Benkeser, D.; Valim, C.; Griggs, A.; Lievens, M.; Abdulla, S.; Adjei, S.; Agbenyega, T.; Agnandji, S. T.; Aide, P.; Anderson, S.; Ansong, D.; Aponte, J. J.; Asante, K. P.; Bejon, P.; Birkett, A. J.; Bruls, M.; Connolly, K. M.; D'Alessandro, U.; Dobano, C.; Gesase, S.; Greenwood, B.; Grimsby, J.; Tinto, H.; Hamel, M. J.; Hoffman, I.; Kamthunzi, P.; Kariuki, S.; Kremsner, P. G.; Leach, A.; Lell, B.; Lennon, N. J.; Lusingu, J.; Marsh, K.; Martinson, F.; Molel, J. T.; Moss, E. L.; Njuguna, P.; Ockenhouse, C. F.; Ogutu, B. Ragama; Otieno, W.; Otieno, L.; Otieno, K.; Owusu-Agyei, S.; Park, D. J.; Pelle, K.; Robbins, D.; Russ, C.; Ryan, E. M.; Sacarlal, J.; Sogoloff, B.; Sorgho, H.; Tanner, M.; Theander, T.; Valea, I.; Volkman, S. K.; Yu, Q.; Lapierre, D.; Birren, B. W.; Gilbert, P. B.; Wirth, D. F.			Genetic Diversity and Protective Efficacy of the RTS, S/AS01 Malaria Vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; CIRCUMSPOROZOITE PROTEIN; EXPANDED-PROGRAM; ENDEMIC AREA; DOUBLE-BLIND; SAFETY; IMMUNOGENICITY; RTS,S/AS02A; SELECTION; CHILDREN	BACKGROUND The RTS, S/AS01 vaccine targets the circumsporozoite protein of Plasmodium falciparum and has partial protective efficacy against clinical and severe malaria disease in infants and children. We investigated whether the vaccine efficacy was specific to certain parasite genotypes at the circumsporozoite protein locus. METHODS We used polymerase chain reaction-based next-generation sequencing of DNA extracted from samples from 4985 participants to survey circumsporozoite protein polymorphisms. We evaluated the effect that polymorphic positions and haplotypic regions within the circumsporozoite protein had on vaccine efficacy against first episodes of clinical malaria within 1 year after vaccination. RESULTS In the per-protocol group of 4577 RTS, S/AS01-vaccinated participants and 2335 control-vaccinated participants who were 5 to 17 months of age, the 1-year cumulative vaccine efficacy was 50.3% (95% confidence interval [CI], 34.6 to 62.3) against clinical malaria in which parasites matched the vaccine in the entire circumsporozoite protein C-terminal (139 infections), as compared with 33.4% (95% CI, 29.3 to 37.2) against mismatched malaria (1951 infections) (P = 0.04 for differential vaccine efficacy). The vaccine efficacy based on the hazard ratio was 62.7% (95% CI, 51.6 to 71.3) against matched infections versus 54.2% (95% CI, 49.9 to 58.1) against mismatched infections (P = 0.06). In the group of infants 6 to 12 weeks of age, there was no evidence of differential allele-specific vaccine efficacy. CONCLUSIONS These results suggest that among children 5 to 17 months of age, the RTS, S vaccine has greater activity against malaria parasites with the matched circumsporozoite protein allele than against mismatched malaria. The overall vaccine efficacy in this age category will depend on the proportion of matched alleles in the local parasite population; in this trial, less than 10% of parasites had matched alleles. (Funded by the National Institutes of Health and others.)	[Neafsey, D. E.; Valim, C.; Griggs, A.; Anderson, S.; Connolly, K. M.; Grimsby, J.; Lennon, N. J.; Moss, E. L.; Park, D. J.; Pelle, K.; Robbins, D.; Russ, C.; Ryan, E. M.; Sogoloff, B.; Volkman, S. K.; Yu, Q.; Birren, B. W.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA; [Valim, C.; Pelle, K.; Volkman, S. K.; Wirth, D. F.] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Volkman, S. K.] Simmons Coll Sch Nursing & Hlth Sci, Boston, MA USA; [Juraska, M.; Bedford, T.; Benkeser, D.; Valim, C.; Gilbert, P. B.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Benkeser, D.; Gilbert, P. B.] Univ Washington, Seattle, WA 98195 USA; [Lievens, M.; Bruls, M.; Leach, A.; Lapierre, D.] GlaxoSmithKline Vaccines, Rixensart, Belgium; [Abdulla, S.; Molel, J. T.] Ifakara Hlth Inst, Bagamoyo, Tanzania; [Gesase, S.; Lusingu, J.] Natl Inst Med Res, Korogwe, Tanzania; [Adjei, S.; Agbenyega, T.] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana; [Asante, K. P.; Greenwood, B.; Owusu-Agyei, S.] Kintampo Hlth Res Ctr, Kintampo, Ghana; [Agnandji, S. T.; Ansong, D.; Kremsner, P. G.; Lell, B.] Albert Schweitzer Hosp, Lambarene, Gabon; [Agnandji, S. T.; Kremsner, P. G.; Lell, B.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Aide, P.; Aponte, J. J.; Dobano, C.; Sacarlal, J.] Ctr Invest Saude Manhica, Manhica, Mozambique; [Aide, P.; Aponte, J. J.; Dobano, C.] Hosp Clin Univ Barcelona, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Birkett, A. J.; Ockenhouse, C. F.] PATH Malaria Vaccine Initiat, Washington, DC USA; [D'Alessandro, U.] MRC Unit, Banjul, Gambia; [Greenwood, B.] London Sch Hyg & Trop Med, London, England; [Tinto, H.; Sorgho, H.; Valea, I.] Inst Rech Sci Sante, Nanoro, Burkina Faso; [Hamel, M. J.] Ctr Dis Control & Prevent CDC, Atlanta, GA USA; [Hoffman, I.] Univ N Carolina, Chapel Hill, NC USA; [Kamthunzi, P.; Martinson, F.] UNC Project, Lilongwe, Malawi; [Bejon, P.; Marsh, K.; Njuguna, P.] Kenya Med Res Inst KEMRI, Wellcome Trust Res Program, Kilifi, Kenya; [Kariuki, S.; Otieno, K.] KEMRI CDC Res & Publ Hlth Collaborat, Kisumu, Kenya; [Ogutu, B. Ragama; Otieno, W.; Otieno, L.; Pelle, K.] KEMRI Walter Reed Project, Kombewa, Kenya; [Tanner, M.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Theander, T.] Univ Copenhagen, Copenhagen, Denmark	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Simmons University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; GlaxoSmithKline; Ifakara Health Institute; Kwame Nkrumah University Science & Technology; Kintampo Health Research Centre; Eberhard Karls University of Tubingen; Centro de Investigacao em Saude de Manhica; University of Barcelona; Hospital Clinic de Barcelona; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Centers for Disease Control & Prevention - USA; University of North Carolina; University of North Carolina Chapel Hill; Kenya Medical Research Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Copenhagen	Wirth, DF (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	pgilbert@fredhutch.org; dfwirth@hsph.harvard.edu	Lusingu, John P. A./GSJ-3228-2022; Kariuki, Simon/AFT-6596-2022; Benkeser, David/X-2042-2019; Leach, Amanda/AAS-1120-2020; Valea, Innocent/ABE-6694-2020; Sacarlal, Jahit/R-3172-2016; Dobaño, Carlota/N-4119-2014; Theander, Thor/F-6714-2015	Leach, Amanda/0000-0002-7114-9967; Sacarlal, Jahit/0000-0003-1059-217X; Dobaño, Carlota/0000-0002-6751-4060; Theander, Thor/0000-0002-3509-7514; Valea, Innocent/0000-0002-3085-0490; /0000-0001-9585-3820; ANSONG, Daniel/0000-0003-1328-9117; Owusu-Agyei, Seth/0000-0002-0807-1781; Benkeser, David/0000-0002-1019-8343; Lusingu, John P. A./0000-0002-9407-0602; Tinto, Halidou/0000-0002-0472-3586; Mollel, Jackson Thomas/0000-0002-9078-793X	National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI110818, R37AI054165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institutes of Health and others.	Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Agnandji ST, 2010, J INFECT DIS, V202, P1076, DOI 10.1086/656190; Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Aide P, 2011, VACCINE, V29, P6059, DOI 10.1016/j.vaccine.2011.03.041; Alloueche A, 2003, AM J TROP MED HYG, V68, P97, DOI 10.4269/ajtmh.2003.68.97; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Aragam NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062427; Asante KP, 2011, LANCET INFECT DIS, V11, P741, DOI 10.1016/S1473-3099(11)70100-1; Bailey JA, 2012, J INFECT DIS, V206, P580, DOI 10.1093/infdis/jis329; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CALLE JMC, 1992, J IMMUNOL, V149, P2695; Campo JJ, 2015, MOL CELL PROTEOMICS, V14, P519, DOI 10.1074/mcp.M114.044677; Edlefsen PT, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1003973; Enosse S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010005; ESPOSITO F, 1988, T ROY SOC TROP MED H, V82, P827, DOI 10.1016/0035-9203(88)90007-7; Follmann D, 2003, BIOMETRICS, V59, P420, DOI 10.1111/1541-0420.00049; Gandhi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101783; Gandhi K, 2012, AM J TROP MED HYG, V86, P775, DOI 10.4269/ajtmh.2012.11-0478; Gilbert PB, 2000, STAT MED, V19, P3065; GOOD MF, 1988, P NATL ACAD SCI USA, V85, P1199, DOI 10.1073/pnas.85.4.1199; Hall BF, 2009, J INFECT DIS, V200, P1639, DOI 10.1086/646611; HOLM S, 1979, SCAND J STAT, V6, P65; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Lalvani A, 1999, J INFECT DIS, V180, P1656, DOI 10.1086/315074; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Plowe CV, 2009, J INFECT DIS, V200, P1646, DOI 10.1086/646613; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; Takala SL, 2007, PLOS MED, V4, P523, DOI 10.1371/journal.pmed.0040093; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; van der Laan Mark J, 2007, Int J Biostat, V3, P3, DOI 10.2202/1557-4679.1022; Waitumbi JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007849; Weedall GD, 2007, INT J PARASITOL, V37, P77, DOI 10.1016/j.ijpara.2006.09.001; WHO, 2013, WORLD MALARIA REPORT 2013, P1	39	228	234	4	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2015	373	21					2025	2037		10.1056/NEJMoa1505819	http://dx.doi.org/10.1056/NEJMoa1505819			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW4JN	26488565	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000364957700008
J	Rosenbaum, L				Rosenbaum, Lisa			Transitional Chaos or Enduring Harm? The EHR and the Disruption of Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Friedberg M, 2014, HLTH AFFAIRS BL 0311; Koppel R, 2012, AHRQ WEB M M     JUL; Rahurkar S, 2015, HEALTH AFFAIR, V34, P477, DOI 10.1377/hlthaff.2014.0729; Soumerai SB, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150187; Wachter Robert, 2015, HOPE HYPE HARM DAWN	5	48	48	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2015	373	17					1585	1588		10.1056/NEJMp1509961	http://dx.doi.org/10.1056/NEJMp1509961			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CU1YH	26488690				2022-12-28	WOS:000363317800001
J	Koplan, J; Eriksen, M				Koplan, Jeffrey; Eriksen, Michael			Smoking cessation for Chinese men and prevention for women	LANCET			English	Editorial Material							MORTALITY; DISEASE; CANCER; BURDEN		[Koplan, Jeffrey] Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA; [Eriksen, Michael] Georgia State Univ, Sch Publ Hlth, Atlanta, GA 30303 USA	Emory University; University System of Georgia; Georgia State University	Koplan, J (corresponding author), Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA.	jkoplan@emory.edu						Chen ZM, 2015, LANCET, V386, P1447, DOI 10.1016/S0140-6736(15)00340-2; Eriksen M, 2015, TOBACCO ATLAS; Gan Q, 2007, TOB CONTROL, V16, P417, DOI 10.1136/tc.2007.021477; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Han J, 2015, INT J ENV RES PUB HE, V12, P4617, DOI 10.3390/ijerph120504617; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Liang XF, 2015, REPORT CHINA CITY AD; Ma SJ, 2008, J HEALTH COMMUN, V13, P654, DOI 10.1080/10810730802412222; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Tye L, 2002, FATHER SPIN EL BERNA	10	14	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2015	386	10002					1422	1423		10.1016/S0140-6736(15)00416-X	http://dx.doi.org/10.1016/S0140-6736(15)00416-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CT5UU	26466027	hybrid, Green Published			2022-12-28	WOS:000362877300006
J	Brody, H				Brody, Herb			Beauty	NATURE			English	Editorial Material																			0	4	6	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					S1	S1		10.1038/526S1a	http://dx.doi.org/10.1038/526S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26444366	Bronze			2022-12-28	WOS:000362399000055
J	Mather, M; Wiles, K; O'Brien, P				Mather, Mary; Wiles, Kate; O'Brien, Patrick			Should women abstain from alcohol throughout pregnancy?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OUTCOMES; EXPOSURE; RISK		[Wiles, Kate] Guys & St Thomas NHS Fdn Trust, London, England; [Wiles, Kate] Kings Coll London, London, England; [O'Brien, Patrick] Univ Coll London Hosp, Obstet & Gynaecol, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University College London Hospitals NHS Foundation Trust; University of London; University College London		marymather@doctors.org.uk; patrick.obrien@uclh.nhs.uk						BMA Board of Science, 2007, FET ALC SPECTR DIS G; Centre for Disease Control and Prevention, 2013, EFF ALC US PREGN LAT; Fenton S., 2015, INDEPENDENT; Flak AL, 2014, ALCOHOL CLIN EXP RES, V38, P214, DOI 10.1111/acer.12214; Gray R, 2006, REV FETAL EFFECTS PR; International Alliance for Responsible Drinking, DRINK GUID PREGN BRE; Kelly Y, 2013, BJOG, V120, P1340, DOI 10.1111/1471-0528.12246; Kelly Y, 2009, INT J EPIDEMIOL, V38, P129, DOI 10.1093/ije/dyn230; May PA, 2001, ALCOHOL RES HEALTH, V25, P159; Mukherjee R, 2013, INT J ALCOHOL DRUG R, V2, P71, DOI 10.7895/ijadr.v2i3.78; National Institute for Health and Care Excellence, 2008, ANT CAR NIC GUID CG6; NHS Choices, ALC IN PREGN; NHS Choices, 2014, CAN I DRINK ALC IM P; Nykjaer C, 2014, J EPIDEMIOL COMMUN H, V68, P542, DOI 10.1136/jech-2013-202934; Royal College of Obstetricians and Gynaecologists, 2015, ALC PREGN; STREISSGUTH AP, 1980, SCIENCE, V209, P353, DOI 10.1126/science.6992275	16	12	12	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 6	2015	351								h5232	10.1136/bmj.h5232	http://dx.doi.org/10.1136/bmj.h5232			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT3SF	26442904				2022-12-28	WOS:000362726500003
J	Lebwohl, B; Ludvigsson, JF; Green, PHR				Lebwohl, Benjamin; Ludvigsson, Jonas F.; Green, Peter H. R.			Celiac disease and non-celiac gluten sensitivity	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SMALL-INTESTINAL HISTOPATHOLOGY; POPULATION-BASED COHORT; BODY-MASS INDEX; FREE DIET; VILLOUS ATROPHY; DOUBLE-BLIND; AT-RISK; LYMPHOPROLIFERATIVE MALIGNANCY; PEDIATRIC GASTROENTEROLOGY; GASTROINTESTINAL SYMPTOMS	Celiac disease is a multisystem immune based disorder that is triggered by the ingestion of gluten in genetically susceptible individuals. The prevalence of celiac disease has risen in recent decades and is currently about 1% in most Western populations. The reason for this rise is unknown, although environmental factors related to the hygiene hypothesis are suspected. The pathophysiology of celiac disease involves both the innate and adaptive immune response to dietary gluten. Clinical features are diverse and include gastrointestinal symptoms, metabolic bone disease, infertility, and many other manifestations. Although a gluten-free diet is effective in most patients, this diet can be burdensome and can limit quality of life; consequently, non-dietary therapies are at various stages of development. This review also covers non-celiac gluten sensitivity. The pathophysiology of this clinical phenotype is poorly understood, but it is a cause of increasing interest in gluten-free diets in the general population.	[Lebwohl, Benjamin; Green, Peter H. R.] Columbia Univ, Coll Phys & Surg, Celiac Dis Ctr, Dept Med, New York, NY 10032 USA; [Lebwohl, Benjamin; Ludvigsson, Jonas F.] Karolinska Univ Hosp, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Lebwohl, Benjamin; Ludvigsson, Jonas F.] Karolinska Inst, Stockholm, Sweden; [Ludvigsson, Jonas F.] Orebro Univ Hosp, Dept Pediat, Orebro, Sweden	Columbia University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Orebro University	Green, PHR (corresponding author), Columbia Univ, Coll Phys & Surg, Celiac Dis Ctr, Dept Med, New York, NY 10032 USA.	PG11@columbia.edu	Ludvigsson, Jonas F/A-8560-2012	Ludvigsson, Jonas F/0000-0003-1024-5602	National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000040]; Orebro University Hospital, Karolinska Institutet; Swedish Society of Medicine; Swedish Research Council-Medicine [522-2A09-195]; Swedish Coeliac Society; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Orebro University Hospital, Karolinska Institutet; Swedish Society of Medicine; Swedish Research Council-Medicine(Swedish Research Council); Swedish Coeliac Society; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	BL: National Center for Advancing Translational Sciences, National Institutes of Health (UL1 TR000040). JFL: Orebro University Hospital, Karolinska Institutet, the Swedish Society of Medicine, the Swedish Research Council-Medicine (522-2A09-195), and the Swedish Coeliac Society.	Adriaanse MPM, 2013, ALIMENT PHARM THER, V37, P482, DOI 10.1111/apt.12194; Aggarwal S, 2012, THER ADV GASTROENTER, V5, P37, DOI 10.1177/1756283X11417038; Aronsson CA, 2015, PEDIATRICS, V135, P239, DOI 10.1542/peds.2014-1787; Austin AS, 2002, SCAND J GASTROENTERO, V37, P978, DOI 10.1080/003655202760230973; Aziz I, 2014, EUR J GASTROEN HEPAT, V26, P33, DOI 10.1097/01.meg.0000435546.87251.f7; Bai JC, 2013, J CLIN GASTROENTEROL, V47, P121, DOI 10.1097/MCG.0b013e31827a6f83; Biagi F, 2008, DIGEST LIVER DIS, V40, P97, DOI 10.1016/j.dld.2007.10.004; Biesiekierski JR, 2014, NUTR CLIN PRACT, V29, P504, DOI 10.1177/0884533614529163; Biesiekierski JR, 2013, GASTROENTEROLOGY, V145, P320, DOI 10.1053/j.gastro.2013.04.051; Biesiekierski JR, 2011, AM J GASTROENTEROL, V106, P508, DOI 10.1038/ajg.2010.487; Brottveit M, 2013, AM J GASTROENTEROL, V108, P842, DOI 10.1038/ajg.2013.91; Caio G, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-26; Carlsson AK, 2001, PEDIATRICS, V107, P42, DOI 10.1542/peds.107.1.42; Cascella NG, 2011, SCHIZOPHRENIA BULL, V37, P94, DOI 10.1093/schbul/sbp055; Cataldo F, 2002, J PEDIATR GASTR NUTR, V35, P233, DOI 10.1097/00005176-200208000-00029; Catassi C, 1999, LANCET, V354, P647, DOI 10.1016/S0140-6736(99)02609-4; Catassi C, 2007, AM J CLIN NUTR, V85, P160, DOI 10.1093/ajcn/85.1.160; Catassi C, 2007, AM J GASTROENTEROL, V102, P1454, DOI 10.1111/j.1572-0241.2007.01173.x; Catassi C, 2013, NUTRIENTS, V5, P3839, DOI 10.3390/nu5103839; Catassi C, 2010, ANN MED, V42, P530, DOI 10.3109/07853890.2010.514285; Cheng JF, 2010, J CLIN GASTROENTEROL, V44, P267, DOI 10.1097/MCG.0b013e3181b7ed58; Chin RL, 2003, NEUROLOGY, V60, P1581, DOI 10.1212/01.WNL.0000063307.84039.C7; Collin P, 2007, J CLIN GASTROENTEROL, V41, P152, DOI 10.1097/01.mcg.0000212618.12455.a8; Comino I, 2012, AM J CLIN NUTR, V95, P670, DOI 10.3945/ajcn.111.026708; COOPER BT, 1980, GASTROENTEROLOGY, V79, P801; Decker E, 2010, PEDIATRICS, V125, pE1433, DOI 10.1542/peds.2009-2260; Di Sabatino A, 2015, CLIN GASTROENTEROL H; Dickerson F, 2010, BIOL PSYCHIAT, V68, P100, DOI 10.1016/j.biopsych.2010.03.021; Digiacomo DV, 2013, SCAND J GASTROENTERO, V48, P921, DOI 10.3109/00365521.2013.809598; Dixit R, 2014, DIGEST DIS SCI, V59, P1509, DOI 10.1007/s10620-014-3025-6; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; Eaton WW, 2006, AM J PSYCHIAT, V163, P521, DOI 10.1176/appi.ajp.163.3.521; Elfstrom P, 2008, J CLIN ENDOCR METAB, V93, P3915, DOI 10.1210/jc.2008-0798; Elfstrom P, 2012, CLIN GASTROENTEROL H, V10, P30, DOI 10.1016/j.cgh.2011.06.029; Elfstrom P, 2011, JNCI-J NATL CANCER I, V103, P436, DOI 10.1093/jnci/djq564; ELLIS A, 1978, LANCET, V1, P1358; Emilsson L, 2013, ALIMENT PHARM THER, V37, P905, DOI 10.1111/apt.12271; Evans KE, 2010, DIGEST DIS SCI, V55, P2999, DOI 10.1007/s10620-010-1261-y; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Fuchs V, 2014, SCAND J GASTROENTERO, V49, P1304, DOI 10.3109/00365521.2014.923502; Golley S, 2015, PUBLIC HEALTH NUTR, V18, P490, DOI 10.1017/S1368980014000652; Grainge MJ, 2011, AM J GASTROENTEROL, V106, P933, DOI 10.1038/ajg.2010.506; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Green PHR, 2015, J ALLERGY CLIN IMMUN, V135, P1099, DOI 10.1016/j.jaci.2015.01.044; Gutierrez-Achury J, 2011, J INTERN MED, V269, P591, DOI 10.1111/j.1365-2796.2011.02375.x; Hadithi M, 2007, WORLD J GASTROENTERO, V13, P1715, DOI 10.3748/wjg.v13.i11.1715; Hadjivassiliou Marios, 2014, Handb Clin Neurol, V120, P607, DOI 10.1016/B978-0-7020-4087-0.00041-3; Harper JW, 2007, AM J HEMATOL, V82, P996, DOI 10.1002/ajh.20996; Hill ID, 2005, J PEDIATR GASTR NUTR, V40, P1, DOI 10.1097/00005176-200501000-00001; Hollon J, 2015, NUTRIENTS, V7, P1565, DOI 10.3390/nu7031565; Huebener S, 2015, J PROTEOME RES, V14, P503, DOI 10.1021/pr500809b; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; HYOTY H, 1995, DIABETES, V44, P652, DOI 10.2337/diabetes.44.6.652; Ilus T, 2014, AM J GASTROENTEROL, V109, P1471, DOI 10.1038/ajg.2014.194; Ivarsson A, 2000, ACTA PAEDIATR, V89, P165, DOI 10.1080/080352500750028771; Ivarsson A, 2002, AM J CLIN NUTR, V75, P914, DOI 10.1093/ajcn/75.5.914; Junker Y, 2012, J EXP MED, V209, P2395, DOI 10.1084/jem.20102660; Kabbani TA, 2012, ALIMENT PHARM THER, V35, P723, DOI 10.1111/j.1365-2036.2012.05001.x; KAGNOFF MF, 1987, GUT, V28, P995, DOI 10.1136/gut.28.8.995; Kang JY, 2013, ALIMENT PHARM THER, V38, P226, DOI 10.1111/apt.12373; Katz KD, 2011, AM J GASTROENTEROL, V106, P1333, DOI 10.1038/ajg.2011.21; Kaukinen K, 2002, GASTROENTEROLOGY, V122, P881, DOI 10.1053/gast.2002.32416; Kelly CP, 2013, ALIMENT PHARM THER, V37, P252, DOI 10.1111/apt.12147; Khashan AS, 2010, HUM REPROD, V25, P528, DOI 10.1093/humrep/dep409; Kiefte-de Jong JC, 2013, GASTROENTEROLOGY, V144, P726, DOI 10.1053/j.gastro.2013.01.003; Lahdeaho ML, 2014, GASTROENTEROLOGY, V146, P1649, DOI 10.1053/j.gastro.2014.02.031; Lau NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066155; Lebwohl B, 2014, Aliment Pharmacol Ther, V39, P488, DOI 10.1111/apt.12621; Lebwohl B, 2013, ALIMENT PHARM THER, V37, P332, DOI 10.1111/apt.12164; Lebwohl B, 2015, CLIN GASTROENTEROL H, V13, P1111, DOI 10.1016/j.cgh.2014.11.018; Lebwohl B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117529; Lebwohl B, 2014, CLIN GASTROENTEROL H, V12, P632, DOI 10.1016/j.cgh.2013.10.031; Lebwohl B, 2014, J CLIN ENDOCR METAB, V99, P609, DOI 10.1210/jc.2013-3164; Lebwohl B, 2014, DIGEST LIVER DIS, V46, P36, DOI 10.1016/j.dld.2013.08.128; Lebwohl B, 2013, AM J EPIDEMIOL, V178, P1721, DOI 10.1093/aje/kwt234; Lebwohl B, 2013, ANN INTERN MED, V159, P169, DOI 10.7326/0003-4819-159-3-201308060-00006; Lebwohl B, 2013, DIGEST DIS SCI, V58, P1293, DOI 10.1007/s10620-012-2551-3; Lee AR, 2007, J HUM NUTR DIET, V20, P423, DOI 10.1111/j.1365-277X.2007.00763.x; Leffler DA, 2007, CLIN GASTROENTEROL H, V5, P445, DOI 10.1016/j.cgh.2006.12.006; Leffler DA, 2012, AM J GASTROENTEROL, V107, P1554, DOI 10.1038/ajg.2012.211; Lionetti E, 2014, NEW ENGL J MED, V371, P1295, DOI 10.1056/NEJMoa1400697; Lis DM, 2015, INT J SPORT NUTR EXE, V25, P37, DOI 10.1123/ijsnem.2013-0247; Lohi S, 2007, ALIMENT PHARM THERAP, V26, P1217, DOI 10.1111/j.1365-2036.2007.03502.x; Ludvigsson JF, 2012, BRIT J CANCER, V106, P217, DOI 10.1038/bjc.2011.536; Ludvigsson JF, 2005, CLIN GASTROENTEROL H, V3, P869, DOI 10.1016/S1542-3565(05)00414-3; Ludvigsson JF, 2005, GASTROENTEROLOGY, V129, P454, DOI 10.1053/j.gastro.2005.05.065; Ludvigsson JF, 2014, NEW ENGL J MED, V371, P1341, DOI 10.1056/NEJMe1408011; Ludvigsson JF, 2014, GUT, V63, P1210, DOI 10.1136/gutjnl-2013-306578; Ludvigsson JF, 2013, JAMA PSYCHIAT, V70, P1224, DOI 10.1001/jamapsychiatry.2013.2048; Ludvigsson JF, 2013, AM J GASTROENTEROL, V108, P818, DOI 10.1038/ajg.2013.60; Ludvigsson JF, 2013, GUT, V62, P43, DOI 10.1136/gutjnl-2011-301346; Ludvigsson JF, 2012, INT J CANCER, V131, pE244, DOI 10.1002/ijc.26454; Ludvigsson JF, 2011, CIRCULATION, V123, P483, DOI 10.1161/CIRCULATIONAHA.110.965624; Ludvigsson JF, 2009, JAMA-J AM MED ASSOC, V302, P1171, DOI 10.1001/jama.2009.1320; Ludvigsson JF, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-19; LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187; Mahadev S, 2011, J CLIN GASTROENTEROL, V45, P912, DOI 10.1097/MCG.0b013e31822d31f7; Makharia GK, 2011, J GASTROEN HEPATOL, V26, P894, DOI 10.1111/j.1440-1746.2010.06606.x; Mardini HE, 2015, DIGEST DIS SCI, V60, P1738, DOI 10.1007/s10620-014-3514-7; Marild K, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-109; Marild K, 2012, GASTROENTEROLOGY, V142, P39, DOI 10.1053/j.gastro.2011.09.047; Martinelli P, 2000, GUT, V46, P332, DOI 10.1136/gut.46.3.332; Master S, 2013, J PEDIATR GASTR NUTR, V57, P527, DOI 10.1097/MPG.0b013e3182a321cc; Matysiak-Budnik T, 2008, J EXP MED, V205, P143, DOI 10.1084/jem.20071204; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Mirzaagha F, 2010, DIGEST LIVER DIS, V42, P620, DOI 10.1016/j.dld.2010.02.006; Mohamed BM, 2006, DIGEST DIS SCI, V51, P1862, DOI 10.1007/s10620-005-9038-4; Mooney PD, 2015, CLIN GASTROENTEROL H, V13, P1278, DOI 10.1016/j.cgh.2015.01.010; Mukherjee Rupa, 2012, Gastrointest Endosc Clin N Am, V22, P811, DOI 10.1016/j.giec.2012.09.001; Murray JA, 2004, AM J CLIN NUTR, V79, P669; Murray JA, 2003, CLIN GASTROENTEROL H, V1, P19, DOI 10.1053/jcgh.2003.50004; Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; Myleus A, 2009, J PEDIATR GASTR NUTR, V49, P170, DOI 10.1097/MPG.0b013e31818c52cc; Nachman F, 2011, CLIN GASTROENTEROL H, V9, P214, DOI 10.1016/j.cgh.2010.06.017; Nadal I, 2007, J MED MICROBIOL, V56, P1669, DOI 10.1099/jmm.0.47410-0; Narotsky D, 2012, EUR J GASTROEN HEPAT, V24, P1071, DOI 10.1097/MEG.0b013e328355a4ab; Nilsen EM, 1998, GASTROENTEROLOGY, V115, P551, DOI 10.1016/S0016-5085(98)70134-9; Nistico L, 2006, GUT, V55, P803, DOI 10.1136/gut.2005.083964; Olivares M, 2015, GUT, V64, P406, DOI 10.1136/gutjnl-2014-306931; Peters U, 2003, ARCH INTERN MED, V163, P1566, DOI 10.1001/archinte.163.13.1566; Rampertab SD, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.08.044; Reilly NR, 2012, MINERVA PEDIATR, V64, P71; Reilly NR, 2011, J PEDIATR GASTR NUTR, V53, P528, DOI 10.1097/MPG.0b013e3182276d5e; Riddle MS, 2012, AM J GASTROENTEROL, V107, P1248, DOI 10.1038/ajg.2012.130; Roberts SE, 2009, ALIMENT PHARM THER, V29, P222, DOI 10.1111/j.1365-2036.2008.03871.x; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Rubio-Tapia A, 2012, AM J GASTROENTEROL, V107, P1538, DOI 10.1038/ajg.2012.219; Rubio-Tapia A, 2010, AM J GASTROENTEROL, V105, P1412, DOI 10.1038/ajg.2010.10; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V137, P88, DOI 10.1053/j.gastro.2009.03.059; Sadr-Azodi O, 2012, CLIN GASTROENTEROL H, V10, P1136, DOI 10.1016/j.cgh.2012.06.023; Samaroo D, 2010, SCHIZOPHR RES, V118, P248, DOI 10.1016/j.schres.2009.08.009; Sanders DS, 2005, ANN SURG, V242, P201, DOI 10.1097/01.sla.0000171301.35513.cf; Sapone A, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-13; Sapone A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-23; Shah S, 2014, AM J GASTROENTEROL, V109, P1304, DOI 10.1038/ajg.2014.29; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sharkey LM, 2013, ALIMENT PHARM THER, V38, P1278, DOI 10.1111/apt.12510; Simell S, 2007, AM J GASTROENTEROL, V102, P2026, DOI 10.1111/j.1572-0241.2007.01360.x; Simpson SM, 2013, DIABETES EDUCATOR, V39, P532, DOI 10.1177/0145721713487998; Smukalla Scott, 2014, Clin Adv Hematol Oncol, V12, P100; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Snook JA, 1996, GUT, V39, P60, DOI 10.1136/gut.39.1.60; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Sorensen HT, 1999, GUT, V44, P736, DOI 10.1136/gut.44.5.736; Stene LC, 2006, AM J GASTROENTEROL, V101, P2333, DOI 10.1111/j.1572-0241.2006.00741.x; Sultan AA, 2015, GUT, V64, P1220, DOI 10.1136/gutjnl-2014-308285; Tang FM, 2009, J EXP MED, V206, P707, DOI 10.1084/jem.20071887; Tavakkoli A, 2014, DIGEST DIS SCI, V59, P1255, DOI 10.1007/s10620-013-2981-6; Taylor TB, 2015, J INVEST DERMATOL, V135, P623, DOI 10.1038/jid.2014.368; Tennyson CA, 2013, THER ADV GASTROENTER, V6, P358, DOI 10.1177/1756283X13492580; Tio M, 2012, ALIMENT PHARM THER, V35, P540, DOI 10.1111/j.1365-2036.2011.04972.x; Tuire I, 2012, AM J GASTROENTEROL, V107, P1563, DOI 10.1038/ajg.2012.220; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Vazquez H, 2001, AM J GASTROENTEROL, V96, P798, DOI 10.1111/j.1572-0241.2001.03625.x; Vazquez-Roque MI, 2013, GASTROENTEROLOGY, V144, P903, DOI 10.1053/j.gastro.2013.01.049; Vilppula A, 2008, DIGEST LIVER DIS, V40, P809, DOI 10.1016/j.dld.2008.03.013; Visser J, 2009, ANN NY ACAD SCI, V1165, P195, DOI 10.1111/j.1749-6632.2009.04037.x; Volta U, 1998, LANCET, V352, P26, DOI 10.1016/S0140-6736(97)11222-3; Volta U, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0194-x; Volta U, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-85; Vriezinga SL, 2014, NEW ENGL J MED, V371, P1304, DOI 10.1056/NEJMoa1404172; Welander A, 2010, PEDIATRICS, V125, pE530, DOI 10.1542/peds.2009-1200; West J, 2004, BRIT MED J, V329, P716, DOI 10.1136/bmj.38169.486701.7C; West J, 2004, ALIMENT PHARM THERAP, V20, P73, DOI 10.1111/j.1365-2036.2004.02008.x; West J, 2003, GUT, V52, P960, DOI 10.1136/gut.52.7.960; West J, 2014, AM J GASTROENTEROL, V109, P757, DOI 10.1038/ajg.2014.55; Yuan JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081151; Zugna D, 2014, CLIN GASTROENTEROL H, V12, P1108, DOI 10.1016/j.cgh.2013.10.012; Zugna D, 2010, GUT, V59, P1471, DOI 10.1136/gut.2010.219030	169	174	178	0	122	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 5	2015	351								h4347	10.1136/bmj.h4347	http://dx.doi.org/10.1136/bmj.h4347			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT3SC	26438584	Green Published			2022-12-28	WOS:000362726200001
J	Tomioka, K				Tomioka, Katsuhiro			ONDENSED-MATTER PHYSICS Flat transistor defies the limit	NATURE			English	Editorial Material									[Tomioka, Katsuhiro] Hokkaido Univ, Grad Sch Informat Sci, Sapporo, Hokkaido 0600814, Japan; [Tomioka, Katsuhiro] Hokkaido Univ, RCIQE, Sapporo, Hokkaido 0600814, Japan	Hokkaido University; Hokkaido University	Tomioka, K (corresponding author), Hokkaido Univ, Grad Sch Informat Sci, Sapporo, Hokkaido 0600814, Japan.	tomioka@rciqe.hokudai.ac.jp	Tomioka, Katsuhiro/A-2815-2014	Tomioka, Katsuhiro/0000-0003-3482-2371				del Alamo JA, 2011, NATURE, V479, P317, DOI 10.1038/nature10677; Ferain I, 2011, NATURE, V479, P310, DOI 10.1038/nature10676; Gandhi R, 2011, IEEE ELECTR DEVICE L, V32, P437, DOI 10.1109/LED.2011.2106757; Gopalakrishnan K, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P289, DOI 10.1109/IEDM.2002.1175835; Jeon K., 2010, IEEE S VLSI, P121; Kim S. H., 2009, IEEE S VLSI, P178; Pillarisetty R, 2011, NATURE, V479, P324, DOI 10.1038/nature10678; Pott V, 2010, P IEEE, V98, P2076, DOI 10.1109/JPROC.2010.2063411; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; Salahuddin S, 2008, NANO LETT, V8, P405, DOI 10.1021/nl071804g; Sarkar D, 2015, NATURE, V526, P91, DOI 10.1038/nature15387; Sarkar D, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3698093; Seabaugh AC, 2010, P IEEE, V98, P2095, DOI 10.1109/JPROC.2010.2070470; Tomioka K., 2012, 2012 IEEE Symposium on VLSI Technology, P47, DOI 10.1109/VLSIT.2012.6242454	14	3	3	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					51	52		10.1038/526051a	http://dx.doi.org/10.1038/526051a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26432242				2022-12-28	WOS:000362095100032
J	Marchalik, D; Jurecic, A				Marchalik, Daniel; Jurecic, Ann			From literature to medicine Stories for survival	LANCET			English	Editorial Material									[Marchalik, Daniel] Georgetown Univ, Sch Med, Dept Urol & Literature & Med Track, Washington, DC 20007 USA; [Jurecic, Ann] Rutgers State Univ, Dept English, New Brunswick, NJ USA	Georgetown University; Rutgers State University New Brunswick	Marchalik, D (corresponding author), Georgetown Univ, Sch Med, Dept Urol & Literature & Med Track, Washington, DC 20007 USA.	dan.marchalik@gmail.com		Marchalik, Daniel/0000-0002-6912-1252					0	0	0	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 26	2015	386	10000					1230	1230		10.1016/S0140-6736(15)00267-6	http://dx.doi.org/10.1016/S0140-6736(15)00267-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR9TQ	26460648	Bronze			2022-12-28	WOS:000361700100016
J	Mate, SE; Kugelman, JR; Nyenswah, TG; Ladner, JT; Wiley, MR; Cordier-Lassalle, T; Christie, A; Schroth, GP; Gross, SM; Davies-Wayne, GJ; Shinde, SA; Murugan, R; Sieh, SB; Badio, M; Fakoli, L; Taweh, F; de Wit, E; van Doremalen, N; Munster, VJ; Pettitt, J; Prieto, K; Humrighouse, BW; Stroher, U; DiClaro, JW; Hensley, LE; Schoepp, RJ; Safronetz, D; Fair, J; Kuhn, JH; Blackley, DJ; Laney, AS; Williams, DE; Lo, T; Gasasira, A; Nichol, ST; Formenty, P; Kateh, FN; De Cock, KM; Bolay, F; Sanchez-Lockhart, M; Palacios, G				Mate, S. E.; Kugelman, J. R.; Nyenswah, T. G.; Ladner, J. T.; Wiley, M. R.; Cordier-Lassalle, T.; Christie, A.; Schroth, G. P.; Gross, S. M.; Davies-Wayne, G. J.; Shinde, S. A.; Murugan, R.; Sieh, S. B.; Badio, M.; Fakoli, L.; Taweh, F.; de Wit, E.; van Doremalen, N.; Munster, V. J.; Pettitt, J.; Prieto, K.; Humrighouse, B. W.; Stroeher, U.; DiClaro, J. W.; Hensley, L. E.; Schoepp, R. J.; Safronetz, D.; Fair, J.; Kuhn, J. H.; Blackley, D. J.; Laney, A. S.; Williams, D. E.; Lo, T.; Gasasira, A.; Nichol, S. T.; Formenty, P.; Kateh, F. N.; De Cock, K. M.; Bolay, F.; Sanchez-Lockhart, M.; Palacios, G.			Molecular Evidence of Sexual Transmission of Ebola Virus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SIERRA-LEONE; OUTBREAK; LIBERIA; CONGO; PERSISTENCE; EVOLUTION; DISEASE; KIKWIT; GUINEA	A suspected case of sexual transmission from a male survivor of Ebola virus disease (EVD) to his female partner (the patient in this report) occurred in Liberia in March 2015. Ebola virus (EBOV) genomes assembled from blood samples from the patient and a semen sample from the survivor were consistent with direct transmission. The genomes shared three substitutions that were absent from all other Western African EBOV sequences and that were distinct from the last documented transmission chain in Liberia before this case. Combined with epidemiologic data, the genomic analysis provides evidence of sexual transmission of EBOV and evidence of the persistence of infective EBOV in semen for 179 days or more after the onset of EVD.	[Mate, S. E.; Kugelman, J. R.; Ladner, J. T.; Wiley, M. R.; Prieto, K.; Sanchez-Lockhart, M.; Palacios, G.] US Army Med Res Inst Infect Dis, Ctr Genome Sci, Frederick, MD 21702 USA; [Schoepp, R. J.] US Army Med Res Inst Infect Dis, Diagnost Syst Div, Frederick, MD 21702 USA; [Pettitt, J.; Hensley, L. E.; Kuhn, J. H.] NIAID, Div Clin Res, Integrated Res Facil Ft Detrick, NIH, Frederick, MD USA; [Nyenswah, T. G.; Sieh, S. B.; Badio, M.; Kateh, F. N.] Minist Hlth & Social Welf, Monrovia, Liberia; [Davies-Wayne, G. J.; Murugan, R.] WHO, Monrovia, Liberia; [Fakoli, L.; Taweh, F.; Bolay, F.] Liberian Inst Biomed Res, Charlesville, Liberia; [Cordier-Lassalle, T.; Christie, A.; Formenty, P.] WHO, Geneva, Switzerland; [Christie, A.; Humrighouse, B. W.; Stroeher, U.; Blackley, D. J.; Laney, A. S.; Williams, D. E.; Lo, T.; Nichol, S. T.; De Cock, K. M.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Schroth, G. P.; Gross, S. M.] Illumina, San Diego, CA USA; [Shinde, S. A.] WHO, New Delhi, India; [de Wit, E.; van Doremalen, N.; Munster, V. J.; Safronetz, D.] NIAID, Rocky Mt Lab, Div Intramural Res, NIH, Hamilton, MT 59840 USA; [DiClaro, J. W.] Naval Med Res Unit 3, Cairo, Egypt; [Fair, J.] Fdn Merieux, Washington, DC USA	United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); World Health Organization; World Health Organization; Centers for Disease Control & Prevention - USA; Illumina; World Health Organization; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3)	Palacios, G (corresponding author), US Army Med Res Inst Infect Dis, 1425 Porter St,Rm 622, Frederick, MD 21702 USA.	gustavo.f.palacios.ctr@us.army.mil	van Doremalen, Neeltje/AAD-2315-2021; Sanchez-Lockhart, Mariano/M-6446-2019; Munster, Vincent/I-7607-2018; de Wit, Emmie/A-1549-2019; Kuhn, Jens H./B-7615-2011; Sanchez-Lockhart, Mariano/H-1321-2019; Schoepp, Randal J./F-3330-2019; Schoepp, Randal/L-8578-2019; Palacios, Gustavo/I-7773-2015; Ladner, Jason/G-3486-2011	Sanchez-Lockhart, Mariano/0000-0001-8009-7540; Munster, Vincent/0000-0002-2288-3196; de Wit, Emmie/0000-0002-9763-7758; Kuhn, Jens H./0000-0002-7800-6045; Sanchez-Lockhart, Mariano/0000-0001-8009-7540; Schoepp, Randal J./0000-0002-5026-0404; Schoepp, Randal/0000-0002-5026-0404; Palacios, Gustavo/0000-0001-5062-1938; Ladner, Jason/0000-0001-7751-4366; Hensley, Lisa/0000-0003-1188-4342; Van Doremalen, Neeltje/0000-0003-4368-6359; Wiley, Michael/0000-0001-6688-007X; Gross, Stephen/0000-0003-0711-787X	Defense Threat Reduction Agency; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001190, ZIAAI001179] Funding Source: NIH RePORTER	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the Defense Threat Reduction Agency and others.	[Anonymous], 2015, MMWR MORB MORTAL WKL, V64, P479; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594; Center for Disease Control, 2015, PLOS NEGL TROP DIS; Clark DV, 2015, LANCET INFECT DIS, V15, P905, DOI 10.1016/S1473-3099(15)70152-0; Cordier-Lassalle T, 2015, SUMMARY SECTOR RESPO; EMOND RTD, 1977, BMJ-BRIT MED J, V2, P541; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Hoenen T, 2015, SCIENCE, V348, P117, DOI 10.1126/science.aaa5646; Kugelman JR, 2015, EMERG INFECT DIS, V21, P1135, DOI 10.3201/eid2107.150522; Kuhn JH, 2014, VIRUSES-BASEL, V6, P4760, DOI 10.3390/v6114760; MARTINI GA, 1968, KLIN WOCHENSCHR, V46, P398, DOI 10.1007/BF01734141; Nyenswah T, 2015, MMWR-MORBID MORTAL W, V64, P500; Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007; Richards GA, 2000, CRIT CARE MED, V28, P240, DOI 10.1097/00003246-200001000-00041; Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291; Rowe AK, 1999, J INFECT DIS, V179, pS28, DOI 10.1086/514318; Simon-Loriere E, 2015, NATURE, V524, P102, DOI 10.1038/nature14612; Tong YG, 2015, NATURE, V524, P93, DOI 10.1038/nature14490; Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306; WHO, 2015, EB SIT REP	22	289	294	3	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2015	373	25					2448	2454		10.1056/NEJMoa1509773	http://dx.doi.org/10.1056/NEJMoa1509773			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5QD	26465384	Green Accepted			2022-12-28	WOS:000366461400011
J	van de Vijver, S; Oti, S; Oduor, C; Ezeh, A; Lange, J; Agyemang, C; Kyobutungi, C				van de Vijver, Steven; Oti, Samuel; Oduor, Clement; Ezeh, Alex; Lange, Joep; Agyemang, Charles; Kyobutungi, Catherine			Challenges of health programmes in slums	LANCET			English	Editorial Material							NAIROBI; KENYA		[van de Vijver, Steven; Oti, Samuel; Oduor, Clement; Ezeh, Alex; Kyobutungi, Catherine] African Populat & Hlth Res Ctr, Nairobi, Kenya; [van de Vijver, Steven; Oti, Samuel; Lange, Joep] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands; [Agyemang, Charles] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1012 WX Amsterdam, Netherlands	African Population & Health Research Centre; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van de Vijver, S (corresponding author), African Populat & Hlth Res Ctr, POB 10787-00100, Nairobi, Kenya.	svijver@aphrc.org	Ezeh, Alex/AAN-8646-2020	Ezeh, Alex/0000-0002-1309-4697; Kyobutungi, Catherine/0000-0002-5344-5631; Otendo, Clement/0000-0003-1716-9294				African Population and Health Research Center, 2014, POP HLTH DYN NAIR IN; Agarwal S, 2005, INDIAN PEDIATR, V42, P653; Agarwal S, 2005, Indian J Public Health, V49, P141; Bakibinga P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006608; Bazant ES, 2009, STUD FAMILY PLANN, V40, P39, DOI 10.1111/j.1728-4465.2009.00185.x; Kimani JK, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-66; Kyobutungi C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-153; Kyobutungi Catherine, 2008, Popul Health Metr, V6, P1, DOI 10.1186/1478-7954-6-1; Mutua MK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-6; de Snyder VNS, 2011, J URBAN HEALTH, V88, P1183, DOI 10.1007/s11524-011-9609-y; Oti SO, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25533; UN Human Settlements Programme, 2008, UN HAB KEN SLUM UPGR; UN Human Settlements Programme, 2010, SLUMS WORLD FAC URB; United Nations Department of Economic and Social Affairs Population Division, 2012, WORLD URB PROSP 2011; United Nations Development Programme, POST 2015 SUST DEV A; United Nations Human Settlements Programme, 2010, STAT AFR CIT 2010 GO; Vlahov D, 2007, J URBAN HEALTH, V84, pI16, DOI 10.1007/s11524-007-9169-3; Ye Y, 2009, AM J TROP MED HYG, V81, P770, DOI 10.4269/ajtmh.2009.09-0070; Ziraba AK, 2011, J URBAN HEALTH, V88, P256, DOI 10.1007/s11524-011-9580-7	19	18	18	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2015	386	10008					2114	2116		10.1016/S0140-6736(15)00385-2	http://dx.doi.org/10.1016/S0140-6736(15)00385-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX8XF	26452707				2022-12-28	WOS:000365987600033
J	Hu, ZH; Zhou, Q; Zhang, CL; Fan, SL; Cheng, W; Zhao, Y; Shao, F; Wang, HW; Sui, SF; Chai, JJ				Hu, Zehan; Zhou, Qiang; Zhang, Chenlu; Fan, Shilong; Cheng, Wei; Zhao, Yue; Shao, Feng; Wang, Hong-Wei; Sui, Sen-Fang; Chai, Jijie			Structural and biochemical basis for induced self-propagation of NLRC4	SCIENCE			English	Article							PRION-LIKE POLYMERIZATION; CRYSTAL-STRUCTURE; CAUSES AUTOINFLAMMATION; IMMUNE RECOGNITION; BACTERIAL LIGANDS; INFLAMMASOME; ACTIVATION; FLAGELLIN; APOPTOSOME; SECRETION	Responding to stimuli, nucleotide-binding domain and leucine-rich repeat-containing proteins (NLRs) oligomerize into multiprotein complexes, termed inflammasomes, mediating innate immunity. Recognition of bacterial pathogens by NLR apoptosis inhibitory proteins (NAIPs) induces NLR family CARD domain-containing protein 4 (NLRC4) activation and formation of NAIP-NLRC4 inflammasomes. The wheel-like structure of a PrgJ-NAIP2-NLRC4 complex determined by cryogenic electronmicroscopy at 6.6 angstrom reveals that NLRC4 activation involves substantial structural reorganization that creates one oligomerization surface (catalytic surface). Once activated, NLRC4 uses this surface to catalyze the activation of an inactive NLRC4, self-propagating its active conformation to form the wheel-like architecture. NAIP proteins possess a catalytic surface matching the other oligomerization surface (receptor surface) of NLRC4 but not those of their own, ensuring that one NAIP is sufficient to initiate NLRC4 oligomerization.	[Hu, Zehan; Zhang, Chenlu; Fan, Shilong; Wang, Hong-Wei; Chai, Jijie] Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Struct Biol Ctr, Minist Educ,Key Lab Prot Sci,Sch Life Sci, Beijing 100084, Peoples R China; [Zhou, Qiang; Sui, Sen-Fang] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Cheng, Wei] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Div Resp & Crit Care Med, Chengdu 610064, Peoples R China; [Cheng, Wei] Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China; [Zhao, Yue] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Tsinghua University; Tsinghua University; Sichuan University; National Institute of Biological Sciences, Beijing	Chai, JJ (corresponding author), Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Struct Biol Ctr, Minist Educ,Key Lab Prot Sci,Sch Life Sci, Beijing 100084, Peoples R China.	suisf@mail.tsinghua.edu.cn; chaijj@tsinghua.edu.cn	Zhou, Qiang/P-8073-2015; Hu, Zehan/AAU-4752-2021; Hu, Zehan/AAH-7139-2020; Zhao, Yue/A-5285-2018	Hu, Zehan/0000-0002-4648-5301; Zhao, Yue/0000-0003-1509-9261; Sui, Sen-Fang/0000-0001-5253-2592; Chai, Jijie/0000-0001-7591-3873; Fan, Shilong/0000-0001-9272-2438	Chinese Ministry of Science and Technology [2014CB910101, 2011CB910501, 2012CB917303]; National Natural Science Foundation of China [31230016]; China Postdoctoral Science Foundation; Center for Life Sciences (CLS) Postdoctoral Fellowship Foundation; CLS Postdoctoral Fellowship Foundation	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Center for Life Sciences (CLS) Postdoctoral Fellowship Foundation; CLS Postdoctoral Fellowship Foundation	We thank Y. Xu and T. Yang at Tsinghua University Branch of China National Center for Protein Sciences Beijing for data collection and computational support, and X. Li for technical instructions of using the K2-Summit camera. We acknowledge the computational facility support on the Explorer 100 cluster system of Tsinghua National Laboratory for Information Science and Technology. The data presented in this paper are tabulated in the main paper and in the supplementary materials. The EM maps have been deposited in the Electron Microscopy Data Bank with accession codes EMD-3139/3140 for the 12- or 11-protomer PrgJ-NAIP2-NLRC4<SUP>FL</SUP> complex, EMD-3141/3142 for the 11- or 10-protomer PrgJ-NAIP2-NLRC4<SUP>Delta CARD</SUP> complex, and EMD-3143 for the FliC_D0<INF>L</INF>-NAIP5-NLRC4<SUP>R288A Delta CARD</SUP> complex. This research was funded by the Chinese Ministry of Science and Technology (2014CB910101 to J.C., 2011CB910501 to S.-F.S., and 2012CB917303 to H.-W.W.) and the National Natural Science Foundation of China (31230016 to S.-F.S.). Z.H. was supported by a China Postdoctoral Science Foundation-funded project and the Center for Life Sciences (CLS) Postdoctoral Fellowship Foundation. Q.Z. was supported by the CLS Postdoctoral Fellowship Foundation.	Cai X, 2014, TRENDS IMMUNOL, V35, P622, DOI 10.1016/j.it.2014.10.003; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Canna SW, 2014, NAT GENET, V46, P1140, DOI 10.1038/ng.3089; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Chuenchor W, 2014, CURR OPIN IMMUNOL, V26, P14, DOI 10.1016/j.coi.2013.10.009; Danot O, 2009, STRUCTURE, V17, P172, DOI 10.1016/j.str.2009.01.001; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Halff EF, 2012, J BIOL CHEM, V287, P38460, DOI 10.1074/jbc.M112.393512; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Kitamura A, 2014, J EXP MED, V211, P2385, DOI 10.1084/jem.20141091; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Pang YX, 2015, GENE DEV, V29, P277, DOI 10.1101/gad.255877.114; Qi SQ, 2010, CELL, V141, P446, DOI 10.1016/j.cell.2010.03.017; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Reubold TF, 2011, STRUCTURE, V19, P1074, DOI 10.1016/j.str.2011.05.013; Romberg N, 2014, NAT GENET, V46, P1135, DOI 10.1038/ng.3066; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Tenthorey JL, 2014, MOL CELL, V54, P17, DOI 10.1016/j.molcel.2014.02.018; Vance RE, 2015, CURR OPIN IMMUNOL, V32, P84, DOI 10.1016/j.coi.2015.01.010; von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Yan N, 2005, ANNU REV CELL DEV BI, V21, P35, DOI 10.1146/annurev.cellbio.21.012704.131040; Yang JL, 2013, P NATL ACAD SCI USA, V110, P14408, DOI 10.1073/pnas.1306376110; Yin Q, 2015, ANNU REV IMMUNOL, V33, P393, DOI 10.1146/annurev-immunol-032414-112258; Yuan SJ, 2013, BIOCHEMISTRY-US, V52, P2319, DOI 10.1021/bi301721g; Yuan SJ, 2011, STRUCTURE, V19, P128, DOI 10.1016/j.str.2010.10.009; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	40	205	215	2	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					399	404		10.1126/science.aac5489	http://dx.doi.org/10.1126/science.aac5489			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26449475				2022-12-28	WOS:000363213400031
J	Rubinstein, R; Thu, CA; Goodman, KM; Wolcott, HN; Bahna, F; Mannepalli, S; Ahlsen, G; Chevee, M; Halim, A; Clausen, H; Maniatis, T; Shapiro, L; Honig, B				Rubinstein, Rotem; Thu, Chan Aye; Goodman, Kerry Marie; Wolcott, Holly Noelle; Bahna, Fabiana; Mannepalli, Seetha; Ahlsen, Goran; Chevee, Maxime; Halim, Adnan; Clausen, Henrik; Maniatis, Tom; Shapiro, Lawrence; Honig, Barry			Molecular Logic of Neuronal Self-Recognition through Protocadherin Domain Interactions	CELL			English	Article							CRYSTAL-STRUCTURES; ALPHA; DSCAM; AVOIDANCE; DIVERSITY; CADHERINS; IDENTITY	Self-avoidance, a process preventing interactions of axons and dendrites from the same neuron during development, is mediated in vertebrates through the stochastic single-neuron expression of clustered protocadherin protein isoforms. Extracellular cadherin (EC) domains mediate isoform-specific homophilic binding between cells, conferring cell recognition through a poorly understood mechanism. Here, we report crystal structures for the EC1-EC3 domain regions from four protocadherin isoforms representing the alpha,beta, and gamma subfamilies. All are rod shaped and monomeric in solution. Biophysical measurements, cell aggregation assays, and computational docking reveal that trans binding between cells depends on the EC1-EC4 domains, which interact in an antiparallel orientation. We also show that the EC6 domains are required for the formation of cis-dimers. Overall, our results are consistent with a model in which protocadherin cis-dimers engage in a head-to-tail interaction between EC1-EC4 domains from apposed cell surfaces, possibly forming a zipper-like protein assembly, and thus providing a size-dependent self-recognition mechanism.	[Rubinstein, Rotem; Thu, Chan Aye; Goodman, Kerry Marie; Wolcott, Holly Noelle; Bahna, Fabiana; Mannepalli, Seetha; Chevee, Maxime; Maniatis, Tom; Shapiro, Lawrence; Honig, Barry] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Rubinstein, Rotem; Ahlsen, Goran; Shapiro, Lawrence; Honig, Barry] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Honig, Barry] Columbia Univ, Dept Med, New York, NY 10032 USA; [Honig, Barry] Columbia Univ, Zuckerman Mind Brain Behav Inst, New York, NY 10032 USA; [Bahna, Fabiana; Ahlsen, Goran; Honig, Barry] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Halim, Adnan; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Dept Cellular Med, Copenhagen Ctr Glyc, DK-2200 Copenhagen, Denmark; [Halim, Adnan; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Dept Mol Med, Copenhagen Ctr Glyc, DK-2200 Copenhagen, Denmark	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; University of Copenhagen; University of Copenhagen	Shapiro, L (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	lss8@columbia.edu; bh6@columbia.edu	Wolcott, Holly N/K-6148-2014; Shapiro, Lawrence/AAE-7172-2019; clausen, henrik/AAD-8016-2021; , Holly/O-8244-2015	Wolcott, Holly N/0000-0002-4470-1162; Honig, Barry/0000-0002-1835-1031; Halim, Adnan/0000-0003-1629-187X; Clausen, Henrik/0000-0002-0915-5055; , Holly/0000-0002-7450-7512; Rubinstein, Rotem/0000-0003-3657-5984	National Science Foundation [MCB-1412472]; National Institutes of Health [R01GM062270]; NIH [R01GM107571]; NIH Training Programs [T32GM008281]; Danish National Research Foundation [DNRF107]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107571, R01GM062270, T32GM008281] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Training Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish National Research Foundation(Danmarks Grundforskningsfond); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. David Hirsh for valuable comments on the manuscript. We thank Igor Kourinov, Surajit Banerjee, and Narayanasami Sukumar at Advanced Photon Source (APS) for support with synchrotron data collection. This work was supported by the National Science Foundation grant to B.H. (MCB-1412472), National Institutes of Health grant to L.S. (R01GM062270), joint NIH grant to T.M. and L.S. (R01GM107571), NIH Training Programs to H.N.W. (T32GM008281), and Danish National Research Foundation (DNRF107) to A.H. and H.C.	Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Chen WV, 2012, NEURON, V75, P402, DOI 10.1016/j.neuron.2012.06.039; Han MH, 2010, MOL CELL PROTEOMICS, V9, P71, DOI 10.1074/mcp.M900343-MCP200; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; Hattori D, 2009, NATURE, V461, P644, DOI 10.1038/nature08431; Jin XS, 2012, P NATL ACAD SCI USA, V109, pE127, DOI 10.1073/pnas.1117538108; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Lommel M, 2013, P NATL ACAD SCI USA, V110, P21024, DOI 10.1073/pnas.1316753110; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Miura SK, 2013, CELL, V155, P1166, DOI 10.1016/j.cell.2013.10.018; Morishita H, 2006, J BIOL CHEM, V281, P33650, DOI 10.1074/jbc.M603298200; Pierce B, 2005, BIOINFORMATICS, V21, P1472, DOI 10.1093/bioinformatics/bti229; Posy S, 2008, J MOL BIOL, V378, P954, DOI 10.1016/j.jmb.2008.02.063; Reiss K, 2006, J BIOL CHEM, V281, P21735, DOI 10.1074/jbc.M602663200; Ribich S, 2006, P NATL ACAD SCI USA, V103, P19719, DOI 10.1073/pnas.0609445104; Schalm SS, 2010, P NATL ACAD SCI USA, V107, P13894, DOI 10.1073/pnas.1007182107; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schreiner D, 2010, P NATL ACAD SCI USA, V107, P14893, DOI 10.1073/pnas.1004526107; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Thu CA, 2014, CELL, V158, P1045, DOI 10.1016/j.cell.2014.07.012; Vester-Christensen MB, 2013, P NATL ACAD SCI USA, V110, P21018, DOI 10.1073/pnas.1313446110; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Wu YH, 2013, BIOPHYS J, V104, P1221, DOI 10.1016/j.bpj.2013.02.009; Wu YH, 2011, NATURE, V475, P510, DOI 10.1038/nature10183; Zipursky SL, 2013, ANNU REV NEUROSCI, V36, P547, DOI 10.1146/annurev-neuro-062111-150414; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	30	99	100	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					629	642		10.1016/j.cell.2015.09.026	http://dx.doi.org/10.1016/j.cell.2015.09.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26478182	Green Accepted, Bronze			2022-12-28	WOS:000364828900017
J	Bernal, W; Jalan, R; Quaglia, A; Simpson, K; Wendon, J; Burroughs, A				Bernal, William; Jalan, Rajiv; Quaglia, Alberto; Simpson, Kenneth; Wendon, Julia; Burroughs, Andrew			Acute-on-chronic liver failure	LANCET			English	Article							SPONTANEOUS BACTERIAL PERITONITIS; EXTRACORPOREAL ALBUMIN DIALYSIS; TERLIPRESSIN PLUS ALBUMIN; CRITICALLY-ILL PATIENTS; CIRRHOTIC-PATIENTS; INTENSIVE-CARE; HEPATIC-ENCEPHALOPATHY; HEPATORENAL-SYNDROME; ORGAN FAILURE; ACUTE DECOMPENSATION	Acute-on-chronic liver failure combines an acute deterioration in liver function in an individual with pre-existing chronic liver disease and hepatic and extrahepatic organ failures, and is associated with substantial short-term mortality. Common precipitants include bacterial and viral infections, alcoholic hepatitis, and surgery, but in more than 40% of patients, no precipitating event is identified. Systemic inflammation and susceptibility to infection are characteristic pathophysiological features. A new diagnostic score, the Chronic Liver Failure Consortium (CLIF-C) organ failure score, has been developed for classification and prognostic assessment of patients with acute-on-chronic liver failure. Disease can be reversed in many patients, and thus clinical management focuses upon the identification and treatment of the precipitant while providing multiorgan-supportive care that addresses the complex pattern of physiological disturbance in critically ill patients with liver disease. Liver transplantation is a highly effective intervention in some specific cases, but recipient identification, organ availability, timing of transplantation, and high resource use are barriers to more widespread application. Recognition of acute-on-chronic liver failure as a clinically and pathophysiologically distinct syndrome with defined diagnostic and prognostic criteria will help to encourage the development of new management pathways and interventions to address the unacceptably high mortality.	[Bernal, William; Wendon, Julia] Kings Coll Hosp London, Liver Intens Therapy Unit, London, England; [Quaglia, Alberto] Kings Coll Hosp London, Inst Liver Studies, Histopathol Sect, London, England; [Jalan, Rajiv] UCL, Div Med, Liver Failure Grp, London, England; [Jalan, Rajiv; Burroughs, Andrew] UCL, Div Med, Inst Liver & Digest Hlth, London, England; [Jalan, Rajiv; Burroughs, Andrew] Royal Free Hosp, Sheila Sherlock Liver Ctr, London NW3 2QG, England; [Simpson, Kenneth] Univ Edinburgh, Dept Hepatol, Edinburgh, Midlothian, Scotland	King's College Hospital NHS Foundation Trust; King's College Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; University College London; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Edinburgh	Bernal, W (corresponding author), Kings Coll London, Liver Intens Therapy Unit, Inst Liver Studies, London SE5 9RS, England.	william.bernal@kcl.ac.uk			Ocera Therapeutics; Vital Therapies; Gambro; Grifols; Sequana Medical	Ocera Therapeutics; Vital Therapies; Gambro; Grifols; Sequana Medical	WB has received consulting fees from Ocera Therapeutics and Vital Therapies. RJ received research funding from Vital Therapies, has served on scientific advisory boards for Conatus Pharma, received lecture fees from Gambro, is doing a research collaboration with Gambro and Grifols, and is the principal investigator of a study sponsored by Sequana Medical. He invented the drug L-ornithine phenyl acetate, which University College London has licensed to Ocera Therapeutics, and is the founder of Yaqrit and Cyberliver. AQ, KS, and JW declare no competing interests.	Acharya SK, 2007, J HEPATOL, V46, P387, DOI 10.1016/j.jhep.2006.09.016; Als-Nielsen B, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003044.pub2, DOI 10.1002/14651858.CD003044.PUB2]; Altamirano J, 2014, GASTROENTEROLOGY, V146, P1231, DOI 10.1053/j.gastro.2014.01.018; Angeli P, 2015, J HEPATOL, V62, P968, DOI 10.1016/j.jhep.2014.12.029; Angeli P, 2013, LIVER INT, V33, P16, DOI 10.1111/j.1478-3231.2012.02807.x; Angus DC, 2003, CRIT CARE, V7, P248, DOI 10.1186/cc2193; [Anonymous], 2013, MEAS UN REV PAT WHO; Arabi YM, 2012, HEPATOLOGY, V56, P2305, DOI 10.1002/hep.25931; Arabi YM, 2010, CAN MED ASSOC J, V182, P1971, DOI 10.1503/cmaj.090707; Arvaniti V, 2010, GASTROENTEROLOGY, V139, P1246, DOI 10.1053/j.gastro.2010.06.019; Bajaj JS, 2014, HEPATOLOGY, V60, P250, DOI 10.1002/hep.27077; Bajaj JS, 2012, HEPATOLOGY, V56, P2328, DOI 10.1002/hep.25947; Bajaj JS, 2012, GUT, V61, P1219, DOI 10.1136/gutjnl-2012-302339; Banares R, 2013, HEPATOLOGY, V57, P1153, DOI 10.1002/hep.26185; Belcher JM, 2014, HEPATOLOGY, V60, P622, DOI 10.1002/hep.26980; Bellot P, 2013, LIVER INT, V33, P31, DOI 10.1111/liv.12021; Bernsmeier C, 2015, GASTROENTEROLOGY, V148, P603, DOI 10.1053/j.gastro.2014.11.045; Berres ML, 2009, LIVER INT, V29, P536, DOI 10.1111/j.1478-3231.2008.01870.x; Berry PA, 2013, ALIMENT PHARM THER, V37, P174, DOI 10.1111/apt.12133; Berry PA, 2010, LIVER INT, V30, P733, DOI 10.1111/j.1478-3231.2010.02219.x; Berry PA, 2011, INTENS CARE MED, V37, P453, DOI 10.1007/s00134-010-2099-7; Bonney GK, 2009, TRANSPLANTATION, V87, P1858, DOI 10.1097/TP.0b013e3181a75b37; Boyer TD, 2014, HEPATOLOGY, V60, p255A; Carbonell N, 2004, HEPATOLOGY, V40, P652, DOI 10.1002/hep.20339; Carpentier B, 2009, GUT, V58, P1690, DOI 10.1136/gut.2008.175380; Cavallin M, 2015, HEPATOLOGY, V62, P567, DOI 10.1002/hep.27709; Chavez-Tapia NC, 2011, ALIMENT PHARM THER, V34, P509, DOI 10.1111/j.1365-2036.2011.04746.x; Chen PH, 2012, J HEPATOL, V57, P1207, DOI 10.1016/j.jhep.2012.07.038; Cholongitas E, 2009, J GASTROEN HEPATOL, V24, P1639, DOI 10.1111/j.1440-1746.2009.05908.x; Cordoba J, 2004, J HEPATOL, V41, P38, DOI 10.1016/j.jhep.2004.03.023; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Das V, 2010, CRIT CARE MED, V38, P2108, DOI 10.1097/CCM.0b013e3181f3dea9; Davies NA, 2009, HEPATOLOGY, V50, P155, DOI 10.1002/hep.22897; de Franchis R, 2010, J HEPATOL, V53, P762, DOI 10.1016/j.jhep.2010.06.004; Dhiman RK, 2014, WORLD J GASTROENTERO, V20, P14934, DOI 10.3748/wjg.v20.i40.14934; Dienstag JL, 2011, HEPATOLOGY, V54, P396, DOI 10.1002/hep.24370; Dominguez M, 2009, GASTROENTEROLOGY, V136, P1639, DOI 10.1053/j.gastro.2009.01.056; Earl TM, 2008, TRANSPLANTATION, V86, P238, DOI 10.1097/TP.0b013e3181778d54; Fede G, 2012, HEPATOLOGY, V55, P1282, DOI 10.1002/hep.25573; Fernandez J, 2007, GASTROENTEROLOGY, V133, P818, DOI 10.1053/j.gastro.2007.06.065; Fernandez J, 2006, HEPATOLOGY, V44, P1288, DOI 10.1002/hep.21352; Fernandez J, 2012, J HEPATOL, V56, pS1, DOI 10.1016/S0168-8278(12)60002-6; Fichet J, 2009, J CRIT CARE, V24, P364, DOI 10.1016/j.jcrc.2009.01.008; Foreman MG, 2003, CHEST, V124, P1016, DOI 10.1378/chest.124.3.1016; Foxton MR, 2010, LIVER TRANSPLANT, V16, P668, DOI 10.1002/lt.22027; Garcia-Martinez R, 2015, J HEPATOL, V62, P799, DOI 10.1016/j.jhep.2014.10.031; Garcia-Martinez R, 2013, HEPATOLOGY, V58, P1836, DOI 10.1002/hep.26338; Garcia-Tsao G, 2010, NEW ENGL J MED, V362, P823, DOI 10.1056/NEJMra0901512; Gines P, 2012, J HEPATOL, V56, pS13, DOI 10.1016/S0168-8278(12)60003-8; Gines P, 2009, NEW ENGL J MED, V361, P1279, DOI 10.1056/NEJMra0809139; Gluud LL, 2010, HEPATOLOGY, V51, P576, DOI 10.1002/hep.23286; Goulis J, 1999, LANCET, V353, P139, DOI 10.1016/S0140-6736(98)06020-6; Grabau CM, 2004, HEPATOLOGY, V40, P484, DOI 10.1002/hep.20317; Gronbaek H, 2012, ALIMENT PHARM THER, V36, P173, DOI 10.1111/j.1365-2036.2012.05134.x; Gustot T, 2015, HEPATOLOGY, V62, P243, DOI 10.1002/hep.27849; Gustot T, 2014, LIVER INT, V34, P1496, DOI 10.1111/liv.12520; Gustot T, 2014, J HEPATOL, V60, P267, DOI 10.1016/j.jhep.2013.09.011; Gustot T, 2009, HEPATOLOGY, V50, P2022, DOI 10.1002/hep.23264; Hassanein TI, 2007, HEPATOLOGY, V46, P1853, DOI 10.1002/hep.21930; Henrion J, 2011, ACTA GASTRO-ENT BELG, V74, P381; Hobolth L, 2010, LIVER INT, V30, P455, DOI 10.1111/j.1478-3231.2009.02169.x; Jacob M, 2005, TRANSPLANTATION, V80, P52, DOI 10.1097/01.TP.0000163292.03640.5C; Jalan R, 2002, BLOOD PURIFICAT, V20, P252, DOI 10.1159/000047017; Jalan R, 2015, J HEPATOL, V62, P831, DOI 10.1016/j.jhep.2014.11.012; Jalan R, 2014, J HEPATOL, V61, P1038, DOI 10.1016/j.jhep.2014.06.012; Jalan R, 2014, GASTROENTEROLOGY, V147, P4, DOI 10.1053/j.gastro.2014.05.005; Jalan R, 2014, J HEPATOL, V60, P1310, DOI 10.1016/j.jhep.2014.01.024; Jalan R, 2012, CRIT CARE, V16, DOI 10.1186/cc11882; Jalan R, 2012, J HEPATOL, V57, P1336, DOI 10.1016/j.jhep.2012.06.026; Jepsen P, 2010, HEPATOLOGY, V51, P1675, DOI 10.1002/hep.23500; Joshi D, 2014, LIVER INT, V34, P362, DOI 10.1111/liv.12257; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kamiyama T, 1996, J CLIN GASTROENTEROL, V22, P126, DOI 10.1097/00004836-199603000-00011; Karvellas CJ, 2013, CRIT CARE, V17, DOI 10.1186/cc12508; Katoonizadeh A, 2010, GUT, V59, P1561, DOI 10.1136/gut.2009.189639; Khungar V, 2012, CLIN LIVER DIS, V16, P73, DOI 10.1016/j.cld.2011.12.007; Kribben A, 2012, GASTROENTEROLOGY, V142, P782, DOI 10.1053/j.gastro.2011.12.056; Krisper P, 2005, J HEPATOL, V43, P451, DOI 10.1016/j.jhep.2005.02.038; Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008; Lebrec D, 2010, GASTROENTEROLOGY, V138, P1755, DOI 10.1053/j.gastro.2010.01.040; Lee M, 2014, J HEPATOL, V60, pS217, DOI 10.1016/S0168-8278(14)60607-3; Lee WM, 2012, HEPATOLOGY, V55, P965, DOI 10.1002/hep.25551; Levy MF, 2001, ANN SURG, V233, P107, DOI 10.1097/00000658-200101000-00016; Li H, 2015, J HEPATOL, V63, P50, DOI 10.1016/j.jhep.2015.01.029; Lisman T, 2006, HEPATOLOGY, V44, P53, DOI 10.1002/hep.21231; Markwick LJL, 2015, GASTROENTEROLOGY, V148, P590, DOI 10.1053/j.gastro.2014.11.041; Martin-Llahi M, 2008, GASTROENTEROLOGY, V134, P1352, DOI 10.1053/j.gastro.2008.02.024; Martin-Llahi M, 2011, GASTROENTEROLOGY, V140, P488, DOI 10.1053/j.gastro.2010.07.043; Massie AB, 2015, AM J TRANSPLANT, V15, P659, DOI 10.1111/ajt.13099; Mathurin P, 2012, J HEPATOL, V56, pS39, DOI 10.1016/S0168-8278(12)60005-1; Mathurin P, 2011, NEW ENGL J MED, V365, P1790, DOI 10.1056/NEJMoa1105703; McPhail MJW, 2015, CLIN GASTROENTEROL H, V13, P1353, DOI 10.1016/j.cgh.2014.08.041; Mehta G, 2015, LIVER INT, V35, P724, DOI 10.1111/liv.12559; Mehta G, 2014, J HEPATOL, V61, P155, DOI 10.1016/j.jhep.2014.03.014; Merli M, 2010, CLIN GASTROENTEROL H, V8, P979, DOI 10.1016/j.cgh.2010.06.024; Moller S, 2010, J HEPATOL, V53, P179, DOI 10.1016/j.jhep.2010.02.023; Mookerjee RP, 2011, CURR OPIN CRIT CARE, V17, P170, DOI 10.1097/MCC.0b013e328344a076; Mookerjee RP, 2003, GUT, V52, P1182, DOI 10.1136/gut.52.8.1182; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Nazar A, 2013, J HEPATOL, V58, P51, DOI 10.1016/j.jhep.2012.08.027; Nguyen-Khac E, 2011, NEW ENGL J MED, V365, P1781, DOI 10.1056/NEJMoa1101214; Nischalke HD, 2011, J HEPATOL, V55, P1010, DOI 10.1016/j.jhep.2011.02.022; O'Brien AJ, 2014, NAT MED, V20, P522, DOI 10.1038/nm.3516; O'Brien J, 2013, NAT REV GASTRO HEPAT, V10, P402, DOI 10.1038/nrgastro.2013.51; O'Shaughnessy DF, 2004, BRIT J HAEMATOL, V126, P11, DOI 10.1111/j.1365-2141.2004.04972.x; Olson JC, 2011, HEPATOLOGY, V54, P1864, DOI 10.1002/hep.24622; Olson JC, 2011, CURR OPIN CRIT CARE, V17, P165, DOI 10.1097/MCC.0b013e328344b42d; Pan HC, 2014, ALIMENT PHARM THER, V40, P1056, DOI 10.1111/apt.12953; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Rahimi RS, 2014, JAMA INTERN MED, V174, P1727, DOI 10.1001/jamainternmed.2014.4746; Rastogi A, 2011, VIRCHOWS ARCH, V459, P121, DOI 10.1007/s00428-011-1115-9; Roberts MS, 2004, LIVER TRANSPLANT, V10, P886, DOI 10.1002/lt.20137; Rodriguez E, 2014, J HEPATOL, V60, P955, DOI 10.1016/j.jhep.2013.12.032; Romero-Gomez M, 2015, J HEPATOL, V62, P437, DOI 10.1016/j.jhep.2014.09.005; Ruiz-del-Arbol W, 2003, HEPATOLOGY, V38, P1210, DOI 10.1053/jhep.2003.50447; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; Schmidt ML, 2015, GASTROENTEROLOGY, V148, P967, DOI 10.1053/j.gastro.2015.01.032; Segal JB, 2005, TRANSFUSION, V45, P1413, DOI 10.1111/j.1537-2995.2005.00546.x; Selvapatt N, 2014, INTENS CARE MED, V40, P1363, DOI 10.1007/s00134-014-3349-x; Shawcross DL, 2011, J HEPATOL, V54, P640, DOI 10.1016/j.jhep.2010.07.045; Shawcross DL, 2012, J HEPATOL, V56, P1054, DOI 10.1016/j.jhep.2011.12.014; Struecker B, 2014, NAT REV GASTRO HEPAT, V11, P166, DOI 10.1038/nrgastro.2013.204; Taylor NJ, 2014, ALIMENT PHARM THER, V40, P705, DOI 10.1111/apt.12886; Terjung B, 2003, DIGESTION, V67, P138, DOI 10.1159/000071293; Thalheimer U, 2005, GUT, V54, P556, DOI 10.1136/gut.2004.048181; Theocharidou E, 2014, AM J GASTROENTEROL, V109, P554, DOI 10.1038/ajg.2013.466; Thevenot T, 2015, J HEPATOL, V62, P822, DOI 10.1016/j.jhep.2014.11.017; Thuluvath PJ, 2003, LIVER TRANSPLANT, V9, P527, DOI 10.1053/jlts.2003.50089; Thursz MR, 2015, NEW ENGL J MED, V372, P1619, DOI 10.1056/NEJMoa1412278; Tripodi A, 2006, HEPATOLOGY, V44, P440, DOI 10.1002/hep.21266; Tripodi A, 2011, NEW ENGL J MED, V365, P147, DOI 10.1056/NEJMra1011170; Tritto G, 2011, J HEPATOL, V55, P574, DOI 10.1016/j.jhep.2010.11.034; Tsai MH, 2006, HEPATOLOGY, V43, P673, DOI 10.1002/hep.21101; Verbeke L, 2011, CRIT CARE, V15, DOI 10.1186/cc10424; Vincent JL, 2013, NEW ENGL J MED, V369, P1726, DOI 10.1056/NEJMra1208943; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Wasmuth HE, 2005, J HEPATOL, V42, P195, DOI 10.1016/j.jhep.2004.10.019; Weeder PD, 2014, TRANSFUS MED REV, V28, P107, DOI 10.1016/j.tmrv.2014.03.002; Wiese S, 2014, NAT REV GASTRO HEPAT, V11, P177, DOI 10.1038/nrgastro.2013.210; Wildhaber BE, 2008, PEDIATR TRANSPLANT, V12, P487, DOI 10.1111/j.1399-3046.2008.00913.x; Wlodzimirow KA, 2013, LIVER INT, V33, P40, DOI 10.1111/j.1478-3231.2012.02790.x	141	196	214	3	54	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2015	386	10003					1576	1587		10.1016/S0140-6736(15)00309-8	http://dx.doi.org/10.1016/S0140-6736(15)00309-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5VC	26423181				2022-12-28	WOS:000362878200032
J	Liu, ZY; Yang, CP; Sugino, K; Fu, CC; Liu, LY; Yao, XH; Lee, LP; Lee, TM				Liu, Zhiyong; Yang, Ching-Po; Sugino, Ken; Fu, Chi-Cheng; Liu, Ling-Yu; Yao, Xiaohao; Lee, Luke P.; Lee, Tzumin			Opposing intrinsic temporal gradients guide neural stem cell production of varied neuronal fates	SCIENCE			English	Article							MESSENGER-RNA; DROSOPHILA-MELANOGASTER; NEUROBLASTS; IDENTITY; BRAIN; IMP; SPECIFICATION; PROGENITORS; EXPRESSION; GURKEN	Neural stem cells show age-dependent developmental potentials, as evidenced by their production of distinct neuron types at different developmental times. Drosophila neuroblasts produce long, stereotyped lineages of neurons. We searched for factors that could regulate neural temporal fate by RNA-sequencing lineage-specific neuroblasts at various developmental times. We found that two RNA-binding proteins, IGF-II mRNA-binding protein (Imp) and Syncrip (Syp), display opposing high-to-low and low-to-high temporal gradients with lineage-specific temporal dynamics. Imp and Syp promote early and late fates, respectively, in both a slowly progressing and a rapidly changing lineage. Imp and Syp control neuronal fates in the mushroom body lineages by regulating the temporal transcription factor Chinmo translation. Together, the opposing Imp/Syp gradients encode stem cell age, specifying multiple cell fates within a lineage.	[Liu, Zhiyong; Yang, Ching-Po; Sugino, Ken; Fu, Chi-Cheng; Liu, Ling-Yu; Yao, Xiaohao; Lee, Tzumin] Janelia Res Campus, Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Fu, Chi-Cheng; Lee, Luke P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Fu, Chi-Cheng; Lee, Luke P.] Univ Calif Berkeley, Dept Elect Engn, Berkeley, CA 94720 USA; [Fu, Chi-Cheng; Lee, Luke P.] Univ Calif Berkeley, Dept Comp Sci, Berkeley, CA 94720 USA; [Fu, Chi-Cheng; Lee, Luke P.] Univ Calif Berkeley, Biophys Grad Program, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Lee, TM (corresponding author), Janelia Res Campus, Howard Hughes Med Inst, 19700 Helix Dr, Ashburn, VA 20147 USA.	leet@janelia.hhmi.org	Lee, Luke/AAN-6695-2021	LIU, ZHIYONG/0000-0002-9675-1233	Transgenic RNAi Project at Harvard Medical School [NIH/NIGMS R01-GM084947]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER	Transgenic RNAi Project at Harvard Medical School; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Jones, T.S. Hays, P. Macdonald, and I. Davis for sharing reagents. We thank the Transgenic RNAi Project at Harvard Medical School (NIH/NIGMS R01-GM084947) and the Vienna Drosophila Resource Center for providing transgenic RNAi fly stocks used in this study. We thank R. Miyares, G. Rubin, J. Truman, C. Wu, and I. Davis and his group for comments. This work was supported by Howard Hughes Medical Institute. RNA-sequencing data are available in the National Center for Biotechnology Information Gene Expression Omnibus, accession no. GSE71103. The supplementary materials contain additional data.	Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Awasaki T, 2014, NAT NEUROSCI, V17, P631, DOI 10.1038/nn.3654; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Gao P, 2014, CELL, V159, P775, DOI 10.1016/j.cell.2014.10.027; Geng CY, 2006, MOL CELL BIOL, V26, P9508, DOI 10.1128/MCB.01136-06; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Kohwi M, 2013, NAT REV NEUROSCI, V14, P823, DOI 10.1038/nrn3618; LASKO P, 2011, RNA, V2, P408; Lee T, 1999, DEVELOPMENT, V126, P4065; Li X, 2013, CURR TOP DEV BIOL, V105, P69, DOI 10.1016/B978-0-12-396968-2.00003-8; Li X, 2013, NATURE, V498, P456, DOI 10.1038/nature12319; Lin SW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001425; Lin SW, 2010, DEVELOPMENT, V137, P43, DOI 10.1242/dev.041699; Mattar P, 2015, NEURON, V85, P497, DOI 10.1016/j.neuron.2014.12.052; McDermott SM, 2012, BIOL OPEN, V1, P488, DOI 10.1242/bio.2012885; Medioni C, 2014, CURR BIOL, V24, P793, DOI 10.1016/j.cub.2014.02.038; Munro TP, 2006, J CELL BIOL, V172, P577, DOI 10.1083/jcb.200510044; Nishino J, 2013, ELIFE, V2, DOI 10.7554/eLife.00924; Svitkin YV, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001564; Toledano H, 2012, NATURE, V485, P605, DOI 10.1038/nature11061; Truman JW, 2010, DEVELOPMENT, V137, P53, DOI 10.1242/dev.041749; Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021; Yu HH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000461; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045	25	70	70	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2015	350	6258					317	320		10.1126/science.aad1886	http://dx.doi.org/10.1126/science.aad1886			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT5HD	26472907				2022-12-28	WOS:000362838700040
J	Bahcall, O				Bahcall, Orli			Precision Medicine	NATURE			English	Editorial Material														Bahcall, Orli/0000-0002-2891-1637					0	35	36	5	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					335	335		10.1038/526335a	http://dx.doi.org/10.1038/526335a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26469043	Bronze			2022-12-28	WOS:000362730200035
J	Dutilh, JC; van Hees, B				Dutilh, Jacob C.; van Hees, Babette			Bursitis and Tenosynovitis Due to Mycobacterium avium Complex	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dutilh, Jacob C.] Isala Hosp Zwolle, Zwolle, Netherlands; [van Hees, Babette] Gelre Hosp Apeldoorn, Apeldoorn, Netherlands	Gelre Hospitals	Dutilh, JC (corresponding author), Isala Hosp Zwolle, Zwolle, Netherlands.	jacobdutilh@hotmail.com							0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2015	373	16					E19	E19		10.1056/NEJMicm1500800	http://dx.doi.org/10.1056/NEJMicm1500800			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5VX	26466012				2022-12-28	WOS:000362880300001
J	Geller, AI; Shehab, N; Weidle, NJ; Lovegrove, MC; Wolpert, BJ; Timbo, BB; Mozersky, RP; Budnitz, DS				Geller, Andrew I.; Shehab, Nadine; Weidle, Nina J.; Lovegrove, Maribeth C.; Wolpert, Beverly J.; Timbo, Babgaleh B.; Mozersky, Robert P.; Budnitz, Daniel S.			Emergency Department Visits for Adverse Events Related to Dietary Supplements	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HERBAL MEDICINES; SURVEILLANCE; MEDICATIONS	BACKGROUND Dietary supplements, such as herbal or complementary nutritional products and micronutrients (vitamins and minerals), are commonly used in the United States, yet national data on adverse effects are limited. METHODS We used nationally representative surveillance data from 63 emergency departments obtained from 2004 through 2013 to describe visits to U.S. emergency departments because of adverse events related to dietary supplements. RESULTS On the basis of 3667 cases, we estimated that 23,005 (95% confidence interval [CI], 18,611 to 27,398) emergency department visits per year were attributed to adverse events related to dietary supplements. These visits resulted in an estimated 2154 hospitalizations (95% CI, 1342 to 2967) annually. Such visits frequently involved young adults between the ages of 20 and 34 years (28.0% of visits; 95% CI, 25.1 to 30.8) and unsupervised children (21.2% of visits; 95% CI, 18.4 to 24.0). After the exclusion of unsupervised ingestion of dietary supplements by children, 65.9% (95% CI, 63.2 to 68.5) of emergency department visits for single-supplement-related adverse events involved herbal or complementary nutritional products; 31.8% (95% CI, 29.2 to 34.3) involved micronutrients. Herbal or complementary nutritional products for weight loss (25.5%; 95% CI, 23.1 to 27.9) and increased energy (10.0%; 95% CI, 8.0 to 11.9) were commonly implicated. Weight-loss or energy products caused 71.8% (95% CI, 67.6 to 76.1) of supplement-related adverse events involving palpitations, chest pain, or tachycardia, and 58.0% (95% CI, 52.2 to 63.7) involved persons 20 to 34 years of age. Among adults 65 years of age or older, choking or pill-induced dysphagia or globus caused 37.6% (95% CI, 29.1 to 46.2) of all emergency department visits for supplement-related adverse events; micronutrients were implicated in 83.1% (95% CI, 73.3 to 92.9) of these visits. CONCLUSIONS An estimated 23,000 emergency department visits in the United States every year are attributed to adverse events related to dietary supplements. Such visits commonly involve cardiovascular manifestations from weight-loss or energy products among young adults and swallowing problems, often associated with micronutrients, among older adults.	[Geller, Andrew I.; Shehab, Nadine; Lovegrove, Maribeth C.; Budnitz, Daniel S.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA USA; [Weidle, Nina J.] Chenega Govt Consulting, Atlanta, GA USA; [Wolpert, Beverly J.; Timbo, Babgaleh B.] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD USA; [Wolpert, Beverly J.; Timbo, Babgaleh B.] US FDA, Div Publ Hlth Informat & Analyt, College Pk, MD USA; [Mozersky, Robert P.] US FDA, Div Dietary Supplement Programs, College Pk, MD USA	Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Geller, AI (corresponding author), CDC, Div Healthcare Qual Promot, 1825 Century Blvd NE,Mailstop D-26, Atlanta, GA 30345 USA.	ageller@cdc.gov		Budnitz, Daniel/0000-0002-0136-2623; Shehab, Nadine/0000-0001-8700-8539	Department of Health and Human Services	Department of Health and Human Services	Funded by the Department of Health and Human Services.	Ang-Lee MK, 2001, JAMA-J AM MED ASSOC, V286, P208, DOI 10.1001/jama.286.2.208; [Anonymous], 2008, SENT IN NAT STRAT MO; [Anonymous], 2001, ADV EV REP DIET SUPP; [Anonymous], 2015, SIZ SHAP OTH PHYS AT; Bailey RL, 2013, JAMA INTERN MED, V173, P355, DOI 10.1001/jamainternmed.2013.2299; Bailey RL, 2011, J NUTR, V141, P261, DOI 10.3945/jn.110.133025; Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858; Budnitz DS, 2011, PEDIATRICS, V127, pE1597, DOI 10.1542/peds.2011-0926; Centers for Disease Control and Prevention, 2010, DIST PUBL HLTH NONR; Cohen AL, 2006, NEW ENGL J MED, V354, P2294, DOI 10.1056/NEJMc060860; Cohen PA, 2014, JAMA-J AM MED ASSOC, V312, P1691, DOI 10.1001/jama.2014.10308; Cohen PA, 2014, NEW ENGL J MED, V370, P1277, DOI 10.1056/NEJMp1315559; Commission on Dietary Supplement Labels, 1997, REP COMM DIET SUPPL; Denham BE, 2011, JAMA-J AM MED ASSOC, V306, P428, DOI 10.1001/jama.2011.982; Dennehy CE, 2005, AM J HEALTH-SYST PH, V62, P1476, DOI 10.2146/ajhp040412; Department of Health and Human Services, 2014, NEW DIET INGR DIET S; Department of Health and Human Services Centers for Disease Control and Prevention National Center for Health Statistics, 2012, 2011 2012 NAT HLTH N; Department of Health and Human Services Food and Drug Administration, 2008 HLTH DIET SURV; Gardiner P, 2008, PHARMACOEPIDEM DR S, V17, P962, DOI 10.1002/pds.1627; Gardiner P, 2015, PATIENT EDUC COUNS, V98, P512, DOI 10.1016/j.pec.2014.12.010; Gardiner Paula, 2013, Glob Adv Health Med, V2, P46, DOI 10.7453/gahmj.2012.071; Gardiner Paula, 2007, BMC Complement Altern Med, V7, P39, DOI 10.1186/1472-6882-7-39; Government Accountability Office, 2013, DIET SUPPL FDA MAY H; Haller CA, 2008, J MED TOXICOL, V4, P84, DOI 10.1007/BF03160960; Harel Z, 2013, JAMA INTERN MED, V173, P926, DOI 10.1001/jamainternmed.2013.379; Hensrud DD, 1999, MAYO CLIN PROC, V74, P443; Iovate Health Sciences International, HYDR WEIGHT LOSS PRO; Jhung MA, 2007, MED CARE, V45, pS96, DOI 10.1097/MLR.0b013e318041f737; Kaye AD, 2000, J CLIN ANESTH, V12, P468, DOI 10.1016/S0952-8180(00)00195-1; Nahin Richard L, 2009, Natl Health Stat Report, P1; Starr RR, 2015, AM J PUBLIC HEALTH, V105, P478, DOI 10.2105/AJPH.2014.302348; Timbo BB, 2006, J AM DIET ASSOC, V106, P1966, DOI 10.1016/j.jada.2006.09.002	32	248	250	3	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2015	373	16					1531	1540		10.1056/NEJMsa1504267	http://dx.doi.org/10.1056/NEJMsa1504267			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5VX	26465986	Green Accepted, Bronze			2022-12-28	WOS:000362880300009
J	Marchant, J				Marchant, Jo			Consider all the evidence on alternative therapies	NATURE			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL					jomarchant26@yahoo.co.uk						Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55	2	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					295	295		10.1038/526295a	http://dx.doi.org/10.1038/526295a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT3TQ	26469005	Bronze			2022-12-28	WOS:000362730200004
J	Amrock, SM; Weitzman, M				Amrock, Stephen M.; Weitzman, Michael			Alternative Tobacco Products as a Second Front in the War on Tobacco	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SNUS USE; CIGARETTE; SMOKING	Associations Between Initial Water Pipe Tobacco Smoking and Snus Use and Subsequent Cigarette Smoking: Results From a Longitudinal Study of US Adolescents and Young Adults Samir Soneji, PhD; James D. Sargent, MD; Susanne E. Tanski, MD, MPH; Brian A. Primack, MD, PhD IMPORTANCE Many adolescents and young adults use alternative tobacco products, such as water pipes and snus, instead of cigarettes. OBJECTIVE To assess whether prior water pipe tobacco smoking and snus use among never smokers are risk factors for subsequent cigarette smoking. DESIGN, SETTING, AND PARTICIPANTS We conducted a 2-wave national longitudinal study in the United States among 2541 individuals aged 15 to 23 years old. At baseline (October 25, 2010, through June 11, 2011), we ascertained whether respondents had smoked cigarettes, smoked water pipe tobacco, or used snus. At the 2-year follow-up (October 27, 2012, through March 31, 2013), we determined whether baseline non-cigarette smokers had subsequently tried cigarette smoking, were current (past 30 days) cigarette smokers, or were high-intensity cigarette smokers. We fit multivariable logistic regression models among baseline non-cigarette smokers to assess whether baseline water pipe tobacco smoking and baseline snus use were associated with subsequent cigarette smoking initiation and current cigarette smoking, accounting for established sociodemographic and behavioral risk factors. We fit similarly specified multivariable ordinal logistic regression models to assess whether baseline water pipe tobacco smoking and baseline snus use were associated with high-intensity cigarette smoking at follow-up. EXPOSURES Water pipe tobacco smoking and the use of snus at baseline. MAIN OUTCOMES AND MEASURES Among baseline non-cigarette smokers, cigarette smoking initiation, current (past 30 days) cigarette smoking at follow-up, and the intensity of cigarette smoking at follow-up. RESULTS Among 1596 respondents, 1048 had never smoked cigarettes at baseline, of whom 71 had smoked water pipe tobacco and 20 had used snus at baseline. At follow-up, accounting for behavioral and sociodemographic risk factors, baseline water pipe tobacco smoking and snus use were independently associated with cigarette smoking initiation (adjusted odds ratios: 2.56; 95% CI, 1.46-4.47 and 3.73; 95% CI, 1.43-9.76, respectively), current cigarette smoking (adjusted odds ratios: 2.48; 95% CI, 1.01-6.06 and 6.19; 95% CI, 1.86-20.56, respectively), and higher intensity of cigarette smoking (adjusted proportional odds ratios: 2.55; 95% CI, 1.48-4.38 and 4.45; 95% CI, 1.75-11.27, respectively). CONCLUSIONS AND RELEVANCE Water pipe tobacco smoking and the use of snus independently predicted the onset of cigarette smoking and current cigarette smoking at follow-up. Comprehensive Food and Drug Administration regulation of these tobacco products may limit their appeal to youth and curb the onset of cigarette smoking.	[Amrock, Stephen M.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Weitzman, Michael] NYU, Sch Med, Dept Pediat, 550 First Ave, New York, NY 10016 USA; [Weitzman, Michael] NYU, Sch Med, Dept Environm Med, New York, NY 10016 USA; [Weitzman, Michael] NYU, Coll Global Publ Hlth, New York, NY 10016 USA	Oregon Health & Science University; New York University; New York University; New York University	Weitzman, M (corresponding author), NYU, Sch Med, Dept Pediat, 550 First Ave, New York, NY 10016 USA.	michael.weitzman@nyumc.org			NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA016087, 3 P30CA016087-33SI] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2014, FED REGISTER, V79, P23142; [Anonymous], 2012, PREV TOB UYOUTH YO; Arrazola RA, 2014, J ADOLESCENT HEALTH, V54, P54, DOI 10.1016/j.jadohealth.2013.08.003; Fielder RL, 2013, ADDICT BEHAV, V38, P2729, DOI 10.1016/j.addbeh.2013.07.006; Galanti MR, 2008, NICOTINE TOB RES, V10, P315, DOI 10.1080/14622200701825858; Soneji S, 2015, JAMA PEDIATR, V169, P129, DOI 10.1001/jamapediatrics.2014.2697; Twombly R, 2010, J NATL CANCER I, V102, P1454, DOI 10.1093/jnci/djq404	7	6	6	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2015	314	14					1507	+		10.1001/jama.2015.11394	http://dx.doi.org/10.1001/jama.2015.11394			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2QI	26461999	Green Accepted			2022-12-28	WOS:000362647800018
J	Brody, H				Brody, Herb			BEAUTY	NATURE			English	Editorial Material																			0	4	6	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					S1	S1		10.1038/526S1a	http://dx.doi.org/10.1038/526S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8AV	26444366	Bronze			2022-12-28	WOS:000371580200001
J	Stevenson, ARL; Solomon, MJ; Lumley, JW; Hewett, P; Clouston, AD; Gebski, VJ; Davies, L; Wilson, K; Hague, W; Simes, J				Stevenson, Andrew R. L.; Solomon, Michael J.; Lumley, John W.; Hewett, Peter; Clouston, Andrew D.; Gebski, Val J.; Davies, Lucy; Wilson, Kate; Hague, Wendy; Simes, John		ALaCaRT Investigators	Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer The ALaCaRT Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TOTAL MESORECTAL EXCISION; MRC CLASICC TRIAL; OPEN SURGERY; TERM OUTCOMES; COLON-CANCER; MULTICENTER; RECURRENCE; SURVIVAL	IMPORTANCE Laparoscopic procedures are generally thought to have better outcomes than open procedures. Because of anatomical constraints, laparoscopic rectal resection may not be better because of limitations in performing an adequate cancer resection. OBJECTIVE To determine whether laparoscopic resection is noninferior to open rectal cancer resection for adequacy of cancer clearance. DESIGN, SETTING, AND PARTICIPANTS Randomized, noninferiority, phase 3 trial (Australasian Laparoscopic Cancer of the Rectum; ALaCaRT) conducted between March 2010 and November 2014. Twenty-six accredited surgeons from 24 sites in Australia and New Zealand randomized 475 patients with T1-T3 rectal adenocarcinoma less than 15 cm from the anal verge. INTERVENTIONS Open laparotomy and rectal resection (n = 237) or laparoscopic rectal resection (n = 238). MAIN OUTCOMES AND MEASURES The primary end point was a composite of oncological factors indicating an adequate surgical resection, with a noninferiority boundary of A = -8%. Successful resection was defined as meeting all the following criteria: (1) complete total mesorectal excision, (2) a clear circumferential margin (>= 1 mm), and (3) a clear distal resection margin (>= 1 mm). Pathologists used standardized reporting and were blinded to the method of surgery. RESULTS A successful resection was achieved in 194 patients (82%) in the laparoscopic surgery group and 208 patients (89%) in the open surgery group (risk difference of -7.0% [95% CI, -12.4% to c]; P = .38 for noninferiority). The circumferential resection margin was clear in 222 patients (93%) in the laparoscopic surgery group and in 228 patients (97%) in the open surgery group (risk difference of -3.7% [95% CI, -7.6% to 0.1%]; P = .06), the distal margin was clear in 236 patients (99%) in the laparoscopic surgery group and in 234 patients (99%) in the open surgery group (risk difference of -0.4% [95% CI, -1.8% to 1.0%]; P = .67), and total mesorectal excision was complete in 206 patients (87%) in the laparoscopic surgery group and 216 patients (92%) in the open surgery group (risk difference of -5.4% [95% CI, -10.9% to 0.2%]; P = .06). The conversion rate from laparoscopic to open surgery was 9%. CONCLUSIONS AND RELEVANCE Among patients with T1-T3 rectal tumors, noninferiority of laparoscopic surgery compared with open surgery for successful resection was not established. Although the overall quality of surgery was high, these findings do not provide sufficient evidence for the routine use of laparoscopic surgery. Longer follow-up of recurrence and survival is currently being acquired.	[Stevenson, Andrew R. L.; Clouston, Andrew D.] Univ Queensland, Fac Med & Biomed Sci, Brisbane, Qld, Australia; [Stevenson, Andrew R. L.; Clouston, Andrew D.] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Solomon, Michael J.] Univ Sydney, Royal Prince Alfred Hosp, Inst Acad Surg, Sydney, NSW 2006, Australia; [Lumley, John W.] Wesley Hosp, Brisbane, Qld, Australia; [Hewett, Peter] Univ Adelaide, Dept Surg, Queen Elizabeth Hosp, Adelaide, SA, Australia; [Gebski, Val J.; Davies, Lucy; Wilson, Kate; Hague, Wendy; Simes, John] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia	University of Queensland; Royal Brisbane & Women's Hospital; University of Sydney; Wesley Hospital; University of Adelaide; University of Sydney	Stevenson, ARL (corresponding author), Univ Queensland, 627 Rode Rd, Chermside, Qld 4032, Australia.	admin@ausces.com	Eglinton, Tim W/H-8606-2019; Clouston, Andrew D/E-7199-2011; Hewett, PJ/AAT-9350-2020; Clark, David A/B-3660-2013; Carroll, Rosemary/W-5427-2018	Clouston, Andrew D/0000-0002-9601-7952; Clark, David A/0000-0002-2065-3012; Carroll, Rosemary/0000-0002-2162-2744; Solomon, Michael/0000-0002-5602-6045; Gebski, Val/0000-0001-8748-1844; Hewett, Peter/0000-0002-8135-1317; Merrie, Arend/0000-0002-3139-8627; Wilson, Catherine/0000-0003-1886-4280	Colorectal Surgical Society of Australia; New Zealand Foundation; National Health and Medical Research Council	Colorectal Surgical Society of Australia; New Zealand Foundation(New Zealand Foundation for Research, Science and Technology); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The study was supported by grants from the Colorectal Surgical Society of Australia and New Zealand Foundation and the National Health and Medical Research Council.	[Anonymous], STRUCT PATH REP CANC; Bagshaw PF, 2012, ANN SURG, V256, P915, DOI 10.1097/SLA.0b013e3182765ff8; Bonjer HJ, 2015, NEW ENGL J MED, V372, P1324, DOI 10.1056/NEJMoa1414882; Bonjer HJ, 2005, LANCET ONCOL, V6, P477, DOI 10.1016/S1470-2045(05)70221-7; Ellis-Clark JM, 2010, ANZ J SURG, V80, P807, DOI 10.1111/j.1445-2197.2010.05335.x; Fleshman J, 2007, ANN SURG, V246, P655, DOI 10.1097/SLA.0b013e318155a762; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; HEALD RJ, 1986, LANCET, V1, P1479; Jayne DG, 2007, J CLIN ONCOL, V25, P3061, DOI 10.1200/JCO.2006.09.7758; Jeong SY, 2014, LANCET ONCOL, V15, P767, DOI 10.1016/S1470-2045(14)70205-0; Kusters M, 2010, EJSO-EUR J SURG ONC, V36, P470, DOI 10.1016/j.ejso.2009.11.011; Nagtegaal ID, 2002, J CLIN ONCOL, V20, P1729, DOI 10.1200/JCO.2002.07.010; Nagtegaal ID, 2008, J CLIN ONCOL, V26, P303, DOI 10.1200/JCO.2007.12.7027; Quirke P, 2009, LANCET, V373, P821, DOI 10.1016/S0140-6736(09)60485-2; van Gijn W, 2011, LANCET ONCOL, V12, P575, DOI 10.1016/S1470-2045(11)70097-3	15	659	724	1	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2015	314	13					1356	1363		10.1001/jama.2015.12009	http://dx.doi.org/10.1001/jama.2015.12009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2PH	26441180	Bronze			2022-12-28	WOS:000362644700013
J	Marshall, CR				Marshall, Charles R.			How stable are food webs during a mass extinction?	SCIENCE			English	Editorial Material							TRIASSIC BOUNDARY; SOUTH-AFRICA; KAROO BASIN; BIOSPHERE		Univ Calif Berkeley, Dept Integrat Biol, Museum Paleontol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Marshall, CR (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Museum Paleontol, Berkeley, CA 94720 USA.	crmarshall@berkeley.edu						Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Benton MJ, 2014, GONDWANA RES, V25, P1308, DOI 10.1016/j.gr.2012.12.010; Dunne JA, 2008, PLOS BIOL, V6, P693, DOI 10.1371/journal.pbio.0060102; Dunne JA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3280; Gastaldo RA, 2015, GEOLOGY, V43, P939, DOI 10.1130/G37040.1; May R.M., 1973, STABILITY COMPLEXITY; Payne JL, 2004, SCIENCE, V305, P506, DOI 10.1126/science.1097023; Roopnarine PD, 2007, P ROY SOC B-BIOL SCI, V274, P2077, DOI 10.1098/rspb.2007.0515; Roopnarine PD, 2015, SCIENCE, V350, P90, DOI 10.1126/science.aab1371; Sephton MA, 2015, GEOLOGY, V43, P159, DOI 10.1130/G36227.1; Smith RMH, 2014, PALAEOGEOGR PALAEOCL, V396, P99, DOI 10.1016/j.palaeo.2014.01.002	12	3	4	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					38	39		10.1126/science.aad2729	http://dx.doi.org/10.1126/science.aad2729			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26430107				2022-12-28	WOS:000362098300033
J	Prockop, DJ				Prockop, Darwin J.			Hardly Tendentious - Repairing Like with Like	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STEM/PROGENITOR CELLS; STEM-CELLS; REGENERATION		Texas A&M Univ, Coll Med, Inst Regenerat Med, Baylor Scott & White Hlth, Temple, TX 76508 USA	Baylor Health Care System; Texas A&M University System	Prockop, DJ (corresponding author), Texas A&M Univ, Coll Med, Inst Regenerat Med, Baylor Scott & White Hlth, Temple, TX 76508 USA.							Lee CH, 2015, J CLIN INVEST, V125, P2690, DOI [10.1172/JCI84508, 10.1172/JCI81589]; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Ozeki N, 2015, STEM CELLS, V33, P1927, DOI 10.1002/stem.2030; Papayannopoulou T, 2008, BLOOD, V111, P3923, DOI 10.1182/blood-2007-08-078147; Prockop DJ, 2014, STEM CELLS, V32, P3055, DOI 10.1002/stem.1806	5	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2015	373	14					1371	1372		10.1056/NEJMcibr1509841	http://dx.doi.org/10.1056/NEJMcibr1509841			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS3CI	26422728				2022-12-28	WOS:000361948600014
J	Quinn, JG; Sadek, I				Quinn, Jason George; Sadek, Irene			Clonal heterogeneity in plasma cell myeloma	LANCET			English	Editorial Material									[Quinn, Jason George; Sadek, Irene] Dalhousie Univ, Dept Pathol & Lab Med, Div Hematol Pathol, Halifax, NS B3H 1V8, Canada	Dalhousie University	Quinn, JG (corresponding author), Dalhousie Univ, Dept Pathol & Lab Med, Div Hematol Pathol, Halifax, NS B3H 1V8, Canada.	jasongquinn@gmail.com							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2016	387	10022					E22	E22		10.1016/S0140-6736(15)00384-0	http://dx.doi.org/10.1016/S0140-6736(15)00384-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF8XP	26456413				2022-12-28	WOS:000371644200001
J	Miyata, H; Satouh, Y; Mashiko, D; Muto, M; Nozawa, K; Shiba, K; Fujihara, Y; Isotani, A; Inaba, K; Ikawa, M				Miyata, Haruhiko; Satouh, Yuhkoh; Mashiko, Daisuke; Muto, Masanaga; Nozawa, Kaori; Shiba, Kogiku; Fujihara, Yoshitaka; Isotani, Ayako; Inaba, Kazuo; Ikawa, Masahito			Sperm calcineurin inhibition prevents mouse fertility with implications for male contraceptive	SCIENCE			English	Article							FLAGELLAR MOVEMENT; IN-VITRO; SPERMATOZOA; MOTILITY; CYCLOSPORINE; CALMODULIN; GLUTATHIONE; PHOSPHATASE; EPIDIDYMIS; ACROSOME	Calcineurin inhibitors, such as cyclosporine A and FK506, are used as immunosuppressant drugs, but their adverse effects on male reproductive function remain unclear. The testis expresses somatic calcineurin and a sperm-specific isoform that contains a catalytic subunit (PPP3CC) and a regulatory subunit (PPP3R2). We demonstrate herein that male mice lacking Ppp3cc or Ppp3r2 genes (knockout mice) are infertile, with reduced sperm motility owing to an inflexible midpiece. Treatment of mice with cyclosporine A or FK506 creates phenocopies of the sperm motility and morphological defects. These defects appear within 4 to 5 days of treatment, which indicates that sperm-specific calcineurin confers midpiece flexibility during epididymal transit. Male mouse fertility recovered a week after we discontinued treatment. Because human spermatozoa contain PPP3CC and PPP3R2 as a form of calcineurin, inhibition of this sperm-specific calcineurin may lead to the development of a reversible male contraceptive that would target spermatozoa in the epididymis.	[Miyata, Haruhiko; Satouh, Yuhkoh; Mashiko, Daisuke; Muto, Masanaga; Nozawa, Kaori; Fujihara, Yoshitaka; Ikawa, Masahito] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Mashiko, Daisuke; Nozawa, Kaori; Ikawa, Masahito] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; [Muto, Masanaga; Ikawa, Masahito] Osaka Univ, Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Shiba, Kogiku; Inaba, Kazuo] Univ Tsukuba, Shimoda Marine Res Ctr, Shizuoka 4150025, Japan; [Isotani, Ayako; Ikawa, Masahito] Osaka Univ, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; University of Tsukuba; Osaka University	Ikawa, M (corresponding author), Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan.	ikawa@biken.osaka-u.ac.jp	ikawa, masahito/A-5315-2009; Fujihara, Yoshitaka/G-2043-2011; Isotani, Ayako/D-4564-2017; Satouh, Yuhkoh/A-9917-2009	ikawa, masahito/0000-0001-9859-6217; Fujihara, Yoshitaka/0000-0001-8332-3507; Isotani, Ayako/0000-0002-4720-2318; Satouh, Yuhkoh/0000-0001-9207-9374; Miyata, Haruhiko/0000-0003-4758-5803; Mashiko, Daisuke/0000-0003-3927-3076	Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science [26830056, 15H05573, 20670006, 25112007, 25250014]; JAMBIO; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JAMBIO; Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank Biotechnology Research and Development (Osaka, Japan) for generating mutant mice, D. E. Clapham (Howard Hughes Medical Institute, Boston, MA) for providing Catsper1 KO mice, and S. A. M. Young and F. Abbasi for review of the manuscript. We also thank M. Okabe for continuous encouragement. This work was partly supported by the Ministry of Education, Culture, Sports, Science and Technology and the Japan Society for the Promotion of Science (26830056 to H.M.; 15H05573 to Y.F.; 20670006, 25112007, and 25250014 to M. I.), JAMBIO, and Takeda Science Foundation. All of the gene-manipulated mouse lines were deposited into the Riken BioResource Center (with stock numbers as follows: Ppp3cc KO, RBRC05878; Ppp3r2 KO, RBRC09504; Ppp3cc-FLAG TG#1, RBRC09502; Ppp3cc-FLAG TG#2, RBRC09503; and Ppp3cc-mCherry TG, RBRC09501) and are available from M.I. under a material transfer agreement with Osaka University. The authors declare no conflict of interest.	AHMAD K, 1995, ARCH ANDROLOGY, V35, P187, DOI 10.3109/01485019508987871; Bath ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009387; Cao Zheng-Guo, 2006, Zhonghua Nan Ke Xue, V12, P405; Bennett JC, 2010, J BIOL CHEM, V285, P26269, DOI 10.1074/jbc.M109.095752; Chung JJ, 2014, CELL, V157, P808, DOI 10.1016/j.cell.2014.02.056; Eid MM, 1996, INT J ANDROL, V19, P338, DOI 10.1111/j.1365-2605.1996.tb00524.x; HABERMAN J, 1991, J UROLOGY, V145, P294, DOI 10.1016/S0022-5347(17)38318-0; Hasuwa H, 2010, EXP ANIM TOKYO, V59, P105, DOI 10.1538/expanim.59.105; Hisatomi A, 1996, TOXICOLOGY, V109, P75, DOI 10.1016/0300-483X(96)03312-4; Ikawa M, 2001, DEV BIOL, V240, P254, DOI 10.1006/dbio.2001.0462; Ishijima S, 2002, MOL REPROD DEV, V61, P376, DOI 10.1002/mrd.10017; Jeulin C, 1996, CELL MOTIL CYTOSKEL, V35, P147, DOI 10.1002/(SICI)1097-0169(1996)35:2<147::AID-CM7>3.3.CO;2-#; Kinukawa M, 2004, REPRODUCTION, V128, P813, DOI 10.1530/rep.1.00324; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; MEISTRICH ML, 1975, NATURE, V258, P145, DOI 10.1038/258145a0; Misro MM, 1999, ARCH ANDROLOGY, V43, P215, DOI 10.1080/014850199262526; MURAMATSU T, 1992, P NATL ACAD SCI USA, V89, P529, DOI 10.1073/pnas.89.2.529; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; SEETHALAKSHMI L, 1987, J UROLOGY, V138, P991, DOI 10.1016/S0022-5347(17)43479-3; Takeo T, 2011, BIOL REPROD, V85, P1066, DOI 10.1095/biolreprod.111.092536; Woolley DM, 2005, CELL MOTIL CYTOSKEL, V61, P74, DOI 10.1002/cm.20067; Yanagimachi R., 1988, PHYSL REPROD, V1; YEUNG CH, 1993, BIOL REPROD, V49, P274, DOI 10.1095/biolreprod49.2.274; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	25	100	101	7	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					442	445		10.1126/science.aad0836	http://dx.doi.org/10.1126/science.aad0836			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26429887				2022-12-28	WOS:000363213400042
J	Baird, DP; Hunter, RW; Neary, JJ				Baird, David P.; Hunter, Robert W.; Neary, John J.			CASE REVIEW Hyperkalaemia on the surgical ward	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MOLECULAR-WEIGHT HEPARIN; RENAL TUBULAR-ACIDOSIS		[Baird, David P.; Hunter, Robert W.; Neary, John J.] Royal Infirm Edinburgh NHS Trust, Dept Renal Med, Edinburgh EH16 4SA, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh	Baird, DP (corresponding author), Royal Infirm Edinburgh NHS Trust, Dept Renal Med, Edinburgh EH16 4SA, Midlothian, Scotland.	davidbaird86@hotmail.com		Baird, David/0000-0002-6338-3788; Hunter, Robert/0000-0003-2344-8978				Acker CG, 1998, ARCH INTERN MED, V158, P917, DOI 10.1001/archinte.158.8.917; Bhaskar B, 2012, J CARDIOTHOR VASC AN, V26, P106, DOI 10.1053/j.jvca.2010.11.016; Choi MJ, 2008, J AM SOC NEPHROL, V19, P424, DOI 10.1681/ASN.2007091017; Evans Kimberley J, 2005, J Intensive Care Med, V20, P272, DOI 10.1177/0885066605278969; Greenberg A, 1998, SEMIN NEPHROL, V18, P46; Haas CS, 2013, CLIN ENDOCRINOL, V78, P706, DOI 10.1111/j.1365-2265.2012.04446.x; Halperin ML, 1998, LANCET, V352, P135; MARCELLI JM, 1989, HORM METAB RES, V21, P402, DOI 10.1055/s-2007-1009248; McDonough AA, 2013, KIDNEY INT, V83, P779, DOI 10.1038/ki.2012.468; OSTER JR, 1995, AM J MED, V98, P575, DOI 10.1016/S0002-9343(99)80017-5; PAICE B, 1983, BRIT MED J, V286, P1189, DOI 10.1136/bmj.286.6372.1189; Palmer BF, 2015, NEW ENGL J MED, V373, P548, DOI 10.1056/NEJMra1503102; Reddy P, 2011, INT J CLIN PRACT, V65, P350, DOI 10.1111/j.1742-1241.2009.02311.x; Renal Association, 2014, TREATM AC HYP AD; Sherman DS, 2000, ANN PHARMACOTHER, V34, P606; Thiele A, 2008, AM J MED, V121, pE1, DOI 10.1016/j.amjmed.2008.03.038; Torres OH, 2010, DRUG AGING, V27, P399, DOI 10.2165/11535440-000000000-00000; Unwin RJ, 2011, NAT REV NEPHROL, V7, P75, DOI 10.1038/nrneph.2010.175	18	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2015	351								h5531	10.1136/bmj.h5531	http://dx.doi.org/10.1136/bmj.h5531			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3GC	26489645				2022-12-28	WOS:000364146000013
J	Anikeeva, P; Koppes, RA				Anikeeva, Polina; Koppes, Ryan A.			Restoring the sense of touch	SCIENCE			English	Editorial Material									[Anikeeva, Polina; Koppes, Ryan A.] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Anikeeva, Polina] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Koppes, Ryan A.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northeastern University	Anikeeva, P (corresponding author), MIT, Elect Res Lab, Cambridge, MA 02139 USA.	anikeeva@mit.edu	Koppes, Ryan/AAK-3044-2020					Bryson JB, 2014, SCIENCE, V344, P94, DOI 10.1126/science.1248523; Kaltenbrunner M, 2013, NATURE, V499, P458, DOI 10.1038/nature12314; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Li Q, 2015, NATURE, V523, P576, DOI 10.1038/nature14647; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Park S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09669; Raspopovic S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006820; Sachs M, 1999, WORLD J SURG, V23, P1088, DOI 10.1007/s002689900628; Tan DW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008669; Tee BCK, 2015, SCIENCE, V350, P313, DOI 10.1126/science.aaa9306	10	12	13	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2015	350	6258					274	275		10.1126/science.aad0910	http://dx.doi.org/10.1126/science.aad0910			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT5HD	26472892	Green Submitted			2022-12-28	WOS:000362838700018
J	Mannige, RV; Haxton, TK; Proulx, C; Robertson, EJ; Battigelli, A; Butterfoss, GL; Zuckermann, RN; Whitelam, S				Mannige, Ranjan V.; Haxton, Thomas K.; Proulx, Caroline; Robertson, Ellen J.; Battigelli, Alessia; Butterfoss, Glenn L.; Zuckermann, Ronald N.; Whitelam, Stephen			Peptoid nanosheets exhibit a new secondary-structure motif	NATURE			English	Article							ENERGY LANDSCAPE; PROTEINS; SIMULATION; POLYMERS; DYNAMICS; BINDING; FUNNELS; CHARMM	A promising route to the synthesis of protein-mimetic materials that are capable of complex functions, such as molecular recognition and catalysis, is provided by sequence-defined peptoid polymers(1,2)-structural relatives of biologically occurring polypeptides. Peptoids, which are relatively non-toxic and resistant to degradation3, can fold into defined structures through a combination of sequence-dependent interactions(3-8). However, the range of possible structures that are accessible to peptoids and other biological mimetics is unknown, and our ability to design protein-like architectures from these polymer classes is limited(9). Here we use molecular-dynamics simulations, together with scattering and microscopy data, to determine the atomic-resolution structure of the recently discovered peptoid nanosheet, an ordered supramolecular assembly that extends macroscopically in only two dimensions. Our simulations show that nanosheets are structurally and dynamically heterogeneous, can be formed only from peptoids of certain lengths, and are potentially porous to water and ions. Moreover, their formation is enabled by the peptoids' adoption of a secondary structure that is not seen in the natural world. This structure, a zigzag pattern that we call a Sigma('sigma')-strand, results from the ability of adjacent backbone monomers to adopt opposed rotational states, thereby allowing the backbone to remain linear and untwisted. Linear backbones tiled in a brick-like way form an extended two-dimensional nanostructure, the Sigma-sheet. The binary rotational-statemotif of the Sigma-strand is not seen in regular protein structures, which are usually built from one type of rotational state. We also show that the concept of building regular structures from multiple rotational states can be generalized beyond the peptoid nanosheet system.	[Mannige, Ranjan V.; Haxton, Thomas K.; Proulx, Caroline; Robertson, Ellen J.; Battigelli, Alessia; Zuckermann, Ronald N.; Whitelam, Stephen] Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94709 USA; [Butterfoss, Glenn L.] New York Univ Abu Dhabi, Ctr Genom & Syst Biol, Abu Dhabi, U Arab Emirates	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Mannige, RV (corresponding author), Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94709 USA.	rvmannige@lbl.gov; swhitelam@lbl.gov	Zuckermann, Ronald/P-3436-2019; Zuckermann, Ronald N/A-7606-2014; Robertson, Ellen/ABH-9880-2020	Zuckermann, Ronald/0000-0002-3055-8860; Zuckermann, Ronald N/0000-0002-3055-8860; 	Office of Science, Office of Basic Energy Sciences of the US Department of Energy [DE-AC02-05CH11231]; Defense Threat Reduction Agency [IACRO-B0845281]; Natural Sciences and Engineering Research Council of Canada (NSERC PDF); Office of Science of the US Department of Energy [DE-AC02-05CH11231]	Office of Science, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Natural Sciences and Engineering Research Council of Canada (NSERC PDF)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Office of Science of the US Department of Energy(United States Department of Energy (DOE))	Portions of this work were done as a User project at the Molecular Foundry at Lawrence Berkeley National Laboratory, supported by the Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract no. DE-AC02-05CH11231. R.V.M., T.K.H., C.P., E.J.R., A.B., R.N.Z. and S.W. were supported by the Defense Threat Reduction Agency under contract no. IACRO-B0845281. C.P. was also supported by the Natural Sciences and Engineering Research Council of Canada (NSERC PDF). R.N.Z. and S.W. were also supported by the Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract no. DE-AC02-05CH11231. We thank G.K. Olivier for providing the AFM data. This work used resources of the National Energy Research Scientific Computing Center, which is supported by the Office of Science of the US Department of Energy under contract no. DE-AC02-05CH11231. Quantum-mechanical calculations were carried out on the High Performance Computing resources at New York University Abu Dhabi.	Allen M. P., 1989, COMPUTER SIMULATION, DOI DOI 10.1093/OSO/9780198803195.001.0001; Berg JM, 2010, BIOCH INT EDITION; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Butterfoss GL, 2012, P NATL ACAD SCI USA, V109, P14320, DOI 10.1073/pnas.1209945109; Butterfoss GL, 2009, J AM CHEM SOC, V131, P16798, DOI 10.1021/ja905267k; CHANTLER CT, 1995, J PHYS CHEM REF DATA, V24, P71, DOI 10.1063/1.555974; Drexler KE, 2011, BIOPOLYMERS, V96, P537, DOI 10.1002/bip.21623; Halle B, 2002, P NATL ACAD SCI USA, V99, P1274, DOI 10.1073/pnas.032522499; Hammer ND, 2008, J ALZHEIMERS DIS, V13, P407; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KARPLUS M, 1981, CRC CR REV BIOCH MOL, V9, P293, DOI 10.3109/10409238109105437; Knight A.S., 2015, ADV MAT; Knowles TPJ, 2010, NAT NANOTECHNOL, V5, P204, DOI [10.1038/nnano.2010.26, 10.1038/NNANO.2010.26]; Kudirka R, 2011, BIOPOLYMERS, V96, P586, DOI 10.1002/bip.21590; Laursen JS, 2013, J AM CHEM SOC, V135, P2835, DOI 10.1021/ja312532x; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LEOPOLD PE, 1992, P NATL ACAD SCI USA, V89, P8721, DOI 10.1073/pnas.89.18.8721; Maulucci N, 2008, CHEM COMMUN, P3927, DOI 10.1039/b806508j; Mennucci B., 2009, GAUSSIAN 09 VERSION, V09; Mirijanian DT, 2014, J COMPUT CHEM, V35, P360, DOI 10.1002/jcc.23478; Nam KT, 2010, NAT MATER, V9, P454, DOI [10.1038/nmat2742, 10.1038/NMAT2742]; Robertson EJ, 2014, P NATL ACAD SCI USA, V111, P13284, DOI 10.1073/pnas.1414843111; ROOTHAAN CCJ, 1951, REV MOD PHYS, V23, P69, DOI 10.1103/RevModPhys.23.69; Rosen MJ, 2012, SURFACTANTS AND INTERFACIAL PHENOMENA, 4TH EDITION, P1, DOI 10.1002/9781118228920; Sanii B, 2014, ACS NANO, V8, P11674, DOI 10.1021/nn505007u; Sanii B, 2011, J AM CHEM SOC, V133, P20808, DOI 10.1021/ja206199d; Schug A, 2010, CURR OPIN PHARMACOL, V10, P709, DOI 10.1016/j.coph.2010.09.012; Shan YB, 2011, J AM CHEM SOC, V133, P9181, DOI 10.1021/ja202726y; Sun J, 2014, J AM CHEM SOC, V136, P2070, DOI 10.1021/ja412123y; Sun J, 2013, ACS NANO, V7, P4715, DOI 10.1021/nn4015714; Yoo B, 2008, CURR OPIN CHEM BIOL, V12, P714, DOI 10.1016/j.cbpa.2008.08.015; Zhang WP, 2014, MOL PHARMACEUT, V11, P3279, DOI 10.1021/mp400566a; Zhao Y, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2126975; Zuckermann RN, 2009, CURR OPIN MOL THER, V11, P299	36	130	131	11	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					415	+		10.1038/nature15363	http://dx.doi.org/10.1038/nature15363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26444241	Green Published			2022-12-28	WOS:000362730200048
J	Naldini, L				Naldini, Luigi			Gene therapy returns to centre stage	NATURE			English	Review							X-LINKED ADRENOLEUKODYSTROPHY; CHRONIC GRANULOMATOUS-DISEASE; CHIMERIC-ANTIGEN-RECEPTOR; SEVERE COMBINED IMMUNODEFICIENCY; LEBERS CONGENITAL AMAUROSIS; STEM-CELL TRANSPLANTATION; WISKOTT-ALDRICH SYNDROME; ZINC-FINGER NUCLEASES; LONG-TERM SAFETY; PHASE I/II TRIAL	Recent clinical trials of gene therapy have shown remarkable therapeutic benefits and an excellent safety record. They provide evidence for the long-sought promise of gene therapy to deliver 'cures' for some otherwise terminal or severely disabling conditions. Behind these advances lie improved vector designs that enable the safe delivery of therapeutic genes to specific cells. Technologies for editing genes and correcting inherited mutations, the engagement of stem cells to regenerate tissues and the effective exploitation of powerful immune responses to fight cancer are also contributing to the revitalization of gene therapy.	[Naldini, Luigi] Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy TIGET, I-20132 Milan, Italy; [Naldini, Luigi] Univ Vita Salute San Raffaele, I-20132 Milan, Italy	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Naldini, L (corresponding author), Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy TIGET, I-20132 Milan, Italy.	naldini.luigi@hsr.it		NALDINI, Luigi/0000-0002-7835-527X	Telethon Foundation; European Union (FP7); European Union (ERC); Italian Association for Cancer Research; Italian ministry of health; Italian ministry of scientific research	Telethon Foundation(Fondazione Telethon); European Union (FP7)(European Commission); European Union (ERC)(European Research Council (ERC)European Commission); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian ministry of health(Ministry of Health, Italy); Italian ministry of scientific research(Ministry of Education, Universities and Research (MIUR))	L.N. apologizes to the many scientists whose contributions to the field could not be acknowledged owing to space limitations. He thanks past and present members of his laboratory and colleagues at the San Raffaele Telethon Institute for Gene Therapy (TIGET) and the San Raffaele Scientific Institute. L.N. is also grateful to the Telethon Foundation, the European Union (FP7 and ERC), the Italian Association for Cancer Research, and the Italian ministries of health and of scientific research for supporting his research.	Abina SHB, 2015, JAMA-J AM MED ASSOC, V313, P1550, DOI 10.1001/jama.2015.3253; Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Bainbridge JWB, 2015, NEW ENGL J MED, V372, P1887, DOI 10.1056/NEJMoa1414221; Balazs AB, 2014, NAT MED, V20, P296, DOI 10.1038/nm.3471; Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Barzel A, 2015, NATURE, V517, P360, DOI 10.1038/nature13864; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Baum C, 2011, STEM CELLS, V29, P1479, DOI 10.1002/stem.716; Baxter, 2015, BAX REP CONT PROGR P; Beane JD, 2015, MOL THER, V23, P1380, DOI 10.1038/mt.2015.71; Berntorp E, 2012, LANCET, V379, P1447, DOI 10.1016/S0140-6736(11)61139-2; Biasco L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010314; Biffi A, 2004, J CLIN INVEST, V113, P1118, DOI 10.1172/JCI200419205; Biffi A, 2006, J CLIN INVEST, V116, P3070, DOI 10.1172/JCI28873; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Biffi A, 2011, BLOOD, V117, P5332, DOI 10.1182/blood-2010-09-306761; Bosley KS, 2015, NAT BIOTECHNOL, V33, P478, DOI 10.1038/nbt.3227; Boztug K, 2010, NEW ENGL J MED, V363, P1918, DOI 10.1056/NEJMoa1003548; Braun CJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007280; Brennan TA, 2014, NAT BIOTECHNOL, V32, P874, DOI 10.1038/nbt.3003; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Candotti F, 2012, BLOOD, V120, P3635, DOI 10.1182/blood-2012-02-400937; Cantore A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1405; Capotondo A, 2012, P NATL ACAD SCI USA, V109, P15018, DOI 10.1073/pnas.1205858109; Cartier N, 2012, METHOD ENZYMOL, V507, P187, DOI 10.1016/B978-0-12-386509-0.00010-7; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chandler RJ, 2015, J CLIN INVEST, V125, P870, DOI 10.1172/JCI79213; Cieri N, 2013, BLOOD, V121, P573, DOI 10.1182/blood-2012-05-431718; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Deichmann A, 2011, MOL THER, V19, P2031, DOI 10.1038/mt.2011.178; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Ferrua F, 2010, CURR OPIN ALLERGY CL, V10, P551, DOI 10.1097/ACI.0b013e32833fea85; Fischer A, 2010, NAT IMMUNOL, V11, P457, DOI 10.1038/ni0610-457; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gaspar HB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005642; Gaspar HB, 2011, SCI TRANSL MED, V3, DOI [10.1126/scitranslmed.3002716, 10.1126/scitranslmed.3002715]; Gattinoni L, 2014, IMMUNITY, V41, P7, DOI 10.1016/j.immuni.2014.07.003; Gennery AR, 2010, J ALLERGY CLIN IMMUN, V126, P602, DOI 10.1016/j.jaci.2010.06.015; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Gieselmann V, 2010, NEUROPEDIATRICS, V41, P1, DOI 10.1055/s-0030-1253412; Girard-Gagnepain A, 2014, BLOOD, V124, P1221, DOI 10.1182/blood-2014-02-558163; Greco R, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00095; Grieger JC, 2012, METHOD ENZYMOL, V507, P229, DOI 10.1016/B978-0-12-386509-0.00012-0; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hacein-Bey-Abina S, 2014, NEW ENGL J MED, V371, P1407, DOI 10.1056/NEJMoa1404588; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hacein-Bey-Abina S, 2010, NEW ENGL J MED, V363, P355, DOI 10.1056/NEJMoa1000164; High KH, 2014, HAEMOPHILIA, V20, P43, DOI 10.1111/hae.12411; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Jacobson SG, 2015, NEW ENGL J MED, V372, P1920, DOI 10.1056/NEJMoa1412965; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; June CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3643; Kang EM, 2010, BLOOD, V115, P783, DOI 10.1182/blood-2009-05-222760; Kang HJ, 2011, MOL THER, V19, P2092, DOI 10.1038/mt.2011.166; Kemp S, 2012, BBA-MOL BASIS DIS, V1822, P1465, DOI 10.1016/j.bbadis.2012.03.012; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Kohn DB, 2015, BLOOD, V125, P3521, DOI 10.1182/blood-2015-04-641720; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Krageloh-Mann I, 2013, BONE MARROW TRANSPL, V48, P369, DOI 10.1038/bmt.2012.155; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Leone P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003454; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Li HJ, 2011, BLOOD, V117, P3311, DOI 10.1182/blood-2010-08-302729; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Lichty BD, 2014, NAT REV CANCER, V14, P559, DOI 10.1038/nrc3770; Lisowski L, 2014, NATURE, V506, P382, DOI 10.1038/nature12875; Logan AC, 2012, CURR OPIN IMMUNOL, V24, P640, DOI 10.1016/j.coi.2012.08.002; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Manno CS, 2006, NAT MED, V12, P592, DOI 10.1038/nm0506-592b; Martino AT, 2013, BLOOD, V121, P2224, DOI 10.1182/blood-2012-10-460733; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Maus MV, 2014, ANNU REV IMMUNOL, V32, P189, DOI 10.1146/annurev-immunol-032713-120136; Melchiorri D, 2013, NAT REV DRUG DISCOV, V12, P719, DOI 10.1038/nrd3835-c1; Miest TS, 2014, NAT REV MICROBIOL, V12, P23, DOI 10.1038/nrmicro3140; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Mingozzi F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005795; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Modlich U, 2006, BLOOD, V108, P2545, DOI 10.1182/blood-2005-08-024976; Modlich U, 2009, MOL THER, V17, P1919, DOI 10.1038/mt.2009.179; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Morrison C, 2015, NAT BIOTECHNOL, V33, P217, DOI 10.1038/nbt0315-217; Naldini L, 2011, NAT REV GENET, V12, P301, DOI 10.1038/nrg2985; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Nault JC, 2015, NAT GENET, V47, P1187, DOI 10.1038/ng.3389; Nayak S, 2010, GENE THER, V17, P295, DOI 10.1038/gt.2009.148; Notarangelo LD, 2009, J ALLERGY CLIN IMMUN, V124, P1161, DOI 10.1016/j.jaci.2009.10.013; Ogwang C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2373; Osborn MJ, 2015, HUM GENE THER, V26, P114, DOI 10.1089/hum.2014.111; Palfi S, 2014, LANCET, V383, P1138, DOI 10.1016/S0140-6736(13)61939-X; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Rampling T, 2015, N ENGL J MED; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rio P, 2014, EMBO MOL MED, V6, P835, DOI 10.15252/emmm.201303374; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2015, CLIN CANCER RES, V21, P1019, DOI 10.1158/1078-0432.CCR-14-2708; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Tardieu M, 2014, HUM GENE THER, V25, P506, DOI 10.1089/hum.2013.238; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Testa F, 2013, OPHTHALMOLOGY, V120, P1283, DOI 10.1016/j.ophtha.2012.11.048; Torikai H, 2012, BLOOD, V119, P5697, DOI 10.1182/blood-2012-01-405365; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wright AF, 2015, NEW ENGL J MED, V372, P1954, DOI 10.1056/NEJMe1503419; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zhou S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062333; Zhou S, 2010, BLOOD, V116, P900, DOI 10.1182/blood-2009-10-250209; Zychlinski D, 2008, MOL THER, V16, P718, DOI 10.1038/mt.2008.5	123	768	805	24	591	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					351	360		10.1038/nature15818	http://dx.doi.org/10.1038/nature15818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26469046				2022-12-28	WOS:000362730200038
J	Sutherland, WJ; Burgman, MA				Sutherland, William J.; Burgman, Mark A.			Use experts wisely	NATURE			English	Editorial Material							JUDGMENTS		[Sutherland, William J.] Univ Cambridge, Conservat Biol, Dept Zool, Cambridge CB2 1TN, England; [Burgman, Mark A.] Univ Melbourne, Bot, Sch Biosci, Parkville, Vic 3052, Australia; [Burgman, Mark A.] Univ Melbourne, Ctr Excellence Biosecur Risk Anal, Sch Biosci, Parkville, Vic 3052, Australia	University of Cambridge; University of Melbourne; University of Melbourne	Sutherland, WJ (corresponding author), Univ Cambridge, Conservat Biol, Dept Zool, Cambridge CB2 1TN, England.	wjs32@cam.ac.uk		Sutherland, William/0000-0002-6498-0437; Burgman, Mark/0000-0003-0435-4829				Aspinall W, 2010, NATURE, V463, P294, DOI 10.1038/463294a; Burgman MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022998; Cooke R. M., 1991, EXPERTS UNCERTAINTY; Englich B, 2009, JUDGM DECIS MAK, V4, P41; McBride MF, 2012, METHODS ECOL EVOL, V3, P906, DOI 10.1111/j.2041-210X.2012.00221.x; O'Hagan A., 2006, UNCERTAIN JUDGEMENTS; Speirs-Bridge A, 2010, RISK ANAL, V30, P512, DOI 10.1111/j.1539-6924.2009.01337.x; Sutherland W.J., 2015, WHAT WORKS CONSERVAT; Sutherland WJ, 2014, ECOL SOC, V19, DOI 10.5751/ES-06082-190203; Tversky Amos, 1982, JUDGMENT UNCERTAINTY, P23	10	120	121	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					317	318		10.1038/526317a	http://dx.doi.org/10.1038/526317a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26469026	Bronze			2022-12-28	WOS:000362730200017
J	Fritz, JM; Magel, JS; McFadden, M; Asche, C; Thackeray, A; Meier, W; Brennan, G				Fritz, Julie M.; Magel, John S.; McFadden, Molly; Asche, Carl; Thackeray, Anne; Meier, Whitney; Brennan, Gerard			Early Physical Therapy vs Usual Care in Patients With Recent-Onset Low Back Pain A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FEAR-AVOIDANCE BELIEFS; PRACTICE GUIDELINES; PREDICTION RULE; SPINAL MANIPULATION; EUROPEAN GUIDELINES; HEALTH-STATUS; MANAGEMENT; COSTS; DISABILITY; ADHERENCE	IMPORTANCE Low back pain (LBP) is common in primary care. Guidelines recommend delaying referrals for physical therapy. OBJECTIVE To evaluate whether early physical therapy (manipulation and exercise) is more effective than usual care in improving disability for patients with LBP fitting a decision rule. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial with 220 participants recruited between March 2011 and November 2013. Participants with no LBP treatment in the past 6 months, aged 18 through 60 years (mean age, 37.4 years [SD, 10.3]), an Oswestry Disability Index (ODI) score of 20 or higher, symptom duration less than 16 days, and no symptoms distal to the knee in the past 72 hours were enrolled following a primary care visit. INTERVENTIONS All participants received education. Early physical therapy (n = 108) consisted of 4 physical therapy sessions. Usual care (n = 112) involved no additional interventions during the first 4 weeks. MAIN OUTCOMES AND MEASURES Primary outcome was change in the ODI score (range: 0-100; higher scores indicate greater disability; minimum clinically important difference, 6 points) at 3 months. Secondary outcomes included changes in the ODI score at 4-week and 1-year follow-up, and change in pain intensity, Pain Catastrophizing Scale (PCS) score, fear-avoidance beliefs, quality of life, patient-reported success, and health care utilization at 4-week, 3-month, and 1-year follow-up. RESULTS One-year follow-up was completed by 207 participants (94.1%). Using analysis of covariance, early physical therapy showed improvement relative to usual care in disability after 3 months (mean ODI score: early physical therapy group, 41.3 [95% CI, 38.7 to 44.0] at baseline to 6.6 [95% CI, 4.7 to 8.5] at 3 months; usual care group, 40.9 [95% CI, 38.6 to 43.1] at baseline to 9.8 [95% CI, 7.9 to 11.7] at 3 months; between-group difference, -3.2 [95% CI, -5.9 to -0.47], P = .02). A significant difference was found between groups for the ODI score after 4 weeks (between-group difference, -3.5 [95% CI, -6.8 to -0.08], P = .045]), but not at 1-year follow-up (between-group difference, -2.0 [95% CI, -5.0 to 1.0], P = .19). There was no improvement in pain intensity at 4-week, 3-month, or 1-year follow-up (between-group difference, -0.42 [95% CI, -0.90 to 0.02] at 4-week follow-up; -0.38 [95% CI, -0.84 to 0.09] at 3-month follow-up; and -0.17 [95% CI, -0.62 to 0.27] at 1-year follow-up). The PCS scores improved at 4 weeks and 3 months but not at 1-year follow-up (between-group difference, -2.7 [95% CI, -4.6 to -0.85] at 4-week follow-up; -2.2 [95% CI, -3.9 to -0.49] at 3-month follow-up; and -0.92 [95% CI, -2.7 to 0.61] at 1-year follow-up). There were no differences in health care utilization at any point. CONCLUSIONS AND RELEVANCE Among adults with recent-onset LBP, early physical therapy resulted in statistically significant improvement in disability, but the improvement was modest and did not achieve the minimum clinically important difference compared with usual care.	[Fritz, Julie M.; Magel, John S.; McFadden, Molly; Thackeray, Anne; Meier, Whitney] Univ Utah, Dept Phys Therapy, Salt Lake City, UT 84108 USA; [Magel, John S.; Thackeray, Anne; Brennan, Gerard] Intermt Healthcare, Dept Phys Therapy, Salt Lake City, UT USA; [Asche, Carl] Univ Illinois, Coll Med Peoria, Dept Internal Med, Peoria, IL USA	Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; University of Illinois System; University of Illinois Peoria	Fritz, JM (corresponding author), Univ Utah, Dept Phys Therapy, 520 Wakara Way, Salt Lake City, UT 84108 USA.	julie.fritz@utah.edu	Fritz, Julie/AAC-5638-2021	Magel, John/0000-0001-9087-4753; Thackeray, Anne/0000-0002-5496-7730	Agency for Healthcare Research and Quality [1R18HS018672]; University of Utah Study Design and Biostatistics Center; National Center for Research Resources of the National Institutes of Health [5UL1TRO01067-02]; National Center for Advancing Translational Sciences of the National Institutes of Health; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS018672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000105, UL1TR001067] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025764] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); University of Utah Study Design and Biostatistics Center; National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was funded by grant 1R18HS018672 from the Agency for Healthcare Research and Quality. The study was supported by the University of Utah Study Design and Biostatistics Center, with funding in part through grant 5UL1TRO01067-02 (formerly 8UL1TR000105 and UL1RR025764) from the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health.	Brennan GP, 2006, SPINE, V31, P623, DOI 10.1097/01.brs.0000202807.72292.a8; Childs JD, 2005, SPINE, V30, P1331, DOI 10.1097/01.brs.0000164099.92112.29; Childs JD, 2004, ANN INTERN MED, V141, P920, DOI 10.7326/0003-4819-141-12-200412210-00008; Chou R, 2007, ANN INTERN MED, V147, P492, DOI 10.7326/0003-4819-147-7-200710020-00007; Cleland JA, 2009, SPINE, V34, P2720, DOI 10.1097/BRS.0b013e3181b48809; Dagenais S, 2010, SPINE J, V10, P514, DOI 10.1016/j.spinee.2010.03.032; Davis MA, 2012, SPINE, V37, P1693, DOI 10.1097/BRS.0b013e3182541f45; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Flynn T, 2002, SPINE, V27, P2835, DOI 10.1097/00007632-200212150-00021; Foster NE, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-108; Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543; Fritz JM, 2001, PHYS THER, V81, P776, DOI 10.1093/ptj/81.2.776; Fritz JM, 2003, SPINE, V28, P1363; Fritz JM, 2007, MED CARE, V45, P973, DOI 10.1097/MLR.0b013e318070c6cd; Fritz JM, 2013, ARCH PHYS MED REHAB, V94, P808, DOI 10.1016/j.apmr.2013.01.008; Fritz JM, 2012, SPINE, V37, P2114, DOI 10.1097/BRS.0b013e31825d32f5; Fullen BM, 2007, EUR J PAIN, V11, P614, DOI 10.1016/j.ejpain.2006.09.007; Gellhorn AC, 2012, SPINE, V37, P775, DOI 10.1097/BRS.0b013e3181d79a09; Goossens MEJB, 2000, J CLIN EPIDEMIOL, V53, P688, DOI 10.1016/S0895-4356(99)00177-8; Graves JM, 2014, HEALTH SERV RES, V49, P645, DOI 10.1111/1475-6773.12098; Hill JC, 2008, ARTHRIT RHEUM-ARTHR, V59, P632, DOI 10.1002/art.23563; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; Hurwitz EL, 2005, SPINE, V30, P1477, DOI 10.1097/01.brs.0000167821.39373.c1; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Kosloff TM, 2013, POPUL HEALTH MANAG, V16, P390, DOI 10.1089/pop.2012.0096; Licciardone John C, 2008, Osteopath Med Prim Care, V2, P11, DOI 10.1186/1750-4732-2-11; Macedo LG, 2009, PHYS THER, V89, P9, DOI 10.2522/ptj.20080103; Mafi JN, 2013, JAMA INTERN MED, V173, P1573, DOI 10.1001/jamainternmed.2013.8992; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Martin R, 1996, THE BACK BOOK; Newcomer KL, 2010, PM&R, V2, P514, DOI 10.1016/j.pmrj.2010.03.034; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; van Tulder M, 2006, EUR SPINE J, V15, pS169, DOI 10.1007/s00586-006-1071-2; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Webster BS, 2014, SPINE, V39, P1433, DOI 10.1097/BRS.0000000000000408; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	40	94	95	1	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2015	314	14					1459	1467		10.1001/jama.2015.11648	http://dx.doi.org/10.1001/jama.2015.11648			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2QI	26461996	Bronze			2022-12-28	WOS:000362647800013
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: The conflict of choice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Coren Mitchell V., 2015, GUARDIAN; General Medical Council, 2013, PRESCR GUID KEEP DAT; General Medical Council, 2008, CONS MAK DEC TOG	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 12	2015	351								h5312	10.1136/bmj.h5312	http://dx.doi.org/10.1136/bmj.h5312			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT8XR	26459410	Bronze			2022-12-28	WOS:000363100700002
J	Wiles, KS; Jarvis, S; Nelson-Piercy, C				Wiles, Kate Sophie; Jarvis, Sheba; Nelson-Piercy, Catherine			UNCERTAINTIES Are we overtreating subclinical hypothyroidism in pregnancy?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MATERNAL THYROID-DEFICIENCY; LEVOTHYROXINE REQUIREMENTS; 1ST TRIMESTER; MANAGEMENT; WOMEN; ASSOCIATION; GUIDELINES; MAGNITUDE; DIAGNOSIS; TESTS		[Wiles, Kate Sophie] St Thomas Hosp, Womens Hlth Acad Ctr, London SE1 7EH, England; [Jarvis, Sheba] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Nelson-Piercy, Catherine] Guys & St Thomas NHS Fdn Trust, Obstet Med, London SE1 7EH, England; [Nelson-Piercy, Catherine] Univ London Imperial Coll Sci Technol & Med, Healthcare NHS Trust, Obstet Med, London W12 0HS, England	Guy's & St Thomas' NHS Foundation Trust; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; Imperial College London	Wiles, KS (corresponding author), St Thomas Hosp, Womens Hlth Acad Ctr, London SE1 7EH, England.	kate.wiles@kcl.ac.uk						Abalovich M, 2010, THYROID, V20, P1175, DOI 10.1089/thy.2009.0457; Alexander EK, 2004, NEW ENGL J MED, V351, P241, DOI 10.1056/NEJMoa040079; Allan WC, 2000, J MED SCREEN, V7, P127, DOI 10.1136/jms.7.3.127; Anselmo J, 2004, JAMA-J AM MED ASSOC, V292, P691, DOI 10.1001/jama.292.6.691; Casey BM, 2007, OBSTET GYNECOL, V109, P1129, DOI 10.1097/01.AOG.0000262054.03531.24; Cleary-Goldman J, 2008, OBSTET GYNECOL, V112, P85, DOI 10.1097/AOG.0b013e3181788dd7; Cotzias C, 2008, EUR J OBSTET GYN R B, V137, P61, DOI 10.1016/j.ejogrb.2007.10.007; Garber JR, 2012, THYROID, V22, P1200, DOI 10.1089/thy.2012.0205; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Lazarus J, 2014, EUR THYROID J, V3, P76, DOI 10.1159/000362597; Lazarus JH, 2012, NEW ENGL J MED, V366, P493, DOI 10.1056/NEJMoa1106104; Li CY, 2014, J CLIN ENDOCR METAB, V99, P73, DOI 10.1210/jc.2013-1674; Loh JA, 2009, THYROID, V19, P269, DOI 10.1089/thy.2008.0413; Maraka S, 2015, JAMA INTERN MED, V175, P1088, DOI 10.1001/jamainternmed.2015.1348; Negro R, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4929; Ong GSY, 2014, J CLIN ENDOCR METAB, V99, pE2668, DOI 10.1210/jc.2014-1918; Reid SM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007752.pub3; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; van den Boogaard E, 2011, HUM REPROD UPDATE, V17, P605, DOI 10.1093/humupd/dmr024	19	21	23	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 12	2015	351								h4726	10.1136/bmj.h4726	http://dx.doi.org/10.1136/bmj.h4726			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT8XR	26459315				2022-12-28	WOS:000363100700001
J	Maxmen, A				Maxmen, Amy			ANIMAL BEHAVIOUR Come mate with me	NATURE			English	Editorial Material							SIGNAL; PREFERENCE; SELECTION											Calabrese GM, 2014, P NATL ACAD SCI USA, V111, P13397, DOI 10.1073/pnas.1321368111; Cummings ME, 2007, EVOLUTION, V61, P530, DOI 10.1111/j.1558-5646.2007.00047.x; Cummings ME, 2015, ANIM BEHAV, V103, P249, DOI 10.1016/j.anbehav.2015.02.021; Darwin C., 1871, P475; Katayama N, 2014, P NATL ACAD SCI USA, V111, P15144, DOI 10.1073/pnas.1407595111; Kemp DJ, 2007, EVOLUTION, V61, P168, DOI 10.1111/j.1558-5646.2007.00014.x; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; White TE, 2015, EVOLUTION, V69, P14, DOI 10.1111/evo.12551; Whittingham LA, 2015, MOL ECOL, V24, P1584, DOI 10.1111/mec.13130; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	10	0	0	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					S8	S10		10.1038/526S8a	http://dx.doi.org/10.1038/526S8a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26444375	Bronze			2022-12-28	WOS:000362399000004
J	Palmer, T				Palmer, Tim			Build imprecise supercomputers	NATURE			English	Editorial Material							MODELS		[Palmer, Tim] Univ Oxford, Climate Phys, Oxford OX1 2JD, England; [Palmer, Tim] Univ Oxford, Oxford Martin Programme Modelling & Predicting Cl, Oxford OX1 2JD, England	University of Oxford; University of Oxford	Palmer, T (corresponding author), Univ Oxford, Climate Phys, Oxford OX1 2JD, England.	tim.palmer@physics.ox.ac.uk		Palmer, Tim/0000-0002-7121-2196				Duben PD, 2014, MON WEATHER REV, V142, P3809, DOI 10.1175/MWR-D-14-00110.1; Faisal AA, 2007, PLOS COMPUT BIOL, V3, P783, DOI 10.1371/journal.pcbi.0030079; Hoos H.H., 2005, STOCHASTIC LOCAL SEA; Mauritsen T, 2015, NAT GEOSCI, V8, P346, DOI 10.1038/NGEO2414; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; Palem KV, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0281; Palmer TN, 2012, Q J ROY METEOR SOC, V138, P841, DOI 10.1002/qj.1923; Palmer T, 2014, NATURE, V515, P338, DOI 10.1038/515338a; Palmer TN, 2015, FRONT COMPUT NEUROSC, V9, DOI [10.3389/fncom/2015.00124, 10.3389/fncom.2015.00124]; Turing A.M., 1950, MIND, P433, DOI DOI 10.1093/MIND/LIX.236.433	10	29	30	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					32	33		10.1038/526032a	http://dx.doi.org/10.1038/526032a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26432226	Bronze			2022-12-28	WOS:000362095100016
J	Qu, QM; Haitina, T; Zhu, M; Ahlberg, PE				Qu, Qingming; Haitina, Tatjana; Zhu, Min; Ahlberg, Per Erik			New genomic and fossil data illuminate the origin of enamel	NATURE			English	Article							MINERALIZATION GENES; BONY VERTEBRATES; TEETH; EVOLUTION; SCALES; FISHES; LOPHOSTEUS; GANOINE; MODELS; TISSUE	Enamel, the hardest vertebrate tissue, covers the teeth of almost all sarcopterygians (lobe-finned bony fishes and tetrapods) as well as the scales and dermal bones of many fossil lobe-fins(1-5). Enamel deposition requires an organic matrix containing the unique enamel matrix proteins (EMPs) amelogenin (AMEL), enamelin (ENAM) and ameloblastin (AMBN)(6). Chondrichthyans (cartilaginous fishes) lack both enamel and EMP genes(7,8). Many fossil and a few living non-teleost actinopterygians (ray-finned bony fishes) such as the gar, Lepisosteus, have scales and dermal bones covered with a proposed enamel homologue called ganoine(1,9). However, no gene or transcript data for EMPs have been described from actinopterygians(10,11). Here we show that Psarolepis romeri, a bony fish from the the Early Devonian period, combines enamel-covered dermal odontodes on scales and skull bones with teeth of naked dentine, and that Lepisosteus oculatus (the spotted gar) has enam andambn genes that are expressed in the skin, probably associated with ganoine formation. The genetic evidence strengthens the hypothesis that ganoine is homologous with enamel. The fossil evidence, further supported by the Silurian bony fish Andreolepis, which has enamel-covered scales but teeth and odontodes on its dermal bones made of naked dentine(12-16), indicates that this tissue originated on the dermal skeleton, probably on the scales. It subsequently underwent heterotopic expansion across two highly conserved patterning boundaries (scales/head-shoulder and dermal/oral) within the odontode skeleton.	[Qu, Qingming; Haitina, Tatjana; Ahlberg, Per Erik] Uppsala Univ, Dept Organismal Biol, Subdept Evolut & Dev, SE-75236 Uppsala, Sweden; [Zhu, Min] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China	Uppsala University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Ahlberg, PE (corresponding author), Uppsala Univ, Dept Organismal Biol, Subdept Evolut & Dev, Norbyvagen 18A, SE-75236 Uppsala, Sweden.	per.ahlberg@ebc.uu.se	Zhu, Min/E-8728-2012; min, zhu/AAL-6712-2021; Qu, Qingming/R-7194-2016	Zhu, Min/0000-0002-4786-0898; Ahlberg, Per/0000-0001-9054-2900; Haitina, Tatjana/0000-0002-8754-5534; Qu, Qingming/0000-0002-8291-8493	Knut and Alice Wallenberg Foundation; Vetenskapsradet (Swedish Research Council); National Basic Research Programme of China [2012CB821902]	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Vetenskapsradet (Swedish Research Council)(Swedish Research Council); National Basic Research Programme of China(National Basic Research Program of China)	This project was inspired in part by initial discussions with K. Kawasaki, whom we gratefully acknowledge. We thank the Broad Institute Genomics Platform and Vertebrate Genome Biology group, Spotted Gar Genome Consortium and K. Lindblad-Toh for making the data for L. oculatus available. We thank W. Zhang and S. Zhang for technical help with thin sections and SEM. The work was supported by the Knut and Alice Wallenberg Foundation through a Wallenberg Scholarship awarded to P.E.A., and by Vetenskapsradet (Swedish Research Council) through a Young Researcher Grant awarded to T.H. M.Z. was funded by the National Basic Research Programme of China (2012CB821902).	Botella H, 2007, NATURE, V448, P583, DOI 10.1038/nature05989; Braasch I, 2015, J EXP ZOOL PART B, V324, P316, DOI 10.1002/jez.b.22589; Chang MM, 1992, J VERTEBR PALEONTOL, V12, P294, DOI 10.1080/02724634.1992.10011461; Cunningham JA, 2012, BIOL LETTERS, V8, P833, DOI 10.1098/rsbl.2012.0357; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Fraser GJ, 2011, J EXP ZOOL PART B, V316B, P99, DOI 10.1002/jez.b.21387; GRADY JE, 1970, ARCH ORAL BIOL, V15, P613, DOI 10.1016/0003-9969(70)90130-5; GROSS W, 1971, LETHAIA, V4, P131, DOI 10.1111/j.1502-3931.1971.tb01285.x; GROSS W, 1968, LETHAIA, V1, P184, DOI 10.1111/j.1502-3931.1968.tb01736.x; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; Kawasaki K, 2005, P NATL ACAD SCI USA, V102, P18063, DOI 10.1073/pnas.0509263102; Kawasaki K, 2014, J EXP ZOOL PART B, V322, P390, DOI 10.1002/jez.b.22546; Kawasaki K, 2011, CELLS TISSUES ORGANS, V194, P108, DOI 10.1159/000324225; Kawasaki K, 2009, DEV GENES EVOL, V219, P147, DOI 10.1007/s00427-009-0276-x; Moffatt P, 2014, CELL TISSUE RES, V358, P843, DOI 10.1007/s00441-014-1989-3; Nakayama Y, 2015, J DENT RES, V94, P697, DOI 10.1177/0022034514566214; PEARSON D M, 1979, Transactions of the Royal Society of Edinburgh, V70, P337; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poole D.F.G., 1967, STRUCTURAL CHEM ORG, P111; Qu QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071890; Qu QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061485; RICHTER M, 1995, ZOOL J LINN SOC-LOND, V114, P173, DOI 10.1006/zjls.1995.0023; Sasagawa I, 2013, J ORAL BIOSCI, V55, P76, DOI 10.1016/j.job.2013.04.001; Satchell PG, 2000, CELL TISSUE RES, V299, P27, DOI 10.1007/s004419900132; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sire JY, 2007, CELLS TISSUES ORGANS, V186, P25, DOI 10.1159/000102679; Sire JY, 2009, J ANAT, V214, P409, DOI 10.1111/j.1469-7580.2009.01046.x; SIRE JY, 1987, AM J ANAT, V180, P391; Smith M.M., 1992, P73; SMITH MM, 1978, J ZOOL, V185, P355; THOMSON KS, 1984, ZOOL J LINN SOC-LOND, V82, P73, DOI 10.1111/j.1096-3642.1984.tb00536.x; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617; Zhu M, 2009, NATURE, V458, P469, DOI 10.1038/nature07855	35	51	54	2	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					108	+		10.1038/nature15259	http://dx.doi.org/10.1038/nature15259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26416752				2022-12-28	WOS:000362095100043
J	Emdin, CA; Anderson, SG; Callender, T; Conrad, N; Salimi-Khorshidi, G; Mohseni, H; Woodward, M; Rahimi, K				Emdin, Connor A.; Anderson, Simon G.; Callender, Thomas; Conrad, Nathalie; Salimi-Khorshidi, Gholamreza; Mohseni, Hamid; Woodward, Mark; Rahimi, Kazem			Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4.2 million adults	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANKLE-BRACHIAL INDEX; PREDICT CARDIOVASCULAR EVENTS; NUTRITION EXAMINATION SURVEY; NATIONAL-HEALTH; UNITED-STATES; MORTALITY; PREVALENCE; ASSOCIATIONS; TRENDS; AGE	OBJECTIVES To determine the subgroup specific associations between usual blood pressure and risk of peripheral arterial disease, and to examine the relation between peripheral arterial disease and a range of other types of vascular disease in a large contemporary cohort. DESIGN Cohort study. SETTING Linked electronic health records from 1990 to 2013 in the United Kingdom. PARTICIPANTS 4 222 459 people aged 30-90 years, registered at a primary care practice for at least one year and with a blood pressure measurement. MAIN OUTCOME MEASURES Time to first diagnosis of new onset peripheral arterial disease and time to first diagnosis of 12 different vascular events. RESULTS A 20 mm Hg higher than usual systolic blood pressure was associated with a 63% higher risk of peripheral arterial disease (hazard ratio 1.63, 95% confidence interval 1.59 to 1.66). The strength of the association declined with increasing age and body mass index (P<0.001 for interaction) but was not modified by sex or smoking status. Peripheral arterial disease was associated with an increased risk of 11 different vascular events, including ischaemic heart disease (1.68, 1.58 to 1.79), heart failure (1.63, 1.52 to 1.75), aortic aneurysm (2.10, 1.79 to 2.45), and chronic kidney disease (1.31, 1.25 to 1.38), but not haemorrhagic stroke. The most common initial vascular event among those with peripheral arterial disease was chronic kidney disease (24.4% of initial events), followed by ischaemic heart disease (18.5% of initial events), heart failure (14.7%), and atrial fibrillation (13.2%). Overall estimates from this cohort were consistent with those derived from traditional studies when we pooled the findings in two meta-analyses. CONCLUSIONS Raised blood pressure is a strong risk factor for peripheral arterial disease in a range of patient subgroups. Furthermore, clinicians should be aware that those with established peripheral arterial disease are at an increased risk of a range of other vascular events, including chronic kidney disease, ischaemic heart disease, heart failure, atrial fibrillation, and stroke.	[Emdin, Connor A.; Anderson, Simon G.; Callender, Thomas; Conrad, Nathalie; Salimi-Khorshidi, Gholamreza; Mohseni, Hamid; Rahimi, Kazem] Univ Oxford, Oxford Martin Sch, George Inst Global Hlth, Oxford OX1 3DB, England; [Woodward, Mark] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Woodward, Mark] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Rahimi, Kazem] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England	University of Oxford; George Institute for Global Health; University of Sydney; Johns Hopkins University; University of Oxford	Rahimi, K (corresponding author), Univ Oxford, Oxford Martin Sch, George Inst Global Hlth, Oxford OX1 3DB, England.	kazem.rahimi@cardiov.ox.ac.uk	Woodward, Mark/L-6817-2017; Rahimi, Kazem/Q-1279-2015; Rahimi, Kazem/AAA-4250-2022; Anderson, Simon G/AGM-2359-2022; Woodward, Mark/D-8492-2015; Conrad, Nathalie/ACZ-2107-2022; Emdin, Connor/B-6746-2015	Rahimi, Kazem/0000-0002-4807-4610; Anderson, Simon G/0000-0002-8896-073X; Conrad, Nathalie/0000-0001-5027-5481; Emdin, Connor/0000-0002-2385-8259; Callender, Thomas/0000-0001-8440-9433; Woodward, Mark/0000-0001-9800-5296	UK National Institute for Health Research Oxford Biomedical Research Centre; NIHR Oxford Biomedical Research Centre; NIHR career development fellowship; Rhodes Trust; Australian Health and Medical Research Council; Oxford Martin School; National Institute of Health Research; National Institute for Health Research [CDF-2013-06-012, CL-2012-06-001] Funding Source: researchfish	UK National Institute for Health Research Oxford Biomedical Research Centre; NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR career development fellowship; Rhodes Trust; Australian Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Oxford Martin School; National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the UK National Institute for Health Research Oxford Biomedical Research Centre. Researchers were independent of the funder; no funders or sponsors were involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. KR is supported by the NIHR Oxford Biomedical Research Centre and NIHR career development fellowship. CAE is supported by the Rhodes Trust. MW is supported by a principal research fellowship from the Australian Health and Medical Research Council and is a consultant for Amgen and Novartis. The work of the George Institute is supported by the Oxford Martin School. SGA is an academic clinical lecturer in cardiology and is funded by the National Institute of Health Research.	Adler AI, 2002, DIABETES CARE, V25, P894, DOI 10.2337/diacare.25.5.894; Anand S, 2007, NEW ENGL J MED, V357, P217; Baker JF, 2007, ANGIOLOGY, V58, P450, DOI 10.1177/0003319707303444; Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Cockcroft JR, 2005, AM J HYPERTENS, V18, P1463, DOI 10.1016/j.amjhyper.2005.05.009; Diehm C, 2006, EUR HEART J, V27, P1743, DOI 10.1093/eurheartj/ehl092; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Golomb BA, 2006, CIRCULATION, V114, P688, DOI 10.1161/CIRCULATIONAHA.105.593442; Gregg EW, 2004, DIABETES CARE, V27, P1591, DOI 10.2337/diacare.27.7.1591; Gu QP, 2012, CIRCULATION, V126, P2105, DOI 10.1161/CIRCULATIONAHA.112.096156; Heald CL, 2006, ATHEROSCLEROSIS, V189, P61, DOI 10.1016/j.atherosclerosis.2006.03.011; Herrett E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2350; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Leng GC, 1996, BMJ-BRIT MED J, V313, P1440, DOI 10.1136/bmj.313.7070.1440; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Rahimi K, 2015, CIRC RES, V116, P925, DOI 10.1161/CIRCRESAHA.116.304723; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Dinesh Shah Anoop, 2015, Lancet, V385 Suppl 1, pS86, DOI [10.1016/S2213-8587(14)70219-0, 10.1016/S0140-6736(15)60401-9]; Springate DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099825; Walley T, 2005, BRIT J CLIN PHARMACO, V60, P543, DOI 10.1111/j.1365-2125.2005.02478.x; Wormser D, 2013, INT J EPIDEMIOL, V42, P849, DOI 10.1093/ije/dyt077	25	71	79	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 29	2015	351								h4865	10.1136/bmj.h4865	http://dx.doi.org/10.1136/bmj.h4865			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS9YU	26419648	hybrid, Green Published			2022-12-28	WOS:000362450900006
J	Guha-Sapir, D; Rodriguez-Llanes, JM; Hicks, MH; Donneau, AF; Coutts, A; Lillywhite, L; Fouad, FM				Guha-Sapir, Debarati; Rodriguez-Llanes, Jose M.; Hicks, Madelyn H.; Donneau, Anne-Francoise; Coutts, Adam; Lillywhite, Louis; Fouad, Fouad M.			Civilian deaths from weapons used in the Syrian conflict	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WAR; CHILDREN; IRAQ		[Guha-Sapir, Debarati] Catholic Univ Louvain, Ctr Res Epidemiol Disasters, Inst Hlth & Soc, Disaster Epidemiol, B-1200 Brussels, Belgium; [Rodriguez-Llanes, Jose M.; Donneau, Anne-Francoise] Catholic Univ Louvain, Ctr Res Epidemiol Disasters, Inst Hlth & Soc, B-1200 Brussels, Belgium; [Hicks, Madelyn H.] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA; [Donneau, Anne-Francoise] Univ Liege, Dept Publ Hlth, Liege, Belgium; [Coutts, Adam] Univ Cambridge, Dept Polit & Int Studies POLIS, Cambridge CB2 1TN, England; [Fouad, Fouad M.] Chatham House Ctr Global Hlth Secur, London, England; [Fouad, Fouad M.] Amer Univ Beirut, Dept Epidemiol & Populat Hlth, Fac Hlth Sci, Publ Hlth, Lebanon, NH USA	Universite Catholique Louvain; Universite Catholique Louvain; University of Massachusetts System; University of Massachusetts Worcester; University of Liege; University of Cambridge; American University of Beirut	Guha-Sapir, D (corresponding author), Catholic Univ Louvain, Ctr Res Epidemiol Disasters, Inst Hlth & Soc, Disaster Epidemiol, B-1200 Brussels, Belgium.	debarati.guha@uclouvain.be	Rodriguez-Llanes, Jose Manuel/L-4537-2019	Rodriguez-Llanes, Jose Manuel/0000-0003-3736-736X				Alkhuzai AH, 2008, NEW ENGL J MED, V358, P484, DOI 10.1056/NEJMsa0707782; Altare C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109022; Baker E, 2015, PHYS HUMAN RIGHTS DO; Carpenter RC, 2006, SECUR DIALOGUE, V37, P83, DOI 10.1177/0967010606064139; Coutts Adam, 2015, Lancet Respir Med, V3, pe8, DOI 10.1016/S2213-2600(15)00041-7; Dardagan H., 2013, STOLEN FUTURES HIDDE; Guha-Sapir D, 2005, EPIDEMIOL REV, V27, P67, DOI 10.1093/epirev/mxi010; Hicks MHR, 2011, LANCET, V378, P906, DOI 10.1016/S0140-6736(11)61023-4; Hicks MHR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000415; Hicks MHR, 2009, NEW ENGL J MED, V360, P1585, DOI 10.1056/NEJMp0807240; Hicks MHR, 2008, PLOS MED, V5, P1658, DOI 10.1371/journal.pmed.0050243; International Committee of the Red Cross, EXPL WEAP POP AR; KUZMAN M, 1993, JAMA-J AM MED ASSOC, V270, P626, DOI 10.1001/jama.270.5.626; Landmine Action, 2009, EXPL VIOL PROBL EXPL; Mujkic A, 2008, ARCH PEDIAT ADOL MED, V162, P140, DOI 10.1001/archpediatrics.2007.31; Oxfam, 2015, FAIL SYR ASS IMP UN; Price M, 2014, UPDATED STAT ANAL DO; Slim H., 2007, KILLING CIVILIANS ME; UN Office of the High Commissioner for Human Rights, 1989, CONV RIGHTS CHILD; United Nations Office of the High Commissioner for Human Rights, 2015, AHRC2869 UN OFF HIGH; Working Group for Mortality Estimation in Emergencies, 2008, EMERG THEMES EPIDEMI, V4, P9; World Health Organization, 2015, REG SIT REP; World Health Organization, 2014, 4 WHO; World Health Organization, 2015, SYR AR REP WHO STAT	24	39	39	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 29	2015	351								h4736	10.1136/bmj.h4736	http://dx.doi.org/10.1136/bmj.h4736			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS9YU	26419494	Green Published			2022-12-28	WOS:000362450900003
J	Pearse, RM; Wijeysundera, DN				Pearse, Rupert M.; Wijeysundera, Duminda N.			Steroids for cardiac surgery: has the story finally ended?	LANCET			English	Editorial Material							CARDIOPULMONARY BYPASS		[Pearse, Rupert M.] Royal London Hosp, Adult Crit Care Unit, London E1 1BB, England; [Pearse, Rupert M.] Queen Mary Univ London, Intens Care Med, London, England; [Wijeysundera, Duminda N.] Toronto Gen Hosp, Toronto, ON, Canada; [Wijeysundera, Duminda N.] Univ Toronto, Toronto, ON, Canada; [Wijeysundera, Duminda N.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Pearse, RM (corresponding author), Royal London Hosp, Adult Crit Care Unit, London E1 1BB, England.	r.pearse@qmul.ac.uk	Pearse, Rupert/H-5426-2011; Wijeysundera, Duminda/L-3350-2018	Pearse, Rupert/0000-0002-4373-5934; Wijeysundera, Duminda/0000-0002-5897-8605	Department of Health [RP_2014-04-022] Funding Source: Medline; National Institute for Health Research [RP_2014-04-022] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Chaney MA, 2002, CHEST, V121, P921, DOI 10.1378/chest.121.3.921; Dieleman JM, 2012, JAMA-J AM MED ASSOC, V308, P1761, DOI 10.1001/jama.2012.14144; Paparella D, 2002, EUR J CARDIO-THORAC, V21, P232, DOI 10.1016/S1010-7940(01)01099-5; Pearse RM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5759; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Weiser TG, 2015, LANCET, V385, P11, DOI 10.1016/S0140-6736(15)60806-6; Whitlock RP, 2015, LANCET, V386, P1243, DOI 10.1016/S0140-6736(15)00273-1	7	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 26	2015	386	10000					1215	1216		10.1016/S0140-6736(15)00303-7	http://dx.doi.org/10.1016/S0140-6736(15)00303-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9TQ	26460640				2022-12-28	WOS:000361700100005
J	Johansson, M; Jorgensen, KJ; Brodersen, J				Johansson, Minna; Jorgensen, Karsten Juhl; Brodersen, John			Harms of screening for abdominal aortic aneurysm: is there more to life than a 0.46% disease-specific mortality reduction?	LANCET			English	Editorial Material							METAANALYSIS; EXPERIENCES; OUTCOMES; REPAIR		[Johansson, Minna] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Dept Publ Hlth & Community Med, Gothenburg, Sweden; [Johansson, Minna] FoUU Ctr Fyrbodal, Res Unit, S-46235 Vanersborg, Sweden; [Johansson, Minna] FoUU Ctr Fyrbodal, Sect Gen Practice, S-46235 Vanersborg, Sweden; [Jorgensen, Karsten Juhl] Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark; [Brodersen, John] Univ Copenhagen, Res Unit Gen Practice, Copenhagen, Denmark; [Brodersen, John] Univ Copenhagen, Dept Publ Hlth, Sect Gen Practice, Copenhagen, Denmark	University of Gothenburg; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Johansson, M (corresponding author), FoUU Ctr Fyrbodal, Res Unit, S-46235 Vanersborg, Sweden.	minna.johansson@vgregion.se		Jorgensen, Karsten/0000-0001-8554-0388; Brodersen, John Brandt/0000-0001-9369-3376				Brodersen J, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-3; Brownsword R, 2010, J MED ETHICS, V36, P827, DOI 10.1136/jme.2010.035519; Chen JY, 2013, CRIT PUBLIC HEALTH, V19, P1; Cosford PA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002945.pub2; Darwood R, 2012, J VASC SURG, V56, P8, DOI 10.1016/j.jvs.2011.12.069; DeFrank JT, 2015, J GEN INTERN MED, V30, P242, DOI 10.1007/s11606-014-2996-5; Guirguis-Blake JM, 2014, ANN INTERN MED, V160, P321, DOI 10.7326/M13-1844; Hansson A, 2012, HEALTH RISK SOC, V14, P341, DOI 10.1080/13698575.2012.680953; Harris RP, 2014, JAMA INTERN MED, V174, P281, DOI 10.1001/jamainternmed.2013.12745; Heleno B, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5334; Huber TS, 2001, J VASC SURG, V33, P304, DOI 10.1067/mva.2001.112703; Johansson M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h825; McCaffery KJ, 2004, J EPIDEMIOL COMMUN H, V58, P968, DOI 10.1136/jech.2004.025114; Pettersson M, 2013, J CARDIOVASC NURS, V28, P387, DOI 10.1097/JCN.0b013e31824bd965; Pettersson M, 2009, J VASC SURG, V50, P492, DOI 10.1016/j.jvs.2009.02.245; Schermerhorn ML, 2015, NEW ENGL J MED, V373, P328, DOI 10.1056/NEJMoa1405778; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Stather PW, 2013, BRIT J SURG, V100, P863, DOI 10.1002/bjs.9101; Sweeting MJ, 2012, BRIT J SURG, V99, P655, DOI 10.1002/bjs.8707; Wanhainen A, 2011, J VASC SURG, V53, P1164, DOI 10.1016/j.jvs.2010.10.099; Waterhouse DF, 2008, AM HEART J, V155, P938, DOI 10.1016/j.ahj.2007.12.013; Welch GH, 2011, OVER DIAGNOSED MAKIN	22	25	25	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2016	387	10015					308	310		10.1016/S0140-6736(15)00472-9	http://dx.doi.org/10.1016/S0140-6736(15)00472-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA9LQ	26474807				2022-12-28	WOS:000368130700037
J	Juthani-Mehta, M; Malani, PN; Mitchell, SL				Juthani-Mehta, Manisha; Malani, Preeti N.; Mitchell, Susan L.			Antimicrobials at the End of Life An Opportunity to Improve Palliative Care and Infection Management	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NURSING-HOME RESIDENTS; ADVANCED DEMENTIA; HOSPICE CARE		[Juthani-Mehta, Manisha] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06520 USA; [Malani, Preeti N.] Univ Michigan Hlth Syst, Div Infect Dis, Dept Internal Med, Ann Arbor, MI USA; [Mitchell, Susan L.] Beth Israel Deaconess Med Ctr, Dept Med, Hebrew SeniorLife Inst Aging Res, Boston, MA 02215 USA; [Mitchell, Susan L.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Yale University; University of Michigan System; University of Michigan; Harvard University; Beth Israel Deaconess Medical Center; Hebrew SeniorLife; Harvard University; Harvard Medical School	Juthani-Mehta, M (corresponding author), Yale Univ, Sch Med, Dept Internal Med, POB 208022, New Haven, CT 06520 USA.	manisha.juthani@yale.edu			NIA NIH HHS [K24 AG033640, K24AG033640] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K24AG033640] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Albrecht JS, 2013, J PAIN SYMPTOM MANAG, V46, P483, DOI 10.1016/j.jpainsymman.2012.09.010; D'Agata E, 2008, ARCH INTERN MED, V168, P357, DOI 10.1001/archinternmed.2007.104; Furuno JP, 2014, ANTIMICROB AGENTS CH, V58, P5473, DOI 10.1128/AAC.02873-14; Givens JL, 2010, ARCH INTERN MED, V170, P1102, DOI 10.1001/archinternmed.2010.181; Levin PD, 2010, CHEST, V138, P588, DOI 10.1378/chest.09-2757; Mitchell SL, 2014, JAMA INTERN MED, V174, P1660, DOI 10.1001/jamainternmed.2014.3918; Morrison RS, 1998, J PAIN SYMPTOM MANAG, V15, P91, DOI 10.1016/S0885-3924(97)00261-3; Rosenberg JH, 2013, J PALLIAT MED, V16, P1568, DOI 10.1089/jpm.2013.0276; Thompson AJ, 2012, AM J HOSP PALLIAT ME, V29, P599, DOI 10.1177/1049909111432625	9	49	50	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2015	314	19					2017	2018		10.1001/jama.2015.13080	http://dx.doi.org/10.1001/jama.2015.13080			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW1PR	26426830	Green Accepted			2022-12-28	WOS:000364764200010
J	Stern, SA; Bagenal, F; Ennico, K; Gladstone, GR; Grundy, WM; McKinnon, WB; Moore, JM; Olkin, CB; Spencer, JR; Weaver, HA; Young, LA; Andert, T; Andrews, J; Banks, M; Bauer, B; Bauman, J; Barnouin, OS; Bedini, P; Beisser, K; Beyer, RA; Bhaskaran, S; Binzel, RP; Birath, E; Bird, M; Bogan, DJ; Bowman, A; Bray, VJ; Brozovic, M; Bryan, C; Buckley, MR; Buie, MW; Buratti, BJ; Bushman, SS; Calloway, A; Carcich, B; Cheng, AF; Conard, S; Conrad, CA; Cook, JC; Cruikshank, DP; Custodio, OS; Ore, CMD; Deboy, C; Dischner, ZJB; Dumont, P; Earle, AM; Elliott, HA; Ercol, J; Ernst, CM; Finley, T; Flanigan, SH; Fountain, G; Freeze, MJ; Greathouse, T; Green, JL; Guo, Y; Hahn, M; Hamilton, DP; Hamilton, SA; Hanley, J; Harch, A; Hart, HM; Hersman, CB; Hill, A; Hill, ME; Hinson, DP; Holdridge, ME; Horanyi, M; Howard, AD; Howett, CJA; Jackman, C; Jacobson, RA; Jennings, DE; Kammer, JA; Kang, HK; Kaufmann, DE; Kollmann, P; Krimigis, SM; Kusnierkiewicz, D; Lauer, TR; Lee, JE; Lindstrom, KL; Linscott, IR; Lisse, CM; Lunsford, AW; Mallder, VA; Martin, N; McComas, DJ; McNutt, RL; Mehoke, D; Mehoke, T; Melin, ED; Mutchler, M; Nelson, D; Nimmo, F; Nunez, JI; Ocampo, A; Owen, WM; Paetzold, M; Page, B; Parker, AH; Parker, JW; Pelletier, F; Peterson, J; Pinkine, N; Piquette, M; Porter, SB; Protopapa, S; Redfern, J; Reitsema, HJ; Reuter, DC; Roberts, JH; Robbins, SJ; Rogers, G; Rose, D; Runyon, K; Retherford, KD; Ryschkewitsch, MG; Schenk, P; Schindhelm, E; Sepan, B; Showalter, MK; Singer, KN; Soluri, M; Stanbridge, D; Steffl, AJ; Strobel, DF; Stryk, T; Summers, ME; Szalay, JR; Tapley, M; Taylor, A; Taylor, H; Throop, HB; Tsang, CCC; Tyler, GL; Umurhan, OM; Verbiscer, AJ; Versteeg, MH; Vincent, M; Webbert, R; Weidner, S; Weigle, GE; White, OL; Whittenburg, K; Williams, BG; Williams, K; Williams, S; Woods, WW; Zangari, AM; Zirnstein, E				Stern, S. A.; Bagenal, F.; Ennico, K.; Gladstone, G. R.; Grundy, W. M.; McKinnon, W. B.; Moore, J. M.; Olkin, C. B.; Spencer, J. R.; Weaver, H. A.; Young, L. A.; Andert, T.; Andrews, J.; Banks, M.; Bauer, B.; Bauman, J.; Barnouin, O. S.; Bedini, P.; Beisser, K.; Beyer, R. A.; Bhaskaran, S.; Binzel, R. P.; Birath, E.; Bird, M.; Bogan, D. J.; Bowman, A.; Bray, V. J.; Brozovic, M.; Bryan, C.; Buckley, M. R.; Buie, M. W.; Buratti, B. J.; Bushman, S. S.; Calloway, A.; Carcich, B.; Cheng, A. F.; Conard, S.; Conrad, C. A.; Cook, J. C.; Cruikshank, D. P.; Custodio, O. S.; Ore, C. M. Dalle; Deboy, C.; Dischner, Z. J. B.; Dumont, P.; Earle, A. M.; Elliott, H. A.; Ercol, J.; Ernst, C. M.; Finley, T.; Flanigan, S. H.; Fountain, G.; Freeze, M. J.; Greathouse, T.; Green, J. L.; Guo, Y.; Hahn, M.; Hamilton, D. P.; Hamilton, S. A.; Hanley, J.; Harch, A.; Hart, H. M.; Hersman, C. B.; Hill, A.; Hill, M. E.; Hinson, D. P.; Holdridge, M. E.; Horanyi, M.; Howard, A. D.; Howett, C. J. A.; Jackman, C.; Jacobson, R. A.; Jennings, D. E.; Kammer, J. A.; Kang, H. K.; Kaufmann, D. E.; Kollmann, P.; Krimigis, S. M.; Kusnierkiewicz, D.; Lauer, T. R.; Lee, J. E.; Lindstrom, K. L.; Linscott, I. R.; Lisse, C. M.; Lunsford, A. W.; Mallder, V. A.; Martin, N.; McComas, D. J.; McNutt, R. L., Jr.; Mehoke, D.; Mehoke, T.; Melin, E. D.; Mutchler, M.; Nelson, D.; Nimmo, F.; Nunez, J. I.; Ocampo, A.; Owen, W. M.; Paetzold, M.; Page, B.; Parker, A. H.; Parker, J. W.; Pelletier, F.; Peterson, J.; Pinkine, N.; Piquette, M.; Porter, S. B.; Protopapa, S.; Redfern, J.; Reitsema, H. J.; Reuter, D. C.; Roberts, J. H.; Robbins, S. J.; Rogers, G.; Rose, D.; Runyon, K.; Retherford, K. D.; Ryschkewitsch, M. G.; Schenk, P.; Schindhelm, E.; Sepan, B.; Showalter, M. K.; Singer, K. N.; Soluri, M.; Stanbridge, D.; Steffl, A. J.; Strobel, D. F.; Stryk, T.; Summers, M. E.; Szalay, J. R.; Tapley, M.; Taylor, A.; Taylor, H.; Throop, H. B.; Tsang, C. C. C.; Tyler, G. L.; Umurhan, O. M.; Verbiscer, A. J.; Versteeg, M. H.; Vincent, M.; Webber, R.; Weidner, S.; Weigle, G. E., II; White, O. L.; Whittenburg, K.; Williams, B. G.; Williams, K.; Williams, S.; Woods, W. W.; Zangari, A. M.; Zirnstein, E.			The Pluto system: Initial results from its exploration by New Horizons	SCIENCE			English	Article							ATMOSPHERE; METHANE; ICES; SATELLITES; NITROGEN	The Pluto system was recently explored by NASA's New Horizons spacecraft, making closest approach on 14 July 2015. Pluto's surface displays diverse landforms, terrain ages, albedos, colors, and composition gradients. Evidence is found for a water-ice crust, geologically young surface units, surface ice convection, wind streaks, volatile transport, and glacial flow. Pluto's atmosphere is highly extended, with trace hydrocarbons, a global haze layer, and a surface pressure near 10 microbars. Pluto's diverse surface geology and long-term activity raise fundamental questions about how small planets remain active many billions of years after formation. Pluto's large moon Charon displays tectonics and evidence for a heterogeneous crustal composition; its north pole displays puzzling dark terrain. Small satellites Hydra and Nix have higher albedos than expected.	[Stern, S. A.; Olkin, C. B.; Spencer, J. R.; Young, L. A.; Andrews, J.; Birath, E.; Buie, M. W.; Conrad, C. A.; Cook, J. C.; Dischner, Z. J. B.; Finley, T.; Howett, C. J. A.; Kammer, J. A.; Kaufmann, D. E.; Parker, A. H.; Parker, J. W.; Peterson, J.; Porter, S. B.; Redfern, J.; Robbins, S. J.; Rose, D.; Schindhelm, E.; Singer, K. N.; Steffl, A. J.; Tsang, C. C. C.; Vincent, M.; Zangari, A. M.] SW Res Inst, Boulder, CO 80302 USA; [Bagenal, F.; Horanyi, M.; Piquette, M.; Szalay, J. R.] Univ Colorado, Lab Atmospher & Space Phys, Boulder, CO 80303 USA; [Ennico, K.; Moore, J. M.; Beyer, R. A.; Cruikshank, D. P.; Ore, C. M. Dalle; Umurhan, O. M.; White, O. L.] NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; [Gladstone, G. R.; Elliott, H. A.; Greathouse, T.; Hanley, J.; McComas, D. J.; Retherford, K. D.; Tapley, M.; Versteeg, M. H.; Weidner, S.; Weigle, G. E., II; Zirnstein, E.] SW Res Inst, San Antonio, TX USA; [Grundy, W. M.] Lowell Observ, Flagstaff, AZ 86001 USA; [McKinnon, W. B.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Weaver, H. A.; Bauer, B.; Barnouin, O. S.; Bedini, P.; Beisser, K.; Bowman, A.; Buckley, M. R.; Bushman, S. S.; Calloway, A.; Cheng, A. F.; Conard, S.; Custodio, O. S.; Deboy, C.; Ercol, J.; Ernst, C. M.; Flanigan, S. H.; Fountain, G.; Freeze, M. J.; Guo, Y.; Hamilton, S. A.; Hart, H. M.; Hersman, C. B.; Hill, A.; Hill, M. E.; Holdridge, M. E.; Kang, H. K.; Kollmann, P.; Krimigis, S. M.; Kusnierkiewicz, D.; Lindstrom, K. L.; Lisse, C. M.; Mallder, V. A.; McNutt, R. L., Jr.; Mehoke, D.; Mehoke, T.; Melin, E. D.; Nunez, J. I.; Pinkine, N.; Roberts, J. H.; Rogers, G.; Runyon, K.; Ryschkewitsch, M. G.; Sepan, B.; Taylor, H.; Webber, R.; Whittenburg, K.; Williams, S.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Andert, T.] Univ Bundeswehr Munchen, D-85577 Neubiberg, Germany; [Banks, M.; Throop, H. B.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Bauman, J.; Bryan, C.; Dumont, P.; Jackman, C.; Nelson, D.; Page, B.; Pelletier, F.; Stanbridge, D.; Taylor, A.; Williams, B. G.; Williams, K.] KinetX Aerosp, Tempe, AZ 85284 USA; [Bhaskaran, S.; Brozovic, M.; Buratti, B. J.; Jacobson, R. A.; Owen, W. M.] NASA, Jet Prop Lab, La Canada Flintridge, CA 91011 USA; [Binzel, R. P.; Earle, A. M.] MIT, Cambridge, MA 02139 USA; [Bird, M.] Univ Bonn, D-53113 Bonn, Germany; [Bogan, D. J.; Green, J. L.; Ocampo, A.] NASA Headquarters, Washington, DC 20546 USA; [Bray, V. J.] Univ Arizona, Tucson, AZ 85721 USA; [Carcich, B.] Cornell Univ, Ithaca, NY 14853 USA; [Hahn, M.; Paetzold, M.] Univ Cologne, Rhein Inst Umweltforsch, D-50931 Cologne, Germany; [Hamilton, D. P.; Protopapa, S.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Harch, A.; Martin, N.; Reitsema, H. J.] SW Res Inst, Boulder, CO 80302 USA; [Hinson, D. P.; Showalter, M. K.] Search Extraterr Intelligence Inst, Mountain View, CA 94043 USA; [Howard, A. D.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; [Jennings, D. E.; Lunsford, A. W.; Reuter, D. C.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Lauer, T. R.] Natl Opt Astron Observ, Tucson, AZ USA; [Lee, J. E.] NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA; [Linscott, I. R.; Tyler, G. L.; Woods, W. W.] Stanford Univ, Stanford, CA 94305 USA; [Mutchler, M.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Nimmo, F.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Schenk, P.] Lunar & Planetary Inst, Houston, TX 77058 USA; [Soluri, M.] Michael Soluri Photog, New York, NY 10014 USA; [Strobel, D. F.] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Stryk, T.] Roane State Community Coll, Jamestown, TN 38556 USA; [Summers, M. E.] George Mason Univ, Fairfax, VA 22030 USA; [Verbiscer, A. J.] Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA	University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Southwest Research Institute; Washington University (WUSTL); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Bundeswehr University Munich; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Massachusetts Institute of Technology (MIT); University of Bonn; National Aeronautics & Space Administration (NASA); University of Arizona; Cornell University; University of Cologne; University System of Maryland; University of Maryland College Park; University of Virginia; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Optical Astronomy Observatory; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; Stanford University; Space Telescope Science Institute; University of California System; University of California Santa Cruz; Johns Hopkins University; George Mason University; University of Virginia	Stern, SA (corresponding author), SW Res Inst, Boulder, CO 80302 USA.	astern@boulder.swri.edu	McNutt, Ralph L/E-8006-2010; Ernst, Carolyn M/I-4902-2012; Núñez, Jorge I./J-4027-2015; Bray, Veronica/K-6914-2017; Olkin, Catherine/AAF-5160-2019; Roberts, James H/I-9030-2012; Zirnstein, Eric/AAA-2836-2020; Bushman, Stewart/ABA-7622-2020; Krimigis, Stamatios/G-4591-2019; Strobel, Darrell5/AAO-6643-2021; Hill, Matthew/H-4312-2016; Kollmann, Peter/C-2583-2016; Weaver, Harold A/D-9188-2016; Lisse, Carey M/B-7772-2016; Barnouin, Olivier S/I-7475-2015; Roberts, James/AAI-3283-2020; Runyon, Kirby D/J-2878-2017	McNutt, Ralph L/0000-0002-4722-9166; Ernst, Carolyn M/0000-0002-9434-7886; Núñez, Jorge I./0000-0003-0930-6674; Olkin, Catherine/0000-0002-5846-716X; Roberts, James H/0000-0003-1766-6127; Zirnstein, Eric/0000-0001-7240-0618; Krimigis, Stamatios/0000-0003-2781-2386; Strobel, Darrell5/0000-0002-0944-8675; Hill, Matthew/0000-0002-5674-4936; Kollmann, Peter/0000-0002-4274-9760; Weaver, Harold A/0000-0003-0951-7762; Lisse, Carey M/0000-0002-9548-1526; Barnouin, Olivier S/0000-0002-3578-7750; Roberts, James/0000-0002-2671-3207; Runyon, Kirby D/0000-0001-6361-6548; Guo, Yanping/0000-0001-6813-4468; Mutchler, Maximilian/0000-0002-0088-3021; DeBoy, Christopher/0000-0003-1290-2282; Protopapa, Silvia/0000-0001-8541-8550; Grundy, Will/0000-0002-8296-6540; Lauer, Tod/0000-0003-3234-7247; Beyer, Ross/0000-0003-4503-3335; Parker, Joel/0000-0002-3672-0603; Hinson, David/0000-0002-1620-4011; Rogers, Gabe/0000-0003-4969-8836; Bray, Veronica/0000-0002-7277-3980; Reitsema, Harold/0000-0002-4119-5700; Retherford, Kurt/0000-0001-9470-150X; Porter, Simon/0000-0003-0333-6055	NASA's New Horizons project	NASA's New Horizons project	We thank M. Sykes and three anonymous referees for their careful work to improve this paper, and R. Tedford and C. Chavez for logistical support. We also thank the many engineers who have contributed to the success of the New Horizons mission and NASA's Deep Space Network (DSN) for a decade of excellent support to New Horizons. We acknowledge the contributions to New Horizons of our late colleagues David C. Slater and Thomas C. Coughlin. Supporting imagery is available in the supplementary material. As contractually agreed to with NASA, fully calibrated New Horizons Pluto system data will be released via the NASA Planetary Data System at https://pds.nasa.gov/in a series of stages in 2016 and 2017 as the data set is fully downlinked and calibrated. This work was supported by NASA's New Horizons project.	Bierhaus EB, 2015, ICARUS, V246, P165, DOI 10.1016/j.icarus.2014.05.044; Brozovic M, 2015, ICARUS, V246, P317, DOI 10.1016/j.icarus.2014.03.015; BURATTI BJ, 1995, ICARUS, V115, P219, DOI 10.1006/icar.1995.1093; Cruikshank DP, 2005, ADV SPACE RES-SERIES, V36, P178, DOI 10.1016/j.asr.2005.07.026; Davies JK, 2008, SOLAR SYSTEM NEPTUNE, P11; Elliot JL, 2007, ASTRON J, V134, P1, DOI 10.1086/517998; ELUSZKIEWICZ J, 1990, GEOPHYS RES LETT, V17, P1753, DOI 10.1029/GL017i010p01753; Gladstone G. R., 2015, LUNAR PLANET SCI, VXLVI; Greenstreet S, 2015, ICARUS, V258, P267, DOI 10.1016/j.icarus.2015.05.026; Grundy WM, 2014, ICARUS, V235, P220, DOI 10.1016/j.icarus.2014.02.025; Grundy WM, 2013, ICARUS, V223, P710, DOI 10.1016/j.icarus.2013.01.019; Lellouch E, 2015, ICARUS, V246, P268, DOI 10.1016/j.icarus.2014.03.027; Lellouch E, 2009, ASTRON ASTROPHYS, V495, pL17, DOI 10.1051/0004-6361/200911633; McKinnon W. B., 2008, SOLAR SYSTEM NEPTUNE, P213; MCKINNON WB, 1989, ASTROPHYS J, V344, pL41, DOI 10.1086/185526; Moore JM, 2015, ICARUS, V246, P65, DOI 10.1016/j.icarus.2014.04.028; Nesvorny D, 2010, ASTRON J, V140, P785, DOI 10.1088/0004-6256/140/3/785; Olkin CB, 2015, ICARUS, V246, P220, DOI 10.1016/j.icarus.2014.03.026; OWEN TC, 1993, SCIENCE, V261, P745, DOI 10.1126/science.261.5122.745; Peale SJ, 2003, CELEST MECH DYN ASTR, V87, P129, DOI 10.1023/A:1026187917994; Person MJ, 2008, ASTRON J, V136, P1510, DOI 10.1088/0004-6256/136/4/1510; Person MJ, 2006, ASTRON J, V132, P1575, DOI 10.1086/507330; Person MJ, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/4/83; Schlichting HE, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/2/36; Showalter MR, 2015, NATURE, V522, P45, DOI 10.1038/nature14469; Sicardy B, 2003, NATURE, V424, P168, DOI 10.1038/nature01766; Singer KN, 2015, ASTROPHYS J LETT, V808, DOI 10.1088/2041-8205/808/2/L50; Steffl AJ, 2006, ASTRON J, V132, P614, DOI 10.1086/505424; Stern SA, 2008, SPACE SCI REV, V140, P3, DOI 10.1007/s11214-007-9295-y; STERN SA, 1992, ANNU REV ASTRON ASTR, V30, P185, DOI 10.1146/annurev.aa.30.090192.001153; Tackley P. J., 2000, GEOCHEM GEOPHY GEOSY, V1, P1, DOI [10.1029/2000GC000036, DOI 10.1029/2000GC000036, 10.1029/200GC000036, 10.1029/2000GC000043]; Tyler GL, 2008, SPACE SCI REV, V140, P217, DOI 10.1007/s11214-007-9302-3; Weaver HA, 2008, SPACE SCI REV, V140, P75, DOI 10.1007/s11214-008-9376-6; Yamashita Y, 2010, ICARUS, V207, P972, DOI 10.1016/j.icarus.2009.11.032; Zalucha AM, 2011, ICARUS, V214, P685, DOI 10.1016/j.icarus.2011.05.015	35	287	290	4	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2015	350	6258							aad1815	10.1126/science.aad1815	http://dx.doi.org/10.1126/science.aad1815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT5HD	26472913	Green Submitted			2022-12-28	WOS:000362838700032
J	Hao, S; Tang, B; Wu, ZY; Ure, K; Sun, YL; Tao, HF; Gao, Y; Patel, AJ; Curry, DJ; Samaco, RC; Zoghbi, HY; Tang, JR				Hao, Shuang; Tang, Bin; Wu, Zhenyu; Ure, Kerstin; Sun, Yaling; Tao, Huifang; Gao, Yan; Patel, Akash J.; Curry, Daniel J.; Samaco, Rodney C.; Zoghbi, Huda Y.; Tang, Jianrong			Forniceal deep brain stimulation rescues hippocampal memory in Rett syndrome mice	NATURE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; BEHAVIORAL DEFICITS; MOUSE MODEL; NEUROGENESIS; ADULT; ENHANCEMENT; LTP; EXTINCTION; PATIENT	Deep brain stimulation (DBS) has improved the prospects for many individuals with diseases affecting motor control, and recently it has shown promise for improving cognitive function as well. Several studies in individuals with Alzheimer disease and in amnesic rats have demonstrated that DBS targeted to the fimbria-fornix(1-3), the region that appears to regulate hippocampal activity, can mitigate defects in hippocampus-dependent memory(3-5). Despite these promising results, DBS has not been tested for its ability to improve cognition in any childhood intellectual disability disorder. Such disorders are a pressing concern: they affect as much as 3% of the population and involve hundreds of different genes. We proposed that stimulating the neural circuits that underlie learning and memory might provide a more promising route to treating these otherwise intractable disorders than seeking to adjust levels of one molecule at a time. We therefore studied the effects of forniceal DBS in a well-characterized mouse model of Rett syndrome (RTT), which is a leading cause of intellectual disability in females. Caused by mutations that impair the function of MeCP2 (ref. 6), RTT appears by the second year of life in humans, causing profound impairment in cognitive, motor and social skills, along with an array of neurological features(7). RTT mice, which reproduce the broad phenotype of this disorder, also show clear deficits in hippocampus-dependent learning and memory and hippocampal synaptic plasticity(8-11). Here we show that forniceal DBS in RTT mice rescues contextual fear memory as well as spatial learning and memory. In parallel, forniceal DBS restores in vivo hippocampal long-term potentiation and hippocampal neurogenesis. These results indicate that forniceal DBS might mitigate cognitive dysfunction in RTT.	[Hao, Shuang; Tang, Bin; Wu, Zhenyu; Ure, Kerstin; Sun, Yaling; Tao, Huifang; Gao, Yan; Patel, Akash J.; Samaco, Rodney C.; Zoghbi, Huda Y.; Tang, Jianrong] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Hao, Shuang; Tang, Bin; Wu, Zhenyu; Zoghbi, Huda Y.; Tang, Jianrong] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Sun, Yaling; Tao, Huifang; Gao, Yan; Samaco, Rodney C.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Patel, Akash J.; Curry, Daniel J.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Zoghbi, HY (corresponding author), Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA.	hzoghbi@bcm.edu; jtang1@bcm.edu	Cabrera, Mariel/GMX-2706-2022	Samaco, Rodney/0000-0001-5636-5314; Zoghbi, Huda/0000-0002-0700-3349	W. M. Keck Foundation; Cockrell Family Foundation; Rett Syndrome Research Trust; Carl. C. Anderson, Sr. and Marie Jo Anderson Charitable Foundation [R01NS057819]; Howard Hughes Medical Institute [DP5OD009134, R25 N070694]; IDDRC at Baylor College of Medicine from Eunice Kennedy Shriver National Institute of Child Health & Human Development [U54HD083092]; National Center for Research Resources [C06RR029965]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR029965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057819] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009134] Funding Source: NIH RePORTER	W. M. Keck Foundation(W.M. Keck Foundation); Cockrell Family Foundation; Rett Syndrome Research Trust; Carl. C. Anderson, Sr. and Marie Jo Anderson Charitable Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); IDDRC at Baylor College of Medicine from Eunice Kennedy Shriver National Institute of Child Health & Human Development; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Xue, M. C. Weston and V. Brandt for comments on the manuscript, members of the Zoghbi laboratory for helpful discussions, and C. M. Spencer, C. T. Wotjak, F. Wei and D. Yu for technical suggestions. This work was supported by the W. M. Keck Foundation (H.Y.Z. and J.T.), the Cockrell Family Foundation, the Rett Syndrome Research Trust, Carl. C. Anderson, Sr. and Marie Jo Anderson Charitable Foundation, R01NS057819 (H.Y.Z.), and the Howard Hughes Medical Institute (H.Y.Z.), DP5OD009134 (R.C.S), R25 N070694 (A.J.P.) and in part by the Neuroconnectivity Core, Mouse Neurobehavioral Core, and Neurovisualization Core of IDDRC at Baylor College of Medicine (U54HD083092 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development), and the C06RR029965 grant from the National Center for Research Resources.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bouwknecht J. Adriaan, 2002, Behavioural Brain Research, V136, P489, DOI 10.1016/S0166-4328(02)00200-0; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Cif L, 2007, MOVEMENT DISORD, V22, P2126, DOI 10.1002/mds.21723; Corcoran KA, 2001, J NEUROSCI, V21, P1720, DOI 10.1523/JNEUROSCI.21-05-01720.2001; Davis S, 1997, J NEUROSCI METH, V75, P75, DOI 10.1016/S0165-0270(97)00053-8; Deon LL, 2012, J CHILD NEUROL, V27, P117, DOI 10.1177/0883073811415853; Encinas JM, 2011, J COMP NEUROL, V519, P6, DOI 10.1002/cne.22503; Franzini A, 2013, WORLD NEUROSURG, V80, DOI 10.1016/j.wneu.2012.06.038; Freund HJ, 2009, ARCH NEUROL-CHICAGO, V66, P781, DOI 10.1001/archneurol.2009.102; GARYBOBO E, 1977, EXP BRAIN RES, V27, P61; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hamani C, 2008, ANN NEUROL, V63, P119, DOI 10.1002/ana.21295; Huang HS, 2013, BEHAV BRAIN RES, V243, P79, DOI 10.1016/j.bbr.2012.12.052; Jafari-Sabet M, 2006, BEHAV BRAIN RES, V169, P120, DOI 10.1016/j.bbr.2005.12.011; Jiao RS, 2009, BIOCHEM BIOPH RES CO, V379, P975, DOI 10.1016/j.bbrc.2008.12.184; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Laxton Adrian W, 2013, Handb Clin Neurol, V116, P307, DOI 10.1016/B978-0-444-53497-2.00025-5; Laxton AW, 2010, ANN NEUROL, V68, P521, DOI 10.1002/ana.22089; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; MAREN S, 1994, BRAIN RES, V661, P25, DOI 10.1016/0006-8993(94)91176-2; Maren S, 1997, NEUROBIOL LEARN MEM, V67, P142, DOI 10.1006/nlme.1996.3752; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Nokia MS, 2012, EUR J NEUROSCI, V36, P3521, DOI 10.1111/ejn.12007; Nokia MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031375; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PHILLIPS RG, 1995, J NEUROSCI, V15, P5308; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Samaco RC, 2013, HUM MOL GENET, V22, P96, DOI 10.1093/hmg/dds406; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shirvalkar PR, 2010, P NATL ACAD SCI USA, V107, P7054, DOI 10.1073/pnas.0911184107; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; Stuchlik A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00106; Suthana N, 2012, NEW ENGL J MED, V366, P502, DOI 10.1056/NEJMoa1107212; Tang JR, 2009, NEURON, V63, P673, DOI 10.1016/j.neuron.2009.07.025; Toda H, 2008, J NEUROSURG, V108, P132, DOI 10.3171/JNS/2008/108/01/0132; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; WENK GL, 1991, NEUROLOGY, V41, P1753, DOI 10.1212/WNL.41.11.1753; Whittle N, 2013, NEUROPHARMACOLOGY, V64, P414, DOI 10.1016/j.neuropharm.2012.06.001; Wichmann T, 2006, NEURON, V52, P197, DOI 10.1016/j.neuron.2006.09.022	47	112	115	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					430	+		10.1038/nature15694	http://dx.doi.org/10.1038/nature15694			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26469053	Green Accepted			2022-12-28	WOS:000362730200051
J	Poldrack, RA; Farah, MJ				Poldrack, Russell A.; Farah, Martha J.			Progress and challenges in probing the human brain	NATURE			English	Review							RESTING-STATE FMRI; BLOOD-FLOW; FUNCTIONAL CONNECTIVITY; PREDICTION ERRORS; PATTERN-ANALYSIS; SEMANTIC SPACE; MULTI-VOXEL; NEUROSCIENCE; NETWORK; CORTEX	Perhaps one of the greatest scientific challenges is to understand the human brain. Here we review current methods in human neuroscience, highlighting the ways that they have been used to study the neural bases of the human mind. We begin with a consideration of different levels of description relevant to human neuroscience, from molecules to large-scale networks, and then review the methods that probe these levels and the ability of these methods to test hypotheses about causal mechanisms. Functional MRI is considered in particular detail, as it has been responsible for much of the recent growth of human neuroscience research. We briefly review its inferential strengths and weaknesses and present examples of new analytic approaches that allow inferences beyond simple localization of psychological processes. Finally, we review the prospects for real-world applications and new scientific challenges for human neuroscience.	[Poldrack, Russell A.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Farah, Martha J.] Univ Penn, Ctr Neurosci & Soc, Philadelphia, PA 19104 USA	Stanford University; University of Pennsylvania	Poldrack, RA (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	poldrack@stanford.edu		Poldrack, Russell/0000-0001-6755-0259				Ariely D, 2010, NAT REV NEUROSCI, V11, P284, DOI 10.1038/nrn2795; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Badre D, 2012, CEREB CORTEX, V22, P527, DOI 10.1093/cercor/bhr117; Bandettini PA, 2012, NEUROIMAGE, V62, P575, DOI 10.1016/j.neuroimage.2012.04.026; Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005; Becerra L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025701; Berns GS, 2012, J CONSUM PSYCHOL, V22, P154, DOI 10.1016/j.jcps.2011.05.001; Blokland GAM, 2011, J NEUROSCI, V31, P10882, DOI 10.1523/JNEUROSCI.5334-10.2011; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Carp J, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00149; Chamberlain SR, 2006, CURR OPIN NEUROL, V19, P607, DOI 10.1097/01.wco.0000247613.28859.77; Charest I, 2014, P NATL ACAD SCI USA, V111, P14565, DOI 10.1073/pnas.1402594111; Chen AC, 2013, P NATL ACAD SCI USA, V110, P19944, DOI 10.1073/pnas.1311772110; Conrad P, 2007, MED SOC; Cowen AS, 2014, NEUROIMAGE, V94, P12, DOI 10.1016/j.neuroimage.2014.03.018; Davis T, 2014, NEUROIMAGE, V97, P271, DOI 10.1016/j.neuroimage.2014.04.037; Davis T, 2014, CEREB CORTEX, V24, P1720, DOI 10.1093/cercor/bht014; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Dubois J, 2015, J NEUROSCI, V35, P2791, DOI 10.1523/JNEUROSCI.4037-14.2015; Einevoll GT, 2013, NAT REV NEUROSCI, V14, P770, DOI 10.1038/nrn3599; Falk EB, 2012, PSYCHOL SCI, V23, P439, DOI 10.1177/0956797611434964; Farah MJ, 2014, HASTINGS CENT REP, V44, pS19, DOI 10.1002/hast.295; Farah MJ, 2014, NAT REV NEUROSCI, V15, P123, DOI 10.1038/nrn3665; Farah Martha J, 2012, AJOB Neurosci, V3, P31; Farah MJ, 2012, ANNU REV PSYCHOL, V63, P571, DOI 10.1146/annurev.psych.093008.100438; Fitz NS, 2015, J MED ETHICS, V41, P410, DOI 10.1136/medethics-2013-101458; Gabrieli JDE, 2015, NEURON, V85, P11, DOI 10.1016/j.neuron.2014.10.047; Gerits A, 2012, CURR BIOL, V22, P1722, DOI 10.1016/j.cub.2012.07.023; Glahn DC, 2010, P NATL ACAD SCI USA, V107, P1223, DOI 10.1073/pnas.0909969107; Goodkind M, 2015, JAMA PSYCHIAT, V72, P305, DOI 10.1001/jamapsychiatry.2014.2206; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hillman EMC, 2014, ANNU REV NEUROSCI, V37, P161, DOI 10.1146/annurev-neuro-071013-014111; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Horvath JC, 2015, BRAIN STIMUL, V8, P535, DOI 10.1016/j.brs.2015.01.400; Huth AG, 2012, NEURON, V76, P1210, DOI 10.1016/j.neuron.2012.10.014; Illes J, 2005, AM J BIOETHICS, V5, P5, DOI 10.1080/15265160590923358; Insel TR, 2014, AM J PSYCHIAT, V171, P395, DOI 10.1176/appi.ajp.2014.14020138; Insel TR, 2013, SCIENCE, V340, P687, DOI 10.1126/science.1239276; Ioannidis JPA, 2007, PLOS MED, V4, P1132, DOI 10.1371/journal.pmed.0040215; Irimia A, 2012, NEUROIMAGE, V60, P1340, DOI 10.1016/j.neuroimage.2012.01.107; Jones OD, 2013, NAT REV NEUROSCI, V14, P730, DOI 10.1038/nrn3585; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; LaRocque KF, 2013, J NEUROSCI, V33, P5466, DOI 10.1523/JNEUROSCI.4293-12.2013; Laumann TO, 2015, NEURON, V87, P657, DOI 10.1016/j.neuron.2015.06.037; Legon W, 2014, NAT NEUROSCI, V17, P322, DOI 10.1038/nn.3620; Lewis-Peacock JA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6768; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mack ML, 2013, CURR BIOL, V23, P2023, DOI 10.1016/j.cub.2013.08.035; Magnain C, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.1.015004; Mayberg HS, 2009, J CLIN INVEST, V119, P717, DOI 10.1172/JCI38454; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Morcom AM, 2007, NEUROIMAGE, V37, P1073, DOI 10.1016/j.neuroimage.2006.09.013; Morse S. J., 2006, OHIO STATE J CRIMINA, V3, P397; Murphy K, 2013, NEUROIMAGE, V80, P349, DOI 10.1016/j.neuroimage.2013.04.001; Naselaris T, 2009, NEURON, V63, P902, DOI 10.1016/j.neuron.2009.09.006; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Nickl-Jockschat T, 2015, BIOL PSYCHIAT; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Owen AM, 2013, ANNU REV PSYCHOL, V64, P109, DOI 10.1146/annurev-psych-113011-143729; Parvizi J, 2012, J NEUROSCI, V32, P14915, DOI 10.1523/JNEUROSCI.2609-12.2012; Plichta MM, 2014, NEUROSCI BIOBEHAV R, V38, P125, DOI 10.1016/j.neubiorev.2013.07.012; Poldrack RA, 2015, ANN REV PSYCHOL; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; Raichle ME, 2015, ANNU REV NEUROSCI, V38, P433, DOI 10.1146/annurev-neuro-071013-014030; Reardon S, 2015, NATURE, V518, P474, DOI 10.1038/518474a; Reveley C, 2015, P NATL ACAD SCI USA, V112, pE2820, DOI 10.1073/pnas.1418198112; Richiardi J, 2015, SCIENCE, V348, P1241, DOI 10.1126/science.1255905; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; Saygin ZM, 2013, J NEUROSCI, V33, P13251, DOI 10.1523/JNEUROSCI.4383-12.2013; Schilling C, 2013, HUM BRAIN MAPP, V34, P374, DOI 10.1002/hbm.21446; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shen K, 2012, J NEUROSCI, V32, P17465, DOI 10.1523/JNEUROSCI.2709-12.2012; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sperling RA, 2013, NAT REV NEUROL, V9, P54, DOI 10.1038/nrneurol.2012.241; Sprague TC, 2015, TRENDS COGN SCI, V19, P215, DOI 10.1016/j.tics.2015.02.005; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Sulzer J, 2013, NEUROIMAGE, V76, P386, DOI 10.1016/j.neuroimage.2013.03.033; Tagliazucchi E, 2014, NEURON, V82, P695, DOI 10.1016/j.neuron.2014.03.020; Thomsen K, 2004, J PHYSIOL-LONDON, V560, P181, DOI 10.1113/jphysiol.2004.068072; Todd MT, 2013, NEUROIMAGE, V77, P157, DOI 10.1016/j.neuroimage.2013.03.039; Underwood E, 2013, SCIENCE, V342, P1029, DOI 10.1126/science.342.6162.1029; Van Essen D. C., 2013, MAPPING CONNECTIONS; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Waskom ML, 2014, J NEUROSCI, V34, P10743, DOI 10.1523/JNEUROSCI.5282-13.2014; Xue G, 2010, SCIENCE, V330, P97, DOI 10.1126/science.1193125; Yacoub E, 2008, P NATL ACAD SCI USA, V105, P10607, DOI 10.1073/pnas.0804110105; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]	101	147	153	4	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					371	379		10.1038/nature15692	http://dx.doi.org/10.1038/nature15692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26469048	Green Submitted			2022-12-28	WOS:000362730200040
J	Moller, H; Gildea, C; Meechan, D; Rubin, G; Round, T; Vedsted, P				Moller, Henrik; Gildea, Carolynn; Meechan, David; Rubin, Greg; Round, Thomas; Vedsted, Peter			Use of the English urgent referral pathway for suspected cancer and mortality in patients with cancer: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COLORECTAL-CANCER; DIAGNOSTIC INTERVALS; WAITING-TIMES; SURVIVAL; CARE; PROGRESSION; DELAY; HEAD	OBJECTIVE To assess the overall effect of the English urgent referral pathway on cancer survival. SETTING 8049 general practices in England. DESIGN Cohort study. Linked information from the national Cancer Waiting Times database, NHS Exeter database, and National Cancer Register was used to estimate mortality in patients in relation to the propensity of their general practice to use the urgent referral pathway. PARTICIPANTS 215 284 patients with cancer, diagnosed or first treated in England in 2009 and followed up to 2013. OUTCOME MEASURE Hazard ratios for death from any cause, as estimated from a Cox proportional hazards regression. RESULTS During four years of follow-up, 91 620 deaths occurred, of which 51 606 (56%) occurred within the first year after diagnosis. Two measures of the propensity to use urgent referral, the standardised referral ratio and the detection rate, were associated with reduced mortality. The hazard ratio for the combination of high referral ratio and high detection rate was 0.96 (95% confidence interval 0.94 to 0.99), applying to 16% (n=34 758) of the study population. Patients with cancer who were registered with general practices with the lowest use of urgent referral had an excess mortality (hazard ratio 1.07 (95% confidence interval 1.05 to 1.08); 37% (n=79 416) of the study population). The comparator group for these two hazard ratios was the remaining 47% (n=101 110) of the study population. This result in mortality was consistent for different types of cancer (apart from breast cancer) and with other stratifications of the dataset, and was not sensitive to adjustment for potential confounders and other details of the statistical model. CONCLUSIONS Use of the urgent referral pathway could be efficacious. General practices that consistently have a low propensity to use urgent referrals could consider increasing the use of this pathway to improve the survival of their patients with cancer.	[Moller, Henrik] Kings Coll London, Canc Epidemiol & Populat Hlth, London SE1 9RT, England; [Gildea, Carolynn; Meechan, David] Publ Hlth England Knowledge & Intelligence Team E, Sheffield, S Yorkshire, England; [Rubin, Greg] Univ Durham, Sch Med Pharm & Hlth, Stockton On Tees, England; [Round, Thomas] Kings Coll London, Div Hlth & Social Care, London SE1 9RT, England; [Vedsted, Peter] Aarhus Univ, Dept Publ Hlth, Ctr Canc Diag Primary Care, Res Unit Gen Practice, Aarhus, Denmark	University of London; King's College London; Durham University; University of London; King's College London; Aarhus University	Moller, H (corresponding author), Kings Coll London, Canc Epidemiol & Populat Hlth, London SE1 9RT, England.	henrik.moller@kcl.ac.uk	Vedsted, Peter/C-2583-2008	Vedsted, Peter/0000-0003-2113-5599; Moller, Henrik/0000-0001-8200-5929	Cancer Research UK (CRUK); National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King''s College London; The Danish Cancer Society [R142-A9081] Funding Source: researchfish	Cancer Research UK (CRUK)(Cancer Research UK); National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King''s College London; The Danish Cancer Society(Danish Cancer Society)	The study was supported by a Cancer Research UK (CRUK) early diagnosis policy research grant and by the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King''s College London. The views expressed are those of the authors and not necessarily those of CRUK, NHS, NIHR, or the Department of Health. The researchers were independent of the funders, and the researchers alone interpreted the data and decided to publish.	Baughan P, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X606591; Department of Health, 2000, NHS CANC PLAN PLAN I; Dregan A, 2013, BRIT J GEN PRACT, V63, pE807, DOI 10.3399/bjgp13X675197; Dyrop HB, 2013, HEALTH POLICY, V113, P110, DOI 10.1016/j.healthpol.2013.09.012; Elit LM, 2014, J CLIN ONCOL, V32, P27, DOI 10.1200/JCO.2013.51.3671; Elliss-Brookes L, 2012, BRIT J CANCER, V107, P1220, DOI 10.1038/bjc.2012.408; Gutierrez RG, FRAILTY MODELS STATA; Hamilton W, 2012, BRIT J CANCER, V107, P1205, DOI 10.1038/bjc.2012.423; Hamilton W, 2009, BRIT J CANCER, V101, pS80, DOI 10.1038/sj.bjc.6605396; Hamilton William, 2015, BMJ, V350, ph3044, DOI 10.1136/bmj.h3044; Hamilton W, 2009, BRIT J GEN PRACT, V59, P441, DOI 10.3399/bjgp09X420860; Health and Social Care Information Centre, 2015, CANC OUTC SERV DAT S; Health and Social Care Information Centre, 2015, NAT CANC WAIT TIM MO; Jensen AR, 2007, RADIOTHER ONCOL, V84, P5, DOI 10.1016/j.radonc.2007.04.001; Maclean R, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1497-1; Meechan D, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X654551; Moller H, 2012, EUR J CANCER, V48, P46, DOI 10.1016/j.ejca.2011.05.018; Morris EJA, 2011, GUT, V60, P1087, DOI 10.1136/gut.2010.229575; Murchie P, 2015, BRIT J CANCER, V112, P1791, DOI 10.1038/bjc.2015.110; National Institute for Health and Care Excellence, 2014, COST REP SUPP NICE C; National Institute for Health and Care Excellence, 2015, NICE GUID 12; Neal RD, 2015, BRIT J CANCER, V112, pS92, DOI 10.1038/bjc.2015.48; Neal RD, 2014, BRIT J CANCER, V110, P584, DOI 10.1038/bjc.2013.791; Neal RD, 2013, BRIT J CANCER, V110, P584; NHS England, 2014, WAIT TIM SUSP DIANG; Olesen F, 2009, BRIT J CANCER, V101, pS5, DOI 10.1038/sj.bjc.6605383; Prades J, 2011, BRIT J CANCER, V105, P753, DOI 10.1038/bjc.2011.308; Probst HB, 2012, HEALTH POLICY, V105, P65, DOI 10.1016/j.healthpol.2011.11.001; Redaniel MT, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-642; Richards MA, 2009, BRIT J CANCER, V101, pS1, DOI 10.1038/sj.bjc.6605382; Richards MA, 1999, BRIT J CANCER, V79, P858, DOI 10.1038/sj.bjc.6690137; Torring ML, 2013, EUR J CANCER, V49, P2187, DOI 10.1016/j.ejca.2013.01.025; Toustrup K, 2011, ACTA ONCOL, V50, P636, DOI 10.3109/0284186X.2010.551139; Valentin-Lopez B, 2012, FAM PRACT, V29, P182, DOI 10.1093/fampra/cmr080; Cartie HV, 2011, REV ESP ENFERM DIG, V103, P402, DOI 10.4321/s1130-01082011000800003; van Harten MC, 2015, ORAL ONCOL, V51, P272, DOI 10.1016/j.oraloncology.2014.12.003; Wang JB, 2012, LUNG CANCER, V78, P51, DOI 10.1016/j.lungcan.2012.06.010; Watson N., 2002, EXETER SYSTEM IS CEN; White E, 2008, PRINCIPLES EXPOSURE, P141	39	57	58	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2015	351								h5102	10.1136/bmj.h5102	http://dx.doi.org/10.1136/bmj.h5102			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT8XS	26462713	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000363100800002
J	Saadatmand, S; Bretveld, R; Siesling, S; Tilanus-Linthorst, MMA				Saadatmand, Sepideh; Bretveld, Reini; Siesling, Sabine; Tilanus-Linthorst, Madeleine M. A.			Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173 797 patients	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PLUS ADJUVANT CHEMOTHERAPY; NODE METASTASES; TRASTUZUMAB; IMPLEMENTATION; PROGNOSIS; AGE	OBJECTIVES To assess the influence of stage at breast cancer diagnosis, tumour biology, and treatment on survival in contemporary times of better (neo-) adjuvant systemic therapy. DESIGN Prospective nationwide population based study. SETTING Nationwide Netherlands Cancer Registry. PARTICIPANTS Female patients with primary breast cancer diagnosed between 1999 and 2012 (n=173 797), subdivided into two time cohorts on the basis of breast cancer diagnosis: 1999-2005 (n=80 228) and 2006-12 (n=93 569). MAIN OUTCOME MEASURES Relative survival was compared between the two cohorts. Influence of traditional prognostic factors on overall mortality was analysed with Cox regression for each cohort separately. RESULTS Compared with 1999-2005, patients from 2006-12 had smaller (<= T1 65% (n=60 570) v 60% (n=48 031); P<0.001), more often lymph node negative (NO 68% (n=63 544) v 65% (n=52 238); P<0.001) tumours, but they received more chemotherapy, hormonal therapy, and targeted therapy (neo-adjuvant/adjuvant systemic therapy 60% (n=56 402) v 53% (n=42 185); P<0.001). Median follow-up was 9.8 years for 1999-2005 and 3.9 years for 2006-12. The relative five year survival rate in 2006-12 was 96%, improved in all tumour and nodal stages compared with 1999-2005, and 100% in tumours <= 1 cm. In multivariable analyses adjusted for age and tumour type, overall mortality was decreased by surgery (especially breast conserving), radiotherapy, and systemic therapies. Mortality increased with progressing tumour size in both cohorts (2006-12 T1c v T1a: hazard ratio 1.54, 95% confidence interval 1.33 to 1.78), but without a significant difference in invasive breast cancers until 1 cm (2006-12 T1b v T1a: hazard ratio 1.04, 0.88 to 1.22), and independently with progressing number of positive lymph nodes (2006-12 N1 v NO: 1.25, 1.17 to 1.32). CONCLUSIONS Tumour stage at diagnosis of breast cancer still influences overall survival significantly in the current era of effective systemic therapy. Diagnosis of breast cancer at an early tumour stage remains vital.	[Saadatmand, Sepideh; Tilanus-Linthorst, Madeleine M. A.] Erasmus Univ, Med Ctr, Inst Canc, Dept Surg, NL-3075 EA Rotterdam, Netherlands; [Bretveld, Reini; Siesling, Sabine] Netherlands Comprehens Canc Org, Dept Res, NL-3511 DT Utrecht, Netherlands; [Siesling, Sabine] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Hlth Technol & Serv Res, NL-7500 AE Enschede, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Twente	Tilanus-Linthorst, MMA (corresponding author), Erasmus Univ, Med Ctr, Inst Canc, Dept Surg, NL-3075 EA Rotterdam, Netherlands.	m.tilanus-linthorst@erasmusmc.nl			ministry of Health, Welfare, and Sport of the Netherlands	ministry of Health, Welfare, and Sport of the Netherlands	The Netherlands Cancer Registry is funded by the ministry of Health, Welfare, and Sport of the Netherlands. The funders had no role in the conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.	Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Brekelmans CTM, 2007, EUR J CANCER, V43, P867, DOI 10.1016/j.ejca.2006.12.009; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Central Bureau of Statistics Netherlands, 1999, POP GEND AG MAR STAT; Cole TJ, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1845; Colzani E, 2011, J CLIN ONCOL, V29, P4014, DOI 10.1200/JCO.2010.32.6462; Cossetti RJD, 2015, J CLIN ONCOL, V33, P65, DOI 10.1200/JCO.2014.57.2461; de Boer M, 2010, J NATL CANCER I, V102, P410, DOI 10.1093/jnci/djq008; de Gelder R, 2015, INT J CANCER, V137, P165, DOI 10.1002/ijc.29364; de Munck L, 2011, BREAST CANCER RES TR, V129, P229, DOI 10.1007/s10549-011-1451-0; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Dickman PW, 2004, STAT MED, V23, P51, DOI 10.1002/sim.1597; Duffy SW, 2013, BREAST CANCER MANAG, V2, P519, DOI 10.2217/BMT.13.53; Edge BD, 2009, AJCC CANC STAGING MA, P345; Ho VKY, 2008, EUR J CANCER, V44, P683, DOI 10.1016/j.ejca.2008.01.027; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Mittendorf EA, 2015, J CLIN ONCOL, V33, P1119, DOI 10.1200/JCO.2014.57.2958; Moossdorff M, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju288; Nationaal Borstkanker Overleg Nederland (NABON), 2005, RICHTL BEH MAMM 2005; Perez EA, 2014, J CLIN ONCOL, V32, P3744, DOI 10.1200/JCO.2014.55.5730; Rakha EA, 2008, J CLIN ONCOL, V26, P3153, DOI 10.1200/JCO.2007.15.5986; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Roumen R M, 2000, Ned Tijdschr Geneeskd, V144, P1864; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Tan LK, 2008, J CLIN ONCOL, V26, P1803, DOI 10.1200/JCO.2007.12.6425; van Herk-Sukel MPP, 2013, BREAST J, V19, P394, DOI 10.1111/tbj.12125; Verbeek ALM, 2003, ANN ONCOL, V14, P1203, DOI 10.1093/annonc/mdg324	28	189	192	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 6	2015	351								h4901	10.1136/bmj.h4901	http://dx.doi.org/10.1136/bmj.h4901			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT3SF	26442924	Green Published, hybrid			2022-12-28	WOS:000362726500001
J	Cohen, JY				Cohen, Jeremiah Y.			Dopamine and serotonin signals for reward across time scales	SCIENCE			English	Editorial Material							AREA		Johns Hopkins Univ, Sch Med, Brain Sci Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Cohen, JY (corresponding author), Johns Hopkins Univ, Sch Med, Brain Sci Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	jeremiah.cohen@jhmi.edu						Bloom F. E., 1975, NEUROSCIENCES PATHS, P211; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cohen JY, 2015, ELIFE, V4, DOI 10.7554/eLife.06346; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Crick F, 1999, PHILOS T ROY SOC B, V354, P2021, DOI 10.1098/rstb.1999.0541; Dayan P, 2009, ANNU REV NEUROSCI, V32, P95, DOI 10.1146/annurev.neuro.051508.135607; Houk JC, 1995, MODELS INFORMATION P, P249; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Olds J., 1977, DRIVES REINFORCEMENT; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593	11	6	6	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					47	48		10.1126/science.aad3003	http://dx.doi.org/10.1126/science.aad3003			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26430113	Bronze			2022-12-28	WOS:000362098300039
J	Sarkar, D; Xie, XJ; Liu, W; Cao, W; Kang, JH; Gong, YJ; Kraemer, S; Ajayan, PM; Banerjee, K				Sarkar, Deblina; Xie, Xuejun; Liu, Wei; Cao, Wei; Kang, Jiahao; Gong, Yongji; Kraemer, Stephan; Ajayan, Pulickel M.; Banerjee, Kaustav			A subthermionic tunnel field-effect transistor with an atomically thin channel	NATURE			English	Article								The fast growth of information technology has been sustained by continuous scaling down of the silicon-based metal-oxide field-effect transistor. However, such technology faces two major challenges to further scaling. First, the device electrostatics (the ability of the transistor's gate electrode to control its channel potential) are degraded when the channel length is decreased, using conventional bulk materials such as silicon as the channel. Recently, two-dimensional semiconducting materials(1-7) have emerged as promising candidates to replace silicon, as they can maintain excellent device electrostatics even at much reduced channel lengths. The second, more severe, challenge is that the supply voltage can no longer be scaled down by the same factor as the transistor dimensions because of the fundamental thermionic limitation of the steepness of turn-on characteristics, or subthreshold swing(8,9). To enable scaling to continue without a power penalty, a different transistor mechanism is required to obtain subthermionic subthreshold swing, such as band-to-band tunnelling(10-16). Here we demonstrate band-to-band tunnel field-effect transistors (tunnelFETs), based on a two-dimensional semiconductor, that exhibit steep turn-on; subthreshold swing is a minimum of 3.9 millivolts per decade and an average of 31.1 millivolts per decade for four decades of drain current at room temperature. By using highly doped germanium as the source and atomically thin molybdenum disulfide as the channel, a vertical heterostructure is built with excellent electrostatics, a strain-free heterointerface, a lowtunnelling barrier, and a large tunnelling area. Our atomically thin and layered semiconducting-channel tunnel-FET(ATLAS-TFET) is the only planar architecture tunnel-FET to achieve subthermionic subthreshold swing over four decades of drain current, as recommended in ref. 17, and is also the only tunnel-FET(inany architecture) to achieve this at a low power-supply voltage of 0.1 volts. Our device is at present the thinnest-channel subthermionic transistor, and has the potential to open up new avenues for ultra-dense and low-power integrated circuits, as well as for ultra-sensitive biosensors and gas sensors(18-21).	[Sarkar, Deblina; Xie, Xuejun; Liu, Wei; Cao, Wei; Kang, Jiahao; Banerjee, Kaustav] Univ Calif Santa Barbara, Dept Elect & Comp Engn, Santa Barbara, CA 93106 USA; [Gong, Yongji; Ajayan, Pulickel M.] Rice Univ, Dept Mat Sci & Nanoengn, Houston, TX 77005 USA; [Kraemer, Stephan] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; Rice University; University of California System; University of California Santa Barbara	Banerjee, K (corresponding author), Univ Calif Santa Barbara, Dept Elect & Comp Engn, Santa Barbara, CA 93106 USA.	kaustav@ece.ucsb.edu	Gong, Yongji/Y-5434-2019; Kang, Jiahao/O-5916-2014; Sarkar, Deblina/AAG-4032-2019; Liu, Wei/B-3584-2015; Gong, Yongji/L-7628-2016	Gong, Yongji/0000-0003-1432-6813; Kang, Jiahao/0000-0002-8467-2503; Liu, Wei/0000-0001-9925-063X; cao, wei/0000-0003-2556-3195; Xie, Xuejun/0000-0002-1161-3836; Sarkar, Deblina/0000-0002-9662-1666	Air Force Office of Scientific Research [FA9550-14-1-0268]; US NSF [CCF-1162633]; Army Research Office (MURI) [W911NF-11-1-0362]; MRSEC Program of the NSF [DMR1121053]; NSF-funded Materials Research Facilities Network; Division of Computing and Communication Foundations [1162633] Funding Source: National Science Foundation	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); US NSF(National Science Foundation (NSF)); Army Research Office (MURI)(MURI); MRSEC Program of the NSF(National Science Foundation (NSF)); NSF-funded Materials Research Facilities Network; Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by the Air Force Office of Scientific Research (grant FA9550-14-1-0268) and the US NSF (grant CCF-1162633). Y.G. was supported by the Army Research Office (MURI grant W911NF-11-1-0362). All process steps for device fabrication were carried out using the Nanostructure Cleanroom Facility at the California NanoSystems Institute and the Nanofabrication Facilities at UCSB-part of the National Nanotechnology Infrastructure Network. We made extensive use of the MRL Central Facilities at UCSB, which are supported by the MRSEC Program of the NSF (award no. DMR1121053), a member of the NSF-funded Materials Research Facilities Network (http://www.mrfn.org).	BABA T, 1992, JPN J APPL PHYS 2, V31, pL455, DOI 10.1143/JJAP.31.L455; Bhuwalka KK, 2004, IEEE T ELECTRON DEV, V51, P279, DOI 10.1109/TED.2003.821575; Britnell L, 2012, SCIENCE, V335, P947, DOI 10.1126/science.1218461; Das S, 2014, ACS NANO, V8, P1681, DOI 10.1021/nn406603h; Datta S, 2014, MICROELECTRON RELIAB, V54, P861, DOI 10.1016/j.microrel.2014.02.002; Fang H, 2012, NANO LETT, V12, P3788, DOI [10.1021/nl3040674, 10.1021/nl301702r]; Georgiou T, 2013, NAT NANOTECHNOL, V8, P100, DOI [10.1038/NNANO.2012.224, 10.1038/nnano.2012.224]; Ionescu AM, 2011, NATURE, V479, P329, DOI 10.1038/nature10679; Khatami Y, 2009, IEEE T ELECTRON DEV, V56, P2752, DOI 10.1109/TED.2009.2030831; Lee CH, 2014, NAT NANOTECHNOL, V9, P676, DOI [10.1038/NNANO.2014.150, 10.1038/nnano.2014.150]; Lin MW, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/34/345102; Liu W, 2013, 2013 IEEE INTERNATIONAL ELECTRON DEVICES MEETING (IEDM), DOI 10.1109/IEDM.2013.6724660; Liu W, 2013, NANO LETT, V13, P1983, DOI 10.1021/nl304777e; Lundstrom M. S, 2006, IEEE INT SOI C P, P17; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Moscatelli A, 2012, NAT NANOTECHNOL, V7, P778, DOI 10.1038/nnano.2012.225; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; QUINN JJ, 1978, SURF SCI, V73, P190, DOI 10.1016/0039-6028(78)90489-2; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; Roy T, 2015, ACS NANO, V9, P2071, DOI 10.1021/nn507278b; Sakurai T, 2004, IEICE T ELECTRON, VE87C, P429; Sarkar D, 2014, ACS NANO, V8, P3992, DOI 10.1021/nn5009148; Sarkar D, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4775358; Sarkar D, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3698093; Sarkar D, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3528338; Sze S. M., 2008, PHYS SEMICONDUCTOR D, V3rd; Tomioka K., 2012, 2012 IEEE Symposium on VLSI Technology, P47, DOI 10.1109/VLSIT.2012.6242454; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Zhang Q, 2006, IEEE ELECTR DEVICE L, V27, P297, DOI 10.1109/LED.2006.871855	29	662	667	40	676	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					91	95		10.1038/nature15387	http://dx.doi.org/10.1038/nature15387			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26432247				2022-12-28	WOS:000362095100039
J	Schlich, T				Schlich, Thomas			The art of medicine Why were surgical gloves not used earlier?	LANCET			English	Editorial Material									McGill Univ, Dept Social Studies Med, Montreal, PQ H3A 1X1, Canada	McGill University	Schlich, T (corresponding author), McGill Univ, Dept Social Studies Med, Montreal, PQ H3A 1X1, Canada.	thomas.schlich@mcgill.ca							0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 26	2015	386	10000					1234	1235		10.1016/S0140-6736(15)00271-8	http://dx.doi.org/10.1016/S0140-6736(15)00271-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR9TQ	26460651	Bronze			2022-12-28	WOS:000361700100019
J	Bhandari, M; Jeray, KJ; Petrisor, BA; Devereaux, PJ; Heels-Ansdell, D; Schemitsch, EH; Anglen, J; Della Rocca, GJ; Jones, C; Kreder, H; Liew, S; McKay, P; Papp, S; Sancheti, P; Sprague, S; Stone, TB; Sun, X; Tanner, SL; Tornetta, P; Tufescu, T; Walter, S; Guyatt, GH				Bhandari, Mohit; Jeray, Kyle J.; Petrisor, Brad A.; Devereaux, P. J.; Heels-Ansdell, Diane; Schemitsch, Emil H.; Anglen, Jeff; Della Rocca, Gregory J.; Jones, Clifford; Kreder, Hans; Liew, Susan; McKay, Paula; Papp, Steven; Sancheti, Parag; Sprague, Sheila; Stone, Trevor B.; Sun, Xin; Tanner, Stephanie L.; Tornetta, Paul, III; Tufescu, Ted; Walter, Stephen; Guyatt, Gordon H.		FLOW Investigators	A Trial of Wound Irrigation in the Initial Management of Open Fracture Wounds	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRESSURE PULSATILE LAVAGE; BENZALKONIUM CHLORIDE; TIBIAL FRACTURES; FLUID LAVAGE; BACITRACIN; BACTERIA; EFFICACY; SOAP; FLOW	BACKGROUND The management of open fractures requires wound irrigation and debridement to remove contaminants, but the effectiveness of various pressures and solutions for irrigation remains controversial. We investigated the effects of castile soap versus normal saline irrigation delivered by means of high, low, or very low irrigation pressure. METHODS In this study with a 2-by-3 factorial design, conducted at 41 clinical centers, we randomly assigned patients who had an open fracture of an extremity to undergo irrigation with one of three irrigation pressures (high pressure [>20 psi], low pressure [5 to 10 psi], or very low pressure [1 to 2 psi]) and one of two irrigation solutions (castile soap or normal saline). The primary end point was reoperation within 12 months after the index surgery for promotion of wound or bone healing or treatment of a wound infection. RESULTS A total of 2551 patients underwent randomization, of whom 2447 were deemed eligible and included in the final analyses. Reoperation occurred in 109 of 826 patients (13.2%) in the high-pressure group, 103 of 809 (12.7%) in the low-pressure group, and 111 of 812 (13.7%) in the very-low-pressure group. Hazard ratios for the three pairwise comparisons were as follows: for low versus high pressure, 0.92 (95% confidence interval [CI], 0.70 to 1.20; P = 0.53), for high versus very low pressure, 1.02 (95% CI, 0.78 to 1.33; P = 0.89), and for low versus very low pressure, 0.93 (95% CI, 0.71 to 1.23; P = 0.62). Reoperation occurred in 182 of 1229 patients (14.8%) in the soap group and in 141 of 1218 (11.6%) in the saline group (hazard ratio, 1.32, 95% CI, 1.06 to 1.66; P = 0.01). CONCLUSIONS The rates of reoperation were similar regardless of irrigation pressure, a finding that indicates that very low pressure is an acceptable, low-cost alternative for the irrigation of open fractures. The reoperation rate was higher in the soap group than in the saline group.	[Bhandari, Mohit; Petrisor, Brad A.; Sprague, Sheila] McMaster Univ, Div Orthopaed Surg, Dept Surg, Hamilton, ON L8N 3Z5, Canada; [Bhandari, Mohit; Devereaux, P. J.; Heels-Ansdell, Diane; McKay, Paula; Sprague, Sheila; Walter, Stephen; Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol, Hamilton, ON L8N 3Z5, Canada; [Bhandari, Mohit; Devereaux, P. J.; Heels-Ansdell, Diane; McKay, Paula; Sprague, Sheila; Walter, Stephen; Guyatt, Gordon H.] McMaster Univ, Dept Biostat, Hamilton, ON L8N 3Z5, Canada; [Devereaux, P. J.; Guyatt, Gordon H.] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Devereaux, P. J.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8N 3Z5, Canada; [Schemitsch, Emil H.; Kreder, Hans] Univ Toronto, Div Orthopaed Surg, Toronto, ON M5S 1A1, Canada; [Kreder, Hans] Univ Toronto, Hlth Policy Management & Evaluat, Toronto, ON M5S 1A1, Canada; [Kreder, Hans] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Papp, Steven] Univ Ottawa, Div Orthopaed Surg, Ottawa, ON, Canada; [Stone, Trevor B.] Univ British Columbia, Fac Med, Dept Orthopaed, Vancouver, BC V5Z 1M9, Canada; [Tufescu, Ted] Univ Manitoba, Dept Surg, Winnipeg, MB R3T 2N2, Canada; [Jeray, Kyle J.; Tanner, Stephanie L.] Greenville Hlth Syst, Dept Orthoped Surg, Greenville, SC USA; [Anglen, Jeff] Indiana Univ, Dept Orthoped Surg, Indianapolis, IN 46204 USA; [Della Rocca, Gregory J.] Univ Missouri, Sch Med, Dept Orthoped Surg, Columbia, MO 65211 USA; [Jones, Clifford] Ctr Orthoped Res & Educ Inst, Phoenix, AZ USA; [Liew, Susan] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia; [Sancheti, Parag] Sancheti Inst Orthoped & Rehabil, Pune, Maharashtra, India; [Sun, Xin] Sichuan Univ, Chinese Evidence Based Med Ctr, Chengdu 610064, Peoples R China; [Tornetta, Paul, III] Boston Univ, Sch Med, Dept Orthoped Surg, Boston, MA 02215 USA	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; Population Health Research Institute; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Ottawa; University of British Columbia; University of Manitoba; Greenville Health System; Indiana University System; Indiana University-Purdue University Indianapolis; University of Missouri System; University of Missouri Columbia; Monash University; Sichuan University; Boston University	Bhandari, M (corresponding author), McMaster Univ, Div Orthopaed Surg, 293 Wellington St N,Suite, Hamilton, ON L8L 8E7, Canada.	bhandam@mcmaster.ca	Petrisor, Brad/AAQ-2278-2021; Devereaux, PJ/AAF-2862-2019; Rajaratnam, Krishan/AAQ-5211-2021; Della Rocca, Gregory/AAM-5281-2021; Bhandari, Mohit/AAQ-1675-2021; Devereaux, PJ/AAY-1757-2021; Madden, Kim/N-5761-2015; Sprague, Sheila/AAQ-4232-2021; Schemitsch, Emil/G-5706-2017; Walter, Stephen/AAB-5548-2022	Madden, Kim/0000-0002-2861-9636; Sprague, Sheila/0000-0003-1466-8063; Schemitsch, Emil/0000-0002-6435-9069; Walter, Stephen/0000-0003-4157-8928; Adams, Samuel/0000-0003-1020-1167; Coles, Chad/0000-0003-0454-3507; Kamali Moaveni, Afshin/0000-0003-4933-1700; Devereaux, PJ/0000-0003-2935-637X; Tornetta, Paul/0000-0002-6448-8864; Frihagen, Frede/0000-0002-4811-669X	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funded by the Canadian Institutes of Health Research and others; FLOW ClinicalTrials.gov number, NCT00788398.	Ackley BJ, 2007, EVIDENCE BASED NURSI, P954; Akl EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2809; Anglen J O, 2001, J Am Acad Orthop Surg, V9, P219; Anglen JO, 2005, J BONE JOINT SURG AM, V87A, P1415, DOI 10.2106/JBJS.D.02615; Anglen JO, 2003, INT ORTHOP, V27, P40; ANGLEN JO, 1994, J ORTHOP TRAUMA, V8, P390, DOI 10.1097/00005131-199410000-00004; [Anonymous], FEAST TOOLBOX; [Anonymous], 2004, JBI REPORTS; Barnes S, 2014, AM J INFECT CONTROL, V42, P525, DOI 10.1016/j.ajic.2014.01.012; Bhandari M, 2000, Int J Surg Investig, V2, P179; Bhandari M, 2002, J BONE JOINT SURG BR, V84B, P1054, DOI 10.1302/0301-620X.84B7.12532; Bhandari M, 1998, J ORTHOP TRAUMA, V12, P479, DOI 10.1097/00005131-199809000-00009; Bhandari M, 1999, J ORTHOP TRAUMA, V13, P526, DOI 10.1097/00005131-199911000-00002; Bhandari M, 2001, J BONE JOINT SURG AM, V83A, P412, DOI 10.2106/00004623-200103000-00014; Bhandari M, 2011, J TRAUMA, V71, P596, DOI 10.1097/TA.0b013e3181f6f2e8; Bhandari M, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-85; Bhandari M, 2008, J BONE JOINT SURG AM, V90A, P2567, DOI 10.2106/JBJS.G.01694; BHASKAR SN, 1971, MIL MED, V136, P264, DOI 10.1093/milmed/136.3.264; Burd T, 1999, Am J Orthop (Belle Mead NJ), V28, P156; Conroy BP, 1999, J ORTHOP TRAUMA, V13, P332, DOI 10.1097/00005131-199906000-00002; Crowley DJ, 2007, J BONE JOINT SURG BR, V89B, P580, DOI 10.1302/0301-620X.89B5.19286; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Foote CJ, 2015, CLIN ORTHOP RELAT R, V473, P2179, DOI 10.1007/s11999-015-4224-y; Gainor BJ, 1997, J ORTHOP TRAUMA, V11, P121, DOI 10.1097/00005131-199702000-00010; GROSS AG, 1971, J ORAL SURG, V29, P187; GUSTILO RB, 1990, J BONE JOINT SURG AM, V72A, P299, DOI 10.2106/00004623-199072020-00023; Hassinger SM, 2005, CLIN ORTHOP RELAT R, P27, DOI 10.1097/01.blo.0000182246.37454.b2; Huyette DR, 2004, CLIN ORTHOP RELAT R, P28, DOI 10.1097/01.blo.0000143558.57014.a9; Jarvinen TLN, 2014, J CLIN EPIDEMIOL, V67, P769, DOI 10.1016/j.jclinepi.2013.11.011; KAYSINGER KK, 1995, J ORTHOP TRAUMA, V9, P303, DOI 10.1097/00005131-199509040-00006; LONGMIRE AW, 1987, AM J EMERG MED, V5, P179, DOI 10.1016/0735-6757(87)90121-5; Mundi R, 2015, JBJS REV, V3, DOI 10.2106/JBJS.RVW.N.00051; Owens BD, 2009, J BONE JOINT SURG AM, V91A, P92, DOI 10.2106/JBJS.G.01566; Penn-Barwell JG, 2012, J ORTHOP TRAUMA, V26, P728, DOI 10.1097/BOT.0b013e31826c19c4; Petrisor B, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-7; Polzin B, 2006, J ORTHOP TRAUMA, V20, P261, DOI 10.1097/00005131-200604000-00005; SPRUNG J, 1990, ANESTH ANALG, V71, P430; Storer A, 2011, CLIN PRACTICE GUIDEL; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Tarbox BB, 1998, CLIN ORTHOP RELAT R, P255; World Health Organization, 2009, GLOB STAT REP ROAD S	41	133	138	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2015	373	27					2629	2641		10.1056/NEJMoa1508502	http://dx.doi.org/10.1056/NEJMoa1508502			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ8UH	26448371	Green Published			2022-12-28	WOS:000367374100008
J	McDonald-Mosley, R				McDonald-Mosley, Raegan			Tearing Down the Fetal Tissue Smokescreen	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[McDonald-Mosley, Raegan] Planned Parenthood Federat Amer, New York, NY 10001 USA		McDonald-Mosley, R (corresponding author), Planned Parenthood Federat Amer, New York, NY 10001 USA.								0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2015	373	24					2376	2377		10.1056/NEJMsb1513242	http://dx.doi.org/10.1056/NEJMsb1513242			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY0QW	26465175				2022-12-28	WOS:000366111600015
J	Fan, GZ; Baker, ML; Wang, Z; Baker, MR; Sinyagovskiy, PA; Chiu, W; Ludtke, SJ; Serysheva, II				Fan, Guizhen; Baker, Matthew L.; Wang, Zhao; Baker, Mariah R.; Sinyagovskiy, Pavel A.; Chiu, Wah; Ludtke, Steven J.; Serysheva, Irina I.			Gating machinery of InsP(3)R channels revealed by electron cryomicroscopy	NATURE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CRYO-EM STRUCTURE; LIGAND-BINDING; CRYSTAL-STRUCTURE; MACROMOLECULAR ASSEMBLIES; STRUCTURE PREDICTION; RESOLUTION STRUCTURE; POTASSIUM CHANNEL; PROTEIN-STRUCTURE; IDENTIFICATION	Inositol-1,4,5-trisphosphate receptors (InsP(3)Rs) are ubiquitous ion channels responsible for cytosolic Ca2+ signalling and essential for a broad array of cellular processes ranging from contraction to secretion, and from proliferation to cell death. Despite decades of research on InsP(3)Rs, a mechanistic understanding of their structure-function relationship is lacking. Here we present the first, to our knowledge, near-atomic (4.7 angstrom) resolution electron cryomicroscopy structure of the tetrameric mammalian type 1 InsP(3)R channel in its apo-state. At this resolution, we are able to trace unambiguously similar to 85% of the protein backbone, allowing us to identify the structural elements involved in gating and modulation of this 1.3-megadalton channel. Although the central Ca2+-conduction pathway is similar to other ion channels, including the closely related ryanodine receptor, the cytosolic carboxy termini are uniquely arranged in a left-handed a-helical bundle, directly interacting with the amino-terminal domains of adjacent subunits. This configuration suggests a molecular mechanism for allosteric regulation of channel gating by intracellular signals.	[Fan, Guizhen; Baker, Mariah R.; Sinyagovskiy, Pavel A.; Serysheva, Irina I.] Univ Texas Med Sch Houston, Struct Biol Imaging Ctr, Dept Biochem & Mol Biol, 6431 Fannin St, Houston, TX 77030 USA; [Baker, Matthew L.; Wang, Zhao; Chiu, Wah; Ludtke, Steven J.] Baylor Coll Med, Natl Ctr Macromol Imaging, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Serysheva, II (corresponding author), Univ Texas Med Sch Houston, Struct Biol Imaging Ctr, Dept Biochem & Mol Biol, 6431 Fannin St, Houston, TX 77030 USA.	irina.i.serysheva@uth.tmc.edu	wang, zhao/E-7013-2015; wang, zhao/E-1996-2016; Ludtke, Steven/A-4478-2008	Ludtke, Steven/0000-0002-1903-1574; Baker, Mariah/0000-0002-1613-9387; Wang, Zhao/0000-0003-4897-9986	National Institutes of Health [R01GM072804, R21AR063255, S10OD016279, P41GM103832, R01GM079429, R01GM080139, R21GM100229]; American Heart Association [14RNT1980029]; Muscular Dystrophy Association [295138]; National Science Foundation [DBI-1356306]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR063255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080139, R01GM072804, R21GM100229, P41GM103832, R01GM079429] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016279] Funding Source: NIH RePORTER; Direct For Biological Sciences [1356388] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1356306] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Muscular Dystrophy Association(Muscular Dystrophy Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank S. Murray for his assistance with RELION1.3. This work was supported by grants from the National Institutes of Health (R01GM072804, R21AR063255, S10OD016279, P41GM103832, R01GM079429, R01GM080139 and R21GM100229), the American Heart Association (14RNT1980029), the Muscular Dystrophy Association (295138) and National Science Foundation (DBI-1356306). We gratefully acknowledge the assistance and computing resources provided by the Center for Computational and Integrative Biomedical Research of Baylor College of Medicine and the Texas Advanced Computing Center at the University of Texas at Austin in the completion of this work.	Abeysinghe SS, 2010, COMPUT GRAPH FORUM, V29, P2243, DOI 10.1111/j.1467-8659.2010.01813.x; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker MR, 2012, STRUCTURE, V20, P450, DOI 10.1016/j.str.2012.01.008; Baker ML, 2012, BIOPOLYMERS, V97, P655, DOI 10.1002/bip.22065; Baker ML, 2011, J STRUCT BIOL, V174, P360, DOI 10.1016/j.jsb.2011.01.015; Baker ML, 2010, METHOD ENZYMOL, V483, P1, DOI 10.1016/S0076-6879(10)83001-0; Baker ML, 2010, NAT PROTOC, V5, P1697, DOI 10.1038/nprot.2010.126; Bhanumathy C, 2012, J BIOL CHEM, V287, P43674, DOI 10.1074/jbc.M112.415786; Boehning D, 2000, EMBO J, V19, P5450, DOI 10.1093/emboj/19.20.5450; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; DANOFF SK, 1991, P NATL ACAD SCI USA, V88, P2951, DOI 10.1073/pnas.88.7.2951; de Beer TAP, 2014, NUCLEIC ACIDS RES, V42, pD292, DOI 10.1093/nar/gkt940; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Efremov RG, 2015, NATURE, V517, P39, DOI 10.1038/nature13916; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fulton JL, 2003, J PHYS CHEM A, V107, P4688, DOI 10.1021/jp0272264; Galvan DL, 2002, J BIOL CHEM, V277, P48248, DOI 10.1074/jbc.M209990200; Gillespie D, 2014, BIOPHYS J, V107, P2263, DOI 10.1016/j.bpj.2014.09.031; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; Jiang W, 2001, J MOL BIOL, V308, P1033, DOI 10.1006/jmbi.2001.4633; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Li YQ, 2009, PROTEINS, V76, P665, DOI 10.1002/prot.22380; Lin CC, 2011, NAT STRUCT MOL BIOL, V18, P1172, DOI 10.1038/nsmb.2112; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Ludtke SJ, 2011, STRUCTURE, V19, P1192, DOI 10.1016/j.str.2011.05.003; Malovannaya A, 2010, P NATL ACAD SCI USA, V107, P2431, DOI 10.1073/pnas.0912599106; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Miyakawa T, 2001, EMBO J, V20, P1674, DOI 10.1093/emboj/20.7.1674; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Murray SC, 2013, STRUCTURE, V21, P900, DOI 10.1016/j.str.2013.04.016; NAKAGAWA T, 1991, P NATL ACAD SCI USA, V88, P6244, DOI 10.1073/pnas.88.14.6244; NUCIFORA FC, 1995, MOL BRAIN RES, V32, P291, DOI 10.1016/0169-328X(95)00089-B; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; Serysheva II, 2014, CELL CALCIUM, V56, P125, DOI 10.1016/j.ceca.2014.08.002; Serysheva II, 2010, CURR TOP MEMBR, V66, P171, DOI 10.1016/S1063-5823(10)66008-5; Soulsby MD, 2004, FEBS LETT, V557, P181, DOI 10.1016/S0014-5793(03)01487-X; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Tu HP, 2003, BIOPHYS J, V85, P290, DOI 10.1016/S0006-3495(03)74474-9; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Yamazaki H, 2010, J BIOL CHEM, V285, P36081, DOI 10.1074/jbc.M110.140129; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950	56	142	147	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					336	+		10.1038/nature15249	http://dx.doi.org/10.1038/nature15249			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26458101	Green Accepted			2022-12-28	WOS:000365356800047
J	Falade-Nwulia, O; Seaberg, EC; Snider, AE; Rinaldo, CR; Phair, J; Witt, MD; Thio, CL				Falade-Nwulia, Oluwaseun; Seaberg, Eric C.; Snider, Anna E.; Rinaldo, Charles R.; Phair, John; Witt, Mallory D.; Thio, Chloe L.			Incident Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Men Who Have Sex With Men From Pre-HAART to HAART Periods A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							MULTICENTER AIDS COHORT; ANTIRETROVIRAL THERAPY; RISK BEHAVIOR; VIRAL LOAD; YOUNG MEN; IMMUNIZATION; RESPONSES; TRENDS	Background: Men who have sex with men (MSM) are at high risk for hepatitis B virus (HBV) infection. Data on the effect of highly active antiretroviral therapy (HAART) on incident HBV infection in HIV-infected and HIV-uninfected MSM are limited. Objective: To determine predictors of incident HBV infection in MSM during pre-HAART and HAART periods. Design: Observational cohort study. Setting: Cohort of MSM who have, or are at risk for, HIV infection. Patients: 2375 HBV-uninfected MSM in the Multicenter AIDS Cohort Study. Measurements: Poisson regression was used to compare incidence rates of HBV infection in the pre-HAART and HAART eras and to identify factors associated with incidence of HBV infection. Results: In 25 322 person-years of follow-up, 244 incident HBV infections occurred. The unadjusted incidence rate was higher in HIV-infected MSM than in HIV-uninfected MSM (incidence rate ratio [IRR], 1.9 [95% CI, 1.5 to 2.4]) and was significantly lower in the HAART era than in the pre-HAART era among HIV-infected (IRR, 0.2 [CI, 0.1 to 0.4]) and HIV-uninfected (IRR, 0.3 [CI, 0.2 to 0.4]) MSM. Age younger than 40 years (IRR, 2.3 [CI, 1.7 to 3.0]), more than 1 recent sexual partner (IRR, 3.1 [CI, 2.3 to 4.2]), and HIV infection (IRR, 2.4 [CI, 1.8 to 3.1]) were independently associated with higher incidence of HBV infection, whereas HBV vaccination was protective (IRR, 0.3 [CI, 0.2 to 0.4]). Highly active antiretroviral therapy with HIV RNA levels less than 400 copies/mL was associated with protection (IRR, 0.2 [CI, 0.1 to 0.5]), but HAART in those with HIV RNA levels of 400 copies/mL or greater was not. Limitation: The observational nature limits inferences about causality. Conclusion: Effective HAART is associated with lower incidence of HBV infection; however, even in the HAART era, incidence of HBV infection remains high among MSM.	[Falade-Nwulia, Oluwaseun] Johns Hopkins Univ, Baltimore, MD 21205 USA; [Snider, Anna E.; Thio, Chloe L.] Johns Hopkins Univ, Baltimore, MD 21231 USA; [Rinaldo, Charles R.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Witt, Mallory D.] Univ Calif Los Angeles, Los Angeles Biomed Res Inst Harbor, Med Ctr, Torrance, CA 90502 USA	Johns Hopkins University; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; Feinberg School of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Falade-Nwulia, O (corresponding author), Johns Hopkins Univ, 725 North Wolfe St,Room 215, Baltimore, MD 21205 USA.	ofalade1@jhmi.edu; ecs@jhu.edu		Falade-Nwulia, Oluwaseun/0000-0003-2321-2295	National Institute of Allergy and Infectious Diseases; National Cancer Institute [UO1-AI-35042, UL1-RR025005, UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041, UL1TR000124, R03AI096918]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035043, U01AI035042, UM1AI035043, U01AI035040, U01AI035039, U01AI035041, R03AI096918] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	By the National Institute of Allergy and Infectious Diseases, with additional funding from the National Cancer Institute (UO1-AI-35042, UL1-RR025005, UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041, UL1TR000124, and R03AI096918).	[Anonymous], 1991, MMWR Recomm Rep, V40, P1; Centers for Disease Control and Prevention, 2015, VIR HEP STAT SURV SU; Centers for Disease Control and Prevention, 2015, VIR HEP CDC REC SPEC; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V52, P1252; Centers for Disease Control and Prevention (CDC), 1982, MMWR-MORBID MORTAL W, V31, P327; Centers for Disease Control (CDC), 1982, MMWR Morb Mortal Wkly Rep, V31, P317; Chen SY, 2002, AM J PUBLIC HEALTH, V92, P1387, DOI 10.2105/AJPH.92.9.1387-a; CHMIEL JS, 1987, AM J EPIDEMIOL, V126, P568, DOI 10.1093/oxfordjournals.aje.a114696; Chun HM, 2010, CLIN INFECT DIS, V50, P426, DOI 10.1086/649885; Detels R, 2012, PUBLIC HEALTH, V126, P196, DOI 10.1016/j.puhe.2011.11.013; Detels R, 2001, AIDS, V15, P347, DOI 10.1097/00002030-200102160-00008; Gatanaga H, 2013, CLIN INFECT DIS, V56, P1812, DOI 10.1093/cid/cit145; Heffelfinger JD, 2007, AM J PUBLIC HEALTH, V97, P1076, DOI 10.2105/AJPH.2005.070417; Heuft MM, 2014, AIDS, V28, P999, DOI 10.1097/QAD.0000000000000180; Hoover KW, 2012, SEX TRANSM DIS, V39, P349, DOI 10.1097/OLQ.0b013e318244a923; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Kellerman SE, 2003, J INFECT DIS, V188, P571, DOI 10.1086/377135; Landrum ML, 2010, AIDS, V24, P545, DOI 10.1097/QAD.0b013e32832cd99e; Leichliter JS, 2013, JAIDS-J ACQ IMM DEF, V63, P254, DOI 10.1097/QAI.0b013e31828e0cfc; MacKellar DA, 2001, AM J PUBLIC HEALTH, V91, P965, DOI 10.2105/AJPH.91.6.965; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Menza TW, 2011, AIDS BEHAV, V15, P319, DOI 10.1007/s10461-009-9626-y; Miyazawa M, 2009, AIDS, V23, P161, DOI 10.1097/QAD.0b013e3283196a80; Mizukoshi E, 2008, J INFECT DIS, V198, P203, DOI 10.1086/589510; Purcell David W, 2012, Open AIDS J, V6, P98, DOI 10.2174/1874613601206010098; Resino S, 2003, J CLIN IMMUNOL, V23, P279, DOI 10.1023/A:1024536816684; Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-8; Watanabe T, 2015, ANTIMICROB AGENTS CH, V59, P1292, DOI 10.1128/AAC.04459-14; Weinbaum CM, 2008, AM J PUBLIC HEALTH, V98, P839, DOI 10.2105/AJPH.2006.101915; Wiegand J, 2010, J VIRAL HEPATITIS, V17, P631, DOI 10.1111/j.1365-2893.2009.01220.x	30	17	17	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 3	2015	163	9					673	+		10.7326/M15-0547	http://dx.doi.org/10.7326/M15-0547			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX3PF	26457744	Green Accepted			2022-12-28	WOS:000365610600004
J	Korstanje, TJ; van der Vlugt, JI; Elsevier, CJ; de Bruin, B				Korstanje, Ties J.; van der Vlugt, Jarl Ivar; Elsevier, Cornelis J.; de Bruin, Bas			Hydrogenation of carboxylic acids with a homogeneous cobalt catalyst	SCIENCE			English	Article							EFFICIENT HYDROGENATION; ESTERS; ALCOHOLS; HYDROGENOLYSIS; COMPLEXES	The reduction of esters and carboxylic acids to alcohols is a highly relevant conversion for the pharmaceutical and fine-chemical industries and for biomass conversion. It is commonly performed using stoichiometric reagents, and the catalytic hydrogenation of the acids previously required precious metals. Here we report the homogeneously catalyzed hydrogenation of carboxylic acids to alcohols using earth-abundant cobalt. This system, which pairs Co(BF4)(2)center dot 6H(2)O with a tridentate phosphine ligand, can reduce a wide range of esters and carboxylic acids under relatively mild conditions (100 degrees C, 80 bar H-2) and reaches turnover numbers of up to 8000.	[Korstanje, Ties J.; van der Vlugt, Jarl Ivar; Elsevier, Cornelis J.; de Bruin, Bas] Univ Amsterdam, Van t Hoff Inst Mol Sci, NL-1098 XH Amsterdam, Netherlands	University of Amsterdam	Elsevier, CJ (corresponding author), Univ Amsterdam, Van t Hoff Inst Mol Sci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.	c.j.elsevier@uva.nl; b.debruin@uva.nl	de Bruin, Bas/K-7761-2012; Korstanje, Ties J/B-5423-2009	de Bruin, Bas/0000-0002-3482-7669; Korstanje, Ties J/0000-0001-8036-5963	Smart Mix Program of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science	Smart Mix Program of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science	This research was performed within the framework of the CatchBio program. The authors gratefully acknowledge the support of the Smart Mix Program of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science. We thank E. Zuidinga for ESI-MS analysis and L. Lefort and P. Alsters for useful discussions. The supplementary crystallographic data for this structure can be obtained free of charge from The Cambridge Crystallographic Data Centre (CCDC) at www.ccdc.cam.ac.uk/getstructures (CCDC number 1420869).	ADDISON AW, 1984, J CHEM SOC DALTON, P1349, DOI 10.1039/dt9840001349; Balaraman E, 2012, CHEM COMMUN, V48, P1111, DOI 10.1039/c1cc15778g; BIANCHINI C, 1986, GAZZ CHIM ITAL, V116, P201; Brewster TP, 2013, J AM CHEM SOC, V135, P16022, DOI 10.1021/ja408149n; Chakraborty S, 2014, J AM CHEM SOC, V136, P7869, DOI 10.1021/ja504034q; Crabtree RH, 2012, CHEM REV, V112, P1536, DOI 10.1021/cr2002905; Drost RM, 2015, CHEMCATCHEM, V7, P2095, DOI 10.1002/cctc.201500200; Dub PA, 2012, ACS CATAL, V2, P1718, DOI 10.1021/cs300341g; Federsel C, 2012, CHEM-EUR J, V18, P72, DOI 10.1002/chem.201101343; Geilen FMA, 2011, J AM CHEM SOC, V133, P14349, DOI 10.1021/ja2034377; Goldberg K. I., 2014, [No title captured], Patent No. [2014/130714, 2014130714, WO2014130714 A1]; Li YH, 2015, ANGEW CHEM INT EDIT, V54, P5196, DOI 10.1002/anie.201500062; Magano J, 2012, ORG PROCESS RES DEV, V16, P1156, DOI 10.1021/op2003826; Manyar HG, 2010, CHEM COMMUN, V46, P6279, DOI 10.1039/c0cc01365j; MEALLI C, 1975, INORG CHEM, V14, P2513, DOI 10.1021/ic50152a044; Ni Y, 2012, CHEM COMMUN, V48, P12056, DOI 10.1039/c2cc36479d; Pritchard J, 2015, CHEM SOC REV, V44, P3808, DOI 10.1039/c5cs00038f; Seyden-Penne J., 1997, REDUCTIONS ALUMINO B; Teunissen HT, 1998, CHEM COMMUN, P1367, DOI 10.1039/a801807c; Teunissen HT, 1997, CHEM COMMUN, P667, DOI 10.1039/a700862g; Toba M, 1999, APPL CATAL A-GEN, V189, P243, DOI 10.1016/S0926-860X(99)00281-1; TUREK T, 1994, CATAL REV, V36, P645, DOI 10.1080/01614949408013931; Tyers D., 2003, PCT Int. Pat. Appl, Patent No. [03/093208, 03093208, WO03/093208]; van Engelen MC, 2003, J MOL CATAL A-CHEM, V206, P185, DOI 10.1016/S1381-1169(03)00427-8; vom Stein T, 2014, J AM CHEM SOC, V136, P13217, DOI 10.1021/ja506023f; Werkmeister S, 2014, ANGEW CHEM INT EDIT, V53, P8722, DOI 10.1002/anie.201402542; Werkmeister S, 2014, ORG PROCESS RES DEV, V18, P289, DOI 10.1021/op4003278; Werpy T., 2004, TOP VALUE ADDED CHEM, DOI DOI 10.2172/15008859; Wood M. A., 2005, [No title captured], Patent No. [2005/051875, 2005051875, WO2005051875 A1]; Zell T, 2014, ANGEW CHEM INT EDIT, V53, P4685, DOI 10.1002/anie.201311221; Zhang J, 2006, ANGEW CHEM INT EDIT, V45, P1113, DOI 10.1002/anie.200503771; Zhang J, 2011, ORGANOMETALLICS, V30, P5716, DOI 10.1021/om200595m	32	243	247	15	415	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2015	350	6258					298	+		10.1126/science.aaa8938	http://dx.doi.org/10.1126/science.aaa8938			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT5HD	26472903	Green Published			2022-12-28	WOS:000362838700035
J	Schneider, R; Persson, S				Schneider, Rene; Persson, Staffan			Another brick in the wall	SCIENCE			English	Editorial Material							CELLULOSE; VISUALIZATION		[Schneider, Rene] Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany; [Persson, Staffan] Univ Melbourne, Sch Biosci, ARC Ctr Excellence Plant Cell Walls, Parkville, Vic 3010, Australia	Max Planck Society; University of Melbourne	Schneider, R (corresponding author), Max Planck Inst Mol Plant Physiol, Muehlenberg 1, D-14476 Potsdam, Germany.	staffan.persson@unimelb.edu.au	Schneider, René/CAI-0366-2022; Persson, Staffan/S-8399-2016	Schneider, René/0000-0003-3951-9742; Persson, Staffan/0000-0002-6377-5132				Dolan L, 2004, DEVELOPMENT, V131, P5215, DOI 10.1242/dev.01439; Kimura S, 1999, PLANT CELL, V11, P2075, DOI 10.1105/tpc.11.11.2075; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; McFarlane HE, 2014, ANNU REV PLANT BIOL, V65, P69, DOI 10.1146/annurev-arplant-050213-040240; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Turner S, 2007, ANNU REV PLANT BIOL, V58, P407, DOI 10.1146/annurev.arplant.57.032905.105236; Watanabe Y, 2015, SCIENCE, V350, P198, DOI 10.1126/science.aac7446; Wightman R, 2008, PLANT J, V54, P794, DOI 10.1111/j.1365-313X.2008.03444.x; Yamaguchi M, 2010, PLANT PHYSIOL, V153, P906, DOI 10.1104/pp.110.154013	11	4	4	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257					156	157		10.1126/science.aad3200	http://dx.doi.org/10.1126/science.aad3200			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9JB	26450193				2022-12-28	WOS:000362405600015
J	Kuo, CS; Krasnow, MA				Kuo, Christin S.; Krasnow, Mark A.			Formation of a Neurosensory Organ by Epithelial Cell Slithering	CELL			English	Article							PULMONARY NEUROENDOCRINE CELLS; NEUROEPITHELIAL BODIES; MESENCHYMAL TRANSITION; IMMUNOREACTIVE CELLS; LUNG DEVELOPMENT; NEURAL CREST; HYPERPLASIA; DISTINCT; LINEAGE; CLARA	Epithelial cells are normally stably anchored, maintaining their relative positions and association with the basement membrane. Developmental rearrangements occur through cell intercalation, and cells can delaminate during epithelial-mesenchymal transitions and metastasis. We mapped the formation of lung neuroepithelial bodies (NEBs), innervated clusters of neuroendocrine/neurosensory cells within the bronchial epithelium, revealing a targeted mode of cell migration that we named "slithering,'' in which cells transiently lose epithelial character but remain associated with the membrane while traversing neighboring epithelial cells to reach cluster sites. Immunostaining, lineage tracing, clonal analysis, and live imaging showed that NEB progenitors, initially distributed randomly, downregulate adhesion and polarity proteins, crawling over and between neighboring cells to converge at diametrically opposed positions at bronchial branchpoints, where they reestablish epithelial structure and express neuroendocrine genes. There is little accompanying progenitor proliferation or apoptosis. Activation of the slithering program may explain why lung cancers arising from neuroendocrine cells are highly metastatic.	[Kuo, Christin S.; Krasnow, Mark A.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Kuo, Christin S.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Kuo, Christin S.; Krasnow, Mark A.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Krasnow, MA (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	krasnow@stanford.edu			NHLBI Progenitor Cell Biology Consortium [5U01HL099995]; Stanford Child Health Research Institute; Parker B. Francis Foundation Fellowship; NIH NHLBI K12 Scholar Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099995, K12HL120001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER	NHLBI Progenitor Cell Biology Consortium; Stanford Child Health Research Institute; Parker B. Francis Foundation Fellowship; NIH NHLBI K12 Scholar Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Makenna Morck for help with slice culture experiments, Jozeph Pendleton for help with mouse colony maintenance, Dr. Andrew Olson (Stanford Neuroscience Microscopy Service, NIH NS069375) for advice on video processing, Dr. Jane Johnson for Ascl1<SUP>CreER</SUP> mice, members of the M.A.K. lab for discussions and comments on the manuscript, and Maria Petersen for help preparing the manuscript and figures. This work was supported by a grant from the NHLBI Progenitor Cell Biology Consortium (5U01HL099995), and a Tashia and John Morgridge Endowed Fellowship in Pediatric Translational Medicine from the Stanford Child Health Research Institute (C.S.K.), Parker B. Francis Foundation Fellowship (C.S.K.), and NIH NHLBI K12 Scholar Award (C.S.K.). M.A.K. is an investigator of the Howard Hughes Medical Institute.	AGUAYO SM, 1992, NEW ENGL J MED, V327, P1285, DOI 10.1056/NEJM199210293271806; Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; ANDERSON DJ, 1986, CELL, V47, P1079, DOI 10.1016/0092-8674(86)90823-8; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Brouns I, 2009, HISTOCHEM CELL BIOL, V131, P55, DOI 10.1007/s00418-008-0495-7; Chai Y, 2000, DEVELOPMENT, V127, P1671; CUBAS P, 1991, GENE DEV, V5, P996, DOI 10.1101/gad.5.6.996; Cutz E, 2007, PEDIATR DEVEL PATHOL, V10, P106, DOI 10.2350/06-06-0113.1; Cutz E, 2013, SEMIN CELL DEV BIOL, V24, P40, DOI 10.1016/j.semcdb.2012.09.003; Deterding RR, 2005, PEDIATR PULM, V40, P157, DOI 10.1002/ppul.20243; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; FEYRTER F, 1954, Z Mikrosk Anat Forsch, V61, P73; GILLAN JE, 1993, PEDIATR PATHOL, V13, P165, DOI 10.3109/15513819309048204; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Guha A, 2012, P NATL ACAD SCI USA, V109, P12592, DOI 10.1073/pnas.1204710109; Guillot C, 2013, SCIENCE, V340, P1185, DOI 10.1126/science.1235249; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Ito T, 2000, DEVELOPMENT, V127, P3913; Kim EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018472; Krens SFG, 2011, CURR TOP DEV BIOL, V95, P189, DOI 10.1016/B978-0-12-385065-2.00006-2; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; LAUWERYN.MJ, 1972, ANAT RECORD, V172, P471, DOI 10.1002/ar.1091720301; LAUWERYNS JM, 1987, J ANAT, V151, P65; LAWRENCE PA, 1966, J CELL SCI, V1, P475; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Morimoto M, 2012, DEVELOPMENT, V139, P4365, DOI 10.1242/dev.083840; Morrison KM, 2009, DEV BIOL, V336, P76, DOI 10.1016/j.ydbio.2009.09.032; Nassar AA, 2011, AM J RESP CRIT CARE, V184, P8, DOI 10.1164/rccm.201010-1685PP; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Packard A, 2013, DEV CELL, V27, P319, DOI 10.1016/j.devcel.2013.09.001; Park KS, 2011, CELL CYCLE, V10, P2806, DOI 10.4161/cc.10.16.17012; Reynolds SD, 2000, AM J PHYSIOL-LUNG C, V278, pL1256, DOI 10.1152/ajplung.2000.278.6.L1256; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; SCHEUERMANN DW, 1987, INT REV CYTOL, V106, P35, DOI 10.1016/S0074-7696(08)61710-6; Song H, 2012, P NATL ACAD SCI USA, V109, P17531, DOI 10.1073/pnas.1207238109; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; Strobl-Mazzulla PH, 2012, SEMIN CANCER BIOL, V22, P411, DOI 10.1016/j.semcancer.2012.04.008; Sutherland KD, 2011, CANCER CELL, V19, P754, DOI 10.1016/j.ccr.2011.04.019; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Van Keymeulen A, 2009, J CELL BIOL, V187, P91, DOI 10.1083/jcb.200907080; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7; Wright MC, 2015, J CELL BIOL, V208, P367, DOI 10.1083/jcb.201407101; Young LR, 2011, CHEST, V139, P1060, DOI 10.1378/chest.10-1304; ZACCONE G, 1989, HISTOCHEMISTRY, V92, P61, DOI 10.1007/BF00495017	50	67	68	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2					394	405		10.1016/j.cell.2015.09.021	http://dx.doi.org/10.1016/j.cell.2015.09.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26435104	Bronze, Green Accepted			2022-12-28	WOS:000362952700016
J	Murray, CJL				Murray, Christopher J. L.			Choosing indicators for the health-related SDG targets	LANCET			English	Editorial Material							SYSTEMATIC ANALYSIS; GLOBAL BURDEN; DISEASE		Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.	cjlm@uw.edu						[Anonymous], 2015, IND MON FRAM SUST DE; Dora C, 2015, LANCET, V385, P380, DOI 10.1016/S0140-6736(14)60605-X; GBD 2013 DALYs and HALE Collaborators, 2015, LANCET; GBD 2013 Risk Factors Collaborators, 2015, LANCET; Murray CJL, 2015, NEW ENGL J MED, V373, P1390, DOI 10.1056/NEJMp1510082; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Shengelia B, 2005, SOC SCI MED, V61, P97, DOI 10.1016/j.socscimed.2004.11.055; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; World Health Organization, 2015, MON FRAM TA IN PRESS	9	11	11	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2015	386	10001					1314	1317		10.1016/S0140-6736(15)00382-7	http://dx.doi.org/10.1016/S0140-6736(15)00382-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS8DP	26460761				2022-12-28	WOS:000362316200007
J	Beals, MJ; Fugal, JP; Shaw, RA; Lu, J; Spuler, SM; Stith, JL				Beals, Matthew J.; Fugal, Jacob P.; Shaw, Raymond A.; Lu, Jiang; Spuler, Scott M.; Stith, Jeffrey L.			Holographic measurements of inhomogeneous cloud mixing at the centimeter scale	SCIENCE			English	Article							IN-LINE; ENTRAINMENT; MICROPHYSICS; EVOLUTION; MODELS	Optical properties and precipitation efficiency of atmospheric clouds are largely determined by turbulent mixing with their environment. When cloud liquid water is reduced upon mixing, droplets may evaporate uniformly across the population or, in the other extreme, a subset of droplets may evaporate completely, leaving the remaining drops unaffected. Here, we use airborne holographic imaging to visualize the spatial structure and droplet size distribution at the smallest turbulent scales, thereby observing their response to entrainment and mixing with clear air. The measurements reveal that turbulent clouds are inhomogeneous, with sharp transitions between cloud and clear air properties persisting to dissipative scales (< 1 centimeter). The local droplet size distribution fluctuates strongly in number density but with a nearly unchanging mean droplet diameter.	[Beals, Matthew J.; Shaw, Raymond A.] Michigan Technol Univ, Atmospher Sci Program, Houghton, MI 49931 USA; [Fugal, Jacob P.] Johannes Gutenberg Univ Mainz, Inst Atmospher Phys, D-55128 Mainz, Germany; [Fugal, Jacob P.] Max Planck Inst Chem, Aerosol & Cloud Phys Grp, D-55128 Mainz, Germany; [Shaw, Raymond A.; Lu, Jiang] Michigan Technol Univ, Dept Phys, Houghton, MI 49931 USA; [Spuler, Scott M.; Stith, Jeffrey L.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA	Michigan Technological University; Johannes Gutenberg University of Mainz; Max Planck Society; Michigan Technological University; National Center Atmospheric Research (NCAR) - USA	Shaw, RA (corresponding author), Michigan Technol Univ, Atmospher Sci Program, Houghton, MI 49931 USA.	rashaw@mtu.edu			U.S. National Science Foundation [AGS-1026123]; U.S. Department of Energy as part of the Atmospheric Radiation Measurement Climate Research Facility; NASA; U.S. National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy as part of the Atmospheric Radiation Measurement Climate Research Facility; NASA(National Aeronautics & Space Administration (NASA)); U.S. National Science Foundation(National Science Foundation (NSF))	We thank J. French and the aircraft staff for assistance with the instrument deployment on the University of Wyoming King Air research group. We thank the staff of the National Center for Atmospheric Research (NCAR) Earth Observing Laboratory for assistance with the instrument deployment on the NSF/NCAR C130. This project was supported by U.S. National Science Foundation grant AGS-1026123, by the U.S. Department of Energy as part of the Atmospheric Radiation Measurement Climate Research Facility, and by a NASA Earth and Space Science Fellowship. NCAR is sponsored by the U.S. National Science Foundation. Data are available according to instructions in the supplementary materials on Science Online.	BAKER BA, 1992, J ATMOS SCI, V49, P387, DOI 10.1175/1520-0469(1992)049<0387:TEAMIC>2.0.CO;2; BAKER MB, 1980, Q J ROY METEOR SOC, V106, P581, DOI 10.1002/qj.49710644914; BAKER MB, 1984, J ATMOS SCI, V41, P299, DOI 10.1175/1520-0469(1984)041<0299:TEOTMI>2.0.CO;2; Bannon PR, 2002, J ATMOS SCI, V59, P1967, DOI 10.1175/1520-0469(2002)059<1967:TFFMOM>2.0.CO;2; BAUMGARDNER D, 1993, J ATMOS OCEAN TECH, V10, P557, DOI 10.1175/1520-0426(1993)010<0557:ATFTMO>2.0.CO;2; BLYTH AM, 1993, J APPL METEOROL, V32, P626, DOI 10.1175/1520-0450(1993)032<0626:EICC>2.0.CO;2; Bodenschatz E, 2010, SCIENCE, V327, P970, DOI 10.1126/science.1185138; BRENGUIER JL, 1993, J APPL METEOROL, V32, P783, DOI 10.1175/1520-0450(1993)032<0783:OOCMAT>2.0.CO;2; Burnet F, 2007, J ATMOS SCI, V64, P1995, DOI 10.1175/JAS3928.1; Chosson F, 2007, J ATMOS SCI, V64, P2670, DOI 10.1175/JAS3975.1; Cooper WA, 2013, J ATMOS SCI, V70, P1727, DOI 10.1175/JAS-D-12-0128.1; Davis AB, 1999, J GEOPHYS RES-ATMOS, V104, P6123, DOI 10.1029/1998JD200078; Feingold G, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016633; Feingold G, 2010, NATURE, V466, P849, DOI 10.1038/nature09314; Fugal JP, 2009, ATMOS MEAS TECH, V2, P259, DOI 10.5194/amt-2-259-2009; Gerber HE, 2008, J METEOROL SOC JPN, V86A, P87, DOI 10.2151/jmsj.86A.87; Grabowski WW, 2007, J ATMOS SCI, V64, P3666, DOI 10.1175/JAS4047.1; Grabowski WW, 2006, J CLIMATE, V19, P4664, DOI 10.1175/JCLI3857.1; Heus T, 2008, J ATMOS SCI, V65, P1003, DOI 10.1175/2007JAS2322.1; Jeffery CA, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008789; JENSEN JB, 1985, J ATMOS SCI, V42, P173, DOI 10.1175/1520-0469(1985)042<0173:TMSEAD>2.0.CO;2; Krueger SK, 1997, J ATMOS SCI, V54, P2697, DOI 10.1175/1520-0469(1997)054<2697:MEAFMI>2.0.CO;2; Lehmann K, 2009, J ATMOS SCI, V66, P3641, DOI 10.1175/2009JAS3012.1; Lu CS, 2013, GEOPHYS RES LETT, V40, P2333, DOI 10.1002/grl.50445; Lu CS, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015944; PALUCH IR, 1989, J ATMOS SCI, V46, P261, DOI 10.1175/1520-0469(1989)046<0261:EAFSMI>2.0.CO;2; Spuler SM, 2011, APPL OPTICS, V50, P1405, DOI 10.1364/AO.50.001405; Stevens B, 2013, SCIENCE, V340, P1053, DOI 10.1126/science.1237554; Wang ZL, 2014, J GEOPHYS RES-ATMOS, V119, DOI 10.1002/2014JD021886	29	80	81	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					87	90		10.1126/science.aab0751	http://dx.doi.org/10.1126/science.aab0751			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26430119				2022-12-28	WOS:000362098300051
J	Birney, E; Soranzo, N				Birney, Ewan; Soranzo, Nicole			HUMAN GENOMICS The end of the start for population sequencing	NATURE			English	Editorial Material							GENETIC-VARIATION; INTEGRATED MAP		[Birney, Ewan] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Soranzo, Nicole] Wellcome Trust Sanger Inst, Hinxton CB10 1HH, England; [Soranzo, Nicole] Univ Cambridge, Sch Clin Med, Cambridge CB2 1TN, England	European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; University of Cambridge	Birney, E (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England.	birney@ebi.ac.uk; ns6@sanger.ac.uk		Birney, Ewan/0000-0001-8314-8497; Soranzo, Nicole/0000-0003-1095-3852				Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; The UK10K Consortium, 2015, NATURE	5	45	46	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					52	53		10.1038/526052a	http://dx.doi.org/10.1038/526052a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26432243				2022-12-28	WOS:000362095100033
J	Coric, I; Mercado, BQ; Bill, E; Vinyard, DJ; Holland, PL				Coric, Ilija; Mercado, Brandon Q.; Bill, Eckhard; Vinyard, David J.; Holland, Patrick L.			Binding of dinitrogen to an iron-sulfur-carbon site	NATURE			English	Article							FEMO-COFACTOR; CATALYTIC-REDUCTION; NITROGENASE; COMPLEXES; AMMONIA; LIGAND; N-2; CO	Nitrogenases are the enzymes by which certain microorganisms convert atmospheric dinitrogen (N-2) to ammonia, thereby providing essential nitrogen atoms for higher organisms. The most common nitrogenases reduce atmospheric N-2 at the FeMo cofactor, a sulfur-rich iron-molybdenum cluster (FeMoco)(1-5). The central iron sites that are coordinated to sulfur and carbon atoms in FeMoco have been proposed to be the substrate binding sites, on the basis of kinetic and spectroscopic studies(5-7). In the resting state, the central iron sites each have bonds to three sulfur atoms and one carbon atom. Addition of electrons to the resting state causes the FeMoco to react with N-2, but the geometry and bonding environment of N-2-bound species remain unknown(5). Here we describe a synthetic complex with a sulfur-rich coordination sphere that, upon reduction, breaks an Fe-S bond and binds N-2. The product is the first synthetic Fe-N-2 complex in which iron has bonds to sulfur and carbon atoms, providing a model for N-2 coordination in the FeMoco. Our results demonstrate that breaking an Fe-S bond is a chemically reasonable route to N-2 binding in the FeMoco, and show structural and spectroscopic details for weakened N-2 on a sulfur-rich iron site.	[Coric, Ilija; Mercado, Brandon Q.; Vinyard, David J.; Holland, Patrick L.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Bill, Eckhard] Max Planck Inst Chem Energy Convers, D-45470 Mulheim, Germany	Yale University; Max Planck Society	Holland, PL (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.	patrick.holland@yale.edu	Coric, Ilija/AFP-1494-2022	Coric, Ilija/0000-0002-0435-1313; Vinyard, David/0000-0002-8058-5998	National Institutes of Health [GM065313]; Max Planck Society; NSF [CHE-0650456, CNS 08-21132]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society(Max Planck Society); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (GM065313 to P.L.H.) and the Max Planck Society (E.B.). We thank A. Gobels for measurement of SQUID data and G. Brudvig for the use of an EPR spectrometer. Elemental analysis data were from the CENTC Elemental Analysis Facility at the University of Rochester, funded by the NSF (CHE-0650456), and we thank W. Brennessel for collecting these data. This work was supported in part by the facilities and staff of the Yale High Performance Computing Center, which was partially funded by the NSF (CNS 08-21132). We thank J. Mayer, N. Hazari, S. Bonyhady, N. Arnet, and C. MacLeod for constructive criticism on the manuscript.	Alwaaly A, 2014, CHEM COMMUN, V50, P4799, DOI 10.1039/c4cc00922c; Anderson JS, 2013, NATURE, V501, P84, DOI 10.1038/nature12435; Bart SC, 2007, INORG CHEM, V46, P7055, DOI 10.1021/ic700869h; Creutz SE, 2015, J AM CHEM SOC, V137, P7310, DOI 10.1021/jacs.5b04738; Creutz SE, 2014, J AM CHEM SOC, V136, P1105, DOI 10.1021/ja4114962; Dance I, 2012, DALTON T, V41, P4859, DOI 10.1039/c2dt00049k; Danopoulos AA, 2005, CHEM COMMUN, P784, DOI 10.1039/b415562a; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; ELLISON JJ, 1994, ANGEW CHEM INT EDIT, V33, P1178, DOI 10.1002/anie.199411781; George SJ, 2012, J INORG BIOCHEM, V112, P85, DOI 10.1016/j.jinorgbio.2012.02.004; Hazari N, 2010, CHEM SOC REV, V39, P4044, DOI 10.1039/b919680n; Hinnemann B, 2004, J AM CHEM SOC, V126, P3920, DOI 10.1021/ja037792s; Hoffman BM, 2014, CHEM REV, V114, P4041, DOI 10.1021/cr400641x; Holland PL, 2005, CAN J CHEM, V83, P296, DOI 10.1139/V05-005; Kastner J, 2007, J AM CHEM SOC, V129, P2998, DOI 10.1021/ja068618h; Lancaster KM, 2011, SCIENCE, V334, P974, DOI 10.1126/science.1206445; Lee SC, 2014, CHEM REV, V114, P3579, DOI 10.1021/cr4004067; MacBeth CE, 2005, CAN J CHEM, V83, P332, DOI 10.1139/V05-017; Moret ME, 2011, ANGEW CHEM INT EDIT, V50, P2063, DOI 10.1002/anie.201006918; Rodriguez MM, 2011, SCIENCE, V334, P780, DOI 10.1126/science.1211906; Saouma CT, 2015, CHEM-EUR J, V21, P9256, DOI 10.1002/chem.201500152; Schimpl J, 2003, J AM CHEM SOC, V125, P15772, DOI 10.1021/ja0367997; Seefeldt LC, 2009, ANNU REV BIOCHEM, V78, P701, DOI 10.1146/annurev.biochem.78.070907.103812; Spatzal T, 2014, SCIENCE, V345, P1620, DOI 10.1126/science.1256679; Spatzal T, 2011, SCIENCE, V334, P940, DOI 10.1126/science.1214025; Suess DLM, 2013, J AM CHEM SOC, V135, P4938, DOI 10.1021/ja400836u; Takaoka A, 2011, J AM CHEM SOC, V133, P8440, DOI 10.1021/ja2020907; Ung G, 2015, ANGEW CHEM INT EDIT, V54, P532, DOI 10.1002/anie.201409454; Wiig JA, 2012, SCIENCE, V337, P1672, DOI 10.1126/science.1224603; Yandulov DV, 2003, SCIENCE, V301, P76, DOI 10.1126/science.1085326	30	155	156	13	262	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					96	99		10.1038/nature15246	http://dx.doi.org/10.1038/nature15246			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26416755	Green Accepted, Green Submitted			2022-12-28	WOS:000362095100040
J	von Appen, A; Kosinski, J; Sparks, L; Ori, A; DiGuilio, AL; Vollmer, B; Mackmull, MT; Banterle, N; Parca, L; Kastritis, P; Buczak, K; Mosalaganti, S; Hagen, W; Andres-Pons, A; Lemke, EA; Bork, P; Antonin, W; Glavy, JS; Bui, KH; Beck, M				von Appen, Alexander; Kosinski, Jan; Sparks, Lenore; Ori, Alessandro; DiGuilio, Amanda L.; Vollmer, Benjamin; Mackmull, Marie-Therese; Banterle, Niccolo; Parca, Luca; Kastritis, Panagiotis; Buczak, Katarzyna; Mosalaganti, Shyamal; Hagen, Wim; Andres-Pons, Amparo; Lemke, Edward A.; Bork, Peer; Antonin, Wolfram; Glavy, Joseph S.; Bui, Khanh Huy; Beck, Martin			In situ structural analysis of the human nuclear pore complex	NATURE			English	Article							PROTEIN-STRUCTURE; ARCHITECTURE; REVEALS; PHOSPHORYLATION; STOICHIOMETRY; TOMOGRAPHY; PREDICTION; MODULE	Nuclear pore complexes are fundamental components of all eukaryotic cells that mediate nucleocytoplasmic exchange. Determining their 110-megadalton structure imposes a formidable challenge and requires in situ structural biology approaches. Of approximately 30 nucleoporins (Nups), 15 are structured and form the Y and innerring complexes. These two major scaffolding modules assemble in multiple copies into an eight-fold rotationally symmetric structure that fuses the inner and outer nuclear membranes to forma central channel of similar to 60 nm in diameter(1). The scaffold is decorated with transport-channel Nups that often contain phenylalanine-repeat sequences and mediate the interaction with cargo complexes. Although the architectural arrangement of parts of the Y complex has been elucidated, it is unclear how exactly it oligomerizes in situ. Here we combine cryo-electron tomography with mass spectrometry, biochemical analysis, perturbation experiments and structural modelling to generate, to our knowledge, the most comprehensive architectural model of the human nuclear pore complex to date. Our data suggest previously unknown protein interfaces across Y complexes and to inner-ring complex members. We show that the transport-channel Nup358 (also known as Ranbp2) has a previously unanticipated role in Y-complex oligomerization. Our findings blur the established boundaries between scaffold and transport-channel Nups. We conclude that, similar to coated vesicles, several copies of the same structural building block-although compositionally identical-engage in different local sets of interactions and conformations.	[von Appen, Alexander; Kosinski, Jan; Sparks, Lenore; Ori, Alessandro; Mackmull, Marie-Therese; Banterle, Niccolo; Parca, Luca; Kastritis, Panagiotis; Buczak, Katarzyna; Mosalaganti, Shyamal; Hagen, Wim; Andres-Pons, Amparo; Lemke, Edward A.; Bork, Peer; Bui, Khanh Huy; Beck, Martin] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [DiGuilio, Amanda L.; Glavy, Joseph S.] Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, Hoboken, NJ 07030 USA; [Vollmer, Benjamin; Antonin, Wolfram] Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany; [Bui, Khanh Huy] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada	European Molecular Biology Laboratory (EMBL); Stevens Institute of Technology; Eberhard Karls University of Tubingen; Max Planck Society; McGill University	Bui, KH (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany.	huy.bui@mcgill.ca; martin.beck@embl.de	Bork, Peer/F-1813-2013; Beck, Martin/B-5589-2011; Antonin, Wolfram/A-8656-2014; Vollmer, Benjamin/AAJ-7327-2021; Kastritis, Panagiotis L/F-2498-2010; Ori, Alessandro/M-8586-2019; Kastritis, Panagiotis/AAL-7029-2021; Parca, Luca/AAN-7665-2020; Ori, Alessandro/B-7067-2011; Kosinski, Jan/V-8540-2019; Antonin, Wolfram/P-3648-2019; Lemke, Edward/J-3337-2015	Bork, Peer/0000-0002-2627-833X; Beck, Martin/0000-0002-7397-1321; Antonin, Wolfram/0000-0003-4669-379X; Vollmer, Benjamin/0000-0002-7526-0582; Kastritis, Panagiotis L/0000-0002-1463-8422; Ori, Alessandro/0000-0002-3046-0871; Kastritis, Panagiotis/0000-0002-1463-8422; Parca, Luca/0000-0002-0924-8518; Ori, Alessandro/0000-0002-3046-0871; Kosinski, Jan/0000-0002-3641-0322; Antonin, Wolfram/0000-0003-4669-379X; Andres-Pons, Amparo/0000-0001-5801-4024; Mackmull, Marie-Therese/0000-0003-2928-1144; Glavy, Joseph/0000-0003-3716-3965; Lemke, Edward/0000-0002-0634-0503; von Appen, Alexander/0000-0001-6528-2123; Mosalaganti, Shyamal/0000-0002-5934-687X; Bui, Khanh Huy/0000-0003-2814-9889; Hagen, Wim/0000-0001-6229-2692; Banterle, Niccolo/0000-0002-1607-0324	EMBL's mechanical workshop; Electron Microscopy and Proteomics Core Facilities; Centre for Statistical Data Analysis; Swiss National Science Foundation; European Molecular Biology Organization; Marie Curie Actions; Alexander von Humboldt Foundation; Robert Crooks Stanley Fellowship at the Stevens Institute of Technology; National Institute on Aging (NIA) [1R21AG047433-01]; EMBL Interdisciplinary Postdoc Programme under Marie Curie COFUND Actions; Ignition Grant Initiative from Stevens Institute of Technology; NIA [1R21AG047433-01]; EMBL; European Research Council [309271-NPCAtlas]; NATIONAL INSTITUTE ON AGING [R21AG047433] Funding Source: NIH RePORTER	EMBL's mechanical workshop; Electron Microscopy and Proteomics Core Facilities; Centre for Statistical Data Analysis; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Marie Curie Actions(European Commission); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Robert Crooks Stanley Fellowship at the Stevens Institute of Technology; National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EMBL Interdisciplinary Postdoc Programme under Marie Curie COFUND Actions; Ignition Grant Initiative from Stevens Institute of Technology; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EMBL; European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to W. Baumeister and J. Plitzko for access to the electron microscopy facility of the Max Planck Institute of Biochemistry. We thank F. Schur, K. Beck, J. Briggs, C. Sachse, E. Hurt and F. Melchior for their critical advice and A. Neal for critical reading of the manuscript. We gratefully acknowledge support from EMBL's mechanical workshop, the Electron Microscopy and Proteomics Core Facilities, the Centre for Statistical Data Analysis and thank J. Krijgsveld, J. Kirkpatrick and B. Klaus. K.H.B. was supported by postdoctoral fellowships from the Swiss National Science Foundation, the European Molecular Biology Organization and Marie Curie Actions. A.O. was supported by postdoctoral fellowships from the Alexander von Humboldt Foundation and Marie Curie Actions. A.L.D. was supported by the Robert Crooks Stanley Fellowship at the Stevens Institute of Technology and National Institute on Aging (NIA) grant 1R21AG047433-01. J. K. was supported by the EMBL Interdisciplinary Postdoc Programme under Marie Curie COFUND Actions. J.S.G. was supported by an Ignition Grant Initiative from Stevens Institute of Technology and NIA grant 1R21AG047433-01. M.B. acknowledges funding by EMBL and the European Research Council (309271-NPCAtlas).	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Bilokapic S, 2012, P NATL ACAD SCI USA, V109, P15241, DOI 10.1073/pnas.1205151109; Boehmer T, 2008, MOL CELL, V30, P721, DOI 10.1016/j.molcel.2008.04.022; Bui KH, 2013, CELL, V155, P1233, DOI 10.1016/j.cell.2013.10.055; Culjkovic-Kraljacic B, 2012, CELL REP, V2, P207, DOI 10.1016/j.celrep.2012.07.007; Damelin M, 2002, BIOPHYS J, V83, P3626, DOI 10.1016/S0006-3495(02)75363-0; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Flemming D, 2012, J STRUCT BIOL, V177, P99, DOI 10.1016/j.jsb.2011.11.008; Fornerod M, 1997, GENOMICS, V42, P538, DOI 10.1006/geno.1997.4767; Gaik M, 2015, J CELL BIOL, V208, P283, DOI 10.1083/jcb.201411003; Glavy JS, 2007, P NATL ACAD SCI USA, V104, P3811, DOI 10.1073/pnas.0700058104; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Hurt E, 2015, CURR OPIN CELL BIOL, V34, P31, DOI 10.1016/j.ceb.2015.04.009; Kampmann M, 2009, NAT STRUCT MOL BIOL, V16, P782, DOI 10.1038/nsmb.1618; Kim DI, 2014, P NATL ACAD SCI USA, V111, pE2453, DOI 10.1073/pnas.1406459111; Kosinski J, 2013, BIOINFORMATICS, V29, P953, DOI 10.1093/bioinformatics/btt062; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Laurell E, 2011, CELL, V144, P539, DOI 10.1016/j.cell.2011.01.012; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Minguez P, 2015, NUCLEIC ACIDS RES, V43, pD494, DOI 10.1093/nar/gku1081; Movassagh T, 2010, NAT STRUCT MOL BIOL, V17, P761, DOI 10.1038/nsmb.1832; Nagy V, 2009, P NATL ACAD SCI USA, V106, P17693, DOI 10.1073/pnas.0909373106; Ori A, 2014, METHOD CELL BIOL, V122, P117, DOI 10.1016/B978-0-12-417160-2.00006-0; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Schur FKM, 2013, J STRUCT BIOL, V184, P394, DOI 10.1016/j.jsb.2013.10.015; Seo HS, 2009, P NATL ACAD SCI USA, V106, P14281, DOI 10.1073/pnas.0907453106; Shi Y, 2014, MOL CELL PROTEOMICS, V13, P2927, DOI 10.1074/mcp.M114.041673; Stuwe T, 2015, SCIENCE, V347, P1148, DOI 10.1126/science.aaa4136; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Theerthagiri G, 2010, J CELL BIOL, V189, P1129, DOI 10.1083/jcb.200912045; Thierbach K, 2013, STRUCTURE, V21, P1672, DOI 10.1016/j.str.2013.07.004; Vollmer B, 2014, BIOL CHEM, V395, P515, DOI 10.1515/hsz-2013-0285; Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Whittle JRR, 2009, J BIOL CHEM, V284, P28442, DOI 10.1074/jbc.M109.023580; Zemp I, 2009, J CELL BIOL, V185, P1167, DOI 10.1083/jcb.200904048	43	230	232	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					140	+		10.1038/nature15381	http://dx.doi.org/10.1038/nature15381			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26416747	Green Accepted			2022-12-28	WOS:000362095100050
J	Haude, M; Ince, H; Abizaid, A; Toelg, R; Lemos, PA; von Birgelen, C; Christiansen, EH; Wijns, W; Neumann, FJ; Kaiser, C; Eeckhout, E; Lim, ST; Escaned, J; Garcia-Garcia, HM; Waksman, R				Haude, Michael; Ince, Hueseyin; Abizaid, Alexandre; Toelg, Ralph; Lemos, Pedro Alves; von Birgelen, Clemens; Christiansen, Evald Hoj; Wijns, William; Neumann, Franz-Josef; Kaiser, Christoph; Eeckhout, Eric; Teik Lim, Soo; Escaned, Javier; Garcia-Garcia, Hector M.; Waksman, Ron			Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial	LANCET			English	Article							MULTI-IMAGING MODALITY; BIORESORBABLE SCAFFOLDS; STENT IMPLANTATION; VASCULAR SCAFFOLD; REVASCULARIZATION; GENERATION; SYSTEM	Background Absorbable scaffolds were designed to overcome the limitations of conventional, non-absorbable metal-based drug-eluting stents. So far, only polymeric absorbable scaffolds are commercially available. We aimed to assess the safety and performance of a novel second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de-novo coronary artery lesions. Methods We did this prospective, multicentre, non-randomised, first-in-man trial at 13 percutaneous coronary intervention centres in Belgium, Brazil, Denmark, Germany, Singapore, Spain, Switzerland, and the Netherlands. Eligible patients had stable or unstable angina or documented silent ischaemia, and a maximum of two de-novo lesions with a reference vessel diameter between 2.2 mm and 3.7 mm. Clinical follow-up was scheduled at months 1, 6, 12, 24, and 36. Patients were scheduled for angiographic follow-up at 6 months, and a subgroup of patients was scheduled for intravascular ultrasound, optical coherence tomography, and vasomotion assessment. All patients were recommended to take dual antiplatelet treatment for at least 6 months. The primary endpoint was in-segment late lumen loss at 6 months. We did analysis by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT01960504. Findings Between Oct 8, 2013, and May 22, 2015, we enrolled 123 patients with 123 coronary target lesions. At 6 months, mean in-segment late lumen loss was 0.27 mm (SD 0.37), and angiographically discernable vasomotion was documented in 20 (80%) of 25 patients. Intravascular ultrasound assessments showed a preservation of the scaffold area (mean 6.24 mm(2) [SD 1.15] post-procedure vs 6.21 mm(2) [1.22] at 6 months) with a low mean neointimal area (0.08 mm(2) [0.09]), and optical coherence tomography did not detect any intraluminal mass. Target lesion failure occurred in four (3%) patients: one (<1%) patient died from cardiac death, one (<1%) patient had periprocedural myocardial infarction, and two (2%) patients needed clinically driven target lesion revascularisation. No definite or probable scaff old thrombosis was observed. Interpretation Our findings show that implantation of the DREAMS 2G device in de-novo coronary lesions is feasible, with favourable safety and performance outcomes at 6 months. This novel absorbable metal scaff old could be an alternative to absorbable polymeric scaffolds for treatment of obstructive coronary disease.	[Haude, Michael] Lukaskrankenhaus GmbH, Med Clin 1, Stadt Kliniken Neuss, D-41464 Neuss, Germany; [Ince, Hueseyin] Vivantes Klinikum Friedrichshain & Urban, Dept Cardiol, Berlin, Germany; [Abizaid, Alexandre] Inst Cardiol Dante Pazzanese, Sao Paulo, Brazil; [Toelg, Ralph] Herzzentrum Segeberger Kliniken GmbH, Bad Segeberg, Germany; [Lemos, Pedro Alves] Univ Sao Paulo, Inst Coracao HCFMUSP, Sao Paulo, Brazil; [von Birgelen, Clemens] Med Spectrum Twente, Dept Cardiol, Thoraxctr Twente, Enschede, Netherlands; [Christiansen, Evald Hoj] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark; [Wijns, William] Onze Lieve Vrouw Hosp, Cardiovasc Res Ctr Aalst, Dept Cardiol, Aalst, Belgium; [Neumann, Franz-Josef] Univ Herzzentrum Freiburg Bad Krozingen, Klin Kardiol & Angiol 2, Bad Krozingen, Germany; [Kaiser, Christoph] Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland; [Eeckhout, Eric] Univ Lausanne Hosp, Dept Cardiol, Lausanne, Switzerland; [Teik Lim, Soo] Natl Heart Ctr Singapore, Dept Cardiol, Singapore, Singapore; [Escaned, Javier] Hosp Clin San Carlos, Div Cardiol, Madrid, Spain; [Garcia-Garcia, Hector M.] Cardialysis BV, Rotterdam, Netherlands; [Waksman, Ron] MedStar Washington Hosp Ctr, Intervent Cardiol, Washington, DC USA	Instituto Dante Pazzanese de Cardiologia; Segeberger Kliniken Group; Universidade de Sao Paulo; Medical Spectrum Twente; Aarhus University; Universitats Herzzentrum Freiburg; University of Freiburg; University of Basel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); National Heart Centre Singapore; Hospital Clinico San Carlos; Cardialysis; MedStar Washington Hospital Center	Haude, M (corresponding author), Lukaskrankenhaus GmbH, Med Clin 1, Stadt Kliniken Neuss, D-41464 Neuss, Germany.	mhaude@lukasneuss.de	Lemos, Pedro A./G-5758-2013; Kaiser, Christoph/AAA-9284-2022; Garcia-Garcia, Hector Manuel/AAG-7471-2020; Escaned, Javier/I-5424-2017	Lemos, Pedro A./0000-0002-6782-750X; Garcia-Garcia, Hector Manuel/0000-0001-5100-0471; Wijns, William/0000-0002-7267-4376	Biotronik AG	Biotronik AG	This trial was funded by Biotronik AG.	Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Ellis SG, 2005, J AM COLL CARDIOL, V45, P1193, DOI 10.1016/j.jacc.2004.11.063; Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8; Garcia-Garcia HM, 2014, JACC-CARDIOVASC IMAG, V7, P1130, DOI 10.1016/j.jcmg.2014.06.018; Gomez-Lara J, 2011, JACC-CARDIOVASC INTE, V4, P992, DOI 10.1016/j.jcin.2011.03.020; Haude M, 2013, LANCET, V381, P836, DOI 10.1016/S0140-6736(12)61765-6; Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651; Hofma SH, 2006, EUR HEART J, V27, P166, DOI 10.1093/eurheartj/ehi571; Iqbal J, 2014, EUR HEART J, V35, P765, DOI 10.1093/eurheartj/eht542; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Karanasos A, 2014, J AM COLL CARDIOL, V64, P2343, DOI 10.1016/j.jacc.2014.09.029; Mauri L, 2005, CIRCULATION, V111, P3435, DOI 10.1161/CIRCULATIONAHA.104.513952; Moussa ID, 2013, J AM COLL CARDIOL, V62, P1563, DOI 10.1016/j.jacc.2013.08.720; Onuma Y, 2013, JACC-CARDIOVASC INTE, V6, P999, DOI 10.1016/j.jcin.2013.05.017; Ormiston JA, 2008, LANCET, V371, P899, DOI 10.1016/S0140-6736(08)60415-8; Serruys PW, 2015, LANCET, V385, P43, DOI 10.1016/S0140-6736(14)61455-0; Serruys PW, 2014, EUROINTERVENTION, V9, P1271, DOI 10.4244/EIJV9I11A217; Serruys PW, 2010, CIRCULATION, V122, P2301, DOI 10.1161/CIRCULATIONAHA.110.970772; Verheye S, 2014, JACC-CARDIOVASC INTE, V7, P89, DOI 10.1016/j.jcin.2013.07.007; Waksman R, 2006, CATHETER CARDIO INTE, V68, P607, DOI 10.1002/ccd.20727; Waksman R, 2013, CIRC-CARDIOVASC INTE, V6, P644, DOI 10.1161/CIRCINTERVENTIONS.113.000693; Waksman R, 2009, JACC-CARDIOVASC INTE, V2, P312, DOI 10.1016/j.jcin.2008.09.015; Wiebe J, 2014, J AM COLL CARDIOL, V64, P2541, DOI 10.1016/j.jacc.2014.09.041; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Windecker S, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.001441; Wittchow E, 2013, EUROINTERVENTION, V8, P1441, DOI 10.4244/EIJV8I12A218; Wohrle J, 2015, EUROINTERVENTION, V11, P149, DOI 10.4244/EIJY14M12_10	27	238	250	4	72	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2016	387	10013					31	39		10.1016/S0140-6736(15)00447-X	http://dx.doi.org/10.1016/S0140-6736(15)00447-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ9ZU	26470647				2022-12-28	WOS:000367457300025
J	Gasteiger, G; Fan, XY; Dikiy, S; Lee, SY; Rudensky, AY				Gasteiger, Georg; Fan, Xiying; Dikiy, Stanislav; Lee, Sue Y.; Rudensky, Alexander Y.			Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs	SCIENCE			English	Article							HEMATOPOIETIC STEM; EXPRESSION; PROGENITOR; INDUCTION; MIGRATION; ILCS; SKIN	Innate lymphoid cells (ILCs) contribute to barrier immunity, tissue homeostasis, and immune regulation at various anatomical sites throughout the body. How ILCs maintain their presence in lymphoid and peripheral tissues thus far has been unclear. We found that in the lymphoid and nonlymphoid organs of adult mice, ILCs are tissue-resident cells that were maintained and expanded locally under physiologic conditions, upon systemic perturbation of immune homeostasis and during acute helminth infection. However, at later time points after infection, cells from hematogenous sources helped to partially replenish the pool of resident ILCs. Thus, ILCs are maintained by self-renewal in broadly different microenvironments and physiological settings. Such an extreme "sedentary" lifestyle is consistent with the proposed roles of ILCs as sentinels and local keepers of tissue function.	[Gasteiger, Georg; Fan, Xiying; Dikiy, Stanislav; Lee, Sue Y.; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Program Immunol, New York, NY 10065 USA; [Gasteiger, Georg; Fan, Xiying; Dikiy, Stanislav; Lee, Sue Y.; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10065 USA; [Gasteiger, Georg] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Med Microbiol & Hyg, D-55131 Mainz, Germany	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Johannes Gutenberg University of Mainz	Gasteiger, G (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Program Immunol, New York, NY 10065 USA.	gasteiger@uni-mainz.de; rudenska@mskcc.org	Dikiy, Stanislav/HIR-5027-2022; Dikiy, Stanislav/GWR-2104-2022	Dikiy, Stanislav/0000-0002-8287-6561; Fan, Xiying/0000-0003-3090-381X; Gasteiger, Georg/0000-0001-6986-127X	Cancer Research Institute; NIH [T32GM07739, R37AI034206]; Cancer Center Support Grant from the NIH National Cancer Institute [P30CA008748]; Ludwig Center at Memorial Sloan Kettering Cancer Center; Hilton-Ludwig Cancer Prevention Initiative (Conrad N. Hilton Foundation); Hilton-Ludwig Cancer Prevention Initiative (Ludwig Cancer Research); NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206, R01AI034206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant from the NIH National Cancer Institute; Ludwig Center at Memorial Sloan Kettering Cancer Center; Hilton-Ludwig Cancer Prevention Initiative (Conrad N. Hilton Foundation); Hilton-Ludwig Cancer Prevention Initiative (Ludwig Cancer Research); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Franklin, S. Dadi, M. Li, and A. Chaudhry for help with parabiosis or cell isolations; D. Artis, L. Monticelli, and B. Hoyos for providing and maintaining worms; K. Wu and A. Bravo for general laboratory support; and T. O'Sullivan, J. Sun, A. Diefenbach, W. Kastenmuller, and members of the Rudensky and Gasteiger laboratories for critical discussions. Data from this study are tabulated in the main paper or in the supplementary materials. This work was supported by an Irvington Fellowship from the Cancer Research Institute (G.G.), NIH Medical Scientist Training Program grant T32GM07739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program (X.F.), Cancer Center Support Grant P30CA008748 from the NIH National Cancer Institute, NIH grant R37AI034206 (A.Y.R.), the Ludwig Center at Memorial Sloan Kettering Cancer Center, and the Hilton-Ludwig Cancer Prevention Initiative (Conrad N. Hilton Foundation and Ludwig Cancer Research) (A.Y.R.). G.G. is an investigator with the Deutsche Forschungsgemeinschaft Emmy Noether Programme, and A.Y.R is an investigator with the Howard Hughes Medical Institute.	Abkowitz JL, 2003, BLOOD, V102, P1249, DOI 10.1182/blood-2003-01-0318; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bando JK, 2015, NAT IMMUNOL, V16, P153, DOI 10.1038/ni.3057; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Camberis M., 2003, CURR PROTOC IMMUNOL; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Gasteiger G, 2014, NAT REV IMMUNOL, V14, P631, DOI 10.1038/nri3726; Gasteiger G, 2013, J EXP MED, V210, P1179, DOI 10.1084/jem.20122571; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Kamran P, 2013, JOVE-J VIS EXP, DOI 10.3791/50556; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kim MH, 2015, IMMUNITY, V43, P107, DOI 10.1016/j.immuni.2015.06.009; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Mackley EC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6862; Marsland BJ, 2008, EUR J IMMUNOL, V38, P479, DOI 10.1002/eji.200737827; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Montaldo E, 2014, IMMUNITY, V41, P988, DOI 10.1016/j.immuni.2014.11.010; Monticelli LA, 2015, MUCOSAL IMMUNOL; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Roediger B., 2015, J ALLERGY CLIN IMMUN; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Teunissen MBM, 2014, J INVEST DERMATOL, V134, P2351, DOI 10.1038/jid.2014.146; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Villanova F, 2014, J INVEST DERMATOL, V134, P984, DOI 10.1038/jid.2013.477; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081	34	501	515	4	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					981	985		10.1126/science.aac9593	http://dx.doi.org/10.1126/science.aac9593			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW4IP	26472762	Green Accepted			2022-12-28	WOS:000364955200050
J	Helfand, I; Sidel, VW				Helfand, Ira; Sidel, Victor W.			Docs and Nukes - Still a Live Issue	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Helfand, Ira; Sidel, Victor W.] Phys Social Responsibil, Washington, DC 20005 USA; [Helfand, Ira; Sidel, Victor W.] Int Phys Prevent Nucl War, Somerville, MA USA; [Helfand, Ira; Sidel, Victor W.] Phys Prevent Nucl War, Leeds, W Yorkshire, England; [Helfand, Ira] Family Care Med Ctr, Springfield, MA USA; [Sidel, Victor W.] Montefiore Med Ctr, Dept Social Med, New York, NY USA	Montefiore Medical Center	Helfand, I (corresponding author), Phys Social Responsibil, Washington, DC 20005 USA.							Federation of American Scientists, STAT WORLD NUCL FORC; Helfand I, 2002, MED GLOBAL SURVIVAL, V7, P68; Helfand I, NUCL FAMINE 2 BILLIO; Robock A, 2007, ATMOS CHEM PHYS, V7, P2003, DOI 10.5194/acp-7-2003-2007; Robock A, 2007, J GEOPHYS RES, V112	5	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2015	373	20					1901	1903		10.1056/NEJMp1509202	http://dx.doi.org/10.1056/NEJMp1509202			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV7IL	26465263				2022-12-28	WOS:000364445500004
J	Lovelock, CE; Cahoon, DR; Friess, DA; Guntenspergen, GR; Krauss, KW; Reef, R; Rogers, K; Saunders, ML; Sidik, F; Swales, A; Saintilan, N; Thuyen, LX; Triet, T				Lovelock, Catherine E.; Cahoon, Donald R.; Friess, Daniel A.; Guntenspergen, Glenn R.; Krauss, Ken W.; Reef, Ruth; Rogers, Kerrylee; Saunders, Megan L.; Sidik, Frida; Swales, Andrew; Saintilan, Neil; Thuyen, Le Xuan; Triet, Tran			The vulnerability of Indo-Pacific mangrove forests to sea-level rise	NATURE			English	Article							NORTHERN AUSTRALIA; SALT-MARSH; SEDIMENTATION; EVOLUTION; ELEVATION; IMPACTS; ADJUST	Sea-level rise can threaten the long-term sustainability of coastal communities and valuable ecosystems such as coral reefs, salt marshes and mangroves(1,2). Mangrove forests have the capacity to keep pace with sea-level rise and to avoid inundation through vertical accretion of sediments, which allows them to maintain wetland soil elevations suitable for plant growth(3). The Indo-Pacific region holds most of the world's mangrove forests(4), but sediment delivery in this region is declining, owing to anthropogenic activities such as damming of rivers(5). This decline is of particular concern because the Indo-Pacific region is expected to have variable, but high, rates of future sea-level rise(6,7). Here we analyse recent trends in mangrove surface elevation changes across the Indo-Pacific region using data from a network of surface elevation table instruments(8-10). We find that sediment availability can enable mangrove forests to maintain rates of soil-surface elevation gain that match or exceed that of sea-level rise, but for 69 per cent of our study sites the current rate of sea-level rise exceeded the soil surface elevation gain. We also present a model based on our field data, which suggests that mangrove forests at sites with low tidal range and low sediment supply could be submerged as early as 2070.	[Lovelock, Catherine E.; Reef, Ruth; Swales, Andrew] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Lovelock, Catherine E.; Reef, Ruth; Saunders, Megan L.] Univ Queensland, Global Change Inst, Brisbane, Qld 4072, Australia; [Cahoon, Donald R.; Guntenspergen, Glenn R.] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD 20708 USA; [Friess, Daniel A.] Natl Univ Singapore, Dept Geog, Singapore 117570, Singapore; [Reef, Ruth] Univ Cambridge, Dept Geog, Cambridge Coastal Res Unit, Cambridge CB2 3EN, England; [Rogers, Kerrylee] Univ Wollongong, Sch Earth & Environm Sci, Wollongong, NSW 2522, Australia; [Sidik, Frida] Minist Marine Affairs & Fisheries, Inst Marine Res & Observat, Bali 82251, Indonesia; [Swales, Andrew] Natl Inst Water & Atmospher Res, Hamilton 3251, New Zealand; [Saintilan, Neil] Macquarie Univ, Dept Environm Sci, Sydney, NSW 2109, Australia; [Thuyen, Le Xuan; Triet, Tran] Vietnam Natl Univ, Univ Sci, Ho Chi Minh City, Vietnam	University of Queensland; University of Queensland; United States Department of the Interior; United States Geological Survey; National University of Singapore; University of Cambridge; University of Wollongong; Ministry of Marine Affairs and Fisheries; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Macquarie University; Vietnam National University Hochiminh City	Lovelock, CE (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia.	c.lovelock@uq.edu.au	Friess, Dan/G-2056-2011; Lovelock, Catherine E./AAF-7294-2020; Lovelock, Catherine E/G-7370-2012; Saunders, Megan/I-7731-2012; Rogers, Kerrylee/AAC-8093-2022	Lovelock, Catherine E./0000-0002-2219-6855; Lovelock, Catherine E/0000-0002-2219-6855; Saunders, Megan/0000-0002-8549-5609; Friess, Daniel/0000-0002-3087-5233; Sidik, Frida/0000-0001-7329-9937; Saintilan, Neil/0000-0001-9226-2005; Andrew, Swales/0000-0003-1385-8017; Reef, Ruth/0000-0001-6639-520X; Tran, Minh-Triet/0000-0003-3046-3041; Rogers, Kerrylee/0000-0003-1350-4737	Australian Research Council [FS100100024]; US Geological Survey Climate and Land Use Research and Development Program	Australian Research Council(Australian Research Council); US Geological Survey Climate and Land Use Research and Development Program	The Global Change Institute at The University of Queensland supported this collaboration, as did the Australian Research Council SuperScience grant number FS100100024 to the Australia Sea Level Rise Partnerships. D.R.C., G.R.G. and K.W.K. acknowledge support from the US Geological Survey Climate and Land Use Research and Development Program. Any use of trade, product, or firm names is for descriptive purposes only and does not imply endorsement by the US Government.	Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; Ball MC, 1988, TREES-STRUCT FUNCT, V2, P129, DOI 10.1007/BF00196018; Black R, 2011, NATURE, V478, P447, DOI 10.1038/478477a; Blondeau-Patissier D, 2014, REMOTE SENS-BASEL, V6, P2963, DOI 10.3390/rs6042963; Brander LM, 2012, ECOSYST SERV, V1, P62, DOI 10.1016/j.ecoser.2012.06.003; Cahoon D. R., 1997, MANGROVES SALT MARSH, V1, P173, DOI [10.1023/A:1009904816246, DOI 10.1023/A:1009904816246]; Cahoon D.R., 2010, NATL WETLANDS NEWSLE, V32, P8; Cahoon DR, 2006, ESTUAR COAST, V29, P889, DOI 10.1007/BF02798648; Cahoon DR, 2002, J SEDIMENT RES, V72, P730, DOI 10.1306/020702720730; Callaway JC, 2013, SSSA BOOK S, V10, P901, DOI 10.2136/sssabookser10.c46; Carrere L., 2012, ESA; Church J. A, 2013, CLIMATE CHANGE 2013, DOI DOI 10.1017/CBO9781107415324; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Fagherazzi S, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000359; Giosan L, 2014, NATURE, V516, P31, DOI 10.1038/516031a; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Horton BP, 2014, QUATERNARY SCI REV, V84, P1, DOI 10.1016/j.quascirev.2013.11.002; Jennerjahn TC, 2013, ESTUAR COAST SHELF S, V130, P152, DOI 10.1016/j.ecss.2013.04.007; Kirwan ML, 2007, P NATL ACAD SCI USA, V104, P6118, DOI 10.1073/pnas.0700958104; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Kondolf GM, 2014, WATER RESOUR RES, V50, P5158, DOI 10.1002/2013WR014651; Krauss KW, 2014, NEW PHYTOL, V202, P19, DOI 10.1111/nph.12605; Lang'at JKS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107868; Lugo A. E., 1974, Annual Review of Ecology and Systematics, V5, P39, DOI 10.1146/annurev.es.05.110174.000351; Mckee KL, 2007, GLOBAL ECOL BIOGEOGR, V16, P545, DOI 10.1111/j.1466-8238.2007.00317.x; Milliman J. D., 2011, RIVER DISCHARGE COAS, DOI 10.1017/CBO9780511781247; Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782; Rogers K, 2005, ESTUARIES, V28, P551, DOI 10.1007/BF02696066; Saintilan N, 2014, GLOBAL CHANGE BIOL, V20, P147, DOI 10.1111/gcb.12341; Stammer D, 2013, ANNU REV MAR SCI, V5, P21, DOI 10.1146/annurev-marine-121211-172406; Swales A, 2015, EARTH SURF PROC LAND, V40, P1672, DOI 10.1002/esp.3759; Webb EL, 2013, NAT CLIM CHANGE, V3, P458, DOI [10.1038/NCLIMATE1756, 10.1038/nclimate1756]; Winterwerp JC, 2013, WETLANDS, V33, P515, DOI 10.1007/s13157-013-0409-x; Woodroffe C., 1993, TROPICAL MANGROVE EC; Woodroffe C. D., ANN REV MAR SCI; WOODROFFE CD, 1995, EARTH SURF PROC LAND, V20, P65, DOI 10.1002/esp.3290200107; Woodruff JD, 2013, NATURE, V504, P44, DOI 10.1038/nature12855	38	427	448	28	505	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					559	U217		10.1038/nature15538	http://dx.doi.org/10.1038/nature15538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26466567	Green Published			2022-12-28	WOS:000364026100047
J	Bloomberg, MR; Bishop, J				Bloomberg, Michael R.; Bishop, Julie			Understanding death, extending life	LANCET			English	Editorial Material									[Bloomberg, Michael R.] Bloomberg Philanthropies, York, NY 10075 USA; [Bishop, Julie] Australian Govt, Dept Foreign Affairs & Trade, Barton, ACT, Australia		Bloomberg, MR (corresponding author), Bloomberg Philanthropies, York, NY 10075 USA.							AbouZahr C, 2015, LANCET, V386, P1407, DOI 10.1016/S0140-6736(15)60170-2; Mikkelsen L, 2015, LANCET, V386, P1395, DOI 10.1016/S0140-6736(15)60171-4; Phillips DE, 2015, LANCET, V386, P1386, DOI 10.1016/S0140-6736(15)60172-6; World Health Organization, 2014, CIV REG WHY COUNT BI	4	9	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2015	386	10003					E18	E19		10.1016/S0140-6736(15)00400-6	http://dx.doi.org/10.1016/S0140-6736(15)00400-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CT5VC	26434355				2022-12-28	WOS:000362878200001
J	Amin, MN; Vassallo, J; Butler, L; Catania, JD				Amin, Muhammad Nauman; Vassallo, Joseph; Butler, Louise; Catania, James Dominic			CASE REVIEW A man with headache and double vision	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							3RD NERVE PALSY; UNRUPTURED INTRACRANIAL ANEURYSMS; OCULOMOTOR NERVE; CEREBRAL ANEURYSMS; CT ANGIOGRAPHY; PUPIL; COILING; PARESIS; MANAGEMENT; SIGNS		[Amin, Muhammad Nauman; Vassallo, Joseph; Butler, Louise; Catania, James Dominic] Stepping Hill Hosp, Stockport NHS Fdn Trust, Dept Elderly Med, Stockport SK2 7JE, Lancs, England		Amin, MN (corresponding author), Stepping Hill Hosp, Stockport NHS Fdn Trust, Dept Elderly Med, Stockport SK2 7JE, Lancs, England.	nomi_189@yahoo.com						Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Birchall D, 1999, AM J NEURORADIOL, V20, P411; Bondeson J, 1997, SCAND J RHEUMATOL, V26, P327, DOI 10.3109/03009749709105324; Brinjikji W, 2011, AM J NEURORADIOL, V32, P1071, DOI 10.3174/ajnr.A2453; David CA, 1999, J NEUROSURG, V91, P396, DOI 10.3171/jns.1999.91.3.0396; Dovey Z, 2001, ARCH NEUROL-CHICAGO, V58, P559, DOI 10.1001/archneur.58.4.559; Hwang JS, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-99; Ikeda K, 2001, NEUROLOGY, V57, P1741, DOI 10.1212/WNL.57.9.1741; Johnston SC, 1999, NEUROLOGY, V52, P1799, DOI 10.1212/WNL.52.9.1799; Johnston SC, 2000, ANN NEUROL, V48, P11; Kasner SE, 1997, NEUROIMAG CLIN N AM, V7, P679; KWAN ESK, 1987, AM J NEURORADIOL, V8, P459; Levy J, 2004, EYE, V18, P325, DOI 10.1038/sj.eye.6700625; Levy RL, 2005, NEUROLOGY, V65, P169, DOI 10.1212/01.wnl.0000167288.10702.03; Li Q, 2009, RADIOLOGY, V252, P808, DOI 10.1148/radiol.2523081911; Louw DF, 2001, NEUROSURG FOCUS, V11, pE4, DOI [10.3171/foc.2001.11.2.5, DOI 10.3171/FOC.2001.11.2.5]; LUSTBADER JM, 1988, ARCH OPHTHALMOL-CHIC, V106, P583; Madge SN, 2006, BRIT J HOSP MED, V67, P268, DOI 10.12968/hmed.2006.67.5.21069; Mathew MRK, 2008, OPHTHALMOLOGY, V115, P1411, DOI 10.1016/j.ophtha.2007.12.021; McKinney A, 2008, RADIOLOGY, V246, P982, DOI 10.1148/radiol.2463071392; Menke J, 2011, ANN NEUROL, V69, P646, DOI 10.1002/ana.22270; Miller N, 1999, WALSH HOYTS CLIN NEU, P509; Newman SA, 1998, WALSH HOYTS CLIN NEU, P3075; OKAWARA SH, 1973, J NEUROSURG, V38, P575, DOI 10.3171/jns.1973.38.5.0575; Polak P, 2005, JCR-J CLIN RHEUMATOL, V11, P242; Sailer AMH, 2014, STROKE, V45, P119, DOI 10.1161/STROKEAHA.113.003133; Satyarthee GD, 2004, J CLIN NEUROSCI, V11, P776, DOI 10.1016/j.jocn.2003.11.016; TROBE JD, 1988, ARCH OPHTHALMOL-CHIC, V106, P601, DOI 10.1001/archopht.1988.01060130655019; Trobe JD, 2009, N AM NEUR ANN M, P21; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Williams Lindsy N, 2013, Neurol Clin Pract, V3, P99; Woodruff MM, 2008, J EMERG MED, V35, P239, DOI 10.1016/j.jemermed.2007.04.020	33	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 16	2015	351								h5375	10.1136/bmj.h5375	http://dx.doi.org/10.1136/bmj.h5375			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT8YC	26475225				2022-12-28	WOS:000363101800002
J	Richter, JD; Coller, J				Richter, Joel D.; Coller, Jeff			Pausing on Polyribosomes: Make Way for Elongation in Translational Control	CELL			English	Review							MENTAL-RETARDATION PROTEIN; FRAGILE-X-SYNDROME; MESSENGER-RNA; CODON OPTIMALITY; INITIATION; MECHANISM; REVEALS; FMRP; LOCALIZATION; DETERMINANT	Among the three phases of mRNA translation-initiation, elongation, and termination-initiation has traditionally been considered to be rate limiting and thus the focus of regulation. Emerging evidence, however, demonstrates that control of ribosome translocation (polypeptide elongation) can also be regulatory and indeed exerts a profound influence on development, neurologic disease, and cell stress. The correspondence of mRNA codon usage and the relative abundance of their cognate tRNAs is equally important for mediating the rate of polypeptide elongation. Here, we discuss recent results showing that ribosome pausing is a widely used mechanism for controlling translation and, as a result, biological transitions in health and disease.	[Richter, Joel D.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Coller, Jeff] Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA	University of Massachusetts System; University of Massachusetts Worcester; Case Western Reserve University	Richter, JD (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	joel.richter@umassmed.edu; jmc71@case.edu		Coller, Jeff/0000-0001-5662-8110	National Institutes of Health [R01 GM46779, R01 NS079415, U54 082013, R01 GM080465]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD082013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046779, R01GM080465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. Lori Lorenz, Botao Liu, and Sophie Martin for comments on the manuscript. Work from the authors' laboratories was supported by grants from the National Institutes of Health (R01 GM46779, R01 NS079415, and U54 082013 to J.D.R. and R01 GM080465 to J.C.).	AKASHI H, 1994, GENETICS, V136, P927; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Andrews S, 2011, RNA, V17, P967, DOI 10.1261/rna.2478611; BALLINGER DG, 1983, CELL, V33, P103, DOI 10.1016/0092-8674(83)90339-2; Baragana B, 2015, NATURE, V522, P315, DOI 10.1038/nature14451; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Bhattacharya A, 2012, NEURON, V76, P325, DOI 10.1016/j.neuron.2012.07.022; Braat AK, 2004, DEV CELL, V7, P125, DOI 10.1016/j.devcel.2004.06.009; BRANDIS JW, 1978, DEV BIOL, V67, P99, DOI 10.1016/0012-1606(78)90303-2; Buxbaum AR, 2014, SCIENCE, V343, P419, DOI 10.1126/science.1242939; Chan CTY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1938; Chapman RE, 1997, CURR BIOL, V7, P850, DOI 10.1016/S0960-9822(06)00373-3; Chen E, 2014, MOL CELL, V54, P407, DOI 10.1016/j.molcel.2014.03.023; Clark IE, 2000, CURR BIOL, V10, P1311, DOI 10.1016/S0960-9822(00)00754-5; Corbin F, 1997, HUM MOL GENET, V6, P1465, DOI 10.1093/hmg/6.9.1465; Darnell JC, 2014, SCIENCE, V345, P378, DOI 10.1126/science.1257193; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Faller WJ, 2015, NATURE, V517, P497, DOI 10.1038/nature13896; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Gingold H, 2014, CELL, V158, P1281, DOI 10.1016/j.cell.2014.08.011; Graber TE, 2013, P NATL ACAD SCI USA, V110, P16205, DOI 10.1073/pnas.1307747110; Gross C, 2015, CELL REP, V11, P681, DOI 10.1016/j.celrep.2015.03.065; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Huang J, 2015, NEURON, V86, P726, DOI 10.1016/j.neuron.2015.03.049; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ishimura R, 2014, SCIENCE, V345, P455, DOI 10.1126/science.1249749; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Koutmou KS, 2015, ELIFE, V4, DOI 10.7554/eLife.05534; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Krisko A, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r44; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Liu BT, 2013, MOL CELL, V49, P453, DOI 10.1016/j.molcel.2012.12.001; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Novoa EM, 2012, TRENDS GENET, V28, P574, DOI 10.1016/j.tig.2012.07.006; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Nalavadi VC, 2012, J NEUROSCI, V32, P2582, DOI 10.1523/JNEUROSCI.5057-11.2012; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Parmley JL, 2006, MOL BIOL EVOL, V23, P301, DOI 10.1093/molbev/msj035; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Pelletier J, 2015, CANCER RES, V75, P250, DOI 10.1158/0008-5472.CAN-14-2789; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; RICHTER JD, 1982, DEV BIOL, V89, P159, DOI 10.1016/0012-1606(82)90304-9; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Schmitt BM, 2014, GENOME RES, V24, P1797, DOI 10.1101/gr.176784.114; Shalgi R, 2013, MOL CELL, V49, P439, DOI 10.1016/j.molcel.2012.11.028; SIEGEL V, 1988, CELL, V52, P39, DOI 10.1016/0092-8674(88)90529-6; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Zaborske JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002015; Zhang YX, 2014, NAT STRUCT MOL BIOL, V21, P1042, DOI 10.1038/nsmb.2908	67	115	117	2	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2					292	300		10.1016/j.cell.2015.09.041	http://dx.doi.org/10.1016/j.cell.2015.09.041			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26451481	Bronze, Green Accepted			2022-12-28	WOS:000362952700008
J	Wald, C				Wald, Chelsea			BEAUTY 4 BIG QUESTIONS	NATURE			English	Editorial Material																			0	1	2	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					S17	S17		10.1038/526S17a	http://dx.doi.org/10.1038/526S17a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VB9ZH	26444371	Bronze			2022-12-28	WOS:000425303500001
J	Zhai, JX; Bischof, S; Wang, HF; Feng, SH; Lee, TF; Teng, C; Chen, XY; Park, SY; Liu, LS; Gallego-Bartolome, J; Liu, WL; Henderson, IR; Meyers, BC; Ausin, I; Jacobsen, SE				Zhai, Jixian; Bischof, Sylvain; Wang, Haifeng; Feng, Suhua; Lee, Tzuu-fen; Teng, Chong; Chen, Xinyuan; Park, Soo Young; Liu, Linshan; Gallego-Bartolome, Javier; Liu, Wanlu; Henderson, Ian R.; Meyers, Blake C.; Ausin, Israel; Jacobsen, Steven E.			A One Precursor One siRNA Model for Pol IV-Dependent siRNA Biogenesis	CELL			English	Article							RNA-POLYMERASE; TRANSCRIPTION; REVEAL; IDENTIFICATION; TRANSPOSONS; INITIATION; OCCUPANCY; SEQUENCES; INTERACT; 21U-RNAS	RNA-directed DNA methylation in Arabidopsis thaliana is driven by the plant-specific RNA Polymerase IV (Pol IV). It has been assumed that a Pol IV transcript can give rise to multiple 24-nt small interfering RNAs (siRNAs) that target DNA methylation. Here, we demonstrate that Pol IV-dependent RNAs (P4RNAs) from wild-type Arabidopsis are surprisingly short in length (30 to 40 nt) and mirror 24-nt siRNAs in distribution, abundance, strand bias, and 50-adenine preference. P4RNAs exhibit transcription start sites similar to Pol II products and are featured with 50-monophosphates and 30-misincorporated nucleotides. The 3'-misincorporation preferentially occurs at methylated cytosines on the template DNA strand, suggesting a co-transcriptional feedback to siRNA biogenesis by DNA methylation to reinforce silencing locally. These results highlight an unusual mechanism of Pol IV transcription and suggest a "one precursor, one siRNA'' model for the biogenesis of 24-nt siRNAs in Arabidopsis.	[Zhai, Jixian; Bischof, Sylvain; Wang, Haifeng; Feng, Suhua; Gallego-Bartolome, Javier; Liu, Wanlu; Henderson, Ian R.; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Wang, Haifeng; Ausin, Israel] Fujian Agr & Forestry Univ, Haixia Inst Sci & Technol, Fuzhou 350002, Peoples R China; [Lee, Tzuu-fen; Teng, Chong; Meyers, Blake C.] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19716 USA; [Lee, Tzuu-fen; Teng, Chong; Meyers, Blake C.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19716 USA; [Teng, Chong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Park, Soo Young; Liu, Linshan] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Gallego-Bartolome, Javier] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Gallego-Bartolome, Javier] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Fujian Agriculture & Forestry University; University of Delaware; University of Delaware; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Salk Institute; Howard Hughes Medical Institute; Salk Institute; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Ausin, I (corresponding author), Fujian Agr & Forestry Univ, Haixia Inst Sci & Technol, Fuzhou 350002, Peoples R China.	israelausin@fafu.edu.cn; jacobsen@ucla.edu	Zhai, Jixian/HCH-9272-2022; Gallego-Bartolomé, Javier/AAV-7369-2020; Ausin, Israel/A-7065-2011; Meyers, Blake/B-6535-2012; Teng, Chong/L-8239-2019; Teng, Chong/B-4501-2011	Ausin, Israel/0000-0002-3707-1780; Meyers, Blake/0000-0003-3436-6097; Teng, Chong/0000-0001-9898-6442; Gallego-Bartolome, Javier/0000-0003-2225-7168; Zhai, Jixian/0000-0002-0217-0666; Henderson, Ian/0000-0001-5066-1489	NIH [GM60398]; NSF [1051576]; Swiss National Science Foundation; Gordon and Betty Moore Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM060398, R01GM060398] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Jacobsen lab for insightful discussions. We thank Molly Megraw for suggestions on TSS analysis and Mahnaz Akhavan for technical assistance. Wethank Dr. Jeffrey A. Long and Jared Sewell for their advice and guidance in performing ChIP-seq experiments and preparing genomic libraries. J.Z. thanks Dr. Chomdao Chommy and Seksan Sapsubbsakul for encouragement. High-throughput sequencing was performed at the UCLA BSCRC BioSequencing Core Facility. This work was supported by NIH grant GM60398 to S.E.J and NSF award 1051576 to B.C.M. S.B. is supported by a postdoctoral fellowship of the Swiss National Science Foundation. J.G-B is a Human Frontiers Science Program fellow (LT000425/2012-L). J.Z. is a Life Science Research Foundation postdoctoral fellow, sponsored by the Gordon and Betty Moore Foundation. S.E.J. is an Investigator of the Howard Hughes Medical Institute.	Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Colome-Tatche M, 2012, P NATL ACAD SCI USA, V109, P16240, DOI 10.1073/pnas.1212955109; Creasey KM, 2014, NATURE, V508, P411, DOI 10.1038/nature13069; Cumbie JS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1670-6; Gu WF, 2012, CELL, V151, P1488, DOI 10.1016/j.cell.2012.11.023; Haag JR, 2012, MOL CELL, V48, P811, DOI 10.1016/j.molcel.2012.09.027; Han BW, 2015, SCIENCE, V348, P817, DOI 10.1126/science.aaa1264; Havecker ER, 2010, PLANT CELL, V22, P321, DOI 10.1105/tpc.109.072199; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Ji LZ, 2011, PURE APPL MATH Q, V7, P1, DOI 10.1371/journal.pgen.1001358; Johnson LM, 2014, NATURE, V507, P124, DOI 10.1038/nature12931; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Law JA, 2013, NATURE, V498, P385, DOI 10.1038/nature12178; Law JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002195; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Li C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000044; Li SF, 2015, GENOME RES, V25, P235, DOI 10.1101/gr.182238.114; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; MARTIN CT, 1989, BIOCHEMISTRY-US, V28, P2760, DOI 10.1021/bi00433a002; McCue AD, 2015, EMBO J, V34, P20, DOI 10.15252/embj.201489499; Mohn F, 2015, SCIENCE, V348, P812, DOI 10.1126/science.aaa1039; Nagano H, 2014, NUCLEIC ACIDS RES, V42, P1845, DOI 10.1093/nar/gkt1077; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Ranjith-Kumar CT, 2002, J VIROL, V76, P12526, DOI 10.1128/JVI.76.24.12526-12536.2002; Ream TS, 2009, MOL CELL, V33, P192, DOI 10.1016/j.molcel.2008.12.015; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Stroud H, 2013, CELL, V152, P352, DOI 10.1016/j.cell.2012.10.054; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yamamoto YY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-67; Ye RQ, 2012, MOL CELL, V46, P859, DOI 10.1016/j.molcel.2012.04.013; Zheng BL, 2009, GENE DEV, V23, P2850, DOI 10.1101/gad.1868009; Zhong XH, 2014, CELL, V157, P1050, DOI 10.1016/j.cell.2014.03.056	43	164	168	3	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2					445	455		10.1016/j.cell.2015.09.032	http://dx.doi.org/10.1016/j.cell.2015.09.032			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26451488	Green Accepted, Bronze			2022-12-28	WOS:000362952700020
J	Pollock, K				Pollock, Kristian			Is home always the best and preferred place of death?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TERMINALLY-ILL PATIENTS; OLDER PEOPLES VIEWS; LIFE CARE; PREFERENCES; END; CANCER; PERSPECTIVES; EXPERIENCES; PATIENT; HOSPICE		Univ Nottingham, Sch Hlth Sci, Queens Med Ctr, Nottingham NG7 2HA, England	University of Nottingham	Pollock, K (corresponding author), Univ Nottingham, Sch Hlth Sci, Queens Med Ctr, Nottingham NG7 2HA, England.	kristian.pollock@nottingham.ac.uk		Pollock, Kristian/0000-0002-6836-8595	Alzheimer&quot;s Society [118] Funding Source: researchfish	Alzheimer&quot;s Society		Bell CL, 2010, J PAIN SYMPTOM MANAG, V39, P591, DOI 10.1016/j.jpainsymman.2009.07.007; Borgstrom E, 2015, CURRENT SOCIOL  0713; Botti S, 2006, J CONSUM RES, V33, P211, DOI 10.1086/506302; Botti S, 2009, J CONSUM RES, V36, P337, DOI 10.1086/598969; Brereton L, 2012, J ADV NURS, V68, P981, DOI 10.1111/j.1365-2648.2011.05900.x; Broom A, 2013, SOCIOL HEALTH ILL, V35, P499, DOI 10.1111/j.1467-9566.2012.01497.x; Burt J, 2010, AGE AGEING, V39, P86, DOI 10.1093/ageing/afp212; Calanzani N, 2013, PALLIATIVE CARE END; Chapple Alison, 2011, BMJ Support Palliat Care, V1, P291, DOI 10.1136/bmjspcare-2011-000091; Collier A, 2015, PALLIATIVE MED, V29, P695, DOI 10.1177/0269216315575677; Cox K, 2013, BMJ SUPPORT PALLIAT, V3, P37, DOI 10.1136/bmjspcare-2012-000203; Department of Health, 2012, END LIF CAR STRAT 4; Department of Health, 2013, MOR CAR LESS PATHW R; Department of Health, 2008, END LIF CAR STRAT PR; Drought Theresa S, 2002, Gerontologist, V42 Spec No 3, P114; Emslie C, 2001, CORONARY HLTH CARE, V5, P25, DOI DOI 10.1054/CHEC.2000.0109; Gao W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001410; Gomes B, 2006, BMJ-BRIT MED J, V332, P515, DOI 10.1136/bmj.38740.614954.55; Gomes B, 2012, ANN ONCOL, V23, P2006, DOI 10.1093/annonc/mdr602; Gomes B, 2008, PALLIATIVE MED, V22, P33, DOI 10.1177/0269216307084606; Gomes B, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-7; Gott M, 2008, SOC SCI MED, V67, P1113, DOI 10.1016/j.socscimed.2008.05.024; Gott M, 2004, PALLIATIVE MED, V18, P460, DOI 10.1191/0269216304pm889oa; Hatziandreu E, 2008, POTENTIAL COST SAVIN; Higginson I J, 2000, J Palliat Med, V3, P287, DOI 10.1089/jpm.2000.3.287; Leadbeater C, 2010, DYING FOR CHANGE; Macdonald E, 2013, DYING DISTRESS LIMIT; Marie Curie Cancer Care, 2014, DIFF CONV DYING PAT; Munday D, 2007, J ROY SOC MED, V100, P211, DOI 10.1258/jrsm.100.5.211; Munday Daniel, 2009, BMJ, V339, pb2391, DOI 10.1136/bmj.b2391; Nakamura S, 2010, GERIATR GERONTOL INT, V10, P154, DOI 10.1111/j.1447-0594.2009.00570.x; National Council for Palliative Care, 2014, DYING MATT SURV; National Council for Palliative Care, 2011, DEATH DYING SURV; Office of National Statistics, 2014, NAT SURV BER PEOPL V; Petkova H., 2012, UNDERSTANDING PLACE; Pollock K, 2015, HLTH SERV DELIVERY R, V3, P31, DOI DOI 10.3310/HSDR03310; Robinson J, 2015, PALLIATIVE MED, V29, P703, DOI 10.1177/0269216315575841; Robinson J, 2014, PALLIATIVE MED, V28, P18, DOI 10.1177/0269216313487568; Salmon P, 2004, J ROY SOC MED, V97, P53, DOI 10.1258/jrsm.97.2.53; Seymour J, 2007, SOCIOL HEALTH ILL, V29, P872, DOI 10.1111/j.1467-9566.2007.01045.x; Small N, 2000, TOO ILL TALK USER IN; Stajduhar KI, 2008, PALLIATIVE MED, V22, P85, DOI 10.1177/0269216307084612; Thomas C, 2004, SOC SCI MED, V58, P2431, DOI 10.1016/j.socscimed.2003.09.005; van der Heide A, 2007, SUPPORT CARE CANCER, V15, P1413, DOI 10.1007/s00520-007-0254-7; Vig EK, 2004, ARCH INTERN MED, V164, P977, DOI 10.1001/archinte.164.9.977; Waghorn M, 2011, BMJ SUPPORT PALLIAT, P1; Wood C, 2013, A TIME AND A PLACE	47	101	102	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 7	2015	351								h4855	10.1136/bmj.h4855	http://dx.doi.org/10.1136/bmj.h4855			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CT3SJ	26446163	Green Submitted, Green Accepted			2022-12-28	WOS:000362726900001
J	Atroshi, I; Hofer, M; Larsson, GU; Ranstam, J				Atroshi, Isam; Hofer, Manfred; Larsson, Gert-Uno; Ranstam, Jonas			Extended Follow-up of a Randomized Clinical Trial of Open vs Endoscopic Release Surgery for Carpal Tunnel Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Atroshi, Isam] Lund Univ, Dept Orthoped Hassleholm Kristionstad, SE-22100 Lund, Sweden; [Hofer, Manfred] Kristianstad Hosp, Dept Phys & Occupat Therapy, Kristianstad, Sweden; [Larsson, Gert-Uno] Hassleholm Hosp, Dept Orthoped, Hassleholm, Sweden; [Ranstam, Jonas] Lund Univ, Dept Clin Sci Lund Orthoped, Lund, Sweden	Lund University; Lund University	Atroshi, I (corresponding author), Lund Univ, Dept Orthoped Hassleholm Kristionstad, Clin Sci, SE-22100 Lund, Sweden.	isam.atroshi@med.lu.se	Ranstam, Jonas/A-4386-2009	Ranstam, Jonas/0000-0002-8287-7273				Atroshi I, 2006, BRIT MED J, V332, P1473, DOI 10.1136/bmj.38863.632789.1F; Atroshi I, 2009, J HAND SURG-AM, V34A, P266, DOI 10.1016/j.jhsa.2008.10.026; Jain NB, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-4; Leinberry CF, 2012, J HAND SURG-AM, V37A, P1997, DOI 10.1016/j.jhsa.2012.07.016; LEVINE DW, 1993, J BONE JOINT SURG AM, V75A, P1585, DOI 10.2106/00004623-199311000-00002; Louie Dexter, 2012, Hand (N Y), V7, P242, DOI 10.1007/s11552-012-9429-x	6	31	31	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2015	314	13					1399	1401		10.1001/jama.2015.12208	http://dx.doi.org/10.1001/jama.2015.12208			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2PH	26441187	Bronze			2022-12-28	WOS:000362644700020
J	Roopnarine, PD; Angielczyk, KD				Roopnarine, Peter D.; Angielczyk, Kenneth D.			Community stability and selective extinction during the Permian-Triassic mass extinction	SCIENCE			English	Article							SOUTH-AFRICA; KAROO-BASIN; BOUNDARY	The fossil record contains exemplars of extreme biodiversity crises. Here, we examined the stability of terrestrial paleocommunities from South Africa during Earth's most severe mass extinction, the Permian-Triassic. We show that stability depended critically on functional diversity and patterns of guild interaction, regardless of species richness. Paleocommunities exhibited less transient instability-relative to model communities with alternative community organization-and significantly greater probabilities of being locally stable during the mass extinction. Functional patterns that have evolved during an ecosystem's history support significantly more stable communities than hypothetical alternatives.	[Roopnarine, Peter D.] Calif Acad Sci, Inst Biodivers Sci & Sustainabil, San Francisco, CA 94118 USA; [Angielczyk, Kenneth D.] Field Museum Nat Hist, Integrat Res Ctr, Chicago, IL 60605 USA	California Academy of Sciences; Field Museum of Natural History (Chicago)	Roopnarine, PD (corresponding author), Calif Acad Sci, Inst Biodivers Sci & Sustainabil, 55 Mus Concourse Dr, San Francisco, CA 94118 USA.	proopnarine@calacademy.org		Roopnarine, Peter/0000-0002-9811-1176	NSF [1336986]; Division Of Earth Sciences [1336986] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Data are available in the supplementary materials. We thank two anonymous reviewers for comments. This work was supported by NSF Earth Life Transitions Grant 1336986 (to P.D.R., K.D.A., and C. Sidor).	Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Botha J, 2007, LETHAIA, V40, P125, DOI 10.1111/j.1502-3931.2007.00011.x; Dunne JA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3280; Frobisch J, 2014, VERTEBR PALEOBIOL PA, P305, DOI 10.1007/978-94-007-6841-3_18; Huttenlocker AK, 2014, PEERJ, V2, DOI 10.7717/peerj.325; Huttenlocker AK, 2011, J VERTEBR PALEONTOL, V31, P405, DOI 10.1080/02724634.2011.546720; Levin S., 2007, HELIX BOOKS; Mace GM, 2014, GLOBAL ENVIRON CHANG, V28, P289, DOI 10.1016/j.gloenvcha.2014.07.009; May R.M., 1973, STABILITY COMPLEXITY; Neubert MG, 1997, ECOLOGY, V78, P653, DOI 10.1890/0012-9658(1997)078[0653:ATRFMT]2.0.CO;2; Pimm S. L., 1982, FOOD WEBS, V1; Roopnarine P., 2010, NAT PRECED, V1, DOI [10.1038/npre.2010.4433.1.-1, DOI 10.1038/NPRE.2010.4433.1.-1]; Roopnarine PD, 2007, P ROY SOC B-BIOL SCI, V274, P2077, DOI 10.1098/rspb.2007.0515; Roopnarine Peter D., 2009, Paleontological Society Papers, V15, P195; Smith RMH, 2014, PALAEOGEOGR PALAEOCL, V396, P99, DOI 10.1016/j.palaeo.2014.01.002; Verdy A, 2008, B MATH BIOL, V70, P1634, DOI 10.1007/s11538-008-9312-7; Williams RJ, 2010, THEOR ECOL-NETH, V3, P45, DOI 10.1007/s12080-009-0052-6	17	53	53	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					90	93		10.1126/science.aab1371	http://dx.doi.org/10.1126/science.aab1371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26430120	Green Submitted			2022-12-28	WOS:000362098300052
J	Anderson, TS; Good, CB; Gellad, WF				Anderson, Timothy S.; Good, Chester B.; Gellad, Walid F.			Prevalence and compensation of academic leaders, professors, and trustees on publicly traded US healthcare company boards of directors: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONFLICTS-OF-INTEREST	OBJECTIVE To identify the prevalence, characteristics, and compensation of members of the boards of directors of healthcare industry companies who hold academic appointments as leaders, professors, or trustees. DESIGN Cross sectional study. SETTING US healthcare companies publicly traded on the NASDAQ or New York Stock Exchange in 2013. PARTICIPANTS 3434 directors of pharmaceutical, biotechnology, medical equipment and supply, and healthcare provider companies. MAIN OUTCOME MEASURES Prevalence, annual compensation, and beneficial stock ownership of directors with affiliations as leaders, professors, or trustees of academic medical and research institutions. RESULTS 446 healthcare companies met the study search criteria, of which 442 (99%) had publicly accessible disclosures on boards of directors. 180 companies (41%) had one or more academically affiliated directors. Directors were affiliated with 85 geographically diverse non-profit academic institutions, including 19 of the top 20 National Institute of Health funded medical schools and all of the 17 US News honor roll hospitals. Overall, these 279 academically affiliated directors included 73 leaders, 121 professors, and 85 trustees. Leaders included 17 chief executive officers and 11 vice presidents or executive officers of health systems and hospitals; 15 university presidents, provosts, and chancellors; and eight medical school deans or presidents. The total annual compensation to academically affiliated directors for their services to companies was $54 995 786 (35 pound 836 000; (sic)49 185 900) (median individual compensation $193 000) and directors beneficially owned 59 831 477 shares of company stock (median 50 699 shares). CONCLUSIONS A substantial number and diversity of academic leaders, professors, and trustees hold directorships at US healthcare companies, with compensation often approaching or surpassing common academic clinical salaries. Dual obligations to for profit company shareholders and non-profit clinical and educational institutions pose considerable personal, financial, and institutional conflicts of interest beyond that of simple consulting relationships. These conflicts have not been fully addressed by professional societies or academic institutions and deserve additional review, regulation, and, in some cases, prohibition when conflicts cannot be reconciled.	[Anderson, Timothy S.] Univ Pittsburgh, Med Ctr, Dept Internal Med, Pittsburgh, PA USA; [Good, Chester B.; Gellad, Walid F.] VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA 15240 USA; [Good, Chester B.] Univ Pittsburgh, VA Ctr Medicat Safety, Dept Vet Affairs, Sch Med, Pittsburgh, PA 15260 USA; [Gellad, Walid F.] Univ Pittsburgh, Ctr Pharmaceut Policy & Prescribing, Pittsburgh, PA 15240 USA; [Gellad, Walid F.] Univ Pittsburgh, Div Gen Internal Med, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gellad, WF (corresponding author), VA Pittsburgh Healthcare Syst, Pittsburgh, PA 15240 USA.	wfg3@pitt.edu	Good, Chester B/K-2818-2019	Good, Chester B/0000-0003-4388-4558	VA Health Services Research and Development award [CDA 09-207]	VA Health Services Research and Development award(US Department of Veterans Affairs)	WFG was supported by a VA Health Services Research and Development award CDA 09-207. The funder had no role in the design and conduct of the study, collection, management, analysis, and interpretation of data, or preparation of the manuscript.	Agrawal S, 2013, NEW ENGL J MED, V368, P1353; American Medical Association, 2007, CONFL INT GUID ORG M; Anderson TS, 2014, JAMA-J AM MED ASSOC, V311, P1353, DOI 10.1001/jama.2013.284925; [Anonymous], 2013, US NEWS WORLD REPORT; Association of American Medical Colleges, 2008, PROT PAT PRES INT AD; Association of American Medical Colleges, 2008, IND FUND MED ED REP; Avorn J., 2004, POWERFUL MED BENEFIT; Blue Ridge Institute for Medical Research, RANK TABL NIH FUND U; Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; Campbell EG, 2007, JAMA-J AM MED ASSOC, V298, P1779, DOI 10.1001/jama.298.15.1779; Centers for Medicare and Medicaid Services, 2013, FED REGISTER, V78, P9458; Freshwater DM, 2011, ARCH INTERN MED, V171, P586, DOI 10.1001/archinternmed.2011.71; Institute of Medicine, 2009, CONFLICT INTEREST ME; Kesselheim AS, 2013, NEW ENGL J MED, V368, P2049, DOI 10.1056/NEJMp1302723; Lo B, 2010, NEW ENGL J MED, V362, P669, DOI 10.1056/NEJMp1000213; NASDAQ, HLTH CAR CO; National Institute for Health and Care Excellence, 2008, COD PRACT DECL DEAL; New York Stock Exchange, 2014, NYSE HEALTHC IND; Pisano ED, 2014, JAMA-J AM MED ASSOC, V311, P1111, DOI 10.1001/jama.2014.788; ProPublica, 2013, DOLL FOR DOCS; Pusser B, 2006, J HIGH EDUC-UK, V77, P747, DOI 10.1353/jhe.2006.0044; Rodwin MA, 2011, CONFLICTS INTEREST F; THOMPSON DF, 1993, NEW ENGL J MED, V329, P573, DOI 10.1056/NEJM199308193290812; US Securities and Exchange Commission, 2014, EL DAT GATH AN RETR; Wartman SA, 2007, ACAD HLTH CTR EVOLVI	25	16	16	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 29	2015	351								h4826	10.1136/bmj.h4826	http://dx.doi.org/10.1136/bmj.h4826			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS9YU	26420786	Green Published, hybrid			2022-12-28	WOS:000362450900005
J	Moher, D; Glasziou, P; Chalmers, I; Nasser, M; Bossuyt, PMM; Korevaar, DA; Graham, ID; Ravaud, P; Boutron, I				Moher, David; Glasziou, Paul; Chalmers, Iain; Nasser, Mona; Bossuyt, Patrick M. M.; Korevaar, Daniel A.; Graham, Ian D.; Ravaud, Philippe; Boutron, Isabelle			Increasing value and reducing waste in biomedical research: who's listening?	LANCET			English	Review							RANDOMIZED CONTROLLED-TRIALS; CLINICAL-TRIALS; AVOIDABLE WASTE; QUALITY; PUBLICATION; OUTCOMES; REGISTRATION; CLINICALTRIALS.GOV; GUIDELINES; DESIGN	The biomedical research complex has been estimated to consume almost a quarter of a trillion US dollars every year. Unfortunately, evidence suggests that a high proportion of this sum is avoidably wasted. In 2014, The Lancet published a series of five reviews showing how dividends from the investment in research might be increased from the relevance and priorities of the questions being asked, to how the research is designed, conducted, and reported. 17 recommendations were addressed to five main stakeholders-funders, regulators, journals, academic institutions, and researchers. This Review provides some initial observations on the possible effects of the Series, which seems to have provoked several important discussions and is on the agendas of several key players. Some examples of individual initiatives show ways to reduce waste and increase value in biomedical research. This momentum will probably move strongly across stakeholder groups, if collaborative relationships evolve between key players; further important work is needed to increase research value. A forthcoming meeting in Edinburgh, UK, will provide an initial forum within which to foster the collaboration needed.	[Moher, David; Graham, Ian D.] Ottawa Hosp, Clin Epidemiol Program, Res Inst, Gen Campus, Ottawa, ON K1H 8L6, Canada; [Moher, David; Graham, Ian D.] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada; [Glasziou, Paul] Bond Univ, Ctr Res Evidence Based Practice, Robina, Qld, Australia; [Chalmers, Iain] James Lind Initiat, Oxford, England; [Nasser, Mona] Univ Plymouth, Peninsula Dent Sch, Plymouth PL4 8AA, Devon, England; [Bossuyt, Patrick M. M.; Korevaar, Daniel A.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Ravaud, Philippe; Boutron, Isabelle] Univ Paris 05, INSERM, Sorbonne Paris Cite, METHODS Team,Ctr Res Epidemiol & Stat,UMR 1153, Paris, France	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Bond University; University of Plymouth; University of Amsterdam; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Moher, D (corresponding author), Ottawa Hosp, Clin Epidemiol Program, Res Inst, Gen Campus, Ottawa, ON K1H 8L6, Canada.	dmoher@ohri.ca	ravaud, philippe/C-1694-2009; Moher, David/I-3408-2019; Korevaar, Daniël A./O-5809-2019; Graham, Ian D./ABD-5259-2021; Bossuyt, Patrick M/AAR-1183-2021; Glasziou, Paul/A-7832-2008; Bossuyt, Patrick M./B-4557-2016	Moher, David/0000-0003-2434-4206; Graham, Ian D./0000-0002-3669-1216; Bossuyt, Patrick M/0000-0003-4427-0128; Glasziou, Paul/0000-0001-7564-073X; Bossuyt, Patrick M./0000-0003-4427-0128; Ravaud, Philippe/0000-0001-8264-9206; Nasser, Mona/0000-0003-2220-6491	University Research Chair	University Research Chair	We wish to acknowledge the help and support of Becky Skidmore, Bryn Robert Belanger, Manosilah Yoganathan, and Raymond Daniel. DM is funded by a University Research Chair.	Abridged Index Medicus, AIM COR CLIN J TITL; American Psychological Association, RESPONSIBLE CONDUCT; [Anonymous], 2015, SCIENCE, DOI [DOI 10.1126/SCIENCE.AAC4716, DOI 10.1126/science.aac4716]; Barnes C, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0460-y; Begley CG, 2015, CIRC RES, V116, P116, DOI 10.1161/CIRCRESAHA.114.303819; Blumle A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087184; Boyack KW, 2013, EUR J CLIN INVEST, V43, P1339, DOI 10.1111/eci.12171; Chalmers I, 2014, LANCET, V384, P1903, DOI 10.1016/S0140-6736(14)62252-2; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Chalmers I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5776; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Chan L, 2014, ARCH PHYS MED REHAB, V95, P415, DOI 10.1016/j.apmr.2013.12.010; Chapman SJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6870; Clavien PA, 2014, ANN SURG, V260, P947, DOI 10.1097/SLA.0000000000001057; Crowe S, 2015, RES INVOLV ENGAGEM, V1, P1, DOI DOI 10.1186/S40900-015-0005-8; Dancey JE, 2010, JNCI-J NATL CANCER I, V102, P670, DOI 10.1093/jnci/djq142; De Angelis C, 2004, CAN MED ASSOC J, V171, P606, DOI 10.1503/cmaj.1041281; Dorsey ER, 2010, JAMA-J AM MED ASSOC, V303, P137, DOI 10.1001/jama.2009.1987; Duff JM, 2010, JNCI-J NATL CANCER I, V102, P702, DOI 10.1093/jnci/djq117; Eccles M, 2005, J CLIN EPIDEMIOL, V58, P107, DOI 10.1016/j.jclinepi.2004.09.002; Emdin CA, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/BMJ.h117, 10.1136/bmj.h117]; EQUATOR Network, SCI M IMPR REP DECR; European Medicines Agency, UNPUB; Frank L, 2014, JAMA-J AM MED ASSOC, V312, P1513, DOI 10.1001/jama.2014.11100; Freedman LP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002165; Glasziou P, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001651; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Grant SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065442; Health Research Authority, GUID SPEC QUEST NEED, P1; HEMMINKI E, 1980, BRIT MED J, V280, P833, DOI 10.1136/bmj.280.6217.833; Hirst A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035621; Hirst JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098856; Hudson KL, 2015, JAMA-J AM MED ASSOC, V313, P355, DOI 10.1001/jama.2014.10716; Institut National de la Sante et de la Recherche Medicale, PLAN STRAT INS 2016; Institute of Medicine, 2015, DISC FRAM CLIN TRIAL; Ioannidis JPA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001747; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V312, P483, DOI 10.1001/jama.2014.6932; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Janz Nicole, 2015, LEADING J VERIFIES A; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Kleinert S, 2014, LANCET, V384, P2176, DOI 10.1016/S0140-6736(14)62047-X; Kleinert S, 2014, LANCET, V383, P197, DOI 10.1016/S0140-6736(13)62678-1; Kuhrt N, SYSTEMKRITIK WISSENS; Kyte D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110229; Leaf C., 2013, TRUTH SMALL DOSES WH; Liberati A, 2004, BMJ-BRIT MED J, V328, P531, DOI 10.1136/bmj.328.7438.531; Light D, 2015, GOOD PHARM PUBLIC HL; Loudon K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2147; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Moher D, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001864; National Archives and Record Administration. United States, FED POL PROT HUM SUB; National Centre for the Replacement Refinement & Reduction of Animals in Research, NC3RS PUBL BIAS WORK; National Institute for Health Research, 2014, POL AND STAND; National Institute for Health Research, GUID NOT APPL ENS PR; National Institute for Health Research, ADD VAL RES QUAL IMP; National Institute of Health Research, RESP COND RES TRAIN; Nosek BA, 2015, SCIENCE, V348, P1422, DOI 10.1126/science.aab2374; Opening Session, 3 ANN NHMRC S RES TR; Panel on Research Ethics. Government of Canada, TCPS 2 2014 LAT ED T; Prayle AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7373; Ramagopalan S., 2014, F1000RESEARCH, V216, P1; Salman RA, 2014, LANCET, V383, P176, DOI 10.1016/S0140-6736(13)62297-7; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Tenaerts P, 2014, NAT REV DRUG DISCOV, V13, P797, DOI 10.1038/nrd4442; The Academy of Medical Sciences, NEW PATHW REG GOV HL; Times Higher Education, WORLD U RANK; Treweek S, 2013, TRIAL SUPPL 1, V14, pO121, DOI DOI 10.1186/1745-6215-14-S1-O121; Tugwell PS, 2015, J RHEUMATOL, V42, P1931, DOI 10.3899/jrheum.141430; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; van de Wetering FT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049599; Williamson P, 2012, J HEALTH SERV RES PO, V17, P1, DOI 10.1258/jhsrp.2011.011131; Yordanov Y, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/BMJ.h809, 10.1136/bmj.h809]; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234	77	236	237	0	48	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2016	387	10027					1573	1586		10.1016/S0140-6736(15)00307-4	http://dx.doi.org/10.1016/S0140-6736(15)00307-4			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI8HH	26423180	Green Submitted			2022-12-28	WOS:000373741600033
J	Weisz, G; Genereux, P; Iniguez, A; Zurakowski, A; Shechter, M; Alexander, KP; Dressler, O; Osmukhina, A; James, S; Ohman, EM; Ben-Yehuda, O; Farzaneh-Far, R; Stone, GW				Weisz, Giora; Genereux, Philippe; Iniguez, Andres; Zurakowski, Aleksander; Shechter, Michael; Alexander, Karen P.; Dressler, Ovidiu; Osmukhina, Anna; James, Stefan; Ohman, E. Magnus; Ben-Yehuda, Ori; Farzaneh-Far, Ramin; Stone, Gregg W.		RIVER-PCI Investigators	Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial	LANCET			English	Article							FRACTIONAL FLOW RESERVE; CHRONIC ANGINA; ARTERY-DISEASE; IMPACT; SURVIVAL; QUANTIFICATION; COMPLETENESS; ANGIOGRAPHY; AMLODIPINE; MORTALITY	Background Incomplete revascularisation is common after percutaneous coronary intervention and is associated with increased mortality and adverse cardiovascular events. We aimed to assess whether adjunctive anti-ischaemic pharmacotherapy with ranolazine would improve the prognosis of patients with incomplete revascularisation after percutaneous coronary intervention. Methods We performed this multicentre, randomised, parallel-group, double-blind, placebo-controlled, event-driven trial at 245 centres in 15 countries in Europe, Israel, Russia, and the USA. Patients (aged >= 18 years) with a history of chronic angina with incomplete revascularisation after percutaneous coronary intervention (defined as one or more lesions with >= 50% diameter stenosis in a coronary artery >= 2 mm diameter) were randomly assigned (1: 1), via an interactive web-based block randomisation system (block sizes of ten), to receive either twice-daily oral ranolazine 1000 mg or matching placebo. Randomisation was stratified by diabetes history (presence vs absence) and acute coronary syndrome presentation (acute coronary syndrome vs non-acute coronary syndrome). Study investigators, including all research teams, and patients were masked to treatment allocation. The primary endpoint was time to first occurrence of ischaemia-driven revascularisation or ischaemia-driven hospitalisation without revascularisation. Analysis was by intention to treat. This study is registered at ClinicalTrials.gov, number NCT01442038. Findings Between Nov 3, 2011, and May 27, 2013, we randomly assigned 2651 patients to receive ranolazine (n=1332) or placebo (n=1319); 2604 (98%) patients comprised the full analysis set. After a median follow-up of 643 days (IQR 575-758), the composite primary endpoint occurred in 345 (26%) patients assigned to ranolazine and 364 (28%) patients assigned to placebo (hazard ratio 0.95, 95% CI 0.82-1.10; p=0.48). Incidence of ischaemia-driven revascularisation and ischaemia-driven hospitalisation did not differ significantly between groups. 189 (14%) patients in the ranolazine group and 137 (11%) patients in the placebo group discontinued study drug because of an adverse event (p=0.04). Interpretation Ranolazine did not reduce the composite rate of ischaemia-driven revascularisation or hospitalisation without revascularisation in patients with a history of chronic angina who had incomplete revascularisation after percutaneous coronary intervention. Further studies are warranted to establish whether other treatment could be effective in improving the prognosis of high-risk patients in this population.	[Weisz, Giora] Shaare Zedek Med Ctr, IL-91031 Jerusalem, Israel; [Weisz, Giora; Stone, Gregg W.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA; [Weisz, Giora; Genereux, Philippe; Dressler, Ovidiu; Ben-Yehuda, Ori; Stone, Gregg W.] Cardiovasc Res Fdn, New York, NY USA; [Genereux, Philippe] Univ Montreal, Hop Sacre Coeur Montreal, Montreal, PQ, Canada; [Iniguez, Andres] Hosp Meixoeiro, Vigo, Spain; [Zurakowski, Aleksander] Amer Heart Poland SA, Katowice, Poland; [Shechter, Michael] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Alexander, Karen P.; Ohman, E. Magnus] Duke Clin Res Inst, Durham, NC USA; [Alexander, Karen P.; Ohman, E. Magnus] Duke Univ, Durham, NC USA; [Osmukhina, Anna; Farzaneh-Far, Ramin] Gilead Sci Inc, Foster City, CA 94404 USA; [James, Stefan] Uppsala Univ, Dept Med Sci, Cardiol, Uppsala, Sweden	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Columbia University; NewYork-Presbyterian Hospital; Cardiovascular Research Foundation (CRF); Universite de Montreal; Complexo Hospitalario Universitario de Vigo; Chaim Sheba Medical Center; Duke University; Duke University; Gilead Sciences; Uppsala University	Weisz, G (corresponding author), Shaare Zedek Med Ctr, Dept Cardiol, IL-91031 Jerusalem, Israel.	weiszg@szmc.org.il	Zhong, Ray Y./K-6918-2012; Widimsky, Petr/P-8088-2016; James, Stefan K/J-4554-2014; Zemánek, David/O-1059-2017	Widimsky, Petr/0000-0001-5686-7752; Zemánek, David/0000-0001-7336-6116; Opolski, Grzegorz/0000-0003-4744-2554; CARRIE, didier/0000-0003-2479-8144; Anderson, R. David/0000-0003-3490-3286; Moreno, Raul/0000-0001-7179-1426	Gilead Sciences; Menarini; Menarini Group	Gilead Sciences(Gilead Sciences); Menarini(Menarini Group); Menarini Group(Menarini Group)	Gilead Sciences, Menarini.; The study was sponsored and funded by Gilead Sciences and the Menarini Group.	Belardinelli L, 2006, HEART, V92, P6, DOI 10.1136/hrt.2005.078790; Chaitman BR, 2004, J AM COLL CARDIOL, V43, P1375, DOI 10.1016/j.jacc.2003.11.045; Chaitman BR, 2004, JAMA-J AM MED ASSOC, V291, P309, DOI 10.1001/jama.291.3.309; De Bruyne B, 2014, NEW ENGL J MED, V371, P1208, DOI 10.1056/NEJMoa1408758; Farooq V, 2013, CIRCULATION, V128, P141, DOI 10.1161/CIRCULATIONAHA.113.001803; Fraser H, 2006, J MOL CELL CARDIOL, V41, P1031, DOI 10.1016/j.yjmcc.2006.08.012; Genereux P, 2012, J AM COLL CARDIOL, V59, P2165, DOI 10.1016/j.jacc.2012.03.010; Gershlick AH, 2015, J AM COLL CARDIOL, V65, P963, DOI 10.1016/j.jacc.2014.12.038; Gilead, 2013, RAN PRESCR INF 8 5 G; Gossl M, 2012, CIRC-CARDIOVASC INTE, V5, P597, DOI 10.1161/CIRCINTERVENTIONS.111.965509; Gutierrez JA, 2015, CLIN CARDIOL, V38, P469, DOI 10.1002/clc.22425; Hannan EL, 2006, CIRCULATION, V113, P2406, DOI 10.1161/CIRCULATIONAHA.106.612267; Hannan EL, 2009, JACC-CARDIOVASC INTE, V2, P17, DOI 10.1016/j.jcin.2008.08.021; Head SJ, 2012, EUR J CARDIO-THORAC, V41, P535, DOI 10.1093/ejcts/ezr105; Hussain F, 2011, CATHETER CARDIO INTE, V78, P540, DOI 10.1002/ccd.23006; Mancini GBJ, 2009, CIRC-CARDIOVASC QUAL, V2, P320, DOI 10.1161/CIRCOUTCOMES.108.830091; McPherson JA, 2012, JACC-CARDIOVASC IMAG, V5, pS76, DOI 10.1016/j.jcmg.2012.01.005; Morrow DA, 2007, JAMA-J AM MED ASSOC, V297, P1775, DOI 10.1001/jama.297.16.1775; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nikolsky Eugenia, 2004, J Invasive Cardiol, V16, P102; Rosner GF, 2012, CIRCULATION, V125, P2613, DOI 10.1161/CIRCULATIONAHA.111.069237; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Stone PH, 2006, J AM COLL CARDIOL, V48, P566, DOI 10.1016/j.jacc.2006.05.044; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; van den Brand MJBM, 2002, J AM COLL CARDIOL, V39, P559, DOI 10.1016/S0735-1097(01)01785-5; Vieira RD, 2012, CIRCULATION, V126, pS158, DOI 10.1161/CIRCULATIONAHA.111.084236; Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520; Weisz G, 2013, AM HEART J, V166, P953, DOI 10.1016/j.ahj.2013.08.004; Wittes J, 2009, CIRCULATION, V119, P912, DOI 10.1161/CIRCULATIONAHA.108.836601; Wu CT, 2011, CIRC-CARDIOVASC INTE, V4, P413, DOI 10.1161/CIRCINTERVENTIONS.111.963058; Zellweger MJ, 2014, JACC-CARDIOVASC INTE, V7, P615, DOI 10.1016/j.jcin.2014.01.161	31	72	74	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2016	387	10014					136	145		10.1016/S0140-6736(15)00459-6	http://dx.doi.org/10.1016/S0140-6736(15)00459-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8LF	26474810				2022-12-28	WOS:000368055500030
J	Thaci, D; Simpson, EL; Beck, LA; Bieber, T; Blauvelt, A; Papp, K; Soong, W; Worm, M; Szepietowski, JC; Sofen, H; Kawashima, M; Wu, R; Weinstein, SP; Graham, NMH; Pirozzi, G; Teper, A; Sutherland, ER; Mastey, V; Stahl, N; Yancopoulos, GD; Ardeleanu, M				Thaci, Diamant; Simpson, Eric L.; Beck, Lisa A.; Bieber, Thomas; Blauvelt, Andrew; Papp, Kim; Soong, Weily; Worm, Margitta; Szepietowski, Jacek C.; Sofen, Howard; Kawashima, Makoto; Wu, Richard; Weinstein, Steven P.; Graham, Neil M. H.; Pirozzi, Gianluca; Teper, Ariel; Sutherland, E. Rand; Mastey, Vera; Stahl, Neil; Yancopoulos, George D.; Ardeleanu, Marius			Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial	LANCET			English	Article							QUALITY-OF-LIFE; ECZEMA AREA; GUIDELINES; PREVALENCE; CHILDREN; MANAGEMENT; HEALTH; CARE; COMORBIDITY; RELIABILITY	Background Data from early-stage studies suggested that interleukin (IL)-4 and IL-13 are requisite drivers of atopic dermatitis, evidenced by marked improvement after treatment with dupilumab, a fully-human monoclonal antibody that blocks both pathways. We aimed to assess the efficacy and safety of several dose regimens of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments. Methods In this randomised, placebo-controlled, double-blind study, we enrolled patients aged 18 years or older who had an Eczema Area and Severity Index (EASI) score of 12 or higher at screening (>= 16 at baseline) and inadequate response to topical treatments from 91 study centres, including hospitals, clinics, and academic institutions, in Canada, Czech Republic, Germany, Hungary, Japan, Poland, and the USA. Patients were randomly assigned (1: 1: 1: 1: 1: 1), stratified by severity (moderate or severe, as assessed by Investigator's Global Assessment) and region (Japan vs rest of world) to receive subcutaneous dupilumab: 300 mg once a week, 300 mg every 2 weeks, 200 mg every 2 weeks, 300 mg every 4 weeks, 100 mg every 4 weeks, or placebo once a week for 16 weeks. We used a central randomisation scheme, provided by an interactive voice response system. Drug kits were coded, providing masking to treatment assignment, and allocation was concealed. Patients on treatment every 2 weeks and every 4 weeks received volume-matched placebo every week when dupilumab was not given to ensure double blinding. The primary outcome was efficacy of dupilumab dose regimens based on EASI score least-squares mean percentage change (SE) from baseline to week 16. Analyses included all randomly assigned patients who received one or more doses of study drug. This trial is registered with ClinicalTrials.gov, number NCT01859988. Findings Between May 15, 2013, and Jan 27, 2014, 452 patients were assessed for eligibility, and 380 patients were randomly assigned. 379 patients received one or more doses of study drug (300 mg once a week [n=63], 300 mg every 2 weeks [n=64], 200 mg every 2 weeks [n=61], 300 mg every 4 weeks [n=65], 100 mg every 4 weeks [n=65]; placebo [n=61]). EASI score improvements favoured all dupilumab regimens versus placebo (p<0.0001): 300 mg once a week (-74% [SE 5.16]), 300 mg every 2 weeks (-68% [5.12]), 200 mg every 2 weeks (-65% [5.19]), 300 mg every 4 weeks (-64% [4.94]), 100 mg every 4 weeks (-45% [4.99]); placebo (-18% [5.20]). 258 (81%) of 318 patients given dupilumab and 49 (80%) of 61 patients given placebo reported treatment-emergent adverse events; nasopharyngitis was the most frequent (28% and 26%, respectively). Interpretation Dupilumab improved clinical responses in adults with moderate-to-severe atopic dermatitis in a dose-dependent manner, without significant safety concerns. Our findings show that IL-4 and IL-13 are key drivers of atopic dermatitis.	[Thaci, Diamant] Univ Hosp Schleswig Holstein, Comprehens Ctr Inflammat Med, D-23538 Lubeck, Germany; [Simpson, Eric L.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA; [Beck, Lisa A.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Bieber, Thomas] Univ Bonn, Dept Dermatol & Allergy, Bonn, Germany; [Blauvelt, Andrew] Oregon Med Res Ctr, Portland, OR USA; [Papp, Kim] K Papp Clin Res & Prob Med Res, Waterloo, ON, Canada; [Soong, Weily] Alabama Allergy & Asthma Ctr, Birmingham, AL USA; [Worm, Margitta] Charite, Dept Dermatol & Allergy, D-13353 Berlin, Germany; [Szepietowski, Jacek C.] Wroclaw Med Univ, Dept Dermatol Venereol & Allergol, Wroclaw, Poland; [Sofen, Howard] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; [Kawashima, Makoto] Tokyo Womens Med Univ, Sch Med, Tokyo, Japan; [Wu, Richard; Weinstein, Steven P.; Graham, Neil M. H.; Stahl, Neil; Yancopoulos, George D.; Ardeleanu, Marius] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Pirozzi, Gianluca; Teper, Ariel] Sanofi, Bridgewater, NJ USA; [Sutherland, E. Rand] Sanofi, Cambridge, MA USA	University of Kiel; Schleswig Holstein University Hospital; Oregon Health & Science University; University of Rochester; University of Bonn; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Wroclaw Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Tokyo Women's Medical University; Regeneron; Sanofi-Aventis; Sanofi-Aventis	Thaci, D (corresponding author), Univ Hosp Schleswig Holstein, Comprehens Ctr Inflammat Med, Campus Lubeck, D-23538 Lubeck, Germany.	diamant.thaci@uksh.de	Thaci, Diamant/AAE-7310-2022; Sofen, Howard/AAD-1321-2021	Sofen, Howard/0000-0001-7789-6915; Papp, Kim A./0000-0001-9557-3642; Worm, Margitta/0000-0002-3449-1245; Szepietowski, Jacek/0000-0003-0766-6342; Thaci, Diamant/0000-0001-8513-550X	Sanofi; Regeneron Pharmaceuticals	Sanofi; Regeneron Pharmaceuticals(Regeneron)	This study was funded by Sanofi and Regeneron Pharmaceuticals. Editorial assistance was provided by Vicki Schwartz of Excerpta Medica, funded by Sanofi and Regeneron Pharmaceuticals. We thank the patients who participated in this study, the co-investigators for their contribution to the study (listed in the appendix) and staff at the participating centres, and the following contributors from the sponsors for providing support with the publication process and critical review of the manuscript content: Linda Williams, Warren Brooks, Judith Cusick, Jacqueline Kuritzky, Diane Roth, Elizabeth Bucknam, Nelson Rita, Yuhwen Soo, Haobo Ren, Qin Li, Mi Young Kwon, Jennifer Hamilton, Usman Chaudhry, and Bolanle Akinlade (Regeneron Pharmaceuticals); and Paul Cavanaugh, Jeff rey Ming, and Pauline Wijnand (Sanofi).	Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Bachert C, 2015, ALLERGY, V70, P107; Bangert C, 2011, DERMATOLOGY, V222, P36, DOI 10.1159/000321711; Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; Chandra RK, 2011, AM J OTOLARYNG, V32, P388, DOI 10.1016/j.amjoto.2010.07.013; Chrostowska-Plak D, 2013, J EUR ACAD DERMATOL, V27, pE239, DOI 10.1111/j.1468-3083.2012.04578.x; Eichenfield LF, 2014, J AM ACAD DERMATOL, V71, P116, DOI 10.1016/j.jaad.2014.03.023; Eichenfield LF, 2014, J AM ACAD DERMATOL, V70, P338, DOI 10.1016/j.jaad.2013.10.010; Eichenfield LE, 2006, J AM ACAD DERMATOL, V54, P715, DOI 10.1016/j.jaad.2005.10.063; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Hamilton JD, 2014, J ALLERGY CLIN IMMUN, V134, P1293, DOI 10.1016/j.jaci.2014.10.013; Hanifin JM, 2001, EXP DERMATOL, V10, P11, DOI 10.1034/j.1600-0625.2001.100102.x; Kaesler S, 2014, J ALLERGY CLIN IMMUN, V134, P92, DOI 10.1016/j.jaci.2014.02.017; Katayama I, 2014, ALLERGOL INT, V63, P377, DOI 10.2332/allergolint.14-RAI-0769; Leshem YA, 2015, BRIT J DERMATOL, V172, P1353, DOI 10.1111/bjd.13662; McKenna SP, 2008, CURR OPIN ALLERGY CL, V8, P228, DOI 10.1097/ACI.0b013e3282ffd6cc; Muto T, 2003, BRIT J DERMATOL, V148, P117, DOI 10.1046/j.1365-2133.2003.05092.x; Phan NQ, 2012, ACTA DERM-VENEREOL, V92, P502, DOI 10.2340/00015555-1246; Odhiambo JA, 2009, J ALLERGY CLIN IMMUN, V124, P1251, DOI 10.1016/j.jaci.2009.10.009; Punekar YS, 2009, CLIN EXP ALLERGY, V39, P1209, DOI 10.1111/j.1365-2222.2009.03248.x; Ring J, 2012, J EUR ACAD DERMATOL, V26, P1176, DOI 10.1111/j.1468-3083.2012.04636.x; Ring J, 2012, J EUR ACAD DERMATOL, V26, P1045, DOI 10.1111/j.1468-3083.2012.04635.x; Roekevisch E, 2014, J ALLERGY CLIN IMMUN, V133, P429, DOI 10.1016/j.jaci.2013.07.049; Sanchez-Perez J, 2013, ACTAS DERMO-SIFILOGR, V104, P44, DOI 10.1016/j.ad.2012.03.008; Schmitt J, 2014, J ALLERGY CLIN IMMUN, V134, P800, DOI 10.1016/j.jaci.2014.07.043; Sidbury R, 2014, J AM ACAD DERMATOL, V71, P327, DOI 10.1016/j.jaad.2014.03.030; Silverberg JI, 2013, J ALLERGY CLIN IMMUN, V132, P1132, DOI 10.1016/j.jaci.2013.08.031; Simpson EL, 2012, CURR DERMATOL REP, V1, P29, DOI 10.1007/s13671-011-0003-5; STALDER JF, 1993, DERMATOLOGY, V186, P23, DOI 10.1159/000247298; Suarez-Farinas M, 2013, J ALLERGY CLIN IMMUN, V132, P361, DOI 10.1016/j.jaci.2013.04.046; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; Yaghmaie P, 2013, J ALLERGY CLIN IMMUN, V131, P428, DOI 10.1016/j.jaci.2012.10.041	32	375	398	1	53	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2016	387	10013					40	52		10.1016/S0140-6736(15)00388-8	http://dx.doi.org/10.1016/S0140-6736(15)00388-8			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ9ZU	26454361				2022-12-28	WOS:000367457300026
J	Thomas, A; O'Brien, JT				Thomas, Alan; O'Brien, John T.			Management of late-life depression: a major leap forward	LANCET			English	Editorial Material							WHITE-MATTER HYPERINTENSITIES; ADJUNCTIVE THERAPY; DOUBLE-BLIND; EFFICACY; DISORDER; ARIPIPRAZOLE; MULTICENTER; SAFETY		[Thomas, Alan] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England; [Thomas, Alan] Newcastle Univ, Inst Ageing, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England; [O'Brien, John T.] Univ Cambridge, Dept Psychiat, Cambridge, England	Newcastle University - UK; Newcastle University - UK; University of Cambridge	Thomas, A (corresponding author), Newcastle Univ, Inst Neurosci, Biomed Res Bldg, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.	alan.thomas@newcastle.ac.uk	Thomas, Alan J/G-4807-2011	O'Brien, John/0000-0002-0837-5080; Thomas, Alan/0000-0002-6667-9533				Berman RM, 2007, J CLIN PSYCHIAT, V68, P843, DOI 10.4088/JCP.v68n0604; Cooper C, 2011, AM J PSYCHIAT, V168, P681, DOI 10.1176/appi.ajp.2011.10081165; Grayson L, 2013, J AFFECT DISORDERS, V150, P161, DOI 10.1016/j.jad.2013.03.021; Herrmann LL, 2008, J NEUROL NEUROSUR PS, V79, P619, DOI 10.1136/jnnp.2007.124651; Kohler S, 2010, BRIT J PSYCHIAT, V196, P143, DOI 10.1192/bjp.bp.109.071399; Kok RM, 2011, AM J GERIAT PSYCHIAT, V19, P249, DOI 10.1097/JGP.0b013e3181ec8085; Lenze EJ, 2015, LANCET, V386, P2404, DOI 10.1016/S0140-6736(15)00308-6; Marcus RN, 2008, J CLIN PSYCHOPHARM, V28, P156, DOI 10.1097/JCP.0b013e31816774f9; Menza M, 2006, AM J PSYCHIAT, V163, P1123, DOI 10.1176/appi.ajp.163.7.1123; Nelson JC, 2008, AM J GERIAT PSYCHIAT, V16, P558, DOI 10.1097/JGP.0b013e3181693288; O'Brien J, 1998, BMJ-BRIT MED J, V317, P982, DOI 10.1136/bmj.317.7164.982; Thomas AJ, 2009, PSYCHOL MED, V39, P725, DOI 10.1017/S0033291708004042	12	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2015	386	10011					2374	2375		10.1016/S0140-6736(15)00304-9	http://dx.doi.org/10.1016/S0140-6736(15)00304-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CY3EE	26423179				2022-12-28	WOS:000366290400011
J	Daniel, H; Erickson, S				Daniel, Hilary; Erickson, Shari		Amer Coll Physicians	Retail Health Clinics: A Policy Position Paper From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							CARE; ILLNESSES; VISITS; COSTS	Retail health clinics are walk-in clinics located in retail stores or pharmacies that are typically staffed by nurse practitioners or physician assistants. When they entered the marketplace in the early 2000s, retail clinics offered a limited number of services for low-acuity conditions that were paid for out of pocket by the consumer. Over the past decade, business models for these clinics have evolved to accept public and private health insurance, and some are expanding their services to include diagnosis, treatment, and management of chronic conditions. Retail health clinics are one of several methods of health care delivery that challenge the traditional primary care delivery model. The positions and recommendations offered by the American College of Physicians in this paper are intended to establish a framework that underscores patient safety, communication, and collaboration among retail health clinics, physicians, and patients.	[Daniel, Hilary; Erickson, Shari] Amer Coll Physicians, Washington, DC 20001 USA	American College of Physicians	Daniel, H (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.	hdaniel@mail.acponline.org		Auron, Moises/0000-0001-6398-6047				Accenture, 2013, RET MED CLIN FOE FRI; Ahmed A, 2010, ANN FAM MED, V8, P117, DOI 10.1370/afm.1052; American Academy of Family Physicians, RET CLIN; American Academy of Physician Assistants, 2012, ROL IN STOR RET HLTH; American College of Physicians, 2007, RET HLTH CLIN; American College of Physicians, 2007, JOINT PRINC PAT CTR; American Medical Association, 2015, H 160 921 STOR BAS H; [Anonymous], 2014, CONSUMER REPORTS; Colby Sandra L., 2014, CURRENT POPULATION R, pP25; Convenient Care Association, FACT SHEET CONV CAR; Convenient Care Association, 2014, CONV CAR ASS QUAL SA; CVS, 2015, PRIC LIST; Deloitte Center for Health Solutions, 2010, RET CLIN UPD IMPL; Ham B., 2014, RETAIL CLIN WHATS ST; Hunter LP, 2009, J AM ACAD NURSE PRAC, V21, P565, DOI 10.1111/j.1745-7599.2009.00447.x; Japsen B., 2014, FORBES; Lipson D., 2011, PATIENT CENTERED MED; Luthra S., 2014, WASHINGTON POST; Mehrotra A, 2010, HLTH CARE AISLE 7 GR; Mehrotra A, 2008, HEALTH AFFAIR, V27, P1272, DOI 10.1377/hlthaff.27.5.1272; Mehrotra A, 2009, ANN INTERN MED, V151, P321, DOI 10.7326/0003-4819-151-5-200909010-00006; National Conference of State Legislatures, 2014, RET HLTH CLIN STAT L; O'Hare C Dennis, 2004, Fam Pract Manag, V11, P35; Osborn R, 2013, COMMONWEALTH FUND 20; Patwardhan A, 2012, J PRIM CARE COMMUNIT, V3, P243, DOI 10.1177/2150131911436251; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; Pollack CE, 2010, HEALTH AFFAIR, V29, P998, DOI 10.1377/hlthaff.2010.0089; Pollack CE, 2009, ARCH INTERN MED, V169, P945, DOI 10.1001/archinternmed.2009.69; PricewaterhouseCoopers, 2014, HEALTHC NEW ENTR WHO; Reid RO, 2013, J GEN INTERN MED, V28, P504, DOI 10.1007/s11606-012-2243-x; Rich E, 2012, AHRQ PUBLICATION, V12-0010; Shih A, 2008, ORGANIZING US HLTH C; Stempniak M, 2013, RETAIL CLIN THREAT O; Thygeson M, 2008, HEALTH AFFAIR, V27, P1283, DOI 10.1377/hlthaff.27.5.1283	34	5	5	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	2015	163	11					869	+		10.7326/M15-0571	http://dx.doi.org/10.7326/M15-0571			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX7FB	26457377				2022-12-28	WOS:000365866500010
J	Saito, Y; Kasahara, Y; Ye, JT; Iwasa, Y; Nojima, T				Saito, Yu; Kasahara, Yuichi; Ye, Jianting; Iwasa, Yoshihiro; Nojima, Tsutomu			Metallic ground state in an ion-gated two-dimensional superconductor	SCIENCE			English	Article							INTERFACE SUPERCONDUCTIVITY; INSULATOR TRANSITION; FLUCTUATION; DISSIPATION	Recently emerging two-dimensional (2D) superconductors in atomically thin layers and at heterogeneous interfaces are attracting growing interest in condensed matter physics. Here, we report that an ion-gated zirconium nitride chloride surface, exhibiting a dome-shaped phase diagram with a maximum critical temperature of 14.8 kelvin, behaves as a superconductor persisting to the 2D limit. The superconducting thickness estimated from the upper critical fields is congruent to 1.8 nanometers, which is thinner than one unit-cell. The majority of the vortex phase diagram down to 2 kelvin is occupied by a metallic state with a finite resistance, owing to the quantum creep of vortices caused by extremely weak pinning and disorder. Our findings highlight the potential of electric-field-induced superconductivity, establishing a new platform for accessing quantum phases in clean 2D superconductors.	[Saito, Yu; Kasahara, Yuichi; Ye, Jianting; Iwasa, Yoshihiro] Univ Tokyo, QPEC, Tokyo 1138656, Japan; [Saito, Yu; Kasahara, Yuichi; Ye, Jianting; Iwasa, Yoshihiro] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; [Kasahara, Yuichi] Kyoto Univ, Dept Phys, Kyoto 6068502, Japan; [Ye, Jianting] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Ye, Jianting; Iwasa, Yoshihiro] RIKEN, CEMS, Wako, Saitama 3510198, Japan; [Nojima, Tsutomu] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan	University of Tokyo; University of Tokyo; Kyoto University; University of Groningen; RIKEN; Tohoku University	Iwasa, Y (corresponding author), Univ Tokyo, QPEC, Tokyo 1138656, Japan.	iwasa@ap.t.u-tokyo.ac.jp; nojima@imr.tohoku.ac.jp	Ye, Jianting/K-8194-2012; Saito, Yu/AAG-3862-2019; Institute, Zernike/W-7033-2019; Iwasa, Yoshihiro/C-1719-2009; Nojima, Tsutomu/C-6539-2009; Ishida, Mari/AAU-3379-2020; Saito, Yu/B-1884-2015; Kasahara, Yuichi/N-8436-2013	Saito, Yu/0000-0001-6155-5278; Nojima, Tsutomu/0000-0001-8669-264X; Saito, Yu/0000-0001-6155-5278; 	Japan Society for the Promotion of Science (JSPS); European Research Council [648855 Ig-QPD]; Japan Science and Technology Agency; JSPS [25000003]; MEXT of Japan [22103004]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); European Research Council(European Research Council (ERC)European Commission); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank M. Nakano and Y. Nakagawa for technical support, M. Yoshida for fruitful discussions, and N. Shiba for useful comments on the manuscript. Y.S. was supported by the Japan Society for the Promotion of Science (JSPS) through a research fellowship for young scientists. J.T.Y. acknowledges the funding from the European Research Council (consolidator grant no. 648855 Ig-QPD). This work was supported by the Strategic International Collaborative Research Program (SICORP-LEMSUPER) of the Japan Science and Technology Agency, Grant-in-Aid for Specially Promoted Research (no. 25000003) from JSPS and Grant-in Aid for Scientific Research on Innovative Areas (no. 22103004) from MEXT of Japan.	ASLAMAZO.LG, 1968, PHYS LETT A, VA 26, P238, DOI 10.1016/0375-9601(68)90623-3; Bollinger AT, 2011, NATURE, V472, P458, DOI 10.1038/nature09998; Brumme T, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.245406; Chen X, 2002, J SOLID STATE CHEM, V169, P149, DOI 10.1006/S0022-4596(02)00034-8; Ephron D, 1996, PHYS REV LETT, V76, P1529, DOI 10.1103/PhysRevLett.76.1529; FEIGELMAN MV, 1990, PHYSICA C, V167, P177, DOI 10.1016/0921-4534(90)90502-6; FISHER MPA, 1990, PHYS REV LETT, V65, P923, DOI 10.1103/PhysRevLett.65.923; Gallagher P, 2014, NAT PHYS, V10, P748, DOI [10.1038/NPHYS3049, 10.1038/nphys3049]; Goldman AM, 2010, INT J MOD PHYS B, V24, P4081, DOI 10.1142/S0217979210056451; Gozar A, 2008, NATURE, V455, P782, DOI 10.1038/nature07293; HAUPT SG, 1994, P SOC PHOTO-OPT INS, V2158, P238, DOI 10.1117/12.182687; HAUPT SG, 1993, ADV MATER, V5, P755, DOI 10.1002/adma.19930051017; Ito T, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.134522; Jiang D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6708; Jo S, 2015, NANO LETT, V15, P1197, DOI 10.1021/nl504314c; Lee Y, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.136809; Leng X, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.027001; Lin YH, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.017002; MAKI K, 1968, PROG THEOR PHYS, V39, P897, DOI 10.1143/PTP.39.897; Mason N, 1999, PHYS REV LETT, V82, P5341, DOI 10.1103/PhysRevLett.82.5341; Qin SY, 2009, SCIENCE, V324, P1314, DOI 10.1126/science.1170775; Qin YG, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.100505; Reyren N, 2007, SCIENCE, V317, P1196, DOI 10.1126/science.1146006; Schneider T, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.064501; Shamoto S, 1998, PHYSICA C, V306, P7, DOI 10.1016/S0921-4534(98)00357-8; Shi W, 2015, SCI REP-UK, V5, DOI 10.1038/srep12534; Shimshoni E, 1998, PHYS REV LETT, V80, P3352, DOI 10.1103/PhysRevLett.80.3352; Taguchi Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.107001; Takano T, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.104518; Takano T, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.023702; THOMPSON RS, 1970, PHYS REV B-SOLID ST, V1, P327, DOI 10.1103/PhysRevB.1.327; Tinkham M., 2004, INTRO SUPERCONDUCTIV, V2nd; Ueno K, 2008, NAT MATER, V7, P855, DOI 10.1038/nmat2298; Ueno K, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.020508; Ueno K, 2011, NAT NANOTECHNOL, V6, P408, DOI [10.1038/nnano.2011.78, 10.1038/NNANO.2011.78]; Wang QY, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/3/037402; Xu C, 2015, NAT MATER, V14, P1135, DOI [10.1038/NMAT4374, 10.1038/nmat4374]; Yamanaka S, 1996, ADV MATER, V8, P771, DOI 10.1002/adma.19960080917; Ye JT, 2012, SCIENCE, V338, P1193, DOI 10.1126/science.1228006; Ye JT, 2010, NAT MATER, V9, P125, DOI [10.1038/NMAT2587, 10.1038/nmat2587]; Zeng SW, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.020503	42	189	190	11	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					409	413		10.1126/science.1259440	http://dx.doi.org/10.1126/science.1259440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26429881	Green Submitted			2022-12-28	WOS:000363213400033
J	Everett, BM; Smith, RJ; Hiatt, WR				Everett, Brendan M.; Smith, Robert J.; Hiatt, William R.			Reducing LDL with PCSK9 Inhibitors - The Clinical Benefit of Lipid Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HIGH-RISK; THERAPY; EVENTS; TRIAL		[Everett, Brendan M.] Harvard Univ, Sch Med, Boston, MA 02138 USA; [Everett, Brendan M.] Brigham & Womens Hosp, Div Cardiovasc & Prevent Med, Dept Med, Boston, MA 02115 USA; [Smith, Robert J.] Brown Univ, Dept Med, Alpert Med Sch, Providence, RI 02912 USA; [Smith, Robert J.] Brown Univ, Dept Hlth Serv Policy & Practice, Sch Publ Hlth, Providence, RI 02912 USA; [Smith, Robert J.] Providence VA Med Ctr, Ocean State Res Inst, Providence, RI 02912 USA; [Hiatt, William R.] Univ Colorado, Sch Med, Dept Med, Div Cardiol, Aurora, CO USA; [Hiatt, William R.] CPC Clin Res, Aurora, CO USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Brown University; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus	Everett, BM (corresponding author), Harvard Univ, Sch Med, Boston, MA 02138 USA.							Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955	5	106	111	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2015	373	17					1588	1591		10.1056/NEJMp1508120	http://dx.doi.org/10.1056/NEJMp1508120			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU1YH	26444323				2022-12-28	WOS:000363317800002
J	Timmis, A				Timmis, Adam			Acute coronary syndromes	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ELEVATION MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR DYSFUNCTION; ST-ELEVATION; CARDIAC REHABILITATION; RANDOMIZED-TRIAL; CHEST-PAIN; MORTALITY; INTERVENTION; SURVIVAL; RISK		Barts Heart Ctr, NIHR Biomed Res Unit, London EC1A 7BE, England		Timmis, A (corresponding author), Barts Heart Ctr, NIHR Biomed Res Unit, London EC1A 7BE, England.	a.d.timmis@qmul.ac.uk			National Institute for Health Research; Medical Research Council [MR/K006584/1] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Barts NIHR Cardiovascular Biomedical Research Unit, funded by the National Institute for Health Research, and Liz Clark for reading and critically reviewing the manuscript.	Adielsson A, 2011, HEART, V97, P1391, DOI 10.1136/hrt.2011.222711; Agewall S, 2011, EUR HEART J, V32, P404, DOI 10.1093/eurheartj/ehq456; Alzuhairi KS, 2015, EUR HEART J IN PRESS; AMBROSIONI E, 1995, NEW ENGL J MED, V332, P80, DOI 10.1056/NEJM199501123320203; Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI [10.1161/CIR.0000000000000134, 10.1161/CIR.0000000000000151]; [Anonymous], 1988, LANCET, V2, P349; BALL SG, 1993, LANCET, V342, P821; Bhatnagar P, 2015, HEART, V101, P1182, DOI 10.1136/heartjnl-2015-307516; Boggon R, 2014, EUR J PREV CARDIOL, V21, P767, DOI 10.1177/2047487312460517; Brandt JT, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.10.010; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Carlton EW, 2015, AM J MED, V128, P1109, DOI 10.1016/j.amjmed.2015.04.012; Chan MY, 2009, CIRCULATION, V119, P3110, DOI 10.1161/CIRCULATIONAHA.108.799981; Choudry FA, 2015, EUR HEART J-ACUTE CA, V4, P378, DOI 10.1177/2048872614555990; de Vries H, 2015, EUR HEART J, V36, P1519, DOI 10.1093/eurheartj/ehv111; DEVITA C, 1994, LANCET, V343, P1115; Dumas F, 2010, CIRC-CARDIOVASC INTE, V3, P200, DOI 10.1161/CIRCINTERVENTIONS.109.913665; Fox KAA, 2006, BMJ-BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55; Gershlick AH, 2015, J AM COLL CARDIOL, V65, P963, DOI 10.1016/j.jacc.2014.12.038; Gurbel PA, 2009, CIRCULATION, V120, P2577, DOI 10.1161/CIRCULATIONAHA.109.912550; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; HJALMARSON A, 1981, LANCET, V2, P823; HJALMARSON A, 1985, EUR HEART J, V6, P199; Ilkhanoff L, 2012, CIRCULATION, V126, P793, DOI 10.1161/CIRCULATIONAHA.112.123588; Jones DA, 2012, HEART, V98, P1722, DOI 10.1136/heartjnl-2012-302414; Kim F, 2014, JAMA-J AM MED ASSOC, V311, P45, DOI 10.1001/jama.2013.282173; KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503; Lechat P, 1999, LANCET, V353, P9; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Mills NL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1533; Mills NL, 2011, JAMA-J AM MED ASSOC, V305, P1210, DOI 10.1001/jama.2011.338; Montalescot G, 2007, EUR HEART J, V28, P1409, DOI 10.1093/eurheartj/ehm031; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Myocardial Ischaemia National Audit Project, 2013, NHS CAR PAT HEART AT; National Institute for Health and Care Excellence, 2014, IMPL CARD DEF CARD R; National Institute for Health and Care Excellence, 2014, AC HEART FAIL DIAGN; National Institute for Health and Care Excellence, 2011, TIC TREATM AC COR SY; National Institute for Health and Care Excellence, 2014, MYOC INF AC EARL RUL; National Institute for Health and Care Excellence, 2010, CHEST PAIN REC ONS A; National Institute for Health and Care Excellence, 2013, MYOC INF ST SEGM EL; National Institute for Health and Care Excellence, 2014, QS68 NAT I HLTH CAR; O'Flaherty M, 2013, HEART, V99, P159, DOI 10.1136/heartjnl-2012-302300; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Ouweneel DM, 2012, HEART, V98, P1246, DOI 10.1136/heartjnl-2012-301963; PEDERSEN TR, 1994, LANCET, V344, P1383; PEDERSEN TR, 1983, CIRCULATION, V67, P49; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Quinn T, 2014, HEART, V100, P944, DOI 10.1136/heartjnl-2013-304599; Quint JK, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6650; Rathore SS, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1807; Ray KK, 2005, J AM COLL CARDIOL, V46, P1405, DOI 10.1016/j.jacc.2005.03.077; Rigotti NA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001837.pub2; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Silvain J, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e553; Sinnaeve PR, 2014, CIRCULATION, V130, P1139, DOI 10.1161/CIRCULATIONAHA.114.009570; Smolina Kate, 2012, BMJ, V344, pd8059, DOI 10.1136/bmj.d8059; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stone GW, 2007, JAMA-J AM MED ASSOC, V297, P591, DOI 10.1001/jama.297.6.591; Stub D, 2015, CIRCULATION, V131, P2143, DOI 10.1161/CIRCULATIONAHA.114.014494; Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410; Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001; Timmis A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h79; Valgimigli M, 2015, LANCET, V385, P2465, DOI 10.1016/S0140-6736(15)60292-6; Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Weinstock MB, 2015, JAMA INTERN MED, V175, P1207, DOI 10.1001/jamainternmed.2015.1674; West R, 2013, HEART, V99, P911, DOI 10.1136/heartjnl-2013-303705; West RR, 2012, HEART, V98, P637, DOI 10.1136/heartjnl-2011-300302; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Yusuf S, 2006, NEW ENGL J MED, V354, P1464; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	76	25	26	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2015	351								h5153	10.1136/bmj.h5153	http://dx.doi.org/10.1136/bmj.h5153			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3FJ	26487159				2022-12-28	WOS:000364143900003
J	Draghici, C; Wang, T; Spiegel, DA				Draghici, Cristian; Wang, Tina; Spiegel, David A.			Concise total synthesis of glucosepane	SCIENCE			English	Article							MAILLARD CROSS-LINKS; PROTEIN; IDENTIFICATION; DERIVATIVES; REARRANGEMENTS; CARBONYL; LENS; SKIN	Glucosepane is a structurally complex protein posttranslational modification that is believed to exist in all living organisms. Research in humans suggests that glucosepane plays a critical role in the pathophysiology of both diabetes and human aging, yet comprehensive biological investigations of this metabolite have been hindered by a scarcity of chemically homogeneous material available for study. Here we report the total synthesis of glucosepane, enabled by the development of a one-pot method for preparation of the nonaromatic 4H-imidazole tautomer in the core. Our synthesis is concise (eight steps starting from commercial materials), convergent, high-yielding (12% overall), and enantioselective. We expect that these results will prove useful in the art and practice of heterocyclic chemistry and beneficial for the study of glucosepane and its role in human health and disease.	[Draghici, Cristian; Wang, Tina; Spiegel, David A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Spiegel, David A.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA	Yale University; Yale University	Spiegel, DA (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.	david.spiegel@yale.edu			SENS Foundation; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER	SENS Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the SENS Foundation for financial support and G. Micalizio, A. de Grey, and W. Bains for helpful discussions.	Aranha RM, 2009, ORG LETT, V11, P575, DOI 10.1021/ol802577z; Biemel KM, 2002, ANGEW CHEM INT EDIT, V41, P801, DOI 10.1002/1521-3773(20020301)41:5<801::AID-ANIE801>3.0.CO;2-I; Biemel KM, 2001, NAHRUNG, V45, P210, DOI 10.1002/1521-3803(20010601)45:3&lt;210::AID-FOOD210&gt;3.0.CO;2-L; Biemel KM, 2002, J BIOL CHEM, V277, P24907, DOI 10.1074/jbc.M202681200; Chermahini AN, 2012, COMPUT THEOR CHEM, V994, P97, DOI 10.1016/j.comptc.2012.06.024; Dai ZY, 2008, J PROTEOME RES, V7, P2756, DOI 10.1021/pr700874a; Fan XJ, 2010, FREE RADICAL BIO MED, V49, P847, DOI 10.1016/j.freeradbiomed.2010.06.003; Hellwig M, 2014, ANGEW CHEM INT EDIT, V53, P10316, DOI 10.1002/anie.201308808; HODGE JE, 1953, J AM CHEM SOC, V75, P316, DOI 10.1021/ja01098a019; LAWSON AJ, 1979, J CHEM SOC CHEM COMM, P456, DOI 10.1039/c39790000456; Lederer MO, 1998, BIOORGAN MED CHEM, V6, P993, DOI 10.1016/S0968-0896(98)00058-3; Liebman J. F., 2008, CHEM HYDROXYLAMINES, V175; MARTIN MJ, 1993, HETEROCYCLES, V36, P157; Monnier VM, 2014, CLIN CHEM LAB MED, V52, P21, DOI 10.1515/cclm-2013-0174; Monnier VM, 2013, J DIABETES COMPLICAT, V27, P141, DOI 10.1016/j.jdiacomp.2012.10.004; OVERMAN LE, 1984, ANGEW CHEM INT EDIT, V23, P579, DOI 10.1002/anie.198405791; PERRIN CL, 1990, CHEM REV, V90, P935, DOI 10.1021/cr00104a002; Rauter AP, 2001, TETRAHEDRON-ASYMMETR, V12, P1131, DOI 10.1016/S0957-4166(01)00197-5; Sanchez-Fernandez EM, 2014, J ORG CHEM, V79, P11722, DOI 10.1021/jo5025283; Sell DR, 2005, J BIOL CHEM, V280, P12310, DOI 10.1074/jbc.M500733200; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Sjoberg JS, 2009, REJUV RES, V12, P137, DOI 10.1089/rej.2009.0846; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023	23	32	33	0	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2015	350	6258					294	298		10.1126/science.aac9655	http://dx.doi.org/10.1126/science.aac9655			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT5HD	26472902				2022-12-28	WOS:000362838700034
J	Teed, P; McCartney, M				Teed, Paul; McCartney, Margaret			LIVING WAGE Are medical organisations leading by example on pay?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												paulteed@doctors.org.uk	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Living Wage Commission, 2014, WORK PAYS FIN REP LI; Living Wage Foundation, LIV WAG EMPL; Marshall P, 2015, DEMOTIX         0128; Pickett K, 2014, YOU COULD DO ONE THI, P22; Public Health England, 2014, HLTH IN LIV WAG; Royal College of Physicians, 2014, IMPL NICE PUBL HLTH; UCL Institute of Health Equity, 2013, WORK HLTH EQ; UCL Institute of Health Equity, 2010, FAIR SOC HLTH LIV	8	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2015	351								h5387	10.1136/bmj.h5387	http://dx.doi.org/10.1136/bmj.h5387			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT8XS	26462997				2022-12-28	WOS:000363100800006
J	Sigal, YM; Speer, CM; Babcock, HP; Zhuang, XW				Sigal, Yaron M.; Speer, Colenso M.; Babcock, Hazen P.; Zhuang, Xiaowei			Mapping Synaptic Input Fields of Neurons with Super-Resolution Imaging	CELL			English	Article							RETINAL GANGLION-CELLS; GABA(A) RECEPTORS; DIRECTIONAL SELECTIVITY; AMACRINE CELLS; GEPHYRIN; RECONSTRUCTION; SYNAPSES; PERFORMANCE; INHIBITION; CHALLENGES	As a basic functional unit in neural circuits, each neuron integrates input signals from hundreds to thousands of synapses. Knowledge of the synaptic input fields of individual neurons, including the identity, strength, and location of each synapse, is essential for understanding how neurons compute. Here, we developed a volumetric super-resolution reconstruction platform for large-volume imaging and automated segmentation of neurons and synapses with molecular identity information. We used this platform to map inhibitory synaptic input fields of On-Off direction-selective ganglion cells (On-Off DSGCs), which are important for computing visual motion direction in the mouse retina. The reconstructions of On-Off DSGCs showed a GABAergic, receptor subtype-specific input field for generating direction selective responses without significant glycinergic inputs for mediating monosynaptic crossover inhibition. These results demonstrate unique capabilities of this super-resolution platform for interrogating neural circuitry.	[Sigal, Yaron M.; Speer, Colenso M.; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Babcock, Hazen P.; Zhuang, Xiaowei] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu		Speer, Colenso/0000-0002-3076-7072; Babcock, Hazen/0000-0003-4835-3692	Howard Hughes Medical Institute (HHMI); National Institute of Mental Health Conte Center Program [P50MH094271]; Army Research Office MURI program [6019269]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094271] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); National Institute of Mental Health Conte Center Program; Army Research Office MURI program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Daisy Spear, Mariah Evarts, and Sara Haddad for assistance with animals and Stephen Turney for providing custom confocal imaging equipment. We thank Joshua Sanes, Arjun Krishnaswamy, Melanie Samuel, Jeremy Kay, and the members of the X.Z. lab for discussions during the course of this project. This work was supported in part by Collaborative Innovation Awards of Howard Hughes Medical Institute (HHMI), the National Institute of Mental Health Conte Center Program (P50MH094271), and the Army Research Office MURI program (6019269). X.Z. is a HHMI investigator.	Alivisatos AP, 2013, SCIENCE, V339, P1284, DOI 10.1126/science.1236939; Anderson JR, 2011, MOL VIS, V17; Auferkorte ON, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035109; Babcock Hazen, 2012, Opt Nanoscopy, V1, DOI 10.1186/2192-2853-1-6; Bargmann CI, 2013, NAT METHODS, V10, P483, DOI 10.1038/NMETH.2451; Bleckert A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069612; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Cai D, 2013, NAT METHODS, V10, P540, DOI [10.1038/NMETH.2450, 10.1038/nmeth.2450]; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P277, DOI 10.1113/jphysiol.1978.sp012233; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/nmeth.1768, 10.1038/NMETH.1768]; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Fischer F, 2000, J COMP NEUROL, V427, P634, DOI 10.1002/1096-9861(20001127)427:4<634::AID-CNE10>3.0.CO;2-X; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Helmstaedter M, 2013, NAT METHODS, V10, P501, DOI [10.1038/nmeth.2476, 10.1038/NMETH.2476]; Holden SJ, 2011, NAT METHODS, V8, P279, DOI 10.1038/nmeth0411-279; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Huang F, 2013, NAT METHODS, V10, P653, DOI [10.1038/NMETH.2488, 10.1038/nmeth.2488]; Ishii T, 2014, J PHYSIOL-LONDON, V592, P4235, DOI 10.1113/jphysiol.2014.271148; Jain V, 2010, CURR OPIN NEUROBIOL, V20, P653, DOI 10.1016/j.conb.2010.07.004; Jensen RJ, 1999, VISUAL NEUROSCI, V16, P205, DOI 10.1017/S0952523899162023; Jia S, 2014, NAT PHOTONICS, V8, P302, DOI [10.1038/nphoton.2014.13, 10.1038/NPHOTON.2014.13]; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; KITTILA CA, 1995, J NEUROPHYSIOL, V73, P703, DOI 10.1152/jn.1995.73.2.703; Kleinfeld D, 2011, J NEUROSCI, V31, P16125, DOI 10.1523/JNEUROSCI.4077-11.2011; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Lim R, 1999, J PHYSIOL-LONDON, V516, P505, DOI 10.1111/j.1469-7793.1999.0505v.x; Loulier K, 2014, NEURON, V81, P505, DOI 10.1016/j.neuron.2013.12.016; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Majumdar S, 2009, J PHYSIOL-LONDON, V587, P3831, DOI 10.1113/jphysiol.2009.171207; Massey SC, 1997, VISUAL NEUROSCI, V14, P939, DOI 10.1017/S0952523800011652; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Miyawaki A, 2015, MICROSCOPY-JPN, V64, P5, DOI 10.1093/jmicro/dfu108; Morgan JL, 2013, NAT METHODS, V10, P494, DOI 10.1038/nmeth.2480; Nanguneri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038098; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pang JJ, 2012, J PHYSIOL-LONDON, V590, P223, DOI 10.1113/jphysiol.2011.222141; Punge A, 2008, MICROSC RES TECHNIQ, V71, P644, DOI 10.1002/jemt.20602; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Saalfeld S, 2012, NAT METHODS, V9, P717, DOI [10.1038/NMETH.2072, 10.1038/nmeth.2072]; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Specht CG, 2013, NEURON, V79, P308, DOI 10.1016/j.neuron.2013.05.013; Stafford BK, 2014, J NEUROSCI, V34, P1942, DOI 10.1523/JNEUROSCI.4461-13.2014; Stasheff SF, 2002, J NEUROPHYSIOL, V88, P1026, DOI 10.1152/jn.2002.88.2.1026; Trenholm S, 2011, NEURON, V71, P683, DOI 10.1016/j.neuron.2011.06.020; Tretter V, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00023; Tyagarajan SK, 2014, NAT REV NEUROSCI, V15, P141, DOI 10.1038/nrn3670; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; Viswanathan S, 2015, NAT METHODS, V12, P568, DOI 10.1038/nmeth.3365; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; Wei W, 2011, NATURE, V469, P402, DOI 10.1038/nature09600; Werblin FS, 2010, VISUAL NEUROSCI, V27, P1, DOI 10.1017/S0952523810000076; Zhang C, 2012, VISUAL NEUROSCI, V29, P11, DOI 10.1017/S0952523812000028	62	74	77	5	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2					493	505		10.1016/j.cell.2015.08.033	http://dx.doi.org/10.1016/j.cell.2015.08.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26435106	Green Accepted, Bronze			2022-12-28	WOS:000362952700022
J	Stam-Slob, MC; Lambalk, CB; van de Ree, MA				Stam-Slob, Manon C.; Lambalk, Cornelis B.; van de Ree, Marcel A.			PRACTICE POINTER Contraceptive and hormonal treatment options for women with history of venous thromboembolism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ORAL-CONTRACEPTIVES; RISK; NORGESTIMATE; THROMBOSIS; ESTROGEN; THERAPY; EVENTS		[Stam-Slob, Manon C.] Diakonessenhuis Utrecht, Dept Internal Med, NL-3508 TG Utrecht, Netherlands; [van de Ree, Marcel A.] Diakonessenhuis Utrecht, Dept Internal Med, Internal & Vasc Med, NL-3508 TG Utrecht, Netherlands; [Stam-Slob, Manon C.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [van de Ree, Marcel A.] Vrije Univ Amsterdam Med Ctr, Dept Obstet & Gynecol, Gynaecol, NL-1007 MB Amsterdam, Netherlands	Diakonessenhuis; Diakonessenhuis; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Stam-Slob, MC (corresponding author), Diakonessenhuis Utrecht, Dept Internal Med, Postbus 80250, NL-3508 TG Utrecht, Netherlands.	mslob@umcutrecht.nl		Lambalk, Cornelis/0000-0003-3947-5129				[Anonymous], 1998, Eur J Contracept Reprod Health Care, V3, P169; Canonico M, 2007, CIRCULATION, V115, P840, DOI 10.1161/CIRCULATIONAHA.106.642280; Christiansen SC, 2010, J THROMB HAEMOST, V8, P2159, DOI 10.1111/j.1538-7836.2010.03994.x; Christiansen SC, 2005, JAMA-J AM MED ASSOC, V293, P2352, DOI 10.1001/jama.293.19.2352; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; d'Arcangues C, 1999, CONTRACEPTION, V59, P31; de Bastos M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010813.pub2; Furness S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000402.pub4; Grimes DA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007541.pub3; Hansson PO, 2000, ARCH INTERN MED, V160, P769, DOI 10.1001/archinte.160.6.769; Hoibraaten E, 2000, THROMB HAEMOSTASIS, V84, P961; Jick SS, 2006, CONTRACEPTION, V73, P223, DOI 10.1016/j.contraception.2006.01.001; Jick SS, 2006, CONTRACEPTION, V73, P566, DOI 10.1016/j.contraception.2006.02.002; Lidegaard O, 2012, BMJ-BRIT MED J, V344, pe2990, DOI DOI 10.1136/BMJ; Lidegaard O, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6423; Mansour D, 2012, J FAM PLAN REPROD H, V38, P148, DOI 10.1136/jfprhc-2012-100345; Mantha S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4944; Olie V, 2011, MENOPAUSE, V18, P488, DOI 10.1097/gme.0b013e3181f9f7c3; Rosendaal FR, 1999, THROMB HAEMOSTASIS, V82, P610; Vaillant-Roussel Helene, 2011, Contraception, V84, pe23, DOI 10.1016/j.contraception.2011.06.008; van Hylckama Vlieg A, 2009, BMJ, V339, pb2921, DOI 10.1136/bmj.b2921; Vandenbroucke JP, 2001, NEW ENGL J MED, V344, P1527, DOI 10.1056/NEJM200105173442007; Vinogradova Y, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2135; Vlieg AVH, 2010, ARTERIOSCL THROM VAS, V30, P2297, DOI 10.1161/ATVBAHA.110.211482; WHO, 2015, MED EL CRIT CONTR US, V5th	25	11	10	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 8	2015	351								h4847	10.1136/bmj.h4847	http://dx.doi.org/10.1136/bmj.h4847			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT3SO	26450167				2022-12-28	WOS:000362727400001
J	Kamerow, D; Doodling, YK				Kamerow, Douglas; Doodling, Yankee			What's happening to cheap generic drugs?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kamerow, Douglas] Robert Graham Ctr, Policy Studies Primary Care, Washington, DC 20036 USA; [Kamerow, Douglas] Georgetown Univ, Family Med, Washington, DC 20057 USA	Georgetown University	Kamerow, D (corresponding author), Robert Graham Ctr, Policy Studies Primary Care, Washington, DC 20036 USA.	dkamerow@aafp.org		Kamerow, Douglas/0000-0001-7000-9957				Alpern JD, 2014, NEW ENGL J MED, V371, P1859, DOI 10.1056/NEJMp1408376; Healy P, 2015, NY TIMES; Johnson Y, 2015, WASHINGTON POST; McCarthy M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5114; Pollack A, 2015, NY TIMES, pB2; Saul S., 2007, NY TIMES; Tanne JH, 2003, BRIT MED J, V327, P565, DOI 10.1136/bmj.327.7414.565	7	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 5	2015	351								h5329	10.1136/bmj.h5329	http://dx.doi.org/10.1136/bmj.h5329			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT3SC	26437788				2022-12-28	WOS:000362726200010
J	Carraro, C; Edenhofer, O; Flachsland, C; Kolstad, C; Stavins, R; Stowe, R				Carraro, Carlo; Edenhofer, Ottmar; Flachsland, Christian; Kolstad, Charles; Stavins, Robert; Stowe, Robert			The IPCC at a crossroads: Opportunities for reform	SCIENCE			English	Editorial Material							POLICY		[Carraro, Carlo] Fdn Eni Enrico Mattei, I-30124 Venice, Italy; [Carraro, Carlo] Ca Foscari Univ Venice, I-30123 Venice, Italy; [Edenhofer, Ottmar; Flachsland, Christian] Mercator Res Inst Global Commons & Climate Change, D-10829 Berlin, Germany; [Edenhofer, Ottmar] Potsdam Inst Climate Res, D-14473 Potsdam, Germany; [Edenhofer, Ottmar] Tech Univ Berlin, D-10623 Berlin, Germany; [Flachsland, Christian] Hertie Sch Governance, D-10117 Berlin, Germany; [Kolstad, Charles] Stanford Univ, Stanford, CA 94305 USA; [Stavins, Robert; Stowe, Robert] Harvard Univ, Cambridge, MA 02138 USA	Fondazione Mattei; Universita Ca Foscari Venezia; Potsdam Institut fur Klimafolgenforschung; Technical University of Berlin; Stanford University; Harvard University	Edenhofer, O (corresponding author), Mercator Res Inst Global Commons & Climate Change, D-10829 Berlin, Germany.	ottmar.edenhofer@pik-potsdam.de	Edenhofer, Ottmar/E-1886-2013; Carraro, Carlo/A-7071-2014	Edenhofer, Ottmar/0000-0001-6029-5208; Carraro, Carlo/0000-0002-8403-2231; Flachsland, Christian/0000-0001-8632-5794				Aldy JE, 2014, CLIMATIC CHANGE, V126, P279, DOI 10.1007/s10584-014-1238-5; Bohringer C., 2014, REV ENV ECON POLICY, V8, P1; Dubash NK, 2014, SCIENCE, V345, P36, DOI 10.1126/science.1255734; Edenhofer O, 2015, ENVIRON SCI POLICY, V51, P56, DOI 10.1016/j.envsci.2015.03.017; Edenhofer O, 2014, SCIENCE, V345, P37, DOI 10.1126/science.1255998; Koch N, 2014, ENERG POLICY, V73, P676, DOI 10.1016/j.enpol.2014.06.024; Ranson M, 2016, CLIM POLICY, V16, P284, DOI 10.1080/14693062.2014.997658; Stavins R. N., 2014, ENV FORUM WASHINGTON, V31, P14; Victor DG, 2014, SCIENCE, V345, P34, DOI 10.1126/science.1255302	9	31	32	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					34	35		10.1126/science.aac4419	http://dx.doi.org/10.1126/science.aac4419			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS5EA	26430104				2022-12-28	WOS:000362098300030
J	Field, CB; Barros, VR				Field, Christopher B.; Barros, Vicente R.			Added value from IPCC approval sessions	SCIENCE			English	Editorial Material							SCIENCE; POLICY		[Field, Christopher B.] Carnegie Inst Sci, Stanford, CA 94305 USA; [Field, Christopher B.] Univ Buenos Aires, Buenos Aires, DF, Argentina	Carnegie Institution for Science; University of Buenos Aires	Field, CB (corresponding author), Carnegie Inst Sci, Stanford, CA 94305 USA.	cfield@ciw.edu						Black R, 2015, NAT CLIM CHANGE, V5, P282, DOI 10.1038/nclimate2534; Bolin B, 2007, HISTORY OF THE SCIENCE AND POLITICS OF CLIMATE CHANGE: THE ROLE OF THE INTERGOVERNMENTAL PANEL ON CLIMATE CHANGE, P1, DOI 10.1017/CBO9780511721731; Cash DW, 2003, P NATL ACAD SCI USA, V100, P8086, DOI 10.1073/pnas.1231332100; Edenhofer O, 2014, SCIENCE, V345, P37, DOI 10.1126/science.1255998; Hulme M, 2010, PROG PHYS GEOG, V34, P705, DOI 10.1177/0309133310373719; IPCC, 2012, MAN RISKS EXTR EV DI; [IPCC] The Intergovernmental Panel on Climate Change, 2013, APP A PRINC GOV IPCC; Perrings C, 2011, SCIENCE, V331, P1139, DOI 10.1126/science.1202400; Vasileiadou E, 2011, ENVIRON SCI POLICY, V14, P1052, DOI 10.1016/j.envsci.2011.07.002; Victor DG, 2015, NATURE, V520, P27, DOI 10.1038/520027a	10	7	8	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					36	36		10.1126/science.aaa8976	http://dx.doi.org/10.1126/science.aaa8976			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS5EA	26430105				2022-12-28	WOS:000362098300031
J	Thamer, M; De Marco, L; Ramasesha, K; Mandal, A; Tokmakoff, A				Thaemer, Martin; De Marco, Luigi; Ramasesha, Krupa; Mandal, Aritra; Tokmakoff, Andrei			Ultrafast 2D IR spectroscopy of the excess proton in liquid water	SCIENCE			English	Article							POTENTIAL-ENERGY SURFACES; HYDRATED PROTON; TRANSPORT; MECHANISM; CLUSTERS; ACID; SIMULATIONS; VIBRATIONS; GROTTHUSS; SPECTRUM	Despite decades of study, the structures adopted to accommodate an excess proton in water and the mechanism by which they interconvert remain elusive. We used ultrafast two-dimensional infrared (2D IR) spectroscopy to investigate protons in aqueous hydrochloric acid solutions. By exciting O-H stretching vibrations and detecting the spectral response throughout the mid-IR region, we observed the interaction between the stretching and bending vibrations characteristic of the flanking waters of the Zundel complex, [H(H2O)(2)](+), at 3200 and 1760 cm(-1), respectively. From time-dependent shifts of the stretch-bend cross peak, we determined a lower limit on the lifetime of this complex of 480 femtoseconds. These results suggest a key role for the Zundel complex in aqueous proton transfer.	[Thaemer, Martin; De Marco, Luigi; Mandal, Aritra; Tokmakoff, Andrei] Univ Chicago, Dept Chem, Inst Biophys Dynam, Chicago, IL 60637 USA; [Thaemer, Martin; De Marco, Luigi; Mandal, Aritra; Tokmakoff, Andrei] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [De Marco, Luigi; Ramasesha, Krupa; Mandal, Aritra] MIT, Dept Chem, Cambridge, MA 02139 USA	University of Chicago; University of Chicago; Massachusetts Institute of Technology (MIT)	Tokmakoff, A (corresponding author), Univ Chicago, Dept Chem, Inst Biophys Dynam, 5735 S Ellis Ave, Chicago, IL 60637 USA.	tokmakoff@uchicago.edu	Ramasesha, Krupa/AAZ-8682-2021		U.S. Department of Energy [DE-SC0011456, DE-SC0014305]; Deutscher Akademischer Austauschdienst; Natural Sciences and Engineering Research Council of Canada	U.S. Department of Energy(United States Department of Energy (DOE)); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the U.S. Department of Energy (grants DE-SC0011456 and DE-SC0014305). M.T. thanks the Deutscher Akademischer Austauschdienst for a postdoctoral fellowship. L.D.M. thanks the Natural Sciences and Engineering Research Council of Canada for a scholarship.	AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; Amir W, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2428299; Ando K, 1997, J PHYS CHEM B, V101, P10464, DOI 10.1021/jp970173j; Asmis KR, 2003, SCIENCE, V299, P1375, DOI 10.1126/science.1081634; Baer MD, 2014, J PHYS CHEM B, V118, P7211, DOI 10.1021/jp501091h; Berkelbach TC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238302; Geissler PL, 2001, SCIENCE, V291, P2121, DOI 10.1126/science.1056991; Guasco TL, 2011, J PHYS CHEM A, V115, P5847, DOI 10.1021/jp109999b; Hassanali A, 2013, P NATL ACAD SCI USA, V110, P13723, DOI 10.1073/pnas.1306642110; Headrick JM, 2005, SCIENCE, V308, P1765, DOI 10.1126/science.1113094; JANOSCHEK R, 1973, J CHEM SOC FARAD T 2, P505, DOI 10.1039/f29736900505; Kim J, 2002, J CHEM PHYS, V116, P737, DOI 10.1063/1.1423327; Kornyshev AA, 2003, J PHYS CHEM B, V107, P3351, DOI 10.1021/jp020857d; Kulig W, 2013, NAT CHEM, V5, P29, DOI [10.1038/NCHEM.1503, 10.1038/nchem.1503]; Kwak K, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2772269; Lapid H, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1814973; Lock AJ, 2001, J PHYS CHEM A, V105, P1238, DOI 10.1021/jp003158e; Markovitch O, 2008, J PHYS CHEM B, V112, P9456, DOI 10.1021/jp804018y; Marx D, 1999, NATURE, V397, P601, DOI 10.1038/17579; Marx D, 2006, CHEMPHYSCHEM, V7, P1848, DOI 10.1002/cphc.200600128; Nibbering ETJ, 2004, CHEM REV, V104, P1887, DOI 10.1021/cr020694p; OJAMAE L, 1995, INT J QUANTUM CHEM, P657; Park M, 2007, J PHYS CHEM A, V111, P10692, DOI 10.1021/jp073912x; Ramasesha K, 2013, NAT CHEM, V5, P935, DOI [10.1038/NCHEM.1757, 10.1038/nchem.1757]; Stoyanov ES, 2010, J AM CHEM SOC, V132, P1484, DOI 10.1021/ja9101826; TUCKERMAN M, 1995, J PHYS CHEM-US, V99, P5749, DOI 10.1021/j100016a003; Vendrell O, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2787596; Vuilleumier R, 1998, CHEM PHYS LETT, V284, P71, DOI 10.1016/S0009-2614(97)01365-1; Wang F, 2008, J AM CHEM SOC, V130, P3120, DOI 10.1021/ja078106i; Woutersen S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.138305; Xu JQ, 2011, J PHYS CHEM LETT, V2, P81, DOI 10.1021/jz101536b; ZUNDEL G, 1976, HYDROGEN BOND RECENT, P687	32	211	214	3	181	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					78	82		10.1126/science.aab3908	http://dx.doi.org/10.1126/science.aab3908			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26430117				2022-12-28	WOS:000362098300049
J	Ullman, KS; Powers, MA				Ullman, Katharine S.; Powers, Maureen A.			Locking down the core of the pore	SCIENCE			English	Editorial Material							NUCLEAR-PORE; COMPLEX; PROTEINS; CYCLE		[Ullman, Katharine S.] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Powers, Maureen A.] Emory Univ, Dept Cell Biol, Sch Med, Atlanta, GA 30322 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Emory University	Ullman, KS (corresponding author), Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA.	mpowers@emory.edu		Ullman, Katharine/0000-0003-3693-2830				Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Bailer SM, 2001, MOL CELL BIOL, V21, P7944, DOI 10.1128/MCB.21.23.7944-7955.2001; Basel-Vanagaite L, 2006, ANN NEUROL, V60, P214, DOI 10.1002/ana.20902; Chug H, 2015, SCIENCE, V350, P106, DOI 10.1126/science.aac7420; FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169; Frey S, 2009, EMBO J, V28, P2554, DOI 10.1038/emboj.2009.199; HURT EC, 1988, EMBO J, V7, P4323, DOI 10.1002/j.1460-2075.1988.tb03331.x; Hurt E, 2015, CURR OPIN CELL BIOL, V34, P31, DOI 10.1016/j.ceb.2015.04.009; Koh J, 2015, CELL, V161, P1361, DOI 10.1016/j.cell.2015.05.013; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; Solmaz SR, 2013, P NATL ACAD SCI USA, V110, P5858, DOI 10.1073/pnas.1302655110; Stuwe T, 2015, SCIENCE, V350, P56, DOI 10.1126/science.aac9176; Ulrich A, 2014, MOL BIOL CELL, V25, P1484, DOI 10.1091/mbc.E13-12-0745; Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201	14	1	1	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					33	34		10.1126/science.aad3797	http://dx.doi.org/10.1126/science.aad3797			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26430103				2022-12-28	WOS:000362098300029
J	Dalal, HM; Doherty, P; Taylor, RS				Dalal, Hasnain M.; Doherty, Patrick; Taylor, Rod S.			Cardiac rehabilitation	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CORONARY-ARTERY-DISEASE; FAILURE SELF-CARE; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; HEART-FAILURE; POSTMYOCARDIAL INFARCTION; PHYSICIAN FACTORS; EXERCISE; MANAGEMENT; ENROLLMENT		[Dalal, Hasnain M.] Univ Exeter, Med Sch Primary Care, Royal Cornwall Hosp, Exeter EX4 4QJ, Devon, England; [Doherty, Patrick] Univ York, Dept Hlth Sci, Cardiovasc Hlth, York YO10 5DD, N Yorkshire, England; [Doherty, Patrick] Univ York, Dept Hlth Sci, Natl Audit Cardiac Rehabil, York YO10 5DD, N Yorkshire, England; [Doherty, Patrick] Univ York, Dept Hlth Sci, Res, York YO10 5DD, N Yorkshire, England; [Taylor, Rod S.] Univ Exeter, Sch Med, Inst Hlth Res, Hlth Serv Res, Exeter EX1 2LU, Devon, England; [Taylor, Rod S.] Univ Exeter, Sch Med, Inst Hlth Res, Exeter Clin Trials Support Network, Exeter EX1 2LU, Devon, England	Royal Cornwall Hospital; University of Exeter; University of York - UK; University of York - UK; University of York - UK; University of Exeter; University of Exeter	Dalal, HM (corresponding author), Univ Exeter, Med Sch Primary Care, Royal Cornwall Hosp, Truro Campus,Knowledge Spa, Exeter EX4 4QJ, Devon, England.	hmdalal@doctors.org.uk	Taylor, Rod/R-9581-2019; McGee, Hannah M/D-6480-2012; Thompson, David R/C-6320-2009; Dinnes, Jacqueline/Y-3673-2018	Taylor, Rod/0000-0002-3043-6011; McGee, Hannah M/0000-0003-1417-993X; Dinnes, Jacqueline/0000-0003-1343-7335; Doherty, Patrick Joseph/0000-0002-1887-0237	National Institute for Health Research [RP-PG-1210-12004, NF-SI-0514-10155] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		ADES PA, 1992, ARCH INTERN MED, V152, P1033, DOI 10.1001/archinte.152.5.1033; Ades PA, 2013, JACC-HEART FAIL, V1, P540, DOI 10.1016/j.jchf.2013.09.002; Ades PA, 2009, CIRCULATION, V119, P2671, DOI 10.1161/CIRCULATIONAHA.108.834184; Anderson L, COCHRANE DA IN PRESS; Anderson L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011273.pub2; Balady GJ, 2007, J CARDIOPULM REHABIL, V27, P121; Balady GJ, 2011, CIRCULATION, V124, P2951, DOI 10.1161/CIR.0b013e31823b21e2; Beatty AL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000568; Bjarnason-Wehrens B, 2010, EUR J CARDIOV PREV R, V17, P410, DOI [DOI 10.1097/HJR.0b013e328334f42d, 10.1097/HJR.0b013e328334f42d]; British Association for Cardiovascular Prevention and Rehabilitation, 2012, BACPR STAND COR COMP; British Heart Foundation, 2014, INP OUTP ACC PHIL; British Heart Foundation, EUROPEAN CARDIOVASCU; British Heart Foundation, HEART STAT; Brown JPR, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008895.pub2; Brown JP, 2010, COCHRANE DB SYST REV, V1; Buck HG, 2015, EUR J CARDIOVASC NUR, V14, P79, DOI 10.1177/1474515113518434; Clark AM, 2014, HEART, V100, P716, DOI 10.1136/heartjnl-2013-304852; Clark AM, 2005, ANN INTERN MED, V143, P659, DOI 10.7326/0003-4819-143-9-200511010-00010; Clark RA, 2015, EUR J PREV CARDIOL, V22, P35, DOI 10.1177/2047487313501093; Dalal H, 2004, BMJ-BRIT MED J, V328, P693, DOI 10.1136/bmj.328.7441.693; Dalal HM, 2007, INT J CARDIOL, V119, P202, DOI 10.1016/j.ijcard.2006.11.018; Dalal HM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000787; Dalal HM, 2003, BRIT MED J, V326, P481, DOI 10.1136/bmj.326.7387.481; Deanfield J, 2014, HEART, V100, P1, DOI 10.1136/heartjnl-2014-305693; Department of Health, 2010, CARD REH COMM PACK; Doherty P, 2012, HEART, V98, P605, DOI 10.1136/heartjnl-2012-301728; Forman DE, 2015, J AM COLL CARDIOL, V65, P2652, DOI 10.1016/j.jacc.2015.04.052; Ghisi GLM, 2013, CLIN CARDIOL, V36, P323, DOI 10.1002/clc.22126; Grace SL, 2008, EUR J CARDIOV PREV R, V15, P548, DOI 10.1097/HJR.0b013e328305df05; Healthcare Commission, 2004, COR HEART DIS SURV P; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub2, 10.1002/14651858.CD001800.pub3]; Jelinek MV, 2015, INT J CARDIOL, V179, P153, DOI 10.1016/j.ijcard.2014.10.154; Jolly K, 2009, HEART, V95, P36, DOI 10.1136/hrt.2007.127209; Lavie CJ, 2006, ARCH INTERN MED, V166, P1878, DOI 10.1001/archinte.166.17.1878; LAVIE CJ, 1994, AM J CARDIOL, V74, P1192, DOI 10.1016/0002-9149(94)90546-0; Lawler PR, 2011, AM HEART J, V162, P571, DOI 10.1016/j.ahj.2011.07.017; Leon AS, 2005, CIRCULATION, V111, P369, DOI 10.1161/01.CIR.0000151788.08740.5C; LEWIN B, 1992, LANCET, V339, P1036, DOI 10.1016/0140-6736(92)90547-G; Lewin R, 2013, HEART, V99, P909, DOI 10.1136/heartjnl-2013-303704; Linden W, 1996, ARCH INTERN MED, V156, P745, DOI 10.1001/archinte.156.7.745; Mampuya WM, 2012, CARDIOVASC DIAGN THE, V2, P38, DOI 10.3978/j.issn.2223-3652.2012.01.02; Menezes AR, 2014, PROG CARDIOVASC DIS, V56, P522, DOI 10.1016/j.pcad.2013.09.018; Milani RV, 2011, AM J CARDIOL, V107, P64, DOI 10.1016/j.amjcard.2010.08.047; National Institute for Health and Care Excellence, 2010, EARL MAN UNST ANG NO; National Institute for Health and Care Excellence, 2010, MAN CHRON HEART FAIL; National Institute for Health and Care Excellence, 2013, SEC PREV PRIM SEC CA; OLDRIDGE NB, 1988, JAMA-J AM MED ASSOC, V260, P945, DOI 10.1001/jama.260.7.945; Pack QR, 2014, J CARDIOPULM REHABIL, V34, P318, DOI 10.1097/HCR.0000000000000076; Pavy B, 2006, ARCH INTERN MED, V166, P2329, DOI 10.1001/archinte.166.21.2329; Piepoli MF, 2014, EUR J PREV CARDIOL, V21, P664, DOI 10.1177/2047487312449597; Sagar VA, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2014-000163; SCHULER G, 1992, J AM COLL CARDIOL, V19, P34, DOI 10.1016/0735-1097(92)90048-R; TAYLOR CB, 1986, J PSYCHOSOM RES, V30, P581, DOI 10.1016/0022-3999(86)90031-0; Anderson Lindsey, 2017, Cochrane Database Syst Rev, V6, pCD007130, DOI [10.1002/14651858.CD007130.pub3, 10.1002/14651858.CD007130.pub4]; Taylor RS, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003331.pub4; VANCAMP SP, 1986, JAMA-J AM MED ASSOC, V256, P1160, DOI 10.1001/jama.256.9.1160; Vanhees L, 2012, EUR J PREV CARDIOL, V19, P1333, DOI 10.1177/2047487312437063; Varnfield M, 2014, HEART, V100, P1770, DOI 10.1136/heartjnl-2014-305783; West R, 2013, HEART, V99, P911, DOI 10.1136/heartjnl-2013-303705; West RR, 2012, HEART, V98, P637, DOI 10.1136/heartjnl-2011-300302; Wingham Jenny, 2006, Eur J Cardiovasc Nurs, V5, P289, DOI 10.1016/j.ejcnurse.2006.02.002; Wood D, 2012, HEART, V98, P607, DOI 10.1136/heartjnl-2012-301811	62	205	213	2	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 29	2015	351								h5000	10.1136/bmj.h5000	http://dx.doi.org/10.1136/bmj.h5000			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS9YU	26419744	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000362450900007
J	Lowe, J; Howlett, D				Lowe, James; Howlett, David			Early warning sign on computed tomography of the head	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lowe, James] Eastbourne Dist Gen Hosp, Eastbourne BN21 2UD, England; [Howlett, David] East Sussex Hosp NHS Trust, Dept Radiol, Eastbourne, England		Lowe, J (corresponding author), Eastbourne Dist Gen Hosp, Eastbourne BN21 2UD, England.	james.lowe1@nhs.net						National Institute for Health and Care Excellence, 2013, MECH CLOT RETR TREAT	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 29	2015	351								h5013	10.1136/bmj.h5013	http://dx.doi.org/10.1136/bmj.h5013			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS9YU	26420229				2022-12-28	WOS:000362450900008
J	von Keudell, AG; Weaver, MJ; Appelton, PT; Bae, DS; Dyer, GSM; Heng, M; Jupiter, JB; Vrahas, MS				von Keudell, Arvind G.; Weaver, Michael J.; Appelton, Paul T.; Bae, Donald S.; Dyer, George S. M.; Heng, Marilyn; Jupiter, Jesse B.; Vrahas, Mark S.			Diagnosis and treatment of acute extremity compartment syndrome	LANCET			English	Article							NEAR-INFRARED SPECTROSCOPY; LOWER LEG; TIBIAL FRACTURES; TISSUE PRESSURE; LOWER-LIMB; ISCHEMIC CONTRACTURE; CHILDREN DIAGNOSIS; MUSCLE ISCHEMIA; SKELETAL-MUSCLE; FOOT	Acute compartment syndrome of the extremities is well known, but diagnosis can be challenging. Ineffective treatment can have devastating consequences, such as permanent dysaesthesia, ischaemic contractures, muscle dysfunction, loss of limb, and even loss of life. Despite many studies, there is no consensus about the way in which acute extremity compartment syndromes should be diagnosed. Many surgeons suggest continuous monitoring of intracompartmental pressure for all patients who have high-risk extremity injuries, whereas others suggest aggressive surgical intervention if acute compartment syndrome is even suspected. Although surgical fasciotomy might reduce intracompartmental pressure, this procedure also carries the risk of long-term complications. In this paper in The Lancet Series about emergency surgery we summarise the available data on acute extremity compartment syndrome of the upper and lower extremities in adults and children, discuss the underlying pathophysiology, and propose a clinical guideline based on the available data.	[von Keudell, Arvind G.; Weaver, Michael J.; Appelton, Paul T.; Dyer, George S. M.; Jupiter, Jesse B.; Vrahas, Mark S.] Harvard Univ, Sch Med, Orthoped Trauma Initiat, Boston, MA 02114 USA; [Dyer, George S. M.; Heng, Marilyn; Jupiter, Jesse B.; Vrahas, Mark S.] Harvard Univ, Sch Med, Dept Orthoped Surg, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Weaver, Michael J.; Dyer, George S. M.; Vrahas, Mark S.] Harvard Univ, Sch Med, Dept Orthoped Surg, Brigham & Womens Hosp, Boston, MA 02114 USA; [Bae, Donald S.] Harvard Univ, Sch Med, Dept Orthoped Surg, Boston Childrens Hosp, Boston, MA 02114 USA; [Appelton, Paul T.] Harvard Univ, Sch Med, Dept Orthoped Surg, Beth Israel Deaconess Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	von Keudell, AG (corresponding author), Harvard Univ, Sch Med, Orthoped Trauma Initiat, Boston, MA 02114 USA.	avonkeudell@mgh.harvard.edu		Heng, Marilyn/0000-0002-4047-6818				Al-Dadah OQ, 2008, INJURY, V39, P1204, DOI 10.1016/j.injury.2008.03.029; ALLEN MJ, 1985, J BONE JOINT SURG BR, V67, P53, DOI 10.1302/0301-620X.67B1.3968144; Bae DS, 2001, J PEDIATR ORTHOPED, V21, P680, DOI 10.1097/00004694-200109000-00025; Balogh ZJ, 2010, CRIT CARE MED, V38, pS445, DOI 10.1097/CCM.0b013e3181ec5d09; Barney BM, 2011, PRACT RADIAT ONCOL, V1, P135, DOI 10.1016/j.prro.2010.11.005; Bedri MI, 2009, J HAND SURG-AM, V34A, P1859, DOI 10.1016/j.jhsa.2009.08.003; Belzunegui T, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-9; Beraldo S, 2006, DIS COLON RECTUM, V49, P1772, DOI 10.1007/s10350-006-0712-1; Bhattacharyya T, 2004, J BONE JOINT SURG AM, V86A, P864, DOI 10.2106/00004623-200404000-00029; Bibbo C, 2000, PEDIATR EMERG CARE, V16, P244, DOI 10.1097/00006565-200008000-00007; Bible JE, 2013, J ORTHOP TRAUMA, V27, P607, DOI 10.1097/BOT.0b013e318291f284; Blaisdell FW, 2002, CARDIOVASC SURG, V10, P620, DOI 10.1016/S0967-2109(02)00070-4; Blakemore LC, 2000, CLIN ORTHOP RELAT R, P32; Boody AR, 2005, J BONE JOINT SURG AM, V87A, P2415, DOI 10.2106/JBJS.D.02826; Botte MJ, 1996, ORTHOPEDICS, V19, P235; Breit GA, 1997, J BONE JOINT SURG AM, V79A, P838, DOI 10.2106/00004623-199706000-00006; Brey Jennifer M B, 2008, Foot Ankle Clin, V13, P767, DOI 10.1016/j.fcl.2008.08.003; Carla Stecco, 2011, Italian Journal of Anatomy and Embryology, V116, P127; Cathcart CC, 2014, J ORTHOP TRAUMA, V28, P365, DOI 10.1097/BOT.0b013e3182a75ceb; Chim H, 2012, J SURG CASE REP, DOI 10.1093/jscr/2012.8.11; Clasper J C, 2010, J R Army Med Corps, V156, P77; Dodd A, 2013, J AM ACAD ORTHOP SUR, V21, P657, DOI 10.5435/JAAOS-21-11-657; Dyer G, 2008, J HAND SURG-AM, V33A, P1309, DOI 10.1016/j.jhsa.2008.04.012; Finkelstein JA, 1996, J TRAUMA, V40, P342, DOI 10.1097/00005373-199603000-00002; Fitzgerald AM, 2000, BRIT J PLAST SURG, V53, P690, DOI 10.1054/bjps.2000.3444; Flynn JM, 2011, J BONE JOINT SURG AM, V93A, P937, DOI 10.2106/JBJS.J.00285; Frink M, 2007, INJURY, V38, P607, DOI 10.1016/j.injury.2006.12.021; Frink M, 2010, CLIN ORTHOP RELAT R, V468, P940, DOI 10.1007/s11999-009-0891-x; GARFIN SR, 1981, J APPL PHYSIOL, V51, P317, DOI 10.1152/jappl.1981.51.2.317; Garr JL, 1999, J TRAUMA, V46, P613, DOI 10.1097/00005373-199904000-00009; Giannoudis PV, 2002, INJURY, V33, P117, DOI 10.1016/S0020-1383(01)00073-0; Grottkau BE, 2005, J PEDIATR SURG, V40, P678, DOI 10.1016/j.jpedsurg.2004.12.007; Hammerberg EM, 2012, J ORTHOP TRAUMA, V26, pE166, DOI 10.1097/BOT.0b013e3182673a3f; Han FC, 2015, J FOOT ANKLE SURG, V54, P417, DOI 10.1053/j.jfas.2014.09.015; HARGENS AR, 1979, J BONE JOINT SURG AM, V61, P192, DOI 10.2106/00004623-197961020-00006; Harrington P, 2000, INJURY, V31, P387, DOI 10.1016/S0020-1383(99)00308-3; Harris IA, 2006, J TRAUMA, V60, P1330, DOI 10.1097/01.ta.0000196001.03681.c3; Heckman M M, 1993, J Orthop Trauma, V7, P199, DOI 10.1097/00005131-199306000-00001; HECKMAN MM, 1994, J BONE JOINT SURG AM, V76A, P1285, DOI 10.2106/00004623-199409000-00002; Hope MJ, 2004, J ORTHOP TRAUMA, V18, P220, DOI 10.1097/00005131-200404000-00005; Huard J, 2002, J BONE JOINT SURG AM, V84A, P822, DOI 10.2106/00004623-200205000-00022; Hwang RW, 2009, J BONE JOINT SURG AM, V91A, P642, DOI 10.2106/JBJS.H.00377; Janzing HMJ, 2001, INJURY, V32, P415, DOI 10.1016/S0020-1383(01)00005-5; Kakar S, 2007, J ORTHOP TRAUMA, V21, P99, DOI 10.1097/BOT.0b013e318032c4f4; Kanj WW, 2013, J CHILD ORTHOP, V7, P225, DOI 10.1007/s11832-013-0492-9; Kanlic EM, 2010, PATIENT SAF SURG, V4, DOI 10.1186/1754-9493-4-13; Kim JYS, 2009, ANN PLAS SURG, V62, P22, DOI 10.1097/SAP.0b013e3181776327; Kleshinski J, 2008, AM J MED SCI, V336, P265, DOI 10.1097/MAJ.0b013e318165650a; MANCINI DM, 1994, J APPL PHYSIOL, V77, P2740, DOI 10.1152/jappl.1994.77.6.2740; MANOLI A, 1990, FOOT ANKLE, V10, P340, DOI 10.1177/107110079001000610; Mars M, 1998, INJURY, V29, P183, DOI 10.1016/S0020-1383(97)00172-1; Masini Brendan D, 2013, J Surg Orthop Adv, V22, P42; MATAVA MJ, 1994, J TRAUMA, V37, P50, DOI 10.1097/00005373-199407000-00010; Matsen F A 3rd, 1977, Bibl Anat, P112; MATSEN FA, 1980, J BONE JOINT SURG AM, V62, P286, DOI 10.2106/00004623-198062020-00016; MATSEN FA, 1979, NEW ENGL J MED, V300, P1210, DOI 10.1056/NEJM197905243002108; MATSEN FA, 1981, J PEDIATR ORTHOPED, V1, P33, DOI 10.1097/01241398-198101010-00005; McQueen MM, 2010, INJURY, V41, P431, DOI 10.1016/j.injury.2009.09.031; McQueen MM, 2000, J BONE JOINT SURG BR, V82B, P200, DOI 10.1302/0301-620X.82B2 .9799; McQueen MM, 1996, J BONE JOINT SURG BR, V78B, P99, DOI 10.1302/0301-620X.78B1.0780099; Reverte MM, 2011, INJURY, V42, P1402, DOI 10.1016/j.injury.2011.09.007; Mithoefer K, 2006, J BONE JOINT SURG AM, V88A, P729, DOI 10.2106/JBJS.E.00336; Mithofer K, 2004, CLIN ORTHOP RELAT R, P223, DOI 10.1097/01.blo.0000137291.48374.22; MITTLMEIER T, 1991, CLIN ORTHOP RELAT R, P241; MOEHRING HD, 1995, ORTHOPEDICS, V18, P631; Mubarak S J, 1983, Instr Course Lect, V32, P92; MUBARAK SJ, 1979, J BONE JOINT SURG BR, V61, P285, DOI 10.1302/0301-620X.61B3.479251; MUBARAK SJ, 1978, J BONE JOINT SURG AM, V60, P1091, DOI 10.2106/00004623-197860080-00012; MYERSON MS, 1991, CLIN ORTHOP RELAT R, P239; O'Sullivan M J, 2002, Ir Med J, V95, P22; ODEH M, 1991, NEW ENGL J MED, V324, P1417; Ojike NI, 2010, INJURY, V41, P133, DOI 10.1016/j.injury.2009.03.016; Ojike NI, 2009, ACTA ORTHOP BELG, V75, P573; Olson SA, 2005, J AM ACAD ORTHOP SUR, V13, P436, DOI 10.5435/00124635-200511000-00003; Ouellette EA, 1996, J BONE JOINT SURG AM, V78A, P1515, DOI 10.2106/00004623-199610000-00009; Prasarn ML, 2011, J AM ACAD ORTHOP SUR, V19, P49, DOI 10.5435/00124635-201101000-00006; Prasarn ML, 2009, J PEDIATR ORTHOPED, V29, P263, DOI 10.1097/BPO.0b013e31819c3d54; Ridha A, 2014, LANCET, V384, P2172, DOI 10.1016/S0140-6736(14)61944-9; Roberts Craig S, 2011, Instr Course Lect, V60, P43; RORABECK CH, 1978, J TRAUMA, V18, P299, DOI 10.1097/00005373-197805000-00001; RORABECK CH, 1984, J BONE JOINT SURG BR, V66, P93, DOI 10.1302/0301-620X.66B1.6693486; RORABECK CH, 1975, CLIN ORTHOP RELAT R, P52; SANTI MD, 1995, FOOT ANKLE INT, V16, P368, DOI 10.1177/107110079501600610; SCHWARTZ JT, 1989, J BONE JOINT SURG AM, V71A, P392, DOI 10.2106/00004623-198971030-00013; Shadgan B, 2008, J ORTHOP TRAUMA, V22, P581, DOI 10.1097/BOT.0b013e318183136d; SHERIDAN GW, 1976, J BONE JOINT SURG AM, V58, P112, DOI 10.2106/00004623-197658010-00020; Shore BJ, 2013, J ORTHOP TRAUMA, V27, P616, DOI 10.1097/BOT.0b013e31828f949c; Shuler FD, 2010, J BONE JOINT SURG AM, V92A, P361, DOI 10.2106/JBJS.I.00411; Shuler MS, 2010, J BONE JOINT SURG AM, V92A, P863, DOI 10.2106/JBJS.I.00816; Shuler MS, 2009, J BONE JOINT SURG AM, V91A, P1360, DOI 10.2106/JBJS.H.00347; SILAS SI, 1995, J BONE JOINT SURG AM, V77A, P356, DOI 10.2106/00004623-199503000-00004; Stark E, 2009, J ORTHOP TRAUMA, V23, P502, DOI 10.1097/BOT.0b013e3181a18235; Staudt JM, 2008, J BONE JOINT SURG BR, V90B, P215, DOI 10.1302/0301-620X.90B2.19678; Tollens T, 1998, ACTA CHIR BELG, V98, P171; Toney J, 2016, J FOOT ANKLE SURG, V55, P418, DOI 10.1053/j.jfas.2015.02.010; Ulmer T, 2002, J ORTHOP TRAUMA, V16, P572, DOI 10.1097/00005131-200209000-00006; VANDERVELPEN G, 1992, ACTA CHIR BELG, P234; Volkman Rv, 1881, CENTRALBLATT CHIR, V8, P801; Wall CJ, 2010, ANZ J SURG, V80, P151, DOI 10.1111/j.1445-2197.2010.05213.x; Wang KL, 2006, AM J KIDNEY DIS, V48, P990, DOI 10.1053/j.ajkd.2006.08.020; White TO, 2003, J TRAUMA, V55, P1133, DOI 10.1097/01.TA.0000100822.13119.AD; WHITESIDES TE, 1975, CLIN ORTHOP RELAT R, P43; Wong JC, 2015, J HAND SURG-AM, V40, P701, DOI 10.1016/j.jhsa.2014.12.003; Zwipp H, 2008, UNFALLCHIRURG, V111, P776, DOI 10.1007/s00113-008-1492-y	104	115	117	3	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 26	2015	386	10000					1299	1310		10.1016/S0140-6736(15)00277-9	http://dx.doi.org/10.1016/S0140-6736(15)00277-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9TQ	26460664				2022-12-28	WOS:000361700100039
J	Siklenka, K; Erkek, S; Godmann, M; Lambrot, R; McGraw, S; Lafleur, C; Cohen, T; Xia, JG; Suderman, M; Hallett, M; Trasler, J; Peters, AHFM; Kimmins, S				Siklenka, Keith; Erkek, Serap; Godmann, Maren; Lambrot, Romain; McGraw, Serge; Lafleur, Christine; Cohen, Tamara; Xia, Jianguo; Suderman, Matthew; Hallett, Michael; Trasler, Jacquetta; Peters, Antoine H. F. M.; Kimmins, Sarah			Disruption of histone methylation in developing sperm impairs offspring health transgenerationally	SCIENCE			English	Article							DNA METHYLATION; MUTATION-RATES; MOUSE; INHERITANCE; CHROMATIN; LSD1; RNA; EXPRESSION; MARKS; PDK1	A father's lifetime experiences can be transmitted to his offspring to affect health and development. However, the mechanisms underlying paternal epigenetic transmission are unclear. Unlike in somatic cells, there are few nucleosomes in sperm, and their function in epigenetic inheritance is unknown. We generated transgenic mice in which overexpression of the histone H3 lysine 4 (H3K4) demethylase KDM1A (also known as LSD1) during spermatogenesis reduced H3K4 dimethylation in sperm. KDM1A overexpression in one generation severely impaired development and survivability of offspring. These defects persisted transgenerationally in the absence of KDM1A germline expression and were associated with altered RNA profiles in sperm and offspring. We show that epigenetic inheritance of aberrant development can be initiated by histone demethylase activity in developing sperm, without changes to DNA methylation at CpG-rich regions.	[Siklenka, Keith; Kimmins, Sarah] McGill Univ, Fac Med, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Erkek, Serap; Peters, Antoine H. F. M.] Friedrich Miescher Inst Biomed Res FMI, CH-4058 Basel, Switzerland; [Erkek, Serap; Peters, Antoine H. F. M.] Univ Basel, Fac Sci, Basel, Switzerland; [Godmann, Maren; Lambrot, Romain; Lafleur, Christine; Cohen, Tamara; Xia, Jianguo; Kimmins, Sarah] McGill Univ, Fac Agr & Environm Sci, Dept Anim Sci, Montreal, PQ, Canada; [McGraw, Serge; Trasler, Jacquetta] McGill Univ, Fac Med, Dept Pediat, Montreal, PQ, Canada; [Xia, Jianguo] McGill Univ, Fac Agr & Environm Sci, Inst Parasitol, Montreal, PQ, Canada; [Suderman, Matthew] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unity, Bristol, Avon, England; [Hallett, Michael] McGill Univ, Fac Sci, Sch Comp Sci, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Trasler, Jacquetta] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Res Inst,Dept Human Genet, Montreal, PQ H3H 1P3, Canada; [Trasler, Jacquetta] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Dept Pharmacol & Therapeut,Res Inst, Montreal, PQ H3H 1P3, Canada	McGill University; Friedrich Miescher Institute for Biomedical Research; University of Basel; McGill University; McGill University; McGill University; University of Bristol; McGill University; McGill University; McGill University	Peters, AHFM (corresponding author), Friedrich Miescher Inst Biomed Res FMI, CH-4058 Basel, Switzerland.	antoine.peters@fmi.ch; sarah.kimmins@mcgill.ca	Erkek, Serap/AAV-5549-2020; Godmann, Maren/B-5899-2016; McGraw, Serge/AAN-4478-2020; Peters, Antoine/ABA-6283-2020; Xia, Jianguo/Z-1935-2019	Godmann, Maren/0000-0002-0214-8012; McGraw, Serge/0000-0002-3504-8253; Xia, Jianguo/0000-0003-2040-2624; Erkek, Serap/0000-0003-4439-5203; Suderman, Matthew/0000-0002-2715-9930; Peters, Antoine/0000-0002-0311-1887; Hallett, Michael/0000-0001-6738-6786	Canadian Institute of Health Research; Genome Quebec; Reseau de Reproduction Quebecois; Fonds de Recherche du Quebec - Nature et Technologies (FRQNT); Boehringer Ingelheim Fond; Swiss National Science Foundation [31003A_125386]; Novartis Research Foundation	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Quebec; Reseau de Reproduction Quebecois; Fonds de Recherche du Quebec - Nature et Technologies (FRQNT); Boehringer Ingelheim Fond(Boehringer Ingelheim); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Research Foundation	We thank M. Stadler, H. Royo, and D. Gaidatzis (FMI) for advice on computational data analysis; B. K. Hall (Dalhousie University) and J. Tanny and D. Bernard (McGill University) for advice; X. Giner for technical expertise; the Laboratoire de Transgenese Center de Recherche, Centre Hospitalier de l'Universite de Montreal, Canada, for microinjection and generation of the transgenic hKDM1A founders; Y. Shi (Harvard University) for providing full-length human KDM1 cDNA; T. Pastinen, G. Bourque, M. Caron, and platform personnel of the McGill Epigenomics Mapping and Data Coordinating Centers in the McGill University, as well as Genome Quebec Innovation Centre, for setting up the RRBS sequencing data analysis pipeline; and F. Lefebvre for support with microarray analysis. This research was funded by the Canadian Institute of Health Research (S.K. and J. T.), Genome Quebec (S.K. and J. T.), the Reseau de Reproduction Quebecois, Fonds de Recherche du Quebec - Nature et Technologies (FRQNT) (S.K. and J. T), Boehringer Ingelheim Fond (S.E.), Swiss National Science Foundation (grant 31003A_125386) (A.H.F.M.P.), and the Novartis Research Foundation (A.H.F.M.P.). The data reported in this paper are available at Gene Expression Omnibus: Microarray data, including both the CEL files and the transcript-level expression values, are under accession number GSE66052; ChIP-seq and nucleosome data are under accession number GSE55471. K.S., S.E., M. G., R.L., S.M., J. T., A.H.F.M.P., and S.K. conceived and designed the experiments. K.S., S.E., M. G., R.L., C.L., T.C., S.M., J. X., J. T., M.S., A. H. F. M.P., and S.K. performed the experiments and analyzed the data. M. H. provided advice on the data analysis and the manuscript. K.S., J. T., A. H. F. M.P., and S.K. wrote the manuscript. We declare no conflicts of interest that would prejudice the impartiality of this work.	Alexa A., 2019, TOPGO ENRICHMENT ANA; [Anonymous], NATL VITAL STAT REPO; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Balhorn R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-227; Barber RC, 2009, MUTAT RES-FUND MOL M, V664, P6, DOI 10.1016/j.mrfmmm.2009.01.011; Bestor TH, 2004, COLD SPRING HARB SYM, V69, P381, DOI 10.1101/sqb.2004.69.381; Blanco-Rodriguez J, 2009, MICROSC RES TECHNIQ, V72, P823, DOI 10.1002/jemt.20730; BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; Borges F, 2013, RNA BIOL, V10, P490, DOI 10.4161/rna.24085; BRAUN RE, 1989, NATURE, V337, P373, DOI 10.1038/337373a0; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Burr KLA, 2007, MUTAT RES-FUND MOL M, V617, P147, DOI 10.1016/j.mrfmmm.2007.01.010; Carone BR, 2014, DEV CELL, V30, P11, DOI 10.1016/j.devcel.2014.05.024; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Carrell DT, 2008, INT J ANDROL, V31, P455, DOI 10.1111/j.1365-2605.2008.00913.x; Cho C, 2001, NAT GENET, V28, P82, DOI 10.1038/ng0501-82; Chong SY, 2007, NAT GENET, V39, P614, DOI 10.1038/ng2031; Collins BJ, 2005, J CELL SCI, V118, P5023, DOI 10.1242/jcs.02617; Courel M, 2008, DEV DYNAM, V237, P1232, DOI 10.1002/dvdy.21516; DELMAS V, 1993, MOL ENDOCRINOL, V7, P1502, DOI 10.1210/me.7.11.1502; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Erkek S, 2013, NAT STRUCT MOL BIOL, V20, P868, DOI 10.1038/nsmb.2599; Furuchi T, 1996, DEVELOPMENT, V122, P1703; Godmann M, 2008, DEV BIOL, V315, P552, DOI 10.1016/j.ydbio.2007.12.018; Goodrich R, 2007, ARCH ANDROLOGY, V53, P161, DOI 10.1080/01485010701216526; Guerrero-Bosagna C, 2012, REPROD TOXICOL, V34, P694, DOI 10.1016/j.reprotox.2012.09.005; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Hisano M, 2013, NAT PROTOC, V8, P2449, DOI 10.1038/nprot.2013.145; Hogan B, 1994, MANIPULATING MOUSE E; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ihara M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004317; Katz DJ, 2009, CELL, V137, P308, DOI 10.1016/j.cell.2009.02.015; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Lalancette C, 2008, J CELL BIOCHEM, V104, P1570, DOI 10.1002/jcb.21756; Lambrot R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3889; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Lienert F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002090; Lobo I, 2008, NAT ED, V1, P18; McGraw S, 2015, NUCLEIC ACIDS RES, V43, P1485, DOI 10.1093/nar/gku1386; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903; Rechavi O, 2011, CELL, V147, P1248, DOI 10.1016/j.cell.2011.10.042; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Russell LB, 2007, MUTAT RES-FUND MOL M, V616, P181, DOI 10.1016/j.mrfmmm.2006.11.003; Sabin LR, 2013, MOL CELL, V49, P783, DOI 10.1016/j.molcel.2013.02.010; Saitou M, 2014, DEV CELL, V30, P6, DOI 10.1016/j.devcel.2014.06.025; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Sendler E, 2013, NUCLEIC ACIDS RES, V41, P4104, DOI 10.1093/nar/gkt132; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Skinner MK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-692; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Vavouri T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002036; Wei YC, 2014, P NATL ACAD SCI USA, V111, P1873, DOI 10.1073/pnas.1321195111; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445; Zeybel M, 2012, NAT MED, V18, P1369, DOI 10.1038/nm.2893; Zhang J, 2013, GENE DEV, V27, P749, DOI 10.1101/gad.210963.112	64	289	296	4	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261							aab2006	10.1126/science.aab2006	http://dx.doi.org/10.1126/science.aab2006			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26449473				2022-12-28	WOS:000364162800042
J	Lockley, SW; Dressman, MA; Licamele, L; Xiao, CF; Fisher, DM; Flynn-Evans, EE; Hull, JT; Torres, R; Lavedan, C; Polymeropoulos, MH				Lockley, Steven W.; Dressman, Marlene A.; Licamele, Louis; Xiao, Changfu; Fisher, Dennis M.; Flynn-Evans, Erin E.; Hull, Joseph T.; Torres, Rosarelis; Lavedan, Christian; Polymeropoulos, Mihael H.			Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials	LANCET			English	Article							RUNNING CIRCADIAN-RHYTHMS; MELATONIN; ENTRAINMENT; ALERTNESS	Background Most totally blind people have non-24-hour sleep-wake disorder (non-24), a rare circadian rhythm disorder caused by an inability of light to reset their circadian pacemaker. In two consecutive placebo-controlled trials (SET and RESET), we assessed safety and efficacy (in terms of circadian entrainment and maintenance) of once-daily tasimelteon, a novel dual-melatonin receptor agonist. Methods We undertook the placebo-controlled, randomised, double-masked trials in 27 US and six German clinical research centres and sleep centres. We screened totally blind adults (18-75 years of age), who were eligible for the randomisation phase of SET if they had a non-24-hour circadian period (t) of 24.25 h or longer (95% CI greater than 24.0 and up to 24.9 h), as calculated from measurements of urinary 6-sulphatoxymelatonin rhythms. For SET, we used block randomisation to assign patients (1: 1) to receive tasimelteon (20 mg) or placebo every 24 h at a fixed clock time 1 h before target bedtime for 26 weeks. Patients who entered the open-label group receiving tasimelteon in SET or who did not meet the SET inclusion criteria but did meet the RESET inclusion criteria were screened for RESET. A subset of the patients who entered the open-label group before the RESET study and who had eligible t values were screened for RESET after completing the open-label treatment. In RESET, we withdrew tasimelteon in a randomised manner (1: 1) in patients who responded (ie, entrained) after a tasimelteon run-in period. Entrainment was defined as having t of 24.1 h or less and a 95% CI that included 24.0 h. In SET, the primary endpoint was the proportion of entrained patients, assessed in the intention-to-treat population. The planned step-down primary endpoint assessed the proportion of patients who had a clinical response (entrainment at month 1 or month 7 plus clinical improvement, measured by the Non-24 Clinical Response Scale). In RESET, the primary endpoint was the proportion of non-entrained patients, assessed in the intention-to-treat population. Safety assessments included adverse events and clinical laboratory measures, assessed in all treated patients. These trials are registered with ClinicalTrials.gov, numbers NCT01163032 and NCT01430754. Findings Between Aug 25, 2010, and July 5, 2012, we screened 391 totally blind patients for SET, of whom 84 (22%) were assigned to receive tasimelteon (n=42) or placebo (n=42). Two patients in the tasimelteon group and four in the placebo group discontinued the study before t was measured, due to adverse events, withdrawal of consent, and a protocol deviation. Circadian entrainment occurred in eight (20%) of 40 patients in the tasimelteon group compared with one (3%) of 38 patients in the placebo group at month 1 (difference 17%, 95% CI 3.2-31.6; p=0.0171). Nine (24%) of 38 patients showed a clinical response, compared with none of 34 in the placebo group (difference 24%, 95% CI 8.4-39.0; p=0.0028). Between Sept 15, 2011, and Oct 4, 2012, we screened 58 patients for eligibility in RESET, 48 (83%) of whom had t assessed and entered the open-label tasimelteon run-in phase. 24 (50%) patients entrained, and 20 (34%) were enrolled in the randomisation phase. Two (20%) of ten patients who were withdrawn to placebo remained entrained compared with nine (90%) of ten who continued to receive tasimelteon (difference 70%, 95% CI 26.4-100.0; p=0.0026). No deaths were reported in either study, and discontinuation rates due to adverse events were comparable between the tasimelteon (3 [6%] of 52 patients) and placebo (2 [4%] of 52 patients) treatment courses. The most common side-effects associated with tasimelteon in SET were headache (7 [17%] of 42 patients given tasimelteon vs 3 [7%] of 42 patients given placebo), elevated liver enzymes (4 [10%] vs 2 [5%]), nightmares or abnormal dreams (4 [10%] vs none), upper respiratory tract infection (3 [7%] vs none], and urinary tract infections (3 [7%] vs 1 [2%]). Interpretation Once-daily tasimelteon can entrain totally blind people with non-24; however, continued tasimelteon treatment is necessary to maintain these improvements.	[Lockley, Steven W.; Flynn-Evans, Erin E.; Hull, Joseph T.] Brigham & Womens Hosp, Dept Med, Div Sleep & Circadian Disorders, Boston, MA 02115 USA; [Lockley, Steven W.; Flynn-Evans, Erin E.; Hull, Joseph T.] Brigham & Womens Hosp, Dept Neurol, Div Sleep & Circadian Disorders, Boston, MA 02115 USA; [Lockley, Steven W.; Flynn-Evans, Erin E.; Hull, Joseph T.] Harvard Univ, Sch Med, Dept Med, Div Sleep Med, Boston, MA USA; [Dressman, Marlene A.; Licamele, Louis; Xiao, Changfu; Torres, Rosarelis; Lavedan, Christian; Polymeropoulos, Mihael H.] Vanda Pharmaceut, Washington, DC USA; [Fisher, Dennis M.] P Less Than, San Francisco, CA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Lockley, SW (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Sleep & Circadian Disorders,Dept Med, Boston, MA 02115 USA.	slockley@hms.harvard.edu		Lockley, Steven/0000-0001-5209-2881	Vanda Pharmaceuticals	Vanda Pharmaceuticals	The clinical trials were sponsored by Vanda Pharmaceuticals. SWL declares two clinical trial service agreements, an investigator-initiated research grant, and three sponsored clinical trial agreements from Vanda Pharmaceuticals, Inc, all via institutional agreements with The Brigham and Women's Hospital; honoraria for writing a review article, website text, and textbook chapters discussing circadian rhythm disorders in the blind, including non-24-h sleep-wake disorder, from Servier, the National Sleep Foundation, and Elsevier, respectively, and for participating in a Continued Medical Education activity reviewing non-24-h sleep-wake disorder in blind people from MediCom Worldwide, supported by Vanda Pharmaceuticals; and minor consulting fees from 14 investment firms discussing publicly available information about the tasimelteon trials. MAD, LL, CX, RT, CL, and MHP are employees of Vanda Pharmaceuticals. DMF is a consultant to Vanda Pharmaceuticals. EEF-E and JTH declare no competing interests	ALDHOUS M E, 1991, Journal of Interdisciplinary Cycle Research, V22, P84; American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS, DOI DOI 10.1176/APPI.BOOKS.9780890425596.893619; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], [No title captured], DOI [DOI 10.1126/SCIENCE.284.5423.2177, 10.1126/science.284.5423.2177]; Buscemi N, 2006, BMJ-BRIT MED J, V332, P385, DOI 10.1136/bmj.38731.532766.F6; DEACON S, 1995, BRAIN RES, V688, P77, DOI 10.1016/0006-8993(95)96872-I; Duffield GE, 2003, J NEUROENDOCRINOL, V15, P991, DOI 10.1046/j.1365-2826.2003.01082.x; FDA, HIGHL PRESCR INF HET; Ferguson SA, 2010, EXPERT REV NEUROTHER, V10, P305, DOI 10.1586/ERN.10.1; Flynn-Evans EE, 2014, J BIOL RHYTHM, V29, P215, DOI 10.1177/0748730414536852; Gillette MU, 1996, BEHAV BRAIN RES, V73, P135; Hack LM, 2003, J BIOL RHYTHM, V18, P420, DOI 10.1177/0748730403256796; Hahm H, 1999, J Am Pharm Assoc (Wash), V39, P27; KLEIN T, 1993, SLEEP, V16, P333, DOI 10.1093/sleep/16.4.333; Lavedan C, 2015, NEUROPHARMACOLOGY, V91, P142, DOI 10.1016/j.neuropharm.2014.12.004; LEWY AJ, 1992, CHRONOBIOL INT, V9, P380, DOI 10.3109/07420529209064550; Lewy AJ, 2003, CHRONOBIOL INT, V20, P837, DOI 10.1081/CBI-120024215; Lewy AJ, 2001, BRAIN RES, V918, P96, DOI 10.1016/S0006-8993(01)02964-X; LEWY AJ, 1983, J CLIN ENDOCR METAB, V56, P1103, DOI 10.1210/jcem-56-6-1103; Licamele L, 2012, 13 M SOC RES BIOL RH, P279; Lockley SW, 2008, J SLEEP RES, V17, P207, DOI 10.1111/j.1365-2869.2008.00656.x; Lockley Steven W, 2007, Dialogues Clin Neurosci, V9, P301; Lockley SW, 2000, J ENDOCRINOL, V164, pR1, DOI 10.1677/joe.0.164R001; Lockley SW, 1997, J BIOL RHYTHM, V12, P16, DOI 10.1177/074873049701200104; Lockley SW, 1997, J CLIN ENDOCR METAB, V82, P3763, DOI 10.1210/jc.82.11.3763; Lockley SW, 1999, SLEEP, V22, P616, DOI 10.1093/sleep/22.5.616; MILES LEM, 1977, SCIENCE, V198, P421, DOI 10.1126/science.910139; Mundt JC, 2010, J PSYCHIATR RES, V44, P1224, DOI 10.1016/j.jpsychires.2010.04.025; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Rajaratnam SMW, 2009, LANCET, V373, P482, DOI 10.1016/S0140-6736(08)61812-7; Rajaratnam SMW, 2003, J CLIN ENDOCR METAB, V88, P4303, DOI 10.1210/jc.2003-030460; REDMAN J, 1983, SCIENCE, V219, P1089, DOI 10.1126/science.6823571; Remler O., 1948, MONATSBLATTER AUGENH, V113, P116; Sack RL, 2000, NEW ENGL J MED, V343, P1070, DOI 10.1056/NEJM200010123431503; SACK RL, 1992, J CLIN ENDOCR METAB, V75, P127, DOI 10.1210/jcem.75.1.1619000; Sack RL, 2001, SLEEP MED REV, V5, P189, DOI 10.1053/smrv.2000.0147; Skene DJ, 1999, CLIN ENDOCRINOL, V50, P715; St Hilaire MA, 2015, SLEEP MED, V16, P800, DOI 10.1016/j.sleep.2015.01.018; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Tabandeh H, 1998, AM J OPHTHALMOL, V126, P707, DOI 10.1016/S0002-9394(98)00133-0	40	69	69	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 31	2015	386	10005					1754	1764		10.1016/S0140-6736(15)60031-9	http://dx.doi.org/10.1016/S0140-6736(15)60031-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0WK	26466871				2022-12-28	WOS:000363974200035
J	Milles, S; Mercadante, D; Aramburu, IV; Jensen, MR; Banterle, N; Koehler, C; Tyagi, S; Clarke, J; Shammas, SL; Blackledge, M; Grater, F; Lemke, EA				Milles, Sigrid; Mercadante, Davide; Aramburu, Iker Valle; Jensen, Malene Ringkjobing; Banterle, Niccolo; Koehler, Christine; Tyagi, Swati; Clarke, Jane; Shammas, Sarah L.; Blackledge, Martin; Graeter, Frauke; Lemke, Edward A.			Plasticity of an Ultrafast Interaction between Nucleoporins and Nuclear Transport Receptors	CELL			English	Article							INTRINSICALLY DISORDERED PROTEINS; IMPORTIN-BETA; PORE COMPLEX; NUCLEOCYTOPLASMIC TRANSPORT; MOLECULAR RECOGNITION; FG-NUCLEOPORINS; REPEAT REGIONS; BINDING; DOMAIN; NMR	The mechanisms by which intrinsically disordered proteins engage in rapid and highly selective binding is a subject of considerable interest and represents a central paradigmto nuclear porecomplex (NPC) function, where nuclear transport receptors (NTRs) move through the NPC by binding disordered phenylalanine- glycine-rich nucleoporins (FG-Nups). Combining single-molecule fluorescence, molecular simulations, and nuclear magnetic resonance, we show that a rapidly fluctuating FG-Nup populates an ensemble of conformations that are prone to bind NTRs with near diffusion-limited on rates, as shown by stopped-flow kinetic measurements. This is achieved using multiple, minimalistic, low-affinity binding motifs that are in rapid exchange when engaging with the NTR, allowing the FG-Nup to maintain an unexpectedly high plasticity in its bound state. We propose that these exceptional physical characteristics enable a rapid and specific transport mechanism in the physiological context, a notion supported by single molecule in-cell assays on intact NPCs.	[Milles, Sigrid; Aramburu, Iker Valle; Banterle, Niccolo; Koehler, Christine; Tyagi, Swati; Lemke, Edward A.] European Mol Biol Lab, Cell Biol & Biophys Unit, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Mercadante, Davide; Graeter, Frauke] HITS gGmbH, Mol Biomech Grp, D-69118 Heidelberg, Germany; [Mercadante, Davide; Graeter, Frauke] IWR Interdisciplinary Ctr Sci Comp, D-69120 Heidelberg, Germany; [Milles, Sigrid; Jensen, Malene Ringkjobing; Blackledge, Martin] Univ Grenoble Alpes, IBS, F-38044 Grenoble, France; [Milles, Sigrid; Jensen, Malene Ringkjobing; Blackledge, Martin] CNRS, IBS, F-38044 Grenoble, France; [Milles, Sigrid; Jensen, Malene Ringkjobing; Blackledge, Martin] CEA, IBS, F-38044 Grenoble, France; [Clarke, Jane; Shammas, Sarah L.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University of Cambridge	Blackledge, M (corresponding author), Univ Grenoble Alpes, IBS, F-38044 Grenoble, France.	martin.blackledge@ibs.fr; frauke.graeter@h-its.org; lemke@embl.de	Gräter, Frauke/D-3450-2009; Lemke, Edward/J-3337-2015	Gräter, Frauke/0000-0003-2891-3381; Lemke, Edward/0000-0002-0634-0503; Jensen, Malene R./0000-0003-0419-2196; Koehler, Christine/0000-0001-5918-5036; Mercadante, Davide/0000-0001-6792-7706; Valle Aramburu, Iker/0000-0003-2363-4770; Banterle, Niccolo/0000-0002-1607-0324	Boehringer Ingelheim Fonds (BIF); EMBO long-term fellowship [ALTF 4682014]; EC via Marie Curie Action [EMBOCOFUND2012, GA-2012-600394]; BIF short-term fellowship; Wellcome Trust [WT/095195]; Emmy Noether program of the DFG; Klaus Tschira Foundation; BIOMS program of Heidelberg University;  [SFB1129]; MRC [MC_U105485808] Funding Source: UKRI	Boehringer Ingelheim Fonds (BIF)(Boehringer Ingelheim); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); EC via Marie Curie Action; BIF short-term fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); Emmy Noether program of the DFG(German Research Foundation (DFG)); Klaus Tschira Foundation; BIOMS program of Heidelberg University; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful for helpful comments and various discussions with Cedric Debes, Martin Beck as well as the whole Lemke group. We thank Guillaume Bouvignies for help with relaxation dispersion experiments, and Damien Maurin for sample preparation. S.M. acknowledges funding from the Boehringer Ingelheim Fonds (BIF) and an EMBO long-term fellowship (ALTF 4682014) and EC (EMBOCOFUND2012, GA-2012-600394) via Marie Curie Action. I.V.A. acknowledges a BIF short-term fellowship. J.C. and S.L.S. are supported by the Wellcome Trust. J.C. is a Wellcome Trust Senior Research Fellow (WT/095195). E.A.L. is grateful to funds from the SFB1129 and the Emmy Noether program of the DFG, F.G. from the Klaus Tschira Foundation, and D.M. from the BIOMS program of Heidelberg University. We are also grateful to instrument access via the EMBL Pepcore facility.	Adams RL, 2013, CELL, V152, P1218, DOI 10.1016/j.cell.2013.02.042; Arai M, 2012, J AM CHEM SOC, V134, P3792, DOI 10.1021/ja209936u; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bednenko J, 2003, J CELL BIOL, V162, P391, DOI 10.1083/jcb.200303085; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; Brabez N, 2011, J MED CHEM, V54, P7375, DOI 10.1021/jm2009937; Bui KH, 2013, CELL, V155, P1233, DOI 10.1016/j.cell.2013.10.055; Chekulaeva M, 2010, NUCLEIC ACIDS RES, V38, P6673, DOI 10.1093/nar/gkq501; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eisele NB, 2013, BIOPHYS J, V105, P1860, DOI 10.1016/j.bpj.2013.09.006; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Hough LE, 2015, ELIFE, V4, DOI 10.7554/eLife.10027; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; Jensen MR, 2010, J AM CHEM SOC, V132, P1270, DOI 10.1021/ja909973n; Jovanovic-Talisman T, 2009, NATURE, V457, P1023, DOI 10.1038/nature07600; Kragelj J, 2015, P NATL ACAD SCI USA, V112, P3409, DOI 10.1073/pnas.1419528112; Kramer RH, 1998, NATURE, V395, P710, DOI 10.1038/27227; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; Lowe AR, 2015, ELIFE, V4, DOI 10.7554/eLife.04052; Mercadante D, 2015, J PHYS CHEM B, V119, P7975, DOI 10.1021/acs.jpcb.5b03440; Milles S, 2014, ANGEW CHEM INT EDIT, V53, P7364, DOI 10.1002/anie.201403694; Morrison J, 2003, J MOL BIOL, V333, P587, DOI 10.1016/j.jmb.2003.08.050; Moussavi-Baygi R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002049; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; Otsuka S, 2008, P NATL ACAD SCI USA, V105, P16101, DOI 10.1073/pnas.0802647105; Ozenne V, 2012, BIOINFORMATICS, V28, P1463, DOI 10.1093/bioinformatics/bts172; Peters R, 2009, BIOESSAYS, V31, P466, DOI 10.1002/bies.200800159; Rasia RM, 2011, J BIOMOL NMR, V51, P369, DOI 10.1007/s10858-011-9567-4; Schleicher KD, 2014, NAT NANOTECHNOL, V9, P525, DOI [10.1038/NNANO.2014.103, 10.1038/nnano.2014.103]; Schneider R, 2015, J AM CHEM SOC, V137, P1220, DOI 10.1021/ja511066q; Schoch RL, 2012, P NATL ACAD SCI USA, V109, P16911, DOI 10.1073/pnas.1208440109; Schuler B, 2008, CURR OPIN STRUC BIOL, V18, P16, DOI 10.1016/j.sbi.2007.12.003; Shammas SL, 2014, P NATL ACAD SCI USA, V111, P12055, DOI 10.1073/pnas.1405815111; Shammas SL, 2013, J PHYS CHEM B, V117, P13346, DOI 10.1021/jp404267e; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Solyom Z, 2013, J BIOMOL NMR, V55, P311, DOI 10.1007/s10858-013-9715-0; Spaar A, 2006, BIOPHYS J, V90, P1913, DOI 10.1529/biophysj.105.075507; Tetenbaum-Novatt J, 2012, MOL CELL PROTEOMICS, V11, P31, DOI 10.1074/mcp.M111.013656; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Toretsky JA, 2014, J CELL BIOL, V206, P579, DOI 10.1083/jcb.201404124; Tu LC, 2013, EMBO J, V32, P3220, DOI 10.1038/emboj.2013.239; Walde S, 2010, TRENDS CELL BIOL, V20, P461, DOI 10.1016/j.tcb.2010.05.001; Wagner RS, 2015, BIOPHYS J, V108, P918, DOI 10.1016/j.bpj.2014.12.041; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201; Ziarek JJ, 2013, J BIOL CHEM, V288, P737, DOI 10.1074/jbc.M112.394064	52	181	180	2	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					734	745		10.1016/j.cell.2015.09.047	http://dx.doi.org/10.1016/j.cell.2015.09.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26456112	hybrid, Green Published			2022-12-28	WOS:000364828900025
J	Cobb, SR				Cobb, Stuart R.			COGNITIVE DISORDERS Deep brain stimulation for Rett syndrome	NATURE			English	Editorial Material							MEMORY		Univ Glasgow, Inst Neurosci & Psychol, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Cobb, SR (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland.	stuart.cobb@glasgow.ac.uk						Garg SK, 2013, J NEUROSCI, V33, P13612, DOI 10.1523/JNEUROSCI.1854-13.2013; Ghosh A, 2013, NAT REV DRUG DISCOV, V12, P777, DOI 10.1038/nrd4102; Hao S, 2015, NATURE, V526, P430, DOI 10.1038/nature15694; Laxton AW, 2010, ANN NEUROL, V68, P521, DOI 10.1002/ana.22089; Lyons MK, 2011, MAYO CLIN PROC, V86, P662, DOI 10.4065/mcp.2011.0045; Lyst MJ, 2015, NAT REV GENET, V16, P261, DOI 10.1038/nrg3897; Shirvalkar PR, 2010, P NATL ACAD SCI USA, V107, P7054, DOI 10.1073/pnas.0911184107; Srivastava AK, 2014, NEUROSCI BIOBEHAV R, V46, P161, DOI 10.1016/j.neubiorev.2014.02.015	8	1	1	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					331	332		10.1038/526331a	http://dx.doi.org/10.1038/526331a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT3TQ	26469040				2022-12-28	WOS:000362730200032
J	Gade, A				Gade, Alexandra			NUCLEAR PHYSICS Sometimes gamma-rays come in twos	NATURE			English	Editorial Material							DECAY; MICROSCOPY		Michigan State Univ, Natl Superconducting Cyclotron Lab, E Lansing, MI 48824 USA	Michigan State University	Gade, A (corresponding author), Michigan State Univ, Natl Superconducting Cyclotron Lab, E Lansing, MI 48824 USA.	gade@nscl.msu.edu	Gade, Alexandra/A-6850-2008	Gade, Alexandra/0000-0001-8825-0976				Breit G, 1940, ASTROPHYS J, V91, P215, DOI 10.1086/144158; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Goppert M, 1929, NATURWISSENSCHAFTEN, V17, P932; Goppert-Mayer M, 1931, ANN PHYS-BERLIN, V9, P273; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; KRAMP J, 1987, NUCL PHYS A, V474, P412, DOI 10.1016/0375-9474(87)90625-7; Lister C. J., 2013, B AM PHYS SOC, V58; Millener D. J., 2011, B AM PHYS SOC, V56; Moran K, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.041303; SCHIRMER J, 1984, PHYS REV LETT, V53, P1897, DOI 10.1103/PhysRevLett.53.1897; SPITZER L, 1951, ASTROPHYS J, V114, P407, DOI 10.1086/145480; Walz C, 2015, NATURE, V526, P406, DOI 10.1038/nature15543	12	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					330	+		10.1038/526330a	http://dx.doi.org/10.1038/526330a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26469039				2022-12-28	WOS:000362730200031
J	Mehrotra, A; Prochazka, A				Mehrotra, Ateev; Prochazka, Allan			Improving Value in Health Care - Against the Annual Physical	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mehrotra, Ateev] Harvard Univ, Sch Med, Dept Hlth Care Policy, Cambridge, MA 02138 USA; [Mehrotra, Ateev] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; [Prochazka, Allan] Univ Colorado, Hlth Sci Ctr, Div Gen Internal Med, Denver, CO 80262 USA	Harvard University; Harvard University; Beth Israel Deaconess Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Mehrotra, A (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Cambridge, MA 02138 USA.		Mehrotra, Ateev/AAO-8454-2021	Mehrotra, Ateev/0000-0003-2223-1582				Boulware LE, 2007, ANN INTERN MED, V146, P289, DOI 10.7326/0003-4819-146-4-200702200-00008; Han PKJ, 1997, ANN INTERN MED, V127, P910, DOI 10.7326/0003-4819-127-10-199711150-00010; Krogsboll LT, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7191; Mehrotra A, 2007, ARCH INTERN MED, V167, P1876, DOI 10.1001/archinte.167.17.1876; Uscher-Pines L, 2013, AM J MANAG CARE, V19, P47	5	46	46	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2015	373	16					1485	1487		10.1056/NEJMp1507485	http://dx.doi.org/10.1056/NEJMp1507485			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CT5VX	26465981				2022-12-28	WOS:000362880300002
J	Sammut, M; Cook, SJ; Nguyen, KCQ; Felton, T; Hall, DH; Emmons, SW; Poole, RJ; Barrios, A				Sammut, Michele; Cook, Steven J.; Nguyen, Ken C. Q.; Felton, Terry; Hall, David H.; Emmons, Scott W.; Poole, Richard J.; Barrios, Arantza			Glia-derived neurons are required for sex-specific learning in C. elegans	NATURE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; MATE-SEARCHING BEHAVIOR; GENE-EXPRESSION; NERVOUS-SYSTEM; FATE SPECIFICATION; CELLS; DROSOPHILA; TRANSDIFFERENTIATION; RECONSTRUCTION; CIRCUIT	Sex differences in behaviour extend to cognitive-like processes such as learning, but the underlying dimorphisms in neural circuit development and organization that generate these behavioural differences are largely unknown. Here we define at the single-cell level-from development, through neural circuit connectivity, to function-the neural basis of a sex-specific learning in the nematode Caenorhabditis elegans. We show that sexual conditioning, a form of associative learning, requires a pair of male-specific interneurons whose progenitors are fully differentiated glia. These neurons are generated during sexual maturation and incorporated into pre-exisiting sex-shared circuits to couple chemotactic responses to reproductive priorities. Our findings reveal a general role for glia as neural progenitors across metazoan taxa and demonstrate that the addition of sex-specific neuron types to brain circuits during sexual maturation is an important mechanism for the generation of sexually dimorphic plasticity in learning.	[Sammut, Michele; Felton, Terry; Poole, Richard J.; Barrios, Arantza] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Cook, Steven J.; Nguyen, Ken C. Q.; Hall, David H.; Emmons, Scott W.] Yeshiva Univ Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA; [Emmons, Scott W.] Yeshiva Univ Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA	University of London; University College London; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Barrios, A (corresponding author), UCL, Dept Cell & Dev Biol, Mortimer St, London WC1E 6BT, England.	r.poole@ucl.ac.uk; a.barrios@ucl.ac.uk		Poole, Richard/0000-0001-6414-2479; Barrios, Arantza/0000-0001-6153-8830	NIH [P40 OD010440, OD010943, 5T32GM007491]; Master it! Scholarship (Malta); Master it! Scholarship (EU); Marie Curie CIG grant [618779]; G. Harold and Leila Y. Mathers Charitable Foundation; Wellcome Trust [097815/Z/11/A]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440, R24OD010943] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Master it! Scholarship (Malta); Master it! Scholarship (EU); Marie Curie CIG grant; G. Harold and Leila Y. Mathers Charitable Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to acknowledge M. Barr, in whose laboratory A.B. discovered the MCMs; WormAtlas for illustrations (reproduced with permission); T. Jarrell for contributions to the EM reconstruction; and W. Letton for the generation of strains and preliminary ablation studies. We thank M. Boxem, D. Portman, H. Baylis, L. Bianchi and R. Garcia for strains and reagents; M. Zhen, O. Hobert, I. Carrera, N. Stefanakis and S. Shaham, for unpublished reagents. Purified ascarosides were a gift from F. Schroeder to the Barr laboratory. Additional strains were obtained from the CGC, which is funded by NIH grant P40 OD010440. We thank L. Cochella, I. Carrera, S. Jarriault, and several of our close colleagues in CDB and NPP at University College London for discussions and comments on the manuscript; C. Barnes for advice on statistical analysis. This work was supported by a Master it! Scholarship Scheme (Malta and EU) to M.S., by NIH grant OD010943 to D.H.H., by Marie Curie CIG grant 618779 to R.J.P. and by a grant from The G. Harold and Leila Y. Mathers Charitable Foundation to S.W.E.; S. J. C. is supported by NIH grant 5T32GM007491; R.J.P. is a Wellcome Trust Research Career Development Fellow 095722/Z/11/Z; A.B. is supported by the Wellcome Trust Institutional Strategic Support Fund 097815/Z/11/A.	Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Altun ZF, 2009, DEV DYNAM, V238, P1936, DOI 10.1002/dvdy.22025; Altun ZF., 2005, WORMATLAS; Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; ARNOLD AP, 1992, J NEUROBIOL, V23, P1506, DOI 10.1002/neu.480231010; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; BARR MM, 2006, WORMBOOK; Barrios A, 2008, CURR BIOL, V18, P1865, DOI 10.1016/j.cub.2008.10.050; Barrios A, 2014, SEMIN CELL DEV BIOL, V33, P10, DOI 10.1016/j.semcdb.2014.06.003; Barrios A, 2012, NAT NEUROSCI, V15, P1675, DOI 10.1038/nn.3253; Beets I, 2012, SCIENCE, V338, P543, DOI 10.1126/science.1226860; Bell LR, 2006, GENETICS, V173, P1275, DOI 10.1534/genetics.106.056721; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011; Eguchi G, 1993, CURR OPIN CELL BIOL, V5, P1023, DOI 10.1016/0955-0674(93)90087-7; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Gower NJD, 2001, J MOL BIOL, V306, P145, DOI 10.1006/jmbi.2000.4388; Gruninger TR, 2006, J NEUROSCI, V26, P169, DOI 10.1523/JNEUROSCI.3364-05.2006; Haklai-Topper L, 2011, GENE EXPR PATTERNS, V11, P144, DOI 10.1016/j.gep.2010.10.008; Hall DH, 2012, METHOD CELL BIOL, V107, P93, DOI 10.1016/B978-0-12-394620-1.00004-7; HALL DH, 1991, J NEUROSCI, V11, P1; Hao LM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-280; Heiman MG, 2009, CELL, V137, P344, DOI 10.1016/j.cell.2009.01.057; HODGKIN J, 1987, GENE DEV, V1, P731, DOI 10.1101/gad.1.7.731; Hong Y, 1998, DEVELOPMENT, V125, P3585; Janssen T, 2009, J NEUROCHEM, V111, P228, DOI 10.1111/j.1471-4159.2009.06323.x; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Jarriault S, 2008, P NATL ACAD SCI USA, V105, P3790, DOI 10.1073/pnas.0712159105; Keleman K, 2012, NATURE, V489, P145, DOI 10.1038/nature11345; Kim K, 2004, J COMP NEUROL, V475, P540, DOI 10.1002/cne.20189; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kratsios P, 2012, NAT NEUROSCI, V15, P205, DOI 10.1038/nn.2989; Lee KH, 2007, CURR BIOL, V17, P1858, DOI 10.1016/j.cub.2007.10.015; Lipton J, 2004, J NEUROSCI, V24, P7427, DOI 10.1523/JNEUROSCI.1746-04.2004; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Mowrey WR, 2014, J NEUROSCI, V34, P1579, DOI 10.1523/JNEUROSCI.4352-13.2014; Ninkovic J, 2013, BIOESSAYS, V35, P242, DOI 10.1002/bies.201200108; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; Oikonomou G, 2011, GLIA, V59, P1253, DOI 10.1002/glia.21084; Okada T.S, 1991, TRANSDIFFERENTIATION; Procko C, 2012, GENETICS, V190, P1405, DOI 10.1534/genetics.111.137786; Rideout EJ, 2010, NAT NEUROSCI, V13, P458, DOI 10.1038/nn.2515; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Ryan DA, 2014, CURR BIOL, V24, P2509, DOI 10.1016/j.cub.2014.09.032; Saalfeld S, 2012, NAT METHODS, V9, P717, DOI [10.1038/NMETH.2072, 10.1038/nmeth.2072]; Saeki S, 2001, J EXP BIOL, V204, P1757; Sakai N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068676; Serrano-Saiz E, 2013, CELL, V155, P659, DOI 10.1016/j.cell.2013.09.052; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Stefanakis N, 2015, NEURON, V87, P733, DOI 10.1016/j.neuron.2015.07.031; Stowers L, 2010, CURR OPIN NEUROBIOL, V20, P770, DOI 10.1016/j.conb.2010.08.015; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Vellai T, 2006, GENETICS, V174, P309, DOI 10.1534/genetics.106.061499; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; White JQ, 2007, CURR BIOL, V17, P1847, DOI 10.1016/j.cub.2007.09.011; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054050; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017; Yoshimura S, 2008, DEVELOPMENT, V135, P2263, DOI 10.1242/dev.019547; Zahn TR, 2001, J COMP NEUROL, V429, P127, DOI 10.1002/1096-9861(20000101)429:1&lt;127::AID-CNE10&gt;3.0.CO;2-H; ZARKOWER D, 2006, WORMBOOK; Zuryn S, 2014, SCIENCE, V345, P826, DOI 10.1126/science.1255885	70	70	71	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					385	+		10.1038/nature15700	http://dx.doi.org/10.1038/nature15700			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26469050	Green Submitted, Green Accepted			2022-12-28	WOS:000362730200042
J	Grijalva, CG; Zhu, YW; Williams, DJ; Self, WH; Ampofo, K; Pavia, AT; Stockmann, CR; McCullers, J; Arnold, SR; Wunderink, RG; Anderson, EJ; Lindstrom, S; Fry, AM; Foppa, IM; Finelli, L; Bramley, AM; Jain, S; Griffin, MR; Edwards, KM				Grijalva, Carlos G.; Zhu, Yuwei; Williams, Derek J.; Self, Wesley H.; Ampofo, Krow; Pavia, Andrew T.; Stockmann, Chris R.; McCullers, Jonathan; Arnold, Sandra R.; Wunderink, Richard G.; Anderson, Evan J.; Lindstrom, Stephen; Fry, Alicia M.; Foppa, Ivo M.; Finelli, Lyn; Bramley, Anna M.; Jain, Seema; Griffin, Marie R.; Edwards, Kathryn M.			Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNIZATION PRACTICES ACIP; TEST-NEGATIVE DESIGN; SEASONAL INFLUENZA; REQUIRING HOSPITALIZATION; VACCINES RECOMMENDATIONS; ADVISORY-COMMITTEE; UNITED-STATES; PREVENTION; CHILDREN; EFFICACY	IMPORTANCE Few studies have evaluated the relationship between influenza vaccination and pneumonia, a serious complication of influenza infection. OBJECTIVE To assess the association between influenza vaccination status and hospitalization for community-acquired laboratory-confirmed influenza pneumonia. DESIGN, SETTING, AND PARTICIPANTS The Etiology of Pneumonia in the Community (EPIC) study was a prospective observational multicenter study of hospitalizations for community-acquired pneumonia conducted from January 2010 through June 2012 at 4 US sites. In this case-control study, we used EPIC data from patients 6 months or older with laboratory-confirmed influenza infection and verified vaccination status during the influenza seasons and excluded patients with recent hospitalization, from chronic care residential facilities, and with severe immunosuppression. Logistic regression was used to calculate odds ratios, comparing the odds of vaccination between influenza-positive (case) and influenza-negative (control) patients with pneumonia, controlling for demographics, comorbidities, season, study site, and timing of disease onset. Vaccine effectiveness was estimated as (1 - adjusted odds ratio) x 100%. EXPOSURE Influenza vaccination, verified through record review. MAIN OUTCOMES AND MEASURES Influenza pneumonia, confirmed by real-time reverse-transcription polymerase chain reaction performed on nasal/oropharyngeal swabs. RESULTS Overall, 2767 patients hospitalized for pneumonia were eligible for the study; 162 (5.9%) had laboratory-confirmed influenza. Twenty-eight of 162 cases (17%) with influenza-associated pneumonia and 766 of 2605 controls (29%) with influenza-negative pneumonia had been vaccinated. The adjusted odds ratio of prior influenza vaccination between cases and controls was 0.43 (95% CI, 0.28-0.68; estimated vaccine effectiveness, 56.7%; 95% CI, 31.9%-72.5%). CONCLUSIONS AND RELEVANCE Among children and adults hospitalized with community-acquired pneumonia, those with laboratory-confirmed influenza-associated pneumonia, compared with those with pneumonia not associated with influenza, had lower odds of having received influenza vaccination.	[Grijalva, Carlos G.; Zhu, Yuwei; Williams, Derek J.; Self, Wesley H.; Griffin, Marie R.; Edwards, Kathryn M.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Grijalva, Carlos G.; Griffin, Marie R.] VA Tennessee Valley, Geriatr Res Educ Clin Ctr, Nashville, TN USA; [Ampofo, Krow; Pavia, Andrew T.; Stockmann, Chris R.] Univ Utah, Sch Med, Salt Lake City, UT USA; [McCullers, Jonathan; Arnold, Sandra R.] Univ Tennessee, Sch Med, Memphis, TN USA; [Wunderink, Richard G.] Northwestern Univ, Sch Med, Chicago, IL USA; [Anderson, Evan J.] Emory Univ, Sch Med, Atlanta, GA USA; [Lindstrom, Stephen; Fry, Alicia M.; Foppa, Ivo M.; Finelli, Lyn; Bramley, Anna M.; Jain, Seema] Ctr Dis Control & Prevent, Atlanta, GA USA; [Foppa, Ivo M.] Battelle Mem Inst, Atlanta, GA USA	Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Utah System of Higher Education; University of Utah; University of Tennessee System; University of Tennessee Health Science Center; Northwestern University; Emory University; Centers for Disease Control & Prevention - USA	Grijalva, CG (corresponding author), Vanderbilt Univ, Sch Med, Dept Hlth Policy, 1500 21st Ave S,Village Vanderbilt Ste 2600, Nashville, TN 37212 USA.	carlos.grijalva@vanderbilt.edu	Foppa, Ivo/I-8694-2016; Finelli, Lyn/AAK-2360-2020; Sherwin, Catherine Mary Turner/B-2888-2012; Arnold, Sandra R/O-4712-2014	Foppa, Ivo/0000-0002-3933-8565; Sherwin, Catherine Mary Turner/0000-0002-0844-3207; Arnold, Sandra R/0000-0001-6130-8154; Self, Wesley/0000-0002-9300-3045; Wunderink, Richard/0000-0002-8527-4195; Grijalva, Carlos/0000-0002-2329-7797	Influenza Division in the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention (CDC); National Center for Immunization and Respiratory Diseases (NCIRD) [U18IP000488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI104779] Funding Source: NIH RePORTER	Influenza Division in the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention (CDC); National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the Influenza Division in the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention (CDC).	Beck CR, 2013, INFLUENZA OTHER RESP, V7, P72, DOI 10.1111/irv.12084; Belongia EA, 2008, LANCET, V372, P352, DOI 10.1016/S0140-6736(08)61137-X; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Castilla J, 2013, CLIN INFECT DIS, V57, P167, DOI 10.1093/cid/cit194; Centers for Disease Control and Prevention, FLU ACT SURV; Centers for Disease Control and Prevention, FLUVIEW NAT REG LEV; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Cowling BJ, 2012, EPIDEMIOLOGY, V23, P930, DOI 10.1097/EDE.0b013e31826b300e; Cowling BJ, 2012, CLIN INFECT DIS, V54, P1778, DOI 10.1093/cid/cis307; Eliakim-Raz N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008983.pub2; Ferdinands JM, 2014, J INFECT DIS, V210, P674, DOI 10.1093/infdis/jiu185; Ferdinands JM, 2013, EPIDEMIOLOGY, V24, P530, DOI 10.1097/EDE.0b013e3182953065; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Fleming DM, 2010, J EPIDEMIOL COMMUN H, V64, P1062, DOI 10.1136/jech.2009.093450; Foppa IM, 2013, VACCINE, V31, P3104, DOI 10.1016/j.vaccine.2013.04.026; Fry AM, 2014, LANCET INFECT DIS, V14, P109, DOI 10.1016/S1473-3099(13)70267-6; Griffin Marie R, 2013, S D Med, VSpec no, P110; Grohskopf LA, 2014, MMWR-MORBID MORTAL W, V63, P691; Jackson LA, 2006, INT J EPIDEMIOL, V35, P345, DOI 10.1093/ije/dyi275; Jackson ML, 2008, LANCET, V372, P398, DOI 10.1016/S0140-6736(08)61160-5; Jackson ML, 2013, AM J EPIDEMIOL, V178, P1327, DOI 10.1093/aje/kwt124; Jackson ML, 2013, VACCINE, V31, P2165, DOI 10.1016/j.vaccine.2013.02.053; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Jain VK, 2013, NEW ENGL J MED, V369, P2481, DOI 10.1056/NEJMoa1215817; Kelly H, 2011, PEDIATR INFECT DIS J, V30, P107, DOI 10.1097/INF.0b013e318201811c; Kostova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066312; Kwong JC, 2013, CLIN INFECT DIS, V57, P820, DOI 10.1093/cid/cit404; Menniti-Ippolito F, 2014, VACCINE, V32, P4466, DOI 10.1016/j.vaccine.2014.06.048; Musto P, 1997, BRIT J HAEMATOL, V97, P505; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Petrie JG, 2011, J INFECT DIS, V203, P1309, DOI 10.1093/infdis/jir015; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Puig-Barbera J, 2012, VACCINE, V30, P5714, DOI 10.1016/j.vaccine.2012.07.006; Staat MA, 2011, VACCINE, V29, P9005, DOI 10.1016/j.vaccine.2011.09.037; Sundaram ME, 2013, CLIN INFECT DIS, V57, P789, DOI 10.1093/cid/cit379; Talbot HK, 2013, CLIN INFECT DIS, V56, P1774, DOI 10.1093/cid/cit124; Talbot HK, 2011, J INFECT DIS, V203, P500, DOI 10.1093/infdis/jiq076; Treanor JJ, 2012, CLIN INFECT DIS, V55, P951, DOI 10.1093/cid/cis574	40	65	67	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2015	314	14					1488	1497		10.1001/jama.2015.12160	http://dx.doi.org/10.1001/jama.2015.12160			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2QI	26436611	Green Accepted, Bronze			2022-12-28	WOS:000362647800016
J	Kirby, T				Kirby, Tony			Feng-Cai Zhu: leading vaccine evaluation in China	LANCET			English	Biographical-Item																		ZHU FC, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2015	386	10002					1437	1437		10.1016/S0140-6736(15)00420-1	http://dx.doi.org/10.1016/S0140-6736(15)00420-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5UU	26466034	Green Published, Bronze			2022-12-28	WOS:000362877300016
J	Stephens, IEL; Elias, JS; Shao-Horn, Y				Stephens, Ifan E. L.; Elias, Joseph S.; Shao-Horn, Yang			The importance of being together	SCIENCE			English	Editorial Material							OXYGEN REDUCTION; OXIDATION; SURFACES; CATALYSTS; SITE; CO		[Stephens, Ifan E. L.; Elias, Joseph S.; Shao-Horn, Yang] MIT, Electrochem Energy Lab, Cambridge, MA 02139 USA; [Stephens, Ifan E. L.] Tech Univ Denmark, Dept Phys, DK-2800 Lyngby, Denmark	Massachusetts Institute of Technology (MIT); Technical University of Denmark	Stephens, IEL (corresponding author), MIT, Electrochem Energy Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	shaohorn@mit.edu	Stephens, Ifan Erfyl Lester/B-7191-2013	Stephens, Ifan Erfyl Lester/0000-0003-2157-492X; Shao-horn, Yang/0000-0001-8714-2121; Elias, Joseph/0000-0002-2941-777X				Bandarenka AS, 2014, PHYS CHEM CHEM PHYS, V16, P13625, DOI 10.1039/c4cp00260a; Calle-Vallejo F, 2015, SCIENCE, V350, P185, DOI 10.1126/science.aab3501; Ding K, 2015, SCIENCE, V350, P189, DOI 10.1126/science.aac6368; Fu Q, 2003, SCIENCE, V301, P935, DOI 10.1126/science.1085721; Jiang T, 2009, J PHYS CHEM C, V113, P10548, DOI 10.1021/jp811185g; Kitchin JR, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.156801; Kuzume A, 2007, J ELECTROANAL CHEM, V599, P333, DOI 10.1016/j.jelechem.2006.05.006; Lai SCS, 2007, TOP CATAL, V46, P320, DOI 10.1007/s11244-007-9010-y; Lee SW, 2009, J AM CHEM SOC, V131, P15669, DOI 10.1021/ja9025648; Mavrikakis M, 1998, PHYS REV LETT, V81, P2819, DOI 10.1103/PhysRevLett.81.2819; Norskov JK, 2004, J PHYS CHEM B, V108, P17886, DOI 10.1021/jp047349j; Stamenkovic VR, 2007, SCIENCE, V315, P493, DOI 10.1126/science.1135941; Strasser P, 2015, SCIENCE, V349, P379, DOI 10.1126/science.aac7861; XU JZ, 1993, J CHEM PHYS, V99, P725, DOI 10.1063/1.465745; Yang M, 2014, SCIENCE, V346, P1498, DOI 10.1126/science.1260526	15	13	13	0	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257					164	165		10.1126/science.aad3716	http://dx.doi.org/10.1126/science.aad3716			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9JB	26450198	Green Submitted			2022-12-28	WOS:000362405600020
J	Basaldella, E; Takeoka, A; Sigrist, M; Arber, S				Basaldella, Emanuela; Takeoka, Aya; Sigrist, Markus; Arber, Silvia			Multisensory Signaling Shapes Vestibulo-Motor Circuit Specificity	CELL			English	Article							SPINAL-CORD; MUSCLE-SPINDLE; ALPHA-MOTONEURONES; SYNAPTIC CONNECTIVITY; PARTITION CELLS; SENSORY NEURONS; CRITICAL PERIOD; CAT; NUCLEUS; MOUSE	The ability to continuously adjust posture and balance is necessary for reliable motor behavior. Vestibular and proprioceptive systems influence postural adjustments during movement by signaling functionally complementary sensory information. Using viral tracing and mouse genetics, we reveal two patterns of synaptic specificity between brainstem vestibular neurons and spinal motor neurons, established through distinct mechanisms. First, vestibular input targets preferentially extensor over flexor motor pools, a pattern established by developmental refinement in part controlled by vestibular signaling. Second, vestibular input targets slow-twitch over fast motor neuron subtypes within extensor pools, while proprioceptors exhibit inversely correlated connectivity profiles. Genetic manipulations affecting the functionality of proprioceptive feedback circuits lead to adjustments in vestibular input to motor neuron subtypes counterbalancing the imposed changes, without changing the sparse vestibular input to flexor pools. Thus, two sensory signaling systems interact to establish complementary synaptic input patterns to the final site of motor output processing.	[Basaldella, Emanuela; Takeoka, Aya; Sigrist, Markus; Arber, Silvia] Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland; [Basaldella, Emanuela; Takeoka, Aya; Sigrist, Markus; Arber, Silvia] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	University of Basel; Friedrich Miescher Institute for Biomedical Research	Arber, S (corresponding author), Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.	silvia.arber@unibas.ch	Takeoka, Aya/AFS-3398-2022	Takeoka, Aya/0000-0003-0322-677X; Arber, Silvia/0000-0002-6261-250X	Werner Siemens Foundation; International Foundation for Research in Paraplegia (IRP) fellowship; ERC; Swiss National Science Foundation; Kanton Basel-Stadt; Novartis Research Foundation	Werner Siemens Foundation; International Foundation for Research in Paraplegia (IRP) fellowship; ERC(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton Basel-Stadt; Novartis Research Foundation	We are grateful to M. Mielich for expert technical help, M. Tripodi for help and guidance during initial stages of the project, F. Roselli for insights into motor neuron subtypes and muscle subcompartments, M. Studer for sharing R4::Cre mice with us, S. Bourke, C. Genoud, and L. Gelman from the FMI imaging facility, N. Ehrenfurchter from the Biozentrum Imaging facility and M. Stadler from the FMI Bioinformatics Platform for help and advice with image acquisition and analysis, and to P. Caroni and B. Roska for discussions and comments on the manuscript. E.B. was supported by a fellowship of the Werner Siemens Foundation, A.T. by an International Foundation for Research in Paraplegia (IRP) fellowship. All authors were supported by an ERC Advanced Grant, the Swiss National Science Foundation, the Kanton Basel-Stadt, and the Novartis Research Foundation.	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Arshian MS, 2014, J NEUROPHYSIOL, V111, P2423, DOI 10.1152/jn.00855.2013; Beraneck M, 2007, J NEUROPHYSIOL, V98, P1549, DOI 10.1152/jn.00590.2007; BRODAL A, 1957, J ANAT, V91, P438; Brown AG, 1981, ORG SPINAL CORD; BURKE RE, 1970, J PHYSIOL-LONDON, V207, P709, DOI 10.1113/jphysiol.1970.sp009090; BURKE RE, 1982, J COMP NEUROL, V209, P17, DOI 10.1002/cne.902090103; BURKE RE, 1967, J PHYSIOL-LONDON, V193, P141, DOI 10.1113/jphysiol.1967.sp008348; Carter R J, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0812s15; Chen HH, 2002, J NEUROSCI, V22, P3512; Di Bonito M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003249; Du Beau A, 2012, NEUROSCIENCE, V227, P67, DOI 10.1016/j.neuroscience.2012.09.037; ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794; Enjin A, 2010, J COMP NEUROL, V518, P2284, DOI 10.1002/cne.22332; Esposito MS, 2014, NATURE, V508, P351, DOI 10.1038/nature13023; FRANK E, 1990, J NEUROSCI, V10, P2250; Geisler HC, 1998, NEUROSCI BIOBEHAV R, V22, P565, DOI 10.1016/S0149-7634(97)00045-6; Geisler Hildegard C., 1993, Acta Neurobiologiae Experimentalis (Warsaw), V53, P517; Grillner S, 1988, Adv Neurol, V47, P425; GRILLNER S, 1970, EXP BRAIN RES, V10, P94, DOI 10.1007/BF00340521; HORAK FB, 1994, EXP BRAIN RES, V100, P93; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Kaplan A, 2014, NEURON, V81, P333, DOI 10.1016/j.neuron.2013.12.009; Leroy F, 2014, ELIFE, V3, DOI 10.7554/eLife.04046; Liang H, 2015, NEUROSCIENCE, V294, P206, DOI 10.1016/j.neuroscience.2015.03.020; Liang H, 2014, BRAIN STRUCT FUNCT, V219, P805, DOI 10.1007/s00429-013-0536-4; LUND S, 1968, ACTA PHYSIOL SCAND, V73, P1, DOI 10.1111/j.1748-1716.1968.tb04075.x; MATTHEWS PBC, 1981, J PHYSIOL-LONDON, V320, P1; Mears SC, 1997, J NEUROSCI, V17, P3128; MENDELL LM, 1968, SCIENCE, V160, P96, DOI 10.1126/science.160.3823.96; Mendelsohn AI, 2015, NEURON, V87, P111, DOI 10.1016/j.neuron.2015.05.045; Moorman SJ, 2002, DEV DYNAM, V223, P285, DOI 10.1002/dvdy.10052; Ohyama T, 2015, NATURE, V520, P633, DOI 10.1038/nature14297; Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249; Paffenholz R, 2004, GENE DEV, V18, P486, DOI 10.1101/gad.1172504; Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000; Pivetta C, 2014, CELL, V156, P537, DOI 10.1016/j.cell.2013.12.014; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Rotterman TM, 2014, J NEUROSCI, V34, P3475, DOI 10.1523/JNEUROSCI.4768-13.2014; Sakurai K, 2013, CELL REP, V5, P87, DOI 10.1016/j.celrep.2013.08.051; SHINODA Y, 1988, PROG BRAIN RES, V76, P17; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Takeoka A, 2014, CELL, V159, P1626, DOI 10.1016/j.cell.2014.11.019; Tourtellotte WG, 1998, NAT GENET, V20, P87, DOI 10.1038/1757; Van Cleave S, 2006, J VESTIBUL RES-EQUIL, V16, P179; Walton KD, 2005, J PHYSIOL-LONDON, V565, P593, DOI 10.1113/jphysiol.2004.074385; Wang Z, 2007, J NEUROSCI, V27, P3686, DOI 10.1523/JNEUROSCI.0197-07.2007; Wenner P, 1995, J NEUROSCI, V15, P8191; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; WILSON VJ, 1968, P NATL ACAD SCI USA, V60, P836, DOI 10.1073/pnas.60.3.836; Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010	53	39	39	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2					301	312		10.1016/j.cell.2015.09.023	http://dx.doi.org/10.1016/j.cell.2015.09.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26451482	Bronze			2022-12-28	WOS:000362952700009
J	Fleshman, J; Branda, M; Sargent, DJ; Boller, AM; George, V; Abbas, M; Peters, WR; Maun, D; Chang, G; Herline, A; Fichera, A; Mutch, M; Wexner, S; Whiteford, M; Marks, J; Birnbaum, E; Margolin, D; Larson, D; Marcello, P; Posner, M; Read, T; Monson, J; Wren, SM; Pisters, PWT; Nelson, H				Fleshman, James; Branda, Megan; Sargent, Daniel J.; Boller, Anne Marie; George, Virgilio; Abbas, Maher; Peters, Walter R., Jr.; Maun, Dipen; Chang, George; Herline, Alan; Fichera, Alessandro; Mutch, Matthew; Wexner, Steven; Whiteford, Mark; Marks, John; Birnbaum, Elisa; Margolin, David; Larson, David; Marcello, Peter; Posner, Mitchell; Read, Thomas; Monson, John; Wren, Sherry M.; Pisters, Peter W. T.; Nelson, Heidi			Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes The ACOSOG Z6051 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TOTAL MESORECTAL EXCISION; SHORT-TERM OUTCOMES; COLORECTAL-CANCER; OPEN-LABEL; SURGERY; METAANALYSIS; SPECIMEN	IMPORTANCE Evidence about the efficacy of laparoscopic resection of rectal cancer is incomplete, particularly for patients with more advanced-stage disease. OBJECTIVE To determine whether laparoscopic resection is noninferior to open resection, as determined by gross pathologic and histologic evaluation of the resected proctectomy specimen. DESIGN, SETTING, AND PARTICIPANTS A multicenter, balanced, noninferiority, randomized trial enrolled patients between October 2008 and September 2013. The trial was conducted by credentialed surgeons from 35 institutions in the United States and Canada. A total of 486 patients with clinical stage II or III rectal cancer within 12 cm of the anal verge were randomized after completion of neoadjuvant therapy to laparoscopic or open resection. INTERVENTIONS Standard laparoscopic and open approaches were performed by the credentialed surgeons. MAIN OUTCOMES AND MEASURES The primary outcome assessing efficacy was a composite of circumferential radial margin greater than 1 mm, distal margin without tumor, and completeness of total mesorectal excision. A 6% noninferiority margin was chosen according to clinical relevance estimation. RESULTS Two hundred forty patients with laparoscopic resection and 222 with open resection were evaluable for analysis of the 486 enrolled. Successful resection occurred in 81.7% of laparoscopic resection cases (95% CI, 76.8%-86.6%) and 86.9% of open resection cases (95% CI, 82.5%-91.4%) and did not support noninferiority (difference, -5.3%; 1-sided 95% CI, -10.8% to infinity; P for noninferiority = .41). Patients underwent low anterior resection (76.7%) or abdominoperineal resection (23.3%). Conversion to open resection occurred in 11.3% of patients. Operative time was significantly longer for laparoscopic resection (mean, 266.2 vs 220.6 minutes; mean difference, 45.5 minutes; 95% CI, 27.7-63.4; P < .001). Length of stay (7.3 vs 7.0 days; mean difference, 0.3 days; 95% CI, -0.6 to 1.1), readmission within 30 days (3.3% vs 4.1%; difference, -0.7%; 95% CI, -4.2% to 2.7%), and severe complications (22.5% vs 22.1%; difference, 0.4%; 95% CI, -4.2% to 2.7%) did not differ significantly. Quality of the total mesorectal excision specimen in 462 operated and analyzed surgeries was complete (77%) and nearly complete (16.5%) in 93.5% of the cases. Negative circumferential radial margin was observed in 90% of the overall group (87.9% laparoscopic resection and 92.3% open resection; P = .11). Distal margin result was negative in more than 98% of patients irrespective of type of surgery (P = .91). CONCLUSIONS AND RELEVANCE Among patients with stage II or III rectal cancer, the use of laparoscopic resection compared with open resection failed to meet the criterion for noninferiority for pathologic outcomes. Pending clinical oncologic outcomes, the findings do not support the use of laparoscopic resection in these patients.	[Fleshman, James] Baylor Univ, Med Ctr, Dallas, TX 75246 USA; [Branda, Megan; Sargent, Daniel J.; Larson, David] Mayo Clin, Alliance Stat & Data Ctr, Rochester, MN USA; [Boller, Anne Marie] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [George, Virgilio] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Abbas, Maher] Cleveland Clin Abu Dhabi, Abu Dhabi, U Arab Emirates; [Peters, Walter R., Jr.] Boone Hosp Ctr, Columbia, MO USA; [Maun, Dipen] Franciscan St Francis Hlth, Indianapolis, IN USA; [Chang, George; Pisters, Peter W. T.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Herline, Alan] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Fichera, Alessandro; Posner, Mitchell] Univ Chicago, Chicago, IL 60637 USA; [Mutch, Matthew; Birnbaum, Elisa] Washington Univ, St Louis, MO USA; [Wexner, Steven] Cleveland Clin Weston, Weston, FL USA; [Whiteford, Mark] Oregon Hlth & Sci Univ, Oregon Clin, Portland, OR 97201 USA; [Marks, John] Lankenau Hosp, Wynnewood, PA USA; [Margolin, David] Ochsner Clin & Alton Ochsner Med Fdn, New Orleans, LA USA; [Marcello, Peter; Read, Thomas] Lahey Clin Fdn, Burlington, MA USA; [Monson, John] Univ Rochester, Rochester, NY USA; [Wren, Sherry M.] Stanford Univ, Palo Alto, CA 94304 USA	Baylor University; Baylor University Medical Center; Mayo Clinic; Northwestern University; Feinberg School of Medicine; Indiana University System; Indiana University Bloomington; Cleveland Clinic Foundation; University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University; University of Chicago; Washington University (WUSTL); Cleveland Clinic Foundation; Oregon Health & Science University; Lankenau Medical Center; Ochsner Health System; Lahey Hospital & Medical Center; University of Rochester; Stanford University	Fleshman, J (corresponding author), Baylor Univ, Med Ctr, Roberts Hosp, 3500 Gaston Ave, Dallas, TX 75246 USA.	James.Fleshman@baylorhealth.edu	Margolin, David/A-6017-2011	Wren, Sherry/0000-0002-5723-8226	National Cancer Institute; Covidien Company; NATIONAL CANCER INSTITUTE [U10CA180821, U10CA180833, P30CA016672, U10CA180882] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Covidien Company; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Cancer Institute, awarded to the American College of Surgeons Oncology Group (ACOSOG). The American Society of Colon and Rectal Surgeons provided support for the comparison of the quality-of-life survey results between the laparoscopic and open resection arms. The Society of American Gastrointestinal and Endoscopic Surgeons provided support for the evaluation of instrumentation in the laparoscopic resection-treated patients. In addition, the Covidien Company provided unrestricted research support to the ACOSOG infrastructure for the trial.	Ahmad NZ, 2013, COLORECTAL DIS, V15, P269, DOI 10.1111/codi.12007; Arezzo A, 2015, SURG ENDOSC, V29, P334, DOI 10.1007/s00464-014-3686-4; Clinical Outcomes of Surgical Therapy Study Group, 2004, NEW ENGL J MED, V350, P2050; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Dorrance HR, 2000, DIS COLON RECTUM, V43, P492, DOI 10.1007/BF02237192; Green BL, 2013, BRIT J SURG, V100, P75, DOI 10.1002/bjs.8945; Jeong SY, 2014, LANCET ONCOL, V15, P767, DOI 10.1016/S1470-2045(14)70205-0; Kang SB, 2010, LANCET ONCOL, V11, P637, DOI 10.1016/S1470-2045(10)70131-5; Kuhry E, 2008, CANCER TREAT REV, V34, P498, DOI 10.1016/j.ctrv.2008.03.011; Martel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035292; Monson JRT, 2013, DIS COLON RECTUM, V56, P535, DOI 10.1097/DCR.0b013e31828cb66c; Nagtegaal ID, 2002, J CLIN ONCOL, V20, P1729, DOI 10.1200/JCO.2002.07.010; Nagtegaal ID, 2008, J CLIN ONCOL, V26, P303, DOI 10.1200/JCO.2007.12.7027; Parfitt JR, 2007, J CLIN PATHOL, V60, P849, DOI 10.1136/jcp.2006.043802; Porter GA, 1998, ANN SURG, V227, P157, DOI 10.1097/00000658-199802000-00001; Quirke P, 2009, LANCET, V373, P821, DOI 10.1016/S0140-6736(09)60485-2; Sajid MS, 2014, WORLD J GASTRO ENDOS, V6, P209, DOI 10.4253/wjge.v6.i5.209; Trastulli S, 2012, COLORECTAL DIS, V14, pE277, DOI 10.1111/j.1463-1318.2012.02985.x; van der Pas MHGM, 2013, LANCET ONCOL, V14, P210, DOI 10.1016/S1470-2045(13)70016-0; Xiong BH, 2014, J SURG RES, V188, P404, DOI 10.1016/j.jss.2014.01.027	20	691	757	2	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2015	314	13					1346	1355		10.1001/jama.2015.10529	http://dx.doi.org/10.1001/jama.2015.10529			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2PH	26441179	Green Accepted, Bronze			2022-12-28	WOS:000362644700012
J	Silverberg, MJ; Lau, B; Achenbach, CJ; Jing, YZ; Althoff, KN; D'Souza, G; Engels, EA; Hessol, NA; Brooks, JT; Burchell, AN; Gill, MJ; Goedert, JJ; Hogg, R; Horberg, MA; Kirk, GD; Kitahata, MM; Korthuis, PT; Mathews, WC; Mayor, A; Modur, SP; Napravnik, S; Novak, RM; Patel, P; Rachlis, AR; Sterling, TR; Willig, JH; Justice, AC; Moore, RD; Dubrow, R				Silverberg, Michael J.; Lau, Bryan; Achenbach, Chad J.; Jing, Yuezhou; Althoff, Keri N.; D'Souza, Gypsyamber; Engels, Eric A.; Hessol, Nancy A.; Brooks, John T.; Burchell, Ann N.; Gill, M. John; Goedert, James J.; Hogg, Robert; Horberg, Michael A.; Kirk, Gregory D.; Kitahata, Mari M.; Korthuis, Philip T.; Mathews, William C.; Mayor, Angel; Modur, Sharada P.; Napravnik, Sonia; Novak, Richard M.; Patel, Pragna; Rachlis, Anita R.; Sterling, Timothy R.; Willig, James H.; Justice, Amy C.; Moore, Richard D.; Dubrow, Robert		Int Epidemiologic Databases	Cumulative Incidence of Cancer Among Persons With HIV in North America A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							AIDS-DEFINING MALIGNANCIES; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; HUMAN-PAPILLOMAVIRUS VACCINE; HIV-1-INFECTED PATIENTS; INFECTED PATIENTS; LUNG-CANCER; ANAL CANCER; VIRAL-HEPATITIS; UNITED-STATES; RISK	Background: Cancer is increasingly common among persons with HIV. Objective: To examine calendar trends in cumulative cancer incidence and hazard rate by HIV status. Design: Cohort study. Setting: North American AIDS Cohort Collaboration on Research and Design during 1996 to 2009. Participants: 86 620 persons with HIV and 196 987 uninfected adults. Measurements: Cancer type-specific cumulative incidence by age 75 years and calendar trends in cumulative incidence and hazard rates, each by HIV status. Results: Cumulative incidences of cancer by age 75 years for persons with and without HIV, respectively, were as follows: Kaposi sarcoma, 4.4% and 0.01%; non-Hodgkin lymphoma, 4.5% and 0.7%; lung cancer, 3.4% and 2.8%; anal cancer, 1.5% and 0.05%; colorectal cancer, 1.0% and 1.5%; liver cancer, 1.1% and 0.4%; Hodgkin lymphoma, 0.9% and 0.09%; melanoma, 0.5% and 0.6%; and oral cavity/pharyngeal cancer, 0.8% and 0.8%. Among persons with HIV, calendar trends in cumulative incidence and hazard rate decreased for Kaposi sarcoma and non-Hodgkin lymphoma. For anal, colorectal, and liver cancer, increasing cumulative incidence, but not hazard rate trends, were due to the decreasing mortality rate trend (-9% per year), allowing greater opportunity to be diagnosed. Despite decreasing hazard rate trends for lung cancer, Hodgkin lymphoma, and melanoma, cumulative incidence trends were not seen because of the compensating effect of the declining mortality rate. Limitation: Secular trends in screening, smoking, and viral co-infections were not evaluated. Conclusion: Cumulative cancer incidence by age 75 years, approximating lifetime risk in persons with HIV, may have clinical utility in this population. The high cumulative incidences by age 75 years for Kaposi sarcoma, non- Hodgkin lymphoma, and lung cancer support early and sustained antiretroviral therapy and smoking cessation.	Kaiser Permanente No Calif, Oakland, CA USA; Johns Hopkins Sch Med, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Northwestern Univ, Feinberg Sch Med, Ctr Global Hlth, Lurie Canc Ctr, Chicago, IL 60611 USA; Univ Illinois, Coll Med, Chicago, IL USA; NCI, NIH, Bethesda, MD 20892 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Univ Toronto, Ontario HIV Treatment Network, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; Univ Calgary, Calgary, AB, Canada; British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; Kaiser Permanente, Midatlantic Permanente Res Inst, Rockville, MD USA; Univ Washington, Seattle, WA 98195 USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Univ Calif San Diego, San Diego, CA 92103 USA; Univ Cent Caribe, Sch Med, Retrovirus Res Ctr, Bayamon, PR USA; Univ N Carolina, Sch Med, Chapel Hill, NC USA; Vanderbilt Univ, Nashville, TN 37235 USA; Univ Alabama Birmingham, Birmingham, AL USA; Vet Affairs Connecticut Healthcare Syst, New Haven, CT USA; Yale Univ, Sch Med, New Haven, CT USA; Yale Univ, Sch Publ Hlth, New Haven, CT USA	Kaiser Permanente; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Calgary; B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; Kaiser Permanente; University of Washington; University of Washington Seattle; Oregon Health & Science University; University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Vanderbilt University; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Yale University	Silverberg, MJ (corresponding author), Kaiser Permanente, Div Res, 2000 Broadway,2nd Floor, Oakland, CA 94612 USA.	Michael.J.Silverberg@kp.org	Dodsley, Maria/G-7083-2016; Althoff, Keri N/HGC-5595-2022; Hogg, Robert S/B-2783-2012; Achenbach, Chad/AAQ-4035-2020; Gill, Michael John/G-7083-2016	Dodsley, Maria/0000-0001-7587-558X; Hogg, Robert S/0000-0003-3463-5488; Althoff, Keri/0000-0002-5068-6595; Mayor, Angel M./0000-0002-7705-837X; Achenbach, Chad/0000-0003-4847-7249; Gill, Michael John/0000-0002-8546-8790; Korthuis, Philip/0000-0001-5556-3597; Justice, Amy/0000-0003-0139-5502	National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIACP010176, Z01CP010176, R01CA165937] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000083, KL2TR000421] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052, UL1RR024131] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K23EY013707, U10EY008067, U10EY008057, U10EY008052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034989, U01AI068634, U01AI031834, U01AI042590, P30AI050410, U01AI037613, U01AI034993, R56AI102622, U01AI035004, U01AI068636, U01AI035039, P30AI027757, U01AI069432, U01AI035040, P30AI054999, P30AI094189, U01AI035043, U01AI035041, K24AI065298, U01AI035042, U01AI069918, K01AI093197, K01AI071754, R24AI067039, P30AI036219, U01AI038858, UM1AI069432, U01AI034994, P30AI027767, UM1AI035043, U01AI038855, U01AI037984, K24AI118591, U01AI069434, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016893, U01AA020790, U01AA013566, U24AA020794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA004334, K24DA000432, R01DA012568, U01DA036935, R01DA011602, F31DA037788, U01DA036297, R01DA004334, F31DA035713] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007587, G12MD007583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	National Institutes of Health.	Allignol A, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-86; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Althoff KN, 2013, HIV MED, V14, P191, DOI 10.1111/hiv.12007; Arias Elizabeth, 2014, Natl Vital Stat Rep, V63, P1; Auluck A, 2010, CANCER-AM CANCER SOC, V116, P2635, DOI 10.1002/cncr.25087; Bagni R, 2009, CURR OPIN HIV AIDS, V4, P22, DOI 10.1097/COH.0b013e32831add5a; Bedimo R, 2004, CLIN INFECT DIS, V39, P1380, DOI 10.1086/424883; Borges AH, 2014, CURR OPIN HIV AIDS, V9, P34, DOI 10.1097/COH.0000000000000025; Borges AH, 2013, AIDS, V27, P1433, DOI 10.1097/QAD.0b013e32835f6b0c; Bruyand M, 2009, CLIN INFECT DIS, V49, P1109, DOI 10.1086/605594; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Chao C, 2011, AIDS, V25, P1771, DOI 10.1097/QAD.0b013e328349c67a; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Dubrow R, 2012, CURR OPIN ONCOL, V24, P506, DOI 10.1097/CCO.0b013e328355e131; Edwards BK, 2014, CANCER-AM CANCER SOC, V120, P1290, DOI 10.1002/cncr.28509; Efron B., 1994, MONOGRAPHS STAT APPL; Engels EA, 2006, AIDS, V20, P1645, DOI 10.1097/01.aids.0000238411.75324.59; Engsig FN, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-272; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Franceschi S, 2008, BRIT J CANCER, V99, P800, DOI 10.1038/sj.bjc.6604520; Galli L, 2014, AIDS, V28, P2407, DOI 10.1097/QAD.0000000000000443; Ganesan A, 2011, J INFECT DIS, V203, P756, DOI 10.1093/infdis/jiq115; Gange SJ, 2007, INT J EPIDEMIOL, V36, P294, DOI 10.1093/ije/dyl286; GAYNOR JJ, 1993, J AM STAT ASSOC, V88, P400, DOI 10.2307/2290318; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Guiguet M, 2009, LANCET ONCOL, V10, P1152, DOI 10.1016/S1470-2045(09)70282-7; Hall EC, 2013, CANCER-AM CANCER SOC, V119, P2300, DOI 10.1002/cncr.28043; Helleberg M, 2014, AIDS, V28, P1499, DOI 10.1097/QAD.0000000000000283; Hleyhel M, 2014, AIDS, V28, P2109, DOI 10.1097/QAD.0000000000000382; Hleyhel M, 2013, CLIN INFECT DIS, V57, P1638, DOI 10.1093/cid/cit497; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Justice Amy C, 2010, Curr HIV/AIDS Rep, V7, P69, DOI 10.1007/s11904-010-0041-9; Kahn JA, 2013, CLIN INFECT DIS, V57, P735, DOI 10.1093/cid/cit319; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; Kaplan JE, 2009, MMWR RECOMM REP, V58, pCE1; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Kesselring A, 2011, CLIN INFECT DIS, V52, P1458, DOI 10.1093/cid/cir207; Kojic EM, 2007, CURR OPIN ONCOL, V19, P464, DOI 10.1097/CCO.0b013e3282c8c84c; Kojic EM, 2014, CLIN INFECT DIS, V59, P127, DOI 10.1093/cid/ciu238; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Latouche A, 2013, J CLIN EPIDEMIOL, V66, P648, DOI 10.1016/j.jclinepi.2012.09.017; Lau B, 2007, JAIDS-J ACQ IMM DEF, V44, P179, DOI 10.1097/01.qai.0000247229.68246.c5; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; Moorman AC, 2013, CLIN INFECT DIS, V56, P40, DOI 10.1093/cid/cis815; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Osinusi A, 2015, JAMA-J AM MED ASSOC, V313, P1232, DOI 10.1001/jama.2015.1373; Overton ET, 2013, CLIN INFECT DIS, V56, P1471, DOI 10.1093/cid/cit053; Park LS, 2014, J AIDS CLIN RES, V5, DOI DOI 10.1038/NCOMMS6318; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Patel P, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu012; Piketty C, 2012, J CLIN ONCOL, V30, P4360, DOI 10.1200/JCO.2012.44.5486; Rahmanian Shiva, 2011, Proc Am Thorac Soc, V8, P313, DOI 10.1513/pats.201009-058WR; Reekie J, 2010, CANCER-AM CANCER SOC, V116, P5306, DOI 10.1002/cncr.25311; Robbins HA, 2014, AIDS, V28, P881, DOI 10.1097/QAD.0000000000000163; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Sigel K, 2014, AIDS, V28, P1007, DOI 10.1097/QAD.0000000000000189; Silverberg MJ, 2012, CLIN INFECT DIS, V54, P1026, DOI 10.1093/cid/cir1012; Silverberg MJ, 2011, CANCER EPIDEM BIOMAR, V20, P2551, DOI 10.1158/1055-9965.EPI-11-0777; Silverberg MJ, 2009, AIDS, V23, P2337, DOI 10.1097/QAD.0b013e3283319184; Simard EP, 2011, CANCER-AM CANCER SOC, V117, P1089, DOI 10.1002/cncr.25547; Simard EP, 2010, ARCH INTERN MED, V170, P1337, DOI 10.1001/archinternmed.2010.253; Stock C, 2010, GASTROINTEST ENDOSC, V71, P366, DOI 10.1016/j.gie.2009.06.018; Sulkowski MS, 2015, JAMA-J AM MED ASSOC, V313, P1223, DOI 10.1001/jama.2015.1328; Tesoriero JM, 2010, AIDS BEHAV, V14, P824, DOI 10.1007/s10461-008-9449-2; U. S. Department of Health and Human Services, 2014, HLTH CONSMOK 50 YE, P151; Wada N, 2013, AM J EPIDEMIOL, V177, P116, DOI 10.1093/aje/kws321; Wells JS, 2014, AIDS PATIENT CARE ST, V28, P350, DOI 10.1089/apc.2013.0358; Wilkin T, 2010, J INFECT DIS, V202, P1246, DOI 10.1086/656320; World Health Organization, 2007, IARC MON EV CARC RIS; Worm SW, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-471	74	209	215	2	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2015	163	7					507	+		10.7326/M14-2768	http://dx.doi.org/10.7326/M14-2768			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT0OQ	26436616	Green Accepted			2022-12-28	WOS:000362496400004
J	Wolfe, BM; Gardiner, B; Frey, CF				Wolfe, Bruce M.; Gardiner, Barry; Frey, Charles F.			Laparoscopic Cholecystectomy A Remarkable Development (Reprinted from JAMA, vol 265, pg 1573-1574, 1991)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		WOLFE BM, 1991, JAMA-J AM MED ASSOC, V265, P1573, DOI 10.1001/jama.265.12.1573	1	7	7	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2015	314	13					1406	1406		10.1001/jama.2014.12014	http://dx.doi.org/10.1001/jama.2014.12014			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2PH	26441196				2022-12-28	WOS:000362644700027
J	Tinetti, ME; McAvay, G; Trentalange, M; Cohen, AB; Allore, HG				Tinetti, Mary E.; McAvay, Gail; Trentalange, Mark; Cohen, Andrew B.; Allore, Heather G.			Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHRONIC HEART-FAILURE; MEDICARE BENEFICIARIES; ATRIAL-FIBRILLATION; AMERICAN-COLLEGE; PREVENTION; MANAGEMENT; MORTALITY; CLAIMS; COMORBIDITY; CANDESARTAN	OBJECTIVE To estimate the association between guideline recommended drugs and death in older adults with multiple chronic conditions. DESIGN Population based cohort study. SETTING Medicare Current Beneficiary Survey cohort, a nationally representative sample of Americans aged 65 years or more. PARTICIPANTS 8578 older adults with two or more study chronic conditions (atrial fibrillation, coronary artery disease, chronic kidney disease, depression, diabetes, heart failure, hyperlipidemia, hypertension, and thromboembolic disease), followed through 2011. EXPOSURES Drugs included beta blockers, calcium channel blockers, clopidogrel, metformin, renin-angiotensin system (RAS) blockers; selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs); statins; thiazides; and warfarin. MAIN OUTCOME MEASURE Adjusted hazard ratios for death among participants with a condition and taking a guideline recommended drug relative to participants with the condition not taking the drug and among participants with the most common combinations of four conditions. RESULTS Over 50% of participants with each condition received the recommended drugs regardless of coexisting conditions; 1287/8578 (15%) participants died during the three years of follow-up. Among cardiovascular drugs, beta blockers, calcium channel blockers, RAS blockers, and statins were associated with reduced mortality for indicated conditions. For example, the adjusted hazard ratio for beta blockers was 0.59 (95% confidence interval 0.48 to 0.72) for people with atrial fibrillation and 0.68 (0.57 to 0.81) for those with heart failure. The adjusted hazard ratios for cardiovascular drugs were similar to those with common combinations of four coexisting conditions, with trends toward variable effects for beta blockers. None of clopidogrel, metformin, or SSRIs/SNRIs was associated with reduced mortality. Warfarin was associated with a reduced risk of death among those with atrial fibrillation (adjusted hazard ratio 0.69, 95% confidence interval 0.56 to 0.85) and thromboembolic disease (0.44, 0.30 to 0.62). Attenuation in the association with reduced risk of death was found with warfarin in participants with some combinations of coexisting conditions. CONCLUSIONS Average effects on survival, particularly for cardiovascular study drugs, were comparable to those reported in randomized controlled trials but varied for some drugs according to coexisting conditions. Determining treatment effects in combinations of conditions may guide prescribing in people with multiple chronic conditions.	[Tinetti, Mary E.] Yale Univ, Sch Med, Dept Internal Med Geriatr, New Haven, CT 06520 USA; [McAvay, Gail; Trentalange, Mark; Cohen, Andrew B.; Allore, Heather G.] Yale Univ, Sch Med, Sect Geriatr, New Haven, CT 06520 USA	Yale University; Yale University	Tinetti, ME (corresponding author), Yale Univ, Sch Med, Dept Internal Med Geriatr, New Haven, CT 06520 USA.			Allore, Heather/0000-0001-7685-8175; Cohen, Andrew/0000-0001-9161-8436	National Institute on Aging [R21 AG045148]; Yale Pepper Center from the National Institute on Aging [P30 AG021342]; NATIONAL INSTITUTE ON AGING [T32AG019134, P50AG047270, P30AG021342, R21AG045148] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Yale Pepper Center from the National Institute on Aging; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grant R21 AG045148 and by the Yale Pepper Center (P30 AG021342), both from the National Institute on Aging. The researchers conducted this study independently from the funders.	Afilalo DJ, 2008, AM COLL CARDIOL, V51, P437; Anglemyer A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000034.pub2; [Anonymous], 1999, TOT MED HLTH PLAN EN; Bajcar JM, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-75; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bogner HR, 2007, DIABETES CARE, V30, P3005, DOI 10.2337/dc07-0974; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; Corley SD, 2004, CIRCULATION, V109, P1509, DOI 10.1161/01.CIR.0000121736.16643.11; Dhruva SS, 2008, ARCH INTERN MED, V168, P136, DOI 10.1001/archinternmed.2007.56; Dogliotti A, 2014, HEART, V100, P396, DOI 10.1136/heartjnl-2013-304347; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fried TR, 2008, J AM GERIATR SOC, V56, P1839, DOI 10.1111/j.1532-5415.2008.01923.x; Gorina Yelena, 2008, Aging Trends, P1; GRADE Working Group, 2015, GRAD QUAL EV STRENGT; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Hakkarainen KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033236; Healthcare Cost and Utilization Project (HCUP), 2012, CLIN CLASS SYST; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hoyert Donna L, 2012, Natl Vital Stat Rep, V61, P1; Ickowicz E, 2012, J AM GERIATR SOC, V60, P1957, DOI 10.1111/j.1532-5415.2012.04187.x; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; Johnson ES, 2013, PHARMACOEPIDEM DR S, V22, P1, DOI 10.1002/pds.3334; Klabunde CN, 2006, MED CARE, V44, P921, DOI 10.1097/01.mlr.0000223480.52713.b9; Lentine KL, 2009, CLIN J AM SOC NEPHRO, V4, P1213, DOI 10.2215/CJN.00670109; Lugtenberg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025987; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; NAGI SZ, 1976, MILBANK FUND Q, V54, P439, DOI 10.2307/3349677; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; National Center for Health Statistics, 2014, HLTH US 2013 SPEC FE; National Center for Health Statistics, 2015, MORT DAT MULT CAUS O; Noyes K, 2011, PSYCHIAT SERV, V62, P1159, DOI 10.1176/ps.62.10.pss6210_1159; O'Brien EC, 2015, JAMA INTERN MED, V175, P848, DOI 10.1001/jamainternmed.2015.13; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Pilotto A, 2009, J GERONTOL A-BIOL, V64, P880, DOI 10.1093/gerona/glp031; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Roussel R, 2010, ARCH INTERN MED, V170, P1892, DOI 10.1001/archinternmed.2010.409; Shrank WH, 2011, J GEN INTERN MED, V26, P546, DOI 10.1007/s11606-010-1609-1; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Sturmer T, 2006, J CLIN EPIDEMIOL, V59, P437, DOI 10.1016/j.jclinepi.2005.07.004; Tache SV, 2011, ANN PHARMACOTHER, V45, P977, DOI 10.1345/aph.1P627; Therneau TM, 2000, MODELING SURVIVAL DA; Tinetti ME, 2011, J AM GERIATR SOC, V59, P1686, DOI 10.1111/j.1532-5415.2011.03573.x; Tinetti ME, 2012, J AM GERIATR SOC, V60, P1448, DOI 10.1111/j.1532-5415.2012.04077.x; Uhlig K, 2014, J GEN INTERN MED, V29, P670, DOI 10.1007/s11606-013-2659-y; Tran VT, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-109; Work Group on Major Depressive Disorder, 2010, PRACT GUID TREATM PA; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7	50	38	38	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 2	2015	351								h4984	10.1136/bmj.h4984	http://dx.doi.org/10.1136/bmj.h4984			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CT0AK	26432468	Green Published, hybrid			2022-12-28	WOS:000362455900001
J	Koppes, M; Hallet, B; Rignot, E; Mouginot, J; Wellner, JS; Boldt, K				Koppes, Michele; Hallet, Bernard; Rignot, Eric; Mouginot, Jeremie; Wellner, Julia Smith; Boldt, Katherine			Observed latitudinal variations in erosion as a function of glacier dynamics	NATURE			English	Article							ANTARCTIC PENINSULA; SEDIMENT ACCUMULATION; PATAGONIA; EVOLUTION; CLIMATE; FJORDS; ICE; LANDSCAPE; VARIABILITY; GLACIATION	Glacial erosion is fundamental to our understanding of the role of Cenozoic-era climate change in the development of topography worldwide, yet the factors that control the rate of erosion by ice remain poorly understood. In many tectonically active mountain ranges, glaciers have been inferred to be highly erosive, and conditions of glaciation are used to explain both the marked relief typical of alpine settings and the limit on mountain heights above the snowline, that is, the glacial buzzsaw(1). In other high-latitude regions, glacial erosion is presumed to be minimal, where a mantle of cold ice effectively protects landscapes from erosion(2-4). Glacial erosion rates are expected to increase with decreasing latitude, owing to the climatic control on basal temperature and the production of meltwater, which promotes glacial sliding, erosion and sediment transfer. This relationship between climate, glacier dynamics and erosion rate is the focus of recent numerical modelling(5-8), yet it is qualitative and lacks an empirical database. Here we present a comprehensive data set that permits explicit examination of the factors controlling glacier erosion across climatic regimes. We report contemporary ice fluxes, sliding speeds and erosion rates inferred from sediment yields from 15 outlet glaciers spanning 19 degrees of latitude from Patagonia to the Antarctic Peninsula. Although this broad region has a relatively uniform tectonic and geologic history, the thermal regimes of its glaciers range from temperate to polar. We find that basin-averaged erosion rates vary by three orders of magnitude over this latitudinal transect. Our findings imply that climate and the glacier thermal regime control erosion rates more than do extent of ice cover, ice flux or sliding speeds.	[Koppes, Michele] Univ British Columbia, Dept Geog, Vancouver, BC V6T 1Z2, Canada; [Hallet, Bernard] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Hallet, Bernard] Univ Washington, Quaternary Res Ctr, Seattle, WA 98195 USA; [Rignot, Eric; Mouginot, Jeremie] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92617 USA; [Rignot, Eric] NASA, Jet Prop Lab, Pasadena, CA 91109 USA; [Wellner, Julia Smith] Univ Houston, Dept Earth & Atmospher Sci, Houston, TX 77204 USA; [Boldt, Katherine] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of British Columbia; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Irvine; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Houston System; University of Houston; University of Washington; University of Washington Seattle	Koppes, M (corresponding author), Univ British Columbia, Dept Geog, 1984 West Mall, Vancouver, BC V6T 1Z2, Canada.	koppes@geog.ubc.ca	Mouginot, Jeremie/G-7045-2015; Rignot, Eric/A-4560-2014	Mouginot, Jeremie/0000-0001-9155-5455; Rignot, Eric/0000-0002-3366-0481; Koppes, Michele/0000-0003-0580-2718	US National Science Foundation [OPP 0338371]	US National Science Foundation(National Science Foundation (NSF))	This research was funded by the US National Science Foundation (OPP 0338371). We thank the crews of the ice breaker RV Nathaniel B. Palmer and the MV Petrel IV, members of Waters of Patagonia, support staff from Raytheon Polar Services, and collaborators from the Centro de Estudios Cientificos in Valdivia, Chile, the University of Washington, Rice University and the University of Houston for assisting in deployments, sampling and analysis of the sediment cores, bathymetric data, ice front geometries and acoustic reflection profiles collected during the cruises. We particularly thank J. Anderson, A. Rivera, M. Jaffrey, J. Evans and T. Verzone for help and logistical support in the field; R. Sylwester for his contribution to the collection of acoustic reflection profiles in Chile; C. Nittrouer, B. Forrest, C. Landowski, J. Berquist and T. Drexler for processing and analysing the sediment cores; T. Pratt for processing of acoustic profiles in Jorge Montt; J. Anderson and R. Fernandez for supporting data and discussions; C. Brookfield for editing and insight; R. Jana at INACH for provision of Landsat imagery of the Antarctic Peninsula; and M. Jaffrey, J. Newton and A. Winter-Billington for help with statistical analyses.	Baty F, 2015, J STAT SOFTW, V66, P1; Boldt K. V., 2014, THESIS U WASHINGTON; Boldt KV, 2013, J GEOPHYS RES-EARTH, V118, P2072, DOI 10.1002/jgrf.20145; Breitsprecher K, 2009, TECTONOPHYSICS, V464, P10, DOI 10.1016/j.tecto.2008.02.013; Carbotte S. M., 2007, 20071047SRP002 US GE; Cook AJ, 2014, ANTARCT SCI, V26, P614, DOI 10.1017/S0954102014000200; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Cowan EA, 2010, GEOL SOC AM BULL, V122, P1067, DOI 10.1130/B26595.1; Cowton T, 2012, GEOLOGY, V40, P343, DOI 10.1130/G32687.1; Cuffey KM, 1999, GEOPHYS RES LETT, V26, P751, DOI 10.1029/1999GL900096; Dalziel IWD, 2013, ANNU REV EARTH PL SC, V41, P767, DOI 10.1146/annurev-earth-050212-124155; DaSilva JL, 1997, MAR GEOL, V143, P103, DOI 10.1016/S0025-3227(97)00092-3; Domack E.W., 1996, ANTARCT RES SER, V70, P135, DOI [10.1029/AR070p0135, DOI 10.1029/AR070P0135]; Egholm DL, 2012, GEOMORPHOLOGY, V141, P47, DOI 10.1016/j.geomorph.2011.12.019; Egholm DL, 2009, NATURE, V460, P884, DOI 10.1038/nature08263; Fernandez RA, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2010JF001685; Forster RR, 1999, J GLACIOL, V45, P325, DOI 10.3189/S0022143000001829; GRIFFITH TW, 1989, MAR GEOL, V85, P181, DOI 10.1016/0025-3227(89)90153-9; Guillaume B, 2013, EARTH PLANET SC LETT, V364, P157, DOI 10.1016/j.epsl.2012.12.036; Hallet B, 1996, ANN GLACIOL, V22, P1; Hallet B, 1996, GLOBAL PLANET CHANGE, V12, P213, DOI 10.1016/0921-8181(95)00021-6; Hebbeln D, 2007, GEOLOGY, V35, P131, DOI 10.1130/G23243A.1; Herman F, 2011, EARTH PLANET SC LETT, V310, P498, DOI 10.1016/j.epsl.2011.08.022; Hooke RL, 1996, GLOBAL PLANET CHANGE, V12, P237, DOI 10.1016/0921-8181(95)00022-4; HUMPHREY NF, 1994, J GLACIOL, V40, P539, DOI 10.1017/S0022143000012429; Iverson NR, 2012, GEOLOGY, V40, P679, DOI 10.1130/G33079.1; Jaeger JM, 1998, BASIN RES, V10, P155, DOI 10.1046/j.1365-2117.1998.00059.x; Kessler MA, 2008, NAT GEOSCI, V1, P365, DOI 10.1038/ngeo201; KOONS PO, 1989, AM J SCI, V289, P1041, DOI 10.2475/ajs.289.9.1041; Koppes M, 2011, CRYOSPHERE, V5, P791, DOI 10.5194/tc-5-791-2011; Koppes M, 2010, QUATERNARY RES, V73, P84, DOI 10.1016/j.yqres.2009.07.006; Koppes M, 2009, J GLACIOL, V55, P207, DOI 10.3189/002214309788608796; Koppes MN, 2009, NAT GEOSCI, V2, P644, DOI 10.1038/NGEO616; Lenaerts JTM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050713; MacGregor KR, 2009, GEOMORPHOLOGY, V103, P189, DOI 10.1016/j.geomorph.2008.04.022; Mayr C, 2007, QUATERNARY SCI REV, V26, P579, DOI 10.1016/j.quascirev.2006.11.013; MORRIS EM, 2003, ANTARCTIC RES SERIES, V79; Mouginot J, 2015, GEOPHYS RES LETT, V42, P1441, DOI 10.1002/2014GL062661; Pritchard HD, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000597; Rau F, 2002, ANN GLACIOL, V34, P95, DOI 10.3189/172756402781817914; Raymond C, 2005, J GLACIOL, V51, P239, DOI 10.3189/172756505781829476; Rignot E, 2003, SCIENCE, V302, P434, DOI 10.1126/science.1087393; Rignot E, 2011, SCIENCE, V333, P1427, DOI 10.1126/science.1208336; Rivera A, 2012, ANN GLACIOL, V53, P147, DOI 10.3189/2012AoG60A152; Sakakibara D, 2014, J GEOPHYS RES-EARTH, V119, P2541, DOI 10.1002/2014JF003148; Stroeven AP, 2002, GEOMORPHOLOGY, V44, P145, DOI 10.1016/S0169-555X(01)00150-7; Szczucinski W, 2009, ESTUAR COAST SHELF S, V85, P345, DOI 10.1016/j.ecss.2009.08.021; Thomson SN, 2010, NATURE, V467, P313, DOI 10.1038/nature09365; Tomkin JH, 2009, GEOMORPHOLOGY, V103, P180, DOI 10.1016/j.geomorph.2008.04.021; Turner J, 2005, INT J CLIMATOL, V25, P279, DOI 10.1002/joc.1130; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Yanites BJ, 2012, EARTH PLANET SC LETT, V325, P63, DOI 10.1016/j.epsl.2012.01.030	52	107	108	4	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					100	+		10.1038/nature15385	http://dx.doi.org/10.1038/nature15385			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26432248				2022-12-28	WOS:000362095100041
J	Lebwohl, M; Strober, B; Menter, A; Gordon, K; Weglowska, J; Puig, L; Papp, K; Spelman, L; Toth, D; Kerdel, F; Armstrong, AW; Stingl, G; Kimball, AB; Bachelez, H; Wu, JJ; Crowley, J; Langley, RG; Blicharski, T; Paul, C; Lacour, JP; Tyring, S; Kircik, L; Chimenti, S; Duffin, KC; Bagel, J; Koo, J; Aras, G; Li, J; Song, W; Milmont, CE; Shi, Y; Erondu, N; Klekotka, P; Kotzin, B; Nirula, A				Lebwohl, M.; Strober, B.; Menter, A.; Gordon, K.; Weglowska, J.; Puig, L.; Papp, K.; Spelman, L.; Toth, D.; Kerdel, F.; Armstrong, A. W.; Stingl, G.; Kimball, A. B.; Bachelez, H.; Wu, J. J.; Crowley, J.; Langley, R. G.; Blicharski, T.; Paul, C.; Lacour, J. -P.; Tyring, S.; Kircik, L.; Chimenti, S.; Duffin, K. C.; Bagel, J.; Koo, J.; Aras, G.; Li, J.; Song, W.; Milmont, C. E.; Shi, Y.; Erondu, N.; Klekotka, P.; Kotzin, B.; Nirula, A.			Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; QUALITY-OF-LIFE; CLINICAL-RESPONSE; PLAQUE PSORIASIS; MODERATE; SKIN; INTERLEUKIN-17; ANTIBODY; CELLS; CANDIDIASIS	BACKGROUND Early clinical studies suggested that the anti-interleukin-17 receptor A monoclonal antibody brodalumab has efficacy in the treatment of psoriasis. METHODS In two phase 3 studies (AMAGINE-2 and AMAGINE-3), patients with moderate-to-severe psoriasis were randomly assigned to receive brodalumab (210 mg or 140 mg every 2 weeks), ustekinumab (45 mg for patients with a body weight <= 100 kg and 90 mg for patients >100 kg), or placebo. At week 12, patients receiving brodalumab were randomly assigned again to receive a brodalumab maintenance dose of 210 mg every 2 weeks or 140 mg every 2 weeks, every 4 weeks, or every 8 weeks; patients receiving ustekinumab continued to receive ustekinumab every 12 weeks, and patients receiving placebo received 210 mg of brodalumab every 2 weeks. The primary aims were to evaluate the superiority of brodalumab over placebo at week 12 with respect to at least a 75% reduction in the psoriasis area-and-severity index score (PASI 75) and a static physician's global assessment (sPGA) score of 0 or 1 (clear or almost clear skin), as well as the superiority of brodalumab over ustekinumab at week 12 with respect to a 100% reduction in PASI score (PASI 100). RESULTS At week 12, the PASI 75 response rates were higher with brodalumab at the 210-mg and 140-mg doses than with placebo (86% and 67%, respectively, vs. 8% [AMAGINE-2] and 85% and 69%, respectively, vs. 6% [AMAGINE-3]; P<0.001); the rates of sPGA scores of 0 or 1 were also higher with brodalumab (P<0.001). The week 12 PASI 100 response rates were significantly higher with 210 mg of brodalumab than with ustekinumab (44% vs. 22% [AMAGINE-2] and 37% vs. 19% [AMAGINE-3], P<0.001). The PASI 100 response rates with 140 mg of brodalumab were 26% in AMAGINE-2 (P = 0.08 for the comparison with ustekinumab) and 27% in AMAGINE-3 (P = 0.007). Rates of neutropenia were higher with brodalumab and with ustekinumab than with placebo. Mild or moderate candida infections were more frequent with brodalumab than with ustekinumab or placebo. Through week 52, the rates of serious infectious episodes were 1.0 (AMAGINE-2) and 1.3 (AMAGINE-3) per 100 patient-years of exposure to brodalumab. CONCLUSIONS Brodalumab treatment resulted in significant clinical improvements in patients with moderate-to-severe psoriasis.	[Lebwohl, M.; Kircik, L.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Strober, B.] Univ Connecticut, Sch Med, Farmington, CT USA; [Strober, B.; Spelman, L.; Toth, D.] Prob Med Res, Windsor, ON, Canada; [Toth, D.] XLR8 Med Res, Windsor, ON, Canada; [Papp, K.] K Papp Med Res, Waterloo, ON, Canada; [Langley, R. G.] Dalhousie Univ, Halifax, NS, Canada; [Menter, A.] Baylor Univ, Med Ctr, Dallas, TX USA; [Gordon, K.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Weglowska, J.] Niepubl Zaklad Opieki Zdrowotnej MultiMed, Wroclaw, Poland; [Blicharski, T.] Lubelskie Ctr Diagnost, Swidnik, Poland; [Puig, L.] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Spelman, L.] Verac Clin Res, Woolloongabba, Qld, Australia; [Kerdel, F.] Florida Acad Dermatol Ctr, Miami, FL USA; [Armstrong, A. W.] Univ Colorado, Denver, CO 80202 USA; [Stingl, G.] Med Univ Wien, Vienna, Austria; [Kimball, A. B.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Kimball, A. B.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Bachelez, H.] Univ Paris Diderot, Sorbonne Paris Cite, AP HP, Hop St Louis, Paris, France; [Paul, C.] Univ Toulouse 3, F-31062 Toulouse, France; [Lacour, J. -P.] Univ Hosp Nice, Nice, France; [Wu, J. J.] Kaiser Permanente Los Angeles Med Ctr, Los Angeles, CA USA; [Crowley, J.] Bakersfield Dermatol & Skin Canc Med Grp, Bakersfield, CA USA; [Koo, J.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Aras, G.; Li, J.; Song, W.; Milmont, C. E.; Shi, Y.; Erondu, N.; Klekotka, P.; Kotzin, B.; Nirula, A.] Amgen Inc, Thousand Oaks, CA USA; [Tyring, S.] Univ Texas Houston, Hlth Sci Ctr, Houston, TX USA; [Kircik, L.] DermResearch, Louisville, KY USA; [Chimenti, S.] Univ Roma Tor Vergata, Rome, Italy; [Duffin, K. C.] Univ Utah, Med Ctr, Salt Lake City, UT USA; [Bagel, J.] Psoriasis Treatment Ctr Cent New Jersey, East Windsor, NJ USA	Icahn School of Medicine at Mount Sinai; University of Connecticut; Dalhousie University; Baylor University; Baylor University Medical Center; Northwestern University; Feinberg School of Medicine; Hospital of Santa Creu i Sant Pau; University of Colorado System; University of Colorado Denver; Medical University of Vienna; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU Nice; Kaiser Permanente; University of California System; University of California San Francisco; Amgen; University of Texas System; University of Texas Health Science Center Houston; University of Rome Tor Vergata; Utah System of Higher Education; University of Utah	Lebwohl, M (corresponding author), Icahn Med Inst, 2nd Fl,1425 Madison Ave, New York, NY 10029 USA.	mark.lebwohl@mountsinai.org	Strober, Bruce/AAQ-6953-2020; Kimball, Alexandra B./M-6347-2019	Strober, Bruce/0000-0002-8394-2057; Kimball, Alexandra B./0000-0001-9405-0479; Wu, Jashin/0000-0002-1722-1892; Papp, Kim A./0000-0001-9557-3642; Blicharski, Tomasz/0000-0001-9747-8817; Lacour, Jean-Philippe/0000-0001-7663-2053; bachelez, herve/0000-0003-3567-9095; Paul, Carle/0000-0003-0165-5263	Amgen	Amgen(Amgen)	Funded by Amgen; AMAGINE-2 and AMAGINE-3 ClinicalTrials.gov numbers, NCT01708603 and NCT01708629.	Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Department of Health and Human Services National Institutes of Health National Cancer Institute, 2010, COMM TERM CRIT ADV E; Elder JT, 2009, GENES IMMUN, V10, P201, DOI 10.1038/gene.2009.11; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Goff KL, 2015, BRIT J DERMATOL, V172, P1665, DOI 10.1111/bjd.13715; Gupta R, 2014, CURR DERMATOL REP, V3, P61, DOI 10.1007/s13671-013-0066-6; Hsu S, 2012, ARCH DERMATOL, V148, P95, DOI 10.1001/archdermatol.2011.1410; Johnston A, 2013, J IMMUNOL, V190, P2252, DOI 10.4049/jimmunol.1201505; Lebwohl MG, 2014, J AM ACAD DERMATOL, V70, P871, DOI 10.1016/j.jaad.2013.12.018; Li Jiawen, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P294; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Maintenance and Support Services Organization, 2014, MED DICT REG ACT VER; Mrowietz U, 2011, ARCH DERMATOL RES, V303, P1, DOI 10.1007/s00403-010-1080-1; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Papp KA, 2012, J INVEST DERMATOL, V132, P2466, DOI 10.1038/jid.2012.163; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Revicki DA, 2008, DERMATOLOGY, V216, P260, DOI 10.1159/000113150; Revicki DA, 2014, J DERMATOL TREAT, V25, P8, DOI 10.3109/09546634.2013.769042; Russell CB, 2014, J IMMUNOL, V192, P3828, DOI 10.4049/jimmunol.1301737; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Viswanathan HN, 2015, J DERMATOL TREAT, V26, P235, DOI 10.3109/09546634.2014.943687; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	24	533	555	2	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2015	373	14					1318	1328		10.1056/NEJMoa1503824	http://dx.doi.org/10.1056/NEJMoa1503824			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3CI	26422722	Bronze			2022-12-28	WOS:000361948600006
J	Tai, V; Leung, W; Grey, A; Reid, IR; Bolland, MJ				Tai, Vicky; Leung, William; Grey, Andrew; Reid, Ian R.; Bolland, Mark J.			Calcium intake and bone mineral density: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							VITAMIN-D SUPPLEMENTATION; RANDOMIZED CONTROLLED-TRIAL; POSTMENOPAUSAL CHINESE WOMEN; HEATED OYSTER SHELL; ELDERLY-WOMEN; DOUBLE-BLIND; MILK SUPPLEMENTATION; PARATHYROID-HORMONE; WEIGHT-REDUCTION; HIP FRACTURE	OBJECTIVE To determine whether increasing calcium intake from dietary sources affects bone mineral density (BMD) and, if so, whether the effects are similar to those of calcium supplements. DESIGN Random effects meta-analysis of randomised controlled trials. Data sources Ovid Medline, Embase, Pubmed, and references from relevant systematic reviews. Initial searches were undertaken in July 2013 and updated in September 2014. Eligibility criteria for selecting studies Randomised controlled trials of dietary sources of calcium or calcium supplements (with or without vitamin D) in participants aged over 50 with BMD at the lumbar spine, total hip, femoral neck, total body, or forearm as an outcome. RESULTS We identified 59 eligible randomised controlled trials: 15 studied dietary sources of calcium (n=1533) and 51 studied calcium supplements (n=12 257). Increasing calcium intake from dietary sources increased BMD by 0.6-1.0% at the total hip and total body at one year and by 0.7-1.8% at these sites and the lumbar spine and femoral neck at two years. There was no effect on BMD in the forearm. Calcium supplements increased BMD by 0.7-1.8% at all five skeletal sites at one, two, and over two and a half years, but the size of the increase in BMD at later time points was similar to the increase at one year. Increases in BMD were similar in trials of dietary sources of calcium and calcium supplements (except at the forearm), in trials of calcium monotherapy versus co-administered calcium and vitamin D, in trials with calcium doses of >= 1000 versus < 1000 mg/day and <= 500 versus >500 mg/day, and in trials where the baseline dietary calcium intake was < 800 versus >= 800 mg/day. CONCLUSIONS Increasing calcium intake from dietary sources or by taking calcium supplements produces small nonprogressive increases in BMD, which are unlikely to lead to a clinically significant reduction in risk of fracture.	[Tai, Vicky; Grey, Andrew; Reid, Ian R.; Bolland, Mark J.] Univ Auckland, Dept Med, Auckland 1142, New Zealand; [Leung, William] Univ Otago, Dept Publ Hlth, Wellington 6242, New Zealand	University of Auckland; University of Otago	Bolland, MJ (corresponding author), Univ Auckland, Dept Med, Private Bag 92019, Auckland 1142, New Zealand.	m.bolland@auckland.ac.nz	Bolland, Mark J/A-7554-2008	Bolland, Mark J/0000-0003-0465-2674; Reid, Ian/0000-0001-6021-5458	Health Research Council (HRC) of New Zealand	Health Research Council (HRC) of New Zealand(Health Research Council of New Zealand)	This study was funded by the Health Research Council (HRC) of New Zealand. The authors are independent of the HRC. The HRC had no role in study design, the collection, analysis, and interpretation of data, the writing of the article, or the decision to submit it for publication.	Albertazzi P, 2004, CLIMACTERIC, V7, P33, DOI 10.1080/13697130310001651454; ALOIA JF, 1994, ANN INTERN MED, V120, P97, DOI 10.7326/0003-4819-120-2-199401150-00001; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Baeksgaard L, 1998, OSTEOPOROSIS INT, V8, P255, DOI 10.1007/s001980050062; Bauer DC, 2013, NEW ENGL J MED, V369, P1537, DOI 10.1056/NEJMcp1210380; BERNSTEIN MJ, 1984, JAMA-J AM MED ASSOC, V252, P799; BLACK DM, 2007, NEW ENGL J MED, V356, P1809, DOI [DOI 10.1056/NEJMOA067312, 10.1056/NEJMoa067312]; Bolland MJ, 2008, BMJ-BRIT MED J, V336, P262, DOI 10.1136/bmj.39440.525752.BE; Bolland MJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4580; Bolland Mark J, 2011, BMJ, V342, pd2040, DOI 10.1136/bmj.d2040; Bolland MJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3691; Bolton-Smith C, 2007, J BONE MINER RES, V22, P509, DOI [10.1359/jbmr.070116, 10.1359/JBMR.070116]; Bonjour JP, 2008, BRIT J NUTR, V100, P866, DOI 10.1017/S0007114508937429; Bonnick S, 2007, CURR MED RES OPIN, V23, P1341, DOI 10.1185/030079907X188035; Bristow SM, 2014, BRIT J NUTR, V112, P1611, DOI 10.1017/S0007114514002785; Castelo-Branco C, 1999, J REPROD MED, V44, P601; Chailurkit LO, 2010, CLIN ENDOCRINOL, V73, P167, DOI 10.1111/j.1365-2265.2010.03779.x; Chapuy MC, 2002, OSTEOPOROSIS INT, V13, P257, DOI 10.1007/s001980200023; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Chee WSS, 2003, OSTEOPOROSIS INT, V14, P828, DOI 10.1007/s00198-003-1448-6; CHEVALLEY T, 1994, OSTEOPOROSIS INT, V4, P245, DOI 10.1007/BF01623348; Cleghorn DB, 2001, MED J AUSTRALIA, V175, P242, DOI 10.5694/j.1326-5377.2001.tb143554.x; Cranney A, 2002, ENDOCR REV, V23, P524, DOI 10.1210/er.2001-4002; Cranney A, 2001, OSTEOPOROSIS INT, V12, P140, DOI 10.1007/s001980170147; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Daly RM, 2006, J BONE MINER RES, V21, P397, DOI 10.1359/JBMR.051206; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; DAWSONHUGHES B, 1990, NEW ENGL J MED, V323, P878, DOI 10.1056/NEJM199009273231305; Doetsch AM, 2004, CALCIFIED TISSUE INT, V75, P183, DOI 10.1007/s00223-004-0167-0; ELDERS PJM, 1991, J CLIN ENDOCR METAB, V73, P533, DOI 10.1210/jcem-73-3-533; Freemantle N, 2013, OSTEOPOROSIS INT, V24, P209, DOI 10.1007/s00198-012-2068-9; FUJITA T, 1990, BONE MINER, V11, P85, DOI 10.1016/0169-6009(90)90017-A; Fujita T, 1996, CALCIFIED TISSUE INT, V58, P226; Fujita T, 2000, J BONE MINER METAB, V18, P212, DOI 10.1007/s007740070022; Grados F, 2003, JOINT BONE SPINE, V70, P203, DOI 10.1016/S1297-319X(03)00046-0; Grey A, 2012, J CLIN ENDOCR METAB, V97, P286, DOI 10.1210/jc.2011-2081; Grey A, 2009, J CLIN ENDOCR METAB, V94, P538, DOI 10.1210/jc.2008-2241; Gui JC, 2012, OSTEOPOROSIS INT, V23, P1563, DOI 10.1007/s00198-012-1895-z; HANSSON T, 1987, CALCIFIED TISSUE INT, V40, P315, DOI 10.1007/BF02556692; Harwood RH, 2004, AGE AGEING, V33, P45, DOI 10.1093/ageing/afh002; Hitz MF, 2007, AM J CLIN NUTR, V86, P251, DOI 10.1093/ajcn/86.1.251; Hosking D, 1998, NEW ENGL J MED, V338, P485, DOI 10.1056/NEJM199802193380801; IOM (Institute of Medicine), 2011, DIETARY REFERENCE IN, DOI [10.17226/13050, DOI 10.17226/13050]; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Karkkainen MK, 2010, MATURITAS, V65, P359, DOI 10.1016/j.maturitas.2009.12.018; Kukuljan S, 2009, OSTEOPOROSIS INT, V20, P1241, DOI 10.1007/s00198-008-0776-y; LAMKE B, 1978, ACTA ORTHOP SCAND, V49, P143, DOI 10.3109/17453677809005740; LAU EMC, 1992, OSTEOPOROSIS INT, V2, P168, DOI 10.1007/BF01623922; Lau EMC, 2001, J BONE MINER RES, V16, P1704, DOI 10.1359/jbmr.2001.16.9.1704; Lewis JR, 2012, J BONE MINER RES, V27, P719, DOI 10.1002/jbmr.1484; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Manios Y, 2007, AM J CLIN NUTR, V86, P781, DOI 10.1093/ajcn/86.3.781; McCloskey EV, 2007, J BONE MINER RES, V22, P135, DOI 10.1359/JBMR.061008; Meier C, 2004, J BONE MINER RES, V19, P1221, DOI 10.1359/JBMR.040511; Nakamura K, 2012, J BONE MINER RES, V27, P2264, DOI 10.1002/jbmr.1676; NELSON ME, 1991, AM J CLIN NUTR, V53, P1304, DOI 10.1093/ajcn/53.5.1304; ORWOLL ES, 1990, ANN INTERN MED, V112, P29, DOI 10.7326/0003-4819-112-1-29; Peacock M, 2000, J CLIN ENDOCR METAB, V85, P3011, DOI 10.1210/jc.85.9.3011; PerezJaraiz MD, 1996, MATURITAS, V23, P327, DOI 10.1016/0378-5122(96)00999-1; POLLEY KJ, 1987, J NUTR, V117, P1929, DOI 10.1093/jn/117.11.1929; PRINCE R, 1995, J BONE MINER RES, V10, P1068, DOI 10.1002/jbmr.5650100711; Prince RL, 2006, ARCH INTERN MED, V166, P869, DOI 10.1001/archinte.166.8.869; PRINCE RL, 1991, NEW ENGL J MED, V325, P1189, DOI 10.1056/NEJM199110243251701; Rajatanavin R, 2013, OSTEOPOROSIS INT, V24, P2871, DOI 10.1007/s00198-013-2387-5; Recker RR, 1996, J BONE MINER RES, V11, P1961; RECKER RR, 1985, AM J CLIN NUTR, V41, P254, DOI 10.1093/ajcn/41.2.254; RECKER RR, 1977, ANN INTERN MED, V87, P649, DOI 10.7326/0003-4819-87-6-649; Reid IR, 2008, ARCH INTERN MED, V168, P2276, DOI 10.1001/archinte.168.20.2276; Reid IR, 2006, AM J MED, V119, P777, DOI 10.1016/j.amjmed.2006.02.038; Reid IR, 2014, LANCET, V383, P146, DOI 10.1016/S0140-6736(13)61647-5; REID IR, 1993, NEW ENGL J MED, V328, P460, DOI 10.1056/NEJM199302183280702; Ricci TA, 1998, J BONE MINER RES, V13, P1045, DOI 10.1359/jbmr.1998.13.6.1045; Riedt CS, 2005, J BONE MINER RES, V20, P455, DOI 10.1359/JBMR.041132; Riggs BL, 1998, J BONE MINER RES, V13, P168, DOI 10.1359/jbmr.1998.13.2.168; RIIS B, 1987, NEW ENGL J MED, V316, P173, DOI 10.1056/NEJM198701223160401; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Ruml L A, 1999, Am J Ther, V6, P303, DOI 10.1097/00045391-199911000-00004; Shea B, 2002, ENDOCR REV, V23, P552, DOI 10.1210/er.2001-7002; SMITH EL, 1981, MED SCI SPORT EXER, V13, P60; SMITH EL, 1989, AM J CLIN NUTR, V50, P833, DOI 10.1093/ajcn/50.4.833; Son SM, 2001, NUTR RES, V21, P1347, DOI 10.1016/S0271-5317(01)00317-7; Storm D, 1998, J CLIN ENDOCR METAB, V83, P3817, DOI 10.1210/jc.83.11.3817; STRAUSE L, 1994, J NUTR, V124, P1060, DOI 10.1093/jn/124.7.1060; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Zhu K, 2008, J CLIN ENDOCR METAB, V93, P743, DOI 10.1210/jc.2007-1466	88	200	214	3	50	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 29	2015	351								h4183	10.1136/bmj.h4183	http://dx.doi.org/10.1136/bmj.h4183			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS9YU	26420598	Green Published, hybrid			2022-12-28	WOS:000362450900001
J	Snyder, A				Snyder, Alison			James Jude Obituary	LANCET			English	Biographical-Item												amsnyder@alum.mit.edu							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 26	2015	386	10000					1236	1236		10.1016/S0140-6736(15)00272-X	http://dx.doi.org/10.1016/S0140-6736(15)00272-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9TQ	26460652				2022-12-28	WOS:000361700100020
J	Jolly, SS; Caims, JA; Yusuf, S; Rokoss, MJ; Gao, P; Meeks, B; Kedev, S; Stankovic, G; Moreno, R; Gershlick, A; Chowdhary, S; Lavi, S; Niemela, K; Bernat, I; Cantor, WJ; Cheema, AN; Steg, PG; Welsh, RC; Sheth, T; Bertrand, OF; Avezum, A; Bhindi, R; Natarajan, MK; Horak, D; Leung, RCM; Kassam, S; Rao, SV; El-Omar, M; Mehta, SR; Velianou, JL; Pancholy, S; Dzavik, V				Jolly, Sanjit S.; Caims, John A.; Yusuf, Salim; Rokoss, Michael J.; Gao, Peggy; Meeks, Brandi; Kedev, Sasko; Stankovic, Goran; Moreno, Raul; Gershlick, Anthony; Chowdhary, Saqib; Lavi, Shahar; Niemela, Kari; Bernat, Ivo; Cantor, Warren J.; Cheema, Asim N.; Steg, Philippe Gabriel; Welsh, Robert C.; Sheth, Tej; Bertrand, Olivier F.; Avezum, Alvaro; Bhindi, Ravinay; Natarajan, Madhu K.; Horak, David; Leung, Raymond C. M.; Kassam, Saleem; Rao, Sunil V.; El-Omar, Magdi; Mehta, Shamir R.; Velianou, James L.; Pancholy, Samir; Dzavik, Vladimr		TOTAL Investigators	Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial	LANCET			English	Article							PERCUTANEOUS CORONARY INTERVENTION; PRIMARY ANGIOPLASTY; INITIAL THROMBOSUCTION; ROUTINE THROMBECTOMY; DISTAL EMBOLIZATION; PRIMARY PCI; IMPACT; REPERFUSION; BENEFIT	Background Two large trials have reported contradictory results at 1 year after thrombus aspiration in ST elevation myocardial infarction (STEMI). In a 1-year follow-up of the largest randomised trial of thrombus aspiration, we aimed to clarify the longer-term benefits, to help guide clinical practice. Methods The trial of routine aspiration ThrOmbecTomy with PCI versus PCI ALone in Patients with STEMI (TOTAL) was a prospective, randomised, investigator-initiated trial of routine manual thrombectomy versus percutaneous coronary intervention (PCI) alone in 10 732 patients with STEMI. Eligible adult patients (aged >= 18 years) from 87 hospitals in 20 countries were enrolled and randomly assigned (1: 1) within 12 h of symptom onset to receive routine manual thrombectomy with PCI or PCI alone. Permuted block randomisation (with variable block size) was done by a 24 h computerised central system, and was stratified by centre. Participants and investigators were not masked to treatment assignment. The trial did not show a difference at 180 days in the primary outcome of cardiovascular death, myocardial infarction, cardiogenic shock, or heart failure. However, the results showed improvements in the surrogate outcomes of ST segment resolution and distal embolisation, but whether or not this finding would translate into a longer term benefit remained unclear. In this longer-term follow-up of the TOTAL study, we report the results on the primary outcome (cardiovascular death, myocardial infarction, cardiogenic shock, or heart failure) and secondary outcomes at 1 year. Analyses of the primary outcome were by modified intention to treat and only included patients who underwent index PCI. This trial is registered with ClinicalTrials.gov, number NCT01149044. Findings Between Aug 5, 2010, and July 25, 2014, 10 732 eligible patients were enrolled and randomly assigned to thrombectomy followed by PCI (n=5372) or to PCI alone (n=5360). After exclusions of patients who did not undergo PCI in each group (337 in the PCI and thrombectomy group and 331 in the PCI alone group), the final study population comprised 10 064 patients (5035 thrombectomy and 5029 PCI alone). The primary outcome at 1 year occurred in 395 (8%) of 5035 patients in the thrombectomy group compared with 394 (8%) of 5029 in the PCI alone group (hazard ratio [HR] 1.00 [95% CI 0.87-1.15], p=0.99). Cardiovascular death within 1 year occurred in 179 (4%) of the thrombectomy group and in 192 (4%) of 5029 in the PCI alone group (HR 0.93 [95% CI 0.76-1.14], p=0.48). The key safety outcome, stroke within 1 year, occurred in 60 patients (1.2%) in the thrombectomy group compared with 36 (0.7%) in the PCI alone group (HR 1.66 [95% CI 1.10-2.51], p=0.015). Interpretation Routine thrombus aspiration during PCI for STEMI did not reduce longer-term clinical outcomes and might be associated with an increase in stroke. As a result, thrombus aspiration can no longer be recommended as a routine strategy in STEMI.	[Jolly, Sanjit S.; Yusuf, Salim; Rokoss, Michael J.; Gao, Peggy; Meeks, Brandi; Sheth, Tej; Natarajan, Madhu K.; Mehta, Shamir R.; Velianou, James L.] McMaster Univ, Hamilton, ON, Canada; [Jolly, Sanjit S.; Yusuf, Salim; Rokoss, Michael J.; Gao, Peggy; Meeks, Brandi; Sheth, Tej; Natarajan, Madhu K.; Mehta, Shamir R.; Velianou, James L.] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Caims, John A.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Lavi, Shahar] London Hlth Sci Ctr, Dept Med, London, ON, Canada; [Cantor, Warren J.] Southlake Reg Hlth Ctr, Newmarket, ON, Canada; [Cheema, Asim N.] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Welsh, Robert C.] Mazankowski Alberta Heart Inst, Dept Med, Edmonton, AB, Canada; [Bertrand, Olivier F.] Univ Laval, Quebec Heart Lung Inst, Quebec City, PQ, Canada; [Leung, Raymond C. M.] CK Hui Heart Ctr, Edmonton, AB, Canada; [Kassam, Saleem] Rouge Valley Hlth Syst, Toronto, ON, Canada; [Dzavik, Vladimr] Univ Hlth Network, Peter Munk Cardiac Ctr, Toronto, ON, Canada; [Kedev, Sasko] Sts Cyril & Methodius Univ, Univ Clin Cardiol, Skopje, Macedonia; [Stankovic, Goran] Univ Belgrade, Clin Ctr Serbia, Belgrade, Serbia; [Stankovic, Goran] Univ Belgrade, Dept Cardiol, Fac Med, Belgrade, Serbia; [Moreno, Raul] Univ Hosp La Paz, Madrid, Spain; [Gershlick, Anthony] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Gershlick, Anthony] Glenfield Hosp, Univ Hosp Leicester NHS Trust, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Chowdhary, Saqib] Univ S Manchester Hosp, Manchester Acad Hlth Sci Ctr, Manchester M20 8LR, Lancs, England; [El-Omar, Magdi] Cent Manchester Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Niemela, Kari] Tampere Univ Hosp, Ctr Heart, Tampere, Finland; [Bernat, Ivo] Univ Hosp & Fac Med Pilsen, Plzen, Czech Republic; [Horak, David] Krajska Nemocnice Liberec, Liberec, Czech Republic; [Steg, Philippe Gabriel] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, U1148,Hop Bichat,AP HP, Paris, France; [Avezum, Alvaro] Univ Santo Amaro, Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Bhindi, Ravinay] Royal N Shore Hosp, Sydney, NSW, Australia; [Rao, Sunil V.] Duke Clin Res Inst, Durham, NC USA; [Pancholy, Samir] Northeast Clin Trials Grp, Scranton, PA USA	McMaster University; McMaster University; Population Health Research Institute; University of British Columbia; London Health Sciences Centre; Southlake Regional Health Centre; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Laval University; Quebec Heart & Lung Institute; University of Toronto; Peter Munk Cardiac Centre; University Toronto Affiliates; University Health Network Toronto; Saints Cyril & Methodius University of Skopje; Clinical Centre of Serbia; University of Belgrade; University of Belgrade; Hospital Universitario La Paz; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; Tampere University; Tampere University Hospital; Charles University Prague; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Instituto Dante Pazzanese de Cardiologia; Universidade de Santo Amaro (UNISA); Royal North Shore Hospital; University of Sydney; Duke University	Jolly, SS (corresponding author), Hamilton Gen Hosp, Rm C3 118,CVSRI Bldg,237 Barton St East, Hamilton, ON L8L 2X2, Canada.	sanjit.jolly@phri.ca	Avezum, Alvaro/AAP-7687-2020; Stankovic, Goran/Q-8507-2019; Avezum, Alvaro AA/K-6137-2016; Lavi, Shahar/G-3317-2011; Moreno, Raul/AAB-9983-2021; Welsh, Robert/ABH-3526-2021; Kedev, Sasko/ABB-2637-2021; STEG, Philippe Gabriel/Z-1567-2019; Cheema, Asim N./AAA-7676-2020; Bernat, Ivo/U-1655-2017	Stankovic, Goran/0000-0002-9414-0885; Avezum, Alvaro AA/0000-0002-3073-6890; Lavi, Shahar/0000-0002-6105-8084; Kedev, Sasko/0000-0003-4844-6434; Cheema, Asim N./0000-0002-3174-8957; Bernat, Ivo/0000-0003-3142-7667; Yusuf, Salim/0000-0003-4776-5601; STEG, Philippe Gabriel/0000-0001-6896-2941; Welsh, Robert/0000-0003-2613-9142; Moreno, Raul/0000-0001-7179-1426	Canadian Institutes of Health Research; Canadian Network and Centre for Trials Internationally; Medtronic Inc.; Medtronic; Canadian Institutes of Health Research (CIHR); Canadian Network and Centre for Trials Internationally - CIHR	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Network and Centre for Trials Internationally; Medtronic Inc.(Medtronic); Medtronic(Medtronic); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Network and Centre for Trials Internationally - CIHR	Canadian Institutes of Health Research, Canadian Network and Centre for Trials Internationally, and Medtronic Inc.; Funding was provided by Medtronic, the Canadian Institutes of Health Research (CIHR), and the Canadian Network and Centre for Trials Internationally, an initiative funded by CIHR. We thank Ashraf Alazzoni and Aiman Alak for doing the systematic review for the research in context panel.	Bhindi R, 2015, EUR HEART J, V36, P1892, DOI 10.1093/eurheartj/ehv176; Buller CE, 2008, CIRCULATION, V118, P1335, DOI 10.1161/CIRCULATIONAHA.108.767772; Bulum J, 2012, CORONARY ARTERY DIS, V23, P487, DOI 10.1097/MCA.0b013e3283587866; Burzotta F, 2005, J AM COLL CARDIOL, V46, P371, DOI 10.1016/j.jacc.2005.04.057; Chao CL, 2008, INT J CLIN PRACT, V62, P555, DOI 10.1111/j.1742-1241.2007.01542.x; Ciszewski M, 2011, CATHETER CARDIO INTE, V78, P523, DOI 10.1002/ccd.22933; De Carlo M, 2012, JACC-CARDIOVASC INTE, V5, P1223, DOI 10.1016/j.jcin.2012.08.013; De Luca L, 2006, HEART, V92, P951, DOI 10.1136/hrt.2005.074716; Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789; Henriques JPS, 2002, EUR HEART J, V23, P1112, DOI 10.1053/euhj.2001.3035; Ikari Y, 2008, JACC-CARDIOVASC INTE, V1, P424, DOI 10.1016/j.jcin.2008.06.004; Jolly SS, 2015, NEW ENGL J MED, V372, P1389, DOI 10.1056/NEJMoa1415098; Jolly SS, 2015, EUR HEART J, V36, P2364, DOI 10.1093/eurheartj/ehv296; Jolly SS, 2014, AM HEART J, V167, P315, DOI 10.1016/j.ahj.2013.12.002; Kaltoft A, 2006, CIRCULATION, V114, P40, DOI 10.1161/CIRCULATIONAHA.105.595660; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Lagerqvist B, 2014, NEW ENGL J MED, V371, P1111, DOI 10.1056/NEJMoa1405707; Liu CP, 2012, INT J CARDIOL, V156, P174, DOI 10.1016/j.ijcard.2010.10.129; Onuma Y, 2013, EUR HEART J, V34, P1050, DOI 10.1093/eurheartj/ehs456; Overgaard CB, 2015, EUROINTERVENTION, V2015; Sardella G, 2010, AM J CARDIOL, V106, P624, DOI 10.1016/j.amjcard.2010.04.014; Silva-Orrego P, 2006, J AM COLL CARDIOL, V48, P1552, DOI 10.1016/j.jacc.2006.03.068; Stone GW, 2013, CIRC-CARDIOVASC INTE, V6, P527, DOI 10.1161/CIRCINTERVENTIONS.113.000644; Stone GW, 2012, JAMA-J AM MED ASSOC, V307, P1817, DOI 10.1001/jama.2012.421; Stone GW, 2002, J AM COLL CARDIOL, V39, P591, DOI 10.1016/S0735-1097(01)01779-X; Svilaas T, 2008, NEW ENGL J MED, V358, P557, DOI 10.1056/NEJMoa0706416; Vlaar PJ, 2008, LANCET, V371, P1915, DOI 10.1016/S0140-6736(08)60833-8	27	128	138	2	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2016	387	10014					127	135		10.1016/S0140-6736(15)00448-1	http://dx.doi.org/10.1016/S0140-6736(15)00448-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8LF	26474811	Green Submitted, Green Accepted			2022-12-28	WOS:000368055500029
J	Haug, CJ				Haug, Charlotte J.			Peer-Review Fraud - Hacking the Scientific Publication Process	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material														Haug, Charlotte Johanne/0000-0001-8217-7376				[Anonymous], 2015, HINDAWI CONCLUDES IN; [Anonymous], 2015, RETRACTION ARTICLES; Ferguson C, 2014, NATURE, V515, P480, DOI 10.1038/515480a; McCook A., RETRACTION WATCH	4	97	101	1	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2015	373	25					2393	2395		10.1056/NEJMp1512330	http://dx.doi.org/10.1056/NEJMp1512330			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CY5QD	26488392				2022-12-28	WOS:000366461400003
J	Lachs, MS; Han, SD				Lachs, Mark S.; Han, S. Duke			Age-Associated Financial Vulnerability: An Emerging Public Health Issue	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OLDER-ADULTS; EXPLOITATION; PREVALENCE; ABUSE		[Lachs, Mark S.] Cornell Univ, Weill Cornell Med Coll, Div Geriatr & Palliat Med, New York, NY 10065 USA; [Han, S. Duke] Rush Univ, Med Ctr, Alzheimers Dis Ctr, Chicago, IL 60612 USA; Vet Affairs Long Beach Healthcare Syst, Mental Hlth Care Grp, Long Beach, CA USA	Cornell University; Rush University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System	Lachs, MS (corresponding author), Cornell Univ, Weill Cornell Med Coll, Div Geriatr & Palliat Med, 1300 York Ave, New York, NY 10065 USA.	mslachs@med.cornell.edu	Han/N-1246-2019		NIA NIH HHS [K24 AG022399, K24AG022399, K23AG040625, K23 AG040625] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K24AG022399, K23AG040625] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alexopoulos GS, 2003, J CLIN PSYCHIAT, V64, P18; Conrad KJ, 2010, GERONTOLOGIST, V50, P758, DOI 10.1093/geront/gnq054; Dong XQ, 2011, JAMA-J AM MED ASSOC, V305, P2460, DOI 10.1001/jama.2011.835; Federal Bureau of Investigation, 2015, HLTH CAR FRAUD; Hafemeister TL, 2011, 233613 US DEP JUST; Investor Protection Trust, 2015, ELD INV FRAUD FIN EX; Kemp BJ, 2005, J AM GERIATR SOC, V53, P1123, DOI 10.1111/j.1532-5415.2005.53353.x; Marson DC, 2000, ARCH NEUROL-CHICAGO, V57, P877, DOI 10.1001/archneur.57.6.877; Peterson JC, 2014, J GEN INTERN MED, V29, P1615, DOI 10.1007/s11606-014-2946-2; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998	10	32	32	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	2015	163	11					877	+		10.7326/M15-0882	http://dx.doi.org/10.7326/M15-0882			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX7FB	26458261	Green Accepted			2022-12-28	WOS:000365866500014
J	Wang, JY; Li, JZ; Zhao, HT; Sheng, G; Wang, M; Yin, ML; Wang, YL				Wang, Jiuyu; Li, Jiazhi; Zhao, Hongtu; Sheng, Gang; Wang, Min; Yin, Maolu; Wang, Yanli			Structural and Mechanistic Basis of PAM-Dependent Spacer Acquisition in CRISPR-Cas Systems	CELL			English	Article							SHORT PALINDROMIC REPEATS; ESCHERICHIA-COLI; ADAPTIVE IMMUNITY; STREPTOCOCCUS-THERMOPHILUS; DNA; PROTEIN; ADAPTATION; PROKARYOTES; DEFENSE; ENDONUCLEASE	Bacteria acquire memory of viral invaders by incorporating invasive DNA sequence elements into the host CRISPR locus, generating a new spacer within the CRISPR array. We report on the structures of Cas1-Cas2-dual-forked DNA complexes in an effort toward understanding how the protospacer is sampled prior to insertion into the CRISPR locus. Our study reveals a protospacer DNA comprising a 23-bp duplex bracketed by tyrosine residues, together with anchored flanking 30 overhang segments. The PAM-complementary sequence in the 30 overhang is recognized by the Cas1a catalytic subunits in a base-specific manner, and subsequent cleavage at positions 5 nt from the duplex boundary generates a 33-nt DNA intermediate that is incorporated into the CRISPR array via a cut-and-paste mechanism. Upon protospacer binding, Cas1-Cas2 undergoes a significant conformational change, generating a flat surface conducive to proper protospacer recognition. Here, our study provides important structure-based mechanistic insights into PAM-dependent spacer acquisition.	[Wang, Jiuyu; Li, Jiazhi; Zhao, Hongtu; Sheng, Gang; Wang, Min; Yin, Maolu; Wang, Yanli] Chinese Acad Sci, Inst Biophys, Key Lab RNA Biol, Beijing 100101, Peoples R China; [Wang, Jiuyu; Li, Jiazhi; Zhao, Hongtu; Sheng, Gang; Wang, Min; Yin, Maolu; Wang, Yanli] Chinese Acad Sci, Inst Biophys, Beijing Key Lab Noncoding RNA, Beijing 100101, Peoples R China; [Li, Jiazhi; Zhao, Hongtu; Yin, Maolu] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, YL (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab RNA Biol, Beijing 100101, Peoples R China.	ylwang@ibp.ac.cn		Wang, Yanli/0000-0002-5969-1745	Natural Science Foundation of China [91440201]; Chinese Ministry of Science and Technology [2014CB910102]; Strategic Priority Research program of the Chinese Academy of Sciences [XDB08010203]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Strategic Priority Research program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank the staff at beamlines BL-17U, BL-18U, and BL-19U at the Shanghai Synchrotron Radiation Facility, beamline 3W1A at Beijing Synchrotron Radiation Facility, and beamlines BL-5A and BL-17A at the Photon Factory. This work was supported by grants from the Natural Science Foundation of China (91440201), the Chinese Ministry of Science and Technology (2014CB910102), and the Strategic Priority Research program of the Chinese Academy of Sciences (XDB08010203). We thank Prof. Dinshaw Patel for discussion and assistance with manuscript editing and Dr. Torsten Juelich for critical reading and linguistic assistance.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Fineran PC, 2012, VIROLOGY, V434, P202, DOI 10.1016/j.virol.2012.10.003; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Goren MG, 2012, J MOL BIOL, V423, P14, DOI 10.1016/j.jmb.2012.06.037; Gunderson FF, 2015, INFECT IMMUN, V83, P1008, DOI 10.1128/IAI.03102-14; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Ka D, 2014, BIOCHEM BIOPH RES CO, V451, P152, DOI 10.1016/j.bbrc.2014.07.087; Kim TY, 2013, BIOCHEM BIOPH RES CO, V441, P720, DOI 10.1016/j.bbrc.2013.10.122; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nam KH, 2012, J BIOL CHEM, V287, P35943, DOI 10.1074/jbc.M112.382598; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Paez-Espino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2440; Pougach K, 2010, MOL MICROBIOL, V77, P1367, DOI 10.1111/j.1365-2958.2010.07265.x; Rollie C, 2015, ELIFE, V4, DOI [10.7554/eLife.08716, 10.7554/eLife.08716.001]; Samai P, 2010, ACTA CRYSTALLOGR F, V66, P1552, DOI 10.1107/S1744309110039801; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Yosef I, 2013, P NATL ACAD SCI USA, V110, P14396, DOI 10.1073/pnas.1300108110; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	35	162	179	4	87	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					840	853		10.1016/j.cell.2015.10.008	http://dx.doi.org/10.1016/j.cell.2015.10.008			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26478180	Bronze			2022-12-28	WOS:000364829700011
J	Ou, SM; Shih, CJ; Chao, PW; Chu, H; Kuo, SC; Lee, YJ; Wang, SJ; Yang, CY; Lin, CC; Chen, TJ; Tarng, DC; Li, SY; Chen, YT				Ou, Shuo-Ming; Shih, Chia-Jen; Chao, Pei-Wen; Chu, Hsi; Kuo, Shu-Chen; Lee, Yi-Jung; Wang, Shuu-Jiun; Yang, Chih-Yu; Lin, Chih-Ching; Chen, Tzeng-Ji; Tarng, Der-Cherng; Li, Szu-Yuan; Chen, Yung-Tai			Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus	ANNALS OF INTERNAL MEDICINE			English	Article							COMPLICATIONS SEVERITY INDEX; CARDIOVASCULAR EVENTS; RISK; MORTALITY; DPP-4; ASSOCIATION; EFFICACY; DISEASE; CARE; HOSPITALIZATION	Background: Recent studies concluded that dipeptidyl peptidase-4 (DPP-4) inhibitors provide glycemic control but also raised concerns about the risk for heart failure in patients with type 2 diabetes mellitus (T2DM). However, large-scale studies of the effects on cardiovascular outcomes of adding DPP-4 inhibitors versus sulfonylureas to metformin therapy remain scarce. Objective: To compare clinical outcomes of adding DPP-4 inhibitors versus sulfonylureas to metformin therapy in patients with T2DM. Design: Nationwide study using Taiwan's National Health Insurance Research Database. Setting: Taiwan. Patients: All patients with T2DM aged 20 years or older between 2009 and 2012. A total of 10 089 propensity score-matched pairs of DPP-4 inhibitor users and sulfonylurea users were examined. Measurements: Cox models with exposure to sulfonylureas and DPP-4 inhibitors included as time-varying covariates were used to compare outcomes. The following outcomes were considered: all-cause mortality, major adverse cardiovascular events (MACEs) (including ischemic stroke and myocardial infarction), hospitalization for heart failure, and hypoglycemia. Patients were followed until death or 31 December 2013. Results: DPP-4 inhibitors were associated with lower risks for all-cause death (hazard ratio [HR], 0.63 [95% CI, 0.55 to 0.72]), MACEs (HR, 0.68 [CI, 0.55 to 0.83]), ischemic stroke (HR, 0.64 [CI, 0.51 to 0.81]), and hypoglycemia (HR, 0.43 [CI, 0.33 to 0.56]) compared with sulfonylureas as add-on therapy to metformin but had no effect on risks for myocardial infarction and hospitalization for heart failure. Limitation: Observational study design. Conclusion: Compared with sulfonylureas, DPP-4 inhibitors were associated with lower risks for all-cause death, MACEs, ischemic stroke, and hypoglycemia when used as add-ons to metformin therapy.	Natl Yang Ming Univ, Taipei 112, Taiwan; [Ou, Shuo-Ming; Yang, Chih-Yu; Lin, Chih-Ching; Tarng, Der-Cherng; Li, Szu-Yuan] Taipei Vet Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan; [Wang, Shuu-Jiun] Taipei Vet Gen Hosp, Dept Neurol, Neurol Inst, Taipei, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Chao, Pei-Wen] Taipei Med Univ, Dept Anesthesiol, Wan Fang Hosp, Taipei, Taiwan; [Chu, Hsi] Taipei City Hosp, Div Resp Med, Dept Chest, Heping Fuyou Branch, Taipei, Taiwan; [Lee, Yi-Jung] Taipei City Hosp, Div Neurol, Dept Med, Ren Ai Branch, Taipei, Taiwan; [Chen, Yung-Tai] Taipei City Hosp, Div Nephrol, Dept Med, Heping Fuyou Branch, Taipei, Taiwan; [Shih, Chia-Jen] Taipei Vet Gen Hosp, Dept Med, Yuanshan Branch, Yilan, Taiwan; [Wang, Shuu-Jiun] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Miaoli County, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei City Hospital; Taipei City Hospital; Taipei City Hospital; Taipei Veterans General Hospital; National Health Research Institutes - Taiwan	Li, SY (corresponding author), Taipei Vet Gen Hosp, Div Nephrol, Dept Med, 201,Sect 2,Shipai Rd, Taipei, Taiwan.	syli@vghtpe.gov.tw; ytchen0117@gmail.com	Chen, TJ/AAH-8430-2021; Yang, Chih-Yu/AAR-6147-2020; chao, P/GSD-8001-2022; Kuo, Shu-Chen/U-6115-2019	Yang, Chih-Yu/0000-0001-9899-3159; Kuo, Shu-Chen/0000-0002-6940-6450; Li, Szu-Yuan/0000-0002-3639-8212	Ministry of Science and Technology; Taipei Veterans General Hospital; National Yang-Ming University; GlaxoSmithKline (Taiwan); Eli Lilly and Company (Taiwan); MSD Taiwan; Allergan; Eli Lilly and Company; Daiichi Sankyo	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Yang-Ming University; GlaxoSmithKline (Taiwan)(GlaxoSmithKline); Eli Lilly and Company (Taiwan)(Eli Lilly); MSD Taiwan; Allergan(AbbVieAllergan); Eli Lilly and Company(Eli Lilly); Daiichi Sankyo(Daiichi Sankyo Company Limited)	Dr. Wang reports grants from the Ministry of Science and Technology, Taipei Veterans General Hospital, and National Yang-Ming University and personal fees from GlaxoSmithKline (Taiwan), Eli Lilly and Company (Taiwan), MSD Taiwan, Allergan, Eli Lilly and Company, and Daiichi Sankyo outside the submitted work. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M15-0308.	Rojas LBA, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-6; Ahren B, 2011, DIABETES OBES METAB, V13, P775, DOI 10.1111/j.1463-1326.2011.01414.x; Bhatt DL, 2014, JACC-HEART FAIL, V2, P583, DOI 10.1016/j.jchf.2014.05.005; Cernea S, 2011, DIABETES CARE, V34, pS264, DOI 10.2337/dc11-s223; Chang HY, 2012, AM J MANAG CARE, V18, P721; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen HL, 2014, J DIABETES COMPLICAT, V28, P612, DOI 10.1016/j.jdiacomp.2014.05.011; Coca-Perraillon M., 2007, SAS GLOB FOR, P1; Consoli A, 2004, DIABETES METAB, V30, P509, DOI 10.1016/S1262-3636(07)70148-9; Darsalia V, 2013, DIABETES, V62, P1289, DOI 10.2337/db12-0988; Engel SS, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-3; Gagne JJ, 2014, ANN INTERN MED, V161, P400, DOI 10.7326/M13-2942; Gallwitz B, 2012, LANCET, V380, P475, DOI 10.1016/S0140-6736(12)60691-6; Greevy RA, 2011, CLIN PHARMACOL THER, V90, P813, DOI 10.1038/clpt.2011.228; Hsu PF, 2013, DIABETES CARE, V36, P894, DOI 10.2337/dc12-0916; Hwang DK, 2014, JAMA OPHTHALMOL, V132, P1446, DOI 10.1001/jamaophthalmol.2014.3333; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; Lee CH, 2011, J NEUROSCI RES, V89, P1103, DOI 10.1002/jnr.22596; Li YP, 2014, DIABETES CARE, V37, P3106, DOI 10.2337/dc14-1306; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lin IP, 2015, J AM BOARD FAM MED, V28, P222, DOI 10.3122/jabfm.2015.02.140141; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Matthews DR, 2010, DIABETES OBES METAB, V12, P780, DOI 10.1111/j.1463-1326.2010.01233.x; McCoy RG, 2012, DIABETES CARE, V35, P1897, DOI 10.2337/dc11-2054; Morgan CL, 2014, DIABETES OBES METAB, V16, P977, DOI 10.1111/dom.12306; Nesto RW, 2004, AM J MED, V116, P11, DOI 10.1016/j.amjmed.2003.10.016; Parker HE, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S146239940900132X; Patil HR, 2012, AM J CARDIOL, V110, P826, DOI 10.1016/j.amjcard.2012.04.061; Pratley RE, 2007, CURR MED RES OPIN, V23, P919, DOI 10.1185/030079906X162746; Roumie CL, 2014, JAMA-J AM MED ASSOC, V311, P2288, DOI 10.1001/jama.2014.4312; Roumie CL, 2012, ANN INTERN MED, V157, P601, DOI 10.7326/0003-4819-157-9-201211060-00003; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Seck T, 2010, INT J CLIN PRACT, V64, P562, DOI 10.1111/j.1742-1241.2010.02353.x; Shannon RP, 2013, DIABETES, V62, P1029, DOI 10.2337/db12-1794; Snell-Bergeon JK, 2012, DIABETES TECHNOL THE, V14, pS51, DOI 10.1089/dia.2012.0031; Stricker BHC, 2010, EUR J EPIDEMIOL, V25, P245, DOI 10.1007/s10654-010-9451-7; Thornberry NA, 2009, BEST PRACT RES CL EN, V23, P479, DOI 10.1016/j.beem.2009.03.004; US Food and Drug Administration, 2008, GUID IND DIAB MELL E; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Young BA, 2008, AM J MANAG CARE, V14, P15; Yousefzadeh P, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/459821	42	79	81	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 3	2015	163	9					663	+		10.7326/M15-0308	http://dx.doi.org/10.7326/M15-0308			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX3PF	26457538				2022-12-28	WOS:000365610600003
J	Sanghavi, P; Jena, AB; Newhouse, JP; Zaslavsky, AM				Sanghavi, Prachi; Jena, Anupam B.; Newhouse, Joseph P.; Zaslavsky, Alan M.			Outcomes of Basic Versus Advanced Life Support for Out-of-Hospital Medical Emergencies	ANNALS OF INTERNAL MEDICINE			English	Article							ADVANCED AIRWAY MANAGEMENT; PREHOSPITAL TRAUMA CARE; CARDIAC-ARREST; ENDOTRACHEAL INTUBATION; INSTRUMENTAL VARIABLES; BRAIN-INJURY; MORTALITY; SURVIVAL; ASSOCIATION	Background: Most Medicare patients seeking emergency medical transport are treated by ambulance providers trained in advanced life support (ALS). Evidence supporting the superiority of ALS over basic life support (BLS) is limited, but some studies suggest ALS may harm patients. Objective: To compare outcomes after ALS and BLS in out-of-hospital medical emergencies. Design: Observational study with adjustment for propensity score weights and instrumental variable analyses based on county-level variations in ALS use. Setting: Traditional Medicare. Patients: 20% random sample of Medicare beneficiaries from nonrural counties between 2006 and 2011 with major trauma, stroke, acute myocardial infarction (AMI), or respiratory failure. Measurements: Neurologic functioning and survival to 30 days, 90 days, 1 year, and 2 years. Results: Except in cases of AMI, patients showed superior unadjusted outcomes with BLS despite being older and having more comorbidities. In propensity score analyses, survival to 90 days among patients with trauma, stroke, and respiratory failure was higher with BLS than ALS (6.1 percentage points [95% CI, 5.4 to 6.8 percentage points] for trauma; 7.0 percentage points [CI, 6.2 to 7.7 percentage points] for stroke; and 3.7 percentage points [CI, 2.5 to 4.8 percentage points] for respiratory failure). Patients with AMI did not exhibit differences in survival at 30 days but had better survival at 90 days with ALS (1.0 percentage point [CI, 0.1 to 1.9 percentage points]). Neurologic functioning favored BLS for all diagnoses. Results from instrumental variable analyses were broadly consistent with propensity score analyses for trauma and stroke, showed no survival differences between BLS and ALS for respiratory failure, and showed better survival at all time points with BLS than ALS for patients with AMI. Limitation: Only Medicare beneficiaries from nonrural counties were studied. Conclusion: Advanced life support is associated with substantially higher mortality for several acute medical emergencies than BLS.	[Sanghavi, Prachi] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA; [Jena, Anupam B.; Newhouse, Joseph P.; Zaslavsky, Alan M.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	University of Chicago; Harvard University; Harvard Medical School	Sanghavi, P (corresponding author), Univ Chicago, Dept Publ Hlth Sci, 5841 South Maryland Ave,MC2000, Chicago, IL 60637 USA.	psanghavi@health.bsd.uchicago.edu	Newhouse, Joseph/AAD-9763-2019; Newhouse, Joseph/AGJ-5632-2022		National Science Foundation Graduate Research Fellowship; Agency for Healthcare Research and Quality [1R36HS022798-01]; National Institutes of Health Early Independence Award [1DP5OD017897-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R36HS022798] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institutes of Health Early Independence Award; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	By a National Science Foundation Graduate Research Fellowship (Dr. Sanghavi), an Agency for Healthcare Research and Quality grant (1R36HS022798-01; Dr. Sanghavi), and the National Institutes of Health Early Independence Award (1DP5OD017897-01; Dr. Jena).	Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; [Anonymous], AR HLTH RES FIL AHRF; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Bur A, 2001, INTENS CARE MED, V27, P1474, DOI 10.1007/s001340101045; Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004; Goodman DC, 2009, 2009 POPULATION ESTI; Grenvik ASP., 1981, BRAIN FAILURE RESUSC, P155; Haas B, 2008, CRIT CARE, V12, DOI 10.1186/cc6980; Hanif MA, 2010, ACAD EMERG MED, V17, P926, DOI 10.1111/j.1553-2712.2010.00829.x; Hasegawa K, 2013, JAMA-J AM MED ASSOC, V309, P257, DOI 10.1001/jama.2012.187612; Haut ER, 2011, ANN SURG, V253, P371, DOI 10.1097/SLA.0b013e318207c24f; Hirano K., 2001, HLTH SERVICES OUTCOM, V2, P259, DOI [10.1023/A:1020371312283, DOI 10.1023/A:1020371312283]; Isenberg DL, 2005, PREHOSPITAL DISASTER, V20, P265, DOI 10.1017/S1049023X0000265X; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jayaraman S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003109.pub2; Lecky F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001429.pub2; Liberman M, 2003, ANN SURG, V237, P153, DOI 10.1097/00000658-200302000-00001; Liberman M, 2000, J TRAUMA, V49, P584, DOI 10.1097/00005373-200010000-00003; Ma MHM, 2007, RESUSCITATION, V74, P461, DOI 10.1016/j.resuscitation.2007.02.006; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; Medicare Payment Advisory Commission, 2012, PAYM BAS AMB SERV PA; Medicare Payment Advisory Commission, 2013, REP C MED HLTH CAR D; Meredith JW, 2002, J TRAUMA, V53, P621, DOI 10.1097/00005373-200210000-00001; Prasad V, 2013, JAMA-J AM MED ASSOC, V309, P241, DOI 10.1001/jama.2012.96867; Ryynanen OP, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-62; Sanghavi P, 2015, JAMA INTERN MED, V175, P196, DOI 10.1001/jamainternmed.2014.5420; Sasser S., 2005, PREHOSPITAL TRAUMA C; Sasser SM, 2006, B WORLD HEALTH ORGAN, V84, P507, DOI 10.2471/BLT.06.033605; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; Stiell IG, 2007, NEW ENGL J MED, V356, P2156, DOI 10.1056/NEJMoa060334; Stiell IG, 2004, NEW ENGL J MED, V351, P647, DOI 10.1056/NEJMoa040325; Stockinger ZT, 2004, J TRAUMA, V56, P531, DOI 10.1097/01.TA.0000111755.94642.29; Sukumaran S, 2005, EMERG MED J, V22, P60, DOI 10.1136/emj.2004.016873; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Wang HE, 2005, CRIT CARE MED, V33, P1718, DOI 10.1097/01.CCM.0000171208.07895.2A; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang HE, 2013, JAMA-J AM MED ASSOC, V309, P285, DOI 10.1001/jama.2012.216998	40	38	38	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 3	2015	163	9					681	+		10.7326/M15-0557	http://dx.doi.org/10.7326/M15-0557			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX3PF	26457627	Green Accepted			2022-12-28	WOS:000365610600005
J	Riek, C; Seletskiy, DV; Moskalenko, AS; Schmidt, JF; Krauspe, P; Eckart, S; Eggert, S; Burkard, G; Leitenstorfer, A				Riek, C.; Seletskiy, D. V.; Moskalenko, A. S.; Schmidt, J. F.; Krauspe, P.; Eckart, S.; Eggert, S.; Burkard, G.; Leitenstorfer, A.			Direct sampling of electric-field vacuum fluctuations	SCIENCE			English	Article							SQUEEZED STATES; ROOM-TEMPERATURE; LIGHT; GENERATION; PHOTONS; PULSES	The ground state of quantum systems is characterized by zero-point motion. This motion, in the form of vacuum fluctuations, is generally considered to be an elusive phenomenon that manifests itself only indirectly. Here, we report direct detection of the vacuum fluctuations of electromagnetic radiation in free space. The ground-state electric-field variance is inversely proportional to the four-dimensional space-time volume, which we sampled electro-optically with tightly focused laser pulses lasting a few femtoseconds. Subcycle temporal readout and nonlinear coupling far from resonance provide signals from purely virtual photons without amplification. Our findings enable an extreme time-domain approach to quantum physics, with nondestructive access to the quantum state of light. Operating at multiterahertz frequencies, such techniques might also allow time-resolved studies of intrinsic fluctuations of elementary excitations in condensed matter.	[Leitenstorfer, A.] Univ Konstanz, Dept Phys, D-78457 Constance, Germany; Univ Konstanz, Ctr Appl Photon, D-78457 Constance, Germany	University of Konstanz; University of Konstanz	Leitenstorfer, A (corresponding author), Univ Konstanz, Dept Phys, D-78457 Constance, Germany.	alfred.leitenstorfer@uni-konstanz.de	Leitenstorfer, Alfred/B-9561-2015; Lippmann, Jan/O-4491-2017; Moskalenko, Andrey S./E-9627-2012; Eckart, Sebastian/ABA-3119-2021; Seletskiy, Denis V/C-1372-2011; Burkard, Guido/A-6949-2008	Leitenstorfer, Alfred/0000-0002-9847-257X; Lippmann, Jan/0000-0002-6636-5075; Moskalenko, Andrey S./0000-0002-0028-4459; Eckart, Sebastian/0000-0002-9245-9059; Seletskiy, Denis V/0000-0003-3480-4595; Burkard, Guido/0000-0001-9053-2200	European Research Council [290876]; Deutsche Forschungsgemeinschaft [SFB767]; NSF [1160764]	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NSF(National Science Foundation (NSF))	Support by the European Research Council (Advanced Grant 290876 "UltraPhase"), by Deutsche Forschungsgemeinschaft (SFB767), and by NSF via a postdoctoral fellowship for D.V.S. (award no. 1160764) is gratefully acknowledged.	ANDERSON ME, 1995, OPT LETT, V20, P620, DOI 10.1364/OL.20.000620; BROWN RH, 1956, NATURE, V177, P27, DOI 10.1038/177027a0; Casimir H. B. G., 1948, P KON NED AKAD WET, V51, P793; Clerk AA, 2010, REV MOD PHYS, V82, P1155, DOI 10.1103/RevModPhys.82.1155; FOX AM, 1995, PHYS REV LETT, V74, P1728, DOI 10.1103/PhysRevLett.74.1728; Furst C, 1997, PHYS REV LETT, V78, P3733, DOI 10.1103/PhysRevLett.78.3733; Gallot G, 1999, J OPT SOC AM B, V16, P1204, DOI 10.1364/JOSAB.16.001204; Grosse NB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.153603; Jackson J.D., 1999, CLASSICAL ELECTRODYN; KIMBLE HJ, 1977, PHYS REV LETT, V39, P691, DOI 10.1103/PhysRevLett.39.691; Kubler C, 2004, APPL PHYS LETT, V85, P3360, DOI 10.1063/1.1808232; LAMB WE, 1947, PHYS REV, V72, P241, DOI 10.1103/PhysRev.72.241; Leitenstorfer A, 1999, APPL PHYS LETT, V74, P1516, DOI 10.1063/1.123601; Liu K, 2004, APPL PHYS LETT, V85, P863, DOI 10.1063/1.1779959; LOUDON R, 1987, J MOD OPTIC, V34, P709, DOI 10.1080/09500348714550721; Lounis B, 2000, NATURE, V407, P491, DOI 10.1038/35035032; Lvovsky AI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.050402; Michler P, 2000, NATURE, V406, P968, DOI 10.1038/35023100; Mosley PJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.133601; MUKHANOV VF, 1992, PHYS REP, V215, P203, DOI 10.1016/0370-1573(92)90044-Z; NAMBA S, 1961, J OPT SOC AM, V51, P76, DOI 10.1364/JOSA.51.000076; Schwabl F., 2007, QUANTUM MECH; Silberhorn C, 2001, PHYS REV LETT, V86, P4267, DOI 10.1103/PhysRevLett.86.4267; SLUSHER RE, 1985, PHYS REV LETT, V55, P2409, DOI 10.1103/PhysRevLett.55.2409; SMITHEY DT, 1993, PHYS REV LETT, V70, P1244, DOI 10.1103/PhysRevLett.70.1244; TRYON EP, 1973, NATURE, V246, P396, DOI 10.1038/246396a0; Vogel W., 2006, QUANTUM OPT, V3rd; Walls D., 2008, QUANTUM OPT, DOI DOI 10.1007/978-3-540-28574-8; Walmsley IA, 2015, SCIENCE, V348, P525, DOI 10.1126/science.aab0097; WU LA, 1986, PHYS REV LETT, V57, P2520, DOI 10.1103/PhysRevLett.57.2520; Wu Q, 1997, APPL PHYS LETT, V71, P1285, DOI 10.1063/1.119873	31	131	132	0	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					420	423		10.1126/science.aac9788	http://dx.doi.org/10.1126/science.aac9788			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26429882	Green Submitted			2022-12-28	WOS:000363213400036
J	Zhang, C; Spevak, W; Zhang, Y; Burton, EA; Ma, Y; Habets, G; Zhang, JZ; Lin, J; Ewing, T; Matusow, B; Tsang, G; Marimuthu, A; Cho, H; Wu, GX; Wang, WR; Fong, D; Nguyen, H; Shi, SY; Womack, P; Nespi, M; Shellooe, R; Carias, H; Powell, B; Light, E; Sanftner, L; Walters, J; Tsai, J; West, BL; Visor, G; Rezaei, H; Lin, PS; Nolop, K; Ibrahim, PN; Hirth, P; Bollag, G				Zhang, Chao; Spevak, Wayne; Zhang, Ying; Burton, Elizabeth A.; Ma, Yan; Habets, Gaston; Zhang, Jiazhong; Lin, Jack; Ewing, Todd; Matusow, Bernice; Tsang, Garson; Marimuthu, Adhirai; Cho, Hanna; Wu, Guoxian; Wang, Weiru; Fong, Daniel; Hoa Nguyen; Shi, Songyuan; Womack, Patrick; Nespi, Marika; Shellooe, Rafe; Carias, Heidi; Powell, Ben; Light, Emily; Sanftner, Laura; Walters, Jason; Tsai, James; West, Brian L.; Visor, Gary; Rezaei, Hamid; Lin, Paul S.; Nolop, Keith; Ibrahim, Prabha N.; Hirth, Peter; Bollag, Gideon			RAF inhibitors that evade paradoxical MAPK pathway activation	NATURE			English	Article							SELECTIVE INHIBITOR; METASTATIC MELANOMA; BRAF; VEMURAFENIB; DABRAFENIB; RESISTANCE; MUTATIONS; SURVIVAL; KINASE; PROLIFERATION	Oncogenic activation of BRAF fuels cancer growth by constitutively promoting RAS-independent mitogen-activated protein kinase (MAPK) pathway signalling(1). Accordingly, RAF inhibitors have brought substantially improved personalized treatment of metastatic melanoma(2-5). However, these targeted agents have also revealed an unexpected consequence: stimulated growth of certain cancers(6-9). Structurally diverse ATP-competitive RAF inhibitors can either inhibit or paradoxically activate the MAPK pathway, depending whether activation is by BRAF mutation or by an upstream event, such as RAS mutation or receptor tyrosine kinase activation(10-12). Here we have identified next-generation RAF inhibitors (dubbed 'paradox breakers') that suppress mutant BRAF cells without activating the MAPK pathway in cells bearing upstream activation. In cells that express the same HRAS mutation prevalent in squamous tumours from patients treated with RAF inhibitors, the first-generation RAF inhibitor vemurafenib stimulated in vitro and in vivo growth and induced expression of MAPK pathway response genes; by contrast the paradox breakers PLX7904 and PLX8394 had no effect. Paradox breakers also overcame several known mechanisms of resistance to first-generation RAF inhibitors. Dissociating MAPK pathway inhibition from paradoxical activation might yield both improved safety and more durable efficacy than first-generation RAF inhibitors, a concept currently undergoing human clinical evaluation with PLX8394.	[Zhang, Chao; Spevak, Wayne; Zhang, Ying; Burton, Elizabeth A.; Ma, Yan; Habets, Gaston; Zhang, Jiazhong; Lin, Jack; Ewing, Todd; Matusow, Bernice; Tsang, Garson; Marimuthu, Adhirai; Cho, Hanna; Wu, Guoxian; Wang, Weiru; Fong, Daniel; Hoa Nguyen; Shi, Songyuan; Womack, Patrick; Nespi, Marika; Shellooe, Rafe; Carias, Heidi; Powell, Ben; Light, Emily; Sanftner, Laura; Walters, Jason; Tsai, James; West, Brian L.; Visor, Gary; Rezaei, Hamid; Lin, Paul S.; Nolop, Keith; Ibrahim, Prabha N.; Hirth, Peter; Bollag, Gideon] Plexxikon Inc, Berkeley, CA 94710 USA	Plexxikon	Bollag, G (corresponding author), Plexxikon Inc, 91 Bolivar Dr, Berkeley, CA 94710 USA.	czhang@plexxikon.com; gbollag@plexxikon.com		Wang, Weiru/0000-0001-8845-301X; West, Brian/0000-0002-5320-3691				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrews MC, 2013, J CLIN ONCOL, V31, pE448, DOI 10.1200/JCO.2013.50.4118; Anforth RM, 2012, BRIT J DERMATOL, V167, P1153, DOI 10.1111/j.1365-2133.2012.11155.x; BALMAIN A, 1984, NATURE, V307, P658, DOI 10.1038/307658a0; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Callahan MK, 2012, NEW ENGL J MED, V367, P2316, DOI 10.1056/NEJMoa1208958; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Choi J, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12197; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Freeman AK, 2013, MOL CELL, V49, P751, DOI 10.1016/j.molcel.2012.12.018; Girotti MR, 2015, CANCER CELL, V27, P85, DOI 10.1016/j.ccell.2014.11.006; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; King AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067583; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Le K, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12092; Lin LP, 2014, P NATL ACAD SCI USA, V111, pE748, DOI 10.1073/pnas.1320956111; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oberholzer PA, 2012, J CLIN ONCOL, V30, P316, DOI 10.1200/JCO.2011.36.7680; Oshima G, 2012, J CANCER RES CLIN, V138, P491, DOI 10.1007/s00432-011-1127-5; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Rizos H, 2014, CLIN CANCER RES, V20, P1965, DOI 10.1158/1078-0432.CCR-13-3122; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Sievert AJ, 2013, P NATL ACAD SCI USA, V110, P5957, DOI 10.1073/pnas.1219232110; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zimmer L, 2012, J CLIN ONCOL, V30, P2375, DOI 10.1200/JCO.2011.41.1660	36	236	246	8	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					583	U298		10.1038/nature14982	http://dx.doi.org/10.1038/nature14982			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26466569				2022-12-28	WOS:000364026100052
J	Farley, EK; Olson, KM; Zhang, W; Brandt, AJ; Rokhsar, DS; Levine, MS				Farley, Emma K.; Olson, Katrina M.; Zhang, Wei; Brandt, Alexander J.; Rokhsar, Daniel S.; Levine, Michael S.			Suboptimization of developmental enhancers	SCIENCE			English	Article							TRANSCRIPTION FACTORS; SIGNALING ESTABLISHES; SUPER-ENHANCERS; MATERNAL GATA; CELL IDENTITY; EYE ENHANCER; NEURAL-TUBE; DNA; COMPLEX; ETS	Transcriptional enhancers direct precise on-off patterns of gene expression during development. To explore the basis for this precision, we conducted a high-throughput analysis of the Otx-a enhancer, which mediates expression in the neural plate of Ciona embryos in response to fibroblast growth factor (FGF) signaling and a localized GATA determinant. We provide evidence that enhancer specificity depends on submaximal recognition motifs having reduced binding affinities ("suboptimization"). Native GATA and ETS (FGF) binding sites contain imperfect matches to consensus motifs. Perfect matches mediate robust but ectopic patterns of gene expression. The native sites are not arranged at optimal intervals, and subtle changes in their spacing alter enhancer activity. Multiple tiers of enhancer suboptimization produce specific, but weak, patterns of expression, and we suggest that clusters of weak enhancers, including certain "superenhancers," circumvent this trade-off in specificity and activity.	[Farley, Emma K.; Olson, Katrina M.; Rokhsar, Daniel S.; Levine, Michael S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Genet Genom & Dev, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Farley, Emma K.; Olson, Katrina M.; Levine, Michael S.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Zhang, Wei] Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA; [Brandt, Alexander J.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Princeton University; University of California System; University of California San Diego; University of California System; University of California Berkeley	Levine, MS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Genet Genom & Dev, Ctr Integrat Genom, 229 Stanley Hall, Berkeley, CA 94720 USA.	ekfarley@princeton.edu; msl2@princeton.edu	Farley, E/HHM-4227-2022; Zhang, Wei/K-4276-2016	Zhang, Wei/0000-0002-0942-1245; Farley, Emma/0000-0002-9241-247X; Rokhsar, Daniel/0000-0002-8704-2224; Levine, Michael/0000-0001-7629-0081	NIH [GM46638, NS076542]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046638, R37GM046638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076542] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Sequencing data for this project have been deposited in the National Center for Biotechnology Information, NIH, Sequencing Read Archive (www.ncbi.nlm.nih.gov/sra), PRJNA294804. We thank M. Chung, C. Anderson, E. Wagner, J. Lyons, and members of the Levine and Rokhsar labs for helpful discussions. This work was supported by grants from the NIH (GM46638 and NS076542). There are no conflicts of interest to declare. Author contributions are as follows: E.K.F., D.S.R., and M.S.L. devised experiments; E.K.F. and K.M.O. performed experiments; W.Z. designed and executed bioinformatics analysis; A.J.B. conducted bioinformatics analyses; and E.K.F., D.S.R., and M.S.L. wrote the paper. All authors discussed the results and commented on the manuscript. MS.L., D.S.R., and E.K.F. have filed a patent application, (no. 62/169,458) that relates to the production of enhancer variants using the SEL-Seq method.	Acampora D, 2005, BRAIN RES BULL, V66, P410, DOI 10.1016/j.brainresbull.2005.02.005; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Beby F, 2013, EXP EYE RES, V111, P9, DOI 10.1016/j.exer.2013.03.007; Bertrand V, 2003, CELL, V115, P615, DOI 10.1016/S0092-8674(03)00928-0; CLORE GM, 1994, STRUCTURE, V2, P89, DOI 10.1016/S0969-2126(00)00011-3; Crocker J, 2015, CELL, V160, P191, DOI 10.1016/j.cell.2014.11.041; Guss KA, 2001, SCIENCE, V292, P1164, DOI 10.1126/science.1058312; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hudson C, 2001, MECH DEVELOP, V100, P189, DOI 10.1016/S0925-4773(00)00528-1; Hume MA, 2015, NUCLEIC ACIDS RES, V43, pD117, DOI 10.1093/nar/gku1045; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Khoueiry P, 2010, CURR BIOL, V20, P792, DOI 10.1016/j.cub.2010.03.063; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; Kulkarni MM, 2005, MOL CELL BIOL, V25, P3411, DOI 10.1128/MCB.25.9.3411-3420.2005; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Lusk RW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000829; Muhlethaler-Mottet A, 2004, J BIOL CHEM, V279, P40529, DOI 10.1074/jbc.M406585200; Nitta KR, 2015, ELIFE, V4, DOI 10.7554/eLife.04837; Oosterveen T, 2013, P NATL ACAD SCI USA, V110, P7330, DOI 10.1073/pnas.1220010110; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Rothbacher U, 2007, DEVELOPMENT, V134, P4023, DOI 10.1242/dev.010850; Shi W, 2008, DEVELOPMENT, V135, P931, DOI 10.1242/dev.011940; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; Stolfi A, 2011, DEVELOPMENT, V138, P5429, DOI 10.1242/dev.072108; Swanson CI, 2011, CURR BIOL, V21, P1186, DOI 10.1016/j.cub.2011.05.056; Swanson CI, 2010, DEV CELL, V18, P359, DOI 10.1016/j.devcel.2009.12.026; Wagner E, 2012, DEVELOPMENT, V139, P2351, DOI 10.1242/dev.078485; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yasuo H, 2007, DEV BIOL, V302, P92, DOI 10.1016/j.ydbio.2006.08.075; Zhang HL, 2001, GENE DEV, V15, P261, DOI 10.1101/gad.861201	33	156	157	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2015	350	6258					325	328		10.1126/science.aac6948	http://dx.doi.org/10.1126/science.aac6948			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT5HD	26472909	Green Accepted			2022-12-28	WOS:000362838700042
J	Mirarab, S; Bayzid, S; Boussau, B; Warnow, T				Mirarab, Siavash; Bayzid, Shamsuzzoha; Boussau, Bastien; Warnow, Tandy			Response to Comment on "Statistical binning enables an accurate coalescent-based estimation of the avian tree"	SCIENCE			English	Editorial Material							GENE TREES; CONCATENATION	Liu and Edwards argue against the use of weighted statistical binning within a species tree estimation pipeline. However, we show that their mathematical argument does not apply to weighted statistical binning. Furthermore, their simulation study does not follow the recommended statistical binning protocol and has data of unknown origin that bias the results against weighted statistical binning.	[Mirarab, Siavash; Bayzid, Shamsuzzoha; Warnow, Tandy] Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA; [Mirarab, Siavash] Univ Calif San Diego, Dept Elect & Comp Engn, San Diego, CA 92103 USA; [Boussau, Bastien] Univ Lyon, Lab Biometrie Biol Evolut, Villeurbanne, France; [Warnow, Tandy] Univ Illinois, Dept Bioengn, Urbana, IL USA; [Warnow, Tandy] Univ Illinois, Dept Comp Sci, Urbana, IL USA	University of Texas System; University of Texas Austin; University of California System; University of California San Diego; VetAgro Sup; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Warnow, T (corresponding author), Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA.	warnow@illinois.edu		Boussau, Bastien/0000-0003-0776-4460; Mirarab, Siavash/0000-0001-5410-1518	Direct For Biological Sciences [1461364] Funding Source: National Science Foundation; Howard Hughes Medical Institute Funding Source: Medline	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bayzid MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129183; Gatesy J, 2014, MOL PHYLOGENET EVOL, V80, P231, DOI 10.1016/j.ympev.2014.08.013; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Liu L, 2015, SCIENCE, V350, DOI 10.1126/science.aaa7343; Liu LA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-302; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mirarab S, 2015, BIOINFORMATICS, V31, P44, DOI 10.1093/bioinformatics/btv234; Mirarab S, 2016, SYST BIOL, V65, P366, DOI 10.1093/sysbio/syu063; Mirarab S, 2014, SCIENCE, V346, P1337, DOI 10.1126/science.1250463; Patel S., 2013, J PHYLOGENET EVOL BI, V1, P2, DOI [10.4172/2329-9002.1000110, DOI 10.4172/2329-9002.1000110]; Roch S, 2015, SYST BIOL, V64, P663, DOI 10.1093/sysbio/syv016; Roch S, 2015, THEOR POPUL BIOL, V100, P56, DOI 10.1016/j.tpb.2014.12.005; Simmons MP, 2015, MOL PHYLOGENET EVOL, V91, P98, DOI 10.1016/j.ympev.2015.05.011; Warnow T, 2015, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.8d41ac0f13d1abedf4c4a59f5d17b1f7	14	7	7	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257								10.1126/science.aaa7719	http://dx.doi.org/10.1126/science.aaa7719			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9JB	26450204				2022-12-28	WOS:000362405600027
J	Chu, HT; Mazmanian, SK				Chu, Hiutung; Mazmanian, Sarkis K.			Winning the Microbial Battle, but Not the War	CELL			English	Editorial Material							CROHNS-DISEASE; INFLAMMATION; MYCOBACTERIUM	An effective immune response leads to rapid elimination of infectious agents, with seemingly little long-term impairment to the host. New findings by Morais da Fonseca et al. reveal that acute infections may result in permanent disruption of tissue homeostasis and immune dysfunction, long after clearance of a pathogen.	[Chu, Hiutung; Mazmanian, Sarkis K.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Mazmanian, SK (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	sarkis@caltech.edu		Chu, Hiutung/0000-0001-7489-0446				Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; CROHN BB, 1984, JAMA-J AM MED ASSOC, V251, P73, DOI 10.1001/jama.251.1.73; da Fonseca DM, 2015, CELL, V163, P354, DOI 10.1016/j.cell.2015.08.030; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Hugot JP, 2003, LANCET, V362, P2012, DOI 10.1016/S0140-6736(03)15024-6; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Sartor RB, 2005, GUT, V54, P896, DOI 10.1136/gut.2004.055889; Wucherpfennig KW, 2001, J CLIN INVEST, V108, P1097, DOI 10.1172/JCI200114235	9	2	2	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2					271	272		10.1016/j.cell.2015.09.050	http://dx.doi.org/10.1016/j.cell.2015.09.050			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26451475	Bronze			2022-12-28	WOS:000362952700002
J	Welte, MA				Welte, Michael A.			How Brain Fat Conquers Stress	CELL			English	Editorial Material							LIPID DROPLETS; GROWTH	A new paper by Bailey et al. reveals that lipid droplets, crucial organelles for energy storage, can also protect against oxidative stress. In Drosophila larvae, lipid droplets in glia allow neuronal stem cells to keep proliferating under hypoxic conditions. Protection likely involves sequestering vulnerable membrane lipids away from reactive oxygen species.	Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester	Welte, MA (corresponding author), Univ Rochester, Dept Biol, RC Box 270211,317 Hutchison Hall, Rochester, NY 14627 USA.	michael.welte@rochester.edu	Welte, Michael/AAH-5589-2019	Welte, Michael/0000-0001-5741-4720				Bailey AP, 2015, CELL, V163, P340, DOI 10.1016/j.cell.2015.09.020; Bensaad K, 2014, CELL REP, V9, P349, DOI 10.1016/j.celrep.2014.08.056; Cheng LY, 2011, CELL, V146, P435, DOI 10.1016/j.cell.2011.06.040; Inloes JM, 2014, P NATL ACAD SCI USA, V111, P14924, DOI 10.1073/pnas.1413706111; Kis V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131250; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Welte MA, 2015, CURR BIOL, V25, pR470, DOI 10.1016/j.cub.2015.04.004	9	13	13	1	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2					269	270		10.1016/j.cell.2015.09.046	http://dx.doi.org/10.1016/j.cell.2015.09.046			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26451474	Bronze			2022-12-28	WOS:000362952700001
J	Moseley, AM; Beckenkamp, PR; Haas, M; Herbert, RD; Lin, CWC				Moseley, Anne M.; Beckenkamp, Paula R.; Haas, Marion; Herbert, Robert D.; Lin, Chung-Wei Christine		EXACT Team	Rehabilitation After Immobilization for Ankle Fracture The EXACT Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICAL-ACTIVITY; AGE; OUTCOMES	IMPORTANCE The benefits of rehabilitation after immobilization for ankle fracture are unclear. OBJECTIVES To determine the effectiveness of a supervised exercise program and advice (rehabilitation) compared with advice alone and to determine if effects are moderated by fracture severity or age and sex. DESIGN, SETTING, AND PARTICIPANTS The EXACT trial was a pragmatic, randomized clinical trial conducted from December 2010 to June 2014. Patients with isolated ankle fracture presenting to fracture clinics in 7 Australian hospitals were randomized on the day of removal of immobilization. Of 571 eligible patients, 357 chose not to participate and 214 were allocated to rehabilitation (n = 106) or advice alone (n = 108), with 194 (91%) followed up at 1 month, 173 (81%) at 3 months, and 170 (79%) at 6 months. There were no withdrawals attributed to adverse effects. Recruitment terminated early on December 31, 2013 (planned enrollment, 342; actual, 214), because funding was exhausted. INTERVENTIONS Supervised exercise program and advice about self-management (rehabilitation) (individually tailored, prescribed, monitored, and progressed) or advice alone, both delivered by a physical therapist. MAIN OUTCOMES AND MEASURES Primary outcomes were activity limitation assessed using the Lower Extremity Functional Scale (score range, 0-80; higher scores indicate better activity), and quality of life assessed using the Assessment of Quality of Life (score range, 0-1; higher scores indicate better quality of life), measured at baseline and at 1, 3 (primary time point), and 6 months. RESULTS Mean activity limitation and quality of life at baseline were 30.1 (SD, 12.5) and 0.51 (SD, 0.24), respectively, for advice and 30.2 (SD, 13.2) and 0.54 (SD, 0.24) for rehabilitation, increasing to 64.3 (SD, 13.5) and 0.85 (SD, 0.17) for advice vs 64.3 (SD, 15.1) and 0.85 (SD, 0.20) for rehabilitation at 3 months. Rehabilitation was not more effective than advice for activity limitation (mean effect at 3 months, 0.4 [95% CI, -3.3 to 4.1]) or quality of life (-0.01 [95% CI, -0.06 to 0.04]). Treatment effects were not moderated by fracture severity or age and sex. CONCLUSIONS AND RELEVANCE A supervised exercise program and advice did not confer additional benefits in activity limitation or quality of life compared with advice alone for patients with isolated and uncomplicated ankle fracture. These findings do not support the routine use of supervised exercise programs after removal of immobilization for patients with isolated and uncomplicated ankle fracture.	[Moseley, Anne M.; Beckenkamp, Paula R.; Lin, Chung-Wei Christine] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2050, Australia; [Moseley, Anne M.; Beckenkamp, Paula R.; Lin, Chung-Wei Christine] Univ Sydney, Sydney Med Sch, Sydney, NSW 2050, Australia; [Haas, Marion] Univ Technol Sydney, CHERE, Sydney, NSW 2007, Australia; [Haas, Marion] Univ Technol Sydney, Sydney, NSW 2007, Australia; [Herbert, Robert D.] Neurosci Res Australia, Sydney, NSW, Australia	George Institute for Global Health; University of Sydney; University of Sydney; University of Technology Sydney; University of Technology Sydney; Neuroscience Research Australia	Moseley, AM (corresponding author), Univ Sydney, George Inst Global Hlth, POB M201,Missenden Rd, Sydney, NSW 2050, Australia.	amoseley@georgeinstitute.org.au	Beckenkamp, Paula/ABC-6591-2020; Haas, Marion Ruth/H-2732-2017; Lin, Chung-Wei Christine/S-8840-2019; Herbert, Rob/E-9442-2012	Beckenkamp, Paula/0000-0003-3986-6111; Lin, Chung-Wei Christine/0000-0001-6192-7238; Herbert, Rob/0000-0003-4188-9195	National Health and Medical Research Council, Australia; National Health and Medical Research Council; International Postgraduate Research Scholarships; Australian Postgraduate Award	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); International Postgraduate Research Scholarships; Australian Postgraduate Award(Australian Government)	This investigator-initiated trial was funded by the National Health and Medical Research Council, Australia. Dr Herbert's and Dr Lin's research fellowships were funded by the National Health and Medical Research Council. Ms Beckenkamp's scholarship was funded by the International Postgraduate Research Scholarships and Australian Postgraduate Award.	Beckenkamp PR, 2014, J ORTHOP SPORT PHYS, V44, P841, DOI 10.2519/jospt.2014.5199; Beckenkamp PR, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-148; Bennell Kim L, 1998, Aust J Physiother, V44, P175; Binkley JM, 1999, PHYS THER, V79, P371; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Davidovitch RI, 2010, ROCKWOOD GREENS FRAC, P1975; Fong DTP, 2007, SPORTS MED, V37, P73, DOI 10.2165/00007256-200737010-00006; Hancock MJ, 2005, J ORTHOP SPORT PHYS, V35, P786, DOI 10.2519/jospt.2005.35.12.786; Hawthorne G, 1999, QUAL LIFE RES, V8, P209, DOI 10.1023/A:1008815005736; Hawthorne G, 2000, 12 CTR HLTH PROGR EV; Hsieh FY, 2003, EVAL HEALTH PROF, V26, P239, DOI 10.1177/0163278703255230; Lachin JM, 2005, STAT MED, V24, P2747, DOI 10.1002/sim.2151; Lin CWC, 2008, J REHABIL MED, V40, P433, DOI 10.2340/16501977-0187; Lin CWC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005595.pub3; Moseley AM, 2005, ARCH PHYS MED REHAB, V86, P1118, DOI 10.1016/j.apmr.2004.11.017; Nilsson GM, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-118; Orsini N, 2006, MED SCI SPORT EXER, V38, P240, DOI 10.1249/01.mss.0000185086.19220.b3; Rashid S, 2013, PAK J MED SCI, V29, P1406; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Samson MM, 2000, AGE AGEING, V29, P235, DOI 10.1093/ageing/29.3.235; Singer BR, 1998, J BONE JOINT SURG BR, V80B, P243, DOI 10.1302/0301-620X.80B2.7762; Tenenhouse A, 2000, OSTEOPOROSIS INT, V11, P897, DOI 10.1007/s001980070050; Wilson F, 1991, NZ J PHYSIOTHERAPY, V19, P11	23	28	29	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2015	314	13					1376	1385		10.1001/jama.2015.12180	http://dx.doi.org/10.1001/jama.2015.12180			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2PH	26441182	Bronze, Green Published			2022-12-28	WOS:000362644700015
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Why shouldn't hospitals challenge inspections?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						[Anonymous], 2015, BBC NEWS; Brindle D, 2014, GUARDIAN; Campbell D., 2015, GUARDIAN; Care Quality Commission, 2015, JOIN INSP SPEC ADV; Care Quality Commission, 2015, Q PERF FIN REP Q4 EN; Care Quality Commission, 2015, INSP REP; Cooper C, 2014, INDEPENDENT; Hazell W, 2015, HLTH SERV J; Manchester Business School King's Fund, 2014, EV CAR QUAL COMM AC; McLellan A, 2014, HLTH SERV J; Sutcliffe A, 2015, SHOOTING MESSENGER; West D, 2015, HLTH SERV J	12	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 6	2015	351								h5320	10.1136/bmj.h5320	http://dx.doi.org/10.1136/bmj.h5320			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT3SF	26443606	Bronze			2022-12-28	WOS:000362726500006
J	Tekeli, K; Kaya, G; Grant, S; Williams, M; Howlett, D				Tekeli, Kemal; Kaya, Guven; Grant, Samuel; Williams, Michael; Howlett, David			Impending airway obstruction after dental extractions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LUDWIGS ANGINA; MANAGEMENT		[Tekeli, Kemal; Williams, Michael] Eastbourne Dist Gen Hosp, Dept Oral & Maxillofacial Surg, Eastbourne, E Sussex, England; [Kaya, Guven; Howlett, David] Eastbourne Dist Gen Hosp, Dept Radiol, Eastbourne, E Sussex, England; [Grant, Samuel] Eastbourne Dist Gen Hosp, Eastbourne, E Sussex, England		Tekeli, K (corresponding author), Eastbourne Dist Gen Hosp, Dept Oral & Maxillofacial Surg, Eastbourne, E Sussex, England.	kmt@doctors.org.uk						Boscolo-Rizzo P, 2012, EUR ARCH OTO-RHINO-L, V269, P1241, DOI 10.1007/s00405-011-1761-1; Eftekharian A, 2009, EUR ARCH OTO-RHINO-L, V266, P273, DOI 10.1007/s00405-008-0734-5; Hasan Wael, 2011, Int J Otolaryngol, V2011, P231816, DOI 10.1155/2011/231816; Lee WI, 2014, FORENSIC SCI MED PAT, V10, P109, DOI 10.1007/s12024-013-9499-2; LOUGHNAN TE, 1985, ANAESTHESIA, V40, P295; Miller WD, 1999, LARYNGOSCOPE, V109, P1873, DOI 10.1097/00005537-199911000-00029; Potter JK, 2002, J ORAL MAXIL SURG, V60, P349, DOI 10.1053/joms.2002.31218; Srirompotong S, 2003, EUR ARCH OTO-RHINO-L, V260, P401, DOI 10.1007/s00405-003-0588-9	8	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 6	2015	351								h5277	10.1136/bmj.h5277	http://dx.doi.org/10.1136/bmj.h5277			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT3SF	26442777				2022-12-28	WOS:000362726500005
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Honesty, placebos, and pain care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; OSTEOARTHRITIS; PARACETAMOL; EFFICACY; SAFETY					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Bhugra D, 2015, INT J SOC PSYCHIATR, V61, P615, DOI 10.1177/0020764015591492; deCraen AJM, 1996, BRIT MED J, V313, P321, DOI 10.1136/bmj.313.7053.321; European Medicines Agency, 2013, NEW SAF ADV DICL CMD; Fox C, 2011, J AM GERIATR SOC, V59, P1477, DOI 10.1111/j.1532-5415.2011.03491.x; Kaptchuk TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015591; Machado GC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1225; Makris UE, 2010, J RHEUMATOL, V37, P1236, DOI 10.3899/jrheum.090935; Moore R Andrew, 2014, Cochrane Database Syst Rev, pCD007938, DOI 10.1002/14651858.CD007938.pub3; Myint PK, 2015, AGE AGEING, V44, P219, DOI 10.1093/ageing/afu185; NHS England Public Health England, 2014, ADV PRESCR RISK MIS; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Roberts E, 2016, ANN RHEUM DIS, V75, P552, DOI 10.1136/annrheumdis-2014-206914; Snowden S, 2011, CARDIOL REV, V19, P184, DOI 10.1097/CRD.0b013e31821ddcf4	14	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 5	2015	351								h5103	10.1136/bmj.h5103	http://dx.doi.org/10.1136/bmj.h5103			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT3SC	26438576	Bronze			2022-12-28	WOS:000362726200004
J	Mawet, D				Mawet, Dimitri			Eyeing up a Jupiter-like exoplanet	SCIENCE			English	Editorial Material							HABITABLE ZONE; DISCOVERY; PLANETS; SPECTROSCOPY; KEPLER		CALTECH, Dept Astron, Jet Prop Lab, Pasadena, CA 91125 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Mawet, D (corresponding author), CALTECH, Dept Astron, Jet Prop Lab, Pasadena, CA 91125 USA.	dmawet@astro.caltech.edu						Borucki WJ, 2013, SCIENCE, V340, P587, DOI 10.1126/science.1234702; Bowler BP, 2015, ASTROPHYS J SUPPL S, V216, DOI 10.1088/0067-0049/216/1/7; Chauvin G, 2004, ASTRON ASTROPHYS, V425, pL29, DOI 10.1051/0004-6361:200400056; Ehrenreich D, 2015, NATURE, V522, P459, DOI 10.1038/nature14501; Fressin F, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/81; Jenkins JM, 2015, ASTRON J, V150, DOI 10.1088/0004-6256/150/2/56; Kaltenegger L, 2013, ASTROPHYS J LETT, V775, DOI 10.1088/2041-8205/775/2/L47; Kenworthy MA, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/2/126; Lagrange AM, 2009, ASTRON ASTROPHYS, V493, pL21, DOI 10.1051/0004-6361:200811325; Macintosh B, 2015, SCIENCE, V350, P64, DOI 10.1126/science.aac5891; NAKAJIMA T, 1995, NATURE, V378, P463, DOI 10.1038/378463a0; Rogers L.A., 2015, IAU GEN ASS M, V29; Sing DK, 2011, MON NOT R ASTRON SOC, V416, P1443, DOI 10.1111/j.1365-2966.2011.19142.x; Welsh WF, 2015, ASTROPHYS J, V809, DOI 10.1088/0004-637X/809/1/26	15	0	0	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					39	40		10.1126/science.aad0904	http://dx.doi.org/10.1126/science.aad0904			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26430108				2022-12-28	WOS:000362098300034
J	Wu, M; McNulty, NP; Rodionov, DA; Khoroshkin, MS; Griffin, NW; Cheng, JY; Latreille, P; Kerstetter, RA; Terrapon, N; Henrissat, B; Osterman, AL; Gordon, JI				Wu, Meng; McNulty, Nathan P.; Rodionov, Dmitry A.; Khoroshkin, Matvei S.; Griffin, Nicholas W.; Cheng, Jiye; Latreille, Phil; Kerstetter, Randall A.; Terrapon, Nicolas; Henrissat, Bernard; Osterman, Andrei L.; Gordon, Jeffrey I.			Genetic determinants of in vivo fitness and diet responsiveness in multiple human gut Bacteroides	SCIENCE			English	Article							OUTER-MEMBRANE PROTEINS; COMPARATIVE GENOMICS; BACTERIAL SYMBIONT; THETAIOTAOMICRON; STARCH; INTESTINE; CATALOG	Libraries of tens of thousands of transposon mutants generated from each of four human gut Bacteroides strains, two representing the same species, were introduced simultaneously into gnotobiotic mice together with 11 other wild-type strains to generate a 15-member artificial human gut microbiota. Mice received one of two distinct diets monotonously, or both in different ordered sequences. Quantifying the abundance of mutants in different diet contexts allowed gene-level characterization of fitness determinants, niche, stability, and resilience and yielded a prebiotic (arabinoxylan) that allowed targeted manipulation of the community. The approach described is generalizable and should be useful for defining mechanisms critical for sustaining and/or approaches for deliberately reconfiguring the highly adaptive and durable relationship between the human gut microbiota and host in ways that promote wellness.	[Wu, Meng; McNulty, Nathan P.; Griffin, Nicholas W.; Cheng, Jiye; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Wu, Meng; Griffin, Nicholas W.; Cheng, Jiye] Washington Univ, Sch Med, Ctr Gut Microbiome & Nutr Res, St Louis, MO 63108 USA; [Rodionov, Dmitry A.; Osterman, Andrei L.] Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Rodionov, Dmitry A.; Khoroshkin, Matvei S.] Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow 127994, Russia; [Latreille, Phil; Kerstetter, Randall A.] Monsanto Co, St Louis, MO 63167 USA; [Terrapon, Nicolas; Henrissat, Bernard] CNRS, Architecture & Fonct Macromol Biol, F-13288 Marseille 9, France; [Terrapon, Nicolas; Henrissat, Bernard] Aix Marseille Univ, F-13288 Marseille 9, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah 21413, Saudi Arabia	Washington University (WUSTL); Washington University (WUSTL); Sanford Burnham Prebys Medical Discovery Institute; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Monsanto; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA.	jgordon@wustl.edu	Henrissat, Bernard/J-2475-2012; Wu, Meng/P-9657-2019; Terrapon, Nicolas/O-3630-2014; Rodionov, Dmitry A/V-2688-2018; Terrapon, Nicolas/AAA-9033-2019	Henrissat, Bernard/0000-0002-3434-8588; Terrapon, Nicolas/0000-0002-3693-6017; Terrapon, Nicolas/0000-0002-3693-6017; Khoroshkin, Matvei/0000-0002-1744-6792	NIH [DK30292, DK70977, DK52574, GM108527]; Crohn's and Colitis Foundation of America; European Union/European Research Council (ERC) [322820]; Monsanto Company; Russian Science Foundation; Russian Science Foundation [14-14-00289] Funding Source: Russian Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070977, R37DK030292, R01DK030292, P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108527, T32GM007067] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; European Union/European Research Council (ERC)(European Research Council (ERC)); Monsanto Company; Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. O'Donnell and M. Karlsson for their assistance with gnotobiotic mouse husbandry; X. Zhou and A. Bell for their work on PacBio sequencing; and A. Reyes, M. Charbonneau, P. Ahern, and A. Hsiao for many helpful suggestions. This work was supported in part by grants from the NIH (DK30292, DK70977, DK52574, and GM108527), the Crohn's and Colitis Foundation of America, the European Union's Seventh Framework Program (FP/2007/2013)/European Research Council (ERC) Grant Agreement 322820 (to B.H.), the Monsanto Company (for PacBio and Illumina sequencing and finishing the B. thetaiotaomicron 7330, B. ovatus ATCC8483, and B. cellulosilyticus WH2 genomes), and the Russian Science Foundation (to D.A.R. and M.S.K.) INSeq, COPRO-seq, and microbial RNA-seq data sets have been deposited in the European Nucleotide Archive (ENA) under accession no. PRJEB9434. The finished and annotated genome sequences of B. thetaiotaomicron 7330, B. ovatus ATCC 8483, and B. cellulosilyticus WH2 have been deposited in the National Center for Biotechnology Information under accession no. PRJNA289334. J.I.G. is cofounder of Matatu, a company characterizing the role of diet-by-microbiota interactions in animal health. N.P.M. is currently an employee of Matatu. A.L.O. is an Adjunct Vice President for Research for Buffalo BioLabs. A U.S. patent application (PCT/US2014/045141) has been filed by Washington University related to methods for identifying dietary supplements, such as arabinoxylans, that can be used to deliberately manipulate the representation of targeted members of the human gut microbiota.	Cullen TW, 2015, SCIENCE, V347, P170, DOI 10.1126/science.1260580; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Degnan PH, 2014, CELL HOST MICROBE, V15, P47, DOI 10.1016/j.chom.2013.12.007; Dodd D, 2011, MOL MICROBIOL, V79, P292, DOI 10.1111/j.1365-2958.2010.07473.x; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Goodman AL, 2011, NAT PROTOC, V6, P1969, DOI 10.1038/nprot.2011.417; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Kashyap PC, 2013, P NATL ACAD SCI USA, V110, P17059, DOI 10.1073/pnas.1306070110; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lindenstrauss AG, 2014, ARCH MICROBIOL, V196, P423, DOI 10.1007/s00203-014-0982-2; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; McNulty NP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001637; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rao C. Radhakrishna, 1995, MULTIVARIATE STAT MA, P143; Ravcheev DA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-873; Reeves AR, 1996, J BACTERIOL, V178, P823, DOI 10.1128/jb.178.3.823-830.1996; Reeves AR, 1997, J BACTERIOL, V179, P643, DOI 10.1128/jb.179.3.643-649.1997; Rogowski A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8481; Shelton CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002360; Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029	27	136	144	3	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256							aac5992	10.1126/science.aac5992	http://dx.doi.org/10.1126/science.aac5992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26430127	Green Accepted			2022-12-28	WOS:000362098300043
J	Deen, GF; Broutet, N; Xu, W; Knust, B; Sesay, FR; McDonald, SLR; Ervin, E; Marrinan, JE; Gaillard, P; Habib, N; Liu, H; Liu, W; Thorson, AE; Yamba, F; Massaquoi, TA; James, F; Ariyarajah, A; Ross, C; Bernstein, K; Coursier, A; Klena, J; Carino, M; Wurie, AH; Zhang, Y; Dumbuya, MS; Abad, N; Idriss, B; Wi, T; Bennett, SD; Davies, T; Ebrahim, FK; Meites, E; Naidoo, D; Smith, SJ; Ongpin, P; Malik, T; Banerjee, A; Erickson, BR; Liu, Y; Liu, Y; Xu, K; Brault, A; Durski, KN; Winter, J; Sealy, T; Nichol, ST; Lamunu, M; Bangura, J; Landoulsi, S; Jambai, A; Morgan, O; Wu, G; Liang, M; Su, Q; Lan, Y; Hao, Y; Formenty, P; Stroher, U; Sahr, F				Deen, G. F.; Broutet, N.; Xu, W.; Knust, B.; Sesay, F. R.; McDonald, S. L. R.; Ervin, E.; Marrinan, J. E.; Gaillard, P.; Habib, N.; Liu, H.; Liu, W.; Thorson, A. E.; Yamba, F.; Massaquoi, T. A.; James, F.; Ariyarajah, A.; Ross, C.; Bernstein, K.; Coursier, A.; Klena, J.; Carino, M.; Wurie, A. H.; Zhang, Y.; Dumbuya, M. S.; Abad, N.; Idriss, B.; Wi, T.; Bennett, S. D.; Davies, T.; Ebrahim, F. K.; Meites, E.; Naidoo, D.; Smith, S. J.; Ongpin, P.; Malik, T.; Banerjee, A.; Erickson, B. R.; Liu, Y.; Liu, Y.; Xu, K.; Brault, A.; Durski, K. N.; Winter, J.; Sealy, T.; Nichol, S. T.; Lamunu, M.; Bangura, J.; Landoulsi, S.; Jambai, A.; Morgan, O.; Wu, G.; Liang, M.; Su, Q.; Lan, Y.; Hao, Y.; Formenty, P.; Stroher, U.; Sahr, F.			Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors - Final Report	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMORRHAGIC-FEVER; SIERRA-LEONE; SEXUAL TRANSMISSION; SEMINAL FLUID; RISK-FACTORS; OUTBREAK; KIKWIT; LIBERIA; CONGO	BACKGROUND Ebola virus has been detected in the semen of men after their recovery from Ebola virus disease (EVD). We report the presence of Ebola virus RNA in semen in a cohort of survivors of EVD in Sierra Leone. METHODS We enrolled a convenience sample of 220 adult male survivors of EVD in Sierra Leone, at various times after discharge from an Ebola treatment unit (ETU), in two phases (100 participants were in phase 1, and 120 in phase 2). Semen specimens obtained at baseline were tested by means of a quantitative reverse-transcriptase-polymerasechain- reaction (RT-PCR) assay with the use of the target sequences of NP and VP40 (in phase 1) or NP and GP (in phase 2). This study did not evaluate directly the risk of sexual transmission of EVD. RESULTS Of 210 participants who provided an initial semen specimen for analysis, 57 (27%) had positive results on quantitative RT-PCR. Ebola virus RNA was detected in the semen of all 7 men with a specimen obtained within 3 months after ETU discharge, in 26 of 42 (62%) with a specimen obtained at 4 to 6 months, in 15 of 60 (25%) with a specimen obtained at 7 to 9 months, in 4 of 26 (15%) with a specimen obtained at 10 to 12 months, in 4 of 38 (11%) with a specimen obtained at 13 to 15 months, in 1 of 25 (4%) with a specimen obtained at 16 to 18 months, and in no men with a specimen obtained at 19 months or later. Among the 46 participants with a positive result in phase 1, the median baseline cycle-threshold values (higher values indicate lower RNA values) for the NP and VP40 targets were lower within 3 months after ETU discharge (32.4 and 31.3, respectively; in 7 men) than at 4 to 6 months (34.3 and 33.1; in 25), at 7 to 9 months (37.4 and 36.6; in 13), and at 10 to 12 months (37.7 and 36.9; in 1). In phase 2, a total of 11 participants had positive results for NP and GP targets (samples obtained at 4.1 to 15.7 months after ETU discharge); cycle-threshold values ranged from 32.7 to 38.0 for NP and from 31.1 to 37.7 for GP. CONCLUSIONS These data showed the long-term presence of Ebola virus RNA in semen and declining persistence with increasing time after ETU discharge. (Funded by the World Health Organization and others.)	[Deen, G. F.; Yamba, F.; James, F.; Wurie, A. H.; Smith, S. J.; Bangura, J.; Jambai, A.] Sierra Leone Minist Hlth & Sanitat, Freetown, Sierra Leone; [Sesay, F. R.; Massaquoi, T. A.; Dumbuya, M. S.; Idriss, B.; Sahr, F.] Sierra Leone Minist Def, Freetown, Sierra Leone; [Davies, T.] Sierra Leone Minist Social Welf Gender & Children, Freetown, Sierra Leone; [Broutet, N.; McDonald, S. L. R.; Marrinan, J. E.; Gaillard, P.; Habib, N.; Thorson, A. E.; Ariyarajah, A.; Coursier, A.; Carino, M.; Wi, T.; Ebrahim, F. K.; Naidoo, D.; Banerjee, A.; Durski, K. N.; Lamunu, M.; Landoulsi, S.; Formenty, P.] WHO, Geneva, Switzerland; [Ongpin, P.] Joint United Nations Program HIV AIDS, Geneva, Switzerland; [Xu, W.; Liu, H.; Liu, W.; Zhang, Y.; Liu, Y.; Liu, Y.; Xu, K.; Wu, G.; Liang, M.; Su, Q.; Hao, Y.] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Lan, Y.] Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China; [Knust, B.; Ervin, E.; Ross, C.; Bernstein, K.; Klena, J.; Abad, N.; Bennett, S. D.; Meites, E.; Malik, T.; Erickson, B. R.; Brault, A.; Winter, J.; Sealy, T.; Nichol, S. T.; Morgan, O.; Stroher, U.] Ctr Dis Control & Prevent, Atlanta, GA USA	Ministry of Health & Sanitation Sierra Leone; World Health Organization; Chinese Center for Disease Control & Prevention; Beijing Institute of Microbiology & Epidemiology; Centers for Disease Control & Prevention - USA	Deen, GF (corresponding author), Connaught Hosp, Freetown, Sierra Leone.	gibrilladeen1960@yahoo.com		Coursier, Antoine/0000-0002-9853-5294; Ervin, Elizabeth/0000-0001-9503-2475; Meites, Elissa/0000-0002-0077-2591; Zhang, Yong/0000-0002-2692-5437; Thorson, Anna/0000-0002-8703-6561; CARINO, Marylin/0000-0001-8122-2075	World Health Organization	World Health Organization(World Health Organization)	Funded by the World Health Organization and others.	Abad N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005827; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Centers for Disease Control and Prevention, 2015, EB EB VIR DIS TRANSM; Centers for Disease Control and Prevention, 2014, EB VIR NP REAL TIM R; Centers for Disease Control and Prevention, 2014, EB VIR VP40 REAL TIM; Christie A, 2015, MMWR-MORBID MORTAL W, V64, P479; Deen GF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005723; Diallo B, 2016, CLIN INFECT DIS, V63, P1353, DOI 10.1093/cid/ciw601; Dietz PM, 2015, CLIN INFECT DIS, V61, P1648, DOI 10.1093/cid/civ568; Dowell SF, 1999, J INFECT DIS, V179, pS87, DOI 10.1086/514284; EMOND RTD, 1977, BMJ-BRIT MED J, V2, P541, DOI 10.1136/bmj.2.6086.541; Erickson BR, 2016, J INFECT DIS, V214, pS258, DOI 10.1093/infdis/jiw296; Kreuels B, 2015, NEW ENGL J MED, V372, P1377, DOI 10.1056/NEJMc1500455; Lee-Kwan SH, 2014, MMWR-MORBID MORTAL W, V63, P1205; MARTINI GA, 1968, KLIN WOCHENSCHR, V46, P398, DOI 10.1007/BF01734141; Medecins Sans Frontieres, 2014, SURV EB HELP OTH FIG; Rabelo I, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00142; Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291; Rogstad KE, 2015, CURR OPIN INFECT DIS, V28, P83, DOI 10.1097/QCO.0000000000000135; Rowe AK, 1999, J INFECT DIS, V179, pS28, DOI 10.1086/514318; SAS Institute, 2014, SAS SYST WIND REL 9; Sissoko D, 2017, LANCET GLOB HEALTH, V5, pE80, DOI 10.1016/S2214-109X(16)30243-1; Soka MJ, 2016, LANCET GLOB HEALTH, V4, pE736, DOI 10.1016/S2214-109X(16)30175-9; Spengler JR, 2015, J INFECT DIS, V212, pS346, DOI 10.1093/infdis/jiv187; Thorson A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008859; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; UNAIDS, 2015, S LEON HIV AIDS EST; UNAIDS, 2015, GUIN HIV AIDS EST; UNAIDS, 2015, LIB HIV AIDS EST; Uyeki TM, 2016, CLIN INFECT DIS, V62, P1552, DOI 10.1093/cid/ciw202; Van Bortel T, 2016, B WORLD HEALTH ORGAN, V94, P210, DOI 10.2471/BLT.15.158543; Wang Q, 2016, BIOMED ENVIRON SCI, V29, P443, DOI 10.3967/bes2016.057; WHO, 2016, INT ADV SEX TRANSM E; World Health Organisation, 2016, EB SIT REP 30 MARCH	34	156	158	4	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 12	2017	377	15					1428	1437		10.1056/NEJMoa1511410	http://dx.doi.org/10.1056/NEJMoa1511410			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FJ4ZP	26465681	Green Accepted			2022-12-28	WOS:000412753100007
J	Coates, LC; Moverley, AR; McParland, L; Brown, S; Navarro-Coy, N; O'Dwyer, JL; Meads, DM; Emery, P; Conaghan, PG; Helliwell, PS				Coates, Laura C.; Moverley, Anna R.; McParland, Lucy; Brown, Sarah; Navarro-Coy, Nuria; O'Dwyer, John L.; Meads, David M.; Emery, Paul; Conaghan, Philip G.; Helliwell, Philip S.			Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial	LANCET			English	Article							QUALITY-OF-LIFE; ANKYLOSING-SPONDYLITIS; DISEASE-ACTIVITY; RHEUMATOID-ARTHRITIS; INSTRUMENT; INDEX; SPONDYLOARTHRITIS; EPIDEMIOLOGY; METHOTREXATE; VALIDATION	Background Early intervention and tight control of inflammation optimise outcomes in rheumatoid arthritis but these approaches have not yet been studied in psoriatic arthritis. We aimed to assess the effect of tight control on early psoriatic arthritis using a treat-to-target approach. Methods For this open-label multicentre randomised controlled trial, adult patients (aged >= 18 years) with early psoriatic arthritis (<24 months symptom duration), who had not previously received treatment with any disease-modifying anti-rheumatic drugs, were enrolled from eight secondary care rheumatology centres in the UK. Enrolled patients were randomly assigned in a 1: 1 ratio to receive either tight control (with review every 4 weeks and with escalation of treatment if minimal disease activity criteria not met) or standard care (standard therapy according to the treating clinician, with review every 12 weeks) for 48 weeks. Randomisation was done by minimisation incorporating a random element, to ensure treatment groups were balanced for randomising centre and pattern of arthritis (oligoarticular vs polyarticular). The randomisation procedure was done through a central 24-h automated telephone system based at the Leeds Institute of Clinical Trials Research (Leeds, UK). This was an open-label study in which patients and clinicians were aware of treatment group assignment. Clinical outcomes were recorded by a masked assessor every 12 weeks. The primary outcome was the proportion of patients achieving an American College of Rheumatology (ACR) 20% (ACR20) response at 48 weeks, analysed by intention to treat with multiple imputation for missing ACR components. Cost-effectiveness was also assessed. This trial is registered with ClinicalTrials.gov, number NCT01106079, and the ISCRCTN registry, number ISCRCTN30147736. Findings Between May 28, 2008, and March 21, 2012, 206 eligible patients were enrolled and randomly assigned to receive tight control (n=101) or standard care (n=105). In the intention-to-treat patient population, the odds of achieving an ACR20 response at 48 weeks were higher in the tight control group than in the standard care group (odds ratio 1.91, 95% CI 1.03-3.55; p=0.0392). Serious adverse events were reported by 20 (10%) patients (25 events in 14 [14%] patients in the tight control group and eight events in six [6%] patients in the standard care group) during the course of the study. No unexpected serious adverse events or deaths occurred. Interpretation Tight control of psoriatic arthritis disease activity through a treat-to-target approach significantly improves joint outcomes for newly diagnosed patients, with no unexpected serious adverse events reported.	[Coates, Laura C.; Moverley, Anna R.; Navarro-Coy, Nuria; Emery, Paul; Conaghan, Philip G.; Helliwell, Philip S.] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England; [McParland, Lucy; Brown, Sarah; Navarro-Coy, Nuria] Univ Leeds, Clin Trials Res Unit, Leeds Inst Clin Trials Res, Leeds, W Yorkshire, England; [O'Dwyer, John L.; Meads, David M.] Univ Leeds, Acad Unit Hlth Econ, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England; [Coates, Laura C.; Moverley, Anna R.; Emery, Paul; Conaghan, Philip G.; Helliwell, Philip S.] Leeds NIHR Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds	Helliwell, PS (corresponding author), Chapel Allerton Hosp, LIRMM, NIHR Leeds Musculoskeletal Biomed Res Unit, Chapel Town Rd, Leeds LS7 4SA, W Yorkshire, England.	p.helliwell@leeds.ac.uk	emery, paul/B-3560-2013	O'Dwyer, John L/0000-0002-7212-6089; Conaghan, Philip/0000-0002-3478-5665	Arthritis Research UK; Pfizer; National Institute for Health Research; Comprehensive Clinical Research Network; Medical Research Council [MR/L01629X/1] Funding Source: researchfish; National Institute for Health Research [CL-2011-02-001] Funding Source: researchfish; Versus Arthritis [18825, 18475] Funding Source: researchfish; MRC [MR/L01629X/1] Funding Source: UKRI	Arthritis Research UK(Versus Arthritis); Pfizer(Pfizer); National Institute for Health Research(National Institute for Health Research (NIHR)); Comprehensive Clinical Research Network; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by Arthritis Research UK and Pfizer. We thank the National Institute for Health Research and the Comprehensive Clinical Research Network for supporting this research.	Armstrong AW, 2013, JAMA DERMATOL, V149, P1180, DOI 10.1001/jamadermatol.2013.5264; Bond SJ, 2007, ANN RHEUM DIS, V66, P370, DOI 10.1136/ard.2006.056457; CALIN A, 1994, J RHEUMATOL, V21, P2281; Cassell SE, 2007, J RHEUMATOL, V34, P123; Chandran V, 2008, J RHEUMATOL, V35, P469; Coates LC, 2010, ANN RHEUM DIS, V69, P48, DOI 10.1136/ard.2008.102053; Coates LC, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-101; Coates LC, 2010, RHEUMATOLOGY, V49, P1793, DOI 10.1093/rheumatology/keq138; Coates LC, 2010, ARTHRIT CARE RES, V62, P965, DOI 10.1002/acr.20155; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Gladman Dafna D, 2005, J Rheumatol, V32, P2262; Gladman DD, 2005, ANN RHEUM DIS, V64, P14, DOI 10.1136/ard.2004.032482; Gladman DD, 1999, J RHEUMATOL, V26, P2409; Gossec L, 2012, ANN RHEUM DIS, V71, P4, DOI 10.1136/annrheumdis-2011-200350; Grigor C, 2004, LANCET, V364, P263, DOI 10.1016/S0140-6736(04)16676-2; Haroon M, 2015, ANN RHEUM DIS, V74, P1045, DOI 10.1136/annrheumdis-2013-204858; Healy PJ, 2008, ARTHRIT RHEUM-ARTHR, V59, P686, DOI 10.1002/art.23568; Healy PJ, 2007, J RHEUMATOL, V34, P1302; Helliwell PS, 2014, ARTHRIT CARE RES, V66, P749, DOI 10.1002/acr.22204; Helliwell PS, 2013, ANN RHEUM DIS, V72, P986, DOI 10.1136/annrheumdis-2012-201341; Kane D, 2003, RHEUMATOLOGY, V42, P1460, DOI 10.1093/rheumatology/keg384; Kingsley GH, 2012, RHEUMATOLOGY, V51, P1368, DOI 10.1093/rheumatology/kes001; McKenna SP, 2004, ANN RHEUM DIS, V63, P162, DOI 10.1136/ard.2003.006296; National Institute for Health and Care Excellence, 2009, RHEUM ARTHR MAN RHEU; Pavy S, 2005, J RHEUMATOL, V32, P80; Reich K, 2009, BRIT J DERMATOL, V160, P1040, DOI 10.1111/j.1365-2133.2008.09023.x; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Schoels MM, 2014, ANN RHEUM DIS, V73, P238, DOI 10.1136/annrheumdis-2013-203860; Sokoll KB, 2001, J RHEUMATOL, V28, P1842; Solomon DH, 2014, ARTHRITIS RHEUMATOL, V66, P775, DOI 10.1002/art.38323; van der Heijde D, 2000, J RHEUMATOL, V27, P261; van Tubergen A, 2003, ANN RHEUM DIS, V62, P140, DOI 10.1136/ard.62.2.140; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	35	297	317	0	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 19	2015	386	10012					2489	2498		10.1016/S0140-6736(15)00347-5	http://dx.doi.org/10.1016/S0140-6736(15)00347-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ1LD	26433318	Green Accepted			2022-12-28	WOS:000366866400023
J	Jiang, JS; Chan, H; Cash, DD; Miracco, EJ; Loo, RRO; Upton, HE; Cascio, D; Johnson, RO; Collins, K; Loo, JA; Zhou, ZH; Feigon, J				Jiang, Jiansen; Chan, Henry; Cash, Darian D.; Miracco, Edward J.; Loo, Rachel R. Ogorzalek; Upton, Heather E.; Cascio, Duilio; Johnson, Reid O'Brien; Collins, Kathleen; Loo, Joseph A.; Zhou, Z. Hong; Feigon, Juli			Structure of Tetrahymena telomerase reveals previously unknown subunits, functions, and interactions	SCIENCE			English	Article							RNA-BINDING DOMAIN; N-TERMINAL DOMAIN; REVERSE-TRANSCRIPTASE; DNA-BINDING; ELECTRON-MICROSCOPY; PROCESSIVITY FACTOR; LENGTH REGULATION; TRIPLE-HELIX; PROTEIN P65; HUMAN CST	Telomerase helps maintain telomeres by processive synthesis of telomere repeat DNA at their 3'-ends, using an integral telomerase RNA (TER) and telomerase reverse transcriptase (TERT). We report the cryo-electron microscopy structure of Tetrahymena telomerase at similar to 9 angstrom resolution. In addition to seven known holoenzyme proteins, we identify two additional proteins that form a complex (TEB) with single-stranded telomere DNA-binding protein Teb1, paralogous to heterotrimeric replication protein A (RPA). The p75-p45-p19 subcomplex is identified as another RPA-related complex, CST (CTC1-STN1-TEN1). This study reveals the paths of TER in the TERT-TER-p65 catalytic core and single-stranded DNA exit; extensive subunit interactions of the TERT essential N-terminal domain, p50, and TEB; and other subunit identities and structures, including p19 and p45C crystal structures. Our findings provide structural and mechanistic insights into telomerase holoenzyme function.	[Jiang, Jiansen; Chan, Henry; Cash, Darian D.; Miracco, Edward J.; Cascio, Duilio; Johnson, Reid O'Brien; Loo, Joseph A.; Feigon, Juli] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Jiang, Jiansen; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Jiang, Jiansen; Zhou, Z. Hong; Feigon, Juli] Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA; [Loo, Rachel R. Ogorzalek; Loo, Joseph A.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Upton, Heather E.; Collins, Kathleen] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Cascio, Duilio; Loo, Joseph A.; Feigon, Juli] Univ Calif Los Angeles, Inst Genom & Prote, UCLA US Dept Energy DOE, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Berkeley; University of California System; University of California Los Angeles	Feigon, J (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	feigon@mbi.ucla.edu	Zhou, Z Hong/HDN-0747-2022		NIH [GM048123, GM071940, GM103479, R01GM054198, P41 RR015301, P41 GM103403]; NSF [MCB1022379]; American Heart Association [14POST18870059]; NIH Ruth L. Kirschstein National Research Service Award (NRSA) [GM101874]; NIH Ruth L. Kirschstein NRSA predoctoral training grant fellowship [GM007185]; NSF Graduate Research Fellowship [DGE-1106400]; DOE [DE-FC0302ER63421, DE-AC02-06CH11357]; Electron Imaging Center for NanoMachines by NIH [S10RR23057, S10OD018111, NSF DBI-133813]; National Center for Advancing Translational Sciences UCLA Clinical and Translational Science Institute [UL1TR000124]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301, S10RR023057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103479, R01GM071940, T32GM007185, F32GM101874, R01GM048123, R01GM054198, P41GM103403] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018111] Funding Source: NIH RePORTER; Direct For Biological Sciences [1517625, 1338135] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); American Heart Association(American Heart Association); NIH Ruth L. Kirschstein National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Ruth L. Kirschstein NRSA predoctoral training grant fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE)); Electron Imaging Center for NanoMachines by NIH; National Center for Advancing Translational Sciences UCLA Clinical and Translational Science Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by grants from the NIH (GM048123) and NSF (MCB1022379) to J.F., NIH grant GM071940 to Z.H.Z., NIH grant GM103479 to J.A.L., NIH grant R01GM054198 to K.C., American Heart Association postdoctoral fellowship 14POST18870059 to J.J., NIH Ruth L. Kirschstein National Research Service Award (NRSA) postdoctoral fellowship GM101874 to E.J.M., NIH Ruth L. Kirschstein NRSA predoctoral training grant fellowship under GM007185 to H.C. and R.O.J., and NSF Graduate Research Fellowship under DGE-1106400 to H.E.U. We acknowledge support for the NMR core, crystallization core, and x-ray core facilities by DOE grant DE-FC0302ER63421 and the Electron Imaging Center for NanoMachines by NIH grants S10RR23057 and S10OD018111 and NSF DBI-133813. The APS of Argonne National Laboratory is supported by NIH grants P41 RR015301 and P41 GM103403. Use of the APS is supported by DOE under contract DE-AC02-06CH11357. Additional support for EM time was provided to J.F. by National Center for Advancing Translational Sciences UCLA Clinical and Translational Science Institute grant UL1TR000124. We thank M. Sawaya and M. Collazo for help with crystallography and M. Capel, K. Rajashankar, N. Sukumar, F. Murphy, and I. Kourinov of NECAT. The 9.4 and 8.9 angstrom cryo-EM density maps of Tetrahymena telomerase holoenzyme have been deposited in the Electron Microscopy Data Bank under accession numbers EMD-6442 and EMD-6443, respectively. Coordinates and structure factors for the x-ray crystal structures of p19 and p45C have been deposited in the PDB with accession codes 5DFM and 5DFN, respectively. Coordinates and restraints for the solution NMR structure of the TER PK and chemical shifts have been deposited in the PDB (accession code 2N6Q) and Biological Magnetic Resonance Bank (accession code 25777), respectively. Nucleotide sequence data are available in the third-party annotation (TPA) section of the DNA Data Bank of Japan, European Molecular Biology Laboratory, and GenBank databases under the accession numbers TPA: BK009378 and BK009379.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], PYMOL MOL GRAPH SYST; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Berman AJ, 2010, MOL CELL BIOL, V30, P4965, DOI 10.1128/MCB.00827-10; de Jesus BB, 2013, TRENDS GENET, V29, P513, DOI 10.1016/j.tig.2013.06.007; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Blackburn EH, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003558; Bley CJ, 2011, P NATL ACAD SCI USA, V108, P20333, DOI 10.1073/pnas.1100270108; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Bryan C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066756; Cash DD, 2013, P NATL ACAD SCI USA, V110, P10970, DOI 10.1073/pnas.1309590110; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chen JL, 2002, NUCLEIC ACIDS RES, V30, P592, DOI 10.1093/nar/30.2.592; Chen LY, 2013, NUCLEUS-AUSTIN, V4, P277, DOI 10.4161/nucl.25701; Chen LY, 2012, NATURE, V488, P540, DOI 10.1038/nature11269; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Eckert B, 2012, J BIOL CHEM, V287, P12805, DOI 10.1074/jbc.M112.339853; Egan ED, 2012, RNA, V18, P1747, DOI 10.1261/rna.034629.112; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erde J, 2014, J PROTEOME RES, V13, P1885, DOI 10.1021/pr4010019; Gillis AJ, 2008, NATURE, V455, P633, DOI 10.1038/nature07283; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hong K, 2013, MOL CELL BIOL, V33, P3962, DOI 10.1128/MCB.00792-13; Huang J, 2014, NAT STRUCT MOL BIOL, V21, P507, DOI 10.1038/nsmb.2819; Jacob NK, 2007, MOL CELL BIOL, V27, P1592, DOI 10.1128/MCB.01975-06; Jacobs SA, 2006, NAT STRUCT MOL BIOL, V13, P218, DOI 10.1038/nsmb1054; Jiang JS, 2013, NATURE, V496, P187, DOI 10.1038/nature12062; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kim NK, 2008, J MOL BIOL, V384, P1249, DOI 10.1016/j.jmb.2008.10.005; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lewis KA, 2012, STRUCTURE, V20, P28, DOI 10.1016/j.str.2011.10.017; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Linger BR, 2011, MOL BIOL CELL, V22, P4161, DOI 10.1091/mbc.E11-06-0551; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lue NF, 2013, NAT STRUCT MOL BIOL, V20, P10, DOI 10.1038/nsmb.2483; Lue NF, 2003, MOL CELL BIOL, V23, P8440, DOI 10.1128/MCB.23.23.8440-8449.2003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mihalusova M, 2011, P NATL ACAD SCI USA, V108, P20339, DOI 10.1073/pnas.1017686108; Min BS, 2010, J BIOL CHEM, V285, P16434, DOI 10.1074/jbc.M110.119172; Min BS, 2009, MOL CELL, V36, P609, DOI 10.1016/j.molcel.2009.09.041; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mitchell M, 2010, NAT STRUCT MOL BIOL, V17, P513, DOI 10.1038/nsmb.1777; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; Nandakumar J, 2013, NAT REV MOL CELL BIO, V14, P71, DOI 10.1038/nrm3505; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; O'Connor CM, 2006, MOL CELL BIOL, V26, P2029, DOI 10.1128/MCB.26.6.2029-2036.2006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Podlevsky JD, 2012, MUTAT RES-FUND MOL M, V730, P3, DOI 10.1016/j.mrfmmm.2011.11.002; Prakash Aishwarya, 2012, Subcell Biochem, V62, P171, DOI 10.1007/978-94-007-4572-8_10; Price CM, 2010, CELL CYCLE, V9, P3157, DOI 10.4161/cc.9.16.12547; Qi XD, 2012, EMBO J, V31, P150, DOI 10.1038/emboj.2011.363; Qiao F, 2008, NAT STRUCT MOL BIOL, V15, P634, DOI 10.1038/nsmb.1420; Rao T, 2014, P NATL ACAD SCI USA, V111, P214, DOI 10.1073/pnas.1316453111; Rouda S, 2007, STRUCTURE, V15, P1403, DOI 10.1016/j.str.2007.09.007; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schmidt JC, 2014, ELIFE, V3, DOI 10.7554/eLife.03563; Sexton AN, 2014, GENE DEV, V28, P1885, DOI 10.1101/gad.246819.114; Sexton AN, 2012, J BIOL CHEM, V287, P34455, DOI 10.1074/jbc.M112.394767; Singh M, 2012, MOL CELL, V47, P16, DOI 10.1016/j.molcel.2012.05.018; Stewart JA, 2012, MUTAT RES-FUND MOL M, V730, P12, DOI 10.1016/j.mrfmmm.2011.08.011; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Sun J, 2009, GENE DEV, V23, P2900, DOI 10.1101/gad.1851909; Talley JM, 2011, J BIOL CHEM, V286, P26431, DOI 10.1074/jbc.M111.228635; Theimer CA, 2005, MOL CELL, V17, P671, DOI 10.1016/j.molcel.2005.01.017; Theimer CA, 2006, CURR OPIN STRUC BIOL, V16, P307, DOI 10.1016/j.sbi.2006.05.005; Tucey TM, 2014, GENE DEV, V28, P2077, DOI 10.1101/gad.246256.114; Upton HE, 2014, MOL CELL BIOL, V34, P4200, DOI 10.1128/MCB.01030-14; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wang F, 2012, CELL REP, V2, P1096, DOI 10.1016/j.celrep.2012.10.007; Wellinger RJ, 2012, GENETICS, V191, P1073, DOI 10.1534/genetics.111.137851; Witkin KL, 2004, GENE DEV, V18, P1107, DOI 10.1101/gad.1201704; Wu P, 2012, CELL, V150, P39, DOI 10.1016/j.cell.2012.05.026; Wu RA, 2014, EMBO J, V33, P921, DOI 10.1002/embj.201387205; Xie MY, 2010, NUCLEIC ACIDS RES, V38, P1982, DOI 10.1093/nar/gkp1198; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Xiong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030630; Zaug AJ, 2008, NAT STRUCT MOL BIOL, V15, P871, DOI 10.1038/nsmb.1462; Zeng ZX, 2011, P NATL ACAD SCI USA, V108, P20357, DOI 10.1073/pnas.1113624108; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012	84	108	117	0	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260							aab4070	10.1126/science.aab4070	http://dx.doi.org/10.1126/science.aab4070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU6RG	26472759	Green Accepted			2022-12-28	WOS:000363660000040
J	Jadoul, M; Horsmans, Y				Jadoul, Michel; Horsmans, Yves			Towards eradication of hepatitis C virus from dialysis units	LANCET			English	Editorial Material							HEMODIALYSIS; EPIDEMIOLOGY; INFECTION		[Jadoul, Michel] Catholic Univ Louvain, Clin Univ St Luc, Dept Nephrol, B-1200 Brussels, Belgium; Catholic Univ Louvain, Clin Univ St Luc, Dept Hepatogastroenterol, B-1200 Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Jadoul, M (corresponding author), Catholic Univ Louvain, Clin Univ St Luc, Dept Nephrol, B-1200 Brussels, Belgium.	michel.jadoul@uclouvain.be						Caro L, 2015, REV ANTIVIRAL THER I, V4; Fabrizi F, 2003, ALIMENT PHARM THER, V18, P1071, DOI 10.1046/j.1365-2036.2003.01780.x; Fissell RB, 2016, HEMODIAL INT, V20, P38, DOI 10.1111/hdi.12315; Fissell RB, 2004, KIDNEY INT, V65, P2335, DOI 10.1111/j.1523-1755.2004.00649.x; Goodkin DA, 2013, AM J NEPHROL, V38, P405, DOI 10.1159/000355615; Jadoul M, 2004, NEPHROL DIAL TRANSPL, V19, P904, DOI 10.1093/ndt/gfh012; Jadoul M, 2014, SEMIN DIALYSIS, V27, P449, DOI 10.1111/sdi.12295; Jadoul M, 2014, NEPHROL DIAL TRANSPL, V29, P1108, DOI 10.1093/ndt/gfu047; Kwo PY, 2015, CURR OPIN ORGAN TRAN, V20, P235, DOI 10.1097/MOT.0000000000000198; Roth D, 2015, LANCET; Webster DP, 2015, LANCET, V385, P1124, DOI [10.1016/S0140-6736(14)62401-6, 10.1016/S0140-6736(14)61932-2]; 2008, KIDNEY INT S, V109, pS1	12	17	17	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2015	386	10003					1514	1515		10.1016/S0140-6736(15)00381-5	http://dx.doi.org/10.1016/S0140-6736(15)00381-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CT5VC	26456906				2022-12-28	WOS:000362878200007
J	Han, B; Compton, WM; Jones, CM; Cai, R				Han, Beth; Compton, Wilson M.; Jones, Christopher M.; Cai, Rong			Nonmedical Prescription Opioid Use and Use Disorders Among Adults Aged 18 Through 64 Years in the United States, 2003-2013	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANALGESIC ABUSE; PAIN RELIEVERS; TRENDS; FREQUENCY	IMPORTANCE Since 1999, the United States has experienced increases in morbidity and mortality associated with nonmedical use of prescription opioids. OBJECTIVE To assess national trends in and characteristics of nonmedical prescription opioid use and use disorders and the national trend in related mortality. DESIGN, SETTING, AND PARTICIPANTS Prevalence of nonmedical use and use disorders and related risk factors were based on data from 472 200 persons aged 18 through 64 years who participated in the 2003-2013 National Surveys on Drug Use and Health. Mortality was based on the 2003-2013 National Vital Statistics System's Multiple Cause of Death Files. EXPOSURES Prevalence of nonmedical use of prescription opioids. MAIN OUTCOMES AND MEASURES Nonmedical prescription opioid use and use disorders. RESULTS Among adults aged 18 through 64 years, the prevalence of nonmedical use of prescription opioids decreased from 5.4% (95% CI, 5.08%-5.70%) in 2003 to 4.9% (95% CI, 4.58%-5.22%) in 2013 (absolute difference, -0.5%; 95% CI, -0.11% to -0.89%), but the prevalence of prescription opioid use disorders increased from 0.6% (95% CI, 0.54%-0.76%) in 2003 to 0.9% (95% CI, 0.75%-1.01%) in 2013 (absolute difference, 0.3%; 95% CI, 0.03%-0.43%). The 12-month prevalence of high-frequency use (>= 200 days) also increased from 0.3% (95% CI, 0.19%-0.35%) in 2003 to 0.4% (95% CI, 0.31%-0.48%) in 2013 (absolute difference, 0.1%; 95% CI, 0.01%-0.29%). Mortality assessed by drug overdose death rates involving prescription opioids increased from 4.5 per 100 000 (95% CI, 4.42-4.61) in 2003 to 7.8 per 100 000 (95% CI, 7.64-7.89) in 2013 (absolute difference, 3.3; 95% CI, 3.09-3.41) among adults aged 18 through 64 years. The mean number of days of nonmedical use of prescription opioids increased from 2.1 (95% CI, 1.83-2.37) in 2003 to 2.6 (95% CI, 2.27-2.85) in 2013 (absolute difference, 0.5, 95% CI, 0.05-0.86). The model-adjusted prevalence of having prescription opioid use disorders among nonmedical users increased to 15.7% (95% CI, 13.87%-17.67%) in 2010,16.1% (95% CI, 14.36%-17.99%) in 2011, 17.0% (95% CI, 15.07%-19.12%) in 2012, and 16.9% (95% CI, 14.95%-19.03%) in 2013 from 12.7% (95% CI, 11.04%-14.53%) in 2003. CONCLUSIONS AND RELEVANCE During the 2003-2013 years, among adults aged 18 through 64 years, the percentage of nonmedical use of prescription opioids decreased. In contrast, the prevalence of prescription opioid use disorders, frequency of use, and related mortality increased.	[Han, Beth; Cai, Rong] Subst Abuse & Mental Hlth Serv Adm, Rockville, MD 20857 USA; [Compton, Wilson M.] NIDA, NIH, Bethesda, MD USA; [Jones, Christopher M.] US FDA, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); US Food & Drug Administration (FDA)	Han, B (corresponding author), Subst Abuse & Mental Hlth Serv Adm, One Choke Cherry Rd,Room 2-1079, Rockville, MD 20857 USA.	beth.han@samhsa.hhs.gov			Substance Abuse and Mental Health Services Administration; National Institute on Drug Abuse; US Food and Drug Administration	Substance Abuse and Mental Health Services Administration(United States Department of Health & Human Services); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); US Food and Drug Administration	This study was jointly sponsored by the Substance Abuse and Mental Health Services Administration, the National Institute on Drug Abuse, and the US Food and Drug Administration. The National Surveys on Drug Use and Health were supported by contracts from the Substance Abuse and Mental Health Services Administration.	American Association for Public Opinion Research, 2015, STAND DEF FIN DISP C, V8th ed, P52; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Baumblatt JAG, 2014, JAMA INTERN MED, V174, P796, DOI 10.1001/jamainternmed.2013.12711; Bieler GS, 2010, AM J EPIDEMIOL, V171, P618, DOI 10.1093/aje/kwp440; Cai R., 2010, Morbidity and Mortality Weekly Report, V59, P705; Center for Behavioral Health Statistics and Quality, 2014, 2013 NAT SURV DRUG U; Center for Behavioral Health Statistics and Quality, 2014, NAT SURV DRUG US HLT; Centers for Disease Control and Prevention, 2014, MULT CAUS OF DEATH D; Centers for Disease Control and Prevention (CDC), 2012, MMWR MORB MORTAL WKL, V61, P10; Compton WM, 2015, PREV MED, V80, P5, DOI 10.1016/j.ypmed.2015.04.003; Compton WM, 2006, DRUG ALCOHOL DEPEN, V81, P103, DOI 10.1016/j.drugalcdep.2005.05.009; Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; Hilbe JM, 2007, NEGATIVE BINOMIAL RE; Jones CM, 2015, AM J PREV MED, V49, P493, DOI 10.1016/j.amepre.2015.03.040; Jones CM, 2015, MMWR-MORBID MORTAL W, V64, P719; Jones CM, 2014, JAMA-J AM MED ASSOC, V312, P1733, DOI 10.1001/jama.2014.13480; Jones CM, 2014, JAMA INTERN MED, V174, P802, DOI 10.1001/jamainternmed.2013.12809; Jones CM, 2013, DRUG ALCOHOL DEPEN, V132, P95, DOI 10.1016/j.drugalcdep.2013.01.007; Jones CM, 2012, ARCH INTERN MED, V172, P1265, DOI 10.1001/archinternmed.2012.2533; Mack KA, 2015, J HEALTH CARE POOR U, V26, P182, DOI 10.1353/hpu.2015.0009; Modarai F, 2013, DRUG ALCOHOL DEPEN, V132, P81, DOI 10.1016/j.drugalcdep.2013.01.006; Murphy Sherry L, 2013, Natl Vital Stat Rep, V61, P1; National Vital Statistics System National Center for Health Statistics CDC, NAT VIT STAT SYST; Office of National Drug Control Policy, 2012, NAT DRUG CONTR STRAT; Olsen Y, 2014, JAMA-J AM MED ASSOC, V311, P1393, DOI 10.1001/jama.2014.2147; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Paulozzi LJ, 2013, J CLIN TOXICOL, V3, P175, DOI DOI 10.4172/2161-0495.1000175; Reifler LM, 2012, PAIN MED, V13, P434, DOI 10.1111/j.1526-4637.2012.01327.x; Research Triangle Institute, 2015, SUDAAN REL 11 0 1; Shiffman S, 2004, NICOTINE TOB RES, V6, P327, DOI 10.1080/1462220042000202481; StataCorp, 2014, STATA STAT SOFTW REL; Substance Abuse and Mental Health Services Administration, NAT SURV DRUG US HLT; Substance Abuse and Mental Health Services Administration, DRUG AB WARN NETW NA; Substance Abuse Mental Health Services Administration, 2014, NSDUH SER H, V(SMA) 14-4863; Tourangeau R, 2013, NONRESPONSE SOCIAL S; Volkow ND, 2014, NEW ENGL J MED, V370, P2063, DOI 10.1056/NEJMp1402780	37	248	249	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2015	314	14					1468	1478		10.1001/jama.2015.11859	http://dx.doi.org/10.1001/jama.2015.11859			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2QI	26461997	Bronze			2022-12-28	WOS:000362647800014
J	Calle-Vallejo, F; Tymoczko, J; Colic, V; Vu, QH; Pohl, MD; Morgenstern, K; Loffreda, D; Sautet, P; Schuhmann, W; Bandarenka, AS				Calle-Vallejo, Federico; Tymoczko, Jakub; Colic, Viktor; Vu, Quang Huy; Pohl, Marcus D.; Morgenstern, Karina; Loffreda, David; Sautet, Philippe; Schuhmann, Wolfgang; Bandarenka, Aliaksandr S.			Finding optimal surface sites on heterogeneous catalysts by counting nearest neighbors	SCIENCE			English	Article							OXYGEN REDUCTION; TRANSITION-METALS; ACTIVE-SITES; PLATINUM; NANOPARTICLES; ELECTROCATALYSIS; IDENTIFICATION; ELECTRODES; ALLOYS; DESIGN	A good heterogeneous catalyst for a given chemical reaction very often has only one specific type of surface site that is catalytically active. Widespread methodologies such as Sabatier-type activity plots determine optimal adsorption energies to maximize catalytic activity, but these are difficult to use as guidelines to devise new catalysts. We introduce "coordination-activity plots" that predict the geometric structure of optimal active sites. The method is illustrated on the oxygen reduction reaction catalyzed by platinum. Sites with the same number of first-nearest neighbors as (111) terraces but with an increased number of second-nearest neighbors are predicted to have superior catalytic activity. We used this rationale to create highly active sites on platinum (111), without alloying and using three different affordable experimental methods.	[Calle-Vallejo, Federico; Loffreda, David; Sautet, Philippe] Univ Lyon 1, CNRS, Ecole Normale Super Lyon, Lab Chim, F-69364 Lyon 07, France; [Calle-Vallejo, Federico] Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands; [Tymoczko, Jakub; Colic, Viktor; Schuhmann, Wolfgang; Bandarenka, Aliaksandr S.] Ruhr Univ Bochum, Ctr Electrochem Sci, D-44780 Bochum, Germany; [Tymoczko, Jakub; Schuhmann, Wolfgang] Ruhr Univ Bochum, Analyt Chem, D-44780 Bochum, Germany; [Colic, Viktor; Pohl, Marcus D.; Bandarenka, Aliaksandr S.] Tech Univ Munich, Dept Phys, Energy Convers & Storage, D-85748 Garching, Germany; [Vu, Quang Huy; Morgenstern, Karina] Ruhr Univ Bochum, Phys Chem 1, D-44780 Bochum, Germany; [Bandarenka, Aliaksandr S.] Nanosyst Initiat Munich, D-80799 Munich, Germany	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Leiden University; Leiden University - Excl LUMC; Ruhr University Bochum; Ruhr University Bochum; Technical University of Munich; Ruhr University Bochum	Bandarenka, AS (corresponding author), Ruhr Univ Bochum, Ctr Electrochem Sci, Univ Str 150, D-44780 Bochum, Germany.	f.calle.vallejo@chem.leidenuniv.nl; philippe.sautet@ens-lyon.fr; bandarenka@ph.tum.de	Schuhmann, Wolfgang/S-2626-2016; Bandarenka, Aliaksandr/AAO-1553-2021; Čolić, Viktor/J-6905-2016; Sautet, Philippe/G-3710-2014; Morgenstern, Karina/P-1563-2019; Calle-Vallejo, Federico/GVU-7047-2022	Schuhmann, Wolfgang/0000-0003-2916-5223; Čolić, Viktor/0000-0003-1118-5592; Sautet, Philippe/0000-0002-8444-3348; Morgenstern, Karina/0000-0002-6660-5286; Calle-Vallejo, Federico/0000-0001-5147-8635	Netherlands Organisation for Scientific Research (NWO), Veni [722.014.009]; European Union [303419]; Cluster of Excellence RESOLV - Deutsche Forschungsgemeinschaft, Helmholtz-Energie-Allianz [HA-E-0002]; Cluster of Excellence Nanosystems Initiative Munich; Centre Informatique National de l'Enseignement Superieur [609]; Cluster of Excellence RESOLV - Deutsche Forschungsgemeinschaft [SFB 749]	Netherlands Organisation for Scientific Research (NWO), Veni(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission); Cluster of Excellence RESOLV - Deutsche Forschungsgemeinschaft, Helmholtz-Energie-Allianz(German Research Foundation (DFG)); Cluster of Excellence Nanosystems Initiative Munich; Centre Informatique National de l'Enseignement Superieur; Cluster of Excellence RESOLV - Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We received funding from The Netherlands Organisation for Scientific Research (NWO), Veni project 722.014.009; the European Union's FP7/2007-2013 program, grant 303419 (PUMA MIND); the Cluster of Excellence RESOLV (EXC 1069) funded by Deutsche Forschungsgemeinschaft, Helmholtz-Energie-Allianz (HA-E-0002), and SFB 749; and the Cluster of Excellence Nanosystems Initiative Munich. We thank Stichting Nationale Computerfaciliteiten (NCF), Institut du Developpement et des Ressources en Informatique Scientifique, Centre Informatique National de l'Enseignement Superieur (project 609, GENCI/CT8), and Pole Scientifique de Modelisation Numerique for CPU time. We thank A. Pathan, M. Schmuck, and A. Zychma (RUB) for supporting measurements. The DFT data appear in tables S1 to S3.	Aaronson BDB, 2013, J AM CHEM SOC, V135, P3873, DOI 10.1021/ja310632k; Bandarenka AS, 2012, ANGEW CHEM INT EDIT, V51, P11845, DOI 10.1002/anie.201205314; Baran JD, 2014, J AM CHEM SOC, V136, P1320, DOI 10.1021/ja4060299; Behrens M, 2012, SCIENCE, V336, P893, DOI [10.1126/science.12198331, 10.1126/science.1219831]; Calle-Vallejo F, 2013, SURF SCI, V607, P47, DOI 10.1016/j.susc.2012.08.005; Calle-Vallejo F, 2014, ANGEW CHEM INT EDIT, V53, P8316, DOI 10.1002/anie.201402958; Calle-Vallejo F, 2013, CHEM SOC REV, V42, P5210, DOI 10.1039/c3cs60026b; Calle-Vallejo F, 2013, CHEM SCI, V4, P1245, DOI 10.1039/c2sc21601a; Dubau L, 2014, J MATER CHEM A, V2, P18497, DOI 10.1039/c4ta03975k; Escudero-Escribano M, 2012, J AM CHEM SOC, V134, P16476, DOI 10.1021/ja306348d; Gasteiger HA, 2005, APPL CATAL B-ENVIRON, V56, P9, DOI 10.1016/j.apcatb.2004.06.021; Greeley J, 2009, NAT CHEM, V1, P552, DOI [10.1038/NCHEM.367, 10.1038/nchem.367]; JOHNSON DC, 1970, ELECTROCHIM ACTA, V15, P1493, DOI 10.1016/0013-4686(70)80070-6; Kleis J, 2011, CATAL LETT, V141, P1067, DOI 10.1007/s10562-011-0632-0; Lee I, 2009, NAT MATER, V8, P132, DOI [10.1038/NMAT2371, 10.1038/nmat2371]; Li HJ, 2014, J AM CHEM SOC, V136, P15694, DOI 10.1021/ja508649p; Mpourmpakis G, 2010, NANO LETT, V10, P1041, DOI 10.1021/nl904299c; Norskov JK, 2009, NAT CHEM, V1, P37, DOI [10.1038/nchem.121, 10.1038/NCHEM.121]; Norskov JK, 2004, J PHYS CHEM B, V108, P17886, DOI 10.1021/jp047349j; SOMORJAL GA, 1986, IND ENG CHEM FUND, V25, P63, DOI 10.1021/i100021a009; Stamenkovic VR, 2007, SCIENCE, V315, P493, DOI 10.1126/science.1135941; Stephens IEL, 2012, ENERG ENVIRON SCI, V5, P6744, DOI 10.1039/c2ee03590a; Stephens IEL, 2011, J AM CHEM SOC, V133, P5485, DOI 10.1021/ja111690g; Strasser P, 2008, PHYS CHEM CHEM PHYS, V10, P3670, DOI 10.1039/b803717e; Strasser P, 2010, NAT CHEM, V2, P454, DOI [10.1038/NCHEM.623, 10.1038/nchem.623]; Suntivich J, 2011, NAT CHEM, V3, P647, DOI 10.1038/NCHEM.1093; Topalov AA, 2012, ANGEW CHEM INT EDIT, V51, P12613, DOI 10.1002/anie.201207256; Van Santen RA, 2009, ACCOUNTS CHEM RES, V42, P57, DOI 10.1021/ar800022m; Vines F, 2014, CHEM SOC REV, V43, P4922, DOI 10.1039/c3cs60421g; Zambelli T, 1996, SCIENCE, V273, P1688, DOI 10.1126/science.273.5282.1688	30	566	567	31	654	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257					185	189		10.1126/science.aab3501	http://dx.doi.org/10.1126/science.aab3501			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9JB	26450207				2022-12-28	WOS:000362405600033
J	Ferguson, SM				Ferguson, Shawn M.			Membrane traffic en route to cancer	SCIENCE			English	Editorial Material							PROTEIN; RAS		[Ferguson, Shawn M.] Yale Univ, Dept Cell Biol, New Haven, CT 06510 USA; [Ferguson, Shawn M.] Yale Univ, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA	Yale University; Yale University	Ferguson, SM (corresponding author), Yale Univ, Dept Cell Biol, New Haven, CT 06510 USA.	shawn.ferguson@yale.edu			NIA NIH HHS [AG047270] Funding Source: Medline; NIGMS NIH HHS [R01 GM105718, GM105718] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG047270] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Chaineau M, 2013, TRAFFIC, V14, P1109, DOI 10.1111/tra.12096; Ferguson SM, 2015, CURR OPIN CELL BIOL, V35, P59, DOI 10.1016/j.ceb.2015.04.014; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Ioannou MS, 2015, J CELL BIOL, V208, P629, DOI 10.1083/jcb.201407068; Liu PD, 2015, CANCER DISCOV, V5, P1194, DOI 10.1158/2159-8290.CD-15-0460; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Tan XJ, 2015, EMBO J, V34, P475, DOI 10.15252/embj.201489425; Wandinger-Ness A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a022616; Wheeler DB, 2015, SCIENCE, V350, P211, DOI 10.1126/science.aaa4903; Wu XD, 2011, P NATL ACAD SCI USA, V108, P18672, DOI 10.1073/pnas.1110415108	14	1	1	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257					162	163		10.1126/science.aad3575	http://dx.doi.org/10.1126/science.aad3575			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9JB	26450197				2022-12-28	WOS:000362405600019
J	Liu, L; Edwards, SV				Liu, Liang; Edwards, Scott V.			Comment on "Statistical binning enables an accurate coalescent-based estimation of the avian tree"	SCIENCE			English	Editorial Material								Mirarab et al. (Research Article, 12 December 2014, p. 1250463) introduced statistical binning to improve the signal in phylogenetic methods using the multispecies coalescent model. We show that all forms of binning-naive, statistical, and weighted statistical-display poor performance and are statistically inconsistent in large regions of parameter space, unlike unbinned sequence data used with species tree methods.	[Liu, Liang] Univ Georgia, Dept Stat, Athens, GA 30602 USA; [Edwards, Scott V.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	University System of Georgia; University of Georgia; Harvard University	Edwards, SV (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	sedwards@fas.harvard.edu	Edwards, Scott V./D-9071-2018	Edwards, Scott V./0000-0003-2535-6217				Bayzid MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129183; Bayzid MS, 2013, BIOINFORMATICS, V29, P2277, DOI 10.1093/bioinformatics/btt394; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Lanier HC, 2012, SYST BIOL, V61, P691, DOI 10.1093/sysbio/syr128; Liu L, 2015, ANN N Y ACAD SCI; Liu LA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-302; Mirarab S, 2014, SCIENCE, V346, P1337, DOI 10.1126/science.1250463; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Roch S, 2015, THEOR POPUL BIOL, V100, P56, DOI 10.1016/j.tpb.2014.12.005; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446	10	13	13	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257								10.1126/science.aaa7343	http://dx.doi.org/10.1126/science.aaa7343			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9JB	26450203				2022-12-28	WOS:000362405600026
J	Fidias, PM; Long, AA; Fintelmann, FJ; Zukerberg, LR				Fidias, Panos M.; Long, Aidan A.; Fintelmann, Florian J.; Zukerberg, Lawrence R.			Case 31-2015: A 29-Year-Old Man with Thymoma, Diarrhea, and Weight Loss	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADULT-AUTOIMMUNE-ENTEROPATHY; THYMIC EPITHELIAL TUMORS; PHASE-II TRIAL; RED-CELL APLASIA; MALIGNANT THYMOMA; EXPERIENCE; CARCINOMA; CHEMOTHERAPY; IMMUNODEFICIENCY; LYMPHOCYTES		[Fidias, Panos M.; Long, Aidan A.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Fintelmann, Florian J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Zukerberg, Lawrence R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Fidias, Panos M.; Long, Aidan A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Fintelmann, Florian J.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Zukerberg, Lawrence R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Fidias, PM (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							Akram S, 2007, CLIN GASTROENTEROL H, V5, P1282, DOI 10.1016/j.cgh.2007.05.013; Barzaghi F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00211; Bedano PM, 2008, J CLIN ONCOL S, V26, p713s; Christodoulou C, 2008, ANN ONCOL, V19, P1361, DOI 10.1093/annonc/mdn388; Ciccocioppo R, 2012, MAYO CLIN PROC, V87, P909, DOI 10.1016/j.mayocp.2012.04.014; Farina G, 2007, LANCET ONCOL, V8, P449, DOI 10.1016/S1470-2045(07)70141-9; FORNASIERO A, 1991, CANCER, V68, P30, DOI 10.1002/1097-0142(19910701)68:1<30::AID-CNCR2820680106>3.0.CO;2-4; Furtado AK, 2012, WORLD J GASTROENTERO, V18, P2430, DOI 10.3748/wjg.v18.i19.2430; Gay CM, 2014, J NATL COMPR CANC NE, V12, P1505, DOI 10.6004/jnccn.2014.0149; Gentile Nicole M, 2012, Curr Gastroenterol Rep, V14, P380, DOI 10.1007/s11894-012-0276-2; Giaccone G, 2009, J THORAC ONCOL, V4, P1270, DOI 10.1097/JTO.0b013e3181b6be57; Girard N, 2009, CLIN CANCER RES, V15, P6790, DOI 10.1158/1078-0432.CCR-09-0644; Gupta NK, 2014, J CLIN GASTROENTEROL, V48, P55, DOI 10.1097/MCG.0b013e3182a4e0ec; HAYWARD AR, 1982, CLIN EXP IMMUNOL, V48, P437; Kelesidis T, 2010, CLIN IMMUNOL, V135, P347, DOI 10.1016/j.clim.2010.01.006; Kelly RJ, 2011, J CLIN ONCOL, V29, P4820, DOI 10.1200/JCO.2011.36.0487; KORNACKI S, 1995, AM J SURG PATHOL, V19, P224, DOI 10.1097/00000478-199502000-00011; Kunitoh H, 2009, BRIT J CANCER, V101, P1549, DOI 10.1038/sj.bjc.6605347; Lemma GL, 2011, J CLIN ONCOL, V29, P2060, DOI 10.1200/JCO.2010.32.9607; LITWIN SD, 1977, NATURE, V266, P57, DOI 10.1038/266057a0; Loehrer PJ, 2004, J CLIN ONCOL, V22, p629S; Loehrer PJ, 2004, J CLIN ONCOL, V22, P293, DOI 10.1200/JCO.2004.02.047; Mais DD, 1999, AM J CLIN PATHOL, V112, P810; Marx A, 2010, J THORAC ONCOL, V5, pS266, DOI 10.1097/JTO.0b013e3181f1f63f; Meamar AR, 2009, J MICROBIOL IMMUNOL, V42, P526; Oritani K, 2000, NAT MED, V6, P659, DOI 10.1038/76233; Palmieri G, 2002, CANCER-AM CANCER SOC, V94, P1414, DOI 10.1002/cncr.10374; Palmieri G, 2010, ANN ONCOL, V21, P1168, DOI 10.1093/annonc/mdp483; Palmieri G, 2007, FRONT BIOSCI-LANDMRK, V12, P757, DOI 10.2741/2098; RA G., 1954, B U MINNESOTA HOSP M, P1; Rajan A, 2014, LANCET ONCOL, V15, P191, DOI 10.1016/S1470-2045(13)70596-5; Salter J.T., 2008, J CLIN ONCOL, V26, p452s; Stein Alexander, 2010, Ther Adv Med Oncol, V2, P51, DOI 10.1177/1758834009355164; Strobel P, 2004, NEW ENGL J MED, V350, P2625, DOI 10.1056/NEJM200406173502523; Thomas A, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.7525; Thompson CA, 2006, BRIT J HAEMATOL, V135, P405, DOI 10.1111/j.1365-2141.2006.06295.x; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Valitutti F, 2014, J CLIN GASTROENTEROL, V48, P264, DOI 10.1097/MCG.0b013e31829e460e; Weber JS, 2012, J CLIN ONCOL, V30, P2691, DOI 10.1200/JCO.2012.41.6750; Zucali PA, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.7527	40	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2015	373	15					1458	1467		10.1056/NEJMcpc1406663	http://dx.doi.org/10.1056/NEJMcpc1406663			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS8XI	26444733				2022-12-28	WOS:000362372800014
J	Vattathil, S; Akey, JM				Vattathil, Selina; Akey, Joshua M.			Small Amounts of Archaic Admixture Provide Big Insights into Human History	CELL			English	Review							NEANDERTHAL ANCESTRY; POSITIVE SELECTION; GENOME SEQUENCE; EAST ASIANS; EUROPEANS; INTROGRESSION; ADAPTATION; CANDIDATE	Modern humans overlapped in time and space with other hominins, such as Neanderthals and Denisovans, and limited amounts of hybridization occurred. Here, we review recent work that has identified archaic hominin sequence that survives in modern human genomes and what these genomic excavations reveal about human evolutionary history.	[Vattathil, Selina; Akey, Joshua M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Akey, JM (corresponding author), Univ Washington, Dept Genome Sci, 3720 15th Ave Northeast,Box 355065, Seattle, WA 98195 USA.	akeyj@uw.edu		Akey, Joshua/0000-0002-4411-1330				Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Enard Wolfgang, 2003, Folia Primatologica, V74, P190; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Jacobs LC, 2013, HUM GENET, V132, P147, DOI 10.1007/s00439-012-1232-9; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Kim BY, 2015, AM J HUM GENET, V96, P454, DOI 10.1016/j.ajhg.2014.12.029; Lachance J, 2012, CELL, V150, P457, DOI 10.1016/j.cell.2012.07.009; Mendez FL, 2012, AM J HUM GENET, V91, P265, DOI 10.1016/j.ajhg.2012.06.015; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Orr HA, 1997, ANNU REV ECOL SYST, V28, P195, DOI 10.1146/annurev.ecolsys.28.1.195; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Racimo F, 2015, NAT REV GENET, V16, P359, DOI 10.1038/nrg3936; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Skoglund P, 2011, P NATL ACAD SCI USA, V108, P18301, DOI 10.1073/pnas.1108181108; Vernot B, 2015, AM J HUM GENET, V96, P448, DOI 10.1016/j.ajhg.2015.01.006; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Wall JD, 2013, GENETICS, V194, P199, DOI 10.1534/genetics.112.148213; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828; Yang MA, 2012, MOL BIOL EVOL, V29, P2987, DOI 10.1093/molbev/mss117	26	38	38	1	76	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2					281	284		10.1016/j.cell.2015.09.042	http://dx.doi.org/10.1016/j.cell.2015.09.042			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26451479	Bronze			2022-12-28	WOS:000362952700006
J	Huang, ZJ; Luo, LQ				Huang, Z. Josh; Luo, Liqun			It takes the world to understand the brain	SCIENCE			English	Editorial Material							AUTISM		[Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Luo, Liqun] Stanford Univ, Dept Biol, HHMI, Stanford, CA 94305 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Stanford University	Huang, ZJ (corresponding author), Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.	huangj@cshl.edu; lluo@stanford.edu		Luo, Liqun/0000-0001-5467-9264	Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [R01 NS050835] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050835] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], 2015, COLD SPRING HARB AS; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jorgenson LA, 2015, PHILOS T R SOC B, V370, P8, DOI 10.1098/rstb.2014.0164; Ramon y Cajal S, 1995, HISTOLOGY NERVOUS SY; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595	6	31	31	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					42	44		10.1126/science.aad4120	http://dx.doi.org/10.1126/science.aad4120			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26430110	Green Accepted			2022-12-28	WOS:000362098300036
J	Wei, MH; Li, BY; David, RLA; Jones, SC; Sarohia, V; Schmitigal, JA; Kornfield, JA				Wei, Ming-Hsin; Li, Boyu; David, R. L. Ameri; Jones, Simon C.; Sarohia, Virendra; Schmitigal, Joel A.; Kornfield, Julia A.			Megasupramolecules for safer, cleaner fuel by end association of long telechelic polymers	SCIENCE			English	Article							SUPRAMOLECULAR POLYMERS; POLYMERIZATION; EQUILIBRIA; COMPLEXES	We used statistical mechanics to design polymers that defy conventional wisdom by self-assembling into "megasupramolecules" (>= 5000 kg/mol) at low concentration (<= 0.3 weight percent). Theoretical treatment of the distribution of individual subunits-end-functional polymers-among cyclic and linear supramolecules (ring-chain equilibrium) predicts that megasupramolecules can format lowtotal polymer concentration if, and only if, the backbones are long (> 400 kg/mol) and end-association strength is optimal. Viscometry and scattering measurements of long telechelic polymers having polycyclooctadiene backbones and acid or amine end groups verify the formation of megasupramolecules. They control misting and reduce drag in the same manner as ultralong covalent polymers. With individual building blocks short enough to avoid hydrodynamic chain scission (weight-average molecular weights of 400 to 1000 kg/mol) and reversible linkages that protect covalent bonds, these megasupramolecules overcome the obstacles of shear degradation and engine incompatibility.	[Wei, Ming-Hsin; Li, Boyu; David, R. L. Ameri; Kornfield, Julia A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Jones, Simon C.] CALTECH, Jet Prop Lab, Electrochem Technol Grp, Pasadena, CA 91109 USA; [Sarohia, Virendra] CALTECH, Jet Prop Lab, Off Chief Technologist, Pasadena, CA 91109 USA; [Schmitigal, Joel A.] US Army RDECOM TARDEC, Warren, MI 48397 USA	California Institute of Technology; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM)	Kornfield, JA (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	jakornfield@cheme.caltech.edu		Li, Boyu/0000-0002-7648-3745	U.S. Army TARDEC; FAA; NASA [NAS7-03001]; Gates Grubstake Fund; Schlumberger Foundation	U.S. Army TARDEC; FAA; NASA(National Aeronautics & Space Administration (NASA)); Gates Grubstake Fund; Schlumberger Foundation(Schlumberger)	Funding for this research was provided from U.S. Army TARDEC, FAA, and NASA (NAS7-03001) and the Gates Grubstake Fund. B.L. is grateful for support from the Schlumberger Foundation Faculty for the Future Program. We thank P. Arakelian (GALCIT) and T. Wynne (JPL) for assistance with the fuel impact tests; B. Hammouda (NIST) and L. He (ORNL) for assistance with SANS; T. Durbin, R. Russell, D. Pacocha, and K. Bumiller at UCR CE-CERT for assistance with engine tests; A. Meyer at Wyatt Technology and Caltech graduate student J. Kim for assistance with MALLS; and Caltech undergraduates S. Li and A. Guo for assistance with shear degradation tests and rheological measurements. A patent application (WO/2014/145920) based on some results reported here has been submitted.	Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; Boal AK, 2000, NATURE, V404, P746, DOI 10.1038/35008037; CHAO KK, 1984, AICHE J, V30, P111, DOI 10.1002/aic.690300116; CHEN ZR, 1995, MACROMOLECULES, V28, P2147, DOI 10.1021/ma00111a007; David RLA, 2009, MACROMOLECULES, V42, P1380, DOI 10.1021/ma802058s; de Greef TFA, 2008, J AM CHEM SOC, V130, P13755, DOI 10.1021/ja8046409; Freed KF, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4730161; Gilli G., 2009, NATURE HYDROGEN BOND, P147; GOLDSTEIN RE, 1986, J CHEM PHYS, V84, P3367, DOI 10.1063/1.450272; Hillmyer MA, 1997, MACROMOLECULES, V30, P718, DOI 10.1021/ma961316n; Ikkala O, 2002, SCIENCE, V295, P2407, DOI 10.1126/science.1067794; JACOBSON H, 1950, J CHEM PHYS, V18, P1600, DOI 10.1063/1.1747547; Ji SX, 2004, MACROMOLECULES, V37, P5485, DOI 10.1021/ma0493067; Larson R. G., 1999, STRUCTURE RHEOLOGY C, P132; Lehn JM, 2002, SCIENCE, V295, P2400, DOI 10.1126/science.1071063; Li SL, 2012, CHEM SOC REV, V41, P5950, DOI 10.1039/c2cs35099h; McKinley GH, 2002, ANNU REV FLUID MECH, V34, P375, DOI 10.1146/annurev.fluid.34.083001.125207; National Research Council Committee on Aviation Fuels with Improved Fire Safety, 1997, AV FUELS IMPR FIR SA; Nickel A, 2012, TOP CATAL, V55, P518, DOI 10.1007/s11244-012-9830-2; Nyden MR, 2004, MAT SCI ENG A-STRUCT, V365, P114, DOI 10.1016/j.msea.2003.09.060; PATERSON RW, 1970, J FLUID MECH, V43, P689, DOI 10.1017/S0022112070002677; PEDLEY AM, 1990, MACROMOLECULES, V23, P2494, DOI 10.1021/ma00211a016; PENG STJ, 1983, J NON-NEWTON FLUID, V12, P95, DOI 10.1016/0377-0257(83)80007-X; PETSCHEK RG, 1986, PHYS REV A, V34, P2391, DOI 10.1103/PhysRevA.34.2391; Sartorius J, 1996, CHEM-EUR J, V2, P1446, DOI 10.1002/chem.19960021118; Sijbesma RP, 1997, SCIENCE, V278, P1601, DOI 10.1126/science.278.5343.1601; Tant M. R., 1997, IONOMERS SYNTHESIS S; Tayi AS, 2012, NATURE, V488, P485, DOI 10.1038/nature11395; Winnik MA, 1997, CURR OPIN COLLOID IN, V2, P424, DOI 10.1016/S1359-0294(97)80088-X; Yang SK, 2011, CHEM SOC REV, V40, P129, DOI 10.1039/c0cs00073f	30	45	50	1	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					72	75		10.1126/science.aab0642	http://dx.doi.org/10.1126/science.aab0642			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26430115				2022-12-28	WOS:000362098300047
J	Lawson, DA; Bhakta, NR; Kessenbrock, K; Prummel, KD; Yu, Y; Takai, K; Zhou, A; Eyob, H; Balakrishnan, S; Wang, CY; Yaswen, P; Goga, A; Werb, Z				Lawson, Devon A.; Bhakta, Nirav R.; Kessenbrock, Kai; Prummel, Karin D.; Yu, Ying; Takai, Ken; Zhou, Alicia; Eyob, Henok; Balakrishnan, Sanjeev; Wang, Chih-Yang; Yaswen, Paul; Goga, Andrei; Werb, Zena			Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells	NATURE			English	Article							TRANSCRIPTOME ANALYSIS; MAMMARY-GLAND; IDENTIFICATION; FATE; INHIBITION; COMMITMENT; MARKERS; GROWTH; TUMORS; GENES	Despite major advances in understanding the molecular and genetic basis of cancer, metastasis remains the cause of >90% of cancer-related mortality(1). Understanding metastasis initiation and progression is critical to developing new therapeutic strategies to treat and prevent metastatic disease. Prevailing theories hypothesize that metastases are seeded by rare tumour cells with unique properties, which may function like stem cells in their ability to initiate and propagate metastatic tumours(2-5). However, the identity of metastasis-initiating cells in human breast cancer remains elusive, and whether metastases are hierarchically organized is unknown(2). Here we show at the single-cell level that early stage metastatic cells possess a distinct stem-like gene expression signature. To identify and isolate metastatic cells from patient-derived xenograft models of human breast cancer, we developed a highly sensitive fluorescence-activated cell sorting (FACS)-based assay, which allowed us to enumerate metastatic cells in mouse peripheral tissues. We compared gene signatures in metastatic cells from tissues with low versus high metastatic burden. Metastatic cells from low-burden tissues were distinct owing to their increased expression of stem cell, epithelial-to-mesenchymal transition, pro-survival, and dormancy-associated genes. By contrast, metastatic cells from high-burden tissues were similar to primary tumour cells, which were more heterogeneous and expressed higher levels of luminal differentiation genes. Transplantation of stem-like metastatic cells from low-burden tissues showed that they have considerable tumour-initiating capacity, and can differentiate to produce luminal-like cancer cells. Progression to high metastatic burden was associated with increased proliferation and MYC expression, which could be attenuated by treatment with cyclin-dependent kinase (CDK) inhibitors. These findings support a hierarchical model for metastasis, in which metastases are initiated by stem-like cells that proliferate and differentiate to produce advanced metastatic disease.	[Lawson, Devon A.; Kessenbrock, Kai; Prummel, Karin D.; Yu, Ying; Takai, Ken; Wang, Chih-Yang; Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Bhakta, Nirav R.; Goga, Andrei] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Kessenbrock, Kai; Zhou, Alicia; Eyob, Henok; Balakrishnan, Sanjeev; Goga, Andrei] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Wang, Chih-Yang] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Yaswen, Paul] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Cell & Mol Biol, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Cheng Kung University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Werb, Z (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	andrei.goga@ucsf.edu; zena.werb@ucsf.edu	Wang, Chihyang/ADO-2306-2022; Kessenbrock, Kai/B-6936-2011; Prummel, Karin/U-5095-2017	Wang, Chihyang/0000-0002-4137-5074; Prummel, Karin/0000-0001-6077-6407	National Cancer Institute [CA180039, CA136717]; Stand Up To Cancer/AACR [DT0409]; Era of Hope Scholar Award [W81XWH-12-1-0272]; Breast Cancer Research Foundation; Atwater Foundation; US Department of Defense Congressionally Directed Medical Research Program postdoctoral fellowship [11-1-0742]; Ministry of Science and Technology, Taiwan [104-2917-I-006-002]; NATIONAL CANCER INSTITUTE [R01CA180039, R01CA136717, T32CA108462, R00CA181490, R01CA057621] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL116657] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stand Up To Cancer/AACR; Era of Hope Scholar Award; Breast Cancer Research Foundation; Atwater Foundation; US Department of Defense Congressionally Directed Medical Research Program postdoctoral fellowship; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank A. Welm for providing access to PDX tissues developed by her group, which served as the foundation for this study. We also thank K. Lee, R. Kumar, A. Le, R. Daneman, J. Stingl and M. Binneweis for comments and technical contributions. This study was supported by funds from the National Cancer Institute (CA180039 and CA136717), Stand Up To Cancer/AACR (DT0409), the Era of Hope Scholar Award (W81XWH-12-1-0272), the Breast Cancer Research Foundation and the Atwater Foundation, and D. and J. Vander Wall. D.A.L. was supported by a US Department of Defense Congressionally Directed Medical Research Program postdoctoral fellowship (11-1-0742), and C.W. is supported by a grant from the Ministry of Science and Technology, Taiwan (104-2917-I-006-002).	[Anonymous], 2012, LANG ENV STAT COMP; Bragado P, 2013, NAT CELL BIOL, V15, P1351, DOI 10.1038/ncb2861; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Devonshire AS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-118; Dieter SM, 2011, CELL STEM CELL, V9, P357, DOI 10.1016/j.stem.2011.08.010; Grigoriadis A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1604; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Horiuchi D, 2012, J EXP MED, V209, P679, DOI 10.1084/jem.20111512; Huskey NE, 2015, STEM CELL REP, V4, P374, DOI 10.1016/j.stemcr.2015.01.019; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Kendrick H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-591; Kim RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035569; Nguyen-Ngoc KV, 2012, P NATL ACAD SCI USA, V109, pE2595, DOI 10.1073/pnas.1212834109; Landis MD, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3355; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Malik N, 1996, J BIOL CHEM, V271, P22754, DOI 10.1074/jbc.271.37.22754; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Parry D, 2010, MOL CANCER THER, V9, P2344, DOI 10.1158/1535-7163.MCT-10-0324; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shehata M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3334; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670	33	563	584	12	240	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					131	+		10.1038/nature15260	http://dx.doi.org/10.1038/nature15260			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26416748	Green Accepted, Green Submitted			2022-12-28	WOS:000362095100048
J	Zilling, T; Grant, J				Zilling, Thomas; Grant, Janet			European regulation of continuing professional development won't improve quality of care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Grant, Janet] UCL, Med Sch, London WC1E 6BT, England; [Grant, Janet] Open Univ, Educ Med, Milton Keynes, Bucks, England; [Grant, Janet] Ctr Med Educ Context CenMEDIC, Hampton TW12 2EB, Middx, England; [Grant, Janet] FAIMER Ctr Distance Learning, Hampton TW12 2EB, Middx, England; [Zilling, Thomas] European Assoc Senior Hosp Phys, B-1040 Brussels, Belgium; [Zilling, Thomas] Lund Univ, Surg, Lund, Sweden	University of London; University College London; Open University - UK; Lund University	Grant, J (corresponding author), UCL, Med Sch, London WC1E 6BT, England.	janet@cenmedic.net						Academy of Medical Royal Colleges, 10 PRINC CPD; Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867; General Medical Council, 2012, REV REG GUID; Grant J, 2012, GOOD CPD GUIDE PRACT; Kiessling A, 2002, BMJ-BRIT MED J, V325, P877, DOI 10.1136/bmj.325.7369.877; Mathers N, 2012, STUDY ASSESS IMPACT; Nath V, 2014, MED REVALIDATION COM; Wenner J, 2005, ANTICANCER RES, V25, P419	8	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 1	2015	351								h5229	10.1136/bmj.h5229	http://dx.doi.org/10.1136/bmj.h5229			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS9ZV	26427726				2022-12-28	WOS:000362454300009
J	Racoosin, JA; Seymour, SM; Cascio, L; Gill, R				Racoosin, Judith A.; Seymour, Sally M.; Cascio, Laurelle; Gill, Rajdeep			Serious Neurologic Events after Epidural Glucocorticoid Injection - The FDA's Risk Assessment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Racoosin, Judith A.] US FDA, Ctr Drug Evaluat & Res, Div Anesthesia Analgesia & Addict Prod, Off Surveillance & Epidemiol, Silver Spring, MD 20993 USA; [Seymour, Sally M.] US FDA, Ctr Drug Evaluat & Res, Div Pulm Allergy & Rheumatol Prod, Off Surveillance & Epidemiol, Silver Spring, MD USA; [Cascio, Laurelle] US FDA, Ctr Drug Evaluat & Res, Off New Drugs, Off Surveillance & Epidemiol, Silver Spring, MD USA; [Cascio, Laurelle] US FDA, Ctr Drug Evaluat & Res, Div Pharmacovigilance, Off Surveillance & Epidemiol, Silver Spring, MD USA; [Gill, Rajdeep] US FDA, Ctr Drug Evaluat & Res, Div Epidemiol, Off Surveillance & Epidemiol, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Racoosin, JA (corresponding author), US FDA, Ctr Drug Evaluat & Res, Div Anesthesia Analgesia & Addict Prod, Off Surveillance & Epidemiol, Silver Spring, MD 20993 USA.							Cohen SP, 2013, REGION ANESTH PAIN M, V38, P175, DOI 10.1097/AAP.0b013e31828ea086; Food and Drug Administration (FDA), 2014, FDA DRUG SAF COMM FD; Friedly JL, 2014, NEW ENGL J MED, V371, P11, DOI 10.1056/NEJMoa1313265; Rathmell JP, 2015, ANESTHESIOLOGY, V122, P974, DOI 10.1097/ALN.0000000000000614; Rathmell JP, 2011, ANESTHESIOLOGY, V114, P918, DOI 10.1097/ALN.0b013e31820fc7f2	5	42	47	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2015	373	24					2299	2301		10.1056/NEJMp1511754	http://dx.doi.org/10.1056/NEJMp1511754			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY0QW	26444582	Bronze			2022-12-28	WOS:000366111600003
J	Halpern, SD				Halpern, Scott D.			Toward Evidence-Based End-of-Life Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ADVANCE DIRECTIVES		[Halpern, Scott D.] Univ Penn, Fostering Improvement End Life Decis Sci FIELD Pr, Leonard Davis Inst Hlth Econ,Dept Med Eth Hlth Po, Div Pulm Allergy & Crit Care Med,Dept Med, Philadelphia, PA 19104 USA; [Halpern, Scott D.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Halpern, SD (corresponding author), Univ Penn, Fostering Improvement End Life Decis Sci FIELD Pr, Leonard Davis Inst Hlth Econ,Dept Med Eth Hlth Po, Div Pulm Allergy & Crit Care Med,Dept Med, Philadelphia, PA 19104 USA.		Harding, Richard/G-9729-2012					Halpern SD, 2015, ANN INTERN MED, V162, P224, DOI 10.7326/M14-2476; Halpern SD, 2013, HEALTH AFFAIR, V32, P408, DOI 10.1377/hlthaff.2012.0895; Hickman SE, 2015, J AM GERIATR SOC, V63, P341, DOI 10.1111/jgs.13248; Nicholas LH, 2011, JAMA-J AM MED ASSOC, V306, P1447, DOI 10.1001/jama.2011.1410; Silveira MJ, 2010, NEW ENGL J MED, V362, P1211, DOI 10.1056/NEJMsa0907901	5	54	54	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2015	373	21					2001	2003		10.1056/NEJMp1509664	http://dx.doi.org/10.1056/NEJMp1509664			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW4JN	26465826				2022-12-28	WOS:000364957700005
J	Urban, P; Meredith, IT; Abizaid, A; Pocock, SJ; Carrie, D; Naber, C; Lipiecki, J; Richardt, G; Iniguez, A; Brunel, P; Valdes-Chavarri, M; Garot, P; Talwar, S; Berland, J; Abdellaoui, M; Eberli, F; Oldroyd, K; Zambahari, R; Gregson, J; Greene, S; Stoll, HP; Morice, MC				Urban, Philip; Meredith, Ian T.; Abizaid, Alexandre; Pocock, Stuart J.; Carrie, Didier; Naber, Christoph; Lipiecki, Janusz; Richardt, Gert; Iniguez, Andres; Brunel, Philippe; Valdes-Chavarri, Mariano; Garot, Philippe; Talwar, Suneel; Berland, Jacques; Abdellaoui, Mohamed; Eberli, Franz; Oldroyd, Keith; Zambahari, Robaayah; Gregson, John; Greene, Samantha; Stoll, Hans-Peter; Morice, Marie-Claude		LEADERS FREE Investigators	Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DUAL ANTIPLATELET THERAPY; BARE-METAL STENTS; ELUTING STENT; IMPLANTATION; TRIALS; COMPLICATIONS; CLOPIDOGREL; EFFICACY; LEADERS; CYPHER	BACKGROUND Patients at high risk for bleeding who undergo percutaneous coronary intervention (PCI) often receive bare-metal stents followed by 1 month of dual antiplatelet therapy. We studied a polymer-free and carrier-free drug-coated stent that transfers umirolimus (also known as biolimus A9), a highly lipophilic sirolimus analogue, into the vessel wall over a period of 1 month. METHODS In a randomized, double-blind trial, we compared the drug-coated stent with a very similar bare-metal stent in patients with a high risk of bleeding who underwent PCI. All patients received 1 month of dual antiplatelet therapy. The primary safety end point, tested for both noninferiority and superiority, was a composite of cardiac death, myocardial infarction, or stent thrombosis. The primary efficacy end point was clinically driven target-lesion revascularization. RESULTS We enrolled 2466 patients. At 390 days, the primary safety end point had occurred in 112 patients (9.4%) in the drug-coated-stent group and in 154 patients (12.9%) in the bare-metal-stent group (risk difference, -3.6 percentage points; 95% confidence interval [CI], -6.1 to -1.0; hazard ratio, 0.71; 95% CI, 0.56 to 0.91; P<0.001 for noninferiority and P = 0.005 for superiority). During the same time period, clinically driven target-lesion revascularization was needed in 59 patients (5.1%) in the drug-coated-stent group and in 113 patients (9.8%) in the bare-metal-stent group (risk difference, -4.8 percentage points; 95% CI, -6.9 to -2.6; hazard ratio, 0.50; 95% CI, 0.37 to 0.69; P<0.001). CONCLUSIONS Among patients at high risk for bleeding who underwent PCI, a polymer-free umirolimus-coated stent was superior to a bare-metal stent with respect to the primary safety and efficacy end points when used with a 1-month course of dual antiplatelet therapy. (Funded by Biosensors Europe; LEADERS FREE ClinicalTrials.gov number, NCT01623180.)	[Urban, Philip] Hop Tour, CH-1217 Geneva, Switzerland; [Eberli, Franz] Triemli Hosp, Zurich, Switzerland; [Greene, Samantha; Stoll, Hans-Peter] Biosensors Europe, Morges, Switzerland; [Meredith, Ian T.] MonashHeart, Melbourne, Vic, Australia; [Meredith, Ian T.] Monash Univ, Melbourne, Vic 3004, Australia; [Abizaid, Alexandre] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil; [Pocock, Stuart J.; Gregson, John] London Sch Hyg & Trop Med, London WC1, England; [Talwar, Suneel] Royal Bournemouth Hosp, Dorset Heart Ctr, Bournemouth, Dorset, England; [Oldroyd, Keith] Golden Jubilee Natl Hosp, West Scotland Reg Heart & Lung Ctr, Glasgow, Lanark, Scotland; [Carrie, Didier] Toulouse Rangueil Hosp, Toulouse, France; [Lipiecki, Janusz] Pole Sante Republ, Clermont Ferrand, France; [Brunel, Philippe] Clin Fontaine, Dijon, France; [Garot, Philippe] Hop Claude Galien, Inst Cardiovasc Paris Sud, Gen Sante, Quincy Sous Senart, France; [Berland, Jacques] Clin St Hilaire, Rouen, France; [Abdellaoui, Mohamed] Grp Hosp Mutualiste Grenoble, Grenoble, France; [Morice, Marie-Claude] ICPS, Gen Sante, Massy, France; [Naber, Christoph] Elisabeth Hosp, Contilia Heart & Vasc Ctr, Essen, Germany; [Richardt, Gert] Herzzentrum Segeberger Kliniken, Bad Segeberg, Germany; [Iniguez, Andres] Complejo Hosp Meixoeiro, Vigo, Spain; [Valdes-Chavarri, Mariano] Arrixaca Univ Hosp, Murcia, Spain; [Zambahari, Robaayah] Inst Jantung Negara, Kuala Lumpur, Malaysia	Triemli Hospital; Monash University; Instituto Dante Pazzanese de Cardiologia; University of London; London School of Hygiene & Tropical Medicine; Golden Jubilee Hospital; CHU de Toulouse; UDICE-French Research Universities; Universite Paris Saclay; Segeberger Kliniken Group; Hospital Clinico Universitario Virgen de la Arrixaca	Urban, P (corresponding author), Hop Tour, CH-1217 Geneva, Switzerland.	philip.urban@latour.ch	Abizaid, Alexandre Antônio Cunha/H-6955-2012	CARRIE, didier/0000-0003-2479-8144; VAN BELLE, ERIC/0000-0001-6509-443X; Moreno, Raul/0000-0001-7179-1426	Biosensors Europe	Biosensors Europe	Funded by Biosensors Europe; LEADERS FREE ClinicalTrials.gov number, NCT01623180.	Berger PB, 2010, CIRCULATION, V121, P2575, DOI 10.1161/CIRCULATIONAHA.109.895342; Collet JP, 2014, LANCET, V384, P1577, DOI 10.1016/S0140-6736(14)60612-7; Costa RA, J AM COLL C IN PRESS; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Kirtane AJ, 2009, CIRCULATION, V119, P3198, DOI 10.1161/CIRCULATIONAHA.108.826479; Levine GN, 2012, CATHETER CARDIO INTE, V79, P453, DOI 10.1002/ccd.23438; Lopes RD, 2009, J AM COLL CARDIOL, V53, P1021, DOI 10.1016/j.jacc.2008.12.021; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Morice MC, 2013, J AM COLL CARDIOL, V61, P1122, DOI 10.1016/j.jacc.2012.11.049; Pilgrim T, 2014, LANCET, V384, P2111, DOI 10.1016/S0140-6736(14)61038-2; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Subherwal S, 2009, CIRCULATION, V119, P1873, DOI 10.1161/CIRCULATIONAHA.108.828541; Tada N, 2010, CIRC-CARDIOVASC INTE, V3, P174, DOI 10.1161/CIRCINTERVENTIONS.109.877522; Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001; Urban P, 2013, AM HEART J, V165, P704, DOI 10.1016/j.ahj.2013.01.008; Urban P, 2011, J AM COLL CARDIOL, V57, P1445, DOI 10.1016/j.jacc.2010.11.028; Valgimigli M, 2015, J AM COLL CARDIOL, V65, P805, DOI 10.1016/j.jacc.2014.11.053; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	23	560	567	2	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2015	373	21					2038	2047		10.1056/NEJMoa1503943	http://dx.doi.org/10.1056/NEJMoa1503943			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW4JN	26466021	Green Accepted			2022-12-28	WOS:000364957700009
J	Chen, AC; Martin, AJ; Choy, B; Fernandez-Penas, P; Dalziell, RA; McKenzie, CA; Scolyer, RA; Dhillon, HM; Vardy, JL; Kricker, A; St George, G; Chinniah, N; Halliday, GM; Damian, DL				Chen, Andrew C.; Martin, Andrew J.; Choy, Bonita; Fernandez-Penas, Pablo; Dalziell, Robyn A.; McKenzie, Catriona A.; Scolyer, Richard A.; Dhillon, Haryana M.; Vardy, Janette L.; Kricker, Anne; St George, Gayathri; Chinniah, Niranthari; Halliday, Gary M.; Damian, Diona L.			A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RADIATION-INDUCED IMMUNOSUPPRESSION; RENAL-TRANSPLANT RECIPIENTS; BASAL-CELL; DOUBLE-BLIND; XERODERMA-PIGMENTOSUM; PREVENTION; CARCINOMAS; REDUCTION; KERATOSES; IMPROVE	BACKGROUND Nonmelanoma skin cancers, such as basal-cell carcinoma and squamous-cell carcinoma, are common cancers that are caused principally by ultraviolet (UV) radiation. Nicotinamide (vitamin B-3) has been shown to have protective effects against damage caused by UV radiation and to reduce the rate of new premalignant actinic keratoses. METHODS In this phase 3, double-blind, randomized, controlled trial, we randomly assigned, in a 1: 1 ratio, 386 participants who had had at least two nonmelanoma skin cancers in the previous 5 years to receive 500 mg of nicotinamide twice daily or placebo for 12 months. Participants were evaluated by dermatologists at 3-month intervals for 18 months. The primary end point was the number of new nonmelanoma skin cancers (i.e., basal-cell carcinomas plus squamous-cell carcinomas) during the 12-month intervention period. Secondary end points included the number of new squamous-cell carcinomas and basal-cell carcinomas and the number of actinic keratoses during the 12-month intervention period, the number of nonmelanoma skin cancers in the 6-month postintervention period, and the safety of nicotinamide. RESULTS At 12 months, the rate of new nonmelanoma skin cancers was lower by 23% (95% confidence interval [CI], 4 to 38) in the nicotinamide group than in the placebo group (P = 0.02). Similar differences were found between the nicotinamide group and the placebo group with respect to new basal-cell carcinomas (20% [95% CI, -6 to 39] lower rate with nicotinamide, P = 0.12) and new squamous-cell carcinomas (30% [95% CI, 0 to 51] lower rate, P = 0.05). The number of actinic keratoses was 11% lower in the nicotinamide group than in the placebo group at 3 months (P = 0.01), 14% lower at 6 months (P<0.001), 20% lower at 9 months (P<0.001), and 13% lower at 12 months (P = 0.001). No noteworthy between-group differences were found with respect to the number or types of adverse events during the 12-month intervention period, and there was no evidence of benefit after nicotinamide was discontinued. CONCLUSIONS Oral nicotinamide was safe and effective in reducing the rates of new nonmelanoma skin cancers and actinic keratoses in high-risk patients. (Funded by the National Health and Medical Research Council; ONTRAC Australian New Zealand Clinical Trials Registry number, ACTRN12612000625875.)	[Chen, Andrew C.; Dalziell, Robyn A.; Halliday, Gary M.; Damian, Diona L.] Univ Sydney, Royal Prince Alfred Hosp, Dept Dermatol, Sydney, NSW, Australia; [Chen, Andrew C.; Dalziell, Robyn A.; Halliday, Gary M.; Damian, Diona L.] Univ Sydney, Royal Prince Alfred Hosp, Bosch Inst, Sydney, NSW, Australia; [Martin, Andrew J.] Sydney Med Sch, Natl Hlth & Med Res Council, Clin Trials Ctr, Sydney, NSW, Australia; [Chen, Andrew C.; Scolyer, Richard A.; Halliday, Gary M.; Damian, Diona L.] Sydney Med Sch, Cent Clin Sch, Sydney, NSW, Australia; [Vardy, Janette L.] Sydney Med Sch, Concord Clin Sch, Sydney, NSW, Australia; [Dhillon, Haryana M.; Vardy, Janette L.] Univ Sydney, Ctr Med Psychol & Evidence Based Decis Making, Sydney, NSW, Australia; [Kricker, Anne] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Scolyer, Richard A.; Damian, Diona L.] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia; [Choy, Bonita; Fernandez-Penas, Pablo; St George, Gayathri; Chinniah, Niranthari] Univ Sydney, Westmead Hosp, Dept Dermatol, Sydney, NSW, Australia; [Vardy, Janette L.] Concord Repatriat Gen Hosp, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney; Melanoma Institute Australia; University of Sydney; University of Sydney; Concord Repatriation General Hospital	Damian, DL (corresponding author), Univ Sydney, Royal Prince Alfred Hosp, Dept Dermatol, Missenden Rd, Camperdown, NSW 2050, Australia.	diona.damian@sswahs.nsw.gov.au	Fernandez-Peñas, Pablo/B-3948-2008; Dhillon, Haryana M/G-8503-2011; Scolyer, Richard/AAE-8511-2019	Fernandez-Peñas, Pablo/0000-0003-4882-1564; Dhillon, Haryana M/0000-0003-4039-5169; Scolyer, Richard/0000-0002-8991-0013; Vardy, Janette/0000-0002-5739-5790; Martin, Andrew/0000-0001-5804-2295	National Health and Medical Research Council; ONTRAC Australian New Zealand	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ONTRAC Australian New Zealand	Funded by the National Health and Medical Research Council; ONTRAC Australian New Zealand Clinical Trials Registry number, ACTRN12612000625875.	Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Armstrong BK, 2001, J PHOTOCH PHOTOBIO B, V63, P8, DOI 10.1016/S1011-1344(01)00198-1; Australian Institute of Health and Welfare, 2007, CANC AUSTR OV 2006; Bastiaens MT, 1998, J INVEST DERMATOL, V110, P880, DOI 10.1046/j.1523-1747.1998.00217.x; BAVINCK JNB, 1995, J CLIN ONCOL, V13, P1933, DOI 10.1200/JCO.1995.13.8.1933; Chen AC, 2014, AUSTRALAS J DERMATOL, V55, P169, DOI 10.1111/ajd.12163; Damian DL, 2008, J INVEST DERMATOL, V128, P447, DOI 10.1038/sj.jid.5701058; Elmets CA, 2010, JNCI-J NATL CANCER I, V102, P1835, DOI 10.1093/jnci/djq442; Fransen M, 2012, MED J AUSTRALIA, V197, P565, DOI 10.5694/mja12.10654; George Renu, 2002, Australas J Dermatol, V43, P269; Green A, 1999, LANCET, V354, P723, DOI 10.1016/S0140-6736(98)12168-2; Green AC, 2011, J CLIN ONCOL, V29, P257, DOI 10.1200/JCO.2010.28.7078; Guy GP, 2014, AM J PUBLIC HEALTH, V104, pE69, DOI [10.2105/AJPH.2013.301850, 10.1016/j.amepre.2014.08.036]; Ismail F, 2006, BRIT J DERMATOL, V155, P916, DOI 10.1111/j.1365-2133.2006.07454.x; Knip M, 2000, DIABETOLOGIA, V43, P1337, DOI 10.1007/s001250051536; KRAEMER KH, 1988, NEW ENGL J MED, V318, P1633, DOI 10.1056/NEJM198806233182501; Kuchel JM, 2005, PHOTOCH PHOTOBIO SCI, V4, P577, DOI 10.1039/b504068j; LeBoit PE, 2006, WHO CLASSIFICATION T; Li X, 2014, BRIT J CANCER, V110, P802, DOI 10.1038/bjc.2013.762; Liu D, 2013, NEUROBIOL AGING, V34, P1564, DOI 10.1016/j.neurobiolaging.2012.11.020; Lomas A, 2012, BRIT J DERMATOL, V166, P1069, DOI 10.1111/j.1365-2133.2012.10830.x; Marquez C, 2010, J DRUGS DERMATOL, V9, P753; McKenna DB, 1999, BRIT J DERMATOL, V140, P656; Moon TE, 1997, CANCER EPIDEM BIOMAR, V6, P949; Park J, 2010, PHOTOCHEM PHOTOBIOL, V86, P942, DOI 10.1111/j.1751-1097.2010.00746.x; Pietkiewicz P, 2014, CLIN EXP DERMATOL, V39, P628, DOI 10.1111/ced.12355; RANCHOFF RE, 1986, J AM ACAD DERMATOL, V15, P116, DOI 10.1016/S0190-9622(86)80149-9; Rubin AI, 2005, NEW ENGL J MED, V353, P2262, DOI 10.1056/NEJMra044151; SHUTTLEWORTH D, 1988, Q J MED, V68, P717; Surjana D, 2013, CARCINOGENESIS, V34, P1144, DOI 10.1093/carcin/bgt017; Tanno O, 2000, BRIT J DERMATOL, V143, P524; Thompson BC, 2014, EXP DERMATOL, V23, P509, DOI 10.1111/exd.12430; THOMPSON SC, 1993, NEW ENGL J MED, V329, P1147, DOI 10.1056/NEJM199310143291602; Yarosh D, 2001, LANCET, V357, P926, DOI 10.1016/S0140-6736(00)04214-8; Yarosh DB, 2004, CUTIS, V74, P10; Yiasemides E, 2009, CARCINOGENESIS, V30, P101, DOI 10.1093/carcin/bgn248	37	305	308	5	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2015	373	17					1618	1626		10.1056/NEJMoa1506197	http://dx.doi.org/10.1056/NEJMoa1506197			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU1YH	26488693				2022-12-28	WOS:000363317800007
J	Yu, Y; Gu, J; Jin, Y; Luo, YC; Preall, JB; Ma, JBA; Czech, B; Hannon, GJ				Yu, Yang; Gu, Jiaqi; Jin, Ying; Luo, Yicheng; Preall, Jonathan B.; Ma, Jinbiao; Czech, Benjamin; Hannon, Gregory J.			Panoramix enforces piRNA-dependent cotranscriptional silencing	SCIENCE			English	Article							DE-NOVO METHYLATION; WIDE RNAI SCREEN; GENE-EXPRESSION; DROSOPHILA OVARY; CHROMATIN STATE; DNA METHYLATION; PIWI; PATHWAY; TRANSPOSONS; GERMLINE	The Piwi-interacting RNA (piRNA) pathway is a small RNA-based innate immune system that defends germ cell genomes against transposons. In Drosophila ovaries, the nuclear Piwi protein is required for transcriptional silencing of transposons, though the precise mechanisms by which this occurs are unknown. Here we show that the CG9754 protein is a component of Piwi complexes that functions downstream of Piwi and its binding partner, Asterix, in transcriptional silencing. Enforced tethering of CG9754 to nascent messenger RNA transcripts causes cotranscriptional silencing of the source locus and the deposition of repressive chromatin marks. We have named CG9754 "Panoramix," and we propose that this protein could act as an adaptor, scaffolding interactions between the piRNA pathway and the general silencing machinery that it recruits to enforce transcriptional repression.	[Yu, Yang; Gu, Jiaqi; Jin, Ying; Luo, Yicheng; Preall, Jonathan B.; Czech, Benjamin; Hannon, Gregory J.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Yu, Yang; Gu, Jiaqi; Luo, Yicheng; Preall, Jonathan B.; Czech, Benjamin; Hannon, Gregory J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Gu, Jiaqi; Ma, Jinbiao] Fudan Univ, State Key Lab Genet Engn, Collaborat Innovat Ctr Genet & Dev, Dept Biochem,Sch Life Sci, Shanghai 200433, Peoples R China; [Czech, Benjamin; Hannon, Gregory J.] Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Cambridge, England; [Hannon, Gregory J.] New York Genome Ctr, New York, NY 10013 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Fudan University; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, POB 100, Cold Spring Harbor, NY 11724 USA.	greg.hannon@cruk.cam.ac.uk	Hannon, Gregory/AAB-3568-2019; Czech, Benjamin/AAJ-8592-2020	Czech, Benjamin/0000-0001-8471-0007; Yu, Yang/0000-0003-0536-2783; Luo, Yicheng/0000-0003-3704-2389	NIH [5R37GM062534-15]; Ministry of Science and Technology [2011CB966304]; American Heart Association; Cancer Research UK [21143] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062534] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); American Heart Association(American Heart Association); Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Nilsen and members of the Hannon lab for helpful discussions and comments on the manuscript and E. Izaurralde, S. Bullock, T. Schupbach, J. Brennecke, and T. Hazelrigg for sharing reagents. All constructs and strains generated for this study are available under a material transfer agreement with Cold Spring Harbor Laboratories. This work was supported in part by grants from the NIH (5R37GM062534-15 to G.J.H.) and the Ministry of Science and Technology (2011CB966304 to J.M.). Y.Y. was supported by a postdoctoral fellowship from the American Heart Association (2009-2011).	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Baron-Benhamou Julie, 2004, Methods Mol Biol, V257, P135, DOI 10.1385/1-59259-750-5:135; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; Di Stefano L, 2007, CURR BIOL, V17, P808, DOI 10.1016/j.cub.2007.03.068; Donertas D, 2013, GENE DEV, V27, P1693, DOI 10.1101/gad.221150.113; Ge DT, 2013, CURR BIOL, V23, pR318, DOI 10.1016/j.cub.2013.03.033; Handler D, 2013, MOL CELL, V50, P762, DOI 10.1016/j.molcel.2013.04.031; Holoch D, 2015, NAT REV GENET, V16, P71, DOI 10.1038/nrg3863; Klenov MS, 2007, NUCLEIC ACIDS RES, V35, P5430, DOI 10.1093/nar/gkm576; Klenov MS, 2011, P NATL ACAD SCI USA, V108, P18760, DOI 10.1073/pnas.1106676108; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Le Thomas A, 2014, GENE DEV, V28, P1667, DOI 10.1101/gad.245514.114; Le Thomas A, 2013, GENE DEV, V27, P390, DOI 10.1101/gad.209841.112; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Mohn F, 2014, CELL, V157, P1364, DOI 10.1016/j.cell.2014.04.031; Molaro A, 2014, GENE DEV, V28, P1544, DOI 10.1101/gad.244350.114; Muerdter F, 2013, MOL CELL, V50, P736, DOI 10.1016/j.molcel.2013.04.006; Ohtani H, 2013, GENE DEV, V27, P1656, DOI 10.1101/gad.221515.113; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Pezic D, 2014, GENE DEV, V28, P1410, DOI 10.1101/gad.240895.114; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Post C, 2014, RNA, V20, P1977, DOI 10.1261/rna.046300.114; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Rozhkov NV, 2013, GENE DEV, V27, P400, DOI 10.1101/gad.209767.112; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sienski G, 2012, CELL, V151, P964, DOI 10.1016/j.cell.2012.10.040; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089	27	123	131	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2015	350	6258					339	+		10.1126/science.aab0700	http://dx.doi.org/10.1126/science.aab0700			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT5HD	26472911	Green Accepted			2022-12-28	WOS:000362838700045
J	Goroll, AH				Goroll, Allan H.			Toward Trusting Therapeutic Relationships - In Favor of the Annual Physical	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Goroll, AH (corresponding author), Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA.							Apa Pesidential Task Force, 2006, AM PSYCHOL, V61, P271, DOI 10.1037/0003-066X.61.4.271; Boulware LE, 2007, ANN INTERN MED, V146, P289, DOI 10.7326/0003-4819-146-4-200702200-00008; Emanuel EJ, 2015, NY TIMES; Kearley KE, 2001, BRIT J GEN PRACT, V51, P712	4	20	20	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2015	373	16					1487	1489		10.1056/NEJMp1508270	http://dx.doi.org/10.1056/NEJMp1508270			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5VX	26465982				2022-12-28	WOS:000362880300003
J	Gupta, S				Gupta, Sujata			SURGERY Diverse interventions	NATURE			English	Editorial Material																		Baudouin JY, 2004, ACTA PSYCHOL, V117, P313, DOI 10.1016/j.actpsy.2004.07.002; Kau C.H., 2010, AM J ORTHOD DENTOFAC, V137; Odunze M, 2008, PLAST RECONSTR SURG, V121, P1002, DOI 10.1097/01.prs.0000299381.40232.79; Weeks DM, 2014, FACIAL PLAST SURG CL, V22, P337, DOI 10.1016/j.fsc.2014.04.005	4	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					S6	S7		10.1038/526S6a	http://dx.doi.org/10.1038/526S6a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26444374	Bronze			2022-12-28	WOS:000362399000003
J	Joshi, KK; Berge, M; Radhakrishnan, SK; Viollier, PH; Chien, P				Joshi, Kamal Kishore; Berge, Matthieu; Radhakrishnan, Sunish Kumar; Viollier, Patrick Henri; Chien, Peter			An Adaptor Hierarchy Regulates Proteolysis during a Bacterial Cell Cycle	CELL			English	Article							AAA PLUS PROTEASE; CAULOBACTER-CRESCENTUS; CHROMOSOME-REPLICATION; DEGRADATION; PROGRESSION; COMPLEX; PHOSPHORYLATION; SUBSTRATE; CLPXP; STABILITY	Regulated protein degradation is essential. The timed destruction of crucial proteins by the ClpXP protease drives cell-cycle progression in the bacterium Caulobacter crescentus. Although ClpXP is active alone, additional factors are inexplicably required for cell-cycle-dependent proteolysis. Here, we show that these factors constitute an adaptor hierarchy wherein different substrates are destroyed based on the degree of adaptor assembly. The hierarchy builds upon priming of ClpXP by the adaptor CpdR, which promotes degradation of one class of substrates and also recruits the adaptor RcdA to degrade a second class of substrates. Adding the PopA adaptor promotes destruction of a third class of substrates and inhibits degradation of the second class. We dissect RcdA to generate bespoke adaptors, identifying critical substrate elements needed for RcdA recognition and uncovering additional cell-cycle-dependent ClpXP substrates. Our work reveals how hierarchical adaptors and primed proteases orchestrate regulated proteolysis during bacterial cell-cycle progression.	[Joshi, Kamal Kishore; Chien, Peter] Univ Massachusetts, Mol & Cellular Biol Grad Program, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Berge, Matthieu; Radhakrishnan, Sunish Kumar; Viollier, Patrick Henri] Univ Geneva, Sch Med, Inst Genet & Genom Geneva iGE3, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland	University of Massachusetts System; University of Massachusetts Amherst; University of Geneva	Chien, P (corresponding author), Univ Massachusetts, Mol & Cellular Biol Grad Program, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.	pchien@biochem.umass.edu	Joshi, Kamal/AFF-8135-2022; Viollier, Patrick/AAD-9405-2021	Viollier, Patrick/0000-0002-5249-9910; Radhakrishnan, Sunish/0000-0001-8729-263X; Joshi, Kamal Kishore/0000-0001-5816-6888; Berge, Matthieu/0000-0002-0910-6114	University of Massachusetts Amherst; NIH [R01GM111706]; SNF [31003A_143660]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111706] Funding Source: NIH RePORTER	University of Massachusetts Amherst; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SNF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Chien and Viollier lab members, E. Vierling, D. Hebert, and C. Babbitt for helpful comments and discussions on the manuscript. We also thank Kathleen R. Ryan (UC Berkeley) for providing us plasmids and strains. K.K.J. thanks Amrita Palaria for helpful discussions. This project was supported by funds from University of Massachusetts Amherst and NIH grant R01GM111706 (to P.C.) and SNF #31003A_143660 (to P.H.V.).	Abel S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003744; Abel S, 2011, MOL CELL, V43, P550, DOI 10.1016/j.molcel.2011.07.018; Ades SE, 2004, CURR BIOL, V14, pR924, DOI 10.1016/j.cub.2004.10.015; Battesti A, 2013, GENE DEV, V27, P2722, DOI 10.1101/gad.229617.113; Battesti A, 2013, CURR OPIN MICROBIOL, V16, P140, DOI 10.1016/j.mib.2013.01.002; Bhat NH, 2013, MOL MICROBIOL, V88, P1083, DOI 10.1111/mmi.12241; Bougdour A, 2006, GENE DEV, V20, P884, DOI 10.1101/gad.1400306; Brilli M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-52; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Chien P, 2007, P NATL ACAD SCI USA, V104, P6590, DOI 10.1073/pnas.0701776104; Curtis PD, 2010, MICROBIOL MOL BIOL R, V74, P13, DOI 10.1128/MMBR.00040-09; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; Dougan DA, 2003, MOL CELL, V12, P373, DOI 10.1016/j.molcel.2003.08.012; Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Guo MS, 2014, CURR BIOL, V24, pR424, DOI 10.1016/j.cub.2014.03.023; Iniesta AA, 2006, P NATL ACAD SCI USA, V103, P10935, DOI 10.1073/pnas.0604554103; Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kirstein J, 2009, NAT REV MICROBIOL, V7, P589, DOI 10.1038/nrmicro2185; Kobayashi H, 2009, MOL MICROBIOL, V73, P586, DOI 10.1111/j.1365-2958.2009.06794.x; Konovalova A, 2014, FEMS MICROBIOL REV, V38, P493, DOI 10.1111/1574-6976.12050; Lau J, 2015, MOL CELL, V59, P104, DOI 10.1016/j.molcel.2015.05.014; Levchenko I, 2003, MOL CELL, V12, P365, DOI 10.1016/j.molcel.2003.08.014; Lori C, 2015, NATURE, V523, P236, DOI 10.1038/nature14473; Marczynski GT, 2002, ANNU REV MICROBIOL, V56, P625, DOI 10.1146/annurev.micro.56.012302.161103; McGrath PT, 2006, CELL, V124, P535, DOI 10.1016/j.cell.2005.12.033; Ozaki S, 2014, MOL MICROBIOL, V94, P580, DOI 10.1111/mmi.12777; Pini F, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005232; POINDEXTER JS, 1981, MICROBIOL REV, V45, P123, DOI 10.1128/MMBR.45.1.123-179.1981; Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2; Radhakrishnan SK, 2010, DEV CELL, V18, P90, DOI 10.1016/j.devcel.2009.10.024; Rood KL, 2012, STRUCTURE, V20, P1223, DOI 10.1016/j.str.2012.04.019; Ryan KR, 2002, J MOL BIOL, V324, P443, DOI 10.1016/S0022-2836(02)01042-2; Schallies KB, 2015, J BACTERIOL, V197, P2139, DOI 10.1128/JB.02593-14; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Smith SC, 2014, P NATL ACAD SCI USA, V111, P14229, DOI 10.1073/pnas.1407862111; Taylor JA, 2009, J MOL BIOL, V394, P46, DOI 10.1016/j.jmb.2009.08.076; Thanbichler M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000331; Zhou YN, 2001, GENE DEV, V15, P627, DOI 10.1101/gad.864401	41	54	54	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2					419	431		10.1016/j.cell.2015.09.030	http://dx.doi.org/10.1016/j.cell.2015.09.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26451486	Green Accepted, Bronze			2022-12-28	WOS:000362952700018
J	Markram, H; Muller, E; Ramaswamy, S; Reimann, MW; Abdellah, M; Sanchez, CA; Ailamaki, A; Alonso-Nanclares, L; Antille, N; Arsever, S; Kahou, GAA; Berger, TK; Bilgili, A; Buncic, N; Chalimourda, A; Chindemi, G; Courcol, JD; Delalondre, F; Delattre, V; Druckmann, S; Dumusc, R; Dynes, J; Eilemann, S; Gal, E; Gevaert, ME; Ghobril, JP; Gidon, A; Graham, JW; Gupta, A; Haenel, V; Hay, E; Heinis, T; Hernando, JB; Hines, M; Kanari, L; Keller, D; Kenyon, J; Khazen, G; Kim, Y; King, JG; Kisvarday, Z; Kumbhar, P; Lasserre, S; Le Be, JV; Magalhaes, BRC; Merchan-Perez, A; Meystre, J; Morrice, BR; Muller, J; Munoz-Cespedes, A; Muralidhar, S; Muthurasa, K; Nachbaur, D; Newton, TH; Nolte, M; Ovcharenko, A; Palacios, J; Pastor, L; Perin, R; Ranjan, R; Riachi, I; Rodriguez, JR; Riquelme, JL; Rossert, C; Sfyrakis, K; Shi, Y; Shillcock, JC; Silberberg, G; Silva, R; Tauheed, F; Telefont, M; Toledo-Rodriguez, M; Trankler, T; Van Geit, W; Diaz, JV; Walker, R; Wang, Y; Zaninetta, SM; DeFelipe, J; Hill, SL; Segev, I; Schurmann, F				Markram, Henry; Muller, Eilif; Ramaswamy, Srikanth; Reimann, Michael W.; Abdellah, Marwan; Sanchez, Carlos Aguado; Ailamaki, Anastasia; Alonso-Nanclares, Lidia; Antille, Nicolas; Arsever, Selim; Kahou, Guy Antoine Atenekeng; Berger, Thomas K.; Bilgili, Ahmet; Buncic, Nenad; Chalimourda, Athanassia; Chindemi, Giuseppe; Courcol, Jean-Denis; Delalondre, Fabien; Delattre, Vincent; Druckmann, Shaul; Dumusc, Raphael; Dynes, James; Eilemann, Stefan; Gal, Eyal; Gevaert, Michael Emiel; Ghobril, Jean-Pierre; Gidon, Albert; Graham, Joe W.; Gupta, Anirudh; Haenel, Valentin; Hay, Etay; Heinis, Thomas; Hernando, Juan B.; Hines, Michael; Kanari, Lida; Keller, Daniel; Kenyon, John; Khazen, Georges; Kim, Yihwa; King, James G.; Kisvarday, Zoltan; Kumbhar, Pramod; Lasserre, Sebastien; Le Be, Jean-Vincent; Magalhaes, Bruno R. C.; Merchan-Perez, Angel; Meystre, Julie; Morrice, Benjamin Roy; Muller, Jeffrey; Munoz-Cespedes, Alberto; Muralidhar, Shruti; Muthurasa, Keerthan; Nachbaur, Daniel; Newton, Taylor H.; Nolte, Max; Ovcharenko, Aleksandr; Palacios, Juan; Pastor, Luis; Perin, Rodrigo; Ranjan, Rajnish; Riachi, Imad; Rodriguez, Jose-Rodrigo; Riquelme, Juan Luis; Roessert, Christian; Sfyrakis, Konstantinos; Shi, Ying; Shillcock, Julian C.; Silberberg, Gilad; Silva, Ricardo; Tauheed, Farhan; Telefont, Martin; Toledo-Rodriguez, Maria; Traenkler, Thomas; Van Geit, Werner; Diaz, Jafet Villafranca; Walker, Richard; Wang, Yun; Zaninetta, Stefano M.; DeFelipe, Javier; Hill, Sean L.; Segev, Idan; Schuermann, Felix			Reconstruction and Simulation of Neocortical Microcircuitry	CELL			English	Article							RAT SOMATOSENSORY CORTEX; LAYER-5 PYRAMIDAL NEURONS; PARVALBUMIN-POSITIVE INTERNEURONS; TRANSMITTER RELEASE MODULATION; DUAL INTRACELLULAR-RECORDINGS; PARALLEL NETWORK SIMULATIONS; CORTICAL NONPYRAMIDAL CELLS; GENE-EXPRESSION PROFILES; MOUSE BARREL CORTEX; ACTIVITY IN-VIVO	We present a first-draft digital reconstruction of the microcircuitry of somatosensory cortex of juvenile rat. The reconstruction uses cellular and synaptic organizing principles to algorithmically reconstruct detailed anatomy and physiology from sparse experimental data. An objective anatomical method defines a neocortical volume of 0.29 +/- 0.01 mm(3) containing similar to 31,000 neurons, and patch-clamp studies identify 55 layer-specific morphological and 207 morphoelectrical neuron subtypes. When digitally reconstructed neurons are positioned in the volume and synapse formation is restricted to biological bouton densities and numbers of synapses per connection, their overlapping arbors form similar to 8 million connections with similar to 37 million synapses. Simulations reproduce an array of in vitro and in vivo experiments without parameter tuning. Additionally, we find a spectrum of network states with a sharp transition from synchronous to asynchronous activity, modulated by physiological mechanisms. The spectrum of network states, dynamically reconfigured around this transition, supports diverse information processing strategies.	[Markram, Henry; Muller, Eilif; Ramaswamy, Srikanth; Reimann, Michael W.; Abdellah, Marwan; Sanchez, Carlos Aguado; Antille, Nicolas; Arsever, Selim; Kahou, Guy Antoine Atenekeng; Bilgili, Ahmet; Buncic, Nenad; Chalimourda, Athanassia; Chindemi, Giuseppe; Courcol, Jean-Denis; Delalondre, Fabien; Dumusc, Raphael; Dynes, James; Eilemann, Stefan; Gevaert, Michael Emiel; Graham, Joe W.; Haenel, Valentin; Heinis, Thomas; Kanari, Lida; Keller, Daniel; Kenyon, John; Khazen, Georges; Kim, Yihwa; King, James G.; Kumbhar, Pramod; Lasserre, Sebastien; Magalhaes, Bruno R. C.; Morrice, Benjamin Roy; Muller, Jeffrey; Muthurasa, Keerthan; Nachbaur, Daniel; Newton, Taylor H.; Nolte, Max; Ovcharenko, Aleksandr; Palacios, Juan; Ranjan, Rajnish; Riachi, Imad; Riquelme, Juan Luis; Roessert, Christian; Sfyrakis, Konstantinos; Shi, Ying; Shillcock, Julian C.; Silva, Ricardo; Tauheed, Farhan; Telefont, Martin; Traenkler, Thomas; Van Geit, Werner; Diaz, Jafet Villafranca; Walker, Richard; Zaninetta, Stefano M.; Hill, Sean L.; Schuermann, Felix] EPFL, Blue Brain Project, CH-1202 Geneva, Switzerland; [Markram, Henry; Berger, Thomas K.; Delattre, Vincent; Ghobril, Jean-Pierre; Gupta, Anirudh; Le Be, Jean-Vincent; Meystre, Julie; Muralidhar, Shruti; Perin, Rodrigo; Ranjan, Rajnish; Shi, Ying] EPFL, Brain Mind Inst, Lab Neural Microcircuitry, CH-1015 Geneva, Switzerland; [Gidon, Albert; Hay, Etay; Segev, Idan] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel; [Druckmann, Shaul; Gal, Eyal; Hay, Etay; Segev, Idan] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, IL-91904 Jerusalem, Israel; [Druckmann, Shaul] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Alonso-Nanclares, Lidia; Merchan-Perez, Angel; Munoz-Cespedes, Alberto; Rodriguez, Jose-Rodrigo; DeFelipe, Javier] Univ Politecn Madrid, Ctr Tecnol Biomed, Lab Cajal Circuitos Corticales, Madrid 28223, Spain; [Alonso-Nanclares, Lidia; Merchan-Perez, Angel; Munoz-Cespedes, Alberto; Rodriguez, Jose-Rodrigo; DeFelipe, Javier] Inst Cajal CSIC, Madrid 28002, Spain; [Alonso-Nanclares, Lidia; Merchan-Perez, Angel; Munoz-Cespedes, Alberto; Rodriguez, Jose-Rodrigo; DeFelipe, Javier] CIBERNED, Madrid 28002, Spain; [Hernando, Juan B.] Univ Politecn Madrid, Ctr Supercomp & Visualizac Madrid, CeSViMa, Madrid 28223, Spain; [Pastor, Luis] Univ Rey Juan Carlos, Modeling & Virtual Real Grp, Madrid 28933, Spain; [Wang, Yun] Wenzhou Med Coll, Key Lab Visual Sci, Wenzhou 325003, Peoples R China; [Wang, Yun] Wenzhou Med Coll, Natl Minist Hlth, Sch Optometry & Opthalmol, Wenzhou 325003, Peoples R China; [Wang, Yun] Tufts Univ, Genesys Res Inst, Caritas St Elizabeths Med Ctr, Boston, MA 02111 USA; [Hines, Michael] Yale Univ, Dept Neurobiol, New Haven, CT 06510 USA; [Kisvarday, Zoltan] Neurosci Res Grp, MTA Debreceni Egyet, H-4032 Debrecen, Hungary; [Toledo-Rodriguez, Maria] Univ Nottingham, Sch Life Sci, Nottingham NG7 2UH, England; [Lasserre, Sebastien] Ecole Polytech Fed Lausanne, Lab Informat & Visualisat, CH-1015 Lausanne, Switzerland; [Ailamaki, Anastasia; Heinis, Thomas; Tauheed, Farhan] Ecole Polytech Fed Lausanne, Data Intens Applicat & Syst Lab, CH-1015 Lausanne, Switzerland; [Heinis, Thomas] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Silberberg, Gilad] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Howard Hughes Medical Institute; Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); CIBERNED; Universidad Politecnica de Madrid; Universidad Rey Juan Carlos; Wenzhou Medical University; Wenzhou Medical University; St. Elizabeth's Medical Center; Tufts University; Yale University; Neuroscience Research Group, HAS; University of Nottingham; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Imperial College London; Karolinska Institutet	Markram, H (corresponding author), EPFL, Blue Brain Project, Biotech Campus, CH-1202 Geneva, Switzerland.	henry.markram@epfl.ch	Alonso-Nanclares, Lidia/K-6330-2013; Merchan-Perez, Angel/D-7417-2014; Van Geit, Werner/M-2655-2015; Ramaswamy, Srikanth/AAF-9133-2020; Rodríguez, José-Rodrigo/J-3775-2018; Muñoz, Alberto/D-4225-2014; Kanari, Lida/AAM-4546-2020; Khazen, Georges/AAC-2923-2020; Pastor, Luis/E-4700-2019; Shillcock, Julian/I-8215-2016; Merchan-Perez, Angel/AAY-8947-2020; Silberberg, Gilad/A-1048-2012; DEFELIPE, JAVIER/D-1195-2014; sanchez, carlos/HDO-1962-2022; Perin, Rodrigo/G-7691-2015	Alonso-Nanclares, Lidia/0000-0003-2649-7097; Merchan-Perez, Angel/0000-0002-7228-5821; Van Geit, Werner/0000-0002-2915-720X; Rodríguez, José-Rodrigo/0000-0003-4855-8073; Muñoz, Alberto/0000-0003-4607-3398; Pastor, Luis/0000-0002-7900-7509; Shillcock, Julian/0000-0002-7885-735X; Merchan-Perez, Angel/0000-0002-7228-5821; Silberberg, Gilad/0000-0001-9964-505X; DEFELIPE, JAVIER/0000-0001-5484-0660; Riquelme, Juan Luis/0000-0003-4604-7405; Kanari, Lida/0000-0002-9539-5070; Perin, Rodrigo/0000-0001-5756-3769; telefont, martin/0000-0002-7537-6251; Newton, Taylor/0000-0001-8429-8702; Chindemi, Giuseppe/0000-0001-6872-2366; Walker, Richard/0000-0003-2123-5565; Segev, Idan/0000-0001-7279-9630; Khazen, Geroges/0000-0002-9244-2978; Nolte, Max/0000-0002-9452-4926; Gal, Eyal/0000-0001-8140-9948; Muller, Eilif/0000-0003-4309-8266; Berger, Thomas/0000-0001-9358-1315	EPFL; ETH Domain for the Blue Brain Project (BBP); European Union [604102]; Gatsby Charitable Foundation; Cajal Blue Brain Project, Ministerio de Economia y Competitividad Spanish Ministry of Education and Science; EPFL-Hebrew University Collaborative Grant; Canton of Geneva; Canton of Vaud; Hans Wilsdorf Foundation; Louis-Jeantet Foundation; University of Geneva; University of Lausanne; Ecole Polytechnique Federale de Lausanne; ETH Board Funding	EPFL; ETH Domain for the Blue Brain Project (BBP); European Union(European Commission); Gatsby Charitable Foundation; Cajal Blue Brain Project, Ministerio de Economia y Competitividad Spanish Ministry of Education and Science; EPFL-Hebrew University Collaborative Grant; Canton of Geneva; Canton of Vaud; Hans Wilsdorf Foundation; Louis-Jeantet Foundation; University of Geneva; University of Lausanne; Ecole Polytechnique Federale de Lausanne; ETH Board Funding	The work was supported by funding from the EPFL to the Laboratory of Neural Microcircuitry (LNMC) and funding from the ETH Domain for the Blue Brain Project (BBP). Additional support was provided by funding for the Human Brain Project from the European Union Seventh Framework Program (FP7/2007-2013) under grant agreement no. 604102 (HBP). Further funding came from The Gatsby Charitable Foundation; the Cajal Blue Brain Project, Ministerio de Economia y Competitividad Spanish Ministry of Education and Science; and an EPFL-Hebrew University Collaborative Grant. In the years 2005-2009, the Blue Gene/L system was funded by the EPFL. Financial support for the subsequent CADMOS Blue Gene/P and Blue Gene/Q systems was provided by the Canton of Geneva, Canton of Vaud, Hans Wilsdorf Foundation, Louis-Jeantet Foundation, University of Geneva, University of Lausanne, and Ecole Polytechnique Federale de Lausanne. The BlueBrain IV BlueGene/Q system is financed by ETH Board Funding to the Blue Brain Project as a National Research Infrastructure and hosted at the Swiss National Supercomputing Center (CSCS). A large proportion of the data used in this study was generated at the Weizmann Institute for Science, Israel between 1996 and 2002 through the support of Thomas McKenna from the Office of Naval Research, USA.	Ali AB, 2007, J PHYSIOL-LONDON, V580, P149, DOI 10.1113/jphysiol.2006.124214; Amitai Y, 2001, REV NEUROSCIENCE, V12, P159, DOI 10.1515/REVNEURO.2001.12.2.159; Amzica F, 2002, J NEUROSCI, V22, P1042, DOI 10.1523/JNEUROSCI.22-03-01042.2002; Angulo MC, 1999, J NEUROPHYSIOL, V82, P1295, DOI 10.1152/jn.1999.82.3.1295; Anwar H, 2009, COMPUT NEUROSCI-MIT, P211; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bannister AP, 2007, CEREB CORTEX, V17, P2190, DOI 10.1093/cercor/bhl126; BEAULIEU C, 1993, BRAIN RES, V609, P284, DOI 10.1016/0006-8993(93)90884-P; BEAULIEU C, 1983, J COMP NEUROL, V217, P337, DOI 10.1002/cne.902170308; Beggs JM, 2003, J NEUROSCI, V23, P11167; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Beierlein M, 2002, J NEUROSCI, V22, P9885; Beierlein M, 2002, J NEUROPHYSIOL, V88, P1924, DOI 10.1152/jn.2002.88.4.1924; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; Borst JGG, 2010, TRENDS NEUROSCI, V33, P259, DOI 10.1016/j.tins.2010.03.003; BOYD J, 1991, BRAIN RES, V560, P207, DOI 10.1016/0006-8993(91)91234-R; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; Carnevale NT, 2006, NEURON BOOK; Cauli B, 1997, J NEUROSCI, V17, P3894; Cauli B, 2000, P NATL ACAD SCI USA, V97, P6144, DOI 10.1073/pnas.97.11.6144; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; CELIO MR, 1986, SCIENCE, V231, P995, DOI 10.1126/science.3945815; Chen NY, 2015, NAT NEUROSCI, V18, P892, DOI 10.1038/nn.4002; Cobb SR, 1997, NEUROSCIENCE, V79, P629, DOI 10.1016/S0306-4522(97)00055-9; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Constantinople CM, 2013, SCIENCE, V340, P1591, DOI 10.1126/science.1236425; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; CRAGG BG, 1967, J ANAT, V101, P639; CRICK FHC, 1979, SCI AM, V241, P219, DOI 10.1038/scientificamerican0979-219; Cunningham MO, 2004, P NATL ACAD SCI USA, V101, P7152, DOI 10.1073/pnas.0402060101; Datwani A, 2002, MOL CELL NEUROSCI, V21, P477, DOI 10.1006/mcne.2002.1195; De Koninck Y, 1997, J NEUROPHYSIOL, V77, P2202, DOI 10.1152/jn.1997.77.4.2202; DeFelipe J, 2002, J NEUROCYTOL, V31, P299, DOI 10.1023/A:1024130211265; DEFELIPE J, 1993, CEREB CORTEX, V3, P273, DOI 10.1093/cercor/3.4.273; DeFelipe J., 1988, CAJAL CEREBRAL CORTE; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; Delattre V, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00220, 10.3389/fncel.2015.00220]; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Druckmann S, 2007, FRONT NEUROSCI-SWITZ, V1, P7, DOI 10.3389/neuro.01.1.1.001.2007; Druckmann S, 2013, CEREB CORTEX, V23, P2994, DOI 10.1093/cercor/bhs290; Druckmann S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002133; Dumitriu D, 2007, CEREB CORTEX, V17, P81, DOI 10.1093/cercor/bhj126; Fairen A., 1984, CEREB CORTEX, V1, P201; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Feldmeyer D, 2006, J PHYSIOL-LONDON, V575, P583, DOI 10.1113/jphysiol.2006.105106; Frick A, 2008, CEREB CORTEX, V18, P397, DOI 10.1093/cercor/bhm074; Frick A, 2007, J PHYSIOL-LONDON, V585, P103, DOI 10.1113/jphysiol.2007.141788; Fuhrmann G, 2002, J NEUROPHYSIOL, V87, P140, DOI 10.1152/jn.00258.2001; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; GLENN LL, 1982, NEUROSCIENCE, V7, P1861, DOI 10.1016/0306-4522(82)90003-3; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Grange P, 2014, P NATL ACAD SCI USA, V111, P5397, DOI 10.1073/pnas.1312098111; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; HALLMAN LE, 1988, J COMP NEUROL, V272, P149, DOI 10.1002/cne.902720111; Harris KD, 2015, NAT NEUROSCI, V18, P170, DOI 10.1038/nn.3917; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hausser M, 1997, J NEUROSCI, V17, P7606; Hay E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002107; HEINEMANN U, 1977, EXP BRAIN RES, V27, P237; HENDRY SHC, 1989, EXP BRAIN RES, V76, P467; HENDRY SHC, 1984, J NEUROSCI, V4, P2497; Hernando J. B., 2012, 2012 IEEE Symposium on Biological Data Visualization (BioVis 2012), P25, DOI 10.1109/BioVis.2012.6378589; Hestrin S, 1996, J NEUROSCI, V16, P5290; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hill SL, 2012, P NATL ACAD SCI USA, V109, pE2885, DOI 10.1073/pnas.1202128109; Hines M, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00049; Hines ML, 2008, J COMPUT NEUROSCI, V25, P439, DOI 10.1007/s10827-008-0087-5; Hines ML, 2008, J COMPUT NEUROSCI, V25, P203, DOI 10.1007/s10827-007-0073-3; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Horton JC, 2005, PHILOS T R SOC B, V360, P837, DOI 10.1098/rstb.2005.1623; Hughes SW, 2002, NEURON, V33, P947, DOI 10.1016/S0896-6273(02)00623-2; JONES HC, 1988, J PHYSIOL-LONDON, V402, P579, DOI 10.1113/jphysiol.1988.sp017223; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Karagiannis A, 2009, J NEUROSCI, V29, P3642, DOI 10.1523/JNEUROSCI.0058-09.2009; Karube F, 2004, J NEUROSCI, V24, P2853, DOI 10.1523/JNEUROSCI.4814-03.2004; KASPER EM, 1994, J COMP NEUROL, V339, P475, DOI 10.1002/cne.903390403; Kasthuri N, 2015, CELL, V162, P648, DOI 10.1016/j.cell.2015.06.054; Kawaguchi Y, 2006, CEREB CORTEX, V16, P696, DOI 10.1093/cercor/bhj015; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V70, P387, DOI 10.1152/jn.1993.70.1.387; Kawaguchi Y, 2002, J NEUROCYTOL, V31, P277, DOI 10.1023/A:1024126110356; Keller A, 1999, J COMP NEUROL, V412, P83, DOI 10.1002/(SICI)1096-9861(19990913)412:1<83::AID-CNE6>3.0.CO;2-7; Khazen G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034786; KHAZIPOV R, 1995, J NEUROPHYSIOL, V74, P2126, DOI 10.1152/jn.1995.74.5.2126; KILLACKEY HP, 1983, J COMP NEUROL, V219, P384, DOI 10.1002/cne.902190403; KISVARDAY ZF, 1985, J COMP NEUROL, V241, P111, DOI 10.1002/cne.902410202; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Krimer LS, 2005, J NEUROPHYSIOL, V94, P3009, DOI 10.1152/jn.00156.2005; LARKMAN AU, 1991, J COMP NEUROL, V306, P307, DOI 10.1002/cne.903060207; LARKMAN AU, 1991, J COMP NEUROL, V306, P332, DOI 10.1002/cne.903060209; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Le Be JV, 2007, CEREB CORTEX, V17, P2204, DOI 10.1093/cercor/bhl127; Lee SH, 2012, NEURON, V76, P209, DOI 10.1016/j.neuron.2012.09.012; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Ling DSF, 1999, J NEUROPHYSIOL, V82, P1793, DOI 10.1152/jn.1999.82.4.1793; Livingstone MS, 1996, J NEUROPHYSIOL, V75, P2467, DOI 10.1152/jn.1996.75.6.2467; Lorincz ML, 2015, J NEUROSCI, V35, P5442, DOI 10.1523/JNEUROSCI.3603-14.2015; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Markram H, 2008, HFSP J, V2, P132, DOI 10.2976/1.2919545; MASON A, 1991, J NEUROSCI, V11, P72; Massimini M, 2001, J NEUROPHYSIOL, V85, P1346, DOI 10.1152/jn.2001.85.3.1346; Mazurek ME, 2002, NAT NEUROSCI, V5, P463, DOI 10.1038/nn836; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; McCormick DA, 2003, CEREB CORTEX, V13, P1219, DOI 10.1093/cercor/bhg104; McGarry LM, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00012; Mercer A, 2005, CEREB CORTEX, V15, P1485, DOI 10.1093/cercor/bhi027; Meyer AH, 2002, J NEUROSCI, V22, P7055; Meyer HS, 2010, CEREB CORTEX, V20, P2287, DOI 10.1093/cercor/bhq069; Meyer HS, 2010, CEREB CORTEX, V20, P2277, DOI 10.1093/cercor/bhq067; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Migliore M, 2006, J COMPUT NEUROSCI, V21, P119, DOI 10.1007/s10827-006-7949-5; Mott DD, 1999, J NEUROPHYSIOL, V82, P1438, DOI 10.1152/jn.1999.82.3.1438; Mountcastle V.B., 1998, PERCEPTUAL NEUROSCIE; Nelson Sacha B., 2002, Neuron, V36, P19, DOI 10.1016/S0896-6273(02)00944-3; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; O'Connor DH, 2009, NATURE, V461, P923, DOI 10.1038/nature08539; Oberlaender M, 2012, CEREB CORTEX, V22, P2375, DOI 10.1093/cercor/bhr317; Ohana O, 1998, J PHYSIOL-LONDON, V513, P135, DOI 10.1111/j.1469-7793.1998.135by.x; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Okun M, 2015, NATURE, V521, P511, DOI 10.1038/nature14273; Olah S, 2007, FRONT NEURAL CIRCUIT, V1, DOI [10.3389/neuro.04/004.2007, 10.3389/neuro.04.004.2007]; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Perrenoud Q, 2013, CEREB CORTEX, V23, P423, DOI 10.1093/cercor/bhs032; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Peters A., 1987, CEREBRAL CORTEX FURT, P267, DOI DOI 10.1007/978-1-4615-6616-8_7; Ramaswamy S, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00044; Ramaswamy S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00233; Ramaswamy S, 2012, J PHYSIOL-LONDON, V590, P737, DOI 10.1113/jphysiol.2011.219576; Ramon y Cajal S., 1909, HISTOLOGIE SYSTEME N, DOI [DOI 10.5962/BHL.TITLE.48637, 10.5962/bhl.title.48637]; Reimann MW, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00120; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Reyes A, 1999, J NEUROSCI, V19, P3827; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Reyes-Puerta V, 2015, CEREB CORTEX, V25, P2001, DOI 10.1093/cercor/bhu007; Rinaldi T, 2008, CEREB CORTEX, V18, P763, DOI 10.1093/cercor/bhm117; Romand S, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00005; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Sancesario G, 1998, EUR J NEUROSCI, V10, P3575, DOI 10.1046/j.1460-9568.1998.00374.x; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Santana R, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00185; Sarid L, 2007, P NATL ACAD SCI USA, V104, P16353, DOI 10.1073/pnas.0707853104; Schroeder CE, 2002, COGNITIVE BRAIN RES, V14, P187, DOI 10.1016/S0926-6410(02)00073-3; Schurmann F., 2014, REBASING I O SCI COM, P331; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Sigalas C, 2015, J NEUROSCI, V35, P11196, DOI 10.1523/JNEUROSCI.5222-14.2015; Silberberg G, 2004, J PHYSIOL-LONDON, V556, P19, DOI 10.1113/jphysiol.2004.060962; Silberberg G, 2008, CURR OPIN NEUROBIOL, V18, P332, DOI 10.1016/j.conb.2008.08.009; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; SILVA LR, 1991, SCIENCE, V251, P432, DOI 10.1126/science.1824881; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Simkus CRL, 2002, J PHYSIOL-LONDON, V545, P509, DOI 10.1113/jphysiol.2002.022095; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; SOMOGYI P, 1982, NEUROSCIENCE, V7, P2577, DOI 10.1016/0306-4522(82)90086-0; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Sporns O., 2004, NAT REV NEUROSCI, V2, pe369; Stepanyants A, 2009, P NATL ACAD SCI USA, V106, P3555, DOI 10.1073/pnas.0810390106; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Tamas G, 1998, J NEUROSCI, V18, P4255; Tan AYY, 2014, NATURE, V509, P226, DOI 10.1038/nature13159; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; Thomson AM, 1998, NEUROSCIENCE, V84, P669, DOI 10.1016/S0306-4522(97)00557-5; Thomson AM, 1996, J PHYSIOL-LONDON, V496, P81, DOI 10.1113/jphysiol.1996.sp021667; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092; Toledo-Rodriguez M, 2005, J PHYSIOL-LONDON, V567, P401, DOI 10.1113/jphysiol.2005.089250; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Wang Y, 2002, CEREB CORTEX, V12, P395, DOI 10.1093/cercor/12.4.395; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; WANG Z, 1993, J NEUROSCI, V13, P2199; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; WESTERINK BHC, 1988, N-S ARCH PHARMACOL, V337, P373, DOI 10.1007/BF00169526; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; WILLIAMS RW, 1988, J COMP NEUROL, V278, P344, DOI 10.1002/cne.902780305; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Wimmer VC, 2010, CEREB CORTEX, V20, P2265, DOI 10.1093/cercor/bhq068; Yoshimura Y, 1999, NEUROSCIENCE, V88, P347, DOI 10.1016/S0306-4522(98)00382-0; Yuste R, 2005, NEURON, V48, P524, DOI 10.1016/j.neuron.2005.11.012; Yuste R, 1997, CEREB CORTEX, V7, P546, DOI 10.1093/cercor/7.6.546; Zagha E, 2014, CURR OPIN NEUROBIOL, V29, P178, DOI 10.1016/j.conb.2014.09.010; Zhu JJ, 2000, J PHYSIOL-LONDON, V526, P571, DOI 10.1111/j.1469-7793.2000.00571.x	209	669	681	15	154	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2					456	492		10.1016/j.cell.2015.09.029	http://dx.doi.org/10.1016/j.cell.2015.09.029			37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26451489	Green Published, Bronze			2022-12-28	WOS:000362952700021
J	Pedicord, VA; Mucida, D				Pedicord, Virginia A.; Mucida, Daniel			"A Sledgehammer Breaks Glass but Forges Steel": Bacteria Adhesion Shapes Gut Immunity	CELL			English	Editorial Material								Gut bacteria are known to affect immune cell development, but most intestinal lymphocytes have no direct contact with luminal bacteria. Two studies by Atarashi et al. and Sano et al. shed light on how bacterial adhesion can cue intestinal epithelial cells to direct differentiation of gut T cells.	[Pedicord, Virginia A.; Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, New York, NY 10065 USA	Rockefeller University	Mucida, D (corresponding author), Rockefeller Univ, Lab Mucosal Immunol, 1230 York Ave, New York, NY 10065 USA.	mucida@rockefeller.edu						Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Derebe MG, 2014, ELIFE, V3, DOI 10.7554/eLife.03206; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Panea C, 2015, CELL REP, V12, P1314, DOI 10.1016/j.celrep.2015.07.040; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165	10	6	6	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2					273	274		10.1016/j.cell.2015.09.040	http://dx.doi.org/10.1016/j.cell.2015.09.040			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26451476	Bronze			2022-12-28	WOS:000362952700003
J	Niederman, MS				Niederman, Michael S.			Community-Acquired Pneumonia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material															American College of Physicians	American College of Physicians	American College of Physicians.		0	12	12	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2015	163	7							ITC1	10.7326/AITC201510060	http://dx.doi.org/10.7326/AITC201510060			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT0OQ	26436631				2022-12-28	WOS:000362496400001
J	Smith, JM				Smith, Jeanette M.			Landscape With Poplars	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2015	314	13					1322	1323		10.1001/jama.2014.12007	http://dx.doi.org/10.1001/jama.2014.12007			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2PH	26441166				2022-12-28	WOS:000362644700001
J	Cao, Q; Han, SJ; Tersoff, J; Franklin, AD; Zhu, Y; Zhang, Z; Tulevski, GS; Tang, JS; Haensch, W				Cao, Qing; Han, Shu-Jen; Tersoff, Jerry; Franklin, Aaron D.; Zhu, Yu; Zhang, Zhen; Tulevski, George S.; Tang, Jianshi; Haensch, Wilfried			End-bonded contacts for carbon nanotube transistors with low, size-independent resistance	SCIENCE			English	Article							HIGH-PERFORMANCE ELECTRONICS; FIELD-EFFECT TRANSISTORS; METAL-GRAPHENE; NANOCONTACTS; CIRCUITS; GATE	Moving beyond the limits of silicon transistors requires both a high-performance channel and high-quality electrical contacts. Carbon nanotubes provide high-performance channels below 10 nanometers, but as with silicon, the increase in contact resistance with decreasing size becomes a major performance roadblock. We report a single-walled carbon nanotube (SWNT) transistor technology with an end-bonded contact scheme that leads to size-independent contact resistance to overcome the scaling limits of conventional side-bonded or planar contact schemes. A high-performance SWNT transistor was fabricated with a sub-10-nanometer contact length, showing a device resistance below 36 kilohms and on-current above 15 microampere per tube. The p-type end-bonded contact, formed through the reaction of molybdenum with the SWNT to form carbide, also exhibited no Schottky barrier. This strategy promises high-performance SWNT transistors, enabling future ultimately scaled device technologies.	[Cao, Qing; Han, Shu-Jen; Tersoff, Jerry; Franklin, Aaron D.; Zhu, Yu; Zhang, Zhen; Tulevski, George S.; Tang, Jianshi; Haensch, Wilfried] IBM Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	International Business Machines (IBM)	Cao, Q (corresponding author), IBM Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA.	qcao@us.ibm.com	Tang, Jianshi/I-5543-2014	Tang, Jianshi/0000-0001-8369-0067; Franklin, Aaron/0000-0002-1128-9327				Appenzeller J, 2008, P IEEE, V96, P201, DOI 10.1109/JPROC.2007.911051; Appenzeller J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.126801; Cao Q, 2008, NATURE, V454, P495, DOI 10.1038/nature07110; Cao Q, 2013, NAT NANOTECHNOL, V8, P180, DOI [10.1038/nnano.2012.257, 10.1038/NNANO.2012.257]; Chen ZH, 2005, NANO LETT, V5, P1497, DOI 10.1021/nl0508624; Cress CD, 2013, SCIENCE, V341, P140, DOI 10.1126/science.1240452; del Alamo JA, 2011, NATURE, V479, P317, DOI 10.1038/nature10677; Franklin AD, 2014, ACS NANO, V8, P7333, DOI 10.1021/nn5024363; Franklin AD, 2013, NATURE, V498, P443, DOI 10.1038/498443a; Franklin AD, 2013, NANO LETT, V13, P2490, DOI 10.1021/nl400544q; Franklin AD, 2012, NANO LETT, V12, P758, DOI 10.1021/nl203701g; Franklin AD, 2010, NAT NANOTECHNOL, V5, P858, DOI [10.1038/nnano.2010.220, 10.1038/NNANO.2010.220]; Grosse KL, 2011, NAT NANOTECHNOL, V6, P287, DOI [10.1038/NNANO.2011.39, 10.1038/nnano.2011.39]; Haensch W, 2006, IBM J RES DEV, V50, P339, DOI 10.1147/rd.504.0339; Javey A, 2003, NATURE, V424, P654, DOI 10.1038/nature01797; Kreupl F, 2012, NATURE, V484, P321, DOI 10.1038/484321a; Leonard F, 2011, NAT NANOTECHNOL, V6, P773, DOI [10.1038/nnano.2011.196, 10.1038/NNANO.2011.196]; Leroy WP, 2007, J APPL PHYS, V101, DOI 10.1063/1.2561173; Martel R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.256805; Matsuda Y, 2010, J PHYS CHEM C, V114, P17845, DOI 10.1021/jp806437y; MORGAN AE, 1988, J APPL PHYS, V64, P344, DOI 10.1063/1.341434; Nemec N, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.076802; Palacios JJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.106801; Rodriguez-Manzo JA, 2009, P NATL ACAD SCI USA, V106, P4591, DOI 10.1073/pnas.0900960106; Service RF, 2009, SCIENCE, V323, P1000, DOI 10.1126/science.323.5917.1000; Shulaker MM, 2013, NATURE, V501, P526, DOI 10.1038/nature12502; Solomon PM, 2011, IEEE ELECTR DEVICE L, V32, P246, DOI 10.1109/LED.2010.2095821; Theis TN, 2010, SCIENCE, V327, P1600, DOI 10.1126/science.1187597; Tulevski GS, 2014, ACS NANO, V8, P8730, DOI 10.1021/nn503627h; Vitale V, 2008, J AM CHEM SOC, V130, P5848, DOI 10.1021/ja8002843; Wang MS, 2010, ADV MATER, V22, P5350, DOI 10.1002/adma.201003010; Xia FN, 2011, NAT NANOTECHNOL, V6, P179, DOI [10.1038/nnano.2011.6, 10.1038/NNANO.2011.6]; Zhang JL, 2011, ACS NANO, V5, P3284, DOI 10.1021/nn2004298; Zhang Y, 1999, SCIENCE, V285, P1719, DOI 10.1126/science.285.5434.1719; Zhang Z, 2013, IEEE ELECTR DEVICE L, V34, P723, DOI 10.1109/LED.2013.2257664	35	148	160	12	295	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					68	72		10.1126/science.aac8006	http://dx.doi.org/10.1126/science.aac8006			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26430114				2022-12-28	WOS:000362098300046
J	Atun, R				Atun, Rifat			INTERNATIONAL HEALTH CARE SYSTEMS Transforming Turkey's Health System - Lessons for Universal Coverage	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat & Hlth Policy & Manage, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Atun, R (corresponding author), Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat & Hlth Policy & Manage, 665 Huntington Ave, Boston, MA 02115 USA.		Atun, Rifat/AAH-5537-2021					Atun R, 2014, LANCET, V383, pE1, DOI 10.1016/S0140-6736(13)62738-5; Atun R, 2013, LANCET, V382, P65, DOI 10.1016/S0140-6736(13)61051-X; World Bank, 2022, WORLD DEV IND	3	36	36	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2015	373	14					1285	1289		10.1056/NEJMp1410433	http://dx.doi.org/10.1056/NEJMp1410433			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS3CI	26422719				2022-12-28	WOS:000361948600001
J	Cullen, L; Parsonage, W; Than, M				Cullen, Louise; Parsonage, William; Than, Martin			Myocardial infarction: rapid ruling out in the emergency room	LANCET			English	Editorial Material							CHEST-PAIN; TROPONIN-I; OUTCOMES		[Cullen, Louise] Royal Brisbane & Womens Hosp, Dept Emergency Med, Brisbane, Qld 4029, Australia; [Parsonage, William] Royal Brisbane & Womens Hosp, Dept Cardiol, Brisbane, Qld 4029, Australia; [Than, Martin] Christchurch Hosp, Emergency Dept, Christchurch, New Zealand	Royal Brisbane & Women's Hospital; Royal Brisbane & Women's Hospital; Christchurch Hospital New Zealand	Cullen, L (corresponding author), Royal Brisbane & Womens Hosp, Dept Emergency Med, Brisbane, Qld 4029, Australia.	louise.cullen@health.qld.gov.au	Cullen, Louise A/D-2274-2013; Cullen, Louise/ABC-9266-2021; Parsonage, William/O-9233-2018	Cullen, Louise A/0000-0001-6611-8229; Cullen, Louise/0000-0001-6611-8229; Parsonage, William/0000-0002-0223-5378				Apple FS, 2015, CLIN BIOCHEM, V48, P201, DOI 10.1016/j.clinbiochem.2014.08.021; Body R, 2011, J AM COLL CARDIOL, V58, P1333, DOI 10.1016/j.jacc.2011.06.026; Cullen L, 2015, MED J AUSTRALIA, V202, P427, DOI 10.5694/mja14.00472; Cullen L, 2013, J AM COLL CARDIOL, V62, P1242, DOI 10.1016/j.jacc.2013.02.078; Goodacre S, 2005, HEART, V91, P229, DOI 10.1136/hrt.2003.027599; Gimenez MR, 2015, AM J MED, V128, P861, DOI 10.1016/j.amjmed.2015.01.046; Shah A. S., 2015, LANCET; Skinner JS, 2010, HEART, V96, P974, DOI 10.1136/hrt.2009.190066; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058	9	4	4	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 19	2015	386	10012					2449	2450		10.1016/S0140-6736(15)00449-3	http://dx.doi.org/10.1016/S0140-6736(15)00449-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ1LD	26454363	Green Submitted, hybrid			2022-12-28	WOS:000366866400006
J	Liu, W; Martinon-Torres, M; Cai, YJ; Xing, S; Tong, HW; Pei, SW; Sier, MJ; Wu, XH; Edwards, RL; Cheng, H; Li, YY; Yang, XX; de Castro, JMB; Wu, XJ				Liu, Wu; Martinon-Torres, Maria; Cai, Yan-jun; Xing, Song; Tong, Hao-wen; Pei, Shu-wen; Sier, Mark Jan; Wu, Xiao-hong; Edwards, R. Lawrence; Cheng, Hai; Li, Yi-yuan; Yang, Xiong-xin; Bermudez de Castro, Jose Maria; Wu, Xiu-jie			The earliest unequivocally modern humans in southern China	NATURE			English	Article							MORPHOMETRIC-ANALYSIS; HOMININ TEETH; AFRICA; REMAINS; DISPERSALS; HISTORY; ROUTE; CAVE; JAVA; SITE	The hominin record from southern Asia for the early Late Pleistocene epoch is scarce. Well-dated and well-preserved fossils older than similar to 45,000 years that can be unequivocally attributed to Homo sapiens are lacking(1-4). Here we present evidence from the newly excavated Fuyan Cave in Damian (southern China). This site has provided 47 human teeth dated to more than 80,000 years old, and with an inferred maximum age of 120,000 years. The morphological and metric assessment of this sample supports its unequivocal assignment to H. sapiens. The Daoxian sample is more derived than any other anatomically modern humans, resembling middle-to-late Late Pleistocene specimens and even contemporary humans. Our study shows that fully modern morphologies were present in southern China 30,000-70,000 years earlier than in the Levant and Europe(5-7). Our data fill a chronological and geographical gap that is relevant for understanding when H. sapiens first appeared in southern Asia. The Damian teeth also support the hypothesis that during the same period, southern China was inhabited by more derived populations than central and northern China. This evidence is important for the study of dispersal routes of modern humans.. Finally, our results are relevant to exploring the reasons for the relatively late entry of H. sapiens into Europe. Some studies have investigated how the competition with H. sapiens may have caused Neanderthals' extinction. (see ref. 8 and references therein). Notably, although fully modern humans were already present in southern China at least as early as 80,000 years ago, there is no evidence that they entered Europe before similar to 45,000 years ago. This could indicate that H. neanderthalensis was indeed an additional ecological barrier for modern humans, who could only enter Europe when the demise of Neanderthals had already started.	[Liu, Wu; Xing, Song; Tong, Hao-wen; Pei, Shu-wen; Wu, Xiu-jie] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China; [Martinon-Torres, Maria; Bermudez de Castro, Jose Maria] UCL Anthropol, London WC1H 0BW, England; [Martinon-Torres, Maria] Univ Burgos, Dept Ciencias Hist & Geog, Burgos 09001, Spain; [Martinon-Torres, Maria; Sier, Mark Jan; Bermudez de Castro, Jose Maria] Ctr Nacl Invest Evoluc Humana CENIEH, Burgos 09002, Spain; [Cai, Yan-jun] Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian 710075, Peoples R China; [Sier, Mark Jan] Univ Utrecht, Fac Geosci, Dept Earth Sci, Paleomagnet Lab Ft Hoofddijk, NL-3584 CD Utrecht, Netherlands; [Sier, Mark Jan] Leiden Univ, Fac Archaeol, NL-2300 RA Leiden, Netherlands; [Wu, Xiao-hong] Peking Univ, Sch Archaeol & Museol, Beijing 100871, Peoples R China; [Edwards, R. Lawrence] Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA; [Cheng, Hai] Xi An Jiao Tong Univ, Inst Global Environm Change, Xian 710049, Peoples R China; [Li, Yi-yuan] Inst Cultural Rel & Archaeol, Changsha 410008, Hunan, Peoples R China; [Yang, Xiong-xin] Cultural Rel Adm Daoxian Cty, Daoxian 425300, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of London; University College London; Universidad de Burgos; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); Chinese Academy of Sciences; Institute of Earth Environment, CAS; Utrecht University; Leiden University; Leiden University - Excl LUMC; Peking University; University of Minnesota System; University of Minnesota Twin Cities; Xi'an Jiaotong University	Martinon-Torres, M (corresponding author), UCL Anthropol, 14 Taviton St, London WC1H 0BW, England.	liuwu@ivpp.ac.cn; maria.martinon-torres@ucl.ac.uk; wuxiujie@ivpp.ac.cn	Sier, Mark/AAA-8778-2020; Pei, Shuwen/G-3979-2019; CHENG, HAI/H-3413-2017; Edwards, R. Lawrence/I-3124-2014; Cai, Yanjun/A-9462-2010; Wu, Xiaohong/AAH-4348-2020	Sier, Mark/0000-0002-4145-0556; Pei, Shuwen/0000-0003-2034-3572; CHENG, HAI/0000-0002-5305-9458; Edwards, R. Lawrence/0000-0002-7027-5881; Cai, Yanjun/0000-0001-7063-5050; Wu, Xiaohong/0000-0002-3819-0829; Bermudez de Castro, Jose Maria/0000-0003-1314-3273	Chinese Academy of Sciences [KZZD-EW-03, XDA05130101, GJHZ201314]; National Natural Science Foundation of China [41272034, 41302016, 41271229]; Netherlands Organisation for Scientific Research [NWO-ALW 823.01.003]; Direccion General de Investigacion of the Spanish Ministerio de Educacion y Ciencia [CGL2012-38434-C03-02]; Direccion General de Investigacion of the Spanish Ministerio de Educacion y Ciencia (Accion Integrada Espana Francia) [HF2007-0115]; Consejeria de Educacion de Junta de Castilla y Leon [CEN074A12-2]; Leakey Foundation	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Direccion General de Investigacion of the Spanish Ministerio de Educacion y Ciencia(Spanish Government); Direccion General de Investigacion of the Spanish Ministerio de Educacion y Ciencia (Accion Integrada Espana Francia); Consejeria de Educacion de Junta de Castilla y Leon; Leakey Foundation	This work has been supported by the grants from the Chinese Academy of Sciences (KZZD-EW-03, XDA05130101, GJHZ201314), National Natural Science Foundation of China (41272034, 41302016, 41271229), Netherlands Organisation for Scientific Research (NWO-ALW 823.01.003), Direccion General de Investigacion of the Spanish Ministerio de Educacion y Ciencia (CGL2012-38434-C03-02, and Accion Integrada Espana Francia HF2007-0115), Consejeria de Educacion de Junta de Castilla y Leon (CEN074A12-2) and The Leakey Foundation (through the support of G. Getty and D. Crook). We are grateful to several people who have provided access to comparative materials and/or advice in several aspects of the manuscript: R. Blasco, J. Rosell, J. M. Pares, M. Salesa, A. Terrific), C. Saiz, I. Hershkovitz, A. Vialet, M. A. de Lumley, C. Bernis, J. Rascon and J. Svoboda. We are also grateful to Y.-S. Lou, L.-M. Zhang and P.-P. Wei who participated in the excavations at the Daoxian site.	Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Bailey S, 2002, THESIS ARIZONA STATE; Bailey SE, 2004, J HUM EVOL, V47, P183, DOI 10.1016/j.jhevol.2004.07.001; Barker G, 2007, J HUM EVOL, V52, P243, DOI 10.1016/j.jhevol.2006.08.011; Benazzi S, 2015, SCIENCE, V348, P793, DOI 10.1126/science.aaa2773; Bowler JM, 2003, NATURE, V421, P837, DOI 10.1038/nature01383; Cheng H, 2013, EARTH PLANET SC LETT, V371, P82, DOI 10.1016/j.epsl.2013.04.006; Dennell R., 2014, SO ASIA AUSTR SEARCH, P33; Dennell R, 2010, NATURE, V468, P512, DOI 10.1038/468512a; Gomez-Robles A, 2008, J HUM EVOL, V55, P627, DOI 10.1016/j.jhevol.2008.03.011; Grine FE, 2007, SCIENCE, V315, P226, DOI 10.1126/science.1136294; Hershkovitz I, 2015, NATURE, V520, P216, DOI 10.1038/nature14134; Kaifu Y, 2005, AM J PHYS ANTHROPOL, V128, P709, DOI 10.1002/ajpa.10425; Kaifu Y, 2006, ANTHROPOL SCI, V114, P35, DOI 10.1537/ase.040729; Liu W, 2013, J HUM EVOL, V64, P337, DOI 10.1016/j.jhevol.2012.10.012; Liu W, 2010, P NATL ACAD SCI USA, V107, P19201, DOI 10.1073/pnas.1014386107; Martinon-Torres M, 2007, P NATL ACAD SCI USA, V104, P13279, DOI 10.1073/pnas.0706152104; Martinon-Torres M, 2012, J HUM EVOL, V62, P7, DOI 10.1016/j.jhevol.2011.08.007; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Oppenheimer S, 2009, QUATERN INT, V202, P2, DOI 10.1016/j.quaint.2008.05.015; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reyes-Centeno H, 2014, P NATL ACAD SCI USA, V111, P7248, DOI 10.1073/pnas.1323666111; Shang H, 2010, EARLY MODERN HUMAN T; Storm P, 2013, J HUM EVOL, V64, P356, DOI 10.1016/j.jhevol.2012.11.002; Villa P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096424; Westaway KE, 2007, J HUM EVOL, V53, P709, DOI 10.1016/j.jhevol.2007.06.002; Xing S, 2015, AM J PHYS ANTHROPOL, V156, P224, DOI 10.1002/ajpa.22641; Xing S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114265	28	234	271	7	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					696	699		10.1038/nature15696	http://dx.doi.org/10.1038/nature15696			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CU8ZH	26466566	Green Submitted			2022-12-28	WOS:000363832100047
J	Gao, T; Estrecho, E; Bliokh, KY; Liew, TCH; Fraser, MD; Brodbeck, S; Kamp, M; Schneider, C; Hofling, S; Yamamoto, Y; Nori, F; Kivshar, YS; Truscott, AG; Dall, RG; Ostrovskaya, EA				Gao, T.; Estrecho, E.; Bliokh, K. Y.; Liew, T. C. H.; Fraser, M. D.; Brodbeck, S.; Kamp, M.; Schneider, C.; Hoefling, S.; Yamamoto, Y.; Nori, F.; Kivshar, Y. S.; Truscott, A. G.; Dall, R. G.; Ostrovskaya, E. A.			Observation of non-Hermitian degeneracies in a chaotic exciton-polariton billiard	NATURE			English	Article							BOSE-EINSTEIN CONDENSATION; QUANTUM DOTS; PHYSICS; LIGHT	Exciton-polaritons are hybrid light-matter quasiparticles formed by strongly interacting photons and excitons (electron-hole pairs) in semiconductor microcavities(1-3). They have emerged as a robust solid-state platform for next-generation optoelectronic applications as well as for fundamental studies of quantum many-body physics. Importantly, exciton-polaritons are a profoundly open (that is, non-Hermitian(4,5)) quantum system, which requires constant pumping of energy and continuously decays, releasing coherent radiation(6). Thus, the exciton-polaritons always exist in a balanced potential landscape of gain and loss. However, the inherent non-Hermitian nature of this potential has so far been largely ignored in exciton-polariton physics. Here we demonstrate that non-Hermiticity dramatically modifies the structure of modes and spectral degeneracies in exciton-polariton systems, and, therefore, will affect their quantum transport, localization and dynamical properties(7-9). Using a spatially structured optical pump(10-12), we create a chaotic exciton-polariton billiard-a two-dimensional area enclosed by a curved potential barrier. Eigenmodes of this billiard exhibit multiple non-Hermitian spectral degeneracies, known as exceptional points(13,14). Such points can cause remarkable wave phenomena, such as unidirectional transport(15), anomalous lasing/absorption(16,17) and chiral modes(18). By varying parameters of the billiard, we observe crossing and anti-crossing of energy levels and reveal the non-trivial topological modal structure exclusive to non-Hermitian systems(9,13-22). We also observe mode switching and a topological Berry phase for a parameter loop encircling the exceptional point(23,24). Our findings pave the way to studies of non-Hermitian quantum dynamics of exciton-polaritons, which may uncover novel operating principles for polariton-based devices.	[Gao, T.; Estrecho, E.; Bliokh, K. Y.; Kivshar, Y. S.; Truscott, A. G.; Dall, R. G.; Ostrovskaya, E. A.] Australian Natl Univ, Res Sch Phys & Engn, Canberra, ACT 2601, Australia; [Bliokh, K. Y.; Fraser, M. D.; Nori, F.] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Liew, T. C. H.] Nanyang Technol Univ, Sch Phys & Math Sci, Singapore 637371, Singapore; [Brodbeck, S.; Kamp, M.; Schneider, C.; Hoefling, S.] Univ Wurzburg, Tech Phys & Wilhelm Conrad Rontgen Res Ctr Comple, D-97074 Wurzburg, Germany; [Hoefling, S.] Univ St Andrews, Sch Phys & Astron, SUPA, St Andrews KY16 9SS, Fife, Scotland; [Yamamoto, Y.] Japan Sci & Technol Agcy, ImPACT Project, Chiyoda Ku, Tokyo 1020076, Japan; [Yamamoto, Y.] Stanford Univ, Edward L Ginzton Lab, Stanford, CA 94305 USA; [Nori, F.] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA	Australian National University; RIKEN; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Wurzburg; University of St Andrews; Japan Science & Technology Agency (JST); Stanford University; University of Michigan System; University of Michigan	Ostrovskaya, EA (corresponding author), Australian Natl Univ, Res Sch Phys & Engn, GPO Box 4, Canberra, ACT 2601, Australia.	elena.ostrovskaya@anu.edu.au	Yamamoto, Yoshihisa/A-2811-2012; Bliokh, Konstantin/A-4024-2013; Fraser, Michael D/D-8603-2017; Gao, Tingge/J-7280-2015; Hofling, Sven/C-3140-2013; Truscott, Andrew/A-8086-2011; Gao, Tingge/GQG-8733-2022; Ostrovskaya, Elena A/G-6367-2010; Liew, Timothy/D-4300-2016; Kivshar, Yuri/AAJ-1901-2020; Estrecho, Eliezer/O-4523-2018; Kivshar, Yuri/ABA-7970-2020; Kamp, Martin/G-9704-2011; Nori, Franco/B-1222-2009	Yamamoto, Yoshihisa/0000-0002-4150-6804; Bliokh, Konstantin/0000-0003-1104-8627; Gao, Tingge/0000-0003-4711-0365; Hofling, Sven/0000-0003-0034-4682; Truscott, Andrew/0000-0003-2106-8613; Ostrovskaya, Elena A/0000-0002-8657-6048; Liew, Timothy/0000-0003-2568-7294; Estrecho, Eliezer/0000-0003-0523-6533; Kivshar, Yuri/0000-0002-3410-812X; Kamp, Martin/0000-0002-7219-2297; Nori, Franco/0000-0003-3682-7432	Australian Research Council; ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan); RIKEN iTHES Project; MURI Center for Dynamic Magneto-Optics; State of Bavaria	Australian Research Council(Australian Research Council); ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan); RIKEN iTHES Project; MURI Center for Dynamic Magneto-Optics(MURI); State of Bavaria	We thank M. Berry and O. Kirillov for comments. This research was supported by the Australian Research Council, the ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan), the RIKEN iTHES Project, the MURI Center for Dynamic Magneto-Optics, a Grant-in-Aid for Scientific Research (type A), and the State of Bavaria.	Akis R, 1997, PHYS REV LETT, V79, P123, DOI 10.1103/PhysRevLett.79.123; Askitopoulos A, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.035305; Bender CM, 2007, REP PROG PHYS, V70, P947, DOI 10.1088/0034-4885/70/6/R03; Berry MV, 2011, J PHYS A-MATH THEOR, V44, DOI 10.1088/1751-8113/44/43/435303; Berry MV, 2004, CZECH J PHYS, V54, P1039, DOI 10.1023/B:CJOP.0000044002.05657.04; BERRY MV, 1981, ANN PHYS-NEW YORK, V131, P163, DOI 10.1016/0003-4916(81)90189-5; Cao H, 2015, REV MOD PHYS, V87, P61, DOI 10.1103/RevModPhys.87.61; Carusotto I, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.299; Choi Y, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.153601; Cristofolini P, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.186403; Dall R, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.200404; Dembowski C, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.056216; Dembowski C, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.034101; Dembowski C, 2001, PHYS REV LETT, V86, P787, DOI 10.1103/PhysRevLett.86.787; Deng H, 2010, REV MOD PHYS, V82, P1489, DOI 10.1103/RevModPhys.82.1489; Eastham PR, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.035319; Ge L, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031011; Guo A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.093902; Heiss WD, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/44/444016; Heiss WD, 1999, EUR PHYS J D, V7, P1, DOI 10.1007/s100530050339; Kaplan A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.274101; Kasprzak J, 2006, NATURE, V443, P409, DOI 10.1038/nature05131; Kavokin A., 2017, MICROCAVITIES; Keeling J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.250401; Lee SB, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.134101; Milner V, 2001, PHYS REV LETT, V86, P1514, DOI 10.1103/PhysRevLett.86.1514; Moiseyev N., 2011, NONHERMITIAN QUANTUM; Peng B, 2014, SCIENCE, V346, P328, DOI 10.1126/science.1258004; Ponomarenko LA, 2008, SCIENCE, V320, P356, DOI 10.1126/science.1154663; Sanvitto D, 2011, NAT PHOTONICS, V5, P610, DOI [10.1038/NPHOTON.2011.211, 10.1038/nphoton.2011.211]; Savvidis PG, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.075311; Sinai Y.G., 1970, USPEHI MAT NAUK, V25, P141, DOI 10.1070/RM1970v025n02ABEH003794; Smirnov LA, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.235310; Sun Y, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.143903; Tosi G, 2012, NAT PHYS, V8, P190, DOI [10.1038/nphys2182, 10.1038/NPHYS2182]; Uzdin R., 2011, J PHYS A, V44; Wertz E, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.216404; Wouters M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.140402; Wouters M, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/7/075020	41	317	317	10	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					554	U203		10.1038/nature15522	http://dx.doi.org/10.1038/nature15522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26458102	Green Submitted, Green Accepted			2022-12-28	WOS:000364026100046
J	Hesdorffer, CS; Longo, DL				Hesdorffer, Charles S.; Longo, Dan L.			Drug-Induced Megaloblastic Anemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							VITAMIN-B-12 DEFICIENCY; COBALAMIN DEFICIENCY; FOLATE-DEFICIENCY; FOLIC-ACID; HOMOCYSTEINE METABOLISM; RECEPTOR; PLASTICITY; NUTRIENTS; PATIENT		[Hesdorffer, Charles S.] George Washington Univ, Washington, DC USA; [Hesdorffer, Charles S.] Washington DC Vet Affairs Med Ctr, Washington, DC 20422 USA	George Washington University	Hesdorffer, CS (corresponding author), Washington DC Vet Affairs Med Ctr, Dept Med, 50 Irving St NW, Washington, DC 20422 USA.	charles.hesdorffer@va.gov	Longo, Dan L./F-6022-2011					Addison T., 1849, LOND MED GAZETTE, V43, P517; Akchiche N, 2012, FASEB J, V26, P3980, DOI 10.1096/fj.12-205757; AMESS JAL, 1978, LANCET, V2, P339; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; Bauman WA, 2000, DIABETES CARE, V23, P1227, DOI 10.2337/diacare.23.9.1227; Bellou A, 1996, J INTERN MED, V240, P161, DOI 10.1046/j.1365-2796.1996.20846000.x; Briani C, 2013, NUTRIENTS, V5, P4521, DOI 10.3390/nu5114521; Carmel R, 2003, BLOOD, V101, P3302, DOI 10.1182/blood-2002-09-2746; Chiang TT, 2013, CASE REP DERMATOL, V5, P186, DOI 10.1159/000353623; Das KC, 2005, MED PRIN PRACT, V14, P2, DOI 10.1159/000086179; de Jager J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2181; Fedosov Sergey N, 2012, Subcell Biochem, V56, P347, DOI 10.1007/978-94-007-2199-9_18; FLIPPO TS, 1993, ARCH SURG-CHICAGO, V128, P1391; Halsted CH, 2002, P NATL ACAD SCI USA, V99, P10072, DOI 10.1073/pnas.112336399; HALSTED CH, 1971, NEW ENGL J MED, V285, P701, DOI 10.1056/NEJM197109232851301; He D, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD009882.PUB223235682; HEALTON EB, 1991, MEDICINE, V70, P229, DOI 10.1097/00005792-199107000-00001; Herbert V., 1959, MEGALOBLASTIC ANEMIA; Ho PI, 2002, J NEUROSCI RES, V70, P694, DOI 10.1002/jnr.10416; Holzgreve W, 2012, J MATERN-FETAL NEO M, V25, P1529, DOI 10.3109/14767058.2011.648672; Hyde JE, 2007, CURR DRUG TARGETS, V8, P31, DOI 10.2174/138945007779315524; Joerger M, 2010, CURR DRUG TARGETS, V11, P37, DOI 10.2174/138945010790030974; Kerek R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.278; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Lam JR, 2013, JAMA-J AM MED ASSOC, V310, P2435, DOI 10.1001/jama.2013.280490; Linnebank M, 2011, ANN NEUROL, V69, P352, DOI 10.1002/ana.22229; Liu QL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100379; Mattson MP, 2003, TRENDS NEUROSCI, V26, P137, DOI 10.1016/S0166-2236(03)00032-8; Mattson MP, 2002, AGEING RES REV, V1, P95, DOI 10.1016/S0047-6374(01)00365-7; Miller AL, 2008, ALTERN MED REV, V13, P216; Min H, 2005, ALCOHOL CLIN EXP RES, V29, P2188, DOI 10.1097/01.alc.0000191756.02856.a8; Moestrup SK, 1996, P NATL ACAD SCI USA, V93, P8612, DOI 10.1073/pnas.93.16.8612; Moestrup SK, 2006, CURR OPIN HEMATOL, V13, P119, DOI 10.1097/01.moh.0000219654.65538.5b; Moffatt Barbara A, 2002, Arabidopsis Book, V1, pe0018, DOI 10.1199/tab.0018; PRASAD AS, 1976, AM J OBSTET GYNECOL, V125, P1063, DOI 10.1016/0002-9378(76)90809-7; Puntambekar P, 2009, J NEUROL SCI, V287, P285, DOI 10.1016/j.jns.2009.07.030; Quadros EV, 2010, BRIT J HAEMATOL, V148, P195, DOI 10.1111/j.1365-2141.2009.07937.x; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; Rollins KD, 2005, CLIN THER, V27, P1343, DOI 10.1016/j.clinthera.2005.09.010; Ruscin JM, 2002, ANN PHARMACOTHER, V36, P812; Scagliotti GV, 2008, CLIN LUNG CANCER, V9, pS122, DOI 10.3816/CLC.2008.s.018; Shipton MJ, 2015, CLIN MED, V15, P145, DOI 10.7861/clinmedicine.15-2-145; STEBBINS R, 1973, SEMIN HEMATOL, V10, P235; Stover PJ, 2011, ADV NUTR, V2, P325, DOI 10.3945/an.111.000596; Tchantchou F, 2006, J ALZHEIMERS DIS, V9, P421; Varela-Moreiras G, 2009, NUTR REV, V67, pS69, DOI 10.1111/j.1753-4887.2009.00163.x; Warnke C, 2013, CLIN NEUROL NEUROSUR, V115, pS90, DOI 10.1016/j.clineuro.2013.09.030; YAGIELA J A, 1991, Anesthesia Progress, V38, P1	48	37	40	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2015	373	17					1649	1658		10.1056/NEJMra1508861	http://dx.doi.org/10.1056/NEJMra1508861			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU1YH	26488695				2022-12-28	WOS:000363317800010
J	McKinlay, CJD; Alsweiler, JM; Ansell, JM; Anstice, NS; Chase, JG; Gamble, GD; Harris, DL; Jacobs, RJ; Jiang, YN; Paudel, N; Signal, M; Thompson, B; Wouldes, TA; Yu, TY; Harding, JE				McKinlay, Christopher J. D.; Alsweiler, Jane M.; Ansell, Judith M.; Anstice, Nicola S.; Chase, J. Geoffrey; Gamble, Gregory D.; Harris, Deborah L.; Jacobs, Robert J.; Jiang, Yannan; Paudel, Nabin; Signal, Matthew; Thompson, Benjamin; Wouldes, Trecia A.; Yu, Tzu-Ying; Harding, Jane E.		CHYLD Study Grp	Neonatal Glycemia and Neurodevelopmental Outcomes at 2 Years	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLUCOSE VARIABILITY; HYPOGLYCEMIA; HYPERGLYCEMIA; PRETERM; INFANTS; INJURY; IMPACT; BABIES; DEATH	BACKGROUND Neonatal hypoglycemia is common and can cause neurologic impairment, but evidence supporting thresholds for intervention is limited. METHODS We performed a prospective cohort study involving 528 neonates with a gestational age of at least 35 weeks who were considered to be at risk for hypoglycemia; all were treated to maintain a blood glucose concentration of at least 47 mg per deciliter (2.6 mmol per liter). We intermittently measured blood glucose for up to 7 days. We continuously monitored interstitial glucose concentrations, which were masked to clinical staff. Assessment at 2 years included Bayley Scales of Infant Development III and tests of executive and visual function. RESULTS Of 614 children, 528 were eligible, and 404 (77% of eligible children) were assessed; 216 children (53%) had neonatal hypoglycemia (blood glucose concentration, <47 mg per deciliter). Hypoglycemia, when treated to maintain a blood glucose concentration of at least 47 mg per deciliter, was not associated with an increased risk of the primary outcomes of neurosensory impairment (risk ratio, 0.95; 95% confidence interval [CI], 0.75 to 1.20; P = 0.67) and processing difficulty, defined as an executive-function score or motion coherence threshold that was more than 1.5 SD from the mean (risk ratio, 0.92; 95% CI, 0.56 to 1.51; P = 0.74). Risks were not increased among children with unrecognized hypoglycemia (a low interstitial glucose concentration only). The lowest blood glucose concentration, number of hypoglycemic episodes and events, and negative interstitial increment (area above the interstitial glucose concentration curve and below 47 mg per deciliter) also did not predict the outcome. CONCLUSIONS In this cohort, neonatal hypoglycemia was not associated with an adverse neurologic outcome when treatment was provided to maintain a blood glucose concentration of at least 47 mg per deciliter.	[McKinlay, Christopher J. D.; Alsweiler, Jane M.; Ansell, Judith M.; Gamble, Gregory D.; Harris, Deborah L.; Jiang, Yannan; Harding, Jane E.] Univ Auckland, Liggins Inst, Auckland 1142, New Zealand; [Alsweiler, Jane M.] Univ Auckland, Dept Paediat, Auckland 1142, New Zealand; [Anstice, Nicola S.; Jacobs, Robert J.; Paudel, Nabin; Thompson, Benjamin; Yu, Tzu-Ying] Univ Auckland, Sch Optometry & Vis Sci, Auckland 1142, New Zealand; [Wouldes, Trecia A.] Univ Auckland, Dept Psychol Med, Auckland 1142, New Zealand; [Chase, J. Geoffrey; Signal, Matthew] Univ Canterbury, Dept Mech Engn, Christchurch 1, New Zealand; [Harris, Deborah L.] Waikato Dist Hlth Board, Neonatal Intens Care Unit, Hamilton, New Zealand; [Thompson, Benjamin] Univ Waterloo, Sch Optometry & Vis Sci, Waterloo, ON N2L 3G1, Canada	University of Auckland; University of Auckland; University of Auckland; University of Auckland; University of Canterbury; University of Waterloo	Harding, JE (corresponding author), Univ Auckland, Liggins Inst, Private Bag 92019,Victoria St W, Auckland 1142, New Zealand.	j.harding@auckland.ac.nz	Anstice, Nicola/AAM-8072-2021; Wouldes, Trecia/AFU-6559-2022; Paudel, Nabin/W-3265-2019; McKinlay, Christopher JD/E-6263-2018	Wouldes, Trecia/0000-0002-6609-8464; Paudel, Nabin/0000-0003-1583-9856; McKinlay, Christopher JD/0000-0003-1088-9467; Anstice, Nicola/0000-0003-1999-5274; Jacobs, Robert/0000-0001-6709-1785; Gamble, Greg/0000-0003-0412-3203; Thompson, Benjamin/0000-0002-3902-2712; Harris, Deborah/0000-0003-2498-9223; Alsweiler, Jane/0000-0002-0874-6654	Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069622] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and others.	Adamkin DH, 2011, PEDIATRICS, V127, P575, DOI 10.1542/peds.2010-3851; Bagshaw SM, 2009, CRIT CARE, V13, DOI 10.1186/cc7921; Bayley N., 2019, BAYLEY SCALES INFANT; Boluyt N, 2006, PEDIATRICS, V117, P2231, DOI 10.1542/peds.2005-1919; Burns CM, 2008, PEDIATRICS, V122, P65, DOI 10.1542/peds.2007-2822; Cans C, 2007, DEV MED CHILD NEUROL, V49, P35, DOI 10.1111/j.1469-8749.2007.tb12626.x; Carlson SA, 2005, DEV NEUROPSYCHOL, V28, P595, DOI 10.1207/s15326942dn2802_3; Cornblath M, 2000, PEDIATRICS, V105, P1141, DOI 10.1542/peds.105.5.1141; DeBoer T, 2005, DEV MED CHILD NEUROL, V47, P525, DOI 10.1017/S0012162205001039; Ennis K, 2015, PEDIATR RES, V77, P84, DOI 10.1038/pr.2014.146; Gioia GA, 2000, BRIEF BEHAV RATING I; Harris DL, 2015, ARCH DIS CHILD-FETAL, V100, pF161, DOI 10.1136/archdischild-2014-306435; Harris DL, 2013, LANCET, V382, P2077, DOI 10.1016/S0140-6736(13)61645-1; Harris DL, 2012, J PEDIATR-US, V161, P787, DOI 10.1016/j.jpeds.2012.05.022; Harris DL, 2011, J PEDIATR-US, V159, P755, DOI 10.1016/j.jpeds.2011.04.026; Harris DL, 2010, J PEDIAT, V157; Hay WW, 2009, J PEDIATR-US, V155, P612, DOI 10.1016/j.jpeds.2009.06.044; Kerstjens JM, 2012, PEDIATRICS, V130, pE265, DOI 10.1542/peds.2012-0079; Kochanska G, 2000, DEV PSYCHOL, V36, P220, DOI 10.1037//0012-1649.36.2.220; March of Dimes Perinatal Data Center, 2011, SPEC CAR NURS ADM; Ranger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076702; Salmond C., 2007, NZDEP2006 INDEX DEPR; Signal M, 2012, DIABETES TECHNOL THE, V14, P883, DOI 10.1089/dia.2012.0111; Stanley CA, 1999, NEW ENGL J MED, V340, P1200, DOI 10.1056/NEJM199904153401510; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Tam EWY, 2008, PEDIATRICS, V122, P507, DOI 10.1542/peds.2007-2002; van der Lugt NM, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-52; Wintergerst KA, 2006, PEDIATRICS, V118, P173, DOI 10.1542/peds.2005-1819; Yu TY, 2013, INVEST OPHTH VIS SCI, V54, P8408, DOI 10.1167/iovs.13-13051; Zelazo PD, 1998, DEV PSYCHOL, V34, P203, DOI 10.1037/0012-1649.34.2.203	30	174	182	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2015	373	16					1507	1518		10.1056/NEJMoa1504909	http://dx.doi.org/10.1056/NEJMoa1504909			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5VX	26465984	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000362880300007
J	Ouakrim, DA; Pizot, C; Boniol, M; Malvezzi, M; Boniol, M; Negri, E; Bota, M; Jenkins, MA; Bleiberg, H; Autier, P				Ouakrim, Driss Ait; Pizot, Cecile; Boniol, Magali; Malvezzi, Matteo; Boniol, Mathieu; Negri, Eva; Bota, Maria; Jenkins, Mark A.; Bleiberg, Harry; Autier, Philippe			Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality database	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDITERRANEAN DIET; RISK-FACTORS; ADHERENCE; PREVENTION; ALCOHOL; RECOMMENDATIONS; PROGNOSIS; COUNTRIES; SOCIETY; NATION	OBJECTIVE To examine changes in colorectal cancer mortality in 34 European countries between 1970 and 2011. DESIGN Retrospective trend analysis. DATA SOURCE World Health Organization mortality database. POPULATION Deaths from colorectal cancer between 1970 and 2011. Profound changes in screening and treatment efficiency took place after 1988; therefore, particular attention was paid to the evolution of colorectal cancer mortality in the subsequent period. MAIN OUTCOMES MEASURES Time trends in rates of colorectal cancer mortality, using joinpoint regression analysis. Rates were age adjusted using the standard European population. RESULTS From 1989 to 2011, colorectal cancer mortality increased by a median of 6.0% for men and decreased by a median of 14.7% for women in the 34 European countries. Reductions in colorectal cancer mortality of more than 25% in men and 30% in women occurred in Austria, Switzerland, Germany, the United Kingdom, Belgium, the Czech Republic, Luxembourg, and Ireland. By contrast, mortality rates fell by less than 17% in the Netherlands and Sweden for both sexes. Over the same period, smaller or no declines occurred in most central European countries. Substantial mortality increases occurred in Croatia, the former Yugoslav republic of Macedonia, and Romania for both sexes and in most eastern European countries for men. In countries with decreasing mortality, reductions were more important for women of all ages and men younger than 65 years. In the 27 European Union member states, colorectal cancer mortality fell by 13.0% in men and 27.0% in women, compared with corresponding reductions of 39.8% and 38.8% in the United States. CONCLUSION Over the past 40 years, there has been considerable disparity in the level of colorectal cancer mortality between European countries, as well as between men and women and age categories. Countries with the largest reductions in colorectal cancer mortality are characterised by better accessibility to screening services, especially endoscopic screening, and specialised care.	[Ouakrim, Driss Ait; Jenkins, Mark A.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Biostat & Epidemiol, Melbourne, Vic, Australia; [Pizot, Cecile; Boniol, Magali; Boniol, Mathieu; Bota, Maria] Int Prevent Res Inst, Dept Biostat, Lyon, France; [Malvezzi, Matteo] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Boniol, Mathieu; Bota, Maria; Autier, Philippe] Univ Strathclyde, Inst Global Publ Hlth iPRI, Lyon, France; [Negri, Eva] IRCCS Ist Ric Farmacol Mario Negri, Dept Epidemiol, Milan, Italy; [Bleiberg, Harry] Inst Jules Bordet, B-1000 Brussels, Belgium; [Autier, Philippe] Int Prevent Res Inst, Dept Populat Res, F-69006 Lyon, France	University of Melbourne; University of Milan; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Institut Jules Bordet	Autier, P (corresponding author), Univ Strathclyde, Inst Global Publ Hlth iPRI, Lyon, France.	philippe.autier@i-pri.org	Bota, Maria/M-9169-2013; Boniol, Mathieu/F-9623-2011; Autier, Philippe/A-4402-2014; Jenkins, Mark/P-7803-2015; Negri, Eva Vanna Lorenza/AAC-5698-2019; Pizot, Cécile/M-9173-2013; Malvezzi, Matteo/K-5372-2014	Bota, Maria/0000-0002-9962-1936; Boniol, Mathieu/0000-0003-1052-5604; Autier, Philippe/0000-0003-1538-5321; Jenkins, Mark/0000-0002-8964-6160; Negri, Eva Vanna Lorenza/0000-0001-9712-8526; Pizot, Cécile/0000-0003-3953-2146; Malvezzi, Matteo/0000-0002-9110-3923; Ait Ouakrim, Driss/0000-0001-7715-2561; Boniol, Magali/0000-0002-3585-3455	International Prevention Research Institute, Lyon (France); Australian National Health and Medical Research Council under Centre for Research Excellence scheme	International Prevention Research Institute, Lyon (France); Australian National Health and Medical Research Council under Centre for Research Excellence scheme(National Health and Medical Research Council (NHMRC) of Australia)	The study was mainly funded by the International Prevention Research Institute, Lyon (France). DAO was supported by the Australian National Health and Medical Research Council under the Centre for Research Excellence scheme. Neither organisation had involvement in the design, conduct, and reporting of the study.	Altobelli E, 2014, PREV MED, V62, P132, DOI 10.1016/j.ypmed.2014.02.010; Au Heather-Jane, 2003, Clin Colorectal Cancer, V3, P165, DOI 10.3816/CCC.2003.n.022; Bach-Faig A, 2011, PUBLIC HEALTH NUTR, V14, P622, DOI 10.1017/S1368980010002752; Binefa G, 2014, WORLD J GASTROENTERO, V20, P6786, DOI 10.3748/wjg.v20.i22.6786; Bojer AS, 2015, EJSO-EUR J SURG ONC, V41, P421, DOI 10.1016/j.ejso.2014.10.065; Bonaccio M, 2014, NUTR METAB CARDIOVAS, V24, P853, DOI 10.1016/j.numecd.2014.02.014; Boniol M, 2010, EUR J CANCER, V46, P2534, DOI 10.1016/j.ejca.2010.07.049; Bosetti C, 2005, INT J CANCER, V113, P339, DOI 10.1002/ijc.20555; Bosetti C, 2011, INT J CANCER, V129, P180, DOI 10.1002/ijc.25653; Boyle P, 1989, Recent Results Cancer Res, V114, P41; Boyle P, 2002, BRIT MED BULL, V64, P1, DOI 10.1093/bmb/64.1.1; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Elmunzer BJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001352; Espey DK, 2007, CANCER-AM CANCER SOC, V110, P2119, DOI 10.1002/cncr.23044; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Harteloh P, 2010, EUR J EPIDEMIOL, V25, P531, DOI 10.1007/s10654-010-9445-5; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jezewski-Serra D., 2013, EVALUATION EPIDEMIOL; Kanavos P, 2010, EUR J HEALTH ECON, V10, P115, DOI 10.1007/s10198-009-0201-2; Kirkegaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5504; La Vecchia Carlo, 2005, J Br Menopause Soc, V11, P166; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lutz JM, 2004, EUR J CANCER PREV, V13, P77, DOI 10.1097/00008469-200402000-00012; MACARTHUR C, 1983, J ROY COLL GEN PRACT, V33, P159; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; McKay A, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-370; Mills KT, 2013, DIS COLON RECTUM, V56, P1304, DOI 10.1097/DCR.0b013e3182a479f9; National Cancer Institute, 2009, JOINTP REGR PROGR VE; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Oliphant R, 2013, BRIT J SURG, V100, P1388, DOI 10.1002/bjs.9227; Ondrusova M, 2011, NEOPLASMA, V58, P283, DOI 10.4149/neo_2011_04_283; Papamichael D, 2015, ANN ONCOL, V26, P463, DOI 10.1093/annonc/mdu253; Peeters PJHL, 2015, DIABETES CARE, V38, P495, DOI 10.2337/dc14-1175; Pox CP, 2012, GASTROENTEROLOGY, V142, P1460, DOI 10.1053/j.gastro.2012.03.022; Quaife SL, 2014, BRIT J CANCER, V110, P12, DOI 10.1038/bjc.2013.684; Rehm J, 2007, INT J EPIDEMIOL, V36, P458, DOI 10.1093/ije/dyl294; Rehm J, 2007, LANCET, V369, P1975, DOI 10.1016/S0140-6736(07)60922-2; Robb K, 2009, Br J Cancer, V101 Suppl 2, pS18, DOI 10.1038/sj.bjc.6605386; Rodrigues SSP, 2008, EUR J CLIN NUTR, V62, P1263, DOI 10.1038/sj.ejcn.1602852; Roy HK, 2009, JAMA-J AM MED ASSOC, V302, P1696, DOI 10.1001/jama.2009.1499; Schreuders EH, 2015, GUT, V64, P1637, DOI 10.1136/gutjnl-2014-309086; Schwingshackl L, 2014, INT J CANCER, V135, P1884, DOI 10.1002/ijc.28824; Stock C, 2010, ENDOSCOPY, V42, P546, DOI 10.1055/s-0029-1244127; Stock C, 2010, GASTROINTEST ENDOSC, V71, P366, DOI 10.1016/j.gie.2009.06.018; Svensson E, 2002, EUR J CANCER PREV, V11, P489, DOI 10.1097/00008469-200210000-00012; Tourlouki E, 2013, ECOL FOOD NUTR, V52, P371, DOI 10.1080/03670244.2012.707431; van der Pool AEM, 2012, COLORECTAL DIS, V14, P56, DOI 10.1111/j.1463-1318.2010.02539.x; Wallace D, 2014, BRIT J CANCER, V111, P577, DOI 10.1038/bjc.2014.300; Waterhouse JAH, 1976, CANC INCIDENCE 5 CON, VIII; Weiss W, 2008, J GASTROEN HEPATOL, V6, P19; Wilschut JA, 2011, JNCI-J NATL CANCER I, V103, P1741, DOI 10.1093/jnci/djr385; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; World Health Organization, 2013, MORT DAT; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5; Zatonski WA, 2012, PUBLIC HEALTH, V126, P248, DOI 10.1016/j.puhe.2011.11.017	58	124	129	2	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 6	2015	351								h4970	10.1136/bmj.h4970	http://dx.doi.org/10.1136/bmj.h4970			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT3SF	26442928	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000362726500002
J	Lenzer, J				Lenzer, Jeanne			Does a popular documentary about a "life saving" heart scan promote overtreatment?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CORONARY; DISEASE; RISK					jlenzer@bmj.com						Allen M, 2011, BODY IMAGING BUSINES; Becker MC, 2011, ARCH INTERN MED, V171, P698, DOI 10.1001/archinternmed.2010.464; Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031; Chi WCH, 2014, AM J MANAG CARE, V20, pE330; Gottlieb I, 2010, J AM COLL CARDIOL, V55, P627, DOI 10.1016/j.jacc.2009.07.072; Greenland P, 2010, J AM COLL CARDIOL, V56, P2182, DOI 10.1016/j.jacc.2010.09.002; Heart Savers, OUR PHYS; Helfand M, 2009, ANN INTERN MED, V151, P496, DOI 10.7326/0003-4819-151-7-200910060-00010; Redberg RF, 2006, CIRCULATION, V113, P336, DOI 10.1161/CIRCULATIONAHA.105.600676; Roy SK, 2011, CATHETER CARDIO INTE, V78, P1127, DOI 10.1002/ccd.23293	10	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 5	2015	351								h4926	10.1136/bmj.h4926	http://dx.doi.org/10.1136/bmj.h4926			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT3SC	26438578				2022-12-28	WOS:000362726200002
J	Bodenschatz, E				Bodenschatz, Eberhard			Clouds resolved	SCIENCE			English	Editorial Material							TURBULENCE		Max Planck Inst Dynam & Self Org, D-37077 Gottingen, Germany	Max Planck Society	Bodenschatz, E (corresponding author), Max Planck Inst Dynam & Self Org, D-37077 Gottingen, Germany.	eberhard.bodenschatz@ds.mpg.de		Bodenschatz, Eberhard/0000-0002-2901-0144				Beals MJ, 2015, SCIENCE, V350, P87, DOI 10.1126/science.aab0751; Bewley GP, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/8/083051; Bony S, 2015, NAT GEOSCI, V8, P261, DOI 10.1038/NGEO2398; Khain AP, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/015004; Majda A, 2000, COMMUN PUR APPL MATH, V53, P1284, DOI 10.1002/1097-0312(200010)53:10<1284::AID-CPA3>3.3.CO;2-S; Risius S, 2015, ATMOS MEAS TECH, V8, P3209, DOI 10.5194/amt-8-3209-2015; Schroder A, 2015, FLOW TURBUL COMBUST, V95, P193, DOI 10.1007/s10494-015-9616-2; Siebert H, 2015, ATMOS MEAS TECH, V8, P3219, DOI 10.5194/amt-8-3219-2015; Stevens B, 2013, NATURE, V503, P47, DOI 10.1038/503047a; Warhaft Z, 2000, ANNU REV FLUID MECH, V32, P203, DOI 10.1146/annurev.fluid.32.1.203	10	4	4	2	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					40	41		10.1126/science.aad1386	http://dx.doi.org/10.1126/science.aad1386			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26430109				2022-12-28	WOS:000362098300035
J	Whitlock, RP; Devereaux, PJ; Teoh, KH; Lamy, A; Vincent, J; Pogue, J; Paparella, D; Sessler, DI; Karthikeyan, G; Villar, JC; Zuo, YX; Avezum, A; Quantz, M; Tagarakis, GI; Shah, PJ; Abbasi, SH; Zheng, H; Pettit, S; Chrolavicius, S; Yusuf, S				Whitlock, Richard P.; Devereaux, P. J.; Teoh, Kevin H.; Lamy, Andre; Vincent, Jessica; Pogue, Janice; Paparella, Domenico; Sessler, Daniel I.; Karthikeyan, Ganesan; Villar, Juan Carlos; Zuo, Yunxia; Avezum, Alvaro; Quantz, Mackenzie; Tagarakis, Georgios I.; Shah, Pallav J.; Abbasi, Seyed Hesameddin; Zheng, Hong; Pettit, Shirley; Chrolavicius, Susan; Yusuf, Salim		SIRS Invest	Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							RISK-EVALUATION EUROSCORE; INFLAMMATORY RESPONSE; CARDIAC-SURGERY; MYOCARDIAL-INFARCTION; EUROPEAN SYSTEM; HEART-SURGERY; GRAFT-SURGERY; STEROIDS; METAANALYSIS; ASSOCIATION	Background Cardiopulmonary bypass initiates a systemic inflammatory response syndrome that is associated with postoperative morbidity and mortality. Steroids suppress inflammatory responses and might improve outcomes in patients at high risk of morbidity and mortality undergoing cardiopulmonary bypass. We aimed to assess the effects of steroids in patients at high risk of morbidity and mortality undergoing cardiopulmonary bypass. Methods The Steroids In caRdiac Surgery (SIRS) study is a double-blind, randomised, controlled trial. We used a central computerised phone or interactive web system to randomly assign (1: 1) patients at high risk of morbidity and mortality from 80 hospital or cardiac surgery centres in 18 countries undergoing cardiac surgery with the use of cardiopulmonary bypass to receive either methylprednisolone (250 mg at anaesthetic induction and 250 mg at initiation of cardiopulmonary bypass) or placebo. Patients were assigned with block randomisation with random block sizes of 2, 4, or 6 and stratified by centre. Patients aged 18 years or older were eligible if they had a European System for Cardiac Operative Risk Evaluation of at least 6. Patients were excluded if they were taking or expected to receive systemic steroids in the immediate postoperative period or had a history of bacterial or fungal infection in the preceding 30 days. Patients, caregivers, and those assessing outcomes were masked to allocation. The primary outcomes were 30-day mortality and a composite of death and major morbidity (ie, myocardial injury, stroke, renal failure, or respiratory failure) within 30 days, both analysed by intention to treat. Safety outcomes were also analysed by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00427388. Findings Patients were recruited between June 21, 2007, and Dec 19, 2013. Complete 30-day data was available for all 7507 patients randomly assigned to methylprednisolone (n= 3755) and to placebo (n= 3752). Methylprednisolone, compared with placebo, did not reduce the risk of death at 30 days (154 [4%] vs 177 [5%] patients; relative risk [RR] 0.87, 95% CI 0.70-1.07, p= 0.19) or the risk of death or major morbidity (909 [24%] vs 885 [24%]; RR 1.03, 95% CI 0.95-1.11, p= 0.52). The most common safety outcomes in the methylprednisolone and placebo group were infection (465 [12%] vs 493 [13%]), surgical site infection (151 [4%] vs 151 [4%]), and delirium (295 [8%] vs 289 [8%]). Interpretation Methylprednisolone did not have a significant effect on mortality or major morbidity after cardiac surgery with cardiopulmonary bypass. The SIRS trial does not support the routine use of methylprednisolone for patients undergoing cardiopulmonary bypass.	[Whitlock, Richard P.; Devereaux, P. J.; Lamy, Andre; Vincent, Jessica; Pogue, Janice; Pettit, Shirley; Chrolavicius, Susan; Yusuf, Salim] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; [Whitlock, Richard P.; Devereaux, P. J.; Lamy, Andre; Vincent, Jessica; Pogue, Janice; Pettit, Shirley; Chrolavicius, Susan; Yusuf, Salim] McMaster Univ, Hamilton, ON, Canada; [Whitlock, Richard P.; Lamy, Andre] McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada; [Whitlock, Richard P.; Devereaux, P. J.; Lamy, Andre] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Devereaux, P. J.; Yusuf, Salim] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Teoh, Kevin H.] Southlake Reg Hlth Ctr, Dept Surg, Newmarket, ON, Canada; [Paparella, Domenico] Univ Bari Aldo Moro, Bari, Italy; [Sessler, Daniel I.] Cleveland Clin, Dept Outcomes Res, Cleveland, OH 44106 USA; [Karthikeyan, Ganesan] All India Inst Med Sci, New Delhi, India; [Villar, Juan Carlos] Fdn Cardio Infantil, Inst Cardiol, Bogota, Colombia; [Zuo, Yunxia] Sichuan Univ, West China Hosp, Dept Anaesthesiol, Chengdu 610064, Peoples R China; [Avezum, Alvaro] Inst Dante Pazzanese Cardiol, Div Pesquisa, Sao Paulo, Brazil; [Quantz, Mackenzie] London Hlth Sci Ctr, London, ON, Canada; [Tagarakis, Georgios I.] Univ Thessaly, Dept Cardiovasc & Thorac Surg, Larisa, Greece; [Shah, Pallav J.] Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Abbasi, Seyed Hesameddin] Univ Tehran Med Sci, Tehran Heart Ctr, Tehran, Iran; [Zheng, Hong] Xinjiang Med Univ, Teaching Hosp 1, Urumqi, Peoples R China	McMaster University; Population Health Research Institute; McMaster University; McMaster University; McMaster University; McMaster University; Southlake Regional Health Centre; Universita degli Studi di Bari Aldo Moro; Cleveland Clinic Foundation; All India Institute of Medical Sciences (AIIMS) New Delhi; Fundacion Cardioinfantil - Instituto de Cardiologia; Sichuan University; Instituto Dante Pazzanese de Cardiologia; London Health Sciences Centre; University of Thessaly; Tehran University of Medical Sciences; Xinjiang Medical University	Whitlock, RP (corresponding author), Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada.	richard.whitlock@phri.ca	Sessler, Daniel/D-3504-2011; Avezum, Alvaro/AAP-7687-2020; Avezum, Alvaro AA/K-6137-2016; Stevens, Louis-Mathieu/E-6453-2016; Abbasi, Seyed Hesameddin/D-5420-2009; Devereaux, PJ/AAY-1757-2021; Villar Centeno, Juan Carlos/AAX-5401-2021; Ruetzler, Kurt/W-2596-2017; Ruetzler, Kurt/P-7101-2019; Myasoedova, Veronika A/K-1024-2016; Devereaux, PJ/AAF-2862-2019; Chan, Matthew/J-2884-2013; Paparella, Domenico/AAJ-4246-2021; LAMY, ANDRE/AAS-3855-2021; Whitlock, Richard/AAQ-1593-2021; Karthikeyan, Ganesan/D-5767-2012	Sessler, Daniel/0000-0001-9932-3077; Avezum, Alvaro AA/0000-0002-3073-6890; Stevens, Louis-Mathieu/0000-0003-3372-3419; Abbasi, Seyed Hesameddin/0000-0002-1068-8860; Ruetzler, Kurt/0000-0003-0467-1736; Ruetzler, Kurt/0000-0003-0467-1736; Myasoedova, Veronika A/0000-0001-8414-5300; Chan, Matthew/0000-0002-3574-7855; Paparella, Domenico/0000-0003-2261-7098; Whitlock, Richard/0000-0002-6863-5884; Karthikeyan, Ganesan/0000-0002-2073-2917; Mazer, Cyril David/0000-0003-2566-4308; Villar, Juan Carlos/0000-0002-7047-7299; Vaquiro Herrera, Eliana/0000-0001-6030-8128; Rex, Steffen/0000-0002-3536-9321; Yusuf, Salim/0000-0003-4776-5601; Schiavi, Davide/0000-0002-3081-1678; Devereaux, PJ/0000-0003-2935-637X	Canadian Institutes of Health Research; Canadian Network and Centre for Trials Internationally	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Network and Centre for Trials Internationally	Canadian Institutes of Health Research.; SIRS was funded by the Canadian Institutes of Health Research and the Canadian Network and Centre for Trials Internationally.	Asimakopoulos G, 1999, ANN THORAC SURG, V68, P1107, DOI 10.1016/S0003-4975(99)00781-X; Boyle EM, 1997, ANN THORAC SURG, V63, P277; BULKLEY BH, 1974, AM J MED, V56, P244, DOI 10.1016/0002-9343(74)90603-2; Chaney MA, 2002, CHEST, V121, P921, DOI 10.1378/chest.121.3.921; Dieleman JM, 2012, JAMA-J AM MED ASSOC, V308, P1761, DOI 10.1001/jama.2012.14144; Domanski MJ, 2011, JAMA-J AM MED ASSOC, V305, P585, DOI 10.1001/jama.2011.99; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; HAMMERMAN H, 1983, CIRCULATION, V68, P446, DOI 10.1161/01.CIR.68.2.446; Ho KM, 2009, CIRCULATION, V119, P1853, DOI 10.1161/CIRCULATIONAHA.108.848218; Kirklin J K, 1987, Cardiovasc Clin, V17, P321; KIRKLIN JK, 1983, J THORAC CARDIOV SUR, V86, P845; Levi M, 1999, LANCET, V354, P1940, DOI 10.1016/S0140-6736(99)01264-7; Malik M, 2010, ANN CARD ANAESTH, V13, P241, DOI 10.4103/0971-9784.69082; Mazumdar M, 2000, STAT MED, V19, P113, DOI 10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O; Mazumdar M, 2003, STAT MED, V22, P559, DOI 10.1002/sim.1333; Mojcik CF, 2001, ANN THORAC SURG, V71, P745, DOI 10.1016/S0003-4975(00)02218-9; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Paparella D, 2002, EUR J CARDIO-THORAC, V21, P232, DOI 10.1016/S1010-7940(01)01099-5; Roberts R, 1976, CIRCULATION S1, V53, P1204; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Royston D, 1996, INT J CARDIOL, V53, pS11, DOI 10.1016/0167-5273(96)02572-7; Rubens FD, 2004, PERFUSION-UK, V19, pS5, DOI 10.1191/0267659104pf717oa; TEOH KHT, 1995, CIRCULATION, V92, P347, DOI 10.1161/01.CIR.92.9.347; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Verrier ED, 2004, JAMA-J AM MED ASSOC, V291, P2319, DOI 10.1001/jama.291.19.2319; Vincent JL, 2000, CRIT CARE MED, V28, P3373, DOI 10.1097/00003246-200009000-00060; Wan S, 1997, AM HEART J, V133, P335, DOI 10.1016/S0002-8703(97)70229-1; Wang C, 2010, J HEART VALVE DIS, V19, P21; Whitlock R, 2014, AM HEART J, V167, P660, DOI 10.1016/j.ahj.2014.01.018; Whitlock RP, 2008, EUR HEART J, V29, P2592, DOI 10.1093/eurheartj/ehn333; Whitlock RP, 2006, J SURG RES, V132, P188, DOI 10.1016/j.jss.2006.02.013; Whitlock RP, 2005, J CARDIOTHOR VASC AN, V19, P250, DOI 10.1053/j.jvca.2005.02.010	32	202	210	0	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 26	2015	386	10000					1243	1253		10.1016/S0140-6736(15)00273-1	http://dx.doi.org/10.1016/S0140-6736(15)00273-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9TQ	26460660				2022-12-28	WOS:000361700100033
J	Bhutta, ZA; Chopra, M				Bhutta, Zulfiqar A.; Chopra, Mickey			Moving ahead: what will a renewed Countdown to 2030 for Women and Children look like?	LANCET			English	Editorial Material							OFFICIAL DEVELOPMENT ASSISTANCE; HEALTH INTERVENTIONS; NEWBORN; PROGRESS; POST-2015; MORTALITY; COVERAGE; SYSTEM		[Bhutta, Zulfiqar A.] Hosp Sick Children, Robert Harding Chair Global Child Hlth & Policy, Ctr Global Child Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Chopra, Mickey] World Bank, 1818 H St NW, Washington, DC 20433 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aga Khan University; The World Bank	Bhutta, ZA (corresponding author), Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON M5G 0A4, Canada.	zulfiqar.bhutta@sickkids.ca	Bhutta, Zulfiqar/L-7822-2015	Bhutta, Zulfiqar/0000-0003-0637-599X				Afnan-Holmes H, 2015, LANCET GLOB HEALTH, V3, pE396, DOI 10.1016/S2214-109X(15)00059-5; Amouzou A, 2012, LANCET, V380, P1169, DOI 10.1016/S0140-6736(12)61376-2; [Anonymous], GLOB STRAT WOM CHILD; Arregoces L, 2015, LANCET GLOB HEALTH, V3, pE410, DOI 10.1016/S2214-109X(15)00057-1; Bhutta ZA, 2012, LANCET, V380, P1125, DOI 10.1016/S0140-6736(12)61382-8; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; Cavagnero E, 2008, LANCET, V371, P1284, DOI 10.1016/S0140-6736(08)60563-2; El Arifeen S, 2014, LANCET, V384, P1366, DOI 10.1016/S0140-6736(14)60955-7; Greco G, 2008, LANCET, V371, P1268, DOI 10.1016/S0140-6736(08)60561-9; Hsu J, 2012, LANCET, V380, P1157, DOI 10.1016/S0140-6736(12)61415-9; International Food Policy Research Institute, 2015, GLOB NUTR REP 2015 A; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Rasanathan K, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4213; Requejo JH, 2015, LANCET, V385, P466, DOI 10.1016/S0140-6736(14)60925-9; UNICEF, 2022, DEM WSPOLCZ DZIETN; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5; Wollum A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0438-9	19	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2016	387	10032					2060	2062		10.1016/S0140-6736(15)00527-9	http://dx.doi.org/10.1016/S0140-6736(15)00527-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL8HJ	26477327				2022-12-28	WOS:000375881500035
J	Torres, J; Colombel, JF				Torres, Joana; Colombel, Jean-Frederic			Genetics and phenotypes in inflammatory bowel disease	LANCET			English	Editorial Material							CLINICAL CHARACTERISTICS; CROHNS-DISEASE		[Torres, Joana; Colombel, Jean-Frederic] Icahn Sch Med Mt Sinai, Henry D Janowitz Div Gastroenterol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Colombel, JF (corresponding author), Icahn Sch Med Mt Sinai, Henry D Janowitz Div Gastroenterol, New York, NY 10029 USA.	jean-frederic.colombel@mssm.edu		Torres, Joana/0000-0003-2895-5821				Cleynen I, 2016, LANCET, V387, P156, DOI 10.1016/S0140-6736(15)00465-1; Colombel JF, 2008, GUT, V57, P429, DOI 10.1136/gut.2007.122192; Colombel JF, 2014, NAT REV GASTRO HEPAT, V11, P652, DOI 10.1038/nrgastro.2014.170; Colombel JF, 1996, GASTROENTEROLOGY, V111, P604, DOI 10.1053/gast.1996.v111.pm8780563; FARMER RG, 1975, GASTROENTEROLOGY, V68, P627; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Halfvarson J, 2003, GASTROENTEROLOGY, V124, P1767, DOI 10.1016/S0016-5085(03)00385-8; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Levine A, 2011, INFLAMM BOWEL DIS, V17, P1314, DOI 10.1002/ibd.21493; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Ventham NT, 2013, GASTROENTEROLOGY, V145, P293, DOI 10.1053/j.gastro.2013.05.050	11	29	32	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2016	387	10014					98	100		10.1016/S0140-6736(15)00464-X	http://dx.doi.org/10.1016/S0140-6736(15)00464-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8LF	26490194	hybrid			2022-12-28	WOS:000368055500007
J	Tsianakas, A; Stander, S				Tsianakas, Athanasios; Staender, Sonja			Dupilumab: a milestone in the treatment of atopic dermatitis	LANCET			English	Editorial Material							ECZEMA		[Tsianakas, Athanasios; Staender, Sonja] Univ Hosp Muenster, Dept Dermatol, D-48149 Munster, Germany	University of Munster	Stander, S (corresponding author), Univ Hosp Muenster, Dept Dermatol, D-48149 Munster, Germany.	sonja.staender@uni-muenster.de		Stander, Sonja/0000-0003-3612-7786				Andrews AL, 2006, J IMMUNOL, V176, P7456, DOI 10.4049/jimmunol.176.12.7456; Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Eyerich K, 2013, ALLERGY, V68, P974, DOI 10.1111/all.12184; Hauk L, 2014, AM FAM PHYSICIAN, V90, P798; Schmitt J, 2007, ACTA DERM-VENEREOL, V87, P100, DOI 10.2340/00015555-0207; Thaci D, 2015, LANCET; Totri CR, 2014, CURR OPIN PEDIATR, V26, P466, DOI 10.1097/MOP.0000000000000109; Williams H, 2006, J ALLERGY CLIN IMMUN, V118, P209, DOI 10.1016/j.jaci.2006.04.043	9	23	28	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2016	387	10013					4	5		10.1016/S0140-6736(15)00389-X	http://dx.doi.org/10.1016/S0140-6736(15)00389-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ9ZU	26454359				2022-12-28	WOS:000367457300005
J	Hite, RK; Yuan, P; Li, ZL; Hsuing, YC; Walz, T; MacKinnon, R				Hite, Richard K.; Yuan, Peng; Li, Zongli; Hsuing, Yichun; Walz, Thomas; MacKinnon, Roderick			Cryo-electron microscopy structure of the Slo2.2 Na+-activated K+ channel	NATURE			English	Article							MIGRATING PARTIAL SEIZURES; GATED POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; CRYO-EM; SENSORY NEURONS; BK CHANNELS; ANGSTROM RESOLUTION; KCNT1 MUTATION; GATING RING; SODIUM	Na+-activated K+ channels are members of the Slo family of large conductance K+ channels that are widely expressed in the brain, where their opening regulates neuronal excitability. These channels fulfil a number of biological roles and have intriguing biophysical properties, including conductance levels that are ten times those of most other K+ channels and gating sensitivity to intracellular Na+. Here we present the structure of a complete Na+-activated K+ channel, chicken Slo2.2, in the Na+-free state, determined by cryo-electron microscopy at a nominal resolution of 4.5 angstroms. The channel is composed of a large cytoplasmic gating ring, in which resides the Na+-binding site and a transmembrane domain that closely resembles voltage-gated K+ channels. In the structure, the cytoplasmic domain adopts a closed conformation and the ion conduction pore is also closed. The structure reveals features that can explain the unusually high conductance of Slo channels and how contraction of the cytoplasmic gating ring closes the pore.	[Hite, Richard K.; Yuan, Peng; Hsuing, Yichun; MacKinnon, Roderick] Rockefeller Univ, New York, NY 10065 USA; [Hite, Richard K.; Yuan, Peng; Hsuing, Yichun; MacKinnon, Roderick] Howard Hughes Med Inst, New York, NY 10065 USA; [Li, Zongli; Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Li, Zongli; Walz, Thomas] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Rockefeller University; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	MacKinnon, R (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu	Li, Zongli/AAB-9100-2020	Walz, Thomas/0000-0003-2606-2835; Yuan, Peng/0000-0002-5660-225X	National Science Foundation [ACI-1053575];  [GM43949]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Z. Yu and J. de la Cruz at the Howard Hughes Medical Institute Janelia Cryo-EM facility for assistance in data collection, S. Harrison and S. Jenni for assistance with Phenix refinement of cryo-EM density maps, and members of the MacKinnon laboratory for discussions. This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number ACI-1053575. This work was supported in part by GM43949. R.K.H. is a Howard Hughes Medical Institute postdoctoral fellow of the Helen Hay Whitney Foundation and T.W. and R.M. are investigators of the Howard Hughes Medical Institute.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; BADER CR, 1985, NATURE, V317, P540, DOI 10.1038/317540a0; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barcia G, 2012, NAT GENET, V44, P1255, DOI 10.1038/ng.2441; Bhattacharjee A, 2002, J COMP NEUROL, V454, P241, DOI 10.1002/cne.10439; Budelli G, 2013, P NATL ACAD SCI USA, V110, P16657, DOI 10.1073/pnas.1313433110; Dai L, 2010, J GEN PHYSIOL, V135, P275, DOI 10.1085/jgp.200910316; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; DRYER SE, 1989, J PHYSIOL-LONDON, V410, P283, DOI 10.1113/jphysiol.1989.sp017533; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garg P, 2013, J GEN PHYSIOL, V142, P523, DOI 10.1085/jgp.201311064; Guo DL, 2003, J GEN PHYSIOL, V122, P485, DOI 10.1085/jgp.200308890; HAIMANN C, 1989, CELL BIOL INT REP, V13, P1133, DOI 10.1016/0309-1651(89)90027-1; HEGINBOTHAM L, 1993, BIOPHYS J, V65, P2089, DOI 10.1016/S0006-3495(93)81244-X; Heron SE, 2012, NAT GENET, V44, P1188, DOI 10.1038/ng.2440; Hille B., 2001, ION CHANNELS EXCITAB, P131; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Huang F, 2013, NAT NEUROSCI, V16, P1284, DOI 10.1038/nn.3468; Ishii A, 2013, GENE, V531, P467, DOI 10.1016/j.gene.2013.08.096; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Kaczmarek LK, 2005, HEARING RES, V206, P133, DOI 10.1016/j.heares.2004.11.023; KAMEYAMA M, 1984, NATURE, V309, P354, DOI 10.1038/309354a0; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Leonetti MD, 2012, P NATL ACAD SCI USA, V109, P19274, DOI 10.1073/pnas.1215078109; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu RR, 2015, J NEUROSCI, V35, P1125, DOI 10.1523/JNEUROSCI.2423-14.2015; Lu SQ, 2010, J NEUROPHYSIOL, V103, P3311, DOI 10.1152/jn.00607.2009; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lyumkis D, 2013, J STRUCT BIOL, V183, P377, DOI 10.1016/j.jsb.2013.07.005; Martin HC, 2014, HUM MOL GENET, V23, P3200, DOI 10.1093/hmg/ddu030; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McTague A, 2013, BRAIN, V136, P1578, DOI 10.1093/brain/awt073; Miller C., 1986, ION CHANNEL RECONSTI; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Paulais M, 2006, J GEN PHYSIOL, V127, P205, DOI 10.1085/jgp.200509360; Penczek PA, 2014, ULTRAMICROSCOPY, V140, P9, DOI 10.1016/j.ultramic.2014.01.009; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; SCHWINDT PC, 1989, J NEUROPHYSIOL, V61, P233, DOI 10.1152/jn.1989.61.2.233; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Thomson SJ, 2015, J BIOL CHEM, V290, P14528, DOI 10.1074/jbc.M115.653089; Vanderver A, 2014, PEDIATR NEUROL, V50, P112, DOI 10.1016/j.pediatrneurol.2013.06.024; Wallen P, 2007, J PHYSIOL-LONDON, V585, P75, DOI 10.1113/jphysiol.2007.138156; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Wilkens CM, 2006, J GEN PHYSIOL, V128, P347, DOI 10.1085/jgp.200609579; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Yan YY, 2012, J MEMBRANE BIOL, V245, P667, DOI 10.1007/s00232-012-9425-7; Yang B, 2007, J NEUROSCI, V27, P2617, DOI 10.1523/JNEUROSCI.5308-06.2007; Yang HH, 2008, NAT STRUCT MOL BIOL, V15, P1152, DOI 10.1038/nsmb.1507; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5; Yuan P, 2012, NATURE, V481, P94, DOI 10.1038/nature10670; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Zhang X, 2006, J GEN PHYSIOL, V128, P317, DOI 10.1085/jgp.200609552; Zhang Z, 2010, J NEUROSCI, V30, P7554, DOI 10.1523/JNEUROSCI.0525-10.2010; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zhou Y, 2011, P NATL ACAD SCI USA, V108, P12161, DOI 10.1073/pnas.1104150108	72	74	76	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					198	+		10.1038/nature14958	http://dx.doi.org/10.1038/nature14958			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RC	26436452	Green Accepted			2022-12-28	WOS:000364396700037
J	Chen, JD; Kriegstein, AR				Chen, Jiadong; Kriegstein, Arnold R.			A GABAergic projection from the zona incerta to cortex promotes cortical neuron development	SCIENCE			English	Article							HUMAN CEREBRAL-CORTEX; ELECTRICAL-ACTIVITY; PYRAMIDAL NEURONS; GABA; INHIBITION; RESPONSES; SYNAPSES; RELEASE; LONG	gamma-Aminobutyric acid (GABA) is the major inhibitory transmitter in the mature brain but is excitatory in the developing cortex. We found that mouse zona incerta (ZI) projection neurons form a GABAergic axon plexus in neonatal cortical layer 1, making synapses with neurons in both deep and superficial layers. A similar depolarizing GABAergic plexus exists in the developing human cortex. Selectively silencing mouse ZI GABAergic neurons at birth decreased synaptic activity and apical dendritic complexity of cortical neurons. The ZI GABAergic projection becomes inhibitory with maturation and can block epileptiform activity in the adult brain. These data reveal an early-developing GABAergic projection from the ZI to cortical layer 1 that is essential for proper development of cortical neurons and balances excitation with inhibition in the adult cortex.	[Chen, Jiadong; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Chen, JD (corresponding author), Univ Calif San Francisco, Dept Neurol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	jardongchen@gmail.com; kriegsteina@stemcell.ucsf.edu			National Institute of Neurological Disorders and Stroke [R37 NS35710]; CARE & CURE Pediatric Epilepsy Fellowship from the Epilepsy Foundation of Greater Los Angeles; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS035710] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CARE & CURE Pediatric Epilepsy Fellowship from the Epilepsy Foundation of Greater Los Angeles; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Huguenard, J. Paz, S. H. Wang, W. Walantus, and Y. Y. Wang for technical assistance; C. R. Yu for TeLC plasmid; G. P. Feng and Y. Zhou for TeLC-2A-GFP viral vectors; K. Deisseroth for ChR2 vectors; A. Alvarez-Buylla and C. Arnold for the stereotaxic injection rig; Kriegstein laboratory members for discussions; and W. P. Ge, S. Mayer, C. Gertz, and T. Nowakowski for critical reading of the manuscript. Supported by National Institute of Neurological Disorders and Stroke grant R37 NS35710 (A.R.K.) and a CARE & CURE Pediatric Epilepsy Fellowship from the Epilepsy Foundation of Greater Los Angeles (J.C.). The supplement contains additional data.	Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Caputi A, 2013, CURR OPIN NEUROBIOL, V23, P179, DOI 10.1016/j.conb.2013.01.021; Chai XJ, 2015, CEREB CORTEX, V25, P3640, DOI 10.1093/cercor/bhu216; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Dammerman RS, 2000, J NEUROPHYSIOL, V84, P428, DOI 10.1152/jn.2000.84.1.428; Demarque M, 2002, NEURON, V36, P1051, DOI 10.1016/S0896-6273(02)01053-X; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Garey LJ, 1998, J NEUROL NEUROSUR PS, V65, P446, DOI 10.1136/jnnp.65.4.446; Glykys J, 2009, NEURON, V63, P657, DOI 10.1016/j.neuron.2009.08.022; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Khazipov R, 2006, TRENDS NEUROSCI, V29, P414, DOI 10.1016/j.tins.2006.05.007; Kolmac C, 1999, ANAT EMBRYOL, V199, P265, DOI 10.1007/s004290050227; LIN CS, 1990, SCIENCE, V248, P1553, DOI 10.1126/science.2360049; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Melzer S, 2012, SCIENCE, V335, P1506, DOI 10.1126/science.1217139; Mitrofanis J, 2005, NEUROSCIENCE, V130, P1, DOI 10.1016/j.neuroscience.2004.08.017; MOLLIVER ME, 1973, BRAIN RES, V50, P403, DOI 10.1016/0006-8993(73)90741-5; Moore AR, 2011, J NEUROSCI, V31, P2391, DOI 10.1523/JNEUROSCI.3886-10.2011; Moore AR, 2009, CEREB CORTEX, V19, P1795, DOI 10.1093/cercor/bhn206; Owens DF, 1996, J NEUROSCI, V16, P6414; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Picardo MA, 2011, NEURON, V71, P695, DOI 10.1016/j.neuron.2011.06.018; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Powell EM, 2003, J NEUROSCI, V23, P622, DOI 10.1523/JNEUROSCI.23-02-00622.2003; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Saunders A, 2015, NATURE, V521, P85, DOI 10.1038/nature14179; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; TORRES F, 1985, J CLIN NEUROPHYSIOL, V2, P89, DOI 10.1097/00004691-198504000-00001; Tyzio R, 1999, J NEUROSCI, V19, P10372; Wang DD, 2008, J NEUROSCI, V28, P5547, DOI 10.1523/JNEUROSCI.5599-07.2008; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Zecevic N, 1998, CEREB CORTEX, V8, P245, DOI 10.1093/cercor/8.3.245; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	42	54	54	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260					554	558		10.1126/science.aac6472	http://dx.doi.org/10.1126/science.aac6472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU6RG	26429884	Green Accepted			2022-12-28	WOS:000363660000047
J	Xing, Y; Zhang, HM; Fu, HL; Liu, HW; Sun, Y; Peng, JP; Wang, F; Lin, X; Ma, XC; Xue, QK; Wang, J; Xie, XC				Xing, Ying; Zhang, Hui-Min; Fu, Hai-Long; Liu, Haiwen; Sun, Yi; Peng, Jun-Ping; Wang, Fa; Lin, Xi; Ma, Xu-Cun; Xue, Qi-Kun; Wang, Jian; Xie, X. C.			Quantum Griffiths singularity of superconductor-metal transition in Ga thin films	SCIENCE			English	Article							FERMI-LIQUID BEHAVIOR; INSULATOR TRANSITION; PHASE-TRANSITIONS; TEMPERATURE; SPIN	The Griffiths singularity in a phase transition, caused by disorder effects, was predicted more than 40 years ago. Its signature, the divergence of the dynamical critical exponent, is challenging to observe experimentally. We report the experimental observation of the quantum Griffiths singularity in a two-dimensional superconducting system. We measured the transport properties of atomically thin gallium films and found that the films undergo superconductor-metal transitions with increasing magnetic field. Approaching the zero-temperature quantum critical point, we observed divergence of the dynamical critical exponent, which is consistent with the Griffiths singularity behavior. We interpret the observed superconductor-metal quantum phase transition as the infinite-randomness critical point, where the properties of the system are controlled by rare large superconducting regions.	[Xing, Ying; Fu, Hai-Long; Liu, Haiwen; Sun, Yi; Wang, Fa; Lin, Xi; Wang, Jian; Xie, X. C.] Peking Univ, Sch Phys, Int Ctr Quantum Mat, Beijing 100871, Peoples R China; [Zhang, Hui-Min; Peng, Jun-Ping; Ma, Xu-Cun] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China; [Ma, Xu-Cun; Xue, Qi-Kun] Tsinghua Univ, Dept Phys, State Key Lab Low Dimens Quantum Phys, Beijing 100084, Peoples R China; [Liu, Haiwen; Wang, Fa; Lin, Xi; Ma, Xu-Cun; Xue, Qi-Kun; Wang, Jian; Xie, X. C.] Collaborat Innovat Ctr Quantum Matter, Beijing, Peoples R China	Peking University; Chinese Academy of Sciences; Institute of Physics, CAS; Tsinghua University	Lin, X (corresponding author), Peking Univ, Sch Phys, Int Ctr Quantum Mat, Beijing 100871, Peoples R China.	xilin@pku.edu.cn; xucunma@mail.tsinghua.edu.cn; jianwangphysics@pku.edu.cn	Wang, Fa/D-3817-2015; lin, xi/GZL-4959-2022; Liu, Haiwen/F-2518-2014	Wang, Fa/0000-0002-6220-5349; Fu, Hailong/0000-0001-5928-2979; Liu, Haiwen/0000-0002-0007-3117; Xing, Ying/0000-0002-2838-0637	National Basic Research Program of China [2013CB934600, 2012CB921300, 2015CB921102]; National Natural Science Foundation of China [11222434, 11174007, 11534001]; Research Fund for the Doctoral Program of Higher Education (RFDP) of China	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education (RFDP) of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	Supported by National Basic Research Program of China grants 2013CB934600, 2012CB921300, and 2015CB921102; National Natural Science Foundation of China grants 11222434, 11174007, and 11534001; and the Research Fund for the Doctoral Program of Higher Education (RFDP) of China.	ABRIKOSOV AA, 1961, SOV PHYS JETP-USSR, V12, P1243; Biscaras J, 2013, NAT MATER, V12, P542, DOI [10.1038/nmat3624, 10.1038/NMAT3624]; BLATTER G, 1994, REV MOD PHYS, V66, P1125, DOI 10.1103/RevModPhys.66.1125; Bollinger AT, 2011, NATURE, V472, P458, DOI 10.1038/nature09998; Castro Neto AH, 1998, PHYS REV LETT, V81, P3531, DOI 10.1103/PhysRevLett.81.3531; de Andrade MC, 1998, PHYS REV LETT, V81, P5620, DOI 10.1103/PhysRevLett.81.5620; Del Maestro A, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.145702; Del Maestro A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.035701; DYNES RC, 1978, PHYS REV LETT, V41, P1509, DOI 10.1103/PhysRevLett.41.1509; Feigel'man MV, 1998, CHEM PHYS, V235, P107, DOI 10.1016/S0301-0104(98)00075-5; Feigel'man MV, 2001, PHYS REV LETT, V86, P1869, DOI 10.1103/PhysRevLett.86.1869; FISHER DS, 1992, PHYS REV LETT, V69, P534, DOI 10.1103/PhysRevLett.69.534; FISHER DS, 1995, PHYS REV B, V51, P6411, DOI 10.1103/PhysRevB.51.6411; FISHER DS, 1991, PHYS REV B, V43, P130, DOI 10.1103/PhysRevB.43.130; FISHER MPA, 1989, PHYS REV B, V40, P546, DOI 10.1063/1.38820; FISHER MPA, 1990, PHYS REV LETT, V65, P923, DOI 10.1103/PhysRevLett.65.923; Galitski VM, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.087001; Goldman AM, 2010, INT J MOD PHYS B, V24, P4081, DOI 10.1142/S0217979210056451; GRIFFITHS RB, 1969, PHYS REV LETT, V23, P17, DOI 10.1103/PhysRevLett.23.17; HARRIS AB, 1974, J PHYS C SOLID STATE, V7, P1671, DOI 10.1088/0022-3719/7/9/009; HAVILAND DB, 1989, PHYS REV LETT, V62, P2180, DOI 10.1103/PhysRevLett.62.2180; HEBARD AF, 1990, PHYS REV LETT, V65, P927, DOI 10.1103/PhysRevLett.65.927; Hoyos JA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.230601; Kapitulnik A, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.125322; Kovacs IA, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.054437; MAKI K, 1968, PROG THEOR PHYS, V40, P193, DOI 10.1143/PTP.40.193; Markovic N, 1998, PHYS REV LETT, V81, P5217, DOI 10.1103/PhysRevLett.81.5217; MCCOY BM, 1968, PHYS REV, V176, P631, DOI 10.1103/PhysRev.176.631; Motrunich O, 2000, PHYS REV B, V61, P1160, DOI 10.1103/PhysRevB.61.1160; Nishio T, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2184758; Pich C, 1998, PHYS REV LETT, V81, P5916, DOI 10.1103/PhysRevLett.81.5916; Reyren N, 2007, SCIENCE, V317, P1196, DOI 10.1126/science.1146006; Rosenstein B, 2010, REV MOD PHYS, V82, P109, DOI 10.1103/RevModPhys.82.109; Sachdev S, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.237003; Sachdev S., 2011, QUANTUM PHASE TRANST; Shi XY, 2014, NAT PHYS, V10, P437, DOI [10.1038/NPHYS2961, 10.1038/nphys2961]; Sondhi SL, 1997, REV MOD PHYS, V69, P315, DOI 10.1103/RevModPhys.69.315; Spivak B, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.214523; Spivak B, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.132502; Ubaid-Kassis S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.066402; Vojta T, 2006, J PHYS A-MATH GEN, V39, pR143, DOI 10.1088/0305-4470/39/22/R01; Vojta T, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.075702; Vojta T, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.024401; Vojta T, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.011111; WERTHAME.NR, 1966, PHYS REV, V147, P295, DOI 10.1103/PhysRev.147.295; YAZDANI A, 1995, PHYS REV LETT, V74, P3037, DOI 10.1103/PhysRevLett.74.3037	46	117	117	16	267	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260					542	545		10.1126/science.aaa7154	http://dx.doi.org/10.1126/science.aaa7154			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU6RG	26472763				2022-12-28	WOS:000363660000044
J	Skou, ST; Roos, EM; Laursen, MB; Rathleff, MS; Arendt-Nielsen, L; Simonsen, O; Rasmussen, S				Skou, Soren T.; Roos, Ewa M.; Laursen, Mogens B.; Rathleff, Michael S.; Arendt-Nielsen, Lars; Simonsen, Ole; Rasmussen, Sten			A Randomized, Controlled Trial of Total Knee Replacement	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OUTCOME SCORE KOOS; NEUROMUSCULAR EXERCISE; REPORTED OUTCOMES; PHYSICAL FUNCTION; NEMEX-TJR; HIP; OSTEOARTHRITIS; ARTHROPLASTY; GUIDELINES; MANAGEMENT	BACKGROUND More than 670,000 total knee replacements are performed annually in the United States; however, high-quality evidence to support the effectiveness of the procedure, as compared with nonsurgical interventions, is lacking. METHODS In this randomized, controlled trial, we enrolled 100 patients with moderate-to-severe knee osteoarthritis who were eligible for unilateral total knee replacement. Patients were randomly assigned to undergo total knee replacement followed by 12 weeks of nonsurgical treatment (total-knee-replacement group) or to receive only the 12 weeks of nonsurgical treatment (nonsurgical-treatment group), which was delivered by physiotherapists and dietitians and consisted of exercise, education, dietary advice, use of insoles, and pain medication. The primary outcome was the change from baseline to 12 months in the mean score on four Knee Injury and Osteoarthritis Outcome Score subscales, covering pain, symptoms, activities of daily living, and quality of life (KOOS4); scores range from 0 (worst) to 100 (best). RESULTS A total of 95 patients completed the 12-month follow-up assessment. In the nonsurgical-treatment group, 13 patients (26%) underwent total knee replacement before the 12-month follow-up; in the total-knee-replacement group, 1 patient (2%) received only nonsurgical treatment. In the intention-to-treat analysis, the total-knee-replacement group had greater improvement in the KOOS4 score than did the nonsurgical-treatment group (32.5 vs. 16.0; adjusted mean difference, 15.8 [95% confidence interval, 10.0 to 21.5]). The total-knee-replacement group had a higher number of serious adverse events than did the nonsurgical-treatment group (24 vs. 6, P=0.005). CONCLUSIONS In patients with knee osteoarthritis who were eligible for unilateral total knee replacement, treatment with total knee replacement followed by nonsurgical treatment resulted in greater pain relief and functional improvement after 12 months than did nonsurgical treatment alone. However, total knee replacement was associated with a higher number of serious adverse events than was nonsurgical treatment, and most patients who were assigned to receive nonsurgical treatment alone did not undergo total knee replacement before the 12-month follow-up. (Funded by the Obel Family Foundation and others; MEDIC ClinicalTrials.gov number, NCT01410409.)	[Skou, Soren T.; Roos, Ewa M.] Univ Southern Denmark, Res Unit Musculoskeletal Funct & Physiotherapy, Inst Sports Sci & Clin Biomech, Odense, Denmark; [Skou, Soren T.] Clin Nursing Res Unit, Aalborg, Denmark; [Skou, Soren T.; Laursen, Mogens B.; Simonsen, Ole; Rasmussen, Sten] Orthoped Surg Res Unit, Aalborg, Denmark; [Skou, Soren T.; Laursen, Mogens B.; Rathleff, Michael S.; Arendt-Nielsen, Lars; Simonsen, Ole; Rasmussen, Sten] Aalborg Univ Hosp, Aalborg, Denmark; [Skou, Soren T.; Laursen, Mogens B.; Rathleff, Michael S.; Arendt-Nielsen, Lars; Simonsen, Ole; Rasmussen, Sten] Ctr Sensory Motor Interac, Dept Hlth Sci & Technol, Fac Med, Aalborg, Denmark; [Laursen, Mogens B.; Simonsen, Ole; Rasmussen, Sten] Aalborg Univ, Dept Clin Med, DK-9000 Aalborg, Denmark	University of Southern Denmark; Aalborg University; Aalborg University Hospital; Aalborg University	Skou, ST (corresponding author), Aalborg Univ, Hosp Sci & Innovat Ctr, 15 Soendre Skovvej, DK-9000 Aalborg, Denmark.	stskou@health.sdu.dk	Roos, Ewa M/A-5416-2012; Skou, Søren T./I-2405-2016; Arendt-Nielsen, Lars/T-4885-2018; Rasmussen, Sten/N-3916-2013	Roos, Ewa M/0000-0001-5425-2199; Skou, Søren T./0000-0003-4336-7059; Rasmussen, Sten/0000-0002-8664-352X; Laursen, Mogens/0000-0002-2791-3921; Rathleff, Michael Skovdal/0000-0003-1173-0335; Arendt-Nielsen, Lars/0000-0003-0892-1579	Obel Family Foundation; MEDIC	Obel Family Foundation; MEDIC	Funded by the Obel Family Foundation and others; MEDIC ClinicalTrials.gov number, NCT01410409.	Ageberg E, 2015, EXERC SPORT SCI REV, V43, P14, DOI 10.1249/JES.0000000000000030; Ageberg E, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-232; Ageberg E, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-265; Ageberg E, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-126; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Carr AJ, 2012, LANCET, V379, P1331, DOI 10.1016/S0140-6736(11)60752-6; Christensen R, 2007, ANN RHEUM DIS, V66, P433, DOI 10.1136/ard.2006.065904; Collins NJ, 2011, ARTHRIT CARE RES, V63, pS208, DOI 10.1002/acr.20632; Danish Knee Arthroplasty Register, 2013, ANN REP 2013 DAN KNE; Endres Stefan, 2011, J Orthop Surg (Hong Kong), V19, P226; Escobar A, 2007, RHEUMATOLOGY, V46, P112, DOI 10.1093/rheumatology/kel184; Fernandes L, 2013, ANN RHEUM DIS, V72, P1125, DOI 10.1136/annrheumdis-2012-202745; Food and Drug Administration, 2014, WHAT IS SER ADV EV; Gossec L, 2011, OSTEOARTHR CARTILAGE, V19, P147, DOI 10.1016/j.joca.2010.10.025; HCUP National Inpatient Sample (NIS), 2012, HEALTHC COST UT PROJ; Hurley MV, 2012, ARTHRIT CARE RES, V64, P238, DOI 10.1002/acr.20642; Jarvinen TLN, 2014, J CLIN EPIDEMIOL, V67, P769, DOI 10.1016/j.jclinepi.2013.11.011; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Lim HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096745; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Miller W, 2002, MOTIVATIONAL INTERVI, V2<feminine; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Nelson AE, 2014, SEMIN ARTHRITIS RHEU, V43, P701, DOI 10.1016/j.semarthrit.2013.11.012; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Roos EM, 1998, J ORTHOP SPORT PHYS, V28, P88, DOI 10.2519/jospt.1998.28.2.88; Roos Ewa M, 2003, Health Qual Life Outcomes, V1, P64, DOI 10.1186/1477-7525-1-64; Roos EM, 2011, CARTILAGE, V2, P122, DOI 10.1177/1947603510391084; Schiphof D, 2011, ANN RHEUM DIS, V70, P1422, DOI 10.1136/ard.2010.147520; Singh JA, 2010, MAYO CLIN PROC, V85, P898, DOI 10.4065/mcp.2010.0115; Skou ST, 2015, OSTEOARTHR CARTILAGE, V23, P1465, DOI 10.1016/j.joca.2015.04.021; Skou ST, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-67; Skou ST, 2014, STAT ANAL PLAN SAP M; Szende A., 2004, MEASURING SELF REPOR; Villadsen A, 2014, J RHEUMATOL, V41, P1385, DOI 10.3899/jrheum.130642; Villadsen A, 2014, ANN RHEUM DIS, V73, P1130, DOI 10.1136/annrheumdis-2012-203135; Wartolowska K, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3253; White DK, 2010, ARTHRIT CARE RES, V62, P1433, DOI 10.1002/acr.20247; Wittrup-Jensen KU, 2009, SCAND J PUBLIC HEALT, V37, P459, DOI 10.1177/1403494809105287; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	39	347	359	4	73	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2015	373	17					1597	1606		10.1056/NEJMoa1505467	http://dx.doi.org/10.1056/NEJMoa1505467			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU1YH	26488691	Green Published, Bronze			2022-12-28	WOS:000363317800005
J	Thomas, GH				Thomas, Gavin H.			EVOLUTION An avian explosion	NATURE			English	Editorial Material							RESOLVE EARLY BRANCHES; BIRDS; TREE; LIFE	The genome sequences of 198 bird species provide an unprecedented combination of breadth and depth of data, and allow the most robust resolution so far of the early evolutionary relationships of modern birds. SEE LETTER P.569	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Thomas, GH (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	gavin.thomas@sheffield.ac.uk	Thomas, Gavin/AAE-8959-2019	Thomas, Gavin/0000-0002-1982-6051				Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Cracraft J, 2015, SCIENCE, V349, DOI 10.1126/science.aab1578; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Lemmon AR, 2012, SYST BIOL, V61, P727, DOI 10.1093/sysbio/sys049; McCormack JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054848; Mitchell KJ, 2015, SCIENCE, V349, P1460, DOI 10.1126/science.aab1062; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Suh A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002224	11	9	9	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					516	517		10.1038/nature15638	http://dx.doi.org/10.1038/nature15638			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26444233				2022-12-28	WOS:000364026100038
J	Zhou, J; Wan, J; Gao, XW; Zhang, XQ; Jaffrey, SR; Qian, SB				Zhou, Jun; wan, Ji; Gao, Xiangwei; Zhang, Xingqian; Jaffrey, Samie R.; Qian, Shu-Bing			Dynamic m(6)A mRNA methylation directs translational control of heat shock response	NATURE			English	Article							GENE-EXPRESSION; STRESS-RESPONSE; N-6-METHYLADENOSINE; INITIATION; REVEALS; HSP70; MECHANISM; DISTINCT; PROGRAM; LEADER	The most abundant mRNA post-transcriptional modification is N-6-methyladenosine (m(6)A), which has broad roles in RNA biology(1-5). In mammalian cells, the asymmetric distribution of m(6)A along mRNAs results in relatively less methylation in the 5' untranslated region (5'UTR) compared to other regions(6,7). However, whether and how 5'UTR methylation is regulated is poorly understood. Despite the crucial role of the 5'UTR in translation initiation, very little is known about whether m(6)A modification influences mRNA translation. Here we show that in response to heat shock stress, certain adenosines within the 5'UTR of newly transcribed mRNAs are preferentially methylated. Wefind that the dynamic 5'UTR methylation is a result of stress-induced nuclear localization of YTHDF2, a well-characterized m(6)A 'reader'. Upon heat shock stress, the nuclear YTHDF2 preserves 5'UTR methylation of stress-induced transcripts by limiting the m(6)A 'eraser' FTO from demethylation. Remarkably, the increased 5'UTR methylation in the form of m(6)A promotes cap-independent translation initiation, providing a mechanism for selective mRNA translation under heat shock stress. Using Hsp70 mRNA as an example, we demonstrate that a single m(6)A modification site in the 5'UTR enables translation initiation independent of the 5' end N-7-methylguanosine cap. The elucidation of the dynamic features of 5'UTR methylation and its critical role in cap-independent translation not only expands the breadth of physiological roles of m(6)A, but also uncovers a previously unappreciated translational control mechanism in heat shock response.	[Zhou, Jun; wan, Ji; Gao, Xiangwei; Zhang, Xingqian; Qian, Shu-Bing] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Jaffrey, Samie R.] Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA	Cornell University; Cornell University	Qian, SB (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	sq38@cornell.edu	Wan, Ji/K-1344-2014; Jun, Zhou/CAG-4742-2022; Zhou, Jun/J-3035-2015	Jun, Zhou/0000-0001-7261-2207; Jaffrey, Samie/0000-0003-3615-6958; Wan, Ji/0000-0002-5279-0345	US National Institutes of Health [DP2 OD006449, R01AG042400]; NIDA [DA037150]; US Department of Defense [W81XWH-14-1-0068]; NATIONAL CANCER INSTITUTE [R01CA186702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG042400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037150] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006449] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Qian laboratory members for helpful discussions and Cornell University Life Sciences Core Laboratory Center for performing deep sequencing. This work was supported by grants from the US National Institutes of Health DP2 OD006449 and R01AG042400 (to S.-B.Q.) and NIDA DA037150 (to S.R.J.) and the US Department of Defense (W81XWH-14-1-0068) (to S.-B.Q.).	Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Harcourt EM, 2013, J AM CHEM SOC, V135, P19079, DOI 10.1021/ja4105792; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kershaw Christopher J, 2012, Methods Mol Biol, V941, P257, DOI 10.1007/978-1-62703-113-4_19; KLEMENZ R, 1985, EMBO J, V4, P2053, DOI 10.1002/j.1460-2075.1985.tb03891.x; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Maroney PA, 2008, NAT PROTOC, V3, P279, DOI 10.1038/nprot.2007.530; MCGARRY TJ, 1985, CELL, V42, P903, DOI 10.1016/0092-8674(85)90286-7; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; PANNIERS R, 1994, BIOCHIMIE, V76, P737, DOI 10.1016/0300-9084(94)90078-7; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rubtsova MP, 2003, J BIOL CHEM, V278, P22350, DOI 10.1074/jbc.M303213200; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Stark MR, 2006, RNA, V12, P2014, DOI 10.1261/rna.93506; Sun J, 2011, J BIOL CHEM, V286, P6791, DOI 10.1074/jbc.M110.172882; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Zhang XQ, 2015, NAT STRUCT MOL BIOL, V22, P404, DOI 10.1038/nsmb.3010; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	33	733	761	6	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					591	U332		10.1038/nature15377	http://dx.doi.org/10.1038/nature15377			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26458103	Green Accepted			2022-12-28	WOS:000364026100054
J	Lu, X				Lu, Xin			The rewards of roughing it	SCIENCE			English	Editorial Material									[Lu, Xin] Wuhan Univ, Zool, Wuhan, Peoples R China; [Lu, Xin] Wuhan Univ Tibet Univ Field Res Stn Tibetan Wildl, Wuhan, Peoples R China	Wuhan University	Lu, X (corresponding author), Wuhan Univ, Zool, Wuhan, Peoples R China.								0	1	1	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2015	350	6258					350	350		10.1126/science.350.6258.350	http://dx.doi.org/10.1126/science.350.6258.350			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT5HD	26472912				2022-12-28	WOS:000362838700046
J	Tee, BCK; Chortos, A; Berndt, A; Nguyen, AK; Tom, A; McGuire, A; Lin, ZLC; Tien, K; Bae, WG; Wang, HL; Mei, P; Chou, HH; Cui, BX; Deisseroth, K; Ng, TN; Bao, ZN				Tee, Benjamin C. -K.; Chortos, Alex; Berndt, Andre; Nguyen, Amanda Kim; Tom, Ariane; McGuire, Allister; Lin, Ziliang Carter; Tien, Kevin; Bae, Won-Gyu; Wang, Huiliang; Mei, Ping; Chou, Ho-Hsiu; Cui, Bianxiao; Deisseroth, Karl; Ng, Tse Nga; Bao, Zhenan			A skin-inspired organic digital mechanoreceptor	SCIENCE			English	Article							NONVOLATILE MEMORY; ELECTRONICS; TRANSISTORS; PROSTHESIS	Human skin relies on cutaneous receptors that output digital signals for tactile sensing in which the intensity of stimulation is converted to a series of voltage pulses. We present a power-efficient skin-inspired mechanoreceptor with a flexible organic transistor circuit that transduces pressure into digital frequency signals directly. The output frequency ranges between 0 and 200 hertz, with a sublinear response to increasing force stimuli that mimics slow-adapting skin mechanoreceptors. The output of the sensors was further used to stimulate optogenetically engineered mouse somatosensory neurons of mouse cortex in vitro, achieving stimulated pulses in accordance with pressure levels. This work represents a step toward the design and use of large-area organic electronic skins with neural-integrated touch feedback for replacement limbs.	[Tee, Benjamin C. -K.; Nguyen, Amanda Kim; Tien, Kevin] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Chortos, Alex; Wang, Huiliang] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Berndt, Andre; Tom, Ariane; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [McGuire, Allister; Lin, Ziliang Carter; Cui, Bianxiao] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Bae, Won-Gyu; Chou, Ho-Hsiu; Bao, Zhenan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Mei, Ping; Ng, Tse Nga] Xerox Palo Alto Res Ctr, Palo Alto, CA USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Bao, ZN (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	zbao@stanford.edu	Chou, Ho-Hsiu/X-4816-2019; Wang, Huiliang/ABE-2916-2020; Tee, Benjamin C.K./U-6403-2019; Tee, Benjamin/T-8906-2017; Bao, Zhenan/AAC-5044-2019; Chou, Ho-Hsiu/V-1043-2018	Chou, Ho-Hsiu/0000-0003-3777-2277; Wang, Huiliang/0000-0003-4063-270X; Tee, Benjamin C.K./0000-0002-9180-4105; Tee, Benjamin/0000-0002-9180-4105; Bao, Zhenan/0000-0002-0972-1715; Chou, Ho-Hsiu/0000-0003-3777-2277; Chortos, Alex/0000-0003-3976-5257; Ng, Tse Nga/0000-0001-6967-559X; Tee, Benjamin C.K./0000-0001-8125-9396; McGuire, Allister/0000-0001-6388-2934; Berndt, Andre/0000-0003-4758-5598	Xerox Foundation; MSIP (Ministry of Science, ICT and Future Planning), Korea, under the IT Consilience Creative Program [NIPA-2014-H0201-14-1001]; National IT Industry Promotion Agency; Agency for Science Technology and Research Singapore (A*STAR); Samsung Electronics; Div Of Electrical, Commun & Cyber Sys [1542152] Funding Source: National Science Foundation	Xerox Foundation; MSIP (Ministry of Science, ICT and Future Planning), Korea, under the IT Consilience Creative Program(Ministry of Science, ICT & Future Planning, Republic of Korea); National IT Industry Promotion Agency(National IT Industry Promotion Agency (NIPA), Republic of Korea); Agency for Science Technology and Research Singapore (A*STAR)(Agency for Science Technology & Research (A*STAR)); Samsung Electronics(Samsung); Div Of Electrical, Commun & Cyber Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	B.C.-K.T., A.C., A.B., and Z.B. conceived the experiments; T.N.N., P.M., B.C.-K.T., K.T., and H.W. worked on equipment and fabricated oscillators; A.C. and B.C.-K.T. designed pressure sensors and A.C. and H.-H.C. characterized them; B.C.-K.T., A.K.N., and A. C. implemented measurement electronics; A. B. and K.D. engineered the channelrhodopsin protein; A. B., A. C., A.K.N., and A. T. performed optogenetic measurements; B. C.-K. T., A. M., and Z. C. L. did measurements using electrical stimulation of neurons; W.-G. B. improved data visualization; B. C.-K. T., A. C., A. B., and Z. B. wrote the manuscript; and all authors reviewed and critiqued the results andmade key revisions to the manuscript. We thank N. Liu for taking SEM images and Lubrizol Co. for supplyingSG80A elastomer for the pressure sensors. Supported by the Xerox Foundation; the MSIP (Ministry of Science, ICT and Future Planning), Korea, under the IT Consilience Creative Program (grant NIPA-2014-H0201-14-1001) supervised by the National IT Industry Promotion Agency; Agency for Science Technology and Research Singapore (A*STAR); and Samsung Electronics.	Abbott A, 2006, NATURE, V442, P125, DOI 10.1038/442125a; Gardner E. P., 2001, TOUCH; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Kaltenbrunner M, 2013, NATURE, V499, P458, DOI 10.1038/nature12314; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Kim J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6747; KNIBESTOL M, 1975, J PHYSIOL-LONDON, V245, P63, DOI 10.1113/jphysiol.1975.sp010835; Lotze M, 1999, NAT NEUROSCI, V2, P501, DOI 10.1038/9145; Mannsfeld SCB, 2010, NAT MATER, V9, P859, DOI [10.1038/NMAT2834, 10.1038/nmat2834]; Mei P, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4896547; Ng TN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00585; Nowak DA, 2005, MOVEMENT DISORD, V20, P11, DOI 10.1002/mds.20299; O'Doherty JE, 2011, NATURE, V479, P228, DOI 10.1038/nature10489; Raspopovic S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006820; Schwartz G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2832; Sekitani T, 2010, NAT MATER, V9, P1015, DOI 10.1038/NMAT2896; Sekitani T, 2009, SCIENCE, V326, P1516, DOI 10.1126/science.1179963; Takei K, 2010, NAT MATER, V9, P821, DOI [10.1038/nmat2835, 10.1038/NMAT2835]; Tan DW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008669	19	569	584	52	949	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2015	350	6258					313	+		10.1126/science.aaa9306	http://dx.doi.org/10.1126/science.aaa9306			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT5HD	26472906	Green Published			2022-12-28	WOS:000362838700039
J	Saloner, B; Karthikeyan, S				Saloner, Brendan; Karthikeyan, Shankar			Changes in Substance Abuse Treatment Use Among Individuals With Opioid Use Disorders in the United States. 2004-2013	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							TRENDS		[Saloner, Brendan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 624 N Broadway,Room 344, Baltimore, MD 21205 USA; [Karthikeyan, Shankar] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Hlth & Social Policy, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Saloner, B (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 624 N Broadway,Room 344, Baltimore, MD 21205 USA.	bsaloner@jhu.edu						Becker WC, 2008, DRUG ALCOHOL DEPEN, V94, P207, DOI 10.1016/j.drugalcdep.2007.11.018; Busch SH, 2014, AM J MANAG CARE, V20, P76; Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]; Jordan BK, 2008, ADDICT BEHAV, V33, P782, DOI 10.1016/j.addbeh.2007.12.007; Olsen Y, 2014, JAMA-J AM MED ASSOC, V311, P1393, DOI 10.1001/jama.2014.2147; Stein BD, 2012, DRUG ALCOHOL DEPEN, V123, P72, DOI 10.1016/j.drugalcdep.2011.10.016	6	159	159	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2015	314	14					1515	1517		10.1001/jama.2015.10345	http://dx.doi.org/10.1001/jama.2015.10345			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2QI	26462001				2022-12-28	WOS:000362647800020
J	Spector, B				Spector, Benjamin			A Doctor's Dilemma (Reprinted from JAMA, vol 194, pg 174-176, 1965)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		SPECTOR B, 1965, J AMER MED ASSOC, V194, P174	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2015	314	14					1524	1524		10.1001/jama.2014.12028	http://dx.doi.org/10.1001/jama.2014.12028			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2QI	26462010				2022-12-28	WOS:000362647800029
J	Landrigan, PJ; Fuller, R; Horton, R				Landrigan, Philip J.; Fuller, Richard; Horton, Richard			Environmental pollution, health, and development: a Lancet-Global Alliance on Health and Pollution-Icahn School of Medicine at Mount Sinai Commission	LANCET			English	Editorial Material									[Landrigan, Philip J.] Icahn Sch Med Mt Sinai, Arnhold Inst Global Hlth, Dept Prevent Med, New York, NY 10029 USA; [Landrigan, Philip J.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Fuller, Richard] Global Alliance Hlth & Pollut, New York, NY USA; [Horton, Richard] The Lancet, London, England	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Landrigan, PJ (corresponding author), Icahn Sch Med Mt Sinai, Arnhold Inst Global Hlth, Dept Prevent Med, New York, NY 10029 USA.	phil.landrigan@mssm.edu		Fuller, Richard/0000-0002-4298-5069				[Anonymous], 2014, BURD DIS JOINT EFF H; Caravanos Jack, 2013, ENV HLTH PERSPECT, V121, P791; Frank AL, 2014, ANN GLOB HEALTH, V80, P257, DOI 10.1016/j.aogh.2014.09.016; Grosse SD, 2002, ENVIRON HEALTH PERSP, V110, P563, DOI 10.1289/ehp.02110563; Haefliger P, 2009, ENVIRON HEALTH PERSP, V117, P1535, DOI 10.1289/ehp.0900696; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Laborde A, 2015, ENVIRON HEALTH PERSP, V123, P201, DOI 10.1289/ehp.1408292; Laudato Si, 2015, ENCYCLICAL LETT CARE; Ottersen OP, 2014, LANCET, V383, P630, DOI 10.1016/S0140-6736(13)62407-1; Trasande L, 2011, HEALTH AFFAIR, V30, P863, DOI 10.1377/hlthaff.2010.1239; United Nations, PREV DISP OBS PEST; Wade L, 2013, SCIENCE, V341, P1448, DOI 10.1126/science.341.6153.1448; Watts N, 2015, LANCET, V386, P1861, DOI 10.1016/S0140-6736(15)60854-6; Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1; WHO, 2014, PREV DIARRH BETT WAT; WHO, 2014, BURD DIS AMB HOUS AI; World Health Organization, 2014, DEATHS EST DEATHS DA	17	19	19	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2015	386	10002					1429	1431		10.1016/S0140-6736(15)00426-2	http://dx.doi.org/10.1016/S0140-6736(15)00426-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CT5UU	26466029				2022-12-28	WOS:000362877300010
J	Merrigan, K; Griffin, T; Wilde, P; Robien, K; Goldberg, J; Dietz, W				Merrigan, Kathleen; Griffin, Timothy; Wilde, Parke; Robien, Kimberly; Goldberg, Jeanne; Dietz, William			Designing a sustainable diet	SCIENCE			English	Editorial Material									[Merrigan, Kathleen] George Washington Univ, Trachtenberg Sch Publ Policy & Publ Adm, Washington, DC 20052 USA; [Griffin, Timothy; Wilde, Parke; Goldberg, Jeanne; Dietz, William] Tufts Univ, Friedman Sch Nutr Sci & Policy, Medford, MA 02155 USA; [Robien, Kimberly] George Washington Univ, Milken Inst Sch Publ Hlth, Washington, DC 20052 USA	George Washington University; Tufts University; George Washington University	Dietz, W (corresponding author), George Washington Univ, Milken Inst Sch Publ Hlth, Washington, DC 20052 USA.	kmerrigan@gwu.edu	Wilde, Parke/B-6011-2009	Wilde, Parke/0000-0002-9596-9230; Merrigan, Kathleen/0000-0002-7637-6683				Dernini S., 2010, SUSTAINABLE DIETS BI; Dietary Guidelines Advisory Committee, 2015, REP DIET GUID ADV CO; FAO, 2012, FOC DEV WORLDS NEW B; Food and Nutrition Board Institute of Medicine, 2014, SUST DIETS FOOD HLTH; Health Council of the Netherlands, 2011, RICHTL VOEDS; Imamura F, 2015, LANCET GLOB HEALTH, V3, pE132, DOI 10.1016/S2214-109X(14)70381-X; Knotter H., 2014, SUSTAIN SOUND DIETAR; Liese AD, 2015, J NUTR, V145, P393, DOI 10.3945/jn.114.205336; Mekonnen MM, 2011, HYDROL EARTH SYST SC, V15, P1577, DOI 10.5194/hess-15-1577-2011; Ministry of Health of Brazil, 2014, DIET GUID BRAZ POP; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959	11	35	37	5	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257					165	166		10.1126/science.aab2031	http://dx.doi.org/10.1126/science.aab2031			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS9JB	26429883				2022-12-28	WOS:000362405600021
J	Fu, XY; Yan, YT; Xu, PS; Geerlof-Vidavsky, I; Chong, WG; Gross, ML; Holy, TE				Fu, Xiaoyan; Yan, Yuetian; Xu, Pei S.; Geerlof-Vidavsky, Ilan; Chong, Wongi; Gross, Michael L.; Holy, Timothy E.			A Molecular Code for Identity in the Vomeronasal System	CELL			English	Article							PHEROMONE-SENSING NEURONS; SEX-DISCRIMINATION; SULFATED STEROIDS; SENSORY NEURONS; MOUSE; BEHAVIOR; MICE; ORGAN; RESPONSES; SIGNALS	In social interactions among mammals, individuals are recognized by olfactory cues, but identifying the key signals among thousands of compounds remains a major challenge. To address this need, we developed a new technique, component-activity matching (CAM), to select candidate ligands that "explain'' patterns of bioactivity across diverse complex mixtures. Using mouse urine from eight different sexes and strains, we identified 23 components to explain firing rates in seven of eight functional classes of vomeronasal sensory neurons. Focusing on a class of neurons selective for females, we identified a novel family of vomeronasal ligands, steroid carboxylic acids. These ligands accounted for much of the neuronal activity of urine from some female strains, were necessary for normal levels of male investigatory behavior of female scents, and were sufficient to trigger mounting behavior. CAM represents the first step toward an exhaustive characterization of the molecular cues for natural behavior in a mammalian olfactory system.	[Fu, Xiaoyan; Xu, Pei S.; Chong, Wongi; Holy, Timothy E.] Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Yan, Yuetian; Geerlof-Vidavsky, Ilan; Gross, Michael L.] Washington Univ, Dept Chem, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Holy, TE (corresponding author), Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	holy@wustl.edu			NIH/NIDCD [R01 DC005964, R01 DC010381]; NIH/NIMS/NIAAA [R01 NS068409]; NIH/NIGMS [P41 GM103422-36]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS068409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010381, R01DC005964] Funding Source: NIH RePORTER	NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH/NIMS/NIAAA; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Amber Tyler for helping collect estrus female mice urine and Petland St. Louis (south city store) for helping collect hamster and rabbit urine. We thank members of the T.E.H. and M.L.G. labs, as well as the anonymous referees, for many constructive comments. This work was supported by NIH/NIDCD (R01 DC005964), NIH/NIMS/NIAAA (R01 NS068409), and NIH/NIDCD (R01 DC010381) (to T.E.H.) and NIH/NIGMS (P41 GM103422-36) (to M.L.G.).	Arnson Hannah A, 2010, J Vis Exp, DOI 10.3791/1845; Arnson HA, 2013, J NEUROSCI, V33, P13388, DOI 10.1523/JNEUROSCI.0967-13.2013; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; DIXON AK, 1975, ANIM BEHAV, V23, P513, DOI 10.1016/0003-3472(75)90128-1; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Haga-Yamanaka S, 2014, ELIFE, V3, DOI 10.7554/eLife.03025; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; He J, 2008, SCIENCE, V320, P535, DOI 10.1126/science.1154476; Holekamp TF, 2008, NEURON, V57, P661, DOI 10.1016/j.neuron.2008.01.011; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Hsu FF, 2008, BIOCHEMISTRY-US, V47, P14009, DOI 10.1021/bi801392j; Kimchi T, 2007, NATURE, V448, P1009, DOI 10.1038/nature06089; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Ma MH, 2007, CRIT REV BIOCHEM MOL, V42, P463, DOI 10.1080/10409230701693359; Nodari F, 2008, J NEUROSCI, V28, P6407, DOI 10.1523/JNEUROSCI.1425-08.2008; Omura M, 2014, CELL REP, V8, P582, DOI 10.1016/j.celrep.2014.06.010; Pankevich DE, 2004, J NEUROSCI, V24, P9451, DOI 10.1523/JNEUROSCI.2376-04.2004; RAJU U, 1990, ANN NY ACAD SCI, V586, P83, DOI 10.1111/j.1749-6632.1990.tb17793.x; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Tolokh II, 2013, J NEUROSCI, V33, P13903, DOI 10.1523/JNEUROSCI.0037-13.2013; Turaga D, 2012, J NEUROSCI, V32, P1612, DOI 10.1523/JNEUROSCI.5339-11.2012; Wang T, 2010, J BIOL CHEM, V285, P7670, DOI 10.1074/jbc.M109.090175; Xu PS, 2013, METHODS MOL BIOL, V1068, P201, DOI 10.1007/978-1-62703-619-1_14	25	32	32	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2					313	323		10.1016/j.cell.2015.09.012	http://dx.doi.org/10.1016/j.cell.2015.09.012			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26435105	Bronze, Green Accepted			2022-12-28	WOS:000362952700010
J	Keller, AJ; Peeters, L; Moca, CP; Weymann, I; Mahalu, D; Umansky, V; Zarand, G; Goldhaber-Gordon, D				Keller, A. J.; Peeters, L.; Moca, C. P.; Weymann, I.; Mahalu, D.; Umansky, V.; Zarand, G.; Goldhaber-Gordon, D.			Universal Fermi liquid crossover and quantum criticality in a mesoscopic system	NATURE			English	Article							RENORMALIZATION-GROUP; KONDO SYSTEM; HEAVY; CONDUCTANCE; BEHAVIOR	Quantum critical systems derive their finite-temperature properties from the influence of a zero-temperature quantum phase transition(1). The paradigm is essential for understanding unconventional high-T-c superconductors and the non-Fermi liquid properties of heavy fermion compounds. However, the microscopic origins of quantum phase transitions in complex materials are often debated. Here we demonstrate experimentally, with support from numerical renormalization group calculations, a universal crossover from quantum critical non-Fermi liquid behaviour to distinct Fermi liquid ground states in a highly controllable quantum dot device. Our device realizes the non-Fermi liquid two-channel Kondo state(2,3), based on a spin-1/2 impurity exchange-coupled equally to two independent electronic reservoirs(4). On detuning the exchange couplings we observe the Fermi liquid scale T*, at energies below which the spin is screened conventionally by the more strongly coupled channel. We extract a quadratic dependence of T* on gate voltage close to criticality, and validate an asymptotically exact description of the universal crossover between strongly correlated non-Fermi liquid and Fermi liquid states(5,6).	[Keller, A. J.; Peeters, L.; Goldhaber-Gordon, D.] Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [Moca, C. P.; Zarand, G.] Budapest Univ Technol & Econ, Inst Phys, BME MTA Exot Quantum Phases Lendulet Grp, H-1521 Budapest, Hungary; [Moca, C. P.] Univ Oradea, Dept Phys, Oradea 410087, Romania; [Weymann, I.] Adam Mickiewicz Univ, Fac Phys, PL-61614 Poznan, Poland; [Mahalu, D.; Umansky, V.] Weizmann Inst Sci, Dept Condensed Matter Phys, IL-96100 Rehovot, Israel	Stanford University; Budapest University of Technology & Economics; University of Oradea; Adam Mickiewicz University; Weizmann Institute of Science	Goldhaber-Gordon, D (corresponding author), Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA.	goldhaber-gordon@stanford.edu	Weymann, Ireneusz/C-9892-2017; Moca, Catalin Pascu/D-9507-2014; Moca, Pascu Catalin/AAF-5433-2019; Umansky, Vladimir/P-1334-2019	Weymann, Ireneusz/0000-0003-4193-6019; Umansky, Vladimir/0000-0001-5727-2064; Zarand, Gergely/0000-0001-7522-1826; Goldhaber-Gordon, David/0000-0001-8549-0560; Keller, Andrew/0000-0003-3030-1149	Gordon and Betty Moore Foundation [GBMF3429]; Hungarian research grant [OTKA K105149]; Polish National Science Centre project [DEC-2013/10/E/ST3/00213]; EU [CIG-303 689]; National Science Foundation [DMR-0906062]; US-Israel BSF [2008149]; Stanford Graduate Fellowship	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Hungarian research grant; Polish National Science Centre project; EU(European Commission); National Science Foundation(National Science Foundation (NSF)); US-Israel BSF(US-Israel Binational Science Foundation); Stanford Graduate Fellowship(Stanford University)	We are grateful to S. Amasha, Y. Oreg, A. Carmi, E. Sela, A. K. Mitchell and M. Heiblum for discussions; H. K. Choi, Y. Chung and J. MacArthur for electronics expertise; M. Heiblum for use of his laboratory during initial device characterization; H. Inoue, N. Ofek, O. Raslin and E. Weisz for fabrication guidance; F.B. Anders, E. Lebanon and the late A. Schiller for their calculations which guided prior experimental work; and M. Stopa for his SETE software for electrostatic quantum dot modelling. The device was fabricated in the Braun Submicron Center at the Weizmann Institute of Science, with final fabrication steps done at Stanford Nano Shared Facilities (SNSF) at Stanford University. This work was supported by the Gordon and Betty Moore Foundation grant no. GBMF3429, the Hungarian research grant OTKA K105149, the Polish National Science Centre project no. DEC-2013/10/E/ST3/00213, EU grant no. CIG-303 689, the National Science Foundation grant no. DMR-0906062, and the US-Israel BSF grant no. 2008149. A. J. K. and L.P. were supported by a Stanford Graduate Fellowship. SETE calculations were run on the Odyssey cluster supported by the FAS Division of Science, Research Computing Group at Harvard University. NRG calculations were performed at the Poznan Supercomputing and Networking Center.	AFFLECK I, 1993, PHYS REV B, V48, P7297, DOI 10.1103/PhysRevB.48.7297; Altland A., 2010, CONDENSED MATTER FIE, V2nd ed.; Anders FB, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.201306; BEENAKKER CWJ, 1991, PHYS REV B, V44, P1646, DOI 10.1103/PhysRevB.44.1646; BESNUS MJ, 1988, J MAGN MAGN MATER, V76-7, P471, DOI 10.1016/0304-8853(88)90458-1; Bolech CJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.036801; Borda L, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.235112; Bork J, 2011, NAT PHYS, V7, P901, DOI [10.1038/NPHYS2076, 10.1038/nphys2076]; Bulla R, 2008, REV MOD PHYS, V80, P395, DOI 10.1103/RevModPhys.80.395; Carmi A, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.115129; Chorley SJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.156804; Cichorek T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.236603; Coleman P, 2001, J PHYS-CONDENS MAT, V13, pR723, DOI 10.1088/0953-8984/13/35/202; COX DL, 1987, PHYS REV LETT, V59, P1240, DOI 10.1103/PhysRevLett.59.1240; EMERY VJ, 1992, PHYS REV B, V46, P10812, DOI 10.1103/PhysRevB.46.10812; FABRIZIO M, 1995, PHYS REV B, V51, P16088, DOI 10.1103/PhysRevB.51.16088; Gegenwart P, 2008, NAT PHYS, V4, P186, DOI 10.1038/nphys892; Jeong H, 2001, SCIENCE, V293, P2221, DOI 10.1126/science.1063182; Kretinin AV, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4740521; Le Hur K, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.035332; Le Hur K, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.045326; Lebanon E, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.155301; Legeza O., 2008, MANUAL FLEXIBLE DM N; Matveev K. A., 1991, Soviet Physics - JETP, V72, P892; Mebrahtu HT, 2013, NAT PHYS, V9, P732, DOI [10.1038/nphys2735, 10.1038/NPHYS2735]; Mebrahtu HT, 2012, NATURE, V488, P61, DOI 10.1038/nature11265; Mitchell AK, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.235127; Mitchell AK, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.035119; Moca CP, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.195128; NOZIERES P, 1980, J PHYS-PARIS, V41, P193, DOI 10.1051/jphys:01980004103019300; Oreg Y, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.136602; Peeters L, 2015, J VAC SCI TECHNOL B, V33, DOI 10.1116/1.4928718; Pioro-Ladriere M, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.115331; Pustilnik M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.216601; RALPH DC, 1994, PHYS REV LETT, V72, P1064, DOI 10.1103/PhysRevLett.72.1064; Sachdev S., 2011, QUANTUM PHASE TRANSI; Schiller A., 2006, NIC S, V32, P191; SEAMAN CL, 1991, PHYS REV LETT, V67, P2882, DOI 10.1103/PhysRevLett.67.2882; Sela E, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.147202; Toth AI, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.155318; Toth AI, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.245109; Weichselbaum A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.076402; WILSON KG, 1975, REV MOD PHYS, V47, P773, DOI 10.1103/RevModPhys.47.773; Yeh SS, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.012411	45	63	63	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					237	+		10.1038/nature15261	http://dx.doi.org/10.1038/nature15261			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26450057	Green Submitted			2022-12-28	WOS:000362399000043
J	Lin, YH; Sohn, CH; Dalal, CK; Cai, L; Elowitz, MB				Lin, Yihan; Sohn, Chang Ho; Dalal, Chiraj K.; Cai, Long; Elowitz, Michael B.			Combinatorial gene regulation by modulation of relative pulse timing	NATURE			English	Article							TRANSCRIPTION FACTOR DYNAMICS; GLUCOSE REPRESSION; MIG1 REPRESSOR; STRESS; MSN2P; PHOSPHORYLATION; OSCILLATIONS; INFORMATION; EXPRESSION; PROTEIN	Studies of individual living cells have revealed that many transcription factors activate in dynamic, and often stochastic, pulses within the same cell. However, it has remained unclear whether cells might exploit the dynamic interaction of these pulses to control gene expression. Here, using quantitative single-cell time-lapse imaging of Saccharomyces cerevisiae, we show that the pulsatile transcription factors Msn2 and Mig1 combinatorially regulate their target genes through modulation of their relative pulse timing. The activator Msn2 and repressor Mig1 showed pulsed activation in either a temporally overlapping or non-overlapping manner during their transient response to different inputs, with only the non-overlapping dynamics efficiently activating target gene expression. Similarly, under constant environmental conditions, where Msn2 and Mig1 exhibit sporadic pulsing, glucose concentration modulated the temporal overlap between pulses of the two factors. Together, these results reveal a time-based mode of combinatorial gene regulation. Regulation through relative signal timing is common in engineering and neurobiology, and these results suggest that it could also function broadly within the signalling and regulatory systems of the cell.	[Lin, Yihan; Dalal, Chiraj K.; Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Lin, Yihan; Dalal, Chiraj K.; Elowitz, Michael B.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Sohn, Chang Ho; Cai, Long] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; California Institute of Technology	Elowitz, MB (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.	melowitz@caltech.edu	Sohn, Chang Ho/D-9492-2015	Sohn, Chang Ho/0000-0002-7585-1841; Dalal, Chiraj/0000-0002-3624-8409	NIH [R01 GM079771B, R01 GM086793A]; NSF [1547056]; DARPA [HR0011-05-1-0057]; Gordon and Betty Moore Foundation [GBMF2809]; Ellison foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079771, R01GM086793] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Ellison foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank U. Alon, R. Corral, R. Deshaies, A. Eldar, J. Garcia-Ojalvo, R. Kishony, A. Moses, G. Seelig, P. Swain, and members of the Elowitz laboratory for comments and feedback on the manuscript. We also thank the core sequencingfacility at Caltech for help on RNA-Seq. This work was supported by the NIH (R01 GM079771B, R01 GM086793A), the NSF (Award no. 1547056), DARPA (HR0011-05-1-0057), and by the Gordon and Betty Moore Foundation through Grant GBMF2809 to the Caltech Programmable Molecular Technology Initiative. L.C. acknowledges the Ellison foundation for support.	Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Alon U., 2006, INTRO SYSTEMS BIOL D; Anderson J. B., 1986, DIGITAL PHASE MODULA, V1st; Batchelor E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.20; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Boy-Marcotte E, 1998, J BACTERIOL, V180, P1044, DOI 10.1128/JB.180.5.1044-1052.1998; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Dalal CK, 2014, CURR BIOL, V24, P2189, DOI 10.1016/j.cub.2014.07.076; De Wever V, 2005, EMBO J, V24, P4115, DOI 10.1038/sj.emboj.7600871; DeVit MJ, 1997, MOL BIOL CELL, V8, P1603, DOI 10.1091/mbc.8.8.1603; Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1016/S0168-6445(00)00035-8; Garmendia-Torres C, 2007, CURR BIOL, V17, P1044, DOI 10.1016/j.cub.2007.05.032; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Hansen AS, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.56; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; Hao N, 2012, NAT STRUCT MOL BIOL, V19, P31, DOI 10.1038/nsmb.2192; Hasan R, 2002, MOL MICROBIOL, V45, P233, DOI 10.1046/j.1365-2958.2002.03011.x; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Levine JH, 2013, SCIENCE, V342, P1193, DOI 10.1126/science.1239999; Levine JH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001252; Locke JCW, 2011, SCIENCE, V334, P366, DOI 10.1126/science.1208144; Lutfiyya LL, 1996, MOL CELL BIOL, V16, P4790; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; NEHLIN JO, 1991, EMBO J, V10, P3373, DOI 10.1002/j.1460-2075.1991.tb04901.x; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Petrenko N, 2013, MOL BIOL CELL, V24, P2045, DOI 10.1091/mbc.E12-12-0870; Ptashne M, 2004, GENETIC SWITCH PHAGE; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Schmitt AP, 1996, P NATL ACAD SCI USA, V93, P5777, DOI 10.1073/pnas.93.12.5777; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Teixeira MC, 2014, NUCLEIC ACIDS RES, V42, pD161, DOI 10.1093/nar/gkt1015; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; Unnikrishnan I, 2003, J BIOL CHEM, V278, P26450, DOI 10.1074/jbc.M211808200; Yissachar N, 2013, MOL CELL, V49, P322, DOI 10.1016/j.molcel.2012.11.003; Yosef N, 2011, CELL, V144, P886, DOI 10.1016/j.cell.2011.02.015; Young JW, 2013, P NATL ACAD SCI USA, V110, P4140, DOI 10.1073/pnas.1213060110	46	75	76	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					54	58		10.1038/nature15710	http://dx.doi.org/10.1038/nature15710			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26466562	Green Accepted			2022-12-28	WOS:000364270700041
J	Abegglen, LM; Caulin, AF; Chan, A; Lee, K; Robinson, R; Campbell, MS; Kiso, WK; Schmitt, DL; Waddell, PJ; Bhaskara, S; Jensen, ST; Maley, CC; Schiffman, JD				Abegglen, Lisa M.; Caulin, Aleah F.; Chan, Ashley; Lee, Kristy; Robinson, Rosann; Campbell, Michael S.; Kiso, Wendy K.; Schmitt, Dennis L.; Waddell, Peter J.; Bhaskara, Srividya; Jensen, Shane T.; Maley, Carlo C.; Schiffman, Joshua D.			Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							P53; APOPTOSIS; MICE; AGE; EXPRESSION; ARREST; GROWTH; CELLS; RISK	IMPORTANCE Evolutionary medicine may provide insights into human physiology and pathophysiology, including tumor biology. OBJECTIVE To identify mechanisms for cancer resistance in elephants and compare cellular response to DNA damage among elephants, healthy human controls, and cancer-prone patients with Li-Fraumeni syndrome (LFS). DESIGN, SETTING, AND PARTICIPANTS A comprehensive survey of necropsy data was performed across 36 mammalian species to validate cancer resistance in large and long-lived organisms, including elephants (n = 644). The African and Asian elephant genomes were analyzed for potential mechanisms of cancer resistance. Peripheral blood lymphocytes from elephants, healthy human controls, and patients with LFS were tested in vitro in the laboratory for DNA damage response. The study included African and Asian elephants (n = 8), patients with LFS (n = 10), and age-matched human controls (n = 11). Human samples were collected at the University of Utah between June 2014 and July 2015. EXPOSURES Ionizing radiation and doxorubicin. MAIN OUTCOMES AND MEASURES Cancer mortality across species was calculated and compared by body size and life span. The elephant genome was investigated for alterations in cancer-related genes. DNA repair and apoptosis were compared in elephant vs human peripheral blood lymphocytes. RESULTS Across mammals, cancer mortality did not increase with body size and/or maximum life span (eg, for rock hyrax, 1% [95% CI, 0%-5%]; African wild dog, 8%[95% CI, 0%-16%]; lion, 2%[95% CI, 0%-7%]). Despite their large body size and long life span, elephants remain cancer resistant, with an estimated cancer mortality of 4.81% (95% CI, 3.14%-6.49%), compared with humans, who have 11% to 25% cancer mortality. While humans have 1 copy (2 alleles) of TP53, African elephants have at least 20 copies (40 alleles), including 19 retrogenes (38 alleles) with evidence of transcriptional activity measured by reverse transcription polymerase chain reaction. In response to DNA damage, elephant lymphocytes underwent p53-mediated apoptosis at higher rates than human lymphocytes proportional to TP53 status (ionizing radiation exposure: patients with LFS, 2.71% [95% CI, 1.93%-3.48%] vs human controls, 7.17%[95% CI, 5.91%-8.44%] vs elephants, 14.64%[95% CI, 10.91%-18.37%]; P < .001; doxorubicin exposure: human controls, 8.10% [95% CI, 6.55%-9.66%] vs elephants, 24.77%[95% CI, 23.0%-26.53%]; P <.001). CONCLUSIONS AND RELEVANCE Compared with other mammalian species, elephants appeared to have a lower-than-expected rate of cancer, potentially related to multiple copies of TP53. Compared with human cells, elephant cells demonstrated increased apoptotic response following DNA damage. These findings, if replicated, could represent an evolutionary-based approach for understanding mechanisms related to cancer suppression.	[Abegglen, Lisa M.; Chan, Ashley; Lee, Kristy; Robinson, Rosann; Schiffman, Joshua D.] Univ Utah, Sch Med, Dept Pediat Hematol Oncol, Salt Lake City, UT USA; [Abegglen, Lisa M.; Chan, Ashley; Lee, Kristy; Robinson, Rosann; Bhaskara, Srividya; Schiffman, Joshua D.] Univ Utah, Sch Med, Dept Oncol Sci, Salt Lake City, UT USA; [Caulin, Aleah F.; Jensen, Shane T.] Univ Penn, Genom & Computat Biol Program, Philadelphia, PA 19104 USA; [Campbell, Michael S.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA; [Kiso, Wendy K.; Schmitt, Dennis L.] Ringling Bros Ctr Elephant Conservat, Polk City, FL USA; [Waddell, Peter J.] Ronin Inst, Dept Stat Genom, W Lafayette, IN USA; [Bhaskara, Srividya] Univ Utah, Sch Med, Dept Radiat Oncol, Salt Lake City, UT USA; [Bhaskara, Srividya; Schiffman, Joshua D.] Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT USA; [Jensen, Shane T.] Univ Penn, Wharton Sch, Dept Stat, Philadelphia, PA 19104 USA; [Maley, Carlo C.] Arizona State Univ, Biodesign Inst, Tempe, AZ USA; [Maley, Carlo C.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Maley, Carlo C.] Univ Calif San Francisco, Ctr Evolut & Canc, San Francisco, CA 94143 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Pennsylvania; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Pennsylvania; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of California System; University of California San Francisco	Schiffman, JD (corresponding author), Huntsman Canc Inst, 2000 Circle Hope, Salt Lake City, UT 84112 USA.	joshua.schiffman@hci.utah.edu		Bhaskara, Srividya/0000-0002-2182-9585	US Department of Energy [DE-FG02-97ER25308]; National Institutes of Health [P01 CA91955, R01 CA149566, R01 CA170595, R01 CA185138, R01 CA140657, R01 LM008626]; Congressionally Directed Medical Research Programs' Breast Cancer Research Program [BC132057]; Huntsman Cancer Institute (HCI) Nuclear Control Program through the Cancer Center Support Grant; National Cancer Institute [CA24014]; Soccer for Hope; Ringling Bros and Barnum & Bailey Circus (Feld Entertainment); Primary Children's Hospital (PCH) Pediatric Cancer Research Program; Intermountain Healthcare Foundation; PCH Foundation; NATIONAL CANCER INSTITUTE [R01CA185138, R01CA140657, P01CA091955, R01CA149566, R01CA170595] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM008626] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Congressionally Directed Medical Research Programs' Breast Cancer Research Program; Huntsman Cancer Institute (HCI) Nuclear Control Program through the Cancer Center Support Grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Soccer for Hope; Ringling Bros and Barnum & Bailey Circus (Feld Entertainment); Primary Children's Hospital (PCH) Pediatric Cancer Research Program; Intermountain Healthcare Foundation; PCH Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported in part by US Department of Energy grant DE-FG02-97ER25308 and National Institutes of Health grants P01 CA91955, R01 CA149566, R01 CA170595, R01 CA185138, and R01 CA140657, R01 LM008626, and Congressionally Directed Medical Research Programs' Breast Cancer Research Program award BC132057. The Huntsman Cancer Institute (HCI) Nuclear Control Program provided pilot support through the Cancer Center Support Grant, and National Cancer Institute grant CA24014 supported HCI core facilities. This research was made possible through funding from Soccer for Hope, Ringling Bros and Barnum & Bailey Circus (Feld Entertainment), and the Primary Children's Hospital (PCH) Pediatric Cancer Research Program, supported by the Intermountain Healthcare Foundation and the PCH Foundation.	[Anonymous], 2009, J EVOLUTION BIOL, V22, P1770; [Anonymous], 1995, ELEPHANT ENCY; Antoccia A, 2009, J RADIAT RES, V50, P457, DOI 10.1269/jrr.09008; Attardi LD, 2004, ONCOGENE, V23, P973, DOI 10.1038/sj.onc.1207026; Bates S, 1996, CURR OPIN GENET DEV, V6, P12, DOI 10.1016/S0959-437X(96)90004-0; Calabrese P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-3; Camplejohn RS, 2003, BRIT J CANCER, V88, P487, DOI 10.1038/sj.bjc.6600767; Caulin AF, 2015, PHILOS TRANS R SOC L, V370, P370; Caulin AF, 2011, TRENDS ECOL EVOL, V26, P175, DOI 10.1016/j.tree.2011.01.002; Eizirik E, 2001, J HERED, V92, P212, DOI 10.1093/jhered/92.2.212; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Gorbunova V, 2012, P NATL ACAD SCI USA, V109, P19392, DOI 10.1073/pnas.1217211109; Griner LA, 1983, PATHOLOGY ZOO ANIMAL; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heinrichs S, 2003, ONCOGENE, V22, P555, DOI 10.1038/sj.onc.1206138; Hollister-Smith JA, 2007, ANIM BEHAV, V74, P287, DOI 10.1016/j.anbehav.2006.12.008; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; McBride KA, 2014, NAT REV CLIN ONCOL, V11, P260, DOI 10.1038/nrclinonc.2014.41; McComb K, 2011, P ROY SOC B-BIOL SCI, V278, P3270, DOI 10.1098/rspb.2011.0168; Nunney L, 1999, P ROY SOC B-BIOL SCI, V266, P493, DOI 10.1098/rspb.1999.0664; Pei BK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r51; PETO R, 1975, BRIT J CANCER, V32, P411, DOI 10.1038/bjc.1975.242; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Rohland N, 2007, PLOS BIOL, V5, P1663, DOI 10.1371/journal.pbio.0050207; Seluanov A, 2008, AGING CELL, V7, P813, DOI 10.1111/j.1474-9726.2008.00431.x; Singh NP, 2003, FERTIL STERIL, V80, P1420, DOI 10.1016/j.fertnstert.2003.04.002; Spaulding CC, 1997, MECH AGEING DEV, V93, P25, DOI 10.1016/S0047-6374(96)01808-8; Testa Joseph R, 2013, Am Soc Clin Oncol Educ Book, P81, DOI 10.1200/EdBook_AM.2013.33.81; The Origins of Human Cancer, 1977, THE ORIGINS OF HUMAN; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Wiese RJ, 2004, ZOO BIOL, V23, P365, DOI 10.1002/zoo.20011; Yoon H, 2002, P NATL ACAD SCI USA, V99, P15632, DOI 10.1073/pnas.242597299	40	227	235	24	179	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2015	314	17					1850	1860		10.1001/jama.2015.13134	http://dx.doi.org/10.1001/jama.2015.13134			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0RO	26447779	Green Submitted, Green Accepted, Bronze, Green Published			2022-12-28	WOS:000363960200017
J	Contreras, R; Hernandez, JR				Contreras, Raul; Rodriguez Hernandez, Job			Megaduodenum in Systemic Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Contreras, Raul; Rodriguez Hernandez, Job] Res Ctr Gastrointestinal & Liver Dis, Pachuca, Mexico		Contreras, R (corresponding author), Res Ctr Gastrointestinal & Liver Dis, Pachuca, Mexico.	rulosofo@gmail.com							0	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2015	373	17							e20	10.1056/NEJMicm1412139	http://dx.doi.org/10.1056/NEJMicm1412139			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU1YH	26488715				2022-12-28	WOS:000363317800012
J	Davies, JA				Davies, Jamie A.			BIOLOGICAL TECHNIQUES Kidney tissue grown from induced stem cells	NATURE			English	Editorial Material							ICE-SHEET; THWAITES	Engineered human cells that can give rise to every cell type have been induced to generate structures that resemble an embryonic kidney. This advance charts a course towards growing transplantable kidneys in culture. SEE LETTER p.564	Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XB, Midlothian, Scotland	University of Edinburgh	Davies, JA (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XB, Midlothian, Scotland.		Davies, Jamie/AAE-7111-2019	Davies, Jamie/0000-0001-6660-4032	MRC [MR/K010735/1] Funding Source: UKRI; Medical Research Council [MR/K010735/1] Funding Source: researchfish; National Centre for the Replacement [G0700480/1] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement		Alley RB, 2015, ANNU REV EARTH PL SC, V43, P207, DOI 10.1146/annurev-earth-060614-105344; Cornford SL, 2015, CRYOSPHERE, V9, P1579, DOI 10.5194/tc-9-1579-2015; Cornford SL, 2013, J COMPUT PHYS, V232, P529, DOI 10.1016/j.jcp.2012.08.037; Gomez N., NATURE COMM IN PRESS; Hellmer HH, 2012, NATURE, V485, P225, DOI 10.1038/nature11064; IPCC, 2013, CLIMATE CHANGE 2022; Joughin I, 2014, SCIENCE, V344, P735, DOI 10.1126/science.1249055; Rignot E, 2014, GEOPHYS RES LETT, V41, P3502, DOI 10.1002/2014GL060140; Rignot E, 2011, SCIENCE, V333, P1427, DOI 10.1126/science.1208336; Timmermann R, 2013, OCEAN DYNAM, V63, P1011, DOI 10.1007/s10236-013-0642-0; Weertman J., 1974, J GLACIOL, V13, P3, DOI [DOI 10.3189/S0022143000023327, 10.3189/S0022143000023327]	11	8	8	0	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					512	U84		10.1038/nature15639	http://dx.doi.org/10.1038/nature15639			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26444235				2022-12-28	WOS:000364026100034
J	Zhang, J; Huang, H; Shen, XM				Zhang, Jun; Huang, Hong; Shen, Xiaoming			Cultivating and investing in clinical research in China	LANCET			English	Editorial Material									[Zhang, Jun; Huang, Hong; Shen, Xiaoming] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Minist Educ,Shanghai Key Lab Childrens Environm H, Shanghai 200092, Peoples R China; [Zhang, Jun; Huang, Hong] Shanghai Jiao Tong Univ, Sch Med, Publ Hlth, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai 200092, Peoples R China.	junjimzhang@sina.com						Chakma J, 2014, NEW ENGL J MED, V370, P3, DOI 10.1056/NEJMp1311068; Crowley WF, 2004, JAMA-J AM MED ASSOC, V291, P1120, DOI 10.1001/jama.291.9.1120; He AJ, 2014, SOC SCI MED, V123, P64, DOI 10.1016/j.socscimed.2014.10.055; Heinig SJ, 1999, ACAD MED, V74, P726, DOI 10.1097/00001888-199906000-00024; Hou Xiaoshuo, 2012, J Int Bioethique, V23, P83; Jia X, 2014, CHINA MED HERALD, V11, P156; Kotting P, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt126; Medical Research Council, 2014, MED RES COUNC ANN RE; Moses H, 2015, JAMA-J AM MED ASSOC, V313, P174, DOI 10.1001/jama.2014.15939; National Health and Family Planning Commission of China, 2014, YB CHIN HLTH STAT; National Institutes of Health, GLOSS ACR LIST; Pang T, 2015, LANCET, V385, P2028, DOI 10.1016/S0140-6736(14)61893-6; Sun YT, 2014, SCIENCE, V345, P1006, DOI 10.1126/science.1253479; The Royal Society, 2012, SCI OP ENT ROYAL SOC; Xie Y, 2014, P NATL ACAD SCI USA, V111, P9437, DOI 10.1073/pnas.1407709111; Yang Z, 2014, LANCET, V383, P200, DOI 10.1016/S0140-6736(13)62387-9; Zeng WQ, 2010, DEV WORLD BIOETH, V10, P164, DOI 10.1111/j.1471-8847.2009.00263.x; Zheng HZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100845	18	3	4	2	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2015	386	10002					1506	1508		10.1016/S0140-6736(15)00341-4	http://dx.doi.org/10.1016/S0140-6736(15)00341-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CT5UU	26466054				2022-12-28	WOS:000362877300033
J	Grotzinger, JP; Gupta, S; Malin, MC; Rubin, DM; Schieber, J; Siebach, K; Sumner, DY; Stack, KM; Vasavada, AR; Arvidson, RE; Calef, F; Edgar, L; Fischer, WF; Grant, JA; Griffes, J; Kah, LC; Lamb, MP; Lewis, KW; Mangold, N; Minitti, ME; Palucis, M; Rice, M; Williams, RME; Yingst, RA; Blake, D; Blaney, D; Conrad, P; Crisp, J; Dietrich, WE; Dromart, G; Edgett, KS; Ewing, RC; Gellert, R; Hurowitz, JA; Kocurek, G; Mahaffy, P; McBride, MJ; McLennan, SM; Mischna, M; Ming, D; Milliken, R; Newsom, H; Oehler, D; Parker, TJ; Vaniman, D; Wiens, RC; Wilson, SA				Grotzinger, J. P.; Gupta, S.; Malin, M. C.; Rubin, D. M.; Schieber, J.; Siebach, K.; Sumner, D. Y.; Stack, K. M.; Vasavada, A. R.; Arvidson, R. E.; Calef, F., III; Edgar, L.; Fischer, W. F.; Grant, J. A.; Griffes, J.; Kah, L. C.; Lamb, M. P.; Lewis, K. W.; Mangold, N.; Minitti, M. E.; Palucis, M.; Rice, M.; Williams, R. M. E.; Yingst, R. A.; Blake, D.; Blaney, D.; Conrad, P.; Crisp, J.; Dietrich, W. E.; Dromart, G.; Edgett, K. S.; Ewing, R. C.; Gellert, R.; Hurowitz, J. A.; Kocurek, G.; Mahaffy, P.; McBride, M. J.; McLennan, S. M.; Mischna, M.; Ming, D.; Milliken, R.; Newsom, H.; Oehler, D.; Parker, T. J.; Vaniman, D.; Wiens, R. C.; Wilson, S. A.			Deposition, exhumation, and paleoclimate of an ancient lake deposit, Gale crater, Mars	SCIENCE			English	Article							ALLUVIAL ARCHITECTURE; POINT-BAR; RIVER; EVOLUTION; ATMOSPHERE; CURIOSITY; DELTAS; ORIGIN; BASIN; SEDIMENTATION	The landforms of northern Gale crater on Mars expose thick sequences of sedimentary rocks. Based on images obtained by the Curiosity rover, we interpret these outcrops as evidence for past fluvial, deltaic, and lacustrine environments. Degradation of the crater wall and rim probably supplied these sediments, which advanced inward from the wall, infilling both the crater and an internal lake basin to a thickness of at least 75 meters. This intracrater lake system probably existed intermittently for thousands to millions of years, implying a relatively wet climate that supplied moisture to the crater rim and transported sediment via streams into the lake basin. The deposits in Gale crater were then exhumed, probably by wind-driven erosion, creating Aeolis Mons (Mount Sharp).	[Grotzinger, J. P.; Siebach, K.; Fischer, W. F.; Griffes, J.; Lamb, M. P.; Palucis, M.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Gupta, S.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Malin, M. C.; Edgett, K. S.; McBride, M. J.] Malin Space Sci Syst, San Diego, CA 92121 USA; [Rubin, D. M.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Schieber, J.] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; [Sumner, D. Y.] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Stack, K. M.; Vasavada, A. R.; Calef, F., III; Blaney, D.; Crisp, J.; Mischna, M.; Parker, T. J.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Arvidson, R. E.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Edgar, L.] US Geol Survey, Astrogeol Sci Ctr, Flagstaff, AZ 86001 USA; [Grant, J. A.; Wilson, S. A.] Smithsonian Inst, Ctr Earth & Planetary Studies, Natl Air & Space Museum, Washington, DC 20560 USA; [Kah, L. C.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; [Lewis, K. W.] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; [Mangold, N.] Le Ctr Natl Rech, Lab Planetol & Geodynam Nantes, Unite Mixte Rech 6112, F-44322 Nantes, France; [Mangold, N.] Univ Nantes, F-44322 Nantes, France; [Minitti, M. E.; Williams, R. M. E.; Yingst, R. A.; Vaniman, D.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Rice, M.] Western Washington Univ, Dept Geol, Bellingham, WA 98225 USA; [Blake, D.] NASA, Ames Res Ctr, Dept Space Sci, Moffett Field, CA 94035 USA; [Conrad, P.; Mahaffy, P.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Dietrich, W. E.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Dromart, G.] Univ Lyon, Lab Geol Lyon, F-69364 Lyon, France; [Ewing, R. C.] Texas A&M Univ, Dept Geol & Geophys, College Stn, TX 77843 USA; [Gellert, R.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; [Hurowitz, J. A.; McLennan, S. M.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Kocurek, G.] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA; [Ming, D.] NASA, Lyndon B Johnson Space Ctr, Astromat Res & Explorat Sci Div, Houston, TX 77058 USA; [Milliken, R.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Newsom, H.] Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA; [Oehler, D.] NASA, Lyndon B Johnson Space Ctr, LZ Technol, Houston, TX 77058 USA; [Wiens, R. C.] Los Alamos Natl Lab, Space Remote Sensing, Los Alamos, NM 87544 USA	California Institute of Technology; Imperial College London; University of California System; University of California Santa Cruz; Indiana University System; Indiana University Bloomington; University of California System; University of California Davis; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Washington University (WUSTL); United States Department of the Interior; United States Geological Survey; Smithsonian Institution; University of Tennessee System; University of Tennessee Knoxville; Johns Hopkins University; Nantes Universite; Western Washington University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of California System; University of California Berkeley; Ecole Normale Superieure de Lyon (ENS de LYON); Texas A&M University System; Texas A&M University College Station; University of Guelph; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Texas System; University of Texas Austin; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Brown University; University of New Mexico; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; United States Department of Energy (DOE); Los Alamos National Laboratory	Grotzinger, JP (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.		Kah, Linda C/J-3754-2019; Crisp, Joy/H-8287-2016; Mischna, Michael/AAF-3861-2020; Sumner, Dawn Y/E-8744-2011; Blaney, Diana/M-1756-2019; Stack Morgan, Kathryn/AGY-7985-2022	Kah, Linda C/0000-0001-7172-2033; Crisp, Joy/0000-0002-3202-4416; Mischna, Michael/0000-0002-8022-5319; Sumner, Dawn Y/0000-0002-7343-2061; Blaney, Diana/0000-0002-4267-7939; McLennan, Scott/0000-0003-4259-7178; Rubin, David/0000-0003-1169-1452; Rice, Melissa/0000-0002-8370-4139; Wilson, Sharon/0000-0001-8872-8546; Gupta, Sanjeev/0000-0001-6415-1332; Siebach, Kirsten/0000-0002-6628-6297; Grant, John/0000-0001-8276-1281; Williams, Rebecca/0000-0003-1571-6952; Ewing, Ryan/0000-0001-6337-610X	UK Space Agency; UK Space Agency [ST/N000579/1, ST/J005169/1] Funding Source: researchfish	UK Space Agency; UK Space Agency	The authors are indebted to the MSL project's engineering and management teams for their exceptionally skilled and diligent efforts in making the mission as effective as possible and enhancing science operations. We are also grateful to all those MSL team members who participated in tactical and strategic operations. Without the support of both the engineering and science teams, the data presented here could not have been collected. Helpful reviews were provided by K. Bohacs and two anonymous reviewers. Some of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. Work in the UK was funded by the UK Space Agency. Data presented in this paper are archived in the Planetary Data System (pds.nasa.gov).	ALEXANDER J, 1992, J GEOL SOC LONDON, V149, P431, DOI 10.1144/gsjgs.149.3.0431; Anderson R. B., 2010, MARS, V5, P76, DOI [DOI 10.1555/MARS.2010.0004, 10.1555/mars.2010.0004]; ANDERSON RY, 1988, PALAEOGEOGR PALAEOCL, V62, P215, DOI 10.1016/0031-0182(88)90055-7; Armstrong JC, 2005, ICARUS, V176, P57, DOI 10.1016/j.icarus.2005.01.005; Atreya SK, 2013, GEOPHYS RES LETT, V40, P5605, DOI 10.1002/2013GL057763; Baganz O., 2012, AM ASS PETROLEUM GEO, V95, P1, DOI [10.13 06/13291383M951283, DOI 10.1306/13291383M951283]; BATES CC, 1953, AAPG BULL, V37, P2119; Bell CM, 2009, ANDEAN GEOL, V36, P51, DOI 10.4067/S0718-71062009000100005; Bhattacharya JP., 2010, SOC SEDIMENTARY GEOL, V6, P233, DOI DOI 10.2110/PEC.06.84.0237; Bristow C, 1996, SEDIMENTOLOGY, V43, P995, DOI 10.1111/j.1365-3091.1996.tb01515.x; Cattaneo Antonio, 2004, Oceanography, V17, P105; Edmonds DA, 2010, NAT GEOSCI, V3, P105, DOI 10.1038/NGEO730; Ewing RC, 2014, EARTH PLANET SC LETT, V406, P110, DOI 10.1016/j.epsl.2014.09.017; Farley KA, 2014, SCIENCE, V343, DOI 10.1126/science.1247166; Forget F, 2013, ICARUS, V222, P81, DOI 10.1016/j.icarus.2012.10.019; Fraeman AA, 2013, GEOLOGY, V41, P1103, DOI 10.1130/G34613.1; FRYBERGER SG, 1988, SEDIMENT GEOL, V55, P1, DOI 10.1016/0037-0738(88)90087-5; Ganti V, 2011, J GEOPHYS RES-EARTH, V116, DOI [10.1029/2010JF001893, 10.1029/20101F001893]; Gibling MR, 2012, NAT GEOSCI, V5, P99, DOI [10.1038/NGEO1376, 10.1038/ngeo1376]; Golombek M. P., 2006, J GEOPHYS RES PLANET, V111; Grant JA, 2014, GEOPHYS RES LETT, V41, P1142, DOI 10.1002/2013GL058909; Grotzinger JP, 2014, SCIENCE, V343, P386, DOI 10.1126/science.1249944; Haberle R. M., 2015, ATMOSPHERE CLIMATE M; Halevy I, 2014, NAT GEOSCI, V7, P865, DOI 10.1038/NGEO2293; HASZELDINE RS, 1983, J SEDIMENT PETROL, V53, P1233; Hunter R E, 1981, RECENT ANCIENT NONMA, V31, P315; Ielpi A, 2014, SEDIMENTOLOGY, V61, P1923, DOI 10.1111/sed.12122; JONES CM, 1979, SEDIMENT GEOL, V24, P85, DOI 10.1016/0037-0738(79)90030-7; Kite ES, 2013, GEOLOGY, V41, P543, DOI 10.1130/G33909.1; Kocurek G, 2007, SEDIMENT GEOL, V197, P313, DOI 10.1016/j.sedgeo.2006.10.006; Kostic S, 2003, J HYDRAUL RES, V41, P127, DOI 10.1080/00221680309499956; Lamb MP, 2012, SOC SEDIMENT GEOL SP, V102, P139; Lamb MP, 2010, GEOL SOC AM BULL, V122, P1389, DOI 10.1130/B30125.1; Lammer H, 2013, SPACE SCI REV, V174, P113, DOI 10.1007/s11214-012-9943-8; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; Le Deit L, 2013, J GEOPHYS RES-PLANET, V118, P2439, DOI 10.1002/2012JE004322; Long DGF, 2006, SEDIMENT GEOL, V190, P71, DOI 10.1016/j.sedgeo.2006.05.006; Mahaffy PR, 2015, SCIENCE, V347, P412, DOI 10.1126/science.1260291; Mahaffy PR, 2013, SCIENCE, V341, P263, DOI 10.1126/science.1237966; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Malin MC, 2003, SCIENCE, V302, P1931, DOI 10.1126/science.1090544; MARTINSNETO MA, 1994, SEDIMENT GEOL, V89, P219, DOI 10.1016/0037-0738(94)90095-7; MCCORMICK DS, 1993, J SEDIMENT PETROL, V63, P398; McKee E.D., 1966, SEDIMENTOLOGY, V7, P3, DOI DOI 10.1111/J.1365-3091.1966.TB01579.X; McLennan SM, 2014, SCIENCE, V343, DOI 10.1126/science.1244734; Milliken RE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041870; Mischna MA, 2013, J GEOPHYS RES-PLANET, V118, P560, DOI 10.1002/jgre.20054; Mortimer E, 2005, BASIN RES, V17, P337, DOI 10.1111/j.1365-2117.2005.00273.x; NANSON GC, 1980, SEDIMENTOLOGY, V27, P3, DOI 10.1111/j.1365-3091.1980.tb01155.x; Olariu C, 2006, J SEDIMENT RES, V76, P212, DOI 10.2110/jsr.2006.026; Palucis M. C., 2014, THESIS; Palucis MC, 2014, J GEOPHYS RES-PLANET, V119, P705, DOI 10.1002/2013JE004583; Parker TJ, 2010, LAKES ON MARS, P249, DOI 10.1016/B978-0-444-52854-4.00009-X; Patruno S, 2015, EARTH-SCI REV, V142, P79, DOI 10.1016/j.earscirev.2015.01.004; Pecsi M., 1990, QUATERN INT, V7, P1, DOI DOI 10.1016/1040-6182(90)90034-2; Pirmez C, 1998, J GEOPHYS RES-SOL EA, V103, P24141, DOI 10.1029/98JB01516; Potter PE, 2005, MUD MUDSTONES; Pye K., 1987, AEOLIAN DUST DUST DE; RAINBIRD RH, 1992, CAN J EARTH SCI, V29, P2537, DOI 10.1139/e92-201; Reesink AJH, 2014, SEDIMENTOLOGY, V61, P1055, DOI 10.1111/sed.12092; Robbins SJ, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE003967; Rubin D. M., 2006, BEDFORMS AND CROSS B, V2; RUBIN DM, 1982, SEDIMENTOLOGY, V29, P121, DOI 10.1111/j.1365-3091.1982.tb01714.x; SADLER PM, 1981, J GEOL, V89, P569, DOI 10.1086/628623; Segura TL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003147; Smith GHS, 2006, SEDIMENTOLOGY, V53, P413, DOI 10.1111/j.1365-3091.2005.000769.x; Smith GHS, 2009, J SEDIMENT RES, V79, P629, DOI 10.2110/jsr.2009.066; Thomson BJ, 2011, ICARUS, V214, P413, DOI 10.1016/j.icarus.2011.05.002; Vasavada AR, 2014, J GEOPHYS RES-PLANET, V119, P1134, DOI 10.1002/2014JE004622; Warner NH, 2013, GEOLOGY, V41, P675, DOI 10.1130/G34172.1; Warner N, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003522; Webster CR, 2013, SCIENCE, V341, P260, DOI 10.1126/science.1237961; Williams RME, 2013, SCIENCE, V340, P1068, DOI 10.1126/science.1237317; Willis BJ, 2010, J SEDIMENT RES, V80, P440, DOI 10.2110/jsr.2010.046; Winston D., 1978, FLUVIAL SEDIMENTOLOG, P343; Wordsworth R, 2013, ICARUS, V222, P1, DOI 10.1016/j.icarus.2012.09.036; Zolitschka B., 2007, ENCY QUATERNARY SCI, P3105, DOI DOI 10.1016/B0-44-452747-8/00065-X	77	396	401	5	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257							AAC7575	10.1126/science.aac7575	http://dx.doi.org/10.1126/science.aac7575			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9JB	26450214				2022-12-28	WOS:000362405600029
J	Bailey, AP; Koster, G; Guillermier, C; Hirst, EMA; MacRae, JI; Lechene, CP; Postle, AD; Gould, AP				Bailey, Andrew P.; Koster, Grielof; Guillermier, Christelle; Hirst, Elizabeth M. A.; MacRae, James I.; Lechene, Claude P.; Postle, Anthony D.; Gould, Alex P.			Antioxidant Role for Lipid Droplets in a Stem Cell Niche of Drosophila	CELL			English	Article							NUTRIENT RESTRICTION; METABOLIC-REGULATION; HYPOXIA; GROWTH; PROLIFERATION; STORAGE; OXYGEN; MODEL; REDOX; NEUROGENESIS	Stem cells reside in specialized microenvironments known as niches. During Drosophila development, glial cells provide a niche that sustains the proliferation of neural stem cells (neuroblasts) during starvation. We now find that the glial cell niche also preserves neuroblast proliferation under conditions of hypoxia and oxidative stress. Lipid droplets that form in niche glia during oxidative stress limit the levels of reactive oxygen species (ROS) and inhibit the oxidation of polyunsaturated fatty acids (PUFAs). These droplets protect glia and also neuroblasts from peroxidation chain reactions that can damage many types of macromolecules. The underlying antioxidant mechanism involves diverting PUFAs, including diet-derived linoleic acid, away from membranes to the core of lipid droplets, where they are less vulnerable to peroxidation. This study reveals an antioxidant role for lipid droplets that could be relevant in many different biological contexts.	[Bailey, Andrew P.; Hirst, Elizabeth M. A.; MacRae, James I.; Gould, Alex P.] Francis Crick Inst, Mill Hill Lab, London NW7 1AA, England; [Koster, Grielof; Postle, Anthony D.] Southampton Gen Hosp, Sir Henry Wellcome Labs, Fac Med, Acad Unit Clin & Expt Sci, Southampton SO16 6YD, Hants, England; [Guillermier, Christelle; Lechene, Claude P.] Harvard Univ, Sch Med, Natl Resource Imaging Mass Spect, Cambridge, MA 02139 USA; [Guillermier, Christelle; Lechene, Claude P.] Brigham & Womens Hosp, Cambridge, MA 02139 USA	Francis Crick Institute; University of Southampton; Harvard University; Harvard University; Brigham & Women's Hospital	Gould, AP (corresponding author), Francis Crick Inst, Mill Hill Lab, Mill Hill, London NW7 1AA, England.	alex.gould@crick.ac.uk	Gould, Alex/A-7479-2010; Gould, Alex/M-5353-2019	Gould, Alex/0000-0002-6875-6985; Gould, Alex/0000-0002-6875-6985; Bailey, Andrew/0000-0003-2143-1689; Postle, Anthony/0000-0001-7361-0756; MacRae, James/0000-0002-1464-8583	Francis Crick Institute; Cancer Research UK; UK Medical Research Council; Wellcome Trust; EMBO ASTF [194-2012]; NIH/NIBIB [P41EB001974]; Ellison Medical Foundation [AG-SS-2215-08]; HEFCE; NIHR Respiratory Biomedical Research Unit, University Hospitals, Southampton; MRC [MC_U117584237] Funding Source: UKRI; Medical Research Council [MC_U117584237] Funding Source: researchfish; The Francis Crick Institute [10012, 10088] Funding Source: researchfish; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001974] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EMBO ASTF(European Molecular Biology Organization (EMBO)); NIH/NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Ellison Medical Foundation(Lawrence Ellison Foundation); HEFCE(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); NIHR Respiratory Biomedical Research Unit, University Hospitals, Southampton; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to G. D'Angelo, T. Lee, F. Matsuzaki, S. Russell, D. St Johnston, P. Wappner, and M. Welte for fly stocks and antibodies. Stocks were also obtained from the Bloomington Drosophila Stock Center (NIH P40OD018537) and the Kyoto Drosophila Genetic Resource and Vienna Drosophila RNAi Centres. We acknowledge D. Anastasiou, R. Breckenridge, J. Briscoe, E. Cinnamon, P. Driscoll, E. Lana-Elola, R. Makki, C. Poczatek, T.J. Ragan, M. Ralser, A. Sawala, I. Stefana, V. Tixier, J.-P. Vincent, and M. Yuneva for advice and critical reading. A.P.B., E.H., J.I.M., and A.P.G. are supported by The Francis Crick Institute, which receives its core funding from Cancer Research UK, the UK Medical Research Council, and the Wellcome Trust, and previously at the National Institute for Medical Research by the UK Medical Research Council (U117584237). A.P.B. was also funded by an EMBO ASTF (194-2012), C.P.L. and C.G. by NIH/NIBIB (P41EB001974) and the Ellison Medical Foundation (AG-SS-2215-08), and A.D.P. by HEFCE and G.K. by the NIHR Respiratory Biomedical Research Unit, University Hospitals, Southampton.	Anand P, 2012, ELIFE, V1, DOI 10.7554/eLife.00003; Atkuri KR, 2007, CURR OPIN PHARMACOL, V7, P355, DOI 10.1016/j.coph.2007.04.005; BAKKER K., 1959, Entomologia Experimentalis et Applicata, V2, P171, DOI 10.1007/BF00302537; BARKER DJP, 1995, P ROY SOC B-BIOL SCI, V262, P37, DOI 10.1098/rspb.1995.0173; Beadle GW, 1938, BIOL BULL-US, V75, P447, DOI 10.2307/1537573; Bensaad K, 2014, CELL REP, V9, P349, DOI 10.1016/j.celrep.2014.08.056; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Blanpain C, 2014, SCIENCE, V344, P1243, DOI 10.1126/science.1242281; Bleier L, 2013, BBA-BIOENERGETICS, V1827, P1320, DOI 10.1016/j.bbabio.2012.12.002; Britton JS, 1998, DEVELOPMENT, V125, P2149; Burgess RJ, 2014, J INTERN MED, V276, P12, DOI 10.1111/joim.12247; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chell JM, 2010, CELL, V143, P1161, DOI 10.1016/j.cell.2010.12.007; Cheng LY, 2011, CELL, V146, P435, DOI 10.1016/j.cell.2011.06.040; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Cunningham LA, 2012, BEHAV BRAIN RES, V227, P410, DOI 10.1016/j.bbr.2011.08.002; de la Cova C, 2014, CELL METAB, V19, P470, DOI 10.1016/j.cmet.2014.01.012; Dumstrei K, 2003, J NEUROSCI, V23, P3325; Dunwoodie SL, 2009, DEV CELL, V17, P755, DOI 10.1016/j.devcel.2009.11.008; Fauny JD, 2005, DEV DYNAM, V232, P725, DOI 10.1002/dvdy.20277; Grant J, 2010, DIS MODEL MECH, V3, P799, DOI 10.1242/dmm.005579; GRUENWALD P, 1963, BIOL NEONATORUM, V5, P215; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Homem CCF, 2014, CELL, V158, P874, DOI 10.1016/j.cell.2014.06.024; Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Kis V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131250; Kuhnlein RP, 2012, J LIPID RES, V53, P1430, DOI 10.1194/jlr.R024299; Kuhnlein RP, 2011, PROG LIPID RES, V50, P348, DOI 10.1016/j.plipres.2011.04.001; Lanet E, 2013, CELL REP, V3, P587, DOI 10.1016/j.celrep.2013.02.006; Lee KE, 2012, CURR OPIN CELL BIOL, V24, P232, DOI 10.1016/j.ceb.2012.01.005; Li X, 2013, CURR TOP DEV BIOL, V105, P69, DOI 10.1016/B978-0-12-396968-2.00003-8; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Nakaya K, 2005, LIPIDS, V40, P501, DOI 10.1007/s11745-005-1410-4; Negre-Salvayre A, 2008, BRIT J PHARMACOL, V153, P6, DOI 10.1038/sj.bjp.0707395; Okano H, 2009, CURR OPIN NEUROBIOL, V19, P112, DOI 10.1016/j.conb.2009.04.003; Olsen LF, 2013, REDOX REP, V18, P245, DOI 10.1179/1351000213Y.0000000059; Parra-Peralbo E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001297; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; RAPPORT EW, 1984, ARCH INSECT BIOCHEM, V1, P243, DOI 10.1002/arch.940010307; Rysman E, 2010, CANCER RES, V70, P8117, DOI 10.1158/0008-5472.CAN-09-3871; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; Sousa-Nunes R, 2011, NATURE, V471, P508, DOI 10.1038/nature09867; Sousa-Nunes R, 2010, CURR OPIN NEUROBIOL, V20, P50, DOI 10.1016/j.conb.2009.12.005; Speder P, 2014, DEV CELL, V30, P309, DOI 10.1016/j.devcel.2014.05.021; Steinhauser ML, 2012, NATURE, V481, P516, DOI 10.1038/nature10734; Taverna E, 2014, ANNU REV CELL DEV BI, V30, P465, DOI 10.1146/annurev-cellbio-101011-155801; Tennessen JM, 2011, CELL METAB, V13, P139, DOI 10.1016/j.cmet.2011.01.005; Tower J, 2012, WIRES DEV BIOL, V1, P789, DOI 10.1002/wdev.56; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Ushio-Fukai M, 2014, ANTIOXID REDOX SIGN, V21, P1587, DOI 10.1089/ars.2014.5931; Wang K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.50; Wilfling F, 2014, CURR OPIN CELL BIOL, V29, P39, DOI 10.1016/j.ceb.2014.03.008; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8; Young SG, 2013, GENE DEV, V27, P459, DOI 10.1101/gad.209296.112	63	290	291	2	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2					340	353		10.1016/j.cell.2015.09.020	http://dx.doi.org/10.1016/j.cell.2015.09.020			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26451484	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000362952700012
J	Watts, G				Watts, Geoff			Frances Oldham Kelsey Obituary	LANCET			English	Biographical-Item																		KELSEY FO, PUBLICATION LIST	1	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2015	386	10001					1334	1334		10.1016/S0140-6736(15)00339-6	http://dx.doi.org/10.1016/S0140-6736(15)00339-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS8DP	26460767	Bronze			2022-12-28	WOS:000362316200017
J	Elgersma, Y				Elgersma, Ype			NEURODEVELOPMENTAL DISEASE A molecular tightrope	NATURE			English	Editorial Material							ANGELMAN SYNDROME; UBE3A; AUTISM; E6AP; GENE		Erasmus MC Univ Med Ctr, ENCORE Expertise Ctr Neurodev Disorders, Dept Neurosci, NL-3015 CN Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Elgersma, Y (corresponding author), Erasmus MC Univ Med Ctr, ENCORE Expertise Ctr Neurodev Disorders, Dept Neurosci, NL-3015 CN Rotterdam, Netherlands.	y.elgersma@erasmusmc.nl	Elgersma, Ype/F-5164-2013	Elgersma, Ype/0000-0002-3758-1297				Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; ANGELMAN H, 1965, DEV MED CHILD NEUROL, V7, P681; Hogart A, 2010, NEUROBIOL DIS, V38, P181, DOI 10.1016/j.nbd.2008.08.011; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kuhnle S, 2011, J BIOL CHEM, V286, P19410, DOI 10.1074/jbc.M110.205211; Louria-Hayon I, 2009, CELL DEATH DIFFER, V16, P1156, DOI 10.1038/cdd.2009.31; Munakata T, 2007, PLOS PATHOG, V3, P1335, DOI 10.1371/journal.ppat.0030139; Noor A, 2015, HUM MUTAT, V36, P689, DOI 10.1002/humu.22800; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Silva-Santos S, 2015, J CLIN INVEST, V125, P2069, DOI 10.1172/JCI80554; Urraca N, 2013, AUTISM RES, V6, P268, DOI 10.1002/aur.1284; Williams CA, 2010, AM J MED GENET C, V154C, P432, DOI 10.1002/ajmg.c.30278; Yi JJ, 2015, CELL, V162, P795, DOI 10.1016/j.cell.2015.06.045	13	9	9	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					50	51		10.1038/526050b	http://dx.doi.org/10.1038/526050b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26432241				2022-12-28	WOS:000362095100031
J	Marraffini, LA				Marraffini, Luciano A.			CRISPR-Cas immunity in prokaryotes	NATURE			English	Review							HORIZONTAL GENE-TRANSFER; SEQUENCE-SPECIFIC ANTIMICROBIALS; GUIDED SURVEILLANCE COMPLEX; ADAPTIVE BACTERIAL IMMUNITY; IN-VITRO RECONSTITUTION; R-LOOP FORMATION; ESCHERICHIA-COLI; STREPTOCOCCUS-THERMOPHILUS; SPACER ACQUISITION; CRYSTAL-STRUCTURE	Prokaryotic organisms are threatened by a large array of viruses and have developed numerous defence strategies. Among these, only clustered, regularly interspaced short palindromic repeat (CRISPR)-Cas systems provide adaptive immunity against foreign elements. Upon viral injection, a small sequence of the viral genome, known as a spacer, is integrated into the CRISPR locus to immunize the host cell. Spacers are transcribed into small RNA guides that direct the cleavage of the viral DNA by Cas nucleases. Immunization through spacer acquisition enables a unique form of evolution whereby a population not only rapidly acquires resistance to its predators but also passes this resistance mechanism vertically to its progeny.	Rockefeller Univ, Bacteriol Lab, New York, NY 10065 USA	Rockefeller University	Marraffini, LA (corresponding author), Rockefeller Univ, Bacteriol Lab, 1230 York Ave, New York, NY 10065 USA.	marraffini@rockefeller.edu			Rita Allen Scholars Program; Irma T. Hirschl Award; Sinsheimer Foundation; NIH [1DP2AI104556-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI104556] Funding Source: NIH RePORTER	Rita Allen Scholars Program; Irma T. Hirschl Award; Sinsheimer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	L.A.M. is supported by the Rita Allen Scholars Program, an Irma T. Hirschl Award, a Sinsheimer Foundation Award and a NIH Director's New Innovator Award (1DP2AI104556-01).	Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; BICKLE TA, 1993, MICROBIOL REV, V57, P434, DOI 10.1128/MMBR.57.2.434-450.1993; Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; Bingham R, 2000, J BIOL CHEM, V275, P23219, DOI 10.1074/jbc.M002546200; Blosser TR, 2015, MOL CELL, V58, P60, DOI 10.1016/j.molcel.2015.01.028; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Burnet FM, 1929, J PATHOL BACTERIOL, V32, P349, DOI 10.1002/path.1700320302; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P3677, DOI 10.1128/JB.186.12.3677-3686.2004; Childs LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101710; Citorik RJ, 2014, NAT BIOTECHNOL, V32, P1141, DOI 10.1038/nbt.3011; d'Herelle F, 1917, CR HEBD ACAD SCI, V165, P373; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Doulatov S, 2004, NATURE, V431, P476, DOI 10.1038/nature02833; El Karoui M, 1999, RES MICROBIOL, V150, P579, DOI 10.1016/S0923-2508(99)00132-1; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Goldfarb T, 2015, EMBO J, V34, P169, DOI 10.15252/embj.201489455; Gomaa AA, 2014, MBIO, V5, DOI 10.1128/mBio.00928-13; Gophna U, 2015, ISME J, V9, P2021, DOI 10.1038/ismej.2015.20; Goren MG, 2012, J MOL BIOL, V423, P14, DOI 10.1016/j.jmb.2012.06.037; Gratia A, 1921, J EXP MED, V34, P115, DOI 10.1084/jem.34.1.115; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hanlon GW, 2001, APPL ENVIRON MICROB, V67, P2746, DOI 10.1128/AEM.67.6.2746-2753.2001; Hatoum-Aslan A, 2013, J BIOL CHEM, V288, P27888, DOI 10.1074/jbc.M113.499244; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Huang H, 2015, ACTA BIOCH BIOPH SIN, V47, DOI 10.1093/abbs/gmv007; Huo YW, 2014, NAT STRUCT MOL BIOL, V21, P771, DOI 10.1038/nsmb.2875; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jiang WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003844; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang Y, 2015, APPL ENVIRON MICROB, V81, P2506, DOI 10.1128/AEM.04023-14; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Liu MS, 2002, SCIENCE, V295, P2091, DOI 10.1126/science.1067467; Lu Meng-Ji, 1994, Trends in Microbiology, V2, P137, DOI 10.1016/0966-842X(94)90601-7; Luria SE, 1943, GENETICS, V28, P491; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2013, BIOCHEM SOC T, V41, P1392, DOI 10.1042/BST20130038; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003765; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; MOLINEUX IJ, 1991, NEW BIOL, V3, P230; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Mulepati S, 2013, J BIOL CHEM, V288, P22184, DOI 10.1074/jbc.M113.472233; Neylon C, 2005, MICROBIOL MOL BIOL R, V69, P501, DOI 10.1128/MMBR.69.3.501-526.2005; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Oh JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku623; Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014; Paez-Espino D, 2015, MBIO, V6, DOI 10.1128/mBio.00262-15; PARMA DH, 1992, GENE DEV, V6, P497, DOI 10.1101/gad.6.3.497; Peng WF, 2015, NUCLEIC ACIDS RES, V43, P406, DOI 10.1093/nar/gku1302; Pennisi E, 2013, SCIENCE, V341, P833, DOI 10.1126/science.341.6148.833; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Rutkauskas M, 2015, CELL REP, V10, P1534, DOI 10.1016/j.celrep.2015.01.067; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Sampson TR, 2013, NATURE, V501, P262, DOI 10.1038/nature12498; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Savitskaya E, 2013, RNA BIOL, V10, P716, DOI 10.4161/rna.24325; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shmakov S, 2014, NUCLEIC ACIDS RES, V42, P5907, DOI 10.1093/nar/gku226; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Smith GR, 2012, MICROBIOL MOL BIOL R, V76, P217, DOI 10.1128/MMBR.05026-11; Sokolowski RD, 2014, NUCLEIC ACIDS RES, V42, P6532, DOI 10.1093/nar/gku308; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Sutherland IW, 2004, FEMS MICROBIOL LETT, V232, P1, DOI 10.1016/S0378-1097(04)00041-2; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Twort FW, 1915, LANCET, V2, P1241, DOI 10.1016/s0140-6736(01)20383-3; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Weinberger AD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002475; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zaleski P, 2005, MICROBIOL-SGM, V151, P3361, DOI 10.1099/mic.0.28184-0; Zebec Z, 2014, NUCLEIC ACIDS RES, V42, P5280, DOI 10.1093/nar/gku161; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733	120	462	486	11	346	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					55	61		10.1038/nature15386	http://dx.doi.org/10.1038/nature15386			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26432244				2022-12-28	WOS:000362095100034
J	Shaw, D				Shaw, David			PERSONAL VIEW Hospitals are wrong to ban e-cigarette use	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Basel, Inst Biomed Eth, CH-4056 Basel, Switzerland	University of Basel	Shaw, D (corresponding author), Univ Basel, Inst Biomed Eth, Bernoullistr 28, CH-4056 Basel, Switzerland.	david.shaw@unibas.ch						[Anonymous], 2013, LANCET, V382, P914, DOI 10.1016/S0140-6736(13)61918-2; Arrazola RA, 2013, MMWR-MORBID MORTAL W, V62, P893; BMA, E CIG; Camden and Islington NHS Foundation Trust, US E CIG C I; Etter JF, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0264-5; Hajek P, 2014, ADDICTION, V109, P1801, DOI 10.1111/add.12659; Johnston LD, 2015, MONITORING FUTURE NA; Nutt DJ, 2014, EUR ADDICT RES, V20, P218, DOI 10.1159/000360220; Public Health England, 2015, E CIG EV UPD; Rutherford N., 2015, BBC NEWS	10	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 30	2015	351								h5063	10.1136/bmj.h5063	http://dx.doi.org/10.1136/bmj.h5063			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS9ZE	26423310				2022-12-28	WOS:000362452200001
J	Patel, V; Chisholm, D; Parikh, R; Charlson, FJ; Degenhardt, L; Dua, T; Ferrari, AJ; Hyman, S; Laxminarayan, R; Levin, C; Lund, C; Mora, MEM; Petersen, I; Scott, J; Shidhaye, R; Vijayakumar, L; Thornicroft, G; Whiteford, H				Patel, Vikram; Chisholm, Dan; Parikh, Rachana; Charlson, Fiona J.; Degenhardt, Louisa; Dua, Tarun; Ferrari, Alize J.; Hyman, Steve; Laxminarayan, Ramanan; Levin, Carol; Lund, Crick; Medina Mora, Maria Elena; Petersen, Inge; Scott, James; Shidhaye, Rahul; Vijayakumar, Lakshmi; Thornicroft, Graham; Whiteford, Harvey		DCP MNS Author Grp	Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition	LANCET			English	Review							COST-EFFECTIVENESS; GLOBAL BURDEN; LOW-INCOME; HEALTH; INJURY; DEPRESSION; IMPACT; PLAN	The burden of mental, neurological, and substance use (MNS) disorders increased by 41% between 1990 and 2010 and now accounts for one in every 10 lost years of health globally. This sobering statistic does not take into account the substantial excess mortality associated with these disorders or the social and economic consequences of MNS disorders on affected persons, their caregivers, and society. A wide variety of effective interventions, including drugs, psychological treatments, and social interventions, can prevent and treat MNS disorders. At the population-level platform of service delivery, best practices include legislative measures to restrict access to means of self-harm or suicide and to reduce the availability of and demand for alcohol. At the community-level platform, best practices include life-skills training in schools to build social and emotional competencies. At the health-care-level platform, we identify three delivery channels. Two of these delivery channels are especially relevant from a public health perspective: self-management (eg, web-based psychological therapy for depression and anxiety disorders) and primary care and community out-reach (eg, non-specialist health worker delivering psychological and pharmacological management of selected disorders). The third delivery channel, hospital care, which includes specialist services for MNS disorders and first-level hospitals providing other types of services (such as general medicine, HIV, or paediatric care), play an important part for a smaller proportion of cases with severe, refractory, or emergency presentations and for the integration of mental health care in other health-care channels, respectively. The costs of providing a significantly scaled up package of specified cost-effective interventions for prioritised MNS disorders in low-income and lower-middle-income countries is estimated at US$3-4 per head of population per year. Since a substantial proportion of MNS disorders run a chronic and disabling course and adversely affect household welfare, intervention costs should largely be met by government through increased resource allocation and financial protection measures (rather than leaving households to pay out-of-pocket). Moreover, a policy of moving towards universal public finance can also be expected to lead to a far more equitable allocation of public health resources across income groups. Despite this evidence, less than 1% of development assistance for health and government spending on health in low-income and middle-income countries is allocated to the care of people with these disorders. Achieving the health gains associated with prioritised interventions will require not just financial resources, but committed and sustained efforts to address a range of other barriers (such as paucity of human resources, weak governance, and stigma). Ultimately, the goal is to massively increase opportunities for people with MNS disorders to access services without the prospect of discrimination or impoverishment and with the hope of attaining optimal health and social outcomes.	[Patel, Vikram] London Sch Hyg & Trop Med, London WC1, England; [Patel, Vikram; Parikh, Rachana; Laxminarayan, Ramanan; Shidhaye, Rahul] Publ Hlth Fdn India, New Delhi, India; [Patel, Vikram] Sangath, Porvorim, Goa, India; [Chisholm, Dan; Dua, Tarun] WHO, Dept Mental Hlth & Subst Abuse, CH-1211 Geneva, Switzerland; [Charlson, Fiona J.; Ferrari, Alize J.; Whiteford, Harvey] Univ Queensland, Sch Publ Hlth, Herston, Qld, Australia; [Charlson, Fiona J.; Ferrari, Alize J.] Queensland Ctr Mental Hlth Res, Wacol, Qld, Australia; [Charlson, Fiona J.; Degenhardt, Louisa; Ferrari, Alize J.; Whiteford, Harvey] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Degenhardt, Louisa] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Degenhardt, Louisa] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Vijayakumar, Lakshmi] Univ Melbourne, Ctr Youth Mental Hlth, Melbourne, Vic, Australia; [Hyman, Steve] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Hyman, Steve] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC USA; [Laxminarayan, Ramanan] Princeton Univ, Princeton Environm Inst, Princeton, NJ 08544 USA; [Levin, Carol] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Lund, Crick] Univ Cape Town, Dept Psychiat & Mental Hlth, Alan J Flisher Ctr Publ Mental Hlth, ZA-7925 Cape Town, South Africa; [Lund, Crick] Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Global Mental Hlth, London WC2R 2LS, England; [Medina Mora, Maria Elena] Natl Inst Psychiat Fuente Muniz, Mexico City, DF, Mexico; [Petersen, Inge] Univ KwaZulu Natal, Sch Appl Human Sci, Durban, South Africa; [Scott, James] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Scott, James] Royal Brisbane & Womens Hosp, Metro North Mental Hlth, Brisbane, Qld, Australia; [Shidhaye, Rahul] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, NL-6200 MD Maastricht, Netherlands; [Vijayakumar, Lakshmi] SNEHA, Volunatary Hlth Serv, Madras, Tamil Nadu, India; [Thornicroft, Graham] Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Global Mental Hlth, London WC2R 2LS, England	University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India; World Health Organization; University of Queensland; Queensland Centre for Mental Health Research; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of New South Wales Sydney; University of Melbourne; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Princeton University; University of Washington; University of Washington Seattle; University of Cape Town; University of London; King's College London; University of Kwazulu Natal; University of Queensland; Royal Brisbane & Women's Hospital; Maastricht University; University of London; King's College London	Patel, V (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	vikram.patel@lshtm.ac.uk	Charlson, Fiona/R-8963-2019; Degenhardt, Louisa J/D-4515-2012; Megiddo, Itamar/N-9839-2015; Ferrari, Alize J/G-1746-2011; Prince, Martin J/A-9170-2010; Charlson, Fiona J/F-5290-2011; Whiteford, Harvey A/A-4840-2009; Laxminarayan, Ramanan/ABD-5050-2021; Scott, James G/D-5900-2012; Shidhaye, Rahul/I-1329-2019; Thornicroft, Graham/B-4027-2010; Evans-Lacko, Sara/A-8768-2011; Erskine, Holly/K-5244-2012	Charlson, Fiona/0000-0003-2876-5040; Degenhardt, Louisa J/0000-0002-8513-2218; Megiddo, Itamar/0000-0001-8391-6660; Ferrari, Alize J/0000-0002-7863-9117; Prince, Martin J/0000-0003-1379-7146; Charlson, Fiona J/0000-0003-2876-5040; Whiteford, Harvey A/0000-0003-4667-6623; Scott, James G/0000-0002-0744-0688; Shidhaye, Rahul/0000-0001-9365-7164; Thornicroft, Graham/0000-0003-0662-0879; Parikh, Rachana/0000-0002-0761-5513; Collins, Pamela Y./0000-0003-3956-448X; Nigam, Aditi/0000-0002-3085-3640; Semrau, Maya/0000-0003-0366-1093; Petersen, Inge/0000-0002-3573-4229; Lund, Crick/0000-0002-5159-8220; Evans-Lacko, Sara/0000-0003-4691-2630; Erskine, Holly/0000-0003-3119-9211; Wassie, Abebaw Fekadu/0000-0003-2219-0952	Bill & Melinda Gates Foundation; Wellcome Trust; National Institute of Mental Health; UK Aid; European Union Seventh Framework Programme Emerald project; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King's College London Foundation Trust; Australian National Health and Medical Research Council principal research fellowship [1041472]; Australian Government under Substance Misuse Prevention and Service Improvements Grant Fund; National Institute for Health Research [NF-SI-0611-10053] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); UK Aid(CGIAR); European Union Seventh Framework Programme Emerald project; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King's College London Foundation Trust; Australian National Health and Medical Research Council principal research fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Government under Substance Misuse Prevention and Service Improvements Grant Fund(Australian Government); National Institute for Health Research(National Institute for Health Research (NIHR))	The Bill & Melinda Gates Foundation provides financial support for the Disease Control Priorities Network project, of which this volume is a part. We thank the Institute of Medicine reviewers, the DCP-3 advisory group, and the WHO-Eastern Mediterranean Regional Office mental health policy meeting participants (London; June 16, 2015) for their valuable comments that improved earlier drafts of this paper. VP is supported by grants from the Bill & Melinda Gates Foundation, Wellcome Trust, National Institute of Mental Health, and UK Aid. GT is supported by the European Union Seventh Framework Programme (FP7/2007-2013) Emerald project and by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King's College London Foundation Trust. The views expressed are those of the authors and do not necessarily represent the decisions, policies, or views of the UK National Health Service, the NIHR, or WHO. LD is supported by an Australian National Health and Medical Research Council principal research fellowship (#1041472). The National Drug and Alcohol Research Centre at University of New South Wales is supported by funding from the Australian Government under the Substance Misuse Prevention and Service Improvements Grant Fund. CL is supported by UK Aid and the National Institute of Mental Health.	Aggarwal NK, 2014, J AFFECT DISORDERS, V163, P88, DOI 10.1016/j.jad.2014.03.036; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Bloom DE, 2011, GLOBAL EC BURDEN NON; Chandra V, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P627; Chang CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019590; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Chisholm D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e609; Chisholm D, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c924; Chisholm DJ, DIS CONTROL PRIORITI, V4; Department of Health, 2013, BETT CAR FUND; Dua T, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001122; Ferrari AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091936; Flaxman AD., 2015, INTEGRATIVE METAREGR; Gater R, 2015, E MEDITERR HEALTH J, V21, P464; Gilbert BJ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001834; Gunnell D, 2007, INT J EPIDEMIOL, V36, P1235, DOI 10.1093/ije/dym164; Gureje O, 2007, WORLD PSYCHIATRY, V6, P42; Hyman S, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P605; Jamison DT, 2015, LANCET; Kaaya S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001447; Lawrence D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2539; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lindner Leandro Mendonça, 2009, Rev. Saúde Pública, V43, P62; Lund C, 2011, LANCET, V378, P1502, DOI 10.1016/S0140-6736(11)60754-X; Ma Hong, 2012, Shanghai Arch Psychiatry, V24, P172, DOI 10.3969/j.issn.1002-0829.2012.03.007; Ngo VK, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001443; Patel V, 2009, PRIORITY PUBLIC HLTH; Patel V, 2012, MENTAL HLTH HUMAN RI; Patel V, 2006, AM J PSYCHIAT, V163, P1312, DOI 10.1176/appi.ajp.163.8.1312; Patel V, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001448; Prukkanone B, 2012, VALUE HEALTH, V15, pS3, DOI 10.1016/j.jval.2011.11.009; Rahman A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001442; Rehm J, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P887; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Saxena S, 2013, LANCET, V381, P1970, DOI 10.1016/S0140-6736(13)61139-3; Strang J, 2012, LANCET, V379, P71, DOI 10.1016/S0140-6736(11)61674-7; van Ginneken N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009149.pub2; Walker ER, 2015, JAMA PSYCHIAT, V72, P334, DOI 10.1001/jamapsychiatry.2014.2502; Whiteford HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116820; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; WHO, 2008, MENT HLTH GAP ACT PR; WHO, 2013, WHO HUM RESP COMP HL; World Health Organization, 2015, MENT HLTH ATL 2014; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR	46	382	385	4	133	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2016	387	10028					1672	1685		10.1016/S0140-6736(15)00390-6	http://dx.doi.org/10.1016/S0140-6736(15)00390-6			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3ZL	26454360	Green Submitted, Bronze			2022-12-28	WOS:000374145100034
J	Shah, ASV; Anand, A; Sandoval, Y; Lee, KK; Smith, SW; Adamson, PD; Chapman, AR; Langdon, T; Sandeman, D; Vaswani, A; Strachan, FE; Ferry, A; Stirzaker, AG; Reid, A; Gray, AJ; Collinson, PO; McAllister, DA; Apple, FS; Newby, DE; Mills, NL				Shah, Anoop S. V.; Anand, Atul; Sandoval, Yader; Lee, Kuan Ken; Smith, Stephen W.; Adamson, Philip D.; Chapman, Andrew R.; Langdon, Timothy; Sandeman, Dennis; Vaswani, Amar; Strachan, Fiona E.; Ferry, Amy; Stirzaker, Alexandra G.; Reid, Alan; Gray, Alasdair J.; Collinson, Paul O.; McAllister, David A.; Apple, Fred S.; Newby, David E.; Mills, Nicholas L.		High-STEACS Investigators	High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; CHEST-PAIN; EMERGENCY-DEPARTMENT; DIAGNOSTIC PROTOCOL; AORTIC-STENOSIS; ASSAY; METAANALYSIS; BIOMARKER; RISK	Background Suspected acute coronary syndrome is the commonest reason for emergency admission to hospital and is a large burden on health-care resources. Strategies to identify low-risk patients suitable for immediate discharge would have major benefits. Methods We did a prospective cohort study of 6304 consecutively enrolled patients with suspected acute coronary syndrome presenting to four secondary and tertiary care hospitals in Scotland. We measured plasma troponin concentrations at presentation using a high-sensitivity cardiac troponin I assay. In derivation and validation cohorts, we evaluated the negative predictive value of a range of troponin concentrations for the primary outcome of index myocardial infarction, or subsequent myocardial infarction or cardiac death at 30 days. This trial is registered with ClinicalTrials.gov (number NCT01852123). Findings 782 (16%) of 4870 patients in the derivation cohort had index myocardial infarction, with a further 32 (1%) re-presenting with myocardial infarction and 75 (2%) cardiac deaths at 30 days. In patients without myocardial infarction at presentation, troponin concentrations were less than 5 ng/L in 2311 (61%) of 3799 patients, with a negative predictive value of 99.6% (95% CI 99.3-99.8) for the primary outcome. The negative predictive value was consistent across groups stratified by age, sex, risk factors, and previous cardiovascular disease. In two independent validation cohorts, troponin concentrations were less than 5 ng/L in 594 (56%) of 1061 patients, with an overall negative predictive value of 99.4% (98.8-99.9). At 1 year, these patients had a lower risk of myocardial infarction and cardiac death than did those with a troponin concentration of 5 ng/L or more (0.6% vs 3.3%; adjusted hazard ratio 0.41, 95% CI 0.21-0.80; p<0.0001). Interpretation Low plasma troponin concentrations identify two-thirds of patients at very low risk of cardiac events who could be discharged from hospital. Implementation of this approach could substantially reduce hospital admissions and have major benefits for both patients and health-care providers. Copyright (C) Shah et al. Open Access article distributed under the terms of CC BY-NC-ND.	[Shah, Anoop S. V.; Anand, Atul; Lee, Kuan Ken; Adamson, Philip D.; Chapman, Andrew R.; Langdon, Timothy; Sandeman, Dennis; Vaswani, Amar; Strachan, Fiona E.; Ferry, Amy; Stirzaker, Alexandra G.; Newby, David E.; Mills, Nicholas L.] Univ Edinburgh, BHF Ctr Cardiovasc Sci, Edinburgh EH16 4SB, Midlothian, Scotland; [McAllister, David A.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH16 4SB, Midlothian, Scotland; [Sandoval, Yader] Hennepin Cty Med Ctr, Dept Med, Div Cardiol, Minneapolis, MN 55415 USA; [Smith, Stephen W.] Hennepin Cty Med Ctr, Dept Emergency Med, Minneapolis, MN 55415 USA; [Reid, Alan] Queen Elizabeth Univ Hosp, Dept Biochem, Glasgow, Lanark, Scotland; [Gray, Alasdair J.] Royal Infirm Edinburgh NHS Trust, Dept Emergency Med, Edinburgh, Midlothian, Scotland; [Collinson, Paul O.] Univ London, Div Clin Sci, London, England; [Smith, Stephen W.; Apple, Fred S.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Edinburgh; University of Edinburgh; Hennepin County Medical Center; Hennepin County Medical Center; Queen Elizabeth University Hospital (QEUH); Royal Infirmary of Edinburgh; University of Edinburgh; University of London; University of Minnesota System; University of Minnesota Twin Cities	Shah, ASV (corresponding author), Univ Edinburgh, BHF Univ Ctr Cardiovasc Sci, SU 305 Chancellors Bldg, Edinburgh EH16 4SB, Midlothian, Scotland.	anoop.shah@ed.ac.uk	Smith, Stephen W/AAY-5334-2020; Newby, David Ernest/AAB-1364-2019; Anand, Atul/ABC-1393-2020; Adamson, Philip/AAC-3699-2019	Anand, Atul/0000-0002-6428-4554; Adamson, Philip/0000-0002-6177-956X; Weir, Christopher/0000-0002-6494-4903; Shah, Anoop/0000-0002-2825-3419; Fox, Keith/0000-0002-0140-2752; Chapman, Andrew/0000-0003-1926-5925; Mills, Nicholas/0000-0003-0533-7991; McAllister, David/0000-0003-3550-1764; Fischbacher, Colin/0000-0003-3090-1857	Chief Scientist Office (Scotland); British Heart Foundation [SP/12/10/29922, PG/15/51/31596, FS/10/024/28266, CH/09/002]; NHS Scotland Health Informatics Challenge Grant from the Chief Scientists Office [HICG/1/40]; Wellcome Trust [WT103782AIA]; NHS Lothian via the Edinburgh Health Services Research Unit; Chief Scientist Office [HICG/1/40] Funding Source: researchfish	Chief Scientist Office (Scotland); British Heart Foundation(British Heart Foundation); NHS Scotland Health Informatics Challenge Grant from the Chief Scientists Office; Wellcome Trust(Wellcome TrustEuropean Commission); NHS Lothian via the Edinburgh Health Services Research Unit; Chief Scientist Office	British Heart Foundation and Chief Scientist Office (Scotland).; This research was funded by the British Heart Foundation (SP/12/10/29922 and PG/15/51/31596) and by an NHS Scotland Health Informatics Challenge Grant (HICG/1/40) from the Chief Scientists Office. NLM and DEN are supported by Intermediate Research Fellowship (FS/10/024/28266) and Chair (CH/09/002) awards, respectively, from the British Heart Foundation. DEN is supported by a Wellcome Trust Senior Investigator Award (WT103782AIA). CJW was supported in this work by NHS Lothian via the Edinburgh Health Services Research Unit. Abbott Laboratories provided the troponin I assay reagents, calibrators, and controls for free.	Apple FS, 2012, CLIN CHEM, V58, P1574, DOI 10.1373/clinchem.2012.192716; Apple FS, 2012, CLIN CHEM, V58, P54, DOI 10.1373/clinchem.2011.165795; Bandstein N, 2014, J AM COLL CARDIOL, V63, P2569, DOI 10.1016/j.jacc.2014.03.017; Body R, 2015, CLIN CHEM, V61, P983, DOI 10.1373/clinchem.2014.231530; Body R, 2011, J AM COLL CARDIOL, V58, P1333, DOI 10.1016/j.jacc.2011.06.026; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Carlton EW, 2015, HEART, V101, P1041, DOI 10.1136/heartjnl-2014-307288; Chin CWL, 2014, EUR HEART J, V35, P2312, DOI 10.1093/eurheartj/ehu189; Cullen L, 2013, J AM COLL CARDIOL, V62, P1242, DOI 10.1016/j.jacc.2013.02.078; Gimenez MR, 2013, INT J CARDIOL, V168, P3896, DOI 10.1016/j.ijcard.2013.06.049; Goodacre S, 2005, HEART, V91, P229, DOI 10.1136/hrt.2003.027599; Goodacre S, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17010; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Makam AN, 2015, JAMA INTERN MED, V175, P67, DOI 10.1001/jamainternmed.2014.5830; Mills NL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1533; Mills NL, 2011, JAMA-J AM MED ASSOC, V305, P1210, DOI 10.1001/jama.2011.338; NICE Diagnostics Guidance DG15, 2014, MYOC INF AC EARL RUL; Niska Richard, 2010, Natl Health Stat Report, P1; Shah ASV, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4222; Shah ASV, 2015, AM J MED, V128, P493, DOI 10.1016/j.amjmed.2014.10.056; Shah ASV, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.h626, 10.1136/bmj.g7873]; Shah ASV, 2014, CIRCULATION, V130, P1607, DOI 10.1161/CIRCULATIONAHA.114.011085; Skinner JS, 2010, HEART, V96, P974, DOI 10.1136/hrt.2009.190066; Than M, 2012, J AM COLL CARDIOL, V59, P2091, DOI 10.1016/j.jacc.2012.02.035; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Zhelev Z, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h15	26	326	332	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 19	2015	386	10012					2481	2488		10.1016/S0140-6736(15)00391-8	http://dx.doi.org/10.1016/S0140-6736(15)00391-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ1LD	26454362	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000366866400022
J	Laschinger, JC; Wu, CF; Ibrahim, NG; Shuren, JE				Laschinger, John C.; Wu, Changfu; Ibrahim, Nicole G.; Shuren, Jeffrey E.			Reduced Leaflet Motion in Bioprosthetic Aortic Valves - The FDA Perspective	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SURVEILLANCE; REGISTRY		[Laschinger, John C.; Wu, Changfu; Ibrahim, Nicole G.; Shuren, Jeffrey E.] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Laschinger, JC (corresponding author), US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA.							Carroll JD, 2015, HEALTH AFFAIR, V34, P328, DOI 10.1377/hlthaff.2014.1010; Carroll JD, 2013, J AM COLL CARDIOL, V62, P1026, DOI 10.1016/j.jacc.2013.03.060; Mylotte D, 2015, EUR HEART J, V36, P1306, DOI 10.1093/eurheartj/ehu388	3	27	28	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2015	373	21					1996	1998		10.1056/NEJMp1512264	http://dx.doi.org/10.1056/NEJMp1512264			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW4JN	26437127				2022-12-28	WOS:000364957700003
J	Peltz, G; Anand, KJS				Peltz, Gary; Anand, Kanwaljeet J. S.			Long-Acting Opioids for Treating Neonatal Abstinence Syndrome A High Price for a Short Stay?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREGNANT-WOMEN; OUTCOMES; COHORT		[Peltz, Gary] Stanford Univ, Dept Anesthesia, Sch Med, Stanford, CA 94305 USA; [Anand, Kanwaljeet J. S.] Stanford Univ, Dept Pediat & Anesthesia, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Peltz, G (corresponding author), Stanford Univ, Sch Med, 300 Pasteur Dr, Stanford, CA 94305 USA.	gpeltz@stanford.edu			NICHD NIH HHS [R01 HD070795] Funding Source: Medline; PHS HHS [1R01 HDO70795-01A1] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070795] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Chu LF, 2009, PHARMACOGENET GENOM, V19, P193, DOI 10.1097/FPC.0b013e328322e73d; Elkomy MH, 2015, CLIN PHARMACOL THER, V97, P167, DOI 10.1002/cpt.5; Hall ES, 2014, PEDIATRICS, V134, pE527, DOI 10.1542/peds.2013-4036; Nygaard E, 2015, PEDIATR RES, V78, P330, DOI 10.1038/pr.2015.95; Parikh R, 2011, ARCH DIS CHILD-FETAL, V96, pF141, DOI 10.1136/adc.2009.181701; Patrick SW, 2015, PEDIATRICS, V135, P842, DOI 10.1542/peds.2014-3299; Patrick SW, 2012, JAMA-J AM MED ASSOC, V307, P1934, DOI 10.1001/jama.2012.3951; Tolia VN, 2015, NEW ENGL J MED, V372, P2118, DOI 10.1056/NEJMsa1500439; Welle-Strand GK, 2013, DRUG ALCOHOL DEPEN, V127, P200, DOI 10.1016/j.drugalcdep.2012.07.001	9	7	7	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2015	314	19					2023	2024		10.1001/jama.2015.13537	http://dx.doi.org/10.1001/jama.2015.13537			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW1PR	26469386				2022-12-28	WOS:000364764200013
J	Greaves, M; Ermini, L				Greaves, Mel; Ermini, Luca			Evolutionary Adaptations to Risk of Cancer Evidence From Cancer Resistance in Elephants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LONGEVITY; INSIGHTS		[Greaves, Mel; Ermini, Luca] Inst Canc Res, Ctr Evolut & Canc, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Greaves, M (corresponding author), Inst Canc Res, Ctr Evolut & Canc, 15 Cotswold Rd,Brookes Lawley Bldg, Sutton SM2 5NG, Surrey, England.	mel.greaves@icr.ac.uk	Ermini, Luca/O-4813-2016	Ermini, Luca/0000-0001-8109-6021	Wellcome Trust [105104/Z/14/Z, 105104] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abegglen LM, 2015, JAMA-J AM MED ASSOC, V314, P1850, DOI 10.1001/jama.2015.13134; Aktipis CA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0219; Caulin AF, 2011, TRENDS ECOL EVOL, V26, P175, DOI 10.1016/j.tree.2011.01.002; Dang CV, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0223; Gorbunova V, 2014, NAT REV GENET, V15, P531, DOI 10.1038/nrg3728; Greaves M, 2007, NAT REV CANCER, V7, P213, DOI 10.1038/nrc2071; Greaves M, 2015, CANCER DISCOV, V5, P806, DOI 10.1158/2159-8290.CD-15-0439; Greaves M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2955; Keane M, 2015, CELL REP, V10, P112, DOI 10.1016/j.celrep.2014.12.008; Lu WJ, 2009, NAT REV CANCER, V9, P758, DOI 10.1038/nrc2732; Peto R, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0198; Scheinfeldt LB, 2013, NAT REV GENET, V14, P692, DOI 10.1038/nrg3604; Schiffman JD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0231; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; WEISS K M, 1989, American Journal of Human Biology, V1, P307, DOI 10.1002/ajhb.1310010311; Zhao Y, 2013, P NATL ACAD SCI USA, V110, P20639, DOI 10.1073/pnas.1320369110	16	11	12	0	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2015	314	17					1806	1807		10.1001/jama.2015.13153	http://dx.doi.org/10.1001/jama.2015.13153			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0RO	26447685				2022-12-28	WOS:000363960200012
J	Rajasethupathy, P; Sankaran, S; Marshel, JH; Kim, CK; Ferenczi, E; Lee, SY; Berndt, A; Ramakrishnan, C; Jaffe, A; Lo, M; Liston, C; Deisseroth, K				Rajasethupathy, Priyamvada; Sankaran, Sethuraman; Marshel, James H.; Kim, Christina K.; Ferenczi, Emily; Lee, Soo Yeun; Berndt, Andre; Ramakrishnan, Charu; Jaffe, Anna; Lo, Maisie; Liston, Conor; Deisseroth, Karl			Projections from neocortex mediate top-down control of memory retrieval	NATURE			English	Article							CELLULAR-RESOLUTION; ASSOCIATIVE MEMORY; REMOTE MEMORIES; MOTOR CORTEX; FEAR MEMORY; IN-VIVO; NETWORKS; NEURONS; STIMULATION; HIPPOCAMPUS	Top-down prefrontal cortex inputs to the hippocampus have been hypothesized to be important in memory consolidation, retrieval, and the pathophysiology of major psychiatric diseases; however, no such direct projections have been identified and functionally described. Here we report the discovery of a monosynaptic prefrontal cortex (predominantly anterior cingulate) to hippocampus (CA3 to CA1 region) projection in mice, and find that optogenetic manipulation of this projection (here termed AC-CA) is capable of eliciting contextual memory retrieval. To explore the network mechanisms of this process, we developed and applied tools to observe cellular-resolution neural activity in the hippocampus while stimulating AC-CA projections during memory retrieval in mice behaving in virtual-reality environments. Using this approach, we found that learning drives the emergence of a sparse class of neurons in CA2/CA3 that are highly correlated with the local network and that lead synchronous population activity events; these neurons are then preferentially recruited by the AC-CA projection during memory retrieval. These findings reveal a sparsely implemented memory retrieval mechanism in the hippocampus that operates via direct top-down prefrontal input, with implications for the patterning and storage of salient memory representations.	[Rajasethupathy, Priyamvada; Marshel, James H.; Kim, Christina K.; Ferenczi, Emily; Lee, Soo Yeun; Berndt, Andre; Ramakrishnan, Charu; Jaffe, Anna; Lo, Maisie; Liston, Conor; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Rajasethupathy, Priyamvada; Sankaran, Sethuraman; Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Kim, Christina K.; Ferenczi, Emily; Lee, Soo Yeun; Berndt, Andre] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Liston, Conor; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	mohamady, mahin/G-2175-2016; , Conor Liston/GQH-8931-2022; Marshel, James/W-2792-2019	Marshel, James/0000-0003-3517-8493; Jaffe, Anna/0000-0002-2335-5598; Kim, Christina/0000-0002-1466-7098; Berndt, Andre/0000-0003-4758-5598	Defense Advanced Research Projects Agency Neuro-FAST program; National Institute of Mental Health, National Science Foundation; National Institute on Drug Abuse, National Science Foundation; Simons Foundation; Tarlton Foundation; Wiegers Family Fund; Nancy and James Grosfeld Foundation; H.L. Snyder Medical Foundation; Samuel and Betsy Reeves Fund; Ellison Life Sciences Research Foundation (LSRF) fellowship; Simons LSRF fellowship; German Academic Exchange Service DAAD; Fidelity Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH097822, R01MH075957] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency Neuro-FAST program; National Institute of Mental Health, National Science Foundation; National Institute on Drug Abuse, National Science Foundation; Simons Foundation; Tarlton Foundation; Wiegers Family Fund; Nancy and James Grosfeld Foundation; H.L. Snyder Medical Foundation; Samuel and Betsy Reeves Fund; Ellison Life Sciences Research Foundation (LSRF) fellowship; Simons LSRF fellowship; German Academic Exchange Service DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Fidelity Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank B. K. Lim for the rabies virus and S. Pak for assistance with histology. We thank the entire Deisseroth laboratory for thoughtful comments, with particular gratitude to M. Lovett-Baron, A. Andalman and W. Allen for their helpful discussions throughout K.D. is supported by the Defense Advanced Research Projects Agency Neuro-FAST program, National Institute of Mental Health, National Institute on Drug Abuse, National Science Foundation, the Simons Foundation, the Tarlton Foundation, the Wiegers Family Fund, the Nancy and James Grosfeld Foundation, the H.L. Snyder Medical Foundation, and the Samuel and Betsy Reeves Fund. This work is supported by an Ellison Life Sciences Research Foundation (LSRF) fellowship (P.R.), a Simons LSRF fellowship (J.H.M.), the German Academic Exchange Service DAAD (A.B.) and the Fidelity Foundation (S.Y.L.). All tools and methods are distributed and supported freely (http://www.optogenetics.org).	Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bero AW, 2014, P NATL ACAD SCI USA, V111, P11852, DOI 10.1073/pnas.1408378111; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; BOUTON ME, 1980, ANIM LEARN BEHAV, V8, P429, DOI 10.3758/BF03199629; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cheng S, 2008, NEURON, V57, P303, DOI 10.1016/j.neuron.2007.11.035; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; Gdalyahu A, 2012, NEURON, V75, P121, DOI 10.1016/j.neuron.2012.04.035; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Hermundstad AM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002063; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Kandel ER, 2014, CELL, V157, P163, DOI 10.1016/j.cell.2014.03.001; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Lesburgueres E, 2011, SCIENCE, V331, P924, DOI 10.1126/science.1196164; Li CYT, 2009, SCIENCE, V324, P643, DOI 10.1126/science.1169957; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Lovett-Barron M, 2014, SCIENCE, V343, P857, DOI 10.1126/science.1247485; MAHONEY WJ, 1976, ANIM LEARN BEHAV, V4, P357, DOI 10.3758/BF03214421; Modi MN, 2014, ELIFE, V3, DOI 10.7554/eLife.01982; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Packer AM, 2015, NAT METHODS, V12, P140, DOI 10.1038/nmeth.3217; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Prakash R, 2012, NAT METHODS, V9, P1171, DOI 10.1038/NMETH.2215; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Rickgauer JP, 2014, NAT NEUROSCI, V17, P1816, DOI 10.1038/nn.3866; Soudais C, 2001, FASEB J, V15, P2283, DOI 10.1096/fj.01-0321fje; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Taylor SF, 2012, BIOL PSYCHIAT, V71, P136, DOI 10.1016/j.biopsych.2011.09.007; Tse D, 2011, SCIENCE, V333, P891, DOI 10.1126/science.1205274; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wilson SJ, 2004, NAT NEUROSCI, V7, P211, DOI 10.1038/nn1200; Winocur G, 2010, NEUROPSYCHOLOGIA, V48, P2339, DOI 10.1016/j.neuropsychologia.2010.04.016; Yassin L, 2010, NEURON, V68, P1043, DOI 10.1016/j.neuron.2010.11.029; Yiu AP, 2014, NEURON, V83, P722, DOI 10.1016/j.neuron.2014.07.017; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	50	248	252	7	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					653	659		10.1038/nature15389	http://dx.doi.org/10.1038/nature15389			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26436451	Green Accepted			2022-12-28	WOS:000363832100039
J	Lemiale, V; Mokart, D; Resche-Rigon, M; Pene, F; Mayaux, J; Faucher, E; Nyunga, M; Girault, C; Perez, P; Guitton, C; Ekpe, K; Kouatchet, A; Theodose, I; Benoit, D; Canet, E; Barbier, F; Rabbat, A; Bruneel, F; Vincent, F; Klouche, K; Loay, K; Mariotte, E; Bouadma, L; Moreau, AS; Seguin, A; Meert, AP; Reignier, J; Papazian, L; Mehzari, I; Cohen, Y; Schenck, M; Hamidfar, R; Darmon, M; Demoule, A; Chevret, S; Azoulay, E				Lemiale, Virginie; Mokart, Djamel; Resche-Rigon, Matthieu; Pene, Frederic; Mayaux, Julien; Faucher, Etienne; Nyunga, Martine; Girault, Christophe; Perez, Pierre; Guitton, Christophe; Ekpe, Kenneth; Kouatchet, Achille; Theodose, Igor; Benoit, Dominique; Canet, Emmanuel; Barbier, Francois; Rabbat, Antoine; Bruneel, Fabrice; Vincent, Francois; Klouche, Kada; Loay, Kontar; Mariotte, Eric; Bouadma, Lila; Moreau, Anne-Sophie; Seguin, Amelie; Meert, Anne-Pascale; Reignier, Jean; Papazian, Laurent; Mehzari, Ilham; Cohen, Yves; Schenck, Maleka; Hamidfar, Rebecca; Darmon, Michael; Demoule, Alexandre; Chevret, Sylvie; Azoulay, Elie		Grp Rech Reanimation Resp Patient	Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory Failure A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CRITICALLY-ILL PATIENTS; MECHANICAL VENTILATION; ONCOLOGY PATIENTS; HEMATOLOGY; SURVIVAL; CANCER; ADMISSION	IMPORTANCE Noninvasive ventilation has been recommended to decrease mortality among immunocompromised patients with hypoxemic acute respiratory failure. However, its effectiveness for this indication remains unclear. OBJECTIVE To determine whether early noninvasive ventilation improved survival in immunocompromised patients with nonhypercapnic acute hypoxemic respiratory failure. DESIGN, SETTING, AND PARTICIPANTS Multicenter randomized trial conducted among 374 critically ill immunocompromised patients, of whom 317 (84.7%) were receiving treatment for hematologic malignancies or solid tumors, at 28 intensive care units (ICUs) in France and Belgium between August 12, 2013, and January 2, 2015. INTERVENTIONS Patients were randomly assigned to early noninvasive ventilation (n = 191) or oxygen therapy alone (n = 183). MAIN OUTCOMES AND MEASURES The primary outcome was day-28 mortality. Secondary outcomes were intubation, Sequential Organ Failure Assessment score on day 3, ICU-acquired infections, duration of mechanical ventilation, and ICU length of stay. RESULTS At randomization, median oxygen flow was 9 L/min (interquartile range, 5-15) in the noninvasive ventilation group and 9 L/min (interquartile range, 6-15) in the oxygen group. All patients in the noninvasive ventilation group received the first noninvasive ventilation session immediately after randomization. On day 28 after randomization, 46 deaths (24.1%) had occurred in the noninvasive ventilation group vs 50 (27.3%) in the oxygen group (absolute difference, -3.2 [95% CI, -12.1 to 5.6]; P = .47). Oxygenation failure occurred in 155 patients overall (41.4%), 73 (38.2%) in the noninvasive ventilation group and 82 (44.8%) in the oxygen group (absolute difference, -6.6 [95% CI, -16.6 to 3.4]; P = .20). There were no significant differences in ICU-acquired infections, duration of mechanical ventilation, or lengths of ICU or hospital stays. CONCLUSIONS AND RELEVANCE Among immunocompromised patients admitted to the ICU with hypoxemic acute respiratory failure, early noninvasive ventilation compared with oxygen therapy alone did not reduce 28-day mortality. However, study power was limited.	[Lemiale, Virginie; Chevret, Sylvie; Azoulay, Elie] St Louis Univ Hosp, Paris, France; [Mokart, Djamel] IPC, Lyon, France; [Resche-Rigon, Matthieu; Pene, Frederic; Theodose, Igor; Canet, Emmanuel; Rabbat, Antoine; Mariotte, Eric; Bouadma, Lila; Demoule, Alexandre] APHP, Paris, France; [Mayaux, Julien] Grp Hosp Pitie Salpetriere Charles Fox, AP HP, Serv Pneumol & Reanimat Med, Paris, France; [Faucher, Etienne] Hosp Civils Lyon, Lyon, France; [Girault, Christophe] Univ Rouen, Charles Nicolle Univ Hosp, Med Intens Care Unit, Rouen, France; [Perez, Pierre] Ctr Hosp Univ Nancy, Nancy, France; [Guitton, Christophe] Univ Hosp Nantes, Nantes, France; [Ekpe, Kenneth] Inst Gustave Roussy, Paris, France; [Kouatchet, Achille] CHRU Angers, Intens Care Unit, Angers, France; [Benoit, Dominique] Intens Care Med, Ghent, Belgium; [Barbier, Francois] La Source Hosp CHR Orleans, Med Intens Care Unit, Orleans, France; [Bruneel, Fabrice] Hop Andre Mignot Le Chesnay, Intens Care Unit, Paris, France; [Vincent, Francois; Cohen, Yves] Hop Avicenne, APHP, F-93009 Bobigny, France; [Klouche, Kada] Lapeyronie Univ Hosp, Montpellier, France; [Loay, Kontar] Ctr Hosp Univ Amiens, Amiens, France; [Moreau, Anne-Sophie] CHRU Lille, Ctr Reanimat, F-59037 Lille, France; [Seguin, Amelie] Ctr Hosp Univ Caen, Caen, France; [Meert, Anne-Pascale] Inst Jules Bordet, B-1000 Brussels, Belgium; [Reignier, Jean] CHU Nantes, Reanimat Med, F-44035 Nantes 01, France; [Papazian, Laurent] Hop Nord Marseille, Reanimat DRIS, Marseille, France; [Mehzari, Ilham] CHSF, Paris, France; [Schenck, Maleka] Hospices Civils Strasbourg, Strasbourg, France; [Hamidfar, Rebecca] CHU Grenoble, F-38043 Grenoble, France; [Darmon, Michael] St Etienne Univ Hosp, Med Surg ICU, St Etienne, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Lyon; CHU de Rouen; Universite de Rouen Normandie; CHU de Nancy; Nantes Universite; CHU de Nantes; UNICANCER; Gustave Roussy; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Ghent University; Ghent University Hospital; Centre Hospitalier Regional d'Orleans; Centre Hospitalier de Versailles; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Avicenne - APHP; Universite Paris 13; Universite de Montpellier; CHU de Montpellier; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Universite de Lille - ISITE; CHU Lille; CHU de Caen NORMANDIE; Universite de Caen Normandie; Institut Jules Bordet; Nantes Universite; CHU de Nantes; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU de St Etienne	Azoulay, E (corresponding author), Hop St Louis, Med Intens Care Unit, 1 Ave Claude Vellefaux, F-75010 Paris, France.	elie.azoulay@sls.aphp.fr	Demoule, Alexandre/ABG-4915-2021; Lascarrou, Jean Baptiste/I-4079-2014; Resche-Rigon, Matthieu/ABA-5374-2021	Demoule, Alexandre/0000-0002-0432-7217; Lascarrou, Jean Baptiste/0000-0003-3706-078X; resche-rigon, matthieu/0000-0003-2220-5085; Chemouni, Frank/0000-0001-6834-1803; chevret, sylvie/0000-0001-6449-4730; Nseir, Saad/0000-0002-7618-0357; Mokart, D/0000-0003-1711-463X; Pene, Frederic/0000-0003-3639-3849; Mariotte, Eric/0000-0002-3614-0457; Darmon, Michael/0000-0003-4198-8038	Legs Poix (Chancellerie des Universites de Paris); OUTCOMEREA study group	Legs Poix (Chancellerie des Universites de Paris); OUTCOMEREA study group	The study was sponsored by 2 grants from the nonprofit organizations Legs Poix (Chancellerie des Universites de Paris) and the OUTCOMEREA study group.	Adda M, 2008, CRIT CARE MED, V36, P2766, DOI 10.1097/CCM.0b013e31818699f6; Azoulay E, 2012, BONE MARROW TRANSPL, V47, P469, DOI 10.1038/bmt.2011.232; Azoulay E, 2008, CRIT CARE MED, V36, P100, DOI 10.1097/01.CCM.0000295590.33145.C4; Azoulay E, 2014, INTENS CARE MED, V40, P1106, DOI 10.1007/s00134-014-3354-0; Azoulay E, 2013, J CLIN ONCOL, V31, P2810, DOI 10.1200/JCO.2012.47.2365; Azoulay E, 2013, INTENS CARE MED, V39, P292, DOI 10.1007/s00134-012-2746-2; Azoulay E, 2010, AM J RESP CRIT CARE, V182, P1038, DOI 10.1164/rccm.201001-0018OC; Canet E, 2011, CRIT CARE, V15, DOI 10.1186/cc10091; Depuydt PO, 2010, J CRIT CARE, V25, P30, DOI 10.1016/j.jcrc.2009.02.016; Depuydt PO, 2004, CHEST, V126, P1299, DOI 10.1378/chest.126.4.1299; Faguer S, 2013, EUR J INTERN MED, V24, pE40, DOI 10.1016/j.ejim.2012.11.018; Frat JP, 2015, RESP CARE, V60, P170, DOI 10.4187/respcare.03075; GAIL M, 1985, BIOMETRICS, V41, P361, DOI 10.2307/2530862; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Gristina GR, 2011, CRIT CARE MED, V39, P2232, DOI 10.1097/CCM.0b013e3182227a27; He HW, 2013, NEW ENGL J MED, V369, P980, DOI 10.1056/NEJMc1308895; Hilbert G, 2001, NEW ENGL J MED, V344, P481, DOI 10.1056/NEJM200102153440703; Keenan SP, 2011, CAN MED ASSOC J, V183, pE195, DOI 10.1503/cmaj.100071; Lemiale V, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-372; Lemiale V, 2014, RESP CARE, V59, P1517, DOI 10.4187/respcare.02693; Malhotra A, 2007, NEW ENGL J MED, V357, P1113, DOI 10.1056/NEJMct074213; Mokart D, 2015, INTENS CARE MED, V41, P296, DOI 10.1007/s00134-014-3615-y; Mokart D, 2014, INTENS CARE MED, V40, P1570, DOI 10.1007/s00134-014-3433-2; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Salvadori Maurizio, 2014, World J Transplant, V4, P243, DOI 10.5500/wjt.v4.i4.243; Cruz RS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009098.pub2; Schellongowski P, 2011, HAEMATOL-HEMATOL J, V96, P231, DOI 10.3324/haematol.2010.031583; Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; van Vliet M, 2014, INTENS CARE MED, V40, P1275, DOI 10.1007/s00134-014-3373-x; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156	30	206	218	1	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2015	314	16					1711	1719		10.1001/jama.2015.12402	http://dx.doi.org/10.1001/jama.2015.12402			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7HC	26444879	Bronze			2022-12-28	WOS:000363706300020
J	Kulmala, M				Kulmala, Markku			China's choking cocktail	NATURE			English	Editorial Material							PARTICLE FORMATION; POLLUTION; AIR		Univ Helsinki, Aerosol Phys, FIN-00014 Helsinki, Finland	University of Helsinki	Kulmala, M (corresponding author), Univ Helsinki, Aerosol Phys, FIN-00014 Helsinki, Finland.	markku.kulmala@helsinki.fi	Kulmala, Markku T/I-7671-2016	Kulmala, Markku T/0000-0003-3464-7825				Ding AJ, 2013, ATMOS CHEM PHYS, V13, P10545, DOI 10.5194/acp-13-10545-2013; Ding AJ, 2013, ATMOS CHEM PHYS, V13, P5813, DOI 10.5194/acp-13-5813-2013; Guo S, 2014, P NATL ACAD SCI USA, V111, P17373, DOI 10.1073/pnas.1419604111; Hari P., 2015, ATMOS CHEM PHYS DISC, V15, P21063, DOI 10.5194/acpd-15-21063-2015; Kulmala M, 2014, ANNU REV PHYS CHEM, V65, P21, DOI 10.1146/annurev-physchem-040412-110014; Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Xiao S, 2015, ATMOS CHEM PHYS, V15, P1769, DOI 10.5194/acp-15-1769-2015; Zhang JF, 2010, LANCET, V375, P1110, DOI 10.1016/S0140-6736(10)60062-1	9	73	81	3	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					497	499		10.1038/526497a	http://dx.doi.org/10.1038/526497a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26490602	Bronze			2022-12-28	WOS:000364026100022
J	Jiao, LY; Liu, X				Jiao, Lianying; Liu, Xin			Structural basis of histone H3K27 trimethylation by an active polycomb repressive complex 2	SCIENCE			English	Article							METHYLTRANSFERASE GENE EZH2; METHYLATION; PRC2; MUTATIONS; BINDING; H3; INACTIVATION; SYSTEM; GENOME; MODEL	Polycomb repressive complex 2 (PRC2) catalyzes histone H3K27 trimethylation (H3K27me3), a hallmark of gene silencing. Here we report the crystal structures of an active PRC2 complex of 170 kilodaltons from the yeast Chaetomium thermophilum in both basal and stimulated states, which contain Ezh2, Eed, and the VEFS domain of Suz12 and are bound to a cancer-associated inhibiting H3K27M peptide and a S-adenosyl-L-homocysteine cofactor. The stimulated complex also contains an additional stimulating H3K27me3 peptide. Eed is engulfed by a belt-like structure of Ezh2, and Suz12(VEFS) contacts both of these two subunits to confer an unusual split active SET domain for catalysis. Comparison of PRC2 in the basal and stimulated states reveals a mobile Ezh2 motif that responds to stimulation to allosterically regulate the active site.	[Liu, Xin] Univ Texas SW Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Basic Res Div, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Liu, X (corresponding author), Univ Texas SW Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA.	xin.liu@utsouthwestern.edu	Jiao, Lianying/A-8783-2019	Jiao, Lianying/0000-0002-7911-3811	Welch Foundation [I-1790]; CPRIT [R1119]; Rita Allen Foundation; University of Texas Southwestern Medical Center Endowed Scholar fund; NIH [GM114576]; Cecil H. and Ida Green Center Training Program in Reproductive Biology Sciences Research; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; Office of Science, Office of Basic Energy Sciences, of the U.S. DOE [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114576] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); CPRIT; Rita Allen Foundation; University of Texas Southwestern Medical Center Endowed Scholar fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cecil H. and Ida Green Center Training Program in Reproductive Biology Sciences Research; DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, of the U.S. DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by Welch Foundation research grant I-1790, CPRIT research grant R1119, Rita Allen Foundation research grant, University of Texas Southwestern Medical Center Endowed Scholar fund, and NIH grant GM114576 to X.L. X.L. is a W.W. Caruth, Jr. Scholar in Biomedical Research. This research also received support from the Cecil H. and Ida Green Center Training Program in Reproductive Biology Sciences Research. This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. DOE under contract no. DE-AC02-05CH11231. We thank R. Kornberg, R. Marmorstein, and L. Kraus for critical reading of the manuscript. The crystal structures described in this study have been deposited in the Protein Data Bank under accession number 5CH1 (PRC2 in the stimulated state) and 5CH2 (PRC2 in the basal state).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Antonysamy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084147; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Bricogne G., 2011, BUSTER VERSION 2 10; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Ciferri C, 2012, ELIFE, V1, DOI 10.7554/eLife.00005; Delest A, 2012, CURR OPIN CELL BIOL, V24, P405, DOI 10.1016/j.ceb.2012.01.008; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Ferrari KJ, 2014, MOL CELL, V53, P49, DOI 10.1016/j.molcel.2013.10.030; Gibson WT, 2012, AM J HUM GENET, V90, P110, DOI 10.1016/j.ajhg.2011.11.018; Han ZF, 2007, STRUCTURE, V15, P1306, DOI 10.1016/j.str.2007.08.007; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Martin C, 2006, J BIOL CHEM, V281, P8365, DOI 10.1074/jbc.M513425200; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rai AN, 2013, MOL CELL BIOL, V33, P4844, DOI 10.1128/MCB.00307-13; Sanulli S, 2015, MOL CELL, V57, P769, DOI 10.1016/j.molcel.2014.12.020; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schrodinger LLC, 2010, THE PYMOL MOLECULAR; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Score J, 2012, BLOOD, V119, P1208, DOI 10.1182/blood-2011-07-367243; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083737; Xiao B, 2003, CURR OPIN STRUC BIOL, V13, P699, DOI 10.1016/j.sbi.2003.10.003; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Yuan W, 2012, SCIENCE, V337, P971, DOI 10.1126/science.1225237; Zheng WH, 2012, J AM CHEM SOC, V134, P18004, DOI 10.1021/ja307060p	46	257	261	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2015	350	6258							aac4383	10.1126/science.aac4383	http://dx.doi.org/10.1126/science.aac4383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT5HD	26472914	Green Accepted			2022-12-28	WOS:000362838700031
J	Pikija, S; Mutzenbach, JS				Pikija, Slaven; Mutzenbach, Johannes S.			Septic Cerebral Venous Thrombosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pikija, Slaven; Mutzenbach, Johannes S.] Paracelsus Med Univ Salzburg, Salzburg, Austria	Paracelsus Private Medical University	Pikija, S (corresponding author), Paracelsus Med Univ Salzburg, Salzburg, Austria.	spikija@gmail.com							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2015	373	16					1553	1553		10.1056/NEJMicm1415937	http://dx.doi.org/10.1056/NEJMicm1415937			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5VX	26465988				2022-12-28	WOS:000362880300011
J	Perico, N; Remuzzi, G				Perico, Norberto; Remuzzi, Giuseppe			Acute kidney injury: more awareness needed, globally	LANCET			English	Editorial Material							ACUTE-RENAL-FAILURE		[Perico, Norberto; Remuzzi, Giuseppe] Ist Ric Farmacol Mario Negri, IRCCS, I-24126 Bergamo, Italy; [Remuzzi, Giuseppe] Azienda Osped Papa Giovanni XXIII, Dept Med, Unit Nephrol & Dialysis, Bergamo, Italy; [Remuzzi, Giuseppe] Univ Milan, Dept Biomed & Clin Sci, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; ASST Papa Giovanni XXIII; University of Milan	Perico, N (corresponding author), Ist Ric Farmacol Mario Negri, IRCCS, I-24126 Bergamo, Italy.	giuseppe.remuzzi@marionegri.it	Perico, Norberto/ABH-3222-2020; Remuzzi, Giuseppe/V-9766-2017	Perico, Norberto/0000-0002-3147-4327; Remuzzi, Giuseppe/0000-0002-6194-3446				Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Fang Y, 2010, BLOOD PURIFICAT, V30, P120, DOI 10.1159/000319972; Kerr M, 2014, NEPHROL DIAL TRANSPL, V29, P1362, DOI 10.1093/ndt/gfu016; Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9; Lewington AJP, 2013, KIDNEY INT, V84, P457, DOI 10.1038/ki.2013.153; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mehta RL, 2015, LANCET, V385, P2616, DOI 10.1016/S0140-6736(15)60126-X; Remuzzi G, 2013, LANCET, V382, P2041, DOI 10.1016/S0140-6736(13)62193-5; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Yang L, 2015, LANCET, V386, P1465, DOI 10.1016/S0140-6736(15)00344-X	11	18	18	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2015	386	10002					1425	1427		10.1016/S0140-6736(15)00425-0	http://dx.doi.org/10.1016/S0140-6736(15)00425-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5UU	26466028				2022-12-28	WOS:000362877300008
J	Yang, L; Xing, GL; Wang, L; Wu, YG; Li, SH; Xu, G; He, Q; Chen, JH; Chen, MH; Liu, XH; Zhu, ZZ; Yang, L; Lian, XY; Ding, F; Li, Y; Wang, HM; Wang, JQ; Wang, R; Mei, CL; Xu, JX; Li, RS; Cao, J; Zhang, L; Wang, Y; Xu, JH; Bao, BY; Liu, BC; Chen, HY; Li, SM; Zha, Y; Luo, Q; Chen, DC; Shen, YL; Liao, YH; Zhang, ZR; Wang, XQ; Zhang, K; Liu, LJ; Mao, PJ; Guo, CX; Li, JG; Wang, ZF; Bai, SJ; Shi, SJ; Wang, YF; Wang, JW; Liu, ZS; Wang, F; Huang, DD; Wang, S; Ge, SW; Shen, QQ; Zhang, P; Wu, LH; Pan, M; Zou, XT; Zhu, P; Zhao, JT; Zhou, MJ; Yang, L; Hu, WP; Wang, J; Liu, B; Zhang, T; Han, JX; Wen, T; Zhao, MH; Wang, HY				Yang, Li; Xing, Guolan; Wang, Li; Wu, Yonggui; Li, Suhua; Xu, Gang; He, Qiang; Chen, Jianghua; Chen, Menghua; Liu, Xiaohua; Zhu, Zaizhi; Yang, Lin; Lian, Xiyan; Ding, Feng; Li, Yun; Wang, Huamin; Wang, Jianqin; Wang, Rong; Mei, Changlin; Xu, Jixian; Li, Rongshan; Cao, Juan; Zhang, Liang; Wang, Yan; Xu, Jinhua; Bao, Beiyan; Liu, Bicheng; Chen, Hongyu; Li, Shaomei; Zha, Yan; Luo, Qiong; Chen, Dongcheng; Shen, Yulan; Liao, Yunhua; Zhang, Zhengrong; Wang, Xianqiu; Zhang, Kun; Liu, Luojin; Mao, Peiju; Guo, Chunxiang; Li, Jiangang; Wang, Zhenfu; Bai, Shoujun; Shi, Shuangjie; Wang, Yafang; Wang, Jinwei; Liu, Zhangsuo; Wang, Fang; Huang, Dandan; Wang, Shun; Ge, Shuwang; Shen, Quanquan; Zhang, Ping; Wu, Lihua; Pan, Miao; Zou, Xiting; Zhu, Ping; Zhao, Jintao; Zhou, Minjie; Yang, Lin; Hu, Wenping; Wang, Jing; Liu, Bing; Zhang, Tong; Han, Jianxin; Wen, Tao; Zhao, Minghui; Wang, Haiyan		ISN AKF 0by25 China Consortiums	Acute kidney injury in China: a cross-sectional survey	LANCET			English	Article							ACUTE-RENAL-FAILURE; RISK-FACTORS; EPIDEMIOLOGY; OUTCOMES; AKI	Background Acute kidney injury (AKI) has become a worldwide public health problem, but little information is available about the disease burden in China. We aimed to evaluate the burden of AKI and assess the availability of diagnosis and treatment in China. Methods We launched a nationwide, cross-sectional survey of adult patients who were admitted to hospital in 2013 in academic or local hospitals from 22 provinces in mainland China. Patients with suspected AKI were screened out on the basis of changes in serum creatinine by the Laboratory Information System, and we reviewed medical records for 2 months (January and July) to confirm diagnoses. We assessed rates of AKI according to two identification criteria: the 2012 Kidney Disease: Improving Global Outcomes (KDIGO) AKI definition and an increase or decrease in serum creatinine by 50% during hospital stay (expanded criteria). We estimated national rates with data from the 2013 report by the Chinese National Health and Family Planning Commission and National Bureau of Statistics. Findings Of 2 223 230 patients admitted to the 44 hospitals screened in 2013, 154 950 (7.0%) were suspected of having AKI by electronic screening, of whom 26 086 patients (from 374 286 total admissions) were reviewed with medical records to confirm the diagnosis of AKI. The detection rate of AKI was 0.99% (3687 of 374 286) by KDIGO criteria and 2.03% (7604 of 374 286) by expanded criteria, from which we estimate that 1.4-2.9 million people with AKI were admitted to hospital in China in 2013. The non-recognition rate of AKI was 74.2% (5608 of 7555 with available data). Renal referral was done in 21.4% (1625 of 7604) of the AKI cases, and renal replacement therapy was done in 59.3% (531 of 896) of those who had the indications. Delayed AKI recognition was an independent risk factor for in-hospital mortality, and renal referral was an independent protective factor for AKI under-recognition and mortality Interpretation AKI has become a huge medical burden in China, with substantial underdiagnosis and undertreatment. Nephrologists should take the responsibility for leading the battle against AKI.	[Yang, Li; Wang, Yafang; Wang, Jinwei; Zhao, Minghui; Wang, Haiyan] Peking Univ, Hosp 1, Beijing 100034, Peoples R China; [Xing, Guolan; Liu, Zhangsuo] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China; [Wang, Li; Wang, Fang] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Wu, Yonggui; Huang, Dandan] Anhui Med Univ, Affiliated Hosp 1, Hefei, Anhui, Peoples R China; [Li, Suhua; Wang, Shun] Xinjiang Med Univ, Affiliated Hosp 1, Urumqi, Peoples R China; [Xu, Gang; Ge, Shuwang] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Wuhan 430074, Peoples R China; [He, Qiang; Shen, Quanquan] Zhejiang Prov Peoples Hosp, Hangzhou, Peoples R China; [Chen, Jianghua; Zhang, Ping] Zhejiang Univ, Affiliated Hosp 1, Hangzhou 310027, Peoples R China; [Chen, Menghua; Wu, Lihua] Ningxia Med Univ, Gen Hosp, Yinchuan, Peoples R China; [Liu, Xiaohua; Pan, Miao] Fujian Med Univ, Ningde Municipal Hosp, Ningde, Peoples R China; [Zhu, Zaizhi; Zou, Xiting] Meishan City Peoples Hosp, Meishan, Peoples R China; [Yang, Lin; Zhu, Ping] China Three Gorges Univ, Coll Clin Med Sci 1, Yichang, Peoples R China; [Lian, Xiyan; Zhao, Jintao] Kunming Med Univ, Affiliated Hosp 2, Kunming, Peoples R China; [Ding, Feng; Zhou, Minjie] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China; [Yang, Lin; Li, Yun] Jiangxi Prov Peoples Hosp, Nanchang, Peoples R China; [Wang, Huamin; Hu, Wenping] Harbin Med Univ, Affiliated Hosp 4, Harbin, Peoples R China; [Wang, Jianqin; Wang, Jing] Lanzhou Univ, Hosp 2, Lanzhou 730000, Peoples R China; [Wang, Rong; Liu, Bing] Shandong Univ, Shandong Prov Hosp, Jinan 250100, Peoples R China; [Mei, Changlin; Zhang, Tong] Second Mil Med Univ, Shanghai Changzheng Hosp, Shanghai, Peoples R China; [Xu, Jixian; Han, Jianxin] Renshou Cty Peoples Hosp, Renshou, Peoples R China; [Li, Rongshan; Wen, Tao] Shanxi Med Univ, Affiliated Prov Peoples Hosp, Taiyuan, Peoples R China; [Cao, Juan] Taixing Peoples Hosp, Taixing, Peoples R China; [Zhang, Liang] Ordos Cent Hosp, Ordos, Inner Mongolia, Peoples R China; [Wang, Yan] Xinganmeng Peoples Hosp, Wulanhaote, Inner Mongolia, Peoples R China; [Xu, Jinhua] Fuyang City Peoples Hosp, Fuyang, Zhejiang, Peoples R China; [Bao, Beiyan] Ningbo Yinzhou Second Hosp, Ningbo, Zhejiang, Peoples R China; [Liu, Bicheng] Southeast Univ, Zhongda Hosp, Nanjing, Jiangsu, Peoples R China; [Chen, Hongyu] Hangzhou Hosp Tradit Chinese Med, Hangzhou, Zhejiang, Peoples R China; [Li, Shaomei] Hebei Med Univ, Hosp 2, Shijiazhuang, Peoples R China; [Zha, Yan] Guizhou Med Univ, Guizhou Prov Peoples Hosp, Guiyang, Peoples R China; [Luo, Qiong] Peking Univ, Shenzhen Hosp, Shenzhen, Peoples R China; [Chen, Dongcheng] Hengxian Peoples Hosp, Hengxian, Peoples R China; [Shen, Yulan] Miyun Cty Hosp, Beijing, Peoples R China; [Liao, Yunhua] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Peoples R China; [Zhang, Zhengrong] Puer City Peoples Hosp, Puer, Peoples R China; [Wang, Xianqiu] Zoucheng City Peoples Hosp, Zoucheng, Peoples R China; [Zhang, Kun] Taihe Hosp Tradit Chinese Med, Taihe, Peoples R China; [Liu, Luojin] Shenzhen Longhua New Dist Cent Hosp, Shenzhen, Peoples R China; [Mao, Peiju] Shanghai Jiao Tong Univ, Tongren Hosp, Sch Med, Shanghai 200030, Peoples R China; [Guo, Chunxiang] Zhongwei City Peoples Hosp, Zhongwei, Peoples R China; [Li, Jiangang] Huaxian Peoples Hosp, Huaxian, Peoples R China; [Wang, Zhenfu] Suihua City First Hosp, Suihua, Peoples R China; [Bai, Shoujun] Fudan Univ, Zhongshan Hosp, Qingpu Branch, Shanghai 200433, Peoples R China; [Shi, Shuangjie] Qingxuxian City Peoples Hosp, Qingxu, Peoples R China	Peking University; Zhengzhou University; Sichuan Provincial People's Hospital; Anhui Medical University; Xinjiang Medical University; Huazhong University of Science & Technology; Zhejiang Provincial People's Hospital; Zhejiang University; Ningxia Medical University; Fujian Medical University; China Three Gorges University; Kunming Medical University; Shanghai Jiao Tong University; Harbin Medical University; Lanzhou University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Naval Medical University; Shanxi Medical University; Southeast University - China; Hebei Medical University; Guizhou Medical University; Peking University; Guangxi Medical University; Shanghai Jiao Tong University; Fudan University	Yang, L (corresponding author), Peking Univ, Hosp 1, Div Renal, Beijing 100034, Peoples R China.	li.yang@bjmu.edu.cn	chen, hongyu/HHS-4314-2022; Jinde, Cao/L-2658-2017	li, rongshan/0000-0002-8082-4389	National 985 Project of China; National Natural Science Foundation of China [81270777]; Beijing Training Program for Talents [20110009001000002]; International Society of Nephrology Research Committee; Bethune Fund Management Committee; Fresenius Medical Care	National 985 Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Training Program for Talents; International Society of Nephrology Research Committee; Bethune Fund Management Committee; Fresenius Medical Care	National 985 Project of China, National Natural Science Foundation of China, Beijing Training Program for Talents, International Society of Nephrology Research Committee, and Bethune Fund Management Committee.; This study was supported by National Project 985 to Peking University for Clinical Study on Cooperation; Beijing Training Program for Talents (20110009001000002); National Natural Science Foundation of China (81270777); International Society of Nephrology Research Committee; Bethune Fund Management Committee; and Fresenius Medical Care. We thank Haixia Li for the technical support in setting up the Laboratory Information System laboratory screening system. We would like to dedicate this Article to our respectable Prof Haiyan Wang.	Che Miao-lin, 2009, Zhonghua Yi Xue Za Zhi, V89, P744; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Fang Y, 2010, BLOOD PURIFICAT, V30, P120, DOI 10.1159/000319972; Finlay S, 2013, CLIN MED, V13, P233, DOI 10.7861/clinmedicine.13-3-233; Gao J, 2015, MINERVA UROL NEFROL, V67, P179; INRUD China Center Group, 2014, ADVERSE DRUG REACT, V16, P321; Lewington AJP, 2013, KIDNEY INT, V84, P457, DOI 10.1038/ki.2013.153; Li PKT, 2013, TRANSPLANTATION, V95, P653, DOI 10.1097/TP.0b013e31828848bc; Lombardi R, 2008, SEMIN NEPHROL, V28, P320, DOI 10.1016/j.semnephrol.2008.04.001; [陆任华 Lu Renhua], 2012, [中华肾脏病杂志, Chinese Journal of Nephrology], V28, P194; Naicker S, 2008, SEMIN NEPHROL, V28, P348, DOI 10.1016/j.semnephrol.2008.04.003; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; National Bureau of Statistics of the People's Republic of China, REP NAT TOT MED EXP; National Bureau of Statistics of the Peoples Republic of China, REP NAT POP YEAR 201; National Health and Family Planning Commission of the People's Republic of China , REP TOT HOSP ADM YEA; Palevsky PM, 2013, ADV CHRONIC KIDNEY D, V20, P76, DOI 10.1053/j.ackd.2012.09.004; Remuzzi G, 2013, LANCET, V382, P2041, DOI 10.1016/S0140-6736(13)62193-5; Ricci Z, 2011, CURR OPIN CRIT CARE, V17, P556, DOI 10.1097/MCC.0b013e32834cd360; Schissler MM, 2013, NEPHROLOGY, V18, P183, DOI 10.1111/nep.12036; Shema L, 2009, ISR MED ASSOC J, V11, P269; Singh T B, 2013, Indian J Nephrol, V23, P24, DOI 10.4103/0971-4065.107192; Srisawat N, 2011, CURR OPIN CRIT CARE, V17, P548, DOI 10.1097/MCC.0b013e32834cd349; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Thomas M, 2011, NEPHROL DIAL TRANSPL, V26, P2161, DOI 10.1093/ndt/gfq710; Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F; Wang Y, 2005, AM J NEPHROL, V25, P514, DOI 10.1159/000088460; Zeng XX, 2014, CLIN J AM SOC NEPHRO, V9, P12, DOI 10.2215/CJN.02730313	28	259	315	18	182	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2015	386	10002					1465	1471		10.1016/S0140-6736(15)00344-X	http://dx.doi.org/10.1016/S0140-6736(15)00344-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5UU	26466051				2022-12-28	WOS:000362877300029
J	Radick, G				Radick, Gregory			Beyond the "Mendel-Fisher controversy"	SCIENCE			English	Editorial Material									Univ Leeds, Sch Philosophy Relig & Hist Sci, Leeds, W Yorkshire, England	University of Leeds	Radick, G (corresponding author), Univ Leeds, Sch Philosophy Relig & Hist Sci, Leeds, W Yorkshire, England.	g.m.radick@leeds.ac.uk		Radick, Gregory/0000-0003-1722-6658				[Anonymous], 1901, COMMUNICATION; [Anonymous], 1900, COMMUNICATION; Bateson B., 1984, W BATESON F R S HIS; Bennett J. H., 1983, NATURAL SELECTION HE; Fisher R. A., 1936, Ann Sci London, V1, P115, DOI 10.1080/00033793600200111; Franklin A., 2008, ENDING MENDEL FISHER, DOI 10.2307/j.ctv10tq47g; Harris JA, 1912, AM NAT, V46, P741, DOI 10.1086/279323; Hartl DL, 2007, GENETICS, V175, P975; Jamieson A., 2013, PHILOS BIOL COMPANIO; Lyon GJ, 2015, GENETICS OF NEURODEVELOPMENTAL DISORDERS, P289; Mendel G., 1866, VERHAND NATURF VER B, V4, P3, DOI DOI 10.5962/BHL.TITLE.61004; Montgomerie B., 2005, ISBE NEWSLETTER, V17, P16; Weldon W. F. R., PEARSON PAPERS U COL; Weldon WFR, 1901, BIOMETRIKA, V1, P228; Wolfe AJ, 2012, J HIST BIOL, V45, P389, DOI 10.1007/s10739-011-9291-7	15	20	20	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257					159	160		10.1126/science.aab3846	http://dx.doi.org/10.1126/science.aab3846			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS9JB	26450195	Green Accepted			2022-12-28	WOS:000362405600017
J	Band, G; Rockett, KA; Spencer, CCA; Kwiatkowski, DP; Band, G; Le, QS; Clarke, GM; Kivinen, K; Leffler, EM; Rockett, KA; Kwiatkowski, DP; Spencer, CCA; Rockett, KA; Spencer, CCA; Cornelius, V; Conway, DJ; Williams, TN; Taylor, T; Kwiatkowski, DP; Conway, DJ; Bojang, KA; Doumbo, O; Thera, MA; Modiano, D; Sirima, SB; Wilson, MD; Koram, KA; Agbenyega, T; Achidi, E; Williams, TN; Marsh, K; Reyburn, H; Drakeley, C; Riley, E; Taylor, T; Molyneux, M; Jallow, M; Bojang, KA; Conway, DJ; Pinder, M; Doumbo, O; Thera, MA; Toure, OB; Konate, S; Sissoko, S; Bougouma, EC; Mangano, VD; Modiano, D; Sirima, SB; Amenga-Etego, LN; Ghansah, AK; Hodgson, AVO; Koram, KA; Wilson, MD; Agbenyega, T; Ansong, D; Enimil, A; Evans, J; Achidi, E; Apinjoh, TO; Macharia, A; Marsh, K; Ndila, CM; Newton, C; Peshu, N; Uyoga, S; Williams, TN; Drakeley, C; Manjurano, A; Reyburn, H; Riley, E; Kachala, D; Molyneux, M; Nyirongo, V; Taylor, T; Rockett, KA; Kivinen, K; Mead, D; Drury, E; Auburn, S; Campino, SG; MacInnis, B; Stalker, J; Gray, E; Hubbart, C; Jeffreys, AE; Rowlands, K; Mendy, A; Craik, R; Fitzpatrick, K; Molloy, S; Hart, L; Hutton, R; Kerasidou, A; Johnson, KJ; Cornelius, V				Band, Gavin; Rockett, Kirk A.; Spencer, Chris C. A.; Kwiatkowski, Dominic P.; Band, Gavin; Le, Quang Si; Clarke, Geraldine M.; Kivinen, Katja; Leffler, Ellen M.; Rockett, Kirk A.; Kwiatkowski, Dominic P.; Spencer, Chris C. A.; Rockett, Kirk A.; Spencer, Chris C. A.; Cornelius, Victoria; Conway, David J.; Williams, Thomas N.; Taylor, Terrie; Kwiatkowski, Dominic P.; Conway, David J.; Bojang, Kalifa A.; Doumbo, Ogobara; Thera, Mahamadou A.; Modiano, David; Sirima, Sodiomon B.; Wilson, Michael D.; Koram, Kwadwo A.; Agbenyega, Tsiri; Achidi, Eric; Williams, Thomas N.; Marsh, Kevin; Reyburn, Hugh; Drakeley, Chris; Riley, Eleanor; Taylor, Terrie; Molyneux, Malcolm; Jallow, Muminatou; Bojang, Kalifa A.; Conway, David J.; Pinder, Margaret; Doumbo, Ogobara; Thera, Mahamadou A.; Toure, Ousmane B.; Konate, Salimata; Sissoko, Sibiri; Bougouma, Edith C.; Mangano, Valentina D.; Modiano, David; Sirima, Sodiomon B.; Amenga-Etego, Lucas N.; Ghansah, Anita K.; Hodgson, Abraham V. O.; Koram, Kwadwo A.; Wilson, Michael D.; Agbenyega, Tsiri; Ansong, Daniel; Enimil, Anthony; Evans, Jennifer; Achidi, Eric; Apinjoh, Tobias O.; Macharia, Alexander; Marsh, Kevin; Ndila, Carolyne M.; Newton, Charles; Peshu, Norbert; Uyoga, Sophie; Williams, Thomas N.; Drakeley, Chris; Manjurano, Alphaxard; Reyburn, Hugh; Riley, Eleanor; Kachala, David; Molyneux, Malcolm; Nyirongo, Vysaul; Taylor, Terrie; Rockett, Kirk A.; Kivinen, Katja; Mead, Daniel; Drury, Eleanor; Auburn, Sarah; Campino, Susana G.; MacInnis, Bronwyn; Stalker, Jim; Gray, Emma; Hubbart, Christina; Jeffreys, Anna E.; Rowlands, Kate; Mendy, Alieu; Craik, Rachel; Fitzpatrick, Kathryn; Molloy, Sile; Hart, Lee; Hutton, Robert; Kerasidou, Angeliki; Johnson, Kimberly J.; Cornelius, Victoria		Malaria Genomic Epidemiology	A novel locus of resistance to severe malaria in a region of ancient balancing selection	NATURE			English	Article							GENOME-WIDE ASSOCIATION; PLASMODIUM-FALCIPARUM; NATURAL-SELECTION; POPULATION-STRUCTURE; ORIGIN; SUSCEPTIBILITY; POLYMORPHISMS; GLYCOPHORINS; ALGORITHM; RECEPTOR	The high prevalence of sickle haemoglobin in Africa shows that malaria has been a major force for human evolutionary selection, but surprisingly few other polymorphisms have been proven to confer resistance to malaria in large epidemiological studies(1-3). To address this problem, we conducted a multi-centre genome-wide association study (GWAS) of life-threatening Plasmodium falciparum infection (severe malaria) in over 11,000 African children, with replication data in a further 14,000 individuals. Here we report a novel malaria resistance locus close to a cluster of genes encoding glycophorins that are receptors for erythrocyte invasion by P. falciparum. We identify a haplotype at this locus that provides 33% protection against severe malaria (odds ratio = 0.67, 95% confidence interval = 0.60-0.76, P value = 9.5 x 10(-11)) and is linked to polymorphisms that have previously been shown to have features of ancient balancing selection, on the basis of haplotype sharing between humans and chimpanzees(4). Taken together with previous observations on the malaria-protective role of blood group O-1-3,O-5, these data reveal that two of the strongest GWAS signals for severe malaria lie in or close to genes encoding the glycosylated surface coat of the erythrocyte cell membrane, both within regions of the genome where it appears that evolution has maintained diversity for millions of years. These findings provide new insights into the host-parasite interactions that are critical in determining the outcome of malaria infection.	[Band, Gavin; Rockett, Kirk A.; Spencer, Chris C. A.; Kwiatkowski, Dominic P.; Band, Gavin; Le, Quang Si; Clarke, Geraldine M.; Leffler, Ellen M.; Rockett, Kirk A.; Kwiatkowski, Dominic P.; Spencer, Chris C. A.; Rockett, Kirk A.; Spencer, Chris C. A.; Cornelius, Victoria; Kwiatkowski, Dominic P.; Rockett, Kirk A.; Auburn, Sarah; Hubbart, Christina; Jeffreys, Anna E.; Rowlands, Kate; Mendy, Alieu; Craik, Rachel; Fitzpatrick, Kathryn; Molloy, Sile; Hart, Lee; Hutton, Robert; Kerasidou, Angeliki; Johnson, Kimberly J.; Cornelius, Victoria] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Rockett, Kirk A.; Kivinen, Katja; Kwiatkowski, Dominic P.; Rockett, Kirk A.; Kwiatkowski, Dominic P.; Rockett, Kirk A.; Kivinen, Katja; Mead, Daniel; Drury, Eleanor; Campino, Susana G.; MacInnis, Bronwyn; Stalker, Jim; Gray, Emma] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Conway, David J.; Conway, David J.; Bojang, Kalifa A.; Jallow, Muminatou; Bojang, Kalifa A.; Conway, David J.; Pinder, Margaret] MRC Unit, Fajara, Gambia; [Conway, David J.; Conway, David J.] Univ London London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1E 7HT, England; [Williams, Thomas N.; Williams, Thomas N.; Marsh, Kevin; Macharia, Alexander; Marsh, Kevin; Ndila, Carolyne M.; Newton, Charles; Peshu, Norbert; Uyoga, Sophie; Williams, Thomas N.] KEMRI Wellcome Trust Res Programme CGMRC, Kilifi, Kenya; [Williams, Thomas N.; Williams, Thomas N.; Williams, Thomas N.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Med, London SW7 2AZ, England; [Taylor, Terrie; Taylor, Terrie; Taylor, Terrie] Queen Elizabeth Cent Hosp, Coll Med, Blantyre Malaria Project, Chichiri, Malawi; [Taylor, Terrie; Taylor, Terrie; Taylor, Terrie] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA; [Doumbo, Ogobara; Thera, Mahamadou A.; Doumbo, Ogobara; Thera, Mahamadou A.; Toure, Ousmane B.; Konate, Salimata; Sissoko, Sibiri] Univ Bamako, Fac Med, Malaria Res & Training Ctr, Bamako, Mali; [Modiano, David; Mangano, Valentina D.; Modiano, David] Univ Roma La Sapienza, I-00185 Rome, Italy; [Sirima, Sodiomon B.; Bougouma, Edith C.; Sirima, Sodiomon B.] CNRFP, Ouagadougou, Burkina Faso; [Wilson, Michael D.; Koram, Kwadwo A.; Ghansah, Anita K.; Koram, Kwadwo A.; Wilson, Michael D.] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Accra, Ghana; [Agbenyega, Tsiri; Agbenyega, Tsiri; Ansong, Daniel; Enimil, Anthony; Mendy, Alieu] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Agbenyega, Tsiri; Ansong, Daniel] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Achidi, Eric; Achidi, Eric] Univ Buea, Dept Med Lab Sci, Buea, South West Regi, Cameroon; [Reyburn, Hugh; Drakeley, Chris; Drakeley, Chris; Manjurano, Alphaxard; Reyburn, Hugh] Kilimanjaro Christian Med Ctr, Joint Malaria Programme, Moshi, Tanzania; [Reyburn, Hugh; Drakeley, Chris; Riley, Eleanor; Drakeley, Chris; Manjurano, Alphaxard; Reyburn, Hugh; Riley, Eleanor] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England; [Molyneux, Malcolm; Kachala, David; Molyneux, Malcolm; Nyirongo, Vysaul] Queen Elizabeth Cent Hosp, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Jallow, Muminatou] Royal Victoria Teaching Hosp, Banjul, Gambia; [Amenga-Etego, Lucas N.; Hodgson, Abraham V. O.] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Evans, Jennifer] Bernhard Nocht Inst Trop Med, Dept Mol Med, D-20324 Hamburg, Germany; [Evans, Jennifer] KNUST, Sch Med Sci, Kumasi Ctr Collaborat Res, Kumasi, Ghana; [Apinjoh, Tobias O.] Univ Buea, Dept Biochem & Mol Biol, Buea, South West Regi, Cameroon; [Kerasidou, Angeliki] Univ Oxford, Nuffield Dept Populat Hlth, Ethox Ctr, Oxford OX3 7LF, England	University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of Malawi; Michigan State University; Michigan State University College of Osteopathic Medicine; University of Bamako; Sapienza University Rome; University of Ghana; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Kilimanjaro Christian Medical Centre; University of London; London School of Hygiene & Tropical Medicine; University of Malawi; Navrongo Health Research Center; Bernhard Nocht Institut fur Tropenmedizin; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; University of Oxford	Band, G (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.		Leffler, Ellen/I-3010-2019; Newton, Charles RJC/B-7578-2014; Campino, Susana/AAM-2577-2020; Enimil, Anthony/AAV-2595-2021; Mead, Daniel/AAE-6629-2019; Riley, Eleanor/AAL-1382-2020; Newton, Charles/V-7872-2019; Pinder, Margaret/AAQ-7129-2020; Riley, Eleanor M/C-8960-2013; Le, Quang/A-4861-2012; Auburn, Sarah/N-2266-2013	Leffler, Ellen/0000-0002-1614-9366; Newton, Charles RJC/0000-0002-6999-5507; Campino, Susana/0000-0003-1403-6138; Mead, Daniel/0000-0001-7717-4330; Riley, Eleanor/0000-0003-3447-3570; Newton, Charles/0000-0002-6999-5507; Riley, Eleanor M/0000-0003-3447-3570; Bojang, Kalifa/0000-0001-7506-0938; Le, Quang/0000-0002-3715-210X; Auburn, Sarah/0000-0002-4638-536X; Kivinen, Katja/0000-0002-1135-7625; Apinjoh, Tobias/0000-0001-9889-7271; SIRIMA, Sodiomon Bienvenu/0000-0002-0972-4211; Mangano, Valentina D/0000-0002-2021-6162; Hart, Lee/0000-0002-6473-0964; ANSONG, Daniel/0000-0003-1328-9117; Conway, David/0000-0002-8711-3037; Thera, Mahamadou A/0000-0002-2679-035X; Spencer, Christopher/0000-0002-8508-456X; Kwiatkowski, Dominic/0000-0002-5023-0176; Johnson, Kimberly J/0000-0002-6365-906X; Band, Gavin/0000-0002-1710-9024; Uyoga, Sophie/0000-0003-1746-7873	Wellcome Trust [WT077383/Z/05/Z, 090770/Z/09/Z, 075491/Z/04, 090532/Z/09/Z, 077012/Z/05/Z, 098051, 076934/Z/05/Z, 091758/Z/10/Z, 084538]; Bill & Melinda Gates Foundation through the Foundations of the National Institutes of Health (NIH) as part of the Grand Challenges in Global Health Initiative [566]; Medical Research Council (MRC) [G0600718, G0600230]; Wellcome Trust Biomedical ethics Enhancement Award [087285]; Strategic Award [096527]; MRC [G19/9, G9901439]; Wellcome Trust Career Development Fellowship [097364/Z/11/Z]; National Institute of Allergy and Infectious Diseases (NIAID) [N01AI85346, U19AI065683]; Fogarty International Centre, NIH [D43TW001589]; Mali-NIAID/NIH International Center for Excellence in Research at the University of Sciences, Techniques, and Technology of Bamako; European Community's Seventh Framework Programme (FP7) [242095-EVIMalaR]; Central African Network for Tuberculosis, HIV/AIDS and Malaria (CANTAM) - European and Developing Countries Clinical Trials Partnership (EDCTP); FOGARTY INTERNATIONAL CENTER [D43TW001589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI085346, U19AI065683] Funding Source: NIH RePORTER; Medical Research Council [G0600718, G19/9, MR/M006212/1, G0600230] Funding Source: researchfish; MRC [G0600718, G0600230, MC_UP_A900_1118, MR/M006212/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Bill & Melinda Gates Foundation through the Foundations of the National Institutes of Health (NIH) as part of the Grand Challenges in Global Health Initiative; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Biomedical ethics Enhancement Award(Wellcome Trust); Strategic Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Career Development Fellowship(Wellcome Trust); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Centre, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Mali-NIAID/NIH International Center for Excellence in Research at the University of Sciences, Techniques, and Technology of Bamako; European Community's Seventh Framework Programme (FP7)(European Commission); Central African Network for Tuberculosis, HIV/AIDS and Malaria (CANTAM) - European and Developing Countries Clinical Trials Partnership (EDCTP); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Malaria Genomic Epidemiology Network Project is supported by the Wellcome Trust (WT077383/Z/05/Z) and the Bill & Melinda Gates Foundation through the Foundations of the National Institutes of Health (NIH; 566) as part of the Grand Challenges in Global Health Initiative. The Resource Centre for Genomic Epidemiology of Malaria is supported by the Wellcome Trust (090770/Z/09/Z). This research was supported by the Medical Research Council (MRC; G0600718; G0600230), the Wellcome Trust Biomedical ethics Enhancement Award (087285) and Strategic Award (096527). D.P.K. receives support from the MRC (G19/9). C.C.A.S. was supported by a Wellcome Trust Career Development Fellowship (097364/Z/11/Z). The Wellcome Trust also provides core awards to The Wellcome Trust Centre for Human Genetics (075491/Z/04; 090532/Z/09/Z) and the Wellcome Trust Sanger Institute (077012/Z/05/Z and 098051). The Mali MRTC-BMP group is supported by a contract (N01AI85346) and a cooperative agreement (U19AI065683) from the National Institute of Allergy and Infectious Diseases (NIAID) and by a grant (D43TW001589) from the Fogarty International Centre, NIH to University of Maryland and University of Bamako and the Mali-NIAID/NIH International Center for Excellence in Research at the University of Sciences, Techniques, and Technology of Bamako. E.A. received partial funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 242095-EVIMalaR and the Central African Network for Tuberculosis, HIV/AIDS and Malaria (CANTAM) funded by the European and Developing Countries Clinical Trials Partnership (EDCTP). T.N.W. is funded by Senior Fellowships from the Wellcome Trust (076934/Z/05/Z and 091758/Z/10/Z) and through the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 242095-EVIMalaR. The KEMRI-Wellcome Trust Programme is funded through core support from the Wellcome Trust. C.M.N. is supported through a strategic award to the KEMRI-Wellcome Trust Programme by the Wellcome Trust (084538). Tanzania/Kilimanjaro Christian Medical College Joint Malaria Programme, Moshi, Tanzania received funding from MRC grant number G9901439. We acknowledge the work of B. Poudiougou and A. Niangaly for their help in collecting clinical data and biological samples for the Bamako study. We thank L. Jostins and M. Pirinen for advice on statistical analyses.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Auguie B, 2017, GRIDEXTRA MISCELLANE; Band G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003509; Baum J, 2002, MOL BIOL EVOL, V19, P223, DOI 10.1093/oxfordjournals.molbev.a004075; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bellenguez C, 2012, BIOINFORMATICS, V28, P134, DOI 10.1093/bioinformatics/btr599; Binks RH, 2001, MOL BIOCHEM PARASIT, V114, P63, DOI 10.1016/S0166-6851(01)00240-7; BLUMENFELD OO, 1995, HUM MUTAT, V6, P199, DOI 10.1002/humu.1380060302; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carrel L, 1999, P NATL ACAD SCI USA, V96, P14440, DOI 10.1073/pnas.96.25.14440; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Fry AE, 2008, HUM MOL GENET, V17, P567, DOI 10.1093/hmg/ddm331; Giannoulatou E, 2008, BIOINFORMATICS, V24, P2209, DOI 10.1093/bioinformatics/btn386; Gilbert SC, 1998, SCIENCE, V279, P1173, DOI 10.1126/science.279.5354.1173; Gurdasani D, 2015, NATURE, V517, P327, DOI 10.1038/nature13997; Hillier LW, 2005, NATURE, V434, P724, DOI 10.1038/nature03466; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; Karlsson EK, 2014, NAT REV GENET, V15, P379, DOI 10.1038/nrg3734; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Ko WY, 2011, AM J HUM GENET, V88, P741, DOI 10.1016/j.ajhg.2011.05.005; Lanzillotti R, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-100; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Leffler EM, 2013, SCIENCE, V339, P1578, DOI 10.1126/science.1234070; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Manjurano A, 2015, J INFECT DIS, V212, P1129, DOI 10.1093/infdis/jiv192; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Mayer DCG, 2009, P NATL ACAD SCI USA, V106, P5348, DOI 10.1073/pnas.0900878106; Otto TD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5754; Pirinen M, 2013, ANN APPL STAT, V7, P369, DOI 10.1214/12-AOAS586; Prugnolle F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001283; Rich SM, 2009, P NATL ACAD SCI USA, V106, P14902, DOI 10.1073/pnas.0907740106; Rockett KA, 2014, NAT GENET, V46, P1197, DOI 10.1038/ng.3107; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Segurel L, 2012, P NATL ACAD SCI USA, V109, P18493, DOI 10.1073/pnas.1210603109; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Su Z, 2009, STAT SCI, V24, P430, DOI 10.1214/09-STS311; Tarazona-Santos E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016123; Teo Yik Ying, 2012, Methods Mol Biol, V850, P525, DOI 10.1007/978-1-61779-555-8_29; Teo YY, 2010, NAT REV GENET, V11, P149, DOI 10.1038/nrg2731; Timmann C, 2012, NATURE, V489, P443, DOI 10.1038/nature11334; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Wang HY, 2003, MOL BIOL EVOL, V20, P1795, DOI 10.1093/molbev/msg185; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	52	121	121	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					253	+		10.1038/nature15390	http://dx.doi.org/10.1038/nature15390			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26416757	Green Accepted, Green Submitted			2022-12-28	WOS:000362399000047
J	Biggin, AJ; Piispa, EJ; Pesonen, LJ; Holme, R; Paterson, GA; Veikkolainen, T; Tauxe, L				Biggin, A. J.; Piispa, E. J.; Pesonen, L. J.; Holme, R.; Paterson, G. A.; Veikkolainen, T.; Tauxe, L.			Palaeomagnetic field intensity variations suggest Mesoproterozoic inner-core nucleation	NATURE			English	Article							GEOMAGNETIC-FIELD; TRANSPORT-PROPERTIES; PALEOINTENSITY; IRON; CONDUCTIVITY; EVOLUTION	The Earth's inner core grows by the freezing of liquid iron at its surface. The point in history at which this process initiated marks a step-change in the thermal evolution of the planet. Recent computational and experimental studies(1-5) have presented radically differing estimates of the thermal conductivity of the Earth's core, resulting in estimates of the timing of inner-core nucleation ranging from less than half a billion to nearly two billion years ago. Recent inner-core nucleation (high thermal conductivity) requires high outer-core temperatures in the early Earth that complicate models of thermal evolution. The nucleation of the core leads to a different convective regime(6) and potentially different magnetic field structures that produce an observable signal in the palaeomagnetic record and allow the date of inner-core nucleation to be estimated directly. Previous studies searching for this signature have been hampered by the paucity of palaeomagnetic intensity measurements, by the lack of an effective means of assessing their reliability, and by shorter-timescale geo-magnetic variations. Here we examine results from an expanded Precambrian database of palaeomagnetic intensity measurements(7) selected using a new set of reliability criteria(8). Our analysis provides intensity-based support for the dominant dipolarity of the time-averaged Precambrian field, a crucial requirement for palaeomagnetic reconstructions of continents. We also present firm evidence for the existence of very long-term variations in geomagnetic strength. The most prominent and robust transition in the record is an increase in both average field strength and variability that is observed to occur between a billion and 1.5 billion years ago. This observation is most readily explained by the nucleation of the inner core occurring during this interval(9); the timing would tend to favour a modest value of core thermal conductivity and supports a simple thermal evolution model for the Earth.	[Biggin, A. J.; Holme, R.] Univ Liverpool, Dept Earth Ocean & Ecol Sci, Liverpool L69 7ZE, Merseyside, England; [Piispa, E. J.] Michigan Technol Univ, Dept Geol & Min Engn & Sci, Houghton, MI 49931 USA; [Pesonen, L. J.; Veikkolainen, T.] Univ Helsinki, Dept Phys, Div Mat Phys, FI-00014 Helsinki, Finland; [Paterson, G. A.] Chinese Acad Sci, Inst Geol & Geophys, Key Lab Earth & Planetary Phys, Beijing 100029, Peoples R China; [Tauxe, L.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of Liverpool; Michigan Technological University; University of Helsinki; Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; University of California System; University of California San Diego; Scripps Institution of Oceanography	Biggin, AJ (corresponding author), Univ Liverpool, Dept Earth Ocean & Ecol Sci, Liverpool L69 7ZE, Merseyside, England.	biggin@liv.ac.uk	Biggin, Andy J/P-6975-2018; Paterson, Greig A/J-4537-2012	Biggin, Andy J/0000-0003-4164-5924; Paterson, Greig A/0000-0002-6864-7420; Veikkolainen, Toni/0000-0003-2740-6185; Pesonen, Lauri J./0000-0001-7410-4193; Piispa, Elisa/0000-0002-5054-0457	European Research Council (ERC) [267631]; Research Council of Norway through its Centres of Excellence funding scheme [CEED 223272]; NERC standard grant [NE/H021043/1]; NSFC [41374072]; NSF [EAR 1345003]; NERC [NE/H021043/1] Funding Source: UKRI; Natural Environment Research Council [NE/H021043/1] Funding Source: researchfish; Directorate For Geosciences [1345003] Funding Source: National Science Foundation	European Research Council (ERC)(European Research Council (ERC)European Commission); Research Council of Norway through its Centres of Excellence funding scheme; NERC standard grant(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NSFC(National Natural Science Foundation of China (NSFC)); NSF(National Science Foundation (NSF)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank T. Torsvik for organising the 7th Nordic Supercontinents Meeting and acknowledge financial support for this from the European Research Council (ERC Advanced Grant 267631) and the Research Council of Norway through its Centres of Excellence funding scheme (CEED 223272). We also thank J. Rees and L. Waszek for discussions. A.J.B. acknowledges funding from a NERC standard grant (NE/H021043/1). G.A.P. acknowledges funding from an NSFC grant (41374072). L. T. acknowledges funding from an NSF grant (EAR 1345003).	Aubert J, 2010, SPACE SCI REV, V155, P337, DOI 10.1007/s11214-010-9684-5; Aubert J, 2009, GEOPHYS J INT, V179, P1414, DOI 10.1111/j.1365-246X.2009.04361.x; Biggin AJ, 2012, NAT GEOSCI, V5, P526, DOI [10.1038/ngeo1521, 10.1038/NGEO1521]; Biggin AJ, 2003, GEOPHYS J INT, V152, P392, DOI 10.1046/j.1365-246X.2003.01849.x; Biggin AJ, 2008, NAT GEOSCI, V1, P395, DOI 10.1038/ngeo181; Biggin AJ, 2014, FRONT EARTH SC-SWITZ, V2, DOI 10.3389/feart.2014.00024; Biggin AJ, 2009, EARTH PLANETS SPACE, V61, P9, DOI 10.1186/BF03352881; de Groot LV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5548; de Koker N, 2012, P NATL ACAD SCI USA, V109, P4070, DOI 10.1073/pnas.1111841109; Dunlop DJ, 2004, GEOPHYS MONOGR SER, V145, P85, DOI 10.1029/145GM07; Evans DAD, 2006, NATURE, V444, P51, DOI 10.1038/nature05203; Gomi H, 2013, PHYS EARTH PLANET IN, V224, P88, DOI 10.1016/j.pepi.2013.07.010; Hunt SA, 2012, EARTH PLANET SC LETT, V319, P96, DOI 10.1016/j.epsl.2011.12.009; Kulakov EV, 2013, STUD GEOPHYS GEOD, V57, P565, DOI 10.1007/s11200-013-0606-3; Macouin M, 2004, PHYS EARTH PLANET IN, V147, P239, DOI 10.1016/j.pepi.2004.07.003; Pozzo M, 2012, NATURE, V485, P355, DOI 10.1038/nature11031; PREVOT M, 1992, GEOPHYS J INT, V108, P613, DOI 10.1111/j.1365-246X.1992.tb04640.x; Seagle CT, 2013, GEOPHYS RES LETT, V40, P5377, DOI 10.1002/2013GL057930; Shaar R, 2015, P NATL ACAD SCI USA, V112, P11187, DOI 10.1073/pnas.1507986112; Smirnov AV, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003445; Tarduno J. A., 2004, GEOPHYS MONOGR SER, V145, P328; Tauxe L, 2013, GEOCHEM GEOPHY GEOSY, V14, P4718, DOI 10.1002/ggge.20282; Tauxe L., 2007, TREATISE GEOPHYS, V5, P510; THOMAS N, 1993, PHYS EARTH PLANET IN, V75, P329, DOI 10.1016/0031-9201(93)90008-W; Valet JP, 2014, GEOCHEM GEOPHY GEOSY, V15, P2426, DOI 10.1002/2014GC005296; Valet JP, 2005, NATURE, V435, P802, DOI 10.1038/nature03674; Valet JP, 2003, REV GEOPHYS, V41, DOI 10.1029/2001RG000104; VANDERVOO R, 1990, TECTONOPHYSICS, V184, P1, DOI 10.1016/0040-1951(90)90116-P; Veikkolainen T, 2014, GEOPHYS J INT, V199, P1515, DOI 10.1093/gji/ggu348; Veikkolainen T, 2014, PRECAMBRIAN RES, V244, P23, DOI 10.1016/j.precamres.2013.09.004; Zhang P, 2015, NATURE, V517, P605, DOI 10.1038/nature14090; Ziegler LB, 2011, GEOPHYS J INT, V184, P1069, DOI 10.1111/j.1365-246X.2010.04905.x	32	132	137	4	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					245	+		10.1038/nature15523	http://dx.doi.org/10.1038/nature15523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26450058				2022-12-28	WOS:000362399000045
J	Cameron, A				Cameron, Andrew			Eric H. Davidson (1937-2015) OBITUARY	NATURE			English	Biographical-Item									[Cameron, Andrew] CALTECH, Pasadena, CA 91125 USA; [Cameron, Andrew] CALTECH, Div Biol & Biol Engn, Eric Davidsons Grp, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Cameron, A (corresponding author), CALTECH, Pasadena, CA 91125 USA.	acameron@caltech.edu						DAVIDSON EH, PUBLICATION LIST	1	3	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					196	196		10.1038/526196a	http://dx.doi.org/10.1038/526196a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26450050	Bronze			2022-12-28	WOS:000362399000030
J	Koch, C; Buice, MA				Koch, Christof; Buice, Michael A.			A Biological Imitation Game	CELL			English	Review							RECONSTRUCTION; POPULATIONS; NEURONS	The digital reconstruction of a slice of rat somatosensory cortex from the Blue Brain Project provides the most complete simulation of a piece of excitable brain matter to date. To place these efforts in context and highlight their strengths and limitations, we introduce a Biological Imitation Game, based on Alan Turing's Imitation Game, that operationalizes the difference between real and simulated brains.	[Koch, Christof; Buice, Michael A.] Allen Inst Brain Sci, Seattle, WA 98109 USA	Allen Institute for Brain Science	Koch, C (corresponding author), Allen Inst Brain Sci, Seattle, WA 98109 USA.	christofk@alleninstitute.org		Koch, Christof/0000-0001-6482-8067				AMARI SI, 1975, BIOL CYBERN, V17, P211, DOI 10.1007/BF00339367; Bauer P, 2015, NATURE, V525, P47, DOI 10.1038/nature14956; BEURLE RL, 1956, PHILOS T ROY SOC B, V240, P55, DOI 10.1098/rstb.1956.0012; Bressloff PC, 2014, LECT N MATH MODEL LI, P1, DOI 10.1007/978-1-4614-8866-8; Carnevale NT, 2006, NEURON BOOK; Harris KD, 2015, NAT NEUROSCI, V18, P170, DOI 10.1038/nn.3917; Hay E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002107; Kandel ER, 2013, NAT REV NEUROSCI, V14, P659, DOI 10.1038/nrn3578; Kasthuri N, 2015, CELL, V162, P648, DOI 10.1016/j.cell.2015.06.054; Koch C, 2006, NATURE, V440, P611, DOI 10.1038/440611a; Koch Christof, 1999, P1; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Markram H, 2015, CELL, V163, P456, DOI 10.1016/j.cell.2015.09.029; Okun M, 2015, NATURE, V521, P511, DOI 10.1038/nature14273; Ramaswamy S, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00044; Reimann MW, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00120; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; STRASSBERG AF, 1993, NEURAL COMPUT, V5, P843, DOI 10.1162/neco.1993.5.6.843; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Xu WF, 2007, NEURON, V55, P119, DOI 10.1016/j.neuron.2007.06.016	21	9	9	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2					277	280		10.1016/j.cell.2015.09.045	http://dx.doi.org/10.1016/j.cell.2015.09.045			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26451478	Bronze			2022-12-28	WOS:000362952700005
J	Urbach, DR				Urbach, David R.			Pledging to Eliminate Low-Volume Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MORTALITY; QUALITY		[Urbach, David R.] Univ Toronto, Dept Surg, Toronto, ON M5S 1A1, Canada; [Urbach, David R.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5S 1A1, Canada; [Urbach, David R.] Univ Hlth Network, Dept Surg, Toronto, ON, Canada; [Urbach, David R.] Univ Hlth Network, Dept Support Syst & Outcomes, Toronto, ON, Canada; [Urbach, David R.] Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Urbach, DR (corresponding author), Univ Toronto, Dept Surg, Toronto, ON M5S 1A1, Canada.							Dimick JB, 2004, JAMA-J AM MED ASSOC, V292, P847, DOI 10.1001/jama.292.7.847; Finks JF, 2011, NEW ENGL J MED, V364, P2128, DOI 10.1056/NEJMsa1010705; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; Osborne NH, 2015, JAMA-J AM MED ASSOC, V313, P496, DOI 10.1001/jama.2015.25; Sternberg S., 2015, US NEWS WORLD REPORT	5	182	183	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2015	373	15					1388	1390		10.1056/NEJMp1508472	http://dx.doi.org/10.1056/NEJMp1508472			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS8XI	26444728				2022-12-28	WOS:000362372800002
J	Skinner, AC; Perrin, EM; Moss, LA; Skelton, JA				Skinner, Asheley C.; Perrin, Eliana M.; Moss, Leslie A.; Skelton, Joseph A.			Cardiometabolic Risks and Severity of Obesity in Children and Young Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS INDEX; ADOLESCENT OVERWEIGHT; WEIGHT STATUS; HEALTH; PREVENTION; PREVALENCE; CHILDHOOD; TRENDS; COMMITTEE; BURDEN	BACKGROUND The prevalence of severe obesity among children and young adults has increased over the past decade. Although the prevalence of cardiometabolic risk factors is relatively low among children and young adults who are overweight or obese, those with more severe forms of obesity may be at greater risk. METHODS We performed a cross-sectional analysis of data from overweight or obese children and young adults 3 to 19 years of age who were included in the National Health and Nutrition Examination Survey from 1999 through 2012 to assess the prevalence of multiple cardiometabolic risk factors according to the severity of obesity. Weight status was classified on the basis of measured height and weight. We used standard definitions of abnormal values for total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein cholesterol, triglycerides, blood pressure, glycated hemoglobin, and fasting glucose and report the prevalence of abnormal values in children and young adults according to weight status. RESULTS Among 8579 children and young adults with a body-mass index at the 85th percentile or higher (according to the Centers for Disease Control and Prevention growth charts), 46.9% were overweight, 36.4% had class I obesity, 11.9% had class II obesity, and 4.8% had class III obesity. Mean values for some, but not all, cardiometabolic variables were higher with greater severity of obesity in both male and female participants, and the values were higher in male participants than in female participants; for HDL cholesterol, the mean values were lower with greater severity of obesity. Multivariable models that controlled for age, race or ethnic group, and sex showed that the greater the severity of obesity, the higher the risks of a low HDL cholesterol level, high systolic and diastolic blood pressures, and high triglyceride and glycated hemoglobin levels. CONCLUSIONS Severe obesity in children and young adults was associated with an increased prevalence of cardiometabolic risk factors, particularly among boys and young men.	[Skinner, Asheley C.; Perrin, Eliana M.] Univ N Carolina, Dept Pediat, Div Gen Pediat & Adolescent Med, Sch Med, Chapel Hill, NC 27599 USA; [Skinner, Asheley C.] Univ N Carolina, Dept Hlth Policy & Management, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Moss, Leslie A.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Skelton, Joseph A.] Brenner Childrens Hosp, Dept Pediat, Wake Forest Sch Med, Winston Salem, NC USA; [Skelton, Joseph A.] Brenner Childrens Hosp, Brenner FIT Families Training, Winston Salem, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Wake Forest University	Skinner, AC (corresponding author), Univ N Carolina, Sch Med, Dept Pediat, 231 MacNider,229B,CB 7225, Chapel Hill, NC 27599 USA.	asheley@unc.edu	Skinner, Asheley/Q-5793-2016					Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062]; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2011, SAS PROGR 2000 CDC G; Centers for Disease Control and Prevention, 2013, NAT HLTH NUTR EX SUR; Children's Hospital Association, OB SERV 2013 SURV FI; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; Danielsson P, 2012, ARCH PEDIAT ADOL MED, V166, P1103, DOI 10.1001/2013.jamapediatrics.319; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Dietz WH, 2015, LANCET, V385, P2521, DOI 10.1016/S0140-6736(14)61748-7; Engeland A, 2004, EPIDEMIOLOGY, V15, P79, DOI 10.1097/01.ede.0000100148.40711.59; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; Field AE, 2005, OBES RES, V13, P163, DOI 10.1038/oby.2005.21; Finkelstein EA, 2008, OBESITY, V16, P1843, DOI 10.1038/oby.2008.290; Flegal KM, 2009, AM J CLIN NUTR, V90, P1314, DOI 10.3945/ajcn.2009.28335; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Freedman DS, 2007, J PEDIATR-US, V150, P12, DOI 10.1016/j.jpeds.2006.08.042; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Guo SS, 2002, AM J CLIN NUTR, V76, P653, DOI 10.1093/ajcn/76.3.653; Inge TH, 2013, PEDIATRICS, V132, P1098, DOI 10.1542/peds.2013-2185; Johnson Clifford L, 2013, Vital Health Stat 2, P1; Johnston CA, 2011, J PEDIATR-US, V158, P624, DOI 10.1016/j.jpeds.2010.09.049; Kalarchian MA, 2009, PEDIATRICS, V124, P1060, DOI 10.1542/peds.2008-3727; Kavey REW, 2003, J PEDIATR-US, V142, P368, DOI 10.1067/mpd.2003.205; Kelly AS, 2013, CIRCULATION, V128, P1689, DOI 10.1161/CIR.0b013e3182a5cfb3; Kit BK, 2015, JAMA PEDIATR, V169, P272, DOI 10.1001/jamapediatrics.2014.3216; Krebs NF, 2007, PEDIATRICS, V120, pS193, DOI 10.1542/peds.2007-2329D; Lambert M, 2008, CAN J CARDIOL, V24, P575, DOI 10.1016/S0828-282X(08)70639-1; National Center for Health Statistics, NAT HLTH NUTR EX SUR; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Schwimmer JB, 2003, JAMA-J AM MED ASSOC, V289, P1813, DOI 10.1001/jama.289.14.1813; Skelton JA, 2009, ACAD PEDIATR, V9, P322, DOI 10.1016/j.acap.2009.04.005; Skinner AC, 2008, PEDIATRICS, V121, pE269, DOI 10.1542/peds.2007-0874; Skinner AC, 2014, JAMA PEDIATR, V168, P561, DOI 10.1001/jamapediatrics.2014.21; Steiner MJ, 2011, PEDIATRICS, V128, P463, DOI 10.1542/peds.2011-0844; Trasande L, 2009, OBESITY, V17, P1749, DOI 10.1038/oby.2009.67; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Whitlock EP, 2010, PEDIATRICS, V125, pE396, DOI 10.1542/peds.2009-1955	39	495	513	7	59	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2015	373	14					1307	1317		10.1056/NEJMoa1502821	http://dx.doi.org/10.1056/NEJMoa1502821			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3CI	26422721	Bronze			2022-12-28	WOS:000361948600005
J	Sudmant, PH; Rausch, T; Gardner, EJ; Handsaker, RE; Abyzov, A; Huddleston, J; Zhang, Y; Ye, K; Jun, G; Fritz, MHY; Konkel, MK; Malhotra, A; Stutz, AM; Shi, XH; Casale, FP; Chen, JM; Hormozdiari, F; Dayama, G; Chen, K; Malig, M; Chaisson, MJP; Walter, K; Meiers, S; Kashin, S; Garrison, E; Auton, A; Lam, HYK; Mu, XJ; Alkan, C; Antaki, D; Bae, T; Cerveira, E; Chines, P; Chong, ZC; Clarke, L; Dal, E; Ding, L; Emery, S; Fan, X; Gujral, M; Kahveci, F; Kidd, JM; Kong, Y; Lameijer, EW; McCarthy, S; Flicek, P; Gibbs, RA; Marth, G; Mason, CE; Menelaou, A; Muzny, DM; Nelson, BJ; Noor, A; Parrish, NF; Pendleton, M; Quitadamo, A; Raeder, B; Schadt, EE; Romanovitch, M; Schlattl, A; Sebra, R; Shabalin, AA; Untergasser, A; Walker, JA; Wang, M; Yu, FL; Zhang, CS; Zhang, J; Zheng-Bradley, X; Zhou, WD; Zichner, T; Sebat, J; Batzer, MA; McCarroll, SA; Mills, RE; Gerstein, MB; Bashir, A; Stegle, O; Devine, SE; Lee, C; Eichler, EE; Korbel, JO				Sudmant, Peter H.; Rausch, Tobias; Gardner, Eugene J.; Handsaker, Robert E.; Abyzov, Alexej; Huddleston, John; Zhang, Yan; Ye, Kai; Jun, Goo; Fritz, Markus Hsi-Yang; Konkel, Miriam K.; Malhotra, Ankit; Stuetz, Adrian M.; Shi, Xinghua; Casale, Francesco Paolo; Chen, Jieming; Hormozdiari, Fereydoun; Dayama, Gargi; Chen, Ken; Malig, Maika; Chaisson, Mark J. P.; Walter, Klaudia; Meiers, Sascha; Kashin, Seva; Garrison, Erik; Auton, Adam; Lam, Hugo Y. K.; Mu, Xinmeng Jasmine; Alkan, Can; Antaki, Danny; Bae, Taejeong; Cerveira, Eliza; Chines, Peter; Chong, Zechen; Clarke, Laura; Dal, Elif; Ding, Li; Emery, Sarah; Fan, Xian; Gujral, Madhusudan; Kahveci, Fatma; Kidd, Jeffrey M.; Kong, Yu; Lameijer, Eric-Wubbo; McCarthy, Shane; Flicek, Paul; Gibbs, Richard A.; Marth, Gabor; Mason, Christopher E.; Menelaou, Androniki; Muzny, Donna M.; Nelson, Bradley J.; Noor, Amina; Parrish, Nicholas F.; Pendleton, Matthew; Quitadamo, Andrew; Raeder, Benjamin; Schadt, Eric E.; Romanovitch, Mallory; Schlattl, Andreas; Sebra, Robert; Shabalin, Andrey A.; Untergasser, Andreas; Walker, Jerilyn A.; Wang, Min; Yu, Fuli; Zhang, Chengsheng; Zhang, Jing; Zheng-Bradley, Xiangqun; Zhou, Wanding; Zichner, Thomas; Sebat, Jonathan; Batzer, Mark A.; McCarroll, Steven A.; Mills, Ryan E.; Gerstein, Mark B.; Bashir, Ali; Stegle, Oliver; Devine, Scott E.; Lee, Charles; Eichler, Evan E.; Korbel, Jan O.		Genomes Project Consortium	An integrated map of structural variation in 2,504 human genomes	NATURE			English	Article							COPY NUMBER VARIATION; INDIVIDUAL HUMAN GENOME; CNVS; TRANSCRIPTOME; MECHANISMS; INSIGHTS; DATABASE; REGIONS; IMPACT	Structural variants are implicated in numerous diseases and make up the majority of varying nucleotides among human genomes. Here we describe an integrated set of eight structural variant classes comprising both balanced and unbalanced variants, which we constructed using short-read DNA sequencing data and statistically phased onto haplotype blocks in 26 human populations. Analysing this set, we identify numerous gene-intersecting structural variants exhibiting population stratification and describe naturally occurring homozygous gene knockouts that suggest the dispensability of a variety of human genes. We demonstrate that structural variants are enriched on haplotypes identified by genome-wide association studies and exhibit enrichment for expression quantitative trait loci. Additionally, we uncover appreciable levels of structural variant complexity at different scales, including genic loci subject to clusters of repeated rearrangement and complex structural variants with multiple breakpoints likely to have formed through individual mutational events. Our catalogue will enhance future studies into structural variant demography, functional impact and disease association.	[Sudmant, Peter H.; Huddleston, John; Hormozdiari, Fereydoun; Malig, Maika; Chaisson, Mark J. P.; Nelson, Bradley J.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Rausch, Tobias; Fritz, Markus Hsi-Yang; Stuetz, Adrian M.; Meiers, Sascha; Raeder, Benjamin; Schlattl, Andreas; Untergasser, Andreas; Zichner, Thomas; Korbel, Jan O.] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Gardner, Eugene J.; Devine, Scott E.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Handsaker, Robert E.; Kashin, Seva; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Handsaker, Robert E.; Kashin, Seva; McCarroll, Steven A.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Abyzov, Alexej; Bae, Taejeong] Mayo Clin, Ctr Individualized Med, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Huddleston, John; Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Zhang, Yan; Chen, Jieming; Mu, Xinmeng Jasmine; Zhang, Jing; Gerstein, Mark B.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Zhang, Yan; Zhang, Jing; Gerstein, Mark B.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Ye, Kai; Ding, Li; Genomes Project Consortium] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Ye, Kai; Ding, Li] Washington Univ, Dept Genet, St Louis, MO 63108 USA; [Jun, Goo; Kidd, Jeffrey M.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Jun, Goo; Kidd, Jeffrey M.] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Jun, Goo] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Human Genet Ctr, Houston, TX 77030 USA; [Konkel, Miriam K.; Walker, Jerilyn A.; Batzer, Mark A.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Malhotra, Ankit; Cerveira, Eliza; Romanovitch, Mallory; Zhang, Chengsheng; Lee, Charles] Jackson Lab Genom Med, Farmington, CT 06030 USA; [Shi, Xinghua; Quitadamo, Andrew] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA; [Casale, Francesco Paolo; Clarke, Laura; Flicek, Paul; Zheng-Bradley, Xiangqun; Stegle, Oliver; Korbel, Jan O.] European Mol Biol Lab, EBI, Cambridge CB10 1SD, England; [Chen, Jieming] Yale Univ, Integrated Grad Program Phys & Engn Biol, New Haven, CT 06520 USA; [Dayama, Gargi; Mills, Ryan E.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Chen, Ken; Chong, Zechen; Fan, Xian; Zhou, Wanding] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Walter, Klaudia; McCarthy, Shane] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Garrison, Erik; Marth, Gabor] Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA; [Auton, Adam; Kong, Yu] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Lam, Hugo Y. K.] Bina Technol, Roche Sequencing, Redwood City, CA 94065 USA; [Mu, Xinmeng Jasmine] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA; [Alkan, Can; Dal, Elif; Kahveci, Fatma] Bilkent Univ, Dept Comp Engn, TR-06800 Ankara, Turkey; [Antaki, Danny; Gujral, Madhusudan; Noor, Amina; Sebat, Jonathan] Univ Calif San Diego, La Jolla, CA 92093 USA; [Chines, Peter] NHGRI, NIH, Bethesda, MD 20892 USA; [Ding, Li] Washington Univ, Dept Med, St Louis, MO 63108 USA; [Ding, Li] Siteman Canc Ctr, St Louis, MO 63110 USA; [Emery, Sarah; Kidd, Jeffrey M.; Mills, Ryan E.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Lameijer, Eric-Wubbo] Leiden Univ, Med Ctr, Mol Epidemiol, NL-2300 RA Leiden, Netherlands; [Gibbs, Richard A.; Wang, Min; Yu, Fuli] Baylor Coll Med, Houston, TX 77030 USA; [Mason, Christopher E.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Mason, Christopher E.] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10065 USA; [Mason, Christopher E.] Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA; [Menelaou, Androniki] Univ Oxford, Oxford OX3 9DS, England; [Menelaou, Androniki] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, NL-3584 CG Utrecht, Netherlands; [Muzny, Donna M.; Pendleton, Matthew; Schadt, Eric E.; Sebra, Robert; Bashir, Ali] Icahn Sch Med Mt Sinai, New York Sch Nat Sci, Dept Genet & Genom Sci, New York, NY 10029 USA; [Parrish, Nicholas F.] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan; [Shabalin, Andrey A.] Virginia Commonwealth Univ, Ctr Biomarker Res & Precis Med, Richmond, VA 23298 USA; [Untergasser, Andreas] Heidelberg Univ, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Gerstein, Mark B.] Yale Univ, Dept Comp Sci, New Haven, CT 06511 USA; [Lee, Charles] Ewha Womans Univ, Dept Grad Studies Life Sci, Seoul 120750, South Korea	University of Washington; University of Washington Seattle; European Molecular Biology Laboratory (EMBL); University System of Maryland; University of Maryland Baltimore; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Mayo Clinic; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Yale University; Yale University; Washington University (WUSTL); Washington University (WUSTL); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Louisiana State University System; Louisiana State University; Jackson Laboratory; University of North Carolina; University of North Carolina Charlotte; European Molecular Biology Laboratory (EMBL); Yale University; University of Michigan System; University of Michigan; University of Texas System; UTMD Anderson Cancer Center; Wellcome Trust Sanger Institute; Boston College; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Ihsan Dogramaci Bilkent University; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Washington University (WUSTL); Siteman Cancer Center; University of Michigan System; University of Michigan; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Baylor College of Medicine; Cornell University; Cornell University; Cornell University; University of Oxford; Utrecht University; Utrecht University Medical Center; Icahn School of Medicine at Mount Sinai; Kyoto University; Virginia Commonwealth University; Ruprecht Karls University Heidelberg; Yale University; Ewha Womans University	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, 3720 15th Ave NE, Seattle, WA 98195 USA.	eee@gs.washington.edu; korbel@embl.de	Jun, Goo/F-1941-2017; Handsaker, Bob/AAX-9095-2021; Zhou, Wanding/K-3709-2016; Ye, Kai/B-3640-2012; Alkan, Can/D-2982-2009; Rausch, Tobias/H-6511-2019; Untergasser, Andreas/AAA-7452-2022; Kahveci, Fatma/E-1621-2017; Mason, Christopher/HCH-3977-2022; Bae, Taejeong/AAW-6003-2021; Kahveci, Fatma/AAA-8614-2019; Mu, Xinmeng/P-2562-2016; Mills, Ryan/F-4225-2010; Abyzov, Alexej/AAT-4615-2020; Ye, Kai/GSD-9856-2022; Malhotra, Ankit/J-8130-2019; Stegle, Oliver/AAU-9177-2020; Chen, Ken/AAU-1432-2021; Zhang, Jing/K-4498-2017; Kahveci, Fatma/AAR-9126-2020; Jun, Goo/M-5235-2016; Abyzov, Alexej/M-4284-2013; Yu, Jin/E-3732-2013	Jun, Goo/0000-0003-0891-0204; Handsaker, Bob/0000-0002-3128-3547; Zhou, Wanding/0000-0001-9126-1932; Alkan, Can/0000-0002-5443-0706; Rausch, Tobias/0000-0001-5773-5620; Kahveci, Fatma/0000-0003-3096-1753; Bae, Taejeong/0000-0002-4626-3725; Kahveci, Fatma/0000-0003-3096-1753; Mu, Xinmeng/0000-0002-8079-0828; Mills, Ryan/0000-0003-3425-6998; Ye, Kai/0000-0002-2851-6741; Malhotra, Ankit/0000-0002-1905-0732; Stegle, Oliver/0000-0002-8818-7193; Chen, Ken/0000-0003-4013-5279; Kahveci, Fatma/0000-0003-3096-1753; Jun, Goo/0000-0003-0891-0204; Dayama, Gargi/0000-0003-1349-8998; Yu, Jin/0000-0002-2990-6602; Gerstein, Mark/0000-0002-9746-3719; Gardner, Eugene/0000-0001-9671-1533; Abyzov, Alexej/0000-0001-5405-6729; Parrish, Nicholas/0000-0002-6971-8016; Flicek, Paul/0000-0002-3897-7955; Antaki, Danny/0000-0003-0381-7801; Zichner, Thomas/0000-0001-9848-7598; Sebat, Jonathan/0000-0002-9087-526X; Mallory, Xian/0000-0003-0365-0909; Zhang, Yan/0000-0002-3357-5121; McCarthy, Shane/0000-0002-2715-4187; Chen, Jieming/0000-0003-3767-9486; Clarke, Laura/0000-0002-5989-6898; Sudmant, Peter/0000-0002-9573-8248; Keinan, Alon/0000-0002-9760-1122; Shabalin, Andrey/0000-0003-0309-6821; Raeder, Benjamin/0000-0002-9494-8884; Quitadamo, Andrew/0000-0001-8748-4586; Meiers, Sascha/0000-0003-2609-0000; Zheng Bradley, Xiangqun/0000-0002-9324-2708	NIH [U41HG007497, RO1GM59290, R01HG002898, R01CA166661, P01HG007497, R01HG007068, RR19895, RR029676-01]; Wellcome Trust [WT085532/Z/08/Z, WT104947/Z/14/Z]; German Research Foundation [KO4037/1-1]; European Molecular Biology Laboratory; NATIONAL CANCER INSTITUTE [R01CA166661, P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895, S10RR029676] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007068, R01HG002898, R01HG002385, U41HG007497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290, T32GM008666] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); German Research Foundation(German Research Foundation (DFG)); European Molecular Biology Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Hurles, R. Durbin and D. Reich for valuable comments during the preparation of this work, S. Scherer for providing PCR-based inversion genotyping data for the initial calibration of our inversion caller, B. Nelson and V. Benes for technical assistance, and T. Brown and N. Habermann for critical review of the manuscript. The following people are acknowledged for contributing to PacBio sequencing or analysis: E. Patel, S. Lee, H. Doddapaneni, L. Lewis, R. Ruth, Q. Meng, V. Vee, Y. Han, J. Jayaseelan, A. English, J. Korlach, M. Hunkapiller, B. Huttel and R. Reinhardt. We acknowledge the Yale University Biomedical High-Performance Computing Center and high-performance compute infrastructure made available through the EMBL and EMBL-EBI IT facilities. We thank the people generously contributing samples to the 1000 Genomes Project. Funding for this research project came from the following grants: NIH U41HG007497 (to C.L., E. E. E., J.O.K., M. A. B., M.G., S. A. M., R. E. M. and J. S.), RO1GM59290 (M. A. B.), R01HG002898 (S. E. D.) and R01CA166661 (S. E. D.), P01HG007497 (to E. E. E.), R01HG007068 (to R. E. M.), RR19895 and RR029676-01 (to M.B.G.), Wellcome Trust WT085532/Z/08/Z and WT104947/Z/14/Z (to P.F.), an Emmy Noether Grant from the German Research Foundation (KO4037/1-1, to J.O.K.) and the European Molecular Biology Laboratory. C.L. is on the scientific advisory board (SAB) of BioNano Genomics. E. E. E. is. on the scientific advisory board (SAB) of DNAnexus, Inc. and is a consultant for Kunming University of Science and Technology (KUST) as part of the 1000 China Talent Program. P.F. is on the SAB of Omicia, Inc. C.L. is an Ewha Womans University Distinguished Professor. E. E. E. is an investigator of the Howard Hughes Medical Institute. J.O.K. is a European Research Council investigator.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Girirajan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002334; Hach F, 2014, NUCLEIC ACIDS RES, V42, pW494, DOI 10.1093/nar/gku370; Handsaker RE, 2015, NAT GENET, V47, P296, DOI 10.1038/ng.3200; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; Kloosterman WP, 2015, GENOME RES, V25, P792, DOI 10.1101/gr.185041.114; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Martinez-Fundichely A, 2014, NUCLEIC ACIDS RES, V42, pD1027, DOI 10.1093/nar/gkt1122; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Moore T, 2014, INT J DEV BIOL, V58, P273, DOI 10.1387/ijdb.130329gd; Pang AW, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r52; Pendleton M, 2015, NAT METHODS, V12, P780, DOI [10.1038/nmeth.3454, 10.1038/NMETH.3454]; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Schlattl A, 2011, GENOME RES, V21, P2004, DOI 10.1101/gr.122614.111; Simons YB, 2014, NAT GENET, V46, P220, DOI 10.1038/ng.2896; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stewart C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002236; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Teague B, 2010, P NATL ACAD SCI USA, V107, P10848, DOI 10.1073/pnas.0914638107; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	39	1178	1215	9	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					75	+		10.1038/nature15394	http://dx.doi.org/10.1038/nature15394			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26432246	hybrid, Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000362095100037
J	Wang, T; Birsoy, K; Hughes, NW; Krupczak, KM; Post, Y; Wei, JJ; Lander, ES; Sabatini, DM				Wang, Tim; Birsoy, Kivanc; Hughes, Nicholas W.; Krupczak, Kevin M.; Post, Yorick; Wei, Jenny J.; Lander, Eric S.; Sabatini, David M.			Identification and characterization of essential genes in the human genome	SCIENCE			English	Article							CELL-LINE; DUPLICATE GENES; FUSION; CHROMOSOMES; SCREENS	Large-scale genetic analysis of lethal phenotypes has elucidated the molecular underpinnings of many biological processes. Using the bacterial clustered regularly interspaced short palindromic repeats (CRISPR) system, we constructed a genome-wide single-guide RNA library to screen for genes required for proliferation and survival in a human cancer cell line. Our screen revealed the set of cell-essential genes, which was validated with an orthogonal gene-trap-based screen and comparison with yeast gene knockouts. This set is enriched for genes that encode components of fundamental pathways, are expressed at high levels, and contain few inactivating polymorphisms in the human population. We also uncovered a large group of uncharacterized genes involved in RNA processing, a number of whose products localize to the nucleolus. Last, screens in additional cell lines showed a high degree of overlap in gene essentiality but also revealed differences specific to each cell line and cancer type that reflect the developmental origin, oncogenic drivers, paralogous gene expression pattern, and chromosomal structure of each line. These results demonstrate the power of CRISPR-based screens and suggest a general strategy for identifying liabilities in cancer cells.	[Wang, Tim; Birsoy, Kivanc; Wei, Jenny J.; Lander, Eric S.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Wang, Tim; Birsoy, Kivanc; Krupczak, Kevin M.; Post, Yorick; Wei, Jenny J.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Wang, Tim; Birsoy, Kivanc; Hughes, Nicholas W.; Krupczak, Kevin M.; Post, Yorick; Lander, Eric S.; Sabatini, David M.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Wang, Tim; Birsoy, Kivanc; Krupczak, Kevin M.; Post, Yorick; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Sabatini, David M.] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Lander, ES (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lander@broadinstitute.org; sabatini@wi.mit.edu		/0000-0002-1446-7256; Wang, Timothy/0000-0001-5730-3019	National Institutes of Health [CA103866]; National Human Genome Research Institute [2U54HG003067-10]; National Science Foundation; Massachussetts Institute of Technology Whitaker Health Sciences Fund; NATIONAL CANCER INSTITUTE [F31CA189437, P30CA014051, R01CA103866] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Science Foundation(National Science Foundation (NSF)); Massachussetts Institute of Technology Whitaker Health Sciences Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Mikkelsen for assistance with oligonucleotide synthesis; Z. Tsun for assistance with figures; C. Hartigan, G. Guzman, M. Schenone, and S. Carr for mass spectrometric analysis; and J. Down and J. Chen for reagents for hemoglobin staining. This work was supported by the National Institutes of Health (CA103866) (D.M.S.), the National Human Genome Research Institute (2U54HG003067-10) (E.S.L.), an award from the National Science Foundation (T.W.), and an award from the Massachussetts Institute of Technology Whitaker Health Sciences Fund (T.W.). D.M.S. is an investigator of the Howard Hughes Medical Institute. T.W., D.M.S., and E.S.L. are inventors on a U.S. patent application (PCT/US2014/062558) for functional genomics using the CRISPR-Cas system, and T.W. and D.M.S. are in the process of forming a company using this technology. The sgRNA plasmid library and other plasmids described here have been deposited in Addgene.	Ahmad Y., 2012, MOL CELL PROTEOMICS, V11, P1, DOI [10.1074/mcp.M111.013680, DOI 10.1074/mcp.M111.013680]; Andersson BS, 1995, LEUKEMIA, V9, P2100; ANDERSSON LC, 1979, INT J CANCER, V23, P143, DOI 10.1002/ijc.2910230202; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bouamar H, 2013, BLOOD, V122, P726, DOI 10.1182/blood-2013-04-495804; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; CONSTANTINOU A, 1990, CANCER RES, V50, P2618; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; GaliegueZouitina S, 1995, CR ACAD SCI III-VIE, V318, P1125; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Iida S, 1996, BLOOD, V88, P1787; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kastenmayer JP, 2006, GENOME RES, V16, P365, DOI 10.1101/gr.4355406; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Liang H, 2007, TRENDS GENET, V23, P375, DOI 10.1016/j.tig.2007.04.005; Liao BY, 2007, TRENDS GENET, V23, P378, DOI 10.1016/j.tig.2007.05.006; Makino T, 2009, TRENDS GENET, V25, P152, DOI 10.1016/j.tig.2009.03.001; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Ohneda K, 2002, ACTA HAEMATOL-BASEL, V108, P237, DOI 10.1159/000065660; Scappini B, 2004, CANCER-AM CANCER SOC, V100, P1459, DOI 10.1002/cncr.20131; Sekiguchi T, 2004, EXP CELL RES, V300, P213, DOI 10.1016/j.yexcr.2004.07.005; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tchasovnikarova IA, 2015, SCIENCE, V348, P1481, DOI 10.1126/science.aaa7227; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; WU SQ, 1995, LEUKEMIA, V9, P858	36	903	930	9	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264					1096	1101		10.1126/science.aac7041	http://dx.doi.org/10.1126/science.aac7041			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY5BJ	26472758	Green Submitted, Green Accepted			2022-12-28	WOS:000366422600045
J	Sewald, X; Ladinsky, MS; Uchil, PD; Beloor, J; Pi, RX; Herrmann, C; Motamedi, N; Murooka, TT; Brehm, MA; Greiner, DL; Shultz, LD; Mempel, TR; Bjorkman, PJ; Kumar, P; Mothes, W				Sewald, Xaver; Ladinsky, Mark S.; Uchil, Pradeep D.; Beloor, Jagadish; Pi, Ruoxi; Herrmann, Christin; Motamedi, Nasim; Murooka, Thomas T.; Brehm, Michael A.; Greiner, Dale L.; Shultz, Leonard D.; Mempel, Thorsten R.; Bjorkman, Pamela J.; Kumar, Priti; Mothes, Walther			Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection	SCIENCE			English	Article							SUBCAPSULAR SINUS; DENDRITIC CELLS; HIV TRANSFER; SIALOADHESIN; MACROPHAGES; ANTIGEN	Dendritic cells can capture and transfer retroviruses in vitro across synaptic cell-cell contacts to uninfected cells, a process called trans-infection. Whether trans-infection contributes to retroviral spread in vivo remains unknown. Here, we visualize how retroviruses disseminate in secondary lymphoid tissues of living mice. We demonstrate that murine leukemia virus (MLV) and human immunodeficiency virus (HIV) are first captured by sinus-lining macrophages. CD169/Siglec-1, an I-type lectin that recognizes gangliosides, captures the virus. MLV-laden macrophages then form long-lived synaptic contacts to trans-infect B-1 cells. Infected B-1 cells subsequently migrate into the lymph node to spread the infection through virological synapses. Robust infection in lymph nodes and spleen requires CD169, suggesting that a combination of fluid-based movement followed by CD169-dependent trans-infection can contribute to viral spread.	[Sewald, Xaver; Uchil, Pradeep D.; Pi, Ruoxi; Herrmann, Christin; Mothes, Walther] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06510 USA; [Ladinsky, Mark S.; Bjorkman, Pamela J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Beloor, Jagadish; Kumar, Priti] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Motamedi, Nasim] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Murooka, Thomas T.; Mempel, Thorsten R.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Brehm, Michael A.; Greiner, Dale L.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA; [Shultz, Leonard D.] Jackson Lab, Bar Harbor, ME 04609 USA	Yale University; California Institute of Technology; Yale University; Yale University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; Jackson Laboratory	Sewald, X (corresponding author), Univ Munich, Max Von Pettenkofer Inst, Munich, Germany.	sewald@mvp.uni-muenchen.de; priti.kumar@yale.edu; walther.mothes@yale.edu		Uchil, Pradeep/0000-0002-7236-858X; Pi, Ruoxi/0000-0002-2491-0979; Murooka, Thomas/0000-0002-3030-2726; Herrmann, Christin/0000-0003-4885-1384; Brehm, Michael/0000-0001-6813-3262	NIH [R01 CA098727, S10 RR026697, P50GM082545, R01 AI097052, R01 DA036298, P01 AI078897, R01 AI112443]; Flow Cytometry Shared Resource of the Yale Cancer Center [P30 CA016359]; Leopoldina Fellowship [LPDS2009-21]; China Scholarship Council; Jackson Laboratory; NATIONAL CANCER INSTITUTE [R01CA098727, P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI078897, P01AI112521, R01AI111595, R01AI112443, R01AI097052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036298] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flow Cytometry Shared Resource of the Yale Cancer Center; Leopoldina Fellowship; China Scholarship Council(China Scholarship Council); Jackson Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Grover, J. Ventura, and K. Haugh for critical reading of the manuscript; P. Van Ness for advice with statistical analyses; and P. Crocker, D. Gonzalez, and A. Haberman for Siglec<SUP>-/-</SUP> mice and DsRed mice, respectively. Siglec<SUP>-/-</SUP> mice are available under a materials transfer agreement with P. Crocker (University of Dundee, UK). This work was supported by the NIH grants R01 CA098727 and S10 RR026697 to W.M.; P50GM082545 to P.J.B and W.M.; R01 AI097052, R01 DA036298, and P01 AI078897 to T.R.M.; R01 AI112443 to P. K; Flow Cytometry Shared Resource of the Yale Cancer Center P30 CA016359 and the Leopoldina Fellowship LPDS2009-21 to X.S.; and a fellowship from the China Scholarship Council-Yale World Scholars to R.P. D.L.G. and M.A.B. are consultants for and receive grants from The Jackson Laboratory.	Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Bennett AE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000591; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; CROCKER PR, 1991, EMBO J, V10, P1661, DOI 10.1002/j.1460-2075.1991.tb07689.x; Felts RL, 2010, P NATL ACAD SCI USA, V107, P13336, DOI 10.1073/pnas.1003040107; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Gray EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038258; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Izquierdo-Useros N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001448; Izquierdo-Useros N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001315; Kang YS, 2004, P NATL ACAD SCI USA, V101, P215, DOI 10.1073/pnas.0307124101; Ladinsky MS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003899; Li F, 2014, J VIROL, V88, P10541, DOI 10.1128/JVI.01104-14; Llewellyn GN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001167; Martinez-Pomares L, 2012, TRENDS IMMUNOL, V33, P66, DOI 10.1016/j.it.2011.11.001; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Murooka TT, 2012, NATURE, V490, P283, DOI 10.1038/nature11398; Oetke C, 2006, MOL CELL BIOL, V26, P1549, DOI 10.1128/MCB.26.4.1549-1557.2006; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Puryear WB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003291; Puryear WB, 2012, P NATL ACAD SCI USA, V109, P7475, DOI 10.1073/pnas.1201104109; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; Sewald X, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2338; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841	27	119	121	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260					563	567		10.1126/science.aab2749	http://dx.doi.org/10.1126/science.aab2749			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU6RG	26429886	Green Accepted			2022-12-28	WOS:000363660000049
J	Fleetcroft, R; Ford, J; Gollop, ND; MacKeith, P; Perera, K; Shafi, AA; Sorefan, J; Thurlow, C; Wakelin, R; Cowie, MR; Steel, N				Fleetcroft, Robert; Ford, John; Gollop, Nicholas D.; MacKeith, Pieter; Perera, Kosala; Shafi, Ashia A.; Sorefan, Jhenaan; Thurlow, Caroline; Wakelin, Rachel; Cowie, Martin R.; Steel, Nicholas			Difficulty accessing data from randomised trials of drugs for heart failure: a call for action	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANGIOTENSIN-RECEPTOR BLOCKER; CONVERTING-ENZYME-INHIBITORS; RAW CLINICAL-DATA; PUBLICATION GUIDANCE; EXERCISE TOLERANCE; JOURNAL EDITORS; CARVEDILOL; CANDESARTAN; PROGRESSION; GUIDELINES		[Fleetcroft, Robert] Norwich Med Sch, Gen Practice, Norwich NR4 7TJ, Norfolk, England; [Ford, John; Sorefan, Jhenaan] Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [MacKeith, Pieter; Thurlow, Caroline; Wakelin, Rachel; Steel, Nicholas] Norwich Med Sch, Primary Care, Norwich NR4 7TJ, Norfolk, England; [Gollop, Nicholas D.] Norfolk & Norwich Univ Hosp, Cardiol, Norwich, Norfolk, England; [Perera, Kosala] JS Med Practice, London N15 4JR, England; [Shafi, Ashia A.] North Cent & East London Deanery, Obstet & Gynaecol, London, England; [Cowie, Martin R.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Cardiol, London, England	University of East Anglia; University of East Anglia; University of East Anglia; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Imperial College London	Fleetcroft, R (corresponding author), Norwich Med Sch, Gen Practice, Norwich NR4 7TJ, Norfolk, England.	r.fleetcroft@uea.ac.uk	Steel, Nicholas/K-1592-2014; Cowie, Martin R/AAQ-2818-2020	Steel, Nicholas/0000-0003-1528-140X; Cowie, Martin R/0000-0001-7457-2552; Ford, John/0000-0001-8033-7081	ResMed; Boston Scientific; Novartis; Sorin; Servier; Pfizer; Bayer; St Jude Medical; NIHR Cardiovascular Biomedical Research Unit at the Royal Brompton Hospital, London	ResMed; Boston Scientific(Boston Scientific); Novartis(Novartis); Sorin; Servier(Servier); Pfizer(Pfizer); Bayer(Bayer AG); St Jude Medical(St. Jude Medical); NIHR Cardiovascular Biomedical Research Unit at the Royal Brompton Hospital, London	We have read and understood BMJ policy on declaration of interests and declare the following: MRC reports grants and personal fees from ResMed, grants and personal fees from Boston Scientific, personal fees from Novartis, personal fees from Sorin, personal fees from Servier, personal fees from Pfizer, grants and personal fees from Bayer, and personal fees from St Jude Medical, outside the submitted work. His salary is supported by the NIHR Cardiovascular Biomedical Research Unit at the Royal Brompton Hospital, London. The remaining authors have no relevant interests to declare.	Adamyan KG, 2010, EUR HEART J, V31, P855; Anderson JL, 2003, J CARD FAIL, V9, P266, DOI 10.1054/jcaf.2003.42; [Anonymous], 2010, CHRON HEART FAIL MAN; Association of Medical Research Charities, 2013, STAT US PAT DAT RES; Boccanelli A, 2009, EUR J HEART FAIL, V11, P68, DOI 10.1093/eurjhf/hfn015; Chang SM, 2010, EUR J HEART FAIL, V12, P738, DOI 10.1093/eurjhf/hfq065; Cicoira M, 2002, J AM COLL CARDIOL, V40, P304, DOI 10.1016/S0735-1097(02)01965-4; Cohen D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5387; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Colucci WS, 1996, CIRCULATION, V94, P2800, DOI 10.1161/01.CIR.94.11.2800; Dalla-Volta S, 1999, CURR THER RES CLIN E, V60, P446, DOI 10.1016/S0011-393X(99)80023-X; Davies MK, 2001, LANCET, V358, P439, DOI 10.1016/S0140-6736(01)05620-3; European Medicines Agency, 2014, EUR MED AG POL PUBL; Flather MD, 2005, EUR HEART J, V26, P215, DOI 10.1093/eurheartj/ehi118; Granger CB, 2003, LANCET, P362; Hjalmarson A, 1999, LANCET, V353, P2001; Hrynaszkiewicz Iain, 2010, BMJ, V340, pc181, DOI [10.1186/1745-6215-11-9, 10.1136/bmj.c181]; Hrynaszkiewicz I, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c181; Institute of Medicine, 2015, SHAR CLIN TRIAL DAT; KLEBER FX, 1992, BRIT HEART J, V67, P289; Krum H, 2011, MED J AUSTRALIA, V194, P405, DOI 10.5694/j.1326-5377.2011.tb03031.x; Krumholz H, 2007, BMJ-BRIT MED J, V334, P120, DOI 10.1136/bmj.39024.487720.68; Krumholz HM, 2012, CIRC-CARDIOVASC QUAL, V5, P141, DOI 10.1161/CIRCOUTCOMES.112.965848; Kum LCC, 2008, INT J CARDIOL, V125, P16, DOI 10.1016/j.ijcard.2007.02.016; Kuula A, 2008, OPEN ACCESS REUSE RE; Lechat P, 1999, LANCET, V353, P9; LECHAT P, 1994, CIRCULATION, V90, P1765, DOI 10.1161/01.CIR.90.4.1765; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Medical Research Council, 2011, MRC POL GUID SHAR RE; Mochizuki S, 2007, LANCET, V369, P1431, DOI 10.1016/S0140-6736(07)60669-2; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7; Prescribing and Primary Care Services. Health and Social Care Information Centre, 2014, QUAL OUTC FRAM PREV; Rathi V, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7570; Riegger GAJ, 1999, CIRCULATION, V100, P2224, DOI 10.1161/01.CIR.100.22.2224; Ross JS, 2012, CIRC-CARDIOVASC QUAL, V5, P238, DOI 10.1161/CIRCOUTCOMES.112.965798; Steel N, 2014, J CLIN EPIDEMIOL, V67, P1251, DOI 10.1016/j.jclinepi.2014.05.020; Sturm B, 2000, EUR J HEART FAIL, V2, P407, DOI 10.1016/S1388-9842(00)00120-3; Treasure T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2085; Treasure T, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004385; Tumasyan LR, 2010, EUR HEART J, V31, P463; Vickers AJ, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-15; Wellcome Trust Technopolis Group, 2015, ASS RES POT ACC CLIN; Witchitz S, 2000, AM J CARDIOL, V85, P1467, DOI 10.1016/S0002-9149(00)00796-7; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yancy CW, 2001, NEW ENGL J MED, V344, P1358, DOI 10.1056/NEJM200105033441803; YODFAT Y, 1991, FAM PRACT, V8, P409, DOI 10.1093/fampra/8.4.409; Yusuf S, 2008, LANCET, V372, P1174, DOI 10.1016/S0140-6736(08)61242-8; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Zannad F, 1998, AM HEART J, V136, P672, DOI 10.1016/S0002-8703(98)70015-8; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	54	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2015	351								h5002	10.1136/bmj.h5002	http://dx.doi.org/10.1136/bmj.h5002			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3GC	26489852	Green Accepted, Green Published			2022-12-28	WOS:000364146000002
J	Tanaka, S; Shinzawa, M; Tokumasu, H; Seto, K; Tanaka, S; Kawakami, K				Tanaka, Shiro; Shinzawa, Maki; Tokumasu, Hironobu; Seto, Kahori; Tanaka, Sachiko; Kawakami, Koji			Secondhand smoke and incidence of dental caries in deciduous teeth among children in Japan: population based retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; EARLY-CHILDHOOD CARIES; PASSIVE SMOKING; SIALIC-ACID; ASSOCIATION; BURDEN	STUDY QUESTION Does maternal smoking during pregnancy and exposure of infants to tobacco smoke at age 4 months increase the risk of caries in deciduous teeth? METHODS Population based retrospective cohort study of 76 920 children born between 2004 and 2010 in Kobe City, Japan who received municipal health check-ups at birth, 4, 9, and 18 months, and 3 years and had information on household smoking status at age 4 months and records of dental examinations at age 18 months and 3 years. Smoking during pregnancy and exposure of infants to secondhand smoke at age 4 months was assessed by standardised parent reported questionnaires. The main outcome measure was the incidence of caries in deciduous teeth, defined as at least one decayed, missing, or filled tooth assessed by qualified dentists without radiographs. Cox regression was used to estimate hazard ratios of exposure to secondhand smoke compared with having no smoker in the family after propensity score adjustment for clinical and lifestyle characteristics. STUDY ANSWER AND LIMITATIONS Prevalence of household smoking among the 76 920 children was 55.3% (n = 42 525), and 6.8% (n = 5268) had evidence of exposure to tobacco smoke. A total of 12 729 incidents of dental caries were observed and most were decayed teeth (3 year follow-up rate 91.9%). The risk of caries at age 3 years was 14.0% (no smoker in family), 20.0% (smoking in household but without evidence of exposure to tobacco smoke), and 27.6% (exposure to tobacco smoke). The propensity score adjusted hazard ratios of the two exposure groups compared with having no smoker in the family were 1.46 (95% confidence interval 1.40 to 1.52) and 2.14 (1.99 to 2.29), respectively. The propensity score adjusted hazard ratio between maternal smoking during pregnancy and having no smoker in the family was 1.10 (0.97 to 1.25). WHAT THIS STUDY ADDS Exposure to tobacco smoke at 4 months of age was associated with an approximately twofold increased risk of caries, and the risk of caries was also increased among those exposed to household smoking, by 1.5-fold, whereas the effect of maternal smoking during pregnancy was not statistically significant.	[Tanaka, Shiro; Shinzawa, Maki; Tokumasu, Hironobu; Seto, Kahori; Tanaka, Sachiko; Kawakami, Koji] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Kawakami, K (corresponding author), Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	kawakami.koji.4e@kyoto-u.ac.jp	Kawakami, Koji/GZA-6582-2022; 田中, 司朗/GON-6916-2022; TANAKA, Sachiko/HCH-0787-2022	Kawakami, Koji/0000-0002-7477-4071; 田中, 司朗/0000-0001-6817-5235; 	 [26860415]		This study was supported by a grant in aid for scientific research 26860415.	Aligne CA, 2003, JAMA-J AM MED ASSOC, V289, P1258, DOI 10.1001/jama.289.10.1258; Alm A, 2008, CARIES RES, V42, P28, DOI 10.1159/000111747; Alves AC, 2009, J MED MICROBIOL, V58, P476, DOI 10.1099/jmm.0.005777-0; Avsar A, 2009, ARCH ORAL BIOL, V54, P457, DOI 10.1016/j.archoralbio.2009.01.017; CAUFIELD PW, 1993, J DENT RES, V72, P37, DOI 10.1177/00220345930720010501; Chou R, 2013, PEDIATRICS, V132, P332, DOI 10.1542/peds.2013-1469; Dong QQ, 2011, ARCH ORAL BIOL, V56, P1005, DOI 10.1016/j.archoralbio.2011.02.017; Du MQ, 2006, J DENT RES, V85, P557, DOI 10.1177/154405910608500615; Dye B.A., 2007, VITAL HLTH STAT, V11, P1; Food and Agriculture Organization of the United Nation, FAOSTAT 2011; Hanioka T, 2011, INT J ENV RES PUB HE, V8, P1503, DOI 10.3390/ijerph8051503; Iida H, 2007, PEDIATRICS, V120, pE944, DOI 10.1542/peds.2006-0124; Julihn A, 2009, EUR J EPIDEMIOL, V24, P753, DOI 10.1007/s10654-009-9399-7; LEVINE MJ, 1978, INFECT IMMUN, V19, P107, DOI 10.1128/IAI.19.1.107-115.1978; Majorana A, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-45; Marcenes W, 2013, J DENT RES, V92, P592, DOI 10.1177/0022034513490168; Ministry of Health Labour and Welfare, 2011, SURV DENT DIS 2011; Ministry of Health Labour and Welfare, MAT CHILD HLTH ACT 2; Nakayama Y, 2015, J PUBLIC HEALTH DENT, V75, P157, DOI 10.1111/jphd.12085; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Rethman MP, 2011, J AM DENT ASSOC, V142, P1065, DOI 10.14219/jada.archive.2011.0329; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; Shulman JD, 2005, CARIES RES, V39, P161, DOI 10.1159/000084792; Strauss RS, 2001, PEDIATRICS, V107, P540, DOI 10.1542/peds.107.3.540; Tanaka K, 2009, J PEDIATR-US, V155, P410, DOI 10.1016/j.jpeds.2009.03.032	25	54	55	3	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2015	351								h5397	10.1136/bmj.h5397	http://dx.doi.org/10.1136/bmj.h5397			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3GC	26489750	Green Published, hybrid			2022-12-28	WOS:000364146000004
J	Richardson, DB; Cardis, E; Daniels, RD; Gillies, M; O'Hagan, JA; Hamra, GB; Haylock, R; Laurier, D; Leuraud, K; Moissonnier, M; Schubauer-Berigan, MK; Thierry-Chef, I; Kesminiene, A				Richardson, David B.; Cardis, Elisabeth; Daniels, Robert D.; Gillies, Michael; O'Hagan, Jacqueline A.; Hamra, Ghassan B.; Haylock, Richard; Laurier, Dominique; Leuraud, Klervi; Moissonnier, Monika; Schubauer-Berigan, Mary K.; Thierry-Chef, Isabelle; Kesminiene, Ausrele			Risk of cancer from occupational exposure to ionising radiation: retrospective cohort study of workers in France, the United Kingdom, and the United States (INWORKS)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ATOMIC-BOMB SURVIVORS; COMBINED MORTALITY DATA; NUCLEAR-FUELS PLC; NATIONAL-REGISTRY; SOLID CANCER; HANFORD SITE; CHILDHOOD; ENERGY; EXPERIENCE; INDUSTRY	STUDY QUESTION Is protracted exposure to low doses of ionising radiation associated with an increased risk of solid cancer? METHODS In this cohort study, 308 297 workers in the nuclear industry from France, the United Kingdom, and the United States with detailed monitoring data for external exposure to ionising radiation were linked to death registries. Excess relative rate per Gy of radiation dose for mortality from cancer was estimated. Follow-up encompassed 8.2 million person years. Of 66 632 known deaths by the end of follow-up, 17 957 were due to solid cancers. STUDY ANSWER AND LIMITATIONS Results suggest a linear increase in the rate of cancer with increasing radiation exposure. The average cumulative colon dose estimated among exposed workers was 20.9 mGy (median 4.1 mGy). The estimated rate of mortality from all cancers excluding leukaemia increased with cumulative dose by 48% per Gy (90% confidence interval 20% to 79%), lagged by 10 years. Similar associations were seen for mortality from all solid cancers (47% (18% to 79%)), and within each country. The estimated association over the dose range of 0-100 mGy was similar in magnitude to that obtained over the entire dose range but less precise. Smoking and occupational asbestos exposure are potential confounders; however, exclusion of deaths from lung cancer and pleural cancer did not affect the estimated association. Despite substantial efforts to characterise the performance of the radiation dosimeters used, the possibility of measurement error remains. WHAT THIS STUDY ADDS The study provides a direct estimate of the association between protracted low dose exposure to ionising radiation and solid cancer mortality. Although high dose rate exposures are thought to be more dangerous than low dose rate exposures, the risk per unit of radiation dose for cancer among radiation workers was similar to estimates derived from studies of Japanese atomic bomb survivors. Quantifying the cancer risks associated with protracted radiation exposures can help strengthen the foundation for radiation protection standards. FUNDING, COMPETING INTERESTS, DATA SHARING Support from the US Centers for Disease Control and Prevention; Ministry of Health, Labour and Welfare of Japan; Institut de Radioprotection et de Surete Nucleaire; AREVA; Electricite de France; US National Institute for Occupational Safety and Health; US Department of Energy; and Public Health England. Data are maintained and kept at the International Agency for Research on Cancer.	[Richardson, David B.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Cardis, Elisabeth] Ctr Res Environm Epidemiol, Barcelona, Spain; [Cardis, Elisabeth] Univ Pompeu Fabra, Barcelona, Spain; [Cardis, Elisabeth] CIBER Epidemiol & Salud Publ, Madrid, Spain; [Daniels, Robert D.; Schubauer-Berigan, Mary K.] NIOSH, Cincinnati, OH 45226 USA; [Gillies, Michael; O'Hagan, Jacqueline A.; Haylock, Richard] Publ Hlth England, Ctr Radiat Chem & Environm Hazards, Chilton, England; [Hamra, Ghassan B.] Drexel Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth, Philadelphia, PA 19104 USA; [Laurier, Dominique; Leuraud, Klervi] Inst Radioprotect & Surete Nucl, Fontenay Aux Roses, France; [Moissonnier, Monika; Thierry-Chef, Isabelle; Kesminiene, Ausrele] Int Agcy Res Canc, F-69372 Lyon, France	University of North Carolina; University of North Carolina Chapel Hill; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Public Health England; Drexel University; World Health Organization; International Agency for Research on Cancer (IARC)	Richardson, DB (corresponding author), Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA.	david.richardson@unc.edu	Cardis, Elisabeth/C-3904-2017; Schubauer-Berigan, Mary/ABC-7996-2020; THIERRY-CHEF, Isabelle/P-8324-2018; Schubauer-Berigan, Mary/B-3149-2009	Cardis, Elisabeth/0000-0003-0999-6839; THIERRY-CHEF, Isabelle/0000-0001-6304-2783; Laurier, Dominique/0000-0003-1432-4738; Schubauer-Berigan, Mary/0000-0002-5175-924X; Daniels, Robert/0000-0002-3915-7991; Leuraud, Klervi/0000-0001-5492-168X	US Centers for Disease Control and Prevention [5RO3 OH010056-02]; Ministry of Health, Labour and Welfare of Japan [2012-02-21-01]; AREVA; EDF; National Institute for Occupational Safety and Health; US Department of Energy; US Department of Health and Human Services; University of North Carolina from the National Institute for Occupational Safety and Health [R03 OH-010056]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R03OH010056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); AREVA; EDF(Electricite de France (EDF)); National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); US Department of Energy(United States Department of Energy (DOE)); US Department of Health and Human Services; University of North Carolina from the National Institute for Occupational Safety and Health; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was partly funded by the US Centers for Disease Control and Prevention (5RO3 OH010056-02) and Ministry of Health, Labour and Welfare of Japan (GA No 2012-02-21-01). The French cohort was coordinated by IRSN, with part funding from AREVA and EDF. US funding was provided by the National Institute for Occupational Safety and Health, US Department of Energy through an agreement with the US Department of Health and Human Services and a grant received by the University of North Carolina from the National Institute for Occupational Safety and Health (R03 OH-010056). The UK cohort was coordinated by Public Health England who operates the UK's National Registry for Radiation Workers. The sponsors had no role in the study design, the data analysis, and interpretation, or the writing of the report.	[Anonymous], 1991, Ann ICRP, V21, P1; [Anonymous], 1994, Lancet, V344, P1039; Armstrong BG, 1998, OCCUP ENVIRON MED, V55, P651, DOI 10.1136/oem.55.10.651; BERAL V, 1985, BRIT MED J, V291, P440, DOI 10.1136/bmj.291.6493.440; BITHELL JF, 1975, BRIT J CANCER, V31, P271, DOI 10.1038/bjc.1975.62; Buckley JP, 2014, EPIDEMIOLOGY, V25, P242, DOI 10.1097/EDE.0000000000000051; Cardis E, 2005, BMJ-BRIT MED J, V331, P77, DOI 10.1136/bmj.38499.599861.E0; CARDIS E, 1995, RADIAT RES, V142, P117, DOI 10.2307/3579020; Doll R, 1997, BRIT J RADIOL, V70, P130, DOI 10.1259/bjr.70.830.9135438; Fix JJ, 1997, RADIAT PROT DOSIM, V74, P39, DOI 10.1093/oxfordjournals.rpd.a032180; FROME EL, 1983, BIOMETRICS, V39, P665, DOI 10.2307/2531094; GILBERT ES, 1993, RADIAT RES, V136, P408, DOI 10.2307/3578555; GILBERT ES, 1989, RADIAT RES, V120, P19, DOI 10.2307/3577633; GILBERT ES, 1992, HEALTH PHYS, V62, P260; Gilbert ES, 1977, METHODS ANAL MORTALI; Gillies M, 2014, J RADIOL PROT, V34, P595, DOI 10.1088/0952-4746/34/3/595; Hamra GB, 2016, INT J EPIDEMIOL, V45, P693, DOI 10.1093/ije/dyv122; Institute of Medicine of the US National Academies National Research Council, 2014, RES HLTH EFF LOW LEV; International Agency for Research on Cancer, 2012, REV HUM CARC E PERS; International Agency for Research on Cancer, 2012, REV HUM CARC D; KENDALL GM, 1992, BRIT MED J, V304, P220, DOI 10.1136/bmj.304.6821.220; Kite AV, 1996, P INT C RAD PROT GEN; Leuraud K, 2015, LANCET HAEMATOL, V2, pE276, DOI 10.1016/S2352-3026(15)00094-0; MANCUSO TF, 1977, HEALTH PHYS, V33, P369, DOI 10.1097/00004032-197711000-00002; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; McGeoghegan D, 2008, INT J EPIDEMIOL, V37, P506, DOI 10.1093/ije/dyn018; Metz-Flamant C, 2013, OCCUP ENVIRON MED, V70, P630, DOI 10.1136/oemed-2012-101149; Muirhead CR, 2009, BRIT J CANCER, V100, P206, DOI 10.1038/sj.bjc.6604825; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pierce DA, 2003, RADIAT RES, V159, P511, DOI 10.1667/0033-7587(2003)159[0511:JEORAS]2.0.CO;2; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Preston D. L., 2003, Radiation Research, V160, P381, DOI 10.1667/RR3049; PRESTON DL, 1987, RADIAT RES, V111, P151, DOI 10.2307/3577030; Rhodes R., 1986, MAKING ATOMIC BOMB; Richardson DB, 2014, AM J EPIDEMIOL, V180, P933, DOI 10.1093/aje/kwu211; Richardson DB, 2011, AM J EPIDEMIOL, V174, P1416, DOI 10.1093/aje/kwr260; ROTHMAN KJ, 1981, AM J EPIDEMIOL, V114, P253, DOI 10.1093/oxfordjournals.aje.a113189; Schubauer-Berigan MK, 2015, RADIAT RES, V183, P620, DOI 10.1667/RR13988.1; Sokolnikov M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117784; Thierry-Chef I, 2007, RADIAT RES, V167, P380, DOI 10.1667/RR0552.1; Thierry-Chef I, 2015, RADIAT RES, V183, P632, DOI 10.1667/RR14006.1; Thierry-Chef I, 2002, RADIAT PROT DOSIM, V102, P101, DOI 10.1093/oxfordjournals.rpd.a006078; Wakeford R, 2005, J RADIOL PROT, V25, P225, DOI 10.1088/0952-4746/25/3/E03; Wakeford R, 2014, BRIT J CANCER, V110, P1, DOI 10.1038/bjc.2013.713; Wakeford R, 2009, J RADIOL PROT, V29, P1, DOI 10.1088/0952-4746/29/1/E02; Wing S, 2004, AM J IND MED, V45, P153, DOI 10.1002/ajim.10332; Zablotska LB, 2014, BRIT J CANCER, V110, P214, DOI 10.1038/bjc.2013.592	48	193	210	1	43	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2015	351								h5359	10.1136/bmj.h5359	http://dx.doi.org/10.1136/bmj.h5359			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3FJ	26487649	Green Published, hybrid			2022-12-28	WOS:000364143900006
J	Sharif, A				Sharif, Adnan			PERSONAL VIEW It will take more than an opt-out system to increase organ donation: prioritise donors to receive organs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRESUMED CONSENT; RATES		Queen Elizabeth Hosp Birmingham, Dept Nephrol & Transplantat, Birmingham B15 2WB, W Midlands, England	University of Birmingham	Sharif, A (corresponding author), Queen Elizabeth Hosp Birmingham, Dept Nephrol & Transplantat, Birmingham B15 2WB, W Midlands, England.	adnan.sharif@uhb.nhs.uk		Sharif, Adnan/0000-0002-7586-9136				Fabre J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4973; Kennedy I, 1998, LANCET, V351, P1650, DOI 10.1016/S0140-6736(97)08212-3; Mayor S, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1098; NHS Blood and Transplant, 2015, ORG DON TRANSPL ACT; NHS Blood and Transplantation, 2013, NHS BLOOD TRANSPLANT; Organ Donation Taskforce, 2008, POT IMP OPT OUT SYST; Organ Donation Wales, 2015, CAN I OPT OUT NOW; Rithalia Amber, 2009, BMJ, V338, pa3162, DOI 10.1136/bmj.a3162; Sharif A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5036; Sharif A, 2013, TRANSPLANTATION, V95, P1425, DOI 10.1097/TP.0b013e31829282eb; Shaw D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5275; Shepherd L, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0131-4	12	3	3	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2015	351								h5165	10.1136/bmj.h5165	http://dx.doi.org/10.1136/bmj.h5165			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3FJ	26487576				2022-12-28	WOS:000364143900004
J	Mao, J; Pfeifer, S; Schlegel, P; Sedrakyan, A				Mao, Jialin; Pfeifer, Samantha; Schlegel, Peter; Sedrakyan, Art			Safety and efficacy of hysteroscopic sterilization compared with laparoscopic sterilization: an observational cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TUBAL-STERILIZATION; PREGNANCY; SURGERY; COMPLICATIONS; FRAMEWORK; ESSURE; RISK	OBJECTIVE To compare the safety and efficacy of hysteroscopic sterilization with the "Essure" device with laparoscopic sterilization in a large, all-inclusive, state cohort. DESIGN Population based cohort study. SETTINGS Outpatient interventional setting in New York State. PARTICIPANTS Women undergoing interval sterilization procedure, including hysteroscopic sterilization with Essure device and laparoscopic surgery, between 2005 and 2013. MAIN OUTCOMES MEASURES Safety events within 30 days of procedures; unintended pregnancies and reoperations within one year of procedures. Mixed model accounting for hospital clustering was used to compare 30 day and 1 year outcomes, adjusting for patient characteristics and other confounders. Time to reoperation was evaluated using frailty model for time to event analysis. RESULTS We identified 8048 patients undergoing hysteroscopic sterilization and 44 278 undergoing laparoscopic sterilization between 2005 and 2013 in New York State. There was a significant increase in the use of hysteroscopic procedures during this period, while use of laparoscopic sterilization decreased. Patients undergoing hysteroscopic sterilization were older than those undergoing laparoscopic sterilization and were more likely to have a history of pelvic inflammatory disease (10.3% v 7.2%, P<0.01), major abdominal surgery (9.4% v 7.9%, P<0.01), and cesarean section (23.2% v 15.4%, P<0.01). At one year after surgery, hysteroscopic sterilization was not associated with a higher risk of unintended pregnancy (odds ratio 0.84 (95% CI 0.63 to 1.12)) but was associated with a substantially increased risk of reoperation (odds ratio 10.16 (7.47 to 13.81)) compared with laparoscopic sterilization. CONCLUSIONS Patients undergoing hysteroscopic sterilization have a similar risk of unintended pregnancy but a more than 10-fold higher risk of undergoing reoperation compared with patients undergoing laparoscopic sterilization. Benefits and risks of both procedures should be discussed with patients for informed decisions making.	[Mao, Jialin; Sedrakyan, Art] Cornell Univ, Weill Med Coll, Dept Hlth Policy & Res, New York, NY 10065 USA; [Pfeifer, Samantha] Cornell Univ, New York Presbyterian Hosp, Weill Med Coll, Dept Obstet & Gynecol, New York, NY 10065 USA; [Schlegel, Peter] Cornell Univ, New York Presbyterian Hosp, Weill Med Coll, Dept Urol, New York, NY 10065 USA	Cornell University; Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital	Sedrakyan, A (corresponding author), Cornell Univ, Weill Med Coll, Dept Hlth Policy & Res, New York, NY 10065 USA.	ars2013@med.cornell.edu	Mao, Jialin/AAA-4433-2021	Mao, Jialin/0000-0001-6671-3474	National Institutes of Health [NIH-1U01FD004494-01]; US Food and Drug Administration; FOOD AND DRUG ADMINISTRATION [U01FD004494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Food and Drug Administration; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services)	The study was funded in part through UO1 grant (NIH-1U01FD004494-01) from the National Institutes of Health and US Food and Drug Administration. AS received the funding for establishing the MDEpiNet Science and Infrastructure Centre. JM is an analyst within the Weill Cornell Medical College (WCMC) Patient Centered Comparative Effectiveness Program and the Medical Device Epidemiology Network's (MDEpiNet) Science and Infrastructure Center: AS is the director of the Center).	[Anonymous], 2013, Obstet Gynecol, V121, P392, DOI 10.1097/01.AOG.0000426425.33845.b2; Burns EM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4836; Chudnoff SG, 2015, J MINIM INVAS GYN, V22, P951, DOI 10.1016/j.jmig.2015.04.017; Chughtai B, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2685; Cleary TP, 2013, CONTRACEPTION, V87, P539, DOI 10.1016/j.contraception.2012.08.006; Connor VF, 2009, J MINIM INVAS GYN, V16, P282, DOI 10.1016/j.jmig.2009.02.009; Cook JA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2820; Cooper JM, 2003, OBSTET GYNECOL, V102, P59, DOI 10.1016/S0029-7844(03)00373-9; DESTEFANO F, 1983, OBSTET GYNECOL, V61, P153; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fernandez H, 2014, EUR J OBSTET GYN R B, V180, P133, DOI 10.1016/j.ejogrb.2014.04.043; Gariepy AM, 2014, CONTRACEPTION, V90, P174, DOI 10.1016/j.contraception.2014.03.010; Gilger L, 2014, ABC15, VABC15; Hurskainen R, 2010, FERTIL STERIL, V94, P16, DOI 10.1016/j.fertnstert.2009.02.080; Jamieson DJ, 2000, OBSTET GYNECOL, V96, P997, DOI 10.1016/S0029-7844(00)01082-6; Jones Jo, 2012, Natl Health Stat Report, P1; Kerin JF, 2003, HUM REPROD, V18, P1223, DOI 10.1093/humrep/deg256; Makela KT, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7592; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; Ouzounelli M, 2015, J MINIM INVAS GYN, V22, P342, DOI 10.1016/j.jmig.2014.12.002; Peterson HB, 1996, AM J OBSTET GYNECOL, V174, P1161, DOI 10.1016/S0002-9378(96)70658-0; Peterson HB, 1997, NEW ENGL J MED, V336, P762, DOI 10.1056/NEJM199703133361104; Rabin RC, 2015, NY TIMES; Rice N, 1996, J Health Serv Res Policy, V1, P154; Sedrakyan A, 2010, MED CARE, V48, pS121, DOI 10.1097/MLR.0b013e3181d991c4; SZIGETVARI I, 1989, J REPROD MED, V34, P465; US Food and Drug Administration, 2015, ESS PERM BIRTH CONTR; US Food and Drug Administration, 2015, MAUDE MAN US FAC DEV; US Food and Drug Administration, 2002, ESS SYST P020014	29	33	35	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2015	351									10.1136/bmj.h5162	http://dx.doi.org/10.1136/bmj.h5162			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT8XS	26462857	hybrid, Green Published			2022-12-28	WOS:000363100800003
J	Watanabe, Y; Meents, MJ; McDonnell, LM; Barkwill, S; Sampathkumar, A; Cartwright, HN; Demura, T; Ehrhardt, DW; Samuels, AL; Mansfield, SD				Watanabe, Y.; Meents, M. J.; McDonnell, L. M.; Barkwill, S.; Sampathkumar, A.; Cartwright, H. N.; Demura, T.; Ehrhardt, D. W.; Samuels, A. L.; Mansfield, S. D.			Visualization of cellulose synthases in Arabidopsis secondary cell walls	SCIENCE			English	Article							PLASMA-MEMBRANE; ORGANIZATION; MICROTUBULES; COMPLEXES	Cellulose biosynthesis in plant secondary cell walls forms the basis of vascular development in land plants, with xylem tissues constituting the vast majority of terrestrial biomass. We used plant lines that contained an inducible master transcription factor controlling xylem cell fate to quantitatively image fluorescently tagged cellulose synthase enzymes during cellulose deposition in living protoxylem cells. The formation of secondary cell wall thickenings was associated with a redistribution and enrichment of CESA7-containing cellulose synthase complexes (CSCs) into narrow membrane domains. The velocities of secondary cell wall-specific CSCs were faster than those of primary cell wall CSCs during abundant cellulose production. Dynamic intracellular trafficking of endomembranes in combination with increased velocity and high density of CSCs, enables cellulose to be synthesized rapidly in secondary cell walls.	[Watanabe, Y.; Meents, M. J.; Samuels, A. L.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Watanabe, Y.; Meents, M. J.; McDonnell, L. M.; Barkwill, S.; Mansfield, S. D.] Univ British Columbia, Dept Wood Sci, Vancouver, BC V5Z 1M9, Canada; [Sampathkumar, A.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Cartwright, H. N.; Ehrhardt, D. W.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Demura, T.] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; [Ehrhardt, D. W.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	University of British Columbia; University of British Columbia; California Institute of Technology; Carnegie Institution for Science; Nara Institute of Science & Technology; Stanford University	Samuels, AL (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	annelacey.samuels@botany.ubc.ca; shawn.mansfield@ubc.ca	Samuels, Anne Lacey/C-9767-2012; Demura, Taku/ABE-7871-2021; Watanabe, Yoichiro/AAG-1311-2020	Samuels, Anne Lacey/0000-0002-0606-8933; Watanabe, Yoichiro/0000-0002-6981-3195; Cartwright, Heather/0000-0001-6639-5808; Meents, Miranda/0000-0003-3706-1766; Sampathkumar, Arun/0000-0003-1703-0137; Mansfield, Shawn/0000-0002-0175-554X	CREATE grant; Discovery grant; Canadian Natural Sciences and Engineering Research Council; NSF [MCB-1158372]; Japan Society for the Promotion of Science KAKENHI [24114002, 25291062]; Grants-in-Aid for Scientific Research [24114001] Funding Source: KAKEN; Direct For Biological Sciences [1158372] Funding Source: National Science Foundation	CREATE grant; Discovery grant; Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Arabidopsis plants containing RFP::TUB6 were the kind gift of C. Ambrose and G. O. Wasteneys. Supported by CREATE and Discovery grants (L.S. and S.D.M.); Canadian Natural Sciences and Engineering Research Council doctoral postgraduate scholarships (Y.W., M.J.M., and L.M.M.); NSF grant MCB-1158372 (D.W.E. and H.N.C.); and Japan Society for the Promotion of Science KAKENHI grants 24114002 and 25291062 (T.D.). We thank the technical support staff of the UBC Bioimaging Facility and R. White for statistical advice. The pTA7001 plasmid (VP16-GR vector) is available from N.-H. Chua of The Rockefeller University under a material transfer agreement; the VND7-GR line is available from T.D.; and the GFP::CESA3 and YFP::CESA7 VND7-GR lines are freely available from L.S. or S.D.M. for noncommercial purposes under a materials transfer agreement on the GVG system with N.-H. Chua. Further data are reported in the supplementary materials.	Ambrose C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1444; Crowell EF, 2009, PLANT CELL, V21, P1141, DOI 10.1105/tpc.108.065334; DeBolt S, 2007, P NATL ACAD SCI USA, V104, P5854, DOI 10.1073/pnas.0700789104; Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104; Gardiner JC, 2003, PLANT CELL, V15, P1740, DOI 10.1105/tpc.012815; Gutierrez R, 2009, NAT CELL BIOL, V11, P797, DOI 10.1038/ncb1886; Joshi CP, 2007, CURR OPIN PLANT BIOL, V10, P220, DOI 10.1016/j.pbi.2007.04.013; McFarlane HE, 2014, ANNU REV PLANT BIOL, V65, P69, DOI 10.1146/annurev-arplant-050213-040240; MUELLER SC, 1980, J CELL BIOL, V84, P315, DOI 10.1083/jcb.84.2.315; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Sampathkumar A, 2013, PLANT PHYSIOL, V162, P675, DOI 10.1104/pp.113.215277; Saxena IM, 2005, ANN BOT-LONDON, V96, P9, DOI 10.1093/aob/mci155; SCHNEIDER B, 1986, PROTOPLASMA, V131, P142, DOI 10.1007/BF01285036; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Wasteneys GO, 2004, CURR OPIN PLANT BIOL, V7, P651, DOI 10.1016/j.pbi.2004.09.008; Wightman R, 2008, PLANT J, V54, P794, DOI 10.1111/j.1365-313X.2008.03444.x; Yamaguchi M, 2010, PLANT PHYSIOL, V153, P906, DOI 10.1104/pp.110.154013	18	97	101	9	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257					198	203		10.1126/science.aac7446	http://dx.doi.org/10.1126/science.aac7446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9JB	26450210				2022-12-28	WOS:000362405600037
J	Berkley, S				Berkley, Seth			Make vaccine coverage a key UN health indicator	NATURE			English	Editorial Material									Gavi, Geneva, Switzerland		Berkley, S (corresponding author), Gavi, Geneva, Switzerland.	sberkley@gavi.org							0	3	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					165	165		10.1038/526165a	http://dx.doi.org/10.1038/526165a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS9GV	26450023	Bronze			2022-12-28	WOS:000362399000012
J	Ciriello, G; Gatza, ML; Beck, AH; Wilkerson, MD; Rhie, SK; Pastore, A; Zhang, HL; McLellan, M; Yau, C; Kandoth, C; Bowlby, R; Shen, H; Hayat, S; Fieldhouse, R; Lester, SC; Tse, GMK; Factor, RE; Collins, LC; Allison, KH; Chen, YY; Jensen, K; Johnson, NB; Oesterreich, S; Mills, GB; Cherniack, AD; Robertson, G; Benz, C; Sander, C; Laird, PW; Hoadley, KA; King, TA; Perou, CM				Ciriello, Giovanni; Gatza, Michael L.; Beck, Andrew H.; Wilkerson, Matthew D.; Rhie, Suhn K.; Pastore, Alessandro; Zhang, Hailei; McLellan, Michael; Yau, Christina; Kandoth, Cyriac; Bowlby, Reanne; Shen, Hui; Hayat, Sikander; Fieldhouse, Robert; Lester, Susan C.; Tse, Gary M. K.; Factor, Rachel E.; Collins, Laura C.; Allison, Kimberly H.; Chen, Yunn-Yi; Jensen, Kristin; Johnson, Nicole B.; Oesterreich, Steffi; Mills, Gordon B.; Cherniack, Andrew D.; Robertson, Gordon; Benz, Christopher; Sander, Chris; Laird, Peter W.; Hoadley, Katherine A.; King, Tari A.; Perou, Charles M.		TCGA Res Network	Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer	CELL			English	Article							ESTROGEN-RECEPTOR BINDING; E-CADHERIN EXPRESSION; TRANSCRIPTION FACTOR; RNA-SEQ; FOXA1; CARCINOMA; CDH1; CHROMATIN; FEATURES; METHYLATION	Invasive lobular carcinoma (ILC) is the second most prevalent histologic subtype of invasive breast cancer. Here, we comprehensively profiled 817 breast tumors, including 127 ILC, 490 ductal (IDC), and 88 mixed IDC/ILC. Besides E-cadherin loss, the best known ILC genetic hallmark, we identified mutations targeting PTEN, TBX3, and FOXA1 as ILC enriched features. PTEN loss associated with increased AKT phosphorylation, which was highest in ILC among all breast cancer subtypes. Spatially clustered FOXA1 mutations correlated with increased FOXA1 expression and activity. Conversely, GATA3 mutations and high expression characterized luminal A IDC, suggesting differential modulation of ER activity in ILC and IDC. Proliferation and immune-related signatures determined three ILC transcriptional subtypes associated with survival differences. Mixed IDC/ILC cases were molecularly classified as ILC-like and IDC-like revealing no true hybrid features. This multidimensional molecular atlas sheds new light on the genetic bases of ILC and provides potential clinical options.	[Ciriello, Giovanni] Univ Lausanne UNIL, Dept Med Genet, CH-1011 Lausanne, Switzerland; [Ciriello, Giovanni; Pastore, Alessandro; Hayat, Sikander; Fieldhouse, Robert; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA; [Gatza, Michael L.; Hoadley, Katherine A.; Perou, Charles M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Gatza, Michael L.] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Beck, Andrew H.; Lester, Susan C.; Collins, Laura C.; Johnson, Nicole B.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Wilkerson, Matthew D.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Rhie, Suhn K.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Zhang, Hailei; Cherniack, Andrew D.] Eli & Edythe L Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [McLellan, Michael] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Yau, Christina; Benz, Christopher] Buck Inst Res Aging, Novato, CA 94945 USA; [Kandoth, Cyriac] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Bowlby, Reanne; Robertson, Gordon] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z4S6, Canada; [Shen, Hui; Laird, Peter W.] Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI 49503 USA; [Tse, Gary M. K.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Factor, Rachel E.] Univ Utah, Sch Med, Dept Pathol, Huntsman Canc Inst, Salt Lake City, UT USA; [Allison, Kimberly H.; Jensen, Kristin] Stanford Univ, Med Ctr, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Jensen, Kristin] VA Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA; [Chen, Yunn-Yi] Univ Calif San Francisco, Dept Pathol & Lab Med, San Francisco, CA 94143 USA; [Oesterreich, Steffi] Univ Pittsburgh, Inst Canc, Dept Pharmacol & Chem Biol, Womens Canc Res Ctr, Pittsburgh, PA 15232 USA; [Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77230 USA; [King, Tari A.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA	University of Lausanne; Memorial Sloan Kettering Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of Southern California; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Washington University (WUSTL); Buck Institute for Research on Aging; Memorial Sloan Kettering Cancer Center; British Columbia Cancer Agency; Van Andel Institute; Chinese University of Hong Kong; Prince of Wales Hospital; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center	Perou, CM (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	cperou@med.unc.edu	/AAR-7818-2021; Holt, Robert A/C-3303-2009; Cherniack, Andrew/AAC-5310-2019; Tiezzi, Daniel G/E-4761-2010; Laird, Peter W/G-8683-2012; Tiezzi, Daniel Guimarães/V-4168-2019; Cherniack, Andrew D./AAY-8132-2020; /AGZ-3814-2022; Shen, Hui/AAO-4387-2020; Jones, Steven J/C-3621-2009; Mungall, Andrew J./U-7067-2018; Tiezzi, Daniel/AAE-6790-2019; Van Den Berg, David J/G-8598-2017; Marra, Marco A/B-5987-2008; Perou, Charles M/H-9934-2014	/0000-0002-3621-4807; Holt, Robert A/0000-0002-7259-1247; Tiezzi, Daniel G/0000-0002-2660-0093; Laird, Peter W/0000-0001-9117-3641; Cherniack, Andrew D./0000-0003-0470-0111; /0000-0002-3621-4807; Jones, Steven J/0000-0003-3394-2208; Mungall, Andrew J./0000-0002-0905-2742; Tiezzi, Daniel/0000-0002-2660-0093; Van Den Berg, David J/0000-0002-5404-5218; Marra, Marco A/0000-0001-7146-7175; Perou, Charles M/0000-0001-9827-2247; Kandoth, Cyriac/0000-0002-1345-3573; Bowen, Jay/0000-0001-6861-9043; Hu, Hai/0000-0001-5345-8371; Heiman, David/0000-0001-7895-4259; Hoadley, Katherine/0000-0002-1216-477X; Meyerson, Matthew/0000-0002-9133-8108; Gehlenborg, Nils/0000-0003-0327-8297; Weinstein, John/0000-0001-9401-6908; Tse, Gary/0000-0002-9405-9665; Rhie, Suhn/0000-0002-5522-5296; Tarnuzzer, Roy/0000-0002-3725-4173; Hayat, Sikander/0000-0001-5919-8371; Ciriello, Giovanni/0000-0003-2021-8683; Benz, Stephen/0000-0002-4067-0602; Auman, James/0000-0002-9328-8829; Gatza, Michael/0000-0001-6796-7791; Shen, Hui/0000-0001-9767-4084; MCLELLAN, MICHAEL/0000-0002-2703-8784; Bootwalla, Moiz/0000-0001-6158-7114; Jensen, Kristin/0000-0003-1177-9104	TCGA Project [U24-CA143848]; NCI Breast SPORE program grant [P50-CA58223-09A1]; Breast Cancer Research Foundation; Gabriella Giorgi-Cavaglieri Foundation; National Cancer Institute of the US NIH award [K99-CA166228]; National Library of Medicine of the NIH [K22LM011931]; Mildred-Scheel Postdoctoral Research Fellowship of the Deutsche Krebshilfe e.V. [111354]; Bayer AG; NATIONAL CANCER INSTITUTE [P30CA008748, F30CA192725, U24CA143848, U24CA143867, R01CA180006, K99CA166228, P50CA058223, R00CA166228, P30CA016672, U24CA143858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM011931] Funding Source: NIH RePORTER	TCGA Project; NCI Breast SPORE program grant; Breast Cancer Research Foundation; Gabriella Giorgi-Cavaglieri Foundation; National Cancer Institute of the US NIH award; National Library of Medicine of the NIH; Mildred-Scheel Postdoctoral Research Fellowship of the Deutsche Krebshilfe e.V.; Bayer AG(Bayer AG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We wish to thank the many members of the TCGA Network, including the Tissue Source Sites, and patients, whom contributed samples to this study. This study was supported by funds from the TCGA Project (U24-CA143848), the NCI Breast SPORE program grant P50-CA58223-09A1, and the Breast Cancer Research Foundation. G.C. is supported by the Gabriella Giorgi-Cavaglieri Foundation, M.L.G. is supported by the National Cancer Institute of the US NIH award number K99-CA166228, A.H.B. is supported by National Library of Medicine of the NIH under Award Number K22LM011931, and A.P. is supported by Mildred-Scheel Postdoctoral Research Fellowship of the Deutsche Krebshilfe e.V. (No. 111354). C.M.P is an equity stock holder, and Board of Director Member, of BioClassifier. C.M.P is also listed an inventor on patent applications on the Breast PAM50 assay. A.D.C. receives research funding from Bayer AG.	Akbani R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4887; Arps DP, 2013, BREAST CANCER RES TR, V138, P719, DOI 10.1007/s10549-013-2493-2; Baay M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/565187; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bharat A, 2009, AM J SURG, V198, P516, DOI 10.1016/j.amjsurg.2009.06.005; Brinck U, 2004, ANTICANCER RES, V24, P2237; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Ciriello G, 2013, BREAST CANCER RES TR, V141, P409, DOI 10.1007/s10549-013-2699-3; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 2007, J MOL BIOL, V366, P720, DOI 10.1016/j.jmb.2006.11.087; Cristofanilli M, 2005, J CLIN ONCOL, V23, P41, DOI 10.1200/JCO.2005.03.111; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dabbs DJ, 2013, AM J SURG PATHOL, V37, pE1, DOI 10.1097/PAS.0b013e3182918a2b; Dabney AR, 2006, BIOINFORMATICS, V22, P122, DOI 10.1093/bioinformatics/bti756; Duvallet E, 2011, ANN MED, V43, P503, DOI 10.3109/07853890.2011.577093; Fan C, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-3; FOOTE FW, 1946, SURGERY, V19, P74; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Gatza ML, 2014, NAT GENET, V46, P1051, DOI 10.1038/ng.3073; Graff JR, 1997, J BIOL CHEM, V272, P22322, DOI 10.1074/jbc.272.35.22322; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Habashy HO, 2008, EUR J CANCER, V44, P1541, DOI 10.1016/j.ejca.2008.04.020; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Iglesia MD, 2014, CLIN CANCER RES, V20, P3818, DOI 10.1158/1078-0432.CCR-13-3368; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kohler S, 2010, J BIOL CHEM, V285, P464, DOI 10.1074/jbc.M109.063149; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Liu XF, 2013, FEBS LETT, V587, P3995, DOI 10.1016/j.febslet.2013.10.036; Liu ZJ, 2014, CELL, V159, P358, DOI 10.1016/j.cell.2014.08.027; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Metzger O, 2012, 35 ANN CTRC AACR SAN, V72, pS1, DOI DOI 10.1158/0008-5472.SABCS12-S1-1; MOLL R, 1993, AM J PATHOL, V143, P1731; Morrogh M, 2012, BREAST CANCER RES TR, V132, P641, DOI 10.1007/s10549-011-1860-0; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pestalozzi BC, 2008, J CLIN ONCOL, V26, P3006, DOI 10.1200/JCO.2007.14.9336; Quon G, 2013, GENOME MED, V5, DOI 10.1186/gm433; Reed AEM, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0519-x; Richards FM, 1999, HUM MOL GENET, V8, P607, DOI 10.1093/hmg/8.4.607; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Ross JS, 2013, CLIN CANCER RES, V19, P2668, DOI 10.1158/1078-0432.CCR-13-0295; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Sahu B, 2011, EMBO J, V30, P3962, DOI 10.1038/emboj.2011.328; Sarrio D, 2003, INT J CANCER, V106, P208, DOI 10.1002/ijc.11197; Serandour AA, 2011, GENOME RES, V21, P555, DOI 10.1101/gr.111534.110; Sikora MJ, 2014, CANCER RES, V74, P1463, DOI 10.1158/0008-5472.CAN-13-2779; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Strobl B, 2011, FRONT BIOSCI-LANDMRK, V16, P3224, DOI 10.2741/3908; Theodorou V, 2013, GENOME RES, V23, P12, DOI 10.1101/gr.139469.112; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wilkerson MD, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku489; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Wu K, 2013, ONCOTARGET, V4, P2430, DOI 10.18632/oncotarget.1431; Zou DH, 2009, J PATHOL, V218, P265, DOI 10.1002/path.2541; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	64	1066	1081	4	116	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2					506	519		10.1016/j.cell.2015.09.033	http://dx.doi.org/10.1016/j.cell.2015.09.033			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26451490	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000362952700023
J	Katsnelson, A				Katsnelson, Alla			COSMETICS Molecular beauty	NATURE			English	Editorial Material							AGED HUMAN SKIN; IN-VIVO											Chang ALS, 2014, J INVEST DERMATOL, V134, P651, DOI 10.1038/jid.2013.381; Chang ALS, 2013, J INVEST DERMATOL, V133, P394, DOI 10.1038/jid.2012.287; Quan TH, 2013, J INVEST DERMATOL, V133, P658, DOI 10.1038/jid.2012.364; Wang F, 2007, ARCH DERMATOL, V143, P155, DOI 10.1001/archderm.143.2.155; WEISS JS, 1988, JAMA-J AM MED ASSOC, V259, P527, DOI 10.1001/jama.259.4.527; Xu J., 2015, J INVEST DERMATOL, V135, pS28	6	6	6	6	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					S4	S5		10.1038/526S4a	http://dx.doi.org/10.1038/526S4a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26444373				2022-12-28	WOS:000362399000002
J	Silberzahn, R; Uhlmann, EL				Silberzahn, Raphael; Uhlmann, Eric L.			Many hands make tight work	NATURE			English	Editorial Material									[Silberzahn, Raphael] IESE Business Sch, Dept Managing People Org, Barcelona, Spain; [Uhlmann, Eric L.] INSEAD, Org Behav, Singapore, Singapore	University of Navarra; IESE Business School; INSEAD Business School	Silberzahn, R (corresponding author), IESE Business Sch, Dept Managing People Org, Barcelona, Spain.	rsilberzahn@iese.edu; eric.uhlmann@insead.edu						Silberzahn R., 2015, PREPRINT; Silberzahn R, 2014, PSYCHOL SCI, V25, P1504, DOI 10.1177/0956797614533802; Silberzahn R, 2013, PSYCHOL SCI, V24, P2437, DOI 10.1177/0956797613494851	3	85	85	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					189	191		10.1038/526189a	http://dx.doi.org/10.1038/526189a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS9GV	26450041	Bronze			2022-12-28	WOS:000362399000022
J	Chhabra, KR; Dimick, JB				Chhabra, Karan R.; Dimick, Justin B.			Hospital Networks and Value-Based Payment Fertile Ground for Regionalizing High-Risk Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Chhabra, Karan R.] Rutgers Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; [Dimick, Justin B.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Dimick, Justin B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chhabra, KR (corresponding author), Rutgers Robert Wood Johnson Med Sch, 675 Hoes Ln W, Piscataway, NJ 08854 USA.	krchhabra@gmail.com	Chhabra, Karan/N-7265-2019					Cutler DM, 2013, JAMA-J AM MED ASSOC, V310, P1964, DOI 10.1001/jama.2013.281675; Jha AK, JAMA FORUM; Livingston EH, 2010, ARCH SURG-CHICAGO, V145, P993, DOI 10.1001/archsurg.2010.218; Merkow RP, 2015, JAMA-J AM MED ASSOC, V313, P483, DOI 10.1001/jama.2014.18614; Reames BN, 2014, ANN SURG, V260, P244, DOI 10.1097/SLA.0000000000000375; Sternberg S., 2015, US NEWS WORLD REPORT; Town R, IMPACT HOSP CONSOLID; Tsai TC, 2013, NEW ENGL J MED, V369, P1134, DOI 10.1056/NEJMsa1303118	8	24	24	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2015	314	13					1335	1336		10.1001/jama.2015.9803	http://dx.doi.org/10.1001/jama.2015.9803			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2PH	26441176				2022-12-28	WOS:000362644700007
J	Mohan, P; Hamide, A				Mohan, Pazhanivel; Hamide, Abdoul			SPOT DIAGNOSIS Characteristic sign of a colonic submucosal lesion	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mohan, Pazhanivel; Hamide, Abdoul] Jawaharlal Inst Postgrad Med Educ & Res, Dept Gastroenterol, Pondicherry 605006, India	Jawaharlal Institute of Postgraduate Medical Education & Research	Mohan, P (corresponding author), Jawaharlal Inst Postgrad Med Educ & Res, Dept Gastroenterol, Pondicherry 605006, India.	dr.pazhani@gmail.com		Mohan, Pazhanivel/0000-0003-1473-4382				Jiang L, 2007, WORLD J GASTROENTERO, V13, P5664, DOI 10.3748/wjg.v13.i42.5664; Mummadi Rajasekhara, 2007, Gastroenterol Hepatol (N Y), V3, P882; Peters Michael B Jr, 2005, JSLS, V9, P342	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 2	2015	351								h5181	10.1136/bmj.h5181	http://dx.doi.org/10.1136/bmj.h5181			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT0AK	26432599				2022-12-28	WOS:000362455900003
J	Chawla, DS				Chawla, Dalmeet Singh			Digital Badges Aim to Clear Up Politics of Authorship	NATURE			English	Editorial Material																		Allen L, 2014, NATURE, V508, P312, DOI 10.1038/508312a	1	3	3	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					145	146						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26432249	Bronze			2022-12-28	WOS:000362095100054
J	Moritz, ML; Ayus, JC				Moritz, Michael L.; Ayus, Juan C.			DISORDERS OF FLUIDS AND ELECTROLYTES Maintenance Intravenous Fluids in Acutely Ill Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HOSPITAL-ACQUIRED HYPONATREMIA; RANDOMIZED CONTROLLED-TRIAL; PERMANENT BRAIN-DAMAGE; POSTOPERATIVE HYPONATREMIA; CHILDREN; THERAPY; SODIUM; WATER; ENCEPHALOPATHY; MANAGEMENT		[Moritz, Michael L.] Univ Pittsburgh, Sch Med, Dept Pediat, Childrens Hosp Pittsburgh,Univ Pittsburgh Med Ctr, Pittsburgh, PA 15261 USA; [Moritz, Michael L.] Univ Pittsburgh, Sch Med, Div Nephrol, Childrens Hosp Pittsburgh,Univ Pittsburgh Med Ctr, Pittsburgh, PA 15261 USA; [Ayus, Juan C.] Renal Consultants Houston, Houston, TX USA; [Ayus, Juan C.] Hosp Italiano Buenos Aires, Div Nephrol, Buenos Aires, DF, Argentina	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Hospital Italiano de Buenos Aires; University of Buenos Aires	Moritz, ML (corresponding author), UPMC, Div Nephrol, Childrens Hosp Pittsburgh, 1 Childrens Hosp Dr,4401 Penn Ave, Pittsburgh, PA 15224 USA.	moritzml@upmc.edu			Otsuka	Otsuka(Otsuka Pharmaceutical)	Drs. Moritz and Ayus report receiving consulting fees from Otsuka and a continuing medical education honorarium from the Global Education Group. No other potential conflict of interest relevant to this article was reported.	Amin A, 2012, J HOSP MED, V7, P634, DOI 10.1002/jhm.1973; ANDERSON RJ, 1985, ANN INTERN MED, V102, P164, DOI 10.7326/0003-4819-102-2-164; [Anonymous], 2009, ISMP CANADA SAFETY B, V9, P1; [Anonymous], 2011, BRIT CONSENSUS GUIDE; ARIEFF AI, 1992, BRIT MED J, V304, P1218, DOI 10.1136/bmj.304.6836.1218; ARIEFF AI, 1986, NEW ENGL J MED, V314, P1529, DOI 10.1056/NEJM198606123142401; Aronson D, 2002, AM J KIDNEY DIS, V40, P940, DOI 10.1053/ajkd.2002.36324; Au AK, 2008, J PEDIATR, V152, P33, DOI 10.1016/j.jpeds.2007.08.040; Ayus JC, 2006, KIDNEY INT, V69, P1319, DOI 10.1038/sj.ki.5000187; AYUS JC, 1992, ANN INTERN MED, V117, P891, DOI 10.7326/0003-4819-117-11-891; Ayus JC, 1999, JAMA-J AM MED ASSOC, V281, P2299, DOI 10.1001/jama.281.24.2299; Ayus JC, 2015, AM J KIDNEY DIS, V65, P435, DOI 10.1053/j.ajkd.2014.09.021; Ayus JC, 2010, CLIN J AM SOC NEPHRO, V5, P167, DOI 10.2215/CJN.09281209; BOMBERGER RA, 1986, J VASC SURG, V4, P164, DOI 10.1067/mva.1986.avs0040164; Carandang F, 2013, J PEDIATR-US, V163, P1646, DOI 10.1016/j.jpeds.2013.07.020; Ayus JC, 2012, NEPHROL DIAL TRANSPL, V27, P3725, DOI 10.1093/ndt/gfs412; Chawla G, 2008, MED EDUC, V42, P613, DOI 10.1111/j.1365-2923.2008.03009.x; CHUNG HM, 1986, ARCH INTERN MED, V146, P333, DOI 10.1001/archinte.146.2.333; Corona G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080451; Coulthard MG, 2007, BRIT J ANAESTH, V98, P146, DOI 10.1093/bja/ael297; Danziger J, 2015, CLIN J AM SOC NEPHRO, V10, P852, DOI 10.2215/CJN.10741013; Davies Polly, 2008, BMC Surg, V8, P10, DOI 10.1186/1471-2482-8-10; Drysdale SB, 2010, EUR J PEDIATR, V169, P813, DOI 10.1007/s00431-009-1117-7; Ellison DH, 2007, NEW ENGL J MED, V356, P2064, DOI 10.1056/NEJMcp066837; Foster BA, 2014, J PEDIAT, V165; Freeman MA, 2012, ACTA PAEDIATR, V101, pE465, DOI 10.1111/j.1651-2227.2012.02780.x; Friedman JN, 2015, JAMA PEDIATR, V169, P445, DOI 10.1001/jamapediatrics.2014.3809; Gankam-Kengne F, 2013, KIDNEY INT, V83, P700, DOI 10.1038/ki.2012.459; Greenberg A, 2015, KIDNEY INT, V88, P167, DOI 10.1038/ki.2015.4; Grissinger Matthew, 2013, P T, V38, P575; Halberthal M, 2001, BRIT MED J, V322, P780, DOI 10.1136/bmj.322.7289.780; Hanna M, 2010, PEDIATR NEPHROL, V25, P1471, DOI 10.1007/s00467-009-1428-y; Hatherill M, 2004, ARCH DIS CHILD, V89, P414, DOI 10.1136/adc.2003.045047; HOLLIDAY MA, 1957, PEDIATRICS, V19, P823; Holliday MA, 2007, ARCH DIS CHILD, V92, P546, DOI 10.1136/adc.2006.106377; Hoorn EJ, 2013, AM J KIDNEY DIS, V62, P139, DOI 10.1053/j.ajkd.2012.09.019; Institute for Safe Medication Practices, 2009, ISMP MED SAFETY ALER, V14, P1; Issa VS, 2013, INT J CARDIOL, V167, P34, DOI 10.1016/j.ijcard.2011.11.087; Rodriguez MJ, 2014, ACTA PAEDIATR, V103, pE7, DOI 10.1111/apa.12439; Kannan L, 2010, PEDIATR NEPHROL, V25, P2303, DOI 10.1007/s00467-010-1600-4; Kinsella S, 2010, CLIN J AM SOC NEPHRO, V5, P275, DOI 10.2215/CJN.06120809; Knepper MA, 2015, NEW ENGL J MED, V372, P1349, DOI 10.1056/NEJMra1404726; Lobo DN, 2014, KIDNEY INT, V86, P1096, DOI 10.1038/ki.2014.105; McNab S, 2014, COCHRANE DB SYST REV, V12, P1; Mcnab S, 2015, LANCET, V385, P1190, DOI 10.1016/S0140-6736(14)61459-8; Mohan S, 2013, AM J MED, V126, P1127, DOI 10.1016/j.amjmed.2013.07.021; Moritz M, 2005, PEDIATR NEPHROL, V20, P1687, DOI 10.1007/s00467-005-1933-6; Moritz ML, 2008, PEDIATR NEPHROL, V23, P955, DOI 10.1007/s00467-008-0757-6; Moritz ML, 2007, NAT CLIN PRACT NEPHR, V3, P374, DOI 10.1038/ncpneph0526; Moritz ML, 2011, CURR OPIN PEDIATR, V23, P186, DOI 10.1097/MOP.0b013e3283440fd9; Moritz ML, 2010, PEDIATR NEPHROL, V25, P1225, DOI 10.1007/s00467-009-1323-6; Moritz ML, 2003, PEDIATRICS, V111, P227, DOI 10.1542/peds.111.2.227; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; Musch W, 1998, QJM-MON J ASSOC PHYS, V91, P749, DOI 10.1093/qjmed/91.11.749; Mythen MG, 2012, PERIOPER MED, V1, DOI 10.1186/2047-0525-1-2; Nair V, 2007, AM J NEPHROL, V27, P184, DOI 10.1159/000100866; National Patient Safety Agency (NPSA), 2007, PAT SAF AL RED RISK; Neville KA, 2005, PEDIATRICS, V116, P1401, DOI 10.1542/peds.2004-2376; Neville KA, 2010, J PEDIAT, V156; Nigro N, 2015, J AM GERIATR SOC, V63, P470, DOI 10.1111/jgs.13325; Oster JR, 1997, ARCH INTERN MED, V157, P721, DOI 10.1001/archinte.157.7.721; Padhi S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7073; Renneboog B, 2006, AM J MED, V119, P71, DOI [10.1016/j.amjmed.2005.09.026, DOI 10.1016/J.AMJMED.2005.09.026]; Saba TG, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-82; Schrier RW, 2006, J AM SOC NEPHROL, V17, P1820, DOI 10.1681/ASN.2006030240; SCHRIER RW, 1988, NEW ENGL J MED, V319, P1127, DOI 10.1056/NEJM198810273191705; Severs D, 2015, NEPHROL DIAL TRANSPL, V30, P178, DOI 10.1093/ndt/gfu005; Shafiee MAS, 2003, QJM-INT J MED, V96, P601, DOI 10.1093/qjmed/hcg101; Shamim A, 2014, INDIAN PEDIATR, V51, P969, DOI 10.1007/s13312-014-0542-5; Spasovski G, 2014, NEPHROL DIAL TRANSPL, V29, P1, DOI 10.1093/ndt/gfu040; Steele A, 1997, ANN INTERN MED, V126, P20, DOI 10.7326/0003-4819-126-1-199701010-00003; TALBOT NB, 1953, NEW ENGL J MED, V248, P1100, DOI 10.1056/NEJM195306252482605; Taylor D, 2004, ARCH DIS CHILD, V89, P411, DOI 10.1136/adc.2003.045302; Upadhyay A, 2006, AM J MED, V119, pS30, DOI 10.1016/j.amjmed.2006.05.005; Verbalis JG, 2010, J BONE MINER RES, V25, P554, DOI 10.1359/jbmr.090827; Yung M, 2009, J PAEDIATR CHILD H, V45, P9, DOI 10.1111/j.1440-1754.2007.01254.x	76	94	99	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2015	373	14					1350	1360		10.1056/NEJMra1412877	http://dx.doi.org/10.1056/NEJMra1412877			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3CI	26422725				2022-12-28	WOS:000361948600009
J	Dzau, VJ				Dzau, Victor J.			The Institute of Medicine: ensuring integrity and independence in scientific advice on health	LANCET			English	Article								National science and medical academies across the world serve a range of roles and functions. In particular, the benefits of an independent academy tasked with the provision of formal advice are compelling. For nearly half a century, the Institute of Medicine (IOM) has served the USA and the world by providing independent, authoritative advice on issues related to health and medicine. Its influence reaches deep into the health and policy worlds. This paper provides insight into the principles, processes, and governance that confer unique credibility to IOM advice. The IOM can serve as a useful model for other academies to consider for strengthening their work or when other countries contemplate the creation of a new academy.	[Dzau, Victor J.] Natl Acad Med, Washington, DC 20001 USA	National Academies of Sciences, Engineering & Medicine	Dzau, VJ (corresponding author), Natl Acad Med, Washington, DC 20001 USA.	vdzau@nas.edu						[Anonymous], AB THE IOM; Dzau VJ, 2015, NEW ENGL J MED, V373, P991, DOI 10.1056/NEJMp1509136; Harris G., VACCINE CLEARED AGAI; *I MED, FOR DRUG DISC DEV TR; *I MED, 2009, US COMM GLOB HLTH RE; Inst Med, 2015, BEYOND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME: REDEFINING AN ILLNESS, P1; Inst. Med, 2013, BEST CAR LOW COST PA; Institute of Medicine, FOR MED PUBL HLTH PR; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI [10.17226/10027, DOI 10.17226/10027]; Institute of Medicine, ROUNDT VAL SCI DRIV; Institute of Medicine, FOR NEUR NERV SYST D; Institute of Medicine, 2009, INV GLOB HLTH SYST S; Institute of Medicine, FOR PUBL PRIV PARTN; Institute of Medicine, IMM SAF REV VACC AUT; Institute of Medicine, INT FOOD NUTR FOR; Institute of Medicine, CLIN RES ROUNDT; Institute of Medicine, ROUNDT POP HLTH IMPR; Institute of Medicine, 2006, FUT DRUG SAF PROM PR; Institute of Medicine, FOR MICR THREATS; Institute of Medicine, 2015, SHAR CLIN TRIAL DAT; Institute of Medicine, FOR SCI HLTH CAR QUA; Institute of Medicine, FOR PROM CHILDR COGN; Institute of Medicine, ROUNDT PROM HLTH EQ; Institute of Medicine, FOOD FOR; Institute of Medicine, 2004, IMM SAF REV VACC AUT; Institute of Medicine, GLOB FOR INN HLTH PR; Institute of Medicine, FOR INV YOUNG CHILDR; Institute of Medicine, ROUNDT OB SOL; Institute of Medicine, 2006, FOOD MARK CHILDR YOU; Institute of Medicine, ROUNDT ENV HLTH SCI; Institute of Medicine, ROUNDT TRANSL GEN BA; Institute of Medicine, FOR GLOB VIOL PREV; Institute of Medicine, FOR AG DIS IND; Institute of Medicine, 2015, NAT CANC POL FOR; Institute of Medicine, ROUNDT HLTH LIT; Institute of Medicine, 2012, PRIM CAR PUBL HLTH E; Institute of Medicine, 2006, PREV HIV INF INJ DRU; Institute of Medicine and National Research Council, 2005, GUID HUM EMBR STEM C; Institute of Medicine (US) Committee on Envisioning a Strategy for the Long-Term Burden of HIV/AIDS: African Needs and U.S. Interests, 2011, PREP FUT HIV AIDS AF; Institutes of Medicine, 1999, ERR IS HUMAN BUILDIN; National Academy of Sciences, HISTORY	41	1	1	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2016	387	10028					1686	1692		10.1016/S0140-6736(15)00468-7	http://dx.doi.org/10.1016/S0140-6736(15)00468-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3ZL	26490196				2022-12-28	WOS:000374145100035
J	Young, P; Bailey, M; Beasley, R; Henderson, S; Mackle, D; McArthur, C; MGuinness, S; Mehrtens, J; Myburgh, J; Psirides, A; Reddy, S; Bellomo, R				Young, Paul; Bailey, Michael; Beasley, Richard; Henderson, Seton; Mackle, Diane; McArthur, Colin; MGuinness, Shay; Mehrtens, Jan; Myburgh, John; Psirides, Alex; Reddy, Sumeet; Bellomo, Rinaldo		SPLIT Investigators ANZICS CTG	Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit The SPLIT Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CRITICALLY-ILL ADULTS; IN-HOSPITAL MORTALITY; FLUID THERAPY SPLIT; PLASMA-LYTE 148; 0.9-PERCENT SALINE; RESUSCITATION; CHLORIDE; ASSOCIATION	IMPORTANCE Saline (0.9% sodium chloride) is the most commonly administered intravenous fluid; however, its use may be associated with acute kidney injury (AKI) and increased mortality. OBJECTIVE To determine the effect of a buffered crystalloid compared with saline on renal complications in patients admitted to the intensive care unit (ICU). DESIGN AND SETTING Double-blind, cluster randomized, double-crossover trial conducted in 4 ICUs in New Zealand from April 2014 through October 2014. Three ICUs were general medical and surgical ICUs; 1 ICU had a predominance of cardiothoracic and vascular surgical patients. PARTICIPANTS All patients admitted to the ICU requiring crystalloid fluid therapy were eligible for inclusion. Patients with established AKI requiring renal replacement therapy (RRT) were excluded. All 2278 eligible patients were enrolled; 1152 of 1162 patients (99.1%) receiving buffered crystalloid and 1110 of 1116 patients (99.5%) receiving saline were analyzed. INTERVENTIONS Participating ICUs were assigned a masked study fluid, either saline or a buffered crystalloid, for alternating 7-week treatment blocks. Two ICUs commenced using 1 fluid and the other 2 commenced using the alternative fluid. Two crossovers occurred so that each ICU used each fluid twice over the 28 weeks of the study. The treating clinician determined the rate and frequency of fluid administration. MAIN OUTCOMES AND MEASURES The primary outcome was proportion of patients with AKI (defined as a rise in serum creatinine level of at least 2-fold or a serum creatinine level of >= 3.96mg/dL with an increase of >= 0.5mg/dL); main secondary outcomes were incidence of RRT use and in-hospital mortality. RESULTS In the buffered crystalloid group, 102 of 1067 patients (9.6%) developed AKI within 90 days after enrollment compared with 94 of 1025 patients (9.2%) in the saline group (absolute difference, 0.4%[95% CI, -2.1% to 2.9%]; relative risk [RR], 1.04 [95% CI, 0.80 to 1.36]; P=.77). In the buffered crystalloid group, RRT was used in 38 of 1152 patients (3.3%) compared with 38 of 1110 patients (3.4%) in the saline group (absolute difference, -0.1% [95% CI, -1.6% to 1.4%]; RR, 0.96 [95% CI, 0.62 to 1.50]; P = .91). Overall, 87 of 1152 patients (7.6%) in the buffered crystalloid group and 95 of 1110 patients (8.6%) in the saline group died in the hospital (absolute difference, -1.0% [95% CI, -3.3% to 1.2%]; RR, 0.88 [95% CI, 0.67 to 1.17]; P=.40). CONCLUSIONS AND RELEVANCE Among patients receiving crystalloid fluid therapy in the ICU, use of a buffered crystalloid compared with saline did not reduce the risk of AKI. Further large randomized clinical trials are needed to assess efficacy in higher-risk populations and to measure clinical outcomes such as mortality.	[Young, Paul; Beasley, Richard; Henderson, Seton; Mackle, Diane; McArthur, Colin; MGuinness, Shay; Reddy, Sumeet] Med Res Inst New Zealand, Wellington 6242, New Zealand; [Young, Paul; Psirides, Alex] Wellington Reg Hosp, Intens Care Unit, Wellington, New Zealand; [Bailey, Michael; McArthur, Colin; MGuinness, Shay; Bellomo, Rinaldo] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia; [Henderson, Seton; Mehrtens, Jan] Christchurch Hosp, Dept Intens Care Med, Christchurch, New Zealand; [McArthur, Colin] Auckland City Hosp, Dept Crit Care Med, Auckland, New Zealand; [MGuinness, Shay] Auckland City Hosp, Cardiothorac & Vasc Intens Care Unit, Auckland, New Zealand; [Myburgh, John] St George Hosp, Intens Care Unit, Sydney, NSW, Australia; [Myburgh, John] George Inst Global Hlth, Crit Care Div, Sydney, NSW, Australia; [Bellomo, Rinaldo] Austin Hosp, Intens Care Unit, Melbourne, Vic 3084, Australia	Medical Research Institute Of New Zealand; Monash University; Christchurch Hospital New Zealand; Auckland City Hospital; Auckland City Hospital; St George Hospital; George Institute for Global Health; University of Sydney; Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Young, P (corresponding author), Med Res Inst New Zealand, Private Bag 7902, Wellington 6242, New Zealand.	paul.young@ccdhb.org.nz	Beasley, Richard/AAH-3908-2019; Bailey, Michael J/A-4499-2012	Beasley, Richard/0000-0003-0337-406X; Bailey, Michael J/0000-0002-5551-1401; Bellomo, Rinaldo/0000-0002-1650-8939; McGuinness, Shay/0000-0003-0620-4787; Forbes, Andrew/0000-0003-4269-914X; Young, Paul/0000-0002-3428-3083; Psirides, Alex/0000-0002-5925-2478; Myburgh, John/0000-0003-4088-7016	Health Research Council of New Zealand; Baxter Healthcare Corporation	Health Research Council of New Zealand(Health Research Council of New Zealand); Baxter Healthcare Corporation	This study was funded by the Health Research Council of New Zealand through a Research Partnership for Health Delivery grant and by Baxter Healthcare Corporation.	Bayer O, 2011, CRIT CARE MED, V39, P1335, DOI 10.1097/CCM.0b013e318212096a; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Chowdhury AH, 2012, ANN SURG, V256, P18, DOI 10.1097/SLA.0b013e318256be72; Finfer S, 2010, CRIT CARE, V14, DOI 10.1186/cc9293; Kellum JA, 2013, CRIT CARE, V17, DOI 10.1186/cc11454; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Krajewski ML, 2015, BRIT J SURG, V102, P24, DOI 10.1002/bjs.9651; Myburgh JA, 2013, NEW ENGL J MED, V369, P1243, DOI 10.1056/NEJMra1208627; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Pilcher D, APD DATA DICT SOFTWA; Raghunathan K, 2014, CRIT CARE MED, V42, P1585, DOI 10.1097/CCM.0000000000000305; Reddy SK, 2015, CRIT CARE RESUSC, V17, P29; Reddy SK, 2014, CRIT CARE RESUSC, V16, P274; Shaw AD, 2014, INTENS CARE MED, V40, P1897, DOI 10.1007/s00134-014-3505-3; Shaw AD, 2012, ANN SURG, V255, P821, DOI 10.1097/SLA.0b013e31825074f5; Young P, STAT ANAL PLAN 0 9 S; Young PJ, 2014, INTENS CARE MED, V40, P1966, DOI 10.1007/s00134-014-3531-1; Yunos NM, 2015, INTENS CARE MED, V41, P257, DOI 10.1007/s00134-014-3593-0; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356; Yunos NM, 2010, CRIT CARE, V14, DOI 10.1186/cc9052	21	400	422	2	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2015	314	16					1701	1710		10.1001/jama.2015.12334	http://dx.doi.org/10.1001/jama.2015.12334			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7HC	26444692	Bronze			2022-12-28	WOS:000363706300019
J	Isbell, F; Craven, D; Connolly, J; Loreau, M; Schmid, B; Beierkuhnlein, C; Bezemer, TM; Bonin, C; Bruelheide, H; de Luca, E; Ebeling, A; Griffin, JN; Guo, QF; Hautier, Y; Hector, A; Jentsch, A; Kreyling, J; Lanta, V; Manning, P; Meyer, ST; Mori, AS; Naeem, S; Niklaus, PA; Polley, HW; Reich, PB; Roscher, C; Seabloom, EW; Smith, MD; Thakur, MP; Tilman, D; Tracy, BF; van der Putten, WH; van Ruijven, J; Weigelt, A; Weisser, WW; Wilsey, B; Eisenhauer, N				Isbell, Forest; Craven, Dylan; Connolly, John; Loreau, Michel; Schmid, Bernhard; Beierkuhnlein, Carl; Bezemer, T. Martijn; Bonin, Catherine; Bruelheide, Helge; de Luca, Enrica; Ebeling, Anne; Griffin, John N.; Guo, Qinfeng; Hautier, Yann; Hector, Andy; Jentsch, Anke; Kreyling, Juergen; Lanta, Vojtech; Manning, Pete; Meyer, Sebastian T.; Mori, Akira S.; Naeem, Shahid; Niklaus, Pascal A.; Polley, H. Wayne; Reich, Peter B.; Roscher, Christiane; Seabloom, Eric W.; Smith, Melinda D.; Thakur, Madhav P.; Tilman, David; Tracy, Benjamin F.; van der Putten, Wim H.; van Ruijven, Jasper; Weigelt, Alexandra; Weisser, Wolfgang W.; Wilsey, Brian; Eisenhauer, Nico			Biodiversity increases the resistance of ecosystem productivity to climate extremes	NATURE			English	Article							GRASSLAND PRODUCTIVITY; STABILITY; DIVERSITY; COMMUNITIES; DROUGHT; POPULATION; VARIABILITY	It remains unclear whether biodiversity buffers ecosystems against climate extremes, which are becoming increasingly frequent worldwide(1). Early results suggested that the ecosystem productivity of diverse grassland plant communities was more resistant, changing less during drought, and more resilient, recovering more quickly after drought, than that of depauperate communities(2). However, subsequent experimental tests produced mixed results(3-13). Here we use data from 46 experiments that manipulated grassland plant diversity to test whether biodiversity provides resistance during and resilience after climate events. We show that biodiversity increased ecosystem resistance for a broad range of climate events, including wet or dry, moderate or extreme, and brief or prolonged events. Across all studies and climate events, the productivity of low-diversity communities with one or two species changed by approximately 50% during climate events, whereas that of high-diversity communities with 16-32 species was more resistant, changing by only approximately 25%. By a year after each climate event, ecosystem productivity had often fully recovered, or overshot, normal levels of productivity in both high-and low-diversity communities, leading to no detectable dependence of ecosystem resilience on biodiversity. Our results suggest that biodiversity mainly stabilizes ecosystem productivity, and productivity-dependent ecosystem services, by increasing resistance to climate events. Anthropogenic environmental changes that drive biodiversity loss thus seem likely to decrease ecosystem stability(14), and restoration of biodiversity to increase it, mainly by changing the resistance of ecosystem productivity to climate events.	[Isbell, Forest; Seabloom, Eric W.; Tilman, David] Univ Minnesota Twin Cities, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Craven, Dylan; Bruelheide, Helge; Roscher, Christiane; Thakur, Madhav P.; Weigelt, Alexandra; Eisenhauer, Nico] German Ctr Integrat Biodivers Res iDiv, D-04103 Leipzig, Germany; [Craven, Dylan; Thakur, Madhav P.; Weigelt, Alexandra; Eisenhauer, Nico] Univ Leipzig, Inst Biol, D-04103 Leipzig, Germany; [Connolly, John] Natl Univ Ireland Univ Coll Dublin, Sch Math & Stat, Ecol & Environm Modelling Grp, Dublin 4, Ireland; [Loreau, Michel] CNRS, Expt Ecol Stn, Ctr Biodivers Theory & Modelling, F-09200 Moulis, France; [Schmid, Bernhard; de Luca, Enrica; Niklaus, Pascal A.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Beierkuhnlein, Carl] Univ Bayreuth, BayCEER, Dept Biogeog, D-95440 Bayreuth, Germany; [Bezemer, T. Martijn; van der Putten, Wim H.] Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, NL-6700 AB Wageningen, Netherlands; [Bonin, Catherine] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Bruelheide, Helge] Univ Halle Wittenberg, Inst Biol, D-06108 Halle, Germany; [Ebeling, Anne] Univ Jena, Inst Ecol, D-07743 Jena, Germany; [Griffin, John N.] Swansea Univ, Dept Biosci, Swansea SA2 8PP, W Glam, Wales; [Guo, Qinfeng] USDA FS, Eastern Forest Environm Threat Assessment Ctr, Res Triangle Pk, NC 27709 USA; [Hautier, Yann] Univ Utrecht, Dept Biol, Ecol & Biodivers Grp, NL-3584 CH Utrecht, Netherlands; [Hector, Andy] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [Jentsch, Anke] Univ Bayreuth, BayCEER, Disturbance Ecol, D-95440 Bayreuth, Germany; [Kreyling, Juergen] Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landscape Ecol, D-17487 Greifswald, Germany; [Lanta, Vojtech] Univ South Bohemia, Fac Sci, Dept Bot, Ceske Budejovice 37005, Czech Republic; [Manning, Pete] Univ Bern, Inst Plant Sci, CH-3013 Bern, Switzerland; [Meyer, Sebastian T.; Weisser, Wolfgang W.] Tech Univ Munich, Sch Life Sci Weihenstephan, Dept Ecol & Ecosyst Management, D-85354 Freising Weihenstephan, Germany; [Mori, Akira S.] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan; [Naeem, Shahid] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Polley, H. Wayne] USDA ARS, Grassland Soil & Water Res Lab, Temple, TX 76502 USA; [Reich, Peter B.] Univ Minnesota Twin Cities, Dept Forest Resources, St Paul, MN 55108 USA; [Roscher, Christiane] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 2753, Australia; [Roscher, Christiane] UFZ Helmholtz Ctr Environm Res, Community Ecol, D-06120 Halle, Germany; [Smith, Melinda D.] Colorado State Univ, Grad Degree Program, Ft Collins, CO 80523 USA; [Smith, Melinda D.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Tilman, David] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Tracy, Benjamin F.] Virginia Tech, Crop & Soil Environm Sci, Blacksburg, VA 24061 USA; [van der Putten, Wim H.] Univ Wageningen & Res Ctr, Nematol Lab, NL-6700 ES Wageningen, Netherlands; [van Ruijven, Jasper] Wageningen Univ, Nat Conservat & Plant Ecol Grp, NL-6700 AA Wageningen, Netherlands; [Wilsey, Brian] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA	University of Minnesota System; University of Minnesota Twin Cities; Leipzig University; University College Dublin; Centre National de la Recherche Scientifique (CNRS); University of Zurich; University of Bayreuth; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Iowa State University; Martin Luther University Halle Wittenberg; Friedrich Schiller University of Jena; Swansea University; United States Department of Agriculture (USDA); United States Forest Service; Utrecht University; University of Oxford; University of Bayreuth; Ernst Moritz Arndt Universitat Greifswald; University of South Bohemia Ceske Budejovice; University of Bern; Technical University of Munich; Yokohama National University; Columbia University; United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities; Western Sydney University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Colorado State University; Colorado State University; University of California System; University of California Santa Barbara; Virginia Polytechnic Institute & State University; Wageningen University & Research; Wageningen University & Research; Iowa State University	Isbell, F (corresponding author), Univ Minnesota Twin Cities, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	isbell@umn.edu	Lanta, Vojtech/AAC-4588-2022; Weisser, Wolfgang W/B-9718-2014; Niklaus, Pascal A/G-5786-2010; Beierkuhnlein, Carl/ABF-9693-2021; van der Putten, Wim H/C-3707-2011; Hautier, Yann/D-5426-2015; van Ruijven, Jasper/D-9848-2011; Beierkuhnlein, Carl/ABF-8797-2021; Eisenhauer, Nico/I-5932-2012; Hautier, Yann/I-2526-2019; Schmid, Bernhard/C-8625-2009; Kreyling, Juergen/G-4697-2018; Hector, Andrew/H-4199-2011; Bruelheide, Helge/G-3907-2013; Mori, Akira S/A-6570-2013; van Ruijven, Jasper/ABE-7791-2020; Meyer, Sebastian Tobias/AAH-3856-2021; Tilman, David/ABD-5309-2021; Thakur, Madhav P./D-9903-2015; Eisenhauer, Nico/I-3191-2019; Smith, Melinda D/J-8987-2014; Isbell, Forest/C-6915-2012; Bezemer, Martijn/A-4068-2009; Lanta, Vojtech/J-7032-2017; Craven, Dylan/K-2717-2012; Thakur, Madhav P./AAB-4898-2022; Manning, Peter/I-6523-2012; KNAW, NIOO-KNAW/A-4320-2012	Lanta, Vojtech/0000-0003-4484-3838; Weisser, Wolfgang W/0000-0002-2757-8959; Niklaus, Pascal A/0000-0002-2360-1357; Beierkuhnlein, Carl/0000-0002-6456-4628; van der Putten, Wim H/0000-0002-9341-4442; Hautier, Yann/0000-0003-4347-7741; Eisenhauer, Nico/0000-0002-0371-6720; Hautier, Yann/0000-0003-4347-7741; Schmid, Bernhard/0000-0002-8430-3214; Kreyling, Juergen/0000-0001-8489-7289; Hector, Andrew/0000-0002-1309-7716; Bruelheide, Helge/0000-0003-3135-0356; Mori, Akira S/0000-0002-8422-1198; van Ruijven, Jasper/0000-0003-0003-2363; Meyer, Sebastian Tobias/0000-0003-0833-1472; Eisenhauer, Nico/0000-0002-0371-6720; Isbell, Forest/0000-0001-9689-769X; Bezemer, Martijn/0000-0002-2878-3479; Lanta, Vojtech/0000-0003-4484-3838; Craven, Dylan/0000-0003-3940-833X; Manning, Peter/0000-0002-7940-2023; Wilsey, Brian J./0000-0002-0628-5006; Seabloom, Eric/0000-0001-6780-9259; Thakur, Madhav/0000-0001-9426-1313; Reich, Peter/0000-0003-4424-662X; Griffin, John/0000-0003-3295-6480; KNAW, NIOO-KNAW/0000-0002-3835-159X	sDiv, the Synthesis Centre of the German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig [DFG FZT 118]; TULIP Laboratory of Excellence [ANR-10-LABX-41]; URPP Global Change and Biodiversity of the University of Zurich; Direct For Biological Sciences [1120064] Funding Source: National Science Foundation	sDiv, the Synthesis Centre of the German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig; TULIP Laboratory of Excellence; URPP Global Change and Biodiversity of the University of Zurich; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This paper is a product of the STABILITY group funded by sDiv, the Synthesis Centre of the German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig (DFG FZT 118). M.L. was supported by the TULIP Laboratory of Excellence (ANR-10-LABX-41). B.S. and P.A.N. were supported by the URPP Global Change and Biodiversity of the University of Zurich.	Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Begueria S, 2010, B AM METEOROL SOC, V91, P1351, DOI 10.1175/2010BAMS2988.1; Caldeira MC, 2005, OIKOS, V110, P115, DOI 10.1111/j.0030-1299.2005.13873.x; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; de Mazancourt C, 2013, ECOL LETT, V16, P617, DOI 10.1111/ele.12088; Griffin John n., 2009, P78; Gross K, 2014, AM NAT, V183, P1, DOI 10.1086/673915; Grossiord C, 2014, P NATL ACAD SCI USA, V111, P14812, DOI 10.1073/pnas.1411970111; Hautier Y, 2015, SCIENCE, V348, P336, DOI 10.1126/science.aaa1788; Hector A, 2010, ECOLOGY, V91, P2213, DOI 10.1890/09-1162.1; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Kahmen A, 2005, FUNCT ECOL, V19, P594, DOI 10.1111/j.1365-2435.2005.01001.x; MCNAUGHTON SJ, 1977, AM NAT, V111, P515, DOI 10.1086/283181; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Pfisterer AB, 2002, NATURE, V416, P84, DOI 10.1038/416084a; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Polley HW, 2013, OIKOS, V122, P1275, DOI 10.1111/j.1600-0706.2013.00338.x; Steiner CF, 2006, ECOLOGY, V87, P996, DOI 10.1890/0012-9658(2006)87[996:PACRIM]2.0.CO;2; Stocker T.F., 2013, IPCC 2013 SUMMARY PO; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Tilman D, 2014, ANNU REV ECOL EVOL S, V45, P471, DOI 10.1146/annurev-ecolsys-120213-091917; van Ruijven J, 2010, J ECOL, V98, P81, DOI 10.1111/j.1365-2745.2009.01603.x; Vicente-Serrano SM, 2013, P NATL ACAD SCI USA, V110, P52, DOI 10.1073/pnas.1207068110; Vogel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036992; Wang YF, 2007, ECOL LETT, V10, P401, DOI 10.1111/j.1461-0248.2007.01031.x; Wright AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7092	30	698	730	177	1675	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					574	U263		10.1038/nature15374	http://dx.doi.org/10.1038/nature15374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26466564	Green Published, Green Accepted			2022-12-28	WOS:000364026100050
J	Petherick, A				Petherick, Anna			SCIENCE MASTERCLASS	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					S49	S49		10.1038/526S49a	http://dx.doi.org/10.1038/526S49a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26488240	Bronze			2022-12-28	WOS:000364026100001
J	Appleby, J				Appleby, John			DATA BRIEFING The rise and rise of generic prescribing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						Aitken M, 2014, MED USE SHIFTING COS; Alderwick H, 2015, BETTER VALUE NHS ROL; Department of Health, 1998, PRESCR DISP COMM; Department of Health, 1987, STAT PRESCR DISP FAM; Department of Health and Social Security, 1988, ENGLAND 1976 1986 B; Health and Social Care Information Centre, 2015, PRESCR DIS COMM STAT; Monitor, 2015, PERFORMANCE FDN TRUS; Smyth C., 2015, TIMES; Trust Development Authority, 2015, NHS TRUSTS FIN POS Q	9	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2015	351								h5507	10.1136/bmj.h5507	http://dx.doi.org/10.1136/bmj.h5507			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3FJ	26486378				2022-12-28	WOS:000364143900008
J	Sokol, D				Sokol, Daniel			ETHICS MAN Doing the right thing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											Sokol, D (corresponding author), 12 Kings Bench Walk, London, England.	Sokol@12kbw.co.uk						Dyer C, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7334; General Medical Council, 2012, RAIS ACT CONC PAT SA; General Medical Council, CONS GUID OBST SHAR; WHO, 2015, EB SIT REP	4	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2015	351								h5288	10.1136/bmj.h5288	http://dx.doi.org/10.1136/bmj.h5288			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3FJ	26486158				2022-12-28	WOS:000364143900005
J	Olsen, AMS; Lindhardsen, J; Gislason, GH; McGettigan, P; Hlatky, MA; Fosbol, E; Kober, L; Torp-Pedersen, C; Lamberts, M				Olsen, Anne-Marie Schjerning; Lindhardsen, Jesper; Gislason, Gunnar H.; McGettigan, Patricia; Hlatky, Mark A.; Fosbol, Emil; Kober, Lars; Torp-Pedersen, Christian; Lamberts, Morten			Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY INTERVENTION; CARDIOVASCULAR EVENTS; ANTIPLATELET THERAPY; AMERICAN-COLLEGE; FOCUSED UPDATE; TASK-FORCE; NSAID USE; RISK; MORTALITY	STUDY QUESTION What is the effect of proton pump inhibitors (PPIs) on the risk of gastrointestinal bleeding in post-myocardial infarction patients taking antithrombotics and treated with non-steroidal anti-inflammatory drugs (NSAIDs)? METHODS This was a nationwide cohort study based on linked administrative registry data from all hospitals in Denmark between 1997 and 2011. The study included patients aged 30 years and over admitted with a first myocardial infarction who survived at least 30 days after discharge. The association between PPIs and risk of gastrointestinal bleeding according to NSAID plus antithrombotic therapy was estimated using adjusted time dependent Cox regression models. STUDY ANSWER AND LIMITATIONS The use of PPIs was independently associated with decreased risk of gastrointestinal bleeding in post-myocardial infarction patients taking antithrombotics and treated with NSAIDs. Of 82 955 post-myocardial infarction patients (mean age 67.4 years, 64% (n=53 070) men), all of whom were taking single or dual antithrombotic therapy, 42.5% (n=35 233) filled at least one prescription for NSAIDs and 45.5% (n=37 771) received PPIs. Over a mean follow-up of 5.1 years, 3229 gastrointestinal bleeds occurred. The crude incidence rates of bleeding (events/100 person years) on NSAID plus antithrombotic therapy were 1.8 for patients taking PPIs and 2.1 for those not taking PPIs. The adjusted risk of bleeding was lower with PPI use (hazard ratio 0.72, 95% confidence interval 0.54 to 0.95) regardless of antithrombotic treatment regimen, type of NSAID, and type of PPI used. The main limitation of the study is its observational non-randomised design. The results suggest that PPI treatment probably has a beneficial effect regardless of underlying gastrointestinal risk and that when NSAIDs cannot be avoided in post-myocardial infarction patients, physicians might prescribe a PPI as well. The study does not clarify whether PPIs might be safely omitted in specific subgroups of patients with a low risk of gastrointestinal bleeding. WHAT THIS STUDY ADDS In post-myocardial infarction patients, bleeding complications have been associated with both antithrombotic and NSAID treatment. Concurrent use of PPIs was independently associated with a decreased risk of gastrointestinal bleeding in post-myocardial infarction patients taking antithrombotics and NSAID, regardless of antithrombotic treatment regimen, type of NSAID, and type of PPI used.	[Olsen, Anne-Marie Schjerning; Lindhardsen, Jesper; Gislason, Gunnar H.] Copenhagen Univ Hosp Herlev & Gentofte, Dept Cardiol, DK-2900 Copenhagen, Denmark; [Olsen, Anne-Marie Schjerning; McGettigan, Patricia] Barts & London Queen Marys Sch Med & Dent, WHRI, London, England; [Gislason, Gunnar H.] Danish Heart Fdn, Copenhagen, Denmark; [Gislason, Gunnar H.] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Hlatky, Mark A.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Fosbol, Emil; Kober, Lars] Copenhagen Univ Hosp Rigshosp, Dept Cardiol, Ctr Heart, Copenhagen, Denmark; [Torp-Pedersen, Christian] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Lamberts, Morten] Copenhagen Univ Hosp Herlev, Dept Cardiol, Copenhagen, Denmark	University of London; Queen Mary University London; University of Southern Denmark; Stanford University; Rigshospitalet; University of Copenhagen; Aalborg University; University of Copenhagen	Olsen, AMS (corresponding author), Copenhagen Univ Hosp Herlev & Gentofte, Dept Cardiol, DK-2900 Copenhagen, Denmark.	aols0073@geh.regionh.dk	Gislason, Gunnar/B-7561-2009	Gislason, Gunnar/0000-0002-0548-402X; Lamberts, Morten/0000-0002-9827-440X; Kober, Lars/0000-0002-6635-1466; Hlatky, Mark/0000-0003-4686-9441; Fosbol, Emil/0000-0002-2048-4167	Danish Council of Independent Research [12-132760]; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF12OC1015957] Funding Source: researchfish	Danish Council of Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	AMSO has received a grant from the Danish Council of Independent Research (grant 12-132760). GHG is supported by an unrestricted research scholarship from the Novo Nordisk Foundation. The funding sources had no influence on study design, interpretation of the results, or the decision to submit the article.	Abraham NS, 2010, J AM COLL CARDIOL, V56, P2051, DOI 10.1016/j.jacc.2010.09.010; Agewall S, 2013, EUR HEART J, V34, P1708, DOI 10.1093/eurheartj/eht042; Andersen TF, 1999, DAN MED BULL, V46, P263; Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; Antman EM, 2007, CIRCULATION, V115, P1634, DOI 10.1161/CIRCULATIONAHA.106.181424; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Bombardier C, 2000, NEW ENGL J MED, V343, P1520; Chan FKL, 2007, LANCET, V369, P1621, DOI 10.1016/S0140-6736(07)60749-1; Davidson BL, 2014, JAMA INTERN MED, V174, P947, DOI 10.1001/jamainternmed.2014.946; Fosbol EL, 2008, PHARMACOEPIDEM DR S, V17, P822, DOI 10.1002/pds.1592; Gaist D, 1997, DAN MED BULL, V44, P445; Gislason GH, 2006, CIRCULATION, V113, P2906, DOI 10.1161/CIRCULATIONAHA.106.616219; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hernandez-Diaz S, 2006, BASIC CLIN PHARMACOL, V98, P266, DOI 10.1111/j.1742-7843.2006.pto_302.x; Lamberts M, 2014, ANN INTERN MED, V161, P690, DOI 10.7326/M13-1581; Lamberts M, 2012, CIRCULATION, V126, P1185, DOI 10.1161/CIRCULATIONAHA.112.114967; Lanas A, 2007, AM J GASTROENTEROL, V102, P507, DOI 10.1111/j.1572-0241.2006.01062.x; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; McGettigan P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001098; Melloni C, 2015, CIRC-CARDIOVASC QUAL, V8, P47, DOI 10.1161/CIRCOUTCOMES.114.001177; National Institute for Health and Care Excellence, 2015, ANT TREATM; National Institute for Health and Care Excellence, 2015, NSAIDS PRESCR ISS; Olsen AMS, 2015, JAMA-J AM MED ASSOC, V313, P805, DOI 10.1001/jama.2015.0809; Olsen AMS, 2012, CIRCULATION, V126, P1955, DOI 10.1161/CIRCULATIONAHA.112.112607; Olsen AMS, 2011, CIRCULATION, V123, P2226, DOI 10.1161/CIRCULATIONAHA.110.004671; Rasmussen S, 2005, MED CARE, V43, P970, DOI 10.1097/01.mlr.0000178195.07110.d3; Ray WA, 2007, GASTROENTEROLOGY, V133, P790, DOI 10.1053/j.gastro.2007.06.058; Scheiman JM, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4177; Scheiman JM, 2006, AM J GASTROENTEROL, V101, P701, DOI 10.1111/j.1572-0241.2006.00499.x; Schmidt M, 2014, CLIN EPIDEMIOL, V6, P155, DOI 10.2147/CLEP.S59156; Sorensen R, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-6; Sorensen R, 2009, LANCET, V374, P1967, DOI 10.1016/S0140-6736(09)61751-7; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Tu JV, 2001, J AM COLL CARDIOL, V37, P992, DOI 10.1016/S0735-1097(01)01109-3	35	14	14	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 19	2015	351								h5096	10.1136/bmj.h5096	http://dx.doi.org/10.1136/bmj.h5096			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3FF	26481405	Green Published, hybrid			2022-12-28	WOS:000364143300001
J	Schapira, M				Schapira, Matthieu			Chromatin complex, crystal clear	SCIENCE			English	Editorial Material							EZH2; INHIBITION; METHYLATION; LYMPHOMA		[Schapira, Matthieu] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Schapira, Matthieu] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto	Schapira, M (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	matthieu.schapira@utoronto.ca						Antonysamy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084147; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799; Ciferri C, 2012, ELIFE, V1, DOI 10.7554/eLife.00005; Gibaja V, 2016, ONCOGENE, V35, P558, DOI 10.1038/onc.2015.114; Jiao LY, 2015, SCIENCE, V350, DOI 10.1126/science.aac4383; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Mack SC, 2014, NATURE, V506, P445, DOI 10.1038/nature13108; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Sanulli S, 2015, MOL CELL, V57, P769, DOI 10.1016/j.molcel.2014.12.020; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Wu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083737	15	0	0	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2015	350	6258					278	+		10.1126/science.aad5203	http://dx.doi.org/10.1126/science.aad5203			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT5HD	26472895				2022-12-28	WOS:000362838700021
J	Aronson, SJ; Rehm, HL				Aronson, Samuel J.; Rehm, Heidi L.			Building the foundation for genomics in precision medicine	NATURE			English	Review							IMPLEMENTATION CONSORTIUM GUIDELINES; SEQUENCE VARIATION; EMERGE NETWORK; LUNG-CANCER; BIG DATA; DATABASE; RECORDS; ASSOCIATION; INFORMATION; PREDICTION	Precision medicine has the potential to profoundly improve the practice of medicine. However, the advances required will take time to implement. Genetics is already being used to direct clinical decision-making and its contribution is likely to increase. To accelerate these advances, fundamental changes are needed in the infrastructure and mechanisms for data collection, storage and sharing. This will create a continuously learning health-care system with seamless cycling between clinical care and research. Patients must be educated about the benefits of sharing data. The building blocks for such a system are already forming and they will accelerate the adoption of precision medicine.	[Aronson, Samuel J.; Rehm, Heidi L.] Partners HealthCare Personalized Med, Boston, MA 02115 USA; [Aronson, Samuel J.] Partners HealthCare Res Informat Serv & Comp, Charlestown, MA 02129 USA; [Rehm, Heidi L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Rehm, Heidi L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Rehm, Heidi L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Partners Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Rehm, HL (corresponding author), Partners HealthCare Personalized Med, Boston, MA 02115 USA.	hrehm@partners.org		Rehm, Heidi L./0000-0002-6025-0015	NIH [U41HG006834, U01HG006500, U19HD077671]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U19HD077671] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG006834, U01HG006500] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	H.L.R. was supported in part by NIH grants U41HG006834, U01HG006500 and U19HD077671. S.J.A. was supported in part by U41HG006834.	Abdallah K, 2015, ONCOLOGIST, V20, P459, DOI 10.1634/theoncologist.2015-0054; Abina SHB, 2015, JAMA-J AM MED ASSOC, V313, P1550, DOI 10.1001/jama.2015.3253; Allen NL, 2014, MAYO CLIN PROC, V89, P738, DOI 10.1016/j.mayocp.2014.03.015; Almalki M, 2015, HEALTH INF SCI SYST, V3, DOI 10.1186/2047-2501-3-S1-S1; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Aronson SJ, 2012, GENET MED, V14, P713, DOI 10.1038/gim.2012.19; Aronson SJ, 2011, HUM MUTAT, V32, P532, DOI 10.1002/humu.21470; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Beroud C, 2000, HUM MUTAT, V15, P86, DOI 10.1002/(SICI)1098-1004(200001)15:1<86::AID-HUMU16>3.0.CO;2-4; Buske O. J., 2015, HUM MUTAT; Cancer Genome Atlas Research Network, 2013, Nat Genet, V45, P1113, DOI 10.1038/ng.2764; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Del Fiol Guilherme, 2006, AMIA Annu Symp Proc, P904; Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Gargis AS, 2012, NAT BIOTECHNOL, V30, P1033, DOI 10.1038/nbt.2403; Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72; Hoffman MA, 2011, HUM GENET, V130, P33, DOI 10.1007/s00439-011-0992-y; Jarchum I, 2015, NAT BIOTECHNOL, V33, P49, DOI 10.1038/nbt.3115; Jian XQ, 2014, GENET MED, V16, P497, DOI 10.1038/gim.2013.176; Joyner MJ, 2015, JAMA-J AM MED ASSOC, V314, P999, DOI 10.1001/jama.2015.7725; Kho AN, 2013, GENET MED, V15, P772, DOI 10.1038/gim.2013.131; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Knoppers Bartha Maria, 2014, Hugo J, V8, P3, DOI 10.1186/s11568-014-0003-1; Korf BR, 2013, JAMA-J AM MED ASSOC, V309, P1511, DOI 10.1001/jama.2013.3239; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lerner-Ellis J, 2015, J MED GENET, V52, P438, DOI 10.1136/jmedgenet-2014-102933; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Martin MA, 2014, CLIN PHARMACOL THER, V95, P499, DOI 10.1038/clpt.2014.38; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Milani L, 2015, J INTERN MED, V277, P188, DOI 10.1111/joim.12320; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Morell CF, 2009, EXPERT OPIN BIOL TH, V9, P631, DOI [10.1517/14712590902902296, 10.1517/14712590902902296 ]; Murphy SN, 2015, J DIGIT IMAGING, V28, P194, DOI 10.1007/s10278-014-9733-9; O'Driscoll A, 2013, J BIOMED INFORM, V46, P774, DOI 10.1016/j.jbi.2013.07.001; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Philippakis A. A., 2015, HUM MUTAT; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Relling MV, 2013, CLIN PHARMACOL THER, V93, P324, DOI 10.1038/clpt.2013.4; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Riggs ER, 2012, HUM MUTAT, V33, P787, DOI 10.1002/humu.22052; Schilsky RL, 2014, J CLIN ONCOL, V32, P2373, DOI 10.1200/JCO.2014.56.2124; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Spurdle AB, 2012, HUM MUTAT, V33, P2, DOI 10.1002/humu.21628; Starren J, 2013, JAMA-J AM MED ASSOC, V309, P1237, DOI 10.1001/jama.2013.1579; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Thompson BA, 2014, NAT GENET, V46, P107, DOI 10.1038/ng.2854; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Toledo JB, 2014, ALZHEIMERS DEMENT, V10, P477, DOI 10.1016/j.jalz.2013.06.003; Tryka KA, 2014, NUCLEIC ACIDS RES, V42, pD975, DOI 10.1093/nar/gkt1211; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; US Department of Veterans Affairs Office of Research & Development, 2002, INF CONS HUM SUBJ RE; Wraith J. E., 2013, COCHRANE DB SYST REV, V11; Xue W, 2011, NATURE, V473, P544, DOI 10.1038/nature09909; Zhang J, 2011, DISCRETE DYN NAT SOC, V2011, DOI [10.1155/2011/958381, 10.1093/database/bar026]	55	280	292	15	199	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					336	342		10.1038/nature15816	http://dx.doi.org/10.1038/nature15816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26469044	Green Accepted			2022-12-28	WOS:000362730200036
J	Takashima, S; Ota, M				Takashima, Shota; Ota, Mitsuhito			CASE SCENARIO Creeping lymphangitis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Takashima, Shota; Ota, Mitsuhito] Chitose City Hosp, Dept Dermatol, Chitose 0668550, Japan		Ota, M (corresponding author), Chitose City Hosp, Dept Dermatol, Chitose 0668550, Japan.	ota@med.hokudai.ac.jp	Takashima, Shota/AAA-1825-2019	Takashima, Shota/0000-0001-8883-7347					0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2015	351								h5416	10.1136/bmj.h5416	http://dx.doi.org/10.1136/bmj.h5416			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT8XS	26463674				2022-12-28	WOS:000363100800007
J	Chan, EYY; Wang, Z; Mark, CKM; Liu, SD				Chan, Emily Y. Y.; Wang, Zhe; Mark, Carman K. M.; Liu, Si Da			Industrial accidents in China: risk reduction and response	LANCET			English	Editorial Material									[Chan, Emily Y. Y.; Mark, Carman K. M.; Liu, Si Da] Univ Oxford, Collaborating Ctr, Oxford OX1 2JD, England; [Chan, Emily Y. Y.; Mark, Carman K. M.; Liu, Si Da] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Fac Med, Disaster & Med Humanitarian Response, Shatin, Hong Kong, Peoples R China; [Wang, Zhe] Chinese Ctr Dis Control & Prevent, Publ Hlth Emergency Ctr, Beijing, Peoples R China	University of Oxford; Chinese University of Hong Kong; Chinese Center for Disease Control & Prevention	Chan, EYY (corresponding author), Univ Oxford, Collaborating Ctr, Oxford OX1 2JD, England.	emily.chan@cuhk.edu.hk	Chan, Emily Ying Yang/H-6849-2017	Chan, Emily Ying Yang/0000-0002-8854-5093				Chan EY, 2011, EUR J EMERG MED, V18, P1; [冯长根 FENG Changgen], 2008, [安全与环境学报, Journal of Safety and Environment], V8, P160; Government of the Peoples Republic of China, OFF ANN TYP QUANT CH; Government of the Peoples Republic of China, 1 OFF ANN EM RESP TI; Government of the Peoples Republic of China, TIANJ BLAST DEATH TO; Government of the Peoples Republic of China, REG ACC INC; National Health and Family Planning Commission of the Peoples Republic of China, 5 EXP TEAM HAS ARR T; State Administration of Work Safety the Peoples Republic of China, LIST RESP ENT MAJ IN; World Health Organization, 2011, DIS RISK MAN HLTH CH	9	13	13	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2015	386	10002					1421	1422		10.1016/S0140-6736(15)00424-9	http://dx.doi.org/10.1016/S0140-6736(15)00424-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CT5UU	26466026	Green Published, Bronze			2022-12-28	WOS:000362877300005
J	Boccaletti, A; Thalmann, C; Lagrange, AM; Janson, M; Augereau, JC; Schneider, G; Milli, J; Grady, C; Debes, J; Langlois, M; Mouillet, D; Henning, T; Dominik, C; Maire, AL; Beuzit, JL; Carson, J; Dohlen, K; Engler, N; Feldt, M; Fusco, T; Ginski, C; Girard, JH; Hines, D; Kasper, M; Mawet, D; Menard, F; Meyer, MR; Moutou, C; Olofsson, J; Rodigas, T; Sauvage, JF; Schlieder, J; Schmid, HM; Turatto, M; Udry, S; Vakili, F; Vigan, A; Wahhaj, Z; Wisniewski, J				Boccaletti, Anthony; Thalmann, Christian; Lagrange, Anne-Marie; Janson, Markus; Augereau, Jean-Charles; Schneider, Glenn; Milli, Julien; Grady, Carol; Debes, John; Langlois, Maud; Mouillet, David; Henning, Thomas; Dominik, Carsten; Maire, Anne-Lise; Beuzit, Jean-Luc; Carson, Joseph; Dohlen, Kjetil; Engler, Natalia; Feldt, Markus; Fusco, Thierry; Ginski, Christian; Girard, Julien H.; Hines, Dean; Kasper, Markus; Mawet, Dimitri; Menard, Franois; Meyer, Michael R.; Moutou, Claire; Olofsson, Johan; Rodigas, Timothy; Sauvage, Jean-Francois; Schlieder, Joshua; Schmid, Hans Martin; Turatto, Massimo; Udry, Stephane; Vakili, Farrokh; Vigan, Arthur; Wahhaj, Zahed; Wisniewski, John			Fast-moving features in the debris disk around AU Microscopii	NATURE			English	Article							BETA-PICTORIS; CIRCUMSTELLAR DISK; EVOLUTIONARY MODELS; BROWN DWARFS; DUST DISK; EXOPLANETS; PLANET	In the 1980s, excess infrared emission was discovered around main-sequence stars; subsequent direct-imaging observations revealed orbiting disks of cold dust to be the source(1). These 'debris disks' were thought to be by-products of planet formation because they often exhibited morphological and brightness asymmetries that may result from gravitational perturbation by planets. This was proved to be true for the beta Pictoris system, in which the known planet generates an observable warp in the disk(2-5). The nearby, young, unusually active late-type star AU Microscopii hosts a well-studied edge-on debris disk; earlier observations in the visible and near-infrared found asymmetric localized structures in the form of intensity variations along the midplane of the disk beyond a distance of 20 astronomical units(6-9). Here we report high-contrast imaging that reveals a series of five large-scale features in the southeast side of the disk, at projected separations of 10-60 astronomical units, persisting over intervals of 1-4 years. All these features appear to move away from the star at projected speeds of 4-10 kilometres per second, suggesting highly eccentric or unbound trajectories if they are associated with physical entities. The origin, localization, morphology and rapid evolution of these features are difficult to reconcile with current theories.	[Boccaletti, Anthony] Univ Paris 06, Univ Paris Diderot, CNRS, Observ Paris,LESIA, F-92190 Meudon, France; [Thalmann, Christian; Engler, Natalia; Meyer, Michael R.; Schmid, Hans Martin] ETH, Inst Astron, CH-8093 Zurich, Switzerland; [Lagrange, Anne-Marie; Augereau, Jean-Charles; Mouillet, David; Beuzit, Jean-Luc] Univ Grenoble Alpes, IPAG, F-38000 Grenoble, France; [Lagrange, Anne-Marie; Augereau, Jean-Charles; Milli, Julien; Beuzit, Jean-Luc; Girard, Julien H.; Kasper, Markus] IPAG, CNRS, F-38000 Grenoble, France; [Janson, Markus] Stockholm Univ, Dept Astron, SE-10691 Stockholm, Sweden; [Janson, Markus; Henning, Thomas; Carson, Joseph; Olofsson, Johan] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Schneider, Glenn] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Milli, Julien; Girard, Julien H.; Vigan, Arthur; Wahhaj, Zahed] ESO, Santiago 19001, Chile; [Grady, Carol] Eureka Sci, Oakland, CA 96002 USA; [Debes, John; Hines, Dean] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Langlois, Maud] Univ Lyon 1, CNRS, Ctr Rech Astrophys Lyon, ENS L, F-69561 St Genis Laval, France; [Langlois, Maud; Dohlen, Kjetil; Fusco, Thierry; Moutou, Claire; Sauvage, Jean-Francois; Vigan, Arthur; Wahhaj, Zahed] Aix Marseille Univ, CNRS, LAM, UMR 7326, F-13388 Marseille, France; [Dominik, Carsten] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 XH Amsterdam, Netherlands; [Maire, Anne-Lise; Turatto, Massimo] INAF Osservatorio Astron Padova, I-35122 Padua, Italy; [Carson, Joseph] Coll Charleston, Dept Phys & Astron, Charleston, SC 29424 USA; [Fusco, Thierry; Sauvage, Jean-Francois] Off Natl Etud & Rech Aerosp, F-92322 Chatillon, France; [Ginski, Christian] Sterrewacht Leiden, NL-2300 RA Leiden, Netherlands; [Kasper, Markus] ESO, D-85748 Garching, Germany; [Mawet, Dimitri] CALTECH, Dept Astron, Pasadena, CA 91125 USA; [Menard, Franois] INSU France, CNRS, UMI, FCA,UMI 3386, Montpellier, France; [Menard, Franois] Univ Chile, Dept Astron, Santiago, Chile; [Rodigas, Timothy] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Schlieder, Joshua] NASA, Ames Res Ctr, Space Sci & Astrobiol Div, Moffett Field, CA 94035 USA; [Udry, Stephane] Univ Geneva, Observ Geneve, CH-1290 Versoix, Switzerland; [Vakili, Farrokh] Univ Nice Sophia Antipolis UNS, CNRS, Lab JL Lagrange, OCA, F-06108 Nice 2, France; [Wisniewski, John] Univ Oklahoma, Dept Phys & Astron, Norman, OK 73019 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; Swiss Federal Institutes of Technology Domain; ETH Zurich; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); Centre National de la Recherche Scientifique (CNRS); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); Stockholm University; Max Planck Society; University of Arizona; European Southern Observatory; Eureka Scientific; Space Telescope Science Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Aix-Marseille Universite; University of Amsterdam; Istituto Nazionale Astrofisica (INAF); College of Charleston; National Office for Aerospace Studies & Research (ONERA); UDICE-French Research Universities; Universite Paris Saclay; Leiden University; Leiden University - Excl LUMC; California Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Montpellier; Universidad de Chile; Carnegie Institution for Science; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Geneva; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of Oklahoma System; University of Oklahoma - Norman	Boccaletti, A (corresponding author), Univ Paris 06, Univ Paris Diderot, CNRS, Observ Paris,LESIA, 5 Pl Jules Janssen, F-92190 Meudon, France.	anthony.boccaletti@obspm.fr	Girard, Julien H/GRJ-2731-2022; Girard, Julien/Q-4917-2019; Olofsson, Johan/AAA-9906-2020; Henning, Thomas K/O-4372-2018	Girard, Julien H/0000-0001-8627-0404; Girard, Julien/0000-0001-8627-0404; Olofsson, Johan/0000-0003-4475-3605; Henning, Thomas K/0000-0002-1493-300X; Fusco, Thierry/0000-0002-0795-0856; udry, Stephane/0000-0001-7576-6236; Janson, Markus/0000-0001-8345-593X; Dominik, Carsten/0000-0002-3393-2459; Turatto, Massimo/0000-0002-9719-3157; Debes, John/0000-0002-1783-8817; Vigan, Arthur/0000-0002-5902-7828; Langlois, M./0000-0003-3574-9903; Augereau, Jean-Charles/0000-0002-2725-6415; Ginski, Christian/0000-0002-4438-1971	ESO; CNRS; MPIA; INAF; FINES; NOVA; European Commission FP6 programme as part of OPTICON [RII3-Ct-2004-001566]; European Commission FP7 programme as part of OPTICON [226604, 312430]; Swiss National Science Foundation; SNSF; ESO Very Large Telescope [60.A-9249]; NASA/ESA Hubble Space Telescope [12228]; NASA [NAS 5-26555];  [ANR-14-CE33-0018]; Division Of Astronomical Sciences [1009203] Funding Source: National Science Foundation	ESO; CNRS(Centre National de la Recherche Scientifique (CNRS)); MPIA; INAF(Istituto Nazionale Astrofisica (INAF)); FINES; NOVA; European Commission FP6 programme as part of OPTICON; European Commission FP7 programme as part of OPTICON; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SNSF(Swiss National Science Foundation (SNSF)); ESO Very Large Telescope; NASA/ESA Hubble Space Telescope(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); ; Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	SPHERE was built by a European consortium led by IPAG (France). SPHERE was funded by the ESO, with additional contributions from CNRS, MPIA, INAF, FINES and NOVA. SPHERE also received funding from the European Commission FP6 and FP7 programmes as part of OPTICON under grant numbers RII3-Ct-2004-001566 (FP6), 226604 (FP7) and 312430 (FP7). French co-authors are supported by ANR-14-CE33-0018. Part of this work has been carried out within the framework of the National Centre for Competence in Research PlanetS supported by the Swiss National Science Foundation. C.T. and M.R.M. acknowledge the financial support of the SNSF. This study is based on observations from program 60.A-9249(C) at ESO Very Large Telescope and from program number 12228 made with the NASA/ESA Hubble Space Telescope, obtained at STScI, which is operated by AURA Inc. under NASA contract NAS 5-26555. We are also grateful to the ESO for releasing the commissioning data for publication. Finally, we thank P. Zarka, N. Meyer-Vernet, B. Stelzer and Q. Kral for discussions. J.S. is a NASA Postdoctoral Program Fellow.	Augereau JC, 2006, ASTRON ASTROPHYS, V455, P987, DOI 10.1051/0004-6361:20054250; Augereau JC, 2001, ASTRON ASTROPHYS, V370, P447, DOI 10.1051/0004-6361:20010199; Baraffe I, 2003, ASTRON ASTROPHYS, V402, P701, DOI 10.1051/0004-6361:20030252; Baudoz P., 2010, P SOC PHOTO-OPT INS, V7735, P5; Beuzit J.-L., 2008, P SOC PHOTO-OPT INS, V7014, P18; Chabrier G, 2000, ASTROPHYS J, V542, P464, DOI 10.1086/309513; Fendt C, 2003, ASTRON ASTROPHYS, V411, P623, DOI 10.1051/0004-6361:20034154; Fitzgerald MP, 2007, ASTROPHYS J, V670, P536, DOI 10.1086/521344; Kalas P, 2004, SCIENCE, V303, P1990, DOI 10.1126/science.1093420; Kivelson MG, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011176; Kral Q, 2015, ASTRON ASTROPHYS, V573, DOI 10.1051/0004-6361/201424309; Krist JE, 2005, ASTRON J, V129, P1008, DOI 10.1086/426755; Lafreniere D, 2007, ASTROPHYS J, V660, P770, DOI 10.1086/513180; Lagrange AM, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201118274; Liu MC, 2004, SCIENCE, V305, P1442, DOI 10.1126/science.1102929; Mamajek EE, 2014, MON NOT R ASTRON SOC, V445, P2169, DOI 10.1093/mnras/stu1894; Metchev SA, 2005, ASTROPHYS J, V622, P451, DOI 10.1086/427869; Milli J, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219687; Moor A, 2013, ASTROPHYS J LETT, V777, DOI 10.1088/2041-8205/777/2/L25; Mouillet D, 1997, MON NOT R ASTRON SOC, V292, P896, DOI 10.1093/mnras/292.4.896; Muto T, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/1/10; Nesvold E. R., 2015, PREPRINT; Roberge A, 2005, ASTROPHYS J, V626, pL105, DOI 10.1086/431899; Robinson RD, 2001, ASTROPHYS J, V554, P368, DOI 10.1086/321379; Schneider G, 2014, ASTRON J, V148, DOI 10.1088/0004-6256/148/4/59; SMITH BA, 1984, SCIENCE, V226, P1421, DOI 10.1126/science.226.4681.1421; Soummer R, 2012, ASTROPHYS J LETT, V755, DOI 10.1088/2041-8205/755/2/L28; Thalmann C, 2010, ASTROPHYS J LETT, V718, pL87, DOI 10.1088/2041-8205/718/2/L87; Weiss JW, 2009, ASTRON J, V138, P272, DOI 10.1088/0004-6256/138/1/272	29	82	82	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					230	+		10.1038/nature15705	http://dx.doi.org/10.1038/nature15705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26450055	Green Accepted			2022-12-28	WOS:000362399000041
J	Henao-Martinez, AF; Madinger, N				Henao-Martinez, Andres F.; Madinger, Nancy			SPOT DIAGNOSIS Even a worm can turn	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRAZIQUANTEL		[Henao-Martinez, Andres F.] Univ Colorado Denver, Div Infect Dis, Dept Med, Med, Aurora, CO 80045 USA; [Madinger, Nancy] Univ Colorado Denver, Div Infect Dis, Dept Med, Med & Pathol, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Henao-Martinez, AF (corresponding author), Univ Colorado Denver, Div Infect Dis, Dept Med, Med, Aurora, CO 80045 USA.	andres.henaomartinez@ucdenver.edu	Henao-Martínez, Andrés F./E-1488-2012	Henao-Martínez, Andrés F./0000-0001-7363-8652				Bohrod M. G., 1945, American Journal of Clinical Pathology, V15, P77; OHNISHI K, 1994, T ROY SOC TROP MED H, V88, P580, DOI 10.1016/0035-9203(94)90171-6; Olds GR, 2003, ACTA TROP, V86, P185, DOI 10.1016/S0001-706X(03)00033-0; VONBONSDORFF B, 1948, BLOOD, V3, P91, DOI 10.1182/blood.V3.1.91.91	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 8	2015	351								h5290	10.1136/bmj.h5290	http://dx.doi.org/10.1136/bmj.h5290			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT3SO	26449624				2022-12-28	WOS:000362727400003
J	Perrin, MD				Perrin, Marshall D.			ASTROPHYSICS Surprisingly fast motions in a dust disk	NATURE			English	Editorial Material							MICROSCOPII DEBRIS DISK; STAR AU-MICROSCOPII; CIRCUMSTELLAR DISK		Space Telescope Sci Inst, Baltimore, MD 21218 USA	Space Telescope Science Institute	Perrin, MD (corresponding author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.	mperrin@stsci.edu		Perrin, Marshall/0000-0002-3191-8151				Boccaletti A, 2015, NATURE, V526, P230, DOI 10.1038/nature15705; Fitzgerald MP, 2007, ASTROPHYS J, V670, P536, DOI 10.1086/521344; Kalas P, 2004, SCIENCE, V303, P1990, DOI 10.1126/science.1093420; Krist JE, 2005, ASTRON J, V129, P1008, DOI 10.1086/426755; Liu MC, 2004, SCIENCE, V305, P1442, DOI 10.1126/science.1102929; Metchev SA, 2005, ASTROPHYS J, V622, P451, DOI 10.1086/427869; Strubbe LE, 2006, ASTROPHYS J, V648, P652, DOI 10.1086/505736; Wang J. J., 2015, ASTROPHYS J IN PRESS	9	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					204	205		10.1038/526204a	http://dx.doi.org/10.1038/526204a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26450054				2022-12-28	WOS:000362399000036
J	Yawar, A				Yawar, Athar			The madness of Charlie Brown	LANCET			English	Editorial Material												athar.yawar@doctors.org.uk						Briggs Raymond, 1998, ETHEL AND ERNEST; Hedges Chris., 2012, DAYS DESTRUCTION DAY; Satrapi M, 2006, CHICKEN WITH PLUMS	3	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2015	386	10001					1332	1333		10.1016/S0140-6736(15)00338-4	http://dx.doi.org/10.1016/S0140-6736(15)00338-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS8DP	26460766	Bronze			2022-12-28	WOS:000362316200016
J	Renne, PR; Sprain, CJ; Richards, MA; Self, S; Vanderkluysen, L; Pande, K				Renne, Paul R.; Sprain, Courtney J.; Richards, Mark A.; Self, Stephen; Vanderkluysen, Loc; Pande, Kanchan			State shift in Deccan volcanism at the Cretaceous-Paleogene boundary, possibly induced by impact	SCIENCE			English	Article							TIME SCALES; TRAP LAVAS; PROVINCE; FLOWS; GEOCHRONOLOGY; GEOCHEMISTRY; ERUPTIONS; RECOVERY; DURATION; BASALTS	Bolide impact and flood volcanism compete as leading candidates for the cause of terminal-Cretaceous mass extinctions. High-precision 40Ar/39Ar data indicate that these two mechanisms may be genetically related, and neither can be considered in isolation. The existing Deccan Traps magmatic system underwent a state shift approximately coincident with the Chicxulub impact and the terminal-Cretaceous mass extinctions, after which similar to 70% of the Traps' total volume was extruded in more massive and more episodic eruptions. Initiation of this new regime occurred within similar to 50,000 years of the impact, which is consistent with transient effects of impact-induced seismic energy. Postextinction recovery of marine ecosystems was probably suppressed until after the accelerated volcanism waned.	[Renne, Paul R.; Sprain, Courtney J.] Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; [Renne, Paul R.; Sprain, Courtney J.; Richards, Mark A.; Self, Stephen] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Vanderkluysen, Loc] Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA; [Pande, Kanchan] Indian Inst Technol, Dept Earth Sci, Bombay 400076, Maharashtra, India	Berkeley Geochronolgy Center; University of California System; University of California Berkeley; Drexel University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Renne, PR (corresponding author), Berkeley Geochronol Ctr, 2455 Ridge Rd, Berkeley, CA 94709 USA.	prenne@bgc.org	Vanderkluysen, Loyc/AAD-5166-2021	Renne, Paul/0000-0003-1769-5235	Ann and Gordon Getty Foundation; University of California-Berkeley; NSF; NSF [EAR-1250440]	Ann and Gordon Getty Foundation; University of California-Berkeley(University of California System); NSF(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	This work was funded by the Ann and Gordon Getty Foundation and by the Esper S. Larsen Fund of the University of California-Berkeley. C.J.S. was supported by a NSF Graduate Research Fellowship. L.V.'s participation was supported by NSF grant EAR-1250440. We thank W. Alvarez, S. Finnegan, C. Guns, R. Ickert, M. Manga, C. Marshall, A. Marzoli, R. Mundil, and H. Sheth for discussion; T. Becker and A. Jaouni for laboratory assistance; and H. Sheth for field assistance. Data are available in the supplementary materials.	Beane J., 1986, B VOLCANOL, V48, P61, DOI DOI 10.1007/BF01073513; Bondre NR, 2004, B VOLCANOL, V66, P29, DOI 10.1007/s00445-003-0294-x; Brown RJ, 2011, B VOLCANOL, V73, P737, DOI 10.1007/s00445-011-0450-7; Carey RJ, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009496; Chenet AL, 2007, EARTH PLANET SC LETT, V263, P1, DOI 10.1016/j.epsl.2007.07.011; Chenet AL, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005644; Chenet AL, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2006JB004635; Courtillot VE, 2003, CR GEOSCI, V335, P113, DOI 10.1016/S1631-0713(03)00006-3; Coxall HK, 2006, GEOLOGY, V34, P297, DOI 10.1130/G21702.1; Ghosh P, 2006, PALAEOGEOGR PALAEOCL, V242, P90, DOI 10.1016/j.palaeo.2006.05.018; Hawkesworth CJ, 2000, J PETROL, V41, P991, DOI 10.1093/petrology/41.7.991; Hooper P, 2010, GEOLOGY, V38, P839, DOI 10.1130/G31072.1; Jay A., 2005, THESIS OPEN U; Karlstrom L, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008159; Keller G, 2012, EARTH PLANET SC LETT, V341, P211, DOI 10.1016/j.epsl.2012.06.021; LIGHTFOOT PC, 1990, J PETROL, V31, P1165, DOI 10.1093/petrology/31.5.1165; MAHONEY J, 1982, EARTH PLANET SC LETT, V60, P47, DOI 10.1016/0012-821X(82)90019-X; Manga M, 2006, ANNU REV EARTH PL SC, V34, P263, DOI 10.1146/annurev.earth.34.031405.125125; Marzoli A, 1999, SCIENCE, V284, P616, DOI 10.1126/science.284.5414.616; Peng ZX, 1998, J GEOPHYS RES-SOL EA, V103, P29843, DOI 10.1029/98JB01514; PENG ZX, 1994, GEOCHIM COSMOCHIM AC, V58, P267, DOI 10.1016/0016-7037(94)90464-2; Renne PR, 2013, SCIENCE, V339, P684, DOI 10.1126/science.1230492; Richards M.A., 2015, GEOL SOC AM B; Schoene B, 2015, SCIENCE, V347, P182, DOI 10.1126/science.aaa0118; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Self S, 2008, J VOLCANOL GEOTH RES, V172, P3, DOI 10.1016/j.jvolgeores.2006.11.012; Self S, 2006, EARTH PLANET SC LETT, V248, P518, DOI 10.1016/j.epsl.2006.05.041; Sen A, 2012, J ASIAN EARTH SCI, V59, P127, DOI 10.1016/j.jseaes.2012.07.021; Shrivastava JP, 2015, LITHOS, V224, P214, DOI 10.1016/j.lithos.2015.03.006; Shrivastava JP, 2012, J GEOL SOC INDIA, V80, P177, DOI 10.1007/s12594-012-0130-z; Simms MJ, 2003, GEOLOGY, V31, P557, DOI 10.1130/0091-7613(2003)031<0557:UESFTL>2.0.CO;2; Sprain CJ, 2015, GEOL SOC AM BULL, V127, P393, DOI 10.1130/B31076.1; Widdowson M, 1997, PALAEOSURFACES RECOG, V120, P269, DOI DOI 10.1144/GSL.SP.1997.120.01.17; Wignall PB, 2001, EARTH-SCI REV, V53, P1, DOI 10.1016/S0012-8252(00)00037-4	34	216	223	3	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					76	78		10.1126/science.aac7549	http://dx.doi.org/10.1126/science.aac7549			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26430116	Green Submitted			2022-12-28	WOS:000362098300048
J	Desai, M; Gutman, J; L'lanziva, A; Otieno, K; Juma, E; Kariuki, S; Ouma, P; Were, V; Laserson, K; Katana, A; Williamson, J; ter Kuile, FO				Desai, Meghna; Gutman, Julie; L'lanziva, Anne; Otieno, Kephas; Juma, Elizabeth; Kariuki, Simon; Ouma, Peter; Were, Vincent; Laserson, Kayla; Katana, Abraham; Williamson, John; ter Kuile, Feiko O.			Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial	LANCET			English	Article							PLASMODIUM-FALCIPARUM MALARIA; SUB-SAHARAN AFRICA; LOW-BIRTH-WEIGHT; WOMEN; AZITHROMYCIN; COMBINATION; RISK; METAANALYSIS; INFECTIONS; MEFLOQUINE	Background Every year, more than 32 million pregnancies in sub-Saharan Africa are at risk of malaria infection and its adverse consequences. The effectiveness of the intermittent preventive treatment with sulfadoxine-pyrimethamine strategy recommended by WHO is threatened by high levels of parasite resistance. We aimed to assess the efficacy and safety of two alternative strategies: intermittent screening with malaria rapid diagnostic tests and treatment of women who test positive with dihydroartemisinin-piperaquine, and intermittent preventive treatment with dihydroartemisinin-piperaquine. Methods We did this open-label, three-group, randomised controlled superiority trial at four sites in western Kenya with high malaria transmission and sulfadoxine-pyrimethamine resistance. HIV-negative pregnant women between 16 and 32 weeks' gestation were randomly assigned (1: 1: 1), via computer-generated permuted-block randomisation (block sizes of three, six, and nine), to receive intermittent screening and treatment with dihydroartemisinin-piperaquine, intermittent preventive treatment with dihydroartemisinin-piperaquine, or intermittent preventive treatment with sulfadoxine-pyrimethamine. Study participants, study clinic nurses, and the study coordinator were aware of treatment allocation, but allocation was concealed from study investigators, delivery unit nurses, and laboratory staff. The primary outcome was malaria infection at delivery, defined as a composite of peripheral or placental parasitaemia detected by placental histology, microscopy, or rapid diagnostic test. The primary analysis was by modified intention to treat. This study is registered with ClinicalTrials.gov, number NCT01669941. Findings Between Aug 21, 2012, and June 19, 2014, we randomly assigned 1546 women to receive intermittent screening and treatment with dihydroartemisinin-piperaquine (n=515), intermittent preventive treatment with dihydroartemisinin-piperaquine (n=516), or intermittent preventive treatment with sulfadoxine-pyrimethamine (n=515); 1368 (88%) women comprised the intention-to-treat population for the primary endpoint. Prevalence of malaria infection at delivery was lower in the intermittent preventive treatment with dihydroartemisinin-piperaquine group than in the intermittent preventive treatment with sulfadoxine-pyrimethamine group (15 [3%] of 457 women vs 47 [10%] of 459 women; relative risk 0.32, 95% CI 0.18-0.56; p<0.0001), but not in the intermittent screening and treatment with dihydroartemisinin-piperaquine group (57 [13%] of 452 women; 1.23, 0.86-1.77; p=0.26). Compared with intermittent preventive treatment with sulfadoxine-pyrimethamine, intermittent preventive treatment with dihydroartemisinin-piperaquine was associated with a lower incidence of malaria infection during pregnancy (192.0 vs 54.4 events per 100 person-years; incidence rate ratio [IRR] 0.28, 95% CI 0.22-0.36; p<0.0001) and clinical malaria during pregnancy (37.9 vs 6.1 events; 0.16, 0.08-0.33; p<0.0001), whereas intermittent screening and treatment with dihydroartemisinin-piperaquine was associated with a higher incidence of malaria infection (232.0 events; 1.21, 1.03-1.41; p=0.0177) and clinical malaria (53.4 events; 1.41, 1.00-1.98; p=0.0475). We recorded 303 maternal and infant serious adverse events, which were least frequent in the intermittent preventive treatment with dihydroartemisinin-piperaquine group. Interpretation At current levels of rapid diagnostic test sensitivity, intermittent screening and treatment is not a suitable alternative to intermittent preventive treatment with sulfadoxine-pyrimethamine in the context of high sulfadoxine-pyrimethamine resistance and malaria transmission. However, dihydroartemisinin-piperaquine is a promising alternative drug to replace sulfadoxine-pyrimethamine for intermittent preventive treatment. Future studies should investigate the efficacy, safety, operational feasibility, and cost-effectiveness of intermittent preventive treatment with dihydroartemisinin-piperaquine.	[Desai, Meghna; Gutman, Julie; Laserson, Kayla] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30329 USA; [Desai, Meghna; L'lanziva, Anne] Ctr Dis Control & Prevent, Kisumu, Kenya; [Katana, Abraham] Ctr Dis Control & Prevent, Nairobi, Kenya; [Otieno, Kephas; Juma, Elizabeth; Kariuki, Simon; Ouma, Peter; Were, Vincent] Ctr Global Hlth Res, Kenya Med Res Inst, Kisumu, Kenya; [ter Kuile, Feiko O.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute; Liverpool School of Tropical Medicine; University of Liverpool	Desai, M (corresponding author), Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30329 USA.	mdesai@cdc.gov	Kariuki, Simon/AFT-6596-2022; Kuile, Feiko ter/ABD-6681-2020	Kuile, Feiko ter/0000-0003-3663-5617; Were, Vincent/0000-0002-3554-795X	Malaria in Pregnancy Consortium - Bill & Melinda Gates Foundation	Malaria in Pregnancy Consortium - Bill & Melinda Gates Foundation	This study is funded by the Malaria in Pregnancy Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the Liverpool School of Tropical Medicine (LSTM). The study drug dihydroartemisinin-piperaquine (Eurartesim) was provided free of charge by the manufacturer (Sigma Tau, Rome, Italy). We thank all the pregnant women who participated in this study. We also thank the study staff members (research nurses: Mary Owidhi, Rodgers Kongina, Epines Chanvangi, Caroline Marlene Achieng, Patience Dali; data management: Benjamin Odera, Linda Odeck, and Alloys Koloo; laboratory technicians: Mary Omwalo, Esther Odongo, Winnie Chebore, Malaki Ogalo; quality assurance: Sophie Omondi; and administration: Edna Otieno); the Siaya County Health Management team for their assistance and support in the conduct of this work within their health facilities; the KEMRI-CDC clinical monitoring department (Emily Kemunto, Emmanuel Rono, and Elizabeth Ayuo); Carl Henry from the clinical monitoring department at LSTM; Martina Oneko for being the local safety monitor for the trial; members of the data safety monitoring committee: Kevin Ault (Emory University School of Medicine, Atlanta, GA, USA), Jennita Reefhuis (CDC National Center on Birth Defects and Developmental Disabilities, Atlanta, GA, USA), Davidson Hamer (Boston University School of Public Health and Medicine, Boston, MA, USA), Kathleen Wannemuehler (CDC Center for Global Health, Atlanta, GA, USA) for their expertise and voluntary independent review of the safety data, protocol, and statistical analysis plan; and the following independent members of our Trial Steering Committee for their expertise and guidance: Laurence Slutsker (CDC Center for Global Health, Atlanta, GA, USA), David Schellenberg (London School of Hygiene & Tropical Medicine, London, UK), Tom Williams (Imperial College, London, UK). This manuscript has been approved by the Director of KEMRI. The findings and conclusions of this report are those of the authors and do not necessarily represent the views of the CDC.	Alifrangis M, 2014, EMERG INFECT DIS, V20, P1280, DOI 10.3201/eid2008.131897; [Anonymous], 2004, STRATEGIC FRAMEWORK; [Anonymous], 2013, WHO POL BRIEF IMPL I; BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; Benjamin JM, 2015, ANTIMICROB AGENTS CH, V59, P4260, DOI 10.1128/AAC.00326-15; Bigira V, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001689; Briand V, 2009, J INFECT DIS, V200, P991, DOI 10.1086/605474; Capan M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-303; Chandra RS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-122; Chico RM, 2015, TROP MED INT HEALTH, V20, P1621, DOI 10.1111/tmi.12595; Chico RM, 2013, EXPERT REV ANTI-INFE, V11, P1303, DOI 10.1586/14787210.2013.851601; Chico RM, 2012, JAMA-J AM MED ASSOC, V307, P2079, DOI 10.1001/jama.2012.3428; Clerk CA, 2008, J INFECT DIS, V198, P1202, DOI 10.1086/591944; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Eisele TP, 2012, LANCET INFECT DIS, V12, P942, DOI 10.1016/S1473-3099(12)70222-0; FIND TDR WHO CDC, 2012, MAL RAP DIAGN TEST P, V4; Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001735; Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733; Gutman J, 2015, J INFECT DIS, V211, P1997, DOI 10.1093/infdis/jiu836; Harrington WE, 2009, P NATL ACAD SCI USA, V106, P9027, DOI 10.1073/pnas.0901415106; Kayentao K, 2013, JAMA-J AM MED ASSOC, V309, P594, DOI 10.1001/jama.2012.216231; Kimani J, 2015, EUR C CLIN MICR INF; Lwin KM, 2012, ANTIMICROB AGENTS CH, V56, P1571, DOI 10.1128/AAC.05877-11; Naidoo I, 2013, TRENDS PARASITOL, V29, P505, DOI 10.1016/j.pt.2013.08.002; Nambozi M, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-5; Newman RD, 2003, TROP MED INT HEALTH, V8, P488, DOI 10.1046/j.1365-3156.2003.01066.x; Schmiegelow C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044773; Tagbor H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132247; Tagbor H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014425; Walker PGT, 2014, LANCET GLOB HEALTH, V2, pE460, DOI 10.1016/S2214-109X(14)70256-6; World Health Organization, 2015, GUID TREATM MAL, Vthird	32	126	126	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 19	2015	386	10012					2507	2519		10.1016/S0140-6736(15)00310-4	http://dx.doi.org/10.1016/S0140-6736(15)00310-4			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ1LD	26429700	Green Accepted, Bronze			2022-12-28	WOS:000366866400025
J	Siu, AL; Bibbins-Domingo, K; Grossman, D				Siu, Albert L.; Bibbins-Domingo, Kirsten; Grossman, David			Evidence-Based Clinical Prevention in the Era of the Patient Protection and Affordable Care Act The Role of the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Siu, Albert L.] Icahn Sch Med Mt Sinai, Dept Geriatr & Palliat Med, New York, NY USA; [Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Grossman, David] Grp Hlth Cooperat Puget Sound, Seattle, WA USA	Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Group Health Cooperative	Siu, AL (corresponding author), Mt Sinai Med Ctr, One Gustave L Levy Pl,POB 1070, New York, NY 10029 USA.	albert.siu@mssm.edu						Clinical Preventive Services forWomen, 2011, CLOS THE GAPS; Goodwin Suzanne M, 2012, Medicare Medicaid Res Rev, V2, DOI 10.5600/mmrr.002.01.a03; Graham R, 2011, I MED US COMMITTEE S; LURIE N, 1987, AM J PUBLIC HEALTH, V77, P801, DOI 10.2105/AJPH.77.7.801; Solanki G, 2000, HEALTH SERV RES, V34, P1331	5	19	19	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2015	314	19					2021	2022		10.1001/jama.2015.13154	http://dx.doi.org/10.1001/jama.2015.13154			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW1PR	26421503				2022-12-28	WOS:000364764200012
J	Llorente, MG; Jones, ER; Eriksson, A; Siska, V; Arthur, KW; Arthur, JW; Curtis, MC; Stock, JT; Coltorti, M; Pieruccini, P; Stretton, S; Brock, F; Higham, T; Park, Y; Hofreiter, M; Bradley, DG; Bhak, J; Pinhasi, R; Manica, A				Llorente, M. Gallego; Jones, E. R.; Eriksson, A.; Siska, V.; Arthur, K. W.; Arthur, J. W.; Curtis, M. C.; Stock, J. T.; Coltorti, M.; Pieruccini, P.; Stretton, S.; Brock, F.; Higham, T.; Park, Y.; Hofreiter, M.; Bradley, D. G.; Bhak, J.; Pinhasi, R.; Manica, A.			Ancient Ethiopian genome reveals extensive Eurasian admixture throughout the African continent	SCIENCE			English	Article							POPULATIONS; ANCESTRY; SOUTHERN	Characterizing genetic diversity in Africa is a crucial step for most analyses reconstructing the evolutionary history of anatomically modern humans. However, historic migrations from Eurasia into Africa have affected many contemporary populations, confounding inferences. Here, we present a 12.5x coverage ancient genome of an Ethiopian male ("Mota") who lived approximately 4500 years ago. We use this genome to demonstrate that the Eurasian backflow into Africa came from a population closely related to Early Neolithic farmers, who had colonized Europe 4000 years earlier. The extent of this backflow was much greater than previously reported, reaching all the way to Central, West, and Southern Africa, affecting even populations such as Yoruba and Mbuti, previously thought to be relatively unadmixed, who harbor 6 to 7% Eurasian ancestry.	[Llorente, M. Gallego; Eriksson, A.; Siska, V.; Manica, A.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Jones, E. R.; Bradley, D. G.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Eriksson, A.] King Abdullah Univ Sci & Technol KAUST, Div Biol & Environm Sci & Eng, Integrat Syst Biol Lab, Thuwal 239556900, Saudi Arabia; [Arthur, K. W.; Arthur, J. W.] Univ South Florida St Petersburg, Dept Soc Culture & Language, St Petersburg, FL 33701 USA; [Curtis, M. C.] Ventura Coll, Dept Anthropol, Ventura, CA 93003 USA; [Curtis, M. C.] Univ California Los Angeles, UCLA Extens, Humanities & Soc Sci Program, Los Angeles, CA 90095 USA; [Stock, J. T.] Univ Cambridge, Dept Archaeol & Anthropol, Cambridge CB2 3QG, England; [Coltorti, M.; Pieruccini, P.] Univ Siena, Dept Phys Sci Earth & Environm, 853100 Siena, Italy; [Stretton, S.] Univ Illinois, Dept Anthropol, Public Serv Archaeol & Architect Program, Urbana, IL 61801 USA; [Brock, F.; Higham, T.] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford Radiocarbon Accelerator Unit, Oxford OX1 3QY, England; [Brock, F.] Cranfield Univ, Cranfield Forens Inst, Defence Acad United Kingdom, Shrivenham SN6 8LA, Oxon, England; [Park, Y.] Theragen Bio Inst, Suwon 443270, South Korea; [Hofreiter, M.] Univ Potsdam, Fac Math & Natural Sci, Inst Biochem & Biol, D-14476 Potsdam, Germany; [Hofreiter, M.] Univ York, Dept Biol, Heslington YO10 5DD, York, England; [Bhak, J.] Ulsan Natl Inst Sci & Technol, Genom Inst, Ulsan 689798, South Korea; [Pinhasi, R.] Univ Coll Dublin, Sch Archaeol & Earth Inst, Dublin 4, Ireland	University of Cambridge; Trinity College Dublin; King Abdullah University of Science & Technology; State University System of Florida; University of South Florida; University of California System; University of California Los Angeles; University of Cambridge; University of Siena; University of Illinois System; University of Illinois Urbana-Champaign; University of Oxford; Cranfield University; University of Potsdam; University of York - UK; Ulsan National Institute of Science & Technology (UNIST); University College Dublin	Llorente, MG (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	mg632@cam.ac.uk; joneser@tcd.ie; ron.pinhasi@ucd.ie; am315@cam.ac.uk	Manica, Andrea/N-9013-2019; Eriksson, Anders/C-9767-2010; Higham, Tom/Y-2707-2019; Brock, Fiona/I-4970-2016; Manica, Andrea/B-5497-2008; Pinhasi, Ron/AAT-1531-2020; Stock, Jay T/B-6453-2011; Hofreiter, Michael/A-3996-2017	Manica, Andrea/0000-0003-1895-450X; Eriksson, Anders/0000-0003-3436-3726; Higham, Tom/0000-0002-5949-598X; Brock, Fiona/0000-0003-0728-6091; Manica, Andrea/0000-0003-1895-450X; Pinhasi, Ron/0000-0003-1629-8131; Stock, Jay T/0000-0003-0147-8631; Hofreiter, Michael/0000-0003-0441-4705; Gallego Llorente, Marcos/0000-0003-3498-6018; Siska, Veronika/0000-0002-8057-1203; PIERUCCINI, PIERLUIGI/0000-0002-8994-2867; Bradley, Daniel G/0000-0001-7335-7092	European Research Council (ERC) [647787]; ERC [263441, 310763, 617627, 295729-CodeX]; UNIST (Ulsan National Institute of Science and Technology) [1.140113.01, 1.140064.01]; Geromics internal research funding; NSF [1027607]; Gates Cambridge Trust; Biotechnology and Biological Sciences Research Council (BBSRC) DTP; National Center for Biotechnology Information, BioProject [PRJNA295861]; Biotechnology and Biological Sciences Research Council [1344400] Funding Source: researchfish	European Research Council (ERC)(European Research Council (ERC)European Commission); ERC(European Research Council (ERC)European Commission); UNIST (Ulsan National Institute of Science and Technology); Geromics internal research funding; NSF(National Science Foundation (NSF)); Gates Cambridge Trust; Biotechnology and Biological Sciences Research Council (BBSRC) DTP(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Center for Biotechnology Information, BioProject; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	A.M. was supported by European Research Council (ERC) Consolidator Grant 647787 "LocalAdaptation"; R.P by ERC Starting Grant 263441, "ADNABIOARC"; M.H. by ERC Consolidator Grant 310763 "GeneFlow"; J.B. by the 2014 Research Fund (1.140113.01, 1.140064.01) of UNIST (Ulsan National Institute of Science and Technology) and Geromics internal research funding; J.T.S. by ERC Consolidator Grant 617627 "ADaPt"; K.W.A. by NSF award 1027607; D.G.B. by ERC Investigator Grant 295729-CodeX; V.S. by a scholarship from the Gates Cambridge Trust; and M.G.L. by a Biotechnology and Biological Sciences Research Council (BBSRC) DTP studentship. Permission for the archaeology was given by the Ethiopian Authority for Research and Conservation of Cultural Heritage and offices of the Ministry of Culture and Tourism for the Southern Nations, Nationalities, and Peoples Region. Raw reads from Mota are available for download through the National Center for Biotechnology Information, BioProject ID PRJNA295861, and the corresponding BAM and VCF files are available at africangenome.org.	Alkorta-Aranburu G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003110; Blench R., 2008, SEMITOHAMITIC FESTSC, P63; Curtis M. C., 2013, OXFORD HDB AFRICAN A, P571; Eriksson A, 2012, P NATL ACAD SCI USA, V109, P16089, DOI 10.1073/pnas.1209494109; Eriksson A, 2012, P NATL ACAD SCI USA, V109, P13956, DOI 10.1073/pnas.1200567109; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Harrower MJ, 2010, AM ANTIQUITY, V75, P452, DOI 10.7183/0002-7316.75.3.452; Hodgson JA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004393; Hofreiter M, 2015, BIOESSAYS, V37, P284, DOI 10.1002/bies.201400160; Huerta-Sanchez E, 2013, MOL BIOL EVOL, V30, P1877, DOI 10.1093/molbev/mst089; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1448; Morris AG, 2014, GENOME BIOL EVOL, V6, P2647, DOI 10.1093/gbe/evu202; Pagani L, 2015, AM J HUM GENET, V96, P986, DOI 10.1016/j.ajhg.2015.04.019; Pagani L, 2012, AM J HUM GENET, V91, P83, DOI 10.1016/j.ajhg.2012.05.015; Pickrell JK, 2014, P NATL ACAD SCI USA, V111, P2632, DOI 10.1073/pnas.1313787111; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Sikora M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004353; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Udpa N, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r36	24	184	184	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					820	822		10.1126/science.aad2879	http://dx.doi.org/10.1126/science.aad2879			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW3MS	26449472	Green Submitted			2022-12-28	WOS:000364897000046
J	Kato, S; Kaplan, HS; Schrodel, T; Skora, S; Lindsay, TH; Yemini, E; Lockery, S; Zimmer, M				Kato, Saul; Kaplan, Harris S.; Schroedel, Tina; Skora, Susanne; Lindsay, Theodore H.; Yemini, Eviatar; Lockery, Shawn; Zimmer, Manuel			Global Brain Dynamics Embed the Motor Command Sequence of Caenorhabditis elegans	CELL			English	Article							C.-ELEGANS; NERVOUS-SYSTEM; FUNCTIONAL-ORGANIZATION; NEURONAL-ACTIVITY; CIRCUIT ACTIVITY; NEURAL CIRCUIT; CHEMOTAXIS; MECHANISMS; NAVIGATION; MOVEMENTS	While isolated motor actions can be correlated with activities of neuronal networks, an unresolved problem is how the brain assembles these activities into organized behaviors like action sequences. Using brain-wide calcium imaging in Caenorhabditis elegans, we show that a large proportion of neurons across the brain share information by engaging in coordinated, dynamical network activity. This brain state evolves on a cycle, each segment of which recruits the activities of different neuronal sub-populations and can be explicitly mapped, on a single trial basis, to the animals' major motor commands. This organization defines the assembly of motor commands into a string of run- and-turn action sequence cycles, including decisions between alternative behaviors. These dynamics serve as a robust scaffold for action selection in response to sensory input. This study shows that the coordination of neuronal activity patterns into global brain dynamics underlies the high-level organization of behavior.	[Kato, Saul; Kaplan, Harris S.; Schroedel, Tina; Skora, Susanne; Zimmer, Manuel] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria; [Lindsay, Theodore H.; Lockery, Shawn] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Yemini, Eviatar] Columbia Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Oregon; Columbia University; Howard Hughes Medical Institute	Zimmer, M (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	zimmer@imp.ac.at	Zimmer, Manuel/C-5275-2015; Yemini, Eviatar/AFP-3776-2022	Zimmer, Manuel/0000-0002-8072-787X; Yemini, Eviatar/0000-0003-1977-0761; Kaplan, Harris/0000-0002-8583-5714	European Community's Seventh Framework Programme (FP7)/ERC [281869]; Simons Foundation [324958]; EMBO Long Term Fellowship [ALTF 345-2014]; NIH training grant [F31 NS061697]; NIH T32 training grant [T32 MH015174-38]; Research Institute of Molecular Pathology (IMP); Boehringer Ingelheim; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS061697] Funding Source: NIH RePORTER	European Community's Seventh Framework Programme (FP7)/ERC; Simons Foundation; EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH T32 training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Institute of Molecular Pathology (IMP); Boehringer Ingelheim(Boehringer Ingelheim); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Cori Bargmann, Larry Abbott, Alipasha Vaziri, Andrew Straw, Hagai Lalazar, Omri Barak, and Sean Escola for critically reading the manuscript, Richard Latham for technical support, and Martin Colombini for manufacturing of mechanical components. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement number 281869 (acronym: elegans Neurocircuits) to M.Z., the Simons Foundation (grant number 324958 to M.Z.), an EMBO Long Term Fellowship to S.K. (number ALTF 345-2014), an NIH training grant to T.H.L. (number F31 NS061697), an NIH T32 training grant to E.Y. (number T32 MH015174-38), and the Research Institute of Molecular Pathology (IMP). The IMP is funded by Boehringer Ingelheim.	Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Anderson DJ, 2014, NEURON, V84, P18, DOI 10.1016/j.neuron.2014.09.005; Bouchard KE, 2013, NATURE, V495, P327, DOI 10.1038/nature11911; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Busch KE, 2012, NAT NEUROSCI, V15, P581, DOI 10.1038/nn.3061; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chartrand R., 2011, ISRN APPL MATH, V2011, P164564, DOI [DOI 10.5402/2011/164564, 10.5402/2011/164564]; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Cisek P, 2010, ANNU REV NEUROSCI, V33, P269, DOI 10.1146/annurev.neuro.051508.135409; Cunningham JP, 2014, NAT NEUROSCI, V17, P1500, DOI 10.1038/nn.3776; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Donnelly JL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001529; Faumont S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024666; Georgopoulos AP, 2015, CURR OPIN NEUROBIOL, V33, P34, DOI 10.1016/j.conb.2015.01.012; Gordus A, 2015, CELL, V161, P215, DOI 10.1016/j.cell.2015.02.018; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Ha HI, 2010, NEURON, V68, P1173, DOI 10.1016/j.neuron.2010.11.025; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Hendricks M, 2012, NATURE, V487, P99, DOI 10.1038/nature11081; Hobert Oliver, 2013, WormBook, P1, DOI 10.1895/wormbook.1.161.1; Iino Y, 2009, J NEUROSCI, V29, P5370, DOI 10.1523/JNEUROSCI.3633-08.2009; Jin X, 2014, NAT NEUROSCI, V17, P423, DOI 10.1038/nn.3632; Jolliffe I. T., 2002, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kawano T, 2011, NEURON, V72, P572, DOI 10.1016/j.neuron.2011.09.005; Kimata Tsubasa, 2012, Worm, V1, P31, DOI 10.4161/worm.19504; Laurent P, 2015, ELIFE, V4, DOI 10.7554/eLife.04241; Lemon WC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8924; Li ZY, 2014, CELL, V159, P751, DOI 10.1016/j.cell.2014.09.056; Luo LJ, 2014, NEURON, V82, P1115, DOI 10.1016/j.neuron.2014.05.010; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Panier T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00065; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Pokala N, 2014, P NATL ACAD SCI USA, V111, P2770, DOI 10.1073/pnas.1400615111; Prevedel R, 2014, NAT METHODS, V11, P727, DOI [10.1038/NMETH.2964, 10.1038/nmeth.2964]; Schrodel T, 2013, NAT METHODS, V10, P1013, DOI [10.1038/NMETH.2637, 10.1038/nmeth.2637]; Seeds AM, 2014, ELIFE, V3, DOI 10.7554/eLife.02951; Shenoy KV, 2013, ANNU REV NEUROSCI, V36, P337, DOI 10.1146/annurev-neuro-062111-150509; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Wen Q, 2012, NEURON, V76, P750, DOI 10.1016/j.neuron.2012.08.039; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	46	202	204	2	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					656	669		10.1016/j.cell.2015.09.034	http://dx.doi.org/10.1016/j.cell.2015.09.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26478179	Bronze			2022-12-28	WOS:000364828900019
J	Whitney, JC; Quentin, D; Sawai, S; LeRoux, M; Harding, BN; Ledvina, HE; Tran, BQ; Robinson, H; Goo, YA; Goodlett, DR; Raunser, S; Mougous, JD				Whitney, John C.; Quentin, Dennis; Sawai, Shin; LeRoux, Michele; Harding, Brittany N.; Ledvina, Hannah E.; Tran, Bao Q.; Robinson, Howard; Goo, Young Ah; Goodlett, David R.; Raunser, Stefan; Mougous, Joseph D.			An Interbacterial NAD(P)(+) Glycohydrolase Toxin Requires Elongation Factor Tu for Delivery to Target Cells	CELL			English	Article							VI SECRETION SYSTEM; PSEUDOMONAS-AERUGINOSA; EF-TU; STRUCTURAL BASIS; BINDING-PROTEIN; EFFECTORS; COMPLEX; PNEUMONIAE; IMMUNITY; RECEPTOR	Type VI secretion (T6S) influences the composition of microbial communities by catalyzing the delivery of toxins between adjacent bacterial cells. Here, we demonstrate that a T6S integral membrane toxin from Pseudomonas aeruginosa, Tse6, acts on target cells by degrading the universally essential dinucleotides NAD(+) and NADP(+). Structural analyses of Tse6 show that it resembles mono-ADP-ribosyltransferase proteins, such as diphtheria toxin, with the exception of a unique loop that both excludes proteinaceous ADP-ribose acceptors and contributes to hydrolysis. We find that entry of Tse6 into target cells requires its binding to an essential housekeeping protein, translation elongation factor Tu (EF-Tu). These proteins participate in a larger assembly that additionally directs toxin export and provides chaperone activity. Visualization of this complex by electron microscopy defines the architecture of a toxin-loaded T6S apparatus and provides mechanistic insight into intercellular membrane protein delivery between bacteria.	[Whitney, John C.; Sawai, Shin; LeRoux, Michele; Harding, Brittany N.; Ledvina, Hannah E.; Mougous, Joseph D.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Quentin, Dennis; Raunser, Stefan] Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany; [Tran, Bao Q.; Goo, Young Ah; Goodlett, David R.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Mougous, Joseph D.] Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Max Planck Society; University System of Maryland; University of Maryland Baltimore; United States Department of Energy (DOE); Brookhaven National Laboratory; Howard Hughes Medical Institute	Mougous, JD (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	mougous@u.washington.edu	Raunser, Stefan/AHE-1573-2022	Raunser, Stefan/0000-0001-9373-3016; Ledvina, Hannah/0000-0002-9631-5626; Quentin, Dennis/0000-0003-3825-7066; LeRoux, Michele/0000-0003-2075-4208	NIH [AI080609]; University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center [SOP1841-IQB2014]; Canadian Institutes of Health Research; Chemiefonds fellowship from the Fonds der Chemischen Industrie; Mary Gates Research Scholarship; Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Chemiefonds fellowship from the Fonds der Chemischen Industrie; Mary Gates Research Scholarship; Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors would like to thank H. Kulasekara for assistance with membrane fractionation, C. Outten for providing pRSFDuet-1, W. Catterall for use of the ITC instrument, J. Woodward for assistance with radioactivity experiments and for providing Aurodox, C. Ralston for assistance with X-ray data collection, I. Attree for providing alpha-OprF antibody, C. Gatsogiannis for electron microscopy expertise, and S. Dove, C. Goulding, C. Hayes, D. Low, A. Merz, D. Veesler, and members of the S.R. and J.D.M. laboratories for helpful discussions. This work was supported by grants from the NIH (AI080609) (to J.D.M.) and by the University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center (SOP1841-IQB2014) (to D.R.G.). J.C.W. was supported by a postdoctoral research fellowship from the Canadian Institutes of Health Research, D.Q. was supported by a Chemiefonds fellowship from the Fonds der Chemischen Industrie, S.S. was supported by a Mary Gates Research Scholarship, and J.D.M. holds an Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund.	Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Barbier M, 2013, MBIO, V4, DOI 10.1128/mBio.00207-13; Barel M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-145; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Clark BFC, 1997, CURR OPIN STRUC BIOL, V7, P110, DOI 10.1016/S0959-440X(97)80014-0; Clemens DL, 2015, CELL, V160, P940, DOI 10.1016/j.cell.2015.02.005; Diniz JA, 2015, J BACTERIOL, V197, P2350, DOI 10.1128/JB.00199-15; Durand E, 2015, NATURE, V523, P555, DOI 10.1038/nature14667; Fieldhouse RJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001029; Fieldhouse RJ, 2008, TRENDS BIOCHEM SCI, V33, P546, DOI 10.1016/j.tibs.2008.08.003; Fritsch MJ, 2013, MOL CELL PROTEOMICS, V12, P2735, DOI 10.1074/mcp.M113.030502; Ghosh J, 2010, J BIOL CHEM, V285, P5683, DOI 10.1074/jbc.M109.070300; Guse AH, 2000, J MOL MED, V78, P26, DOI 10.1007/s001090000076; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Jiang F, 2014, CELL HOST MICROBE, V15, P600, DOI 10.1016/j.chom.2014.04.010; JOHNSON SL, 1970, J BIOL CHEM, V245, P4519; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lathe WC, 2001, FEBS LETT, V502, P113, DOI 10.1016/S0014-5793(01)02639-4; LeRoux M, 2015, ELIFE, V4, DOI 10.7554/eLife.05701; LeRoux M, 2012, P NATL ACAD SCI USA, V109, P19804, DOI 10.1073/pnas.1213963109; Li M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002613; Ma LS, 2014, CELL HOST MICROBE, V16, P94, DOI 10.1016/j.chom.2014.06.002; Madden JC, 2001, CELL, V104, P143, DOI 10.1016/S0092-8674(01)00198-2; Mohan S, 2014, MOL IMMUNOL, V62, P249, DOI 10.1016/j.molimm.2014.06.029; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Russell AB, 2013, NATURE, V496, P508, DOI 10.1038/nature12074; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Shneider MM, 2013, NATURE, V500, P350, DOI 10.1038/nature12453; Silverman JM, 2013, MOL CELL, V51, P584, DOI 10.1016/j.molcel.2013.07.025; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Simon NC, 2014, NAT REV MICROBIOL, V12, P599, DOI 10.1038/nrmicro3310; Smith CL, 2011, STRUCTURE, V19, P192, DOI 10.1016/j.str.2010.12.013; Soufo HJD, 2010, P NATL ACAD SCI USA, V107, P3163, DOI 10.1073/pnas.0911979107; Vogeley L, 2001, J BIOL CHEM, V276, P17149, DOI 10.1074/jbc.M100017200; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Yates SP, 2006, TRENDS BIOCHEM SCI, V31, P123, DOI 10.1016/j.tibs.2005.12.007; Zhang DP, 2014, CURR OPIN STRUC BIOL, V26, P92, DOI 10.1016/j.sbi.2014.05.008; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18	46	128	133	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					607	619		10.1016/j.cell.2015.09.027	http://dx.doi.org/10.1016/j.cell.2015.09.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26456113	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000364828900015
J	McDonald, TJ; Oram, RA; Vaidya, B				McDonald, Timothy J.; Oram, Richard A.; Vaidya, Bijay			RATIONAL TESTING Investigating hyperkalaemia in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PSEUDOHYPERKALEMIA; DISORDERS; SERUM		[McDonald, Timothy J.] Royal Devon & Exeter Hosp, Dept Blood Sci, Exeter EX2 5DW, Devon, England; [McDonald, Timothy J.; Oram, Richard A.] Univ Exeter, Sch Med, NIHR Exeter Clin Res Facil, Exeter, Devon, England; [Oram, Richard A.] Royal Devon & Exeter Hosp, Dept Renal Med, Exeter EX2 5DW, Devon, England; [Vaidya, Bijay] Royal Devon & Exeter Hosp, Dept Endocrinol, Exeter EX2 5DW, Devon, England; [Vaidya, Bijay] Univ Exeter, Sch Med, Exeter, Devon, England	University of Exeter; University of Exeter; University of Exeter; University of Exeter; University of Exeter	Vaidya, B (corresponding author), Royal Devon & Exeter Hosp, Dept Endocrinol, Exeter EX2 5DW, Devon, England.	b.vaidya@exeter.ac.uk	Vaidya, Bijay/AAF-1947-2020	Oram, Richard/0000-0003-3581-8980; McDonald, Timothy James/0000-0003-3559-6660; Vaidya, Bijay/0000-0002-2223-0494	National Institute for Health Research [CL-2015-23-001] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Acker CG, 1998, ARCH INTERN MED, V158, P917, DOI 10.1001/archinte.158.8.917; Comes MP, 2008, ANN CLIN BIOCHEM, V45, P601, DOI 10.1258/acb.2008.007241; Cowley NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f16; DON BR, 1990, NEW ENGL J MED, V322, P1290, DOI 10.1056/NEJM199005033221806; EGAN TJ, 1959, PEDIATRICS, V24, P761; Einhorn LM, 2009, ARCH INTERN MED, V169, P1156, DOI 10.1001/archinternmed.2009.132; FREEMAN SJ, 1993, BRIT J ANAESTH, V70, P226, DOI 10.1093/bja/70.2.226; Halperin ML, 1998, LANCET, V352, P135; Liamis G, 2013, AM J MED, V126, P256, DOI 10.1016/j.amjmed.2012.06.037; MOORE ML, 1989, NEW ZEAL MED J, V102, P557; PAICE B, 1983, BRIT MED J, V286, P1189, DOI 10.1136/bmj.286.6372.1189; Pathology-Harmony-Group, 2011, HARM REF INT; Perazella MA, 2000, AM J MED, V109, P307, DOI 10.1016/S0002-9343(00)00496-4; Sevastos N, 2006, J LAB CLIN MED, V147, P139, DOI 10.1016/j.lab.2005.11.008; Slovis C, 2002, BRIT MED J, V324, P1320, DOI 10.1136/bmj.324.7349.1320; Soar J, 2010, RESUSCITATION, V81, P1400, DOI 10.1016/j.resuscitation.2010.08.015; Stewart GW, 1999, BEST PRACT RES CL HA, V12, P707, DOI 10.1053/beha.1999.0049; The Renal Association, 2021, CLIN PRACTICE GUIDEL; Vaidya B, 2002, LANCET, V359, P848, DOI 10.1016/S0140-6736(02)07956-4; VERRESEN L, 1986, CLIN CHEM, V32, P698; Wiederkehr MR, 2000, AM J KIDNEY DIS, V36, P1049	21	9	10	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2015	351								h4762	10.1136/bmj.h4762	http://dx.doi.org/10.1136/bmj.h4762			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3FJ	26487322				2022-12-28	WOS:000364143900001
J	Boger, DL				Boger, Dale L.			When sugar is not so sweet	SCIENCE			English	Editorial Material							GLYCATION END-PRODUCTS; MAILLARD CROSS-LINKS; GLUCOSEPANE		Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Boger, DL (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	boger@scripps.edu						Biemel KM, 2002, ANGEW CHEM INT EDIT, V41, P801, DOI 10.1002/1521-3773(20020301)41:5<801::AID-ANIE801>3.0.CO;2-I; Biemel KM, 2002, J BIOL CHEM, V277, P24907, DOI 10.1074/jbc.M202681200; Chikazawa M, 2013, J BIOL CHEM, V288, P13204, DOI 10.1074/jbc.M113.452177; Draghici C, 2015, SCIENCE, V350, P294, DOI 10.1126/science.aac9655; Hellwig M, 2014, ANGEW CHEM INT EDIT, V53, P10316, DOI 10.1002/anie.201308808; Lederer MO, 1999, BIOORGAN MED CHEM, V7, P1081, DOI 10.1016/S0968-0896(99)00040-1; Monnier VM, 2014, CLIN CHEM LAB MED, V52, P21, DOI 10.1515/cclm-2013-0174; Monnier VM, 2013, J DIABETES COMPLICAT, V27, P141, DOI 10.1016/j.jdiacomp.2012.10.004; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P533, DOI 10.1196/annals.1333.061; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591	10	3	3	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2015	350	6258					275	276		10.1126/science.aad3298	http://dx.doi.org/10.1126/science.aad3298			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT5HD	26472893				2022-12-28	WOS:000362838700019
J	Cooper, MM; Ebert-May, D; Fata-Hartley, CL; Jardeleza, SE; Krajcik, JS; Laverty, JT; Matz, RL; Posey, LA; Underwood, SM				Cooper, Melanie M.; Ebert-May, Diane; Fata-Hartley, Cori L.; Jardeleza, Sarah E.; Krajcik, Joseph S.; Laverty, James T.; Matz, Rebecca L.; Posey, Lynmarie A.; Underwood, Sonia M.			Challenge faculty to transform STEM learning	SCIENCE			English	Editorial Material									[Cooper, Melanie M.; Ebert-May, Diane; Fata-Hartley, Cori L.; Jardeleza, Sarah E.; Krajcik, Joseph S.; Laverty, James T.; Matz, Rebecca L.; Posey, Lynmarie A.; Underwood, Sonia M.] Michigan State Univ, E Lansing, MI 48824 USA	Michigan State University	Cooper, MM (corresponding author), Michigan State Univ, E Lansing, MI 48824 USA.	mmc@msu.edu	Underwood, Sonia/AAF-2718-2021; Underwood, Sonia/AAW-5740-2021; Matz, Rebecca L./AAF-2969-2021	Underwood, Sonia/0000-0002-4919-2758; Matz, Rebecca L./0000-0002-8220-7720; Caballero, Marcos/0000-0003-0717-4583; Cooper, Melanie/0000-0002-7050-8649; Posey, Lynmarie/0000-0001-7713-0637				[Anonymous], 2012, ENGAGE EXCEL PRODUCI; Brewer CA, 2011, VISION CHANGE UNDERG; Freeman S, 2014, P NATL ACAD SCI USA, V111, P8410, DOI 10.1073/pnas.1319030111; Hake RR, 1998, AM J PHYS, V66, P64, DOI 10.1119/1.18809; KRAJCIK JS, 2012, MAKING IT TANGIBLE L, P261; National Research Council, 2012, FRAM K 12 SCI ED PRA; National Research Council, 2001, KNOWING WHAT STUDENT; National Research Council, 1999, PEOPLE LEARN BRAIN M; National Research Council, 2014, DEV ASS NEXT GEN SCI, DOI 10.17226/18409; National Research Council, 2012, DISCIPLINE BASED ED; Windschitl M, 2004, J RES SCI TEACH, V41, P481, DOI 10.1002/tea.20010; Wood WB, 2009, SCIENCE, V325, P1627, DOI 10.1126/science.1180821	12	87	87	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2015	350	6258					281	282		10.1126/science.aab0933	http://dx.doi.org/10.1126/science.aab0933			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT5HD	26472897				2022-12-28	WOS:000362838700023
J	Biankin, AV; Piantadosi, S; Hollingsworth, SJ				Biankin, Andrew V.; Piantadosi, Steven; Hollingsworth, Simon J.			Patient-centric trials for therapeutic development in precision oncology	NATURE			English	Review							CELL LUNG-CANCER; CLINICAL-TRIALS; BREAST-CANCER; TARGETED THERAPY; FREE SURVIVAL; TUMOR-DNA; MEDICINE; GENOME; CHEMOTHERAPY; VALIDATION	An enhanced understanding of the molecular pathology of disease gained from genomic studies is facilitating the development of treatments that target discrete molecular subclasses of tumours. Considerable associated challenges include how to advance and implement targeted drug-development strategies. Precision medicine centres on delivering the most appropriate therapy to a patient on the basis of clinical and molecular features of their disease. The development of therapeutic agents that target molecular mechanisms is driving innovation in clinical-trial strategies. Although progress has been made, modifications to existing core paradigms in oncology drug development will be required to realize fully the promise of precision medicine.	[Biankin, Andrew V.] Univ Glasgow, Wolfson Wohl Canc Res Ctr, Inst Canc Sci, Glasgow G61 1BD, Lanark, Scotland; [Biankin, Andrew V.] Garvan Inst Med Res, Kinghorn Canc Ctr, Canc Div, Sydney, NSW 2010, Australia; [Biankin, Andrew V.] Bankstown Hosp, Dept Surg, Sydney, NSW 2200, Australia; [Biankin, Andrew V.] Univ New S Wales, South Western Sydney Clin Sch, Fac Med, Liverpool, NSW 2170, Australia; [Piantadosi, Steven] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90095 USA; [Hollingsworth, Simon J.] AstraZeneca, Innovat Med & Early Dev Oncol, Cambridge CB4 0FZ, England	University of Glasgow; Garvan Institute of Medical Research; University of New South Wales Sydney; Cedars Sinai Medical Center; AstraZeneca	Biankin, AV (corresponding author), Univ Glasgow, Wolfson Wohl Canc Res Ctr, Inst Canc Sci, Glasgow G61 1BD, Lanark, Scotland.	andrew.biankin@glasgow.ac.uk		Biankin, Andrew/0000-0002-0362-5597	Cancer Research UK [17263] Funding Source: researchfish; Wellcome Trust [103721/Z/14/Z] Funding Source: researchfish; Wellcome Trust [103721] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission)		Academy of Medical Sciences, 2013, REAL POT STRAT MED; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Andre F, 2014, LANCET ONCOL, V15, P267, DOI 10.1016/S1470-2045(13)70611-9; [Anonymous], 2015, ISPY 2 CLIN TRIALS; [Anonymous], 2015, LUNG CANC MAST PROT; Association of the British Pharmaceutical Industry, 2014, STRAT DIS PERS MED; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Biankin AV, 2011, HUM GENET, V130, P79, DOI 10.1007/s00439-011-1010-0; Cancer Research UK, 2014, STRAT MED LUNG CANC; Chantrill LA, 2015, CLIN CANCER RES, V21, P2029, DOI 10.1158/1078-0432.CCR-15-0426; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; Chin L, 2011, NAT MED, V17, P297, DOI 10.1038/nm.2323; Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Dienstmann R, 2012, MOL CANCER THER, V11, P2062, DOI 10.1158/1535-7163.MCT-12-0290; Douillard JY, 2014, J THORAC ONCOL, V9, P1345, DOI 10.1097/JTO.0000000000000263; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; EORTC, 2015, EORTC FUT CANC THER; EORTC, 2015, SPECTACOLOR EORTC CO; Esserman LJ, 2012, J CLIN ONCOL, V30, P3242, DOI 10.1200/JCO.2011.39.2779; Esserman LJ, 2012, BREAST CANCER RES TR, V132, P1049, DOI 10.1007/s10549-011-1895-2; European Medicines Agency, 2015, EUR PUBL ASS REP; Food and Drug Administration, 2020, NUCL AC BAS TESTS; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Gerber DE, 2010, CANCER CELL, V18, P548, DOI 10.1016/j.ccr.2010.11.033; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Hollebecque A, 2013, ASCO M, V31, P2512; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Hylton NM, 2012, RADIOLOGY, V263, P663, DOI 10.1148/radiol.12110748; Institute of Medicine (US) Forum on Drug Discovery Development and Translation, 2010, TRANSF CLIN RES US C; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Kalf RRJ, 2014, GENET MED, V16, P85, DOI 10.1038/gim.2013.80; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Lara PN, 2001, J CLIN ONCOL, V19, P1728, DOI 10.1200/JCO.2001.19.6.1728; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le Tourneau C, 2015, J CLIN ONCOL, V33; Le Tourneau C, 2012, TARGET ONCOL, V7, P253, DOI 10.1007/s11523-012-0237-6; Ledermann J, 2014, LANCET ONCOL, V15, P852, DOI 10.1016/S1470-2045(14)70228-1; Lee CK, 2009, MED J AUSTRALIA, V190, P631, DOI 10.5694/j.1326-5377.2009.tb02592.x; Lewin J, 2015, CURR OPIN ONCOL, V27, P250, DOI 10.1097/CCO.0000000000000185; Lin C, 2012, BREAST CANCER RES TR, V132, P871, DOI 10.1007/s10549-011-1670-4; Lindsay CR, 2015, EXPERT REV MOL DIAGN, V15, P287, DOI 10.1586/14737159.2015.992417; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mandrekar SJ, 2009, J CLIN ONCOL, V27, P4027, DOI 10.1200/JCO.2009.22.3701; Matsumoto S, 2015, J CLIN ONCOL, V33; Medical Research Council Clinical Trials Unit. Medical Research Council Clinical Trials Unit, 2014, FOCUS4 MOL SEL THER; National Cancer Institute, MOL AN THER CHOIC; National Institutes of Health, MOL PROF BAS ASS CAN; Printz C, 2015, CANCER-AM CANCER SOC, V121, P1529, DOI 10.1002/cncr.28994; Roper N, 2015, CANCER TREAT REV, V41, P385, DOI 10.1016/j.ctrv.2015.02.009; Sargent DJ, 2005, J CLIN ONCOL, V23, P2020, DOI 10.1200/JCO.2005.01.112; Seguin L, 2014, NAT CELL BIOL, V16, P457, DOI 10.1038/ncb2953; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Simon R, 2013, NAT REV DRUG DISCOV, V12, P359, DOI 10.1038/nrd3979; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Sleijfer S, 2013, J CLIN ONCOL, V31, P1834, DOI 10.1200/JCO.2012.45.3639; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tam AL, 2013, J THORAC ONCOL, V8, P436, DOI 10.1097/JTO.0b013e318287c91e; TrialReach, 2012, CLIN STUD PAT CANC V; Tsimberidou AM, 2012, CLIN CANCER RES, V18, P6373, DOI 10.1158/1078-0432.CCR-12-1627; U.S. Food and Drug Administration,, 2015, ANDA GEN DRUG APPR; U.S. Food and Drug Administration, 2015, LIST CLEAR APPR COMP; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0; Von Hoff DD, 2010, J CLIN ONCOL, V28, P4877, DOI 10.1200/JCO.2009.26.5983; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Watson IR, 2013, NAT REV GENET, V14, P703, DOI 10.1038/nrg3539; Worldwide International Networking, WORLDW INT NETW PERS; Yap TA, 2010, NAT REV CANCER, V10, P514, DOI 10.1038/nrc2870; Zardavas D, 2014, BRIT J CANCER, V111, P1881, DOI 10.1038/bjc.2014.341; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438	76	188	190	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					361	370		10.1038/nature15819	http://dx.doi.org/10.1038/nature15819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26469047	Green Accepted			2022-12-28	WOS:000362730200039
J	Miller, T; Ashworth, J; Richards, S				Miller, Thabo; Ashworth, Jennifer; Richards, Sarah			CASE SCENARIO Sister Mary Joseph nodule	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Miller, Thabo; Ashworth, Jennifer; Richards, Sarah] Royal United Hosp, Dept Surg, Bath BA1 3NG, Avon, England		Miller, T (corresponding author), Royal United Hosp, Dept Surg, Bath BA1 3NG, Avon, England.	thabomiller@nhs.net							0	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 15	2015	351								h5224	10.1136/bmj.h5224	http://dx.doi.org/10.1136/bmj.h5224			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT8XW	26472774				2022-12-28	WOS:000363101200001
J	Lumsden, MA; Hamoodi, I; Gupta, J; Hickey, M				Lumsden, Mary Ann; Hamoodi, Ibraheem; Gupta, Janesh; Hickey, Martha			Fibroids: diagnosis and management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							UTERINE ARTERY EMBOLIZATION; ULIPRISTAL ACETATE; RISK-FACTORS; WOMEN; LEIOMYOMA; MYOMECTOMY; PREGNANCY; COMPLICATIONS; PROGESTERONE; MULTICENTER		[Lumsden, Mary Ann; Hamoodi, Ibraheem] Univ Glasgow, Glasgow G31 2ER, Lanark, Scotland; [Gupta, Janesh] Univ Birmingham, Birmingham Womens Hosp, Birmingham, W Midlands, England; [Hickey, Martha] Univ Melbourne, Melbourne, Vic, Australia; [Hickey, Martha] Royal Womens Hosp, Melbourne, Vic, Australia	University of Glasgow; Birmingham Women's Hospital; University of Birmingham; University of Melbourne	Lumsden, MA (corresponding author), Univ Glasgow, Glasgow Royal Infirm Campus, Glasgow G31 2ER, Lanark, Scotland.	Maryann.Lumsden@glasgow.ac.uk						Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Bosteels J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009461.pub3; Brohl AS, 2015, ONCOLOGIST, V20, P433, DOI 10.1634/theoncologist.2014-0361; Cano Lopez Humberto, 2012, Ginecol Obstet Mex, V80, P654; Carranza-Mamane B, 2015, J OBSTET GYNAECOL CA, V37, P277, DOI 10.1016/S1701-2163(15)30318-2; Casini ML, 2006, GYNECOL ENDOCRINOL, V22, P106, DOI 10.1080/09513590600604673; Chen CR, 2001, AM J EPIDEMIOL, V153, P20, DOI 10.1093/aje/153.1.20; D'Aloisio AA, 2010, ENVIRON HEALTH PERSP, V118, P375, DOI 10.1289/ehp.0901423; Donnez J, 2012, NEW ENGL J MED, V366, P421, DOI 10.1056/NEJMoa1103180; Donnez J, 2012, NEW ENGL J MED, V366, P409, DOI 10.1056/NEJMoa1103182; Drayer SM, 2015, INT J GYNAECOL OBSTE; Dubuisson JB, 2000, HUM REPROD, V15, P869, DOI 10.1093/humrep/15.4.869; Evans P, 2007, AM FAM PHYSICIAN, V75, P1503; Goto A, 2002, INT J GYNECOL CANCER, V12, P354, DOI 10.1046/j.1525-1438.2002.01086.x; Gov. UK, PAYM RES NHS TAR 201; Gupta JK, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005073.pub4; Gupta S, 2008, BEST PRACT RES CL OB, V22, P615, DOI 10.1016/j.bpobgyn.2008.01.008; Gupta S, 2009, BEST PRACT RES CL OB, V23, P609, DOI 10.1016/j.bpobgyn.2009.01.012; Gyamfi-Bannerman C, 2012, OBSTET GYNECOL, V120, P1332, DOI [10.1097/AOG.0b013e318273695b, http://10.1097/AOG.0b013e318273695b]; Kaump GR, 2013, J VASC INTERV RADIOL, V24, P459, DOI 10.1016/j.jvir.2012.12.002; Kongnyuy EJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005355.pub5; LAMORTE AI, 1993, OBSTET GYNECOL, V82, P897; Laughlin SK, 2009, OBSTET GYNECOL, V113, P630, DOI 10.1097/AOG.0b013e318197bbaf; Lefebvre G, 2003, J OBSTET GYNAECOL CA, V25, P419; Lefebvre Guylaine, 2003, J Obstet Gynaecol Can, V25, P396; Ligon AH, 2000, GENE CHROMOSOME CANC, V28, P235, DOI 10.1002/1098-2264(200007)28:3<235::AID-GCC1>3.3.CO;2-Z; Manyonda IT, 2012, CARDIOVASC INTER RAD, V35, P530, DOI 10.1007/s00270-011-0228-5; Maruo T, 2000, STEROIDS, V65, P585, DOI 10.1016/S0039-128X(00)00171-9; Mavrelos D, 2010, ULTRASOUND OBST GYN, V35, P238, DOI 10.1002/uog.7482; McPherson K, 2004, BJOG-INT J OBSTET GY, V111, P688, DOI 10.1111/j.1471-0528.2004.00174.x; Metwally M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003857.pub3; Moravek MB, 2015, HUM REPROD UPDATE, V21, P1, DOI 10.1093/humupd/dmu048; MURAM D, 1980, AM J OBSTET GYNECOL, V138, P16, DOI 10.1016/0002-9378(80)90005-8; National Institute for Health and Care Excellence, 2007, HEAV MENSTR BLEED CL; National Institute for Health and Care Excellence, 2010, INT PROC OV UT ART E; Palomba S, 2007, FERTIL STERIL, V88, P933, DOI 10.1016/j.fertnstert.2006.12.047; Pritts EA, 2009, FERTIL STERIL, V91, P1215, DOI 10.1016/j.fertnstert.2008.01.051; ROSS RK, 1986, BRIT MED J, V293, P359, DOI 10.1136/bmj.293.6543.359; Royal College of Obstetricians and Gynaecologists and Royal College of Radiologists, 2013, CLIN REC US UT ART E; Sato K, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.12.028; Seshadri S, 2015, HUM REPROD UPDATE, V21, P262, DOI 10.1093/humupd/dmu057; Shwayder J, 2014, J MINIM INVAS GYN, V21, P362, DOI 10.1016/j.jmig.2013.11.011; Sizzi O, 2007, J MINIM INVAS GYN, V14, P453, DOI 10.1016/j.jmig.2007.01.013; Spielmann AL, 2006, AM J ROENTGENOL, V187, P1499, DOI 10.2214/AJR.05.1476; Spitz IM, 2009, CURR OPIN OBSTET GYN, V21, P318, DOI 10.1097/GCO.0b013e32832e07e8; Terry KL, 2007, EPIDEMIOLOGY, V18, P758, DOI 10.1097/EDE.0b013e3181567eed; Varma R, 2009, EUR J OBSTET GYN R B, V142, P154, DOI 10.1016/j.ejogrb.2008.10.006; Vercellini P, 1997, HUM REPROD, V12, P1768, DOI 10.1093/humrep/12.8.1768; Wise LA, 2004, AM J EPIDEMIOL, V159, P113, DOI 10.1093/aje/kwh016; Yang CH, 2002, MATURITAS, V43, P35, DOI 10.1016/S0378-5122(02)00159-7	50	33	37	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2015	351								h4887	10.1136/bmj.h4887	http://dx.doi.org/10.1136/bmj.h4887			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT8XS	26463991	Green Published			2022-12-28	WOS:000363100800001
J	Jiang, LX; Krumholz, HM; Li, X; Li, J; Hu, SS				Jiang, Lixin; Krumholz, Harlan M.; Li, Xi; Li, Jing; Hu, Shengshou			Achieving best outcomes for patients with cardiovascular disease in China by enhancing the quality of medical care and establishing a learning health-care system	LANCET			English	Review							ACUTE MYOCARDIAL-INFARCTION; ACUTE CORONARY SYNDROMES; ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; ASSOCIATION TASK-FORCE; TO-BALLOON TIMES; NONCOMMUNICABLE DISEASES; SECONDARY PREVENTION; PRACTICE PATTERNS; AMERICAN-COLLEGE	China has an immediate need to address the rapidly growing population with cardiovascular disease events and the increasing number of people living with this illness. Despite progress in increasing access to services, China faces the dual challenge of addressing gaps in quality of care and producing more evidence to support clinical practice. In this Review, we address opportunities to strengthen performance measurement, programmes to improve quality of care, and national capacity to produce high-impact knowledge for clinical practice. Moreover, we propose recommendations, with implications for other diseases, for how China can immediately make use of its Hospital Quality-Monitoring System and other existing national platforms to assess and improve performance of medical care, and to generate new knowledge to inform clinical decisions and national policies.	[Jiang, Lixin; Li, Xi; Li, Jing; Hu, Shengshou] Chinese Acad Med Sci, Natl Clin Res Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Jiang, Lixin; Li, Xi; Li, Jing; Hu, Shengshou] Peking Union Med Coll, Beijing 100021, Peoples R China; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Fdn Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Yale University; Robert Wood Johnson Foundation (RWJF); Yale University; Yale University; Yale University	Hu, SS (corresponding author), Fuwai Hosp, Natl Clin Res Ctr Cardiovasc Dis, Beijing 100037, Peoples R China.	shengshouhu@yahoo.com	, Harlan/AAI-2875-2020	Li, Xi/0000-0003-2249-688X	National Key Technology R&D Program from the Ministry of Science and Technology of China [2013BAI09B01]; Center for Cardiovascular Outcomes Research at Yale University from the National Heart, Lung, and Blood Institute [U01 HL105270-05]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	National Key Technology R&D Program from the Ministry of Science and Technology of China(National Key Technology R&D Program); Center for Cardiovascular Outcomes Research at Yale University from the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Nicholas S Downing and Karthik Murugiah from Yale-New Haven Hospital Center for Outcomes Research and Evaluation, New Haven, CT, USA; Clive Weston from Swansea University, UK; Xue Du from National Clinical Research Center of Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Beijing, China, for their contribution in collection and summarisation of data in tables (quality measures and initiatives in the USA, UK, and India). We thank Xue Du, who searched published work, extracted data, and summarised data in tables (studies on quality of care for cardiovascular diseases in China). This project was supported by the National Key Technology R&D Program (2013BAI09B01) from the Ministry of Science and Technology of China. HMK is supported by grant U01 HL105270-05 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute. The funders had no role in the preparation or approval of the manuscript.	Alexander T, 2014, GLOB HEART, V9, P419, DOI 10.1016/j.gheart.2014.04.005; Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P195; [Anonymous], 2012, LANCET, V379, P1764, DOI 10.1016/S0140-6736(12)60729-6; [Anonymous], 2010, LANCET, V376, P657, DOI 10.1016/S0140-6736(10)61315-3; Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; ational Health and Family Planning Commission of the Peoples Republic of China, 2014, GUID STAND TRAIN CLI; Berenson RA, 2012, NEW ENGL J MED, V366, P1364, DOI 10.1056/NEJMp1201268; Bi YF, 2009, AM HEART J, V157, P509, DOI 10.1016/j.ahj.2008.09.026; Blumenthal D, 2013, J HOSP MED, V8, P271, DOI 10.1002/jhm.2045; Bradley EH, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-25; Bray BD, 2013, STROKE, V44, P3129, DOI 10.1161/STROKEAHA.113.001981; Buckley GJ., 2015, IMPROVING QUALITY CA; Centers for Medicare & Medicaid Services, 2008, HOSP QUAL IN OV; Centers for Medicare & Medicaid Services, 2006, OV SPEC MEAS DISPL H; Chan PS, 2010, JAMA-J AM MED ASSOC, V304, P2129, DOI 10.1001/jama.2010.1576; [张海波 ZHANG Haibo], 2011, [临床心血管病杂志, Journal of Clinical Cardiology], V27, P422; [李静 Li Jing], 2011, [中华高血压杂志, Chinese Journal of Hypertension], V19, P246; Chen ZM, 2005, LANCET, V366, P1622; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; [China Biomedical Engineering Society of pacing and electrophysiology China editorial board of Journal of cardiac pacing and electrophysiology Editorial Committee of Chinese Journal of Cardiology Chinese society of Cardiology], 2005, CHIN J CARDIAC PACIN, V19, P3; China Society of Cardiology of Chinese Medical Association, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P675; China Society of Cardiology of Chinese Medical Association Editorial Board of Chinese Journal of Cardiology Editorial Board of Chinese Journal of Circulation, 2001, CHIN CIRC J, V16, P407; Chinese Medical Society of Cardiology Chinese Journal of Cardiology Editorial Board, 2014, CHIN J CARDIOL, V42, P98, DOI DOI 10.3760/CMA.J.ISSN.0253-3758.2014.02.004; [Chinese society of Cardiology Editorial Committee of Chinese Journal of Cardiology Cardiovascular disease branch of Chinese Medical Association of interventional cardiology], 2012, CHIN J FRONT MED SCI, V4, P50; Chung SC, 2014, LANCET, V383, P1305, DOI 10.1016/S0140-6736(13)62070-X; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; CSo C, 2012, CHIN J CARDIOL, V40, P353, DOI DOI 10.3760/CMA.J.ISSN.0253-3758.2012.05.001; Cumbler E, 2014, STROKE, V45, P231, DOI 10.1161/STROKEAHA.113.003617; Department of Health, 2000, NAT SERV FRAM COR AR; Desta Z, 2002, CLIN PHARMACOKINET, V41, P913, DOI 10.2165/00003088-200241120-00002; Du X, 2014, CIRC-CARDIOVASC QUAL, V7, P217, DOI 10.1161/CIRCOUTCOMES.113.000526; [Editorial Committee of Chinese Journal of Cardiology Chinese Society of Cardiology], 2010, CHIN J CARDIOL CHIN, V40, P353; Eggleston K, 2008, HEALTH ECON, V17, P149, DOI 10.1002/hec.1306; Fonarow GC, 2014, JAMA-J AM MED ASSOC, V311, P1632, DOI 10.1001/jama.2014.3203; Gale CP, 2012, EUR HEART J, V33, P630, DOI 10.1093/eurheartj/ehr381; Gao R, 2008, HEART, V94, P554, DOI 10.1136/hrt.2007.119750; Gao Y, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001250; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; Haynes R, 2013, EUR HEART J, V34, P1279, DOI 10.1093/eurheartj/eht055; Holmes D, 2012, LANCET, V380, P1809, DOI 10.1016/S0140-6736(12)62017-0; Hospital Compare, MEAS DISPL HOSP COMP; Hu J., 2012, 18 NAT C COMM PART C; Hu SS, 2012, CIRC-CARDIOVASC QUAL, V5, P214, DOI 10.1161/CIRCOUTCOMES.111.962365; Huang C, 2014, LANCET, V384, P783, DOI 10.1016/S0140-6736(14)61214-9; [Institute of Medicine Committee on the Learning Health Care System in America], 2013, BEST CARE LOWER COST; Institute of Medicine (US), 2001, COMMITTEE QUALITY HL, DOI [10.17226/10027, DOI 10.17226/10027]; Jiang Li-Xin, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P925; Jing Z, 2010, CHIN J FRONT MED SCI, V2011, P2; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Li J, 2014, J AM COLL CARDIOL, V63, pA134, DOI 10.1016/S0735-1097(14)60134-0; Li J, 2015, LANCET, V385, P441, DOI 10.1016/S0140-6736(14)60921-1; Li K, 2014, 2 SESS 12 NAT PEOPL; Li SS, 2015, AM HEART J, V169, P349, DOI 10.1016/j.ahj.2014.12.005; Li X, 2012, CHINESE MED J-PEKING, V125, P1703, DOI 10.3760/cma.j.issn.0366-6999.2012.10.005; Li YB, 2012, HEALTH AFFAIR, V31, P1075, DOI 10.1377/hlthaff.2010.0965; Liu Qun, 2009, Zhonghua Xinxueguanbing Zazhi, V37, P213, DOI 10.3760/cma.j.issn.0253-3758.2009.03.004; Long F, 2013, CHIN J GERIATR HEART, V8, P828; Medical Administration Department of the National Commission for Health and Family Planning of the Peoples Republic of China, 2008, QUAL CONTR IND 6 SPE; Medical Administration Department of the National Commission for Health and Family Planning of the Peoples Republic of China, 2012, NOT ACCR STAND SEC G; Medical Administration Department of the National Commission for Health and Family Planning of the Peoples Republic of China, 2011, NOT ACCR STAND TERT; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; MINAP Steering Group, 9 MINAP STEER GROUP; Ministry of Health of the Peoples Republic of China, 2009, NOT LAUNCH PIL CLIN; Ministry of Health of the Peoples Republic of China, 2010, CHIN NAT NCD RISK FA; Ministry of Health of the Peoples Republic of China, 2013, CHIN PUBL HLTH STAT; Ministry of Health of the Peoples Republic of China, 2005, CHIN NUTR HLTH SURV; Ministry of Science and Technology of the Peoples Republic of China, 2012, ANN REP STAT PROGR S; Nallamothu BK, 2015, LANCET, V385, P1114, DOI 10.1016/S0140-6736(14)61932-2; National Center for Cardiovascular Diseases, 2015, REP CARD DIS CHIN 20; National Health and Family Planning Commission of the Peoples Republic of China, 2014, NOT PUBL CONS MED QU; National Institute for Health and Care Excellence, 2014, AC COR SYNDR INCL MY; National Institute for Health and Care Excellence, 2010, STROK QUAL STAND; National Natural Science Foundation of China, 2011, APPL FUND REP NAT NA; Neurology Branch Chinese Medical Association. The ischemic stroke secondary prevention guideline writing group of cerebrovascular disease group, 2010, CHIN J NEUROL, V43, P154; Neurology Branch of Chinese Medical Association Group of Cerebrovascular Disease, 2010, CHIN J NEUROL, V43, P146; Newhouse JP, 1996, J ECON LIT, V34, P1263; Ranasinghe I, 2014, CIRC-CARDIOVASC QUAL, V7, P209, DOI 10.1161/CIRCOUTCOMES.113.000527; Reynolds L, 2011, INT J HEALTH PLAN M, V26, P449, DOI 10.1002/hpm.1112; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; Royal College of Physicians. Sentinel Stroke National Audit Programme (SSNAP), SENT STROK NAT AUD P; Rudd AG, 2011, J NEUROL NEUROSUR PS, V82, P14, DOI 10.1136/jnnp.2009.203174; Schwamm LH, 2013, CIRC-CARDIOVASC QUAL, V6, P543, DOI 10.1161/CIRCOUTCOMES.111.000303; Su QJ, 2014, VASCULAR, V22, P181, DOI 10.1177/1708538113484022; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Wang YL, 2015, AM HEART J, V169, P767, DOI 10.1016/j.ahj.2015.03.008; Wang YL, 2011, STROKE, V42, P1658, DOI 10.1161/STROKEAHA.110.604249; Watts J, 2008, LANCET, V372, P1455, DOI 10.1016/S0140-6736(08)61561-5; Wei JW, 2010, STROKE, V41, P967, DOI 10.1161/STROKEAHA.109.571463; Weston C, MYOCARDIAL ISCHAEMIA; World Health Organization, 2006, QUAL CAR PROC MAK ST; World Health Organization, 2005, WHO GLOB REP 2005 PR; Xavier D, 2008, LANCET, V371, P1435, DOI 10.1016/S0140-6736(08)60623-6; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yang Z, 2014, LANCET, V383, P200, DOI 10.1016/S0140-6736(13)62387-9; Yip W, 2014, LANCET, V384, P805, DOI 10.1016/S0140-6736(14)61120-X; Zhang Dan, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P397	102	57	83	0	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2015	386	10002					1493	1505		10.1016/S0140-6736(15)00343-8	http://dx.doi.org/10.1016/S0140-6736(15)00343-8			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CT5UU	26466053	Green Accepted			2022-12-28	WOS:000362877300032
J	Pelish, HE; Liau, BB; Nitulescu, II; Tangpeerachaikul, A; Poss, ZC; Da Silva, DH; Caruso, BT; Arefolov, A; Fadeyi, O; Christie, AL; Du, K; Banka, D; Schneider, EV; Jestel, A; Zou, G; Si, C; Ebmeier, CC; Bronson, RT; Krivtsov, AV; Myers, AG; Kohl, NE; Kung, AL; Armstrong, SA; Lemieux, ME; Taatjes, DJ; Shair, MD				Pelish, Henry E.; Liau, Brian B.; Nitulescu, Ioana I.; Tangpeerachaikul, Anupong; Poss, Zachary C.; Da Silva, Diogo H.; Caruso, Brittany T.; Arefolov, Alexander; Fadeyi, Olugbeminiyi; Christie, Amanda L.; Du, Karrie; Banka, Deepti; Schneider, Elisabeth V.; Jestel, Anja; Zou, Ge; Si, Chong; Ebmeier, Christopher C.; Bronson, Roderick T.; Krivtsov, Andrei V.; Myers, Andrew G.; Kohl, Nancy E.; Kung, Andrew L.; Armstrong, Scott A.; Lemieux, Madeleine E.; Taatjes, Dylan J.; Shair, Matthew D.			Mediator kinase inhibition further activates super-enhancer-associated genes in AML	NATURE			English	Article							TRANSCRIPTION FACTORS; CDK7 INHIBITOR; CELL IDENTITY; GENOME; CANCER; LIGAND; GUIDELINES; ULTRAFAST; KNOWLEDGE; ALIGNMENT	Super-enhancers (SEs), which are composed of large clusters of enhancers densely loaded with the Mediator complex, transcription factors and chromatin regulators, drive high expression of genes implicated in cell identity and disease, such as lineage-controlling transcription factors and oncogenes(1,2). BRD4 and CDK7 are positive regulators of SE-mediated transcription(3-5). By contrast, negative regulators of SE-associated genes have not been well described. Here we show that the Mediator-associated kinases cyclin-dependent kinase 8 (CDK8) and CDK19 restrain increased activation of key SE-associated genes in acute myeloid leukaemia (AML) cells. We report that the natural product cortistatin A (CA) selectively inhibits Mediator kinases, has anti-leukaemic activity in vitro and in vivo, and disproportionately induces upregulation of SE-associated genes in CA-sensitiveAML cell lines but not in CA-insensitive cell lines. In AML cells, CA upregulated SE-associated genes with tumour suppressor and lineage-controlling functions, including the transcription factors CEBPA, IRF8, IRF1 and ETV6 (refs 6-8). The BRD4 inhibitor I-BET151 downregulated these SE-associated genes, yet also has anti-leukaemic activity. Individually increasing or decreasing the expression of these transcription factors suppressed AML cell growth, providing evidence that leukaemia cells are sensitive to the dosage of SE-associated genes. Our results demonstrate that Mediator kinases can negatively regulate SE-associated gene expression in specific cell types, and can be pharmacologically targeted as a therapeutic approach to AML.	[Pelish, Henry E.; Liau, Brian B.; Nitulescu, Ioana I.; Tangpeerachaikul, Anupong; Da Silva, Diogo H.; Caruso, Brittany T.; Arefolov, Alexander; Fadeyi, Olugbeminiyi; Du, Karrie; Zou, Ge; Si, Chong; Myers, Andrew G.; Shair, Matthew D.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Poss, Zachary C.; Ebmeier, Christopher C.; Taatjes, Dylan J.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA; [Christie, Amanda L.; Kohl, Nancy E.] Dana Farber Canc Inst, Lurie Family Imaging Ctr, Boston, MA 02215 USA; [Banka, Deepti] Childrens Hosp, Div Hematol Oncol, Boston, MA 02215 USA; [Schneider, Elisabeth V.; Jestel, Anja] Proteros Biostruct GmbH, D-82152 Martinsried, Germany; [Schneider, Elisabeth V.] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Bronson, Roderick T.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Krivtsov, Andrei V.; Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Krivtsov, Andrei V.; Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA; [Kung, Andrew L.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Lemieux, Madeleine E.] Bioinfo, Plantagenet, ON K0B 1L0, Canada	Harvard University; University of Colorado System; University of Colorado Boulder; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Max Planck Society; Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Columbia University	Shair, MD (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	shair@chemistry.harvard.edu	Kung, Andrew L/AEU-0826-2022; Krivtsov, Andrei/AAJ-9966-2021; Kung, Andrew/AAL-2384-2020	Kung, Andrew L/0000-0002-9091-488X; Lemieux, Madeleine/0000-0001-6355-8691; Nitulescu, Ioana/0000-0002-9486-2319; Krivtsov, Andrei/0000-0002-5511-1686; Arefolov, Alexander/0000-0002-3447-3223	NIH [CA66996, T32 GM08759]; NCI [R01 CA170741, F31 CA180419]; Leukemia and Lymphoma Society Translational Research Program; Blavatnik Biomedical Accelerator Programat Harvard; Starr Cancer Consortium;  [P30-CA046934]; NATIONAL CANCER INSTITUTE [P01CA066996, P30CA008748, R01CA176745, R01CA170741, P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society Translational Research Program(Leukemia and Lymphoma Society); Blavatnik Biomedical Accelerator Programat Harvard; Starr Cancer Consortium; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Levine, R. King, B. Ebert, B. Bernstein, S. Gillespie, M. Galbraith, M. Patricelli and T. Nomanbhoy for discussions. Lentiviral packaging was completed at the University of Massachusetts Medical School RNAi core facility. Microarray data collection was performed at DFCI MicroArray Core Facility and UMass Medical School Genomics Core Facility. Formulation was performed at VivoPath. In-vivo portions of pharmacokinetic, natural killer and SET-2 studies were performed at Charles River. We thank S. Trauger and G. Byrd of Harvard FAS Small Molecule Mass Spectrometry for PK data acquisition and Harvard FAS Center for Systems Biology for flow sorting and high-throughput sequencing. Recombinant expression of CDK8 module subunits was completed at the Tissue Culture Shared Resource at the University of Colorado Cancer Center, supported by the NCI (P30 CA046934). HCT116 RNA-seq was carried out at the Genomics Shared Resource at the University of Colorado Cancer Center and supported by grant P30-CA046934. We thank A. Odell and R. Dowell for HCT116 RNA-seq data analysis, the R. Levine laboratory (MSKCC) for carrying out the SET-2 RNA-seq acquisition, the M. Geyer laboratory for purified CDK12-CCNK and CDK13-CCNK complexes, and P. Kovarik for STAT1 plasmids. This work was supported by NIH grant CA66996 (S. A. A.), NCI grants R01 CA170741 (D.J.T.) and F31 CA180419 (Z.C.P.), NIH T32 GM08759 (Z.C.P.), a Leukemia and Lymphoma Society Translational Research Program Grant (M.D.S.), the Blavatnik Biomedical Accelerator Programat Harvard (M.D.S.) and the Starr Cancer Consortium (M.D.S.).	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2010, PYMOL MOL GRAPH SYST; Bancerek J, 2013, IMMUNITY, V38, P250, DOI 10.1016/j.immuni.2012.10.017; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cee VJ, 2009, ANGEW CHEM INT EDIT, V48, P8952, DOI 10.1002/anie.200904778; Dawson MA, 2014, LEUKEMIA, V28, P311, DOI 10.1038/leu.2013.338; De Braekeleer E, 2012, LEUKEMIA RES, V36, P945, DOI 10.1016/j.leukres.2012.04.010; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Etchin J, 2013, LEUKEMIA, V27, P66, DOI 10.1038/leu.2012.219; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Flyer AN, 2010, NAT CHEM, V2, P886, DOI [10.1038/NCHEM.794, 10.1038/nchem.794]; Fragale A, 2013, J GENET SYNDR GENE T, V4, P205; Galbraith MD, 2013, CELL, V153, P1327, DOI 10.1016/j.cell.2013.04.048; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutterer C, 2015, ANTIMICROB AGENTS CH, V59, P2062, DOI 10.1128/AAC.04534-14; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Knuesel MT, 2009, MOL CELL BIOL, V29, P650, DOI 10.1128/MCB.00993-08; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee HM, 2008, J AM CHEM SOC, V130, P16864, DOI 10.1021/ja8071918; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Okerberg Eric, 2013, Curr Protoc Chem Biol, V5, P213, DOI 10.1002/9780470559277.ch130084; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Pierce AC, 2002, PROTEINS, V49, P567, DOI 10.1002/prot.10259; Prange KHM, 2014, EXP HEMATOL, V42, P637, DOI 10.1016/j.exphem.2014.04.012; Putz EM, 2013, CELL REP, V4, P437, DOI 10.1016/j.celrep.2013.07.012; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Schneider EV, 2011, J MOL BIOL, V412, P251, DOI 10.1016/j.jmb.2011.07.020; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zacharias N, 2002, TRENDS PHARMACOL SCI, V23, P281, DOI 10.1016/S0165-6147(02)02027-8; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	53	228	238	2	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					273	+		10.1038/nature14904	http://dx.doi.org/10.1038/nature14904			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26416749	Green Accepted, Green Submitted			2022-12-28	WOS:000362399000051
J	Wald, C				Wald, Chelsea			NEUROSCIENCE The aesthetic brain	NATURE			English	Editorial Material							FACES											Chatterjee A, 2009, NEUROPSYCHOLOGY, V23, P135, DOI 10.1037/a0014430; Jones B. C., 2015, LEADERSHIP Q; LANGLOIS JH, 1990, PSYCHOL SCI, V1, P115, DOI 10.1111/j.1467-9280.1990.tb00079.x; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Scott IM, 2014, P NATL ACAD SCI USA, V111, P14388, DOI 10.1073/pnas.1409643111	5	11	13	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					S2	S3		10.1038/526S2a	http://dx.doi.org/10.1038/526S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS9GV	26444372				2022-12-28	WOS:000362399000001
J	Krupic, J				Krupic, Julija			Brain crystals	SCIENCE			English	Editorial Material							ENTORHINAL CORTEX		UCL, Dept Cell & Dev Biol, London WC1E 6BT, England	University of London; University College London	Krupic, J (corresponding author), UCL, Dept Cell & Dev Biol, London WC1E 6BT, England.	j.krupic@ucl.ac.uk		Krupic, Julija/0000-0001-6299-1629				[Anonymous], THE ICICLE ATLAS; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Chen ASH, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.026307; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Krupic J, 2015, NATURE, V518, P232, DOI 10.1038/nature14153; Krupic J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0188; Krupic J, 2012, SCIENCE, V337, P853, DOI 10.1126/science.1222403; Moser EI, 2008, HIPPOCAMPUS, V18, P1142, DOI 10.1002/hipo.20483; Ray S, 2014, SCIENCE, V343, P891, DOI 10.1126/science.1243028; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466	11	1	1	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					47	48		10.1126/science.aad3002	http://dx.doi.org/10.1126/science.aad3002			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26430112				2022-12-28	WOS:000362098300038
J	James, B				James, Bethan			ASTROPHYSICS Primordial stars brought to light	NATURE			English	Editorial Material							POPULATION-III STARS; 1ST STARS; LY-ALPHA; GALAXIES; EMISSION		Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England	University of Cambridge	James, B (corresponding author), Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England.	bjames@ast.cam.ac.uk			Science and Technology Facilities Council [ST/K000985/1] Funding Source: researchfish; STFC [ST/K000985/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Bromm V, 2004, ANNU REV ASTRON ASTR, V42, P79, DOI 10.1146/annurev.astro.42.053102.134034; Gnedin NY, 2000, ASTROPHYS J, V535, P530, DOI 10.1086/308876; Hirano S, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/2/60; Matthee J., 2015, PREPRINT; Pallottini A, 2015, MON NOT R ASTRON SOC, V453, P2465, DOI 10.1093/mnras/stv1795; Schaerer D, 2003, ASTRON ASTROPHYS, V397, P527, DOI 10.1051/0004-6361:20021525; Schaerer D, 2002, ASTRON ASTROPHYS, V382, P28, DOI 10.1051/0004-6361:20011619; Sobral D, 2015, ASTROPHYS J, V808, DOI 10.1088/0004-637X/808/2/139; Stiavelli M, 2010, ASTROPHYS J LETT, V716, pL190, DOI 10.1088/2041-8205/716/2/L190; Tornatore L, 2007, MON NOT R ASTRON SOC, V382, P945, DOI 10.1111/j.1365-2966.2007.12215.x; Tumlinson J, 2001, ASTROPHYS J, V550, pL1, DOI 10.1086/319477	11	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					46	47		10.1038/526046a	http://dx.doi.org/10.1038/526046a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26432239				2022-12-28	WOS:000362095100028
J	Bhangu, A; Soreide, K; Di Saverio, S; Assarsson, JH; Drake, FT				Bhangu, Aneel; Soreide, Kjetil; Di Saverio, Salomone; Assarsson, Jeanette Hansson; Drake, Frederick Thurston			Acute appendicitis: modern understanding of pathogenesis, diagnosis, and management	LANCET			English	Article							UNCOMPLICATED ACUTE APPENDICITIS; PREDICTING ACUTE APPENDICITIS; RANDOMIZED CONTROLLED-TRIAL; POPULATION-BASED-COHORT; LAPAROSCOPIC APPENDECTOMY; ANTIBIOTIC-THERAPY; NEGATIVE APPENDECTOMY; CLAVULANIC-ACID; ABDOMINAL-PAIN; ALVARADO SCORE	Acute appendicitis is one of the most common abdominal emergencies worldwide. The cause remains poorly understood, with few advances in the past few decades. To obtain a confident preoperative diagnosis is still a challenge, since the possibility of appendicitis must be entertained in any patient presenting with an acute abdomen. Although biomarkers and imaging are valuable adjuncts to history and examination, their limitations mean that clinical assessment is still the mainstay of diagnosis. A clinical classification is used to stratify management based on simple (non-perforated) and complex (gangrenous or perforated) inflammation, although many patients remain with an equivocal diagnosis, which is one of the most challenging dilemmas. An observed divide in disease course suggests that some cases of simple appendicitis might be self-limiting or respond to antibiotics alone, whereas another type often seems to perforate before the patient reaches hospital. Although the mortality rate is low, postoperative complications are common in complex disease. We discuss existing knowledge in pathogenesis, modern diagnosis, and evolving strategies in management that are leading to stratified care for patients.	[Bhangu, Aneel] Queen Elizabeth Hosp, Acad Dept Surg, Birmingham B15 2TH, W Midlands, England; [Bhangu, Aneel] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Soreide, Kjetil] Stavanger Univ Hosp, Dept Gastrointestinal Surg, N-4068 Stavanger, Norway; [Soreide, Kjetil] Univ Bergen, Dept Clin Med, Bergen, Norway; [Di Saverio, Salomone] CA Pizzardi Maggiore Hosp, Emergency & Gen Surg Dept, Bologna, Italy; [Assarsson, Jeanette Hansson] Kalmar Cty Hosp, Dept Surg, Kalmar, Sweden; [Drake, Frederick Thurston] Univ Washington, Dept Surg, Seattle, WA 98195 USA	University of Birmingham; University of Birmingham; Stavanger University Hospital; University of Bergen; AUSL di Bologna; University of Washington; University of Washington Seattle	Soreide, K (corresponding author), Stavanger Univ Hosp, Dept Gastrointestinal Surg, POB 8100, N-4068 Stavanger, Norway.	ksoreide@mac.com	Søreide, Kjetil/A-9797-2010; Drake, Frederick/AAI-9164-2020; Di Saverio, Salomone/G-1437-2012	Søreide, Kjetil/0000-0001-7594-4354; Drake, Frederick/0000-0002-3191-0950; Di Saverio, Salomone/0000-0001-5685-5022	National Institute for Health Research [CL-2014-09-002] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Adisa AO, 2012, JSLS-J SOC LAPAROEND, V16, P576, DOI 10.4293/108680812X13462882737131; Ali N, 2012, Niger J Med, V21, P223; Andersen BR, 2005, COCHRANE DB SYST REV, V3; Anderson JE, 2012, WORLD J SURG, V36, P2787, DOI 10.1007/s00268-012-1749-z; Andersson M, 2014, WORLD J SURG, V38, P2777, DOI 10.1007/s00268-014-2708-7; Andersson RE, 2014, BRIT J SURG, V101, P1135, DOI 10.1002/bjs.9552; Andersson RE, 2007, ANN SURG, V246, P741, DOI 10.1097/SLA.0b013e31811f3f9f; Andersson RE, 2007, WORLD J SURG, V31, P86, DOI 10.1007/s00268-006-0056-y; Andersson RE, 2013, WORLD J SURG, V37, P974, DOI 10.1007/s00268-012-1856-x; Azodi OS, 2009, BRIT J SURG, V96, P1336, DOI 10.1002/bjs.6736; Bhangu A, 2013, BRIT J SURG, V100, P1240, DOI 10.1002/bjs.9201; Bhangu A, 2014, ANN SURG, V259, P315, DOI [10.1097/SLA.0000000000000492, 10.1097/SLA.0b013e31828a0d22]; Bingener J, 2014, BRIT J SURG, V101, pE80, DOI 10.1002/bjs.9352; Bliss LA, 2014, SURG ENDOSC, V146, P1057; Carr N J, 2000, Ann Diagn Pathol, V4, P46, DOI 10.1016/S1092-9134(00)90011-X; Carter JT, 2014, J AM COLL SURGEONS, V218, P950, DOI 10.1016/j.jamcollsurg.2013.12.052; Charfi S, 2014, INT J COLORECTAL DIS, V29, P1009, DOI 10.1007/s00384-014-1934-7; Chen JM, 2015, MINIM INVASIV THER, V24, P195, DOI 10.3109/13645706.2014.995675; Cheong LHA, 2014, J PEDIATR SURG, V49, P1714, DOI 10.1016/j.jpedsurg.2014.09.004; Ciarrocchi A, 2014, J MINIM ACCESS SURG, V10, P4, DOI 10.4103/0972-9941.124451; Clanton J, 2013, WORLD J GASTRO SURG, V5, P233, DOI 10.4240/wjgs.v5.i8.233; Cuschieri J, 2008, ANN SURG, V248, P557, DOI 10.1097/SLA.0b013e318187aeca; Daskalakis K, 2014, SCAND J SURG, V103, P14, DOI 10.1177/1457496913497433; Decadt B, 1999, BRIT J SURG, V86, P1383, DOI 10.1046/j.1365-2168.1999.01239.x; Di Saverio S, 2014, J TRAUMA ACUTE CARE, V77, P338, DOI 10.1097/TA.0000000000000288; Di Saverio S, 2014, ANN SURG, V260, P109, DOI 10.1097/SLA.0000000000000560; Di Saverio S, 2014, J AM COLL SURGEONS, V218, pE51, DOI 10.1016/j.jamcollsurg.2013.12.003; Drake FT, 2014, JAMA SURG, V149, P837, DOI 10.1001/jamasurg.2014.77; Dzabic M, 2008, INFLAMM BOWEL DIS, V14, P236, DOI 10.1002/ibd.20299; Ergul E, 2007, SCAND J SURG, V96, P290, DOI 10.1177/145749690709600405; ERIKSSON S, 1995, BRIT J SURG, V82, P166, DOI 10.1002/bjs.1800820207; Faiz O, 2008, ANN SURG, V248, P800, DOI 10.1097/SLA.0b013e31818b770c; Frisch M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b716; Guller U, 2011, BRIT J SURG, V98, P589, DOI 10.1002/bjs.7395; Guinane CM, 2013, MBIO, V4, DOI 10.1128/mBio.00366-12; Hansson J, 2009, BRIT J SURG, V96, P473, DOI 10.1002/bjs.6482; Hansson J, 2014, J GASTROINTEST SURG, V18, P961, DOI 10.1007/s11605-013-2413-0; Hansson J, 2012, WORLD J SURG, V36, P2028, DOI [10.1007/s00268-012-1641-x, 10.1007/s00268-012-1647-4]; Kaplan GG, 2007, GUT, V56, P1387, DOI 10.1136/gut.2007.121467; Kim K, 2012, NEW ENGL J MED, V366, P1596, DOI 10.1056/NEJMoa1110734; Kollar D, 2015, WORLD J SURG, V39, P104, DOI 10.1007/s00268-014-2794-6; Kong VY, 2013, SAMJ S AFR MED J, V103, P742, DOI [10.7196/SAMJ.7109, 10.7196/samj.7109]; Lamps LW, 2010, INFECT DIS CLIN N AM, V24, P995, DOI 10.1016/j.idc.2010.07.012; Lee JH, 2010, J EPIDEMIOL, V20, P97, DOI 10.2188/jea.JE20090011; Lee SL, 2011, ARCH SURG-CHICAGO, V146, P156, DOI 10.1001/archsurg.2010.328; Leeuwenburgh MMN, 2014, BRIT J SURG, V101, pE147, DOI 10.1002/bjs.9350; Leeuwenburgh MMN, 2014, ACAD EMERG MED, V21, P488, DOI 10.1111/acem.12374; Lefrancois M, 2015, ANN SURG, V261, P1167, DOI 10.1097/SLA.0000000000000795; Leppaniemi A, 2014, BRIT J SURG, V101, pE134, DOI 10.1002/bjs.9325; Livingston EH, 2007, ANN SURG, V245, P886, DOI 10.1097/01.sla.0000256391.05233.aa; Maggio Adam Q, 2008, Int J Surg, V6, P400, DOI 10.1016/j.ijsu.2008.06.004; Morino M, 2006, ANN SURG, V244, P881, DOI 10.1097/01.sla.0000246886.80424.ad; Ohene-Yeboah M, 2009, West Afr J Med, V28, P122; Ohene-Yeboah Michael, 2006, West Afr J Med, V25, P138; Ohle R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-139; Riber C, 1999, SCAND J GASTROENTERO, V34, P46; Ruber M, 2010, SURGERY, V147, P366, DOI 10.1016/j.surg.2009.09.039; Salminen P, 2015, JAMA-J AM MED ASSOC, V313, P2340, DOI 10.1001/jama.2015.6154; Sauerland S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001546.pub3; Sesia SB, 2013, EUR J PEDIATR SURG, V23, P238, DOI 10.1055/s-0032-1333119; Shindoh J, 2010, J GASTROINTEST SURG, V14, P309, DOI 10.1007/s11605-009-1094-1; Stewart B, 2014, BRIT J SURG, V101, pE9, DOI 10.1002/bjs.9329; Styrud J, 2006, WORLD J SURG, V30, P1033, DOI 10.1007/s00268-005-0304-6; Svensson JF, 2015, ANN SURG, V261, P67, DOI 10.1097/SLA.0000000000000835; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; Terasawa T, 2004, ANN INTERN MED, V141, P537, DOI 10.7326/0003-4819-141-7-200410050-00011; Turhan AN, 2009, ULUS TRAVMA ACIL CER, V15, P459; van Rossem CC, 2014, BRIT J SURG, V101, P715, DOI 10.1002/bjs.9481; Varadhan KK, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2156; Vons C, 2011, LANCET, V377, P1573, DOI 10.1016/S0140-6736(11)60410-8; Wei PL, 2012, J SURG RES, V178, P670, DOI 10.1016/j.jss.2012.06.034; Wilasrusmee C, 2012, BRIT J SURG, V99, P1470, DOI 10.1002/bjs.8889; Yu CW, 2013, BRIT J SURG, V100, P322, DOI 10.1002/bjs.9008; Yu TC, 2014, EUR J PEDIATR SURG, V24, P341, DOI 10.1055/s-0033-1349055; Zingone F, 2015, ANN SURG, V261, P332, DOI 10.1097/SLA.0000000000000780	75	452	493	4	83	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 26	2015	386	10000					1278	1287		10.1016/S0140-6736(15)00275-5	http://dx.doi.org/10.1016/S0140-6736(15)00275-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9TQ	26460662				2022-12-28	WOS:000361700100037
J	Rakoczy, EP; Lai, CM; Magno, AL; Wikstrom, ME; French, MA; Pierce, CM; Schwartz, SD; Blumenkranz, MS; Chalberg, TW; Degli-Esposti, MA; Constable, IJ				Rakoczy, Elizabeth P.; Lai, Chooi-May; Magno, Aaron L.; Wikstrom, Matthew E.; French, Martyn A.; Pierce, Cora M.; Schwartz, Steven D.; Blumenkranz, Mark S.; Chalberg, Thomas W.; Degli-Esposti, Mariapia A.; Constable, Ian J.			Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial	LANCET			English	Article							ENDOTHELIAL GROWTH-FACTOR; CHOROIDAL NEOVASCULARIZATION; GEOGRAPHIC ATROPHY; OCULAR NEOVASCULARIZATION; INTRAVITREAL RANIBIZUMAB; INTRAOCULAR-PRESSURE; DOSING REGIMEN; INHIBITION; INJECTION; VEGF	Background Neovascular, or wet, age-related macular degeneration causes central vision loss and represents a major health problem in elderly people, and is currently treated with frequent intraocular injections of anti-VEGF protein. Gene therapy might enable long-term anti-VEGF therapy from a single treatment. We tested the safety of rAAV. sFLT-1 in treatment of wet age-related macular degeneration with a single subretinal injection. Methods In this single-centre, phase 1, randomised controlled trial, we enrolled patients with wet age-related macular degeneration at the Lions Eye Institute and the Sir Charles Gairdner Hospital (Nedlands, WA, Australia). Eligible patients had to be aged 65 years or older, have age-related macular degeneration secondary to active subfoveal choroidal neovascularisation, with best corrected visual acuity (BCVA) of 3/60-6/24 and 6/60 or better in the other eye. Patients were randomly assigned (3: 1) to receive either 1 x 10(10) vector genomes (vg; low-dose rAAV. sFLT-1 group) or 1 x 10(11) vg (high-dose rAAV. sFLT-1 group), or no gene-therapy treatment (control group). Randomisation was done by sequential group assignment. All patients and investigators were unmasked. Staff doing the assessments were masked to the study group at study visits. All patients received ranibizumab at baseline and week 4, and rescue treatment during follow-up based on prespecified criteria including BCVA measured on the Early Treatment Diabetic Retinopathy Study (EDTRS) scale, optical coherence tomography, and fluorescein angiography. The primary endpoint was ocular and systemic safety. This trial is registered with ClinicalTrials.gov, number NCT01494805. Findings From Dec 16, 2011, to April 5, 2012, we enrolled nine patients of whom eight were randomly assigned to receive either intervention (three patients in the low-dose rAAV. sFLT-1 group and three patients in the high-dose rAAV. sFLT-1 group) or no treatment (two patients in the control group). Subretinal injection of rAAV. sFLT-1 was highly reproducible. No drug-related adverse events were noted; procedure-related adverse events (subconjunctival or subretinal haemorrhage and mild cell debris in the anterior vitreous) were generally mild and self-resolving. There was no evidence of chorioretinal atrophy. Clinical laboratory assessments generally remained unchanged from baseline. Four (67%) of six patients in the treatment group required zero rescue injections, and the other two (33%) required only one rescue injection each. Interpretation rAAV. sFLT-1 was safe and well tolerated. These results support ocular gene therapy as a potential long-term treatment option for wet age-related macular degeneration.	[Rakoczy, Elizabeth P.; Lai, Chooi-May; Wikstrom, Matthew E.; Degli-Esposti, Mariapia A.; Constable, Ian J.] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Crawley, WA, Australia; [French, Martyn A.] Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA, Australia; [Rakoczy, Elizabeth P.; Lai, Chooi-May; Magno, Aaron L.; Wikstrom, Matthew E.; Pierce, Cora M.; Degli-Esposti, Mariapia A.; Constable, Ian J.] Lions Eye Inst, Nedlands, WA 6009, Australia; [Schwartz, Steven D.] Univ Calif Los Angeles, Los Angeles, CA USA; [Blumenkranz, Mark S.] Stanford Univ, Palo Alto, CA 94304 USA; [Chalberg, Thomas W.] Avalanche Biotechnol Inc, Menlo Pk, CA USA; [Constable, Ian J.] Sir Charles Gairdner Hosp, Nedlands, WA 6009, Australia	University of Western Australia; University of Western Australia; Lions Eye Institute; University of Western Australia; University of California System; University of California Los Angeles; Stanford University; University of Western Australia	Rakoczy, EP (corresponding author), Lions Eye Inst, 2 Verdun St, Nedlands, WA 6009, Australia.	elizabeth.rakoczy@uwa.edu.au	Lai, Chooi-May/H-5224-2014	constable, ian/0000-0002-2140-6478; French, Martyn/0000-0002-4644-1982; Magno, Aaron/0000-0001-6099-819X; Degli-Esposti, Mariapia/0000-0002-7808-5935	National Health and Medical Research Council of Australia; Richard Pearce Bequest; Lions Save Sight Foundation; Brian King Fellowship; Avalanche Biotechnologies, Inc.	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Richard Pearce Bequest; Lions Save Sight Foundation; Brian King Fellowship; Avalanche Biotechnologies, Inc.	National Health and Medical Research Council of Australia, Richard Pearce Bequest, Lions Save Sight Foundation, Brian King Fellowship, and Avalanche Biotechnologies, Inc.	Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bakri SJ, 2014, OPHTHALMOLOGY, V121, P1102, DOI 10.1016/j.ophtha.2013.11.029; Bennett J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002865; Bouck N, 2002, TRENDS MOL MED, V8, P330, DOI 10.1016/S1471-4914(02)02362-6; Bressler NM, 2012, RETINA-J RET VIT DIS, V32, P1821, DOI 10.1097/IAE.0b013e31825db6ba; Campochiaro PA, 2006, HUM GENE THER, V17, P167, DOI 10.1089/hum.2006.17.167; Chakravarthy U, 2013, LANCET, V382, P1258, DOI 10.1016/S0140-6736(13)61501-9; Channa R, 2015, AM J OPHTHALMOL, V159, P9, DOI 10.1016/j.ajo.2014.09.012; Cohen SY, 2013, RETINA-J RET VIT DIS, V33, P474, DOI 10.1097/IAE.0b013e31827b6324; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; CZERKINSKY CC, 1983, J IMMUNOL METHODS, V65, P109, DOI 10.1016/0022-1759(83)90308-3; Day S, 2011, AM J OPHTHALMOL, V152, P266, DOI 10.1016/j.ajo.2011.01.053; Fung AE, 2007, AM J OPHTHALMOL, V143, P566, DOI 10.1016/j.ajo.2007.01.028; Grunwald JE, 2015, OPHTHALMOLOGY, V122, P809, DOI 10.1016/j.ophtha.2014.11.007; Grunwald JE, 2014, OPHTHALMOLOGY, V121, P150, DOI 10.1016/j.ophtha.2013.08.015; Holekamp NM, 2014, AM J OPHTHALMOL, V157, P825, DOI 10.1016/j.ajo.2013.12.018; Holz FG, 2011, OPHTHALMOLOGY, V118, P663, DOI 10.1016/j.ophtha.2010.12.019; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jager RD, 2004, RETINA-J RET VIT DIS, V24, P676, DOI 10.1097/00006982-200410000-00002; Kaiser PK, 2007, AM J OPHTHALMOL, V144, P850; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kliffen M, 1997, BRIT J OPHTHALMOL, V81, P154, DOI 10.1136/bjo.81.2.154; Lai CM, 2012, GENE THER, V19, P999, DOI 10.1038/gt.2011.169; Lai CM, 2009, INVEST OPHTH VIS SCI, V50, P4279, DOI 10.1167/iovs.08-3253; Lai CM, 2005, MOL THER, V12, P659, DOI 10.1016/j.ymthe.2005.04.022; Lai YKY, 2002, GENE THER, V9, P804, DOI 10.1038/sj.gt.3301695; Lebherz C, 2005, DIABETES, V54, P1141, DOI 10.2337/diabetes.54.4.1141; Lebherz C, 2008, J GENE MED, V10, P375, DOI 10.1002/jgm.1126; Levison D., 2012, OEI031000360 US DEP; Lopez PF, 1996, INVEST OPHTH VIS SCI, V37, P855; Lukason M, 2011, MOL THER, V19, P260, DOI 10.1038/mt.2010.230; Luo L, 2013, ELIFE, V2, DOI 10.7554/eLife.00324; MacLachlan TK, 2011, MOL THER, V19, P326, DOI 10.1038/mt.2010.258; MacLaren RE, 2014, LANCET, V383, P1129, DOI 10.1016/S0140-6736(13)62117-0; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Nuzzi R, 2015, SEMIN OPHTHALMOL, V30, P129, DOI 10.3109/08820538.2013.835833; Ohno-Matsui K, 2001, J CELL PHYSIOL, V189, P323, DOI 10.1002/jcp.10026; Pershing S, 2013, OPHTHAL SURG LAS IM, V44, P460, DOI 10.3928/23258160-20130909-07; Provost N, 2005, MOL THER, V11, P275, DOI 10.1016/j.ymthe.2004.09.022; Regillo CD, 2008, AM J OPHTHALMOL, V145, P239, DOI 10.1016/j.ajo.2007.10.004; Ritter M, 2011, BRIT J OPHTHALMOL, V95, P381, DOI 10.1136/bjo.2009.175976; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Sadda S, 2014, AM AC OPHTH ANN M; Sahel JA, 2013, ANNU REV NEUROSCI, V36, P467, DOI 10.1146/annurev-neuro-062012-170304; Schmidt-Erfurth U, 2014, OPHTHALMOLOGY, V121, P193, DOI 10.1016/j.ophtha.2013.08.011; Schmidt-Erfurth U, 2010, EXPERT OPIN DRUG SAF, V9, P149, DOI 10.1517/14740330903418422; Silva R, 2013, OPHTHALMOLOGY, V120, P130, DOI 10.1016/j.ophtha.2012.07.026; Singer MA, 2012, OPHTHALMOLOGY, V119, P1175, DOI 10.1016/j.ophtha.2011.12.016; Sophie R, 2014, OPHTHALMOLOGY, V121, P150; Sophie R, 2014, OPHTHALMOLOGY, V121, pE34, DOI 10.1016/j.ophtha.2013.12.043; VEGF Inhibition Study (V.I.S.I.O.N.) Clinical Trial Group, 2005, OPHTHALMOLOGY, V113; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5	54	119	131	2	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2015	386	10011					2395	2403		10.1016/S0140-6736(15)00345-1	http://dx.doi.org/10.1016/S0140-6736(15)00345-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY3EE	26431823	Green Submitted			2022-12-28	WOS:000366290400033
J	Giroir, BP; Wilensky, GR				Giroir, Brett P.; Wilensky, Gail R.			Reforming the Veterans Health Administration - Beyond Palliation of Symptoms	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Giroir, Brett P.] Texas Med Ctr, Hlth Policy Inst, Houston, TX 77030 USA; [Wilensky, Gail R.] Project HOPE, Bethesda, MD USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Giroir, BP (corresponding author), Texas Med Ctr, Hlth Policy Inst, Houston, TX 77030 USA.							CMS Alliance to Modernize Healthcare, 2015, IND ASS HLTH CAR DEL, V1	1	12	12	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2015	373	18					1693	1695		10.1056/NEJMp1511438	http://dx.doi.org/10.1056/NEJMp1511438			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CU4QH	26422644	Green Published			2022-12-28	WOS:000363514100005
J	Peifer, M; Hertwig, F; Roels, F; Dreidax, D; Gartlgruber, M; Menon, R; Kramer, A; Roncaioli, JL; Sand, F; Heuckmann, JM; Ikram, F; Schmidt, R; Ackermann, S; Engesser, A; Kahlert, Y; Vogel, W; Altmuller, J; Nurnberg, P; Thierry-Mieg, J; Thierry-Mieg, D; Mariappan, A; Heynck, S; Mariotti, E; Henrich, KO; Gloeckner, C; Bosco, G; Leuschner, I; Schweiger, MR; Savelyeva, L; Watkins, SC; Shao, CX; Bell, E; Hofer, T; Achter, V; Lang, U; Theissen, J; Volland, R; Saadati, M; Eggert, A; de Wilde, B; Berthold, F; Peng, ZY; Zhao, C; Shi, LM; Ortmann, M; Buttner, R; Perner, S; Hero, B; Schramm, A; Schulte, JH; Herrmann, C; O'Sullivan, RJ; Westermann, F; Thomas, RK; Fischer, M				Peifer, Martin; Hertwig, Falk; Roels, Frederik; Dreidax, Daniel; Gartlgruber, Moritz; Menon, Roopika; Kraemer, Andrea; Roncaioli, Justin L.; Sand, Frederik; Heuckmann, Johannes M.; Ikram, Fakhera; Schmidt, Rene; Ackermann, Sandra; Engesser, Anne; Kahlert, Yvonne; Vogel, Wenzel; Altmueller, Janine; Nuernberg, Peter; Thierry-Mieg, Jean; Thierry-Mieg, Danielle; Mariappan, Aruljothi; Heynck, Stefanie; Mariotti, Erika; Henrich, Kai-Oliver; Gloeckner, Christian; Bosco, Graziella; Leuschner, Ivo; Schweiger, Michal R.; Savelyeva, Larissa; Watkins, Simon C.; Shao, Chunxuan; Bell, Emma; Hoefer, Thomas; Achter, Viktor; Lang, Ulrich; Theissen, Jessica; Volland, Ruth; Saadati, Maral; Eggert, Angelika; de Wilde, Bram; Berthold, Frank; Peng, Zhiyu; Zhao, Chen; Shi, Leming; Ortmann, Monika; Buettner, Reinhard; Perner, Sven; Hero, Barbara; Schramm, Alexander; Schulte, Johannes H.; Herrmann, Carl; O'Sullivan, Roderick J.; Westermann, Frank; Thomas, Roman K.; Fischer, Matthias			Telomerase activation by genomic rearrangements in high-risk neuroblastoma	NATURE			English	Article							TERT PROMOTER MUTATIONS; GENE; LANDSCAPE; ENHANCERS; MELANOMA	Neuroblastoma is a malignant paediatric tumour of the sympathetic nervous system(1). Roughly half of these tumours regress spontaneously or are cured by limited therapy. By contrast, high-risk neuroblastomas have an unfavourable clinical course despite intensive multimodal treatment, and their molecular basis has remained largely elusive(2-4). Here we have performed whole-genome sequencing of 56 neuroblastomas (high-risk, n = 39; low-risk, n = 17) and discovered recurrent genomic rearrangements affecting a chromosomal region at 5p15.33 proximal of the telomerase reverse transcriptase gene (TERT). These rearrangements occurred only in high-risk neuroblastomas (12/39, 31%) in a mutually exclusive fashion with MYCN amplifications and ATRX mutations, which are known genetic events in this tumour type(1,2,5). In an extended case series (n = 217), TERT rearrangements defined a subgroup of high-risk tumours with particularly poor outcome. Despite a large structural diversity of these rearrangements, they all induced massive transcriptional upregulation of TERT. In the remaining high-risk tumours, TERT expression was also elevated in MYCN-amplified tumours, whereas alternative lengthening of telomeres was present in neuroblastomas without TERT or MYCN alterations, suggesting that telomere lengthening represents a central mechanism defining this subtype. The 5p15.33 rearrangements juxtapose the TERT coding sequence to strong enhancer elements, resulting in massive chromatin remodelling and DNA methylation of the affected region. Supporting a functional role of TERT, neuroblastoma cell lines bearing rearrangements or amplified MYCN exhibited both upregulated TERT expression and enzymatic telomerase activity. In summary, our findings show that remodelling of the genomic context abrogates transcriptional silencing of TERT in high-risk neuroblastoma and places telomerase activation in the centre of transformation in a large fraction of these tumours.	[Peifer, Martin; Bosco, Graziella; Thomas, Roman K.] Univ Cologne, Ctr Integrated Oncol Cologne Bonn, Fac Med, Dept Translat Genom, D-50931 Cologne, Germany; [Peifer, Martin; Hertwig, Falk; Roels, Frederik; Kraemer, Andrea; Sand, Frederik; Ikram, Fakhera; Ackermann, Sandra; Nuernberg, Peter; Mariappan, Aruljothi; Fischer, Matthias] Univ Cologne, Ctr Mol Med Cologne CMMC, D-50931 Cologne, Germany; [Hertwig, Falk; Roels, Frederik; Kraemer, Andrea; Ikram, Fakhera; Ackermann, Sandra; Engesser, Anne; Kahlert, Yvonne; Theissen, Jessica; Volland, Ruth; Berthold, Frank; Hero, Barbara; Fischer, Matthias] Univ Cologne, Univ Childrens Hosp Cologne, Fac Med, Dept Pediat Oncol & Hematol, D-50937 Cologne, Germany; [Dreidax, Daniel; Gartlgruber, Moritz; Henrich, Kai-Oliver; Savelyeva, Larissa; Bell, Emma; Westermann, Frank] German Canc Res Ctr, Div Neuroblastoma Genom B087, D-69120 Heidelberg, Germany; [Menon, Roopika; Vogel, Wenzel; Perner, Sven] Univ Hosp Bonn, Ctr Integrated Oncol Cologne Bonn, Inst Pathol, Dept Prostate Canc Res, D-53127 Bonn, Germany; [Menon, Roopika; Heuckmann, Johannes M.; Heynck, Stefanie; Mariotti, Erika; Gloeckner, Christian] NEO New Oncol AG, D-51105 Cologne, Germany; [Roncaioli, Justin L.; O'Sullivan, Roderick J.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Ikram, Fakhera; Altmueller, Janine; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Schmidt, Rene] Univ Munster, Inst Biostat & Clin Res, D-48149 Munster, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Thierry-Mieg, Jean; Thierry-Mieg, Danielle] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; [Leuschner, Ivo] Univ Kiel, Dept Pathol, D-24118 Kiel, Germany; [Schweiger, Michal R.] Univ Cologne, Funct Epigen, D-50931 Cologne, Germany; [Watkins, Simon C.] Univ Pittsburgh, Ctr Biol Imaging, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Shao, Chunxuan; Hoefer, Thomas] German Canc Res Ctr, Div Theoret Syst Biol, D-69120 Heidelberg, Germany; [Achter, Viktor; Lang, Ulrich] Univ Cologne, Comp Ctr, D-50931 Cologne, Germany; [Lang, Ulrich] Univ Cologne, Dept Informat, D-50931 Cologne, Germany; [Saadati, Maral] German Canc Res Ctr, Div Biostat, D-69120 Heidelberg, Germany; [Eggert, Angelika; Schulte, Johannes H.] Charite Univ Med Ctr Berlin, Dept Pediat Oncol & Hematol, D-10117 Berlin, Germany; [de Wilde, Bram] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Peng, Zhiyu] BGI Shenzhen, Shenzhen 518083, Guangdong, Peoples R China; [Zhao, Chen; Shi, Leming] Fudan Univ, Ctr Pharmacogen, State Key Lab Genet Engn, Shanghai 201203, Peoples R China; [Zhao, Chen; Shi, Leming] Fudan Univ, Fudan Zhangjiang Ctr Clin Genom, State Key Lab Genet Engn, Shanghai 201203, Peoples R China; [Zhao, Chen; Shi, Leming] Fudan Univ, Sch Pharm, MOE Key Lab Contemporary Anthropol, Shanghai 201203, Peoples R China; [Zhao, Chen; Shi, Leming] Fudan Univ, Sch Life Sci, Shanghai 201203, Peoples R China; [Ortmann, Monika; Buettner, Reinhard; Thomas, Roman K.] Univ Cologne, Dept Pathol, D-50937 Cologne, Germany; [Schramm, Alexander] Univ Childrens Hosp, Dept Pediat Oncol & Hematol, D-45147 Essen, Germany; [Schulte, Johannes H.] German Canc Consortium DKTK, D-10117 Berlin, Germany; [Schulte, Johannes H.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Herrmann, Carl] Heidelberg Univ, Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany; [Herrmann, Carl] Heidelberg Univ, Bioquant Ctr, D-69120 Heidelberg, Germany; [Herrmann, Carl] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Fischer, Matthias] Max Planck Inst Metab Res, D-50931 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; Helmholtz Association; German Cancer Research Center (DKFZ); University of Bonn; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Cologne; University of Munster; University of Cologne; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of Kiel; University of Cologne; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Helmholtz Association; German Cancer Research Center (DKFZ); University of Cologne; University of Cologne; Helmholtz Association; German Cancer Research Center (DKFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ghent University; Beijing Genomics Institute (BGI); Fudan University; Fudan University; Fudan University; Fudan University; University of Cologne; University of Duisburg Essen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Fischer, M (corresponding author), Univ Cologne, Ctr Mol Med Cologne CMMC, D-50931 Cologne, Germany.	mpeifer@uni-koeln.de; frank.westermann@dkfz-heidelberg.de; roman.thomas@uni-koeln.de; matthias.fischer@uk-koeln.de	Peng, Zhiyu/GXV-5301-2022; Watkins, Simon/ABG-2590-2021; Lang, Ulrich/O-1487-2013; Herrmann, Carl/AAR-3167-2020; THIERRY-MIEG, Jean/F-1975-2017; Eggert, Angelika/AAE-6907-2022; Westermann, Frank/F-7509-2013; Ikram, Fakhera/E-3162-2017; Schramm, Alexander/G-5688-2010; Hofer, Thomas/G-5665-2013	Watkins, Simon/0000-0003-4092-1552; Lang, Ulrich/0000-0001-7166-0805; Herrmann, Carl/0000-0003-4989-4722; THIERRY-MIEG, Jean/0000-0002-0396-6789; Eggert, Angelika/0000-0003-3476-8184; Schramm, Alexander/0000-0001-7670-7529; Hertwig, Falk/0000-0003-4784-6516; Hofer, Thomas/0000-0003-3560-8780; Thierry-Mieg, Danielle/0000-0001-9568-4211; Schulte, Johannes Hubertus/0000-0003-0671-1201; Ikram, Fakhera/0000-0001-7796-4746; Altmuller, Janine/0000-0003-4372-1521; Bosco, Graziella/0000-0001-6601-4518; De Wilde, Bram/0000-0003-0213-1322; Peifer, Martin/0000-0002-5243-5503	German Cancer Aid [110122]; German Ministry of Science and Education (BMBF) as part of the e:Med initiative [01ZX1303A, 01ZX1406, 01ZX1307D]; BMBF [0316076A]; European Union [259348]; Fordergesellschaft Kinderkrebs-Neuroblastom-Forschung e.V.; German-Israeli Helmholtz Research School in Cancer Biology; Volkswagenstiftung (Lichtenberg Program); Center for Molecular Medicine Cologne; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER	German Cancer Aid(Deutsche Krebshilfe); German Ministry of Science and Education (BMBF) as part of the e:Med initiative(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Fordergesellschaft Kinderkrebs-Neuroblastom-Forschung e.V.; German-Israeli Helmholtz Research School in Cancer Biology; Volkswagenstiftung (Lichtenberg Program); Center for Molecular Medicine Cologne; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are indebted to the patients and their parents for making available the tumour specimens analysed in this study. We thank the German Neuroblastoma Biobank for providing samples from patients. The Institutional Review Board approved collection and use of all specimens in this study. We also thank our colleagues N. Hemstedt, H. Duren, E. Hess, J. Kreth, and J. Gopalakrishnan; and our collaboration partners I. Amit and F. Paul at the Weizmann Institute of Science for technical assistance. We further acknowledge the Center for Molecular Medicine Cologne light microscope facility for helping us to obtain high-quality data of FISH analyses, and S. Wolf and the Next Generation Sequencing Unit at the German Cancer Research Center (DKFZ) for sequencing. This work was supported by the German Cancer Aid (grant 110122) to M.F., F.W., J.H.S., A.S., and S.A.; the German Ministry of Science and Education (BMBF) as part of the e:Med initiative (grant 01ZX1303A to M.P., M.F.,J.H.S., R.B., U.L., and R.K.T., grant 01ZX1406 to M.P., and grant01ZX1307D to M.F. and F.W.); the BMBF (grant 0316076A to F.W.); the European Union (grant 259348 to F.W); the Fordergesellschaft Kinderkrebs-Neuroblastom-Forschung e.V. (to M.F); the German-Israeli Helmholtz Research School in Cancer Biology (to M.G. and F.W.); the Volkswagenstiftung (Lichtenberg Program) (to M.R.S.); and the Center for Molecular Medicine Cologne.	Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Castelo-Branco P, 2013, LANCET ONCOL, V14, P534, DOI 10.1016/S1470-2045(13)70110-4; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Cheung NKV, 2012, JAMA-J AM MED ASSOC, V307, P1062, DOI 10.1001/jama.2012.228; COBRINIK D, 2013, CANCER, V52, P1150, DOI DOI 10.1002/GCC.22110; Davis CF, 2014, CANCER CELL, V26, P319, DOI 10.1016/j.ccr.2014.07.014; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farooqi AS, 2014, J NEURO-ONCOL, V119, P17, DOI 10.1007/s11060-014-1456-8; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Kumps C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052321; Mac SM, 2000, MOL CARCINOGEN, V29, P76, DOI 10.1002/1098-2744(200010)29:2<76::AID-MC4>3.0.CO;2-Y; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Nagel I, 2010, BLOOD, V116, P1317, DOI 10.1182/blood-2009-09-240440; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; O'Sullivan RJ, 2014, NAT STRUCT MOL BIOL, V21, P167, DOI 10.1038/nsmb.2754; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zhao YJ, 2009, GENE CHROMOSOME CANC, V48, P963, DOI 10.1002/gcc.20698	24	339	344	5	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					700	704		10.1038/nature14980	http://dx.doi.org/10.1038/nature14980			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26466568	Green Accepted			2022-12-28	WOS:000363832100048
J	Frederick, KK; Michaelis, VK; Corzilius, B; Ong, TC; Jacavone, AC; Griffin, RG; Lindquist, S				Frederick, Kendra K.; Michaelis, Vladimir K.; Corzilius, Bjoern; Ong, Ta-Chung; Jacavone, Angela C.; Griffin, Robert G.; Lindquist, Susan			Sensitivity-Enhanced NMR Reveals Alterations in Protein Structure by Cellular Milieus	CELL			English	Article							DYNAMIC NUCLEAR-POLARIZATION; SOLID-STATE NMR; YEAST PRION; MEMBRANE-PROTEINS; HUMAN-CELLS; SPECTROSCOPY; SYSTEM; PSI+; DNP; CONFORMATION	Biological processes occur in complex environments containing a myriad of potential interactors. Unfortunately, limitations on the sensitivity of biophysical techniques normally restrict structural investigations to purified systems, at concentrations that are orders of magnitude above endogenous levels. Dynamic nuclear polarization (DNP) can dramatically enhance the sensitivity of nuclear magnetic resonance (NMR) spectroscopy and enable structural studies in biologically complex environments. Here, we applied DNP NMR to investigate the structure of a protein containing both an environmentally sensitive folding pathway and an intrinsically disordered region, the yeast prion protein Sup35. We added an exogenously prepared isotopically labeled protein to deuterated lysates, rendering the biological environment "invisible'' and enabling highly efficient polarization transfer for DNP. In this environment, structural changes occurred in a region known to influence biological activity but intrinsically disordered in purified samples. Thus, DNP makes structural studies of proteins at endogenous levels in biological contexts possible, and such contexts can influence protein structure.	[Frederick, Kendra K.; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Michaelis, Vladimir K.; Corzilius, Bjoern; Ong, Ta-Chung; Jacavone, Angela C.; Griffin, Robert G.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Michaelis, Vladimir K.; Corzilius, Bjoern; Ong, Ta-Chung; Jacavone, Angela C.; Griffin, Robert G.] MIT, Francis Bitter Magnet Lab, Cambridge, MA 02139 USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Frederick, KK (corresponding author), UT Southwestern, Dept Biophys, Dallas, TX 75390 USA.	kendra.frederick@utsouthwestern.edu; lindquist_admin@wi.mit.edu	Corzilius, Björn/C-9111-2009; Corzilius, Björn/AAI-6840-2020	Corzilius, Björn/0000-0003-3937-9137; Corzilius, Björn/0000-0003-3937-9137; Frederick, Kendra/0000-0002-1656-5167; Ong, Ta-Chung/0000-0001-9463-4765	Life Science Research Foundation; Natural Sciences and Engineering Research Council of Canada; Government of Canada; Deutsche Forschungsgemeinschaft [CO 802/1-1]; G. Harold and Leila Y. Mathers Foundation; NIH [GM-025874, EB-003151, EB-002804, EB-002026]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026, R01EB002804, R01EB001960, R01EB003151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025874, R01GM025874] Funding Source: NIH RePORTER	Life Science Research Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Government of Canada(CGIAR); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); G. Harold and Leila Y. Mathers Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the S.L. and R.G.G. groups for valuable discussions and comments during the course of this research. S.L. is an investigator of the Howard Hughes Medical Institute. K.K.F. was supported by the Life Science Research Foundation as an HHMI fellow. V.K.M. is grateful to the Natural Sciences and Engineering Research Council of Canada and the Government of Canada for a Banting postdoctoral fellowship. B.C. was supported by the Deutsche Forschungsgemeinschaft (research fellowship CO 802/1-1). This work was funded by grants from the G. Harold and Leila Y. Mathers Foundation (S.L.) and by NIH grants GM-025874 to S.L. and EB-003151, EB-002804, and EB-002026 to R.G.G.	Abragam A., 1983, PRINCIPLES NUCL MAGN; Akbey U, 2013, TOP CURR CHEM, V338, P181, DOI 10.1007/128_2013_436; Akbey U, 2010, ANGEW CHEM INT EDIT, V49, P7803, DOI 10.1002/anie.201002044; Allen KD, 2005, GENETICS, V169, P1227, DOI 10.1534/genetics.104.037168; Ashok Kumar T, 2013, WIDE SPECTRUM, V1, P15, DOI DOI 10.5281/ZENODO.50733; Bagriantsev SN, 2008, MOL BIOL CELL, V19, P2433, DOI 10.1091/mbc.E08-01-0078; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; Bajaj VS, 2009, J AM CHEM SOC, V131, P118, DOI 10.1021/ja8045926; Banci L, 2013, NAT CHEM BIOL, V9, P297, DOI [10.1038/NCHEMBIO.1202, 10.1038/nchembio.1202]; Barnes AB, 2012, J MAGN RESON, V224, P1, DOI 10.1016/j.jmr.2012.08.002; BESHAH K, 1987, J CHEM PHYS, V86, P4730, DOI 10.1063/1.452693; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Corzilius B, 2014, J MAGN RESON, V240, P113, DOI 10.1016/j.jmr.2013.11.013; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Frederick KK, 2014, CHEM BIOL, V21, P295, DOI 10.1016/j.chembiol.2013.12.013; Freedberg DI, 2014, ANNU REV BIOPHYS, V43, P171, DOI 10.1146/annurev-biophys-051013-023136; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goddard TD, 2006, SPARKY; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Helsen CW, 2012, J BIOL CHEM, V287, P542, DOI 10.1074/jbc.M111.302869; Inomata K, 2009, NATURE, V458, P106, DOI 10.1038/nature07839; Jacso T, 2012, ANGEW CHEM INT EDIT, V51, P432, DOI 10.1002/anie.201104987; Jaipuria G, 2012, ADV EXP MED BIOL, V992, P95, DOI 10.1007/978-94-007-4954-2_6; Joye CD, 2006, IEEE T PLASMA SCI, V34, P518, DOI 10.1109/TPS.2006.875776; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kiktev DA, 2012, MOL CELL BIOL, V32, P4960, DOI 10.1128/MCB.00875-12; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Lange S, 2012, J MAGN RESON, V216, P209, DOI 10.1016/j.jmr.2012.01.002; Leiting B, 1998, ANAL BIOCHEM, V265, P351, DOI 10.1006/abio.1998.2904; Linden AH, 2011, J BIOMOL NMR, V51, P283, DOI 10.1007/s10858-011-9535-z; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; del Amo JML, 2013, J BIOMOL NMR, V56, P359, DOI 10.1007/s10858-013-9755-5; Luckgei N, 2013, ANGEW CHEM INT EDIT, V52, P12741, DOI 10.1002/anie.201304699; Masison DC, 2009, PRION, V3, P65, DOI 10.4161/pri.3.2.9134; Mehrnejad F, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3530072; Michaelis VK, 2014, ISR J CHEM, V54, P207, DOI 10.1002/ijch.201300126; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Polymenidou M, 2012, J EXP MED, V209, P889, DOI 10.1084/jem.20120741; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Reckel S, 2012, CHEMBIOCHEM, V13, P534, DOI 10.1002/cbic.201100721; Renault M, 2012, ANGEW CHEM INT EDIT, V51, P2998, DOI 10.1002/anie.201105984; Rosay M, 2010, PHYS CHEM CHEM PHYS, V12, P5850, DOI 10.1039/c003685b; Saibil HR, 2012, P NATL ACAD SCI USA, V109, P14906, DOI 10.1073/pnas.1211976109; Sakakibara D, 2009, NATURE, V458, P102, DOI 10.1038/nature07814; Selenko P, 2006, P NATL ACAD SCI USA, V103, P11904, DOI 10.1073/pnas.0604667103; Serio TR, 1999, METHOD ENZYMOL, V309, P649; Song CS, 2006, J AM CHEM SOC, V128, P11385, DOI 10.1021/ja061284b; SZEVERENYI NM, 1982, J MAGN RESON, V47, P462, DOI 10.1016/0022-2364(82)90213-X; Takahashi H, 2014, J MAGN RESON, V239, P91, DOI 10.1016/j.jmr.2013.12.005; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Tuite MF, 2011, TOP CURR CHEM, V305, P257, DOI 10.1007/128_2011_172; Tyedmers J, 2010, P NATL ACAD SCI USA, V107, P8633, DOI 10.1073/pnas.1003895107; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Vagenende V, 2009, BIOCHEMISTRY-US, V48, P11084, DOI 10.1021/bi900649t; Vaiphei ST, 2011, MOL BIOTECHNOL, V47, P205, DOI 10.1007/s12033-010-9330-1; Volkmann G, 2010, MOL BIOSYST, V6, P2110, DOI 10.1039/c0mb00034e; Wang T, 2013, P NATL ACAD SCI USA, V110, P16444, DOI 10.1073/pnas.1316290110; Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102; Watts JC, 2013, P NATL ACAD SCI USA, V110, P19555, DOI 10.1073/pnas.1318268110; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Yamamoto K, 2015, BBA-BIOMEMBRANES, V1848, P342, DOI 10.1016/j.bbamem.2014.07.008	72	96	97	0	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					620	628		10.1016/j.cell.2015.09.024	http://dx.doi.org/10.1016/j.cell.2015.09.024			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26456111	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000364828900016
J	Prum, RO; Berv, JS; Dornburg, A; Field, DJ; Townsend, JP; Lemmon, EM; Lemmon, AR				Prum, Richard O.; Berv, Jacob S.; Dornburg, Alex; Field, Daniel J.; Townsend, Jeffrey P.; Lemmon, Emily Moriarty; Lemmon, Alan R.			A comprehensive phylogeny of birds (Aves) using targeted next-generation DNA sequencing	NATURE			English	Article							SPECIES DIVERGENCE TIMES; RELAXED PHYLOGENETICS; MOLECULAR EVOLUTION; TREE; RATES; DIVERSIFICATION; SUBSTITUTION; CALIBRATIONS; NUCLEOTIDE; SELECTION	Although reconstruction of the phylogeny of living birds has progressed tremendously in the last decade, the evolutionary history of Neoaves-a clade that encompasses nearly all living bird species-remains the greatest unresolved challenge in dinosaur systematics. Here we investigate avian phylogeny with an unprecedented scale of data: >390,000 bases of genomic sequence data from each of 198 species of living birds, representing all major avian lineages, and two crocodilian outgroups. Sequence data were collected using anchored hybrid enrichment, yielding 259 nuclear loci with an average length of 1,523 bases for a total data set of over 7.8x10(7) bases. Bayesian and maximum likelihood analyses yielded highly supported and nearly identical phylogenetic trees for all major avian lineages. Five major clades form successive sister groups to the rest of Neoaves: (1) a clade including nightjars, other caprimulgiforms, swifts, and hummingbirds; (2) a clade uniting cuckoos, bustards, and turacos with pigeons, mesites, and sandgrouse; (3) cranes and their relatives; (4) a comprehensive waterbird clade, including all diving, wading, and shorebirds; and (5) a comprehensive landbird clade with the enigmatic hoatzin (Opisthocomus hoazin) as the sister group to the rest. Neither of the two main, recently proposed Neoavian clades-Columbea and Passerea(1)-were supported as monophyletic. The results of our divergence time analyses are congruent with the palaeontological record, supporting a major radiation of crown birds in the wake of the Cretaceous-Palaeogene (K-Pg) mass extinction.	[Prum, Richard O.; Dornburg, Alex; Townsend, Jeffrey P.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Prum, Richard O.; Dornburg, Alex; Field, Daniel J.] Yale Univ, Peabody Museum Nat Hist, New Haven, CT 06520 USA; [Berv, Jacob S.] Cornell Univ, Fuller Evolutionary Biol Program, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Berv, Jacob S.] Cornell Lab Ornithol, Ithaca, NY 14853 USA; [Dornburg, Alex] North Carolina Museum Nat Sci, Raleigh, NC 27601 USA; [Field, Daniel J.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Townsend, Jeffrey P.] Yale Univ, Dept Biostat, New Haven, CT 06520 USA; [Townsend, Jeffrey P.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Lemmon, Emily Moriarty] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Lemmon, Alan R.] Florida State Univ, Dept Comp Sci, Tallahassee, FL 32306 USA	Yale University; Yale University; Cornell University; Cornell University; Yale University; Yale University; Yale University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Prum, RO (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	richard.prum@yale.edu; jsb439@cornell.edu	Townsend, Jeffrey/H-2747-2019; Dornburg, Alex/CAF-1206-2022; Berv, Jacob Samuel/H-5421-2019	Townsend, Jeffrey/0000-0002-9890-3907; Berv, Jacob Samuel/0000-0002-5962-0621; Dornburg, Alex/0000-0003-0863-2283; Prum, Richard/0000-0002-4741-7132; Field, Daniel/0000-0002-1786-0352	Yale University; NSF; NIH; Direct For Biological Sciences [1120516] Funding Source: National Science Foundation	Yale University; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The research was supported by W. R. Coe Funds from Yale University to R.O.P., and by NSF grants to A.R.L. and E.M.L. We thank the ornithology curators and staff of the following collections for granting research access to the invaluable avian tissue collections that made this work possible: American Museum of Natural History, Field Museum of Natural History, Royal Ontario Museum, University of Kansas Museum of Natural History and Biodiversity Research Center, University of Washington Burke Museum of Natural History, and Yale Peabody Museum of Natural History. We thank M. Kortyna and H. Ralicki for contributions to laboratory work, S. Gullapalli for computational assistance, and N. J. Carriero and R. D. Bjornson at the Yale University Biomedical High Performance Computing Center, which is supported by the NIH. Bird illustrations reproduced with permission from the Handbook of the Birds of the World Alive Online, Lynx Edicions, Barcelona<SUP>30</SUP>. The research was aided by discussions with R. Bowie, S. Edwards, I. Lovette, J. Musser, T. Near, and K. Zyskowski.	Aberer AJ, 2014, MOL BIOL EVOL, V31, P2553, DOI 10.1093/molbev/msu236; Baker AJ, 2007, BIOL LETTERS, V3, P205, DOI 10.1098/rsbl.2006.0606; Barker FK, 2004, P NATL ACAD SCI USA, V101, P11040, DOI 10.1073/pnas.0401892101; Bayzid MS, 2013, BIOINFORMATICS, V29, P2277, DOI 10.1093/bioinformatics/btt394; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Benton MJ, 1999, BIOESSAYS, V21, P1043; Berv JS, 2014, MOL PHYLOGENET EVOL, V81, P120, DOI 10.1016/j.ympev.2014.09.001; Bogdanowicz D, 2012, EVOL BIOINFORM, V8, P475, DOI 10.4137/EBO.S9657; Brandley MC, 2011, SYST BIOL, V60, P3, DOI 10.1093/sysbio/syq045; Clarke J, 2004, B AM MUS NAT HIST, P1; DeGiorgio M, 2010, MOL BIOL EVOL, V27, P552, DOI 10.1093/molbev/msp250; del Hoyo J., 2015, HDB BIRDS WORLD ALIV; Dornburg A, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0169-0; Dornburg A, 2012, MOL BIOL EVOL, V29, P721, DOI 10.1093/molbev/msr228; Dornburg A, 2008, SYST BIOL, V57, P905, DOI 10.1080/10635150802562392; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Drummond AJ., 2015, BAYESIAN EVOLUTIONAR, DOI DOI 10.1017/CBO9781139095112; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Feduccia A., 1999, ORIGIN EVOLUTION BIR, V2; Field DJ, 2015, PALAEONTOLOGY, V58, P401, DOI 10.1111/pala.12165; Gill F., 2015, IOC WORLD BIRD LIST; Gill F. B., 1995, ORNITHOLOGY; GOLDSMITH TH, 1980, SCIENCE, V207, P786, DOI 10.1126/science.7352290; Graybeal A, 1998, SYST BIOL, V47, P9, DOI 10.1080/106351598260996; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Hedges SB, 1996, NATURE, V381, P226, DOI 10.1038/381226a0; Heled J, 2012, SYST BIOL, V61, P138, DOI 10.1093/sysbio/syr087; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Hope Sylvia, 2002, P339; Hsiang AY, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0358-5; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jetz W, 2014, CURR BIOL, V24, P919, DOI 10.1016/j.cub.2014.03.011; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kimball RT, 2013, MOL PHYLOGENET EVOL, V69, P1021, DOI 10.1016/j.ympev.2013.05.029; Klopfstein S, 2010, SYST BIOL, V59, P226, DOI 10.1093/sysbio/syp105; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lemmon AR, 2012, SYST BIOL, V61, P727, DOI 10.1093/sysbio/sys049; Liu L, 2011, SYST BIOL, V60, P661, DOI 10.1093/sysbio/syr027; Liu LA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-302; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Longrich NR, 2011, P NATL ACAD SCI USA, V108, P15253, DOI 10.1073/pnas.1110395108; Lopez-Giraldez F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-152; Mayr G., 2009, PALEOGENE FOSSIL BIR, DOI DOI 10.1007/978-3-540-89628-9; Mayr G, 2013, SYST BIODIVERS, V11, P7, DOI 10.1080/14772000.2013.765521; Mayr G, 2011, J ZOOL SYST EVOL RES, V49, P58, DOI 10.1111/j.1439-0469.2010.00586.x; McCormack JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054848; Meyer M., 2010, COLD SPRING HARB PRO; Mirarab S, 2014, BIOINFORMATICS, V30, pI541, DOI 10.1093/bioinformatics/btu462; Mirarab S., 2014, SCIENCE, V346; Mirarab S., 2014, SYST BIOL; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; Nam K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r68; Nye TMW, 2008, SYST BIOL, V57, P785, DOI 10.1080/10635150802424072; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Pereira SL, 2006, MOL BIOL EVOL, V23, P1731, DOI 10.1093/molbev/msl038; Phillips MJ, 2010, SYST BIOL, V59, P90, DOI 10.1093/sysbio/syp079; Phillips MJ, 2009, GENE, V441, P132, DOI 10.1016/j.gene.2008.08.017; Pond SLK, 2005, STAT BIOL HEALTH, P125, DOI 10.1007/0-387-27733-1_6; Rannala B, 2003, GENETICS, V164, P1645; ROBINSON DF, 1979, LECT NOTES MATH, V748, P119, DOI [10.1007/bfb0102690, DOI 10.1007/BFB0102690, DOI 10.1007/BFB0102678]; Rokyta DR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-312; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Shaw TI, 2013, NUCLEIC ACIDS RES, V41, pW238, DOI 10.1093/nar/gkt377; Simmons MP, 2004, MOL PHYLOGENET EVOL, V32, P913, DOI 10.1016/j.ympev.2004.04.011; Springer MS, 2014, TRENDS PLANT SCI, V19, P267, DOI 10.1016/j.tplants.2014.02.012; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tonini J., 2015, PLOS CURRENTS TREE L, V1; Townsend JP, 2007, SYSTEMATIC BIOL, V56, P222, DOI 10.1080/10635150701311362; Townsend JP, 2012, SYST BIOL, V61, P835, DOI 10.1093/sysbio/sys036; Townsend JP, 2011, SYST BIOL, V60, P358, DOI 10.1093/sysbio/syq097; Townsend JP, 2010, SYST BIOL, V59, P446, DOI 10.1093/sysbio/syq025; Weyenberg G, 2014, BIOINFORMATICS, V30, P2280, DOI 10.1093/bioinformatics/btu258; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024	79	934	960	29	588	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					569	U247		10.1038/nature15697	http://dx.doi.org/10.1038/nature15697			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26444237				2022-12-28	WOS:000364026100049
J	Robel, A				Robel, Alexander			CLIMATE SCIENCE The long future of Antarctic melting	NATURE			English	Editorial Material									[Robel, Alexander] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Robel, Alexander] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	California Institute of Technology; University of Chicago	Robel, A (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	robel@caltech.edu		Robel, Alexander/0000-0003-4520-0105				Banwell AF, 2013, GEOPHYS RES LETT, V40, P5872, DOI 10.1002/2013GL057694; Golberg D., 2009, J GEOPHYS RES, V114; Golledge NR, 2015, NATURE, V526, P421, DOI 10.1038/nature15706; Gudmundsson GH, 2012, CRYOSPHERE, V6, P1497, DOI 10.5194/tc-6-1497-2012; Harig C, 2015, EARTH PLANET SC LETT, V415, P134, DOI 10.1016/j.epsl.2015.01.029; Levermann A, 2013, P NATL ACAD SCI USA, V110, P13745, DOI 10.1073/pnas.1219414110; Mercer J.H., 1968, INT ASSOC SCIENTIFIC, V79, P217; Pollard D, 2015, EARTH PLANET SC LETT, V412, P112, DOI 10.1016/j.epsl.2014.12.035; Scambos T, 2003, ANTARCT RES SER, V79, P79; Schaeffer M, 2012, NAT CLIM CHANGE, V2, P867, DOI [10.1038/nclimate1584, 10.1038/NCLIMATE1584]; Schoof C, 2007, J FLUID MECH, V573, P27, DOI 10.1017/S0022112006003570	11	1	1	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					327	328		10.1038/526327a	http://dx.doi.org/10.1038/526327a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT3TQ	26469037				2022-12-28	WOS:000362730200029
J	Lahue, SC				Lahue, Sara Catherine			Armchairs and Bow Ties	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lahue, SC (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.	saralahue@gmail.com						[Anonymous], 1999, BMJ, V319; Larner AJ, 1999, BMJ-BRIT MED J, V319, P362, DOI 10.1136/bmj.319.7206.362	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2015	314	14					1451	1452		10.1001/jama.2015.7651	http://dx.doi.org/10.1001/jama.2015.7651			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2QI	26461994				2022-12-28	WOS:000362647800009
J	Hausenloy, DJ; Candilio, L; Evans, R; Ariti, C; Jenkins, DP; Kolvekar, S; Knight, R; Kunst, G; Laing, C; Nicholas, J; Pepper, J; Robertson, S; Xenou, M; Clayton, T; Yellon, DM				Hausenloy, D. J.; Candilio, L.; Evans, R.; Ariti, C.; Jenkins, D. P.; Kolvekar, S.; Knight, R.; Kunst, G.; Laing, C.; Nicholas, J.; Pepper, J.; Robertson, S.; Xenou, M.; Clayton, T.; Yellon, D. M.		ERICCA Trial Investigators	Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BYPASS GRAFT-SURGERY; PERCUTANEOUS CORONARY INTERVENTION; CONTROLLED CLINICAL-TRIAL; ARTERY-DISEASE; METAANALYSIS; INJURY; CARDIOPROTECTION; MYOCARDIUM; ISOFLURANE; IMPROVE	BACKGROUND Whether remote ischemic preconditioning (transient ischemia and reperfusion of the arm) can improve clinical outcomes in patients undergoing coronary-artery bypass graft (CABG) surgery is not known. We investigated this question in a randomized trial. METHODS We conducted a multicenter, sham-controlled trial involving adults at increased surgical risk who were undergoing on-pump CABG (with or without valve surgery) with blood cardioplegia. After anesthesia induction and before surgical incision, patients were randomly assigned to remote ischemic preconditioning (four 5-minute inflations and deflations of a standard blood-pressure cuff on the upper arm) or sham conditioning (control group). Anesthetic management and perioperative care were not standardized. The combined primary end point was death from cardiovascular causes, nonfatal myocardial infarction, coronary revascularization, or stroke, assessed 12 months after randomization. RESULTS We enrolled a total of 1612 patients (811 in the control group and 801 in the ischemic-preconditioning group) at 30 cardiac surgery centers in the United Kingdom. There was no significant difference in the cumulative incidence of the primary end point at 12 months between the patients in the remote ischemic preconditioning group and those in the control group (212 patients [26.5%] and 225 patients [27.7%], respectively; hazard ratio with ischemic preconditioning, 0.95; 95% confidence interval, 0.79 to 1.15; P = 0.58). Furthermore, there were no significant between-group differences in either adverse events or the secondary end points of perioperative myocardial injury (assessed on the basis of the area under the curve for the high-sensitivity assay of serum troponin T at 72 hours), inotrope score (calculated from the maximum dose of the individual inotropic agents administered in the first 3 days after surgery), acute kidney injury, duration of stay in the intensive care unit and hospital, distance on the 6-minute walk test, and quality of life. CONCLUSIONS Remote ischemic preconditioning did not improve clinical outcomes in patients undergoing elective on-pump CABG with or without valve surgery.	[Hausenloy, D. J.; Candilio, L.; Xenou, M.; Yellon, D. M.] UCL, Hatter Cardiovasc Inst, London WC1E 6HX, England; [Hausenloy, D. J.; Yellon, D. M.] Univ Coll London Hosp, Biomed Res Ctr, Natl Inst Hlth Res, London, England; [Evans, R.; Knight, R.; Nicholas, J.; Robertson, S.; Clayton, T.] London Sch Hyg & Trop Med, Clin Trials Unit, London, England; [Ariti, C.] Nuffield Trust, London, England; [Kolvekar, S.] Univ Coll London Hosp, Heart Hosp, London, England; [Kunst, G.] Kings Coll London, London WC2R 2LS, England; [Kunst, G.] Kings Coll Hosp London, London, England; [Laing, C.] Royal Free Hosp, London, England; [Pepper, J.] Royal Brompton & Harefield NHS Trust, Natl Inst Hlth Res, Cardiovasc Biomed Res Unit, London, England; [Jenkins, D. P.] Papworth Hosp, Cambridge CB3 8RE, England; [Hausenloy, D. J.] Natl Heart Ctr Singapore, Natl Heart Res Inst, Singapore, Singapore; [Hausenloy, D. J.] Duke Natl Univ Singapore, Cardiovasc & Metab Disorders Program, Singapore, Singapore	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Papworth Hospital; National Heart Centre Singapore; National University of Singapore	Hausenloy, DJ (corresponding author), UCL, Hatter Cardiovasc Inst, 67 Chenies Mews, London WC1E 6HX, England.	d.hausenloy@ucl.ac.uk	Kunst, Gudrun/AAJ-3045-2021; Yellon, Derek M/ABD-5110-2021; Hamarneh, Ashraf/AAP-5884-2020; Luckraz, Heyman/AAV-7206-2020	Hamarneh, Ashraf/0000-0002-9489-4476; Luckraz, Heyman/0000-0003-1218-1243; Iles-Smith, Heather/0000-0002-0520-2694; Clayton, Tim/0000-0002-1266-3288; Kunst, Gudrun/0000-0002-9789-1334; Hausenloy, Derek/0000-0003-0729-4956; Punjabi, Prof Prakash P/0000-0002-6587-1603; Tehrani, Shana/0000-0003-1478-0629; Goodwin, Andrew/0000-0003-0270-7037; Yellon, Derek/0000-0001-7791-9320; Moscarelli, Marco/0000-0002-8373-8486	Efficacy and Mechanism Evaluation Program (Medical Research Council) [09/100/05]; British Heart Foundation; Efficacy and Mechanism Evaluation Program (National Institute of Health Research partnership) [09/100/05]; British Heart Foundation [RG/08/015/26411] Funding Source: researchfish; Medical Research Council [MC_G1002673] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10164] Funding Source: researchfish; Rosetrees Trust [M274] Funding Source: researchfish; MRC [MC_G1002673] Funding Source: UKRI	Efficacy and Mechanism Evaluation Program (Medical Research Council); British Heart Foundation(British Heart Foundation); Efficacy and Mechanism Evaluation Program (National Institute of Health Research partnership); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants from the Efficacy and Mechanism Evaluation Program (a Medical Research Council and National Institute of Health Research partnership) (09/100/05) and the British Heart Foundation.	Bautin A. E., 2014, Anesteziologiya i Reanimatologiya, P11; Candilio L, 2015, HEART, V101, P185, DOI 10.1136/heartjnl-2014-306178; D'Ascenzo F, 2014, EUROINTERVENTION, V9, P1463, DOI 10.4244/EIJV9I12A244; D'Ascenzo F, 2012, HEART, V98, P1267, DOI 10.1136/heartjnl-2011-301551; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3; Hausenloy DJ, 2012, CLIN RES CARDIOL, V101, P339, DOI 10.1007/s00392-011-0397-x; Hausenloy DJ, 2008, CARDIOVASC RES, V79, P377, DOI 10.1093/cvr/cvn114; Healy DA, 2014, INT J CARDIOL, V176, P20, DOI 10.1016/j.ijcard.2014.06.018; Heusch G, 2015, J AM COLL CARDIOL, V65, P177, DOI 10.1016/j.jacc.2014.10.031; Heusch G, 2013, LANCET, V381, P166, DOI 10.1016/S0140-6736(12)60916-7; Hong DM, 2014, EUR HEART J, V35, P176, DOI 10.1093/eurheartj/eht346; Karuppasamy P, 2011, BASIC RES CARDIOL, V106, P511, DOI 10.1007/s00395-011-0185-9; Kellum JA, 2013, CRIT CARE, V17, DOI 10.1186/cc11454; Kharbanda RK, 2002, CIRCULATION, V106, P2881, DOI 10.1161/01.CIR.0000043806.51912.9B; Ko WJ, 2002, ANN THORAC SURG, V73, P538, DOI 10.1016/S0003-4975(01)03330-6; Kottenberg E, 2012, ACTA ANAESTH SCAND, V56, P30, DOI 10.1111/j.1399-6576.2011.02585.x; Kottenberg E, 2014, J THORAC CARDIOV SUR, V147, P376, DOI 10.1016/j.jtcvs.2013.01.005; Lee MS, 2006, J AM COLL CARDIOL, V47, P864, DOI 10.1016/j.jacc.2005.09.072; Lucchinetti E, 2012, ANESTHESIOLOGY, V116, P296, DOI 10.1097/ALN.0b013e318242349a; McCrindle BW, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000964; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Rahman IA, 2010, CIRCULATION, V122, pS53, DOI 10.1161/CIRCULATIONAHA.109.926667; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Sivaraman V, 2015, ANAESTHESIA, V70, P732, DOI 10.1111/anae.12973; Thielmann M, 2013, LANCET, V382, P597, DOI 10.1016/S0140-6736(13)61450-6; Thielmann M, 2010, BASIC RES CARDIOL, V105, P657, DOI 10.1007/s00395-010-0104-5; Thorsteinsson K, 2015, EUR J CARDIO-THORAC; Venugopal V, 2009, HEART, V95, P1567, DOI 10.1136/hrt.2008.155770; Zhang BS, 2014, INT J CARDIOL, V172, pE33, DOI 10.1016/j.ijcard.2013.12.086	30	471	484	1	85	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2015	373	15					1408	1417		10.1056/NEJMoa1413534	http://dx.doi.org/10.1056/NEJMoa1413534			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS8XI	26436207	Green Published, Green Accepted			2022-12-28	WOS:000362372800007
J	Kim, JI; Ganesan, S; Luo, SX; Wu, YW; Park, E; Huang, EJ; Chen, L; Ding, JB				Kim, Jae-Ick; Ganesan, Subhashree; Luo, Sarah X.; Wu, Yu-Wei; Park, Esther; Huang, Eric J.; Chen, Lu; Ding, Jun B.			Aldehyde dehydrogenase 1a1 mediates a GABA synthesis pathway in midbrain dopaminergic neurons	SCIENCE			English	Article							ALCOHOL-METABOLIZING GENES; RETINOIC ACID; SYNAPTIC PLASTICITY; PARKINSONS-DISEASE; MODULATION; STRIATUM; PUTRESCINE; SYSTEM; TRANSMISSION; POLYAMINES	Midbrain dopamine neurons are an essential component of the basal ganglia circuitry, playing key roles in the control of fine movement and reward. Recently, it has been demonstrated that gamma-aminobutyric acid (GABA), the chief inhibitory neurotransmitter, is co-released by dopamine neurons. Here, we show that GABA co-release in dopamine neurons does not use the conventional GABA-synthesizing enzymes, glutamate decarboxylases GAD65 and GAD67. Our experiments reveal an evolutionarily conserved GABA synthesis pathway mediated by aldehyde dehydrogenase 1a1 (ALDH1a1). Moreover, GABA co-release is modulated by ethanol (EtOH) at concentrations seen in blood alcohol after binge drinking, and diminished ALDH1a1 leads to enhanced alcohol consumption and preference. These findings provide insights into the functional role of GABA co-release in midbrain dopamine neurons, which may be essential for reward-based behavior and addiction.	[Kim, Jae-Ick; Ganesan, Subhashree; Wu, Yu-Wei; Park, Esther; Chen, Lu; Ding, Jun B.] Stanford Univ, Sch Med, Dept Neurosurg, Palo Alto, CA 94304 USA; [Luo, Sarah X.; Huang, Eric J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Luo, Sarah X.; Huang, Eric J.] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA; [Huang, Eric J.] San Francisco VA Med Ctr, Pathol Serv 113B, San Francisco, CA 94121 USA; [Ding, Jun B.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA	Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Stanford University	Ding, JB (corresponding author), Stanford Univ, Sch Med, Dept Neurosurg, Palo Alto, CA 94304 USA.	dingjun@stanford.edu	Kim, Jae-Ick/AAY-6005-2020; Huang, Eric J./AAH-7997-2019; Ding, Jun/B-2513-2009; Kim, Jae-Ick/R-4007-2017; Wu, Yu-Wei/V-9303-2019; Wu, Yu-Wei/C-3263-2018	Huang, Eric J./0000-0002-5381-3801; Ding, Jun/0000-0003-0690-1312; Kim, Jae-Ick/0000-0001-9705-0394; Wu, Yu-Wei/0000-0002-4459-087X; Wu, Yu-Wei/0000-0002-4459-087X; Park, Esther/0000-0002-1594-7753; Chen, Lu/0000-0002-8097-2699	National Institute of Neurological Disorders and Stroke, NIH [NS075136, NS091144]; Klingenstein Foundation; National Institute of Mental Health, NIH [MH086403, MH091193]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086403, R01MH091193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS075136, R01NS091144] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Klingenstein Foundation(Klingenstein Philanthropies); National Institute of Mental Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank A. Du and Y. Liu for technical assistance; D. Ron for suggestions on using the two-bottle-choice behavior test; and T. Sudhof, G. Panagiotakos, W. Wei, Z. Khaliq, and members of the Ding laboratory for helpful discussions. Supported by grants from the National Institute of Neurological Disorders and Stroke, NIH, NS075136, NS091144 (J.B.D.), the Klingenstein Foundation (J.B.D.), and National Institute of Mental Health, NIH, MH086403 (L.C.) and MH091193 (L.C.). The authors declare no conflicts of interest. All primary electrophysiological and immunohistochemical data are archived on a server in the Department of Neurosurgery at Stanford University School of Medicine.	Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; BARRES BA, 1990, NEURON, V4, P507, DOI 10.1016/0896-6273(90)90109-S; Bell MR, 2011, NAT NEUROSCI, V14, P505, DOI 10.1038/nn.2777; Ben Hamida S, 2013, J NEUROSCI, V33, P14369, DOI 10.1523/JNEUROSCI.1954-13.2013; Chen BT, 2010, ANN NY ACAD SCI, V1187, P129, DOI 10.1111/j.1749-6632.2009.05154.x; Chen G, 2011, ALCOHOL CLIN EXP RES, V35, P1739, DOI 10.1111/j.1530-0277.2011.01520.x; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fan XH, 2003, MOL CELL BIOL, V23, P4637, DOI 10.1128/MCB.23.13.4637-4648.2003; Goldstein DS, 2013, J NEUROCHEM, V126, P591, DOI 10.1111/jnc.12345; Gonzalez-Hernandez T, 2001, EUR J NEUROSCI, V13, P57, DOI 10.1046/j.1460-9568.2001.01371.x; Heusner CL, 2008, GENESIS, V46, P357, DOI 10.1002/dvg.20405; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; Hoerbelt P, 2015, J NEUROSCI, V35, P3525, DOI 10.1523/JNEUROSCI.4390-14.2015; Lammel S, 2015, NEURON, V85, P429, DOI 10.1016/j.neuron.2014.12.036; LASCHET J, 1992, NEUROSCIENCE, V48, P151, DOI 10.1016/0306-4522(92)90345-3; Liu GX, 2014, J CLIN INVEST, V124, P3032, DOI 10.1172/JCI72176; Liu JX, 2011, ALCOHOL CLIN EXP RES, V35, P304, DOI 10.1111/j.1530-0277.2010.01346.x; Lovinger DM, 2010, NEUROPHARMACOLOGY, V58, P951, DOI 10.1016/j.neuropharm.2010.01.008; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; MCCAFFERY P, 1994, P NATL ACAD SCI USA, V91, P7772, DOI 10.1073/pnas.91.16.7772; NOTO T, 1986, PHARMACOL BIOCHEM BE, V25, P411, DOI 10.1016/0091-3057(86)90017-1; O'Dell LE, 2004, ALCOHOL CLIN EXP RES, V28, P1676, DOI 10.1097/01.ALC.0000145781.11923.4E; Pennartz CMA, 2009, J NEUROSCI, V29, P12831, DOI 10.1523/JNEUROSCI.3177-09.2009; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Root DH, 2014, NAT NEUROSCI, V17, P1543, DOI 10.1038/nn.3823; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Sequerra EB, 2007, NEUROSCIENCE, V146, P489, DOI 10.1016/j.neuroscience.2007.01.062; Shabel SJ, 2014, SCIENCE, V345, P1494, DOI 10.1126/science.1250469; Shelp BJ, 2012, PLANT SCI, V193, P130, DOI 10.1016/j.plantsci.2012.06.001; Sherva R, 2009, ALCOHOL CLIN EXP RES, V33, P848, DOI 10.1111/j.1530-0277.2009.00904.x; Tritsch NX, 2014, ELIFE, V3, DOI 10.7554/eLife.01936; Tritsch NX, 2012, NATURE, V490, P262, DOI 10.1038/nature11466; Tritsch NX, 2012, NEURON, V76, P33, DOI 10.1016/j.neuron.2012.09.023; Vasiliou V, 2000, CHEM-BIOL INTERACT, V129, P1, DOI 10.1016/S0009-2797(00)00211-8; Wang J, 2012, J NEUROSCI, V32, P15124, DOI 10.1523/JNEUROSCI.2783-12.2012; Weiner JL, 2006, PHARMACOL THERAPEUT, V111, P533, DOI 10.1016/j.pharmthera.2005.11.002; Williams K, 1997, CELL SIGNAL, V9, P1, DOI 10.1016/S0898-6568(96)00089-7; Xing SG, 2007, PLANT PHYSIOL BIOCH, V45, P560, DOI 10.1016/j.plaphy.2007.05.007; Yamasaki EN, 1999, INT J DEV NEUROSCI, V17, P201, DOI 10.1016/S0736-5748(99)00002-7	39	116	117	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					102	106		10.1126/science.aac4690	http://dx.doi.org/10.1126/science.aac4690			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26430123	Green Published, Green Accepted			2022-12-28	WOS:000362098300055
J	Fiore, M; Baker, T				Fiore, Michael; Baker, Timothy			Reduced-Nicotine Cigarettes - A Promising Regulatory Pathway	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fiore, Michael] Univ Wisconsin, Ctr Tobacco Res & Intervent, Sch Med & Publ Hlth, Madison, WI 53706 USA; Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Fiore, M (corresponding author), Univ Wisconsin, Ctr Tobacco Res & Intervent, Sch Med & Publ Hlth, Madison, WI 53706 USA.				NCI NIH HHS [R35 CA197573, P50 CA143188, P01 CA180945] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA197573, P50CA143188, P01CA180945] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BENOWITZ NL, 1994, NEW ENGL J MED, V331, P123, DOI 10.1056/NEJM199407143310212; Benowitz NL, 2015, ADDICTION; Henningfield JE, 1998, TOB CONTROL, V7, P281, DOI 10.1136/tc.7.3.281; RUSSELL MAH, 1976, BRIT MED J, V1, P1430, DOI 10.1136/bmj.1.6023.1430; Zeller M, 2013, TOB CONTROL, V22, P40, DOI 10.1136/tobaccocontrol-2012-050789	5	8	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2015	373	14					1289	1291		10.1056/NEJMp1509510	http://dx.doi.org/10.1056/NEJMp1509510			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS3CI	26422720	Green Accepted			2022-12-28	WOS:000361948600002
J	Moberly, T				Moberly, Tom			Problems with the junior doctors' contract: how did we get here?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Jacques H., 2013, BMJ CAREERS; Jacques H., 2012, BMJ CAREERS; Kmietowicz Z, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3883; NHS Employers, 2015, UPD CONS JUN DOCT CO; Office of Manpower Statistics, DDRB BIOGR; Rimmer A, 2015, BMJ CAREERS; Rimmer A, 2014, BMJ CAREERS; White C., 2013, BMJ CAREERS	8	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 29	2015	351								h5183	10.1136/bmj.h5183	http://dx.doi.org/10.1136/bmj.h5183			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS9YU	26419520				2022-12-28	WOS:000362450900013
J	De Mestral, C; Nathens, AB				De Mestral, Charles; Nathens, Avery B.			Cholecystectomy in mild gallstone pancreatitis: don't defer	LANCET			English	Editorial Material							DELAYED-CHOLECYSTECTOMY; MANAGEMENT; TRIAL		[De Mestral, Charles; Nathens, Avery B.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Surg, Toronto, ON M4N 3M5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	De Mestral, C (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Surg, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	charles.demestral@mail.utoronto.ca						Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; da Costa DW, 2015, LANCET, V386, P1261, DOI 10.1016/S0140-6736(15)00274-3; de Mestral C, 2014, ANN SURG, V259, P10, DOI 10.1097/SLA.0b013e3182a5cf36; Gutt CN, 2013, ANN SURG, V258, P385, DOI 10.1097/SLA.0b013e3182a1599b; Hoyt David B, 2011, Bull Am Coll Surg, V96, P5; Kulvatunyou N, 2014, AM J SURG, V208, P981, DOI 10.1016/j.amjsurg.2014.09.003; Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218; Trust MD, 2011, SURGERY, V150, P515, DOI 10.1016/j.surg.2011.07.072	8	3	3	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 26	2015	386	10000					1218	1219		10.1016/S0140-6736(15)00302-5	http://dx.doi.org/10.1016/S0140-6736(15)00302-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9TQ	26460641				2022-12-28	WOS:000361700100007
J	Marchalik, D; Jurecic, A				Marchalik, Daniel; Jurecic, Ann			Novel remedies	LANCET			English	Editorial Material									[Marchalik, Daniel] Georgetown Univ, Sch Med, Dept Urol & Literature & Med Track, Washington, DC 20007 USA; [Jurecic, Ann] Rutgers State Univ, Dept English, New Brunswick, NJ USA	Georgetown University; Rutgers State University New Brunswick	Marchalik, D (corresponding author), Georgetown Univ, Sch Med, Dept Urol & Literature & Med Track, Washington, DC 20007 USA.	dan.marchalik@gmail.com		Marchalik, Daniel/0000-0002-6912-1252				Charon R., 2006, NARRATIVE MED HONORI; Dovey C., 2015, NEW YORKER, V9; Frank AW., 2013, WOUNDED STORYTELLER; Gunderman Richard, 2014, ATLANTIC; Jurecic A., 2012, ILLNESS AS NARRATIVE; Kidd DC, 2013, SCIENCE, V342, P377, DOI 10.1126/science.1239918; Kleinman A., 1988, ILLNESS NARRATIVES; Mar RA, 2011, COGNITION EMOTION, V25, P818, DOI 10.1080/02699931.2010.515151; Siegel L., 2013, NEW YORKER; Sontag S., 1978, ILLNESS METAPHOR	10	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 26	2015	386	10000					1223	1223		10.1016/S0140-6736(15)00301-3	http://dx.doi.org/10.1016/S0140-6736(15)00301-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR9TQ	26460642				2022-12-28	WOS:000361700100010
J	Watts, G				Watts, Geoff			Kjetil Soreide: rising young surgeon, adept with pen and scalpel	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 26	2015	386	10000					1233	1233		10.1016/S0140-6736(15)00270-6	http://dx.doi.org/10.1016/S0140-6736(15)00270-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9TQ	26460650	Bronze			2022-12-28	WOS:000361700100018
J	Dennell, R				Dennell, Robin			PALAEOANTHROPOLOGY Homo sapiens in China 80,000 years ago	NATURE			English	Editorial Material							MODERN HUMAN COLONIZATION; ARCHAEOLOGICAL PERSPECTIVES; SOUTHERN ASIA; DISPERSAL; EAST; PLEISTOCENE		Univ Exeter, Dept Archaeol, Exeter EX4 4QH, Devon, England	University of Exeter	Dennell, R (corresponding author), Univ Exeter, Dept Archaeol, Exeter EX4 4QH, Devon, England.	r.w.dennell@exeter.ac.uk						Boivin N, 2013, QUATERN INT, V300, P32, DOI 10.1016/j.quaint.2013.01.008; Dennell R., 2014, SO ASIA AUSTR SEARCH, P33; Dennell R, 2012, QUATERNARY SCI REV, V47, P15, DOI 10.1016/j.quascirev.2012.05.002; Dennell R, 2010, NATURE, V468, P512, DOI 10.1038/468512a; Groucutt HS, 2015, EVOL ANTHROPOL, V24, P149, DOI 10.1002/evan.21455; Kaifu Y, 2012, QUATERN INT, V248, P2, DOI 10.1016/j.quaint.2011.02.017; Lewis L, 2014, QUATERN INT, V350, P7, DOI 10.1016/j.quaint.2014.09.013; Liu W, 2015, NATURE, V526, P696, DOI 10.1038/nature15696; Liu W, 2010, P NATL ACAD SCI USA, V107, P19201, DOI 10.1073/pnas.1014386107; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Mellars P, 2013, P NATL ACAD SCI USA, V110, P10699, DOI 10.1073/pnas.1306043110; Nigst PR, 2014, P NATL ACAD SCI USA, V111, P14394, DOI 10.1073/pnas.1412201111; ROBERTS RG, 1994, QUATERNARY SCI REV, V13, P575, DOI 10.1016/0277-3791(94)90080-9; Shang H, 2007, P NATL ACAD SCI USA, V104, P6573, DOI 10.1073/pnas.0702169104; Shea JJ, 2008, QUATERNARY SCI REV, V27, P2253, DOI 10.1016/j.quascirev.2008.08.015; Xing S, 2015, AM J PHYS ANTHROPOL, V156, P224, DOI 10.1002/ajpa.22641	16	11	14	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					647	648		10.1038/nature15640	http://dx.doi.org/10.1038/nature15640			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU8ZH	26466570				2022-12-28	WOS:000363832100036
J	Kaul, U; Bangalore, S; Seth, A; Arambam, P; Abhaychand, RK; Patel, TM; Banker, D; Abhyankar, A; Mullasari, AS; Shah, S; Jain, R; Kumar, PR; Bahuleyan, CG				Kaul, Upendra; Bangalore, Sripal; Seth, Ashok; Arambam, Priyadarshini; Abhaychand, Rajpal K.; Patel, Tejas M.; Banker, Darshan; Abhyankar, Atul; Mullasari, Ajit S.; Shah, Sanjay; Jain, Rajneesh; Kumar, Premchand R.; Bahuleyan, C. G.		TUXEDO-India Investigators	Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BARE METAL STENTS; SIROLIMUS; MELLITUS; OUTCOMES	BACKGROUND The choice of drug-eluting stent in the treatment of patients with diabetes mellitus and coronary artery disease who are undergoing percutaneous coronary intervention (PCI) has been debated. Previous studies comparing paclitaxel-eluting stents with stents eluting rapamycin (now called sirolimus) or its analogues (everolimus or zotarolimus) have produced contradictory results, ranging from equivalence between stent types to superiority of everolimus-eluting stents. METHODS We randomly assigned 1830 patients with diabetes mellitus and coronary artery disease who were undergoing PCI to receive either a paclitaxel-eluting stent or an everolimus-eluting stent. We used a noninferiority trial design with a noninferiority margin of 4 percentage points for the upper boundary of the 95% confidence interval of the risk difference. The primary end point was target-vessel failure, which was defined as a composite of cardiac death, target-vessel myocardial infarction, or ischemia-driven target-vessel revascularization at the 1-year follow-up. RESULTS At 1 year, paclitaxel-eluting stents did not meet the criterion for noninferiority to everolimus-eluting stents with respect to the primary end point (rate of target-vessel failure, 5.6% vs. 2.9%; risk difference, 2.7 percentage points [95% confidence interval, 0.8 to 4.5]; relative risk, 1.89 [95% confidence interval, 1.20 to 2.99]; P = 0.38 for noninferiority). There was a significantly higher 1-year rate in the paclitaxel-eluting stent group than in the everolimus-eluting stent group of target-vessel failure (P = 0.005), spontaneous myocardial infarction (3.2% vs. 1.2%, P = 0.004), stent thrombosis (2.1% vs. 0.4%, P = 0.002), target-vessel revascularization (3.4% vs. 1.2%, P = 0.002), and target-lesion revascularization (3.4% vs. 1.2%, P = 0.002). CONCLUSIONS In patients with diabetes mellitus and coronary artery disease undergoing PCI, paclitaxel-eluting stents were not shown to be noninferior to everolimus-eluting stents, and they resulted in higher rates of target-vessel failure, myocardial infarction, stent thrombosis, and target-vessel revascularization at 1 year. (Funded by Boston Scientific; TUXEDO-India Clinical Trials Registry-India number, CTRI/2011/06/001830).	[Kaul, Upendra; Seth, Ashok; Arambam, Priyadarshini] Fortis Escorts Heart Inst, New Delhi 110025, India; [Jain, Rajneesh] Sir Ganga Ram Hosp, Dharma Vira Heart Ctr, New Delhi, India; [Abhaychand, Rajpal K.] G Kuppuswamy Naidu Mem Hosp, LRG Naidu Cardiol Res Inst & Clin, Coimbatore, Tamil Nadu, India; [Patel, Tejas M.] SAL Hosp & Med Inst, Ahmadabad, Gujarat, India; [Shah, Sanjay] Apex Heart Inst, Ahmadabad, Gujarat, India; [Banker, Darshan] Bankers Heart Inst, Vadodara, India; [Abhyankar, Atul] Shree BD Mehta Mahavir Heart Inst, Surat, India; [Mullasari, Ajit S.] Madras Med Miss, Inst Cardiovasc Dis, Madras, Tamil Nadu, India; [Kumar, Premchand R.] Krishna Inst Med Sci, Secunderabad, India; [Bahuleyan, C. G.] Ananthapuri Hosp & Res Inst, Trivandrum, Kerala, India; [Bangalore, Sripal] NYU, Sch Med, New York, NY USA	New York University	Kaul, U (corresponding author), Fortis Escorts Heart Inst, New Delhi 110025, India.	kaul.upendra@gmail.com	Abhyankar, Atul/AAG-4551-2020; Patel, Tejas/AAT-6528-2020	Bangalore, Sripal/0000-0001-9485-0652	Boston Scientific	Boston Scientific(Boston Scientific)	Funded by Boston Scientific	Aronson D, 2010, REV ENDOCR METAB DIS, V11, P75, DOI 10.1007/s11154-010-9135-3; Bangalore S, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.115.002626; Bangalore S, 2015, NEW ENGL J MED, V373, P582, DOI 10.1056/NEJMc1506944; Bangalore S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5170; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, EUR HEART J, V28, P26, DOI 10.1093/eurheartj/ehl412; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; Frye RL, 2009, NEW ENGL J MED, V360, P2503, DOI [DOI 10.1056/NEJMOA0805796, 10.1056/NEJMoa0805796]; Kastrati A, 2011, CIRCULATION, V124, P869, DOI 10.1161/CIRCULATIONAHA.111.049544; Ong ATL, 2005, AM J CARDIOL, V96, P358, DOI 10.1016/j.amjcard.2005.03.075; Ost A, 2010, MOL MED, V16, P235, DOI 10.2119/molmed.2010.00023; Sianos Georgios, 2005, EuroIntervention, V1, P219; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Stankovic G, 2006, AM J CARDIOL, V98, P362, DOI 10.1016/j.amjcard.2006.01.104; Stone GW, 2011, CIRCULATION, V124, P893, DOI 10.1161/CIRCULATIONAHA.111.031070; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Wessely R, 2006, J AM COLL CARDIOL, V47, P708, DOI 10.1016/j.jacc.2005.09.047	17	76	78	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2015	373	18					1709	1719		10.1056/NEJMoa1510188	http://dx.doi.org/10.1056/NEJMoa1510188			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU4QH	26466202	Bronze			2022-12-28	WOS:000363514100007
J	Kommineni, S; Bretl, DJ; Lam, V; Chakraborty, R; Hayward, M; Simpson, P; Cao, YM; Bousounis, P; Kristich, CJ; Salzman, NH				Kommineni, Sushma; Bretl, Daniel J.; Lam, Vy; Chakraborty, Rajrupa; Hayward, Michael; Simpson, Pippa; Cao, Yumei; Bousounis, Pavlos; Kristich, Christopher J.; Salzman, Nita H.			Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract	NATURE			English	Article							RESISTANT ENTEROCOCCI; INFECTIONS; MICROBIOTA; FAECALIS; HEALTH; AS-48	Enterococcus faecalis is both a common commensal of the human gastrointestinal tract and a leading cause of hospital-acquired infections(1). Systemic infections with multidrug-resistant enterococci occur subsequent to gastrointestinal colonization(2). Preventing colonization by multidrug-resistant E. faecalis could therefore be a valuable approach towards limiting infection. However, little is known about the mechanisms E. faecalis uses to colonize and compete for stable gastrointestinal niches. Pheromone-responsive conjugative plasmids encoding bacteriocins are common among enterococcal strains(3) and could modulate niche competition among enterococci or between enterococci and the intestinal microbiota. We developed a model of colonization of the mouse gut with E. faecalis, without disrupting the microbiota, to evaluate the role of the conjugative plasmid pPD1 expressing baderiocin 21 (ref. 4) in enterococcal colonization. Here we show that E. faecalis harbouring pPD1 replaces indigenous enterococci and outcompetes E. faecalis lacking pPD1. Furthermore, in the intestine, pPD1 is transferred to other E. faecalis strains by conjugation, enhancing their survival. Colonization with an E. faecalis strain carrying a conjugation-defective pPD1 mutant subsequently resulted in clearance of vancomycin-resistant enterococci, without plasmid transfer. Therefore, bacteriocin expression by commensal bacteria can influence niche competition in the gastrointestinal tract, and bacteriocins, delivered by commensals that occupy a precise intestinal bacterial niche, may be an effective therapeutic approach to specifically eliminate intestinal colonization by multidrug-resistant bacteria, without profound disruption of the indigenous microbiota.	[Kommineni, Sushma; Lam, Vy; Chakraborty, Rajrupa; Hayward, Michael; Bousounis, Pavlos; Salzman, Nita H.] Med Coll Wisconsin, Div Gastroenterol, Dept Pediat, Milwaukee, WI 53226 USA; [Simpson, Pippa; Cao, Yumei] Med Coll Wisconsin, Div Quantitat Hlth Sci, Dept Pediat, Milwaukee, WI 53226 USA; [Kommineni, Sushma; Bretl, Daniel J.; Chakraborty, Rajrupa; Kristich, Christopher J.; Salzman, Nita H.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Salzman, NH (corresponding author), Med Coll Wisconsin, Div Gastroenterol, Dept Pediat, Milwaukee, WI 53226 USA.	ckristich@mcw.edu; nsalzman@mcw.edu	simpson, pippa/AAI-8172-2020	simpson, pippa/0000-0003-1458-3748; Salzman, Nita/0000-0003-0939-6139	National Institutes of Health [AI057757, AI097619, GM099526, AI081692, 0D006447]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097619, R01AI081692, R21AI057757, R01AI057757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099526] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006447] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank I. Banla for constructing the IB1 (V583<INF>r</INF>) strain. We are grateful to J. Barbieri and the members of the Salzman and Kristich laboratories for critical review of the manuscript. We thank MS. Gilmore for providing enterococcal strains. This work was supported by grants from the National Institutes of Health; AI057757 (N.H.S), AI097619 (N.H.S), GM099526 (N.H.S.), AI081692 (C.J.K.) and 0D006447 (C.J.K).	Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Broaders E, 2013, GUT MICROBES, V4, P271, DOI 10.4161/gmic.24627; Corr SC, 2007, P NATL ACAD SCI USA, V104, P7617, DOI 10.1073/pnas.0700440104; Cruz VL, 2013, BBA-BIOMEMBRANES, V1828, P2524, DOI 10.1016/j.bbamem.2013.05.036; Dobson A, 2012, APPL ENVIRON MICROB, V78, P1, DOI 10.1128/AEM.05576-11; FUJIMOTO S, 1995, J BACTERIOL, V177, P5574, DOI 10.1128/jb.177.19.5574-5581.1995; GALVEZ A, 1989, RES MICROBIOL, V140, P57, DOI 10.1016/0923-2508(89)90060-0; Burgos MJG, 2014, INT J MOL SCI, V15, P22706, DOI 10.3390/ijms151222706; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Nes I.F., 2014, ENTEROCOCCI COMMENSA; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Perez RH, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S3; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Shepard BD, 2002, MICROBES INFECT, V4, P215, DOI 10.1016/S1286-4579(01)01530-1; Tomita H, 1997, J BACTERIOL, V179, P7843, DOI 10.1128/jb.179.24.7843-7855.1997; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918	20	242	254	4	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					719	722		10.1038/nature15524	http://dx.doi.org/10.1038/nature15524			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26479034	Green Accepted			2022-12-28	WOS:000363832100052
J	Kim, HJ; Barnitz, RA; Kreslavsky, T; Brown, FD; Moffett, H; Lemieux, ME; Kaygusuz, Y; Meissner, T; Holderried, TAW; Chan, S; Kastner, P; Haining, WN; Cantor, H				Kim, Hye-Jung; Barnitz, R. Anthony; Kreslavsky, Taras; Brown, Flavian D.; Moffett, Howell; Lemieux, Madeleine E.; Kaygusuz, Yasemin; Meissner, Torsten; Holderried, Tobias A. W.; Chan, Susan; Kastner, Philippe; Haining, W. Nicholas; Cantor, Harvey			Stable inhibitory activity of regulatory T cells requires the transcription factor Helios	SCIENCE			English	Article							FOXP3 EXPRESSION; CIS-ELEMENT; DIFFERENTIATION; SURVIVAL; STAT5	The maintenance of immune homeostasis requires regulatory T cells (T-regs). Given their intrinsic self-reactivity, Tregs must stably maintain a suppressive phenotype to avoid autoimmunity. We report that impaired expression of the transcription factor (TF) Helios by FoxP3(+) CD4 and Qa-1-restricted CD8 T-regs results in defective regulatory activity and autoimmunity in mice. Helios-deficient T-regs develop an unstable phenotype during inflammatory responses characterized by reduced FoxP3 expression and increased effector cytokine expression secondary to diminished activation of the STAT5 pathway. CD8 T-regs also require Helios-dependent STAT5 activation for survival and to prevent terminal T cell differentiation. The definition of Helios as a key transcription factor that stabilizes T-regs in the face of inflammatory responses provides a genetic explanation for a core property of T-regs.	[Kim, Hye-Jung; Kreslavsky, Taras; Moffett, Howell; Kaygusuz, Yasemin; Meissner, Torsten; Holderried, Tobias A. W.; Cantor, Harvey] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02215 USA; [Kim, Hye-Jung; Kreslavsky, Taras; Meissner, Torsten; Holderried, Tobias A. W.; Cantor, Harvey] Harvard Univ, Sch Med, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA USA; [Barnitz, R. Anthony; Brown, Flavian D.; Haining, W. Nicholas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Barnitz, R. Anthony; Haining, W. Nicholas] Boston Childrens Hosp, Dept Pediat, Boston, MA USA; [Lemieux, Madeleine E.] Bioinfo, Plantagenet, ON, Canada; [Chan, Susan; Kastner, Philippe] Univ Strasbourg, IGBMC, INSERM U964, CNRS UMR 7104, F-67404 Illkirch Graffenstaden, France; [Chan, Susan; Kastner, Philippe] Univ Strasbourg, Fac Med, Strasbourg, France; [Haining, W. Nicholas] Broad Inst MIT & Harvard, Cambridge, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Cantor, H (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & Virol, 450 Brookline Ave, Boston, MA 02215 USA.	harvey_cantor@dfci.harvard.edu	Holderried, Tobias/ABG-1525-2020	Holderried, Tobias/0000-0002-2474-523X; Lemieux, Madeleine/0000-0001-6355-8691; Kreslavsky, Taras/0000-0002-6672-1914	LeRoy Schecter Research Foundation; Arthritis National Research Foundation;  [NIH R01AI37562]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037562] Funding Source: NIH RePORTER	LeRoy Schecter Research Foundation; Arthritis National Research Foundation(National Research Foundation of Korea); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Thornton and E. Shevach (NIH) for provision of Helios<SUP>fl/fl</SUP>.CD4-Cre mice, S. Crotty (La Jolla Institute for Allergy and Immunology) for provision of retroviral vector STAT5-CA, R. Bronson (DF/HCC Rodent Histopathology Core) for histology analysis, and A. Angel for manuscript and figure preparation. The data reported in this manuscript are tabulated in the main paper and in the supplementary materials. Raw data are archived in the Gene Expression Omnibus under accession numbers GSE72997 (ChIP-Sec) and GSE73015 (microarray). These studies were supported in part by research grants NIH R01AI37562 and the LeRoy Schecter Research Foundation to H.C. and the Arthritis National Research Foundation to H.-J.K. A provisional patent (U.S. patent application 62/170,379) has been filed pertaining to biological applications relating to the conversion of regulatory T cells into effector T cells for immunotherapy.	Bin Dhuban K, 2015, J IMMUNOL, V194, P3687, DOI 10.4049/jimmunol.1401803; Cai Q, 2009, J IMMUNOL, V183, P2303, DOI 10.4049/jimmunol.0901407; Castro I, 2011, J IMMUNOL, V187, P5170, DOI 10.4049/jimmunol.1003961; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Golding A, 2013, ARTHRITIS RHEUM-US, V65, P2898, DOI 10.1002/art.38119; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kim HJ, 2011, SEMIN IMMUNOL, V23, P446, DOI 10.1016/j.smim.2011.06.001; Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Li XD, 2014, CELL, V158, P734, DOI 10.1016/j.cell.2014.07.030; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Martinez RJ, 2012, J IMMUNOL, V188, P170, DOI 10.4049/jimmunol.1101311; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Pierson W, 2013, NAT IMMUNOL, V14, P959, DOI 10.1038/ni.2649; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tripathi P, 2010, J IMMUNOL, V185, P2116, DOI 10.4049/jimmunol.1000842	23	235	248	5	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2015	350	6258					334	+		10.1126/science.aad0616	http://dx.doi.org/10.1126/science.aad0616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT5HD	26472910	Green Accepted			2022-12-28	WOS:000362838700044
J	Weber, F; Chung, S; Beier, KT; Xu, M; Luo, LQ; Dan, Y				Weber, Franz; Chung, Shinjae; Beier, Kevin T.; Xu, Min; Luo, Liqun; Dan, Yang			Control of REM sleep by ventral medulla GABAergic neurons	NATURE			English	Article							LOCUS-COERULEUS NEURONS; RETICULAR-FORMATION; PARADOXICAL SLEEP; MUSCLE TONE; C-FOS; CAT; NUCLEUS; LOCALIZATION; TRANSECTIONS; LESIONS	Rapid eye movement (REM) sleep is a distinct brain state characterized by activated electroencephalogram and complete skeletal muscle paralysis, and is associated with vivid dreams(1-3). Transection studies by Jouvet first demonstrated that the brainstem is both necessary and sufficient for REM sleep generation(2), and the neural circuits in the pons have since been studied extensively(4-8). The medulla also contains neurons that are active during REM sleep(9-13), but whether they play a causal role in REM sleep generation remains unclear. Here we show that a GABAergic (gamma-aminobutyric-acidreleasing) pathway originating from the ventral medulla powerfully promotes REM sleep in mice. Optogenetic activation of ventral medulla GABAergic neurons rapidly and reliably initiated REM sleep episodes and prolonged their durations, whereas inactivating these neurons had the opposite effects. Optrode recordings from channelrhodopsin-2-tagged ventral medulla GABAergic neurons showed that they were most active during REM sleep (REMmax), and during wakefulness they were preferentially active during eating and grooming. Furthermore, dual retrograde tracing showed that the rostral projections to the pons and midbrain and caudal projections to the spinal cord originate from separate ventral medulla neuron populations. Activating the rostral GABAergic projections was sufficient for both the induction and maintenance of REM sleep, which are probably mediated in part by inhibition of REM suppressing GABAergic neurons in the ventrolateral periaqueductal grey. These results identify a key component of the pontomedullary network controlling REM sleep. The capability to induce REM sleep on command may offer a powerful tool for investigating its functions.	[Weber, Franz; Chung, Shinjae; Xu, Min; Dan, Yang] Univ Calif Berkeley, Howard Hughes Med Inst, Helen Wills Neurosci Inst, Div Neurobiol,Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Beier, Kevin T.; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; Stanford University	Dan, Y (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Helen Wills Neurosci Inst, Div Neurobiol,Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	ydan@berkeley.edu	Core, Vector/CAF-4832-2022; Xu, Min/AGD-5135-2022	Xu, Min/0000-0002-6936-7543; Luo, Liqun/0000-0001-5467-9264; Beier, Kevin/0000-0002-4934-1338; Dan, Yang/0000-0002-3818-877X	EMBO; Human Frontier Science Program; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA038913] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank A. Popescu for the help with in vivo physiology, M. Bikov and S. Chung for technical assistance, the University of North Carolina Virus Core for supplying AAV, and T. Kilduff and J. Cox for discussions. This work was supported by EMBO and Human Frontier Science Program postdoctoral fellowships (to F.W.).	Anikeeva P, 2012, NAT NEUROSCI, V15, P163, DOI 10.1038/nn.2992; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; ASERINSKY E, 1953, SCIENCE, V118, P273, DOI 10.1126/science.118.3062.273; ASTONJONES G, 1986, SCIENCE, V234, P734, DOI 10.1126/science.3775363; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Boissard R, 2003, EUR J NEUROSCI, V18, P1627, DOI 10.1046/j.1460-9568.2003.02861.x; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; Clement O, 2011, SLEEP, V34, P419, DOI 10.1093/sleep/34.4.419; DEMENT W, 1958, ELECTROEN CLIN NEURO, V10, P291, DOI 10.1016/0013-4694(58)90037-3; Franklin K.B.J., 2007, MOUSE BRAIN STEREOTA, P88; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; HOLMES CJ, 1994, NEUROSCIENCE, V62, P1179, DOI 10.1016/0306-4522(94)90352-2; Jego S, 2013, NAT NEUROSCI, V16, P1637, DOI 10.1038/nn.3522; JOUVET M, 1962, Arch Ital Biol, V100, P125; Kaur S, 2001, SYNAPSE, V42, P141, DOI 10.1002/syn.1109; Kohyama J, 1998, SLEEP, V21, P695, DOI 10.1093/sleep/21.7.695; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; LOEWY AD, 1981, BRAIN RES REV, V3, P63, DOI 10.1016/0165-0173(81)90012-6; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; MAGOUN HW, 1946, J NEUROPHYSIOL, V9, P165, DOI 10.1152/jn.1946.9.3.165; Maloney KJ, 2000, J NEUROSCI, V20, P4669, DOI 10.1523/JNEUROSCI.20-12-04669.2000; Miyamichi K, 2013, NEURON, V80, P1232, DOI 10.1016/j.neuron.2013.08.027; SAKAI K, 1979, CR ACAD SCI D NAT, V289, P557; Sapin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004272; SCHENKEL E, 1989, NEUROSCI LETT, V98, P159, DOI 10.1016/0304-3940(89)90503-X; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; SIEGEL JM, 1983, BRAIN RES, V268, P344, DOI 10.1016/0006-8993(83)90501-2; SIEGEL JM, 1979, BRAIN RES, V179, P49, DOI 10.1016/0006-8993(79)90488-8; Sirieix C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028724; Taheri S, 2002, ANNU REV NEUROSCI, V25, P283, DOI 10.1146/annurev.neuro.25.112701.142826; Van Dort CJ, 2015, P NATL ACAD SCI USA, V112, P584, DOI 10.1073/pnas.1423136112; VANNIMERCIER G, 1991, NEUROSCI LETT, V130, P41, DOI 10.1016/0304-3940(91)90222-F; WEBSTER HH, 1986, SLEEP, V9, P1; WHITE SR, 1991, PROG BRAIN RES, V88, P343	34	164	170	3	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					435	+		10.1038/nature14979	http://dx.doi.org/10.1038/nature14979			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26444238	Green Accepted, Green Submitted			2022-12-28	WOS:000362730200052
J	Guh, AY; Bulens, SN; Mu, Y; Jacob, JT; Reno, J; Scott, J; Wilson, LE; Vaeth, E; Lynfield, R; Shaw, KM; Vagnone, PMS; Bamberg, WM; Janelle, SJ; Dumyati, G; Concannon, C; Beldavs, Z; Cunningham, M; Cassidy, PM; Phipps, EC; Kenslow, N; Travis, T; Lonsway, D; Rasheed, JK; Limbago, BM; Kallen, AJ				Guh, Alice Y.; Bulens, Sandra N.; Mu, Yi; Jacob, Jesse T.; Reno, Jessica; Scott, Janine; Wilson, Lucy E.; Vaeth, Elisabeth; Lynfield, Ruth; Shaw, Kristin M.; Vagnone, Paula M. Snippes; Bamberg, Wendy M.; Janelle, Sarah J.; Dumyati, Ghinwa; Concannon, Cathleen; Beldavs, Zintars; Cunningham, Margaret; Cassidy, P. Maureen; Phipps, Erin C.; Kenslow, Nicole; Travis, Tatiana; Lonsway, David; Rasheed, J. Kamile; Limbago, Brandi M.; Kallen, Alexander J.			Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ESCHERICHIA-COLI INFECTION; SPECTRUM BETA-LACTAMASE; TERM-CARE FACILITIES; KLEBSIELLA-PNEUMONIAE; UNITED-STATES; ACTIVE SURVEILLANCE; PREVENTION; EMERGENCE; BURDEN	IMPORTANCE Carbapenem-resistant Enterobacteriaceae (CRE) are increasingly reported worldwide as a cause of infections with high-mortality rates. Assessment of the US epidemiology of CRE is needed to inform national prevention efforts. OBJECTIVE To determine the population-based CRE incidence and describe the characteristics and resistance mechanism associated with isolates from 7 US geographical areas. DESIGN, SETTING, AND PARTICIPANTS Population-and laboratory-based active surveillance of CRE conducted among individuals living in 1 of 7 US metropolitan areas in Colorado, Georgia, Maryland, Minnesota, New Mexico, New York, and Oregon. Cases of CRE were defined as carbapenem-nonsusceptible (excluding ertapenem) and extended-spectrum cephalosporin-resistant Escherichia coli, Enterobacter aerogenes, Enterobacter cloacae complex, Klebsiella pneumoniae, or Klebsiella oxytoca that were recovered from sterile-site or urine cultures during 2012-2013. Case records were reviewed and molecular typing for common carbapenemases was performed. EXPOSURES Demographics, comorbidities, health care exposures, and culture source and location. MAIN OUTCOMES AND MEASURES Population-based CRE incidence, site-specific standardized incidence ratios (adjusted for age and race), and clinical and microbiological characteristics. RESULTS Among 599 CRE cases in 481 individuals, 520 (86.8%; 95% CI, 84.1%-89.5%) were isolated from urine and 68 (11.4%; 95% CI, 8.8%-13.9%) from blood. The median age was 66 years (95% CI, 62.1-65.4 years) and 284 (59.0%; 95% CI, 54.6%-63.5%) were female. The overall annual CRE incidence rate per 100 000 population was 2.93 (95% CI, 2.65-3.23). The CRE standardized incidence ratio was significantly higher than predicted for the sites in Georgia (1.65 [95% CI, 1.20-2.25]; P < .001), Maryland (1.44 [95% CI, 1.06-1.96]; P = .001), and New York (1.42 [95% CI, 1.05-1.92]; P = .048), and significantly lower than predicted for the sites in Colorado (0.53 [95% CI, 0.39-0.71]; P < .001), New Mexico (0.41 [95% CI, 0.30-0.55]; P = .01), and Oregon (0.28 [95% CI, 0.21-0.38]; P < .001). Most cases occurred in individuals with prior hospitalizations (399/531 [75.1%; 95% CI, 71.4%-78.8%]) or indwelling devices (382/525 [72.8%; 95% CI, 68.9%-76.6%]); 180 of 322 (55.9%; 95% CI, 50.0%-60.8%) admitted cases resulted in a discharge to a long-term care setting. Death occurred in 51 (9.0%; 95% CI, 6.6%-11.4%) cases, including in 25 of 91 cases (27.5%; 95% CI, 18.1%-36.8%) with CRE isolated from normally sterile sites. Of 188 isolates tested, 90 (47.9%; 95% CI, 40.6%-55.1%) produced a carbapenemase. CONCLUSIONS AND RELEVANCE In this population-and laboratory-based active surveillance system in 7 states, the incidence of CRE was 2.93 per 100 000 population. Most CRE cases were isolated from a urine source, and were associated with high prevalence of prior hospitalizations or indwelling devices, and discharge to long-term care settings.	[Guh, Alice Y.; Bulens, Sandra N.; Mu, Yi; Travis, Tatiana; Lonsway, David; Rasheed, J. Kamile; Limbago, Brandi M.; Kallen, Alexander J.] US Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30329 USA; [Jacob, Jesse T.] Emory Univ, Sch Med, Atlanta, GA USA; [Jacob, Jesse T.; Reno, Jessica; Scott, Janine] Georgia Emerging Infect Program, Decatur, GA USA; [Reno, Jessica; Scott, Janine] Atlanta Res & Educ Fdn, Decatur, GA USA; [Reno, Jessica; Scott, Janine] Atlanta Vet Affairs Med Ctr, Atlanta, GA USA; [Wilson, Lucy E.; Vaeth, Elisabeth] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA; [Lynfield, Ruth; Shaw, Kristin M.; Vagnone, Paula M. Snippes] Minnesota Dept Hlth, St Paul, MN USA; [Bamberg, Wendy M.; Janelle, Sarah J.] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Dumyati, Ghinwa; Concannon, Cathleen] New York Emerging Infect Program, Rochester, NY USA; [Dumyati, Ghinwa; Concannon, Cathleen] Univ Rochester, Med Ctr, Rochester, NY 14627 USA; [Beldavs, Zintars; Cunningham, Margaret; Cassidy, P. Maureen] Oregon Hlth Author, Portland, OR USA; [Phipps, Erin C.; Kenslow, Nicole] Univ New Mexico, Albuquerque, NM 87131 USA	Centers for Disease Control & Prevention - USA; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Maryland Department of Health & Mental Hygiene; Minnesota Department of Health (MHD); Colorado Department of Public Health & Environment; University of Rochester; University of New Mexico	Kallen, AJ (corresponding author), US Ctr Dis Control & Prevent, Div Healthcare Qual Promot, 1600 Clifton Rd,MS A-31, Atlanta, GA 30329 USA.	akallen@cdc.gov	Jacob, Jesse/A-8836-2009; jacob, jesse/P-5664-2019	jacob, jesse/0000-0001-9811-6260	Emerging Infections Program; National Center for Emerging and Zoonotic Infectious Diseases at the US Centers for Disease Control and Prevention	Emerging Infections Program; National Center for Emerging and Zoonotic Infectious Diseases at the US Centers for Disease Control and Prevention	This work was supported by the Emerging Infections Program and the National Center for Emerging and Zoonotic Infectious Diseases at the US Centers for Disease Control and Prevention.	Association for Professionals in Infection Control and Epidemiology Inc, 2015, SUMM STAT CRE REP RE; Banerjee R, 2013, INFECT CONT HOSP EP, V34, P947, DOI 10.1086/671725; Chitnis AS, 2012, INFECT CONT HOSP EP, V33, P984, DOI 10.1086/667738; Cleveland AA, 2012, CLIN INFECT DIS, V55, P1352, DOI 10.1093/cid/cis697; Clinical and Laboratory Standards Institute, 2012, PERF STAND ANT SUSC; Dantes R, 2013, JAMA INTERN MED, V173, P1970, DOI 10.1001/jamainternmed.2013.10423; Doi Y, 2013, CLIN INFECT DIS, V56, P641, DOI 10.1093/cid/cis942; Elemam A, 2009, CLIN INFECT DIS, V49, P271, DOI 10.1086/600042; Gaviria Diana, 2011, Morbidity and Mortality Weekly Report, V60, P1418; Guh AY, 2014, EXPERT REV ANTI-INFE, V12, P565, DOI 10.1586/14787210.2014.902306; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Jacob JT, 2013, MMWR-MORBID MORTAL W, V62, P165; Kitchel B, 2013, 53 M ICAC DENV COL S; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Lin MY, 2013, CLIN INFECT DIS, V57, P1246, DOI 10.1093/cid/cit500; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Prabaker K, 2012, INFECT CONT HOSP EP, V33, P1193, DOI 10.1086/668435; Rasheed JK, 2013, EMERG INFECT DIS, V19, P870, DOI 10.3201/eid1906.121515; Reno J, 2014, INFECT CONT HOSP EP, V35, P336, DOI 10.1086/675608; Rodriguez-Bano J, 2009, J ANTIMICROB CHEMOTH, V63, P781, DOI 10.1093/jac/dkp028; Rosamond, UNDERSTANDING FUNDAM; Stone ND, 2012, INFECT CONT HOSP EP, V33, P965, DOI 10.1086/667743; United States Census Bureau, POPULATION ESTIMATES; US Centers for Disease Control and Prevention, UR TRACT INF UTI EV; US Centers for Disease Control and Prevention, TRACK CRE; US Centers for Disease Control and Prevention, GUID CONTR CARB RES; Won SY, 2011, CLIN INFECT DIS, V53, P532, DOI 10.1093/cid/cir482	29	212	230	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2015	314	14					1479	1487		10.1001/jama.2015.12480	http://dx.doi.org/10.1001/jama.2015.12480			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2QI	26436831	Green Accepted, Bronze			2022-12-28	WOS:000362647800015
J	D'Silva, J				D'Silva, Jeetha			BMJ AWARDS SOUTH ASIA 2015 BMJ Awards South Asia 2015: judging South Asia's unsung healthcare heroes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												j.dsilva@gmail.com						[Anonymous], 2011, DAWN; Chawla B, 2016, BRIT J OPHTHALMOL, V100, P172, DOI 10.1136/bjophthalmol-2015-306672; D'Silva J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3426; D'Silva J, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5454; World Health Organization, RET	5	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 7	2015	351								h5305	10.1136/bmj.h5305	http://dx.doi.org/10.1136/bmj.h5305			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT3SJ	26445977				2022-12-28	WOS:000362726900008
J	Steiner, CA; Maggard-Gibbons, M; Raetzman, SO; Barrett, ML; Sacks, GD; Owens, PL				Steiner, Claudia A.; Maggard-Gibbons, Melinda; Raetzman, Susan Oehme; Barrett, Marguerite L.; Sacks, Greg D.; Owens, Pamela L.			Return to Acute Care Following Ambulatory Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Steiner, Claudia A.; Owens, Pamela L.] Agcy Healthcare Res & Qual, Ctr Delivery Org & Markets, Rockville, MD 20850 USA; [Maggard-Gibbons, Melinda] RAND Corp, Santa Monica, CA USA; [Raetzman, Susan Oehme] Truven Hlth Analyt, Bethesda, MD USA; [Barrett, Marguerite L.] ML Barrett Inc, Del Mar, CA USA; [Sacks, Greg D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA	Agency for Healthcare Research & Quality; RAND Corporation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Steiner, CA (corresponding author), Agcy Healthcare Res & Qual, 540 Gaither Rd, Rockville, MD 20850 USA.	claudia.steiner@ahrq.hhs.gov						Agency for Healthcare Research and Quality, 2014, HEALTHC COST UT PROJ; Coley KC, 2002, J CLIN ANESTH, V14, P349, DOI 10.1016/S0952-8180(02)00371-9; Morton JM, 2014, ANN SURG, V259, P286, DOI 10.1097/SLA.0000000000000227; National Center for Health Statistics, HLTH US 2012 SPEC FE; Owens PL, 2014, JAMA-J AM MED ASSOC, V311, P709, DOI 10.1001/jama.2014.4; Perron-Burdick M, 2011, OBSTET GYNECOL, V117, P1136, DOI 10.1097/AOG.0b013e318215dd4e	6	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2015	314	13					1397	1399		10.1001/jama.2015.12210	http://dx.doi.org/10.1001/jama.2015.12210			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2PH	26441186	Bronze			2022-12-28	WOS:000362644700019
J	Victora, CG; Requejo, JH; Barros, AJD; Berman, P; Bhutta, Z; Boerma, T; Chopra, M; de Francisco, A; Daelmans, B; Hazel, E; Lawn, J; Maliqi, B; Newby, H; Bryce, J				Victora, Cesar G.; Requejo, Jennifer Harris; Barros, Aluisio J. D.; Berman, Peter; Bhutta, Zulfiqar; Boerma, Ties; Chopra, Mickey; de Francisco, Andres; Daelmans, Bernadette; Hazel, Elizabeth; Lawn, Joy; Maliqi, Blerta; Newby, Holly; Bryce, Jennifer			Countdown to 2015: a decade of tracking progress for maternal, newborn, and child survival	LANCET			English	Review							HEALTH INTERVENTIONS; DEVELOPMENT ASSISTANCE; UNDER-5 MORTALITY; DEVELOPMENT GOALS; COVERAGE; EQUITY; UNDERNUTRITION; CARE; GAP	Conceived in 2003 and born in 2005 with the launch of its first report and country profiles, the Countdown to 2015 for Maternal, Newborn, and Child Survival has reached its originally proposed lifespan. Major reductions in the deaths of mothers and children have occurred since Countdown's inception, even though most of the 75 priority countries failed to achieve Millennium Development Goals 4 and 5. The coverage of life-saving interventions tracked in Countdown increased steadily over time, but wide inequalities persist between and within countries. Key drivers of coverage such as financing, human resources, commodities, and conducive health policies also showed important, yet insufficient increases. As a multistakeholder initiative of more than 40 academic, international, bilateral, and civil society institutions, Countdown was successful in monitoring progress and raising the visibility of the health of mothers, newborns, and children. Lessons learned from this initiative have direct bearing on monitoring progress during the Sustainable Development Goals era.	[Victora, Cesar G.; Barros, Aluisio J. D.] Univ Fed Pelotas, BR-96001 Pelotas, Brazil; [Requejo, Jennifer Harris; de Francisco, Andres] Partnership Maternal Newborn & Child Hlth, Geneva, Switzerland; [Berman, Peter] Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA; [Bhutta, Zulfiqar] Hosp Sick Children, Robert Harding Chair Global Child Hlth & Policy, Ctr Global Child Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Bhutta, Zulfiqar] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Boerma, Ties; Daelmans, Bernadette; Maliqi, Blerta] World Hlth Org, Geneva, Switzerland; [Chopra, Mickey; Newby, Holly] United Nations Childrens Fund, New York, NY USA; [Hazel, Elizabeth; Bryce, Jennifer] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Baltimore, MD USA; [Lawn, Joy] London Sch Hyg & Trop Med, London WC1, England	Universidade Federal de Pelotas; Harvard University; Harvard T.H. Chan School of Public Health; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aga Khan University; World Health Organization; UNICEF; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine	Victora, CG (corresponding author), Univ Fed Pelotas, BR-96001 Pelotas, Brazil.	cvictora@gmail.com	Victora, Cesar G/D-4476-2013; Barros, Aluisio JD/A-7417-2008; Lawn, Joy/ABE-6382-2020; Victora, Cesar Gomes/Y-2455-2019; Bhutta, Zulfiqar/L-7822-2015	Victora, Cesar G/0000-0002-2465-2180; Barros, Aluisio JD/0000-0002-2022-8729; Lawn, Joy/0000-0002-4573-1443; Victora, Cesar Gomes/0000-0002-2465-2180; Hazel, Elizabeth A./0000-0002-9176-3278; Bhutta, Zulfiqar/0000-0003-0637-599X	Bill & Melinda Gates Foundation; Wellcome Trust; World Bank; Governments of Australia, Canada, Norway, Sweden, the USA; Governments of Australia, Canada, Norway, Sweden, the UK	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Wellcome Trust(Wellcome TrustEuropean Commission); World Bank(The World Bank India); Governments of Australia, Canada, Norway, Sweden, the USA; Governments of Australia, Canada, Norway, Sweden, the UK	The views expressed are of the individual authors and not of the World Health Organization. Our work was supported by the Bill & Melinda Gates Foundation, the Wellcome Trust, the World Bank, and the Governments of Australia, Canada, Norway, Sweden, the USA, and the UK. The funders had no role in the conceptualisation of the paper or in the material presented. Countdown would like to thank the following: Lois Park, Colleen Murray, Agbessi Amouzou, Liliana Carvajal, Courtney Ng, Neha Singh, Giovanny Franca, Fernando Wehrmeister, Amani Syam, Matthews Matthai, Jo Borghi, Robin Gorna, Adam Deixel, Corrina Moucheraud, Helen Owen, Robert Black, and Li Liu.	AbouZahr C, 2011, REPROD HEALTH MATTER, V19, P117, DOI 10.1016/S0968-8080(11)37550-7; Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; [Anonymous], 2012, BUILD FUT WOM CHILDR; [Anonymous], 2008, CLOS GAP GEN HLTH EQ; [Anonymous], 2005, TRACK PROGR CHILD SU; [Anonymous], 2008, TRACK PROGR MAT NEON; [Anonymous], 2010, COUNTD 2015 DEC REP; [Anonymous], 2014, COUNTD 2015 FULF HLT; [Anonymous], 2013, COUNTD 2015 ACC MAT; [Anonymous], 2015, ECONOMIST; Arregoces L, 2015, LANCET GLOB HEALTH, V3, pE410, DOI 10.1016/S2214-109X(15)00057-1; Barros AJD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001390; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Beaglehole R, NCD COUNTDOWN 2025 A; Bhutta ZA, 2016, LANCET, V387, P2060, DOI 10.1016/S0140-6736(15)00527-9; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Campbell H, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001422, 10.1371/journal.pmed.1001421]; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; Commission on information and accountability for Womens and Childrens Health, 2011, KEEP PROM MEAS RES; Dean SV, 2014, REPROD HEALTH, V11, DOI [10.1186/1742-4755-11-S3-S1, 10.1186/1742-4755-11-S3-S3]; Desalegn H, 2015, LANCET, V386, P105, DOI 10.1016/S0140-6736(15)61224-7; Dieleman JL, 2015, JAMA-J AM MED ASSOC, V313, P2359, DOI 10.1001/jama.2015.5825; El Arifeen S, 2014, LANCET, V384, P1366, DOI 10.1016/S0140-6736(14)60955-7; Fund UNsC, 2015, AV LEARN MDGS; Handley K, 2015, LANCET GLOB HEALTH, V3, pE437, DOI 10.1016/S2214-109X(15)00067-4; Independent Expert Review Group, 2015, EV WOM EV CHILD EV A; International Food Policy Research Institute, 2015, GLOB NUTR REP 2015 A; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Mason E, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S3-S8; Misra S, 2014, REPORT EXTERNAL REV; Organization GHWAaWH, 2013, UN TRUTH NO HLTH WOR; Requejo J, 2014, INT J EPIDEMIOL, V43, P586, DOI 10.1093/ije/dyu034; Requejo JH, 2015, LANCET, V385, P466, DOI 10.1016/S0140-6736(14)60925-9; Requejo JH, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001416; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Schmidt H, 2015, LANCET, V386, P928, DOI 10.1016/S0140-6736(15)60244-6; Stokstad E, 2015, SCIENCE, V347, P702, DOI 10.1126/science.347.6223.702; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Waage J, 2010, LANCET, V376, P991, DOI 10.1016/S0140-6736(10)61196-8; Walker N, 2013, LANCET, V382, P1029, DOI 10.1016/S0140-6736(13)61748-1; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; WHO, 2007, EV BUS STRENGTH HLTH; [WHO Partnership for Maternal NaCH], 2014, MULT POL COMP RMNCH; [World Health Organization UNCsF United Nations Population Fund United Nations Population Division and World Bank Maternal mortality estimation inter-agency group], 2014, TRENDS MAT MORT 1990; You DZ, 2015, LANCET, V386, P2275, DOI 10.1016/S0140-6736(15)00120-8	53	213	218	0	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2016	387	10032					2049	2059		10.1016/S0140-6736(15)00519-X	http://dx.doi.org/10.1016/S0140-6736(15)00519-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8HJ	26477328	Green Accepted, Bronze			2022-12-28	WOS:000375881500034
J	Gladman, DD				Gladman, Dafna D.			Is it time for treat to target in psoriatic arthritis?	LANCET			English	Editorial Material							INTERNATIONAL TASK-FORCE; MINIMAL DISEASE-ACTIVITY; RHEUMATOID-ARTHRITIS; RECOMMENDATIONS; TRIAL		[Gladman, Dafna D.] Toronto Western Hosp, Ctr Prognosis Studies Rheumat Dis, Toronto, ON M5T 2S8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Gladman, DD (corresponding author), Toronto Western Hosp, Ctr Prognosis Studies Rheumat Dis, Toronto, ON M5T 2S8, Canada.	dafna.gladman@utoronto.ca						COATES L, 2015, LANCET; Coates LC, 2010, ANN RHEUM DIS, V69, P48, DOI 10.1136/ard.2008.102053; Coates LC, 2010, ARTHRIT CARE RES, V62, P965, DOI 10.1002/acr.20155; Coates LC, 2010, ARTHRIT CARE RES, V62, P970, DOI 10.1002/acr.20162; Grigor C, 2004, LANCET, V364, P263, DOI 10.1016/S0140-6736(04)16676-2; Kavanaugh A, 2016, ARTHRIT CARE RES, V68, P267, DOI 10.1002/acr.22576; Smolen JS, 2014, ANN RHEUM DIS, V73, P6, DOI 10.1136/annrheumdis-2013-203419; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Solomon DH, 2014, ARTHRITIS RHEUMATOL, V66, P775, DOI 10.1002/art.38323	9	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 19	2015	386	10012					2450	2452		10.1016/S0140-6736(15)00348-7	http://dx.doi.org/10.1016/S0140-6736(15)00348-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ1LD	26433319				2022-12-28	WOS:000366866400007
J	Menon, DK; Maas, AIR				Menon, David K.; Maas, Andrew I. R.			EPO in traumatic brain injury: two strikes ... but not out?	LANCET			English	Editorial Material									[Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge CB2 2QQ, England; [Maas, Andrew I. R.] Univ Antwerp, Univ Antwerp Hosp, Dept Neurosurg, Edegem, Belgium	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Antwerp	Menon, DK (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge CB2 2QQ, England.	dkm13@wbic.cam.ac.uk			National Institute for Health Research [NF-SI-0512-10090] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Collino M, 2015, PHARMACOL THERAPEUT, V151, P32, DOI 10.1016/j.pharmthera.2015.02.005; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; JENNETT B, 1975, LANCET, V1, P480; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Nichol A, 2015, LANCET; Ponce Lucido L, 2013, Pathophysiology, V20, P31, DOI 10.1016/j.pathophys.2012.02.005; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; US Food and Drug Administration, 2013, PRESCR INF EP EP ALF	10	4	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 19	2015	386	10012					2452	2454		10.1016/S0140-6736(15)00387-6	http://dx.doi.org/10.1016/S0140-6736(15)00387-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ1LD	26452708				2022-12-28	WOS:000366866400008
J	Lenze, EJ; Mulsant, BH; Blumberger, DM; Karp, JF; Newcomer, JW; Anderson, SJ; Dew, MA; Butters, MA; Stack, JA; Begley, AE; Reynolds, CF				Lenze, Eric J.; Mulsant, Benoit H.; Blumberger, Daniel M.; Karp, Jordan F.; Newcomer, John W.; Anderson, Stewart J.; Dew, Mary Amanda; Butters, Meryl A.; Stack, Jacqueline A.; Begley, Amy E.; Reynolds, Charles F., III			Effi cacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							MAJOR DEPRESSION; INTERPERSONAL PSYCHOTHERAPY; GERIATRIC OUTPATIENTS; INCOMPLETE RESPONSE; OLDER; ANTIDEPRESSANTS; DISORDER; SCALE; NORTRIPTYLINE; METAANALYSIS	Background Treatment-resistant major depression is common and potentially life-threatening in elderly people, in whom little is known about the benefits and risks of augmentation pharmacotherapy. We aimed to assess whether aripiprazole is associated with a higher probability of remission than is placebo. Methods We did a randomised, double-blind, placebo-controlled trial at three centres in the USA and Canada to test the efficacy and safety of aripiprazole augmentation for adults aged older than 60 years with treatment-resistant depression (Montgomery Asberg Depression Rating Scale [MADRS] score of >= 15). Patients who did not achieve remission during a pre-trial with venlafaxine extended-release (150-300 mg/day) were randomly assigned (1: 1) to the addition of aripiprazole (target dose 10 mg [maximum 15 mg] daily) daily or placebo for 12 weeks. The computer-generated randomisation was done in blocks and stratified by site. Only the database administrator and research pharmacists had knowledge of treatment assignment. The primary endpoint was remission, defined as an MADRS score of 10 or less (and at least 2 points below the score at the start of the randomised phase) at both of the final two consecutive visits, analysed by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00892047. Findings From July 20, 2009, to Dec 30, 2013, we recruited 468 eligible participants, 181 (39%) of whom did not remit and were randomly assigned to aripiprazole (n=91) or placebo (n=90). A greater proportion of participants in the aripiprazole group achieved remission than did those in the placebo group (40 [44%] vs 26 [29%] participants; odds ratio [OR] 2.0 [95% CI 1.1-3.7], p=0.03; number needed to treat [NNT] 6.6 [95% CI 3.5-81.8]). Akathisia was the most common adverse effect of aripiprazole (reported in 24 [26%] of 91 participants on aripiprazole vs 11 [12%] of 90 on placebo). Compared with placebo, aripiprazole was also associated with more Parkinsonism (15 [17%] of 86 vs two [2%] of 81 participants), but not with treatment-emergent suicidal ideation (13 [21%] of 61 vs 19 [29%] of 65 participants) or other measured safety variables. Interpretation In adults aged 60 years or older who do not achieve remission from depression with a first-line antidepressant, the addition of aripiprazole is effective in achieving and sustaining remission. Tolerability concerns include the potential for akathisia and Parkinsonism.	[Lenze, Eric J.] Washington Univ, Sch Med, St Louis, MO USA; [Mulsant, Benoit H.; Blumberger, Daniel M.] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Mulsant, Benoit H.; Blumberger, Daniel M.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Karp, Jordan F.; Dew, Mary Amanda; Butters, Meryl A.; Stack, Jacqueline A.; Begley, Amy E.; Reynolds, Charles F., III] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Newcomer, John W.] Florida Atlantic Univ, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA; [Anderson, Stewart J.; Reynolds, Charles F., III] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA	Washington University (WUSTL); University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University System of Florida; Florida Atlantic University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lenze, EJ (corresponding author), 660 S Euclid,Box 8134, St Louis, MO 63110 USA.	lenzee@psychiatry.wustl.edu	Butters, Meryl/AAR-2863-2021; Lenze, Eric J/AAW-8652-2021	Anderson, Stewart/0000-0001-8948-0650; Lenze, Eric/0000-0002-0471-9368; Newcomer, John/0000-0003-2153-9382	National Institute of Mental Health; UPMC Endowment in Geriatric Psychiatry; Taylor Family Institute for Innovative Psychiatric Research; National Center for Advancing Translational Sciences; Campbell Family Mental Health Research Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, UL1TR000005, KL2TR000146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090250, P30MH090333, R01MH083648, R01MH083660, R01MH083643, R01MH084921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024827, R01AG049369] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); UPMC Endowment in Geriatric Psychiatry; Taylor Family Institute for Innovative Psychiatric Research; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Campbell Family Mental Health Research Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute of Mental Health, UPMC Endowment in Geriatric Psychiatry, Taylor Family Institute for Innovative Psychiatric Research, National Center for Advancing Translational Sciences, and the Campbell Family Mental Health Research Institute.	Allard P, 2004, INT J GERIATR PSYCH, V19, P1123, DOI 10.1002/gps.1190; Amiel JM, 2008, CURR OPIN PSYCHIATR, V21, P613, DOI 10.1097/YCO.0b013e328314b74b; Ballard C, 2009, LANCET NEUROL, V8, P151, DOI 10.1016/S1474-4422(08)70295-3; Beach SR, 2013, PSYCHOSOMATICS, V54, P1, DOI 10.1016/j.psym.2012.11.001; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; Bruce ML, 2004, JAMA-J AM MED ASSOC, V291, P1081, DOI 10.1001/jama.291.9.1081; Cooper C, 2011, AM J PSYCHIAT, V168, P681, DOI 10.1176/appi.ajp.2011.10081165; Crossley NA, 2007, J CLIN PSYCHIAT, V68, P935, DOI 10.4088/JCP.v68n0617; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT, V18; Eden J., 2012, MENTAL HLTH SUBSTANC; Friedman RA, 2014, NEW ENGL J MED, V371, P1666, DOI 10.1056/NEJMp1408480; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Haupt DW, 2007, NEUROPSYCHOPHARMACOL, V32, P2561, DOI 10.1038/sj.npp.1301392; Hedeker D., 2006, LONGITUDINAL DATA AN; Hirose T, 2004, J PSYCHOPHARMACOL, V18, P375, DOI 10.1177/026988110401800308; Kamel EG, 2000, INT J OBESITY, V24, P607, DOI 10.1038/sj.ijo.0801204; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kinon BJ, 2015, J GERIATR PSYCH NEUR, V28, P67, DOI 10.1177/0891988714541867; Leontjevas R, 2013, LANCET, V381, P2255, DOI 10.1016/S0140-6736(13)60590-5; Lingjaerde O, 1987, Acta Psychiatr Scand Suppl, V334, P1; Mamo D, 2007, AM J PSYCHIAT, V164, P1411, DOI 10.1176/appi.ajp.2007.06091479; Maust DT, 2013, AM J GERIAT PSYCHIAT, V21, P973, DOI 10.1016/j.jagp.2013.01.030; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Nelson JC, 2008, AM J GERIAT PSYCHIAT, V16, P558, DOI 10.1097/JGP.0b013e3181693288; Nelson JC, 2009, AM J PSYCHIAT, V166, P980, DOI 10.1176/appi.ajp.2009.09030312; Randolph C., 1998, REPEATABLE BATTERY A; Raskin J, 2007, AM J PSYCHIAT, V164, P900, DOI 10.1176/appi.ajp.164.6.900; Reynolds CF, 2006, NEW ENGL J MED, V354, P1130, DOI 10.1056/NEJMoa052619; Reynolds CF, 1999, JAMA-J AM MED ASSOC, V281, P39, DOI 10.1001/jama.281.1.39; Reynolds CF, 2010, INT J GERIATR PSYCH, V25, P1134, DOI 10.1002/gps.2443; Rutherford B, 2007, INT J GERIATR PSYCH, V22, P986, DOI 10.1002/gps.1775; Schatzberg A, 2006, AM J GERIAT PSYCHIAT, V14, P361, DOI 10.1097/01.JGP.0000194645.70869.3b; Schneider LS, 2006, NEW ENGL J MED, V355, P1525, DOI 10.1056/NEJMoa061240; SENN S, 1994, STAT MED, V13, P1715, DOI 10.1002/sim.4780131703; Sheffrin M, 2009, J CLIN PSYCHIAT, V70, P208, DOI 10.4088/JCP.07m03805; Steffens DC, 2011, INT J GERIATR PSYCH, V26, P564, DOI 10.1002/gps.2564; Trivedi MH, 2006, NEW ENGL J MED, V354, P1243, DOI 10.1056/NEJMoa052964; Ware JE, 1993, SF36 HLTH SURVEY MAN; Weber E, 2000, AM J GERIAT PSYCHIAT, V8, P245; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6	41	125	128	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2015	386	10011					2404	2412		10.1016/S0140-6736(15)00308-6	http://dx.doi.org/10.1016/S0140-6736(15)00308-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY3EE	26423182	Green Accepted, Bronze			2022-12-28	WOS:000366290400034
J	Ginsburg, PB; Rivlin, AM				Ginsburg, Paul B.; Rivlin, Alice M.			Challenges for Medicare at 50	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ginsburg, Paul B.] Univ So Calif, Price Sch Publ Policy, Los Angeles, CA 90089 USA; [Ginsburg, Paul B.] Univ So Calif, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA; [Rivlin, Alice M.] Brookings Inst, Ctr Hlth Policy, Washington, DC 20036 USA	University of Southern California; University of Southern California; Brookings Institution	Ginsburg, PB (corresponding author), Univ So Calif, Price Sch Publ Policy, Los Angeles, CA 90089 USA.							Aaron HJ, 2015, WORKING PAPER SERIES; Congressional Budget Office, 2013, PREM SUPP SYST MED A; Miller HD, 2015, BUNDLING BADLY PROBL	3	6	6	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2015	373	21					1993	1995		10.1056/NEJMp1511272	http://dx.doi.org/10.1056/NEJMp1511272			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW4JN	26422645				2022-12-28	WOS:000364957700002
J	Tao, YY; Cheung, LS; Li, S; Eom, JS; Chen, LQ; Xu, Y; Perry, K; Frommer, WB; Feng, L				Tao, Yuyong; Cheung, Lily S.; Li, Shuo; Eom, Joon-Seob; Chen, Li-Qing; Xu, Yan; Perry, Kay; Frommer, Wolf B.; Feng, Liang			Structure of a eukaryotic SWEET transporter in a homotrimeric complex	NATURE			English	Article							SUGAR TRANSPORTER; CRYSTAL-STRUCTURE; PROTEIN; BACTERIAL; OLIGOMERIZATION; NUTRITION; MECHANISM	Eukaryotes rely on efficient distribution of energy and carbon skeletons between organs in the form of sugars. Glucose in animals and sucrose in plants serve as the dominant distribution forms. Cellular sugar uptake and release require vesicular and/or plasma membrane transport proteins. Humans and plants use proteins from three superfamilies for sugar translocation: the major facilitator superfamily (MFS), the sodium solute symporter family (SSF; only in the animal kingdom), and SWEETs1-5. SWEETs carry mono-and disaccharides(6) across vacuolar or plasma membranes. Plant SWEETs play key roles in sugar translocation between compartments, cells, and organs, notably in nectar secretion(7), phloem loading for long distance translocation(8), pollen nutrition(9), and seed filling(10). Plant SWEETs cause pathogen susceptibility possibly by sugar leakage from infected cells(3,11,12). The vacuolar Arabidopsis thaliana AtSWEET2 sequesters sugars in root vacuoles; loss-of-function mutants show increased susceptibility to Pythium infection(13). Here we show that its orthologue, the vacuolar glucose transporter OsSWEET2b from rice (Oryza sativa), consists of an asymmetrical pair of triple-helix bundles, connected by an inversion linker transmembrane helix (TM4) to create the translocation pathway. Structural and biochemical analyses show OsSWEET2b in an apparent inward (cytosolic) open state forming homomeric trimers. TM4 tightly interacts with the first triple-helix bundle within a protomer and mediates key contacts among protomers. Structure-guided mutagenesis of the close paralogue SWEET1 from Arabidopsis identified key residues in substrate translocation and protomer crosstalk. Insights into the structure-function relationship of SWEETs are valuable for understanding the transport mechanism of eukaryotic SWEETs and may be useful for engineering sugar flux.	[Tao, Yuyong; Li, Shuo; Xu, Yan; Feng, Liang] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Cheung, Lily S.; Eom, Joon-Seob; Chen, Li-Qing; Frommer, Wolf B.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Li, Shuo] Sichuan Univ, Coll Life Sci, Ctr Growth Metab & Aging, Key Lab Bioresource & Ecoenvironm,Minist Educ, Chengdu 610014, Peoples R China; [Perry, Kay] Cornell Univ, Argonne Natl Lab, NE CAT, Argonne, IL 60439 USA; [Perry, Kay] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, Argonne, IL 60439 USA	Stanford University; Carnegie Institution for Science; Sichuan University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Feng, L (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA.	liangf@stanford.edu	Frommer, Wolf B/K-5042-2017; Cheung, Lily S/AAA-8344-2022; Frommer, Wolf B/A-8256-2008	Frommer, Wolf B/0000-0001-6465-0115; Cheung, Lily S/0000-0001-8089-7783; Frommer, Wolf B/0000-0001-6465-0115	Stanford University; Harold and Leila Y. Mathers Charitable Foundation; Alfred P. Sloan Foundation; Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences at the US Department of Energy [DOE DE-FG02-04ER15542]; National Science Foundation [IOS-1258018]; National Science Foundation Postdoctoral Research Fellowship in Biology [1401855]; National Natural Science Foundation of China [31300618]; National Institute of General Medical Sciences (NIH) [P41 GM103403]; US DOE [DE-AC02-06CH11357]; Division Of Integrative Organismal Systems [1401855] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, R01GM117108] Funding Source: NIH RePORTER	Stanford University(Stanford University); Harold and Leila Y. Mathers Charitable Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences at the US Department of Energy; National Science Foundation(National Science Foundation (NSF)); National Science Foundation Postdoctoral Research Fellowship in Biology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of General Medical Sciences (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US DOE(United States Department of Energy (DOE)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at Beamline 23ID-B and 23ID-D (APS, Argon ne National Laboratory) and at Beamline 5.0.2 (Advanced Light Source) for assistance at the synchrotron. This work was made possible by support from Stanford University, the Harold and Leila Y. Mathers Charitable Foundation and the Alfred P. Sloan Foundation to L.F. and the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences at the US Department of Energy (DOE DE-FG02-04ER15542) to W.B.F. The functional characterization of OsSWEET2b was supported by grants from the National Science Foundation (IOS-1258018) to W.B.F. L.F. is a Klingenstein-Simons Fellow. L.S.C. was supported by the National Science Foundation Postdoctoral Research Fellowship in Biology (1401855). S.L. was supported by the National Natural Science Foundation of China (31300618). Part of this work was conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team, supported by a grant from the National Institute of General Medical Sciences (NIH, P41 GM103403). Use of the Advanced Photon Source, an Office of Science User Facility operated for the US Department of Energy (DOE) and the Office of Science by Argonne National Laboratory, was supported by US DOE (DE-AC02-06CH11357).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Chen HY, 2015, PLANT J, V83, P1046, DOI 10.1111/tpj.12948; Chen LQ, 2015, ANNU REV BIOCHEM, V84, P865, DOI 10.1146/annurev-biochem-060614-033904; Chen LQ, 2015, PLANT CELL, V27, P607, DOI 10.1105/tpc.114.134585; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cohn M, 2014, MOL PLANT MICROBE IN, V27, P1186, DOI 10.1094/MPMI-06-14-0161-R; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; De Zutter JK, 2013, J BIOL CHEM, V288, P20734, DOI 10.1074/jbc.M113.469023; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eom JS, 2015, CURR OPIN PLANT BIOL, V25, P53, DOI 10.1016/j.pbi.2015.04.005; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hou BH, 2011, NAT PROTOC, V6, P1818, DOI 10.1038/nprot.2011.392; Jaehme M, 2015, TRENDS BIOCHEM SCI, V40, P183, DOI 10.1016/j.tibs.2015.02.002; Jaehme M, 2014, NAT STRUCT MOL BIOL, V21, P1013, DOI 10.1038/nsmb.2909; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kazmier K, 2014, NAT STRUCT MOL BIOL, V21, P472, DOI 10.1038/nsmb.2816; Keller R, 2014, BIOL CHEM, V395, P1379, DOI 10.1515/hsz-2014-0224; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Lanquar V, 2009, PLANT CELL, V21, P3610, DOI 10.1105/tpc.109.068593; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7112; Lin IW, 2014, NATURE, V508, P1, DOI 10.1038/nature13082; Loque D, 2007, NATURE, V446, P195, DOI 10.1038/nature05579; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Niittylae T, 2007, MOL CELL PROTEOMICS, V6, P1711, DOI 10.1074/mcp.M700164-MCP200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RYPNIEWSKI WR, 1993, BIOCHEMISTRY-US, V32, P9851, DOI 10.1021/bi00088a041; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Sun MX, 2013, PLANT REPROD, V26, P83, DOI 10.1007/s00497-012-0208-1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Veenhoff LM, 1999, J BIOL CHEM, V274, P33244, DOI 10.1074/jbc.274.47.33244; Wang J, 2014, CELL RES, V24, P1486, DOI 10.1038/cr.2014.144; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Wright EM, 2013, MOL ASPECTS MED, V34, P183, DOI 10.1016/j.mam.2012.11.002; Xu Y, 2014, NATURE, V515, P448, DOI 10.1038/nature13670; Xuan YH, 2013, P NATL ACAD SCI USA, V110, pE3685, DOI 10.1073/pnas.1311244110; Yee DC, 2013, FEBS J, V280, P5780, DOI 10.1111/febs.12499; Yuan LX, 2013, PLANT CELL, V25, P974, DOI 10.1105/tpc.112.108027; Zhou JH, 2015, PLANT J, V82, P632, DOI 10.1111/tpj.12838	48	101	107	8	161	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					259	+		10.1038/nature15391	http://dx.doi.org/10.1038/nature15391			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RC	26479032	Green Accepted, Green Submitted			2022-12-28	WOS:000364396700050
J	Baudrimont, A; Becskei, A				Baudrimont, Antoine; Becskei, Attila			GENE REGULATION Expression feels two pulses	NATURE			English	Editorial Material									[Baudrimont, Antoine; Becskei, Attila] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Baudrimont, A (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	attila.becskei@unibas.ch		Becskei, Attila/0000-0002-9462-0934; Baudrimont, Antoine/0000-0001-9410-6356				Corrigan AM, 2014, CURR BIOL, V24, P205, DOI 10.1016/j.cub.2013.12.011; De Wever V, 2005, EMBO J, V24, P4115, DOI 10.1038/sj.emboj.7600871; Drengstig T, 2008, J PHYS CHEM B, V112, P16752, DOI 10.1021/jp806818c; Gerstner W, 2001, NEURAL NETWORKS, V14, P599, DOI 10.1016/S0893-6080(01)00053-3; Hansen AS, 2015, ELIFE, V4, DOI 10.7554/eLife.06559; Hsu C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1687; Jacquet M, 2003, J CELL BIOL, V161, P497, DOI 10.1083/jcb.200303030; Liang HQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5048; Lin YH, 2015, NATURE, V527, P54, DOI 10.1038/nature15710	9	0	0	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					46	47		10.1038/nature15634	http://dx.doi.org/10.1038/nature15634			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26466565				2022-12-28	WOS:000364270700039
J	McMahon, GT; Bennett, JA				McMahon, Graham T.; Bennett, Jennifer A.			Case 33-2015: A 57-Year-Old Woman with Hair Loss and Deepening Voice	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									[McMahon, Graham T.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02138 USA; [McMahon, Graham T.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA; [Bennett, Jennifer A.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	McMahon, GT (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02138 USA.		Bennett, Jenny/AAH-2377-2020; McMahon, Graham/D-3740-2009	McMahon, Graham/0000-0003-4288-6535; Bennett, Jennifer/0000-0001-8155-7131	Philips Healthcare Incubator	Philips Healthcare Incubator	Dr. Bennett reports receiving personal fees from Philips Healthcare Incubator. No other potential conflict of interest relevant to this article was reported.	Alpanes M, 2012, J CLIN ENDOCR METAB, V97, P2584, DOI 10.1210/jc.2012-1683; Bachman E, 2014, J GERONTOL A-BIOL, V69, P725, DOI 10.1093/gerona/glt154; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Markopoulos MC, 2015, EUR J ENDOCRINOL, V172, DOI 10.1530/EJE-14-0468; Souto SB, 2014, ARQ BRAS ENDOCRINOL, V58, P68, DOI 10.1590/0004-2730000002461; Vollaard ES, 2011, J CLIN ENDOCR METAB, V96, P1197, DOI 10.1210/jc.2010-1991	6	2	2	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2015	373	17					1660	1666		10.1056/NEJMcpc1413304	http://dx.doi.org/10.1056/NEJMcpc1413304			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU1YH	26488697				2022-12-28	WOS:000363317800013
J	Germain, RN				Germain, Ronald N.			William E. Paul (1936-2015) OBITUARY	NATURE			English	Biographical-Item									[Germain, Ronald N.] US Natl Inst Allergy & Infect Dis, Lab Syst Biol, NIH, Bethesda, MD 20850 USA; [Germain, Ronald N.] Immunol Lab, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Germain, RN (corresponding author), US Natl Inst Allergy & Infect Dis, Lab Syst Biol, NIH, Bethesda, MD 20850 USA.	rgermain@niaid.nih.gov	Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020					PAUL WE, PUBLICATION LIST	1	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					324	324		10.1038/526324a	http://dx.doi.org/10.1038/526324a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26469035	Bronze			2022-12-28	WOS:000362730200027
J	Helleday, T				Helleday, Thomas			Poisoning Cancer Cells with Oxidized Nucleosides	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MTH1		Karolinska Inst, Dept Med Biochem & Biophys, Div Translat Med & Chem Biol, Sci Life Lab, Stockholm, Sweden	Karolinska Institutet	Helleday, T (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Translat Med & Chem Biol, Sci Life Lab, Stockholm, Sweden.			Helleday, Thomas/0000-0002-7384-092X				Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Neff T, 1996, EXP HEMATOL, V24, P1340; Zauri M, 2015, NATURE, V524, P114, DOI 10.1038/nature14948	4	13	13	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2015	373	16					1570	1571		10.1056/NEJMcibr1510335	http://dx.doi.org/10.1056/NEJMcibr1510335			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5VX	26465992				2022-12-28	WOS:000362880300015
J	Polak, T				Polak, Tal			Help others-and help your career	SCIENCE			English	Editorial Material								As a Ph.D. student, I try to volunteer at every conference I attend. Initially, the motivation was purely monetary: Students who volunteer usually get discounted registration fees. However, during my first conference, I came to appreciate how important volunteering can be for networking. While welcoming people at the admission desk or offering speakers assistance, volunteers get to know a lot of scientists. During my second large conference, the 2013 International Congress for Conservation Biology (ICCB) in Baltimore, Maryland, I leveraged my volunteer position to create an even more rewarding networking opportunity.	[Polak, Tal] Univ Queensland, Conservat Biol, St Lucia, Qld, Australia; [Polak, Tal] Australian Res Council Ctr Excellence Environm De, Brisbane, Qld, Australia	University of Queensland	Polak, T (corresponding author), Univ Queensland, Conservat Biol, St Lucia, Qld, Australia.								0	0	0	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257					246	246		10.1126/science.350.6257.246	http://dx.doi.org/10.1126/science.350.6257.246			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS9JB	26450212				2022-12-28	WOS:000362405600043
J	Ejlerskov, P; Hultberg, JG; Wang, JY; Carlsson, R; Ambjorn, M; Kuss, M; Liu, YW; Porcu, G; Kolkova, K; Rundsten, CF; Ruscher, K; Pakkenberg, B; Goldmann, T; Loreth, D; Prinz, M; Rubinsztein, DC; Issazadeh-Navikas, S				Ejlerskov, Patrick; Hultberg, Jeanette Goransdotter; Wang, JunYang; Carlsson, Robert; Ambjorn, Malene; Kuss, Martin; Liu, Yawei; Porcu, Giovanna; Kolkova, Kateryna; Rundsten, Carsten Friis; Ruscher, Karsten; Pakkenberg, Bente; Goldmann, Tobias; Loreth, Desiree; Prinz, Marco; Rubinsztein, David C.; Issazadeh-Navikas, Shohreh			Lack of Neuronal IFN-beta-IFNAR Causes Lewy Body- and Parkinson's Disease-like Dementia	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; ALPHA-SYNUCLEIN; INTERFERON-BETA; IN-VIVO; ALZHEIMERS-DISEASE; CELLS; MICE; DOPAMINE; BRAIN; DYSFUNCTION	Neurodegenerative diseases have been linked to inflammation, but whether altered immunomodulation plays a causative role in neurodegeneration is not clear. We show that lack of cytokine interferon-beta (IFN-beta) signaling causes spontaneous neurodegeneration in the absence of neurodegenerative disease-causing mutant proteins. Mice lacking Ifnb function exhibited motor and cognitive learning impairments with accompanying alpha-synuclein-containing Lewy bodies in the brain, as well as a reduction in dopaminergic neurons and defective dopamine signaling in the nigrostriatal region. Lack of IFN-beta signaling caused defects in neuronal autophagy prior to alpha-synucleinopathy, which was associated with accumulation of senescent mitochondria. Recombinant IFN-beta promoted neurite growth and branching, autophagy flux, and alpha-synuclein degradation in neurons. In addition, lentiviral IFN-beta overexpression prevented dopaminergic neuron loss in a familial Parkinson's disease model. These results indicate a protective role for IFN-beta in neuronal homeostasis and validate Ifnb mutant mice as a model for sporadic Lewy body and Parkinson's disease dementia.	[Ejlerskov, Patrick; Hultberg, Jeanette Goransdotter; Wang, JunYang; Carlsson, Robert; Ambjorn, Malene; Kuss, Martin; Liu, Yawei; Porcu, Giovanna; Kolkova, Kateryna; Rundsten, Carsten Friis; Issazadeh-Navikas, Shohreh] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen, Denmark; [Ruscher, Karsten] Lund Univ, Dept Clin Sci, S-22100 Lund, Sweden; [Pakkenberg, Bente] Bispebjerg Hosp, Res Lab Stereol & Neurosci, DK-2200 Copenhagen, Denmark; [Goldmann, Tobias; Prinz, Marco] Univ Freiburg, Inst Neuropathol, D-79106 Freiburg, Germany; [Loreth, Desiree] Univ Freiburg, Dept Neurol, D-79106 Freiburg, Germany; [Prinz, Marco] Univ Freiburg, Ctr Biol Signaling Studies, D-79106 Freiburg, Germany; [Rubinsztein, David C.] Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England	University of Copenhagen; Lund University; University of Copenhagen; Bispebjerg Hospital; University of Freiburg; University of Freiburg; University of Freiburg; University of Cambridge	Issazadeh-Navikas, S (corresponding author), Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen, Denmark.	shohreh.issazadeh@bric.ku.dk	Rubinsztein, David C/C-3472-2011; Issazadeh-Navikas, Shohreh/AAI-7900-2021	Goldmann, Tobias/0000-0001-9754-9144; Ejlerskov, Patrick/0000-0002-2514-3185; Carlsson, Robert/0000-0001-5955-2916; pakkenberg, bente/0000-0003-3851-6494	Danish Council For Independent Research (DFF)-Medical Sciences; Alzheimer-forskningsfonden; Danish Multiple Sclerosis Society; Danish Cancer Society; Lundbeck Foundation	Danish Council For Independent Research (DFF)-Medical Sciences; Alzheimer-forskningsfonden; Danish Multiple Sclerosis Society; Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden)	Support to S.I.-N. was from Danish Council For Independent Research (DFF)-Medical Sciences, Alzheimer-forskningsfonden, Danish Multiple Sclerosis Society, Danish Cancer Society, and Lundbeck Foundation. D.C.R. is a Wellcome Trust Principal Research Fellow. The authors thank Marja Jaattela for help establishing lysosomal assays, Janne Kock for efficient experimental animal facility arrangement, Elin Pietras for help with IN Cell analysis, Mohamoud Osman, Alexandra Muller, Ana Rita Antunes, Sigrun Nestel, and Barbara Joch for technical assistance, and Klaus Qvortrup for electron microscopy help.	Arima K, 1999, BRAIN RES, V843, P53, DOI 10.1016/S0006-8993(99)01848-X; Artegiani B, 2015, EMBO J, V34, P896, DOI 10.15252/embj.201490061; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018; Chort A, 2013, BRAIN, V136, P1732, DOI 10.1093/brain/awt061; Congdon EE, 2013, J BIOL CHEM, V288, P35452, DOI 10.1074/jbc.M113.491001; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110; Ejlerskov P, 2013, J BIOL CHEM, V288, P17313, DOI 10.1074/jbc.M112.401174; Erlandsson L, 1998, CURR BIOL, V8, P223, DOI 10.1016/S0960-9822(98)70086-7; Fossale E, 2011, HUM MOL GENET, V20, P4258, DOI 10.1093/hmg/ddr355; Francis PT, 2009, J NEUROL, V256, pS280, DOI 10.1007/s00415-009-5247-7; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harris H, 2012, NAT REV NEUROL, V8, P108, DOI 10.1038/nrneurol.2011.200; Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018; Jellinger KA, 2000, J NEURAL TRANSM-SUPP, P185; Jellinger KA, 2008, NEURODEGENER DIS, V5, P118, DOI 10.1159/000113679; Jellinger KA, 2008, ACTA NEUROPATHOL, V115, P427, DOI 10.1007/s00401-008-0347-5; Lee YK, 2009, NEUROBIOL LEARN MEM, V92, P356, DOI 10.1016/j.nlm.2009.04.003; Linnartz B, 2012, J NEUROSCI, V32, P946, DOI 10.1523/JNEUROSCI.3830-11.2012; Lippa CF, 1998, AM J PATHOL, V153, P1365, DOI 10.1016/S0002-9440(10)65722-7; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Liu YW, 2014, NAT MED, V20, P272, DOI 10.1038/nm.3485; Liu YW, 2013, J NEUROSCI, V33, P14231, DOI 10.1523/JNEUROSCI.5812-12.2013; Maccioni RB, 2009, ANN NY ACAD SCI, V1153, P240, DOI 10.1111/j.1749-6632.2008.03972.x; Mori F, 2003, J NEUROPATH EXP NEUR, V62, P812, DOI 10.1093/jnen/62.8.812; Mrak Robert E, 2007, Neuropsychiatr Dis Treat, V3, P619; Narayanan NS, 2013, REV NEUROSCIENCE, V24, P267, DOI 10.1515/revneuro-2013-0004; Nelson AL, 2010, MABS-AUSTIN, V2, P77, DOI 10.4161/mabs.2.1.10786; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Rockenstein E, 2014, BRAIN, V137, P1496, DOI 10.1093/brain/awu057; Segura-Aguilar J, 2014, J NEUROCHEM, V129, P898, DOI 10.1111/jnc.12686; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Shulman JM, 2009, NAT GENET, V41, P1261, DOI 10.1038/ng1209-1261; Tansey MG, 2008, FRONT BIOSCI-LANDMRK, V13, P709, DOI 10.2741/2713; Teige I, 2003, J IMMUNOL, V170, P4776, DOI 10.4049/jimmunol.170.9.4776; Teige I, 2006, J IMMUNOL, V177, P3542, DOI 10.4049/jimmunol.177.6.3542; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Yong VW, 1998, NEUROLOGY, V51, P682	44	121	126	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2					324	339		10.1016/j.cell.2015.08.069	http://dx.doi.org/10.1016/j.cell.2015.08.069			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26451483	hybrid, Green Published			2022-12-28	WOS:000362952700011
J	Iftikhar, Z; Jezouin, S; Anthore, A; Gennser, U; Parmentier, FD; Cavanna, A; Pierre, F				Iftikhar, Z.; Jezouin, S.; Anthore, A.; Gennser, U.; Parmentier, F. D.; Cavanna, A.; Pierre, F.			Two-channel Kondo effect and renormalization flow with macroscopic quantum charge states	NATURE			English	Article							SINGLE-ELECTRON TRANSISTOR; COULOMB-BLOCKADE; CARBON NANOTUBES; CHANNEL; METALS; CONDUCTANCE; SYSTEMS; PHYSICS	Many-body correlations and macroscopic quantum behaviours are fascinating condensed matter problems. A powerful test-bed for the many-body concepts and methods is the Kondo effect(1,2), which entails the coupling of a quantum impurity to a continuum of states. It is central in highly correlated systems(3-5) and can be explored with tunable nanostructures(6-9). Although Kondo physics is usually associated with the hybridization of itinerant electrons with microscopic magnetic moments(10), theory predicts that it can arise whenever degenerate quantum states are coupled to a continuum(4,11-14). Here we demonstrate the previously elusive 'charge' Kondo effect in a hybrid metal-semiconductor implementation of a single-electron transistor, with a quantum pseudospin of 1/2 constituted by two degenerate macroscopic charge states of a metallic island(11,15-20). In contrast to other Kondo nanostructures, each conduction channel connecting the island to an electrode constitutes a distinct and fully tunable Kondo channel(11), thereby providing unprecedented access to the two-channel Kondo effect and a clear path to multi-channel Kondo physics(1,4,21,22). Using a weakly coupled probe, we find the renormalization flow, as temperature is reduced, of two Kondo channels competing to screen the charge pseudospin. This provides a direct view of how the predicted quantum phase transition develops across the symmetric quantum critical point(4,21). Detuning the pseudospin away from degeneracy, we demonstrate, on a fully characterized device, quantitative agreement with the predictions for the finite-temperature crossover from quantum criticality(17).	[Iftikhar, Z.; Jezouin, S.; Anthore, A.; Gennser, U.; Parmentier, F. D.; Cavanna, A.; Pierre, F.] CNRS, Lab Photon & Nanostruct LPN, F-91460 Marcoussis, France; [Anthore, A.] Univ Paris Diderot, Sorbonne Paris Cite, LPN, F-91460 Marcoussis, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Pierre, F (corresponding author), CNRS, Lab Photon & Nanostruct LPN, F-91460 Marcoussis, France.	frederic.pierre@lpn.cnrs.fr	Pierre, Frederic/J-3119-2016; Parmentier, François/GZG-3568-2022; Gennser, Ulf/F-2728-2019; Iftikhar, Zubair/I-8317-2016	Pierre, Frederic/0000-0003-1243-6808; Parmentier, François/0000-0003-1301-3305; Parmentier, Francois/0000-0001-9319-565X; Anthore, Anne/0000-0002-5870-3513; Gennser, Ulf/0000-0003-2423-2140; Iftikhar, Zubair/0000-0001-6487-1620	ERC [ERC-2010-StG-20091028, 259033]; French RENATECH network	ERC(European Research Council (ERC)European Commission); French RENATECH network	This work was supported by the ERC (ERC-2010-StG-20091028, no. 259033) and the French RENATECH network. We acknowledge E. Boulat, J. von Delft, S. De Franceschi, L. Glazman, D. Goldhaber-Gordon, K. Le Hur, A. Keller, K. Matveev, L. Peeters, P. Simon and G. Zarand for critical reading of our manuscript and discussions.	BEENAKKER CWJ, 1991, PHYS REV B, V44, P1646, DOI 10.1103/PhysRevB.44.1646; Bulla R, 2008, REV MOD PHYS, V80, P395, DOI 10.1103/RevModPhys.80.395; Cox DL, 1998, ADV PHYS, V47, P599, DOI 10.1080/000187398243500; Cronenwett SM, 1998, SCIENCE, V281, P540, DOI 10.1126/science.281.5376.540; FENDLEY P, 1995, PHYS REV B, V52, P8934, DOI 10.1103/PhysRevB.52.8934; Furusaki A, 1995, PHYS REV B, V52, P16676, DOI 10.1103/PhysRevB.52.16676; Glazman L. I., 1990, Soviet Physics - JETP, V71, P1031; Goldhaber-Gordon D, 1998, NATURE, V391, P156, DOI 10.1038/34373; Goldhaber-Gordon D, 1998, PHYS REV LETT, V81, P5225, DOI 10.1103/PhysRevLett.81.5225; Goldstein M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.017002; Hewson A. C., 1997, KONDO PROBLEM HEAVY, V2; Jarillo-Herrero P, 2005, NATURE, V434, P484, DOI 10.1038/nature03422; Jezouin S, 2013, SCIENCE, V342, P601, DOI 10.1126/science.1241912; Jezouin S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2810; Joyez P, 1997, PHYS REV LETT, V79, P1349, DOI 10.1103/PhysRevLett.79.1349; KONDO J, 1964, PROG THEOR PHYS, V32, P37, DOI 10.1143/PTP.32.37; Le Hur K, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165338; Le Hur K, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.140506; le Sueur H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.056803; Lebanon E, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.041311; Liang WJ, 2002, NATURE, V417, P725, DOI 10.1038/nature00790; Matveev K. A., 1991, Soviet Physics - JETP, V72, P892; MATVEEV KA, 1995, PHYS REV B, V51, P1743, DOI 10.1103/PhysRevB.51.1743; NOZIERES P, 1980, J PHYS-PARIS, V41, P193, DOI 10.1051/jphys:01980004103019300; Nygard J, 2000, NATURE, V408, P342, DOI 10.1038/35042545; Oreg Y, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.136602; Park J, 2002, NATURE, V417, P722, DOI 10.1038/nature00791; Parmentier FD, 2011, NAT PHYS, V7, P935, DOI [10.1038/NPHYS2092, 10.1038/nphys2092]; Pierre F, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.085413; Pustilnik M, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.115316; RALPH DC, 1994, PHYS REV LETT, V72, P1064, DOI 10.1103/PhysRevLett.72.1064; Safi I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.126602; Sasaki S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.017205; Sela E, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.147202; WELLSTOOD FC, 1994, PHYS REV B, V49, P5942, DOI 10.1103/PhysRevB.49.5942; Yi HM, 1998, PHYS REV B, V57, pR5579, DOI 10.1103/PhysRevB.57.R5579; Zarand G, 2000, PHYS REV B, V62, P8137, DOI 10.1103/PhysRevB.62.8137	39	96	96	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					233	+		10.1038/nature15384	http://dx.doi.org/10.1038/nature15384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26450056	Green Submitted			2022-12-28	WOS:000362399000042
J	Kappos, L; Wiendl, H; Selmaj, K; Arnold, DL; Havrdova, E; Boyko, A; Kaufman, M; Rose, J; Greenberg, S; Sweetser, M; Riester, K; O'Neill, G; Elkins, J				Kappos, L.; Wiendl, H.; Selmaj, K.; Arnold, D. L.; Havrdova, E.; Boyko, A.; Kaufman, M.; Rose, J.; Greenberg, S.; Sweetser, M.; Riester, K.; O'Neill, G.; Elkins, J.			Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THERAPY	BACKGROUND Daclizumab high-yield process (HYP) is a humanized monoclonal antibody that binds to CD25 (alpha subunit of the interleukin-2 receptor) and modulates interleukin-2 signaling. Abnormalities in interleukin-2 signaling have been implicated in the pathogenesis of multiple sclerosis and other autoimmune disorders. METHODS We conducted a randomized, double-blind, active-controlled, phase 3 study involving 1841 patients with relapsing-remitting multiple sclerosis to compare daclizumab HYP, administered subcutaneously at a dose of 150 mg every 4 weeks, with interferon beta-1a, administered intramuscularly at a dose of 30 mu g once weekly, for up to 144 weeks. The primary end point was the annualized relapse rate. RESULTS The annualized relapse rate was lower with daclizumab HYP than with interferon beta-1a (0.22 vs. 0.39; 45% lower rate with daclizumab HYP; P<0.001). The number of new or newly enlarged hyperintense lesions on T-2-weighted magnetic resonance imaging (MRI) over a period of 96 weeks was lower with daclizumab HYP than with interferon beta-1a (4.3 vs. 9.4; 54% lower number of lesions with daclizumab HYP; P<0.001). At week 144, the estimated incidence of disability progression confirmed at 12 weeks was 16% with daclizumab HYP and 20% with interferon beta-1a (P = 0.16). Serious adverse events, excluding relapse of multiple sclerosis, were reported in 15% of the patients in the daclizumab HYP group and in 10% of those in the interferon beta-1a group. Infections were more common in the daclizumab HYP group than in the interferon beta-1a group (in 65% vs. 57% of the patients, including serious infection in 4% vs. 2%), as were cutaneous events such as rash or eczema (in 37% vs. 19%, including serious events in 2% vs. <1%) and elevations in liver aminotransferase levels that were more than 5 times the upper limit of the normal range (in 6% vs. 3%). CONCLUSIONS Among patients with relapsing-remitting multiple sclerosis, daclizumab HYP showed efficacy superior to that of interferon beta-1a with regard to the annualized relapse rate and lesions, as assessed by means of MRI, but was not associated with a significantly lower risk of disability progression confirmed at 12 weeks. The rates of infection, rash, and abnormalities on liver-function testing were higher with daclizumab HYP than with interferon beta-1a.	[Kappos, L.] Univ Basel Hosp, Neurol Clin & Policlin, Dept Med, Dept Clin Res, CH-4031 Basel, Switzerland; [Kappos, L.] Univ Basel Hosp, Dept Biomed & Biomed Engn, CH-4031 Basel, Switzerland; [Wiendl, H.] Univ Munster, Dept Neurol, D-48149 Munster, Germany; [Selmaj, K.] Med Univ Lodz, Dept Neurol, Lodz, Poland; [Arnold, D. L.] McGill Univ, NeuroRx Res & Montreal Neurol Inst, Montreal, PQ, Canada; [Havrdova, E.] Charles Univ Prague, Dept Neurol, Fac Med 1, Prague, Czech Republic; [Boyko, A.] Russian Natl Res Med Univ, Dept Neurol & Neurosurg, Moscow, Russia; [Boyko, A.] Moscow Multiple Sclerosis Ctr, Moscow, Russia; [Kaufman, M.] Univ Tennessee, Cole Neurol Inst, Knoxville, TN USA; [Rose, J.] Univ Utah, Dept Neurol, Salt Lake City, UT USA; [Rose, J.] Univ Utah, Neurovirol Res Lab, Salt Lake City, UT USA; [Rose, J.] Vet Affairs Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Greenberg, S.] AbbVie Biotherapeut, Redwood City, CA USA; [Sweetser, M.; Riester, K.; O'Neill, G.; Elkins, J.] Biogen, Cambridge, MA USA	University of Basel; University of Basel; University of Munster; Medical University Lodz; McGill University; Charles University Prague; Pirogov Russian National Research Medical University; University of Tennessee System; University of Tennessee Knoxville; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; AbbVie; Biogen	Kappos, L (corresponding author), Univ Basel Hosp, Neurol Clin & Policlin, Dept Med, Dept Clin Res, Petersgraben 4, CH-4031 Basel, Switzerland.	kapposl-pa@usb.ch	Wiendl, Heinz/AAX-6041-2021; Boyko, Alexey N/Z-2106-2018; Havrdova, Eva Kubala/P-4892-2017	Havrdova, Eva Kubala/0000-0002-9543-4359; Wiendl, Heinz/0000-0003-4310-3432; Selmaj, Krzysztof/0000-0003-1213-7218; Arnold, Douglas/0000-0003-4266-0106; Boyko, Alexei/0000-0003-3306-9541	Biogen; AbbVie Biotherapeutics	Biogen(Biogen); AbbVie Biotherapeutics(AbbVie)	Supported by Biogen and AbbVie Biotherapeutics.	Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Bielekova B, 2013, NEUROTHERAPEUTICS, V10, P55, DOI 10.1007/s13311-012-0147-4; Gold R, 2013, LANCET, V381, P2167, DOI 10.1016/S0140-6736(12)62190-4; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Martin R, 2012, CLIN IMMUNOL, V142, P9, DOI 10.1016/j.clim.2011.10.008; Neurostatus Systems, 2007, NEUR TRAIN; Perry JSA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004140; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rockey DC, 2010, HEPATOLOGY, V51, P2117, DOI 10.1002/hep.23577; Temple R, 2006, PHARMACOEPIDEM DR S, V15, P241, DOI 10.1002/pds.1211; Wiendl H, 2013, NAT REV NEUROL, V9, P394, DOI 10.1038/nrneurol.2013.95	12	192	198	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2015	373	15					1418	1428		10.1056/NEJMoa1501481	http://dx.doi.org/10.1056/NEJMoa1501481			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS8XI	26444729	Bronze			2022-12-28	WOS:000362372800008
J	Kullberg, BJ; Arendrup, MC				Kullberg, Bart Jan; Arendrup, Maiken C.			Invasive Candidiasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CRITICALLY-ILL PATIENTS; CARE-UNIT PATIENTS; D-GLUCAN ASSAY; ESCMID-ASTERISK GUIDELINE; PLACEBO-CONTROLLED TRIAL; 3RD EUROPEAN CONFERENCE; AMPHOTERICIN-B; ECHINOCANDIN RESISTANCE; FUNGAL-INFECTIONS; SURGICAL-PATIENTS	Invasive candidiasis is the most common fungal disease among hospitalized patients in the developed world. Invasive candidiasis comprises both candidemia and deep-seated tissue candidiasis. Candidemia is generally viewed as the more common type of the disease, and it accounts for the majority of cases included in clinical trials. Deep-seated candidiasis arises from either hematogenous dissemination or direct inoculation of candida species to a sterile site, such as the peritoneal cavity (Fig. 1). Mortality among patients with invasive candidiasis is as high as 40%, even when patients receive antifungal therapy. In addition, the global shift in favor of nonalbicans candida species is troubling, as is the emerging resistance to antifungal drugs. During the past few years, new insights have substantially changed diagnostic and therapeutic strategies.	[Kullberg, Bart Jan] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6500 HB Nijmegen, Netherlands; [Kullberg, Bart Jan] Radboud Univ Nijmegen, Med Ctr, Radboudumc Ctr Infect Dis, NL-6525 ED Nijmegen, Netherlands; [Arendrup, Maiken C.] Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen, Denmark	Radboud University Nijmegen; Radboud University Nijmegen; Statens Serum Institut	Kullberg, BJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med, POB 9101, NL-6500 HB Nijmegen, Netherlands.	bj.kullberg@radboudumc.nl		Arendrup, Maiken Cavling/0000-0002-4747-0144	Cidara; Pfizer; Astellas; Merck; Gilead; Basilea	Cidara; Pfizer(Pfizer); Astellas(Astellas Pharmaceuticals); Merck(Merck & Company); Gilead(Gilead Sciences); Basilea	Dr. Kullberg reports receiving fees for serving on an advisory board from Cidara, lecture fees and travel support from Pfizer, and grant support from Astellas; and Dr. Arendrup, receiving fees for serving on advisory boards from Merck, lecture fees from Gilead, Merck, Pfizer, and Basilea, grant support through her institution from Gilead, fees paid to her institution from Gilead, Pfizer, Astellas, and Basilea for participation in the national surveillance fungemia program in Denmark, fees paid to her institution from Astellas for contract work, and fees paid to her institution from Basilea for microbiologic testing. No other potential conflict of interest relevant to this article was reported.	Alexander BD, 2013, CLIN INFECT DIS, V56, P1724, DOI 10.1093/cid/cit136; Andes DR, 2012, CLIN INFECT DIS, V54, P1110, DOI 10.1093/cid/cis021; Arendrup M, 2002, INFECTION, V30, P286, DOI 10.1007/s15010-002-2131-0; Arendrup MC, 2014, CURR OPIN INFECT DIS, V27, P484, DOI 10.1097/QCO.0000000000000111; Arendrup MC, 2010, CURR OPIN CRIT CARE, V16, P445, DOI 10.1097/MCC.0b013e32833e84d2; Arendrup MC, 2011, J CLIN MICROBIOL, V49, P3300, DOI 10.1128/JCM.00179-11; Avni T, 2011, J CLIN MICROBIOL, V49, P665, DOI 10.1128/JCM.01602-10; Brass EP, 2010, CLIN INFECT DIS, V51, P304, DOI 10.1086/653936; Bruyere R, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-385; Chang SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054564; Clancy CJ, 2013, CLIN INFECT DIS, V56, P1284, DOI 10.1093/cid/cit006; Cleveland AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120452; Cornely OA, 2012, CLIN MICROBIOL INFEC, V18, P19, DOI 10.1111/1469-0691.12039; Cuenca-Estrella M, 2012, CLIN MICROBIOL INFEC, V18, P9, DOI 10.1111/1469-0691.12038; Eggimann P, 1999, CRIT CARE MED, V27, P1066, DOI 10.1097/00003246-199906000-00019; Eschenauer GA, 2013, J ANTIMICROB CHEMOTH, V68, P922, DOI 10.1093/jac/dks482; Fortun J, 2014, J ANTIMICROB CHEMOTH, V69, P3134, DOI 10.1093/jac/dku225; Garey KW, 2006, CLIN INFECT DIS, V43, P25, DOI 10.1086/504810; Gradel KO, 2014, CLIN EPIDEMIOL, V6, P301, DOI 10.2147/CLEP.S66998; Guinea J, 2014, ANTIMICROB AGENTS CH, V58, P1529, DOI 10.1128/AAC.02155-13; Horn DL, 2010, EUR J CLIN MICROBIOL, V29, P223, DOI 10.1007/s10096-009-0843-0; Johnson MD, 2012, CLIN INFECT DIS, V54, P502, DOI 10.1093/cid/cir827; Karageorgopoulos DE, 2011, CLIN INFECT DIS, V52, P750, DOI 10.1093/cid/ciq206; Kollef M, 2012, CLIN INFECT DIS, V54, P1739, DOI 10.1093/cid/cis305; Kullberg BJ, 2014, CURR OPIN INFECT DIS, V27, P511, DOI 10.1097/QCO.0000000000000105; Kullberg BJ, 2005, LANCET, V366, P1435, DOI 10.1016/S0140-6736(05)67490-9; Kumar V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5675; Kuse ER, 2007, LANCET, V369, P1519, DOI 10.1016/S0140-6736(07)60605-9; Lamoth F, 2012, CLIN INFECT DIS, V54, P633, DOI 10.1093/cid/cir897; Lashof AMLO, 2003, EUR J CLIN MICROBIOL, V22, P43, DOI 10.1007/s10096-002-0854-6; Leon C, 2009, CRIT CARE MED, V37, P1624, DOI 10.1097/CCM.0b013e31819daa14; Leroy O, 2009, CRIT CARE MED, V37, P1612, DOI 10.1097/CCM.0b013e31819efac0; Lortholary O, 2014, INTENS CARE MED, V40, P1303, DOI 10.1007/s00134-014-3408-3; Lortholary O, 2011, ANTIMICROB AGENTS CH, V55, P532, DOI 10.1128/AAC.01128-10; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Mikulska M, 2010, CRIT CARE, V14, DOI 10.1186/cc9365; Mora-Duarte J, 2002, NEW ENGL J MED, V347, P2020, DOI 10.1056/NEJMoa021585; Muldoon EG, 2014, CLIN INFECT DIS, V58, P1227, DOI 10.1093/cid/ciu080; Mylonakis E, 2015, CLIN INFECT DIS, V60, P892, DOI 10.1093/cid/ciu959; Nguyen MH, 2012, CLIN INFECT DIS, V54, P1240, DOI 10.1093/cid/cis200; Nucci M, 2010, CLIN INFECT DIS, V51, P295, DOI 10.1086/653935; Ostrosky-Zeichner L, 2005, CLIN INFECT DIS, V41, P654, DOI 10.1086/432470; Ostrosky-Zeichner L, 2014, CLIN INFECT DIS, V58, P1219, DOI 10.1093/cid/ciu074; Pappas PG, 2007, CLIN INFECT DIS, V45, P883, DOI 10.1086/520980; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Pelz RK, 2001, ANN SURG, V233, P542, DOI 10.1097/00000658-200104000-00010; Plantinga TS, 2012, J INFECT DIS, V205, P934, DOI 10.1093/infdis/jir867; Playford EG, 2009, INTENS CARE MED, V35, P2141, DOI 10.1007/s00134-009-1619-9; Poissy J, 2014, CRIT CARE, V18, DOI 10.1186/cc13953; Puig-Asensio M, 2014, CRIT CARE MED, V42, P1423, DOI 10.1097/CCM.0000000000000221; Reboli AC, 2007, NEW ENGL J MED, V356, P2472, DOI 10.1056/NEJMoa066906; Reboli AC, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-261; REX JH, 1994, NEW ENGL J MED, V331, P1325, DOI 10.1056/NEJM199411173312001; Rex JH, 2003, CLIN INFECT DIS, V36, P1221, DOI 10.1086/374850; Ruhnke M, 2012, CLIN MICROBIOL INFEC, V18, P680, DOI 10.1111/j.1469-0691.2012.03784.x; Sendid B, 2002, J MED MICROBIOL, V51, P433, DOI 10.1099/0022-1317-51-5-433; Shah DN, 2012, ANTIMICROB AGENTS CH, V56, P3239, DOI 10.1128/AAC.00019-12; Shields RK, 2014, ANTIMICROB AGENTS CH, V58, P7601, DOI 10.1128/AAC.04134-14; Shorr AF, 2005, CRIT CARE MED, V33, P1928, DOI 10.1097/01.CCM.0000178352.14703.49; Sulahian A, 2014, J CLIN MICROBIOL, V52, P2328, DOI 10.1128/JCM.03567-13; Tissot F, 2013, AM J RESP CRIT CARE, V188, P1100, DOI 10.1164/rccm.201211-2069OC; Vaz C, 2011, DIAGN MICR INFEC DIS, V71, P159, DOI 10.1016/j.diagmicrobio.2011.05.014; Vazquez J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-97; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	64	677	719	10	120	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2015	373	15					1445	1456		10.1056/NEJMra1315399	http://dx.doi.org/10.1056/NEJMra1315399			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS8XI	26444731	Green Published			2022-12-28	WOS:000362372800011
J	MacCoun, R; Perlmutter, S				MacCoun, Robert; Perlmutter, Saul			Hide results to seek the truth	NATURE			English	Editorial Material									[MacCoun, Robert] Stanford Univ, Law, Stanford, CA 94305 USA; [Perlmutter, Saul] Univ Calif Berkeley, Phys, Berkeley, CA 94720 USA	Stanford University; University of California System; University of California Berkeley	MacCoun, R (corresponding author), Stanford Univ, Law, Stanford, CA 94305 USA.	rmaccoun@stanford.edu; saul@lbl.gov	MacCoun, Robert/N-1765-2019	MacCoun, Robert/0000-0003-0929-4423				Conley A, 2006, ASTROPHYS J, V644, P1, DOI 10.1086/503533; Feynman Richard, 1985, SURELY YOURE JOKING; Kaplan RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132382; Klein JR, 2005, ANNU REV NUCL PART S, V55, P141, DOI 10.1146/annurev.nucl.55.090704.151521; LORD CG, 1984, J PERS SOC PSYCHOL, V47, P1231, DOI 10.1037/0022-3514.47.6.1231; MacCoun RJ, 1998, ANNU REV PSYCHOL, V49, P259, DOI 10.1146/annurev.psych.49.1.259; Meinert CL, 1998, NEW ENGL J MED, V338, P1381, DOI 10.1056/NEJM199805073381911; Miguel E, 2014, SCIENCE, V343, P30, DOI 10.1126/science.1245317; Miller LE, 2011, CONTEMP CLIN TRIALS, V32, P240, DOI 10.1016/j.cct.2010.11.004; Simonton DK, 2011, REV GEN PSYCHOL, V15, P158, DOI 10.1037/a0022912	10	96	97	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					187	189		10.1038/526187a	http://dx.doi.org/10.1038/526187a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS9GV	26450040	Bronze			2022-12-28	WOS:000362399000021
J	Schiermeier, Q				Schiermeier, Quirin			RESEARCH PROFILES A tag of one's own	NATURE			English	Editorial Material								Digital identifiers can sort out different scientists with the same names, and create a lifelong record of their work.											0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					281	283		10.1038/nj7572-281a	http://dx.doi.org/10.1038/nj7572-281a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26460395				2022-12-28	WOS:000362399000053
J	Schultz, JK; Yaqub, S; Wallon, C; Blecic, L; Forsmo, HM; Folkesson, J; Buchwald, P; Korner, H; Dahl, FA; Oresland, T				Schultz, Johannes Kurt; Yaqub, Sheraz; Wallon, Conny; Blecic, Ljiljana; Forsmo, Havard Mjorud; Folkesson, Joakim; Buchwald, Pamela; Korner, Hartwig; Dahl, Fredrik A.; Oresland, Tom		SCANDIV Study Grp	Laparoscopic Lavage vs Primary Resection for Acute Perforated Diverticulitis The SCANDIV Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLONIC DIVERTICULITIS; SIGMOID DIVERTICULITIS; HARTMANNS PROCEDURE; PRIMARY ANASTOMOSIS; GENERALIZED PERITONITIS; SURGERY; MULTICENTER	IMPORTANCE Perforated colonic diverticulitis usually requires surgical resection, which is associated with significant morbidity. Cohort studies have suggested that laparoscopic lavage may treat perforated diverticulitis with less morbidity than resection procedures. OBJECTIVE To compare the outcomes from laparoscopic lavage with those for colon resection for perforated diverticulitis. DESIGN, SETTING, AND PARTICIPANTS Multicenter, randomized clinical superiority trial recruiting participants from 21 centers in Sweden and Norway from February 2010 to June 2014. The last patient follow-up was in December 2014 and final review and verification of the medical records was assessed in March 2015. Patients with suspected perforated diverticulitis, a clinical indication for emergency surgery, and free air on an abdominal computed tomography scan were eligible. Of 509 patients screened, 415 were eligible and 199 were enrolled. INTERVENTIONS Patients were assigned to undergo laparoscopic peritoneal lavage (n = 101) or colon resection (n = 98) based on a computer-generated, center-stratified block randomization. All patients with fecal peritonitis (15 patients in the laparoscopic peritoneal lavage group vs 13 in the colon resection group) underwent colon resection. Patients with a pathology requiring treatment beyond that necessary for perforated diverticulitis (12 in the laparoscopic lavage group vs 13 in the colon resection group) were also excluded from the protocol operations and treated as required for the pathology encountered. MAIN OUTCOMES AND MEASURES The primary outcome was severe postoperative complications (Clavien-Dindo score >Illa) within 90 days. Secondary outcomes included other postoperative complications, reoperations, length of operating time, length of postoperative hospital stay, and quality of life. RESULTS The primary outcome was observed in 31 of 101 patients (30.7%) in the laparoscopic lavage group and 25 of 96 patients (26.0%) in the colon resection group (difference, 4.7% [95% CI, -7.9% to 17.0%]; P = .53). Mortality at 90 days did not significantly differ between the laparoscopic lavage group (14 patients [13.9%]) and the colon resection group (11 patients [11.5%]; difference, 2.4% [95% CI, -7.2% to 11.9%]; P = .67). The reoperation rate was significantly higher in the laparoscopic lavage group (15 of 74 patients [20.3%]) than in the colon resection group (4 of 70 patients [5.7%]; difference, 14.6% [95% CI, 3.5% to 25.6%]; P = .01) for patients who did not have fecal peritonitis. The length of operating time was significantly shorter in the laparoscopic lavage group; whereas, length of postoperative hospital stay and quality of life did not differ significantly between groups. Four sigmoid carcinomas were missed with laparoscopic lavage. CONCLUSIONS AND RELEVANCE Among patients with likely perforated diverticulitis and undergoing emergency surgery, the use of laparoscopic lavage vs primary resection did not reduce severe postoperative complications and led to worse outcomes in secondary end points. These findings do not support laparoscopic lavage for treatment of perforated diverticulitis.	[Schultz, Johannes Kurt; Oresland, Tom] Akershus Univ Hosp, Dept Gastrointestinal Surg, N-1478 Lerenskog, Norway; [Schultz, Johannes Kurt; Oresland, Tom] Univ Oslo, Fac Med, Oslo, Norway; [Yaqub, Sheraz] Oslo Univ Hosp, Dept Gastrointestinal Surg, Oslo, Norway; [Wallon, Conny] Linkoping Univ Hosp, Dept Surg, S-58185 Linkoping, Sweden; [Blecic, Ljiljana] Ostfold Hosp, Dept Gastrointestinal Surg, Fredrikstad, Norway; [Forsmo, Havard Mjorud] Haukeland Hosp, Dept Gastrointestinal & Emergency Surg, N-5021 Bergen, Norway; [Folkesson, Joakim] Uppsala Univ, Colorectal Unit, Dept Surg Sci, Uppsala, Sweden; [Buchwald, Pamela] Helsingborg Hosp, Colorectal Unit, Dept Surg, Helsingborg, Sweden; [Korner, Hartwig] Stavanger Univ Hosp, Dept Gastrointestinal Surg, Stavanger, Norway; [Dahl, Fredrik A.] Akershus Univ Hosp, Hlth Serv Res Unit, Lerenskog, Norway	University of Oslo; University of Oslo; Linkoping University; University of Bergen; Haukeland University Hospital; Uppsala University; Helsingborgs Hospital; Stavanger University Hospital	Schultz, JK (corresponding author), Akershus Univ Hosp, Dept Gastrointestinal Surg, PB 1000, N-1478 Lerenskog, Norway.	josc@ahus.no	Schultz, Johannes Kurt/AAM-6624-2021; Yaqub, Sheraz/AAC-3906-2019; Kørner, Hartwig/T-9372-2019	Schultz, Johannes Kurt/0000-0002-9427-2087; Yaqub, Sheraz/0000-0002-5696-2319; Dahl, Fredrik Andreas/0000-0002-6835-0985	South-Eastern Norway Regional Health Authority [PNR 2719011]; Akershus University Hospital [PNR 2619041, 2629038, 2649054]	South-Eastern Norway Regional Health Authority; Akershus University Hospital	The study was funded by the South-Eastern Norway Regional Health Authority with a fellowship awarded to Johannes Kurt Schultz (PNR 2719011). The study was also sponsored with research funding by Akershus University Hospital, which covered running expenses (PNR 2619041, 2629038, and 2649054).	Afshar S, 2012, COLORECTAL DIS, V14, P135, DOI 10.1111/j.1463-1318.2011.02606.x; Andeweg CS, 2013, DIGEST SURG, V30, P278, DOI 10.1159/000354035; Angenete E, 2016, ANN SURG, V263, P117, DOI 10.1097/SLA.0000000000001061; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Binda GA, 2012, COLORECTAL DIS, V14, P1403, DOI 10.1111/j.1463-1318.2012.03117.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Constantinides VA, 2006, DIS COLON RECTUM, V49, P966, DOI 10.1007/s10350-006-0547-9; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Feingold D, 2014, DIS COLON RECTUM, V57, P284, DOI 10.1097/DCR.0000000000000075; Gielens MPM, 2012, TECH COLOPROCTOL, V16, P363, DOI 10.1007/s10151-012-0853-2; Hinchey E J, 1978, Adv Surg, V12, P85; Kiran RP, 2003, AM J GASTROENTEROL, V98, P1783, DOI 10.1016/S0002-9270(03)00443-X; KRONBORG O, 1993, BRIT J SURG, V80, P505, DOI 10.1002/bjs.1800800434; KRUKOWSKI ZH, 1984, BRIT J SURG, V71, P921, DOI 10.1002/bjs.1800711202; Makela J, 2002, DIS COLON RECTUM, V45, P955, DOI 10.1007/s10350-004-6335-5; Morris AM, 2014, JAMA-J AM MED ASSOC, V311, P287, DOI 10.1001/jama.2013.282025; Morris CR, 2008, BRIT J SURG, V95, P876, DOI 10.1002/bjs.6226; Myers E, 2008, BRIT J SURG, V95, P97, DOI 10.1002/bjs.6024; Newcombe RG, 1998, STAT MED, V17, P2635, DOI 10.1002/(SICI)1097-0258(19981130)17:22<2635::AID-SIM954>3.0.CO;2-C; Oberkofler CE, 2012, ANN SURG, V256, P819, DOI 10.1097/SLA.0b013e31827324ba; Regenbogen SE, 2014, JAMA SURG, V149, P292, DOI 10.1001/jamasurg.2013.5477; Salem L, 2004, DIS COLON RECTUM, V47, P1953, DOI 10.1007/s10350-004-0701-1; Toorenvliet BR, 2010, COLORECTAL DIS, V12, P862, DOI 10.1111/j.1463-1318.2009.02052.x; Vennix S, 2014, COLORECTAL DIS, V16, P866, DOI 10.1111/codi.12659; Vennix S, 2015, LANCET, V386, P1269, DOI 10.1016/S0140-6736(15)61168-0; Zeitoun G, 2000, BRIT J SURG, V87, P1366, DOI 10.1046/j.1365-2168.2000.01552.x	26	153	155	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2015	314	13					1364	1375		10.1001/jama.2015.12076	http://dx.doi.org/10.1001/jama.2015.12076			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2PH	26441181	Bronze			2022-12-28	WOS:000362644700014
J	Lodato, MA; Woodworth, MB; Lee, S; Evrony, GD; Mehta, BK; Karger, A; Lee, S; Chittenden, TW; D'Gama, AM; Cai, XY; Luquette, LJ; Lee, E; Park, PJ; Walsh, CA				Lodato, Michael A.; Woodworth, Mollie B.; Lee, Semin; Evrony, Gilad D.; Mehta, Bhaven K.; Karger, Amir; Lee, Soohyun; Chittenden, Thomas W.; D'Gama, Alissa M.; Cai, Xuyu; Luquette, Lovelace J.; Lee, Eunjung; Park, Peter J.; Walsh, Christopher A.			Somatic mutation in single human neurons tracks developmental and transcriptional history	SCIENCE			English	Article							COPY-NUMBER VARIATION; GENOME; CANCER; CELL; MOSAICISM; LANDSCAPE	Neurons live for decades in a postmitotic state, their genomes susceptible to DNA damage. Here we survey the landscape of somatic single-nucleotide variants (SNVs) in the human brain. We identified thousands of somatic SNVs by single-cell sequencing of 36 neurons from the cerebral cortex of three normal individuals. Unlike germline and cancer SNVs, which are often caused by errors in DNA replication, neuronal mutations appear to reflect damage during active transcription. Somatic mutations create nested lineage trees, allowing them to be dated relative to developmental landmarks and revealing a polyclonal architecture of the human cerebral cortex. Thus, somatic mutations in the brain represent a durable and ongoing record of neuronal life history, from development through postmitotic function.	[Lodato, Michael A.; Woodworth, Mollie B.; Evrony, Gilad D.; Mehta, Bhaven K.; D'Gama, Alissa M.; Cai, Xuyu; Walsh, Christopher A.] Boston Childrens Hosp, Manton Ctr Orphan Dis, Div Genet & Genom, Boston, MA USA; [Lodato, Michael A.; Woodworth, Mollie B.; Evrony, Gilad D.; Mehta, Bhaven K.; D'Gama, Alissa M.; Cai, Xuyu; Walsh, Christopher A.] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA USA; [Lodato, Michael A.; Woodworth, Mollie B.; Evrony, Gilad D.; Mehta, Bhaven K.; D'Gama, Alissa M.; Cai, Xuyu; Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Lodato, Michael A.; Woodworth, Mollie B.; Evrony, Gilad D.; Mehta, Bhaven K.; D'Gama, Alissa M.; Cai, Xuyu; Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Lodato, Michael A.; Woodworth, Mollie B.; Evrony, Gilad D.; Mehta, Bhaven K.; D'Gama, Alissa M.; Cai, Xuyu; Walsh, Christopher A.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Lee, Semin; Lee, Soohyun; Luquette, Lovelace J.; Lee, Eunjung; Park, Peter J.] Harvard Univ, Sch Med, Dept Biomed Informat, Boston, MA 02452 USA; [Karger, Amir; Chittenden, Thomas W.] Harvard Univ, Sch Med, Res Comp, Boston, MA USA; [Chittenden, Thomas W.] Complex Biol Syst Alliance, N Andover, MA USA; [Lee, Eunjung; Park, Peter J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Park, PJ (corresponding author), Harvard Univ, Sch Med, Dept Biomed Informat, Boston, MA 02452 USA.	peter_park@harvard.edu; christopher.walsh@childrens.harvard.edu	Lodato, Michael/AAX-9211-2021; Lee, Semin/S-2629-2016	Lee, Semin/0000-0002-9015-6046; Mehta, Bhaven/0000-0003-1077-7895; Lodato, Michael/0000-0003-4175-1073; Park, Peter/0000-0001-9378-960X; Walsh, Christopher/0000-0002-0156-2238; Lee, Soohyun/0000-0002-3594-6213; Evrony, Gilad/0000-0001-7621-2630; Woodworth, Mollie/0000-0003-2130-2289; Karger, Amir/0000-0002-4561-3850	National Center for Research Resources [1S10RR028832-01]; National Institute on Aging [T32 AG000222]; Leonard and Isabelle Goldenson Research Fellowship; National Institute of General Medical Sciences (NIGMS) [T32 GM007753]; Louis Lange III Scholarship in Translational Research; NIGMS [T32 GM007753, T32 GM007226]; Eleanor and Miles Shore Fellowship; National Institute of Mental Health [P50 MH106933]; National Institute of Neurological Disorders and Stroke [R01 NS032457, R01 NS079277, U01 MH106883]; Manton Center for Orphan Disease Research; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, T32GM007226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH106933, U01MH106883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032457, R01NS079277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000222] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Leonard and Isabelle Goldenson Research Fellowship; National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Louis Lange III Scholarship in Translational Research; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Eleanor and Miles Shore Fellowship; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Manton Center for Orphan Disease Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Rozzo, R. S. Hill, H. Lehmann, and W. Paolella for assistance; J. Macklis and N. Sestan for helpful comments on the manuscript; the Dana-Farber Cancer Institute Hematologic Neoplasia Flow Cytometry Core; and the Research Computing group at Harvard Medical School for computing resources, including the Orchestra computing cluster (partially provided through National Center for Research Resources grant 1S10RR028832-01). Human tissue was obtained from the NIH NeuroBioBank at the University of Maryland. We thank R. Johnson of the NeuroBioBank for assistance with tissues, and we thank the donors and their families for their invaluable donations for the advancement of scientific understanding. Figure 3A was illustrated by K. Probst (Xavier Studio). Supported by National Institute on Aging grant T32 AG000222 (M.A.L.), the Leonard and Isabelle Goldenson Research Fellowship (M.B.W.), National Institute of General Medical Sciences (NIGMS) grant T32 GM007753 and the Louis Lange III Scholarship in Translational Research (G.D.E.), NIGMS grants T32 GM007753 and T32 GM007226 (A.M.D.), the Eleanor and Miles Shore Fellowship (E.L.), National Institute of Mental Health grant P50 MH106933 (P.J.P.), and National Institute of Neurological Disorders and Stroke grants R01 NS032457, R01 NS079277, and U01 MH106883 and the Manton Center for Orphan Disease Research (C.A.W.). C.A.W. is a Distinguished Investigator of the Paul G. Allen Family Foundation and an Investigator of the Howard Hughes Medical Institute. Supplement contains additional data. Sequencing data have been deposited in the NCBI SRA under accession numbers SRP041470 and SRP061939.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Behjati S, 2014, NATURE, V513, P422, DOI 10.1038/nature13448; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cai XY, 2014, CELL REP, V8, P1280, DOI 10.1016/j.celrep.2014.07.043; De S, 2011, TRENDS GENET, V27, P217, DOI 10.1016/j.tig.2011.03.002; Dumanski JP, 2012, METHODS MOL BIOL, V838, P249, DOI 10.1007/978-1-61779-507-7_12; Evrony GD, 2015, NEURON, V85, P49, DOI 10.1016/j.neuron.2014.12.028; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Frank SA, 2010, P NATL ACAD SCI USA, V107, P1725, DOI 10.1073/pnas.0909343106; Gao P, 2014, CELL, V159, P775, DOI 10.1016/j.cell.2014.10.027; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Morita Y, 2014, J NEUROSCI, V34, P4929, DOI 10.1523/JNEUROSCI.1423-13.2014; Parihar R, 2013, J HUM GENET, V58, P573, DOI 10.1038/jhg.2013.77; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Polak P, 2008, GENOME RES, V18, P1216, DOI 10.1101/gr.076570.108; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025	26	327	331	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					94	98		10.1126/science.aab1785	http://dx.doi.org/10.1126/science.aab1785			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26430121	Green Accepted			2022-12-28	WOS:000362098300053
J	Green, ED; Watson, JD; Collins, FS				Green, Eric D.; Watson, James D.; Collins, Francis S.			Twenty-five years of big biology	NATURE			English	Editorial Material									[Green, Eric D.] US Natl Inst Hlth, US Natl Human Genome Res Inst, Bethesda, MD 20892 USA; [Watson, James D.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Watson, James D.] US Natl Ctr Human Genome Res, Kansas City, KS USA; [Collins, Francis S.] US Natl Inst Hlth, Bethesda, MD USA; [Collins, Francis S.] US Natl Human Genome Res Inst, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Cold Spring Harbor Laboratory; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Green, ED (corresponding author), US Natl Inst Hlth, US Natl Human Genome Res Inst, Bethesda, MD 20892 USA.	egreen@nhgri.nih.gov; collinsf@mail.nih.gov						Collins FS, 2003, SCIENCE, V300, P286, DOI 10.1126/science.1084564; GREEN ED, 2001, METABOLIC MOL BASES, P259; Hudson KL, 2015, NEW ENGL J MED, V373, P2293, DOI 10.1056/NEJMp1512205; Insel TR, 2013, SCIENCE, V340, P687, DOI 10.1126/science.1239276; Knoppers Bartha Maria, 2014, Hugo J, V8, P3, DOI 10.1186/s11568-014-0003-1; McEwen JE, 2014, ANNU REV GENOM HUM G, V15, P481, DOI 10.1146/annurev-genom-090413-025327; Rotimi C, 2014, SCIENCE, V344, P1346, DOI 10.1126/science.1251546; Stein LD, 2015, NATURE, V523, P149, DOI 10.1038/523149a	8	113	121	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					29	31		10.1038/526029a	http://dx.doi.org/10.1038/526029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS5CY	26432225	Green Published, Bronze			2022-12-28	WOS:000362095100015
J	Starrs, A				Starrs, Ann			A Lancet Commission on sexual and reproductive health and rights: going beyond the Sustainable Development Goals	LANCET			English	Editorial Material									Alan Guttmacher Inst, New York, NY 10038 USA		Starrs, A (corresponding author), Alan Guttmacher Inst, New York, NY 10038 USA.	astarrs@guttmacher.org						Barot, 2014, GUTTMACHER POLICY RE, V17, P22; Family Care International, 2015, BRIEF CARDS SEX REPR; Glasier A, 2006, LANCET, V368, P1595, DOI 10.1016/S0140-6736(06)69478-6; Requejo JH, 2015, LANCET, V385, P466, DOI 10.1016/S0140-6736(14)60925-9; Singh S., 2014, ADDING IT COSTS BENE; Sustainable Development Solutions Network, 2015, IND MON FRAM SUST DE; UNFPA, 2010, UN ACC REPR HLTH REV; United Nations, 2015, TERMS REF INT EXP GR; United Nations Department of Public Information, 2015, CONS REACH NEW SUST; United Nations Economic and Social Council Commission on Population and Development, 2014, E201425ECN920147 UN	10	7	7	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2015	386	9999					1111	1112		10.1016/S0140-6736(15)00250-0	http://dx.doi.org/10.1016/S0140-6736(15)00250-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR5GE	26461889				2022-12-28	WOS:000361368000007
J	Frobert, O; James, SK				Frobert, Ole; James, Stefan K.			Coronary thrombus aspiration: a lesson for clinical medicine	LANCET			English	Editorial Material							ELEVATION MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION; MANUAL THROMBECTOMY; INTERVENTION; GUIDELINES; MANAGEMENT; TRIAL; PCI		[Frobert, Ole] Univ Orebro, Fac Hlth, Dept Cardiol, S-70185 Orebro, Sweden; [James, Stefan K.] Uppsala Univ, Uppsala Clin Res Ctr, Dept Med Sci, Uppsala, Sweden; [James, Stefan K.] Uppsala Univ, Uppsala Clin Res Ctr, Dept Cardiol, Uppsala, Sweden	Orebro University; Uppsala University; Uppsala University	Frobert, O (corresponding author), Univ Orebro, Fac Hlth, Dept Cardiol, S-70185 Orebro, Sweden.	ole.frobert@regionorebrolan.se	James, Stefan K/J-4554-2014	Frobert, Ole/0000-0002-5846-345X				Bhindi R, 2015, EUR HEART J, V36, P1892, DOI 10.1093/eurheartj/ehv176; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; FALK E, 1983, BRIT HEART J, V50, P127; Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789; Inaba Y, 2009, EUROINTERVENTION, V5, P375, DOI 10.4244/V5I3A59; Jolly SS, 2015, NEW ENGL J MED, V372, P1389, DOI 10.1056/NEJMoa1415098; Jolly SS, 2016, LANCET, V387, P127, DOI 10.1016/S0140-6736(15)00448-1; Kynaston-Pearson F, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6956; Lagerqvist B, 2014, NEW ENGL J MED, V371, P1111, DOI 10.1056/NEJMoa1405707; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Vlaar PJ, 2008, LANCET, V371, P1915, DOI 10.1016/S0140-6736(08)60833-8	12	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2016	387	10014					97	98		10.1016/S0140-6736(15)00460-2	http://dx.doi.org/10.1016/S0140-6736(15)00460-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8LF	26474808				2022-12-28	WOS:000368055500006
J	Wei, J; Tong, L				Wei, Jia; Tong, Liang			Crystal structure of the 500-kDa yeast acetyl-CoA carboxylase holoenzyme dimer	NATURE			English	Article							BACTERIAL BIOTIN CARBOXYLASE; FATTY-ACID SYNTHESIS; CARBOXYLTRANSFERASE DOMAIN; PYRUVATE-CARBOXYLASE; COENZYME; DIMERIZATION; INHIBITION; INSIGHTS; SUBUNIT; COMPLEX	Acetyl-CoA carboxylase (ACC) has crucial roles in fatty acid metabolism and is an attractive target for drug discovery against diabetes, cancer and other diseases(1-6). Saccharomyces cerevisiae ACC (ScACC) is crucial for the production of very-long-chain fatty acids and the maintenance of the nuclear envelope(7,8). ACC contains biotin carboxylase (BC) and carboxyltransferase (CT) activities, and its biotin is linked covalently to the biotin carboxyl carrier protein (BCCP). Most eukaryotic ACCs are 250-kilodalton (kDa), multi-domain enzymes and function as homodimers and higher oligomers. They contain a unique, 80-kDa central region that shares no homology with other proteins. Although the structures of the BC, CT and BCCP domains and other biotin-dependent carboxylase holoenzymes are known(1,9-14), there is currently no structural information on the ACC holoenzyme. Here we report the crystal structure of the full-length, 500-kDa holoenzyme dimer of ScACC. The structure is remarkably different from that of the other biotin-dependent carboxylases. The central region contains five domains and is important for positioning the BC and CT domains for catalysis. The structure unexpectedly reveals a dimer of the BC domain and extensive conformational differences compared to the structure of the BC domain alone, which is a monomer. These structural changes reveal why the BC domain alone is catalytically inactive and define the molecular mechanism for the inhibition of eukaryotic ACC by the natural product soraphen A(15,16) and by phosphorylation of a Ser residue just before the BC domain core in mammalian ACC. The BC and CT active sites are separated by 80 angstrom, and the entire BCCP domain must translocate during catalysis.	[Wei, Jia; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu	Wei, Jia/N-6628-2019	Wei, Jia/0000-0002-7301-3297; Tong, Liang/0000-0002-0563-6468	NIH [S100D012018, R01DK067238]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067238] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012018] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Bush, C.-Y. Chou, Y. Shen, L. Yu and H. Zhang for carrying out initial studies in this project; R. Jackimowicz, B. Nolan, N. Whalen, A. Heroux and H. Robinson for access to the X29A and X25 beamlines at the NSLS; S. Banerjee, K. Perry, R. Rajashankar, J. Schuermann, N. Sukumar for access to NE-CAT 24-C and 24-E beamlines at the Advanced Photon Source; W. Rice and E. Eng at New York Structural Biology Center for assistance with electron microscopy. The in-house X-ray diffraction instrument was purchased with an NIH grant to LT. (S100D012018). This research was supported in part by a grant from the NIH (R01DK067238) to L.T.	Abramson HN, 2011, J MED CHEM, V54, P5615, DOI 10.1021/jm2005805; ChapmanSmith A, 1997, J BIOL CHEM, V272, P26017, DOI 10.1074/jbc.272.41.26017; Cho YS, 2010, BIOCHEM BIOPH RES CO, V391, P187, DOI 10.1016/j.bbrc.2009.11.029; Chou CY, 2011, J BIOL CHEM, V286, P24417, DOI 10.1074/jbc.M111.220517; Chou CY, 2009, J BIOL CHEM, V284, P11690, DOI 10.1074/jbc.M805783200; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; Fan C, 2012, J BIOL CHEM, V287, P9389, DOI 10.1074/jbc.M111.319475; Harwood HJ, 2003, J BIOL CHEM, V278, P37099, DOI 10.1074/jbc.M304481200; Hoja U, 1998, EUR J BIOCHEM, V254, P520, DOI 10.1046/j.1432-1327.1998.2540520.x; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Huang CS, 2012, NATURE, V481, P219, DOI 10.1038/nature10691; Huang CS, 2010, NATURE, V466, P1001, DOI 10.1038/nature09302; Hung CL, 2007, J BIOL CHEM, V282, P12220, DOI 10.1074/jbc.M609134200; Polyak SW, 2012, APPL MICROBIOL BIOT, V93, P983, DOI 10.1007/s00253-011-3796-z; Raymer B, 2009, BIOORG MED CHEM LETT, V19, P2804, DOI 10.1016/j.bmcl.2009.03.107; Schneiter R, 1996, MOL CELL BIOL, V16, P7161; Shen Y, 2004, MOL CELL, V16, P881, DOI 10.1016/j.molcel.2004.11.034; Shen Y, 2006, MOL CELL, V22, P807, DOI 10.1016/j.molcel.2006.04.026; Smith AC, 2012, J BACTERIOL, V194, P72, DOI 10.1128/JB.06309-11; Solbiati J, 2002, J BIOL CHEM, V277, P21604, DOI 10.1074/jbc.M201928200; St Maurice M, 2007, SCIENCE, V317, P1076, DOI 10.1126/science.1144504; Tong L, 2013, CELL MOL LIFE SCI, V70, P863, DOI 10.1007/s00018-012-1096-0; Tran TH, 2015, NATURE, V518, P120, DOI 10.1038/nature13912; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; WALDROP GL, 1994, BIOCHEMISTRY-US, V33, P10249, DOI 10.1021/bi00200a004; Waldrop GL, 2012, PROTEIN SCI, V21, P1597, DOI 10.1002/pro.2156; Weatherly SC, 2004, BIOCHEM J, V380, P105, DOI 10.1042/BJ20031960; Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393; Zhang HL, 2004, STRUCTURE, V12, P1683, DOI 10.1016/j.str.2004.07.009; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366	30	45	45	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					723	727		10.1038/nature15375	http://dx.doi.org/10.1038/nature15375			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26458104	Green Accepted			2022-12-28	WOS:000363832100053
J	Zhang, LM; Chen, SB; Ruan, JB; Wu, JY; Tong, AB; Yin, Q; Li, Y; David, L; Lu, A; Wang, WL; Marks, C; Ouyang, Q; Zhang, XZ; Mao, YD; Wu, H				Zhang, Liman; Chen, Shuobing; Ruan, Jianbin; Wu, Jiayi; Tong, Alexander B.; Yin, Qian; Li, Yang; David, Liron; Lu, Alvin; Wang, Wei Li; Marks, Carolyn; Ouyang, Qi; Zhang, Xinzheng; Mao, Youdong; Wu, Hao			Cryo-EM structure of the activated NAIP2-NLRC4 inflammasome reveals nucleated polymerization	SCIENCE			English	Article							CAUSES AUTOINFLAMMATION; BACTERIAL LIGANDS; CRYSTAL-STRUCTURE; NLRC4 CAUSES; APOPTOSOME; SECRETION; MUTATION; SIGNAL; RECOGNITION; CASPASE-1	The NLR family apoptosis inhibitory proteins (NAIPs) bind conserved bacterial ligands, such as the bacterial rod protein PrgJ, and recruit NLR family CARD-containing protein 4 (NLRC4) as the inflammasome adapter to activate innate immunity. We found that the PrgJ-NAIP2-NLRC4 inflammasome is assembled into multisubunit disk-like structures through a unidirectional adenosine triphosphatase polymerization, primed with a single PrgJ-activated NAIP2 per disk. Cryo-electron microscopy (cryo-EM) reconstruction at subnanometer resolution revealed a similar to 90 degrees hinge rotation accompanying NLRC4 activation. Unlike in the related heptameric Apaf-1 apoptosome, in which each subunit needs to be conformationally activated by its ligand before assembly, a single PrgJ-activated NAIP2 initiates NLRC4 polymerization in a domino-like reaction to promote the disk assembly. These insights reveal the mechanism of signal amplification in NAIP-NLRC4 inflammasomes.	[Zhang, Liman; Ruan, Jianbin; Tong, Alexander B.; Yin, Qian; Li, Yang; David, Liron; Lu, Alvin; Wu, Hao] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Zhang, Liman; Ruan, Jianbin; Tong, Alexander B.; Yin, Qian; Li, Yang; David, Liron; Lu, Alvin; Wu, Hao] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Chen, Shuobing; Wu, Jiayi; Ouyang, Qi; Mao, Youdong] Peking Univ, Peking Tsinghua Joint Ctr Life, State Key Lab Artificial Microstruct & Mesoscop,S, Ctr Quantitat Biol,Acad Adv Interdisciplinary Stu, Beijing 100871, Peoples R China; [Chen, Shuobing; Wu, Jiayi; Wang, Wei Li; Mao, Youdong] Dana Farber Canc Inst, Intel Parallel Comp Ctr Struct Biol, Dept Canc Immunol & Virol, Boston, MA 02215 USA; [Wang, Wei Li; Mao, Youdong] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Marks, Carolyn] Harvard Univ, Ctr Nanoscale Syst, Cambridge, MA 02138 USA; [Zhang, Xinzheng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Peking University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Wu, H (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	youdong_mao@dfci.harvard.edu; wu@crystal.harvard.edu	chen, shuobing/B-1868-2019; Wang, Wei L/B-8061-2009; 吴, 家怡/GSI-7419-2022; Mao, Youdong/AFJ-2673-2022; Zhang, Xinzheng/E-6339-2013; zhang, xinzheng/L-6254-2019	chen, shuobing/0000-0001-8730-5234; Wang, Wei L/0000-0002-5064-8097; Mao, Youdong/0000-0001-9302-2257; Lu, Alvin/0000-0003-2353-848X; Ruan, Jianbin/0000-0001-5843-8273; Tong, Alex/0000-0003-3793-2533	NIH K99 grant [AI108793]; Cancer Research Institute; Intel academic grant; Peking University; NIH [1DP1HD087988]; NIH grant Center for HIV/AIDS Vaccine Immunology and Immunogen Design (CHAVI-ID) [AI100645]; NSF [ECS-0335765]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100645, K99AI108793] Funding Source: NIH RePORTER	NIH K99 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Intel academic grant; Peking University(Peking University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grant Center for HIV/AIDS Vaccine Immunology and Immunogen Design (CHAVI-ID); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank G. Bozkurt for technical assistance; H. Ploegh for providing engineered, Ca<SUP>2+</SUP>-independent sortase and the peptide-fluorophore conjugate Gly-Gly-Gly-TAMRA (GGG-TAMRA); and M. Ericsson for use of the Harvard Medical School EM facility. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Cryo-EM maps and atomic coordinates have been deposited in the Electron Microscopy Data Bank (EMDB IDs EMD-6458, EMD-6459, and EMD-6460 for C<INF>11</INF>, C<INF>12</INF>, and C<INF>10</INF> reconstructions, respectively) and Protein Data Bank (PDB ID 3JBL for the C11 reconstruction). Supported by NIH K99 grant AI108793 (Q.Y.), a Cancer Research Institute postdoctoral fellowship (L.D.), an Intel academic grant, research funds at Peking University, and NIH grant 1DP1HD087988. The cryo-EMfacility was funded through the NIH grant AI100645 Center for HIV/AIDS Vaccine Immunology and Immunogen Design (CHAVI-ID). The experiments were performed in part at the Center for Nanoscale Systems at Harvard University, a member of the National Nanotechnology Infrastructure Network (NNIN), which is supported by NSF award ECS-0335765.	Bao Q, 2007, MOL CELL, V25, P181, DOI 10.1016/j.molcel.2006.12.013; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Canna SW, 2014, NAT GENET, V46, P1140, DOI 10.1038/ng.3089; Diez E, 2003, NAT GENET, V33, P55, DOI 10.1038/ng1065; Franchi L, 2012, NAT IMMUNOL, V13, P449, DOI 10.1038/ni.2263; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Garaude J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002868; Growney JD, 2000, GENOME RES, V10, P1158, DOI 10.1101/gr.10.8.1158; Halff EF, 2012, J BIOL CHEM, V287, P38460, DOI 10.1074/jbc.M112.393512; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Hu ZH, 2015, SCIENCE, V350, P399, DOI 10.1126/science.aac5489; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Janowski AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00370; Kitamura A, 2014, J EXP MED, V211, P2385, DOI 10.1084/jem.20141091; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Qi SQ, 2010, CELL, V141, P446, DOI 10.1016/j.cell.2010.03.017; Reubold TF, 2009, J BIOL CHEM, V284, P32717, DOI 10.1074/jbc.M109.014027; Romberg N, 2014, NAT GENET, V46, P1135, DOI 10.1038/ng.3066; Tenthorey JL, 2014, MOL CELL, V54, P17, DOI 10.1016/j.molcel.2014.02.018; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013; Yang JL, 2013, P NATL ACAD SCI USA, V110, P14408, DOI 10.1073/pnas.1306376110; Yuan SJ, 2013, STRUCTURE, V21, P501, DOI 10.1016/j.str.2013.02.024; Yuan SJ, 2011, STRUCTURE, V19, P128, DOI 10.1016/j.str.2010.10.009; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	30	245	254	3	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					404	409		10.1126/science.aac5789	http://dx.doi.org/10.1126/science.aac5789			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26449474	Green Accepted			2022-12-28	WOS:000363213400032
J	Landau, DA; Tausch, E; Taylor-Weiner, AN; Stewart, C; Reiter, JG; Bahlo, J; Kluth, S; Bozic, I; Lawrence, M; Bottcher, S; Carter, SL; Cibulskis, K; Mertens, D; Sougnez, CL; Rosenberg, M; Hess, JM; Edelmann, J; Kless, S; Kneba, M; Ritgen, M; Fink, A; Fischer, K; Gabriel, S; Lander, ES; Nowak, MA; Doehner, H; Hallek, M; Neuberg, D; Getz, G; Stilgenbauer, S; Wu, CJ				Landau, Dan A.; Tausch, Eugen; Taylor-Weiner, Amaro N.; Stewart, Chip; Reiter, Johannes G.; Bahlo, Jasmin; Kluth, Sandra; Bozic, Ivana; Lawrence, Mike; Boettcher, Sebastian; Carter, Scott L.; Cibulskis, Kristian; Mertens, Daniel; Sougnez, Carrie L.; Rosenberg, Mara; Hess, Julian M.; Edelmann, Jennifer; Kless, Sabrina; Kneba, Michael; Ritgen, Matthias; Fink, Anna; Fischer, Kirsten; Gabriel, Stacey; Lander, Eric S.; Nowak, Martin A.; Doehner, Hartmut; Hallek, Michael; Neuberg, Donna; Getz, Gad; Stilgenbauer, Stephan; Wu, Catherine J.			Mutations driving CLL and their evolution in progression and relapse	NATURE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; BRAF MUTATIONS; CANCER; HETEROGENEITY; REVEALS; DRIVER; MYC	Which genetic alterations drive tumorigenesis and how they evolve over the course of disease and therapy are central questions in cancer biology. Here we identify 44 recurrently mutated genes and 11 recurrent somatic copy number variations through whole-exome sequencing of 538 chronic lymphocytic leukaemia (CLL) and matched germline DNA samples, 278 of which were collected in a prospective clinical trial. These include previously unrecognized putative cancer drivers (RPS15, IKZF3), and collectively identify RNA processing and export, MYC activity, and MAPK signalling as central pathways involved in CLL. Clonality analysis of this large data set further enabled reconstruction of temporal relationships between driver events. Direct comparison between matched pre-treatment and relapse samples from 59 patients demonstrated highly frequent clonal evolution. Thus, large sequencing data sets of clinically informative samples enable the discovery of novel genes associated with cancer, the network of relationships between the driver events, and their impact on disease relapse and clinical outcome.	[Landau, Dan A.; Taylor-Weiner, Amaro N.; Stewart, Chip; Reiter, Johannes G.; Lawrence, Mike; Carter, Scott L.; Cibulskis, Kristian; Sougnez, Carrie L.; Rosenberg, Mara; Hess, Julian M.; Gabriel, Stacey; Lander, Eric S.; Getz, Gad; Wu, Catherine J.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Landau, Dan A.; Reiter, Johannes G.; Wu, Catherine J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Landau, Dan A.; Wu, Catherine J.] Brigham & Womens Hosp, Dept Internal Med, Boston, MA 02115 USA; [Landau, Dan A.; Wu, Catherine J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Tausch, Eugen; Mertens, Daniel; Edelmann, Jennifer; Kless, Sabrina; Doehner, Hartmut; Stilgenbauer, Stephan] Univ Ulm, Dept Internal Med 3, D-89081 Ulm, Germany; [Reiter, Johannes G.] IST Austria, A-3400 Klosterneuburg, Austria; [Reiter, Johannes G.; Bozic, Ivana; Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Bahlo, Jasmin; Kluth, Sandra; Fink, Anna; Fischer, Kirsten; Hallek, Michael] Univ Hosp, Dept Internal Med, D-50937 Cologne, Germany; [Bahlo, Jasmin; Kluth, Sandra; Fink, Anna; Fischer, Kirsten; Hallek, Michael] Univ Hosp, Ctr Integrated Oncol Cologne Bonn, D-50937 Cologne, Germany; [Bozic, Ivana; Nowak, Martin A.] Harvard Univ, Dept Math, Cambridge, MA 02138 USA; [Boettcher, Sebastian; Kneba, Michael; Ritgen, Matthias] Univ Hosp Schleswig Holstein, Dept Internal Med 2, D-24105 Kiel, Germany; [Carter, Scott L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Joint Ctr Canc Precis Med,Dana Farber Canc Inst, Boston, MA 02215 USA; [Mertens, Daniel] German Canc Res Ctr, Mechanisms Leukemogenesis, D-69121 Heidelberg, Germany; [Nowak, Martin A.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Hallek, Michael] Cologne Cluster Excellence Cellular Stress Respon, D-50931 Cologne, Germany; [Neuberg, Donna] Dana Farber Canc Inst, Biostat & Computat Biol, Boston, MA 02115 USA; [Getz, Gad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02129 USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02129 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Ulm University; Institute of Science & Technology - Austria; Harvard University; University of Cologne; University of Cologne; Harvard University; University of Kiel; Schleswig Holstein University Hospital; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; University of Cologne; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Wu, CJ (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	gadgetz@broadinstitute.org; Stephan.Stilgenbauer@uniklinik-ulm.de; cwu@partners.org	Döhner, Hartmut/C-8933-2016; Hallek, Michael/Y-3191-2019; Bozic, Ivana/C-5003-2008; Cibulskis, Kristian/AAC-7380-2019; Stilgenbauer, Stephan/ABE-6609-2020; Mertens, Daniel/F-4681-2011; Reiter, Johannes G./Y-4083-2019	Döhner, Hartmut/0000-0003-2116-5536; Hallek, Michael/0000-0002-7425-4455; Bozic, Ivana/0000-0003-2761-825X; Mertens, Daniel/0000-0003-0227-7188; Reiter, Johannes G./0000-0002-0170-7353; Rosenberg, Mara/0000-0001-6400-3161; Fink, Anna Maria/0000-0002-7669-7890; Cibulskis, Kristian/0000-0003-1343-1582	ACS; ASH; Burroughs Wellcome Fund Career Award for Medical Scientists; NIH Big Data to Knowledge initiative (BD2K) [1K01ES025431-01]; European Research Council (ERC) [279307]; Austrian Science Fund (FWF) [P23499-N23]; FWF NFN [S11407-N23 RiSE]; German Jose Carreras Leukemia Foundation [R06/03v]; Deutsche Forschungsgemeinschaft [KFO 286, SFB 1074]; Else Kroner-Fresenius-Stiftung [2010_Kolleg24, 2012_A146]; Virtual Helmholtz Institute [VH-VI-404]; CLL Global Research Foundation (Alliance); Blavatnik Family Foundation; AACR; NIH/NCI [1R01CA182461-02, 1R01CA184922-01, 1U10CA180861-01]; NATIONAL CANCER INSTITUTE [R01CA184922, U10CA180861, P01CA081534, R01CA182461] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116452] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K01ES025431] Funding Source: NIH RePORTER	ACS(American Cancer Society); ASH; Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); NIH Big Data to Knowledge initiative (BD2K); European Research Council (ERC)(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); FWF NFN(Austrian Science Fund (FWF)); German Jose Carreras Leukemia Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung; Virtual Helmholtz Institute; CLL Global Research Foundation (Alliance); Blavatnik Family Foundation; AACR; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank all members of the Broad Institute's Biological Samples, Genetic Analysis and Genome Sequencing Platforms, who made this work possible (NHGRI-U54HG003067). We further thank all patients and their physicians for CLL8 trial participation and donation of samples; M. Mendila, N. Valente, S. Zurfluh, M. Wenger and J. Wingate for their support in conception and conduct of the CLL8 trial. D.A.L. is supported by an ACS Postdoctoral Fellowship, ASH Scholar Award, and the Burroughs Wellcome Fund Career Award for Medical Scientists and by the NIH Big Data to Knowledge initiative (BD2K, 1K01ES025431-01). J.G.R. was supported by the European Research Council (ERC) start grant 279307: Graph Games, Austrian Science Fund (FWF) grant no. P23499-N23, and FWF NFN grant no S11407-N23 RiSE. S.B. is supported by the German Jose Carreras Leukemia Foundation (project R06/03v). M.H. is supported by the Deutsche Forschungsgemeinschaft (KFO 286, Project 6). S. S. is supported by the Else Kroner-Fresenius-Stiftung (2010_Kolleg24, 2012_A146), Virtual Helmholtz Institute (VH-VI-404), CLL Global Research Foundation (Alliance), and Deutsche Forschungsgemeinschaft (SFB 1074 projects B1, B2). C.J.W. acknowledges support from the Blavatnik Family Foundation, AACR (SU2C Innovative Research Grant), and NIH/NCI (1R01CA182461-02, 1R01CA184922-01, 1U10CA180861-01).	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Bea S, 2002, AM J PATHOL, V161, P957, DOI 10.1016/S0002-9440(10)64256-3; Billot K, 2011, BLOOD, V117, P1917, DOI 10.1182/blood-2010-09-307140; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Brastianos PK, 2014, NAT GENET, V46, P161, DOI 10.1038/ng.2868; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Damm F, 2014, CANCER DISCOV, V4, P1088, DOI 10.1158/2159-8290.CD-14-0104; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; De Paoli L, 2013, LEUKEMIA LYMPHOMA, V54, P1087, DOI 10.3109/10428194.2012.723706; Edelmann J, 2012, BLOOD, V120, P4783, DOI 10.1182/blood-2012-04-423517; Ferreiros-Vidal I, 2013, BLOOD, V121, P1769, DOI 10.1182/blood-2012-08-450114; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Hallek M, 2010, LANCET, V376, P1164, DOI 10.1016/S0140-6736(10)61381-5; Hallek M, 2015, AM J HEMATOL, V90, P446, DOI 10.1002/ajh.23979; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Jebaraj BMC, 2013, LEUKEMIA LYMPHOMA, V54, P1177, DOI 10.3109/10428194.2012.742525; Jiang X, 2014, HAEMATOLOGICA, V99, P1834, DOI 10.3324/haematol.2014.106401; Landau DA, 2013, GENOME MED, V5, DOI 10.1186/gm451; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; Nuckel H, 2009, BRIT J HAEMATOL, V144, P268, DOI 10.1111/j.1365-2141.2008.07442.x; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Park J, 2010, J BIOL CHEM, V285, P31895, DOI 10.1074/jbc.M110.147520; Puente XS, 2013, NAT GENET, V45, P229, DOI 10.1038/ng.2556; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rossi D, 2013, BLOOD, V121, P1403, DOI 10.1182/blood-2012-09-458265; Sashida G, 2009, MOL CELL BIOL, V29, P3687, DOI 10.1128/MCB.01551-08; Schlosser I, 2005, ONCOGENE, V24, P520, DOI 10.1038/sj.onc.1208198; Schuh A, 2012, BLOOD, V120, P4191, DOI 10.1182/blood-2012-05-433540; Stilgenbauer S, 2014, BLOOD, V123, P3247, DOI 10.1182/blood-2014-01-546150; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Wang J, 2014, ELIFE, V3, DOI 10.7554/eLife.03496; Winkelmann N, 2015, HAEMATOLOGICA, V100, pE237, DOI 10.3324/haematol.2014.120238; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646; [张建恒 Zhang Jianheng], 2013, [海洋环境科学, Marine Environmental Science], V32, P1	38	656	667	3	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					525	U132		10.1038/nature15395	http://dx.doi.org/10.1038/nature15395			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26466571	Green Accepted, Green Submitted			2022-12-28	WOS:000364026100040
J	Takasato, M; Er, PX; Chiu, HS; Maier, B; Baillie, GJ; Ferguson, C; Parton, RG; Wolvetang, EJ; Roost, MS; Lopes, SMCD; Little, MH				Takasato, Minoru; Er, Pei X.; Chiu, Han S.; Maier, Barbara; Baillie, Gregory J.; Ferguson, Charles; Parton, Robert G.; Wolvetang, Ernst J.; Roost, Matthias S.; Lopes, Susana M. Chuva de Sousa; Little, Melissa H.			Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis	NATURE			English	Article							PLURIPOTENT STEM-CELLS; INTERMEDIATE MESODERM; RETINOIC ACID; NEPHRON PROGENITORS; LATERAL PLATE; DIFFERENTIATION; POPULATION; EXPRESSION; APOPTOSIS; ORIGIN	The human kidney contains up to 2 million epithelial nephrons responsible for blood filtration. Regenerating the kidney requires the induction of the more than 20 distinct cell types required for excretion and the regulation of pH, and electrolyte and fluid balance. We have previously described the simultaneous induction of progenitors for both collecting duct and nephrons via the directed differentiation of human pluripotent stem cells(1). Paradoxically, although both are of intermediate mesoderm in origin, collecting duct and nephrons have distinct temporospatial origins. Here we identify the developmental mechanism regulating the preferential induction of collecting duct versus kidney mesenchyme progenitors. Using this knowledge, we have generated kidney organoids that contain nephrons associated with a collecting duct network surrounded by renal interstitium and endothelial cells. Within these organoids, individual nephrons segment into distal and proximal tubules, early loops of Henle, and glomeruli containing podocytes elaborating foot processes and undergoing vascularization. When transcription profiles of kidney organoids were compared to human fetal tissues, they showed highest congruence with first trimester human kidney. Furthermore, the proximal tubules endocytose dextran and differentially apoptose in response to cisplatin, a nephrotoxicant. Such kidney organoids represent powerful models of the human organ for future applications, including nephrotoxicity screening, disease modelling and as a source of cells for therapy.	[Takasato, Minoru; Er, Pei X.; Little, Melissa H.] Royal Childrens Hosp Melbourne, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Takasato, Minoru; Chiu, Han S.; Maier, Barbara; Baillie, Gregory J.; Ferguson, Charles; Parton, Robert G.; Little, Melissa H.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Wolvetang, Ernst J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld 4072, Australia; [Roost, Matthias S.; Lopes, Susana M. Chuva de Sousa] Leiden Univ, Med Ctr, Dept Anat & Embryol, NL-2333 ZC Leiden, Netherlands; [Little, Melissa H.] Univ Melbourne, Dept Paediat, Parkville, Vic 3010, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Queensland; University of Queensland; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Melbourne	Takasato, M (corresponding author), Royal Childrens Hosp Melbourne, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	minoru.takasato@mcri.edu.au; melissa.little@mcri.edu.au	Baillie, Gregory J/F-9478-2013; Wolvetang, Ernst jurgen/D-6644-2017; Little, Melissa H/A-6170-2010; Takasato, Minoru/K-2035-2014; Wilson, Matthew H/K-3193-2013; Parton, Robert/C-5673-2009	Baillie, Gregory J/0000-0002-6130-250X; Wolvetang, Ernst jurgen/0000-0002-2146-6614; Little, Melissa H/0000-0003-0380-2263; Takasato, Minoru/0000-0002-0458-7414; Parton, Robert/0000-0002-7494-5248	National Health and Medical Research Council (NHMRC) of Australia [APP1041277, APP1037320]; Australian Research Council (ARC) [SRI110001002, CE140100036]; Bontius Stiching; Organovo Inc.	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Bontius Stiching; Organovo Inc.	This research was supported by National Health and Medical Research Council (NHMRC) of Australia (APP1041277, APP1037320), Australian Research Council (ARC) (SRI110001002, CE140100036), Bontius Stiching and Organovo Inc. M.H.L. and R.G.P. are NHMRC Senior Principal Research Fellows. B.M. is a Rosamond Siemon Postgraduate Scholar. We thank A. Christ and T. Bruxner at the IMB Sequencing Facility for providing NGS service. We also acknowledge the IMB ACRF Imaging Facility and the Australian Microscopy & Microanalysis Research Facility at the Center for Microscopy and Microanalysis at The University of Queensland.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Briggs JA, 2013, STEM CELLS, V31, P467, DOI 10.1002/stem.1297; Brunskill EW, 2008, DEV CELL, V15, P781, DOI 10.1016/j.devcel.2008.09.007; Brunskill EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024640; Cheng XG, 2009, DRUG METAB DISPOS, V37, P2178, DOI 10.1124/dmd.109.027177; Cummings BS, 2002, J PHARMACOL EXP THER, V302, P8, DOI 10.1124/jpet.302.1.8; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Floege J, 1997, KIDNEY INT, V51, P1140, DOI 10.1038/ki.1997.157; James RG, 2003, DEV BIOL, V253, P109, DOI 10.1006/dbio.2002.0863; Kang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094888; Kobayashi A, 2014, STEM CELL REP, V3, P650, DOI 10.1016/j.stemcr.2014.08.008; Lam AQ, 2014, J AM SOC NEPHROL, V25, P1211, DOI 10.1681/ASN.2013080831; Loughna S, 1998, BIOCHEM BIOPH RES CO, V247, P361, DOI 10.1006/bbrc.1998.8768; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; Mese H, 2000, CANCER CHEMOTH PHARM, V46, P241, DOI 10.1007/s002800000145; Mugford JW, 2008, DEV BIOL, V324, P88, DOI 10.1016/j.ydbio.2008.09.010; Park JS, 2012, DEV CELL, V23, P637, DOI 10.1016/j.devcel.2012.07.008; Roost MS, 2015, STEM CELL REP, V4, P1112, DOI 10.1016/j.stemcr.2015.05.002; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; Short KM, 2014, DEV CELL, V29, P188, DOI 10.1016/j.devcel.2014.02.017; Sims-Lucas S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065993; Sweetman D, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-63; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Takasato M., 2015, PROTOC EXCH; Takasato M, 2015, DEVELOPMENT, V142, P1937, DOI 10.1242/dev.104802; Thiagarajan RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017286; Xia Y, 2013, NAT CELL BIOL, V15, P1507, DOI 10.1038/ncb2872; Xu JS, 2014, DEV CELL, V31, P434, DOI 10.1016/j.devcel.2014.10.015	31	791	827	16	242	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					564	U238		10.1038/nature15695	http://dx.doi.org/10.1038/nature15695			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26444236				2022-12-28	WOS:000364026100048
J	Gepner, Y; Golan, R; Harman-Boehm, I; Henkin, Y; Schwarzfuchs, D; Shelef, I; Durst, R; Kovsan, J; Bolotin, A; Leitersdorf, E; Shpitzen, S; Balag, S; Shemesh, E; Witkow, S; Tangi-Rosental, O; Chassidim, Y; Liberty, IF; Sarusi, B; Ben-Avraham, S; Helander, A; Ceglarek, U; Stumvoll, M; Bluher, M; Thiery, J; Rudich, A; Stampfer, MJ; Shai, I				Gepner, Yftach; Golan, Rachel; Harman-Boehm, Ilana; Henkin, Yaakov; Schwarzfuchs, Dan; Shelef, Ilan; Durst, Ronen; Kovsan, Julia; Bolotin, Arkady; Leitersdorf, Eran; Shpitzen, Shoshana; Balag, Shai; Shemesh, Elad; Witkow, Shula; Tangi-Rosental, Osnat; Chassidim, Yoash; Liberty, Idit F.; Sarusi, Benjamin; Ben-Avraham, Sivan; Helander, Anders; Ceglarek, Uta; Stumvoll, Michael; Blueher, Matthias; Thiery, Joachim; Rudich, Assaf; Stampfer, Meir J.; Shai, Iris			Effects of Initiating Moderate Alcohol Intake on Cardiometabolic Risk in Adults With Type 2 Diabetes A 2-Year Randomized, Controlled Trial	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; ESTER TRANSFER PROTEIN; RED WINE; ALDEHYDE DEHYDROGENASE; CARDIOVASCULAR-DISEASE; HEMOSTATIC FACTORS; HOMEOSTASIS MODEL; CONSUMPTION; METAANALYSIS; MELLITUS	Background: Recommendations for moderate alcohol consumption remain controversial, particularly in type 2 diabetes mellitus (T2DM). Long-term randomized, controlled trials (RCTs) are lacking. Objective: To assess cardiometabolic effects of initiating moderate alcohol intake in persons with T2DM and whether the type of wine matters. Design: 2-year RCT (CASCADE [CArdiovaSCulAr Diabetes & Ethanol] trial). (ClinicalTrials.gov: NCT00784433) Setting: Ben-Gurion University of the Negev-Soroka Medical Center and Nuclear Research Center Negev, Israel. Patients: Alcohol-abstaining adults with well-controlled T2DM. Intervention: Patients were randomly assigned to 150 mL of mineral water, white wine, or red wine with dinner for 2 years. Wines and mineral water were provided. All groups followed a Mediterranean diet without caloric restriction. Measurements: Primary outcomes were lipid and glycemic control profiles. Genetic measurements were done, and patients were followed for blood pressure, liver biomarkers, medication use, symptoms, and quality of life. Results: Of the 224 patients who were randomly assigned, 94% had follow-up data at 1 year and 87% at 2 years. In addition to the changes in the water group (Mediterranean diet only), red wine significantly increased high-density lipoprotein cholesterol (HDL-C) level by 0.05 mmol/L (2.0 mg/dL) (95% CI, 0.04 to 0.06 mmol/L [1.6 to 2.2 mg/dL]; P < 0.001) and apolipoprotein(a) 1 level by 0.03 g/L (CI, 0.01 to 0.06 g/L; P = 0.05) and decreased the total cholesterol-HDL-C ratio by 0.27 (CI, -0.52 to -0.01; P = 0.039). Only slow ethanol metabolizers (alcohol dehydrogenase alleles [ADH1B*1] carriers) significantly benefited from the effect of both wines on glycemic control (fasting plasma glucose, homeostatic model assessment of insulin resistance, and hemoglobin A(1c)) compared with fast ethanol metabolizers (persons homozygous for ADH1B*2). Across the 3 groups, no material differences were identified in blood pressure, adiposity, liver function, drug therapy, symptoms, or quality of life, except that sleep quality improved in both wine groups compared with the water group (P = 0.040). Overall, compared with the changes in the water group, red wine further reduced the number of components of the metabolic syndrome by 0.34 (CI, -0.68 to -0.001; P = 0.049). Limitation: Participants were not blinded to treatment allocation. Conclusion: This long-term RCT suggests that initiating moderate wine intake, especially red wine, among well-controlled diabetics as part of a healthy diet is apparently safe and modestly decreases cardiometabolic risk. The genetic interactions suggest that ethanol plays an important role in glucose metabolism, and red wine's effects also involve nonalcoholic constituents.	[Gepner, Yftach; Golan, Rachel; Kovsan, Julia; Bolotin, Arkady; Witkow, Shula; Tangi-Rosental, Osnat; Ben-Avraham, Sivan; Rudich, Assaf; Shai, Iris] Ben Gurion Univ Negev, Dept Publ Hlth, IL-8410501 Beer Sheva, Israel; [Harman-Boehm, Ilana; Henkin, Yaakov; Shelef, Ilan; Shemesh, Elad; Chassidim, Yoash; Liberty, Idit F.] Soroka Med Ctr, IL-85025 Beer Sheva, Israel; [Schwarzfuchs, Dan; Sarusi, Benjamin] Nucl Res Ctr Negev, IL-8477605 Dimona, Israel; [Durst, Ronen; Leitersdorf, Eran; Shpitzen, Shoshana; Balag, Shai] Hadassah Hebrew Univ, Med Ctr, Kiryat Hadassah, IL-91120 Jerusalem, Israel; [Helander, Anders] Karolinska Univ, Karolinska Inst, Dept Lab Med, Div Clin Chem,Lab Hudding, SE-14186 Stockholm, Sweden; [Ceglarek, Uta; Stumvoll, Michael; Blueher, Matthias; Thiery, Joachim] Univ Leipzig, Dept Diagnost, D-04103 Leipzig, Germany; [Stampfer, Meir J.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Stampfer, Meir J.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Ben Gurion University; Ben Gurion University; Soroka Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Karolinska Institutet; Karolinska University Hospital; Leipzig University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Gepner, Y (corresponding author), Ben Gurion Univ Negev, Dept Publ Hlth, POB 653, IL-8410501 Beer Sheva, Israel.		Shemesh, Elad/O-5039-2019; Stumvoll, Michael/ABE-1121-2021; Golan, Rachel/AAA-5961-2021; Ceglarek, Uta/GOE-5561-2022	Shemesh, Elad/0000-0003-1162-2991; Stumvoll, Michael/0000-0001-6225-8240; Shai, Iris/0000-0001-9050-4605; Helander, Anders/0000-0001-7480-8078; Rudich, Assaf/0000-0002-1366-1444; Ben-Avraham, Sivan/0000-0002-9130-0062; Durst, Ronen/0000-0003-3559-1050; shelef, ilan/0000-0002-8398-6455	European Foundation for the Study of Diabetes	European Foundation for the Study of Diabetes	European Foundation for the Study of Diabetes.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011, 10.2337/dc12-s004]; Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227; Bantle AE, 2008, METABOLISM, V57, P241, DOI 10.1016/j.metabol.2007.09.007; Baraona E, 2001, ALCOHOL CLIN EXP RES, V25, P502, DOI 10.1097/00000374-200104000-00004; Beulens JWJ, 2007, DIABETES, V56, P2388, DOI 10.2337/db07-0181; Black S., 1819, CLIN PATHOLOGICAL RE, P1; Briasoulis A, 2012, J CLIN HYPERTENS, V14, P792, DOI 10.1111/jch.12008; Brien SE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d636; Carlsson S, 2005, DIABETOLOGIA, V48, P1051, DOI 10.1007/s00125-005-1768-5; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Chiva-Blanch G, 2012, AM J CLIN NUTR, V95, P326, DOI 10.3945/ajcn.111.022889; Cleophas TJ, 1999, BIOMED PHARMACOTHER, V53, P417, DOI 10.1016/S0753-3322(99)80121-8; Dakeishi M, 2008, ALCOHOL ALCOHOLISM, V43, P143, DOI 10.1093/alcalc/agm173; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Edenberg HJ, 2007, ALCOHOL RES HEALTH, V30, P5; EHRIG T, 1990, ALCOHOL ALCOHOLISM, V25, P105, DOI 10.1093/oxfordjournals.alcalc.a044985; Estruch R, 2011, NUTR METAB CARDIOVAS, V21, P46, DOI 10.1016/j.numecd.2009.07.006; Gavin JR, 1997, DIABETES CARE, V20, P1183; Golan R, 2012, DIABETES CARE, V35, P640, DOI 10.2337/dc11-1583; Goldberg IJ, 2001, CIRCULATION, V103, P472; Gronbaek M, 2009, J INTERN MED, V265, P407, DOI 10.1111/j.1365-2796.2009.02082.x; Haffner SM, 1997, DIABETES CARE, V20, P1087, DOI 10.2337/diacare.20.7.1087; Hannuksela ML, 1996, ARTERIOSCL THROM VAS, V16, P213, DOI 10.1161/01.ATV.16.2.213; Hansen AS, 2005, EUR J CLIN NUTR, V59, P449, DOI 10.1038/sj.ejcn.1602107; Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164; Howard AA, 2004, ANN INTERN MED, V140, P211, DOI 10.7326/0003-4819-140-6-200403160-00011; Karavia EA, 2014, EXPERT REV CARDIOVAS, V12, P521, DOI 10.1586/14779072.2014.896741; Katsuki A, 2001, DIABETES CARE, V24, P362, DOI 10.2337/diacare.24.2.362; Kim SH, 2009, METABOLISM, V58, P387, DOI 10.1016/j.metabol.2008.10.013; Koppes LLJ, 2006, DIABETOLOGIA, V49, P648, DOI 10.1007/s00125-005-0127-x; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Kroon PA, 2004, AM J CLIN NUTR, V80, P15; Liu YX, 2015, CLIN NUTR, V34, P27, DOI 10.1016/j.clnu.2014.03.009; Monnier L, 2003, DIABETES CARE, V26, P881, DOI 10.2337/diacare.26.3.881; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; Neumark YD, 2004, ALCOHOL CLIN EXP RES, V28, P10, DOI 10.1097/01.ALC.0000108667.79219.4D; NISHIWAKI M, 1994, ATHEROSCLEROSIS, V111, P99, DOI 10.1016/0021-9150(94)90195-3; Organisation for Economic Co-operation and Development, 2015, HLTH GLANC 2011 OCED; PUHAKAINEN I, 1991, DIABETES, V40, P1319, DOI 10.2337/diabetes.40.10.1319; Rimm EB, 1996, BRIT MED J, V312, P731, DOI 10.1136/bmj.312.7033.731; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; Sahebkar A, 2013, NUTR REV, V71, P822, DOI 10.1111/nure.12081; SAVOLAINEN MJ, 1990, EUR J CLIN INVEST, V20, P593, DOI 10.1111/j.1365-2362.1990.tb01906.x; Schuetze M, 2009, EUR J CLIN NUTR, V63, P1143, DOI 10.1038/ejcn.2009.39; Shai I, 2005, J NUTR, V135, P573, DOI 10.1093/jn/135.3.573; Shai I, 2004, DIABETOLOGIA, V47, P1760, DOI 10.1007/s00125-004-1526-0; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Shai I, 2007, DIABETES CARE, V30, P3011, DOI 10.2337/dc07-1103; Silva ERDE, 2000, CIRCULATION, V102, P2347, DOI 10.1161/01.CIR.102.19.2347; Solomon CG, 2000, CIRCULATION, V102, P494; STAMPFER MJ, 1988, AM J EPIDEMIOL, V128, P549, DOI 10.1093/oxfordjournals.aje.a115002; STAMPFER MJ, 1988, NEW ENGL J MED, V319, P267, DOI 10.1056/NEJM198808043190503; Suter PM, 2005, CRIT REV CL LAB SCI, V42, P197, DOI 10.1080/10408360590913542; Szmitko PE, 2005, AM J PHYSIOL-HEART C, V288, pH2023, DOI 10.1152/ajpheart.00868.2004; Tanasescu M, 2001, J AM COLL CARDIOL, V38, P1836, DOI 10.1016/S0735-1097(01)01655-2; van der Gaag MS, 2001, J LIPID RES, V42, P2077; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.230S, 10.1093/ajcn/81.1.243S]	59	112	114	0	65	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2015	163	8					569	+		10.7326/M14-1650	http://dx.doi.org/10.7326/M14-1650			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7QV	26458258				2022-12-28	WOS:000363737400015
J	Lisse, C				Lisse, Carey			Comet Siding Spring, up close and personal	SCIENCE			English	Editorial Material							MARS; A1		Johns Hopkins Univ, Appl Phys Lab, Baltimore, MD 20723 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Lisse, C (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Baltimore, MD 20723 USA.	carey.lisse@jhuapl.edu	Lisse, Carey M/B-7772-2016	Lisse, Carey M/0000-0002-9548-1526				Benna M, 2015, GEOPHYS RES LETT, V42, P4670, DOI 10.1002/2015GL064159; Bodewits D, 2015, ASTROPHYS J LETT, V802, DOI 10.1088/2041-8205/802/1/L6; Delamere A., 2014, B AM ASTRON SOC, V46; Gurnett DA, 2015, GEOPHYS RES LETT, V42, P4745, DOI 10.1002/2015GL063726; Kiss C., 2015, IAU M, V29; Li JY, 2014, ASTROPHYS J LETT, V797, DOI 10.1088/2041-8205/797/1/L8; Lisse C. M., 2015, LPI CONTRIBUTION, V1832, P2377; Lisse C. M., 2014, B AM ASTRON SOC, V46; Restano M, 2015, GEOPHYS RES LETT, V42, P4663, DOI 10.1002/2015GL064150; Schneider NM, 2015, GEOPHYS RES LETT, V42, P4755, DOI 10.1002/2015GL063863; Stevenson R, 2015, ASTROPHYS J LETT, V798, DOI 10.1088/2041-8205/798/2/L31; Tricarico P, 2015, GEOPHYS RES LETT, V42, P4752, DOI 10.1002/2015GL064726	12	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2015	350	6258					277	278		10.1126/science.aac7879	http://dx.doi.org/10.1126/science.aac7879			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT5HD	26472894				2022-12-28	WOS:000362838700020
J	Golledge, NR; Kowalewski, DE; Naish, TR; Levy, RH; Fogwill, CJ; Gasson, EGW				Golledge, N. R.; Kowalewski, D. E.; Naish, T. R.; Levy, R. H.; Fogwill, C. J.; Gasson, E. G. W.			The multi-millennial Antarctic commitment to future sea-level rise	NATURE			English	Article							ICE-SHEET; PINE ISLAND; RETREAT; MODEL; GLACIERS; COLLAPSE; SURFACE; STABILITY; DISCHARGE; THWAITES	Atmospheric warming is projected to increase global mean surface temperatures by 0.3 to 4.8 degrees Celsius above pre-industrial values by the end of this century(1). If anthropogenic emissions continue unchecked, the warming increase may reach 8-10 degrees Celsius by 2300 (ref. 2). The contribution that large ice sheets will make to sea-level rise under such warming scenarios is difficult to quantify because the equilibrium-response timescale of ice sheets is longer than those of the atmosphere or ocean. Here we use a coupled ice-sheet/ice-shelf model to show that if atmospheric warming exceeds 1.5 to 2 degrees Celsius above present, collapse of the major Antarctic ice shelves triggers a centennial-to millennial-scale response of the Antarctic ice sheet in which enhanced viscous flow produces a long-term commitment (an unstoppable contribution) to sea-level rise. Our simulations represent the response of the present-day Antarctic ice-sheet system to the oceanic and climatic changes of four representative concentration pathways (RCPs) from the Fifth Assessment Report of the Intergovernmental Panel on Climate Change(3). We find that substantial Antarctic ice loss can be prevented only by limiting greenhouse gas emissions to RCP 2.6 levels. Higher-emissions scenarios lead to ice loss from Antarctic that will raise sea level by 0.6-3 metres by the year 2300. Our results imply that greenhouse gas emissions in the next few decades will strongly influence the long-term contribution of the Antarctic ice sheet to global sea level.	[Golledge, N. R.; Naish, T. R.] Victoria Univ Wellington, Antarctic Res Ctr, Wellington 6140, New Zealand; [Golledge, N. R.; Naish, T. R.; Levy, R. H.] GNS Sci, Lower Hutt 5011, New Zealand; [Kowalewski, D. E.] Worcester State Univ, Dept Earth Environm & Phys, Worcester, MA 01602 USA; [Fogwill, C. J.] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia; [Gasson, E. G. W.] Univ Massachusetts, Climate Syst Res Ctr, Amherst, MA 01003 USA	Victoria University Wellington; GNS Science - New Zealand; Massachusetts System of Public Higher Education; Worcester State University; University of New South Wales Sydney; University of Massachusetts System; University of Massachusetts Amherst	Golledge, NR (corresponding author), Victoria Univ Wellington, Antarctic Res Ctr, Wellington 6140, New Zealand.	nicholas.golledge@vuw.ac.nz	Fogwill, Chris/AAW-3502-2021	Fogwill, Chris/0000-0002-6471-1106; Golledge, Nicholas/0000-0001-7676-8970; Naish, Tim/0000-0002-1185-9932; Kowalewski, Douglas/0000-0002-7847-026X; Gasson, Edward/0000-0003-4653-6217; Levy, Richard/0000-0002-8783-0167	Royal Society of New Zealand's Marsden Fund [VUW1203]; Antarctic Research Centre; Victoria University of Wellington; ANDRILL; GNS Science (NZ Ministry of Business Innovation and Employment) [C05X1001]; National Science Foundation [ANT-1043712]; Australian Research Council (ARC); Office of Polar Programs (OPP) [1245899] Funding Source: National Science Foundation	Royal Society of New Zealand's Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Antarctic Research Centre; Victoria University of Wellington; ANDRILL; GNS Science (NZ Ministry of Business Innovation and Employment); National Science Foundation(National Science Foundation (NSF)); Australian Research Council (ARC)(Australian Research Council); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the CMIP community for making their data openly available, and J. Lenaerts for providing present-day surface mass balance data. We are also grateful to K. Buckley (Victoria University high-performance computing cluster), C. Khroulev, T. Albrecht and the Parallel Ice Sheet Model groups at the University of Alaska, Fairbanks, and the Potsdam Institute for Climate Impact Research. This work was funded by contract VUW1203 of the Royal Society of New Zealand's Marsden Fund, with support from the Antarctic Research Centre, Victoria University of Wellington, ANDRILL, GNS Science (NZ Ministry of Business Innovation and Employment contract C05X1001), National Science Foundation grant ANT-1043712, and the Australian Research Council (ARC). J. Renwick and D. Zwartz provided comments that improved the manuscript.	Albrecht T, 2012, J GLACIOL, V58, P165, DOI 10.3189/2012JoG11J191; Bindschadler RA, 2013, J GLACIOL, V59, P195, DOI 10.3189/2013JoG12J125; Bueler E, 2007, ANN GLACIOL-SER, V46, P97, DOI 10.3189/172756407782871567; Bueler E, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001179; CLARKE GKC, 1977, REV GEOPHYS, V15, P235, DOI 10.1029/RG015i002p00235; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Comiso JC, 2000, J CLIMATE, V13, P1674, DOI 10.1175/1520-0442(2000)013<1674:VATIAS>2.0.CO;2; Cornford SL, 2015, CRYOSPHERE, V9, P1579, DOI 10.5194/tc-9-1579-2015; Durand G, 2009, ANN GLACIOL, V50, P109, DOI 10.3189/172756409789624283; Dutrieux P, 2013, CRYOSPHERE, V7, P1543, DOI 10.5194/tc-7-1543-2013; Favier L, 2014, NAT CLIM CHANGE, V4, P117, DOI [10.1038/nclimate2094, 10.1038/NCLIMATE2094]; Feldmann J, 2015, CRYOSPHERE, V9, P631, DOI 10.5194/tc-9-631-2015; Feldmann J, 2014, J GLACIOL, V60, P353, DOI 10.3189/2014JoG13J093; Fretwell P, 2013, CRYOSPHERE, V7, P375, DOI 10.5194/tc-7-375-2013; Frieler K, 2015, NAT CLIM CHANGE, V5, P348, DOI 10.1038/nclimate2574; Golledge NR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6107; Golledge NR, 2012, P NATL ACAD SCI USA, V109, P16052, DOI 10.1073/pnas.1205385109; Gomez N, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002128; Graversen RG, 2009, CLIM DYNAM, V33, P629, DOI 10.1007/s00382-009-0535-6; Harig C, 2015, EARTH PLANET SC LETT, V415, P134, DOI 10.1016/j.epsl.2015.01.029; Hay CC, 2015, NATURE, V517, P481, DOI 10.1038/nature14093; Holland DM, 1999, J PHYS OCEANOGR, V29, P1787, DOI 10.1175/1520-0485(1999)029<1787:MTIOIA>2.0.CO;2; Joughin I, 2014, SCIENCE, V344, P735, DOI 10.1126/science.1249055; Joughin I, 2011, NAT GEOSCI, V4, P506, DOI [10.1038/ngeo1194, 10.1038/NGEO1194]; Le Brocq A. M., 2010, EARTH SYSTEM SCI DAT, V3, P195, DOI [10.5194/essd-2-247-2010, DOI 10.5194/ESSD-2-247-2010, DOI 10.5194/ESSDD-3-195-2010]; Leguy GR, 2014, CRYOSPHERE, V8, P1239, DOI 10.5194/tc-8-1239-2014; Lenaerts JTM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050713; Levermann A, 2014, EARTH SYST DYNAM, V5, P271, DOI 10.5194/esd-5-271-2014; Levermann A, 2012, CRYOSPHERE, V6, P273, DOI 10.5194/tc-6-273-2012; Levermann A, 2013, P NATL ACAD SCI USA, V110, P13745, DOI 10.1073/pnas.1219414110; Liu Y, 2015, P NATL ACAD SCI USA, V112, P3263, DOI 10.1073/pnas.1415137112; Masson-Delmotte V, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P383; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Naish T, 2009, NATURE, V458, P322, DOI 10.1038/nature07867; Naish T, 2012, NAT CLIM CHANGE, V2, P317; Pal JS, 2007, B AM METEOROL SOC, V88, P1395, DOI 10.1175/BAMS-88-9-1395; Paolo FS, 2015, SCIENCE, V348, P327, DOI 10.1126/science.aaa0940; Pattyn F, 2013, J GLACIOL, V59, P410, DOI 10.3189/2013JoG12J129; Pollard D, 2012, CRYOSPHERE, V6, P953, DOI 10.5194/tc-6-953-2012; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Rignot E, 2014, GEOPHYS RES LETT, V41, P3502, DOI 10.1002/2014GL060140; Rignot E, 2011, SCIENCE, V333, P1427, DOI 10.1126/science.1208336; Roemmich D, 2015, NAT CLIM CHANGE, V5, P240, DOI [10.1038/NCLIMATE2513, 10.1038/nclimate2513]; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Scambos TA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020670; Schaeffer M, 2012, NAT CLIM CHANGE, V2, P867, DOI [10.1038/nclimate1584, 10.1038/NCLIMATE1584]; Schmidtko S, 2014, SCIENCE, V346, P1227, DOI 10.1126/science.1256117; Schoof C, 2006, J FLUID MECH, V556, P227, DOI 10.1017/S0022112006009591; Steig EJ, 2009, NATURE, V457, P459, DOI 10.1038/nature07669; Thompson SL, 1997, J CLIMATE, V10, P871, DOI 10.1175/1520-0442(1997)010<0871:GAAMBF>2.0.CO;2; Tsai VC, 2015, J GLACIOL, V61, P205, DOI 10.3189/2015JoG14J221; Vaughan DG, 1996, NATURE, V379, P328, DOI 10.1038/379328a0; Winkelmann R, 2012, NATURE, V492, P239, DOI 10.1038/nature11616; Winkelmann R, 2011, CRYOSPHERE, V5, P715, DOI 10.5194/tc-5-715-2011; Winkelmann R., 2015, CRYOSPHERE DISCUSS, V9, P1705, DOI DOI 10.5194/TCD-9-1705-2015; Wouters B, 2015, SCIENCE, V348, P899, DOI 10.1126/science.aaa5727; Zickfeld K, 2013, J CLIMATE, V26, P5782, DOI 10.1175/JCLI-D-12-00584.1	59	240	243	3	149	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					421	+		10.1038/nature15706	http://dx.doi.org/10.1038/nature15706			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26469052				2022-12-28	WOS:000362730200049
J	Hunger, SP; Mullighan, CG				Hunger, Stephen P.; Mullighan, Charles G.			Acute Lymphoblastic Leukemia in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MINIMAL RESIDUAL DISEASE; INTRACHROMOSOMAL AMPLIFICATION; PROGNOSTIC-FACTORS; CHILDHOOD; THERAPY; ADOLESCENTS; MUTATIONS; RISK; RELAPSE; IMATINIB	Approximately 6000 cases of acute lymphoblastic leukemia (ALL) are diagnosed in the United States annually; half the cases occur in children and teenagers. In the United States, ALL is the most common cancer among children and the most frequent cause of death from cancer before 20 years of age. 1,2 Presenting symptoms of ALL include bruising or bleeding due to thrombocytopenia, pallor and fatigue from anemia, and infection caused by neutropenia. Leukemic infiltration of the liver, spleen, lymph nodes, and mediastinum is common at diagnosis. Extramedullary leukemia in the central nervous system (CNS) or testicles may require specific modifications in therapy. Since the first description in 1948 of temporary remission of leukemia induced by chemotherapy, 3 pediatric ALL has provided a model for improvement of survival among patients with cancer by progressive improvements in the efficacy of multi-agent chemotherapy regimens and by stratification of treatment intensity according to the clinical features of the patient, the biologic features of the leukemia cells, and the early response to treatment, all of which are predictive of the risk of relapse. Collectively, these advances have increased the survival rate from less than 10% in the 1960s to 90% today (Fig. 1). New discoveries are revealing the promise and challenges of precision-medicine strategies that integrate leukemia genomics into contemporary therapy.	[Hunger, Stephen P.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Oncol, Philadelphia, PA 19104 USA; [Hunger, Stephen P.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Mullighan, Charles G.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Mullighan, Charles G.] St Jude Childrens Res Hosp, Hematol Malignancies Program, Memphis, TN 38105 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Hunger, SP (corresponding author), Childrens Hosp Philadelphia, 3060 Colket Translat Res Bldg,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	charles.mullighan@stjude.org	Mullighan, Charles/H-3253-2011; Pui, Ching-Hon/N-8076-2018	Mullighan, Charles/0000-0002-1871-1850; Pui, Ching-Hon/0000-0003-0303-5658	Spectrum Pharmaceuticals; Amgen; Incyte Pharmaceuticals; Amgen Pharmaceuticals; Jazz Pharmaceuticals; Sigma-Tau Pharmaceuticals	Spectrum Pharmaceuticals; Amgen(Amgen); Incyte Pharmaceuticals; Amgen Pharmaceuticals(Amgen); Jazz Pharmaceuticals(Jazz Pharmaceuticals); Sigma-Tau Pharmaceuticals	Dr. Hunger reports receiving consulting fees from Jazz Pharmaceuticals, Sigma-Tau Pharmaceuticals, and Spectrum Pharmaceuticals and owning stock in Amgen; Dr. Mullighan, receiving consulting fees from Incyte Pharmaceuticals and speaking fees from Amgen Pharmaceuticals; and Drs. Hunger and Mullighan, being named as inventors on a pending patent application related to gene-expression signatures for detection of underlying Philadelphia chromosome-like events and therapeutic targeting in leukemia (PCT/US2012/069228). No other potential conflict of interest relevant to this article was reported.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Andersson AK, 2015, NAT GENET, V47, P330, DOI 10.1038/ng.3230; Arico M, 2010, J CLIN ONCOL, V28, P4755, DOI 10.1200/JCO.2010.30.1325; AUR RJA, 1971, BLOOD-J HEMATOL, V37, P272, DOI 10.1182/blood.V37.3.272.272; Bhatia S, 2014, BLOOD, V124, P2345, DOI 10.1182/blood-2014-01-552166; Biondi A, 2012, LANCET ONCOL, V13, P936, DOI 10.1016/S1470-2045(12)70377-7; Blanco E, 2012, LEUKEMIA LYMPHOMA, V53, P878, DOI 10.3109/10428194.2011.639018; Borowitz MJ, 2008, BLOOD, V111, P5477, DOI 10.1182/blood-2008-01-132837; Buitenkamp TD, 2014, BLOOD, V123, P70, DOI 10.1182/blood-2013-06-509463; Campana D, 2012, CURR OPIN HEMATOL, V19, P313, DOI 10.1097/MOH.0b013e3283543d5c; Clappier E, 2014, LEUKEMIA, V28, P70, DOI 10.1038/leu.2013.277; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Conter V, 2010, BLOOD, V115, P3206, DOI 10.1182/blood-2009-10-248146; Coustan-Smith E, 2000, BLOOD, V96, P2691, DOI 10.1182/blood.V96.8.2691; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; DeAngelo DJ, 2015, LEUKEMIA, V29, P526, DOI 10.1038/leu.2014.229; Den Boer ML, 2009, LANCET ONCOL, V10, P125, DOI 10.1016/S1470-2045(08)70339-5; Domenech C, 2014, HAEMATOLOGICA, V99, P1220, DOI 10.3324/haematol.2014.103507; Faham M, 2012, BLOOD, V120, P5173, DOI 10.1182/blood-2012-07-444042; FARBER S, 1948, NEW ENGL J MED, V238, P787, DOI 10.1056/NEJM194806032382301; GEORGE P, 1968, J PEDIATR-US, V72, P399, DOI 10.1016/S0022-3476(68)80217-3; Harrison CJ, 2014, LEUKEMIA, V28, P1015, DOI 10.1038/leu.2013.317; Harrison CJ, 2009, BRIT J HAEMATOL, V144, P147, DOI 10.1111/j.1365-2141.2008.07417.x; Harvey RC, 2010, BLOOD, V115, P5312, DOI 10.1182/blood-2009-09-245944; Heerema NA, 2013, J CLIN ONCOL, V31, P3397, DOI 10.1200/JCO.2013.49.1308; Holmfeldt L, 2013, NAT GENET, V45, P242, DOI 10.1038/ng.2532; Hunger SP, 2015, BLOOD; Hunger SP, 2012, J CLIN ONCOL, V30, P1663, DOI 10.1200/JCO.2011.37.8018; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Krull KR, 2013, J CLIN ONCOL, V31, P4407, DOI 10.1200/JCO.2012.48.2315; Kuiper RP, 2007, LEUKEMIA, V21, P1258, DOI 10.1038/sj.leu.2404691; Kuiper RP, 2010, LEUKEMIA, V24, P1258, DOI 10.1038/leu.2010.87; Li BS, 2015, NAT MED, V21, P563, DOI 10.1038/nm.3840; Lim JYS, 2014, CANCER-AM CANCER SOC, V120, P955, DOI 10.1002/cncr.28531; Linabery AM, 2008, CANCER, V112, P416, DOI 10.1002/cncr.23169; Liu GJ, 2014, GENE DEV, V28, P1337, DOI 10.1101/gad.240416.114; Ma XT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7604; Mattano LA, 2012, LANCET ONCOL, V13, P906, DOI 10.1016/S1470-2045(12)70274-7; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Meyer C, 2013, LEUKEMIA, V27, P2165, DOI 10.1038/leu.2013.135; Meyer JA, 2013, NAT GENET, V45, P290, DOI 10.1038/ng.2558; Moorman AV, 2010, LANCET ONCOL, V11, P429, DOI 10.1016/S1470-2045(10)70066-8; Moriyama T, 2015, BLOOD; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Nachman JB, 2007, BLOOD, V110, P1112, DOI 10.1182/blood-2006-07-038299; Navarrete M, 2014, PEDIATR BLOOD CANCER, V61, P803, DOI 10.1002/pbc.24911; Nguyen K, 2008, LEUKEMIA, V22, P2142, DOI 10.1038/leu.2008.251; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Perez-Andreu V, 2013, NAT GENET, V45, P1494, DOI 10.1038/ng.2803; Peters C, 2015, J CLIN ONCOL, V33, P1265, DOI 10.1200/JCO.2014.58.9747; Pui CH, 2003, JAMA-J AM MED ASSOC, V290, P2001, DOI 10.1001/jama.290.15.2001; Pui CH, 2015, LANCET ONCOL, V16, P465, DOI 10.1016/S1470-2045(15)70082-3; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Pulte D, 2009, BLOOD, V113, P1408, DOI 10.1182/blood-2008-06-164863; Raetz EA, 2012, HEMATOL-AM SOC HEMAT, P129, DOI 10.1182/asheducation-2012.1.129; RIEHM H, 1980, AM J PEDIAT HEMATOL, V2, P299; Ries L.A.G., 1999, CANC INCIDENCE SURVI; Roberts KG, 2014, NEW ENGL J MED, V371, P1005, DOI 10.1056/NEJMoa1403088; Ross DM, 2013, BLOOD, V122, P515, DOI 10.1182/blood-2013-02-483750; Russell LJ, 2009, LEUKEMIA, V23, P614, DOI 10.1038/leu.2008.250; Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; Schmiegelow K, 2010, LEUKEMIA, V24, P345, DOI 10.1038/leu.2009.251; Schrappe M, 2011, BLOOD, V118, P2077, DOI 10.1182/blood-2011-03-338707; Schultz KR, 2014, LEUKEMIA, V28, P1467, DOI 10.1038/leu.2014.30; Schultz KR, 2009, J CLIN ONCOL, V27, P5175, DOI 10.1200/JCO.2008.21.2514; Schwickert TA, 2014, NAT IMMUNOL, V15, P283, DOI 10.1038/ni.2828; Shah S, 2013, NAT GENET, V45, P1226, DOI 10.1038/ng.2754; Smith M, 1996, J CLIN ONCOL, V14, P18, DOI 10.1200/JCO.1996.14.1.18; Smith MA, 2010, J CLIN ONCOL, V28, P2625, DOI 10.1200/JCO.2009.27.0421; Stary J, 2014, J CLIN ONCOL, V32, P174, DOI 10.1200/JCO.2013.48.6522; Stock W, 2010, HEMATOL-AM SOC HEMAT, P21, DOI 10.1182/asheducation-2010.1.21; te Winkel ML, 2014, HAEMATOLOGICA, V99, P430, DOI 10.3324/haematol.2013.095562; Topp MS, 2015, LANCET ONCOL, V16, P57, DOI 10.1016/S1470-2045(14)71170-2; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Tzoneva G, 2013, NAT MED, V19, P368, DOI 10.1038/nm.3078; Van der Meulen J, 2015, BLOOD, V125, P13, DOI 10.1182/blood-2014-05-577270; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Veerman AJ, 2009, LANCET ONCOL, V10, P957, DOI 10.1016/S1470-2045(09)70228-1; Vora A, 2014, LANCET ONCOL, V15, P809, DOI 10.1016/S1470-2045(14)70243-8; Vora A, 2013, LANCET ONCOL, V14, P199, DOI 10.1016/S1470-2045(12)70600-9; Vrooman LM, 2013, J CLIN ONCOL, V31, P1202, DOI 10.1200/JCO.2012.43.2070; Weston BW, 2013, J CLIN ONCOL, V31, pE413, DOI 10.1200/JCO.2012.47.6770; Wiemels JL, 1999, LANCET, V354, P1499, DOI 10.1016/S0140-6736(99)09403-9; Yeoh AEJ, 2013, LANCET ONCOL, V14, pE508, DOI 10.1016/S1470-2045(13)70452-2; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang JH, 2011, BLOOD, V118, P3080, DOI 10.1182/blood-2011-03-341412; Zhang MY, 2015, NAT GENET, V47, P180, DOI 10.1038/ng.3177	92	974	1028	19	192	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2015	373	16					1541	1552		10.1056/NEJMra1400972	http://dx.doi.org/10.1056/NEJMra1400972			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5VX	26465987	Green Accepted, Green Submitted			2022-12-28	WOS:000362880300010
J	Martin, T; Marugan-Lobon, J; Vullo, R; Martin-Abad, H; Luo, ZX; Buscalioni, AD				Martin, Thomas; Marugan-Lobon, Jesus; Vullo, Romain; Martin-Abad, Hugo; Luo, Zhe-Xi; Buscalioni, Angela D.			A Cretaceous eutriconodont and integument evolution in early mammals	NATURE			English	Article							MAMMALIAFORM; FOLLICLES; DESIGN; SKIN	The Mesozoic era (252-66 million years ago), known as the domain of dinosaurs, witnessed a remarkable ecomorphological diversity of early mammals. The key mammalian characteristics originated during this period and were prerequisite for their evolutionary success after extinction of the non-avian dinosaurs 66 million years ago. Many ecomorphotypes familiar to modern mammal fauna evolved independently early in mammalian evolutionary history. Here we report a 125-million-year-old eutriconodontan mammal from Spain with extraordinary preservation of skin and pelage that extends the record of key mammalian integumentary features into the Mesozoic era. The new mammalian specimen exhibits such typical mammalian features as pelage, mane, pinna, and a variety of skin structures: keratinous dermal scutes, protospines composed of hair-like tubules, and compound follicles with primary and secondary hairs. The skin structures of this new Mesozoic mammal encompass the same combination of integumentary features as those evolved independently in other crown Mammalia, with similarly broad structural variations as in extant mammals. Soft tissues in the thorax and abdomen (alveolar lungs and liver) suggest the presence of a muscular diaphragm. The eutriconodont has molariform tooth replacement, ossified Meckel's cartilage of the middle ear, and specialized xenarthrous articulations of posterior dorsal vertebrae, convergent with extant xenarthran mammals, which strengthened the vertebral column for locomotion.	[Martin, Thomas] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, D-53115 Bonn, Germany; [Marugan-Lobon, Jesus; Martin-Abad, Hugo; Buscalioni, Angela D.] Univ Autonoma Madrid, Fac Ciencias, Dept Biol, Unidad Paleontol, E-28049 Madrid, Spain; [Marugan-Lobon, Jesus] Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA 90007 USA; [Vullo, Romain] Univ Rennes 1, UMR CNRS 6118, Geosci Rennes, F-35042 Rennes, France; [Luo, Zhe-Xi] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Bonn; Autonomous University of Madrid; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Rennes; University of Chicago	Martin, T (corresponding author), Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Nussallee 8, D-53115 Bonn, Germany.	tmartin@uni-bonn.de; zxluo@uchicago.edu; angela.delgado@uam.es	Buscalioni, Angela D./AAA-5874-2019; Martín-Abad, Hugo/B-5380-2012; Marugán-Lobón, Jesús/AAA-7614-2019; Luo, Zhe-XI/AAU-2263-2021	Martín-Abad, Hugo/0000-0001-9283-8203; Delgado Buscalioni, Angela/0000-0003-1598-7963; Marugan Lobon, Jesus Carlos/0000-0002-3766-8560	Spanish MINECO [CGL-2013-42643 P]; Junta de Comunidades de Castilla-La Mancha	Spanish MINECO(Spanish Government); Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha)	Research funds were provided by Spanish MINECO, Project CGL-2013-42643 P and Junta de Comunidades de Castilla-La Mancha. We thank J. L. Sanudo for finding the specimen, M. Llandres and O. Dulfer for preparation, D. Kranz for artwork, O. Sanisidro for the lifelike reconstruction of S. xenarthrosus, G. Oleschinski for photography, M. Furio and A. Valera for SEM, K. Jager for three-dimensional reconstructions, and T. McCann for improving the English. R. L. Cifelli is thanked for review and B. Mahler for discussion on actuo-taphonomical experiments on rat carcasses.	Alibardi L, 2012, J EXP ZOOL PART B, V318B, P325, DOI 10.1002/jez.b.22447; BRAMBLE DM, 1993, SCIENCE, V262, P235, DOI 10.1126/science.8211141; Buscalioni AD, 2010, J IBER GEOL, V36, P297, DOI 10.5209/rev_JIGE.2010.v36.n2.13; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; Chernova OF, 2006, BIOL BULL+, V33, P43, DOI 10.1134/S1062359006010067; Chow M., 1984, Journal of Vertebrate Paleontology, V3, P226; Cuenca-Bescos G, 2003, ACTA PALAEONTOL POL, V48, P575; Dal Sasso C, 1998, NATURE, V392, P383; Evans HE., 2012, MILLERS ANATOMY DOG, V4; Foster JR, 2009, PALEOBIOS, V28, P114; Fregenal-Martinez M.A., 2000, AAPG STUDIES GEOLOGY, V46, P303; Gaetano LC, 2011, J VERTEBR PALEONTOL, V31, P829, DOI 10.1080/02724634.2011.589877; Gao CL, 2010, P ROY SOC B-BIOL SCI, V277, P237, DOI 10.1098/rspb.2009.1014; Gaudin Timothy J., 1999, Fieldiana Geology, V41, P1; Hausman LA, 1932, AM NAT, V66, P461, DOI 10.1086/280452; Hu Y.-M, 2006, THESIS U NEW YORK; Jenkins F.A. Jr, 1988, Journal of Vertebrate Paleontology, V8, P1; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Ji Q, 1999, NATURE, V398, P326; KERMACK KA, 1973, ZOOL J LINN SOC-LOND, V53, P87, DOI 10.1111/j.1096-3642.1973.tb00786.x; Kielan-Jaworowska Z, 1998, ACTA PALAEONTOL POL, V43, P413; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; Kirk EC, 2008, J HUM EVOL, V55, P278, DOI 10.1016/j.jhevol.2008.02.008; Kusuhashi N, 2009, GEOBIOS-LYON, V42, P765, DOI 10.1016/j.geobios.2009.06.003; Lessertisseur J., 1967, TRAITE ZOOLOGIE, P709; Li CK, 2003, CHINESE SCI BULL, V48, P1129, DOI 10.1360/02wd0134; Linnaeus C., 1758, SYSTEMA NATURAE REGN, DOI [10.5962/bhl.title.542, DOI 10.5962/BHL.TITLE.542]; LOVELL JE, 1957, AM J VET RES, V18, P873; Luo ZX, 2007, NATURE, V446, P288, DOI 10.1038/nature05627; Luo ZX, 2011, ANNU REV ECOL EVOL S, V42, P355, DOI 10.1146/annurev-ecolsys-032511-142302; Luo ZX, 2005, SCIENCE, V308, P103, DOI 10.1126/science.1108875; Meng J, 1997, NATURE, V385, P712, DOI 10.1038/385712a0; Meng J, 2006, NATURE, V444, P889, DOI 10.1038/nature05234; Meng J, 2011, NATURE, V472, P181, DOI 10.1038/nature09921; Meng QJ, 2015, SCIENCE, V347, P764, DOI 10.1126/science.1260879; Montandon SA, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-33; ROSE KD, 1993, MAMMAL PHYLOGENY : PLACENTALS, P81; Rougier GW, 2007, ANN CARNEGIE MUS, V76, P73, DOI 10.2992/0097-4463(2007)76[73:AECMFT]2.0.CO;2; Rudnicka L., 2012, ATLAS TRICHOSCOPY DE, P11; Spencer B., 1899, Q J MICROSC SCI, V36, P549; Stanley WT, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0486; STORCH G, 1981, Senckenbergiana Lethaea, V61, P247; Sweetman SC, 2006, PALAEONTOLOGY, V49, P889, DOI 10.1111/j.1475-4983.2006.00564.x; Ting S.-Y., 1987, PALAEONTOL SIN, V17, P85; VINCENT JFV, 1986, J ZOOL, V210, P55, DOI 10.1111/j.1469-7998.1986.tb03620.x; Vullo R, 2010, NATURWISSENSCHAFTEN, V97, P683, DOI 10.1007/s00114-010-0677-8; Weibel ER, 2005, RESP PHYSIOL NEUROBI, V148, P3, DOI 10.1016/j.resp.2005.03.005; WHITELEY HJ, 1958, NATURE, V181, P850, DOI 10.1038/181850a0; Zhou CF, 2013, NATURE, V500, P163, DOI 10.1038/nature12429	50	49	53	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					380	+		10.1038/nature14905	http://dx.doi.org/10.1038/nature14905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26469049				2022-12-28	WOS:000362730200041
J	Toh, S; Holbrook-Smith, D; Stogios, PJ; Onopriyenko, O; Lumba, S; Tsuchiya, Y; Savchenko, A; McCourt, P				Toh, Shigeo; Holbrook-Smith, Duncan; Stogios, Peter J.; Onopriyenko, Olena; Lumba, Shelley; Tsuchiya, Yuichiro; Savchenko, Alexei; McCourt, Peter			Structure-function analysis identifies highly sensitive strigolactone receptors in Striga	SCIENCE			English	Article							PARASITIC PLANTS; ARABIDOPSIS; GERMINATION; PERCEPTION; RICE; HERMONTHICA	Strigolactones are naturally occurring signaling molecules that affect plant development, fungi-plant interactions, and parasitic plant infestations. We characterized the function of 11 strigolactone receptors from the parasitic plant Striga hermonthica using chemical and structural biology. We found a clade of polyspecific receptors, including one that is sensitive to picomolar concentrations of strigolactone. A crystal structure of a highly sensitive strigolactone receptor from Striga revealed a larger binding pocket than that of the Arabidopsis receptor, which could explain the increased range of strigolactone sensitivity. Thus, the sensitivity of Striga to strigolactones from host plants is driven by receptor sensitivity. By expressing strigolactone receptors in Arabidopsis, we developed a bioassay that can be used to identify chemicals and crops with altered strigolactone levels.	[Toh, Shigeo; Holbrook-Smith, Duncan; Lumba, Shelley; McCourt, Peter] Univ Toronto, Cell & Syst Biol, Toronto, ON M5S 3B2, Canada; [Stogios, Peter J.; Onopriyenko, Olena; Savchenko, Alexei] Univ Toronto, Banting & Best Dept Med Res, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada; [Stogios, Peter J.] NIAID, Ctr Struct Genom Infect Dis, NIH, Bethesda, MD 20892 USA; [Tsuchiya, Yuichiro] Nagoya Univ, Inst Transformat Biomol, Chikusa Ku, Nagoya, Aichi 4648602, Japan	University of Toronto; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Nagoya University	McCourt, P (corresponding author), Univ Toronto, Cell & Syst Biol, 25 Willcocks St, Toronto, ON M5S 3B2, Canada.	peter.mccourt@utoronto.ca	Toh, Shigeo/E-4438-2014; Toh, Shigeo/ABB-9441-2021; Tsuchiya, Yuichiro/D-9777-2015	Toh, Shigeo/0000-0002-6077-4556; Tsuchiya, Yuichiro/0000-0002-4599-1069; Holbrook-Smith, Duncan/0000-0003-0787-3165; Stogios, Peter/0000-0001-8663-1425	National Science and Engineering Research Council of Canada	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank A. Babikier for providing the Striga seeds and T. Nakagawa for the pGWB611 binary vector. Rice lines were provided by the National Genetic Resources Program at the U.S. Department of Agriculture. This work was supported by a grant from the National Science and Engineering Research Council of Canada to P.M. We thank R. Di Leo for technical assistance. Nucleotide and amino acid sequences corresponding to ShD14 and ShHTLs have been deposited with GenBank under accession KR013120 to KR013131. S.T., D.H.-S., P.M., and the University of Toronto have filed a U.S. provisional patent application (US62/151,701) that relates to the specific topic "Strigolactone biosensors." We declare no financial conflicts of interest in relation to the work. The supplementary materials contain additional data.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Arite T, 2009, PLANT CELL PHYSIOL, V50, P1416, DOI 10.1093/pcp/pcp091; Awad AA, 2006, PLANT GROWTH REGUL, V48, P221, DOI 10.1007/s10725-006-0009-3; Conn CE, 2015, SCIENCE, V349, P540, DOI 10.1126/science.aab1140; Ejeta G., 2007, INTEGRATING NEW TECH, P3, DOI [10.1142/9789812771506_0001, DOI 10.1142/9789812771506_0001]; FISCHER NH, 1990, PHYTOCHEMISTRY, V29, P2479, DOI 10.1016/0031-9422(90)85170-K; Guo YX, 2013, P NATL ACAD SCI USA, V110, P8284, DOI 10.1073/pnas.1306265110; Jamil M, 2011, NEW PHYTOL, V192, P964, DOI 10.1111/j.1469-8137.2011.03850.x; Jiang L, 2013, NATURE, V504, P401, DOI 10.1038/nature12870; Neyfakh AA, 2002, MOL MICROBIOL, V44, P1123, DOI 10.1046/j.1365-2958.2002.02965.x; Ruyter-Spira C, 2013, TRENDS PLANT SCI, V18, P72, DOI 10.1016/j.tplants.2012.10.003; Toh S, 2014, CHEM BIOL, V21, P988, DOI 10.1016/j.chembiol.2014.07.005; Toh S, 2012, PLANT CELL PHYSIOL, V53, P107, DOI 10.1093/pcp/pcr176; Tsuchiya Y, 2015, SCIENCE, V349, P864, DOI 10.1126/science.aab3831; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Xie XN, 2010, ANNU REV PHYTOPATHOL, V48, P93, DOI 10.1146/annurev-phyto-073009-114453; Zhou F, 2013, NATURE, V504, P406, DOI 10.1038/nature12878	17	151	157	11	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257					203	207		10.1126/science.aac9476	http://dx.doi.org/10.1126/science.aac9476			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9JB	26450211				2022-12-28	WOS:000362405600038
J	da Fonseca, DM; Hand, TW; Han, SJ; Gerner, MY; Zaretsky, AG; Byrd, AL; Harrison, OJ; Ortiz, AM; Quinones, M; Trinchieri, G; Brenchley, JM; Brodsky, IE; Germain, RN; Randolph, GJ; Belkaid, Y				da Fonseca, Denise Morais; Hand, Timothy W.; Han, Seong-Ji; Gerner, Michael Y.; Zaretsky, Arielle Glatman; Byrd, Allyson L.; Harrison, Oliver J.; Ortiz, Alexandra M.; Quinones, Mariam; Trinchieri, Giorgio; Brenchley, Jason M.; Brodsky, Igor E.; Germain, Ronald N.; Randolph, Gwendalyn J.; Belkaid, Yasmine			Microbiota-Dependent Sequelae of Acute Infection Compromise Tissue-Specific Immunity	CELL			English	Article							MESENTERIC LYMPH-NODES; DENDRITIC CELLS; CROHNS-DISEASE; ANTIGEN; INFLAMMATION; PERMEABILITY; TRAFFICKING; HOMEOSTASIS; PROTECTION; HELMINTHS	Infections have been proposed as initiating factors for inflammatory disorders; however, identifying associations between defined infectious agents and the initiation of chronic disease has remained elusive. Here, we report that a single acute infection can have dramatic and long-term consequences for tissue-specific immunity. Following clearance of Yersinia pseudotuberculosis, sustained inflammation and associated lymphatic leakage in the mesenteric adipose tissue deviates migratory dendritic cells to the adipose compartment, thereby preventing their accumulation in the mesenteric lymph node. As a consequence, canonical mucosal immune functions, including tolerance and protective immunity, are persistently compromised. Post-resolution of infection, signals derived from the microbiota maintain inflammatory mesentery remodeling and consequently, transient ablation of the microbiota restores mucosal immunity. Our results indicate that persistent disruption of communication between tissues and the immune system following clearance of an acute infection represents an inflection point beyond which tissue homeostasis and immunity is compromised for the long-term.	[da Fonseca, Denise Morais; Hand, Timothy W.; Han, Seong-Ji; Zaretsky, Arielle Glatman; Byrd, Allyson L.; Harrison, Oliver J.; Belkaid, Yasmine] NIAID, Mucosal Immunol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [da Fonseca, Denise Morais; Hand, Timothy W.; Han, Seong-Ji; Zaretsky, Arielle Glatman; Byrd, Allyson L.; Harrison, Oliver J.; Belkaid, Yasmine] NIAID, Immun Barrier Sites Initiat, NIH, Bethesda, MD 20892 USA; [da Fonseca, Denise Morais] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Biochem & Immunol, BR-14049900 Ribeirao Preto, Brazil; [Gerner, Michael Y.; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Byrd, Allyson L.] NHGRI, Translat & Funct Genom Branch, NIH, Bethesda, MD 20892 USA; [Byrd, Allyson L.] Boston Univ, Dept Bioinformat, Boston, MA 02215 USA; [Ortiz, Alexandra M.; Brenchley, Jason M.] NIAID, Program Tissue Immun & Repair, NIH, Bethesda, MD 20892 USA; [Ortiz, Alexandra M.; Brenchley, Jason M.] NIAID, Immunopathogenesis Sect, NIH, Bethesda, MD 20892 USA; [Quinones, Mariam] NIAID, Bioinformat & Computat Biosci Branch, NIH, Bethesda, MD 20892 USA; [Trinchieri, Giorgio] NCI, Canc & Inflammat Program, Ctr Canc Res, Bethesda, MD 20892 USA; [Brodsky, Igor E.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Randolph, Gwendalyn J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade de Sao Paulo; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Boston University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Pennsylvania; Washington University (WUSTL)	Belkaid, Y (corresponding author), NIAID, Mucosal Immunol Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov	Germain, Ronald/ABE-7090-2020; Brenchley, Jason/AAC-5085-2019; Hand, Timothy W/AAH-1216-2021; Germain, Ronald N./Z-1945-2019; Trinchieri, Giorgio/F-9369-2015; Fonseca, Denise/E-7419-2012	Hand, Timothy W/0000-0002-2684-9462; Trinchieri, Giorgio/0000-0001-5892-7464; Fonseca, Denise/0000-0001-8310-0186; Harrison, Oliver/0000-0003-1515-9586; Brenchley, Jason/0000-0001-8357-2984; Gerner, Michael/0000-0001-5406-8308; Quinones, Mariam/0000-0002-8520-5114; Belkaid, Yasmine/0000-0001-9962-3571	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID), NIH; FAPESP [2012/14669-7]; CNPq/CAPES [10986-13-8]; FDA/ODS Scholarship; NATIONAL CANCER INSTITUTE [ZIABC011153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001115, ZIAAI001034, ZIAAI001029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP1DK109668] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID), NIH; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq/CAPES(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FDA/ODS Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID), NIH. D.M.F. was supported by FAPESP (2012/14669-7) and CNPq/CAPES (10986-13-8). T.W.H. was supported by a FDA/ODS Scholarship. We thank J.D. Clements (University of Tulane School of Medicine) for providing the E. coli dmLT. We thank D. Trageser-Cesler and C. Acevedo (NIAID Gnotobiotic Animal Facility); NIAID animal facility staff; K. Holmes, C. Eigsti, T. Moyer, and E. Stregevsky (NIAID Flow Cytometry facility); O. Schwartz, J. Kabat, L. Koo, and M. Smelkinson (NIAID Biological Imaging facility) and N. Bubunenko, D. Sun, R. Winkler-Pickett, K. Beacht, J. Davis, M. Solano-Dias and J. Legrand for technical assistance. We thank N. Bouladoux, S. Henri, A. Poholek, M. Constantinides, V. Ridaura and all the members of the Y.B. laboratory for critical reading of the manuscript and helpful discussions.	Aldrich MB, 2013, CYTOKINE, V64, P362, DOI 10.1016/j.cyto.2013.05.015; Asano S, 2012, J CLIN EXP HEMATOP, V52, P1; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Behr MA, 2010, INFLAMM BOWEL DIS, V16, P896, DOI 10.1002/ibd.21171; Bekiaris V, 2014, IMMUNOL REV, V260, P86, DOI 10.1111/imr.12194; Belkaid Y, 2014, SCIENCE, V346, P954, DOI 10.1126/science.1260144; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bergman MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000573; Bergsbaken T, 2015, NAT IMMUNOL; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; COOMBES JL, 2007, J EXP MED; Cromer WE, 2014, ANGIOGENESIS, V17, P395, DOI 10.1007/s10456-013-9393-2; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Estes J, 2008, J INFECT DIS, V198, P456, DOI 10.1086/590112; Fahlgren A, 2014, INFECT IMMUN, V82, P3471, DOI 10.1128/IAI.01793-14; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Gaya M, 2015, SCIENCE, V347, P667, DOI 10.1126/science.aaa1300; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Ghanem ENB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003015; Grainger JR, 2014, IMMUNOL REV, V259, P75, DOI 10.1111/imr.12167; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Jamieson AM, 2013, SCIENCE, V340, P1230, DOI 10.1126/science.1233632; Johnston CJ, 2014, TRANSPLANTATION, V97, P127, DOI 10.1097/TP.0b013e3182a53f59; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Khalifeh-Soltani A, 2014, NAT MED, V20, P175, DOI 10.1038/nm.3450; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Korpe PS, 2012, TRENDS MOL MED, V18, P328, DOI 10.1016/j.molmed.2012.04.007; Kuan EL, 2015, J IMMUNOL, V194, P5200, DOI 10.4049/jimmunol.1500221; Levine MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-129; LINDENBAUM J, 1972, AM J CLIN NUTR, V25, P1056; Lucey BC, 2005, RADIOGRAPHICS, V25, P351, DOI 10.1148/rg.252045108; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; McPhee JB, 2012, INFECT IMMUN, V80, P2519, DOI 10.1128/IAI.06364-11; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Oldenhove G., 2009, IMMUNITY; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Peyrin-Biroulet L, 2012, GUT, V61, P78, DOI 10.1136/gutjnl-2011-300370; Randolph GJ, 2014, J CLIN INVEST, V124, P929, DOI 10.1172/JCI71610; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Scallan JP, 2013, J PHYSIOL-LONDON, V591, P5071, DOI 10.1113/jphysiol.2013.260042; Schaub B, 2006, J ALLERGY CLIN IMMUN, V117, P969, DOI 10.1016/j.jaci.2006.03.003; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; SIMONET M, 1992, INFECT IMMUN, V60, P4414, DOI 10.1128/IAI.60.10.4414-4417.1992; St John AL, 2014, IMMUNITY, V41, P440, DOI 10.1016/j.immuni.2014.07.013; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Vernacchio L, 2006, PEDIATR INFECT DIS J, V25, P2, DOI 10.1097/01.inf.0000195623.57945.87; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Weinstock JV, 2004, GUT, V53, P7, DOI 10.1136/gut.53.1.7; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Wren BW, 2003, NAT REV MICROBIOL, V1, P55, DOI 10.1038/nrmicro730; Zhang Y, 2012, INFECT IMMUN, V80, P206, DOI 10.1128/IAI.05971-11; Zulian A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078495	70	171	172	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2					354	366		10.1016/j.cell.2015.08.030	http://dx.doi.org/10.1016/j.cell.2015.08.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26451485	Bronze, Green Accepted			2022-12-28	WOS:000362952700013
J	Hassan, BA; Hiesinger, PR				Hassan, Bassem A.; Hiesinger, P. Robin			Beyond Molecular Codes: Simple Rules to Wire Complex Brains	CELL			English	Review							VISUAL-SYSTEM DEVELOPMENT; PATTERN-FORMATION; SELF-AVOIDANCE; AXON GUIDANCE; DROSOPHILA; MECHANISMS; MAP; PROTOCADHERINS; SPECIFICITY; ESTABLISHES	Molecular codes, like postal zip codes, are generally considered a robust way to ensure the specificity of neuronal target selection. However, a code capable of unambiguously generating complex neural circuits is difficult to conceive. Here, we re-examine the notion of molecular codes in the light of developmental algorithms. We explore how molecules and mechanisms that have been considered part of a code may alternatively implement simple pattern formation rules sufficient to ensure wiring specificity in neural circuits. This analysis delineates a pattern-based framework for circuit construction that may contribute to our understanding of brain wiring.	[Hassan, Bassem A.] VIB, Ctr Biol Dis, B-3000 Leuven, Belgium; [Hassan, Bassem A.] Univ Leuven, Sch Med, Ctr Human Genet, B-3000 Leuven, Belgium; [Hiesinger, P. Robin] Free Univ Berlin, Inst Biol, Div Neurobiol, D-14195 Berlin, Germany; [Hiesinger, P. Robin] Charite, NeuroCure Cluster Excellence, D-10117 Berlin, Germany	Flanders Institute for Biotechnology (VIB); KU Leuven; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hassan, BA (corresponding author), VIB, Ctr Biol Dis, B-3000 Leuven, Belgium.	bh@kuleuven.be; robin.hiesinger@fu-berlin.de	Hassan, Bassem A/D-5221-2012	Hassan, Bassem A/0000-0001-9533-4908	FWO [G.0503.12]; belspo (WiBrain Network); EMBO; European Commission; NeuroCure Cluster of Excellence; NIH [RO1EY018884, RO1EY023333]; Muscular Dystrophy Association; Deutsche Forschungsgemeinschaft [SFB958]; FU Berlin; VIB; University of Leuven; NATIONAL EYE INSTITUTE [R01EY023333, R01EY018884] Funding Source: NIH RePORTER	FWO(FWO); belspo (WiBrain Network); EMBO(European Molecular Biology Organization (EMBO)); European Commission(European CommissionEuropean Commission Joint Research Centre); NeuroCure Cluster of Excellence; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FU Berlin; VIB; University of Leuven(KU Leuven); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We would like to thank our laboratories and many friends and colleagues for enduring discussions leading to this text. In particular, we want to thank for critical and very valuable discussions and comments on this article: Tom Clandinin, Alex Kolodkin, Dietmar Schmucker, Nevine Shalaby, Steven Altschuler, Lani Wu, and Joris de Wit. Work in the Hassan laboratory is funded by VIB, University of Leuven, FWO (G.0503.12), belspo (WiBrain Network), EMBO, and the European Commission's Marie Sklodowska Curie programs. Work in the Hiesinger laboratory at the Freie Universitat Berlin is funded by the NeuroCure Cluster of Excellence, the NIH (RO1EY018884, RO1EY023333), the Muscular Dystrophy Association, the Deutsche Forschungsgemeinschaft (SFB958), and the FU Berlin.	Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Carthew RW, 2007, CURR OPIN GENET DEV, V17, P309, DOI 10.1016/j.gde.2007.05.001; Chan CC, 2011, DEV NEUROBIOL, V71, P1227, DOI 10.1002/dneu.20940; Charron F, 2005, DEVELOPMENT, V132, P2251, DOI 10.1242/dev.01830; Chow RW, 2015, DEVELOPMENT, V142, P2665, DOI 10.1242/dev.122473; Clarke PGH, 2012, P ROY SOC B-BIOL SCI, V279, P1665, DOI 10.1098/rspb.2011.2629; Ganguly K, 2013, NEURON, V80, P729, DOI 10.1016/j.neuron.2013.10.028; He HH, 2014, SCIENCE, V344, P1182, DOI 10.1126/science.1251852; Hiesinger PR, 2006, CURR BIOL, V16, P1835, DOI 10.1016/j.cub.2006.07.047; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Kise Y, 2013, CURR OPIN NEUROBIOL, V23, P983, DOI 10.1016/j.conb.2013.09.011; Kolodkin Alex L, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a001727; Kostadinov D, 2015, ELIFE, V4, DOI 10.7554/eLife.08964; Langen M, 2015, CELL, V162, P120, DOI 10.1016/j.cell.2015.05.055; Langen M, 2013, ELIFE, V2, DOI 10.7554/eLife.00337; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; de la Pompa JL, 2012, DEV CELL, V22, P244, DOI 10.1016/j.devcel.2012.01.014; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Miura SK, 2013, CELL, V155, P1166, DOI 10.1016/j.cell.2013.10.018; Muckli L, 2009, P NATL ACAD SCI USA, V106, P13034, DOI 10.1073/pnas.0809688106; Petrovic M, 2015, BIOESSAYS, V37, P996, DOI 10.1002/bies.201400222; Petrovic M, 2008, NATURE, V456, P800, DOI 10.1038/nature07407; PRUSINKIEWICZ P, 1990, ALGORITHMIC BEAUTY P; Raper J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001933; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schwabe T, 2014, CURR BIOL, V24, P1304, DOI 10.1016/j.cub.2014.04.047; Schwabe T, 2013, CELL, V154, P351, DOI 10.1016/j.cell.2013.06.011; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; Srahna M, 2006, PLOS BIOL, V4, P2076, DOI 10.1371/journal.pbio.0040348; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Williamson WR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000553; Yogev S, 2014, ANNU REV CELL DEV BI, V30, P417, DOI 10.1146/annurev-cellbio-100913-012953; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009; Zschatzsch M, 2014, ELIFE, V3, DOI 10.7554/eLife.01699	38	58	58	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2					285	291		10.1016/j.cell.2015.09.031	http://dx.doi.org/10.1016/j.cell.2015.09.031			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26451480	Green Accepted, Bronze			2022-12-28	WOS:000362952700007
J	Berger, ER; Greenberg, CC; Bilimoria, KY				Berger, Elizabeth R.; Greenberg, Caprice C.; Bilimoria, Karl Y.			Challenges in Reducing Surgical "Never Events"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Berger, Elizabeth R.; Bilimoria, Karl Y.] Amer Coll Surg, Div Res & Optimal Patient Care, Chicago, IL 60611 USA; [Berger, Elizabeth R.] Loyola Univ Hlth Syst, Dept Surg, Maywood, IL USA; [Greenberg, Caprice C.] Univ Wisconsin Hosp & Clin, Wisconsin Surg Outcomes Res Program, Dept Surg, Madison, WI 53792 USA; [Bilimoria, Karl Y.] Northwestern Univ, Feinberg Sch Med, Surg Outcomes & Qual Improvement Ctr, Dept Surg, Chicago, IL 60611 USA	American College of Surgeons; Loyola University Chicago; University of Wisconsin System; University of Wisconsin Madison; Northwestern University; Feinberg School of Medicine	Berger, ER (corresponding author), Amer Coll Surg, 633 N St Clair St,22nd Floor, Chicago, IL 60611 USA.	eberger@facs.org						Bahill AT, 1998, IEEE T SYST MAN CY C, V28, P516, DOI 10.1109/5326.725338; Gawande AA, 2003, NEW ENGL J MED, V348, P229, DOI 10.1056/NEJMsa021721; Hempel S, 2015, JAMA SURG, V150, P796, DOI 10.1001/jamasurg.2015.0301; Hu YY, 2012, J SURG RES, V177, P37, DOI 10.1016/j.jss.2012.04.029; Koury J, 2012, SAGES MANNUAL OF QUALITY, OUTCOMES AND PATIENT SAFETY, P177, DOI 10.1007/978-1-4419-7901-8_20; Pennsylvania Patient Safety Authority, PENNS PAT SAF REP SY; Seiden SC, 2006, ARCH SURG-CHICAGO, V141, P931, DOI 10.1001/archsurg.141.9.931; Thiels CA, 2015, SURGERY, V158, P515, DOI 10.1016/j.surg.2015.03.053	8	13	13	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2015	314	13					1386	1387		10.1001/jama.2015.12327	http://dx.doi.org/10.1001/jama.2015.12327			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2PH	26441183				2022-12-28	WOS:000362644700016
J	Berkowitz, AL				Berkowitz, Aaron L.			All for One	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Berkowitz, AL (corresponding author), Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA.	aberkowitz3@partners.org						Farmer PE., 2010, PARTNER POOR P FARME, P409	1	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2015	314	13					1341	1342		10.1001/jama.2015.4888	http://dx.doi.org/10.1001/jama.2015.4888			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2PH	26441177				2022-12-28	WOS:000362644700010
J	Wandling, MW; Guillamondegui, OD				Wandling, Michael W.; Guillamondegui, Oscar D.			Eliminating the Confusion Sorrounding Concussions in Sports	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wandling, Michael W.] Northwestern Univ, Surg Outcomes & Qual Improvement Ctr, Dept Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Wandling, Michael W.] NW Mem Hosp, Chicago, IL 60611 USA; [Wandling, Michael W.] Northwestern Univ, Ctr Healthcare Studies, Feinberg Sch Med, Chicago, IL 60611 USA; [Guillamondegui, Oscar D.] Vanderbilt Univ, Sch Med, Div Trauma & Surg Crit Care, Dept Surg, Nashville, TN 37212 USA; [Guillamondegui, Oscar D.] Vanderbilt Univ, Med Ctr, Comprehens Traumat Brain Injury Clin, Nashville, TN USA	Northwestern University; Feinberg School of Medicine; Northwestern Memorial Hospital; Northwestern University; Feinberg School of Medicine; Vanderbilt University; Vanderbilt University	Wandling, MW (corresponding author), Northwestern Univ, Ctr Healthcare Studies, Feinberg Sch Med, 633 N St Clair,20th Floor, Chicago, IL 60611 USA.	m-wandling@northwestern.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM113513] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32 GM113513] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985	6	0	0	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2015	314	13					1388	1389		10.1001/jama.2015.12329	http://dx.doi.org/10.1001/jama.2015.12329			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2PH	26441184				2022-12-28	WOS:000362644700017
J	Davis, A; Ramsay, L				Davis, Amy; Ramsay, Lauren			SPOT DIAGNOSIS To feed or not to feed?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Davis, Amy; Ramsay, Lauren] St George Hosp, London, England	St Georges University London	Davis, A (corresponding author), St George Hosp, London, England.	adavis@bmj.com						Information S., 2011, PAT SAF AL NPSA 2011	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 2	2015	351								h5194	10.1136/bmj.h5194	http://dx.doi.org/10.1136/bmj.h5194			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT0AK	26431715				2022-12-28	WOS:000362455900004
J	Dance, A				Dance, Amber			CONNECTOMES MAKE THE MAP	NATURE			English	Editorial Material							MOUSE-BRAIN		[Dance, Amber] No Org, Los Angeles, CA USA									Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Malloy M, 2015, MICROSCOPY TODAY, V23, P12, DOI DOI 10.1017/S1551929515000012; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Ragan T, 2012, NAT METHODS, V9, P255, DOI [10.1038/nmeth.1854, 10.1038/NMETH.1854]; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041	6	8	10	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					147	149		10.1038/526147a	http://dx.doi.org/10.1038/526147a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26432252	Bronze			2022-12-28	WOS:000362095100057
J	Cleynen, I; Boucher, G; Jostins, L; Schumm, LP; Zeissig, S; Ahmad, T; Andersen, V; Andrews, JM; Annese, V; Brand, S; Brant, SR; Cho, JH; Daly, MJ; Dubinsky, M; Duerr, RH; Ferguson, LR; Franke, A; Gearry, RB; Goyette, P; Hakonarson, H; Halfvarson, J; Hov, JR; Huang, HL; Kennedy, NA; Kupcinskas, L; Lawrance, IC; Lee, JC; Satsangi, J; Schreiber, S; Theatre, E; van der Meulen-de Jong, AE; Weersma, RK; Wilson, DC; Parkes, M; Vermeire, S; Rioux, JD; Mansfield, J; Silverberg, MS; Radford-Smith, G; McGovern, DPB; Barrett, JC; Lees, CW				Cleynen, Isabelle; Boucher, Gabrielle; Jostins, Luke; Schumm, L. Philip; Zeissig, Sebastian; Ahmad, Tariq; Andersen, Vibeke; Andrews, Jane M.; Annese, Vito; Brand, Stephan; Brant, Steven R.; Cho, Judy H.; Daly, Mark J.; Dubinsky, Marla; Duerr, Richard H.; Ferguson, Lynnette R.; Franke, Andre; Gearry, Richard B.; Goyette, Philippe; Hakonarson, Hakon; Halfvarson, Jonas; Hov, Johannes R.; Huang, Hailang; Kennedy, Nicholas A.; Kupcinskas, Limas; Lawrance, Ian C.; Lee, James C.; Satsangi, Jack; Schreiber, Stephan; Theatre, Emilie; van der Meulen-de Jong, Andrea E.; Weersma, Rinse K.; Wilson, David C.; Parkes, Miles; Vermeire, Severine; Rioux, John D.; Mansfield, John; Silverberg, Mark S.; Radford-Smith, Graham; McGovern, Dermot P. B.; Barrett, Jeffrey C.; Lees, Charlie W.		Int Inflammatory Bowel Dis Genet	Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study	LANCET			English	Article							INFLAMMATORY-BOWEL-DISEASE; PRIMARY SCLEROSING CHOLANGITIS; MAINTENANCE THERAPY; CLINICAL-COURSE; FOLLOW-UP; POPULATION; CLASSIFICATION; SUSCEPTIBILITY; INDUCTION; RISK	Background Crohn's disease and ulcerative colitis are the two major forms of inflammatory bowel disease; treatment strategies have historically been determined by this binary categorisation. Genetic studies have identified 163 susceptibility loci for inflammatory bowel disease, mostly shared between Crohn's disease and ulcerative colitis. We undertook the largest genotype association study, to date, in widely used clinical subphenotypes of inflammatory bowel disease with the goal of further understanding the biological relations between diseases. Methods This study included patients from 49 centres in 16 countries in Europe, North America, and Australasia. We applied the Montreal classification system of inflammatory bowel disease subphenotypes to 34 819 patients (19 713 with Crohn's disease, 14 683 with ulcerative colitis) genotyped on the Immunochip array. We tested for genotype-phenotype associations across 156 154 genetic variants. We generated genetic risk scores by combining information from all known inflammatory bowel disease associations to summarise the total load of genetic risk for a particular phenotype. We used these risk scores to test the hypothesis that colonic Crohn's disease, ileal Crohn's disease, and ulcerative colitis are all genetically distinct from each other, and to attempt to identify patients with a mismatch between clinical diagnosis and genetic risk profile. Findings After quality control, the primary analysis included 29 838 patients (16 902 with Crohn's disease, 12 597 with ulcerative colitis). Three loci (NOD2, MHC, and MST1 3p21) were associated with subphenotypes of inflammatory bowel disease, mainly disease location (essentially fixed over time; median follow-up of 10.5 years). Little or no genetic association with disease behaviour (which changed dramatically over time) remained after conditioning on disease location and age at onset. The genetic risk score representing all known risk alleles for inflammatory bowel disease showed strong association with disease subphenotype (p=1.65 x 10(-78)), even after exclusion of NOD2, MHC, and 3p21 (p=9.23 x 10(-18)). Predictive models based on the genetic risk score strongly distinguished colonic from ileal Crohn's disease. Our genetic risk score could also identify a small number of patients with discrepant genetic risk profiles who were significantly more likely to have a revised diagnosis after follow-up (p=6.8 x 10(-4)). Interpretation Our data support a continuum of disorders within inflammatory bowel disease, much better explained by three groups (ileal Crohn's disease, colonic Crohn's disease, and ulcerative colitis) than by Crohn's disease and ulcerative colitis as currently defined. Disease location is an intrinsic aspect of a patient's disease, in part genetically determined, and the major driver to changes in disease behaviour over time.	[Cleynen, Isabelle; Jostins, Luke; Barrett, Jeffrey C.] Wellcome Trust Sanger Inst, Cambridge, England; [Cleynen, Isabelle; Vermeire, Severine] Katholieke Univ Leuven, TARGID, Dept Clin & Expt Med, Leuven, Belgium; [Boucher, Gabrielle; Goyette, Philippe; Rioux, John D.] Univ Montreal, Montreal, PQ, Canada; [Boucher, Gabrielle; Goyette, Philippe; Rioux, John D.] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Jostins, Luke] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Jostins, Luke] Univ Oxford, Christ Church, St Aldates, England; [Schumm, L. Philip] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA; [Zeissig, Sebastian; Schreiber, Stephan] Univ Kiel, Dept Gen Internal Med, Kiel, Germany; [Franke, Andre; Schreiber, Stephan] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Ahmad, Tariq] Peninsula Coll Med & Dent, Exeter, Devon, England; [Andersen, Vibeke] Viborg Reg Hosp, Dept Med, Viborg, Denmark; [Andersen, Vibeke] Hosp Southern Jutland Aabenraa, Aabenraa, Denmark; [Andrews, Jane M.] Royal Adelaide Hosp, Dept Gastroenterol & Hepatol, Inflammatory Bowel Dis Serv, Adelaide, SA 5000, Australia; [Andrews, Jane M.] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Annese, Vito] Ist Ricovero & Cura Carattere Sci Casa Sollievo S, Gastroenterol Unit, San Giovanni Rotondo, Italy; [Annese, Vito] Azienda Osped Univ AOU Careggi, Unit Gastroenterol SOD2, Florence, Italy; [Brand, Stephan] Univ Munich, Univ Hosp Munich Grosshadern, Dept Med 2, Munich, Germany; [Brant, Steven R.] Johns Hopkins Univ, Sch Med, Dept Med, Meyerhoff Inflammatory Bowel Dis Ctr, Baltimore, MD 21205 USA; [Brant, Steven R.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Cho, Judy H.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Daly, Mark J.; Huang, Hailang] Broad Inst MIT & Harvard, Cambridge, MA USA; [Dubinsky, Marla] Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA; [Duerr, Richard H.] Univ Pittsburgh, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA; [Duerr, Richard H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Ferguson, Lynnette R.] Univ Auckland, Fac Med & Hlth Sci, Sch Med Sci, Auckland 1, New Zealand; [Gearry, Richard B.] Univ Otago, Dept Med, Christchurch, New Zealand; [Gearry, Richard B.] Christchurch Hosp, Dept Gastroenterol, Christchurch, New Zealand; [Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Gen, Philadelphia, PA 19104 USA; [Halfvarson, Jonas] Univ Orebro, Fac Med & Hlth, Dept Gastroenterol, SE-70182 Orebro, Sweden; [Halfvarson, Jonas] Univ Orebro, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden; [Hov, Johannes R.] Univ Oslo, Norwegian PSC Res Ctr, Res Insitute Internal Med, Oslo, Norway; [Hov, Johannes R.] Oslo Univ Hosp, Dept Transplantat Med, N-0450 Oslo, Norway; [Hov, Johannes R.] Univ Oslo, Oslo, Norway; [Kennedy, Nicholas A.; Satsangi, Jack; Lees, Charlie W.] Univ Edinburgh, Inst Genet & Mol Med, Gastrointestinal Unit, Edinburg, TX USA; [Wilson, David C.] Univ Edinburgh, Child Life & Hlth, Edinburg, TX USA; [Kupcinskas, Limas] Lithuanian Univ Hlth Sci, Dept Gastroenterol, Kaunas, Lithuania; [Lawrance, Ian C.] St John God Hosp, Ctr Inflammatory Bowel Dis, Subiaco Wa, Australia; [Lawrance, Ian C.] Univ Western Australia, Sch Med & Pharmcol, Harry Perkins Inst Med Res, Murdoch, WA, Australia; [Lee, James C.; Parkes, Miles] Univ Cambridge, Addenbrookes Hosp, Inflammatory Bowel Dis Res Grp, Cambridge CB2 2QQ, England; [Theatre, Emilie] Univ Liege, Grp Interdisciplinaire Genoproteom Appl GIGA R, Unit Anim Genom, Liege, Belgium; [Theatre, Emilie] Univ Liege, Fac Vet Med, Liege, Belgium; [Theatre, Emilie] Univ Liege, Ctr Hosp Univ, Div Gastroenterol, Liege, Belgium; [van der Meulen-de Jong, Andrea E.] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands; [Weersma, Rinse K.] Univ Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Weersma, Rinse K.] Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Wilson, David C.] Royal Hosp Sick Children, Paediat Gastroenterol & Nutr, Glasgow, Lanark, Scotland; [Vermeire, Severine] Univ Hosp Gasthuisberg, Div Gastroenterol, Leuven, Belgium; [Mansfield, John] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Silverberg, Mark S.] Univ Toronto, Mt Sinai Hosp, Ctr Inflammatory Bowel Dis, Toronto, ON M5G 1X5, Canada; [Radford-Smith, Graham] Queensland Inst Med Res, Inflammatory Bowel Dis Genet & Computat Biol, Brisbane, Qld 4006, Australia; [Radford-Smith, Graham] Univ Queensland, Dept Gastroenterol, Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Radford-Smith, Graham] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [McGovern, Dermot P. B.] Cedars Sinai Med Ctr, Inflammatory Bowel & Immunobiol Res Inst, F Widjaja Fdn, Los Angeles, CA 90048 USA	Wellcome Trust Sanger Institute; KU Leuven; Universite de Montreal; Universite de Montreal; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Chicago; University of Kiel; University of Kiel; University of Exeter; University of Plymouth; Aarhus University; Royal Adelaide Hospital; University of Adelaide; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Munich; Johns Hopkins University; Johns Hopkins University; Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Cedars Sinai Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Auckland; University of Otago; Christchurch Hospital New Zealand; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Orebro University; Orebro University; University of Oslo; University of Oslo; University of Oslo; Lithuanian University of Health Sciences; St John of God Health Care; Harry Perkins Institute of Medical Research; University of Western Australia; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Liege; University of Liege; University of Liege; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; University of Groningen; University of Glasgow; KU Leuven; University Hospital Leuven; Newcastle University - UK; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland; University of Queensland; Cedars Sinai Medical Center	Lees, CW (corresponding author), Western Gen Hosp, Gastrointestinal Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	barrett@sanger.ac.uk; Charlie.lees@ed.ac.uk	Lee, James/ABD-5920-2020; Van Limbergen, Johan/L-1855-2019; Hov, Johannes R/J-1480-2019; Palmieri, Orazio/J-7697-2012; Radford-Smith, Graham/H-2792-2013; Franke, Andre/B-2151-2010; Ellinghaus, David/G-4467-2012; Gearry, Richard B/H-3959-2019; Rioux, John D/A-9599-2015; van der Meulen, Andrea/AAU-9430-2020; Kennedy, Nicholas Alexander/AET-5648-2022; Wijmenga, Cisca/D-2173-2009; Halfvarson, Jonas/AAU-4687-2020; Daly, Mark J/B-2453-2017; Annese, Vito/AGW-4200-2022; Weersma, Rinse/ABE-3807-2021; Duerr, Richard H/B-4188-2009; Radford-Smith, Graham L/G-5749-2017; Zeissig, Sebastian/B-6297-2012; D'Amato, Mauro/F-2450-2010; Silverberg, Mark/B-4183-2008; Ng, Siew Chien/N-4733-2015; D'Amato, Mauro/B-5050-2019; Lawrance, Ian C/H-5252-2014; Andersen, Vibeke/I-7932-2012; Prescott, Natalie/F-6490-2011	Lee, James/0000-0001-5711-9385; Van Limbergen, Johan/0000-0001-5822-4371; Hov, Johannes R/0000-0002-5900-8096; Palmieri, Orazio/0000-0002-0019-7929; Radford-Smith, Graham/0000-0002-2047-6239; Franke, Andre/0000-0003-1530-5811; Gearry, Richard B/0000-0002-2298-5141; Rioux, John D/0000-0001-7560-8326; van der Meulen, Andrea/0000-0001-9353-5431; Kennedy, Nicholas Alexander/0000-0003-4368-1961; Daly, Mark J/0000-0002-0949-8752; Annese, Vito/0000-0002-0082-892X; Duerr, Richard H/0000-0001-6586-3905; Radford-Smith, Graham L/0000-0002-2047-6239; Zeissig, Sebastian/0000-0001-5124-0897; D'Amato, Mauro/0000-0003-2743-5197; Ng, Siew Chien/0000-0002-6850-4454; D'Amato, Mauro/0000-0003-2743-5197; Andersen, Vibeke/0000-0002-0127-2863; Lees, Charlie/0000-0002-0732-8215; Brant, Steven/0000-0003-3019-4240; Simms, Lisa/0000-0002-5387-7397; ZHANG, HU/0000-0002-3281-4661; Vermeire, Severine/0000-0001-9942-3019; Ellinghaus, David/0000-0002-4332-6110; Nothen, Markus/0000-0002-8770-2464; Prescott, Natalie/0000-0002-5901-7371; Parkes, Miles/0000-0002-6467-0631; Massey, Dunecan/0000-0002-7144-4579; Mitrovic, Mitja/0000-0002-7648-7674; Anderson, Carl/0000-0003-1719-7009; Laukens, Debby/0000-0002-1984-5850; Hawkey, Chris/0000-0002-6031-1017; Newman, William/0000-0002-6382-4678; Schumm, Phil/0000-0002-3050-2429; Barrett, Jeffrey/0000-0002-1152-370X	International Inflammatory Bowel Disease Genetics Consortium; National Association for Colitis and Crohn's disease; Wellcome Trust [098051, 098759, 083948/Z/07/Z, 085475/B/08/Z, 085475/Z/08/Z]; Medical Research Council UK; Catherine McEwan Foundation; Peninsula College of Medicine and Dentistry, Exeter; National Institute for Health Research, through the Comprehensive Local Research Network; National Institute for Health Research through Biomedical Research Centre; Crohn's AMP; Colitis Foundation of America [5-2229]; Cedars-Sinai F Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute Research Funds; Agency for Healthcare Research and Quality [DK062413, AI067068, U54DE023789-01, HS021747]; European Union [305479]; Leona M and Harry B Helmsley Charitable Trust; FWO grant from the Flemish Funds for Scientific Research (FWO); Interuniversity Attraction Poles programme of the Belgian federal scientific policy office [P7/43 BeMGI]; Walloon Region (IPSEQ, Crohn AMP; CIBLES projects); FEDER; Politique Scientifique Federale (IAP BeMGI); Fonds National de la Recherche Scientifique (FNRS); Communaute Francaise de Belgique (ARC IBD@ULg); VIDI grant from the Netherlands Organisation for Scientific Research (NWO) [016.136.308]; German Ministry of Education and Research through the National Genome Research Network; PopGen biobank, through the Deutsche Forschungsgemeinschaft (DFG) cluster of excellence "Inflammation at Interfaces"; DFG [FR 2821/2-1, BR 1912/6-1]; Else-Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium) [2010_EKES.32]; Italian Ministry of Health [GR-2008-1144485]; Swedish Society of Medicine; Ihre Foundation; Orebro University Hospital Research Foundation; Karolinska Institute; Swedish National Program for IBD Genetics; Swedish Organization for IBD; Swedish Research Council [JH 521-2011-2764]; Viborg Regional Hospital, Denmark; SHS Aabenraa, Denmark; Royal Brisbane and Women's Hospital Foundation; National Health and Medical Research Council, Australia; European Community; NIDDK; National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute; National Institute of Child Health and Human Development; Juvenile Diabetes Research Foundation;  [DK062431];  [DK062422];  [DK062429];  [DK062420];  [DK062432];  [DK062423];  [DK076984];  [DK084554];  [DK062429-S1];  [CA141743];  [PO1DK046763];  [U01 DK062418]; MRC [G0800675, G0600329, G0800759] Funding Source: UKRI; Medical Research Council [G0800759, G0600329, G0800675, 1202121] Funding Source: researchfish; Medical Research Foundation [C0482] Funding Source: researchfish; Crohn&quot;s and Colitis UK [M11-1] Funding Source: researchfish; Chief Scientist Office [ETM/137, ETM/75] Funding Source: researchfish; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS021747] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA141743, P30CA016359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U54DE023789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK076984, P30DK089502, U01DK062420, U01DK062431, U01DK062422, P30DK043351, U24DK062429, U01DK062423, U01DK062429, U01DK062413, U01DK062432, P01DK046763, R21DK084554, U01DK062418] Funding Source: NIH RePORTER	International Inflammatory Bowel Disease Genetics Consortium; National Association for Colitis and Crohn's disease; Wellcome Trust(Wellcome Trust); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Catherine McEwan Foundation; Peninsula College of Medicine and Dentistry, Exeter; National Institute for Health Research, through the Comprehensive Local Research Network; National Institute for Health Research through Biomedical Research Centre; Crohn's AMP; Colitis Foundation of America; Cedars-Sinai F Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute Research Funds; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); European Union(European Commission); Leona M and Harry B Helmsley Charitable Trust; FWO grant from the Flemish Funds for Scientific Research (FWO)(FWO); Interuniversity Attraction Poles programme of the Belgian federal scientific policy office; Walloon Region (IPSEQ, Crohn AMP; CIBLES projects); FEDER(European Commission); Politique Scientifique Federale (IAP BeMGI); Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Communaute Francaise de Belgique (ARC IBD@ULg); VIDI grant from the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); German Ministry of Education and Research through the National Genome Research Network; PopGen biobank, through the Deutsche Forschungsgemeinschaft (DFG) cluster of excellence "Inflammation at Interfaces"(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Else-Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium); Italian Ministry of Health(Ministry of Health, Italy); Swedish Society of Medicine; Ihre Foundation; Orebro University Hospital Research Foundation; Karolinska Institute(Karolinska Institutet); Swedish National Program for IBD Genetics; Swedish Organization for IBD; Swedish Research Council(Swedish Research CouncilEuropean Commission); Viborg Regional Hospital, Denmark; SHS Aabenraa, Denmark; Royal Brisbane and Women's Hospital Foundation; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); European Community(European Commission); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); ; ; ; ; ; ; ; ; ; ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Crohn&quot;s and Colitis UK; Chief Scientist Office; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	International Inflammatory Bowel Disease Genetics Consortium members funding sources (see Acknowledgments for full list).r We thank all the individuals who contributed samples and the physicians and nursing staff who helped with recruitment worldwide. We also thank Prof Gil McVean (professor of Statistical Genetics, Wellcome Trust Centre of Human Genetics, University of Oxford, UK) for thorough review of all statistical methods. UK case collections were supported by the National Association for Colitis and Crohn's disease; Wellcome Trust grants 098051 (JCB) and 098759 (LJ); Medical Research Council UK; the Catherine McEwan Foundation; Peninsula College of Medicine and Dentistry, Exeter; the National Institute for Health Research, through the Comprehensive Local Research Network, and through Biomedical Research Centre awards to Guy's and Saint Thomas' National Health Service Trust, King's College London, Addenbrooke's Hospital, University of Cambridge School of Clinical Medicine and to the University of Manchester and Central Manchester Foundation Trust. The Wellcome Trust Case Control Consortium projects were supported by Wellcome Trust grants 083948/Z/07/Z, 085475/B/08/Z, and 085475/Z/08/Z. North American collections and data processing were supported by funds to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium, which is funded by the following grants: DK062431 (SRB), DK062422 and DK062429 (LPS, JHC), DK062420 (RHD), DK062432 (JDR), DK062423 (MSS), DK076984 and DK084554 (MJD). Additional funds were provided by funding to JHC (DK062429-S1 and Crohn's & Colitis Foundation of America, Senior Investigator Award [5-2229]), and RHD (CA141743). IBD Research at Cedars-Sinai is supported by grant PO1DK046763 and the Cedars-Sinai F Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute Research Funds. DPBM is supported by DK062413, AI067068, and U54DE023789-01, grant HS021747 from the Agency for Healthcare Research and Quality, grant 305479 from the European Union, and the Leona M and Harry B Helmsley Charitable Trust. We also acknowledge the University of Pittsburgh Genomics and Proteomics Core Laboratories who undertook genotyping for the Immunochip project. IC and SV are supported by an FWO grant from the Flemish Funds for Scientific Research (FWO) and received funding from the Interuniversity Attraction Poles programme of the Belgian federal scientific policy office, project P7/43 BeMGI. The University of Liege, Belgium is funded by the Walloon Region (IPSEQ, Crohn & CIBLES projects), by the FEDER, by the Politique Scientifique Federale (IAP BeMGI), by the Fonds National de la Recherche Scientifique (FNRS), and by the Communaute Francaise de Belgique (ARC IBD@ULg). The University of Liege thanks the GIGA-R genotranscriptomic platform for their contribution to genotyping. RKW is supported by a VIDI grant (016.136.308) from the Netherlands Organisation for Scientific Research (NWO). This study was also supported by the German Ministry of Education and Research through the National Genome Research Network, the PopGen biobank, through the Deutsche Forschungsgemeinschaft (DFG) cluster of excellence "Inflammation at Interfaces" and DFG grant no. FR 2821/2-1. SB was supported by DFG BR 1912/6-1 and the Else-Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium 2010_EKES.32).; Italian case collections were supported by the Italian Group for IBD and the Italian Society for Paediatric Gastroenterology, Hepatology and Nutrition and funded by the Italian Ministry of Health GR-2008-1144485.r Activities in Sweden were supported by the Swedish Society of Medicine, Ihre Foundation, Orebro University Hospital Research Foundation, Karolinska Institute, the Swedish National Program for IBD Genetics, the Swedish Organization for IBD, and the Swedish Research Council (JH 521-2011-2764). We acknowledge a grant from Viborg Regional Hospital, Denmark. VAnd was supported by SHS Aabenraa, Denmark. We acknowledge funding provided by the Royal Brisbane and Women's Hospital Foundation, National Health and Medical Research Council, Australia, and by the European Community (5th PCRDT). We acknowledge the following groups that provided biological samples or data for this study: the Inflammatory Bowel disease in South Eastern Norway (IBSEN) study group, including Bjorn Moum, Morten Vatn, and Marte Lie Hoivik, is acknowledged for providing patients with inflammatory bowel disease and data updates; the Avon Longitudinal Study of Parents and Children; the Human Biological Data Interchange and Diabetes UK; and Banco Nacional de ADN, Salamanca. This research also uses resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the NIDDK, National Institute of Allergy and Infectious Diseases, National Human Genome Research Institute, National Institute of Child Health and Human Development, and Juvenile Diabetes Research Foundation, and supported by U01 DK062418.	Ahmad T, 2002, GASTROENTEROLOGY, V122, P854, DOI 10.1053/gast.2002.32413; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Brant SR, 2003, INFLAMM BOWEL DIS, V9, P281, DOI 10.1097/00054725-200309000-00001; Chen GB, 2014, HUM MOL GENET, V23, P4710, DOI 10.1093/hmg/ddu174; Cleynen I, 2013, GUT, V62, P1556, DOI 10.1136/gutjnl-2011-300777; Crohn BB, 1932, J AMER MED ASSOC, V99, P1323, DOI 10.1001/jama.1932.02740680019005; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; DALZIEL TK, 1989, DIS COLON RECTUM, V32, P1076, DOI 10.1007/BF02553886; De La Concha EG, 2000, GASTROENTEROLOGY, V119, P1491, DOI 10.1053/gast.2000.20258; Dignass A, 2010, J CROHNS COLITIS, V4, P28, DOI 10.1016/j.crohns.2009.12.002; Dignass A, 2012, J CROHNS COLITIS, V6, P991, DOI 10.1016/j.crohns.2012.09.002; Donaldson PT, DUAL ASS HLA DR2 DR3; Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x; Everhart JE, 2009, GASTROENTEROLOGY, V136, P376, DOI 10.1053/j.gastro.2008.12.015; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Feagan BG, 2013, NEW ENGL J MED, V369, P699, DOI 10.1056/NEJMoa1215734; Frolkis AD, 2013, GASTROENTEROLOGY, V145, P996, DOI 10.1053/j.gastro.2013.07.041; Goyette P, 2015, NAT GENET, V47, P172, DOI 10.1038/ng.3176; Halfvarson J, 2003, GASTROENTEROLOGY, V124, P1767, DOI 10.1016/S0016-5085(03)00385-8; Hamshere ML, 2011, BRIT J PSYCHIAT, V198, P284, DOI 10.1192/bjp.bp.110.087866; Hanauer SB, 2006, GASTROENTEROLOGY, V130, P323, DOI 10.1053/j.gastro.2005.11.030; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Henckaerts L, 2009, CLIN GASTROENTEROL H, V7, P972, DOI 10.1016/j.cgh.2009.05.001; Jostins L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076328; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kirschner BS, 1996, PEDIATR CLIN N AM, V43, P235, DOI 10.1016/S0031-3955(05)70404-1; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Loftus EV, 2005, GUT, V54, P91, DOI 10.1136/gut.2004.046615; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Moum B, 1997, GUT, V40, P328, DOI 10.1136/gut.40.3.328; Mowat C, 2011, GUT, V60, P571, DOI 10.1136/gut.2010.224154; Neovius M, 2013, GASTROENTEROLOGY, V144, P536, DOI 10.1053/j.gastro.2012.12.004; Newman B, 2004, AM J GASTROENTEROL, V99, P306, DOI 10.1111/j.1572-0241.2004.04038.x; Pera A, 1987, GASTROENTEROLOGY, V92, P181, DOI 10.1016/0016-5085(87)90856-0; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reinisch W, 2011, GUT, V60, P780, DOI 10.1136/gut.2010.221127; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sandborn WJ, 2013, NEW ENGL J MED, V369, P711, DOI 10.1056/NEJMoa1215739; Sandborn WJ, 2012, GASTROENTEROLOGY, V142, P257, DOI 10.1053/j.gastro.2011.10.032; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Silverberg MS, 2003, INFLAMM BOWEL DIS, V9, P1, DOI 10.1097/00054725-200301000-00001; Solberg IC, 2007, CLIN GASTROENTEROL H, V5, P1430, DOI 10.1016/j.cgh.2007.09.002; Solberg IC, 2009, SCAND J GASTROENTERO, V44, P431, DOI 10.1080/00365520802600961; Spurkland A, 1999, TISSUE ANTIGENS, V53, P459, DOI 10.1034/j.1399-0039.1999.530502.x	47	428	446	6	108	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2016	387	10014					156	167		10.1016/S0140-6736(15)00465-1	http://dx.doi.org/10.1016/S0140-6736(15)00465-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8LF	26490195	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000368055500032
J	Young, P; Saxena, M; Bellomo, R; Freebairn, R; Hammond, N; van Haren, F; Holliday, M; Henderson, S; Mackle, D; McArthur, C; McGuinness, S; Myburgh, J; Weatherall, M; Webb, S; Beasley, R				Young, Paul; Saxena, Manoj; Bellomo, Rinaldo; Freebairn, Ross; Hammond, Naomi; van Haren, Frank; Holliday, Mark; Henderson, Seton; Mackle, Diane; McArthur, Colin; McGuinness, Shay; Myburgh, John; Weatherall, Mark; Webb, Steve; Beasley, Richard		HEAT Investigators; Australian New Zealand Intensive	Acetaminophen for Fever in Critically Ill Patients with Suspected Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; INTENSIVE-CARE PATIENTS; NEW-ZEALAND; TEMPERATURE MANAGEMENT; POINT PREVALENCE; BODY-TEMPERATURE; HEAT TRIAL; PARACETAMOL; MORTALITY; STROKE	BACKGROUND Acetaminophen is a common therapy for fever in patients in the intensive care unit (ICU) who have probable infection, but its effects are unknown. METHODS We randomly assigned 700 patients with fever (body temperature, >= 38 degrees C) and known or suspected infection to receive either 1 g of intravenous acetaminophen or placebo every 6 hours until ICU discharge, resolution of fever, cessation of antimicrobial therapy, or death. The primary outcome was ICU-free days (days alive and free from the need for intensive care) from randomization to day 28. RESULTS The number of ICU-free days to day 28 did not differ significantly between the acetaminophen group and the placebo group: 23 days (interquartile range, 13 to 25) among patients assigned to acetaminophen and 22 days (interquartile range, 12 to 25) among patients assigned to placebo (Hodges-Lehmann estimate of absolute difference, 0 days; 96.2% confidence interval [CI], 0 to 1; P = 0.07). A total of 55 of 345 patients in the acetaminophen group (15.9%) and 57 of 344 patients in the placebo group (16.6%) had died by day 90 (relative risk, 0.96; 95% CI, 0.66 to 1.39; P = 0.84). CONCLUSIONS Early administration of acetaminophen to treat fever due to probable infection did not affect the number of ICU-free days. (Funded by the Health Research Council of New Zealand and others; HEAT Australian New Zealand Clinical Trials Registry number, ACTRN12612000513819.)	[Young, Paul; Mackle, Diane] Wellington Reg Hosp, Intens Care Unit, Private Bag 7902, Wellington, New Zealand; [Young, Paul; Freebairn, Ross; Holliday, Mark; Henderson, Seton; Mackle, Diane; McArthur, Colin; McGuinness, Shay; Beasley, Richard] Med Res Inst New Zealand, Wellington, New Zealand; [Weatherall, Mark] Univ Otago, Wellington Sch Med, Wellington, New Zealand; [Freebairn, Ross] Hawkes Bay Hosp, Intens Care Unit, Hastings, New Zealand; [Henderson, Seton] Christchurch Hosp, Intens Care Unit, Christchurch, New Zealand; [McArthur, Colin] Auckland City Hosp, Dept Crit Care Med, Auckland, New Zealand; [McGuinness, Shay] Auckland City Hosp, Cardiothorac & Vasc Intens Care Unit, Auckland, New Zealand; [Saxena, Manoj; Hammond, Naomi; Myburgh, John] George Inst Global Hlth, Crit Care & Trauma Div, Sydney, NSW, Australia; [Saxena, Manoj; Myburgh, John] St George Hosp, Intens Care Unit, Kogarah, NSW, Australia; [Hammond, Naomi] Royal N Shore Hosp, Malcolm Fisher Dept Intens Care Med, St Leonards, NSW 2065, Australia; [Myburgh, John] Univ New S Wales, St George Clin Sch, Fac Med, Kensington, NSW 2033, Australia; [Bellomo, Rinaldo] Austin Hosp, Intens Care Unit, Melbourne, Vic 3084, Australia; [Bellomo, Rinaldo] Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia; [Bellomo, Rinaldo] Univ Melbourne, Fac Med, Melbourne, Vic, Australia; [van Haren, Frank] Canberra Hosp, Intens Care Unit, Canberra, ACT, Australia; [Webb, Steve] Royal Perth Hosp, Intens Care Unit, Perth, WA 6001, Australia; [Webb, Steve] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia	Medical Research Institute Of New Zealand; University of Otago; Christchurch Hospital New Zealand; Auckland City Hospital; Auckland City Hospital; George Institute for Global Health; University of Sydney; St George Hospital; Royal North Shore Hospital; University of New South Wales Sydney; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Monash University; University of Melbourne; Australian National University; Canberra Hospital; Royal Perth Hospital; University of Western Australia; University of Western Australia	Young, P (corresponding author), Wellington Reg Hosp, Intens Care Unit, Private Bag 7902, Wellington, New Zealand.	paul.young@ccdhb.org.nz	Weatherall, Mark/Y-6824-2019; Freebairn, Ross C/F-4255-2010; Van Haren, Frank/G-1335-2015; Beasley, Richard/AAH-3908-2019	Weatherall, Mark/0000-0002-0051-9107; Van Haren, Frank/0000-0001-8037-4229; Beasley, Richard/0000-0003-0337-406X; Bellomo, Rinaldo/0000-0002-1650-8939; Saxena, Manoj/0000-0002-0385-6731; Myburgh, John/0000-0003-4088-7016; McGuinness, Shay/0000-0003-0620-4787; Young, Paul/0000-0002-3428-3083; Micallef, Sharon/0000-0002-8496-2324; Rajbhandari, Dorrilyn/0000-0001-8883-0428; Freebairn, Ross/0000-0002-1967-8183; Hammond, Naomi/0000-0002-6559-7747; Bhonagiri, Deepak/0000-0003-4376-6682; Knowles, Serena/0000-0002-5028-3825	Health Research Council of New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand)	Funded by the Health Research Council of New Zealand and others	BERMAN JD, 1981, AM J TROP MED HYG, V30, P318, DOI 10.4269/ajtmh.1981.30.318; CHU CM, 1982, J VIROL, V41, P353, DOI 10.1128/JVI.41.2.353-359.1982; Dippel DWJ, 2003, NEUROLOGY, V61, P677, DOI 10.1212/01.WNL.0000080364.40229.0B; EMERSON SS, 1989, BIOMETRICS, V45, P905, DOI 10.2307/2531692; Greenberg RS, 2010, J CRIT CARE, V25, DOI 10.1016/j.jcrc.2009.07.005; Hammond NE, 2013, CRIT CARE RESUSC, V15, P228; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LEHMANN EL, 1963, ANN MATH STAT, V34, P1507, DOI 10.1214/aoms/1177703882; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; MACKOWIAK PA, 1981, AM J CLIN PATHOL, V76, P57; MANTHOUS CA, 1995, AM J RESP CRIT CARE, V151, P10, DOI 10.1164/ajrccm.151.1.7812538; Moench M., 1926, J LAB CLIN MED, V57, P665; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Saxena M, 2015, INTENS CARE MED, V41, P823, DOI 10.1007/s00134-015-3676-6; Saxena MK, 2013, CRIT CARE RESUSC, V15, P110; Schortgen F, 2012, AM J RESP CRIT CARE, V185, P1088, DOI 10.1164/rccm.201110-1820OC; SMALL PM, 1986, INFECT IMMUN, V52, P484, DOI 10.1128/IAI.52.2.484-487.1986; Suzuki S, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0865-1; Young P, 2012, CRIT CARE RESUSC, V14, P211; Young P, 2011, CRIT CARE RESUSC, V13, P97; Young PJ, 2013, CRIT CARE RESUSC, V15, P279; Young PJ, 2012, CRIT CARE RESUSC, V14, P290; Young PJ, 2012, INTENS CARE MED, V38, P437, DOI 10.1007/s00134-012-2478-3; Zhang ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117279	24	116	117	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2015	373	23					2215	2224		10.1056/NEJMoa1508375	http://dx.doi.org/10.1056/NEJMoa1508375			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5LM	26436473				2022-12-28	WOS:000365743100005
J	Vallejo, DM; Juarez-Carreno, S; Bolivar, J; Morante, J; Dominguez, M				Vallejo, Diana M.; Juarez-Carreno, Sergio; Bolivar, Jorge; Morante, Javier; Dominguez, Maria			A brain circuit that synchronizes growth and maturation revealed through Dilp8 binding to Lgr3	SCIENCE			English	Article							INSULIN-LIKE PEPTIDES; PROTEIN-COUPLED RECEPTORS; DROSOPHILA-MELANOGASTER; CONSTITUTIVE ACTIVITY; ORPHAN RECEPTORS; BODY-SIZE; RELAXIN; CELL; EXPRESSION; NEURONS	Body-size constancy and symmetry are signs of developmental stability. Yet, it is unclear exactly how developing animals buffer size variation. Drosophila insulin-like peptide Dilp8 is responsive to growth perturbations and controls homeostatic mechanisms that coordinately adjust growth and maturation to maintain size within the normal range. Here we show that Lgr3 is a Dilp8 receptor. Through the use of functional and adenosine 3',5'-monophosphate assays, we defined a pair of Lgr3 neurons that mediate homeostatic regulation. These neurons have extensive axonal arborizations, and genetic and green fluorescent protein reconstitution across synaptic partners show that these neurons connect with the insulin-producing cells and prothoracicotropic hormone-producing neurons to attenuate growth and maturation. This previously unrecognized circuit suggests how growth and maturation rate are matched and co-regulated according to Dilp8 signals to stabilize organismal size.	[Vallejo, Diana M.; Juarez-Carreno, Sergio; Morante, Javier; Dominguez, Maria] CSIC, Inst Neurocien, Alicante, Spain; [Vallejo, Diana M.; Juarez-Carreno, Sergio; Morante, Javier; Dominguez, Maria] Univ Miguel Hernandez, Campus Sant Joan, Alicante, Spain; [Bolivar, Jorge] Univ Cadiz, Fac Cienc, Dept Biomed Biotecnol Salud Publ, Puerto Real, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; Universidad de Cadiz	Morante, J (corresponding author), CSIC, Inst Neurocien, Alicante, Spain.	j.morante@umh.es; m.dominguez@umh.es	Morante, Javier/E-3292-2014; Dominguez, Maria/G-2171-2014; Juarez-Carreño, Sergio/AGF-7910-2022; Martínez, Diana Marcela Vallejo/AAE-7604-2019; Morante, Javier/P-2976-2019; BOLIVAR, JORGE/G-4322-2015; Martínez, Diana Marcela Vallejo/AAE-8516-2019	Morante, Javier/0000-0002-5594-0644; Dominguez, Maria/0000-0002-3329-7862; Juarez-Carreño, Sergio/0000-0001-8860-6979; Martínez, Diana Marcela Vallejo/0000-0003-0447-4265; Morante, Javier/0000-0002-5594-0644; BOLIVAR, JORGE/0000-0002-2645-9528; 	NIH [P40OD018537, OD010949-10]; NIH National Institute of General Medical Sciences [R01-GM084947]; Ramon y Cajal [RyC-2010-07155]; Ministerio de Economia y Competitividad [SAF2012-31467]; Junta de Andalucia PAIDI group [CTS-569]; Spanish national [SAF2012-35181, SEV-2013-0317]; Generalitat Valenciana [PROMETEO II/2013/001]; Botin Foundation; Formacion del Personal Investigador; Spanish Ministerio de Economia y Competitividad [BES-2013-064947]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010949, P40OD018537] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ramon y Cajal(Spanish Government); Ministerio de Economia y Competitividad(Spanish Government); Junta de Andalucia PAIDI group(Junta de Andalucia); Spanish national; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Botin Foundation; Formacion del Personal Investigador; Spanish Ministerio de Economia y Competitividad(Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank P. Leopold for reagents and the PTTH antibody; M. Vidal for the lgr2 plasmid; E. Hafen and H. Stocker for Dilp antibodies; A. Garelli for stock construct and initial work on this project; A. Gontijo for plasmid design; and J. Casanova, J. C. P. Yin, B. J. Dickson, J. Blau, B. Hassan, and F. Matsuzaki for fly stocks or antibodies. We also thank the Bloomington Stock Center (NIH grant P40OD018537), the DGRC (NIH grant OD010949-10), and the Transgenic RNAi Project at Harvard Medical School (NIH National Institute of General Medical Sciences grant R01-GM084947) for providing the fly stocks and plasmids used in this study and the Developmental Studies Hybridoma Bank at the University of Iowa for antibodies. This work was supported by a Ramon y Cajal grant (RyC-2010-07155) and a Ministerio de Economia y Competitividad grant (SAF2012-31467) to J.M.; a Junta de Andalucia PAIDI group CTS-569 to J.B.; and Spanish national grants (SAF2012-35181 and SEV-2013-0317) and a Generalitat Valenciana grant (PROMETEO II/2013/001) to M.D. M.D. was also supported by the Botin Foundation. S.J.-C. is a fellow from Formacion del Personal Investigador (grant BES-2013-064947) from the Spanish Ministerio de Economia y Competitividad	Andersen DS, 2013, TRENDS CELL BIOL, V23, P336, DOI 10.1016/j.tcb.2013.03.005; Bader R, 2013, J CELL SCI, V126, P2571, DOI 10.1242/jcs.120261; Bathgate RAD, 2013, PHYSIOL REV, V93, P405, DOI 10.1152/physrev.00001.2012; Belgacem YH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000187; Berni J, 2012, CURR BIOL, V22, P1861, DOI 10.1016/j.cub.2012.07.048; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; CASANOVA J, 1993, NATURE, V362, P152, DOI 10.1038/362152a0; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; Colombani J, 2012, SCIENCE, V336, P582, DOI 10.1126/science.1216689; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Evans CJ, 2009, NAT METHODS, V6, P603, DOI 10.1038/nmeth.1356; Flatt T, 2005, BIOESSAYS, V27, P999, DOI 10.1002/bies.20290; Garelli A, 2012, SCIENCE, V336, P579, DOI 10.1126/science.1216735; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Hackney JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049105; Hampel S, 2011, NAT METHODS, V8, P253, DOI 10.1038/NMETH.1566; Hariharan IK, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003238; Hodge JJL, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.013.2009; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Karapanou O, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-115; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Milligan G, 2003, MOL PHARMACOL, V64, P1271, DOI 10.1124/mol.64.6.1271; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Mirth CK, 2014, P NATL ACAD SCI USA, V111, P7018, DOI 10.1073/pnas.1313058111; Morante Javier, 2011, Cold Spring Harb Protoc, V2011, P652, DOI 10.1101/pdb.prot5629; Nassel DR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00252; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Nicolai LJJ, 2010, P NATL ACAD SCI USA, V107, P20553, DOI 10.1073/pnas.1010198107; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Parker NF, 2011, DEV BIOL, V357, P318, DOI 10.1016/j.ydbio.2011.07.002; Rewitz KF, 2013, CURR TOP DEV BIOL, V103, P1, DOI 10.1016/B978-0-12-385979-2.00001-0; Rewitz KF, 2009, SCIENCE, V326, P1403, DOI 10.1126/science.1176450; Riddiford LM, 2010, DEVELOPMENT, V137, P1117, DOI 10.1242/dev.037218; Scopelliti A, 2014, CURR BIOL, V24, P1199, DOI 10.1016/j.cub.2014.04.007; Shingleton AW, 2010, ORGANOGENESIS, V6, P76, DOI 10.4161/org.6.2.10375; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Smith CM, 2012, GENES BRAIN BEHAV, V11, P94, DOI 10.1111/j.1601-183X.2011.00730.x; Summers RJ, 2009, ANN NY ACAD SCI, V1160, P99, DOI 10.1111/j.1749-6632.2009.03828.x; Tanenhaus AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045130; Tennessen JM, 2011, CURR BIOL, V21, pR750, DOI 10.1016/j.cub.2011.06.033; TOLSON TP, 2012, FRONT ENDOCRINOL, V3, P45; Van Hiel MB, 2015, PEPTIDES, V68, P83, DOI 10.1016/j.peptides.2014.07.014; Van Hiel MB, 2012, PEPTIDES, V34, P193, DOI 10.1016/j.peptides.2011.11.004; Wolpert L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000477; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Yamanaka N, 2013, SCIENCE, V341, P1113, DOI 10.1126/science.1241210; Zhang H, 2009, P NATL ACAD SCI USA, V106, P19617, DOI 10.1073/pnas.0905083106	56	106	107	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262							aac6767	10.1126/science.aac6767	http://dx.doi.org/10.1126/science.aac6767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW3MS	26429885				2022-12-28	WOS:000364897000036
J	Shimbo, D; Abdalla, M; Falzon, L; Townsend, RR; Muntner, P				Shimbo, Daichi; Abdalla, Marwah; Falzon, Louise; Townsend, Raymond R.; Muntner, Paul			Role of Ambulatory and Home Blood Pressure Monitoring in Clinical Practice A Narrative Review	ANNALS OF INTERNAL MEDICINE			English	Review							WHITE-COAT HYPERTENSION; AMERICAN-HEART-ASSOCIATION; SOCIETY-OF-HYPERTENSION; PRIMARY-CARE PHYSICIANS; MASKED HYPERTENSION; EUROPEAN-SOCIETY; CARDIOVASCULAR RISK; PRACTICE GUIDELINES; PROGNOSTIC VALUE; INTERNATIONAL DATABASE	Hypertension, a common risk factor for cardiovascular disease, is usually diagnosed and treated based on blood pressure readings obtained in the clinic setting. Blood pressure may differ considerably when measured inside versus outside of the clinic setting. Over the past several decades, evidence has accumulated on the following 2 approaches for measuring blood pressure outside of the clinic: ambulatory blood pressure monitoring (ABPM) and home blood pressure monitoring (HBPM). Both of these methods have a stronger association with cardiovascular disease outcomes than clinic blood pressure measurement. Controversy exists about whether ABPM or HBPM is superior for estimating risk for cardiovascular disease and under what circumstances these methods should be used in clinical practice for assessing blood pressure outside of the clinic. This review describes ABPM and HBPM procedures, the blood pressure phenotypic measurements that can be ascertained, and the evidence that supports the use of each approach to measuring blood pressure outside of the clinic. It also describes barriers to the successful implementation of ABPM and HBPM in clinical practice, proposes core competencies for the conduct of these procedures, and highlights important areas for future research.	[Shimbo, Daichi; Abdalla, Marwah; Falzon, Louise] Columbia Univ, Med Ctr, New York, NY 10032 USA; [Townsend, Raymond R.] Univ Penn, Perelman Sch Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Muntner, Paul] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA	Columbia University; University of Pennsylvania; Pennsylvania Medicine; University of Alabama System; University of Alabama Birmingham	Shimbo, D (corresponding author), Columbia Univ, Med Ctr, 622 West 168th St,PH 9-310, New York, NY 10032 USA.	ds2231@cumc.columbia.edu	Falzon, Louise/AAG-2404-2019; Falzon, Louise/HCI-2175-2022	Falzon, Louise/0000-0002-9449-6056; 	National Heart, Lung, and Blood Institute, National Institutes of Health [HL047540, HL117323, HL117323-02S2, K24-HL125704]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117323, P01HL047540, K24HL125704] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By the National Heart, Lung, and Blood Institute, National Institutes of Health (HL047540, HL117323, HL117323-02S2, and K24-HL125704).	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; American Society of Hypertension, CURR ASH CERT HYP CT; Aronow WS, 2011, J AM SOC HYPERTENS, V5, P259, DOI 10.1016/j.jash.2011.06.001; Association for the Advancement of Medical Instrumentation, 2003, SP102002 AASIAAMI; Banegas JR, 2007, HYPERTENSION, V49, P62, DOI 10.1161/01.HYP.0000250557.63490.55; Bilo G, 2007, J HYPERTENS, V25, P2058, DOI 10.1097/HJH.0b013e32829c6a60; Bjorklund K, 2003, CIRCULATION, V107, P1297, DOI 10.1161/01.CIR.0000054622.45012.12; Boggia J, 2007, LANCET, V370, P1219, DOI 10.1016/S0140-6736(07)61538-4; British Hypertension Society, BP MON; Centers for Disease Control and Prevention, 2013, SELF MEAS BLOOD PRES; Cheng Cynthia, 2003, Blood Press Monit, V8, P249, DOI 10.1097/00126097-200312000-00005; Dasgupta K, 2014, CAN J CARDIOL, V30, P485, DOI 10.1016/j.cjca.2014.02.002; Diaz KM, 2015, AM J HYPERTENS, V28, P900, DOI 10.1093/ajh/hpu241; Fagard RH, 2005, J HUM HYPERTENS, V19, P801, DOI 10.1038/sj.jhh.1001903; Fagard RH, 2008, HYPERTENSION, V51, P55, DOI 10.1161/HYPERTENSIONAHA.107.100727; Fagard RH, 2007, J HYPERTENS, V25, P2193, DOI 10.1097/HJH.0b013e3282ef6185; Fletcher BR, 2015, AM J HYPERTENS; Franklin SS, 2015, HYPERTENSION, V65, P16, DOI 10.1161/HYPERTENSIONAHA.114.04522; Franklin SS, 2013, HYPERTENSION, V62, P982, DOI 10.1161/HYPERTENSIONAHA.113.01275; Franklin SS, 2012, HYPERTENSION, V59, P564, DOI 10.1161/HYPERTENSIONAHA.111.180653; Go AS, 2014, J AM COLL CARDIOL, V63, P1230, DOI 10.1016/j.jacc.2013.11.007; Green BB, 2015, J AM SOC HYPERTENS, V9, P137, DOI 10.1016/j.jash.2014.12.010; Hanninen MRA, 2012, J HYPERTENS, V30, P705, DOI 10.1097/HJH.0b013e328350a69b; Hansen TW, 2007, J HYPERTENS, V25, P1554, DOI 10.1097/HJH.0b013e3281c49da5; Hansen TW, 2011, HYPERTENSION, V57, P3, DOI 10.1161/HYPERTENSIONAHA.109.133900; Hansen TW, 2010, HYPERTENSION, V55, P1049, DOI [10.1161/HYPERTENSIONAHA.109.140798, 10.1161/HYP.0b013e3181dfc0ad]; Hansen TW, 2008, J CLIN HYPERTENS, V10, P377, DOI 10.1111/j.1751-7176.2008.07681.x; Hansen TW, 2006, AM J HYPERTENS, V19, P243, DOI 10.1016/j.amjhyper.2005.09.018; Hermida RC, 2010, CHRONOBIOL INT, V27, P1629, DOI 10.3109/07420528.2010.510230; Imai, 1996, Blood Press Monit, V1, P251; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Kario K, 2001, J AM COLL CARDIOL, V38, P238, DOI 10.1016/S0735-1097(01)01325-0; Kario K, 2010, HYPERTENSION, V56, P765, DOI 10.1161/HYPERTENSIONAHA.110.157149; Kent ST, 2014, J AM SOC HYPERTENS, V8, P898, DOI 10.1016/j.jash.2014.09.020; Kidney Disease Improving Global Outcomes (KDIGO) Blood Pressure Work Group, 2012, KIDNEY INT SUPPL, V2, P337, DOI DOI 10.1038/kisup.2012.46; Kikuya M, 2007, CIRCULATION, V115, P2145, DOI 10.1161/CIRCULATIONAHA.106.662254; Krause T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4891; Kumar N, 2015, J AM SOC HYPERTENS, V9, P130, DOI 10.1016/j.jash.2014.12.001; Logan AG, 2008, J HYPERTENS, V26, P446, DOI 10.1097/HJH.0b013e3282f2fdd4; Mancia G, 2006, HYPERTENSION, V47, P846, DOI 10.1161/01.HYP.0000215363.69793.bb; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Muxfeldt ES, 2015, AM J HYPERTENS, V28, P190, DOI 10.1093/ajh/hpu145; Muxfeldt ES, 2012, HYPERTENSION, V59, P384, DOI 10.1161/HYPERTENSIONAHA.111.185405; Myers MG, 2014, J AM SOC HYPERTENS, V8, P350, DOI 10.1016/j.jash.2014.02.001; Myers MG, 2012, J HYPERTENS, V30, P1894, DOI 10.1097/HJH.0b013e3283577b05; Niiranen TJ, 2014, HYPERTENSION, V64, P281, DOI 10.1161/HYPERTENSIONAHA.114.03292; O'Brien E, 2005, J HYPERTENS, V23, P697, DOI 10.1097/01.hjh.0000163132.84890.c4; O'Brien E, 2008, HYPERTENSION, V51, P1435, DOI 10.1161/HYPERTENSIONAHA.107.100008; O'Brien E, 2013, J HYPERTENS, V31, P1731, DOI 10.1097/HJH.0b013e328363e964; O'Brien E, 2010, BLOOD PRESS MONIT, V15, P23, DOI 10.1097/MBP.0b013e3283360e98; OBRIEN E, 1993, J HYPERTENS, V11, P677, DOI 10.1097/00004872-199306000-00013; Ohkubo T, 2005, J AM COLL CARDIOL, V46, P508, DOI 10.1016/j.jacc.2005.03.070; Parati G, 2010, J HUM HYPERTENS, V24, P779, DOI 10.1038/jhh.2010.54; Parati G, 2008, J HYPERTENS, V26, P1505, DOI 10.1097/HJH.0b013e328308da66; Parati G, 2006, J HYPERTENS, V24, P1699, DOI 10.1097/01.hjh.0000242390.76978.1a; Parati G, 2012, CURR HYPERTENS REP, V14, P421, DOI 10.1007/s11906-012-0290-7; Parati G, 2009, LANCET, V373, P876, DOI 10.1016/S0140-6736(09)60526-2; Parati G, 2009, HYPERTENSION, V54, P181, DOI 10.1161/HYPERTENSIONAHA.108.122853; Peacock J, 2014, J HUM HYPERTENS, V28, P521, DOI 10.1038/jhh.2014.9; Pickering TG, 2002, HYPERTENSION, V40, P795, DOI 10.1161/01.HYP.0000038733.08436.98; PICKERING TG, 1988, JAMA-J AM MED ASSOC, V259, P225, DOI 10.1001/jama.259.2.225; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Pickering TG, 2008, J CARDIOVASC NURS, V23, P299, DOI 10.1097/01.JCN.0000317429.98844.04; Pickering TG, 2006, NEW ENGL J MED, V354, P2368, DOI 10.1056/NEJMra060433; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Pickering TG, 2008, J CLIN HYPERTENS, V10, P850, DOI 10.1111/j.1751-7176.2008.00043.x; Pickering TG, 2008, NAT CLIN PRACT CARD, V5, P762, DOI 10.1038/ncpcardio1374; Pickering TG, 2008, J HYPERTENS, V26, P2259, DOI 10.1097/HJH.0b013e32831313c4; Pierdomenico SD, 2011, AM J HYPERTENS, V24, P52, DOI 10.1038/ajh.2010.203; Piper MA, 2015, ANN INTERN MED, V162, P192, DOI 10.7326/M14-1539; Sega R, 2005, CIRCULATION, V111, P1777, DOI 10.1161/01.CIR.0000160923.04524.5B; SOKOLOW M, 1966, CIRCULATION, V34, P279; Staessen JA, 2004, JAMA-J AM MED ASSOC, V291, P955, DOI 10.1001/jama.291.8.955; Staessen JA, 1997, JAMA-J AM MED ASSOC, V278, P1065, DOI 10.1001/jama.278.13.1065; Stergiou GS, 2014, HYPERTENS RES, V37, P565, DOI 10.1038/hr.2014.2; Stergiou GS, 2014, HYPERTENSION, V63, P675, DOI 10.1161/HYPERTENSIONAHA.113.02741; THIJS L, 1994, J HUM HYPERTENS, V8, P239; Tirabassi J, 2013, J CLIN HYPERTENS, V15, P224, DOI 10.1111/jch.12059; Tisler A, 2006, J HYPERTENS, V24, P1729, DOI 10.1097/01.hjh.0000242396.15097.f3; U. S. Preventive Services Task Force, 2014, REC STAT HY IN PRESS; Uhlig K, 2012, AHRQ PUBLICATION; Verberk WJ, 2005, J AM COLL CARDIOL, V46, P743, DOI 10.1016/j.jacc.2005.05.058; Verdecchia P, 2009, HYPERTENSION, V54, P188, DOI 10.1161/HYPERTENSIONAHA.108.122861; Viera AJ, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-59; Ward AM, 2012, J HYPERTENS, V30, P449, DOI 10.1097/HJH.0b013e32834e4aed; Weber MA, 2014, J HYPERTENS, V32, P3, DOI [10.1111/jch.12237, 10.1097/HJH.0000000000000065]; White WB, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-014-0556-6; White WB, 2014, J AM SOC HYPERTENS, V8, P939, DOI 10.1016/j.jash.2014.10.005	88	123	126	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 3	2015	163	9					691	+		10.7326/M15-1270	http://dx.doi.org/10.7326/M15-1270			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX3PF	26457954	Green Accepted			2022-12-28	WOS:000365610600006
J	Howe, JA; Wang, H; Fischmann, TO; Balibar, CJ; Xiao, L; Galgoci, AM; Malinverni, JC; Mayhood, T; Villafania, A; Nahvi, A; Murgolo, N; Barbieri, CM; Mann, PA; Carr, D; Xia, E; Zuck, P; Riley, D; Painter, RE; Walker, SS; Sherborne, B; de Jesus, R; Pan, WD; Plotkin, MA; Wu, J; Rindgen, D; Cummings, J; Garlisi, CG; Zhang, RM; Sheth, PR; Gill, CJ; Tang, HF; Roemer, T				Howe, John A.; Wang, Hao; Fischmann, Thierry O.; Balibar, Carl J.; Xiao, Li; Galgoci, Andrew M.; Malinverni, Juliana C.; Mayhood, Todd; Villafania, Artjohn; Nahvi, Ali; Murgolo, Nicholas; Barbieri, Christopher M.; Mann, Paul A.; Carr, Donna; Xia, Ellen; Zuck, Paul; Riley, Dan; Painter, Ronald E.; Walker, Scott S.; Sherborne, Brad; de Jesus, Reynalda; Pan, Weidong; Plotkin, Michael A.; Wu, Jin; Rindgen, Diane; Cummings, John; Garlisi, Charles G.; Zhang, Rumin; Sheth, Payal R.; Gill, Charles J.; Tang, Haifeng; Roemer, Terry			Selective small-molecule inhibition of an RNA structural element	NATURE			English	Article							FLAVIN MONONUCLEOTIDE RIBOSWITCH; ANTIBACTERIAL DRUG TARGETS; RIBOFLAVIN BIOSYNTHESIS; STREPTOMYCES-DAVAWENSIS; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; GENE-EXPRESSION; ANTIBIOTIC ROSEOFLAVIN; FMN RIBOSWITCH; TRANSCRIPTION	Riboswitches are non-coding RNA structures located in messenger RNAs that bind endogenous ligands, such as a specific metabolite or ion, to regulate gene expression. As such, riboswitches serve as a novel, yet largely unexploited, class of emerging drug targets. Demonstrating this potential, however, has proven difficult and is restricted to structurally similar antimetabolites and semi-synthetic analogues of their cognate ligand, thus greatly restricting the chemical space and selectivity sought for such inhibitors. Here we report the discovery and characterization of ribocil, a highly selective chemical modulator of bacterial riboflavin riboswitches, which was identified in a phenotypic screen and acts as a structurally distinct synthetic mimic of the natural ligand, flavin mononucleotide, to repress riboswitch-mediated ribB gene expression and inhibit bacterial cell growth. Our findings indicate that non-coding RNA structural elements may be more broadly targeted by synthetic small molecules than previously expected.	[Howe, John A.; Wang, Hao; Fischmann, Thierry O.; Balibar, Carl J.; Xiao, Li; Galgoci, Andrew M.; Malinverni, Juliana C.; Mayhood, Todd; Villafania, Artjohn; Murgolo, Nicholas; Barbieri, Christopher M.; Mann, Paul A.; Carr, Donna; Xia, Ellen; Painter, Ronald E.; Walker, Scott S.; Sherborne, Brad; de Jesus, Reynalda; Pan, Weidong; Plotkin, Michael A.; Wu, Jin; Rindgen, Diane; Cummings, John; Garlisi, Charles G.; Zhang, Rumin; Sheth, Payal R.; Gill, Charles J.; Tang, Haifeng; Roemer, Terry] Merck Res Labs, Kenilworth, NJ 07033 USA; [Nahvi, Ali] Merck Res Labs, West Point, PA 19486 USA; [Zuck, Paul; Riley, Dan] Merck Res Labs, N Wales, PA 19454 USA	Merck & Company; Merck & Company; Merck & Company	Roemer, T (corresponding author), Merck Res Labs, Kenilworth, NJ 07033 USA.	terry_roemer@merck.com		Barbieri, Christopher/0000-0002-3266-0201; Fischmann, Thierry/0000-0003-3406-3061; Zhang, Rumin/0000-0002-6590-6036				Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Blount KF, 2006, NAT BIOTECHNOL, V24, P1558, DOI 10.1038/nbt1268; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Eberhardt S, 1996, EUR J BIOCHEM, V242, P712, DOI 10.1111/j.1432-1033.1996.0712r.x; Gelfand MS, 1999, TRENDS GENET, V15, P439, DOI 10.1016/S0168-9525(99)01856-9; Guan LR, 2012, ACS CHEM BIOL, V7, P73, DOI 10.1021/cb200447r; KIL YV, 1992, MOL GEN GENET, V233, P483, DOI 10.1007/BF00265448; Kodali S, 2005, J BIOL CHEM, V280, P1669, DOI 10.1074/jbc.M406848200; Langer S, 2013, J BACTERIOL, V195, P4037, DOI 10.1128/JB.00646-13; Langer S, 2013, BIOCHEMISTRY-US, V52, P4288, DOI 10.1021/bi400348d; Lee ER, 2009, RNA BIOL, V6, P187, DOI 10.4161/rna.6.2.7727; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; Lunse CE, 2014, INT J MED MICROBIOL, V304, P79, DOI 10.1016/j.ijmm.2013.09.002; Mack M, 1998, J BACTERIOL, V180, P950, DOI 10.1128/JB.180.4.950-955.1998; Matzner D, 2015, J MED CHEM, V58, P3275, DOI 10.1021/jm500868e; Mellin JR, 2015, TRENDS GENET, V31, P150, DOI 10.1016/j.tig.2015.01.005; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; Moffat JG, 2014, NAT REV DRUG DISCOV, V13, P588, DOI 10.1038/nrd4366; Mulhbacher J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000865; OTANI S, 1974, J ANTIBIOT, V27, P88, DOI 10.7164/antibiotics.27.88; Ott E, 2009, RNA BIOL, V6, P276, DOI 10.4161/rna.6.3.8342; Pedrolli D, 2015, FEBS J, V282, P3230, DOI 10.1111/febs.13226; Pedrolli DB, 2011, BIOCHEM PHARMACOL, V82, P1853, DOI 10.1016/j.bcp.2011.08.029; Pedrolli DB, 2013, CURR PHARM DESIGN, V19, P2552; Pedrolli DB, 2012, NUCLEIC ACIDS RES, V40, P8662, DOI 10.1093/nar/gks616; Rode AB, 2015, ANGEW CHEM INT EDIT, V54, P905, DOI 10.1002/anie.201407385; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Serganov A, 2009, NATURE, V458, P233, DOI 10.1038/nature07642; Sudarsan N, 2005, CHEM BIOL, V12, P1325, DOI 10.1016/j.chembiol.2005.10.007; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Swoboda JG, 2009, ACS CHEM BIOL, V4, P875, DOI 10.1021/cb900151k; Vitreschak AG, 2002, NUCLEIC ACIDS RES, V30, P3141, DOI 10.1093/nar/gkf433; Walsh C., 2003, ANTIBIOTICS ACTIONS; Wang H, 2013, CHEM BIOL, V20, P272, DOI 10.1016/j.chembiol.2012.11.013; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zlitni S, 2013, NAT CHEM BIOL, V9, P796, DOI [10.1038/nchembio.1361, 10.1038/NCHEMBIO.1361]	41	229	233	7	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					672	677		10.1038/nature15542	http://dx.doi.org/10.1038/nature15542			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26416753				2022-12-28	WOS:000363832100042
J	Raap, U; Werfel, T				Raap, Ulrike; Werfel, Thomas			Bullous Pemphigoid	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Raap, Ulrike; Werfel, Thomas] Hannover Med Sch, Hannover, Germany	Hannover Medical School	Raap, U (corresponding author), Hannover Med Sch, Hannover, Germany.	raap.ulrike@mh-hannover.de	Werfel, Thomas/B-6921-2012						0	5	5	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2015	373	17					1659	1659		10.1056/NEJMicm1500430	http://dx.doi.org/10.1056/NEJMicm1500430			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU1YH	26488696				2022-12-28	WOS:000363317800011
J	Robinson, A				Robinson, Andrew			Cracking the Indus script	NATURE			English	Editorial Material												andrew.robinson33@virgin.net						FAIRSERVIS WA, 1983, SCI AM, V248, P58, DOI 10.1038/scientificamerican0383-58; Farmer S., 2004, ELECT J VEDIC STUDIE, V11, P19, DOI DOI 10.11588/EJVS.2004.2.620; Lawler A, 2004, SCIENCE, V306, P2026, DOI 10.1126/science.306.5704.2026; Parpola A, 2010, SUOM TIEDEAKAT TOIM, V359, P1; Parpola A., 1987, CORPUS INDUS SEALS I, V1-3.1; Parpola A., 1991, CORPUS INDUS SEALS I, V1-3.1; Parpola A. H. S., 1994, DECIPHERING INDUS SC; Rao RPN, 2009, SCIENCE, V324, P1165, DOI 10.1126/science.1170391; Rao S. R., 1982, DECIPHERMENT INDUS S; Sproat R, 2014, LANGUAGE, V90, P457, DOI 10.1353/lan.2014.0031; Wells BK., 2015, ARCHAEOLOGY EPIGRAPH, DOI 10.2307/j.ctvr43jmf; Wheeler M., 1968, INDUS CIVILIZATION, P101	12	5	5	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					499	501		10.1038/526499a	http://dx.doi.org/10.1038/526499a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26490603	Bronze			2022-12-28	WOS:000364026100023
J	Rochmyaningsih, D				Rochmyaningsih, Dyna			Indigenous peoples must benefit from science	NATURE			English	Editorial Material												drochmya87@gmail.com							0	2	2	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					477	477		10.1038/526477a	http://dx.doi.org/10.1038/526477a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV1NX	26490580	Bronze			2022-12-28	WOS:000364026100011
J	Schulman, KA; Balu, S; Reed, SD				Schulman, Kevin A.; Balu, Suresh; Reed, Shelby D.			Specialty Pharmaceuticals for Hyperlipidemia - Impact on Insurance Premiums	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DRUGS		[Schulman, Kevin A.; Reed, Shelby D.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27708 USA; [Balu, Suresh] Duke Univ, Sch Med, Duke Inst Hlth Innovat, Durham, NC USA; [Schulman, Kevin A.; Reed, Shelby D.] Duke Univ, Sch Med, Duke Translat Med Inst, Durham, NC USA; [Schulman, Kevin A.; Reed, Shelby D.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA	Duke University; Duke University; Duke University; Duke University	Schulman, KA (corresponding author), Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27708 USA.							Food and Drug Administration, PRAL AL PRESCR INF; Hirsch BR, 2014, HEALTH AFFAIR, V33, P1714, DOI 10.1377/hlthaff.2014.0558; Kuklina E. V., 2013, TRENDS HIGH LDL CHOL, P7; Lotvin AM, 2014, HEALTH AFFAIR, V33, P1736, DOI 10.1377/hlthaff.2014.0511; Valverde AM, 2012, HEALTH AFFAIR, V31, P2528, DOI 10.1377/hlthaff.2012.0235	5	28	28	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2015	373	17					1591	1593		10.1056/NEJMp1509863	http://dx.doi.org/10.1056/NEJMp1509863			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CU1YH	26444460				2022-12-28	WOS:000363317800003
J	Maybury, CM; Pink, A; Lewis, F				Maybury, Catriona M.; Pink, Andrew; Lewis, Fiona			CASE REVIEW A persistent vulval ulcer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NICORANDIL; ULCERATIONS		[Maybury, Catriona M.; Lewis, Fiona] Guys & St Thomas NHS Fdn Trust, St Johns Inst Dermatol, London, England; [Maybury, Catriona M.; Lewis, Fiona] Kings Coll London, London WC2R 2LS, England; [Pink, Andrew] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; University of London; King's College London	Maybury, CM (corresponding author), Guys & St Thomas NHS Fdn Trust, St Johns Inst Dermatol, London, England.	Catriona.maybury@kcl.ac.uk		Pink, Andrew/0000-0001-5151-5539	National Institute for Health Research [CL-2014-17-002] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Chhabra S, 2014, J OBSTET GYNAECOL, V34, P165, DOI 10.3109/01443615.2013.834310; Claeys A, 2006, BRIT J DERMATOL, V155, P494, DOI 10.1111/j.1365-2133.2006.07363.x; Edwards SK, 2015, INT J STD AIDS, V26, P611, DOI 10.1177/0956462414554271; Egred M, 2007, EUR J GASTROEN HEPAT, V19, P395, DOI 10.1097/MEG.0b013e328010b184; El-Dars LD, 2009, J OBSTET GYNAECOL, V29, P674, DOI 10.1080/01443610903104486; Fraser SJ, 2009, BJOG-INT J OBSTET GY, V116, P1400, DOI 10.1111/j.1471-0528.2009.02260.x; Goldsmith L, 2012, FITZPATRICKS DERMATO, V1; Healy CM, 2004, HEART, V90, DOI 10.1136/hrt.2003.031831; Hoang MP, 2014, AM J DERMATOPATH, V36, P689, DOI 10.1097/DAD.0000000000000149; Lee BC, 2011, DIGEST DIS SCI, V56, P2404, DOI 10.1007/s10620-011-1634-x; Lewis FM, 2005, CLIN OBSTET GYNECOL, V48, P824, DOI 10.1097/01.grf.0000179669.21811.8f; Malik R, 2005, BRIT J DERMATOL, V152, P809, DOI 10.1111/j.1365-2133.2005.06501.x; McKenna DJ, 2007, BRIT J DERMATOL, V156, P394, DOI 10.1111/j.1365-2133.2006.07643.x; Oyama N, 2003, LANCET, V362, P118, DOI 10.1016/S0140-6736(03)13863-9; Reichert S, 1997, EUR J DERMATOL, V7, P132; Spencer RJ, 2011, MENOPAUSE, V18, P1067, DOI 10.1097/gme.0b013e3182175a68; Trechot P, 2015, INT WOUND J, V12, P527, DOI 10.1111/iwj.12147; Watson A, 2002, LANCET, V360, P546, DOI 10.1016/S0140-6736(02)09710-6	18	0	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 16	2015	351								h5421	10.1136/bmj.h5421	http://dx.doi.org/10.1136/bmj.h5421			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT8YC	26475594				2022-12-28	WOS:000363101800001
J	MacKay, DJC; Cramton, P; Ockentels, A; Stoft, S				MacKay, David J. C.; Cramton, Peter; Ockentels, Axel; Stoft, Steven			Price carbon - I will if you will	NATURE			English	Editorial Material									[MacKay, David J. C.] Univ Cambridge, Engn, Cambridge CB2 1TN, England; [Cramton, Peter] Univ Maryland, Econ, College Pk, MD 20742 USA; [Ockentels, Axel] Univ Cologne, Econ, Cologne, Germany	University of Cambridge; University System of Maryland; University of Maryland College Park; University of Cologne	MacKay, DJC (corresponding author), Univ Cambridge, Engn, Cambridge CB2 1TN, England.	steven@stoft.com	Cramton, Peter/ABG-7651-2021	Cramton, Peter/0000-0001-8621-1092				Ad Hoc Working Group on the Durban Platform, 2014, PARTIES VIEWS AND PR; Bovenberg AL, 1999, INT TAX PUBLIC FINAN, V6, P421, DOI 10.1023/A:1008715920337; Cramton P, 2015, ECON ENERGY ENV POL, V4, P1; Cramton P, 2012, ECON ENERGY ENV POL, V1, P125, DOI 10.5547/2160-5890.1.2.9; Depledge J., 2000, ORIGINS KYOTO PROTOC; Kraft-Todd G, 2015, CURR OPIN BEHAV SCI, V3, P96, DOI 10.1016/j.cobeha.2015.02.006; Ledyard JO, 1995, HDB EXPT EC, P111, DOI DOI 10.3987/CONTENTS-12-85-7; Ostrom E., 1990, GOVERNING COMMONS EV; Stiglitz Joseph, 2006, MAKING GLOBALIZATION	9	25	25	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					315	316		10.1038/526315a	http://dx.doi.org/10.1038/526315a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT3TQ	26469025	Bronze, Green Accepted			2022-12-28	WOS:000362730200016
J	Samanta, J; Grund, EM; Silva, HM; Lafaille, JJ; Fishell, G; Salzer, JL				Samanta, Jayshree; Grund, Ethan M.; Silva, Hernandez M.; Lafaille, Juan J.; Fishell, Gord; Salzer, James L.			Inhibition of Gli1 mobilizes endogenous neural stem cells for remyelination	NATURE			English	Article							SONIC HEDGEHOG; MULTIPLE-SCLEROSIS; SUBVENTRICULAR ZONE; DISCRETE POPULATIONS; PRECURSOR CELLS; SPINAL-CORD; CNS; DEMYELINATION; PROGENITORS; MYELIN	Enhancing repair of myelin is an important but still elusive therapeutic goal in many neurological disorders(1). In multiple sclerosis, an inflammatory demyelinating disease, endogenous remyelination does occur but is frequently insufficient to restore function. Both parenchymal oligodendrocyte progenitor cells and endogenous adult neural stem cells resident within the subventricular zone are known sources of remyelinating cells(2). Here we characterize the contribution to remyelination of a subset of adult neural stem cells, identified by their expression of Gli1, a transcriptional effector of the sonic hedgehog pathway. We show that these cells are recruited from the subventricular zone to populate demyelinated lesions in the forebrain but never enter healthy, white matter tracts. Unexpectedly, recruitment of this pool of neural stem cells, and their differentiation into oligodendrocytes, is significantly enhanced by genetic or pharmacological inhibition of Gli1. Importantly, complete inhibition of canonical hedgehog signalling was ineffective, indicating that the role of Gli1 both in augmenting hedgehog signalling and in retarding myelination is specialized. Indeed, inhibition of Gli1 improves the functional outcome in a relapsing/remitting model of experimental autoimmune encephalomyelitis and is neuroprotective. Thus, endogenous neural stem cells can be mobilized for the repair of demyelinated lesions by inhibiting Gli1, identifying a new therapeutic avenue for the treatment of demyelinating disorders.	[Samanta, Jayshree; Grund, Ethan M.; Fishell, Gord; Salzer, James L.] NYU, Sch Med, Dept Neurosci & Physiol, Inst Neurosci, New York, NY 10016 USA; [Silva, Hernandez M.; Lafaille, Juan J.] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA	New York University; New York University	Samanta, J (corresponding author), NYU, Sch Med, Dept Neurosci & Physiol, Inst Neurosci, New York, NY 10016 USA.	jayshree.samanta@nyumc.org; james.salzer@nyumc.org	Samanta, Jayshree/AAH-7807-2020	Samanta, Jayshree/0000-0003-1240-3395; Fishell, Gordon/0000-0002-9640-9278; Salzer, James/0000-0001-9126-7197	New York State Department of Health Stem Cell Board; National Multiple Sclerosis Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026001] Funding Source: NIH RePORTER	New York State Department of Health Stem Cell Board; National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Joyner for providing mouse lines and for advice during the course of this project, M. Bhat, M. Wegner, and M. Rasband for providing antibodies, G. Zanazzi for providing human brain tissue, A. Liang for assistance with immunoelectron microscopy, and G. Multani for technical assistance during initial studies. This research was supported by grants to J.L.S. from the New York State Department of Health Stem Cell Board and the National Multiple Sclerosis Society. J.S. was a recipient of a postdoctoral fellowship from the National Multiple Sclerosis Society.	Aharoni R, 2011, J AUTOIMMUN, V37, P228, DOI 10.1016/j.jaut.2011.06.003; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Bai CB, 2002, DEVELOPMENT, V129, P4753; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Bambakidis NC, 2012, VITAM HORM, V88, P379, DOI 10.1016/B978-0-12-394622-5.00017-1; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; ELSWORTH S, 1973, RES VET SCI, V14, P385, DOI 10.1016/S0034-5288(18)33893-1; Ferent J, 2013, J NEUROSCI, V33, P1759, DOI 10.1523/JNEUROSCI.3334-12.2013; Franklin RJM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020594; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Garcia ADR, 2010, J NEUROSCI, V30, P13597, DOI 10.1523/JNEUROSCI.0830-10.2010; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Glausier JR, 2009, CEREB CORTEX, V19, P1820, DOI 10.1093/cercor/bhn212; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Nait-Oumesmar B, 2007, P NATL ACAD SCI USA, V104, P4694, DOI 10.1073/pnas.0606835104; Petrova R, 2014, DEVELOPMENT, V141, P3445, DOI 10.1242/dev.083691; Powers BE, 2013, P NATL ACAD SCI USA, V110, P4075, DOI 10.1073/pnas.1210293110; Recks MS, 2013, CLIN IMMUNOL, V149, P32, DOI 10.1016/j.clim.2013.06.004; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; TUOHY VK, 1988, J IMMUNOL, V140, P1868; Wujek JR, 2002, J NEUROPATH EXP NEUR, V61, P23, DOI 10.1093/jnen/61.1.23; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Xing YL, 2014, J NEUROSCI, V34, P14128, DOI 10.1523/JNEUROSCI.3491-13.2014; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	32	99	101	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					448	+		10.1038/nature14957	http://dx.doi.org/10.1038/nature14957			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26416758	Green Accepted			2022-12-28	WOS:000362730200055
J	Chen, ZM; Peto, R; Zhou, MG; Iona, A; Smith, M; Yang, L; Guo, Y; Chen, YP; Bian, Z; Lancaster, G; Sherliker, P; Pang, ST; Wang, H; Su, H; Wu, M; Wu, XP; Chen, JS; Collins, R; Li, LM				Chen, Zhengming; Peto, Richard; Zhou, Maigeng; Iona, Andri; Smith, Margaret; Yang, Ling; Guo, Yu; Chen, Yiping; Bian, Zheng; Lancaster, Garry; Sherliker, Paul; Pang, Shutao; Wang, Hao; Su, Hua; Wu, Ming; Wu, Xianping; Chen, Junshi; Collins, Rory; Li, Liming		China Kadoorie Biobank CKB Collabo	Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies	LANCET			English	Article							CIGARETTE-SMOKING; PREVALENCE; HAZARDS; DISEASE; HEALTH; METAANALYSIS; KADOORIE; DEATHS; RISK	Background Chinese men now smoke more than a third of the world's cigarettes, following a large increase in urban then rural usage. Conversely, Chinese women now smoke far less than in previous generations. We assess the oppositely changing effects of tobacco on male and female mortality. Methods Two nationwide prospective studies 15 years apart recruited 220 000 men in about 1991 at ages 40-79 years (first study) and 210 000 men and 300 000 women in about 2006 at ages 35-74 years (second study), with follow-up during 1991-99 (mid-year 1995) and 2006-14 (mid-year 2010), respectively. Cox regression yielded sex-specific adjusted mortality rate ratios (RRs) comparing smokers (including any who had stopped because of illness, but not the other ex-smokers, who are described as having stopped by choice) versus never-smokers. Findings Two-thirds of the men smoked; there was little dependence of male smoking prevalence on age, but many smokers had not smoked cigarettes throughout adult life. Comparing men born before and since 1950, in the older generation, the age at which smoking had started was later and, particularly in rural areas, lifelong exclusive cigarette use was less common than in the younger generation. Comparing male mortality RRs in the first study (mid-year 1995) versus those in the second study (mid-year 2010), the proportional excess risk among smokers (RR-1) approximately doubled over this 15-year period (urban: RR 1.32 [95% CI 1.24-1.41] vs 1.65 [1.53-1.79]; rural: RR 1.13 [1.09-1.17] vs 1.22 [1.16-1.29]), as did the smoking-attributed fraction of deaths at ages 40-79 years (urban: 17% vs 26%; rural: 9% vs 14%). In the second study, urban male smokers who had started before age 20 years (which is now typical among both urban and rural young men) had twice the never-smoker mortality rate (RR 1.98, 1.79-2.19, approaching Western RRs), with substantial excess mortality from chronic obstructive pulmonary disease (COPD RR 9.09, 5.11-16.15), lung cancer (RR 3.78, 2.78-5.14), and ischaemic stroke or ischaemic heart disease (combined RR 2.03, 1.66-2.47). Ex-smokers who had stopped by choice (only 3% of ever-smokers in 1991, but 9% in 2006) had little smoking-attributed risk more than 10 years after stopping. Among Chinese women, however, there has been a tenfold intergenerational reduction in smoking uptake rates. In the second study, among women born in the 1930s, 1940s, 1950s, and since 1960 the proportions who had smoked were, respectively, 10%, 5%, 2%, and 1% (3097/30 943, 3265/62 246, 2339/97 344, and 1068/111 933). The smoker versus non-smoker RR of 1.51 (1.40-1.63) for all female mortality at ages 40-79 years accounted for 5%, 3%, 1%, and <1%, respectively, of all the female deaths in these four successive birth cohorts. In 2010, smoking caused about 1 million (840 000 male, 130 000 female) deaths in China. Interpretation Smoking will cause about 20% of all adult male deaths in China during the 2010s. The tobacco-attributed proportion is increasing in men, but low, and decreasing, in women. Although overall adult mortality rates are falling, as the adult population of China grows and the proportion of male deaths due to smoking increases, the annual number of deaths in China that are caused by tobacco will rise from about 1 million in 2010 to 2 million in 2030 and 3 million in 2050, unless there is widespread cessation.	[Chen, Zhengming; Peto, Richard; Iona, Andri; Smith, Margaret; Yang, Ling; Chen, Yiping; Lancaster, Garry; Sherliker, Paul; Collins, Rory] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England; [Chen, Zhengming; Peto, Richard; Iona, Andri; Smith, Margaret; Yang, Ling; Chen, Yiping; Lancaster, Garry; Sherliker, Paul; Collins, Rory] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit CTSU, Oxford, England; [Zhou, Maigeng] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Guo, Yu; Bian, Zheng; Li, Liming] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Pang, Shutao] Qingdao CDC, Qingdao, Peoples R China; [Wang, Hao] Zhejiang Prov CDC, Hangzhou, Zhejiang, Peoples R China; [Su, Hua] Heilongjiang Prov CDC, Harbin, Peoples R China; [Wu, Ming] Jiangsu Prov CDC, Nanjing, Jiangsu, Peoples R China; [Wu, Xianping] Sichuan Prov CDC, Chengdu, Peoples R China; [Chen, Junshi] Natl Ctr Food Safety Risk Assessment, Beijing, Peoples R China; [Li, Liming] Peking Univ, Sch Publ Hlth, Beijing 100191, Peoples R China	University of Oxford; University of Oxford; Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking University	Chen, ZM (corresponding author), CTSU, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England.	zhengming.chen@ctsu.ox.ac.uk; lmlee@vip.163.com	Walters, Robin G/E-6069-2010; Collins, Rory/ABA-8487-2020; Zhou, Maigeng/HCH-7703-2022	Walters, Robin G/0000-0002-9179-0321; Smith, Margaret/0000-0002-0946-742X; Du, Huaidong/0000-0002-9814-0049; Chen, Zhengming/0000-0001-6423-105X	Wellcome Trust [088158/Z/09/Z, 104085/Z/14/Z]; MRC; BHF; CR-UK; Kadoorie Charitable Foundation; Chinese MoST; NSFC; Cancer Research UK; UK Medical Research Council; British Heart Foundation; World Bank; Canadian International Development Research Centre; CTSU; Chinese Ministry of Science and Technology [2011BAI09B01]; National Natural Science Foundation of China [81390541]; MRC (Newton Fund) [MCPC13049]; MRC [MC_U137686851, MC_U137686859] Funding Source: UKRI; Medical Research Council [MC_U137686851, MC_U137686859] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BHF(British Heart Foundation); CR-UK(Cancer Research UK); Kadoorie Charitable Foundation; Chinese MoST(Ministry of Science and Technology, China); NSFC(National Natural Science Foundation of China (NSFC)); Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); World Bank(The World Bank India); Canadian International Development Research Centre; CTSU; Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MRC (Newton Fund)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Wellcome Trust, MRC, BHF, CR-UK, Kadoorie Charitable Foundation, Chinese MoST and NSFC; The chief acknowledgment is to the participants, the project staff, the China National Centre for Disease Control and Prevention, and its regional offices. The two prospective studies already span 25 years, throughout which Cancer Research UK, the UK Medical Research Council, and the British Heart Foundation core-funded the Oxford CTSU. The first study's baseline survey was funded by the World Bank and Canadian International Development Research Centre, with long-term continuation funded by the CTSU and organised by Gonghuang Yang; fuller acknowledgments have been published. 16 The second study's baseline survey was funded by the Kadoorie Charitable Foundation, with blood storage through the core-funded CTSU Wolfson Laboratories (director Mike Hill) and Fu Wai China National Cardiovascular Centre, with long-term continuation funded by the CTSU, Wellcome Trust (088158/Z/09/Z, 104085/Z/14/Z), MRC (Newton Fund MCPC13049), Chinese Ministry of Science and Technology (2011BAI09B01), and National Natural Science Foundation of China (81390541); the Chinese National Health Insurance scheme provides linkage to all hospital admission data.	[Anonymous], HLTH CONS SMOK REP S; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; Chen ZM, 1997, JAMA-J AM MED ASSOC, V278, P1500, DOI 10.1001/jama.278.18.1500; Chen ZM, 2005, INT J EPIDEMIOL, V34, P1243, DOI 10.1093/ije/dyi174; Chinese Ministry of Health, 2011, CHIN STAT YB HLTH; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Gu DF, 2009, NEW ENGL J MED, V360, P150, DOI 10.1056/NEJMsa0802902; Han J, 2015, INT J ENV RES PUB HE, V12, P4617, DOI 10.3390/ijerph120504617; Huang X., 2006, CHINA TOBACCO HIST; Huxley RR, 2011, LANCET, V378, P1297, DOI 10.1016/S0140-6736(11)60781-2; Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Lam TH, 1997, JAMA-J AM MED ASSOC, V278, P1505, DOI 10.1001/jama.278.18.1505; Lam TH, 2001, BRIT MED J, V323, P361, DOI 10.1136/bmj.323.7309.361; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; Niu SR, 1998, BRIT MED J, V317, P1423, DOI 10.1136/bmj.317.7170.1423; Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9; Peto R, 1999, NAT MED, V5, P15, DOI 10.1038/4691; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Thun MJ, 2013, NEW ENGL J MED, V368, P351, DOI 10.1056/NEJMsa1211127; UN Population Devision, 2012, WORLD POP PROSP 2012; Wang JB, 2010, CANCER CAUSE CONTROL, V21, P959, DOI 10.1007/s10552-010-9523-8; WENG XZ, 1987, CHINESE MED J-PEKING, V100, P886; World Health Organization, 2012, WHO GLOB REP MORT AT; Yang G H, 1997, Biomed Environ Sci, V10, P1; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; Yang GH, 2014, TOB CONTROL, V23, P167, DOI 10.1136/tobaccocontrol-2012-050691; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yuan JM, 1996, JAMA-J AM MED ASSOC, V275, P1646, DOI 10.1001/jama.275.21.1646; Zhang Mei, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P404; Zhang QL, 2013, INT J EPIDEMIOL, V42, P1464, DOI 10.1093/ije/dyt158; Zheng W, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001631	35	238	291	7	77	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2015	386	10002					1447	1456		10.1016/S0140-6736(15)00340-2	http://dx.doi.org/10.1016/S0140-6736(15)00340-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5UU	26466050	Green Published, hybrid			2022-12-28	WOS:000362877300027
J	Meng, QY; Fang, H; Liu, XY; Yuan, BB; Xu, J				Meng, Qingyue; Fang, Hai; Liu, Xiaoyun; Yuan, Beibei; Xu, Jin			Consolidating the social health insurance schemes in China: towards an equitable and efficient health system	LANCET			English	Review							COOPERATIVE MEDICAL SCHEME; UNIVERSAL COVERAGE; SOUTH-KOREA; CARE; LESSONS; TAIWAN; COUNTRIES; AFRICA; POOR	Fragmentation in social health insurance schemes is an important factor for inequitable access to health care and financial protection for people covered by different health insurance schemes in China. To fulfil its commitment of universal health coverage by 2020, the Chinese Government needs to prioritise addressing this issue. After analysing the situation of fragmentation, this Review summarises efforts to consolidate health insurance schemes both in China and internationally. Rural migrants, elderly people, and those with non-communicable diseases in China will greatly benefit from consolidation of the existing health insurance schemes with extended funding pools, thereby narrowing the disparities among health insurance schemes in fund level and benefit package. Political commitments, institutional innovations, and a feasible implementation plan are the major elements needed for success in consolidation. Achievement of universal health coverage in China needs systemic strategies including consolidation of the social health insurance schemes.	[Meng, Qingyue; Fang, Hai; Liu, Xiaoyun; Yuan, Beibei; Xu, Jin] Peking Univ, China Ctr Hlth Dev Studies, Beijing 100191, Peoples R China	Peking University	Meng, QY (corresponding author), Peking Univ, China Ctr Hlth Dev Studies, Beijing 100191, Peoples R China.	qmeng@bjmu.edu.cn						[Anonymous], 2012, S CHIN J EC; Atun R, 2015, LANCET, V385, P1230, DOI 10.1016/S0140-6736(14)61646-9; Atun R, 2013, LANCET, V382, P65, DOI 10.1016/S0140-6736(13)61051-X; Babiarz KS, 2012, HEALTH AFFAIR, V31, P1065, DOI 10.1377/hlthaff.2010.1311; Busse R, 2014, HEALTH SYSTEMS IN TR, V16, P1; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Cheng TM, 2015, HEALTH AFFAIR, V34, P502, DOI 10.1377/hlthaff.2014.1332; Chiang TL, 1997, HEALTH POLICY, V39, P225, DOI 10.1016/S0168-8510(96)00877-9; Chinese Communist Party Committee and State Council, 2009, 6 CHIN COMM PART COM; Fang X, 2008, THESIS XINJIANG MED; Feng XL, 2014, B WORLD HEALTH ORGAN, V92, P29, DOI 10.2471/BLT.13.124495; Fu R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108571; Hu D., 2014, CHINA HLTH INSUR CHI, V5, P32; Hu H., 2009, THESIS SHANGHAI JIAO; Hughes D, 2007, HEALTH AFFAIR, V26, P999, DOI 10.1377/hlthaff.26.4.999; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Kwon S, 2009, HEALTH POLICY PLANN, V24, P63, DOI 10.1093/heapol/czn037; Lagomarsino G, 2012, LANCET, V380, P933, DOI 10.1016/S0140-6736(12)61147-7; Lee SY, 2008, HEALTH POLICY, V85, P105, DOI 10.1016/j.healthpol.2007.07.006; Levy H, 2008, ANNU REV PUBL HEALTH, V29, P399, DOI 10.1146/annurev.publhealth.28.021406.144042; Li C, 2013, THESIS LIAONING U; Li J, 2012, THESIS NANJING AGR U; Liang L., 2013, LONG MARCH UNIVERSAL; Limwattananon S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-S1-S6; Lin WC, 2009, HEALTH ECON, V18, pS83, DOI 10.1002/hec.1500; Liu BX, 2014, INT J MED SCI, V11, P905, DOI 10.7150/ijms.8877; Liu C, 2012, THESIS PEKING UNION; Liu K, 2014, SOC SCI MED, V113, P95, DOI 10.1016/j.socscimed.2014.05.011; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Lu JFR, 2011, HEALTH ECON POLICY L, V6, P85, DOI 10.1017/S1744133109990351; McIntyre D, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-36; McIntyre D, 2008, B WORLD HEALTH ORGAN, V86, P871, DOI 10.2471/BLT.08.053413; Meng QY, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001694; Meng QY, 2014, B WORLD HEALTH ORGAN, V92, P447, DOI 10.2471/BLT.13.131532; Ministry of Health, 2012, CHIN HLTH STAT YB 20; National Bureau of Statistics of China, 2014, NAT DAT; [National Health and Family Planning Commission China National Health Development Research Centre], 2015, CHIN NAT HLTH ACC 20; Pan J., 2013, EC RES J, V4, P130; Pan J, 2016, HEALTH ECON, V25, P1389, DOI 10.1002/hec.3225; Pei C, 2014, CHINA HLTH INSUR, V5, P35; Qiu PY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-520; Shibuya K, 2011, LANCET, V378, P1265, DOI 10.1016/S0140-6736(11)61098-2; State Council, 2013, WORK PLAN I GOV REF; Sun XY, 2010, HEALTH POLICY PLANN, V25, P419, DOI 10.1093/heapol/czq010; Sun Y, 2007, THESIS SHANXI MED U; Tangcharoensathien V, 2011, LANCET, V377, P863, DOI 10.1016/S0140-6736(10)61890-9; Wagstaff A, 2009, J HEALTH ECON, V28, P1, DOI 10.1016/j.jhealeco.2008.10.007; Wu L, 2010, INSUR STUD, V6, P60; Xie E., 2009, EC RES J, V44, P92, DOI DOI 10.1007/s11459-011-0125-5; [谢敬敏 XIE Jingmin], 2011, [中国药房, China Pharmacy], V22, P1443; Xu W, 2011, THESIS NANJING AGR U; Yang C., 2014, CHINA HLTH INSUR, V5, P16; Yang W, 2015, HEALTH POLICY PLANN, V30, P187, DOI 10.1093/heapol/czt111; Yang X, 2010, THESIS HUAZHONG U SC; You XD, 2009, HEALTH POLICY, V91, P1, DOI 10.1016/j.healthpol.2008.11.012; Yuan X, 2014, CHINA HLTH INSUR, V5, P26; Zhang LY, 2010, TROP MED INT HEALTH, V15, P468, DOI 10.1111/j.1365-3156.2010.02469.x; Zheng G., 2014, CHINA HLTH INSUR, V2, P8; Zhuang H, 2014, CHINA HLTH INSUR, V5, P29; Zuo Y-L, 2008, CHINESE J HOSP ADM, V24, P190	60	294	299	49	251	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2015	386	10002					1484	1492		10.1016/S0140-6736(15)00342-6	http://dx.doi.org/10.1016/S0140-6736(15)00342-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CT5UU	26466052				2022-12-28	WOS:000362877300031
J	Davis, RL				Davis, Ronald L.			SnapShot: Olfactory Classical Conditioning of Drosophila	CELL			English	Editorial Material							MEMORY	This SnapShot summarizes current knowledge about the molecules and circuitry that mediate olfactory memory formation in Drosophila, with emphasis on neural circuits carrying the learned sensory information; the molecular mechanisms for acquisition, memory storage, and forgetting; and the output pathways for memory expression. To view this SnapShot, open or download the PDF.	[Davis, Ronald L.] Scripps Res Inst Florida, Dept Neurosci, Jupiter, FL 33458 USA	Scripps Research Institute	Davis, RL (corresponding author), Scripps Res Inst Florida, Dept Neurosci, Jupiter, FL 33458 USA.		Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608	 [R37NS19904-32];  [5R01NS052351-09]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052351, R37NS019904, R01NS019904] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Dr. J. Berry produced some of the original artwork for a prior publication. The artwork has been modified and reproduced with permission from Berry and Davis (Progress in Brain Research 208, 293-304) and Davis (Neuron 70, 8-19). I thank S. Tomchik and J. Berry for comments. Research was supported by R37NS19904-32 and 5R01NS052351-09.	Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04580; Berry JA, 2015, CELL, V161, P1656, DOI 10.1016/j.cell.2015.05.027; Davis RL, 2011, NEURON, V70, P8, DOI 10.1016/j.neuron.2011.03.012; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Masse NY, 2009, CURR BIOL, V19, pR700, DOI 10.1016/j.cub.2009.06.026; Owald D, 2015, NEURON, V86, P417, DOI 10.1016/j.neuron.2015.03.025; Sejourne J, 2011, NAT NEUROSCI, V14, P903, DOI 10.1038/nn.2846; Shuai YC, 2010, CELL, V140, P579, DOI 10.1016/j.cell.2009.12.044; TOMCHIK SM, 2013, LEARN MEMORY, V22, P357; Waddell S, 2013, CURR OPIN NEUROBIOL, V23, P324, DOI 10.1016/j.conb.2013.01.005	10	6	6	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2							524.e1	10.1016/j.cell.2015.09.043	http://dx.doi.org/10.1016/j.cell.2015.09.043			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26451491	Bronze			2022-12-28	WOS:000362952700026
J	Mathew, R; Rashid, A				Mathew, Rammya; Rashid, Ahmed			CASE REVIEW Polymyalgia rheumatica in primary care: managing diagnostic uncertainty	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGEMENT		[Mathew, Rammya] UCL, Dept Primary Care & Populat Hlth, London, England; [Rashid, Ahmed] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England	University of London; University College London; University of Cambridge	Mathew, R (corresponding author), UCL, Dept Primary Care & Populat Hlth, London, England.	rammya.mathew@nhs.net						Bahlas S, 2000, CLIN RHEUMATOL, V19, P278, DOI 10.1007/s100670070045; Barraclough K, 2008, FAM PRACT, V25, P328, DOI 10.1093/fampra/cmn044; BOWNESS P, 1991, BRIT J RHEUMATOL, V30, P349; Cantini F, 2000, SEMIN ARTHRITIS RHEU, V30, P17, DOI 10.1053/sarh.2000.8366; Cantini F, 2004, SEMIN ARTHRITIS RHEU, V33, P294, DOI 10.1016/j.semarthrit.2003.09.008; Caylor TL, 2013, AM FAM PHYSICIAN, V88, P676; Dasgupta B, 2010, RHEUMATOLOGY, V49, P186, DOI 10.1093/rheumatology/kep303a; Hutchings A, 2007, ARTHRIT RHEUM-ARTHR, V57, P803, DOI 10.1002/art.22777; Mackie SL, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6937; National Institute for Health and Care Excellence, 2013, POL RHEUM CLIN KNOWL; Olivieri I, 2001, CURR OPIN RHEUMATOL, V13, P280, DOI 10.1097/00002281-200107000-00006; Salvarani C, 2002, NEW ENGL J MED, V347, P261, DOI 10.1056/NEJMra011913; Salvarani C, 2008, LANCET, V372, P234, DOI 10.1016/S0140-6736(08)61077-6	13	4	6	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 7	2015	351								h5199	10.1136/bmj.h5199	http://dx.doi.org/10.1136/bmj.h5199			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT3SJ	26446092				2022-12-28	WOS:000362726900002
J	Linnarsson, S				Linnarsson, Sten			A tree of the human brain	SCIENCE			English	Editorial Material									Karolinska Inst, Div Mol Neurobiol, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Karolinska Institutet	Linnarsson, S (corresponding author), Karolinska Inst, Div Mol Neurobiol, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	sten.linnarsson@ki.se	Linnarsson, Sten/HCH-3909-2022					Behjati S, 2014, NATURE, V513, P422, DOI 10.1038/nature13448; Frumkin D, 2005, PLOS COMPUT BIOL, V1, P382, DOI 10.1371/journal.pcbi.0010050; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; Lodato MA, 2015, SCIENCE, V350, P94, DOI 10.1126/science.aab1785; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600	6	3	3	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					37	37		10.1126/science.aad2792	http://dx.doi.org/10.1126/science.aad2792			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26430106				2022-12-28	WOS:000362098300032
J	Vize, R				Vize, Richard			NHS What went wrong at Addenbrooke's?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												richard.vize@gmail.com							0	6	6	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 2	2015	351								h5278	10.1136/bmj.h5278	http://dx.doi.org/10.1136/bmj.h5278			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT0AK	26432754				2022-12-28	WOS:000362455900011
J	Robling, M; Bekkers, MJ; Bell, K; Butler, CC; Cannings-John, R; Channon, S; Martin, BC; Gregory, JW; Hood, K; Kemp, A; Kenkre, J; Montgomery, AA; Moody, G; Owen-Jones, E; Pickett, K; Richardson, G; Roberts, ZES; Ronaldson, S; Sanders, J; Stamuli, E; Torgerson, D				Robling, Michael; Bekkers, Marie-Jet; Bell, Kerry; Butler, Christopher C.; Cannings-John, Rebecca; Channon, Sue; Martin, Belen Corbacho; Gregory, John W.; Hood, Kerry; Kemp, Alison; Kenkre, Joyce; Montgomery, Alan A.; Moody, Gwenllian; Owen-Jones, Eleri; Pickett, Kate; Richardson, Gerry; Roberts, Zoe E. S.; Ronaldson, Sarah; Sanders, Julia; Stamuli, Eugena; Torgerson, David			Effectiveness of a nurse-led intensive home-visitation programme for first-time teenage mothers (Building Blocks): a pragmatic randomised controlled trial	LANCET			English	Article							PREGNANCY OUTCOMES; CHILD MALTREATMENT; VISITING PROGRAMS; SURE START; FAMILY; PARTNERSHIP; PREVENTION; ADULTHOOD; NEGLECT; ENGLAND	Background Many countries now off er support to teenage mothers to help them to achieve long-term socioeconomic stability and to give a successful start to their children. The Family Nurse Partnership (FNP) is a licensed intensive home-visiting intervention developed in the USA and introduced into practice in England that involves up to 64 structured home visits from early pregnancy until the child's second birthday by specially recruited and trained family nurses. We aimed to assess the effectiveness of giving the programme to teenage first-time mothers on infant and maternal outcomes up to 24 months after birth. Methods We did a pragmatic, non-blinded, randomised controlled, parallel-group trial in community midwifery settings at 18 partnerships between local authorities and primary and secondary care organisations in England. Eligible participants were nulliparous and aged 19 years or younger, and were recruited at less than 25 weeks' gestation. Field-based researchers randomly allocated mothers (1:1) via remote randomisation (telephone and web) to FNP plus usual care (publicly funded health and social care) or to usual care alone. Allocation was stratified by site and minimised by gestation (<16 weeks vs >= 16 weeks), smoking status (yes vs no), and preferred language of data collection (English vs non-English). Mothers and assessors (local researchers at baseline and 24 months' follow-up) were not masked to group allocation, but telephone interviewers were blinded. Primary endpoints were biomarker-calibrated self-reported tobacco use by the mother at late pregnancy, birthweight of the baby, the proportion of women with a second pregnancy within 24 months post-partum, and emergency attendances and hospital admissions for the child within 24 months post-partum. Analyses were by intention to treat. This trial is registered with ISRCTN, number ISRCTN23019866. Findings Between June 16, 2009, and July 28, 2010, we screened 3251 women. After enrolment, 823 women were randomly assigned to receive FNP and 822 to usual care. All follow-up data were retrieved by April 25, 2014. 304 (56%) of 547 women assigned to FNP and 306 (56%) of 545 assigned to usual care smoked at late pregnancy (adjusted odds ratio [AOR] 0.90, 97.5% CI 0.64-1.28). Mean birthweight of 742 babies with mothers assigned to FNP was 3217.4 g (SD 618.0), whereas birthweight of 768 babies assigned to usual care was 3197.5 g (SD 581.5; adjusted mean difference 20.75 g, 97.5% CI -47.73 to 89.23. 587 (81%) of 725 assessed children with mothers assigned to FNP and 577 (77%) of 753 assessed children assigned to usual care attended an emergency department or were admitted to hospital at least once before their second birthday (AOR 1.32, 97 . 5% CI 0.99-1.76). 426 (66%) of 643 assessed women assigned to FNP and 427 (66%) 646 assigned to usual care had a second pregnancy within 2 years (AOR 1 . 01, 0.77-1.33). At least one serious adverse event (mainly clinical events associated with pregnancy and infancy period) was reported for 310 (38%) of 808 participants (mother-child) in the usual care group and 357 (44%) of 810 in the FNP group, none of which were considered related to the intervention. Interpretation Adding FNP to the usually provided health and social care provided no additional short-term benefit to our primary outcomes. Programme continuation is not justified on the basis of available evidence, but could be reconsidered should supportive longer-term evidence emerge.	[Robling, Michael; Bekkers, Marie-Jet; Cannings-John, Rebecca; Channon, Sue; Hood, Kerry; Moody, Gwenllian; Owen-Jones, Eleri] Cardiff Univ, Ctr Trials Res, South East Wales Trials Unit, Cardiff CF10 3AX, S Glam, Wales; [Gregory, John W.; Kemp, Alison; Roberts, Zoe E. S.] Cardiff Univ, Sch Med, Cardiff CF10 3AX, S Glam, Wales; [Sanders, Julia] Cardiff Univ, Sch Hlthcare Sci, Cardiff CF10 3AX, S Glam, Wales; [Bell, Kerry; Martin, Belen Corbacho; Ronaldson, Sarah; Stamuli, Eugena; Torgerson, David] Univ York, York Trials Unit, York YO10 5DD, N Yorkshire, England; [Pickett, Kate] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Richardson, Gerry] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Butler, Christopher C.] Univ Oxford, Nuffield Dept Primary Hlth Care Sci, Oxford, England; [Kenkre, Joyce] Univ New S Wales, Fac Life Sci & Educ, Pontypridd, M Glam, Wales; [Montgomery, Alan A.] Univ Nottingham, Nottingham Clin Trials Unit, Nottingham NG7 2RD, England; [Montgomery, Alan A.] Univ Bristol, Bristol Randomised Trials Collaborat, Bristol, Avon, England	Cardiff University; Cardiff University; Cardiff University; University of York - UK; University of York - UK; University of York - UK; University of Oxford; University of Nottingham; University of Bristol	Robling, M (corresponding author), Cardiff Univ, South East Wales Trials Unit, Cardiff CF14 4YS, Wales.	roblingmr@cardiff.ac.uk	Hood, Kerenza/C-2528-2008; Torgerson, David/L-4566-2019	Hood, Kerenza/0000-0002-5268-8631; Torgerson, David/0000-0002-1667-4275; Montgomery, Alan/0000-0003-0450-1606; Bell, Kerry Jane/0000-0001-5124-138X; Butler, Christopher/0000-0002-0102-3453; Ronaldson, Sarah Jane/0000-0001-8321-786X; Robling, Michael/0000-0002-1004-036X	Department of Health Policy Research Programme; Policy Research Programme in the Department of Health [006/0060]; Wales Assembly Government through Health and Care Research Wales; Medical Research Council [MR/K023233/1] Funding Source: researchfish; National Institute for Health Research [CSA/03/07/014, NF-SI-0515-10056] Funding Source: researchfish; MRC [MR/K023233/1] Funding Source: UKRI	Department of Health Policy Research Programme; Policy Research Programme in the Department of Health; Wales Assembly Government through Health and Care Research Wales; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Department of Health Policy Research Programme.; This is an independent report commissioned and funded by the Policy Research Programme in the Department of Health (reference 006/0060). The views expressed are not necessarily those of the Department of Health. The South East Wales Trials Unit (SEWTU) is funded by the Wales Assembly Government through Health and Care Research Wales and the authors gratefully acknowledge SEWTU's contribution to study implementation. We thank all the women who participated in the study, the local professionals who facilitated recruitment and study implementation, and the family nurses who delivered the intervention. We acknowledge all other contributors to the study who are listed in full in the published full study report. We thank the trial steering committee independent members: Ann Louise Kinmonth (Chair), Silvia van den Heijkant, Pamela Park, Stavros Petrou, Rachel Tonkin; and the data monitoring committee independent members: Gordon Taylor (Chair), Lucy Akhtar, Sara Kenyon. We would like to pay special tribute to the late Professor Paul Wainwright who was the initial Chair of the Data Monitoring Committee. We thank the stakeholder involvement work package members: Joyce Kenkre (lead), Lily Bidmead, Kamila Hawthorne, Lesley Lowes, with contributions from members of the Books & Babies Group, and the Young Mums Groups. The trial administrators were Jackie Swain, Katy Addison, and Rhys Thomas.	Avellar SA, 2013, PEDIATRICS, V132, pS90, DOI 10.1542/peds.2013-1021G; Barnes J, 2011, FAMILY NURSE PARTNER; Barnes J., 2008, NURSE FAMILY PARTNER; Barnes J, 2009, NURSE FAMILY PARTNER; Evans GW, 2002, CHILD DEV, V73, P1238, DOI 10.1111/1467-8624.00469; Filene JH, 2013, PEDIATRICS, V132, pS100, DOI 10.1542/peds.2013-1021H; FURSTENBERG FF, 1987, FAM PLANN PERSPECT, V19, P142, DOI 10.2307/2135159; Gartlehner G, 2006, AHRQ TECHNICAL REV C; Hall D., 2007, DCSFRW022; HARDEN A, 2006, YOUNG PEOPLE PREGNAN; [Healthy Child Programme Health Do], 2009, PREGN 1 5 YEARS LIF; Kitzman H, 1997, JAMA-J AM MED ASSOC, V278, P644, DOI 10.1001/jama.278.8.644; Kuh D, 2002, BRIT MED J, V325, P1076, DOI 10.1136/bmj.325.7372.1076; LISSAU I, 1994, LANCET, V343, P324, DOI 10.1016/S0140-6736(94)91163-0; Mejdoubi J, 2014, MIDWIFERY, V30, P688, DOI 10.1016/j.midw.2013.08.006; Melhuish E, 2010, ARCH DIS CHILD, V95, P159, DOI 10.1136/adc.2009.161018; Melhuish E., 2010, QUALITY GROUP CHILDC; Melhuish E, 2008, LANCET, V372, P1641, DOI 10.1016/S0140-6736(08)61687-6; Olds David L, 2002, Prev Sci, V3, P153, DOI 10.1023/A:1019990432161; Olds DL, 2006, INFANT MENT HEALTH J, V27, P5, DOI 10.1002/imhj.20077; OLDS DL, 1986, PEDIATRICS, V77, P16; OLDS DL, 1986, PEDIATRICS, V78, P65; Olds DL, 2002, PEDIATRICS, V110, P486, DOI 10.1542/peds.110.3.486; Owen-Jones E, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-114; Paranjothy S, 2009, ARCH DIS CHILD, V94, P239, DOI 10.1136/adc.2007.115915; Peacock S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-17; Power C, 1997, LANCET, V350, P1584, DOI 10.1016/S0140-6736(97)07474-6; Sweet MA, 2004, CHILD DEV, V75, P1435, DOI 10.1111/j.1467-8624.2004.00750.x; Tremblay RE, 2010, J CHILD PSYCHOL PSYC, V51, P341, DOI 10.1111/j.1469-7610.2010.02211.x; Turley RNL, 2003, CHILD DEV, V74, P465; TYGART CE, 1991, YOUTH SOC, V22, P525, DOI 10.1177/0044118X91022004005; Zielinski DS, 2009, DEV PSYCHOPATHOL, V21, P441, DOI 10.1017/S0954579409000248	32	153	157	2	65	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2016	387	10014					146	155		10.1016/S0140-6736(15)00392-X	http://dx.doi.org/10.1016/S0140-6736(15)00392-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA8LF	26474809	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000368055500031
J	Piskounova, E; Agathocleous, M; Murphy, MM; Hu, ZP; Huddlestun, SE; Zhao, ZY; Leitch, AM; Johnson, TM; DeBerardinis, RJ; Morrison, SJ				Piskounova, Elena; Agathocleous, Michalis; Murphy, Malea M.; Hu, Zeping; Huddlestun, Sara E.; Zhao, Zhiyu; Leitch, A. Marilyn; Johnson, Timothy M.; DeBerardinis, Ralph J.; Morrison, Sean J.			Oxidative stress inhibits distant metastasis by human melanoma cells	NATURE			English	Article							BREAST-TUMOR CELLS; CANCER-CELLS; CARDIOVASCULAR-DISEASE; ANTIOXIDANTS; METABOLISM; LUNG; PREVENTION; MORTALITY; DORMANCY; SURVIVAL	Solid cancer cells commonly enter the blood and disseminate systemically, but are highly inefficient at forming distant metastases for poorly understood reasons. Here we studied human melanomas that differed in their metastasis histories in patients and in their capacity to metastasize in NOD-SCID-Il2rg(-/-) (NSG) mice. We show that melanomas had high frequencies of cells that formed subcutaneous tumours, but much lower percentages of cells that formed tumours after intravenous or intrasplenic transplantation, particularly among inefficiently metastasizing melanomas. Melanoma cells in the blood and visceral organs experienced oxidative stress not observed in established subcutaneous tumours. Successfully metastasizing melanomas underwent reversible metabolic changes during metastasis that increased their capacity to withstand oxidative stress, including increased dependence on NADPH-generating enzymes in the folate pathway. Antioxidants promoted distant metastasis in NSG mice. Folate pathway inhibition using low-dose methotrexate, ALDH1L2 knockdown, or MTHFD1 knockdown inhibited distant metastasis without significantly affecting the growth of subcutaneous tumours in the same mice. Oxidative stress thus limits distant metastasis by melanoma cells in vivo.	[Piskounova, Elena; Agathocleous, Michalis; Murphy, Malea M.; Hu, Zeping; Huddlestun, Sara E.; Zhao, Zhiyu; DeBerardinis, Ralph J.; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Childrens Res Inst, Dallas, TX 75390 USA; [Piskounova, Elena; Agathocleous, Michalis; Murphy, Malea M.; Hu, Zeping; Huddlestun, Sara E.; Zhao, Zhiyu; DeBerardinis, Ralph J.; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Leitch, A. Marilyn] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Johnson, Timothy M.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Morrison, SJ (corresponding author), Univ Texas SW Med Ctr Dallas, Childrens Res Inst, Dallas, TX 75390 USA.	sean.morrison@utsouthwestern.edu	Hu, Zeping/F-6205-2010; Morrison, Sean/ABD-5326-2021	Hu, Zeping/0000-0003-4146-7750; Morrison, Sean/0000-0003-1587-8329; Murphy, Malea/0000-0001-7071-6862; Piskounova, Elena/0000-0002-8554-8475	NATIONAL CANCER INSTITUTE [K99CA201228, P30CA142543] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [K99 CA201228, P30 CA142543] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Cameron MD, 2000, CANCER RES, V60, P2541; Chandel NS, 2014, NEW ENGL J MED, V371, P177, DOI 10.1056/NEJMcibr1405701; Chen EI, 2007, CANCER RES, V67, P1472, DOI 10.1158/0008-5472.CAN-06-3137; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Deghan Manshadi S., 2014, PLOS ONE, V9; Dey S, 2015, J CLIN INVEST, V125, P2592, DOI 10.1172/JCI78031; Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022; Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622; ENGELL HC, 1959, ANN SURG, V149, P457, DOI 10.1097/00000658-195904000-00001; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Fortmann SP, 2013, ANN INTERN MED, V159, P824, DOI 10.7326/0003-4819-159-12-201312170-00729; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Glasauer A, 2014, BIOCHEM PHARMACOL, V92, P90, DOI 10.1016/j.bcp.2014.07.017; Glasauer A, 2014, J CLIN INVEST, V124, P117, DOI 10.1172/JCI71714; Goodman GE, 2004, J NATL CANCER I, V96, P1743, DOI 10.1093/jnci/djh320; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; GRIFFITHS JD, 1973, CANCER-AM CANCER SOC, V31, P226, DOI 10.1002/1097-0142(197301)31:1<226::AID-CNCR2820310130>3.0.CO;2-M; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; Kamarajugadda S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.20; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Lu X, 2010, J BIOL CHEM, V285, P9317, DOI 10.1074/jbc.C110.104448; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Mullen AR, 2014, CELL REP, V7, P1679, DOI 10.1016/j.celrep.2014.04.037; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Qu Y, 2011, J CLIN INVEST, V121, P212, DOI 10.1172/JCI43144; Quintana E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004599; SALSBURY AJ, 1975, CANCER TREAT REV, V2, P55, DOI 10.1016/S0305-7372(75)80015-6; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Stott SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000403; Teoh-Fitzgerald ML, 2014, ONCOGENE, V33, P358, DOI 10.1038/onc.2012.582; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Ye JB, 2014, CANCER DISCOV, V4, P1406, DOI 10.1158/2159-8290.CD-14-0250; Yu M, 2014, SCIENCE, V345, P216, DOI 10.1126/science.1253533; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	49	686	704	11	248	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					186	+		10.1038/nature15726	http://dx.doi.org/10.1038/nature15726			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RC	26466563	Green Accepted			2022-12-28	WOS:000364396700035
J	Lubchenco, J; Grorud-Colvert, K				Lubchenco, Jane; Grorud-Colvert, Kirsten			Making waves: The science and politics of ocean protection	SCIENCE			English	Editorial Material							MARINE RESERVES; AREAS; CONSERVATION		[Lubchenco, Jane; Grorud-Colvert, Kirsten] Oregon State Univ, Corvallis, OR 97331 USA	Oregon State University	Lubchenco, J (corresponding author), Oregon State Univ, Corvallis, OR 97331 USA.	grorudck@science.oregonstate.edu						Barner AK, 2015, OCEANOGRAPHY, V28, P252, DOI 10.5670/oceanog.2015.51; Caselle JE, 2015, SCI REP-UK, V5, DOI 10.1038/srep14102; Grorud-Colvert K, 2017, SCI PARKS PARKS SCI; Grorud-Colvert K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102298; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Lester SE, 2008, MAR ECOL PROG SER, V367, P49, DOI 10.3354/meps07599; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; McLeod K., 2009, ECOSYSTEM BASED MANA; Micheli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040832; Olds AD, 2014, GLOBAL CHANGE BIOL, V20, P3050, DOI 10.1111/gcb.12606; Pressey B, 2014, NATURE, V515, P28; Sala E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058799; Secretariat of the Convention on Biological Diversity, 2014, GLOB BIOD OUTL 4; Toonen RJ, 2013, MAR POLLUT BULL, V77, P7, DOI 10.1016/j.marpolbul.2013.10.039; White C, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001826	15	218	219	2	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					382	383		10.1126/science.aad5443	http://dx.doi.org/10.1126/science.aad5443			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0NG	26472764				2022-12-28	WOS:000363213400022
J	Jost, M; Fernandez-Zapata, J; Polanco, MC; Ortiz-Guerrero, JM; Chen, PYT; Kang, G; Padmanabhan, S; Elias-Arnanz, M; Drennan, CL				Jost, Marco; Fernandez-Zapata, Jesus; Carmen Polanco, Maria; Manuel Ortiz-Guerrero, Juan; Chen, Percival Yang-Ting; Kang, Gyunghoon; Padmanabhan, S.; Elias-Arnanz, Montserrat; Drennan, Catherine L.			Structural basis for gene regulation by a B-12-dependent photoreceptor	NATURE			English	Article							CRYSTAL-STRUCTURE; DNA-BINDING; LIGHT; EXPRESSION; FAMILY; SENSOR; ADENOSYLCOBALAMIN; PHOTOLYSIS; MECHANISM; B-12	Photoreceptor proteins enable organisms to sense and respond to light. The newly discovered CarH-type photoreceptors use a vitamin B-12 derivative, adenosylcobalamin, as the light-sensing chromophore to mediate light-dependent gene regulation. Here we present crystal structures of Thermus thermophilus CarH in all three relevant states: in the dark, both free and bound to operator DNA, and after light exposure. These structures provide visualizations of how adenosylcobalamin mediates CarH tetramer formation in the dark, how this tetramer binds to the promoter 235 element to repress transcription, and how light exposure leads to a large-scale conformational change that activates transcription. In addition to the remarkable functional repurposing of adenosylcobalamin from an enzyme cofactor to a light sensor, we find that nature also repurposed two independent protein modules in assembling CarH. These results expand the biological role of vitamin B-12 and provide fundamental insight into a new mode of light-dependent gene regulation.	[Jost, Marco; Chen, Percival Yang-Ting; Kang, Gyunghoon; Drennan, Catherine L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Fernandez-Zapata, Jesus; Padmanabhan, S.] CSIC, Inst Quim Fis Rocasolano, Madrid 28006, Spain; [Carmen Polanco, Maria; Manuel Ortiz-Guerrero, Juan; Elias-Arnanz, Montserrat] Univ Murcia, Fac Biol, Inst Quim Fis Rocasolano,CSIC, Dept Genet & Microbiol,Area Genet,Unidad Asociada, E-30100 Murcia, Spain	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Murcia	Padmanabhan, S (corresponding author), CSIC, Inst Quim Fis Rocasolano, Madrid 28006, Spain.	padhu@iqfr.csic.es; melias@um.es; cdrennan@mit.edu	Padmanabhan, S./E-8943-2017; Paniagua, Enrique/H-3536-2015; Polanco, Maria Carmen/H-5571-2015; Elias-Arnanz, Montserrat/H-4707-2015	Paniagua, Enrique/0000-0001-5006-6428; Polanco, Maria Carmen/0000-0002-5968-5791; Padmanabhan, S./0000-0002-8772-0152; Elias-Arnanz, Montserrat/0000-0003-1980-3092; Fernandez-Zapata, Jesus/0000-0002-7686-5591	National Institutes of Health (NIH) [GM069857]; Ministerio de Economia y Competitividad, Spain [BFU2012-40184-C02-01]; FEDER (Fondo Europeo de Desarrollo Regional) [BFU2012-40184-C02-02]; CSIC-JAE- Predoc (Spain) fellowship; MIT Poitras pre-doctoral fellowship; National Institute of General Medical Sciences (NIGMS) [P41GM103403]; NIH; US Department of Energy Office of Science User Facility [DE-AC02-06CH11357]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; NIGMS [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, P41GM103403, R01GM069857] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Economia y Competitividad, Spain; FEDER (Fondo Europeo de Desarrollo Regional)(European Commission); CSIC-JAE- Predoc (Spain) fellowship; MIT Poitras pre-doctoral fellowship; National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy Office of Science User Facility(United States Department of Energy (DOE)); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Murillo for his contributions and support, J. A. Madrid for technical assistance (Universidad de Murcia), and A. Cohen (SSRL) and N. Ando (MIT) for help with single crystal UV-vis spectroscopy. This work was supported in part by the National Institutes of Health (NIH, grant GM069857 to C.L.D.), the Ministerio de Economia y Competitividad, Spain (grants BFU2012-40184-C02-01 co-financed by FEDER (Fondo Europeo de Desarrollo Regional) funds to M.E.-A.; BFU2012-40184-C02-02 to S.P.; PhD fellowship to J.F.-Z.), a CSIC-JAE- Predoc (Spain) fellowship (to J.M.O.-G.), and an MIT Poitras pre-doctoral fellowship (to M.J.). C.L.D. is a Howard Hughes Medical Institute Investigator. This work used the Northeastern Collaborative Access Team beamlines of the Advanced Photon Source, which are supported by National Institute of General Medical Sciences (NIGMS) grant P41GM103403 and the NIH. The Advanced Photon Source is a US Department of Energy Office of Science User Facility operated under Contract No. DE-AC02-06CH11357. Use of the Stanford Synchrotron Radiation Lightsource is supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under contract number DE-AC02-76SF00515, the Department of Energy Office of Biological and Environmental Research, and by the NIH and NIGMS (including P41GM103393).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bandarian V, 2003, P NATL ACAD SCI USA, V100, P8156, DOI 10.1073/pnas.1133218100; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; BARKER HA, 1960, J BIOL CHEM, V235, P480; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burgie ES, 2014, PLANT CELL, V26, P4568, DOI 10.1105/tpc.114.131623; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng Z, 2014, MOL MICROBIOL, V91, P649, DOI 10.1111/mmi.12491; Conrad KS, 2014, NAT CHEM BIOL, V10, P801, DOI [10.1038/NCHEMBIO.1633, 10.1038/nchembio.1633]; Diez AI, 2013, EUR BIOPHYS J BIOPHY, V42, P463, DOI 10.1007/s00249-013-0897-x; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; Elias-Arnanz M, 2011, CURR OPIN MICROBIOL, V14, P128, DOI 10.1016/j.mib.2010.12.009; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FIRTH RA, 1967, BIOCHEMISTRY-US, V6, P2178, DOI 10.1021/bi00859a040; Frey PA, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P501; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Girvan HM, 2013, J BIOL CHEM, V288, P13194, DOI 10.1074/jbc.R112.422642; Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138; Herrou J, 2011, NAT REV MICROBIOL, V9, P713, DOI 10.1038/nrmicro2622; HILL JA, 1964, J CHEM SOC, P5149, DOI 10.1039/jr9640005149; Jain SS, 2008, NAT PROTOC, V3, P1092, DOI 10.1038/nprot.2008.72; Jarrett JT, 1996, BIOORGAN MED CHEM, V4, P1237, DOI 10.1016/0968-0896(96)00119-8; Jenkins GI, 2014, PLANT CELL, V26, P21, DOI 10.1105/tpc.113.119446; Johnson JE, 2012, NATURE, V492, P133, DOI 10.1038/nature11607; Jost M, 2015, BIOCHEMISTRY-US, V54, P3231, DOI 10.1021/acs.biochem.5b00416; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kutta RJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8907; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Linden H, 1997, EMBO J, V16, P98, DOI 10.1093/emboj/16.1.98; Losi A, 2012, ANNU REV PLANT BIOL, V63, P49, DOI 10.1146/annurev-arplant-042811-105538; Ortiz-Guerrero JM, 2011, P NATL ACAD SCI USA, V108, P7565, DOI 10.1073/pnas.1018972108; MARQUES HM, 1990, INORG CHIM ACTA, V170, P259, DOI 10.1016/S0020-1693(00)80484-3; Matthews RG, 2001, ACCOUNTS CHEM RES, V34, P681, DOI 10.1021/ar0000051; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Nahvi A, 2004, NUCLEIC ACIDS RES, V32, P143, DOI 10.1093/nar/gkh167; Nash AI, 2011, P NATL ACAD SCI USA, V108, P9449, DOI 10.1073/pnas.1100262108; Navarro-Aviles G, 2007, MOL MICROBIOL, V63, P980, DOI 10.1111/j.1365-2958.2006.05567.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Perez-Marin MC, 2008, MOL MICROBIOL, V67, P804, DOI 10.1111/j.1365-2958.2007.06086.x; Peselis A, 2012, NAT STRUCT MOL BIOL, V19, P1182, DOI 10.1038/nsmb.2405; Purcell EB, 2008, CURR OPIN MICROBIOL, V11, P168, DOI 10.1016/j.mib.2008.02.014; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Takano H, 2014, MICROBIOL-SGM, V160, P2650, DOI 10.1099/mic.0.082263-0; Takano H, 2011, J BACTERIOL, V193, P2451, DOI 10.1128/JB.01125-10; TENEYCK LF, 1985, METHOD ENZYMOL, V115, P324; van Dijk M, 2009, NUCLEIC ACIDS RES, V37, pW235, DOI 10.1093/nar/gkp287; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Watanabe S, 2008, P NATL ACAD SCI USA, V105, P4121, DOI 10.1073/pnas.0709188105; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995; Ziegelhoffer EC, 2009, NAT REV MICROBIOL, V7, P856, DOI 10.1038/nrmicro2237	64	113	114	5	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					536	U167		10.1038/nature14950	http://dx.doi.org/10.1038/nature14950			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26416754	Green Accepted, Green Submitted			2022-12-28	WOS:000364026100042
J	Zetsche, B; Gootenberg, JS; Abudayyeh, OO; Slaymaker, IM; Makarova, KS; Essletzbichler, P; Volz, SE; Joung, J; van der Oost, J; Regev, A; Koonin, EV; Zhang, F				Zetsche, Bernd; Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Slaymaker, Ian M.; Makarova, Kira S.; Essletzbichler, Patrick; Volz, Sara E.; Joung, Julia; van der Oost, John; Regev, Aviv; Koonin, Eugene V.; Zhang, Feng			Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System	CELL			English	Article							CRYSTAL-STRUCTURE; STREPTOCOCCUS-THERMOPHILUS; SURVEILLANCE COMPLEX; ADAPTIVE IMMUNITY; ESCHERICHIA-COLI; TARGET DNA; BACTERIA; SPECIFICITY; PROKARYOTES; CLEAVAGE	The microbial adaptive immune system CRISPR mediates defense against foreign genetic elements through two classes of RNA-guided nuclease effectors. Class 1 effectors utilize multi-protein complexes, whereas class 2 effectors rely on single-component effector proteins such as the well-characterized Cas9. Here, we report characterization of Cpf1, a putative class 2 CRISPR effector. We demonstrate that Cpf1 mediates robust DNA interference with features distinct from Cas9. Cpf1 is a single RNA-guided endonuclease lacking tracrRNA, and it utilizes a T-rich protospacer-adjacent motif. Moreover, Cpf1 cleaves DNA via a staggered DNA double-stranded break. Out of 16 Cpf1-family proteins, we identified two candidate enzymes from Acid-aminococcus and Lachnospiraceae, with efficient genome-editing activity in human cells. Identifying this mechanism of interference broadens our understanding of CRISPR-Cas systems and advances their genome editing applications.	[Zetsche, Bernd; Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Slaymaker, Ian M.; Essletzbichler, Patrick; Volz, Sara E.; Joung, Julia; Regev, Aviv; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Zetsche, Bernd; Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Slaymaker, Ian M.; Essletzbichler, Patrick; Volz, Sara E.; Joung, Julia; Zhang, Feng] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Zetsche, Bernd; Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Slaymaker, Ian M.; Essletzbichler, Patrick; Volz, Sara E.; Joung, Julia; Zhang, Feng] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Zetsche, Bernd; Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Slaymaker, Ian M.; Essletzbichler, Patrick; Volz, Sara E.; Joung, Julia; Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Zetsche, Bernd] Bonn Med Sch, Inst Pathol, Dept Dev Pathol, D-53127 Bonn, Germany; [Gootenberg, Jonathan S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Makarova, Kira S.; Koonin, Eugene V.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [van der Oost, John] Wageningen Univ, Dept Agrotechnol & Food Sci, Microbiol Lab, NL-6703 HB Wageningen, Netherlands; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Bonn; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Wageningen University & Research; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	zhang@broadinstitute.org	van+der+Oost, John/Y-2548-2019; Gootenberg, Jonathan/AAY-8174-2021; Macrae, Rhiannon/AAX-1536-2020; Abudayyeh, Omar/ABF-1746-2020; Joung, Julia/HCH-8944-2022	Gootenberg, Jonathan/0000-0003-2757-2175; Abudayyeh, Omar/0000-0002-7979-3220; Essletzbichler, Patrick/0000-0003-2237-0005	intramural program of the US Department of Health and Human Services; D.O.E. Computational Science Graduate Fellowship; NIMH [5DP1-MH100706]; Poitras Center Foundation; Vallee Foundation; Paul G. Allen Foundation; New York Stem Cell Foundation; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH110049, DP1MH100706] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000061] Funding Source: NIH RePORTER	intramural program of the US Department of Health and Human Services; D.O.E. Computational Science Graduate Fellowship(United States Department of Energy (DOE)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Poitras Center Foundation; Vallee Foundation; Paul G. Allen Foundation; New York Stem Cell Foundation; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We would like to thank R. Macrae for critical reading of the manuscript. We would like to thank Wayne Conlan and David S. Weiss for generously providing F. novicida genomic DNA and cell pellets, respectively, Doug Daniels for kindly providing us with the bacterial expression vector, and Sergei Shmakov and Yuri Wolf for help with sequence analysis. E.V.K. and K.S.M are supported by the intramural program of the US Department of Health and Human Services (to the National Library of Medicine). J.S.G. is supported by a D.O.E. Computational Science Graduate Fellowship. F.Z. is supported by the NIMH (5DP1-MH100706), the Poitras Center, Vallee, Simons, Paul G. Allen, and New York Stem Cell Foundations, David R. Cheng, Tom Harriman, and Bob Metcalfe. A patent application has been filed related to this work, and the authors plan to make the reagents widely available to the academic community through Addgene and to provide software tools via the Zhang lab website (www.genome-engineering.org). F.Z. is a founder of Editas Medicine and a scientific advisor for Editas Medicine and Horizon Discovery.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cencic R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109213; Chan F, 2011, NUCLEIC ACIDS RES, V39, P5955, DOI 10.1093/nar/gkr196; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P428, DOI 10.1093/femsre/fuv023; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Edgar RC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-18; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gardner MJ, 2002, NATURE, V419, P531, DOI 10.1038/nature01094; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Heidrich N., 2015, CRISPR, P1; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Makarova Kira S, 2015, Methods Mol Biol, V1311, P47, DOI 10.1007/978-1-4939-2687-9_4; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Makarova KS, 2015, NAT REV MICROBIOL; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Schunder E, 2013, INT J MED MICROBIOL, V303, P51, DOI 10.1016/j.ijmm.2012.11.004; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Vestergaard G, 2014, RNA BIOL, V11, P156, DOI 10.4161/rna.27990; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001	43	2270	2888	92	844	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					759	771		10.1016/j.cell.2015.09.038	http://dx.doi.org/10.1016/j.cell.2015.09.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26422227	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000364828900027
J	Relling, MV; Evans, WE				Relling, Mary V.; Evans, William E.			Pharmacogenomics in the clinic	NATURE			English	Review							ACUTE LYMPHOBLASTIC-LEUKEMIA; IMPLEMENTATION CONSORTIUM GUIDELINES; ELECTRONIC MEDICAL-RECORDS; ADVERSE DRUG-REACTIONS; PERSONALIZED MEDICINE; GENOMIC MEDICINE; RESEARCH NETWORK; PREEMPTIVE PHARMACOGENOMICS; MERCAPTOPURINE INTOLERANCE; COMPANION DIAGNOSTICS	After decades of discovery, inherited variations have been identified in approximately 20 genes that affect about 80 medications and are actionable in the clinic. And some somatically acquired genetic variants direct the choice of 'targeted' anticancer drugs for individual patients. Current efforts that focus on the processes required to appropriately act on pharmacogenomic variability in the clinic are moving away from discovery and towards implementation of an evidenced-based strategy for improving the use of medications, thereby providing a cornerstone for precision medicine.	[Relling, Mary V.; Evans, William E.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Relling, MV (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA.	mary.relling@stjude.org	Evans, William E./C-2069-2012; Relling, Mary/N-5032-2018	Evans, William E./0000-0002-9333-5322; Loh, Mignon/0000-0003-4099-4700	NIH [P50 GM115279, RO1 CA36401, R24 GM115264, RO1 CA142665, P30 CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA036401, R01CA142665, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM115264, P50GM115279] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank their many colleagues who have collaborated in research to elucidate the pharmacogenomics of medications used to treat their patients, as well as those who have collaborated to translate pharmacogenomics to optimize the care of patients. They also thank the many patients and parents who have willingly participated in their research. This work was supported in part by NIH grants P50 GM115279, RO1 CA36401, R24 GM115264, RO1 CA142665, P30 CA21765 and by the American Lebanese Syrian Associated Charities.	Abrams J, 2014, 2014 AM SOC CLIN ONC, P71; Agundez JAG, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00188; Becquement L, 2011, PHARMACOGENOMICS, V12, P113, DOI 10.2217/PGS.10.147; Bell GC, 2014, J AM MED INFORM ASSN, V21, pE93, DOI 10.1136/amiajnl-2013-001993; BEUTLER E, 1994, BLOOD, V84, P3613, DOI 10.1182/blood.V84.11.3613.bloodjournal84113613; Bielinski SJ, 2014, MAYO CLIN PROC, V89, P25, DOI 10.1016/j.mayocp.2013.10.021; BLUM M, 1991, P NATL ACAD SCI USA, V88, P5237, DOI 10.1073/pnas.88.12.5237; Bonifaz-Pena V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112640; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Brauch H, 2014, BRIT J CLIN PHARMACO, V77, P695, DOI 10.1111/bcp.12229; Brauch H, 2013, J CLIN ONCOL, V31, P176, DOI 10.1200/JCO.2012.44.6625; Buchanan J, 2013, PHARMACOGENOMICS, V14, P1833, DOI 10.2217/pgs.13.183; Burke W, 2009, CURRENT PROTOCOLS HU; Carr DF, 2014, GENES-BASEL, V5, P430, DOI 10.3390/genes5020430; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; Caudle KE, 2014, CURR DRUG METAB, V15, P209, DOI 10.2174/1389200215666140130124910; Caulfield T, 2012, CLIN GENET, V81, P4, DOI 10.1111/j.1399-0004.2011.01799.x; Cavallari LH, 2014, CLIN PHARMACOL THER, V96, P22, DOI 10.1038/clpt.2014.78; Chan NC, 2014, BLOOD, V124, P689, DOI 10.1182/blood-2014-01-512723; Chen ZB, 2014, NEUROLOGY, V83, P2077, DOI 10.1212/WNL.0000000000001034; Cheng Q, 2005, NAT GENET, V37, P878, DOI 10.1038/ng1612; Cooper DN, 2014, PERS MED, V11, P615, DOI 10.2217/pme.14.59; Crawford DC, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00184; Crews KR, 2014, CLIN PHARMACOL THER, V95, P376, DOI 10.1038/clpt.2013.254; Dalabira E, 2014, PUBLIC HEALTH GENOM, V17, P265, DOI 10.1159/000365895; Dunnenberger HM, 2015, ANNU REV PHARMACOL, V55, P89, DOI 10.1146/annurev-pharmtox-010814-124835; Ehmann F, 2015, PHARMACOGENOMICS J, V15, P201, DOI 10.1038/tpj.2014.86; EVANS DAP, 1960, BRIT MED J, V2, P485, DOI 10.1136/bmj.2.5197.485; Evans WE, 2004, NATURE, V429, P464, DOI 10.1038/nature02626; Fernandez CA, 2012, CLIN PHARMACOL THER, V92, P360, DOI 10.1038/clpt.2012.95; Flockhart DA, 2009, CLIN PHARMACOL THER, V86, P109, DOI 10.1038/clpt.2009.39; Gaedigk A, 2013, INT REV PSYCHIATR, V25, P534, DOI 10.3109/09540261.2013.825581; GONZALEZ FJ, 1988, NATURE, V331, P442, DOI 10.1038/331442a0; Gordon AS, 2014, HUM MOL GENET, V23, P1957, DOI 10.1093/hmg/ddt588; Gottesman O, 2013, CLIN PHARMACOL THER, V94, P214, DOI 10.1038/clpt.2013.72; Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72; Grosse SD, 2006, GENET MED, V8, P448, DOI 10.1097/01.gim.0000227935.26763.c6; Haga SB, 2012, CLIN GENET, V82, P388, DOI 10.1111/j.1399-0004.2012.01908.x; Haga SB, 2012, CLIN GENET, V82, P115, DOI 10.1111/j.1399-0004.2012.01848.x; Hayden EC, 2013, NATURE, V498, P16, DOI 10.1038/498017a; Hughes D, 2015, NAT REV GENET, V16, P459, DOI 10.1038/nrg3922; HUGHES HB, 1954, AM REV TUBERC PULM, V70, P266; Ingelman-Sundberg M, 2008, NEW ENGL J MED, V358, P637, DOI 10.1056/NEJMe0708842; Irvin WJ, 2011, J CLIN ONCOL, V29, P3232, DOI 10.1200/JCO.2010.31.4427; Ishiguro A, 2013, J HUM GENET, V58, P313, DOI 10.1038/jhg.2013.36; Johnson JA, 2012, CLIN PHARMACOL THER, V92, P437, DOI 10.1038/clpt.2012.125; KALOW W, 1957, CAN J BIOCHEM PHYS, V35, P339, DOI 10.1139/o57-041; Kinch MS, 2014, DRUG DISCOV TODAY, V19, P1033, DOI 10.1016/j.drudis.2014.03.018; Korf BR, 2014, GENET MED, V16, P804, DOI 10.1038/gim.2014.35; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Levy KD, 2014, CLIN PHARMACOL THER, V96, P307, DOI 10.1038/clpt.2014.101; LOOK AT, 1984, NEW ENGL J MED, V311, P231, DOI 10.1056/NEJM198407263110405; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Manolio TA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab0194; Manolio TA, 2014, GENET MED, V16, P571, DOI 10.1038/gim.2014.6; Manolio TA, 2014, AM J MED GENET C, V166, P1, DOI 10.1002/ajmg.c.31384; Marshall E, 2003, SCIENCE, V302, P588, DOI 10.1126/science.302.5645.588; Martin MA, 2014, CLIN PHARMACOL THER, V95, P499, DOI 10.1038/clpt.2014.38; McCarthy JJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005785; McLeod HL, 2013, SCIENCE, V339, P1563, DOI 10.1126/science.1234139; Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543; Minarro-Gimenez JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093769; MOTULSKY AG, 1957, JAMA-J AM MED ASSOC, V165, P835, DOI 10.1001/jama.1957.72980250010016; O'Donnell PH, 2014, AM J MED GENET C, V166, P68, DOI 10.1002/ajmg.c.31385; Oetjens MT, 2013, PHARMACOGENOMICS, V14, P735, DOI [10.2217/pgs.13.64, 10.2217/PGS.13.64]; Overby CL, 2014, J PERS MED, V4, P35, DOI 10.3390/jpm4010035; Overby CL, 2013, GENET MED, V15, P817, DOI 10.1038/gim.2013.128; Percha Bethany, 2013, AMIA Annu Symp Proc, V2013, P1123; PharmGKB, 2015, CPIC GEN DRUGS; Pignatti F, 2014, CLIN CANCER RES, V20, P1458, DOI 10.1158/1078-0432.CCR-13-1571; Pirmohamed M, 2015, TRENDS PHARMACOL SCI, V36, P153, DOI 10.1016/j.tips.2015.01.003; Prainsack B, 2013, PHARMACOGENOMICS, V14, P403, DOI [10.2217/PGS.13.10, 10.2217/pgs.13.10]; Province MA, 2014, CLIN PHARMACOL THER, V96, P144, DOI 10.1038/clpt.2014.100; Province MA, 2014, CLIN PHARMACOL THER, V95, P216, DOI 10.1038/clpt.2013.186; PUI CH, 1990, BLOOD, V76, P1449; Pulley JM, 2012, CLIN PHARMACOL THER, V92, P87, DOI 10.1038/clpt.2011.371; Rasmussen-Torvik LJ, 2014, CLIN PHARMACOL THER, V96, P482, DOI 10.1038/clpt.2014.137; Ratain MJ, 2013, CLIN PHARMACOL THER, V94, P184, DOI 10.1038/clpt.2013.66; Rattanavipapong W, 2013, EPILEPSIA, V54, P1628, DOI 10.1111/epi.12325; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Relling MV, 2014, CLIN PHARMACOL THER, V96, P169, DOI 10.1038/clpt.2014.97; Relling MV, 2011, CLIN PHARMACOL THER, V89, P464, DOI 10.1038/clpt.2010.279; ROLLHANSEN N, 1989, BIOL PHILOS, V4, P303, DOI 10.1007/BF02426630; Samwald M, 2013, PHARMACOGENOMICS, V14, P1529, DOI 10.2217/pgs.13.121; Schroeder SA, 2013, NEW ENGL J MED, V368, P2029, DOI 10.1056/NEJMsb1302322; Scott SA, 2011, GENET MED, V13, P987, DOI 10.1097/GIM.0b013e318238b38c; Senderowicz AM, 2014, CLIN CANCER RES, V20, P1445, DOI 10.1158/1078-0432.CCR-13-1761; Shuldiner AR, 2013, CLIN PHARMACOL THER, V94, P207, DOI 10.1038/clpt.2013.59; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Stanek EJ, 2012, CLIN PHARMACOL THER, V91, P450, DOI 10.1038/clpt.2011.306; Stocco G, 2009, CLIN PHARMACOL THER, V85, P164, DOI 10.1038/clpt.2008.154; Sukasem C, 2014, ASIAN PAC J ALLERGY, V32, P111; Swen JJ, 2008, CLIN PHARMACOL THER, V83, P781, DOI 10.1038/sj.clpt.6100507; Swen JJ, 2011, CLIN PHARMACOL THER, V89, P662, DOI 10.1038/clpt.2011.34; Toh DSL, 2014, PHARMACOGENOMICS J, V14, P316, DOI 10.1038/tpj.2013.46; Tutton R, 2014, PHARMACOGENOMICS, V15, P297, DOI 10.2217/pgs.13.198; US FDA, 2015, TABL PHARM BIOM DRUG; Van Allen EM, 2013, J CLIN ONCOL, V31, P1825, DOI 10.1200/JCO.2013.48.7215; VATSIS KP, 1991, P NATL ACAD SCI USA, V88, P6333, DOI 10.1073/pnas.88.14.6333; VESELL ES, 1968, SCIENCE, V161, P72, DOI 10.1126/science.161.3836.72; Vogel F., 1959, ERG INN MED KINDERHK, V12, P52, DOI 10.1007/978-3-642-94744-5_2; Wang LW, 2011, NEW ENGL J MED, V364, P1144, DOI 10.1056/NEJMra1010600; Weber GM, 2014, JAMA-J AM MED ASSOC, V311, P2479, DOI 10.1001/jama.2014.4228; Wheeler HE, 2013, NAT REV GENET, V14, P23, DOI 10.1038/nrg3352; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; Wiener CM, 2010, ACAD MED, V85, P498, DOI 10.1097/ACM.0b013e3181ccbebf; Yang JJ, 2015, J CLIN ONCOL, V33, P1235, DOI 10.1200/JCO.2014.59.4671; Yang SK, 2014, NAT GENET, V46, P1017, DOI 10.1038/ng.3060; Yates CR, 1997, ANN INTERN MED, V126, P608, DOI 10.7326/0003-4819-126-8-199704150-00003; Yeh P, 2013, CLIN CANCER RES, V19, P1894, DOI 10.1158/1078-0432.CCR-12-1894; Zhu Q, 2013, J BIOMED INFORM, V46, P286, DOI 10.1016/j.jbi.2012.11.004	111	450	466	8	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					343	350		10.1038/nature15817	http://dx.doi.org/10.1038/nature15817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26469045	Green Accepted			2022-12-28	WOS:000362730200037
J	Veldhorst, M; Yang, CH; Hwang, JCC; Huang, W; Dehollain, JP; Muhonen, JT; Simmons, S; Laucht, A; Hudson, FE; Itoh, KM; Morello, A; Dzurak, AS				Veldhorst, M.; Yang, C. H.; Hwang, J. C. C.; Huang, W.; Dehollain, J. P.; Muhonen, J. T.; Simmons, S.; Laucht, A.; Hudson, F. E.; Itoh, K. M.; Morello, A.; Dzurak, A. S.			A two-qubit logic gate in silicon	NATURE			English	Article							QUANTUM-DOT; ELECTRON-SPIN; QUBIT; ENTANGLEMENT; OSCILLATIONS; COMPUTATION; FIDELITY	Quantum computation requires qubits that can be coupled in a scalable manner, together with universal and high-fidelity one-and two-qubit logic gates(1,2). Many physical realizations of qubits exist, including single photons(3), trapped ions(4), superconducting circuits(5), single defects or atoms in diamond(6,7) and silicon(8), and semiconductor quantum dots(9), with single-qubit fidelities that exceed the stringent thresholds required for fault-tolerant quantum computing(10). Despite this, high-fidelity two-qubit gates in the solid state that can be manufactured using standard lithographic techniques have so far been limited to superconducting qubits(5), owing to the difficulties of coupling qubits and dephasing in semiconductor systems(11-13). Here we present a two-qubit logic gate, which uses single spins in isotopically enriched silicon(14) and is realized by performing single-and two-qubit operations in a quantum dot system using the exchange interaction, as envisaged in the Loss-DiVincenzo proposal(2). We realize CNOT gates via controlled-phase operations combined with single-qubit operations. Direct gate-voltage control provides single-qubit addressability, together with a switchable exchange interaction that is used in the two-qubit controlled-phase gate. By independently reading out both qubits, we measure clear anticorrelations in the two-spin probabilities of the CNOT gate.	[Veldhorst, M.; Yang, C. H.; Hwang, J. C. C.; Huang, W.; Dehollain, J. P.; Muhonen, J. T.; Simmons, S.; Laucht, A.; Hudson, F. E.; Morello, A.; Dzurak, A. S.] Univ New S Wales, Sch Elect Engn & Telecommun, Ctr Quantum Computat & Commun Technol, Sydney, NSW 2052, Australia; [Itoh, K. M.] Keio Univ, Sch Fundamental Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	University of New South Wales Sydney; Keio University	Veldhorst, M (corresponding author), Univ New S Wales, Sch Elect Engn & Telecommun, Ctr Quantum Computat & Commun Technol, Sydney, NSW 2052, Australia.	M.Veldhorst@unsw.edu.au; A.Dzurak@unsw.edu.au	Dzurak, Andrew S/C-5973-2009; Morello, Andrea/B-6475-2008; Itoh, Kohei/C-5738-2014; Muhonen, Juha/E-7152-2011; , A/J-6892-2012; Dehollain, Juan Pablo/G-9915-2012	Dzurak, Andrew S/0000-0003-1389-5096; Morello, Andrea/0000-0001-7445-699X; Muhonen, Juha/0000-0001-6520-6999; , A/0000-0001-7892-7963; Dehollain, Juan Pablo/0000-0002-0425-4345; Yang, Henry/0000-0002-8713-150X; Huang, Wister/0000-0001-9996-6371; Hudson, Fay/0000-0003-0134-3657; Hwang, Jason/0000-0002-6345-2675	Australian Research Council [CE11E0001017]; US Army Research Office [W911NF-13-1-0024]; NSW Node of the Australian National Fabrication Facility; Netherlands Organization for Scientific Research (NWO) through Rubicon Grant; MEXT; NanoQuine; FIRST; JSPS Core-to-Core Program	Australian Research Council(Australian Research Council); US Army Research Office; NSW Node of the Australian National Fabrication Facility; Netherlands Organization for Scientific Research (NWO) through Rubicon Grant(Netherlands Organization for Scientific Research (NWO)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NanoQuine; FIRST; JSPS Core-to-Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank S. Bartlett for discussions and C. M. Cheng for contributions to the preparation of the experimental setup. We acknowledge support from the Australian Research Council (CE11E0001017), the US Army Research Office (W911NF-13-1-0024) and the NSW Node of the Australian National Fabrication Facility. M.V. acknowledges support from the Netherlands Organization for Scientific Research (NWO) through a Rubicon Grant. The work at Keio was supported in part by the Grant-in-Aid for Scientific Research by MEXT, in part by NanoQuine, in part by FIRST and in part by the JSPS Core-to-Core Program.	Angus SJ, 2007, NANO LETT, V7, P2051, DOI 10.1021/nl070949k; Brown KR, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.030303; Brunner R, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.146801; Dehollain JP, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/1/015202; Dial OE, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.146804; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; Dolde F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4371; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Fowler AG, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032324; Itoh KM, 2014, MRS COMMUN, V4, P143, DOI 10.1557/mrc.2014.32; Kawakami E, 2014, NAT NANOTECHNOL, V9, P666, DOI [10.1038/nnano.2014.153, 10.1038/NNANO.2014.153]; Kok P, 2007, REV MOD PHYS, V79, P135, DOI 10.1103/RevModPhys.79.135; Koppens FHL, 2006, NATURE, V442, P766, DOI 10.1038/nature05065; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Maune BM, 2012, NATURE, V481, P344, DOI 10.1038/nature10707; Medford J, 2013, NAT NANOTECHNOL, V8, P654, DOI [10.1038/nnano.2013.168, 10.1038/NNANO.2013.168]; Meunier T, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.121403; Muhonen JT, 2014, NAT NANOTECHNOL, V9, P986, DOI [10.1038/nnano.2014.211, 10.1038/NNANO.2014.211]; Nowack KC, 2011, SCIENCE, V333, P1269, DOI 10.1126/science.1209524; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Shulman MD, 2012, SCIENCE, V336, P202, DOI 10.1126/science.1217692; Veldhorst M, 2014, NAT NANOTECHNOL, V9, P981, DOI [10.1038/nnano.2014.216, 10.1038/NNANO.2014.216]; Waldherr G, 2014, NATURE, V506, P204, DOI 10.1038/nature12919; Yang CH, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4901218; Yang CH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3069	27	596	625	15	336	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					410	414		10.1038/nature15263	http://dx.doi.org/10.1038/nature15263			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26436453	Green Submitted			2022-12-28	WOS:000362730200047
J	Wiesner, T; Lee, W; Obenauf, AC; Ran, LL; Murali, R; Zhang, QF; Wong, EWP; Hu, WH; Scott, SN; Shah, RH; Landa, I; Button, J; Lailler, N; Sboner, A; Gao, D; Murphy, DA; Cao, Z; Shukla, S; Hollmann, TJ; Wang, L; Borsu, L; Merghoub, T; Schwartz, GK; Postow, MA; Ariyan, CE; Fagin, JA; Zheng, DY; Ladanyi, M; Busam, KJ; Berger, MF; Chen, Y; Chi, P				Wiesner, Thomas; Lee, William; Obenauf, Anna C.; Ran, Leili; Murali, Rajmohan; Zhang, Qi Fan; Wong, Elissa W. P.; Hu, Wenhuo; Scott, Sasinya N.; Shah, Ronak H.; Landa, Inigo; Button, Julia; Lailler, Nathalie; Sboner, Andrea; Gao, Dong; Murphy, Devan A.; Cao, Zhen; Shukla, Shipra; Hollmann, Travis J.; Wang, Lu; Borsu, Laetitia; Merghoub, Taha; Schwartz, Gary K.; Postow, Michael A.; Ariyan, Charlotte E.; Fagin, James A.; Zheng, Deyou; Ladanyi, Marc; Busam, Klaus J.; Berger, Michael F.; Chen, Yu; Chi, Ping			Alternative transcription initiation leads to expression of a novel ALK isoform in cancer	NATURE			English	Article							DNA-SEQUENCING DATA; GENE; NEUROBLASTOMA; MUTATIONS; RECEPTOR; SEQ; IDENTIFICATION; DISCOVERY; FRAMEWORK; CHROMATIN	Activation of oncogenes by mechanisms other than genetic aberrations such as mutations, translocations, or amplifications is largely undefined. Here we report a novel isoform of the anaplastic lymphoma kinase (ALK) that is expressed in similar to 11% of melanomas and sporadically in other human cancer types, but not in normal tissues. The novelALK transcript initiates from a de novo alternative transcription initiation (ATI) site in ALK intron 19, and was termed ALK(ATI). In ALK(ATI)-expressing tumours, the ATI site is enriched for H3K4me3 and RNA polymerase II, chromatin marks characteristic of active transcription initiation sites(1). ALK(ATI) is expressed from both ALK alleles, and no recurrent genetic aberrations are found at the ALK locus, indicating that the transcriptional activation is independent of genetic aberrations at the ALK locus. The ALK(ATI) transcript encodes three proteins with molecular weights of 61.1, 60.8 and 58.7 kilodaltons, consisting primarily of the intracellular tyrosine kinase domain. ALK(ATI) stimulates multiple oncogenic signalling pathways, drives growth-factor-independent cell proliferation in vitro, and promotes tumorigenesis in vivo in mouse models. ALK inhibitors can suppress the kinase activity of ALK(ATI), suggesting that patients with ALK(ATI)-expressing tumours may benefit from ALK inhibitors. Our findings suggest a novel mechanism of oncogene activation in cancer through de novo alternative transcription initiation.	[Wiesner, Thomas; Ran, Leili; Zhang, Qi Fan; Wong, Elissa W. P.; Hu, Wenhuo; Scott, Sasinya N.; Shah, Ronak H.; Landa, Inigo; Button, Julia; Gao, Dong; Murphy, Devan A.; Cao, Zhen; Shukla, Shipra; Fagin, James A.; Ladanyi, Marc; Berger, Michael F.; Chen, Yu; Chi, Ping] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Wiesner, Thomas] Med Univ Graz, Dept Dermatol, A-8010 Graz, Austria; [Lee, William] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA; [Lee, William] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA; [Obenauf, Anna C.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Murali, Rajmohan; Scott, Sasinya N.; Shah, Ronak H.; Hollmann, Travis J.; Wang, Lu; Borsu, Laetitia; Ladanyi, Marc; Busam, Klaus J.; Berger, Michael F.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Murali, Rajmohan; Lailler, Nathalie; Berger, Michael F.] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, New York, NY 10065 USA; [Sboner, Andrea] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Sboner, Andrea] New York Presbyterian Hosp, Weill Cornell Med Coll, Inst Computat Biomed, New York, NY 10065 USA; [Sboner, Andrea] New York Presbyterian Hosp, Weill Cornell Med Coll, Inst Precis Med, New York, NY 10065 USA; [Merghoub, Taha] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY USA; [Schwartz, Gary K.] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Ctr Canc, New York, NY 10032 USA; [Postow, Michael A.; Fagin, James A.; Chen, Yu; Chi, Ping] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Postow, Michael A.; Fagin, James A.; Chen, Yu; Chi, Ping] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Ariyan, Charlotte E.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; [Zheng, Deyou] Yeshiva Univ Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Zheng, Deyou] Yeshiva Univ Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Zheng, Deyou] Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Memorial Sloan Kettering Cancer Center; Medical University of Graz; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center; Columbia University; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Chen, Y (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.	cheny1@mskcc.org; chip@mskcc.org	Merghoub, Taha/ABD-8362-2021; Wang, Lu/N-8128-2018; Shah, Ronak H/H-9726-2017; Ladanyi, Marc/AAG-8585-2019; Landa, Iñigo/AAK-8789-2020; Murali, Rajmohan/A-7960-2008	Wang, Lu/0000-0002-0073-0666; Shah, Ronak H/0000-0001-9042-6213; Landa, Iñigo/0000-0002-2817-8295; Ariyan, Charlotte/0000-0003-0818-3895; Wiesner, Thomas/0000-0001-5877-2992; Shukla, Shipra/0000-0001-9537-9540; Gao, Dong/0000-0003-1821-2741; Hollmann, Travis/0000-0003-1599-0433; Murali, Rajmohan/0000-0001-6988-4295; Zheng, Deyou/0000-0003-4354-5337; Obenauf, Anna/0000-0002-9556-5914	Harry J. Lloyd Trust; Jubilaumsfonds of the Oesterreichische Nationalbank [15461]; Charles H. Revson Senior Fellowship; National Institutes of Health (NIH) [DP2CA174499, K08CA151660]; Geoffrey Beene Cancer Research Fund; NIH [K08CA140946, P50CA172012, P01CA12943, P30 CA008748]; Alfred Bressler Scholars Endowment Fund; Gerstner Young Investigator Award; NATIONAL CANCER INSTITUTE [P50CA172012, K08CA151660, DP2CA174499, P30CA008748, K08CA140946] Funding Source: NIH RePORTER	Harry J. Lloyd Trust; Jubilaumsfonds of the Oesterreichische Nationalbank; Charles H. Revson Senior Fellowship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Geoffrey Beene Cancer Research Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred Bressler Scholars Endowment Fund; Gerstner Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P. Romanienko for the northern blot; W. Pao for the EML4-ALK construct; L. Garraway for the 501Mel and WW94 cell lines; P. Koppikar for the Ba/F3 cells; and C. Sawyers, O. Abdel-Wahab, K. Griewank, and O. Guryanova for reviewing the manuscript. Next generation sequencing, array CGH and NanoString nCounter Assay were performed at the Center for Molecular Oncology, and interphase fluorescence in situ hybridization in theMolecular Cytogenetics Core at Memorial Sloan Kettering Cancer Center. This work was supported by grants from the Harry J. Lloyd Trust, the Jubilaumsfonds of the Oesterreichische Nationalbank (15461) and a Charles H. Revson Senior Fellowship to T.W.; the National Institutes of Health (NIH) grants DP2CA174499 and K08CA151660, and the Geoffrey Beene Cancer Research Fund to P. C.; the NIH grant K08CA140946, Alfred Bressler Scholars Endowment Fund and Gerstner Young Investigator Award to Y.C.; the NIH grant P50CA172012 to J.A.F.; the NIH grant P01CA12943 to M.L., M.F.B, L.W. and L.B.; and the NIH grant P30 CA008748 to Memorial Sloan Kettering Cancer Center (Core Grant).	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Boeva V, 2011, BIOINFORMATICS, V27, P268, DOI 10.1093/bioinformatics/btq635; Bresler SC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002950; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Chi P, 2010, NATURE, V467, P849, DOI 10.1038/nature09409; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Montavon G, 2014, ONCOTARGET, V5, P4452, DOI 10.18632/oncotarget.2036; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Passoni L, 2009, CANCER RES, V69, P7338, DOI 10.1158/0008-5472.CAN-08-4419; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Reis PP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-46; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schulte JH, 2011, CLIN CANCER RES, V17, P5082, DOI 10.1158/1078-0432.CCR-10-2809; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Won HH, 2013, JOVE-J VIS EXP, DOI 10.3791/50710; Xie MC, 2013, NAT GENET, V45, P836, DOI 10.1038/ng.2649; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	39	142	152	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					453	+		10.1038/nature15258	http://dx.doi.org/10.1038/nature15258			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26444240	Green Accepted			2022-12-28	WOS:000362730200056
J	Huang, ES; Davis, AM				Huang, Elbert S.; Davis, Andrew M.			Glycemic Control in Older Adults With Diabetes Mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Huang, Elbert S.; Davis, Andrew M.] Univ Chicago, Gen Internal Med Sect, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA	University of Chicago	Huang, ES (corresponding author), Univ Chicago, Gen Internal Med Sect, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.	ehuang@medicine.bsd.uchicago.edu			AHRQ HHS [R01 HS018542] Funding Source: Medline; NCATS NIH HHS [UL1 TR000430] Funding Source: Medline; NIDDK NIH HHS [R01 DK081796, K24 DK105340, P30 DK092949] Funding Source: Medline; AHRQ [5R01HS018542-03, 5R01HS018542-02] Funding Source: Federal RePORTER; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018542] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092949, R01DK081796, K24DK105340] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2005, DIABETES CARE, V28, pS4; [Anonymous], 2014, RATE PER 100 CIVILIA; Cegelka A, 2013, J AM GERIATR SOC, V61, P2020, DOI 10.1111/jgs.12514; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Huang ES, 2011, DIABETES CARE, V34, P1329, DOI 10.2337/dc10-2377; Ickowicz E, 2003, J AM GERIATR SOC, V51, pS265; Kirkman MS, 2012, DIABETES CARE, V35, P2650, DOI 10.2337/dc12-1801; Lipska KJ, 2015, JAMA INTERN MED, V175, P356, DOI 10.1001/jamainternmed.2014.7345; Moreno G, 2013, J AM GERIATR SOC, V61, P2027, DOI 10.1111/jgs.12513	9	12	13	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2015	314	14					1509	1510		10.1001/jama.2015.8345	http://dx.doi.org/10.1001/jama.2015.8345			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2QI	26462000	Green Accepted			2022-12-28	WOS:000362647800019
J	Herman, F; Beyssac, O; Brughelli, M; Lane, SN; Leprince, S; Adatte, T; Lin, JYY; Avouac, JP; Cox, SC				Herman, Frederic; Beyssac, Olivier; Brughelli, Mattia; Lane, Stuart N.; Leprince, Sebastien; Adatte, Thierry; Lin, Jiao Y. Y.; Avouac, Jean-Philippe; Cox, Simon C.			Erosion by an Alpine glacier	SCIENCE			English	Article							FRANZ-JOSEF GLACIER; NEW-ZEALAND; SEDIMENT EVACUATION; CLIMATE; MODEL; EVOLUTION; ICE; OVERDEEPENINGS; FEEDBACKS; HYDROLOGY	Assessing the impact of glaciation on Earth's surface requires understanding glacial erosion processes. Developing erosion theories is challenging because of the complex nature of the erosion processes and the difficulty of examining the ice/bedrock interface of contemporary glaciers. We demonstrate that the glacial erosion rate is proportional to the ice-sliding velocity squared, by quantifying spatial variations in ice-sliding velocity and the erosion rate of a fast-flowing Alpine glacier. The nonlinear behavior implies a high erosion sensitivity to small variations in topographic slope and precipitation. A nonlinear rate law suggests that abrasion may dominate over other erosion processes in fast-flowing glaciers. It may also explain the wide range of observed glacial erosion rates and, in part, the impact of glaciation on mountainous landscapes during the past few million years.	[Herman, Frederic; Brughelli, Mattia; Lane, Stuart N.] Univ Lausanne, Inst Earth Surface Dynam, CH-1015 Lausanne, Switzerland; [Beyssac, Olivier] Univ Paris 06, Sorbonne Univ, Inst Mineral Phys Mat & Cosmochim,CNRS, Museum Natl Hist Nat,Inst Rech Dev,UMR 206,UMR 75, F-75005 Paris, France; [Leprince, Sebastien; Avouac, Jean-Philippe] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Adatte, Thierry] Univ Lausanne, Inst Earth Sci, CH-1015 Lausanne, Switzerland; [Lin, Jiao Y. Y.] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; [Cox, Simon C.] Inst Geol & Nucl Sci, Dunedin, New Zealand	University of Lausanne; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; California Institute of Technology; University of Lausanne; California Institute of Technology; GNS Science - New Zealand	Herman, F (corresponding author), Univ Lausanne, Inst Earth Surface Dynam, CH-1015 Lausanne, Switzerland.	frederic.herman@unil.ch	Beyssac, Olivier/F-6811-2012; IMPMC, ROCKS @/U-8478-2017; Lin, Jiao/A-2529-2016; Avouac, Jean-Philippe/B-5699-2015	Lin, Jiao/0000-0001-9233-0100; Avouac, Jean-Philippe/0000-0002-3060-8442; Herman, Frederic/0000-0002-7237-4656; Cox, Simon C./0000-0001-5899-8035	Swiss National Science Foundation [PP00P2_138956]; Gordon and Betty Moore Foundation [GBM 2808]; NSF Earth Sciences grant [1348704]; City of Paris (Emergence Program); Institut National des Sciences de l'Univers; Sorbonne Universites (Per-SU program); Division Of Earth Sciences [1348704] Funding Source: National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF Earth Sciences grant(National Science Foundation (NSF)); City of Paris (Emergence Program)(Region Ile-de-France); Institut National des Sciences de l'Univers; Sorbonne Universites (Per-SU program); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The authors thank B. Anderson for field support. F.H., M.B., and S.L thank the Fonds d'Investissement from the Faculty of Geosciences and Environnement at the University of Lausanne. F.H. was funded by Swiss National Science Foundation grant PP00P2_138956. S.L, J.Y.Y.L., and J.-P.A. were funded by the Gordon and Betty Moore Foundation through grant GBM 2808 and NSF Earth Sciences grant 1348704. O.B. was funded by the City of Paris (Emergence Program), Institut National des Sciences de l'Univers, and Sorbonne Universites (Per-SU program). Three anonymous reviewers are thanked for their constructive reviews. K. Cuffey is thanked for his feedback. Data are available in the supplementary materials.	Alley RB, 2003, NATURE, V424, P758, DOI 10.1038/nature01839; Anderson B, 2006, J GLACIOL, V52, P597, DOI 10.3189/172756506781828449; Anderson B, 2014, ARCT ANTARCT ALP RES, V46, P919, DOI 10.1657/1938-4246-46.4.919; Beaud F, 2014, GEOMORPHOLOGY, V219, P176, DOI 10.1016/j.geomorph.2014.04.036; Beyssac O, 2002, J METAMORPH GEOL, V20, P859, DOI 10.1046/j.1525-1314.2002.00408.x; Braun J, 1999, ANN GLACIOL-SER, V28, P282, DOI 10.3189/172756499781821797; Creyts TT, 2013, J GEOPHYS RES-EARTH, V118, P423, DOI 10.1002/jgrf.20033; Cuffey K., 2010, PHYS GLACIERS; Denton GH, 2010, SCIENCE, V328, P1652, DOI 10.1126/science.1184119; Egholm DL, 2009, NATURE, V460, P884, DOI 10.1038/nature08263; Hallet B, 1996, ANN GLACIOL, V22, P1; Hallet B, 1996, GLOBAL PLANET CHANGE, V12, P213, DOI 10.1016/0921-8181(95)00021-6; Hallet B, 1979, J GLACIOL, V17, P209; HARBOR JM, 1988, NATURE, V333, P347, DOI 10.1038/333347a0; Herman F, 2013, NATURE, V504, P423, DOI 10.1038/nature12877; Herman F, 2011, EARTH PLANET SC LETT, V310, P498, DOI 10.1016/j.epsl.2011.08.022; Hilton RG, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002905; HOOKE RL, 1991, GEOL SOC AM BULL, V103, P1104, DOI 10.1130/0016-7606(1991)103<1104:PFAWEO>2.3.CO;2; HUMPHREY NF, 1994, J GLACIOL, V40, P539, DOI 10.1017/S0022143000012429; Iverson NR, 2012, GEOLOGY, V40, P679, DOI 10.1130/G33079.1; Kessler MA, 2008, NAT GEOSCI, V1, P365, DOI 10.1038/ngeo201; Koppes MN, 2009, NAT GEOSCI, V2, P644, DOI 10.1038/NGEO616; Little TA, 2005, GEOL SOC AM BULL, V117, P707, DOI 10.1130/B25500.1; MacGregor KR, 2009, GEOMORPHOLOGY, V103, P189, DOI 10.1016/j.geomorph.2008.04.022; MacGregor KR, 2000, GEOLOGY, V28, P1031, DOI 10.1130/0091-7613(2000)28<1031:NSOGLP>2.0.CO;2; MOLNAR P, 1990, NATURE, V346, P29, DOI 10.1038/346029a0; Oerlemans J, 1997, ARCTIC ALPINE RES, V29, P233, DOI 10.2307/1552052; Riihimaki CA, 2005, J GEOPHYS RES-EARTH, V110, DOI 10.1029/2004JF000189; Swift DA, 2005, EARTH SURF PROC LAND, V30, P867, DOI 10.1002/esp.1197; Tomkin JH, 2007, EARTH PLANET SC LETT, V262, P385, DOI 10.1016/j.epsl.2007.07.040	30	108	111	4	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257					193	195		10.1126/science.aab2386	http://dx.doi.org/10.1126/science.aab2386			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9JB	26450208				2022-12-28	WOS:000362405600035
J	Winkelman, JW				Winkelman, John W.			Insomnia Disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; SHORT-SLEEP DURATION; PSYCHIATRIC-DISORDERS; BENZODIAZEPINE USE; DOUBLE-BLIND; EFFICACY; SYMPTOMS; RISK; SAFETY; ADULTS	A 77-year-old overweight woman with hypertension and arthritis reports that she has had trouble sleeping for "as long as I can remember." She has taken hypnotic medications nightly for almost 50 years; her medication was recently switched from lorazepam (1 mg), which had been successful, to trazodone (25 mg) by her primary care physician, who was concerned about her use of the former. She spends 9 hours in bed, from 11 p.m. to 8 a.m. She has only occasional difficulty falling asleep, but she awakens two to three times per night to urinate and lies in bed for over an hour at those times, "just worrying." How should her case be managed?	[Winkelman, John W.] Massachusetts Gen Hosp, Sleep Disorders Clin Res Program, Boston, MA 02114 USA; [Winkelman, John W.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Winkelman, JW (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, 1 Bowdoin Sq,9th Fl, Boston, MA 02114 USA.	jwwinkelman@partners.org			Merck; UCB Pharma; XenoPort; Flex Pharma; Purdue Pharma; Transcept Pharmaceuticals; NeuroMetrix	Merck(Merck & Company); UCB Pharma(UCB Pharma SA); XenoPort; Flex Pharma; Purdue Pharma; Transcept Pharmaceuticals; NeuroMetrix	Dr. Winkelman reports receiving fees for serving on advisory boards from Merck, UCB Pharma, XenoPort, and Flex Pharma, fees for providing expert testimony in a patent suit between a potential generic manufacturer and patent holders (Purdue Pharma and Transcept Pharmaceuticals), and grant support from UCB Pharma, XenoPort, Purdue Pharma, and NeuroMetrix and holding stock options in Flex Pharma. No other potential conflict of interest relevant to this article was reported.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2005, SLEEP, V28, P1049; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Bertisch SM, 2014, SLEEP, V37, P343, DOI 10.5665/sleep.3410; Bonnet MH, 2010, SLEEP MED REV, V14, P9, DOI 10.1016/j.smrv.2009.05.002; Buysse DJ, 2011, ARCH INTERN MED, V171, P887, DOI 10.1001/archinternmed.2010.535; de Gage SB, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5205; Edinger JD, 2013, J CLIN SLEEP MED, V9, P483, DOI 10.5664/jcsm.2672; Edinger JD, 2011, ARCH GEN PSYCHIAT, V68, P992, DOI 10.1001/archgenpsychiatry.2011.64; Edinger JD, 2009, SLEEP, V32, P499, DOI 10.1093/sleep/32.4.499; Fernandez-Mendoza J, 2012, HYPERTENSION, V60, P929, DOI 10.1161/HYPERTENSIONAHA.112.193268; Ferracioli-Oda E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063773; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Glass JR, 2008, J CLIN PSYCHOPHARM, V28, P182, DOI 10.1097/JCP.0b013e31816a9e4f; Harvey AG, 2012, PSYCHOL BULL, V138, P77, DOI 10.1037/a0025730; Herring W.J., 2014, BIOL PSYCHIAT; Krystal AD, 2008, SLEEP, V31, P79, DOI 10.1093/sleep/31.1.79; Krystal AD, 2011, SLEEP, V34, P1433, DOI 10.5665/SLEEP.1294; Kyle SD, 2014, SLEEP, V37, P229, DOI 10.5665/sleep.3386; Kyle SD, 2010, SLEEP MED REV, V14, P69, DOI 10.1016/j.smrv.2009.07.004; Laugsand LE, 2014, EUR HEART J, V35, P1382, DOI 10.1093/eurheartj/eht019; Laugsand LE, 2011, CIRCULATION, V124, P2073, DOI 10.1161/CIRCULATIONAHA.111.025858; Laugsand LE, 2014, SLEEP, V37, P1776, DOI 10.5665/sleep.4170; Li YP, 2014, CIRCULATION, V129, P737, DOI 10.1161/CIRCULATIONAHA.113.004500; Matthews EE, 2013, SLEEP MED REV, V17, P453, DOI 10.1016/j.smrv.2013.01.001; Mayer G, 2009, SLEEP, V32, P351, DOI 10.1093/sleep/32.3.351; Michelson D, 2014, LANCET NEUROL, V13, P461, DOI 10.1016/S1474-4422(14)70053-5; Mitchell MD, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-40; Morgenthaler T, 2006, SLEEP, V29, P1415; Morin CM, 2009, JAMA-J AM MED ASSOC, V301, P2005, DOI 10.1001/jama.2009.682; Morin CM, 2009, ARCH INTERN MED, V169, P447, DOI 10.1001/archinternmed.2008.610; Morin CM, 2005, SLEEP, V28, P1465, DOI 10.1093/sleep/28.11.1465; Morin CM, 2005, BEHAV RES THER, V43, P1, DOI 10.1016/j.brat.2003.12.002; Nierenberg AA, 1999, J CLIN PSYCHIAT, V60, P221, DOI 10.4088/JCP.v60n0403; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Ohayon MM, 2003, J PSYCHIAT RES, V37, P9, DOI 10.1016/S0022-3956(02)00052-3; Ribeiro JD, 2012, J AFFECT DISORDERS, V136, P743, DOI 10.1016/j.jad.2011.09.049; Ritterband LM, 2009, ARCH GEN PSYCHIAT, V66, P692, DOI 10.1001/archgenpsychiatry.2009.66; Roehrs T, 2001, PSYCHOPHARMACOLOGY, V155, P11, DOI 10.1007/s002130000661; Roth T, 2011, BIOL PSYCHIAT, V69, P592, DOI 10.1016/j.biopsych.2010.10.023; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Shahly V, 2012, ARCH GEN PSYCHIAT, V69, P1054, DOI 10.1001/archgenpsychiatry.2011.2188; Shekleton JA, 2014, SLEEP, V37, P107, DOI 10.5665/sleep.3318; Smink BE, 2010, CNS DRUGS, V24, P639, DOI 10.2165/11533170-000000000-00000; Trauer JM, 2015, ANN INTERN MED, V163, P191, DOI 10.7326/M14-2841; Vgontzas AN, 2013, SLEEP MED REV, V17, P241, DOI 10.1016/j.smrv.2012.09.005; Vgontzas AN, 2009, DIABETES CARE, V32, P1980, DOI 10.2337/dc09-0284; Walsh JK, 2007, SLEEP, V30, P959, DOI 10.1093/sleep/30.8.959; Walsh JK, 2011, SLEEP, V34, P997, DOI 10.5665/SLEEP.1150; Winkler A, 2014, CNS DRUGS, V28, P799, DOI 10.1007/s40263-014-0198-7; Woolcott JC, 2009, ARCH INTERN MED, V169, P1952, DOI 10.1001/archinternmed.2009.357	51	105	115	0	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2015	373	15					1437	1444		10.1056/NEJMcp1412740	http://dx.doi.org/10.1056/NEJMcp1412740			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS8XI	26444730				2022-12-28	WOS:000362372800010
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Why I let some patients stay longer in hospital	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Appleby J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1563; College of Emergency Medicine, 2014, CROWD EM DEP; GILLON R, 1994, BRIT MED J, V309, P184, DOI 10.1136/bmj.309.6948.184; Hall K, 2012, UNDERSTANDING IMPROV; HealthWatch England, 2015, SAF HOM WHAT HAPP OL; King's Fund, 2015, 16 KINGS FUND; NHS England, 2015, TRANSF URG EM CAR SE; Oliver D, 2014, MAKING HLTH CARE SYS	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 2	2015	351								h5225	10.1136/bmj.h5225	http://dx.doi.org/10.1136/bmj.h5225			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT0AK	26432800	Bronze			2022-12-28	WOS:000362455900005
J	Ball, P				Ball, Philip			Leading mathematician launches arXiv 'overlay' journal	NATURE			English	Editorial Material																			0	6	6	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					146	146		10.1038/nature.2015.18351	http://dx.doi.org/10.1038/nature.2015.18351			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS5CY	26432251	Bronze			2022-12-28	WOS:000362095100055
J	Leus, M; van de Ven, A				Leus, Manon; van de Ven, Annenienke			An Acute Dystonic Reaction after Treatment with Metoclopramide	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Leus, Manon; van de Ven, Annenienke] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	van de Ven, A (corresponding author), Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	Annenienke.vandeVen@radboudumc.nl	van de Ven, Annenienke/P-9494-2015						0	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2015	373	14							e16	10.1056/NEJMicm1412207	http://dx.doi.org/10.1056/NEJMicm1412207			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS3CI	26422744	Green Published			2022-12-28	WOS:000361948600011
J	Boyce, N				Boyce, Niall			Travelling light: 10 000 issues of The Lancet	LANCET			English	Editorial Material												niall.boyce@lancet.com							0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 26	2015	386	10000					1229	1229		10.1016/S0140-6736(15)00266-4	http://dx.doi.org/10.1016/S0140-6736(15)00266-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR9TQ	26460647				2022-12-28	WOS:000361700100015
J	da Costa, DW; Bouwense, SA; Schepers, NJ; Besselink, MG; van Santvoort, HC; van Brunschot, S; Bakker, OJ; Bollen, TL; Dejong, CH; van Goor, H; Boermeester, MA; Bruno, MJ; van Eijck, CH; Timmer, R; Weusten, BL; Consten, EC; Brink, MA; Spanier, BWM; Bilgen, EJS; Nieuwenhuijs, VB; Hofker, HS; Rosman, C; Voorburg, AM; Bosscha, K; van Duijvendijk, P; Gerritsen, JJ; Heisterkamp, J; de Hingh, IH; Witteman, BJ; Kruyt, PM; Scheepers, JJ; Molenaar, IQ; Schaapherder, AF; Manusama, ER; van der Waaij, LA; van Unen, J; Dijkgraaf, MG; van Ramshorst, B; Gooszen, HG; Boerma, D				da Costa, David W.; Bouwense, Stefan A.; Schepers, Nicolien J.; Besselink, Marc G.; van Santvoort, Hjalmar C.; van Brunschot, Sandra; Bakker, Olaf J.; Bollen, Thomas L.; Dejong, Cornelis H.; van Goor, Harry; Boermeester, Marja A.; Bruno, Marco J.; van Eijck, Casper H.; Timmer, Robin; Weusten, Bas L.; Consten, Esther C.; Brink, Menno A.; Spanier, B. W. Marcel; Bilgen, Ernst Jan Spillenaar; Nieuwenhuijs, Vincent B.; Hofker, H. Sijbrand; Rosman, Camiel; Voorburg, Annet M.; Bosscha, Koop; van Duijvendijk, Peter; Gerritsen, Jos J.; Heisterkamp, Joos; de Hingh, Ignace H.; Witteman, Ben J.; Kruyt, Philip M.; Scheepers, Joris J.; Molenaar, I. Quintus; Schaapherder, Alexander F.; Manusama, Eric R.; van der Waaij, Laurens A.; van Unen, Jacco; Dijkgraaf, Marcel G.; van Ramshorst, Bert; Gooszen, Hein G.; Boerma, Djamila		Dutch Pancreatitis Study Grp	Same-admission versus interval cholecystectomy for mild gallstone pancreatitis (PONCHO): a multicentre randomised controlled trial	LANCET			English	Article							LAPAROSCOPIC CHOLECYSTECTOMY; ENDOSCOPIC SPHINCTEROTOMY; BILIARY PANCREATITIS; MANAGEMENT; ASSOCIATION; GUIDELINES; SURGERY	Background In patients with mild gallstone pancreatitis, cholecystectomy during the same hospital admission might reduce the risk of recurrent gallstone-related complications, compared with the more commonly used strategy of interval cholecystectomy. However, evidence to support same-admission cholecystectomy is poor, and concerns exist about an increased risk of cholecystectomy-related complications with this approach. In this study, we aimed to compare same-admission and interval cholecystectomy, with the hypothesis that same-admission cholecystectomy would reduce the risk of recurrent gallstone-related complications without increasing the difficulty of surgery. Methods For this multicentre, parallel-group, assessor-masked, randomised controlled superiority trial, inpatients recovering from mild gallstone pancreatitis at 23 hospitals in the Netherlands (with hospital discharge foreseen within 48 h) were assessed for eligibility. Adult patients (aged >= 18 years) were eligible for randomisation if they had a serum C-reactive protein concentration less than 100 mg/L, no need for opioid analgesics, and could tolerate a normal oral diet. Patients with American Society of Anesthesiologists (ASA) class III physical status who were older than 75 years of age, all ASA class IV patients, those with chronic pancreatitis, and those with ongoing alcohol misuse were excluded. A central study coordinator randomly assigned eligible patients (1: 1) by computer-based randomisation, with varying block sizes of two and four patients, to cholecystectomy within 3 days of randomisation (same-admission cholecystectomy) or to discharge and cholecystectomy 25-30 days after randomisation (interval cholecystectomy). Randomisation was stratified by centre and by whether or not endoscopic sphincterotomy had been done. Neither investigators nor participants were masked to group assignment. The primary endpoint was a composite of readmission for recurrent gallstone-related complications (pancreatitis, cholangitis, cholecystitis, choledocholithiasis needing endoscopic intervention, or gallstone colic) or mortality within 6 months after randomisation, analysed by intention to treat. The trial was designed to reduce the incidence of the primary endpoint from 8% in the interval group to 1% in the same-admission group. Safety endpoints included bile duct leakage and other complications necessitating re-intervention. This trial is registered with Current Controlled Trials, number ISRCTN72764151, and is complete. Findings Between Dec 22, 2010, and Aug 19, 2013, 266 inpatients from 23 hospitals in the Netherlands were randomly assigned to interval cholecystectomy (n= 137) or same-admission cholecystectomy (n= 129). One patient from each group was excluded from the final analyses, because of an incorrect diagnosis of pancreatitis in one patient (in the interval group) and discontinued follow-up in the other (in the same-admission group). The primary endpoint occurred in 23 (17%) of 136 patients in the interval group and in six (5%) of 128 patients in the same-admission group (risk ratio 0.28, 95% CI 0.12-0.66; p= 0.002). Safety endpoints occurred in four patients: one case of bile duct leakage and one case of postoperative bleeding in each group. All of these were serious adverse events and were judged to be treatment related, but none led to death. Interpretation Compared with interval cholecystectomy, same-admission cholecystectomy reduced the rate of recurrent gallstone-related complications in patients with mild gallstone pancreatitis, with a very low risk of cholecystectomy-related complications.			Boerma, D (corresponding author), St Antonius Hosp, Dutch Pancreatitis Study Grp, POB 2500, NL-3430 EM Nieuwegein, Netherlands.	d.boerma@antoniusziekenhuis.nl	Besselink, Marc/H-3294-2019; Bouwense, Stefan/P-6468-2015; Besselink, Marc G/R-4268-2019; van Eijck, casper/K-5983-2019; Van Eijck, Casper/ABD-1655-2020; rosman, camiel/F-9059-2016; bosscha, koop/AAL-2916-2021; van Goor, H./H-8035-2014; van Duijvendijk, Peter/AAB-9876-2022; Bosscha, Koop/AAC-3641-2020	Bouwense, Stefan/0000-0002-7600-9429; Besselink, Marc G/0000-0003-2650-9350; rosman, camiel/0000-0002-9152-3987; bosscha, koop/0000-0002-7961-3314; van Goor, H./0000-0003-0323-4876; Boermeester, Marja/0000-0003-3890-8105; De Hingh, Ignace/0000-0003-3491-4268	Dutch Digestive Disease Foundation; Dutch Digestive Disease Foundation (Maag Lever Darm Stichting) [WO 11-03]	Dutch Digestive Disease Foundation; Dutch Digestive Disease Foundation (Maag Lever Darm Stichting)	Dutch Digestive Disease Foundation.; This trial was supported by the Dutch Digestive Disease Foundation (Maag Lever Darm Stichting), grant number WO 11-03. All authors vouch for the accuracy and completeness of the data and analyses.	Aboulian A, 2010, ANN SURG, V251, P615, DOI 10.1097/SLA.0b013e3181c38f1f; Bakker OJ, 2011, BRIT J SURG, V98, P1446, DOI 10.1002/bjs.7587; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Bergman JJGHM, 1996, GUT, V38, P141, DOI 10.1136/gut.38.1.141; Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; Bouwense SA, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-225; Buddingh KT, 2011, WORLD J SURG, V35, P1235, DOI 10.1007/s00268-011-1061-3; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Dutch Society of Internal Medicine, 2005, DUTCH AC PANCR GUID; El-Dhuwaib Y, 2012, ANN ROY COLL SURG, V94, P402, DOI 10.1308/003588412X13171221591934; Forsmark CE, 2007, GASTROENTEROLOGY, V132, P2022, DOI 10.1053/j.gastro.2007.03.065; Frossard JL, 2008, LANCET, V371, P143, DOI 10.1016/S0140-6736(08)60107-5; Giger UF, 2006, J AM COLL SURGEONS, V203, P723, DOI 10.1016/j.jamcollsurg.2006.07.018; Gurusamy KS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005440.pub3; Heider TR, 2006, J GASTROINTEST SURG, V10, P1, DOI 10.1016/j.gassur.2005.10.009; Hwang SS, 2013, JAMA SURG, V148, P867, DOI 10.1001/jamasurg.2013.3033; Ito K, 2008, J GASTROINTEST SURG, V12, P2164, DOI 10.1007/s11605-008-0603-y; Johnson CD, 2005, GUT, V54, P1, DOI 10.1136/gut.200A.057026; Johnstone M, 2014, SURG-J R COLL SURG E, V12, P134, DOI 10.1016/j.surge.2013.07.006; KELLY TR, 1988, SURGERY, V104, P600; Kulvatunyou N, 2014, AM J SURG, V208, P981, DOI 10.1016/j.amjsurg.2014.09.003; Lankisch PG, 2005, PANCREATOLOGY, V5, P591, DOI 10.1159/000087501; Mayumi T, 2007, J HEPATO-BILIARY-PAN, V14, P114, DOI 10.1007/s00534-006-1163-8; McAlister VC, 2007, COCHRANE DB SYST REV, V4; Mofidi R, 2006, BRIT J SURG, V93, P738, DOI 10.1002/bjs.5290; Monkhouse SJW, 2009, BRIT J SURG, V96, P751, DOI 10.1002/bjs.6644; Nealon WH, 2004, ANN SURG, V239, P741, DOI 10.1097/01.sla.0000128688.97556.94; Nguyen GC, 2010, PANCREAS, V39, pE42, DOI 10.1097/MPA.0b013e3181bd6387; Pezzilli R, 2007, DIGEST LIVER DIS, V39, P838, DOI 10.1016/j.dld.2007.05.014; Reinders JSK, 2010, GASTROENTEROLOGY, V138, P2315, DOI 10.1053/j.gastro.2010.02.052; Sandzen B, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-80; Sanjay P, 2008, SURG ENDOSC, V22, P1832, DOI 10.1007/s00464-007-9710-1; Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218; van Baal MC, 2012, ANN SURG, V255, P860, DOI 10.1097/SLA.0b013e3182507646; Venneman Niels G, 2003, Ann Hepatol, V2, P30; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068	36	176	178	2	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 26	2015	386	10000					1261	1268		10.1016/S0140-6736(15)00274-3	http://dx.doi.org/10.1016/S0140-6736(15)00274-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9TQ	26460661				2022-12-28	WOS:000361700100035
J	Head, SJ; Kappetein, AP				Head, Stuart J.; Kappetein, A. Pieter			Coronary artery disease: a dam in the river for ranolazine	LANCET			English	Editorial Material							CHRONIC ANGINA; INTERVENTION; SURGERY		[Head, Stuart J.; Kappetein, A. Pieter] Erasmus Univ, Med Ctr, Dept Cardiothorac Surg, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Head, SJ (corresponding author), Erasmus Univ, Med Ctr, Dept Cardiothorac Surg, NL-3000 CA Rotterdam, Netherlands.	s.head@erasmusmc.nl						Bangalore S, 2015, NEW ENGL J MED, V372, P1213, DOI 10.1056/NEJMoa1412168; Brooke BS, 2015, LANCET, V386, P884, DOI 10.1016/S0140-6736(15)60087-3; Chaitman BR, 2004, JAMA-J AM MED ASSOC, V291, P309, DOI 10.1001/jama.291.3.309; De Bruyne B, 2014, NEW ENGL J MED, V371, P1208, DOI 10.1056/NEJMoa1408758; Gutierrez JA, 2015, CLIN CARDIOL, V38, P469, DOI 10.1002/clc.22425; Head SJ, 2014, EUR HEART J, V35, P2821, DOI 10.1093/eurheartj/ehu213; Head SJ, 2013, EUR HEART J, V34, P2510, DOI 10.1093/eurheartj/eht059; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; Weisz G, 2016, LANCET, V387, P136, DOI 10.1016/S0140-6736(15)00459-6; Wilson SR, 2009, J AM COLL CARDIOL, V53, P1510, DOI 10.1016/j.jacc.2009.01.037; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]	11	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2016	387	10014					100	102		10.1016/S0140-6736(15)00458-4	http://dx.doi.org/10.1016/S0140-6736(15)00458-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8LF	26474812				2022-12-28	WOS:000368055500008
J	Siu, AL				Siu, A. L.		US Preventive Serv Task Force	Screening for High Blood Pressure in Adults: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	2	3	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					JC1	JC1		10.7326/P15-9036	http://dx.doi.org/10.7326/P15-9036			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26458190				2022-12-28	WOS:000365746400002
J	Pipoly, I; Bokony, V; Kirkpatrick, M; Donald, PF; Szekely, T; Liker, A				Pipoly, Ivett; Bokony, Veronika; Kirkpatrick, Mark; Donald, Paul F.; Szekely, Tomas; Liker, Andras			The genetic sex-determination system predicts adult sex ratios in tetrapods	NATURE			English	Article							EVOLUTION; POPULATIONS; SELECTION; BIRDS; PHYLOGENIES; CONFLICT; MEN; TOO	The adult sex ratio (ASR) has critical effects on behaviour, ecology and population dynamics(1,2), but the causes of variation in ASRs are unclear(3,4). Here we assess whether the type of genetic sex determination influences the ASR using data from 344 species in 117 families of tetrapods. We show that taxa with female heterogamety have a significantly more male-biased ASR (proportion of males: 0.55 +/- 0.01 (mean +/- s.e.m.)) than taxa with male heterogamety (0.43 +/- 0.01). The genetic sex-determination system explains 24% of interspecific variation in ASRs in amphibians and 36% in reptiles. We consider several genetic factors that could contribute to this pattern, including meiotic drive and sex-linked deleterious mutations, but further work is needed to quantify their effects. Regardless of the mechanism, the effects of the genetic sex-determination system on the adult sex ratio are likely to have profound effects on the demography and social behaviour of tetrapods.	[Pipoly, Ivett; Bokony, Veronika; Liker, Andras] Univ Pannonia, Dept Limnol, H-8201 Veszprem, Hungary; [Bokony, Veronika] Hungarian Acad Sci, Ctr Agr Res, Inst Plant Protect, Lendulet Evolutionary Ecol Res Grp, H-1022 Budapest, Hungary; [Kirkpatrick, Mark] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Donald, Paul F.] Royal Soc Protect Birds, RSPB Ctr Conservat Sci, Sandy SG19 2DL, Beds, England; [Donald, Paul F.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge CB2 3EJ, England; [Szekely, Tomas] Univ Bath, Dept Biol & Biochem, Milner Ctr Evolut, Bath BA2 7AY, Avon, England	University of Pannonia; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; University of Texas System; University of Texas Austin; Royal Society for Protection of Birds; University of Cambridge; University of Bath	Liker, A (corresponding author), Univ Pannonia, Dept Limnol, Pf 158, H-8201 Veszprem, Hungary.	aliker@almos.uni-pannon.hu	Bókony, Veronika/AAH-7679-2020; Szekely, Tamas/I-7089-2016	Bókony, Veronika/0000-0002-2136-5346; Szekely, Tamas/0000-0003-2093-0056; Pipoly, Ivett/0000-0002-4541-6056; Donald, Paul F./0000-0003-0023-6200	European Union [TAMOP-4.2.2.B-15/1/KONV-2015-0004]; US National Science Foundation [DEB-0819901]; Humboldt Award; MTA-DE 'Lendulet' grant; Hungarian Scientific Research Fund [OTKA K112838]; Marie Curie Intra-European Fellowship	European Union(European Commission); US National Science Foundation(National Science Foundation (NSF)); Humboldt Award(Alexander von Humboldt Foundation); MTA-DE 'Lendulet' grant; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Marie Curie Intra-European Fellowship(European Commission)	M. Pennell and G. Imreh helped construct the phylogeny figure. We thank T. H. Clutton-Brock, S. P. Otto, D. Bachtrog and K. Reinhold for suggestions, and R. P. Freckleton for advice on analyses. We were supported by the European Union (TAMOP-4.2.2.B-15/1/KONV-2015-0004), and by the US National Science Foundation (DEB-0819901 to M.K.). T.S. was supported by a Humboldt Award and MTA-DE 'Lendulet' grant in projects that lead to the current work. A.L. was supported by the Hungarian Scientific Research Fund (OTKA K112838) and a Marie Curie Intra-European Fellowship.	Adkins-Regan E, 2014, AM NAT, V183, P519, DOI 10.1086/675303; Bachtrog D, 2006, CURR OPIN GENET DEV, V16, P578, DOI 10.1016/j.gde.2006.10.007; Bachtrog D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001899; Bessa-Gomes C, 2004, ECOL LETT, V7, P802, DOI 10.1111/j.1461-0248.2004.00632.x; Burt A, 2008, GENES CONFLICT BIOL; COCKBURN A, 1985, OECOLOGIA, V66, P427, DOI 10.1007/BF00378310; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; Field DL, 2013, EVOLUTION, V67, P661, DOI 10.1111/evo.12001; Griskevicius V, 2012, J PERS SOC PSYCHOL, V102, P69, DOI 10.1037/a0024761; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hough J, 2013, EVOLUTION, V67, P1915, DOI 10.1111/evo.12066; Jaenike J, 2001, ANNU REV ECOL SYST, V32, P25, DOI 10.1146/annurev.ecolsys.32.081501.113958; Kokko H, 2008, J EVOLUTION BIOL, V21, P919, DOI 10.1111/j.1420-9101.2008.01540.x; Le Galliard JF, 2005, P NATL ACAD SCI USA, V102, P18231, DOI 10.1073/pnas.0505172102; Liker A, 2005, EVOLUTION, V59, P890, DOI 10.1554/04-560; Liker A, 2014, CURR BIOL, V24, P880, DOI 10.1016/j.cub.2014.02.059; Liker A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2600; Mank JE, 2013, TRENDS GENET, V29, P677, DOI 10.1016/j.tig.2013.07.005; Morrison C, 2003, J ANIM ECOL, V72, P270, DOI 10.1046/j.1365-2656.2003.00696.x; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Qi Y, 2013, ECOL EVOL, V3, P1219, DOI 10.1002/ece3.532; Roberts RB, 2009, SCIENCE, V326, P998, DOI 10.1126/science.1174705; Schacht R, 2014, TRENDS ECOL EVOL, V29, P214, DOI 10.1016/j.tree.2014.02.001; Szekely T, 2014, J EVOLUTION BIOL, V27, P1500, DOI 10.1111/jeb.12415; Szekely T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0342; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; van Doorn GS, 2010, GENETICS, V186, P629, DOI 10.1534/genetics.110.118596; Werren JH, 1998, ANNU REV ECOL SYST, V29, P233, DOI 10.1146/annurev.ecolsys.29.1.233; Wilson E.O., 1975, P1	30	71	72	2	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					91	94		10.1038/nature15380	http://dx.doi.org/10.1038/nature15380			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26444239	Green Submitted			2022-12-28	WOS:000364270700049
J	Mayor, A; Bardaji, A; Macete, E; Nhampossa, T; Fonseca, AM; Gonzalez, R; Maculuve, S; Cistero, P; Ruperez, M; Campo, J; Vala, A; Sigauque, B; Jimenez, A; Machevo, S; de la Fuente, L; Nhama, A; Luis, L; Aponte, JJ; Acacio, S; Nhacolo, A; Chitnis, C; Dobano, C; Sevene, E; Alonso, PL; Menendez, C				Mayor, Alfredo; Bardaji, Azucena; Macete, Eusebio; Nhampossa, Tacilta; Maria Fonseca, Ana; Gonzalez, Raquel; Maculuve, Sonia; Cistero, Pau; Ruperez, Maria; Campo, Joe; Vala, Anifa; Sigauque, Betuel; Jimenez, Alfons; Machevo, Sonia; de la Fuente, Laura; Nhama, Abel; Luis, Leopoldina; Aponte, John J.; Acacio, Sozinho; Nhacolo, Arsenio; Chitnis, Chetan; Dobano, Carlota; Sevene, Esperanza; Luis Alonso, Pedro; Menendez, Clara			Changing Trends in P. falciparum Burden, Immunity, and Disease in Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLASMODIUM-FALCIPARUM; CHONDROITIN SULFATE; INFECTED ERYTHROCYTES; MALARIA; WOMEN; ANTIBODIES; SURFACE; TRANSMISSION; CONSEQUENCES; PREVALENCE	BACKGROUND Prevention of reinfection and resurgence is an integral component of the goal to eradicate malaria. However, the adverse effects of malaria resurgences are not known. METHODS We assessed the prevalence of Plasmodium falciparum infection among 1819 Mozambican women who delivered infants between 2003 and 2012. We used microscopic and histologic examination and a quantitative polymerase-chain-reaction (qPCR) assay, as well as flow-cytometric analysis of IgG antibody responses against two parasite lines. RESULTS Positive qPCR tests for P. falciparum decreased from 33% in 2003 to 2% in 2010 and increased to 6% in 2012, with antimalarial IgG antibody responses mirroring these trends. Parasite densities in peripheral blood on qPCR assay were higher in 2010-2012 (geometric mean [+/-SD], 409+/-1569 genomes per microliter) than in 2003-2005 (44+/-169 genomes per microliter, P=0.02), as were parasite densities in placental blood on histologic assessment (50+/-39% of infected erythrocytes vs. 4+/-6%, P<0.001). The malaria-associated reduction in maternal hemoglobin levels was larger in 2010-2012 (10.1+/-1.8 g per deciliter in infected women vs. 10.9+/-1.7 g per deciliter in uninfected women; mean difference, -0.82 g per deciliter; 95% confidence interval [CI], -1.39 to -0.25) than in 2003-2005 (10.5+/-1.1 g per deciliter vs. 10.6+/-1.5 g per deciliter; difference, -0.12 g per deciliter; 95% CI, -0.67 to 0.43), as was the reduction in birth weight (2863+/-440 g in women with past or chronic infections vs. 3070+/-482 g in uninfected women in 2010-2012; mean difference, -164.5 g; 95% CI, -289.7 to -39.4; and 2994+/-487 g vs. 3117+/-455 g in 2003-2005; difference, -44.8 g; 95% CI, -139.1 to 49.5). CONCLUSIONS Antimalarial antibodies were reduced and the adverse consequences of P. falciparum infections were increased in pregnant women after 5 years of a decline in the prevalence of malaria. (Funded by Malaria Eradication Scientific Alliance and others.)	[Mayor, Alfredo; Bardaji, Azucena; Maria Fonseca, Ana; Gonzalez, Raquel; Cistero, Pau; Ruperez, Maria; Campo, Joe; Jimenez, Alfons; de la Fuente, Laura; Aponte, John J.; Dobano, Carlota; Luis Alonso, Pedro; Menendez, Clara] Barcelona Ctr Int Hlth Res CRESIB, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain; [Mayor, Alfredo; Bardaji, Azucena; Maria Fonseca, Ana; Gonzalez, Raquel; Cistero, Pau; Ruperez, Maria; Campo, Joe; Jimenez, Alfons; de la Fuente, Laura; Aponte, John J.; Dobano, Carlota; Luis Alonso, Pedro; Menendez, Clara] Hosp Clin Univ Barcelona, E-08007 Barcelona, Spain; [Jimenez, Alfons] Ctr Invest Biomed Red Epidemiol & Salud Publ, Madrid, Spain; [Mayor, Alfredo; Bardaji, Azucena; Macete, Eusebio; Nhampossa, Tacilta; Gonzalez, Raquel; Maculuve, Sonia; Ruperez, Maria; Vala, Anifa; Sigauque, Betuel; Machevo, Sonia; Nhama, Abel; Luis, Leopoldina; Aponte, John J.; Acacio, Sozinho; Nhacolo, Arsenio; Dobano, Carlota; Sevene, Esperanza; Luis Alonso, Pedro; Menendez, Clara] CISM, Maputo, Mozambique; [Nhampossa, Tacilta; Maculuve, Sonia; Sigauque, Betuel; Nhama, Abel; Acacio, Sozinho] Minist Hlth, Inst Nacl Saude, Maputo, Mozambique; [Machevo, Sonia; Sevene, Esperanza] Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique; [Maria Fonseca, Ana] Univ Porto, Grad Program Areas Basic & Appl Biol, P-4100 Oporto, Portugal; [Chitnis, Chetan] Int Ctr Genet Engn & Biotechnol, New Delhi, India	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Centro de Investigacao em Saude de Manhica; Eduardo Mondlane University; Universidade do Porto; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Mayor, A (corresponding author), Hosp Univ Barcelona, CRESIB, ISGlobal, Carrer Rossello 153 CEK, E-08036 Barcelona, Spain.	alfredo.mayor@isglobal.org	Gonzalez, Raquel/J-3604-2017; Bardají, Azucena/AAE-9145-2019; Menéndez, Clara/Q-3446-2016; Cisteró, Pau/H-2468-2017; Mayor, Alfredo/H-7488-2017; Dobaño, Carlota/N-4119-2014; Alonso, Azucena Bardají/V-5978-2018; JIMENEZ, ALFONS/L-2106-2019; Alonso, Pedro L/AAZ-3645-2020; Fonseca, Ana Maria/J-4048-2017	Gonzalez, Raquel/0000-0001-5487-801X; Menéndez, Clara/0000-0002-2641-6907; Cisteró, Pau/0000-0001-7225-4331; Mayor, Alfredo/0000-0003-3890-2897; Dobaño, Carlota/0000-0002-6751-4060; Alonso, Azucena Bardají/0000-0002-5135-0540; JIMENEZ, ALFONS/0000-0003-0301-3344; Alonso, Pedro L/0000-0003-3292-3443; Chitnis, Chetan/0000-0002-8773-9865; Ruperez, Maria/0000-0001-8322-7881; Fonseca, Ana Maria/0000-0001-8051-4850; Fuente-Soro, Laura/0000-0002-8580-5857	Malaria Eradication Scientific Alliance	Malaria Eradication Scientific Alliance	Funded by Malaria Eradication Scientific Alliance and others.	Aitken EH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029874; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000398; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Alonso PL, 2002, POPULATION HLTH DEV, P189; Ataide R, 2014, TRENDS PARASITOL, V30, P85, DOI 10.1016/j.pt.2013.12.007; Bouyou-Akotet Marielle Karine, 2011, Sante, V21, P199, DOI 10.1684/san.2011.0266; Bouyou-Akotet MK, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-18; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Feng GA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012012; Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733; Gonzalez R, 2012, EXPERT REV ANTI-INFE, V10, P153, DOI [10.1586/ERI.11.167, 10.1586/eri.11.167]; Guinovart C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032362; Kalayjian BC, 2013, AM J TROP MED HYG, V89, P1129, DOI 10.4269/ajtmh.13-0250; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Mayor A, 2013, J INFECT DIS, V207, P1664, DOI 10.1093/infdis/jit083; Mayor A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-9; Megnekou R, 2005, INFECT IMMUN, V73, P4112, DOI 10.1128/IAI.73.7.4112-4118.2005; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; O'Neil-Dunne I, 2001, INFECT IMMUN, V69, P7487, DOI 10.1128/IAI.69.12.7487-7492.2001; Ordi J, 1998, AM J SURG PATHOL, V22, P1006, DOI 10.1097/00000478-199808000-00011; Planche T, 2001, AM J TROP MED HYG, V65, P599, DOI 10.4269/ajtmh.2001.65.599; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; ROGERSON SJ, 1995, J EXP MED, V182, P15, DOI 10.1084/jem.182.1.15; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Serra-Casas E, 2010, J INFECT DIS, V201, P123, DOI 10.1086/648595; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; Staalsoe T, 2001, J INFECT DIS, V184, P618, DOI 10.1086/322809; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Swysen C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-223; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Tutterrow YL, 2012, INFECT IMMUN, V80, P1479, DOI 10.1128/IAI.00071-12; WALTON GA, 1949, ANN TROP MED PARASIT, V43, P117, DOI 10.1080/00034983.1949.11685399; YAMADA M, 1989, AM J TROP MED HYG, V41, P161, DOI 10.4269/ajtmh.1989.41.161	38	51	51	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2015	373	17					1607	1617		10.1056/NEJMoa1406459	http://dx.doi.org/10.1056/NEJMoa1406459			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU1YH	26488692	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000363317800006
J	Baron, JA; Barry, EL; Mott, LA; Rees, JR; Sandler, RS; Snover, DC; Bostick, RM; Ivanova, A; Cole, BF; Ahnen, DJ; Beck, GJ; Bresalier, RS; Burke, CA; Church, TR; Cruz-Correa, M; Figueiredo, JC; Goodman, M; Kim, AS; Robertson, DJ; Rothstein, R; Shaukat, A; Seabrook, ME; Summers, RW				Baron, John A.; Barry, Elizabeth L.; Mott, Leila A.; Rees, Judy R.; Sandler, Robert S.; Snover, Dale C.; Bostick, Roberd M.; Ivanova, Anastasia; Cole, Bernard F.; Ahnen, Dennis J.; Beck, Gerald J.; Bresalier, Robert S.; Burke, Carol A.; Church, Timothy R.; Cruz-Correa, Marcia; Figueiredo, Jane C.; Goodman, Michael; Kim, Adam S.; Robertson, Douglas J.; Rothstein, Richard; Shaukat, Aasma; Seabrook, March E.; Summers, Robert W.			A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							D-RECEPTOR POLYMORPHISMS; CANCER-RISK; COLON CARCINOGENESIS; 25-HYDROXYVITAMIN D; RANDOMIZED-TRIAL; SUPPLEMENTATION; METAANALYSIS; FRACTURES; MORTALITY; MEN	BACKGROUND Epidemiologic and preclinical data suggest that higher intake and serum levels of vitamin D and higher intake of calcium reduce the risk of colorectal neoplasia. To further study the chemopreventive potential of these nutrients, we conducted a randomized, double-blind, placebo-controlled trial of supplementation with vitamin D, calcium, or both for the prevention of colorectal adenomas. METHODS We recruited patients with recently diagnosed adenomas and no known colorectal polyps remaining after complete colonoscopy. We randomly assigned 2259 participants to receive daily vitamin D-3 (1000 IU), calcium as carbonate (1200 mg), both, or neither in a partial 2x2 factorial design. Women could elect to receive calcium plus random assignment to vitamin D or placebo. Follow-up colonoscopy was anticipated to be performed 3 or 5 years after the baseline examinations, according to the endoscopist's recommendation. The primary end point was adenomas diagnosed in the interval from randomization through the anticipated surveillance colonoscopy. RESULTS Participants who were randomly assigned to receive vitamin D had a mean net increase in serum 25-hydroxyvitamin D levels of 7.83 ng per milliliter, relative to participants given placebo. Overall, 43% of participants had one or more adenomas diagnosed during follow-up. The adjusted risk ratios for recurrent adenomas were 0.99 (95% confidence interval [CI], 0.89 to 1.09) with vitamin D versus no vitamin D, 0.95 (95% CI, 0.85 to 1.06) with calcium versus no calcium, and 0.93 (95% CI, 0.80 to 1.08) with both agents versus neither agent. The findings for advanced adenomas were similar. There were few serious adverse events. CONCLUSIONS Daily supplementation with vitamin D-3 (1000 IU), calcium (1200 mg), or both after removal of colorectal adenomas did not significantly reduce the risk of recurrent colorectal adenomas over a period of 3 to 5 years.	[Baron, John A.; Robertson, Douglas J.; Rothstein, Richard] Geisel Sch Med Dartmouth, Dept Med, Hanover, NH USA; [Baron, John A.; Barry, Elizabeth L.; Mott, Leila A.; Rees, Judy R.] Geisel Sch Med Dartmouth, Dept Epidemiol, Hanover, NH USA; [Robertson, Douglas J.; Rothstein, Richard] Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03766 USA; [Baron, John A.; Sandler, Robert S.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Ivanova, Anastasia] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Snover, Dale C.] Fairview Southdale Hosp, Dept Pathol, Edina, MN USA; [Church, Timothy R.] Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN USA; [Kim, Adam S.] Univ Minnesota, Dept Med, Minnesota Gastroenterol, Minneapolis, MN 55455 USA; [Shaukat, Aasma] Minneapolis Vet Affairs VA Med Ctr, Minneapolis, MN USA; [Bostick, Roberd M.; Goodman, Michael] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Bostick, Roberd M.; Goodman, Michael] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Cole, Bernard F.] Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA; [Robertson, Douglas J.] VA Outcomes Grp, White River Jct, VT USA; [Ahnen, Dennis J.] Univ Colorado, Sch Med, Dept Med, Denver, CO USA; [Beck, Gerald J.] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH USA; [Burke, Carol A.] Cleveland Clin, Dept Gastroenterol & Hepatol, Cleveland, OH USA; [Bresalier, Robert S.] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Cruz-Correa, Marcia] Univ Puerto Rico, Puerto Rico Canc Ctr, San Juan, PR 00936 USA; [Figueiredo, Jane C.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Summers, Robert W.] Univ Iowa, Dept Internal Med, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA	Dartmouth College; Dartmouth College; Dartmouth College; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Emory University; Rollins School Public Health; Emory University; University of Vermont; VA Outcomes Group; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Texas System; UTMD Anderson Cancer Center; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Southern California; University of Iowa	Baron, JA (corresponding author), Univ N Carolina, CB 7555,4160-A Bioinformat Bldg,130 Mason Farm Rd, Chapel Hill, NC 27599 USA.	jabaron@med.unc.edu	Barry, Elizabeth/AAB-7916-2019; Church, Timothy/AAH-7017-2020	Church, Timothy/0000-0003-3292-5035; Bresalier, Robert/0000-0002-9740-281X; Kim, Adam/0000-0001-8263-6528	National Cancer Institute; ClinicalTrials.gov [NCT00153816]; NATIONAL CANCER INSTITUTE [P30CA023108, R01CA098286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ClinicalTrials.gov; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Cancer Institute; ClinicalTrials.gov number, NCT00153816.	Avenell A, 2012, J CLIN ENDOCR METAB, V97, P614, DOI 10.1210/jc.2011-1309; Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; Barry EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108094; BEATY MM, 1993, J NUTR, V123, P144, DOI 10.1093/jn/123.1.144; Bolland MJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3691; Bonithon-Kopp C, 2000, LANCET, V356, P1300, DOI 10.1016/S0140-6736(00)02813-0; Brown AJ, 1999, AM J PHYSIOL-RENAL, V277, pF157, DOI 10.1152/ajprenal.1999.277.2.F157; Chu DZJ, 2011, CLIN COLORECTAL CANC, V10, P310, DOI 10.1016/j.clcc.2011.06.005; Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005; Feldman D, 2014, NAT REV CANCER, V14, P342, DOI 10.1038/nrc3691; Gandini S, 2011, INT J CANCER, V128, P1414, DOI 10.1002/ijc.25439; Grau MV, 2003, J NATL CANCER I, V95, P1765, DOI 10.1093/jnci/djg110; Harris DM, 2004, J NUTR, V134, p3463S, DOI 10.1093/jn/134.12.3463S; Huncharek M, 2009, NUTR CANCER, V61, P47, DOI 10.1080/01635580802395733; Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 1997, DIET REF INT CALC PH; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Lee JE, 2011, NUTR RES PRACT, V5, P464, DOI 10.4162/nrp.2011.5.5.464; Leyssens C, 2013, ENDOCR-RELAT CANCER, V20, pR31, DOI 10.1530/ERC-12-0381; Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566; PENCE BC, 1993, MUTAT RES, V290, P87, DOI 10.1016/0027-5107(93)90036-F; Touvier M, 2011, CANCER EPIDEM BIOMAR, V20, P1003, DOI 10.1158/1055-9965.EPI-10-1141; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Wei MY, 2008, CANCER EPIDEM BIOMAR, V17, P2958, DOI 10.1158/1055-9965.EPI-08-0402; Weinstein SJ, 2011, AM J EPIDEMIOL, V173, P499, DOI 10.1093/aje/kwq398; Yin L, 2011, PREV MED, V53, P10, DOI 10.1016/j.ypmed.2011.05.013	26	204	211	1	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2015	373	16					1519	1530		10.1056/NEJMoa1500409	http://dx.doi.org/10.1056/NEJMoa1500409			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5VX	26465985	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000362880300008
J	Bel, S; Hooper, LV				Bel, Shai; Hooper, Lora V.			IMMUNOLOGY A bacterial nudge to T-cell function	NATURE			English	Editorial Material									[Bel, Shai; Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Hooper, Lora V.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute	Bel, S (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.	lora.hooper@utsouthwestern.edu	Bel, Shai/AAH-7870-2021	Bel, Shai/0000-0002-7166-4870				Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Burkett PR, 2015, J CLIN INVEST, V125, P2211, DOI 10.1172/JCI78085; Davis D. P., 1974, INFECT IMMUN, V10, P948; Derebe MG, 2014, ELIFE, V3, DOI 10.7554/eLife.03206; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	8	2	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					328	330		10.1038/526328a	http://dx.doi.org/10.1038/526328a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26469038				2022-12-28	WOS:000362730200030
J	Gachter, S				Gaechter, Simon			BEHAVIOURAL ECONOMICS Visible inequality breeds more inequality	NATURE			English	Editorial Material							COOPERATION		Univ Nottingham, Ctr Decis Res & Expt Econ, Nottingham NG7 2RD, England	University of Nottingham	Gachter, S (corresponding author), Univ Nottingham, Ctr Decis Res & Expt Econ, Nottingham NG7 2RD, England.	simon.gaechter@nottingham.ac.uk	Gachter, Simon/C-9787-2009	Gachter, Simon/0000-0002-7182-8505				Atkinson A., 2015, INEQUALITY WHAT CAN; Chin G, 2014, SCIENCE, V344, P818, DOI 10.1126/science.344.6186.818; Dohmen T, 2011, J PUBLIC ECON, V95, P279, DOI 10.1016/j.jpubeco.2010.11.025; Frank R., 2013, FALLING; Hopkins E, 2010, AM ECON J-MICROECON, V2, P106, DOI 10.1257/mic.2.3.106; Huck S, 2000, INT J IND ORGAN, V18, P39, DOI 10.1016/S0167-7187(99)00033-8; Nikiforakis N, 2010, GAME ECON BEHAV, V68, P689, DOI 10.1016/j.geb.2009.09.004; Nishi A, 2015, NATURE, V526, P426, DOI 10.1038/nature15392; Sadrieh A, 2006, EUR ECON REV, V50, P1197, DOI 10.1016/j.euroecorev.2005.01.009; VEBLEN T, 1999, THEORY LEISURE CLASS	10	3	3	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					333	334		10.1038/526333a	http://dx.doi.org/10.1038/526333a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT3TQ	26469042	Green Submitted			2022-12-28	WOS:000362730200034
J	Herzfeld, DJ; Kojima, Y; Soetedjo, R; Shadmehr, R				Herzfeld, David J.; Kojima, Yoshiko; Soetedjo, Robijanto; Shadmehr, Reza			Encoding of action by the Purkinje cells of the cerebellum	NATURE			English	Article							CAUDAL FASTIGIAL NUCLEUS; SACCADIC EYE-MOVEMENTS; OCULOMOTOR VERMIS; MACAQUE MONKEY; SPIKE ACTIVITY; MOSSY FIBERS; ADAPTATION; GENERATION; PATTERNS; CORTEX	Execution of accurate eye movements depends critically on the cerebellum(1-3), suggesting that the major output neurons of the cerebellum, Purkinje cells, may predict motion of the eye. However, this encoding of action for rapid eye movements (saccades) has remained unclear: Purkinje cells show little consistent modulation with respect to saccade amplitude(4,5) or direction(4), and critically, their discharge lasts longer than the duration of a saccade(6,7). Here we analysed Purkinje-cell discharge in the oculomotor vermis of behaving rhesus monkeys (Macaca mulatta)(8,9) and found neurons that increased or decreased their activity during saccades. We estimated the combined effect of these two populations via their projections to the caudal fastigial nucleus, and uncovered a simple-spike population response that precisely predicted the real-time motion of the eye. When we organized the Purkinje cells according to each cell's complex-spike directional tuning, the simple-spike population response predicted both the real-time speed and direction of saccade multiplicatively via a gain field. This suggests that the cerebellum predicts the real-time motion of the eye during saccades via the combined inputs of Purkinje cells onto individual nucleus neurons. A gain-field encoding of simple spikes emerges if the Purkinje cells that project onto a nucleus neuron are not selected at random but share a common complex-spike property.	[Herzfeld, David J.; Shadmehr, Reza] Johns Hopkins Univ, Sch Med, Lab Computat Motor Control, Dept Biomed Engn, Baltimore, MD 21205 USA; [Kojima, Yoshiko; Soetedjo, Robijanto] Univ Washington, Dept Physiol & Biophys, Washington Natl Primate Ctr, Seattle, WA 98195 USA	Johns Hopkins University; University of Washington; University of Washington Seattle	Herzfeld, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Lab Computat Motor Control, Dept Biomed Engn, Baltimore, MD 21205 USA.	dherzfe1@jhmi.edu; shadmehr@jhu.edu			NIH [R01NS078311, R01EY019258, R01EY023277, F31NS090860]; NATIONAL EYE INSTITUTE [R01EY019258, R01EY023277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS090860, R01NS078311] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These data were collected in the laboratory of A. Fuchs. The authors are grateful to his generosity. The authors would like to thank S. du Lac for comments. The work was supported by NIH grants R01NS078311, R01EY019258, R01EY023277 and F31NS090860.	ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; Barash S, 1999, J NEUROSCI, V19, P10931, DOI 10.1523/JNEUROSCI.19-24-10931.1999; Catz N, 2005, CURR BIOL, V15, P2179, DOI 10.1016/j.cub.2005.11.037; Catz N, 2008, P NATL ACAD SCI USA, V105, P7309, DOI 10.1073/pnas.0706032105; Dash S, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00003; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; FUCHS AF, 1993, J NEUROPHYSIOL, V70, P1723, DOI 10.1152/jn.1993.70.5.1723; FUCHS AF, 1966, J APPL PHYSIOL, V21, P1068, DOI 10.1152/jappl.1966.21.3.1068; Gad YP, 2010, NEURAL NETWORKS, V23, P789, DOI 10.1016/j.neunet.2010.05.007; HELMCHEN C, 1995, EXP BRAIN RES, V103, P198; Herzfeld DJ, 2014, SCIENCE, V345, P1349, DOI 10.1126/science.1253138; KASE M, 1980, J PHYSIOL-LONDON, V300, P539, DOI 10.1113/jphysiol.1980.sp013178; Kojima Y, 2010, BRAIN RES, V1366, P93, DOI 10.1016/j.brainres.2010.10.027; Kojima Y, 2010, J NEUROSCI, V30, P3715, DOI 10.1523/JNEUROSCI.4953-09.2010; Kralj-Hans I, 2007, EXP BRAIN RES, V177, P209, DOI 10.1007/s00221-006-0661-x; Krauzlis RJ, 2000, NEUROREPORT, V11, P1045, DOI 10.1097/00001756-200004070-00029; LISBERGER SG, 1986, J NEUROSCI, V6, P346; MCLAUGHLIN SC, 1967, PERCEPT PSYCHOPHYS, V2, P359, DOI 10.3758/BF03210071; OHTSUKA K, 1995, J NEUROPHYSIOL, V74, P1828, DOI 10.1152/jn.1995.74.5.1828; Paninski L, 2004, J NEUROSCI, V24, P8551, DOI 10.1523/JNEUROSCI.0919-04.2004; Person AL, 2012, NATURE, V481, P502, DOI 10.1038/nature10732; Prsa M, 2009, J NEUROSCI, V29, P250, DOI 10.1523/JNEUROSCI.4791-08.2009; ROBINSON FR, 1993, J NEUROPHYSIOL, V70, P1741, DOI 10.1152/jn.1993.70.5.1741; Soetedjo R, 2008, J NEUROPHYSIOL, V100, P1949, DOI 10.1152/jn.90526.2008; Telgkamp P, 2004, NEURON, V41, P113, DOI 10.1016/S0896-6273(03)00802-X; Thier P, 2000, NATURE, V405, P72, DOI 10.1038/35011062; Xu-Wilson M, 2009, J NEUROSCI, V29, P12930, DOI 10.1523/JNEUROSCI.3115-09.2009; YAMADA J, 1987, J COMP NEUROL, V265, P224, DOI 10.1002/cne.902650207	28	158	159	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					439	+		10.1038/nature15693	http://dx.doi.org/10.1038/nature15693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26469054	Green Accepted			2022-12-28	WOS:000362730200053
J	Chan, MA				Chan, Marjorie A.			The martian lake chronicles	SCIENCE			English	Editorial Material									Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Chan, MA (corresponding author), Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA.	marjorie.chan@utah.edu							0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257					167	167		10.1126/science.aad0902	http://dx.doi.org/10.1126/science.aad0902			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9JB	26450199				2022-12-28	WOS:000362405600022
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION Units of sampling, observation, and analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sedgwick, Philip] Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Barrett G, 2006, BMJ-BRIT MED J, V332, P1068, DOI 10.1136/bmj.38805.473738.7C; Sedgwick P, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4155; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2276; Sedgwick P, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4654	4	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2015	351								h5396	10.1136/bmj.h5396	http://dx.doi.org/10.1136/bmj.h5396			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT3SV	26453018				2022-12-28	WOS:000362728100002
J	Dolgin, E				Dolgin, Elie			MENTAL HEALTH Monsters in the mirror	NATURE			English	Editorial Material							BODY DYSMORPHIC DISORDER											Arienzo D, 2013, NEUROPSYCHOPHARMACOL, V38, P1130, DOI 10.1038/npp.2013.18; Dey JK, 2015, JAMA FACIAL PLAST SU, V17, P137, DOI 10.1001/jamafacial.2014.1492; Enander Jesper, 2014, BMJ Open, V4, pe005923, DOI 10.1136/bmjopen-2014-005923; Feusner JD, 2010, ARCH GEN PSYCHIAT, V67, P197, DOI 10.1001/archgenpsychiatry.2009.190; Phillips KA, 2015, J OBSESS-COMPULS REL, V6, P72, DOI 10.1016/j.jocrd.2015.06.004; Sarwer David B, 2002, Aesthet Surg J, V22, P531, DOI 10.1067/maj.2002.129451; Wilhelm S, 2014, BEHAV THER, V45, P314, DOI 10.1016/j.beth.2013.12.007	7	0	0	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					S14	S15		10.1038/526S14a	http://dx.doi.org/10.1038/526S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26444369				2022-12-28	WOS:000362399000007
J	Ford, AF; Shorter, J				Ford, Alice Flynn; Shorter, James			Fleeting Amyloid-like Forms of Rim4 Ensure Meiotic Fidelity	CELL			English	Editorial Material							PRION-LIKE DOMAINS; RNA-BINDING PROTEINS; ALS; DISEASE	Berchowitz et al. establish that transient amyloid-like forms of Rim4, a yeast RNA-binding protein with a predicted prion domain, translationally repress cyclin CLB3 in meiosis I, thereby ensuring homologous chromosome segregation. These findings suggest that prion domains might enable formation of tightly regulated amyloid-like effectors in diverse functional settings.	[Ford, Alice Flynn; Shorter, James] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Ford, Alice Flynn; Shorter, James] Univ Penn, Perelman Sch Med, Neurosci Grad Grp, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Shorter, J (corresponding author), Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	jshorter@mail.med.upenn.edu	Shorter, James/ABE-7307-2020	Shorter, James/0000-0001-5269-8533	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099836] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM099836] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Carlile TM, 2008, CELL, V133, P280, DOI 10.1016/j.cell.2008.02.032; Hennig S, 2015, J CELL BIOL, V210, P529, DOI 10.1083/jcb.201504117; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008	9	5	5	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2					275	276		10.1016/j.cell.2015.09.049	http://dx.doi.org/10.1016/j.cell.2015.09.049			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26451477	Bronze, Green Accepted			2022-12-28	WOS:000362952700004
J	Hemingway, J				Hemingway, Janet			MALARIA Fifteen years of interventions	NATURE			English	Editorial Material									Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Hemingway, J (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	janet.hemingway@lstmed.ac.uk						Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bright AT, 2013, NATURE, V498, P446, DOI 10.1038/498446b; Hemingway J., 2015, LANCET; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X	4	11	11	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					198	199		10.1038/526198a	http://dx.doi.org/10.1038/526198a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS9GV	26450051				2022-12-28	WOS:000362399000031
J	Meybohm, P; Bein, B; Brosteanu, O; Cremer, J; Gruenewald, M; Stoppe, C; Coburn, M; Schaelte, G; Boning, A; Niemann, B; Roesner, J; Kletzin, F; Strouhal, U; Reyher, C; Laufenberg-Feldmann, R; Ferner, M; Brandes, IF; Bauer, M; Stehr, SN; Kortgen, A; Wittmann, M; Baumgarten, G; Meyer-Treschan, T; Kienbaum, P; Heringlake, M; Schon, J; Sander, M; Treskatsch, S; Smul, T; Wolwender, E; Schilling, T; Fuernau, G; Hasenclever, D; Zacharowski, K				Meybohm, P.; Bein, B.; Brosteanu, O.; Cremer, J.; Gruenewald, M.; Stoppe, C.; Coburn, M.; Schaelte, G.; Boening, A.; Niemann, B.; Roesner, J.; Kletzin, F.; Strouhal, U.; Reyher, C.; Laufenberg-Feldmann, R.; Ferner, M.; Brandes, I. F.; Bauer, M.; Stehr, S. N.; Kortgen, A.; Wittmann, M.; Baumgarten, G.; Meyer-Treschan, T.; Kienbaum, P.; Heringlake, M.; Schoen, J.; Sander, M.; Treskatsch, S.; Smul, T.; Wolwender, E.; Schilling, T.; Fuernau, G.; Hasenclever, D.; Zacharowski, K.		RIPHeart Study Collaborators	A Multicenter Trial of Remote Ischemic Preconditioning for Heart Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BYPASS GRAFT-SURGERY; RANDOMIZED CONTROLLED-TRIAL; ACUTE KIDNEY INJURY; CARDIAC-SURGERY; MYOCARDIAL-INFARCTION; DOUBLE-BLIND; METAANALYSIS; THERAPY; CARDIOPROTECTION; COMPLICATIONS	BACKGROUND Remote ischemic preconditioning (RIPC) is reported to reduce biomarkers of ischemic and reperfusion injury in patients undergoing cardiac surgery, but uncertainty about clinical outcomes remains. METHODS We conducted a prospective, double-blind, multicenter, randomized, controlled trial involving adults who were scheduled for elective cardiac surgery requiring cardiopulmonary bypass under total anesthesia with intravenous propofol. The trial compared upper-limb RIPC with a sham intervention. The primary end point was a composite of death, myocardial infarction, stroke, or acute renal failure up to the time of hospital discharge. Secondary end points included the occurrence of any individual component of the primary end point by day 90. RESULTS A total of 1403 patients underwent randomization. The full analysis set comprised 1385 patients (692 in the RIPC group and 693 in the sham-RIPC group). There was no significant between-group difference in the rate of the composite primary end point (99 patients [14.3%] in the RIPC group and 101 [14.6%] in the sham-RIPC group, P = 0.89) or of any of the individual components: death (9 patients [1.3%] and 4 [0.6%], respectively; P = 0.21), myocardial infarction (47 [6.8%] and 63 [9.1%], P = 0.12), stroke (14 [2.0%] and 15 [2.2%], P = 0.79), and acute renal failure (42 [6.1%] and 35 [5.1%], P = 0.45). The results were similar in the per-protocol analysis. No treatment effect was found in any subgroup analysis. No significant differences between the RIPC group and the sham-RIPC group were seen in the level of troponin release, the duration of mechanical ventilation, the length of stay in the intensive care unit or the hospital, new onset of atrial fibrillation, and the incidence of postoperative delirium. No RIPC-related adverse events were observed. CONCLUSIONS Upper-limb RIPC performed while patients were under propofol-induced anesthesia did not show a relevant benefit among patients undergoing elective cardiac surgery.	[Meybohm, P.; Strouhal, U.; Reyher, C.; Zacharowski, K.] Univ Hosp Frankfurt, Dept Anesthesiol, Intens Care Med & Pain Therapy, D-60590 Frankfurt, Germany; [Meybohm, P.; Bein, B.; Gruenewald, M.] Univ Hosp Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Kiel, Germany; [Cremer, J.] Univ Hosp Schleswig Holstein, Dept Cardiovasc Surg, Kiel, Germany; [Brosteanu, O.] Univ Leipzig, Ctr Heart, Clin Trial Ctr, D-04109 Leipzig, Germany; [Fuernau, G.] Univ Leipzig, Ctr Heart, Dept Internal Med Cardiol, D-04109 Leipzig, Germany; [Hasenclever, D.] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04109 Leipzig, Germany; [Stoppe, C.; Coburn, M.; Schaelte, G.] Univ Hosp Aachen, Dept Anesthesiol, Aachen, Germany; [Boening, A.; Niemann, B.] Univ Giessen, Dept Cardiovasc Surg, D-35390 Giessen, Germany; [Roesner, J.; Kletzin, F.] Univ Hosp Rostock, Clin Anesthesiol & Intens Care Med, Rostock, Germany; [Laufenberg-Feldmann, R.; Ferner, M.] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Anesthesiol, Mainz, Germany; [Brandes, I. F.; Bauer, M.] Univ Hosp Gottingen, Dept Anesthesiol & Intens Care Med, Gottingen, Germany; [Stehr, S. N.; Kortgen, A.] Jena Univ Hosp, Dept Anesthesiol & Intens Care Med, Jena, Germany; [Stehr, S. N.; Kortgen, A.] Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany; [Wittmann, M.; Baumgarten, G.] Univ Hosp Bonn, Dept Anesthesiol & Intens Care Med, Bonn, Germany; [Meyer-Treschan, T.; Kienbaum, P.] Univ Hosp Dusseldorf, Dept Anesthesiol & Intens Care Med, Dusseldorf, Germany; [Heringlake, M.; Schoen, J.] Med Univ Lubeck, Dept Anesthesiol & Intens Care Med, Lubeck, Germany; [Sander, M.; Treskatsch, S.] Charite, Dept Anesthesiol & Intens Care Med, D-13353 Berlin, Germany; [Smul, T.; Wolwender, E.] Univ Hosp Wurzburg, Dept Anesthesiol, Wurzburg, Germany; [Schilling, T.] Univ Hosp Magdeburg, Dept Anesthesiol, Magdeburg, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Leipzig University; RWTH Aachen University; RWTH Aachen University Hospital; Justus Liebig University Giessen; University of Rostock; Johannes Gutenberg University of Mainz; University of Gottingen; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Bonn; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Lubeck; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg; University Hospital Magdeburg	Meybohm, P (corresponding author), Univ Hosp Frankfurt, Dept Anesthesiol, Intens Care Med & Pain Therapy, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	patrick.meybohm@kgu.de	Niemann, Bernd/AAS-3019-2020; Gruenewald, Matthias/F-9485-2012; Meyer-Treschan, Tanja A./S-6624-2017; Wittmann, Maria/I-2125-2018; Meybohm, Patrick/K-4066-2017; Kienbaum, Peter/ABG-7729-2020; Treskatsch, Sascha/ABB-2449-2021; Albrecht, Martin/AAW-9303-2021; Sander, Michael/H-5434-2012; Fuernau, Georg/HCI-4640-2022; Fuernau, Georg/T-8798-2017; Heringlake, Matthias/AAJ-8249-2020; Wittmann, Maria/AAN-5276-2021	Meyer-Treschan, Tanja A./0000-0001-9363-1028; Wittmann, Maria/0000-0003-4786-7712; Meybohm, Patrick/0000-0002-2666-8696; Albrecht, Martin/0000-0003-2580-768X; Sander, Michael/0000-0003-1677-3609; Fuernau, Georg/0000-0002-3813-8772; Fuernau, Georg/0000-0002-3813-8772; Wittmann, Maria/0000-0003-4786-7712; Coburn, Mark/0000-0002-7930-0270; Stoppe, Christian/0000-0002-2028-2039; Zacharowski, Kai/0000-0002-0212-9110; Treskatsch, Sascha/0000-0002-0549-7680; Kienbaum, Peter/0000-0002-0655-9177	German Research Foundation [ME 3559/1-1]; Pulsion Medical Systems; 3M; Merck Sharp Dohme; Edwards Lifesciences; CSL Behring; Orion Pharma; AbbVie; GE Healthcare; Ratiopharm; Medicines Company; Fresenius Medical Care	German Research Foundation(German Research Foundation (DFG)); Pulsion Medical Systems; 3M(3M); Merck Sharp Dohme(Merck & Company); Edwards Lifesciences; CSL Behring; Orion Pharma; AbbVie(AbbVie); GE Healthcare(General ElectricGE Healthcare); Ratiopharm; Medicines Company; Fresenius Medical Care	Supported by a grant (ME 3559/1-1) from the German Research Foundation.; Dr. Bein reports receiving fees for serving on advisory boards from Pulsion Medical Systems, 3M, and Merck Sharp & Dohme; acting as medical advisor to the Medicines Company; receiving consulting and lecture fees from Edwards Lifesciences, CSL Behring, Orion Pharma, AbbVie, and GE Healthcare; receiving devices for research purposes from 3M; and receiving grant support from AbbVie and GE Healthcare. Dr. Boning reports receiving honoraria for presentations from Maquet, Bayer, AstraZeneca, and Orion Pharma. Dr. Stehr reports receiving honoraria and travel support from Teva/Ratiopharm. Dr. Heringlake reports receiving consulting and lecture fees from Orion Pharma. Dr. Sander reports receiving grant support from Ratiopharm, Pulsion Medical Systems, Edwards Lifesciences, the Medicines Company, and Fresenius Medical Care. No other potential conflict of interest relevant to this article was reported.	Ali ZA, 2007, CIRCULATION, V116, pI98, DOI 10.1161/circulationaha.106.679167; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Cheung MMH, 2006, J AM COLL CARDIOL, V47, P2277, DOI 10.1016/j.jacc.2006.01.066; GOULD AL, 1992, STAT MED, V11, P55, DOI 10.1002/sim.4780110107; Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3; Hausenloy DJ, 2011, NAT REV CARDIOL, V8, P619, DOI 10.1038/nrcardio.2011.85; Healy DA, 2014, INT J CARDIOL, V176, P20, DOI 10.1016/j.ijcard.2014.06.018; Hong DM, 2014, EUR HEART J, V35, P176, DOI 10.1093/eurheartj/eht346; Hoole SP, 2009, CIRCULATION, V119, P820, DOI 10.1161/CIRCULATIONAHA.108.809723; Hougaard KD, 2014, STROKE, V45, P159, DOI 10.1161/STROKEAHA.113.001346; Joung KW, 2013, KOREAN J ANESTHESIOL, V65, P418, DOI 10.4097/kjae.2013.65.5.418; Karuppasamy P, 2011, BASIC RES CARDIOL, V106, P511, DOI 10.1007/s00395-011-0185-9; Kottenberg E, 2012, ACTA ANAESTH SCAND, V56, P30, DOI 10.1111/j.1399-6576.2011.02585.x; Krogstad LEB, 2015, SCAND CARDIOVASC J, V49, P117, DOI 10.3109/14017431.2015.1010565; Li L, 2010, J SURG RES, V164, pE21, DOI 10.1016/j.jss.2010.06.016; Liakopoulos OJ, 2008, EUR HEART J, V29, P1548, DOI 10.1093/eurheartj/ehn198; Lomivorotov VV, 2012, INTERACT CARDIOV TH, V15, P18, DOI 10.1093/icvts/ivs118; Lucchinetti E, 2012, ANESTHESIOLOGY, V116, P296, DOI 10.1097/ALN.0b013e318242349a; Meybohm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064743; Meybohm P, 2012, EUR HEART J, V33, P1423; Morricone L, 1999, ACTA DIABETOL, V36, P77, DOI 10.1007/s005920050149; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Pickard JMJ, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-014-0453-6; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Rahman IA, 2010, CIRCULATION, V122, pS53, DOI 10.1161/CIRCULATIONAHA.109.926667; Thielmann M, 2013, LANCET, V382, P597, DOI 10.1016/S0140-6736(13)61450-6; Thielmann M, 2010, BASIC RES CARDIOL, V105, P657, DOI 10.1007/s00395-010-0104-5; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Venugopal V, 2009, HEART, V95, P1567, DOI 10.1136/hrt.2008.155770; Venugopal V, 2010, AM J KIDNEY DIS, V56, P1043, DOI 10.1053/j.ajkd.2010.07.014; WITYK RJ, 1994, STROKE, V25, P362, DOI 10.1161/01.STR.25.2.362; Young PJ, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0256-6; Zhou CH, 2013, J CARDIOTHOR VASC AN, V27, P305, DOI 10.1053/j.jvca.2012.09.028; Zimmerman RF, 2011, KIDNEY INT, V80, P861, DOI 10.1038/ki.2011.156	35	427	437	3	86	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2015	373	15					1397	1407		10.1056/NEJMoa1413579	http://dx.doi.org/10.1056/NEJMoa1413579			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS8XI	26436208	Green Published, Bronze			2022-12-28	WOS:000362372800006
J	Bilimoria, KY				Bilimoria, Karl Y.			Facilitating Quality Improvement Pushing the Pendulum Back Toward Process Measures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bilimoria, Karl Y.] Northwestern Univ, Feinberg Sch Med, SOQIC, Dept Surg, Chicago, IL 60611 USA; [Bilimoria, Karl Y.] Northwestern Univ, Feinberg Sch Med, Ctr Healthcare Studies, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Bilimoria, KY (corresponding author), Northwestern Univ, Feinberg Sch Med, SOQIC, Dept Surg, 633 N St Clair St,20th Floor, Chicago, IL 60611 USA.	k-bilimoria@northwestern.edu						Berenson RA, ACHIEVING POTENTIAL; Bilimoria KY, 2013, JAMA-J AM MED ASSOC, V310, P1482, DOI 10.1001/jama.2013.280048; Conway P, HEALTHAFFAIRS CLOG; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Rajaram R, 2015, JAMA-J AM MED ASSOC, V314, P375; Rajaram R, 2015, JAMA-J AM MED ASSOC, V13, P897	6	45	45	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2015	314	13					1333	1334		10.1001/jama.2015.12470	http://dx.doi.org/10.1001/jama.2015.12470			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2PH	26441175				2022-12-28	WOS:000362644700006
J	Cho, J; Yu, NK; Choi, JH; Sim, SE; Kang, SJ; Kwak, C; Lee, SW; Kim, JI; Choi, DI; Kim, VN; Kaang, BK				Cho, Jun; Yu, Nam-Kyung; Choi, Jun-Hyeok; Sim, Su-Eon; Kang, SukJae Joshua; Kwak, Chuljung; Lee, Seung-Woo; Kim, Ji-il; Choi, Dong Il; Kim, V. Narry; Kaang, Bong-Kiun			Multiple repressive mechanisms in the hippocampus during memory formation	SCIENCE			English	Article							LASTING SYNAPTIC PLASTICITY; MESSENGER-RNA TRANSLATION; CONSOLIDATION; SUPPRESSOR; MICRORNAS; PERIODS; GENOME; TARGET	Memory stabilization after learning requires translational and transcriptional regulations in the brain, yet the temporal molecular changes that occur after learning have not been explored at the genomic scale. We used ribosome profiling and RNA sequencing to quantify the translational status and transcript levels in the mouse hippocampus after contextual fear conditioning. We revealed three types of repressive regulations: translational suppression of ribosomal protein-coding genes in the hippocampus, learning-induced early translational repression of specific genes, and late persistent suppression of a subset of genes via inhibition of estrogen receptor 1 (ESR1/ER alpha) signaling. In behavioral analyses, overexpressing Nrsn1, one of the newly identified genes undergoing rapid translational repression, or activating ESR1 in the hippocampus impaired memory formation. Collectively, this study unveils the yet-unappreciated importance of gene repression mechanisms for memory formation.	[Cho, Jun; Kim, V. Narry] Inst for Basic Sci Korea, Ctr RNA Res, Seoul 151742, South Korea; [Cho, Jun; Yu, Nam-Kyung; Choi, Jun-Hyeok; Sim, Su-Eon; Kang, SukJae Joshua; Kwak, Chuljung; Lee, Seung-Woo; Kim, Ji-il; Choi, Dong Il; Kim, V. Narry; Kaang, Bong-Kiun] Seoul Natl Univ, Dept Biol Sci, Coll Nat Sci, Seoul 151747, South Korea	Institute for Basic Science - Korea (IBS); Seoul National University (SNU)	Kim, VN (corresponding author), Inst for Basic Sci Korea, Ctr RNA Res, Seoul 151742, South Korea.	narrykim@snu.ac.kr; kaang@snu.ac.kr			Institute for Basic Science from the Ministry of Science, Information, Communication and Technology and Future Planning of Korea [IBS-R008-D1]; National Research Foundation of the Ministry of Science, Information, Communication and Technology [2012R1A3A1050385]; Pohang Iron and Steel Company (POSCO) Tae Joon (TJ) Park Foundation	Institute for Basic Science from the Ministry of Science, Information, Communication and Technology and Future Planning of Korea; National Research Foundation of the Ministry of Science, Information, Communication and Technology; Pohang Iron and Steel Company (POSCO) Tae Joon (TJ) Park Foundation	We thank H. Chang, S.-C. Kwon, J. Park, Y. Choi, and J.-E. Park of the V. Narry Kim lab and H. K. Choe for helpful discussion of data analysis; and Y. Kim of the same lab for critical commentary on the manuscript. V.N.K was supported by grant IBS-R008-D1 from the Institute for Basic Science from the Ministry of Science, Information, Communication and Technology and Future Planning of Korea. B.-K.K. was supported by the National Honor Scientist Program (2012R1A3A1050385) from the National Research Foundation of the Ministry of Science, Information, Communication and Technology. J.-i.K. was supported by the Pohang Iron and Steel Company (POSCO) Tae Joon (TJ) Park Foundation. High-throughput sequencing data have been deposited in the National Center for Biotechnology Information Gene Expression Omnibus (GEO) database with accession number GSE72064.	Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; Alberini CM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021741; ARAKI M, 2009, RECENT RES DEV NEURO, V3, P111; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Bliss TVP, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-5; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; Cho J, 2012, CELL, V151, P765, DOI 10.1016/j.cell.2012.10.019; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Dash PK, 2006, J NEUROSCI, V26, P8048, DOI 10.1523/JNEUROSCI.0671-06.2006; Dias BG, 2014, NEURON, V83, P906, DOI 10.1016/j.neuron.2014.07.019; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Han XX, 2013, J NEUROSCI, V33, P2671, DOI 10.1523/JNEUROSCI.4937-12.2013; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Ida M, 2004, NEUROSCI RES, V50, P199, DOI 10.1016/j.neures.2004.06.018; Igaz LM, 2002, J NEUROSCI, V22, P6781; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kitchen RR, 2014, NAT NEUROSCI, V17, P1491, DOI 10.1038/nn.3829; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Raab-Graham KF, 2006, SCIENCE, V314, P144, DOI 10.1126/science.1131693; Santini E, 2014, PROG MOL BIOL TRANSL, V122, P131, DOI 10.1016/B978-0-12-420170-5.00005-2; Wang WY, 2012, LEARN MEMORY, V19, P359, DOI 10.1101/lm.026492.112	27	80	83	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					82	87		10.1126/science.aac7368	http://dx.doi.org/10.1126/science.aac7368			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26430118				2022-12-28	WOS:000362098300050
J	Sawada, M; Kato, K; Kunieda, T; Mikuni, N; Miyamoto, S; Onoe, H; Isa, T; Nishimura, Y				Sawada, Masahiro; Kato, Kenji; Kunieda, Takeharu; Mikuni, Nobuhiro; Miyamoto, Susumu; Onoe, Hirotaka; Isa, Tadashi; Nishimura, Yukio			Function of the nucleus accumbens in motor control during recovery after spinal cord injury	SCIENCE			English	Article							PREFRONTAL CORTEX; GRANGER CAUSALITY; VENTRAL STRIATUM; REWARD MAGNITUDE; HAND DEXTERITY; REACTION-TIME; RATS; ORGANIZATION; DOPAMINE; CIRCUITS	Motivation facilitates recovery after neuronal damage, but its mechanism is elusive. It is generally thought that the nucleus accumbens (NAc) regulates motivation-driven effort but is not involved in the direct control of movement. Using causality analysis, we identified the flow of activity from the NAc to the sensorimotor cortex (SMC) during the recovery of dexterous finger movements after spinal cord injury at the cervical level in macaque monkeys. Furthermore, reversible pharmacological inactivation of the NAc during the early recovery period diminished high-frequency oscillatory activity in the SMC, which was accompanied by a transient deficit of amelioration in finger dexterity obtained by rehabilitation. These results demonstrate that during recovery after spinal damage, the NAc up-regulates the high-frequency activity of the SMC and is directly involved in the control of finger movements.	[Sawada, Masahiro; Kato, Kenji; Isa, Tadashi; Nishimura, Yukio] Natl Inst Nat Sci, Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan; [Sawada, Masahiro; Kunieda, Takeharu; Miyamoto, Susumu] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068507, Japan; [Kato, Kenji; Isa, Tadashi; Nishimura, Yukio] Grad Univ Adv Studies, Sch Life Sci, Dept Physiol Sci, SOKENDAI, Hayama 2400193, Japan; [Mikuni, Nobuhiro] Sapporo Med Univ, Dept Neurosurg, Sapporo, Hokkaido 0608543, Japan; [Onoe, Hirotaka] RIKEN Ctr Life Sci Technol, Div Biofunct Dynam Imaging, Kobe, Hyogo 6500047, Japan; [Nishimura, Yukio] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Tokyo 1020076, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Kyoto University; Graduate University for Advanced Studies - Japan; Sapporo Medical University; RIKEN; Japan Science & Technology Agency (JST)	Nishimura, Y (corresponding author), Natl Inst Nat Sci, Natl Inst Physiol Sci, Dept Dev Physiol, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	yukio@nips.ac.jp		Sawada, Masahiro/0000-0002-3178-4552	MEXT [KAKENHI] [24300196, 15H01819]; Brain Machine Interface Development;  [26112008];  [26112003]; Grants-in-Aid for Scientific Research [26112008, 15H01818, 15H05871] Funding Source: KAKEN	MEXT [KAKENHI](Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Brain Machine Interface Development; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank P. Redgrave for comments on the manuscript and Y. Itani, N. Takahashi, M. Togawa, and K. Isa for technical help. The monkeys used in this study were provided by the National Institute of Natural Sciences through the National Bio-resource Project of the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). This work was supported by grants from the "Brain Machine Interface Development" and performed under the Strategic Research Program for Brain Sciences from MEXT and the Japan Agency for Medical Research and Development to Y.N., a Grant-in-Aid for Scientific Research on Innovative Areas "Adaptive circuit shift" to T.I. (Project no. 26112008) and H.O. (26112003), and a Grant-in-Aid for Scientific Research from MEXT to H.O. [KAKENHI (B) no. 24300196 and (A) no.15H01819]. All data are stored at the Department of Developmental Physiology at the National Institutes for Physiological Sciences, Okazaki, Japan.	Alstermark B, 2012, ANNU REV NEUROSCI, V35, P559, DOI 10.1146/annurev-neuro-062111-150527; AMALRIC M, 1987, J NEUROSCI, V7, P2129; ANNETT LE, 1989, PSYCHOPHARMACOLOGY, V99, P222, DOI 10.1007/BF00442812; Bernasconi C, 1999, BIOL CYBERN, V81, P199, DOI 10.1007/s004220050556; BRODAL A, 1973, BRAIN, V96, P675, DOI 10.1093/brain/96.4.675; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Brown VJ, 1995, EUR J NEUROSCI, V7, P2479, DOI 10.1111/j.1460-9568.1995.tb01046.x; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Chantal E. S., 1994, BEHAV BRAIN RES, V61, P9; Chemerinski E, 2001, STROKE, V32, P113, DOI 10.1161/01.STR.32.1.113; Giertler C, 2004, BEHAV PHARMACOL, V15, P55, DOI 10.1097/00008877-200402000-00007; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hesse W, 2003, J NEUROSCI METH, V124, P27, DOI 10.1016/S0165-0270(02)00366-7; Ikemoto S, 2003, SYNAPSE, V47, P117, DOI 10.1002/syn.10151; Jonas A., 2011, J NEUROSCI, V7, P2481; Kinoshita M, 2012, NATURE, V487, P235, DOI 10.1038/nature11206; LAWRENCE DG, 1968, BRAIN, V91, P1, DOI 10.1093/brain/91.1.1; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; McGinty VB, 2013, NEURON, V78, P910, DOI 10.1016/j.neuron.2013.04.010; Miyachi S, 2005, J NEUROSCI, V25, P2547, DOI 10.1523/JNEUROSCI.4186-04.2005; Miyachi S, 2006, NEUROSCI RES, V56, P300, DOI 10.1016/j.neures.2006.07.012; Nishimura Y, 2007, SCIENCE, V318, P1150, DOI 10.1126/science.1147243; Nishimura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024854; Nishimura Y, 2009, BRAIN, V132, P709, DOI 10.1093/brain/awn338; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P461, DOI 10.1007/s00213-006-0668-9; Sasaki S, 2004, J NEUROPHYSIOL, V92, P3142, DOI 10.1152/jn.00342.2004; Saxena SK, 2007, ACTA NEUROL SCAND, V115, P339, DOI 10.1111/j.1600-0404.2006.00751.x; Sugiyama Y, 2013, J NEUROPHYSIOL, V109, P2853, DOI 10.1152/jn.00814.2012; Supratim R., 2008, J NEUROSCI, V45, P11526	30	59	61	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					98	101		10.1126/science.aab3825	http://dx.doi.org/10.1126/science.aab3825			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26430122	Green Submitted			2022-12-28	WOS:000362098300054
J	Chico, RM; Moss, WJ				Chico, R. Matthew; Moss, William J.			Prevention of malaria in pregnancy: a fork in the road?	LANCET			English	Editorial Material							SULFADOXINE-PYRIMETHAMINE; INFECTION; THERAPY; AFRICA; WOMEN		[Chico, R. Matthew] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Moss, William J.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Chico, RM (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	matthew.chico@lshtm.ac.uk	Chico, R. Matthew/ABC-7601-2020					[Anonymous], 2004, STRATEGIC FRAMEWORK; BHATTACHARYYA MN, 1980, J REPROD MED, V24, P71; Chico RM, 2015, TROP MED INT HEALTH, V20, P1621, DOI 10.1111/tmi.12595; Chico RM, 2013, EXPERT REV ANTI-INFE, V11, P1303, DOI 10.1586/14787210.2013.851601; Clerk CA, 2008, J INFECT DIS, V198, P1202, DOI 10.1086/591944; Desai M, 2015, LANCET; Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733; Gutman J, 2015, J INFECT DIS, V211, P1997, DOI 10.1093/infdis/jiu836; Kayentao K, 2013, JAMA-J AM MED ASSOC, V309, P594, DOI 10.1001/jama.2012.216231; Roper C, 2003, LANCET, V361, P1174, DOI 10.1016/S0140-6736(03)12951-0; Schurmann D, 2002, EUR J CLIN MICROBIOL, V21, P353, DOI 10.1007/s10096-002-0723-3; Tagbor H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014425; World Health Organization (WHO), 2006, GUID COTR PROPH HIV	13	12	12	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 19	2015	386	10012					2454	2456		10.1016/S0140-6736(15)00325-6	http://dx.doi.org/10.1016/S0140-6736(15)00325-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ1LD	26429701	Green Accepted			2022-12-28	WOS:000366866400009
J	Siu, AL				Siu, Albert L.		US Preventive Serv Task Force	Screening for High Blood Pressure in Adults: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							WHITE-COAT HYPERTENSION; 10-YEAR FOLLOW-UP; CARDIOVASCULAR RISK; LABELING PATIENTS; PROGNOSTIC VALUE; OLDER PATIENTS; HOME; POPULATION; DIAGNOSIS; OFFICE	Description: Update of the 2007 U.S. Preventive Services Task Force (USPSTF) reaffirmation recommendation statement on screening for high blood pressure in adults. Methods: The USPSTF reviewed the evidence on the diagnostic accuracy of different methods for confirming a diagnosis of hypertension after initial screening and the optimal rescreening interval for diagnosing hypertension. Population: This recommendation applies to adults aged 18 years or older without known hypertension. Recommendation: The USPSTF recommends screening for high blood pressure in adults aged 18 years or older. (A recommendation) The USPSTF recommends obtaining measurements outside of the clinical setting for diagnostic confirmation before starting treatment.					Phillips, William R./V-1065-2017	Phillips, William R./0000-0003-2802-4349; Davidson, Karina/0000-0002-9162-477X; Kemper, Alex/0000-0001-5491-3997				AMELING EH, 1991, J CARDIOVASC PHARM, V18, P752, DOI 10.1097/00005344-199111000-00014; American Academy of Family Physicians, 2007, CLIN PREV SERV REC H; American Congress of Obstetricians and Gynecologists, 2013, WEE WOM REC; American Heart Association, 2014, UND BLOOD PRESS READ; Asayama K, 2006, HYPERTENSION, V48, P737, DOI 10.1161/01.HYP.0000240332.01877.11; Celis H, 2002, BLOOD PRESSURE, V11, P352, DOI 10.1080/080370502321095311; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clement DL, 2003, NEW ENGL J MED, V348, P2407, DOI 10.1056/NEJMoa022273; Cuspidi C, 2011, BLOOD PRESSURE, V20, P335, DOI 10.3109/08037051.2011.587280; Dolan E, 2005, HYPERTENSION, V46, P156, DOI 10.1161/01.HYP.0000170138.56903.7a; Fagard RH, 2005, J HUM HYPERTENS, V19, P801, DOI 10.1038/sj.jhh.1001903; Fogari, 1996, Blood Press Monit, V1, P51; Gasowski J, 2008, AM J HYPERTENS, V21, P994, DOI 10.1038/ajh.2008.231; Gerc V, 2000, BLOOD PRESS MONIT, V5, P203, DOI 10.1097/00126097-200008000-00002; Graves JW, 2010, BLOOD PRESS MONIT, V15, P146, DOI 10.1097/MBP.0b013e328337ce76; Gustavsen PH, 2003, J HUM HYPERTENS, V17, P811, DOI 10.1038/sj.jhh.1001643; Hermida RC, 2011, J AM COLL CARDIOL, V58, P1165, DOI 10.1016/j.jacc.2011.04.043; Hond ED, 2003, J HYPERTENS, V21, P717, DOI 10.1097/00004872-200304000-00014; Hozawa A, 2002, HYPERTENS RES, V25, P57, DOI 10.1291/hypres.25.57; Inden Y, 1998, CLIN CARDIOL, V21, P801, DOI 10.1002/clc.4960211104; International Organization for Standardization, 2009, IEC806012302009 INT; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Kaczorowski J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d442; Kario K, 2014, J HUM HYPERTENS, V28, P176, DOI 10.1038/jhh.2013.73; KHOURY S, 1992, AM J HYPERTENS, V5, P616, DOI 10.1093/ajh/5.9.616; MANN AH, 1977, PSYCHOL MED, V7, P431, DOI 10.1017/S0033291700004402; Manning G, 2000, AM J HYPERTENS, V13, P1035, DOI 10.1016/S0895-7061(00)00261-2; Manning G, 1999, J HUM HYPERTENS, V13, P817, DOI 10.1038/sj.jhh.1000924; Martinez MA, 1999, AM J HYPERTENS, V12, P251, DOI 10.1016/S0895-7061(98)00262-3; Mesquita-Bastos J, 2010, BLOOD PRESS MONIT, V15, P240, DOI 10.1097/MBP.0b013e32833c8b08; Myers Martin G, 2014, Can Fam Physician, V60, P127; Myers MG, 2010, J HYPERTENS, V28, P703, DOI 10.1097/HJH.0b013e328335d091; Myers MG, 2009, BLOOD PRESS MONIT, V14, P108, DOI 10.1097/MBP.0b013e32832c5167; Nasothimiou EG, 2014, J HUM HYPERTENS, V28, P224, DOI 10.1038/jhh.2013.104; Nasothimiou EG, 2012, HYPERTENS RES, V35, P750, DOI 10.1038/hr.2012.19; Niiranen TJ, 2010, HYPERTENSION, V55, P1346, DOI 10.1161/HYPERTENSIONAHA.109.149336; Nwankwo Tatiana, 2013, NCHS Data Brief, P1; Ohkubo T, 2005, J AM COLL CARDIOL, V46, P508, DOI 10.1016/j.jacc.2005.03.070; Ohkubo T, 1998, J HYPERTENS, V16, P971, DOI 10.1097/00004872-199816070-00010; Pessanha P, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-57; PIERDOMENICO SD, 1995, EUR HEART J, V16, P692, DOI 10.1093/oxfordjournals.eurheartj.a060975; Piper MA., 2014, 1305194EF1 AG HEALTH; Piper MA, 2015, ANN INTERN MED, V162, P192, DOI 10.7326/M14-1539; Sheridan S, 2003, AM J PREV MED, V25, P151, DOI 10.1016/S0749-3797(03)00121-1; Spruill TM, 2013, J PSYCHOSOM RES, V74, P433, DOI 10.1016/j.jpsychores.2013.01.009; Staessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539, DOI 10.1001/jama.282.6.539; Talleruphuus U, 2006, BLOOD PRESSURE, V15, P347, DOI 10.1080/08037050601103885; Tanabe P, 2008, ANN EMERG MED, V51, P221, DOI 10.1016/j.annemergmed.2007.10.017; Toyama H, 2008, HYPERTENS RES, V31, P1063, DOI 10.1291/hypres.31.1063; Ungar A, 2004, J HUM HYPERTENS, V18, P897, DOI 10.1038/sj.jhh.1001756; VERDECCHIA P, 1995, AM J HYPERTENS, V8, P790, DOI 10.1016/0895-7061(95)00151-E; Verdecchia P, 2007, HYPERTENSION, V49, P777, DOI 10.1161/01.HYP.0000258215.26755.20; Viera AJ, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-59; Viera AJ, 2010, J AM BOARD FAM MED, V23, P571, DOI 10.3122/jabfm.2010.05.100047; Wolff T, 2007, ANN INTERN MED, V147, P787, DOI 10.7326/0003-4819-147-11-200712040-00010; Wright JT, 2014, ANN INTERN MED, V160, P499, DOI 10.7326/M13-2981; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339; ZABLUDOWSKI JR, 1992, ISRAEL J MED SCI, V28, P345; Zawadzka A, 1998, J HUM HYPERTENS, V12, P249, DOI 10.1038/sj.jhh.1000583	59	323	323	3	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					778	+		10.7326/M15-2223	http://dx.doi.org/10.7326/M15-2223			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26458123				2022-12-28	WOS:000365746400020
J	Roth, D; Nelson, DR; Bruchfeld, A; Liapakis, A; Silva, M; Monsour, H; Martin, P; Pol, S; Londono, MC; Hassanein, T; Zamor, PJ; Zuckerman, E; Wan, S; Jackson, B; Nguyen, BY; Robertson, M; Barr, E; Wahl, J; Greaves, W				Roth, David; Nelson, David R.; Bruchfeld, Annette; Liapakis, AnnMarie; Silva, Marcelo; Monsour, Howard, Jr.; Martin, Paul; Pol, Stanislas; Londono, Maria-Carlota; Hassanein, Tarek; Zamor, Philippe J.; Zuckerman, Eli; Wan, Shuyan; Jackson, Beth; Nguyen, Bach-Yen; Robertson, Michael; Barr, Eliav; Wahl, Janice; Greaves, Wayne			Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study	LANCET			English	Article							TRANSIENT ELASTOGRAPHY; DIALYSIS PATIENTS; RANDOMIZED-TRIAL; LIVER FIBROSIS; RENAL-DISEASE; RIBAVIRIN; CIRRHOSIS; MK-5172; HCV; TRANSPLANTATION	Background Chronic hepatitis C virus (HCV) infection in patients with stage 4-5 chronic kidney disease increases the risk of death and renal graft failure, yet patients with hepatitis C and chronic kidney disease have few treatment options. This study assesses an all-oral, ribavirin-free regimen in patients with HCV genotype 1 infection and stage 4-5 chronic kidney disease. Methods In this phase 3 randomised study of safety and observational study of efficacy, patients with HCV genotype 1 infection and chronic kidney disease (stage 4-5 with or without haemodialysis dependence) were randomly assigned to receive grazoprevir (100 mg, NS3/4A protease inhibitor) and elbasvir (50 mg, NS5A inhibitor; immediate treatment group) or placebo (deferred treatment group) once daily for 12 weeks. Randomisation was done centrally with an interactive voice response system. An additional cohort of patients who were not randomised received the same regimen open-label and underwent intensive pharmacokinetic sampling. The primary efficacy outcome was a non-randomised comparison of sustained virological response at 12 weeks (SVR12) after the end of therapy for the combined immediate treatment group and the pharmacokinetic population with a historical control. The primary safety outcome was a randomised comparison between the immediate treatment group and the deferred treatment group. After 4 weeks of follow-up (study week 16), unmasking occurred and patients in the deferred treatment group received grazoprevir and elbasvir. The primary efficacy hypothesis was tested at a two-sided significance level (type I error) of 0.0 using an exact test for a binomial proportion. Safety event rates were compared between immediate treatment and deferred treatment groups using the stratified Miettinen and Nurminen method with baseline dialysis status as the strata. The study is registered at ClinicalTrials.gov, number NCT02092350. Findings 224 patients were randomly assigned to the immediate treatment group with grazoprevir and elbasvir (n=111) or the deferred treatment group (n=113), and 11 were assigned to the intensive pharmacokinetic population. Overall, 179 (76%) were haemodialysis-dependent, 122 (52%) had HCV genotype 1a infection, 189 (80%) were HCV treatment-naive, 14 (6%) were cirrhotic, and 108 (46%) were African American. Of the 122 patients receiving grazoprevir and elbasvir, six were excluded from the primary efficacy analysis for non-virological reasons (death, lost-to-follow-up [n=2], non-compliance, patient withdrawal, and withdrawal by physician for violent behaviour). No patients in the combined immediate treatment group and intensive pharmacokinetic population and five (4%) in the deferred treatment group discontinued because of an adverse event. Most common adverse events were headache, nausea, and fatigue, occurring at similar frequencies in patients receiving active and placebo drugs. SVR12 in the combined immediate treatment group and intensive pharmacokinetic population was 99% (95% CI 95.3-100.0; 115/116), with one relapse 12 weeks after end of treatment when compared with a historical control of 45%, based on meta-analyses of interferon-based regimens used in clinical trials of patients infected with HCV who are on haemodialysis. Interpretation Once-daily grazoprevir and elbasvir for 12 weeks had a low rate of adverse events and was effective in patients infected with HCV genotype 1 and stage 4-5 chronic kidney disease.	[Roth, David] Univ Miami, Miller Sch Med, Div Nephrol & Hypertens, Miami, FL 33136 USA; [Nelson, David R.] Univ Florida, Clin & Translat Sci Inst, Gainesville, FL USA; [Bruchfeld, Annette] Karolinska Inst, Karolinska Univ Hosp, Dept Renal Med, Stockholm, Sweden; [Liapakis, AnnMarie] Yale Univ Digest Dis, Yale New Haven Hosp, Transplant Ctr, New Haven, CT USA; [Silva, Marcelo] Hosp Univ Austral, Pilar, Argentina; [Monsour, Howard, Jr.] Houston Methodist Hosp, Hepatol & Transplant Med, Houston, TX USA; [Martin, Paul] Univ Miami, Miller Sch Med, Div Hepatol, Miami, FL 33136 USA; [Pol, Stanislas] Hop Cochin, Unite Hepatol, F-75674 Paris, France; [Pol, Stanislas] Univ Paris 05, Paris, France; [Pol, Stanislas] Inst Pasteur, UMS20, Paris, France; [Londono, Maria-Carlota] Hosp Clin Barcelona, CIBERehd, IDIBAPS, Liver Unit, Barcelona, Spain; [Hassanein, Tarek] Southern Calif Res Ctr, Coronado, CA USA; [Zamor, Philippe J.] Carolinas Med Ctr, Div Hepatol, Charlotte, NC 28203 USA; [Zuckerman, Eli] Technion Fac Med, Liver Unit, Carmel Med Ctr, Haifa, Israel; [Wan, Shuyan; Jackson, Beth; Nguyen, Bach-Yen; Robertson, Michael; Barr, Eliav; Wahl, Janice; Greaves, Wayne] Merck & Co Inc, Kenilworth, NJ USA	University of Miami; State University System of Florida; University of Florida; Karolinska Institutet; Karolinska University Hospital; Yale University; Austral University; Hospital Universitario Austral; The Methodist Hospital System; The Methodist Hospital - Houston; University of Miami; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Carolinas Medical Center; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Merck & Company	Roth, D (corresponding author), 1120 NW 14th St,Room 813, Miami, FL 33136 USA.	d.roth@med.miami.edu			Merck Sharp Dohme Corp.	Merck Sharp Dohme Corp.(Merck & Company)	Merck Sharp & Dohme Corp.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Boursier J, 2012, HEPATOLOGY, V55, P58, DOI 10.1002/hep.24654; Bruchfeld A, 2004, TRANSPLANTATION, V78, P745, DOI 10.1097/01.TP.0000131948.29742.24; Butt AA, 2011, AM J KIDNEY DIS, V57, P396, DOI 10.1053/j.ajkd.2010.09.023; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Cruzado JM, 2001, AM J TRANSPLANT, V1, P171, DOI 10.1034/j.1600-6143.2001.10212.x; Fabrizi F, 2008, J VIRAL HEPATITIS, V15, P79, DOI [10.1111/j.1365-2893.2007.00907.x, 10.1111/j.1365-2893.2008.01039.x]; Fabrizi F, 2005, AM J TRANSPLANT, V5, P2433, DOI 10.1111/j.1600-6143.2005.01040.x; Fabrizi F, 2012, J VIRAL HEPATITIS, V19, P601, DOI 10.1111/j.1365-2893.2012.01633.x; Forns X, 2015, J HEPATOL, V63, P564, DOI 10.1016/j.jhep.2015.04.009; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lawitz E, 2015, LANCET, V385, P1075, DOI 10.1016/S0140-6736(14)61795-5; Legendre C, 1998, TRANSPLANTATION, V65, P667, DOI 10.1097/00007890-199803150-00011; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Liu CH, 2013, ANN INTERN MED, V159, P729, DOI 10.7326/0003-4819-159-11-201312030-00005; Mauss S, 2014, HEPATOLOGY, V59, P46, DOI 10.1002/hep.26602; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Noureddine LA, 2010, AM J NEPHROL, V32, P311, DOI 10.1159/000319456; Pereira Brian J. G., 1995, Transplantation (Baltimore), V60, P799; Sulkowski M, 2015, LANCET, V385, P1087, DOI 10.1016/S0140-6736(14)61793-1; Summa V, 2012, ANTIMICROB AGENTS CH, V56, P4161, DOI 10.1128/AAC.00324-12; Tsui JI, 2007, ARCH INTERN MED, V167, P1271, DOI 10.1001/archinte.167.12.1271; Yeh WW, 2014, HEPATOLOGY, V60, p1137A; Zeuzem S, 2015, ANN INTERN MED, V163, P1, DOI 10.7326/M15-0785	26	501	524	1	36	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2015	386	10003					1537	1545		10.1016/S0140-6736(15)00349-9	http://dx.doi.org/10.1016/S0140-6736(15)00349-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5VC	26456905	Green Submitted			2022-12-28	WOS:000362878200027
J	Iyengar, R; Altman, RB; Troyanskya, O; FitzGerald, GA				Iyengar, Ravi; Altman, Russ B.; Troyanskya, Olga; FitzGerald, Garret A.			Personalization in practice	SCIENCE			English	Editorial Material									[Iyengar, Ravi] Icahn Sch Med Mt Sinai, Syst Biol Ctr New York, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Altman, Russ B.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Troyanskya, Olga] Princeton Univ, Dept Comp Sci, Princeton, NJ 08544 USA; [Troyanskya, Olga] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Troyanskya, Olga] Simons Fdn, Simons Ctr Data Anal, New York, NY 10010 USA; [FitzGerald, Garret A.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA	Icahn School of Medicine at Mount Sinai; Stanford University; Princeton University; Princeton University; University of Pennsylvania; Pennsylvania Medicine	Iyengar, R (corresponding author), Icahn Sch Med Mt Sinai, Syst Biol Ctr New York, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	ravi.iyengar@mssm.edu; garret@exchange.upenn.edu		Altman, Russ/0000-0003-3859-2905	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL117798] Funding Source: NIH RePORTER; NHLBI NIH HHS [U54 HL117798] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Azeloglu EU, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004621; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; Committee on a Framework for Developing a New Taxonomy of Disease, 2011, PREC MED BUILD KNOWL; Crotti L, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-18; Fries S, 2006, GASTROENTEROLOGY, V130, P55, DOI 10.1053/j.gastro.2005.10.002; Greene CS, 2015, NAT GENET, V47, P569, DOI 10.1038/ng.3259; Tiscornia G, 2011, NAT MED, V17, P1570, DOI 10.1038/nm.2504	7	16	17	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2015	350	6258					282	283		10.1126/science.aad5204	http://dx.doi.org/10.1126/science.aad5204			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT5HD	26472898				2022-12-28	WOS:000362838700024
J	Eisenstein, M				Eisenstein, Michael			SUPER-RESOLVE ME: FROM MICRO TO NANO	NATURE			English	Editorial Material							NANOSCOPY; LIMIT											Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Huang F, 2013, NAT METHODS, V10, P653, DOI [10.1038/NMETH.2488, 10.1038/nmeth.2488]; Jia S, 2014, NAT PHOTONICS, V8, P302, DOI [10.1038/nphoton.2014.13, 10.1038/NPHOTON.2014.13]; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Ries J, 2012, NAT METHODS, V9, P582, DOI [10.1038/NMETH.1991, 10.1038/nmeth.1991]; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Staudt T, 2011, OPT EXPRESS, V19, P5644, DOI 10.1364/OE.19.005644	9	4	4	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					459	462		10.1038/526459a	http://dx.doi.org/10.1038/526459a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT3TQ	26469055	Bronze			2022-12-28	WOS:000362730200059
J	Khodakhah, K				Khodakhah, Kamran			NEUROSCIENCE Decrypting a brain enigma	NATURE			English	Editorial Material							PURKINJE-CELLS; OCULOMOTOR VERMIS; EYE-MOVEMENTS; CEREBELLUM; MONKEY; SIGNAL; TIME		Albert Einstein Coll Med, Dominik P Purpura Dept Neurosci, New York, NY 10461 USA	Yeshiva University	Khodakhah, K (corresponding author), Albert Einstein Coll Med, Dominik P Purpura Dept Neurosci, New York, NY 10461 USA.	k.khodakhah@einstein.yu.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050808, R01NS079750] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS050808, R01 NS079750] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barash S, 1999, J NEUROSCI, V19, P10931, DOI 10.1523/JNEUROSCI.19-24-10931.1999; Gad YP, 2010, NEURAL NETWORKS, V23, P789, DOI 10.1016/j.neunet.2010.05.007; HELMCHEN C, 1995, EXP BRAIN RES, V103, P198; Herzfeld DJ, 2015, NATURE, V526, P439, DOI 10.1038/nature15693; KASE M, 1980, J PHYSIOL-LONDON, V300, P539, DOI 10.1113/jphysiol.1980.sp013178; Medina JF, 2007, J NEUROSCI, V27, P6832, DOI 10.1523/JNEUROSCI.1323-07.2007; OHTSUKA K, 1995, J NEUROPHYSIOL, V74, P1828, DOI 10.1152/jn.1995.74.5.1828; Person AL, 2012, NATURE, V481, P502, DOI 10.1038/nature10732; SHIDARA M, 1993, NATURE, V365, P50, DOI 10.1038/365050a0; Soetedjo R, 2008, J NEUROPHYSIOL, V100, P1949, DOI 10.1152/jn.90526.2008; Thier P, 2000, NATURE, V405, P72, DOI 10.1038/35011062	11	1	1	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					326	327		10.1038/526326a	http://dx.doi.org/10.1038/526326a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT3TQ	26469036				2022-12-28	WOS:000362730200028
J	Walz, C; Scheit, H; Pietralla, N; Aumann, T; Lefol, R; Ponomarev, VY				Walz, C.; Scheit, H.; Pietralla, N.; Aumann, T.; Lefol, R.; Ponomarev, V. Yu.			Observation of the competitive double-gamma nuclear decay	NATURE			English	Article							2-PHOTON DECAY; STATE	The double-gamma (gamma gamma)-decay of a quantum system in an excited state is a fundamental second-order process of quantum electrodynamics. In contrast to the well-known single-gamma (gamma)-decay, the gamma-decay is characterized by the simultaneous emission of two gamma quanta, each with a continuous energy spectrum. In nuclear physics, this exotic decay mode has only been observed for transitions between states with spin-parity quantum numbers J(pi) = 0(+) (refs 1-3). Single-gamma decays the main experimental obstacle to observing the yy-decay are strictly forbidden for these 0(+) -> 0(+) transitions. Here we report the observation of the gamma-decay of an excited nuclear state (J(pi) = 11/2(-)) that is directly competing with an allowed y-decay (to ground state J(pi) = 3/2(+)). The branching ratio of the competitive gamma gamma-decay of the 11/2- isomer of Ba-137 to the ground state relative to its single gamma-decay was determined to be (2.05 +/- 0.37) X 10(-6). From the measured angular correlation and the shape of the energy spectra of the individual gamma-rays, the contributing combinations of multipolarities of the gamma radiation were determined. Transition matrix elements calculated using the quasipartide-phonon model reproduce our measurements well. The gamma gamma-decay rate gives access to so far unexplored important nuclear structure information, such as the generalized (off-diagonal) nuclear electric polarizabilities and magnetic susceptibilities(3).	[Walz, C.; Scheit, H.; Pietralla, N.; Aumann, T.; Lefol, R.; Ponomarev, V. Yu.] Tech Univ Darmstadt, Inst Kernphys, D-64289 Darmstadt, Germany; [Lefol, R.] Univ Saskatchewan, Dept Phys, Saskatoon, SK S7N 5E2, Canada	Technical University of Darmstadt; University of Saskatchewan	Scheit, H (corresponding author), Tech Univ Darmstadt, Inst Kernphys, Petersenstr 30, D-64289 Darmstadt, Germany.	hscheit@ikp.tu-darmstadt.de	Pietralla, Norbert/L-8465-2017; Scheit, Heiko/B-4779-2008; Aumann, Thomas/B-1455-2012; Ponomarev, Vladimir Yu./K-6344-2018	Pietralla, Norbert/0000-0002-4797-3032; Scheit, Heiko/0000-0002-8937-1101; Aumann, Thomas/0000-0003-1660-9294; Ponomarev, Vladimir/0000-0002-3353-942X	State of Hesse under the Helmholtz International Center for FAIR; German Research Council (DFG) [SFB 634]	State of Hesse under the Helmholtz International Center for FAIR; German Research Council (DFG)(German Research Foundation (DFG))	This work was supported by the State of Hesse under the Helmholtz International Center for FAIR (HIC for FAIR) and by the German Research Council (DFG) under grant no. SFB 634. We thank D. J. Millener, R. J. Sutter for an open discussion and for generously sharing their preliminary results before publication, and C. J. Lister for discussions. H.S. thanks Dirk Schwalm for raising interest in this topic.	Basenko V. K., 1992, Bulletin of the Russian Academy of Sciences. Physics, V56, P94; Beusch W, 1960, HELV PHYS ACTA, V33, P363; FRIAR JL, 1975, ANN PHYS-NEW YORK, V95, P170, DOI 10.1016/0003-4916(75)90049-4; Goeppert-Mayer M, 1935, PHYS REV, V48, P512, DOI 10.1103/PhysRev.48.512; Goeppert-Mayer M., 1931, ANN PHYS, V401, P273, DOI DOI 10.1002/ANDP.19314010303; Goppert M, 1929, NATURWISSENSCHAFTEN, V17, P932; HAYES AC, 1990, PHYS REV C, V41, P1727, DOI 10.1103/PhysRevC.41.1727; Ilakovac K, 2006, RADIAT PHYS CHEM, V75, P1451, DOI 10.1016/j.radphyschem.2005.07.008; KRAMP J, 1987, NUCL PHYS A, V474, P412, DOI 10.1016/0375-9474(87)90625-7; Lister CJ, 2013, B AM PHYS SOC, V58; Millener D. J., 2011, B AM PHYS SOC, V56; Mokler PH, 2004, PHYS SCRIPTA, V69, pC1, DOI 10.1238/Physica.Regular.069a000C1; Moran K, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.041303; SCHIRMER J, 1984, PHYS REV LETT, V53, P1897, DOI 10.1103/PhysRevLett.53.1897; Soloviev V. G., 1989, THEORY ATOMIC NUCL Q; WATSON BA, 1975, PHYS REV LETT, V35, P1333, DOI 10.1103/PhysRevLett.35.1333	16	16	16	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					406	409		10.1038/nature15543	http://dx.doi.org/10.1038/nature15543			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26469051				2022-12-28	WOS:000362730200046
J	Batista, CAS; Larson, RG; Kotov, NA				Batista, Carlos A. Silvera; Larson, Ronald G.; Kotov, Nicholas A.			Nonadditivity of nanoparticle interactions	SCIENCE			English	Review							DER-WAALS INTERACTIONS; GOLD NANOPARTICLES; COLLOIDAL PARTICLES; POISSON-BOLTZMANN; NANOCRYSTAL SUPERLATTICES; HYDROPHOBIC INTERACTIONS; QUASI-CRYSTALLINE; SELF-ORGANIZATION; IONIC-STRENGTH; PROTEIN CORONA	Understanding interactions between inorganic nanoparticles (NPs) is central to comprehension of self-organization processes and a wide spectrum of physical, chemical, and biological phenomena. However, quantitative description of the interparticle forces is complicated by many obstacles that are not present, or not as severe, for microsize particles (mu Ps). Here we analyze the sources of these difficulties and chart a course for future research. Such difficulties can be traced to the increased importance of discreteness and fluctuations around NPs (relative to mPs) and to multiscale collective effects. Although these problems can be partially overcome by modifying classical theories for colloidal interactions, such an approach fails to manage the nonadditivity of electrostatic, van der Waals, hydrophobic, and other interactions at the nanoscale. Several heuristic rules identified here can be helpful for discriminating between additive and nonadditive nanoscale systems. Further work on NP interactions would benefit from embracing NPs as strongly correlated reconfigurable systems with diverse physical elements and multiscale coupling processes, which will require new experimental and theoretical tools. Meanwhile, the similarity between the size of medium constituents and NPs makes atomic simulations of their interactions increasingly practical. Evolving experimental tools can stimulate improvement of existing force fields. New scientific opportunities for a better understanding of the electronic origin of classical interactions are converging at the scale of NPs.	[Batista, Carlos A. Silvera; Larson, Ronald G.; Kotov, Nicholas A.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Batista, Carlos A. Silvera; Larson, Ronald G.] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA; [Larson, Ronald G.; Kotov, Nicholas A.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Kotov, Nicholas A.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Larson, RG (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	rlarson@umich.edu; kotov@umich.edu	Kotov, Nicholas/AAZ-4204-2021	Kotov, Nicholas/0000-0002-6864-5804	U.S. Department of Defense [W911NF-10-1-0518]; NSF [0938019]; Center for Photonic and Multiscale Nanomaterials (C-PHOM) - NSF Materials Research Science and Engineering Center program Division of Materials Research (DMR) [1120923]; NSF Chemical, Bioengineering, Environmental, and Transport Systems (CBET) [1036672, 1403777, 1463474, 1538180]; DMR [1411014]; University of Michigan; Direct For Mathematical & Physical Scien [1411014] Funding Source: National Science Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [1403777] Funding Source: National Science Foundation	U.S. Department of Defense(United States Department of Defense); NSF(National Science Foundation (NSF)); Center for Photonic and Multiscale Nanomaterials (C-PHOM) - NSF Materials Research Science and Engineering Center program Division of Materials Research (DMR); NSF Chemical, Bioengineering, Environmental, and Transport Systems (CBET); DMR; University of Michigan(University of Michigan System); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the Multidisciplinary University Research Initiative project from the U.S. Department of Defense (grant W911NF-10-1-0518, "Reconfigurable Matter from Programmable Colloids") and the Emerging Frontiers in Research and Innovation-BioSensing and BioActuation grant 0938019 project of the NSF. Partial support was also provided by the Center for Photonic and Multiscale Nanomaterials (C-PHOM) funded by the NSF Materials Research Science and Engineering Center program Division of Materials Research (DMR) grant 1120923; NSF Chemical, Bioengineering, Environmental, and Transport Systems (CBET) grants 1036672, 1403777, 1463474, and 1538180; and DMR grant 1411014. C.A.S.B. and N.A.K. acknowledge a Presidential Fellowship from the University of Michigan.	ALLEN LH, 1971, J COLLOID INTERF SCI, V35, P66, DOI 10.1016/0021-9797(71)90186-X; Andersson Y, 1996, PHYS REV LETT, V76, P102, DOI 10.1103/PhysRevLett.76.102; Ang JC, 2014, PHYS CHEM CHEM PHYS, V16, P10157, DOI 10.1039/c4cp00293h; Antypov D, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061106; Artemyev MV, 1999, PHYS REV B, V60, P1504, DOI 10.1103/PhysRevB.60.1504; Bahng JH, 2015, NATURE, V517, P596, DOI 10.1038/nature14092; Barros K, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.017801; Besteman K, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061501; Bian SW, 2011, LANGMUIR, V27, P6059, DOI 10.1021/la200570n; Bishop KJM, 2009, SMALL, V5, P1600, DOI 10.1002/smll.200900358; Boles MA, 2015, J AM CHEM SOC, V137, P4494, DOI 10.1021/jacs.5b00839; Bolintineanu DS, 2014, LANGMUIR, V30, P11075, DOI 10.1021/la502795z; Bostrom M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.168103; Bozorgui B, 2013, NANO LETT, V13, P2732, DOI 10.1021/nl401378r; BRUS LE, 1983, J CHEM PHYS, V79, P5566, DOI 10.1063/1.445676; Cha S.-H., 2015, ACS NANO, DOI [10.1021/acsnano.5b03247, DOI 10.1021/ACSNAN0.5B03247]; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Chen Q, 2015, ACS CENTRAL SCI, V1, P33, DOI 10.1021/acscentsci.5b00001; Chopra G, 2011, P NATL ACAD SCI USA, V108, P14455, DOI 10.1073/pnas.1110626108; Dahirel V, 2010, CURR OPIN COLLOID IN, V15, P2, DOI 10.1016/j.cocis.2009.05.006; Davis JG, 2013, NAT CHEM, V5, P796, DOI [10.1038/NCHEM.1716, 10.1038/nchem.1716]; Davis JG, 2012, NATURE, V491, P582, DOI 10.1038/nature11570; Del Pino P, 2014, MATER HORIZ, V1, P301, DOI 10.1039/c3mh00106g; Derjaguin B. V., 1941, ACTA PHYSICOCHIM URS, V14, P633, DOI DOI 10.1016/0079-6816(93)90013-L; Dijkstra M, 2001, CURR OPIN COLLOID IN, V6, P372, DOI 10.1016/S1359-0294(01)00106-6; dos Santos AP, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.167801; dos Santos AP, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3098556; DUCKER WA, 1991, NATURE, V353, P239, DOI 10.1038/353239a0; DZUGUTOV M, 1992, PHYS REV A, V46, pR2984, DOI 10.1103/PhysRevA.46.R2984; Dzyaloshinskii I. E., 1961, SOV PHYS USP, V4, P153, DOI [10.1070/pu1961v004n02abeh003330, DOI 10.1070/PU1961V004N02ABEH003330]; DZYALOSHINSKII IE, 1961, ADV PHYS, V10, P165, DOI 10.1080/00018736100101281; Ebbinghaus S, 2007, P NATL ACAD SCI USA, V104, P20749, DOI 10.1073/pnas.0709207104; Eichmann SL, 2008, LANGMUIR, V24, P714, DOI 10.1021/la702571z; ELIMELECH M, 1990, COLLOID SURFACE, V44, P165, DOI 10.1016/0166-6622(90)80194-9; Faure B, 2011, LANGMUIR, V27, P8659, DOI 10.1021/la201387d; Fischer NO, 2002, P NATL ACAD SCI USA, V99, P5018, DOI 10.1073/pnas.082644099; Forsman J, 2004, J PHYS CHEM B, V108, P9236, DOI 10.1021/jp049571u; Garcia GIG, 2014, J PHYS CHEM B, V118, P8854, DOI 10.1021/jp5045173; Geyer T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.128302; Ghorai PK, 2007, J PHYS CHEM C, V111, P15857, DOI 10.1021/jp0746289; Gobre VV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3341; Gray JJ, 1999, NATURE, V402, P750, DOI 10.1038/45445; Guerrero-Garcia GI, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3656763; Guo PJ, 2011, J PHYS CHEM C, V115, P6484, DOI 10.1021/jp201598k; Haji-Akbari A, 2009, NATURE, V462, P773, DOI 10.1038/nature08641; Hamaker HC, 1937, PHYSICA, V4, P1058, DOI 10.1016/S0031-8914(37)80203-7; He J, 2012, J AM CHEM SOC, V134, P11342, DOI 10.1021/ja3032295; Heikkila E, 2012, J PHYS CHEM C, V116, P9805, DOI 10.1021/jp301094m; Hentschel M, 2010, NANO LETT, V10, P2721, DOI 10.1021/nl101938p; Hermanson KD, 2001, SCIENCE, V294, P1082, DOI 10.1126/science.1063821; Hobbie EK, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.245439; Horinek D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.226104; Hu JD, 2010, SCI TOTAL ENVIRON, V408, P3477, DOI 10.1016/j.scitotenv.2010.03.033; Huang JX, 2005, NAT MATER, V4, P896, DOI 10.1038/nmat1517; Huang RX, 2013, LANGMUIR, V29, P11560, DOI 10.1021/la4020674; Iacovella CR, 2011, P NATL ACAD SCI USA, V108, P20935, DOI 10.1073/pnas.1019763108; Ishii D, 2003, NATURE, V423, P628, DOI 10.1038/nature01663; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; Guerrero-Garcia GI, 2013, ACS NANO, V7, P9714, DOI 10.1021/nn404477b; Guerrero-Garcia GI, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3622046; Jabes BS, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4897541; Jackson AM, 2004, NAT MATER, V3, P330, DOI 10.1038/nmat1116; Jenkins S, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2906462; Jones MR, 2011, J AM CHEM SOC, V133, P18865, DOI 10.1021/ja206777k; Kalcher I, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.097802; Kaushik AP, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3689973; Kielland J, 1937, J AM CHEM SOC, V59, P1675, DOI 10.1021/ja01288a032; Kim HY, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2170091; Kim HY, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.053201; Kim HY, 2007, LANGMUIR, V23, P1735, DOI 10.1021/la061802w; Kim HY, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3244645; Kjellander R, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/42/424101; Kobayashi M, 2005, J COLLOID INTERF SCI, V292, P139, DOI 10.1016/j.jcis.2005.05.093; KOTOV NA, 1994, J PHYS CHEM-US, V98, P8827, DOI 10.1021/j100087a002; KOTOV NA, 1994, J PHYS CHEM-US, V98, P2735, DOI 10.1021/j100062a006; Kotov NA, 2010, SCIENCE, V330, P188, DOI 10.1126/science.1190094; Kulkarni GU, 2002, PURE APPL CHEM, V74, P1581, DOI 10.1351/pac200274091581; Kwaadgras BW, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4792137; Laaksonen T, 2006, CHEMPHYSCHEM, V7, P2143, DOI 10.1002/cphc.200600307; Landman U, 2004, FARADAY DISCUSS, V125, P1, DOI [10.1039/b3l2640b, 10.1039/B312640B]; Larsen AE, 1997, NATURE, V385, P230, DOI 10.1038/385230a0; Lee HY, 2014, ACS NANO, V8, P9979, DOI 10.1021/nn504734v; Li M, 1999, NATURE, V402, P393, DOI 10.1038/46509; Luedtke WD, 1996, J PHYS CHEM-US, V100, P13323, DOI 10.1021/jp961721g; Ma CD, 2015, NATURE, V517, P347, DOI 10.1038/nature14018; MARCUS Y, 1988, CHEM REV, V88, P1475, DOI 10.1021/cr00090a003; Merk V, 2014, LANGMUIR, V30, P4213, DOI 10.1021/la404556a; Messina R, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/11/113102; Min YJ, 2008, NAT MATER, V7, P527, DOI 10.1038/nmat2206; Motte L, 1996, ADV MATER, V8, P1018, DOI 10.1002/adma.19960081218; MURRAY CB, 1995, SCIENCE, V270, P1335, DOI 10.1126/science.270.5240.1335; Naicker PK, 2005, J PHYS CHEM B, V109, P15243, DOI 10.1021/jp050963q; Netz RR, 2001, EUR PHYS J E, V5, P557, DOI 10.1007/s101890170039; Nie ZH, 2007, NAT MATER, V6, P609, DOI 10.1038/nmat1954; Nie ZH, 2010, NAT NANOTECHNOL, V5, P15, DOI [10.1038/NNANO.2009.453, 10.1038/nnano.2009.453]; Ninham BW, 2010, CAMBRIDGE MOL SCI SE; O'Brien MN, 2014, J AM CHEM SOC, V136, P7603, DOI 10.1021/ja503509k; PARSEGIAN VA, 1973, J THEOR BIOL, V38, P101, DOI 10.1016/0022-5193(73)90227-0; Parsegian VA., 2006, VANDERWAALS FORCES; Parsons DF, 2010, LANGMUIR, V26, P3323, DOI 10.1021/la903061h; Parsons DF, 2009, J PHYS CHEM A, V113, P1141, DOI 10.1021/jp802984b; Patel AJ, 2012, J PHYS CHEM B, V116, P2498, DOI 10.1021/jp2107523; Pfeiffer C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0931; Pinchuk AO, 2012, J PHYS CHEM C, V116, P20099, DOI 10.1021/jp3061784; Qin Y, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2776259; Qin Y, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.020401; Rajter R, 2010, INT J MATER RES, V101, P27, DOI 10.3139/146.110250; Rankin BM, 2013, J AM CHEM SOC, V135, P8818, DOI 10.1021/ja4036303; Ruiz-Cabello FJM, 2015, SOFT MATTER, V11, P1562, DOI 10.1039/c4sm02510e; Ruiz-Cabello FJM, 2014, LANGMUIR, V30, P4551, DOI 10.1021/la500612a; Salerno KM, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4874638; Sanchez-Iglesias A, 2012, ACS NANO, V6, P11059, DOI 10.1021/nn3047605; Sauceda HE, 2012, J PHYS CHEM C, V116, P25147, DOI 10.1021/jp309499t; Schwierz N, 2013, LANGMUIR, V29, P2602, DOI 10.1021/la303924e; Shanbhag S, 2006, J PHYS CHEM B, V110, P12211, DOI 10.1021/jp0611119; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Singh C, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.226106; Singh G, 2014, SCIENCE, V345, P1149, DOI 10.1126/science.1254132; Sinha P, 2013, J PHYS CHEM LETT, V4, P648, DOI 10.1021/jz4000609; SOGAMI I, 1984, J CHEM PHYS, V81, P6320, DOI 10.1063/1.447541; Srivastava S, 2010, SCIENCE, V327, P1355, DOI 10.1126/science.1177218; STAFFORD CA, 1994, PHYS REV LETT, V72, P3590, DOI 10.1103/PhysRevLett.72.3590; Sun WF, 2013, LANGMUIR, V29, P2175, DOI 10.1021/la305156s; Szczerba W, 2010, ANAL BIOANAL CHEM, V398, P1967, DOI 10.1007/s00216-010-4200-z; Talapin DV, 2007, NANO LETT, V7, P1213, DOI 10.1021/nl070058c; Talapin DV, 2009, NATURE, V461, P964, DOI 10.1038/nature08439; Tang ZY, 2006, SCIENCE, V314, P274, DOI 10.1126/science.1128045; Tang ZY, 2002, SCIENCE, V297, P237, DOI 10.1126/science.1072086; Tao JM, 2012, P NATL ACAD SCI USA, V109, P18, DOI 10.1073/pnas.1118245108; Tong LM, 2011, NANO LETT, V11, P4505, DOI 10.1021/nl1036116; Torres-Vega JJ, 2014, PHYSICA B, V436, P74, DOI 10.1016/j.physb.2013.11.036; Treuel L, 2014, ACS NANO, V8, P503, DOI 10.1021/nn405019v; van der Linden M, 2015, J PHYS CHEM LETT, V6, P2881, DOI 10.1021/acs.jpclett.5b01300; Verwey T. J., 1948, THEORY STABILITY LYO; Wagner C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6568; White A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.075436; Widmer-Cooper A, 2014, NANO LETT, V14, P57, DOI 10.1021/nl403067p; Wu XL, 2013, J AM CHEM SOC, V135, P18629, DOI 10.1021/ja4095445; Xia YS, 2011, NAT NANOTECHNOL, V6, P580, DOI [10.1038/nnano.2011.121, 10.1038/NNANO.2011.121]; Yeom J, 2015, NAT MATER, V14, P66, DOI [10.1038/NMAT4125, 10.1038/nmat4125]; Yu YX, 2015, FARADAY DISCUSS, V181, P181, DOI 10.1039/c5fd00006h; Yu YX, 2004, J CHEM PHYS, V120, P7223, DOI 10.1063/1.1676121; Zobel M, 2015, SCIENCE, V347, P292, DOI 10.1126/science.1261412; ZUKOSKI CF, 1986, J COLLOID INTERF SCI, V114, P32, DOI 10.1016/0021-9797(86)90238-9	145	334	334	12	421	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257					138	+	1242477	10.1126/science.1242477	http://dx.doi.org/10.1126/science.1242477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9JB	26450215				2022-12-28	WOS:000362405600028
J	Soreide, K; Thorsen, K; Harrison, EM; Bingener, J; Moller, MH; Ohene-Yeboah, M; Soreide, JA				Soreide, Kjetil; Thorsen, Kenneth; Harrison, Ewen M.; Bingener, Juliane; Moller, Morten H.; Ohene-Yeboah, Michael; Soreide, Jon Arne			Perforated peptic ulcer	LANCET			English	Article							TRANSLUMINAL ENDOSCOPIC SURGERY; HELICOBACTER-PYLORI; GASTRODUODENAL ULCERS; GASTRIC PERFORATION; EMERGENCY-SURGERY; DUODENAL-ULCER; TERM MORTALITY; DISEASE; POPULATION; COMPLICATIONS	Perforated peptic ulcer is a common emergency condition worldwide, with associated mortality rates of up to 30%. A scarcity of high-quality studies about the condition limits the knowledge base for clinical decision making, but a few published randomised trials are available. Although Helicobacter pylori and use of non-steroidal anti-inflammatory drugs are common causes, demographic differences in age, sex, perforation location, and underlying causes exist between countries, and mortality rates also vary. Clinical prediction rules are used, but accuracy varies with study population. Early surgery, either by laparoscopic or open repair, and proper sepsis management are essential for good outcome. Selected patients can be managed non-operatively or with novel endoscopic approaches, but validation of such methods in trials is needed. Quality of care, sepsis care bundles, and postoperative monitoring need further assessment. Adequate trials with low risk of bias are urgently needed to provide better evidence. We summarise the evidence for perforated peptic ulcer management and identify directions for future clinical research.	[Soreide, Kjetil; Thorsen, Kenneth; Soreide, Jon Arne] Stavanger Univ Hosp, Dept Gastrointestinal Surg, N-4068 Stavanger, Norway; [Soreide, Kjetil; Soreide, Jon Arne] Univ Bergen, Dept Clin Med, Bergen, Norway; [Harrison, Ewen M.] Univ Edinburgh, MRC Ctr Inflammat Res, Royal Infirm Edinburgh, Edinburgh, Midlothian, Scotland; [Bingener, Juliane] Mayo Clin, Dept Surg, Rochester, MN 55905 USA; [Moller, Morten H.] Univ Copenhagen, Dept Intens Care 4131, Hosp Rigshosp, Copenhagen, Denmark; [Ohene-Yeboah, Michael] Kwame Nkrumah Univ Sci & Technol, Dept Surg, Kumasi, Ghana	Stavanger University Hospital; University of Bergen; Royal Infirmary of Edinburgh; University of Edinburgh; Mayo Clinic; Rigshospitalet; University of Copenhagen; Kwame Nkrumah University Science & Technology	Soreide, K (corresponding author), Stavanger Univ Hosp, Dept Gastrointestinal Surg, N-4068 Stavanger, Norway.	ksoreide@mac.com	Søreide, Kjetil/A-9797-2010; Møller, Morten Hylander/AAQ-6891-2020; Søreide, Jon Arne/H-7518-2019	Søreide, Kjetil/0000-0001-7594-4354; Møller, Morten Hylander/0000-0002-6378-9673; Søreide, Jon Arne/0000-0001-7572-1089; Harrison, Ewen/0000-0002-5018-3066	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK093553] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aga H, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000271; Antoniou SA, 2013, JSLS-J SOC LAPAROEND, V17, P15, DOI 10.4293/108680812X13517013317752; Arveen S, 2009, WORLD J SURG, V33, P1600, DOI 10.1007/s00268-009-0056-9; Asefa Zelalem, 2012, Ethiop Med J, V50, P145; Bae S, 2012, J EPIDEMIOL, V22, P508, DOI 10.2188/jea.JE20120056; Banerjee S, 2010, GASTROINTEST ENDOSC, V71, P663, DOI 10.1016/j.gie.2009.11.026; Bashinskaya B, 2011, J GLOB INFECT DIS, V3, P366, DOI 10.4103/0974-777X.91061; Bergstrom M, 2013, ENDOSCOPY, V45, P222, DOI 10.1055/s-0032-1325885; Bertleff MJOE, 2010, SURG ENDOSC, V24, P1231, DOI 10.1007/s00464-009-0765-z; Bertleff MJOE, 2009, JSLS-J SOC LAPAROEND, V13, P550, DOI 10.4293/108680809X12589998404362; Bin-Taleb AK, 2008, SAUDI MED J, V29, P245; Bingener J, 2014, BRIT J SURG, V101, pE80, DOI 10.1002/bjs.9352; Bingener J, 2013, SURG ENDOSC, V27, P2201, DOI 10.1007/s00464-012-2740-3; BOEY J, 1987, ANN SURG, V205, P22, DOI 10.1097/00000658-198701000-00005; Bonin EA, 2012, SURG ENDOSC, V26, P1534, DOI 10.1007/s00464-011-2063-9; Buck DL, 2014, BRIT J SURG, V101, P993, DOI 10.1002/bjs.9529; Buck DL, 2013, BRIT J SURG, V100, P1045, DOI 10.1002/bjs.9175; Buck DL, 2012, SCAND J GASTROENTERO, V47, P28, DOI 10.3109/00365521.2011.639078; Cao F, 2014, ASIAN J SURG, V37, P148, DOI 10.1016/j.asjsur.2013.10.002; Chalya PL, 2011, WORLD J EMERG SURG, V6, DOI 10.1186/1749-7922-6-31; CHENG CLY, 1994, ANN EMERG MED, V23, P126, DOI 10.1016/S0196-0644(94)70018-4; Cid TP, 2013, HELICOBACTER, V18, P12, DOI 10.1111/hel.12076; CROFTS TJ, 1989, NEW ENGL J MED, V320, P970, DOI 10.1056/NEJM198904133201504; Dakubo J C B, 2009, East Afr Med J, V86, P100; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Di Carlo I, 2009, HEPATO-GASTROENTEROL, V56, P575; Donovan AJ, 1998, ARCH SURG-CHICAGO, V133, P1166, DOI 10.1001/archsurg.133.11.1166; Ergul E, 2009, LANGENBECK ARCH SURG, V394, P643, DOI 10.1007/s00423-008-0331-5; Etonyeaku A C, 2013, Afr Health Sci, V13, P907, DOI 10.4314/ahs.v13i4.7; Furukawa A, 2005, ABDOM IMAGING, V30, P524, DOI 10.1007/s00261-004-0289-x; Ghekiere O, 2007, J COMPUT ASSIST TOMO, V31, P169, DOI 10.1097/01.rct.0000237809.11123.8e; Gokakin AK, 2012, ULUS TRAVMA ACIL CER, V18, P339, DOI 10.5505/tjtes.2012.61257; Gonenc M, 2014, AM J SURG, V207, P807, DOI 10.1016/j.amjsurg.2013.07.025; Gu WJ, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0570-5; Guerra JB, 2006, GUT, V55, P132, DOI 10.1136/gut.2005.077362; Guglielminotti Piero, 2009, World J Emerg Surg, V4, P28, DOI 10.1186/1749-7922-4-28; Gupta V, 2013, WORLD J SURG, V37, P2542, DOI 10.1007/s00268-013-2196-1; Guzel H, 2014, TURK J GASTROENTEROL, V25, P152, DOI 10.5152/tjg.2014.5526; Hermansson M, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-25; Hirschowitz BI, 2005, CLIN GASTROENTEROL H, V3, P39, DOI 10.1016/S1542-3565(04)00606-8; HOROWITZ J, 1989, ANN SURG, V209, P693, DOI 10.1097/00000658-198906000-00006; Imhof M, 2008, WORLD J SURG, V32, P408, DOI 10.1007/s00268-007-9370-2; Ishikawa S, 2012, HEPATO-GASTROENTEROL, V59, P147, DOI 10.5754/hge09689; Joneja Jaspreet S, 2004, J Assoc Physicians India, V52, P207; Jones H G, 2012, Ann R Coll Surg Engl, V94, pe144, DOI 10.1308/003588412X13171221588659; Kamani F, 2010, TURK J GASTROENTEROL, V21, P125, DOI 10.4318/tjg.2010.0069; Kang JY, 2006, ALIMENT PHARM THERAP, V24, P65, DOI 10.1111/j.1365-2036.2006.02960.x; Kumar A, 2012, J TRAUMA ACUTE CARE, V73, P542, DOI 10.1097/TA.0b013e31825c157f; Kumar P, 2014, WORLD J GASTRO SURG, V6, P5, DOI 10.4240/wjgs.v6.i1.5; Lanas A, 1997, GASTROENTEROLOGY, V112, P683, DOI 10.1053/gast.1997.v112.pm9041228; Lanas A, 2011, ALIMENT PHARM THER, V33, P585, DOI 10.1111/j.1365-2036.2010.04563.x; Lassen A, 2006, AM J GASTROENTEROL, V101, P945, DOI 10.1111/j.1572-0241.2006.00518.x; Lau JY, 2011, DIGESTION, V84, P102, DOI 10.1159/000323958; Lau JYW, 2013, LANCET, V381, P2033, DOI 10.1016/S0140-6736(13)60596-6; Levy MM, 2014, INTENS CARE MED, V40, P1623, DOI 10.1007/s00134-014-3496-0; Liu L, 2015, BRIT J SURG, V102, pE158, DOI 10.1002/bjs.9724; Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7; Monkemuller K, 2014, DIGEST ENDOSC, V26, P350, DOI 10.1111/den.12145; Mogasale V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093784; Moller MH, 2013, BRIT J SURG, V100, P543, DOI 10.1002/bjs.9028; Moller MH, 2011, BRIT J SURG, V98, P802, DOI 10.1002/bjs.7429; Moller MH, 2013, SCAND J GASTROENTERO, V48, P168, DOI 10.3109/00365521.2012.746393; Moller MH, 2010, SCAND J GASTROENTERO, V45, P785, DOI 10.3109/00365521003783320; Moran EA, 2010, J AM COLL SURGEONS, V210, P474, DOI 10.1016/j.jamcollsurg.2009.11.014; Mori H, 2013, ENDOSCOPY, V45, P649, DOI 10.1055/s-0033-1344156; Ohene-Yeboah Michael, 2006, West Afr J Med, V25, P205; Pai D, 1999, AUST NZ J SURG, V69, P210, DOI 10.1046/j.1440-1622.1999.01524.x; Parodi A, 2010, GASTROINTEST ENDOSC, V72, P881, DOI 10.1016/j.gie.2010.04.006; Prakash Advait, 2008, Indian J Gastroenterol, V27, P107; Salama NR, 2013, NAT REV MICROBIOL, V11, P385, DOI 10.1038/nrmicro3016; Sanabria A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004778.pub3; Sanogo Z Z, 2012, Mali Med, V27, P19; Shan YS, 2003, BRIT J SURG, V90, P1215, DOI 10.1002/bjs.4267; Sonnenberg A, 2007, GASTROENTEROLOGY, V132, P2320, DOI 10.1053/j.gastro.2007.03.108; Soreide K, 2015, EUR J TRAUMA EMERG S, V41, P91, DOI 10.1007/s00068-014-0417-4; Soreide K, 2014, BRIT J SURG, V101, pE51, DOI 10.1002/bjs.9368; Soreide K, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0099-x; Surapaneni S, 2013, J CLIN DIAGN RES, V7, P880, DOI 10.7860/JCDR/2013/4925.2965; Svanes C, 1997, GUT, V41, P177, DOI 10.1136/gut.41.2.177; Svanes C, 1999, SCAND J GASTROENTERO, V34, P18; Tanaka R, 2013, J GASTROINTEST SURG, V17, P2074, DOI 10.1007/s11605-013-2362-7; TAYLOR H, 1946, LANCET, V251, P441; Thorsen K, 2014, J GASTROINTEST SURG, V18, P1261, DOI 10.1007/s11605-014-2485-5; Thorsen K, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-25; Thorsen K, 2013, WORLD J GASTROENTERO, V19, P347, DOI 10.3748/wjg.v19.i3.347; Thorsen K, 2011, J GASTROINTEST SURG, V15, P1329, DOI 10.1007/s11605-011-1482-1; Tokunaga Y, 1998, J AM COLL SURGEONS, V186, P659, DOI 10.1016/S1072-7515(98)00128-8; Wang YR, 2010, ANN SURG, V251, P51, DOI 10.1097/SLA.0b013e3181b975b8; Weber DG, 2014, BRIT J SURG, V101, pE109, DOI 10.1002/bjs.9360; Wendling MR, 2013, SURG ENDOSC, V27, P384, DOI 10.1007/s00464-012-2492-0; Wilhelmsen M, 2015, BRIT J SURG, V102, P382, DOI 10.1002/bjs.9753; Wong BPY, 2006, J PEDIATR SURG, V41, P2073, DOI 10.1016/j.jpedsurg.2006.08.009; Wong CS, 2013, J SURG RES, V182, P219, DOI 10.1016/j.jss.2012.10.046; Wright GP, 2014, SURGERY, V156, P1003, DOI 10.1016/j.surg.2014.06.047; Wysocki A, 2011, WORLD J SURG, V35, P811, DOI 10.1007/s00268-010-0917-2; Yuan Y, 2013, COCHRANE DB SYST REV, V12; [No title captured]; [No title captured]; [No title captured]	99	132	141	1	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 26	2015	386	10000					1288	1298		10.1016/S0140-6736(15)00276-7	http://dx.doi.org/10.1016/S0140-6736(15)00276-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9TQ	26460663	Green Accepted			2022-12-28	WOS:000361700100038
J	Taylor, S; Williams, B; Magnus, D; Goenka, A; Modi, N				Taylor, Sebastian; Williams, Bhanu; Magnus, Dan; Goenka, Anu; Modi, Neena			From MDG to SDG: good news for global child health?	LANCET			English	Editorial Material							INEQUALITIES; MORTALITY		[Taylor, Sebastian; Williams, Bhanu; Modi, Neena] Royal Coll Paediat & Child Hlth, London, England; [Williams, Bhanu] Natl Hlth Serv Trust, London North West Hosp, Dept Paediat, London HA1 3UJ, England; [Magnus, Dan] Hosp Sick Children, Div Paediat Emergency Med, Toronto, ON M5G 1X8, Canada; [Goenka, Anu] Univ Manchester, Manchester, Lancs, England; [Modi, Neena] Univ London Imperial Coll Sci Technol & Med, London, England	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Manchester; Imperial College London	Taylor, S (corresponding author), Royal Coll Paediat & Child Hlth, London, England.	bhanu.williams@nhs.net	Goenka, Anu/M-6700-2019	Goenka, Anu/0000-0002-8152-2155	Medical Research Council [MR/N001427/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abe SK, 2015, LANCET GLOB HEALTH, V3, pE350, DOI 10.1016/S2214-109X(15)00043-1; Adamson P., 2013, CHILD WELL BEING RIC, P44; Amouzou A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-216; Bendavid E, 2014, PEDIATRICS, V134, pE1551, DOI 10.1542/peds.2014-2320; Davies K, 2014, MIRROR MIRROR WALL P; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Murray C, 2015, LANCET, V386, P3, DOI 10.1016/S0140-6736(15)61171-0; Royal College of Paediatrics and Child Health, 2012, TURN TID HARN POW CH; UN, 2015, MILLENNIUM DEV GOALS; United Nations, SUST DEV GOALS; Viner RM, 2014, LANCET, V384, P880, DOI 10.1016/S0140-6736(14)60485-2; Wolfe I, 2015, ARCH DIS CHILD, V100, P907, DOI 10.1136/archdischild-2014-306752; Yuan BB, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-634	13	8	8	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 26	2015	386	10000					1213	1214		10.1016/S0140-6736(15)00300-1	http://dx.doi.org/10.1016/S0140-6736(15)00300-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR9TQ	26460639				2022-12-28	WOS:000361700100004
J	Meyers, T				Meyers, Todd			The art of medicine How is comorbidity lived?	LANCET			English	Editorial Material									Wayne State Univ, Dept Anthropol, Detroit, MI 48202 USA	Wayne State University	Meyers, T (corresponding author), Wayne State Univ, Dept Anthropol, Detroit, MI 48202 USA.	toddemeyers@gmail.com						Biehl J, 2013, VITA LIFE ZONE SOCIA; Canguilhem G, 2012, FORM LIVING, P1; FEINSTEIN AR, 1970, J CHRON DIS, V23, P455, DOI 10.1016/0021-9681(70)90054-8; Meyers T, 2013, IN VIVO-CULT MEDIAT, P1; Starfield B, 2006, ANN FAM MED, V4, P101, DOI 10.1370/afm.524	5	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2015	386	9999					1128	1129		10.1016/S0140-6736(15)00210-X	http://dx.doi.org/10.1016/S0140-6736(15)00210-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR5GE	26461893				2022-12-28	WOS:000361368000015
